age,death,sex,hospdead,slos,d.time,dzgroup,dzclass,num.co,edu,income,charges,totcst,avtisst,race,aps,hday,diabetes,dementia,ca,prg2m,prg6m,dnr,dnrday,meanbp,wblc,hrt,resp,temp,pafi,alb,bili,crea,sod,ph,glucose,bun,urine,adlsc,sfdm2_imputed
62.84998,0,male,0,5,2029,Lung Cancer,Cancer,0,11.0,$11-$25k,9715.0,14452.7344,7.0,other,20.0,1,0,0,metastatic,0.5,0.25,no dnr,5.0,97.0,6.0,69.0,22.0,36.0,388.0,1.7998047,0.19998169,1.19995117,141.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
60.33899,1,female,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,34496.0,14452.7344,29.0,white,74.0,3,0,0,no,0.0,0.0,no dnr,14.58258953168044,43.0,17.0976562,112.0,34.0,34.59375,98.0,3.5,1.01,5.5,132.0,7.25,135.0,23.0,2502.0,1.0,<2 mo. follow-up
52.74698,1,female,0,17,47,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,41094.0,14452.7344,13.0,white,45.0,4,0,0,no,0.75,0.5,no dnr,17.0,70.0,8.5,88.0,28.0,37.39844,231.65625,3.5,2.19970703,2.0,134.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.38498,1,female,0,3,133,Lung Cancer,Cancer,2,11.0,under $11k,3075.0,14452.7344,7.0,white,19.0,1,0,0,metastatic,0.899999619,0.5,no dnr,3.0,75.0,9.09960938,88.0,32.0,35.0,333.3,3.5,1.01,0.79992676,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.88495,0,female,0,16,2029,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,50127.0,14452.7344,18.666656,white,30.0,3,0,0,no,0.899999619,0.9,no dnr,16.0,59.0,13.5,112.0,20.0,37.89844,173.3125,3.5,1.01,0.79992676,143.0,7.509766,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
93.01599,1,male,1,4,4,Coma,Coma,1,14.0,under $11k,6884.0,14452.7344,5.0,white,27.0,1,0,0,no,0.0,0.0,no dnr,4.0,110.0,10.3984375,101.0,44.0,38.39844,266.625,3.5,1.01,0.69995117,140.0,7.65918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
62.37097,1,male,0,9,659,CHF,COPD/CHF/Cirrhosis,1,14.0,$25-$50k,30460.0,14452.7344,8.0,white,46.0,1,0,0,no,0.699999809,0.7,no dnr,9.0,78.0,11.6992188,120.0,28.0,37.39844,309.5,4.7998047,0.39996338,1.59985352,132.0,7.479492,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
86.83899,1,male,0,7,142,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,30460.0,14452.7344,6.5,white,53.0,1,1,0,no,0.799999714,0.4,no dnr,7.0,72.0,13.5996094,100.0,26.0,37.59375,404.75,3.5,1.01,2.0,139.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
85.65594,1,male,0,12,63,Lung Cancer,Cancer,2,12.0,under $11k,59995.78781114967,14452.7344,8.5,black,17.0,1,0,1,metastatic,0.049999982,0.000125,dnr after sadm,2.0,97.0,9.69921875,56.0,20.0,36.59375,357.125,3.5,0.39996338,1.0,143.0,7.449219,135.0,23.0,2502.0,7.0,<2 mo. follow-up
42.25897,1,female,0,8,370,Colon Cancer,Cancer,0,11.0,$25-$50k,9914.0,14452.7344,8.0,hispanic,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,84.0,11.2988281,94.0,20.0,38.19531,333.3,4.6992188,0.19998169,0.79992676,139.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
47.94498,1,male,0,7,114,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,15558.0,14452.7344,12.5,white,14.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,70.0,10.8984375,105.0,24.0,36.5,333.3,4.1992188,0.5,1.0,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
59.20099,1,male,1,13,13,Lung Cancer,Cancer,0,14.0,under $11k,29388.0,14452.7344,8.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,12.0,77.0,10.7988281,90.0,22.0,36.39844,333.3,3.5,1.01,1.09985352,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
29.002,1,female,0,4,160,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,$11-$25k,4353.0,14452.7344,8.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,56.0,5.5,56.0,20.0,37.19531,333.3,2.8999023,6.09960938,0.69995117,130.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.14197,1,male,0,8,1866,CHF,COPD/CHF/Cirrhosis,0,12.0,$11-$25k,19783.0,14452.7344,16.0,white,34.0,1,0,0,no,0.899999619,0.7,no dnr,8.0,68.0,9.3984375,80.0,22.0,36.0,333.3,3.5,0.59997559,2.59960938,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
43.53998,0,female,0,115,2022,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,706577.0,390460.5,38.25,white,39.0,148,0,0,no,0.899999619,0.9,no dnr,115.0,67.0,24.5976562,172.0,20.0,38.79688,113.32812,3.5,1.01,0.59997559,134.0,7.399414,135.0,23.0,2502.0,2.7641602,SIP>=30
58.823,1,female,0,7,503,Lung Cancer,Cancer,1,12.0,>$50k,10758.0,14452.7344,10.0,white,11.0,1,0,0,metastatic,0.899999619,0.7,no dnr,7.0,97.0,15.8984375,92.0,20.0,37.19531,333.3,4.2998047,0.19998169,0.79992676,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
45.418,1,male,0,7,827,Lung Cancer,Cancer,2,12.0,under $11k,8400.0,14452.7344,7.0,white,4.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,97.0,10.7988281,100.0,24.0,37.29688,585.125,3.5,0.29998779,1.09985352,137.0,7.489258,135.0,23.0,2502.0,3.3515625,<2 mo. follow-up
63.66299,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,22.0,$25-$50k,283303.0,156674.125,40.0,white,58.0,13,0,0,no,0.099999964,0.001,dnr after sadm,12.0,69.0,30.0976562,108.0,22.0,36.69531,155.53125,2.8999023,14.0,2.89990234,130.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
31.84399,1,male,1,15,15,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,under $11k,27985.0,17528.4375,10.0,white,42.0,1,0,0,no,0.699999809,0.5,dnr after sadm,12.0,83.0,5.0,100.0,24.0,37.39844,333.3,1.6999512,12.7988281,0.29998779,122.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
55.13797,1,male,0,10,179,CHF,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,18191.0,14452.7344,14.5,hispanic,25.0,1,0,0,no,0.5,0.5,no dnr,10.0,78.0,9.0,72.0,20.0,36.0,333.3,3.5,1.01,1.5,134.0,7.419922,135.0,23.0,2502.0,2.5110989,no(M2 and SIP pres)
68.25494,1,male,0,7,227,Lung Cancer,Cancer,0,13.0,>$50k,10755.0,14452.7344,8.0,white,16.0,1,0,0,metastatic,0.899999619,0.7,no dnr,7.0,91.0,5.0,92.0,20.0,36.5,333.3,4.2998047,0.29998779,1.19995117,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.70398,1,male,0,23,30,Lung Cancer,Cancer,0,16.0,under $11k,55384.0,33002.5,9.666664,other,35.0,1,0,0,metastatic,0.5,0.125,dnr after sadm,11.0,66.0,12.5,125.0,30.0,37.0,170.0,3.5,1.01,1.0,133.0,7.519531,135.0,23.0,2502.0,3.2636719,<2 mo. follow-up
49.61298,0,female,0,50,2019,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,542266.0,288592.25,33.75,white,42.0,29,0,0,no,0.599999905,0.5,no dnr,50.0,67.0,11.0,120.0,48.0,38.89844,200.0,2.0,4.09960938,0.59997559,130.0,7.399414,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
50.724,1,female,0,3,817,Lung Cancer,Cancer,0,12.0,$25-$50k,4913.0,14452.7344,10.0,asian,11.0,1,0,0,metastatic,1.0,1.0,no dnr,3.0,71.0,9.79882812,88.0,24.0,37.39844,333.3,3.5,1.01,0.89990234,141.0,7.419922,135.0,23.0,2502.0,2.065918,no(M2 and SIP pres)
29.36099,1,female,0,4,399,Colon Cancer,Cancer,0,17.0,$25-$50k,7792.0,14452.7344,13.0,white,10.0,1,0,0,metastatic,0.5,0.1,no dnr,4.0,96.0,10.5996094,112.0,20.0,37.0,333.3,3.699707,1.39990234,0.59997559,137.0,7.419922,135.0,23.0,2502.0,1.8149414,no(M2 and SIP pres)
53.84,1,male,0,7,1064,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,9871.0,6112.4609,8.0,white,16.0,1,0,0,no,0.899999619,0.6,dnr after sadm,4.0,134.0,7.79980469,106.0,22.0,37.89844,304.125,3.7998047,0.5,0.79992676,141.0,7.379883,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
82.41498,1,female,1,5,5,Lung Cancer,Cancer,0,12.0,under $11k,7212.0,14452.7344,9.0,white,33.0,1,0,0,metastatic,0.699999809,0.5,dnr before sadm,-1.0,75.0,6.79980469,114.0,20.0,37.19531,333.3,3.0996094,1.01,1.79980469,131.0,7.419922,135.0,23.0,2502.0,3.7041016,<2 mo. follow-up
27.32399,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,19.0,under $11k,160060.0,82131.25,39.0,asian,85.0,28,0,0,yes,0.049999982,0.000125,dnr after sadm,5.0,77.0,0.09999084,144.0,36.0,38.89844,45.0,2.3999023,5.0,1.39990234,147.0,7.30957,135.0,23.0,2502.0,2.0,<2 mo. follow-up
30.10799,0,male,0,10,2013,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,57611.0,29342.3906,30.5,asian,21.0,4,0,0,no,0.699999809,0.5,no dnr,10.0,92.0,8.79882812,112.0,27.0,37.59375,225.0,3.5,1.01,0.39996338,134.0,7.459961,135.0,23.0,2502.0,2.8461914,<2 mo. follow-up
50.37097,0,male,0,105,2013,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,465380.0,304749.25,22.25,white,18.0,2,0,0,no,0.699999809,0.5,no dnr,105.0,98.0,8.3984375,82.0,20.0,37.39844,197.5,3.0,6.79980469,0.69995117,138.0,7.319336,135.0,23.0,2502.0,1.0,SIP>=30
74.48297,0,male,0,15,2012,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,18134.0,12751.7344,7.666664,white,27.0,1,0,0,no,0.949999809,0.6,no dnr,15.0,111.0,6.89941406,60.0,32.0,36.79688,333.3,3.7998047,0.59997559,1.59985352,142.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
55.73199,0,male,0,13,2012,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,52092.0,28262.7031,17.0,hispanic,25.0,1,0,0,no,0.899999619,0.9,no dnr,13.0,121.0,19.6992188,118.0,18.0,37.39844,404.75,2.199707,0.89990234,0.79992676,117.0,7.379883,135.0,23.0,2502.0,6.0,SIP>=30
77.21295,1,female,0,7,51,COPD,COPD/CHF/Cirrhosis,2,0.0,under $11k,9078.0,6898.4922,12.0,hispanic,39.0,1,0,0,no,0.75,0.75,dnr after sadm,2.0,113.0,8.29882812,93.0,25.0,36.19531,250.0,3.5,1.01,2.09960938,145.0,7.269531,135.0,23.0,2502.0,7.0,<2 mo. follow-up
61.02399,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,109627.0,57442.7812,30.333328,white,49.0,1,0,0,no,0.599999905,0.6,dnr after sadm,17.0,80.0,15.3984375,128.0,30.0,38.5,217.5,2.2998047,0.39996338,2.39990234,143.0,7.329102,135.0,23.0,2502.0,2.8251953,<2 mo. follow-up
56.48999,1,female,0,5,113,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,38548.0,20959.2031,16.0,hispanic,53.0,4,0,0,no,0.699999809,0.5,no dnr,5.0,38.0,9.0,92.0,20.0,36.0,333.3,3.5,1.01,6.0,133.0,7.419922,135.0,23.0,2502.0,3.0981445,<2 mo. follow-up
57.53299,0,female,0,28,2010,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,under $11k,156556.0,103090.438,14.5,hispanic,37.0,1,0,0,no,0.699999809,0.5,no dnr,28.0,77.0,12.1992188,92.0,18.0,37.59375,552.375,2.5,23.5976562,0.89990234,132.0,7.439453,135.0,23.0,2502.0,3.1318359,no(M2 and SIP pres)
68.98596,1,female,0,4,603,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,5763.0,2965.9512,3.0,white,21.0,1,0,0,no,0.989999771,0.95,no dnr,4.0,76.0,9.0,78.0,26.0,36.59375,280.9375,4.0,1.01,0.79992676,142.0,7.359375,135.0,23.0,2502.0,0.0,SIP>=30
41.97897,1,male,0,6,518,CHF,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,5552.0,3679.8398,12.0,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,120.0,8.3984375,86.0,22.0,37.5,295.1875,3.5,1.01,1.79980469,129.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
19.79199,0,male,0,33,2008,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,167971.0,14452.7344,21.25,black,5.0,4,0,0,no,0.899999619,0.75,no dnr,33.0,83.0,9.59960938,52.0,6.0,39.0,310.0,3.5,1.01,1.01,131.0,7.439453,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
57.50897,1,female,0,4,841,CHF,COPD/CHF/Cirrhosis,0,14.0,under $11k,6403.0,3672.0723,11.0,black,27.0,1,0,0,no,1.0,1.0,no dnr,4.0,83.0,14.2988281,106.0,24.0,36.79688,280.9375,3.5,1.01,2.29980469,138.0,7.449219,135.0,23.0,2502.0,6.0,SIP>=30
73.40698,0,male,0,9,2007,Colon Cancer,Cancer,1,12.0,under $11k,22934.0,14292.2656,12.5,white,23.0,1,0,0,metastatic,0.899999619,0.4,no dnr,9.0,71.0,16.5,76.0,10.0,37.0,333.3,4.0,0.59997559,0.79992676,141.0,7.419922,135.0,23.0,2502.0,2.4677734,<2 mo. follow-up
68.31799,1,male,0,6,172,Colon Cancer,Cancer,1,21.0,>$50k,9205.0,5793.1914,11.0,white,8.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,89.0,10.5996094,92.0,18.0,39.0,333.3,3.5,0.5,1.0,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.79498,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,271250.0,136387.875,42.333313,white,76.0,8,0,0,no,0.699999809,0.5,dnr after sadm,21.0,59.0,30.5976562,90.0,22.0,37.5,70.90625,1.8999023,5.39941406,2.69970703,128.0,7.329102,135.0,23.0,2502.0,2.6855469,<2 mo. follow-up
45.71899,0,male,0,20,2006,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,115112.0,61771.0625,25.666656,white,30.0,1,0,0,no,0.899999619,0.5,no dnr,20.0,57.0,12.2988281,96.0,22.0,36.0,185.0,3.8999023,1.01,1.39990234,135.0,7.599609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.48798,1,male,0,36,79,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,120920.0,64202.375,23.25,hispanic,39.0,1,0,0,no,0.5,0.5,dnr after sadm,16.0,62.0,21.796875,102.0,24.0,36.59375,415.0,3.5,1.01,4.0,124.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
74.995,1,female,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,348931.0,173763.5,43.0,white,53.0,10,0,0,no,0.699999809,0.5,dnr after sadm,23.0,50.0,51.1953125,120.0,18.0,36.19531,237.5,2.8999023,1.0,4.79980469,135.0,7.439453,135.0,23.0,2502.0,2.4423828,<2 mo. follow-up
56.19397,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,under $11k,230733.0,119196.0,41.333313,other,70.0,15,0,0,no,0.699999809,0.5,dnr after sadm,20.0,68.0,26.6992188,130.0,28.0,38.5,121.65625,1.6999512,3.89990234,2.09960938,131.0,7.449219,135.0,23.0,2502.0,3.0,<2 mo. follow-up
44.849,1,female,0,12,229,MOSF w/Malig,ARF/MOSF,2,10.0,$11-$25k,25176.0,12210.7812,19.5,hispanic,32.0,1,0,0,yes,0.599999905,0.4,no dnr,12.0,91.0,4.69921875,70.0,32.0,37.09375,447.5625,2.2998047,7.0,0.79992676,136.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
51.09698,1,female,0,19,489,CHF,COPD/CHF/Cirrhosis,1,11.0,under $11k,30877.0,17287.9531,12.0,black,43.0,1,0,0,no,0.949999809,0.95,no dnr,19.0,100.0,5.69921875,120.0,32.0,37.59375,203.6875,4.1992188,0.19998169,4.0,140.0,7.459961,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
36.30899,1,male,0,11,653,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,23476.0,14620.8047,15.5,white,31.0,1,0,0,no,0.599999905,0.5,no dnr,11.0,64.0,6.79980469,115.0,20.0,36.29688,333.3,4.3994141,4.5,1.29980469,121.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.25696,0,male,0,9,2001,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,14926.0,8138.4414,7.5,white,32.0,1,0,0,no,0.899999619,0.75,no dnr,9.0,74.0,9.29882812,96.0,30.0,36.39844,266.625,3.5,1.09985352,1.19995117,141.0,7.399414,135.0,23.0,2502.0,2.0,<2 mo. follow-up
51.30499,1,male,0,25,162,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,52187.0,30876.375,11.75,black,33.0,2,0,0,no,0.799999714,0.75,no dnr,25.0,71.0,9.0,104.0,18.0,36.5,333.3,3.5,1.01,2.39990234,128.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.54297,0,female,0,7,2000,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,9631.0,5835.1602,8.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,83.0,14.1992188,92.0,22.0,36.39844,164.0,3.2998047,0.29998779,0.79992676,137.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.30798,1,male,0,12,536,Lung Cancer,Cancer,1,17.0,$25-$50k,29939.0,17625.75,14.5,white,8.0,1,0,0,metastatic,1.0,1.0,no dnr,12.0,95.0,11.5996094,108.0,22.0,38.0,183.0,3.5,1.01,0.79992676,136.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.57697,1,female,0,3,244,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3124.0,2022.1035,6.0,other,27.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,90.0,12.3984375,84.0,32.0,36.59375,276.1875,3.5,1.01,0.79992676,139.0,7.469727,135.0,23.0,2502.0,2.3085938,<2 mo. follow-up
84.95795,0,male,0,17,1998,CHF,COPD/CHF/Cirrhosis,4,14.0,>$50k,30942.0,18401.7188,8.666664,white,21.0,1,0,0,no,0.949999809,0.85,no dnr,17.0,92.0,13.6992188,80.0,32.0,37.19531,313.3125,3.7998047,0.29998779,1.29980469,137.0,7.429688,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
41.52197,1,male,1,21,21,MOSF w/Malig,ARF/MOSF,2,18.0,>$50k,320843.0,165178.875,32.666657,white,78.0,26,0,0,yes,0.099999964,0.001,no dnr,21.0,66.0,0.19998169,130.0,18.0,37.5,315.0,1.8999023,3.79980469,7.29980469,134.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
39.685,0,female,0,35,1995,ARF/MOSF w/Sepsis,ARF/MOSF,0,22.0,$25-$50k,220639.0,109700.75,33.0,white,56.0,7,1,0,no,0.599999905,0.6,no dnr,35.0,62.0,36.6953125,125.0,24.0,39.19531,208.5625,1.5998535,0.39996338,7.69921875,139.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.55896,1,female,1,4,4,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,4894.0,3078.6016,6.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,123.0,13.2988281,98.0,32.0,37.19531,144.875,3.5,1.01,0.5,136.0,7.339844,135.0,23.0,2502.0,3.9550781,<2 mo. follow-up
60.10098,1,male,0,15,195,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,63466.0,32079.9531,27.666656,white,40.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,110.0,6.29980469,125.0,10.0,38.09375,208.0,2.7998047,3.39990234,1.0,142.0,7.439453,135.0,23.0,2502.0,2.3813477,<2 mo. follow-up
70.81195,0,male,0,8,1992,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,6254.0,4126.0742,5.0,black,20.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,88.0,6.89941406,80.0,22.0,37.0,333.3,3.5,1.01,1.79980469,142.0,7.419922,135.0,23.0,2502.0,2.5957031,<2 mo. follow-up
30.76199,0,male,0,6,1990,CHF,COPD/CHF/Cirrhosis,1,10.0,under $11k,8437.0,5632.8516,10.0,hispanic,37.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,70.0,6.59960938,122.0,16.0,36.5,528.5,3.5,1.01,2.09960938,133.0,7.459961,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
64.23798,1,male,0,61,974,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,321716.0,162087.25,34.5,white,32.0,5,0,0,no,0.899999619,0.9,no dnr,61.0,68.0,9.5,122.0,12.0,38.69531,114.0,3.5,1.01,1.29980469,136.0,7.319336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
51.70999,0,male,0,12,1987,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,31222.0,18348.2188,16.0,asian,21.0,1,0,0,no,0.799999714,0.2,no dnr,12.0,50.0,6.69921875,75.0,20.0,36.79688,333.3,3.699707,1.01,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.64294,1,male,0,17,254,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,180786.0,95272.6875,25.333328,white,49.0,17,1,0,no,0.699999809,0.5,no dnr,17.0,68.0,13.2988281,92.0,38.0,38.79688,113.67188,3.3999023,1.09985352,2.29980469,133.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.41498,1,male,0,6,101,Lung Cancer,Cancer,2,16.0,$25-$50k,8706.0,5389.1289,8.0,white,11.0,1,0,1,metastatic,0.699999809,0.5,dnr after sadm,2.0,109.0,5.29980469,68.0,20.0,36.89844,333.3,2.699707,1.01,0.69995117,133.0,7.419922,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
57.19098,1,male,0,9,42,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,28476.0,17331.0938,18.0,white,42.0,1,0,0,no,0.299999952,0.1,no dnr,9.0,59.0,16.0,85.0,26.0,36.79688,204.75,3.5,0.5,0.79992676,126.0,7.449219,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
37.73297,1,male,0,9,20,CHF,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,26278.0,14961.0938,19.0,white,23.0,1,0,0,no,0.199999928,0.05,no dnr,9.0,67.0,7.5,130.0,16.0,36.5,347.5625,3.0,0.59997559,0.89990234,132.0,7.469727,135.0,23.0,2502.0,7.0,<2 mo. follow-up
44.05499,1,female,0,7,293,Colon Cancer,Cancer,0,16.0,>$50k,18563.0,11069.4688,8.0,white,5.0,1,0,0,metastatic,1.0,0.7,no dnr,7.0,85.0,8.5,72.0,20.0,37.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.15594,0,male,0,35,1984,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,187014.0,95392.75,27.25,white,29.0,7,0,0,no,0.799999714,0.8,no dnr,35.0,75.0,17.296875,120.0,24.0,38.29688,257.5,2.5996094,4.89941406,0.69995117,135.0,7.5,135.0,23.0,2502.0,2.7045898,adl>=4 (>=5 if sur)
45.56598,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,3,18.0,$25-$50k,181701.0,92664.625,51.0,white,133.0,39,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,33.0,0.29998779,140.0,33.0,38.5,129.0,2.2998047,31.3984375,4.79980469,142.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
41.95999,1,male,0,4,503,Lung Cancer,Cancer,1,16.0,>$50k,4173.0,2648.0977,3.0,white,7.0,1,0,0,metastatic,0.949999809,0.8,no dnr,4.0,97.0,10.7988281,88.0,20.0,36.39844,380.9375,3.7998047,0.5,1.09985352,133.0,7.479492,135.0,23.0,2502.0,2.1796875,no(M2 and SIP pres)
59.31,0,male,0,72,1981,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,>$50k,538692.0,301788.5,32.5,white,71.0,13,0,0,no,0.5,0.4,no dnr,72.0,60.0,19.3984375,160.0,38.0,37.29688,113.32812,3.0996094,13.0996094,1.29980469,142.0,7.509766,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
45.61499,1,female,1,44,44,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,>$50k,302353.0,155929.75,30.5,white,55.0,1,0,0,no,0.299999952,0.25,dnr after sadm,41.0,57.0,13.5996094,112.0,28.0,38.59375,134.4375,1.6999512,1.5,0.89990234,139.0,7.179688,135.0,23.0,2502.0,3.5454102,<2 mo. follow-up
65.98499,1,female,0,10,540,Colon Cancer,Cancer,1,12.0,under $11k,18980.0,9559.2266,13.5,hispanic,19.0,1,1,0,metastatic,0.699999809,0.5,no dnr,10.0,127.0,17.796875,96.0,26.0,38.89844,372.0,4.0996094,0.29998779,0.79992676,140.0,7.399414,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
95.79199,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,74764.0,36613.2812,29.0,white,18.0,1,0,1,no,0.699999809,0.5,dnr after sadm,16.0,88.0,11.5996094,65.0,8.0,37.19531,360.0,2.5996094,1.01,1.69995117,147.0,7.419922,135.0,23.0,2502.0,5.9414062,<2 mo. follow-up
76.59094,1,male,0,8,142,Colon Cancer,Cancer,1,17.0,$11-$25k,7137.0,4350.3672,4.5,white,6.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,83.0,12.7988281,76.0,18.0,38.29688,390.4375,4.0996094,0.79992676,0.79992676,146.0,7.439453,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.10095,0,male,0,4,1979,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,9586.0,5151.0469,7.0,white,33.0,1,0,0,no,0.899999619,0.7,no dnr,4.0,72.0,5.89941406,80.0,18.0,36.79688,333.3,3.5,1.01,2.19970703,137.0,7.419922,135.0,23.0,2502.0,1.9719238,no(M2 and SIP pres)
78.85297,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,39420.0,20195.5781,27.0,white,30.0,3,0,1,no,0.699999809,0.5,dnr after sadm,4.0,60.0,36.1953125,112.0,11.0,36.59375,214.28125,3.5,1.09985352,1.09985352,137.0,7.419922,135.0,23.0,2502.0,4.9472656,<2 mo. follow-up
37.87,0,male,0,120,1977,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,397017.0,207528.5,31.0,white,48.0,14,0,0,no,0.099999964,0.001,no dnr,120.0,83.0,23.5,122.0,26.0,37.59375,257.5,3.5,3.09960938,5.19921875,134.0,7.379883,135.0,23.0,2502.0,2.5400391,<2 mo. follow-up
74.90997,1,female,0,6,18,COPD,COPD/CHF/Cirrhosis,1,16.0,under $11k,8166.0,4166.6992,8.0,white,9.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,106.0,11.3984375,84.0,22.0,37.0,424.0,3.5,1.01,0.79992676,142.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
31.702,0,female,0,49,1973,Cirrhosis,COPD/CHF/Cirrhosis,0,14.0,under $11k,231119.0,101867.938,15.5,black,24.0,1,0,0,no,0.199999928,0.1,no dnr,49.0,77.0,7.69921875,80.0,20.0,37.19531,490.4375,2.199707,2.69970703,1.39990234,127.0,7.489258,135.0,23.0,2502.0,1.0,SIP>=30
54.93997,1,female,0,10,55,CHF,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,27561.0,15429.6172,21.0,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,55.0,6.19921875,104.0,24.0,36.79688,504.0,3.5996094,1.09985352,0.79992676,136.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.30197,1,male,1,39,39,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,283145.0,108597.562,13.75,hispanic,33.0,1,0,0,no,0.699999809,0.5,no dnr,39.0,83.0,10.0,80.0,20.0,37.0,333.3,2.0996094,13.0,1.0,130.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
54.92999,1,female,0,8,50,Lung Cancer,Cancer,0,12.0,$25-$50k,15392.0,7098.3008,10.0,asian,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,143.0,10.6992188,84.0,40.0,36.19531,333.3,3.2998047,1.01,0.79992676,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.21497,1,male,0,7,173,Colon Cancer,Cancer,1,12.0,$11-$25k,8442.0,5144.7188,11.5,white,27.0,1,1,0,metastatic,0.899999619,0.5,no dnr,7.0,117.0,10.1992188,22.0,18.0,38.0,333.3,3.0996094,0.69995117,1.29980469,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.09399,0,female,0,27,1969,Cirrhosis,COPD/CHF/Cirrhosis,2,3.0,under $11k,71992.0,37093.125,17.5,black,28.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,104.0,21.796875,82.0,20.0,37.0,333.3,2.0,6.59960938,0.59997559,135.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.05096,1,male,0,10,125,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,14944.0,9489.5391,9.0,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,77.0,12.0996094,72.0,22.0,36.39844,333.3,2.5,21.6992188,1.19995117,130.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
69.34698,1,male,1,42,42,MOSF w/Malig,ARF/MOSF,2,18.0,under $11k,433684.0,214329.25,38.25,asian,27.0,11,1,0,metastatic,0.699999809,0.5,no dnr,42.0,112.0,10.3984375,125.0,14.0,36.5,274.25,3.7998047,5.69921875,1.09985352,140.0,7.449219,135.0,23.0,2502.0,4.0,<2 mo. follow-up
64.98798,1,female,0,4,33,Lung Cancer,Cancer,0,12.0,under $11k,8137.0,4735.9922,9.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,110.0,18.796875,80.0,20.0,36.39844,333.3,3.5,1.01,0.69995117,134.0,7.419922,135.0,23.0,2502.0,2.1987305,<2 mo. follow-up
80.62097,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,104163.0,53111.3125,38.0,white,77.0,14,0,0,no,0.699999809,0.5,dnr after sadm,2.0,61.0,23.0,140.0,32.0,39.19531,75.54688,2.2998047,1.5,1.89990234,135.0,7.129883,135.0,23.0,2502.0,3.3618164,<2 mo. follow-up
72.172,1,male,1,12,12,Lung Cancer,Cancer,1,12.0,under $11k,62158.0,31507.8125,25.0,white,47.0,1,0,0,metastatic,0.5,0.25,no dnr,12.0,63.0,5.09960938,140.0,36.0,36.5,176.65625,2.699707,1.01,1.09985352,135.0,7.55957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.06198,1,male,0,3,28,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,6734.0,3384.6172,4.0,white,28.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,77.0,10.8984375,72.0,24.0,36.39844,280.9375,3.8999023,1.01,0.79992676,126.0,7.479492,135.0,23.0,2502.0,2.6191406,<2 mo. follow-up
52.50699,1,female,1,6,6,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,20735.0,11022.1016,9.0,white,24.0,1,1,0,no,0.599999905,0.2,dnr after sadm,6.0,67.0,8.5,88.0,20.0,36.59375,333.3,3.0996094,0.69995117,1.39990234,129.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
74.97095,1,male,0,19,259,Colon Cancer,Cancer,0,12.0,under $11k,43009.0,22430.0625,12.333328,white,26.0,1,0,0,metastatic,0.899999619,0.85,no dnr,19.0,91.0,6.79980469,88.0,20.0,36.79688,333.3,4.5996094,2.5,1.09985352,142.0,7.419922,135.0,23.0,2502.0,1.9162598,<2 mo. follow-up
53.34998,1,male,0,52,126,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,>$50k,483991.0,285715.25,39.0,asian,71.0,9,0,0,no,0.5,0.2,no dnr,52.0,73.0,19.5,158.0,36.0,39.29688,187.5,3.5996094,11.0996094,2.69970703,154.0,7.369141,135.0,23.0,2502.0,6.0,<2 mo. follow-up
89.58795,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,19238.0,9710.9062,34.0,white,80.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,33.0,13.6992188,0.0,0.0,38.5,122.0,2.2998047,0.5,1.0,130.0,7.289062,135.0,23.0,2502.0,5.5683594,<2 mo. follow-up
56.62399,1,male,0,11,559,Colon Cancer,Cancer,0,12.0,>$50k,27408.0,15270.6484,12.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,116.0,8.19921875,102.0,18.0,38.39844,333.3,4.2998047,0.29998779,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.04199,1,male,0,6,123,Colon Cancer,Cancer,0,16.0,under $11k,8723.0,5835.2305,16.0,hispanic,47.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,123.0,16.296875,112.0,28.0,36.0,352.375,2.8999023,1.69995117,7.59960938,134.0,7.479492,135.0,23.0,2502.0,2.2495117,SIP>=30
75.76196,0,male,0,21,1962,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,74162.0,40581.0,23.666656,white,28.0,8,0,0,no,0.799999714,0.8,no dnr,21.0,68.0,16.5976562,79.0,20.0,37.19531,132.71875,3.5,1.01,1.09985352,132.0,7.489258,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
32.99899,1,female,1,10,10,Cirrhosis,COPD/CHF/Cirrhosis,2,19.0,$25-$50k,88720.0,46155.375,39.5,other,75.0,1,0,0,no,0.0,0.0,dnr after sadm,10.0,62.0,11.5996094,130.0,8.0,36.59375,296.625,2.0,31.0,4.19921875,127.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.39697,1,female,0,4,26,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,11588.0,6508.8789,6.0,black,29.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,115.0,6.59960938,104.0,20.0,37.29688,460.0,3.5,1.01,2.29980469,138.0,7.549805,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.5,1,male,0,12,539,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,29870.0,16443.3594,17.5,white,29.0,1,0,0,no,0.25,0.75,no dnr,12.0,85.0,10.8984375,88.0,16.0,36.39844,333.3,3.5,1.01,2.29980469,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.78296,1,male,0,24,153,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,45798.0,26877.8594,16.666656,white,40.0,1,0,0,no,0.799999714,0.75,no dnr,24.0,65.0,13.5,105.0,26.0,39.0,132.5,2.8999023,0.5,1.69995117,139.0,7.519531,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
61.56897,0,female,0,11,1958,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,22040.0,13137.5078,9.0,white,26.0,1,0,0,no,1.0,0.9,no dnr,11.0,90.0,6.5,80.0,20.0,36.0,333.3,4.6992188,1.09985352,1.69995117,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
52.43298,1,female,0,8,53,Colon Cancer,Cancer,1,16.0,$11-$25k,12161.0,6753.2773,7.0,black,10.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,89.0,7.89941406,46.0,20.0,36.79688,333.3,3.5,0.39996338,0.89990234,140.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
66.93195,0,female,0,17,1955,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,88469.0,46006.1562,18.666656,black,55.0,4,0,0,yes,0.949999809,0.85,no dnr,17.0,141.0,22.296875,148.0,28.0,37.5,256.625,2.199707,0.79992676,1.09985352,142.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
84.76697,1,female,0,8,128,COPD,COPD/CHF/Cirrhosis,1,16.0,under $11k,19608.0,9826.8906,14.0,white,44.0,1,0,0,no,0.5,0.4,no dnr,8.0,70.0,11.5,75.0,50.0,36.5,200.0,3.5,1.01,0.79992676,138.0,7.429688,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
80.172,1,male,0,6,1730,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,6148.0,3811.3106,9.0,white,16.0,1,0,0,no,0.949999809,0.8,no dnr,6.0,83.0,15.8984375,85.0,20.0,36.0,462.5,3.5,0.29998779,1.29980469,136.0,7.349609,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
79.96997,1,male,0,11,275,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,17554.0,10868.0859,10.0,other,27.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,69.0,11.1992188,62.0,20.0,36.5,352.375,3.5,1.01,1.5,140.0,7.469727,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
66.45599,0,male,0,12,1952,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,25668.0,14813.8359,17.5,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,85.0,4.79980469,70.0,20.0,36.39844,333.3,3.699707,1.19995117,0.89990234,129.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.116,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,33960.0,16787.625,46.0,white,60.0,2,0,0,no,0.199999928,0.2,dnr after sadm,4.0,66.0,18.8984375,130.0,30.0,37.69531,81.32812,2.2998047,10.5,0.79992676,143.0,7.459961,135.0,23.0,2502.0,2.7563477,<2 mo. follow-up
67.49097,0,male,0,24,1951,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,172597.0,87621.75,24.666656,white,41.0,9,0,0,no,0.899999619,0.9,no dnr,24.0,100.0,18.296875,102.0,20.0,37.39844,156.0,4.7998047,1.39990234,5.79980469,141.0,7.469727,135.0,23.0,2502.0,2.7509766,<2 mo. follow-up
52.09,1,male,0,11,35,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,13414.0,8930.6719,7.5,white,34.0,1,0,0,no,0.899999619,0.8,no dnr,11.0,89.0,6.39941406,92.0,20.0,37.39844,442.8125,2.199707,10.8984375,1.19995117,133.0,7.429688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.59296,1,male,0,5,49,CHF,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,5872.0,3679.9609,7.0,black,36.0,1,0,0,no,0.949999809,0.8,no dnr,5.0,76.0,6.5,84.0,24.0,36.39844,533.25,3.699707,3.39990234,1.59985352,139.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.13998,0,male,0,5,1949,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,6083.0,3908.0156,11.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,109.0,5.39941406,80.0,20.0,36.59375,333.3,3.0,1.09985352,1.89990234,139.0,7.419922,135.0,23.0,2502.0,2.0625,<2 mo. follow-up
63.76199,1,male,0,11,48,Colon Cancer,Cancer,2,12.0,under $11k,7737.0,5288.8438,5.5,white,11.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,104.0,7.79980469,78.0,22.0,36.59375,333.3,3.5,1.01,1.01,137.0,7.419922,135.0,23.0,2502.0,2.7080078,<2 mo. follow-up
39.73199,1,male,0,8,394,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,16616.0,9458.5,13.0,black,16.0,1,0,0,no,0.5,0.5,no dnr,8.0,69.0,9.0,112.0,22.0,37.19531,333.3,3.5,1.01,1.39990234,137.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
60.40198,0,male,0,3,1944,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,9381.0,5027.7227,12.0,white,9.0,1,0,0,no,0.699999809,0.75,no dnr,3.0,80.0,9.09960938,106.0,18.0,37.0,333.3,4.2998047,0.89990234,1.09985352,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.771,1,male,0,9,1745,Colon Cancer,Cancer,1,12.0,under $11k,25187.0,14744.7969,6.5,other,20.0,1,0,0,metastatic,1.0,1.0,no dnr,9.0,111.0,9.29882812,88.0,20.0,38.0,333.3,4.2998047,0.89990234,1.5,138.0,7.419922,135.0,23.0,2502.0,2.0932617,<2 mo. follow-up
48.07397,1,male,0,4,831,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5570.0,3670.0703,9.0,other,39.0,1,1,0,no,0.899999619,0.7,no dnr,4.0,69.0,8.19921875,88.0,28.0,36.39844,255.0,3.5,1.01,1.69995117,135.0,7.5,135.0,23.0,2502.0,2.3574219,<2 mo. follow-up
76.68396,1,female,1,58,58,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,229314.0,109920.375,29.0,black,27.0,3,0,0,yes,0.699999809,0.5,dnr after sadm,44.0,84.0,24.796875,145.0,16.0,38.69531,150.0,3.5,0.29998779,0.79992676,138.0,7.509766,135.0,23.0,2502.0,3.0,<2 mo. follow-up
78.35699,1,male,0,4,374,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4629.0,3081.2656,7.0,black,30.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,60.0,8.59960938,115.0,20.0,36.0,404.75,3.5,1.01,1.5,137.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
85.29999,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20365.0,10969.5312,18.0,white,36.0,4,0,0,no,0.099999964,0.001,dnr after sadm,1.0,62.0,12.0996094,64.0,36.0,36.89844,142.84375,2.5996094,0.59997559,1.29980469,146.0,7.299805,135.0,23.0,2502.0,2.9472656,<2 mo. follow-up
62.47498,1,male,0,22,150,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,68367.0,36036.9688,22.666656,white,40.0,1,0,0,no,0.5,0.1,no dnr,22.0,55.0,11.2988281,105.0,24.0,36.69531,333.3,3.2998047,2.39990234,1.5,125.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.41296,1,female,0,4,449,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,4386.0,2759.834,8.0,black,31.0,1,0,0,no,0.75,0.5,no dnr,4.0,113.0,3.19970703,80.0,20.0,36.29688,333.3,3.0996094,0.79992676,2.19970703,144.0,7.419922,135.0,23.0,2502.0,2.3959961,adl>=4 (>=5 if sur)
45.11398,1,male,1,11,11,Lung Cancer,Cancer,1,12.0,under $11k,13100.0,7766.0273,7.5,black,11.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,109.0,10.7988281,98.0,18.0,36.39844,333.3,3.199707,1.01,0.59997559,130.0,7.419922,135.0,23.0,2502.0,3.7583008,<2 mo. follow-up
68.12598,1,female,0,5,460,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,6992.0,4581.8008,6.0,black,20.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,80.0,6.39941406,80.0,16.0,37.19531,485.6875,2.5,3.39990234,0.69995117,133.0,7.459961,135.0,23.0,2502.0,2.2592773,<2 mo. follow-up
82.17694,1,female,0,10,597,Lung Cancer,Cancer,1,15.0,$25-$50k,15942.0,10364.7812,13.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,no dnr,10.0,90.0,17.296875,80.0,24.0,37.69531,333.3,4.3994141,1.0,0.89990234,140.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
41.87,0,male,0,15,1935,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,>$50k,68108.0,38119.4688,23.333328,white,17.0,3,0,0,no,0.5,0.6,no dnr,15.0,95.0,18.296875,64.0,16.0,36.5,235.0,3.5,2.29980469,1.09985352,140.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.20795,1,female,0,3,23,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,3644.0,2314.8516,5.0,black,29.0,1,1,0,no,0.199999928,0.008,no dnr,3.0,103.0,4.79980469,90.0,20.0,37.69531,333.3,3.5,1.01,1.5,124.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
60.04398,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,506141.0,272995.25,44.0,white,42.0,60,0,0,no,0.5,0.25,no dnr,11.0,67.0,1.09985352,82.0,26.0,37.39844,228.875,4.0,1.39990234,2.09960938,131.0,7.399414,135.0,23.0,2502.0,2.0,<2 mo. follow-up
77.13898,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,$11-$25k,159553.0,81082.1875,46.0,white,45.0,17,0,0,no,0.699999809,0.5,dnr after sadm,8.0,67.0,14.5996094,94.0,24.0,36.19531,156.90625,3.5,1.79980469,2.5,137.0,7.5,135.0,23.0,2502.0,4.0,<2 mo. follow-up
72.96399,0,female,0,8,1934,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,42243.0,22744.0781,23.5,white,26.0,6,0,0,no,0.899999619,0.8,no dnr,8.0,56.0,3.89990234,69.0,20.0,38.5,110.0,2.5996094,1.01,0.59997559,135.0,7.349609,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
59.40598,1,male,0,9,96,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,19852.0,11541.8047,17.5,white,53.0,1,0,0,no,0.849999905,0.75,no dnr,9.0,57.0,7.59960938,114.0,28.0,36.5,333.3,4.0,1.09985352,2.79980469,135.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
72.83795,1,male,1,109,109,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,740010.0,357918.75,47.5,white,43.0,9,0,0,no,0.699999809,0.5,dnr after sadm,67.0,67.0,11.5996094,95.0,18.0,38.79688,140.0,2.699707,1.01,3.5,134.0,7.469727,135.0,23.0,2502.0,2.8237305,Coma or Intub
50.23099,0,female,0,13,1933,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,44480.0,24166.0312,19.5,white,19.0,3,0,0,no,0.949999809,0.9,no dnr,13.0,94.0,11.8984375,97.0,38.0,39.19531,204.0625,3.5,1.01,1.09985352,140.0,7.429688,135.0,23.0,2502.0,3.4614258,<2 mo. follow-up
71.56195,1,female,0,8,817,Colon Cancer,Cancer,1,12.0,$25-$50k,15051.0,8141.4531,9.0,white,14.0,1,0,0,metastatic,0.949999809,0.5,no dnr,8.0,137.0,15.3984375,80.0,20.0,38.5,333.3,4.3994141,1.01,0.69995117,141.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
71.90399,1,male,0,9,385,Colon Cancer,Cancer,1,10.0,under $11k,24612.0,14901.6641,7.5,hispanic,20.0,1,0,0,metastatic,0.949999809,0.857,no dnr,9.0,106.0,13.8984375,88.0,20.0,36.0,333.3,3.8999023,0.59997559,1.29980469,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.62997,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,40418.0,20818.8438,30.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,78.0,28.296875,122.0,16.0,38.69531,204.4375,4.1992188,1.01,1.0,140.0,7.5,135.0,23.0,2502.0,2.3632812,<2 mo. follow-up
51.98398,1,female,0,12,588,Colon Cancer,Cancer,1,17.0,>$50k,29303.0,16406.4062,17.0,white,12.0,1,0,0,metastatic,0.949999809,0.857,no dnr,12.0,95.0,13.8984375,64.0,18.0,37.5,300.0,4.5996094,1.09985352,0.59997559,137.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
53.82599,1,male,0,16,26,CHF,COPD/CHF/Cirrhosis,0,12.0,$25-$50k,24587.0,14452.7344,9.0,hispanic,27.0,1,0,0,no,0.849999905,0.614,no dnr,16.0,63.0,8.0,96.0,18.0,35.89844,333.3,3.5,1.01,1.59985352,129.0,7.419922,135.0,23.0,2502.0,2.6064453,<2 mo. follow-up
50.431,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,70463.0,35895.0938,47.0,white,78.0,4,0,0,yes,0.699999809,0.5,dnr after sadm,6.0,54.0,12.6992188,136.0,32.0,36.89844,175.0,3.5,7.79980469,2.69970703,132.0,7.189453,135.0,23.0,2502.0,3.1044922,<2 mo. follow-up
31.69099,1,male,0,28,1167,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,274531.0,165149.0,26.75,hispanic,43.0,6,0,0,no,0.75,0.7,no dnr,28.0,140.0,13.3984375,50.0,28.0,38.89844,167.5,3.8999023,27.5,0.89990234,137.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.30896,1,female,0,25,866,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,84901.0,40449.3125,16.0,white,18.0,1,0,0,no,0.899999619,0.8,no dnr,25.0,99.0,14.5996094,150.0,16.0,37.39844,348.5625,3.5,1.01,0.69995117,136.0,7.469727,135.0,23.0,2502.0,3.0009766,SIP>=30
81.54095,1,male,0,15,91,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,20850.0,13284.5781,10.0,white,27.0,1,0,1,yes,0.25,0.1,no dnr,15.0,84.0,65.0,61.0,20.0,37.19531,359.25,2.2998047,1.01,1.79980469,139.0,7.449219,135.0,23.0,2502.0,6.0,<2 mo. follow-up
66.39795,1,male,0,6,106,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,17247.0,10426.7891,20.0,white,35.0,1,0,0,no,0.699999809,0.7,no dnr,6.0,59.0,6.09960938,54.0,18.0,36.59375,376.1875,4.1992188,1.01,1.5,134.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.20099,1,male,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,218924.0,100290.0,33.75,white,63.0,13,0,0,no,0.099999964,0.001,dnr after sadm,16.0,60.0,3.89990234,145.0,27.0,37.69531,122.5,3.5,0.5,3.39990234,134.0,7.229492,135.0,23.0,2502.0,2.5366211,<2 mo. follow-up
88.29797,1,male,0,29,623,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,63639.0,39865.0938,13.25,white,41.0,2,0,0,no,0.699999809,0.5,no dnr,29.0,72.0,11.1992188,80.0,26.0,37.19531,180.0,3.5,1.01,2.0,131.0,7.479492,135.0,23.0,2502.0,2.0,<2 mo. follow-up
58.41498,1,female,0,23,217,Colon Cancer,Cancer,1,14.0,$25-$50k,58940.0,26872.9688,19.666656,white,11.0,1,0,0,metastatic,0.899999619,0.75,no dnr,23.0,91.0,5.09960938,88.0,24.0,37.0,333.3,3.5,1.0,1.0,138.0,7.419922,135.0,23.0,2502.0,2.5058594,<2 mo. follow-up
56.34998,1,female,0,15,74,Lung Cancer,Cancer,2,12.0,under $11k,26731.0,13389.5703,14.333328,white,39.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,7.0,67.0,7.59960938,140.0,36.0,39.0,216.65625,3.5,1.01,0.79992676,135.0,7.459961,135.0,23.0,2502.0,3.6875,<2 mo. follow-up
71.69897,0,female,0,5,1922,Colon Cancer,Cancer,0,19.0,under $11k,5319.0,3470.7637,8.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,68.0,5.29980469,60.0,20.0,37.0,333.3,3.2998047,0.59997559,0.89990234,143.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
32.13998,1,male,1,27,27,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,256835.0,123820.938,33.25,other,63.0,12,0,0,yes,0.099999964,0.001,no dnr,27.0,24.0,20.1992188,145.0,30.0,38.69531,222.5,3.5,1.0,2.19970703,125.0,7.349609,135.0,23.0,2502.0,2.2148438,<2 mo. follow-up
48.10999,1,female,0,26,41,Cirrhosis,COPD/CHF/Cirrhosis,2,2.0,$11-$25k,56562.0,31515.375,16.75,hispanic,42.0,1,0,0,no,0.799999714,0.4,no dnr,26.0,77.0,4.79980469,92.0,30.0,36.19531,333.3,3.5,17.796875,1.0,131.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.383,0,male,0,11,1921,Colon Cancer,Cancer,1,12.0,under $11k,24788.0,14783.8203,15.5,other,16.0,1,0,0,metastatic,0.949999809,0.75,no dnr,11.0,82.0,5.5,62.0,18.0,37.0,390.4375,4.2998047,0.5,1.0,134.0,7.389648,135.0,23.0,2502.0,2.262207,<2 mo. follow-up
57.81,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,125797.0,58915.1875,30.0,white,36.0,1,0,0,no,0.399999857,0.3,dnr after sadm,8.0,113.0,20.5976562,82.0,16.0,37.0,267.5,3.5,4.39941406,2.69970703,144.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.76794,1,female,0,11,657,Colon Cancer,Cancer,1,12.0,under $11k,15358.0,9215.3125,9.5,white,22.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,79.0,3.29980469,87.0,19.0,36.5,333.3,3.5,0.5,1.29980469,139.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
46.45898,1,male,0,7,414,Colon Cancer,Cancer,1,16.0,>$50k,21906.0,12927.0312,10.0,white,9.0,1,0,0,metastatic,0.949999809,0.75,no dnr,7.0,89.0,9.69921875,80.0,20.0,37.5,333.3,4.2998047,0.19998169,1.09985352,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.34796,1,female,0,20,451,Colon Cancer,Cancer,1,12.0,$11-$25k,77328.0,42579.8125,16.0,white,25.0,1,0,0,metastatic,0.899999619,0.75,no dnr,20.0,120.0,11.0996094,112.0,28.0,38.79688,333.3,2.699707,0.69995117,0.79992676,138.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.23596,1,female,0,12,539,Colon Cancer,Cancer,1,12.0,$11-$25k,26189.0,14225.7031,19.5,asian,22.0,1,0,0,metastatic,0.949999809,0.75,no dnr,12.0,103.0,10.2988281,90.0,20.0,37.0,628.0,4.3994141,0.5,1.29980469,137.0,7.289062,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.60394,1,male,0,14,1691,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,58853.0,31826.5625,19.666656,white,41.0,7,0,1,no,0.699999809,0.6,no dnr,14.0,157.0,14.6992188,40.0,16.0,36.0,220.0,3.5,0.59997559,1.79980469,136.0,7.359375,135.0,23.0,2502.0,4.6474609,<2 mo. follow-up
36.45999,0,female,0,33,1913,Coma,Coma,0,12.0,under $11k,201322.0,112886.875,30.75,white,36.0,5,0,0,no,0.699999809,0.5,no dnr,33.0,110.0,16.0,123.0,34.0,39.0,104.0,5.6992188,1.01,0.69995117,139.0,7.5,135.0,23.0,2502.0,2.3637695,<2 mo. follow-up
63.77298,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,89043.0,47001.0,24.0,white,24.0,15,0,1,no,0.5,0.15,dnr after sadm,17.0,71.0,11.5996094,96.0,32.0,38.0,128.5625,3.5996094,0.5,0.79992676,127.0,7.479492,135.0,23.0,2502.0,4.4150391,<2 mo. follow-up
65.70599,1,male,0,7,140,Colon Cancer,Cancer,1,18.0,$25-$50k,8729.0,4916.8086,9.5,hispanic,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,84.0,10.5,81.0,20.0,37.89844,333.3,3.5,5.0,1.19995117,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
20.83199,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,392950.0,197040.125,37.0,white,106.0,63,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,0.0,5.79980469,0.0,0.0,37.79688,130.0,4.0,10.5,3.59960938,132.0,7.279297,135.0,23.0,2502.0,1.1416016,<2 mo. follow-up
52.668,1,female,1,13,13,Coma,Coma,0,12.0,under $11k,104602.0,52896.7812,37.0,white,6.0,6,0,0,no,0.699999809,0.5,no dnr,14.58258953168044,88.0,14.8984375,72.0,12.0,36.19531,277.5,3.5,1.01,0.5,138.0,7.579102,135.0,23.0,2502.0,2.5009766,<2 mo. follow-up
75.36798,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,125256.0,64887.8125,35.0,white,73.0,8,1,0,no,0.049999982,0.000125,no dnr,13.0,63.0,12.8984375,60.0,4.0,37.79688,166.0,3.5,1.09985352,8.59960938,132.0,7.469727,135.0,23.0,2502.0,2.9306641,<2 mo. follow-up
53.86697,0,male,0,4,1909,CHF,COPD/CHF/Cirrhosis,2,18.0,under $11k,20923.0,12116.0312,6.0,white,25.0,2,0,0,no,0.699999809,0.5,no dnr,4.0,63.0,6.5,68.0,26.0,36.0,400.0,3.8999023,0.09999084,1.29980469,139.0,7.459961,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
44.35898,1,male,0,5,543,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,12042.0,6767.7578,12.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,69.0,9.5,136.0,20.0,36.39844,261.875,3.5,0.5,1.59985352,137.0,7.419922,135.0,23.0,2502.0,2.4326172,no(M2 and SIP pres)
53.62097,1,female,0,34,58,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,279530.0,180716.375,21.75,white,21.0,1,0,0,no,0.649999619,0.4,no dnr,34.0,76.0,6.5,88.0,18.0,37.19531,333.3,2.199707,1.5,1.09985352,128.0,7.419922,135.0,23.0,2502.0,2.4321289,<2 mo. follow-up
84.90295,1,female,0,7,1227,Colon Cancer,Cancer,2,15.0,$11-$25k,9291.0,5748.9297,3.5,white,21.0,1,0,0,metastatic,0.799999714,0.5,no dnr,7.0,86.0,4.79980469,80.0,20.0,36.29688,333.3,3.0996094,0.69995117,1.69995117,141.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
70.83899,1,male,0,6,24,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,10955.0,6502.7344,11.0,white,46.0,1,0,1,no,0.699999809,0.5,dnr after sadm,2.0,68.0,10.0,61.0,39.0,37.09375,383.625,3.5,1.01,3.29980469,133.0,7.579102,135.0,23.0,2502.0,4.1845703,<2 mo. follow-up
70.06195,1,male,0,11,266,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,15687.0,10228.8594,11.0,hispanic,43.0,1,1,0,no,0.849999905,0.7,no dnr,11.0,111.0,7.39941406,80.0,16.0,35.89844,304.75,3.199707,1.39990234,2.69970703,134.0,7.479492,135.0,23.0,2502.0,1.0,SIP>=30
37.71899,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,268805.0,132976.5,48.0,white,78.0,48,0,0,no,0.099999964,0.001,no dnr,14.58258953168044,61.0,0.09999084,140.0,45.0,39.09375,238.0,3.5,0.79992676,2.79980469,148.0,7.429688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.45697,1,female,1,19,19,Lung Cancer,Cancer,1,13.0,$11-$25k,41397.0,23832.0,12.0,black,21.0,1,0,0,metastatic,0.449999809,0.2,dnr after sadm,17.0,90.0,18.8984375,68.0,18.0,36.19531,285.6875,3.7998047,0.69995117,1.0,134.0,7.459961,135.0,23.0,2502.0,5.0,<2 mo. follow-up
29.88399,1,female,0,33,34,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,223581.0,103008.562,28.75,white,30.0,9,0,0,yes,0.799999714,0.8,dnr after sadm,33.0,81.0,10.5996094,118.0,20.0,38.0,95.0,2.5996094,6.0,0.59997559,135.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
87.521,1,female,0,90,1530,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,469824.0,232752.25,32.25,white,54.0,12,0,0,no,0.699999809,0.5,no dnr,90.0,127.0,15.5,120.0,34.0,37.79688,75.0,2.0996094,0.09999084,1.19995117,134.0,7.469727,135.0,23.0,2502.0,3.3193359,<2 mo. follow-up
18.146,0,male,0,85,1899,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,641888.0,328378.5,43.25,hispanic,87.0,1,0,0,no,0.799999714,0.8,no dnr,85.0,44.0,2.0,142.0,27.0,37.19531,314.25,1.8999023,0.29998779,10.6992188,134.0,7.349609,135.0,23.0,2502.0,0.0,Coma or Intub
42.92398,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,277421.0,133680.875,33.0,white,70.0,54,0,0,no,0.699999809,0.5,dnr after sadm,9.0,63.0,32.59375,132.0,50.0,39.5,77.32812,2.0996094,1.01,1.5,135.0,7.209961,135.0,23.0,2502.0,3.0610352,<2 mo. follow-up
37.396,1,female,1,17,17,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,166927.0,86323.875,43.666657,black,51.0,5,0,0,yes,0.699999809,0.5,dnr after sadm,16.0,73.0,5.89941406,120.0,24.0,37.09375,233.3125,3.5,1.01,3.19970703,132.0,7.40918,135.0,23.0,2502.0,2.8491211,<2 mo. follow-up
63.46899,1,male,0,12,1023,Colon Cancer,Cancer,1,12.0,under $11k,29732.0,16300.9844,16.5,white,23.0,1,0,0,metastatic,0.949999809,0.8,no dnr,12.0,124.0,5.39941406,118.0,20.0,37.39844,313.3125,4.6992188,0.79992676,0.79992676,133.0,7.419922,135.0,23.0,2502.0,2.1762695,<2 mo. follow-up
53.57999,1,female,0,5,1572,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,5132.0,2881.541,9.0,white,31.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,93.0,12.3984375,92.0,12.0,36.59375,256.0,3.5,0.29998779,1.09985352,136.0,7.519531,135.0,23.0,2502.0,2.3583984,<2 mo. follow-up
70.07495,1,male,0,20,324,CHF,COPD/CHF/Cirrhosis,1,11.0,$11-$25k,33290.0,18993.5312,12.333328,black,22.0,1,0,0,no,0.699999809,0.5,no dnr,20.0,80.0,9.0,90.0,18.0,36.79688,333.3,4.0996094,1.01,2.0,132.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
47.633,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,138674.0,71315.3125,15.0,asian,83.0,21,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,25.0,4.5,125.0,10.0,36.0,167.34375,3.5,32.3984375,3.59960938,142.0,7.5,135.0,23.0,2502.0,1.6940918,<2 mo. follow-up
51.54797,1,male,0,37,466,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,170244.0,79871.5,24.0,white,32.0,10,0,0,yes,0.25,0.0156,no dnr,37.0,65.0,17.5976562,126.0,29.0,37.89844,165.0,3.5,1.01,0.59997559,132.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
90.83899,1,female,0,14,708,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,14065.0,8867.6719,8.333328,white,28.0,1,0,0,no,0.5,0.25,dnr after sadm,1.0,100.0,10.8984375,82.0,22.0,36.19531,210.0,3.5,1.01,1.0,145.0,7.519531,135.0,23.0,2502.0,3.8759766,<2 mo. follow-up
35.625,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,23421.0,12434.3672,39.0,black,80.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,25.0,19.796875,150.0,28.0,37.19531,309.5,3.5,1.01,2.5,135.0,7.15918,135.0,23.0,2502.0,2.0986328,<2 mo. follow-up
63.85999,1,female,1,5,5,Coma,Coma,0,12.0,under $11k,47424.0,25078.2031,15.0,white,22.0,5,0,0,no,0.699999809,0.5,no dnr,14.58258953168044,139.0,8.29882812,122.0,10.0,38.69531,350.0,3.5,1.01,0.69995117,149.0,7.529297,135.0,23.0,2502.0,2.5307617,<2 mo. follow-up
67.04199,1,male,0,31,1216,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,100735.0,55332.7812,13.0,white,35.0,7,0,0,no,0.979999542,0.95,no dnr,31.0,129.0,9.3984375,125.0,36.0,38.0,272.5,3.199707,1.01,1.0,138.0,7.489258,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
61.16098,0,female,0,106,1889,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,970982.0,39.496,38.25,white,56.0,29,0,0,no,0.5,0.5,no dnr,106.0,66.0,14.6992188,105.0,20.0,36.5,274.0,3.199707,6.09960938,2.59960938,134.0,7.40918,135.0,23.0,2502.0,2.8037109,adl>=4 (>=5 if sur)
77.13098,1,male,0,5,465,Lung Cancer,Cancer,3,12.0,under $11k,29403.0,5321.5938,17.0,white,33.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,62.0,5.59960938,82.0,12.0,36.39844,276.1875,3.5,1.01,1.19995117,135.0,7.429688,135.0,23.0,2502.0,2.9814453,<2 mo. follow-up
19.14,0,male,0,56,1889,CHF,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,216359.0,134573.25,15.75,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,56.0,61.0,8.5,108.0,26.0,36.5,333.3,4.2998047,1.09985352,0.89990234,125.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.18097,1,male,0,11,683,Colon Cancer,Cancer,2,14.0,$11-$25k,26311.0,13976.2734,16.5,white,21.0,1,1,0,metastatic,0.899999619,0.75,no dnr,11.0,100.0,9.29882812,120.0,18.0,37.5,333.3,4.2998047,1.09985352,0.79992676,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.30298,0,female,0,9,1887,Colon Cancer,Cancer,1,12.0,under $11k,17823.0,8599.2031,10.5,white,12.0,1,0,0,metastatic,0.949999809,0.9,no dnr,9.0,89.0,10.1992188,120.0,20.0,39.69531,333.3,3.5,0.39996338,0.69995117,138.0,7.419922,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
55.28799,1,female,0,9,91,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,19419.0,11965.4844,13.0,white,38.0,1,0,0,yes,0.799999714,0.2,no dnr,9.0,59.0,5.79980469,145.0,20.0,37.0,456.625,2.8999023,0.79992676,0.89990234,133.0,7.369141,135.0,23.0,2502.0,3.1230469,no(M2 and SIP pres)
53.14697,1,male,0,6,1162,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,16552.0,9827.4219,20.0,asian,23.0,1,0,0,no,0.799999714,0.4,no dnr,6.0,75.0,6.69921875,72.0,18.0,36.09375,333.3,4.6992188,2.79980469,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
32.44098,1,male,0,281,386,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,1273347.0,633212.0,38.5,white,44.0,58,0,0,no,0.299999952,0.3,no dnr,281.0,51.0,16.6992188,96.0,30.0,37.39844,108.5625,2.3999023,1.0,0.69995117,143.0,7.509766,135.0,23.0,2502.0,7.0,Coma or Intub
58.95999,0,female,0,26,1882,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,207902.0,121042.438,23.0,white,17.0,19,0,0,no,0.799999714,0.75,no dnr,26.0,115.0,6.19921875,132.0,20.0,39.79688,326.625,3.5,1.01,0.59997559,136.0,7.5,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
27.411,0,male,0,27,1881,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,122322.0,63008.5625,18.5,white,40.0,1,0,0,no,0.5,0.8,no dnr,27.0,78.0,27.5976562,130.0,8.0,38.5,228.0,2.5996094,1.59985352,0.69995117,137.0,7.529297,135.0,23.0,2502.0,1.0,<2 mo. follow-up
77.09497,1,male,0,9,248,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,23862.0,13112.5312,17.5,white,30.0,1,1,0,no,0.299999952,0.1,no dnr,9.0,93.0,11.5996094,86.0,22.0,36.59375,333.3,3.5,1.01,3.39990234,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.69299,1,female,0,9,117,CHF,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,46112.0,24669.1562,25.5,white,40.0,3,1,0,no,0.699999809,0.5,dnr after sadm,3.0,52.0,10.6992188,122.0,32.0,39.09375,333.3,3.5,1.01,0.89990234,134.0,7.419922,135.0,23.0,2502.0,3.0,SIP>=30
62.185,1,female,0,18,1780,Lung Cancer,Cancer,1,12.0,under $11k,35575.0,23257.5938,9.0,black,9.0,1,0,0,metastatic,0.799999714,0.7,no dnr,18.0,86.0,7.69921875,60.0,18.0,37.19531,333.3,4.3994141,0.19998169,0.89990234,140.0,7.419922,135.0,23.0,2502.0,2.390625,<2 mo. follow-up
53.52197,0,female,0,9,1874,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,20893.0,12010.2578,10.5,white,36.0,2,0,0,no,0.899999619,0.7,no dnr,9.0,92.0,9.0,112.0,36.0,37.5,174.96875,3.2998047,0.29998779,0.69995117,139.0,7.369141,135.0,23.0,2502.0,4.2832031,no(M2 and SIP pres)
23.39999,1,female,1,96,96,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$11-$25k,943804.0,473212.25,28.5,hispanic,42.0,36,0,0,no,0.899999619,0.9,no dnr,96.0,87.0,5.19921875,144.0,45.0,37.29688,335.0,3.0,4.09960938,1.19995117,130.0,7.469727,135.0,23.0,2502.0,0.0,Coma or Intub
65.60999,1,female,0,7,279,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,25467.0,13346.1172,11.5,white,38.0,3,0,0,no,0.699999809,0.5,no dnr,7.0,94.0,7.39941406,140.0,24.0,35.79688,390.4375,3.5,1.01,2.69970703,122.0,7.479492,135.0,23.0,2502.0,2.0,SIP>=30
70.28094,1,male,1,14,14,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,28159.0,15654.1641,9.666664,white,40.0,1,0,0,no,1.0,1.0,no dnr,14.0,106.0,10.3984375,74.0,20.0,37.0,333.3,3.0996094,4.69921875,3.0,129.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
60.71997,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,63858.0,32674.75,48.0,white,53.0,12,0,0,yes,0.699999809,0.5,dnr after sadm,4.0,47.0,14.7988281,80.0,14.0,35.79688,135.0,2.5996094,1.89990234,4.0,138.0,7.30957,135.0,23.0,2502.0,2.6665039,<2 mo. follow-up
77.00494,1,female,0,11,40,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,15565.0,10120.9297,8.0,white,20.0,1,1,0,no,0.5,0.25,no dnr,11.0,99.0,8.59960938,80.0,24.0,36.5,333.3,3.5,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,3.0146484,<2 mo. follow-up
42.05298,1,male,0,9,149,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,24897.0,14291.5391,15.0,hispanic,22.0,1,0,0,no,0.799999714,0.5,no dnr,9.0,62.0,10.0996094,120.0,24.0,36.79688,333.3,4.5,1.0,1.29980469,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.75,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,254366.0,144957.75,47.0,asian,71.0,9,0,0,no,0.699999809,0.5,dnr after sadm,6.0,63.0,17.5,150.0,32.0,38.69531,89.0,2.8999023,7.09960938,2.29980469,139.0,7.30957,135.0,23.0,2502.0,2.5249023,<2 mo. follow-up
71.28796,1,male,1,5,5,CHF,COPD/CHF/Cirrhosis,1,15.0,under $11k,4854.0,3407.7559,6.0,white,36.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,63.0,7.29980469,82.0,12.0,36.19531,333.3,3.5,1.01,1.69995117,127.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
22.66899,1,female,0,9,101,CHF,COPD/CHF/Cirrhosis,1,15.0,under $11k,18751.0,10188.0078,16.0,hispanic,47.0,1,0,0,no,0.599999905,0.2,no dnr,9.0,35.0,6.69921875,115.0,40.0,36.39844,175.5,3.5,1.01,1.29980469,117.0,7.5,135.0,23.0,2502.0,3.1831989,adl>=4 (>=5 if sur)
59.12399,0,female,0,9,1867,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,43164.0,22028.3438,24.0,white,56.0,2,1,0,no,0.699999809,0.5,no dnr,9.0,57.0,17.6992188,156.0,14.0,37.5,170.0,3.0996094,1.29980469,1.5,140.0,7.299805,135.0,23.0,2502.0,7.0,<2 mo. follow-up
63.896,0,male,0,55,1867,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,>$50k,227392.0,139701.25,21.5,hispanic,45.0,1,0,0,no,0.699999809,0.5,no dnr,55.0,72.0,8.59960938,105.0,18.0,38.39844,338.0625,2.3999023,9.0,1.0,135.0,7.469727,135.0,23.0,2502.0,5.0,SIP>=30
87.43097,1,male,1,16,16,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,89889.0,43052.125,31.333328,white,49.0,2,0,0,no,0.699999809,0.5,dnr after sadm,14.0,75.0,13.3984375,135.0,8.0,37.79688,138.0,3.5,1.01,3.19970703,125.0,7.299805,135.0,23.0,2502.0,3.5537109,<2 mo. follow-up
78.89899,0,male,0,22,1863,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,40247.0,22146.5,10.333328,white,21.0,1,0,0,no,0.799999714,0.5,no dnr,22.0,94.0,8.79882812,75.0,26.0,36.5,326.0625,3.5,1.01,0.89990234,139.0,7.329102,135.0,23.0,2502.0,0.0,<2 mo. follow-up
83.64099,0,male,0,12,1862,CHF,COPD/CHF/Cirrhosis,1,10.0,under $11k,25653.0,14852.3984,14.5,white,55.0,1,0,0,no,0.899999619,0.9,no dnr,12.0,63.0,10.6992188,62.0,28.0,39.39844,214.28125,3.5,1.0,2.5,131.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
47.737,0,female,0,116,1861,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,592486.0,298585.25,45.5,black,79.0,2,0,0,no,0.699999809,0.5,no dnr,116.0,47.0,13.0996094,164.0,31.0,39.29688,52.0,3.5,1.01,3.0,130.0,7.139648,135.0,23.0,2502.0,1.0,Coma or Intub
78.84998,0,female,0,9,1860,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,9914.0,6578.9141,7.0,black,38.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,114.0,8.3984375,78.0,20.0,37.79688,328.5625,3.8999023,0.79992676,1.29980469,137.0,7.459961,135.0,23.0,2502.0,6.0,SIP>=30
51.18399,0,male,0,10,1860,CHF,COPD/CHF/Cirrhosis,3,6.0,under $11k,22621.0,13689.9297,17.5,black,14.0,2,0,0,no,0.799999714,0.6,no dnr,10.0,88.0,7.0,80.0,18.0,36.69531,333.3,3.5,3.5,1.09985352,126.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
61.45398,1,male,0,16,523,Colon Cancer,Cancer,1,30.0,>$50k,60175.0,33484.4375,17.666656,white,24.0,1,0,0,metastatic,0.949999809,0.75,no dnr,16.0,102.0,12.8984375,90.0,20.0,37.0,333.3,3.5996094,0.5,1.5,137.0,7.419922,135.0,23.0,2502.0,2.0556641,no(M2 and SIP pres)
55.20297,1,male,0,3,1285,CHF,COPD/CHF/Cirrhosis,4,15.0,under $11k,3035.0,2104.1055,3.0,other,16.0,1,1,0,no,0.799999714,0.7,no dnr,3.0,93.0,11.1992188,74.0,24.0,36.0,333.3,3.8999023,0.69995117,1.29980469,136.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
74.06396,0,male,0,11,1859,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,44728.0,25857.0625,22.0,white,20.0,3,0,0,no,0.699999809,0.5,no dnr,11.0,115.0,10.0,95.0,12.0,37.5,113.84375,3.5,1.01,1.09985352,135.0,7.449219,135.0,23.0,2502.0,2.402832,<2 mo. follow-up
90.90796,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,69364.0,35313.4375,21.333328,white,24.0,1,0,0,no,0.199999928,0.2,dnr after sadm,13.0,133.0,16.296875,115.0,9.0,38.5,372.5,2.7998047,1.01,1.0,137.0,7.399414,135.0,23.0,2502.0,5.0,<2 mo. follow-up
38.94897,1,male,1,24,24,Cirrhosis,COPD/CHF/Cirrhosis,1,9.0,$11-$25k,133918.0,68405.4375,18.333328,hispanic,59.0,1,0,0,no,0.75,0.5,dnr after sadm,23.0,64.0,12.0996094,102.0,18.0,36.39844,333.3,2.0,10.1992188,2.79980469,126.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
65.14697,1,female,0,4,27,Lung Cancer,Cancer,1,12.0,under $11k,5223.0,3330.9004,7.0,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,83.0,8.09960938,106.0,22.0,36.39844,333.3,3.5,1.01,0.69995117,136.0,7.419922,135.0,23.0,2502.0,2.4189453,<2 mo. follow-up
51.62799,1,female,0,8,557,CHF,COPD/CHF/Cirrhosis,3,13.0,$25-$50k,23146.0,13344.6172,16.0,white,17.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,65.0,15.8984375,88.0,16.0,36.29688,333.3,4.1992188,1.0,1.09985352,128.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.20499,1,male,0,20,153,Lung Cancer,Cancer,2,12.0,under $11k,42041.0,27174.3594,12.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,20.0,107.0,8.19921875,92.0,20.0,37.19531,304.75,4.1992188,0.29998779,0.89990234,135.0,7.439453,135.0,23.0,2502.0,2.7797852,no(M2 and SIP pres)
65.88599,0,female,0,5,1857,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,19662.0,10503.0391,21.0,white,31.0,1,0,0,no,0.899999619,0.9,no dnr,5.0,61.0,8.3984375,60.0,30.0,37.0,217.125,1.8999023,0.69995117,0.5,139.0,7.489258,135.0,23.0,2502.0,2.237793,<2 mo. follow-up
69.19598,1,male,0,9,115,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,24859.0,14226.4688,20.5,asian,45.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,47.0,13.7988281,70.0,20.0,36.79688,565.0,3.699707,0.69995117,2.39990234,126.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.74695,1,male,0,6,422,Lung Cancer,Cancer,1,12.0,under $11k,16325.0,7677.7969,11.0,other,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,89.0,19.296875,80.0,18.0,36.89844,333.3,3.5,0.5,1.29980469,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.09595,1,male,0,3,1314,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,5293.0,3081.8906,8.0,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,93.0,9.0,80.0,20.0,36.79688,333.3,3.5,1.01,0.69995117,131.0,7.419922,135.0,23.0,2502.0,6.0,SIP>=30
71.54596,1,male,0,7,77,Lung Cancer,Cancer,1,20.0,>$50k,23304.0,12482.875,12.0,white,26.0,3,0,0,metastatic,0.699999809,0.5,no dnr,7.0,120.0,3.5,89.0,26.0,36.89844,257.125,3.5,0.59997559,1.19995117,137.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.61899,1,male,0,17,236,CHF,COPD/CHF/Cirrhosis,1,14.0,under $11k,49079.0,26983.6719,16.0,white,31.0,1,0,0,no,0.949999809,0.9,no dnr,17.0,50.0,6.09960938,110.0,20.0,36.79688,333.3,3.699707,0.39996338,1.19995117,135.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
58.478,1,male,0,4,896,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3580.0,1780.9941,11.0,white,36.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,106.0,9.09960938,88.0,36.0,36.39844,333.3,3.5,1.01,1.89990234,139.0,7.419922,135.0,23.0,2502.0,2.6030273,<2 mo. follow-up
52.67899,0,male,0,5,1853,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,17110.0,10086.7188,21.0,asian,27.0,1,0,0,no,0.899999619,0.9,no dnr,5.0,60.0,3.59960938,150.0,16.0,36.79688,333.3,4.0996094,0.69995117,1.09985352,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
70.48596,1,male,0,37,336,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,149983.0,76851.75,27.5,white,27.0,1,0,1,no,0.699999809,0.5,no dnr,37.0,62.0,14.0996094,80.0,15.0,38.5,146.0,2.3999023,0.39996338,1.09985352,134.0,7.449219,135.0,23.0,2502.0,3.6967773,<2 mo. follow-up
50.58197,1,male,0,7,81,Cirrhosis,COPD/CHF/Cirrhosis,1,10.0,$25-$50k,9113.0,5367.9805,13.0,hispanic,38.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,70.0,3.59960938,82.0,20.0,36.79688,385.6875,1.8999023,1.79980469,1.59985352,128.0,7.489258,135.0,23.0,2502.0,3.1831989,Coma or Intub
25.487,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,126732.0,61916.2188,19.666656,white,61.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,19.0,123.0,1.69995117,100.0,48.0,38.5,191.8125,3.0996094,9.0,2.29980469,143.0,7.40918,135.0,23.0,2502.0,2.3955078,<2 mo. follow-up
88.69495,1,male,1,9,9,Coma,Coma,2,12.0,>$50k,24242.0,14263.6172,16.0,white,41.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,102.0,11.5996094,123.0,14.0,38.39844,397.125,3.0996094,0.69995117,5.69921875,135.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.01898,1,male,0,81,277,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,659433.0,324373.75,42.25,white,58.0,30,0,0,metastatic,0.699999809,0.5,no dnr,81.0,70.0,12.5996094,115.0,10.0,37.5,218.0,2.5996094,7.69921875,2.79980469,134.0,7.479492,135.0,23.0,2502.0,3.2172852,<2 mo. follow-up
81.77698,1,female,0,7,927,Cirrhosis,COPD/CHF/Cirrhosis,2,7.0,under $11k,5405.0,3686.4316,5.0,black,32.0,1,0,0,no,0.699999809,0.8,no dnr,7.0,107.0,3.59960938,92.0,26.0,36.79688,333.3,2.199707,1.01,0.69995117,138.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
71.86298,1,male,0,3,12,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3869.0,2602.3711,6.0,white,25.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,87.0,8.09960938,80.0,20.0,36.09375,342.8125,3.5,1.01,1.5,138.0,7.439453,135.0,23.0,2502.0,2.2963867,<2 mo. follow-up
72.19696,0,female,0,8,1849,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,9991.0,6090.7852,7.0,black,34.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,107.0,6.69921875,72.0,18.0,36.79688,333.3,3.5,1.01,2.29980469,141.0,7.419922,135.0,23.0,2502.0,3.4404297,<2 mo. follow-up
53.40997,0,male,0,12,1847,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,102911.0,52412.25,24.0,white,35.0,9,0,0,no,0.949999809,0.9,no dnr,12.0,113.0,25.5,120.0,25.0,37.29688,260.0,2.5,5.79980469,0.79992676,136.0,7.489258,135.0,23.0,2502.0,2.5112305,no(M2 and SIP pres)
34.35699,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,110596.0,55677.625,51.0,hispanic,72.0,9,0,0,no,0.199999928,0.008,no dnr,8.0,48.0,6.19921875,120.0,33.0,38.5,150.0,2.3999023,6.0,2.29980469,130.0,7.30957,135.0,23.0,2502.0,5.0,<2 mo. follow-up
56.66498,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,206651.0,102511.375,47.666657,white,81.0,31,0,0,no,0.5,0.5,dnr after sadm,10.0,63.0,18.5976562,125.0,30.0,38.5,148.0,3.5,16.796875,4.09960938,147.0,7.189453,135.0,23.0,2502.0,2.3227539,<2 mo. follow-up
53.67798,1,female,0,11,308,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,14583.0,8907.6328,9.5,white,43.0,1,0,0,no,0.5,0.25,no dnr,11.0,113.0,7.5,100.0,24.0,37.0,333.3,2.0,19.8984375,1.29980469,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.32898,0,male,0,6,1845,Lung Cancer,Cancer,2,12.0,$25-$50k,11985.0,7751.6758,12.0,asian,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,93.0,9.0,112.0,20.0,37.19531,333.3,3.5,1.01,0.89990234,136.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
54.056,1,male,1,8,8,Coma,Coma,2,18.0,$25-$50k,46156.0,22832.2656,31.0,white,53.0,1,0,0,no,0.699999809,0.5,dnr after sadm,8.0,110.0,29.5976562,165.0,34.0,39.19531,223.3125,3.5,1.89990234,1.69995117,128.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
70.80396,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,222230.0,110654.812,40.333313,hispanic,60.0,14,1,0,no,0.699999809,0.5,dnr after sadm,19.0,83.0,16.8984375,135.0,34.0,39.0,296.25,3.5,12.0996094,1.39990234,134.0,7.5,135.0,23.0,2502.0,3.2109375,<2 mo. follow-up
86.57098,1,female,1,4,4,Coma,Coma,1,12.0,under $11k,10662.0,5654.9883,14.0,white,40.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,97.0,15.0996094,80.0,28.0,36.79688,24.0,3.5,1.01,1.19995117,133.0,7.239258,135.0,23.0,2502.0,3.831543,<2 mo. follow-up
52.44897,1,male,0,6,1079,Lung Cancer,Cancer,2,12.0,under $11k,10469.0,6520.1992,10.0,white,16.0,1,1,0,metastatic,0.699999809,0.5,no dnr,6.0,84.0,11.5,80.0,20.0,36.19531,333.3,4.5,0.29998779,1.0,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
50.97897,1,male,0,9,1600,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,27015.0,12740.8125,11.5,white,29.0,5,0,0,no,0.979999542,0.95,no dnr,9.0,122.0,9.09960938,110.0,32.0,36.5,124.48438,3.5,1.01,0.79992676,137.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
77.75995,1,male,1,7,7,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,34038.0,18083.2969,27.0,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,58.0,4.89941406,60.0,16.0,36.19531,333.3,4.2998047,1.01,1.59985352,133.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.18198,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,17.0,>$50k,40620.0,20159.0312,46.0,white,64.0,2,0,0,yes,0.0,0.0,dnr after sadm,4.0,60.0,4.5,190.0,40.0,39.5,90.0,1.6999512,0.5,1.19995117,130.0,7.30957,135.0,23.0,2502.0,1.0,<2 mo. follow-up
34.17398,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,39002.0,14452.7344,56.0,white,53.0,3,0,0,no,0.099999964,0.001,dnr after sadm,4.0,67.0,1.59985352,85.0,34.0,33.89844,46.0,3.5,1.89990234,0.29998779,128.0,7.399414,135.0,23.0,2502.0,3.0,<2 mo. follow-up
80.52295,1,male,0,5,164,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5853.0,3727.5195,8.0,white,35.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,97.0,7.19921875,88.0,20.0,36.79688,319.0,4.0,0.69995117,3.19970703,136.0,7.489258,135.0,23.0,2502.0,2.6611328,<2 mo. follow-up
50.53,1,male,0,6,1349,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,18574.0,11205.3984,16.0,white,18.0,3,0,0,no,0.699999809,0.5,no dnr,6.0,66.0,4.89941406,80.0,24.0,36.69531,333.3,3.5,1.01,1.39990234,134.0,7.419922,135.0,23.0,2502.0,2.0595703,<2 mo. follow-up
56.82397,1,female,0,15,699,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,49730.0,23862.5781,13.0,black,15.0,2,0,0,yes,0.699999809,0.65,no dnr,15.0,70.0,22.0,60.0,19.0,37.0,165.6875,3.5,1.01,1.0,137.0,7.449219,135.0,23.0,2502.0,3.105957,adl>=4 (>=5 if sur)
45.892,1,male,0,76,105,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,330735.0,14452.7344,20.5,black,34.0,54,0,0,no,0.699999809,0.5,no dnr,76.0,115.0,9.79882812,145.0,32.0,38.69531,510.0,2.0,0.29998779,0.89990234,136.0,7.40918,135.0,23.0,2502.0,2.6865234,<2 mo. follow-up
69.71698,1,female,1,4,4,Coma,Coma,2,12.0,under $11k,21696.0,11611.6016,34.0,white,25.0,1,1,0,no,0.099999964,0.001,dnr after sadm,3.0,115.0,14.0,95.0,16.0,36.39844,236.65625,3.5,0.39996338,1.79980469,141.0,7.469727,135.0,23.0,2502.0,2.9838867,<2 mo. follow-up
65.89996,1,male,0,20,693,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,143419.0,14452.7344,25.0,white,50.0,18,0,0,no,0.799999714,0.8,no dnr,20.0,130.0,6.69921875,110.0,26.0,38.19531,365.0,2.0996094,0.19998169,1.19995117,131.0,7.5,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
38.491,0,male,0,21,1821,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,111543.0,56904.375,22.333328,white,43.0,4,0,0,no,0.599999905,0.6,no dnr,21.0,123.0,12.8984375,125.0,38.0,39.79688,162.0,2.8999023,3.39990234,0.69995117,134.0,7.259766,135.0,23.0,2502.0,2.4545898,<2 mo. follow-up
65.53595,1,male,0,14,1332,MOSF w/Malig,ARF/MOSF,1,27.0,>$50k,61126.0,30566.9375,21.333328,black,27.0,1,0,0,yes,0.5,0.5,no dnr,14.0,108.0,10.6992188,100.0,12.0,39.29688,220.0,2.2998047,0.89990234,1.79980469,136.0,7.40918,135.0,23.0,2502.0,2.1010742,no(M2 and SIP pres)
59.146,1,male,0,10,585,Lung Cancer,Cancer,2,11.0,under $11k,17737.0,9855.5469,10.5,white,23.0,1,0,0,metastatic,0.5,0.1,no dnr,10.0,74.0,2.69970703,128.0,24.0,38.89844,333.3,3.5,1.19995117,0.89990234,138.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
53.922,1,female,0,24,78,Colon Cancer,Cancer,1,16.0,$25-$50k,46135.0,28130.0312,12.666664,white,14.0,1,0,0,metastatic,0.899999619,0.5,no dnr,24.0,83.0,10.5,100.0,24.0,37.39844,333.3,4.5996094,0.39996338,0.79992676,135.0,7.419922,135.0,23.0,2502.0,2.050293,<2 mo. follow-up
40.63199,0,male,0,13,1816,CHF,COPD/CHF/Cirrhosis,1,1.0,$11-$25k,29551.0,16497.9375,17.0,hispanic,23.0,1,0,0,no,0.75,0.6,no dnr,13.0,95.0,9.0,94.0,26.0,36.0,333.3,3.5,1.01,1.5,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.67596,1,male,0,25,62,Lung Cancer,Cancer,1,12.0,under $11k,57969.0,33842.3438,10.25,white,35.0,1,0,0,metastatic,0.799999714,0.3,dnr after sadm,12.0,64.0,11.3984375,134.0,32.0,38.79688,309.5,2.5996094,1.01,0.79992676,132.0,7.519531,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
53.10098,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,15394.0,7895.8438,29.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,43.0,13.2988281,150.0,22.0,36.69531,610.0,3.7998047,1.5,1.29980469,132.0,7.679688,135.0,23.0,2502.0,2.8071289,<2 mo. follow-up
43.28299,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,100051.0,14452.7344,21.5,white,63.0,22,0,0,yes,0.5,0.3,dnr after sadm,3.0,87.0,0.29998779,140.0,44.0,38.5,259.125,2.699707,3.19970703,1.5,146.0,7.479492,135.0,23.0,2502.0,3.5332031,<2 mo. follow-up
35.14297,1,male,0,5,1131,Lung Cancer,Cancer,0,14.0,>$50k,7880.0,4021.0273,10.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,77.0,8.29882812,80.0,18.0,35.39844,333.3,3.5,1.01,0.89990234,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
51.49899,1,female,0,4,28,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,5765.0,3633.0703,9.0,white,27.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,87.0,6.09960938,88.0,20.0,36.59375,366.625,2.2998047,2.0,1.19995117,130.0,7.549805,135.0,23.0,2502.0,3.0,<2 mo. follow-up
76.44897,1,male,0,18,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,92307.0,49963.5,23.666656,white,37.0,6,0,0,no,0.5,0.5,no dnr,18.0,108.0,14.7988281,140.0,20.0,39.0,333.3,3.5,1.01,2.0,144.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
81.24597,1,female,1,3,3,Coma,Coma,1,12.0,under $11k,15473.0,7722.8047,43.0,white,58.0,1,0,1,no,0.049999982,0.000125,dnr before sadm,0.0,58.0,8.5,70.0,30.0,37.5,178.0,2.5,1.5,2.29980469,135.0,7.369141,135.0,23.0,2502.0,5.2402344,<2 mo. follow-up
19.60599,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,413774.0,14452.7344,48.0,white,59.0,40,0,0,no,0.0,0.0,dnr after sadm,5.0,48.0,6.09960938,131.0,12.0,38.79688,156.25,4.3994141,16.3984375,1.09985352,155.0,7.519531,135.0,23.0,2502.0,2.1264648,<2 mo. follow-up
63.431,0,male,0,61,1809,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,409250.0,14452.7344,34.5,white,34.0,15,0,0,no,0.699999809,0.6,no dnr,61.0,90.0,3.39990234,130.0,20.0,37.09375,230.0,2.7998047,4.69921875,2.09960938,141.0,7.489258,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
52.37198,1,male,0,5,644,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,6622.0,3758.2363,11.0,black,10.0,1,0,0,no,1.0,1.0,no dnr,5.0,102.0,15.5,80.0,18.0,37.0,300.0,3.5,1.01,1.0,140.0,7.429688,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
38.883,0,male,0,15,1807,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,34680.0,18825.9219,18.666656,hispanic,21.0,1,0,0,no,0.599999905,0.5,no dnr,15.0,83.0,7.0,110.0,30.0,38.69531,257.125,3.5996094,0.09999084,0.69995117,133.0,7.449219,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
77.67596,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,26620.0,13928.5234,39.0,white,73.0,4,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,38.0,10.0996094,110.0,20.0,38.79688,207.6875,3.5,2.79980469,2.09960938,131.0,7.279297,135.0,23.0,2502.0,3.7626953,<2 mo. follow-up
75.96698,1,female,0,9,34,Lung Cancer,Cancer,2,12.0,under $11k,12424.0,7979.4453,7.5,white,30.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,5.0,107.0,25.5,100.0,20.0,36.39844,333.3,3.8999023,1.01,1.5,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.38699,1,female,1,12,12,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,221026.0,108952.438,35.0,white,56.0,24,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,112.0,1.39990234,70.0,18.0,36.59375,144.0,4.5996094,7.5,3.89990234,143.0,7.459961,135.0,23.0,2502.0,2.3369141,<2 mo. follow-up
47.24698,1,female,0,10,108,Lung Cancer,Cancer,1,16.0,under $11k,29076.0,15755.8828,27.0,asian,44.0,1,0,0,metastatic,0.899999619,0.5,no dnr,10.0,47.0,12.7988281,140.0,32.0,38.59375,246.9375,2.5996094,1.29980469,1.29980469,135.0,7.369141,135.0,23.0,2502.0,2.9604492,<2 mo. follow-up
69.66699,1,male,1,14,14,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,122908.0,62152.9062,44.333313,white,38.0,3,0,0,no,0.699999809,0.5,dnr after sadm,13.0,93.0,12.2988281,150.0,14.0,37.0,142.84375,2.3999023,5.39941406,0.89990234,138.0,7.279297,135.0,23.0,2502.0,2.5512695,<2 mo. follow-up
57.58197,1,male,0,10,1395,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,26110.0,15292.6016,17.5,white,38.0,1,0,0,no,0.849999905,0.75,no dnr,10.0,65.0,5.0,125.0,26.0,36.89844,400.0,3.8999023,2.79980469,1.29980469,140.0,7.539062,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
50.64798,0,male,0,10,1798,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,23376.0,13861.8125,21.5,black,28.0,1,0,0,no,0.799999714,0.5,no dnr,10.0,67.0,5.29980469,115.0,30.0,36.79688,419.0,3.3999023,1.39990234,1.19995117,143.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.07898,1,male,0,11,800,Colon Cancer,Cancer,1,12.0,>$50k,22300.0,13441.8594,11.5,white,18.0,1,0,0,metastatic,0.949999809,0.75,no dnr,11.0,103.0,4.29980469,110.0,18.0,36.79688,283.3125,4.2998047,0.29998779,1.09985352,142.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.47998,1,male,0,11,406,Colon Cancer,Cancer,1,12.0,under $11k,11506.0,7928.3516,11.0,white,24.0,1,0,0,metastatic,0.989999771,0.75,no dnr,11.0,108.0,6.5,58.0,20.0,38.89844,333.3,4.0996094,0.29998779,1.5,143.0,7.419922,135.0,23.0,2502.0,2.2626953,<2 mo. follow-up
62.875,1,male,0,9,1126,Colon Cancer,Cancer,1,14.0,>$50k,23575.0,14252.5938,8.0,white,20.0,1,0,0,metastatic,0.949999809,0.75,no dnr,9.0,96.0,12.5,120.0,24.0,39.0,333.3,4.5996094,0.19998169,0.79992676,137.0,7.419922,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
74.10797,1,male,1,17,17,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,73695.0,34402.0938,26.333328,white,35.0,1,0,1,no,0.5,0.4,dnr after sadm,5.0,63.0,22.0,160.0,12.0,37.0,134.0,3.5,1.01,0.59997559,140.0,7.429688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
66.73199,1,male,0,18,576,Colon Cancer,Cancer,2,16.0,$25-$50k,30052.0,18453.2812,11.666664,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,18.0,110.0,9.19921875,90.0,28.0,37.19531,333.3,3.8999023,0.5,0.89990234,140.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
71.39996,1,female,0,40,42,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,163714.0,85802.9375,20.25,white,29.0,5,1,0,no,0.699999809,0.5,dnr after sadm,32.0,120.0,10.7988281,65.0,22.0,36.59375,86.65625,3.5,0.5,1.59985352,143.0,7.469727,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
60.85699,1,female,0,9,309,Lung Cancer,Cancer,0,12.0,under $11k,22052.0,13990.0859,11.0,white,29.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,98.0,3.79980469,110.0,20.0,37.5,196.0,4.1992188,0.09999084,1.09985352,136.0,7.40918,135.0,23.0,2502.0,2.5507812,<2 mo. follow-up
47.37598,1,female,1,19,19,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,266998.0,128401.812,38.333313,white,52.0,23,0,0,yes,0.799999714,0.8,dnr after sadm,19.0,78.0,7.59960938,130.0,25.0,39.69531,152.0,3.5,1.19995117,4.59960938,145.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.15094,1,female,1,13,13,CHF,COPD/CHF/Cirrhosis,5,10.0,$11-$25k,27021.0,15741.9766,22.5,black,40.0,1,1,0,no,0.699999809,0.5,dnr after sadm,10.0,127.0,6.69921875,110.0,24.0,37.5,455.5,3.5,1.0,3.5,140.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.24597,0,female,0,15,1788,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,32157.0,17095.1094,12.666664,hispanic,47.0,2,0,0,no,0.949999809,0.95,no dnr,15.0,77.0,33.59375,110.0,22.0,38.0,346.625,3.5,1.59985352,3.0,143.0,7.269531,135.0,23.0,2502.0,1.0,<2 mo. follow-up
21.63699,1,female,0,10,591,Colon Cancer,Cancer,1,16.0,>$50k,17730.0,11209.3672,9.5,white,15.0,1,0,0,metastatic,0.949999809,0.9,no dnr,10.0,88.0,17.0976562,74.0,20.0,36.39844,333.3,3.5,4.19921875,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.58899,1,male,1,7,7,Lung Cancer,Cancer,2,12.0,>$50k,17989.0,10208.0312,11.5,white,26.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,6.0,117.0,12.3984375,135.0,26.0,36.5,333.3,3.5,0.29998779,1.09985352,133.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.20599,1,female,0,13,829,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,28330.0,15057.5703,12.5,black,19.0,1,0,0,no,0.599999905,0.4,no dnr,13.0,93.0,5.79980469,95.0,26.0,37.29688,223.3125,3.5,1.01,0.69995117,142.0,7.379883,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
66.54596,1,male,1,45,45,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,>$50k,348628.0,177669.875,37.75,white,38.0,27,0,0,no,0.949999809,0.95,dnr after sadm,45.0,67.0,19.6992188,150.0,20.0,39.39844,182.5,3.7998047,1.69995117,1.5,127.0,7.469727,135.0,23.0,2502.0,2.9897461,<2 mo. follow-up
66.66895,1,female,1,164,164,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,922581.0,14452.7344,37.75,asian,32.0,1,0,0,no,0.699999809,0.5,dnr after sadm,162.0,112.0,19.5,150.0,19.0,40.19531,177.5,2.5996094,4.09960938,0.89990234,148.0,7.489258,135.0,23.0,2502.0,2.265625,Coma or Intub
73.36597,1,male,1,64,64,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,536925.0,268835.5,44.5,white,68.0,4,1,0,no,0.699999809,0.5,dnr after sadm,64.0,65.0,21.1992188,140.0,14.0,36.5,164.0,2.0,4.79980469,2.39990234,144.0,7.379883,135.0,23.0,2502.0,3.1137695,<2 mo. follow-up
37.59299,1,male,0,5,391,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,29615.0,15255.3672,10.0,white,20.0,3,0,0,no,0.799999714,0.5,no dnr,5.0,103.0,7.29980469,120.0,28.0,36.5,380.0,3.5,1.01,0.79992676,139.0,7.429688,135.0,23.0,2502.0,2.9033203,<2 mo. follow-up
61.34399,1,female,0,9,643,Colon Cancer,Cancer,2,11.0,under $11k,30431.0,16560.6875,26.0,hispanic,24.0,1,1,0,metastatic,0.899999619,0.7,no dnr,9.0,140.0,9.79882812,70.0,26.0,37.5,380.0,3.199707,0.89990234,0.89990234,140.0,7.379883,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
65.92499,1,male,0,7,275,Colon Cancer,Cancer,2,16.0,>$50k,6228.0,3760.6777,9.0,asian,20.0,1,1,0,metastatic,0.5,0.2,no dnr,7.0,73.0,5.09960938,82.0,16.0,37.79688,333.3,3.7998047,0.39996338,1.0,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.33197,0,female,0,8,1783,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,35296.0,15546.6953,10.5,white,52.0,1,0,0,no,0.5,0.4,no dnr,8.0,73.0,12.0996094,140.0,36.0,36.19531,185.6875,3.5,1.01,0.39996338,133.0,7.339844,135.0,23.0,2502.0,4.0380859,<2 mo. follow-up
32.18298,1,female,0,10,16,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,12924.0,7960.1914,10.5,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,82.0,12.1992188,80.0,28.0,36.0,242.84375,3.5,1.01,1.39990234,134.0,7.519531,135.0,23.0,2502.0,2.8623047,<2 mo. follow-up
48.04398,1,male,1,49,49,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,786088.0,421848.5,47.5,white,61.0,6,0,0,no,0.399999857,0.2,dnr after sadm,47.0,107.0,21.5,150.0,30.0,37.79688,138.0,2.699707,16.8984375,1.39990234,143.0,7.469727,135.0,23.0,2502.0,3.0,<2 mo. follow-up
71.66296,1,female,1,5,5,Coma,Coma,0,12.0,under $11k,21598.0,14452.7344,18.0,white,16.0,1,0,0,no,0.009999998,1e-06,dnr after sadm,5.0,113.0,10.1992188,110.0,20.0,39.89844,215.53125,3.5,1.01,0.89990234,127.0,7.439453,135.0,23.0,2502.0,2.2768555,<2 mo. follow-up
64.45197,1,male,0,8,59,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,30265.0,16595.1406,24.0,white,52.0,1,0,0,no,0.099999964,0.001,dnr after sadm,4.0,45.0,16.8984375,135.0,36.0,37.39844,108.15625,3.0,1.29980469,1.69995117,126.0,7.549805,135.0,23.0,2502.0,2.0,<2 mo. follow-up
24.515,0,female,0,19,1782,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,83772.0,45348.7812,23.666656,hispanic,38.0,9,0,0,no,0.5,0.5,no dnr,19.0,120.0,5.69921875,110.0,28.0,37.5,69.0,3.5,1.01,0.89990234,140.0,7.5,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
74.034,1,female,1,9,9,Colon Cancer,Cancer,1,12.0,under $11k,6429.0,4587.7227,7.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,18.3984375,104.0,24.0,36.19531,333.3,3.5,3.29980469,0.69995117,127.0,7.419922,135.0,23.0,2502.0,3.3735352,<2 mo. follow-up
72.03296,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,61750.0,30964.6875,25.0,white,39.0,1,0,0,no,0.699999809,0.5,dnr after sadm,11.0,117.0,15.3984375,120.0,12.0,37.59375,60.0,3.0,0.29998779,1.69995117,138.0,7.319336,135.0,23.0,2502.0,3.8081055,<2 mo. follow-up
68.60797,1,male,0,7,267,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8303.0,5529.5977,10.0,white,18.0,1,1,0,no,0.799999714,0.7,no dnr,7.0,87.0,9.0,80.0,24.0,36.5,332.0,3.5,1.01,1.79980469,142.0,7.479492,135.0,23.0,2502.0,2.9321289,<2 mo. follow-up
59.40598,1,male,0,46,1278,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,157585.0,111605.25,12.25,asian,19.0,9,0,0,no,0.699999809,0.5,no dnr,46.0,78.0,7.19921875,80.0,24.0,37.0,333.3,3.5,0.5,1.0,132.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
20.312,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,99728.0,51038.1562,45.5,white,72.0,5,0,0,no,0.019999996,0.02,no dnr,7.0,117.0,6.29980469,160.0,26.0,40.09375,130.0,2.8999023,2.5,3.0,141.0,7.439453,135.0,23.0,2502.0,3.0,<2 mo. follow-up
80.19397,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,29857.0,15619.8047,17.0,white,25.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,98.0,11.0996094,90.0,32.0,38.5,355.5,3.5,1.01,1.19995117,141.0,7.439453,135.0,23.0,2502.0,2.9487305,<2 mo. follow-up
42.06699,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,18.0,$11-$25k,137943.0,71544.75,44.0,white,78.0,21,0,0,yes,0.699999809,0.5,no dnr,4.0,47.0,2.59960938,175.0,36.0,39.29688,244.875,3.0,4.79980469,5.39941406,135.0,7.449219,135.0,23.0,2502.0,2.2294922,<2 mo. follow-up
23.81699,1,male,0,73,144,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,245347.0,129712.875,15.0,black,55.0,25,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,127.0,17.0,140.0,28.0,37.89844,53.32812,3.5,1.01,1.39990234,135.0,7.429688,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
65.97095,1,male,0,6,676,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,16273.0,9118.7188,23.0,white,37.0,1,0,0,yes,0.699999809,0.5,no dnr,6.0,52.0,8.8984375,80.0,32.0,36.39844,247.59375,3.5996094,1.79980469,1.19995117,136.0,7.479492,135.0,23.0,2502.0,2.4047852,<2 mo. follow-up
67.00098,1,male,0,5,11,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,15242.0,8664.9688,12.0,white,31.0,1,0,0,no,0.75,0.6,no dnr,5.0,42.0,7.79980469,85.0,20.0,36.89844,333.3,3.5996094,0.19998169,1.39990234,138.0,7.419922,135.0,23.0,2502.0,2.1396484,<2 mo. follow-up
58.09698,0,male,0,21,1775,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$25-$50k,150445.0,80889.1875,31.333328,hispanic,38.0,1,1,0,no,0.699999809,0.5,no dnr,21.0,57.0,16.5976562,120.0,10.0,38.29688,192.0,3.199707,0.5,1.09985352,137.0,7.549805,135.0,23.0,2502.0,2.3178711,no(M2 and SIP pres)
34.99799,1,female,0,15,455,Coma,Coma,0,18.0,>$50k,8265.0,36901.7812,12.666664,white,14.0,4,0,0,no,0.5,0.2,no dnr,15.0,103.0,10.0996094,115.0,20.0,37.39844,330.0,3.5,1.01,0.69995117,134.0,7.479492,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
65.96295,1,male,0,55,1760,ARF/MOSF w/Sepsis,ARF/MOSF,0,4.0,under $11k,181645.0,100455.625,21.75,hispanic,21.0,2,0,0,no,0.699999809,0.6,no dnr,55.0,80.0,15.0996094,120.0,30.0,39.0,340.0,3.0996094,0.69995117,0.89990234,142.0,7.5,135.0,23.0,2502.0,2.097168,no(M2 and SIP pres)
43.85999,0,female,0,43,1773,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,186293.0,104734.0,17.25,hispanic,63.0,1,0,0,no,0.5,0.3,no dnr,43.0,46.0,3.5,80.0,20.0,37.19531,300.0,2.3999023,38.3984375,1.89990234,138.0,7.469727,135.0,23.0,2502.0,3.0,<2 mo. follow-up
29.769,0,male,0,34,1772,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,181539.0,97215.5625,30.5,asian,34.0,4,0,0,no,0.699999809,0.5,no dnr,34.0,110.0,16.0,120.0,30.0,37.69531,397.5,2.0,4.29980469,0.69995117,135.0,7.459961,135.0,23.0,2502.0,2.1264648,<2 mo. follow-up
52.71997,1,female,1,9,9,Cirrhosis,COPD/CHF/Cirrhosis,3,20.0,$11-$25k,45273.0,24780.7969,23.5,white,40.0,7,0,0,no,0.009999998,1e-06,dnr after sadm,4.0,97.0,9.5,75.0,18.0,36.39844,290.4375,3.5,2.0,2.5,137.0,7.429688,135.0,23.0,2502.0,3.0878906,<2 mo. follow-up
26.24799,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,260829.0,118488.25,40.0,white,117.0,47,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,35.0,0.04999542,40.0,52.0,36.69531,206.0,1.6999512,3.79980469,1.89990234,138.0,7.219727,135.0,23.0,2502.0,3.0917969,<2 mo. follow-up
66.75397,1,male,0,46,69,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,306038.0,165393.375,33.5,white,37.0,8,0,0,no,0.699999809,0.5,no dnr,46.0,67.0,24.0976562,120.0,22.0,37.0,106.65625,3.5,1.01,1.29980469,139.0,7.509766,135.0,23.0,2502.0,2.4399414,<2 mo. follow-up
53.125,1,male,0,14,139,Lung Cancer,Cancer,1,8.0,$11-$25k,13872.0,7457.1602,5.666664,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,14.0,70.0,9.19921875,72.0,18.0,36.79688,376.1875,3.5,0.19998169,1.0,136.0,7.459961,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
70.74097,1,male,0,14,117,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,>$50k,72222.0,38194.5,37.666657,white,49.0,6,0,0,yes,0.699999809,0.5,no dnr,14.0,77.0,23.0,115.0,28.0,39.0,120.40625,2.7998047,0.09999084,1.19995117,135.0,7.5,135.0,23.0,2502.0,2.4282227,no(M2 and SIP pres)
54.67798,1,male,0,12,37,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,38322.0,22746.25,17.5,white,40.0,6,0,0,no,0.699999809,0.5,no dnr,12.0,58.0,9.0,65.0,18.0,36.09375,333.3,2.5,1.79980469,1.29980469,145.0,7.5,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
81.45398,1,male,0,30,163,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,92518.0,46889.4062,21.75,white,42.0,5,0,0,no,0.399999857,0.3,no dnr,30.0,60.0,8.3984375,75.0,40.0,38.89844,391.0,3.0,1.01,1.09985352,132.0,7.529297,135.0,23.0,2502.0,2.4912109,<2 mo. follow-up
58.27499,1,female,0,40,607,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,161257.0,74216.125,25.25,black,30.0,1,0,0,no,0.199999928,0.15,no dnr,40.0,77.0,16.5976562,115.0,12.0,37.29688,68.0,3.3999023,1.01,0.89990234,144.0,7.299805,135.0,23.0,2502.0,6.0,<2 mo. follow-up
36.96899,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,85027.0,46872.9375,37.0,other,73.0,22,0,0,no,0.699999809,0.5,dnr after sadm,1.0,111.0,21.6992188,120.0,70.0,39.89844,333.3,4.5,54.296875,5.69921875,138.0,7.419922,135.0,23.0,2502.0,2.4121094,<2 mo. follow-up
44.47897,0,male,0,8,1767,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,$25-$50k,12696.0,8186.1445,5.0,white,35.0,1,0,0,no,0.5,0.5,no dnr,8.0,100.0,4.69921875,82.0,18.0,36.79688,333.3,2.2998047,14.1992188,0.79992676,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.98096,0,male,0,13,1768,Colon Cancer,Cancer,1,16.0,>$50k,42514.0,27452.6562,16.0,white,20.0,1,0,0,metastatic,0.899999619,0.75,no dnr,13.0,115.0,4.19921875,70.0,22.0,38.39844,333.3,3.0996094,1.59985352,1.0,142.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
82.245,1,female,1,10,10,Coma,Coma,0,12.0,under $11k,73656.0,39791.0,34.0,white,19.0,4,0,0,no,0.699999809,0.5,dnr after sadm,3.0,123.0,9.0,75.0,9.0,36.69531,295.0,3.5,1.01,1.19995117,140.0,7.479492,135.0,23.0,2502.0,2.355957,<2 mo. follow-up
38.49698,0,male,0,62,1766,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,>$50k,463001.0,269057.0,26.5,white,35.0,8,0,0,no,0.799999714,0.75,no dnr,62.0,73.0,10.0996094,130.0,18.0,38.59375,237.5,3.0996094,13.7988281,1.09985352,145.0,7.529297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.37598,1,male,0,19,110,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,64372.0,33652.5,20.0,black,53.0,2,1,0,yes,0.5,0.3,no dnr,19.0,70.0,0.69995117,120.0,32.0,37.0,396.625,2.0996094,0.69995117,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.44998,1,male,0,20,33,CHF,COPD/CHF/Cirrhosis,2,20.0,under $11k,30148.0,18298.875,7.0,white,29.0,1,0,0,no,0.989999771,0.95,no dnr,20.0,85.0,6.19921875,90.0,28.0,37.0,403.3125,3.5,1.01,1.69995117,133.0,7.5,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
83.30194,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,49455.0,23976.9219,23.5,white,42.0,4,1,0,no,0.5,0.3,dnr after sadm,9.0,130.0,11.8984375,80.0,10.0,38.5,242.84375,3.5,1.01,1.0,138.0,7.509766,135.0,23.0,2502.0,3.5644531,<2 mo. follow-up
43.995,0,female,0,50,1760,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,260514.0,173060.625,23.5,white,33.0,9,0,0,no,0.699999809,0.6,no dnr,50.0,80.0,20.8984375,130.0,20.0,36.29688,485.0,2.7998047,3.0,1.89990234,136.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
50.09698,1,male,0,15,376,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,29840.0,16369.5781,14.333328,other,5.0,1,0,0,yes,0.799999714,0.7,no dnr,15.0,97.0,11.0996094,80.0,16.0,37.39844,419.0,3.5,0.69995117,1.19995117,136.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
80.18896,1,male,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,>$50k,257589.0,125511.5,25.0,white,37.0,4,0,0,no,0.399999857,0.2,dnr after sadm,39.0,133.0,10.1992188,120.0,36.0,38.69531,204.4375,3.5,0.5,1.09985352,147.0,7.469727,135.0,23.0,2502.0,2.0,<2 mo. follow-up
40.20499,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,151181.0,74438.9375,47.0,white,77.0,28,0,0,yes,0.699999809,0.5,dnr after sadm,5.0,52.0,6.5,150.0,35.0,36.79688,122.0,2.699707,10.5996094,1.19995117,143.0,7.349609,135.0,23.0,2502.0,3.0107422,<2 mo. follow-up
57.01797,1,female,0,5,1462,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,12504.0,7491.3047,9.0,white,13.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,93.0,12.1992188,88.0,18.0,37.19531,423.75,4.6992188,0.59997559,0.89990234,133.0,7.419922,135.0,23.0,2502.0,2.4633789,<2 mo. follow-up
38.90799,1,female,0,12,1480,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,48336.0,23679.7969,19.5,white,49.0,2,0,0,no,0.899999619,0.9,no dnr,12.0,107.0,18.6992188,120.0,28.0,37.5,280.0,3.5,1.01,4.29980469,125.0,7.289062,135.0,23.0,2502.0,3.0,<2 mo. follow-up
75.54297,1,male,0,11,484,Colon Cancer,Cancer,1,14.0,$25-$50k,18233.0,11379.5781,11.5,white,11.0,1,0,0,metastatic,0.949999809,0.8,no dnr,11.0,93.0,13.8984375,84.0,20.0,36.19531,333.3,3.5,1.19995117,1.0,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
34.80899,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,71315.0,32862.0938,41.0,white,76.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,5.0,62.0,0.69995117,135.0,60.0,38.5,82.0,2.5996094,6.09960938,0.5,141.0,7.40918,135.0,23.0,2502.0,3.0834961,<2 mo. follow-up
73.72998,1,male,0,15,879,Colon Cancer,Cancer,1,12.0,under $11k,41836.0,24937.7812,11.333328,white,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,15.0,127.0,5.29980469,88.0,18.0,36.79688,333.3,4.2998047,1.69995117,1.09985352,141.0,7.419922,135.0,23.0,2502.0,2.1674805,<2 mo. follow-up
42.543,1,male,1,12,12,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,217970.0,106592.312,31.0,white,65.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,8.0,50.0,1.09985352,140.0,30.0,38.5,396.625,3.5,1.01,6.69921875,137.0,7.429688,135.0,23.0,2502.0,2.6279297,<2 mo. follow-up
68.70099,1,male,0,4,100,Lung Cancer,Cancer,1,12.0,under $11k,8570.0,4938.3711,11.0,white,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,121.0,4.19921875,74.0,8.0,37.79688,333.3,3.5,1.01,1.0,137.0,7.419922,135.0,23.0,2502.0,2.2436523,<2 mo. follow-up
73.56299,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,192983.0,104663.5,25.0,white,62.0,10,0,0,yes,0.199999928,0.008,dnr after sadm,20.0,133.0,28.5976562,140.0,39.0,38.89844,61.0,3.5,1.01,0.79992676,132.0,7.399414,135.0,23.0,2502.0,2.9082031,<2 mo. follow-up
69.10297,1,female,0,12,1479,Colon Cancer,Cancer,1,12.0,under $11k,39080.0,21387.7969,21.0,white,29.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,97.0,10.6992188,115.0,28.0,37.29688,333.3,3.0,3.89990234,0.89990234,145.0,7.419922,135.0,23.0,2502.0,2.4438477,<2 mo. follow-up
67.41095,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,19247.0,10152.1172,32.0,white,73.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,35.0,13.0,140.0,10.0,41.0,171.40625,3.5,1.01,4.29980469,151.0,7.509766,135.0,23.0,2502.0,2.9233398,<2 mo. follow-up
79.72095,1,male,1,7,7,CHF,COPD/CHF/Cirrhosis,1,18.0,>$50k,23327.0,12108.2656,24.0,asian,54.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,33.0,8.09960938,100.0,16.0,36.19531,333.3,2.8999023,1.01,5.5,129.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
48.35898,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,60676.0,31216.8438,36.5,hispanic,22.0,4,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,87.0,3.69970703,125.0,17.0,36.59375,90.65625,3.5,1.01,0.59997559,143.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
60.67398,1,male,1,94,94,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,481475.0,247740.75,31.0,white,59.0,3,1,0,no,0.699999809,0.5,dnr after sadm,72.0,77.0,9.29882812,100.0,36.0,36.59375,127.5,3.5,1.01,2.59960938,125.0,7.529297,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
58.31897,1,female,0,5,562,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,5877.0,3397.6699,7.0,hispanic,21.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,87.0,4.89941406,80.0,20.0,37.19531,333.3,2.199707,4.79980469,1.0,135.0,7.419922,135.0,23.0,2502.0,3.1245117,<2 mo. follow-up
59.88498,0,male,0,11,1742,CHF,COPD/CHF/Cirrhosis,1,14.0,$25-$50k,25441.0,15499.7812,19.0,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,67.0,9.29882812,110.0,18.0,36.79688,333.3,4.1992188,0.39996338,1.39990234,140.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
64.02698,1,male,0,4,285,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,11926.0,6952.0156,12.0,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,62.0,5.39941406,70.0,18.0,36.5,252.375,4.5996094,1.19995117,1.09985352,136.0,7.429688,135.0,23.0,2502.0,1.6655273,<2 mo. follow-up
34.461,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,193371.0,93435.3125,33.0,white,70.0,35,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,33.0,1.09985352,130.0,35.0,35.89844,80.0,2.5,0.89990234,1.29980469,141.0,7.369141,135.0,23.0,2502.0,1.9511719,<2 mo. follow-up
47.33499,0,female,0,26,1740,Colon Cancer,Cancer,1,12.0,under $11k,53037.0,29296.4375,13.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,26.0,93.0,10.0,100.0,20.0,38.59375,333.3,4.0,6.19921875,0.69995117,140.0,7.419922,135.0,23.0,2502.0,2.6083984,<2 mo. follow-up
47.77798,0,female,0,7,1739,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,14867.0,14452.7344,5.5,other,30.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,91.0,5.59960938,76.0,20.0,37.0,333.3,1.8999023,5.29980469,0.69995117,134.0,7.419922,135.0,23.0,2502.0,2.1303711,<2 mo. follow-up
49.28998,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,73143.0,38012.75,60.0,white,103.0,1,0,0,no,0.5,0.5,no dnr,6.0,47.0,2.39990234,160.0,40.0,34.0,85.0,3.5,1.01,3.0,139.0,7.069336,135.0,23.0,2502.0,2.1860352,<2 mo. follow-up
51.573,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,121630.0,59514.5625,35.666657,white,32.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,22.0,98.0,10.0996094,85.0,28.0,37.19531,44.4375,3.3999023,1.89990234,1.29980469,133.0,7.40918,135.0,23.0,2502.0,3.3798828,<2 mo. follow-up
73.90295,0,male,0,4,1736,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,6676.0,4164.0781,11.0,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,100.0,14.8984375,100.0,20.0,36.79688,333.3,3.5,1.01,1.5,137.0,7.419922,135.0,23.0,2502.0,2.2524414,<2 mo. follow-up
71.28497,0,male,0,7,1736,Lung Cancer,Cancer,2,12.0,under $11k,16142.0,10552.0469,7.0,white,17.0,1,1,0,metastatic,1.0,0.95,no dnr,7.0,95.0,16.0,70.0,22.0,37.5,495.1875,3.5,1.01,1.39990234,137.0,7.40918,135.0,23.0,2502.0,2.5341797,<2 mo. follow-up
55.29898,0,female,0,11,1735,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,85170.0,43481.7812,23.0,white,31.0,7,0,0,no,0.699999809,0.5,no dnr,11.0,83.0,8.09960938,150.0,32.0,38.69531,350.0,3.5,1.01,0.89990234,130.0,7.489258,135.0,23.0,2502.0,2.8974609,<2 mo. follow-up
52.68997,1,male,0,8,353,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,50315.0,27577.9062,13.0,white,28.0,6,0,0,metastatic,0.699999809,0.5,no dnr,8.0,125.0,15.5996094,118.0,36.0,37.0,310.0,3.5,1.01,0.89990234,141.0,7.469727,135.0,23.0,2502.0,3.7290039,<2 mo. follow-up
81.38794,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,207883.0,108700.562,42.5,white,58.0,21,0,0,no,0.699999809,0.5,dnr after sadm,9.0,63.0,17.5,70.0,37.0,39.0,285.0,2.199707,3.19970703,4.19921875,138.0,7.449219,135.0,23.0,2502.0,3.1708984,<2 mo. follow-up
49.29999,1,male,0,29,160,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,241565.0,129540.125,27.5,white,54.0,2,0,0,no,0.099999964,0.001,no dnr,29.0,87.0,5.79980469,110.0,16.0,35.19531,194.28125,2.199707,4.0,3.09960938,148.0,7.439453,135.0,23.0,2502.0,3.9243164,<2 mo. follow-up
64.69299,1,male,0,9,523,Colon Cancer,Cancer,1,12.0,$25-$50k,24410.0,13153.6484,14.0,white,21.0,1,0,0,metastatic,0.899999619,0.75,no dnr,9.0,67.0,9.8984375,110.0,12.0,37.5,215.0,4.5,0.79992676,1.09985352,135.0,7.449219,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
61.67798,1,male,0,9,926,Colon Cancer,Cancer,1,12.0,>$50k,18565.0,11830.1406,9.5,white,16.0,1,0,0,metastatic,0.899999619,0.8,no dnr,9.0,95.0,11.7988281,88.0,20.0,37.0,333.3,3.5,0.59997559,1.29980469,139.0,7.419922,135.0,23.0,2502.0,2.5693359,no(M2 and SIP pres)
64.25195,1,male,0,4,1049,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,7339.0,4110.2852,6.0,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,73.0,3.89990234,110.0,24.0,36.39844,256.625,3.5,1.01,1.5,136.0,7.339844,135.0,23.0,2502.0,2.1958008,no(M2 and SIP pres)
56.95798,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,80188.0,43882.9062,37.5,other,59.0,7,0,0,no,0.699999809,0.5,dnr after sadm,7.0,68.0,17.5,125.0,32.0,36.39844,193.875,3.5,35.0,9.09960938,146.0,7.479492,135.0,23.0,2502.0,2.5454102,<2 mo. follow-up
29.71399,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,55429.0,31358.9688,38.0,other,30.0,2,0,0,yes,0.699999809,0.5,dnr after sadm,7.0,120.0,2.69970703,55.0,14.0,36.09375,190.0,3.5,1.01,1.5,128.0,7.449219,135.0,23.0,2502.0,2.3691406,<2 mo. follow-up
35.56998,1,female,0,33,66,MOSF w/Malig,ARF/MOSF,1,19.0,>$50k,141926.0,69217.8125,21.0,black,46.0,8,0,0,yes,0.699999809,0.5,no dnr,33.0,113.0,0.04999542,120.0,28.0,37.59375,419.0,2.5,1.09985352,0.69995117,133.0,7.459961,135.0,23.0,2502.0,6.0,<2 mo. follow-up
38.42297,1,male,0,10,520,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,36468.0,21043.3125,10.0,black,38.0,2,1,0,no,0.699999809,0.5,no dnr,10.0,114.0,21.0,98.0,20.0,38.0,333.3,3.5,1.01,10.5,131.0,7.419922,135.0,23.0,2502.0,3.4711914,<2 mo. follow-up
62.53497,1,male,0,24,149,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,188728.0,91829.375,29.666656,white,29.0,17,0,0,no,0.5,0.4,dnr after sadm,1.0,88.0,3.69970703,130.0,24.0,39.5,140.0,3.5,1.01,1.19995117,148.0,7.5,135.0,23.0,2502.0,2.7363281,<2 mo. follow-up
76.49597,1,male,1,5,5,Lung Cancer,Cancer,1,12.0,under $11k,7422.0,4047.9668,11.0,white,51.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,2.0,110.0,13.8984375,72.0,26.0,36.19531,209.0625,3.5,0.39996338,2.0,146.0,7.40918,135.0,23.0,2502.0,3.1860352,<2 mo. follow-up
83.16199,1,male,1,3,3,Coma,Coma,1,12.0,under $11k,13767.0,7227.2383,25.0,white,29.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,93.0,18.0,150.0,32.0,37.89844,593.0,3.5,1.01,1.19995117,136.0,7.439453,135.0,23.0,2502.0,3.2773438,<2 mo. follow-up
57.52798,0,male,0,20,1722,Coma,Coma,0,12.0,under $11k,82244.0,39760.5938,25.333328,white,19.0,1,0,0,no,0.099999964,0.001,no dnr,20.0,60.0,19.796875,75.0,15.0,36.89844,210.0,3.5,1.01,1.0,137.0,7.469727,135.0,23.0,2502.0,2.3989258,<2 mo. follow-up
73.66498,1,male,0,7,31,Colon Cancer,Cancer,1,12.0,under $11k,9640.0,6026.8203,7.0,white,22.0,1,0,0,metastatic,0.599999905,0.2,dnr after sadm,1.0,93.0,3.5,84.0,20.0,36.39844,333.3,3.5,1.01,1.5,133.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
46.51099,0,male,0,74,1717,Cirrhosis,COPD/CHF/Cirrhosis,1,15.0,$25-$50k,603388.0,324555.0,42.0,black,83.0,1,0,0,no,0.5,0.5,no dnr,74.0,67.0,17.5976562,110.0,36.0,39.0,420.0,1.5,31.5976562,5.5,137.0,7.629883,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
78.91895,1,female,1,37,37,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,219537.0,104714.062,35.0,white,43.0,2,0,0,no,0.699999809,0.5,dnr after sadm,28.0,60.0,27.5976562,100.0,18.0,38.5,282.8125,2.699707,1.01,2.59960938,140.0,7.359375,135.0,23.0,2502.0,3.2841797,<2 mo. follow-up
68.91394,1,female,0,11,253,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,30869.0,17227.4375,15.0,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,67.0,16.0976562,135.0,32.0,37.19531,222.84375,3.0996094,0.59997559,0.5,135.0,7.5,135.0,23.0,2502.0,2.762207,<2 mo. follow-up
42.29199,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,161776.0,84674.25,53.0,white,77.0,36,0,0,yes,0.699999809,0.5,dnr after sadm,4.0,42.0,14.2988281,115.0,35.0,38.39844,32.0,3.5,1.69995117,3.5,125.0,7.25,135.0,23.0,2502.0,2.1401367,<2 mo. follow-up
46.57898,1,male,0,7,316,CHF,COPD/CHF/Cirrhosis,1,22.0,under $11k,17254.0,10264.8203,12.0,black,23.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,72.0,6.29980469,100.0,20.0,36.19531,333.3,3.5,1.01,1.59985352,136.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
54.03998,0,male,0,15,1712,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,135849.0,92919.4375,22.666656,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,68.0,5.29980469,110.0,12.0,36.09375,353.3125,3.0996094,1.79980469,1.19995117,129.0,7.529297,135.0,23.0,2502.0,1.0,<2 mo. follow-up
45.10599,0,male,0,8,1711,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,35204.0,18938.3125,19.5,white,33.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,92.0,8.0,120.0,36.0,37.09375,142.84375,2.8999023,1.01,1.29980469,134.0,7.5,135.0,23.0,2502.0,2.7602539,<2 mo. follow-up
87.46295,1,female,0,10,1503,CHF,COPD/CHF/Cirrhosis,1,12.0,>$50k,12163.0,7719.5469,6.5,white,21.0,1,0,0,no,0.949999809,0.8,no dnr,10.0,93.0,8.3984375,84.0,20.0,36.39844,342.8125,3.5,1.01,0.79992676,126.0,7.489258,135.0,23.0,2502.0,3.7792969,no(M2 and SIP pres)
79.24695,1,female,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,174898.0,83313.125,32.5,black,51.0,3,0,0,no,0.699999809,0.5,dnr after sadm,18.0,73.0,10.5996094,110.0,25.0,37.59375,115.0,2.0996094,1.01,1.09985352,135.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
39.73999,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,352017.0,237611.75,50.0,other,75.0,12,0,0,no,0.699999809,0.5,no dnr,4.0,60.0,20.5976562,130.0,44.0,39.29688,238.0,3.2998047,11.0996094,4.59960938,146.0,7.429688,135.0,23.0,2502.0,3.2241211,<2 mo. follow-up
78.17395,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,372459.0,185530.625,45.0,asian,82.0,48,0,0,no,0.699999809,0.5,dnr after sadm,5.0,45.0,10.5,120.0,28.0,36.89844,317.5,5.7998047,23.1992188,2.29980469,131.0,7.439453,135.0,23.0,2502.0,2.9794922,<2 mo. follow-up
79.13196,1,female,0,13,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,36811.0,19305.6875,19.0,white,39.0,1,0,0,metastatic,0.699999809,0.5,no dnr,13.0,47.0,18.1992188,90.0,22.0,37.19531,100.0,3.5,0.69995117,0.89990234,136.0,7.449219,135.0,23.0,2502.0,4.6357422,<2 mo. follow-up
70.63898,1,male,0,32,376,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,104045.0,60743.4688,14.5,white,32.0,12,0,0,no,0.149999976,0.00337,no dnr,32.0,80.0,11.2988281,95.0,18.0,37.0,148.3125,4.1992188,0.69995117,5.79980469,139.0,7.229492,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
41.26498,1,female,1,118,118,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,597427.0,312839.5,40.0,white,87.0,1,0,0,no,0.799999714,0.7,dnr after sadm,118.0,53.0,8.09960938,129.0,26.0,36.5,92.0,4.0,11.6992188,4.19921875,151.0,7.319336,135.0,23.0,2502.0,3.331543,no(M2 and SIP pres)
38.35699,1,female,0,5,303,Colon Cancer,Cancer,1,12.0,under $11k,5573.0,3331.4453,12.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,71.0,8.3984375,80.0,16.0,36.79688,333.3,3.0,0.5,0.79992676,139.0,7.419922,135.0,23.0,2502.0,2.0043945,<2 mo. follow-up
59.92099,1,male,0,11,30,Lung Cancer,Cancer,1,12.0,under $11k,19491.0,12055.1172,10.5,black,22.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,6.0,81.0,20.5976562,72.0,18.0,36.39844,118.35938,3.5996094,1.01,1.59985352,130.0,7.40918,135.0,23.0,2502.0,3.5507812,<2 mo. follow-up
58.11899,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,40421.0,20993.2344,51.0,white,112.0,3,0,0,no,0.699999809,0.5,dnr after sadm,2.0,15.0,0.89990234,40.0,20.0,33.09375,245.0,2.0996094,1.39990234,2.69970703,127.0,7.40918,135.0,23.0,2502.0,2.1513672,<2 mo. follow-up
35.25,1,female,0,38,1607,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,271731.0,130874.125,26.75,white,55.0,33,0,0,yes,0.699999809,0.5,no dnr,38.0,60.0,6.79980469,135.0,33.0,39.0,128.875,3.0,0.19998169,5.5,133.0,7.519531,135.0,23.0,2502.0,2.2861328,<2 mo. follow-up
66.18994,1,female,0,12,635,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,53786.0,28395.1875,25.0,white,27.0,3,1,0,no,0.699999809,0.5,no dnr,12.0,113.0,13.0996094,110.0,20.0,36.0,232.5,3.5,1.01,1.69995117,143.0,7.429688,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
41.02698,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,237244.0,115715.938,43.0,white,59.0,3,0,0,no,0.799999714,0.7,dnr after sadm,16.0,57.0,4.0,120.0,18.0,35.19531,175.0,3.5,9.59960938,2.0,141.0,7.429688,135.0,23.0,2502.0,3.1860352,<2 mo. follow-up
54.93198,0,male,0,49,1701,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,59995.78781114967,215823.25,27.75,white,46.0,3,0,0,no,0.099999964,0.001,no dnr,49.0,43.0,8.5,120.0,14.0,38.89844,763.25,3.5,1.01,3.79980469,145.0,7.55957,135.0,23.0,2502.0,2.9755859,no(M2 and SIP pres)
78.58997,1,male,1,8,8,Colon Cancer,Cancer,1,12.0,under $11k,5871.0,4175.8438,6.5,black,24.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,8.69921875,90.0,20.0,35.59375,333.3,3.5,1.01,1.0,144.0,7.419922,135.0,23.0,2502.0,3.1899414,<2 mo. follow-up
82.21497,1,male,0,37,659,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$11-$25k,135785.0,73608.75,22.25,white,30.0,3,1,0,no,0.5,0.5,no dnr,37.0,63.0,9.3984375,50.0,14.0,36.59375,148.0,3.0996094,0.89990234,1.19995117,143.0,7.509766,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
40.34198,1,male,1,40,40,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,370093.0,183324.25,29.5,white,65.0,25,0,0,yes,0.699999809,0.5,dnr after sadm,37.0,57.0,1.29980469,140.0,16.0,38.69531,184.0,3.5,1.19995117,5.79980469,139.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
60.84097,1,male,1,23,23,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,173498.0,87509.5625,42.666657,white,43.0,1,0,0,no,0.75,0.75,no dnr,23.0,63.0,10.6992188,110.0,18.0,37.09375,120.0,2.8999023,1.09985352,1.59985352,136.0,7.489258,135.0,23.0,2502.0,2.7094727,<2 mo. follow-up
67.82996,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,242746.0,117194.312,46.333313,white,54.0,6,0,0,yes,0.699999809,0.5,dnr after sadm,5.0,58.0,9.59960938,85.0,16.0,39.79688,65.0,3.5,1.01,5.69921875,145.0,7.279297,135.0,23.0,2502.0,2.4858398,<2 mo. follow-up
65.41296,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,86956.0,41667.4375,49.0,black,99.0,4,1,0,no,0.199999928,0.2,dnr after sadm,5.0,57.0,19.6992188,110.0,90.0,34.5,87.5,3.5,4.09960938,2.5,133.0,7.299805,135.0,23.0,2502.0,2.5546875,<2 mo. follow-up
74.297,0,male,0,7,1690,CHF,COPD/CHF/Cirrhosis,2,18.0,>$50k,19565.0,10881.6172,24.0,white,53.0,1,0,0,no,0.5,0.25,no dnr,7.0,62.0,6.5,80.0,18.0,37.0,41.0,3.5,1.01,2.09960938,134.0,7.169922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
61.78799,0,female,0,3,1690,Lung Cancer,Cancer,1,12.0,under $11k,4226.0,14452.7344,12.0,black,23.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,93.0,8.09960938,106.0,24.0,37.0,333.3,3.5,0.29998779,1.59985352,129.0,7.419922,135.0,23.0,2502.0,2.5039062,no(M2 and SIP pres)
45.43198,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,2,16.0,$11-$25k,110902.0,55334.2188,47.5,hispanic,57.0,18,0,0,yes,0.699999809,0.5,dnr after sadm,7.0,63.0,11.7988281,120.0,32.0,37.69531,92.21875,2.2998047,1.01,1.69995117,136.0,7.5,135.0,23.0,2502.0,2.4604492,<2 mo. follow-up
62.45297,0,male,0,43,1686,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,269517.0,156722.375,20.0,white,26.0,1,0,0,no,0.899999619,0.8,no dnr,43.0,63.0,7.89941406,100.0,20.0,36.59375,333.3,3.5,1.01,1.39990234,134.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
70.28094,1,male,0,12,659,Colon Cancer,Cancer,1,12.0,under $11k,25535.0,16605.7656,12.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,87.0,20.5976562,76.0,20.0,36.59375,333.3,4.0996094,0.79992676,1.29980469,137.0,7.419922,135.0,23.0,2502.0,2.3105469,<2 mo. follow-up
52.28497,0,female,0,29,1684,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,303548.0,185368.625,18.0,white,73.0,10,0,0,no,0.699999809,0.7,no dnr,29.0,58.0,18.3984375,170.0,36.0,38.29688,173.3125,3.7998047,16.296875,1.5,141.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.76599,1,male,0,16,654,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,30477.0,18391.8281,11.0,black,36.0,1,1,0,no,1.0,0.8,no dnr,16.0,80.0,11.3984375,120.0,28.0,36.0,490.4375,3.5,3.5,1.29980469,136.0,7.55957,135.0,23.0,2502.0,3.3032227,<2 mo. follow-up
54.74298,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,79089.0,41714.1562,22.0,white,55.0,27,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,72.0,0.04999542,110.0,32.0,37.89844,91.65625,2.0,1.01,0.59997559,128.0,7.549805,135.0,23.0,2502.0,3.3017578,<2 mo. follow-up
54.78198,1,male,0,7,92,Lung Cancer,Cancer,2,12.0,under $11k,7383.0,4346.3086,7.0,black,13.0,1,1,0,metastatic,0.699999809,0.5,no dnr,7.0,88.0,5.89941406,114.0,22.0,37.39844,333.3,3.5,1.01,1.01,139.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
46.69998,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,105684.0,53072.8438,41.0,other,88.0,19,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,28.0,0.09999084,135.0,35.0,36.09375,51.0,3.5,1.01,1.5,132.0,7.319336,135.0,23.0,2502.0,1.8427734,<2 mo. follow-up
36.59097,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,80565.0,38249.9688,41.5,white,98.0,3,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,58.0,0.5,140.0,40.0,38.89844,95.375,3.0,1.69995117,2.29980469,128.0,7.279297,135.0,23.0,2502.0,2.6972656,<2 mo. follow-up
83.39496,0,male,0,5,1682,CHF,COPD/CHF/Cirrhosis,1,13.0,$11-$25k,3968.0,2632.3965,9.0,black,27.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,77.0,5.69921875,80.0,22.0,37.19531,333.3,4.0996094,0.69995117,1.5,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
41.29797,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,182264.0,94687.875,29.333328,black,59.0,22,1,0,no,0.799999714,0.75,dnr after sadm,18.0,52.0,25.6992188,140.0,10.0,39.0,282.8125,2.5996094,0.39996338,4.69921875,128.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
90.13794,1,male,0,27,53,MOSF w/Malig,ARF/MOSF,2,24.0,under $11k,124700.0,63788.7812,23.5,white,61.0,26,0,0,metastatic,0.0,0.0,dnr before sadm,-5.0,63.0,25.1992188,65.0,28.0,36.5,172.5,2.0,2.89990234,1.79980469,138.0,7.479492,135.0,23.0,2502.0,5.7294922,<2 mo. follow-up
20.09599,1,female,0,18,365,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,51152.0,14452.7344,16.666656,black,37.0,2,1,0,no,1.0,0.75,no dnr,18.0,63.0,16.5,125.0,32.0,39.0,333.3,3.5,1.01,1.39990234,130.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
38.92999,0,male,0,4,1681,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,$25-$50k,4117.0,2564.5,5.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,96.0,6.89941406,92.0,22.0,38.39844,333.3,2.5996094,8.29882812,0.79992676,129.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
39.81897,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,79944.0,41072.2812,38.0,white,105.0,16,0,0,no,0.699999809,0.5,dnr after sadm,3.0,23.0,38.09375,135.0,48.0,36.39844,130.0,4.3994141,5.69921875,3.79980469,138.0,7.199219,135.0,23.0,2502.0,3.0444336,<2 mo. follow-up
53.09497,1,female,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,0,12.0,under $11k,47800.0,23203.7656,36.0,white,78.0,3,0,0,no,0.699999809,0.5,dnr after sadm,1.0,65.0,22.1992188,195.0,22.0,40.0,150.0,3.5,34.5,2.29980469,137.0,7.519531,135.0,23.0,2502.0,3.5976562,<2 mo. follow-up
53.38498,0,female,0,13,1676,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,81459.0,58011.0938,17.0,white,52.0,2,0,0,no,0.699999809,0.5,no dnr,13.0,73.0,5.19921875,120.0,12.0,38.39844,190.0,3.8999023,0.29998779,7.39941406,128.0,7.359375,135.0,23.0,2502.0,2.7265625,no(M2 and SIP pres)
79.81396,1,male,0,22,650,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,98268.0,50717.0312,28.666656,white,53.0,3,1,0,no,0.5,0.5,dnr after sadm,7.0,102.0,15.8984375,135.0,12.0,38.5,122.0,2.8999023,2.79980469,2.69970703,144.0,7.30957,135.0,23.0,2502.0,3.371582,adl>=4 (>=5 if sur)
68.45996,1,female,0,11,136,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26493.0,14291.1875,10.0,black,16.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,100.0,7.29980469,60.0,22.0,37.79688,222.0,3.5,0.79992676,0.69995117,138.0,7.469727,135.0,23.0,2502.0,3.9082031,adl>=4 (>=5 if sur)
52.52597,1,female,0,8,1206,CHF,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,20605.0,12221.1406,15.0,black,28.0,1,0,0,no,0.5,0.3,no dnr,8.0,63.0,6.0,65.0,20.0,36.39844,400.0,4.0,0.39996338,2.69970703,136.0,7.339844,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
62.50198,1,male,0,4,595,CHF,COPD/CHF/Cirrhosis,4,4.0,$11-$25k,8761.0,5023.8125,7.0,hispanic,26.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,70.0,9.29882812,60.0,20.0,36.0,352.375,3.5,0.29998779,1.5,138.0,7.449219,135.0,23.0,2502.0,2.5043945,<2 mo. follow-up
57.02899,1,male,0,27,45,Cirrhosis,COPD/CHF/Cirrhosis,3,17.0,$11-$25k,145874.0,74736.375,30.0,white,44.0,2,0,0,yes,0.5,0.0,dnr after sadm,17.0,67.0,5.09960938,130.0,25.0,37.0,212.5,2.5,8.3984375,1.09985352,136.0,7.55957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.448,1,male,0,8,608,CHF,COPD/CHF/Cirrhosis,3,3.0,under $11k,13444.0,7088.8398,12.0,black,20.0,1,0,0,no,0.949999809,0.8,no dnr,8.0,117.0,7.0,82.0,28.0,36.59375,428.5625,3.8999023,1.09985352,1.19995117,139.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
87.76697,1,female,0,28,57,COPD,COPD/CHF/Cirrhosis,1,16.0,under $11k,109552.0,53782.9062,25.25,white,54.0,1,0,0,no,0.5,0.4,dnr after sadm,1.0,55.0,23.796875,165.0,36.0,37.79688,273.3125,3.0,1.01,0.5,143.0,7.299805,135.0,23.0,2502.0,4.4589844,<2 mo. follow-up
65.71399,1,male,1,6,6,Coma,Coma,2,12.0,under $11k,45707.0,21547.7344,37.0,white,72.0,1,0,0,no,0.0,0.0,dnr after sadm,5.0,43.0,14.8984375,80.0,26.0,38.89844,174.0,3.5,9.8984375,7.69921875,137.0,7.449219,135.0,23.0,2502.0,2.753418,<2 mo. follow-up
46.97098,0,female,0,4,1666,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,5975.0,3269.1504,8.0,hispanic,9.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,112.0,8.19921875,72.0,20.0,37.59375,238.09375,3.5,1.01,0.79992676,139.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
62.10797,1,male,0,11,664,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,22091.0,13650.9375,11.5,white,16.0,1,0,0,no,0.5,0.3,no dnr,11.0,95.0,5.5,75.0,22.0,36.0,333.3,3.8999023,1.01,1.29980469,138.0,7.419922,135.0,23.0,2502.0,5.0,SIP>=30
81.99896,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,117689.0,53773.375,27.0,white,37.0,5,0,0,no,0.75,0.5,dnr after sadm,13.0,65.0,31.1992188,50.0,26.0,36.79688,331.375,3.7998047,1.09985352,1.89990234,133.0,7.519531,135.0,23.0,2502.0,3.9467773,<2 mo. follow-up
62.53,1,female,0,16,130,Colon Cancer,Cancer,1,12.0,under $11k,16862.0,10397.3203,10.666664,white,7.0,1,0,0,metastatic,0.849999905,0.9,no dnr,16.0,97.0,5.09960938,96.0,20.0,37.39844,342.8125,3.7998047,0.79992676,0.79992676,134.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.52197,0,female,0,145,1664,CHF,COPD/CHF/Cirrhosis,2,13.0,>$50k,414803.0,14452.7344,17.0,white,54.0,1,0,0,no,0.799999714,0.5,no dnr,145.0,37.0,7.5,90.0,24.0,36.29688,122.5,3.3999023,1.59985352,1.39990234,135.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
49.87,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59913.0,29431.5938,46.0,white,94.0,2,0,0,yes,0.699999809,0.5,dnr after sadm,4.0,57.0,0.09999084,165.0,28.0,41.19531,85.0,2.5,2.09960938,1.69995117,133.0,7.30957,135.0,23.0,2502.0,2.2265625,<2 mo. follow-up
61.69199,1,female,0,25,292,Colon Cancer,Cancer,2,12.0,$11-$25k,75618.0,41915.4688,10.5,white,32.0,1,0,0,metastatic,0.849999905,0.7,no dnr,25.0,103.0,10.3984375,106.0,24.0,38.19531,333.3,3.7998047,0.29998779,2.39990234,141.0,7.419922,135.0,23.0,2502.0,4.5273972,no(M2 and SIP pres)
39.14899,1,female,0,37,945,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,147711.0,14452.7344,24.0,black,31.0,1,0,0,no,0.699999809,0.6,no dnr,37.0,58.0,6.19921875,105.0,34.0,36.69531,333.3,3.5,0.79992676,0.89990234,130.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
50.45599,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,202111.0,102048.125,46.5,white,71.0,29,0,0,yes,0.699999809,0.5,dnr after sadm,5.0,63.0,0.89990234,115.0,16.0,38.19531,89.21875,2.7998047,4.19921875,2.39990234,143.0,7.459961,135.0,23.0,2502.0,2.5595703,<2 mo. follow-up
50.57599,0,female,0,46,1657,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,303934.0,139610.125,32.5,white,74.0,1,0,0,no,0.799999714,0.8,no dnr,46.0,55.0,5.29980469,75.0,12.0,36.19531,443.3125,2.199707,44.3984375,5.09960938,147.0,7.229492,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
68.80798,1,female,0,4,870,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,7354.0,4315.8477,8.0,black,25.0,1,1,0,no,0.949999809,0.85,no dnr,4.0,94.0,5.39941406,84.0,20.0,36.39844,576.0,3.5,1.01,1.69995117,128.0,7.459961,135.0,23.0,2502.0,3.1831989,SIP>=30
46.07797,1,male,0,41,313,Cirrhosis,COPD/CHF/Cirrhosis,3,18.0,>$50k,353422.0,190804.0,35.5,white,72.0,2,0,0,metastatic,0.699999809,0.5,no dnr,41.0,63.0,3.59960938,170.0,10.0,35.29688,160.0,3.5996094,51.296875,5.0,147.0,7.589844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.16498,0,female,0,3,1655,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3974.0,2517.9512,8.0,white,21.0,1,0,0,no,0.899999619,0.8,no dnr,3.0,139.0,6.19921875,76.0,24.0,36.39844,466.625,3.5,1.01,1.0,141.0,7.459961,135.0,23.0,2502.0,2.2495117,<2 mo. follow-up
81.758,1,female,0,15,36,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,22800.0,13578.2578,8.666664,white,41.0,1,0,0,no,0.599999905,0.216,no dnr,15.0,110.0,11.1992188,80.0,24.0,36.39844,285.6875,3.5,0.29998779,1.59985352,128.0,7.519531,135.0,23.0,2502.0,6.0,<2 mo. follow-up
76.98798,0,female,0,36,1655,COPD,COPD/CHF/Cirrhosis,0,16.0,under $11k,113045.0,14452.7344,10.25,white,51.0,2,0,0,no,0.5,0.3,dnr after sadm,7.0,48.0,12.0996094,170.0,28.0,36.5,155.0,3.5,1.01,0.59997559,134.0,7.40918,135.0,23.0,2502.0,5.0,<2 mo. follow-up
81.66498,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,$11-$25k,31827.0,16880.5469,22.0,white,19.0,3,0,0,no,0.699999809,0.6,dnr after sadm,2.0,97.0,22.0976562,100.0,24.0,38.39844,225.6875,3.5,1.01,1.0,135.0,7.449219,135.0,23.0,2502.0,3.6464844,<2 mo. follow-up
54.26999,0,male,0,13,1654,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,44608.0,22993.125,15.0,white,46.0,2,0,0,no,0.699999809,0.5,no dnr,13.0,107.0,7.09960938,125.0,28.0,36.0,120.40625,3.5,1.19995117,2.29980469,138.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
22.825,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,254601.0,115477.625,49.5,white,80.0,29,0,0,metastatic,0.699999809,0.5,dnr after sadm,10.0,43.0,2.89990234,145.0,28.0,38.69531,146.0,3.5,6.5,4.29980469,139.0,7.359375,135.0,23.0,2502.0,2.9663086,<2 mo. follow-up
58.43698,1,female,0,11,271,Colon Cancer,Cancer,1,20.0,>$50k,14670.0,9659.4062,8.0,white,19.0,1,0,0,metastatic,0.75,0.25,dnr after sadm,2.0,65.0,7.19921875,72.0,12.0,37.0,333.3,3.7998047,0.69995117,0.69995117,135.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
58.28598,1,male,0,10,872,Colon Cancer,Cancer,1,14.0,>$50k,24073.0,15612.7109,11.0,white,9.0,1,0,0,metastatic,0.949999809,0.8,no dnr,10.0,81.0,11.7988281,72.0,22.0,38.89844,333.3,4.3994141,0.59997559,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.29297,1,female,0,3,1291,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5110.0,3391.9277,14.0,white,22.0,1,0,0,no,0.899999619,0.8,no dnr,3.0,103.0,9.3984375,130.0,20.0,36.0,423.75,3.5,1.01,1.29980469,137.0,7.609375,135.0,23.0,2502.0,3.0571289,<2 mo. follow-up
47.01999,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,56169.0,28008.9219,31.0,white,73.0,2,0,0,no,0.5,0.4,dnr after sadm,9.0,28.0,10.0,110.0,26.0,36.29688,148.3125,3.5,1.01,12.0,149.0,7.479492,135.0,23.0,2502.0,3.171875,<2 mo. follow-up
42.28897,0,female,0,6,1649,Cirrhosis,COPD/CHF/Cirrhosis,2,15.0,$11-$25k,6057.0,3922.8438,5.0,white,38.0,1,0,0,no,0.699999809,0.7,no dnr,6.0,70.0,2.59960938,72.0,20.0,37.0,333.3,2.7998047,11.8984375,0.89990234,133.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
86.37097,0,male,0,14,1649,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,14836.0,9444.3281,6.666664,white,32.0,1,0,0,no,0.75,0.5,no dnr,14.0,107.0,4.29980469,80.0,20.0,36.79688,333.3,3.5996094,0.69995117,2.5,135.0,7.419922,135.0,23.0,2502.0,4.03125,<2 mo. follow-up
72.23499,1,male,0,10,579,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,23972.0,13201.7969,13.0,white,37.0,1,1,0,no,0.5,0.2,dnr after sadm,1.0,95.0,6.09960938,98.0,26.0,37.79688,83.32812,3.0,1.39990234,1.89990234,157.0,7.439453,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
85.35199,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,239683.0,122276.312,41.5,white,95.0,26,0,0,no,0.049999982,0.000125,dnr before sadm,-1.0,33.0,14.0,120.0,35.0,35.89844,170.0,3.7998047,35.6953125,2.59960938,137.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
49.13898,1,female,0,12,85,Lung Cancer,Cancer,1,12.0,under $11k,17775.0,10275.0859,9.0,black,35.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,2.0,55.0,9.09960938,122.0,28.0,38.29688,333.3,3.5,1.01,0.69995117,129.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
79.04395,1,female,1,15,15,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,36520.0,16195.8438,11.333328,white,51.0,1,0,0,yes,0.599999905,0.4,dnr after sadm,2.0,120.0,9.29882812,110.0,26.0,36.39844,110.0,3.699707,1.01,0.89990234,139.0,7.179688,135.0,23.0,2502.0,4.4482422,<2 mo. follow-up
41.61798,1,male,1,19,19,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,161755.0,71957.1875,30.333328,white,59.0,1,0,0,yes,0.199999928,1.0,dnr after sadm,9.0,127.0,3.19970703,200.0,38.0,36.39844,179.0,3.5,2.5,1.19995117,149.0,7.369141,135.0,23.0,2502.0,2.9682617,<2 mo. follow-up
25.49199,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,359124.0,168043.625,31.0,white,55.0,80,0,0,yes,0.199999928,0.2,dnr after sadm,3.0,103.0,2.79980469,145.0,46.0,39.0,109.32812,3.5,3.09960938,1.09985352,125.0,7.469727,135.0,23.0,2502.0,2.6630859,<2 mo. follow-up
50.754,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,448431.0,236295.25,33.0,white,59.0,27,0,0,no,0.25,0.25,dnr after sadm,13.0,42.0,10.6992188,118.0,12.0,38.89844,270.0,3.5996094,13.6992188,1.69995117,131.0,7.509766,135.0,23.0,2502.0,3.8657227,<2 mo. follow-up
53.09198,0,female,0,7,1642,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,>$50k,13434.0,6912.5508,8.0,white,35.0,1,0,0,no,0.899999619,0.9,no dnr,7.0,66.0,13.1992188,102.0,20.0,36.59375,333.3,2.3999023,5.29980469,1.19995117,124.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.80798,1,male,0,26,29,Lung Cancer,Cancer,2,3.0,>$50k,73798.0,39726.125,10.5,white,78.0,3,0,0,metastatic,0.399999857,0.05,dnr after sadm,12.0,137.0,29.1992188,160.0,56.0,38.0,146.0,2.7998047,1.01,1.09985352,143.0,7.469727,135.0,23.0,2502.0,4.0,<2 mo. follow-up
75.99695,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$11-$25k,99364.0,46090.7812,53.0,white,81.0,3,0,0,no,0.699999809,0.5,dnr after sadm,6.0,52.0,23.296875,150.0,44.0,37.0,170.0,3.5,3.89990234,4.5,134.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.491,0,male,0,6,1638,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,9974.0,5706.2227,10.0,white,25.0,1,0,0,no,1.0,1.0,no dnr,6.0,95.0,6.89941406,78.0,18.0,36.39844,333.3,2.3999023,5.59960938,0.89990234,125.0,7.419922,135.0,23.0,2502.0,3.3310547,<2 mo. follow-up
27.51799,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,132130.0,64562.0938,46.0,hispanic,81.0,20,0,0,yes,0.5,0.5,dnr after sadm,5.0,76.0,2.79980469,200.0,56.0,38.39844,277.0,3.5,1.39990234,2.69970703,136.0,7.289062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.62198,1,male,0,4,274,Lung Cancer,Cancer,2,12.0,>$50k,11765.0,5337.5898,10.0,white,15.0,1,1,0,metastatic,1.0,0.5,no dnr,4.0,96.0,11.6992188,104.0,20.0,36.19531,333.3,3.5,1.01,1.19995117,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.12695,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,107073.0,49515.3125,34.666657,white,44.0,2,0,1,no,0.0,0.0,no dnr,23.0,60.0,24.0976562,70.0,44.0,38.89844,96.65625,2.0,1.01,1.09985352,141.0,7.429688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
30.023,0,male,0,17,1636,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,108131.0,52857.5625,24.666656,white,16.0,2,0,0,no,0.699999809,0.5,no dnr,17.0,97.0,4.89941406,110.0,12.0,38.59375,267.5,3.0996094,5.79980469,1.09985352,141.0,7.439453,135.0,23.0,2502.0,2.0869141,no(M2 and SIP pres)
52.70099,1,female,0,4,370,Lung Cancer,Cancer,1,14.0,$25-$50k,6521.0,4240.2422,6.0,white,9.0,1,0,0,metastatic,0.699999809,0.15,no dnr,4.0,80.0,9.19921875,64.0,20.0,36.39844,333.3,4.2998047,0.39996338,1.0,140.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
52.767,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,45767.0,22561.2812,16.0,black,47.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,77.0,17.0976562,115.0,24.0,38.19531,208.5625,3.3999023,4.0,5.39941406,145.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
50.38199,0,female,0,14,1629,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,25748.0,15329.3125,9.666664,black,9.0,1,0,0,no,0.75,0.6,no dnr,14.0,60.0,9.0,50.0,20.0,36.09375,333.3,3.5,1.01,0.79992676,138.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
37.336,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,168270.0,83700.5,48.0,other,80.0,23,0,0,yes,0.799999714,0.8,dnr after sadm,3.0,57.0,1.89990234,140.0,14.0,38.5,231.65625,3.2998047,7.5,5.69921875,145.0,7.299805,135.0,23.0,2502.0,2.4541016,<2 mo. follow-up
65.57697,1,male,0,10,12,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,42780.0,20734.2188,19.5,white,38.0,5,0,0,no,0.699999809,0.5,no dnr,10.0,52.0,3.79980469,70.0,30.0,38.29688,251.40625,3.5,1.01,1.5,142.0,7.529297,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.29398,1,male,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,49389.0,24999.875,37.0,white,73.0,3,0,0,no,0.049999982,0.000125,dnr after sadm,5.0,67.0,23.5976562,130.0,32.0,36.5,167.5,3.199707,8.0,2.59960938,134.0,7.529297,135.0,23.0,2502.0,3.9550781,<2 mo. follow-up
55.31799,1,female,0,12,68,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,16717.0,9094.3281,7.0,white,24.0,1,0,0,no,0.5,0.3,no dnr,12.0,120.0,7.5,80.0,18.0,37.59375,333.3,2.5,3.69970703,0.59997559,121.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
51.89899,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,85777.0,39979.0,23.0,white,40.0,14,0,0,metastatic,0.699999809,0.5,dnr before sadm,-9.0,40.0,3.79980469,120.0,34.0,38.19531,333.3,3.5,1.01,1.01,138.0,7.419922,135.0,23.0,2502.0,3.7719727,<2 mo. follow-up
48.98599,1,male,1,16,16,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,131400.0,60309.4688,38.0,white,50.0,5,0,0,no,0.699999809,0.5,dnr after sadm,10.0,60.0,16.3984375,115.0,36.0,38.0,132.0,2.3999023,4.19921875,1.0,138.0,7.549805,135.0,23.0,2502.0,3.5107422,<2 mo. follow-up
76.33398,1,male,0,11,93,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,24988.0,13437.4375,19.0,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,60.0,5.79980469,72.0,20.0,36.19531,333.3,4.0,2.09960938,1.5,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
24.493,0,male,0,37,1619,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,149776.0,73399.875,28.0,white,41.0,5,0,0,no,0.979999542,0.98,no dnr,37.0,108.0,29.796875,140.0,10.0,38.69531,394.25,2.2998047,7.59960938,0.79992676,132.0,7.449219,135.0,23.0,2502.0,0.0,SIP>=30
70.46698,1,female,0,14,717,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,57539.0,31008.5938,14.333328,other,50.0,5,0,0,no,0.799999714,0.7,no dnr,14.0,135.0,5.09960938,120.0,26.0,37.69531,195.90625,3.5,1.01,2.29980469,128.0,7.439453,135.0,23.0,2502.0,3.690918,<2 mo. follow-up
58.31897,1,male,0,87,98,MOSF w/Malig,ARF/MOSF,1,23.0,under $11k,542326.0,14452.7344,41.0,white,40.0,2,0,0,yes,0.399999857,0.1,dnr before sadm,-1.0,112.0,4.29980469,205.0,15.0,37.69531,52.0,3.3999023,1.89990234,0.89990234,137.0,7.279297,135.0,23.0,2502.0,2.6416016,adl>=4 (>=5 if sur)
80.25494,1,female,1,5,5,Coma,Coma,2,12.0,under $11k,14297.0,6564.4648,19.0,white,34.0,1,0,0,no,0.099999964,0.001,dnr after sadm,4.0,127.0,13.5996094,135.0,32.0,38.89844,357.125,3.5,1.01,0.59997559,138.0,7.469727,135.0,23.0,2502.0,3.5532227,<2 mo. follow-up
67.58398,1,male,0,4,482,Lung Cancer,Cancer,3,12.0,$11-$25k,10819.0,5204.7305,17.0,black,18.0,1,0,0,metastatic,0.599999905,0.3,no dnr,4.0,97.0,12.0,80.0,20.0,35.79688,333.3,3.5,1.01,1.19995117,135.0,7.419922,135.0,23.0,2502.0,2.7944336,no(M2 and SIP pres)
40.96399,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,93417.0,48108.6875,35.5,hispanic,55.0,6,0,0,no,0.699999809,0.5,dnr after sadm,7.0,70.0,2.29980469,95.0,14.0,36.69531,271.375,3.5996094,38.3984375,4.69921875,136.0,7.389648,135.0,23.0,2502.0,3.1333008,<2 mo. follow-up
26.683,0,female,0,19,1611,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,109747.0,51558.0,30.0,other,48.0,1,0,0,no,0.699999809,0.6,no dnr,19.0,118.0,24.0976562,120.0,10.0,38.0,58.32812,2.3999023,12.5996094,1.39990234,136.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.85397,1,female,1,21,21,MOSF w/Malig,ARF/MOSF,2,11.0,under $11k,173968.0,93752.5625,23.666656,white,78.0,15,0,0,yes,0.5,0.4,dnr after sadm,20.0,113.0,0.04999542,180.0,28.0,39.69531,352.375,2.0996094,2.29980469,1.79980469,134.0,7.549805,135.0,23.0,2502.0,3.4663086,<2 mo. follow-up
77.53595,1,male,1,3,3,Coma,Coma,0,12.0,under $11k,20078.0,9221.7812,42.0,white,67.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,40.0,10.3984375,55.0,10.0,35.59375,64.0,3.8999023,1.29980469,2.29980469,138.0,7.239258,135.0,23.0,2502.0,2.9956055,<2 mo. follow-up
70.03998,1,female,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,444556.0,233671.25,19.5,white,40.0,14,0,0,yes,0.699999809,0.5,no dnr,35.0,93.0,10.5996094,105.0,32.0,39.0,288.0,4.0996094,3.59960938,1.09985352,132.0,7.269531,135.0,23.0,2502.0,4.0,<2 mo. follow-up
66.00098,0,male,0,7,1608,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,31463.0,15501.3281,9.0,white,40.0,1,0,0,no,0.599999905,0.5,no dnr,7.0,57.0,8.69921875,115.0,22.0,36.5,333.3,4.7998047,0.39996338,1.59985352,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.995,1,female,0,14,642,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,41479.0,17930.9219,15.666664,hispanic,32.0,1,0,0,yes,0.699999809,0.6,no dnr,14.0,77.0,4.19921875,95.0,40.0,36.19531,266.625,3.5,0.09999084,0.89990234,133.0,7.319336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
49.91599,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,220490.0,101904.875,36.0,black,25.0,19,0,0,metastatic,0.099999964,0.001,dnr after sadm,5.0,115.0,15.0,55.0,14.0,36.09375,136.65625,2.0,1.0,0.59997559,136.0,7.5,135.0,23.0,2502.0,3.3061523,<2 mo. follow-up
51.56699,0,female,0,6,1607,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,1435423.0,3877.0879,11.0,other,63.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,58.0,10.5,72.0,24.0,36.0,333.3,2.199707,19.796875,2.09960938,126.0,7.419922,135.0,23.0,2502.0,2.4399414,<2 mo. follow-up
55.13998,0,female,0,4,1604,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,7322.0,3337.082,10.0,white,25.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,71.0,7.59960938,84.0,20.0,36.79688,223.78125,3.5,1.01,0.69995117,136.0,7.439453,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
30.69099,1,male,0,19,673,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,138003.0,66716.625,26.0,white,33.0,9,0,0,no,0.699999809,0.5,no dnr,19.0,110.0,17.1992188,150.0,45.0,38.69531,357.5,3.5,1.01,0.59997559,135.0,7.479492,135.0,23.0,2502.0,2.5795898,<2 mo. follow-up
47.34799,1,female,0,6,19,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,23807.0,11111.2266,24.0,white,26.0,1,0,0,no,0.979999542,0.9,no dnr,6.0,77.0,14.2988281,100.0,45.0,38.09375,196.65625,3.5,0.59997559,0.59997559,143.0,7.469727,135.0,23.0,2502.0,3.4794922,<2 mo. follow-up
60.23297,1,male,0,9,17,Lung Cancer,Cancer,1,12.0,under $11k,16410.0,9693.4141,11.0,other,56.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,79.0,19.8984375,160.0,16.0,36.39844,228.5625,4.1992188,1.29980469,1.79980469,134.0,7.459961,135.0,23.0,2502.0,3.3388672,<2 mo. follow-up
37.08099,0,male,0,7,1601,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,7547.0,4304.6484,6.5,white,24.0,1,0,0,no,0.949999809,0.5,no dnr,7.0,105.0,7.59960938,100.0,22.0,38.79688,333.3,3.5,6.89941406,0.59997559,133.0,7.419922,135.0,23.0,2502.0,3.2421875,<2 mo. follow-up
63.25,0,male,0,5,1599,Lung Cancer,Cancer,1,13.0,$25-$50k,15400.0,7650.8516,11.0,asian,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,87.0,11.1992188,100.0,30.0,38.0,333.3,4.5996094,0.5,0.89990234,134.0,7.419922,135.0,23.0,2502.0,1.8708496,no(M2 and SIP pres)
51.87698,1,male,0,11,202,Lung Cancer,Cancer,1,16.0,>$50k,22975.0,10616.9688,13.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,91.0,3.89990234,100.0,20.0,36.59375,285.6875,2.8999023,0.29998779,0.89990234,133.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.50299,1,male,0,13,25,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,45162.0,22656.4219,18.5,white,43.0,4,0,0,no,0.699999809,0.5,no dnr,13.0,53.0,14.5996094,110.0,20.0,36.89844,306.0,3.5,1.01,1.69995117,127.0,7.269531,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
84.43799,1,male,0,8,31,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,25793.0,11553.2656,17.5,white,35.0,1,0,0,yes,0.799999714,0.2,no dnr,8.0,60.0,4.19921875,85.0,38.0,37.5,246.9375,3.5,0.29998779,1.0,131.0,7.589844,135.0,23.0,2502.0,3.6225586,<2 mo. follow-up
46.60397,1,male,0,6,593,Lung Cancer,Cancer,1,16.0,>$50k,17707.0,9833.4844,9.0,white,19.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,60.0,7.69921875,134.0,22.0,38.79688,333.3,3.5,1.01,0.89990234,135.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
60.07397,1,female,1,4,4,Lung Cancer,Cancer,1,12.0,under $11k,6149.0,2807.7559,11.0,white,22.0,1,0,0,metastatic,0.049999982,0.000125,dnr after sadm,2.0,107.0,10.8984375,116.0,24.0,36.0,228.0,2.8999023,1.01,0.39996338,144.0,7.489258,135.0,23.0,2502.0,3.4169922,<2 mo. follow-up
62.27197,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,under $11k,150556.0,75833.1875,38.5,white,70.0,12,0,0,no,0.699999809,0.5,dnr after sadm,6.0,68.0,6.79980469,140.0,36.0,38.0,369.5625,3.3999023,6.09960938,7.29980469,132.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
48.353,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,565876.0,341404.25,59.0,white,97.0,54,1,0,no,0.699999809,0.5,dnr after sadm,2.0,20.0,49.8984375,135.0,24.0,36.29688,76.0,4.3994141,24.0976562,3.39990234,149.0,7.239258,135.0,23.0,2502.0,2.8876953,<2 mo. follow-up
78.33795,1,male,1,4,4,Coma,Coma,0,12.0,under $11k,31356.0,14755.6641,39.0,white,65.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,50.0,6.59960938,150.0,22.0,37.5,143.3125,3.5,1.01,2.09960938,128.0,7.40918,135.0,23.0,2502.0,3.2514648,<2 mo. follow-up
58.14099,1,female,0,3,1241,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,4642.0,2539.3711,5.0,white,19.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,117.0,9.09960938,105.0,24.0,36.5,252.375,3.5,1.01,0.89990234,140.0,7.289062,135.0,23.0,2502.0,2.5004883,<2 mo. follow-up
60.87299,1,female,0,11,449,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,29509.0,15321.5625,23.5,black,20.0,1,1,0,no,0.699999809,0.5,no dnr,11.0,67.0,9.79882812,75.0,20.0,36.29688,333.3,3.5,1.39990234,1.19995117,131.0,7.419922,135.0,23.0,2502.0,3.6489258,no(M2 and SIP pres)
51.62198,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,85043.0,42495.0,47.0,black,111.0,17,0,0,yes,0.699999809,0.5,no dnr,4.0,57.0,0.04999542,145.0,40.0,40.0,178.0,3.5,2.19970703,7.79980469,133.0,7.289062,135.0,23.0,2502.0,2.7714844,<2 mo. follow-up
48.62399,1,female,0,42,138,MOSF w/Malig,ARF/MOSF,2,16.0,$11-$25k,95852.0,14452.7344,14.75,white,42.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,26.0,62.0,8.09960938,110.0,20.0,37.5,333.3,2.3999023,2.0,2.09960938,141.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
29.63699,1,male,0,20,30,Coma,Coma,1,12.0,under $11k,168489.0,14452.7344,24.333328,hispanic,20.0,7,0,0,yes,0.399999857,0.3,no dnr,20.0,67.0,17.3984375,40.0,14.0,35.89844,230.0,3.5,1.01,0.89990234,135.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.146,1,male,0,11,824,Colon Cancer,Cancer,1,16.0,>$50k,44109.0,24268.8281,17.0,white,22.0,1,0,0,metastatic,0.949999809,0.75,no dnr,11.0,117.0,18.3984375,90.0,14.0,37.0,333.3,5.0996094,3.0,1.0,133.0,7.419922,135.0,23.0,2502.0,2.1723633,<2 mo. follow-up
68.16998,0,female,0,11,1591,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,38996.0,19592.3438,13.5,white,33.0,1,1,0,no,0.699999809,0.5,no dnr,11.0,97.0,19.3984375,110.0,22.0,37.0,282.8125,1.8999023,3.39990234,0.79992676,137.0,7.339844,135.0,23.0,2502.0,3.621582,<2 mo. follow-up
47.73398,1,male,0,10,806,CHF,COPD/CHF/Cirrhosis,2,15.0,under $11k,30953.0,14452.7344,14.5,black,32.0,1,0,0,no,0.75,0.7,no dnr,10.0,43.0,5.29980469,90.0,22.0,36.0,333.3,3.699707,3.09960938,1.19995117,126.0,7.419922,135.0,23.0,2502.0,4.5273972,no(M2 and SIP pres)
91.84399,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,11415.0,5410.4688,7.0,white,49.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,73.0,28.296875,100.0,36.0,35.29688,332.0,2.8999023,0.5,1.69995117,143.0,7.549805,135.0,23.0,2502.0,4.0322266,<2 mo. follow-up
59.39798,1,male,0,6,134,Colon Cancer,Cancer,1,16.0,$25-$50k,8512.0,4250.8945,14.0,white,11.0,1,0,0,metastatic,0.899999619,0.4,no dnr,6.0,71.0,6.09960938,60.0,22.0,37.79688,333.3,3.3999023,1.01,0.89990234,139.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
49.59598,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,102876.0,14452.7344,43.5,white,85.0,2,0,0,no,0.699999809,0.5,dnr after sadm,9.0,50.0,15.1992188,170.0,24.0,39.29688,65.32812,4.1992188,24.1992188,7.09960938,143.0,7.479492,135.0,23.0,2502.0,2.527832,<2 mo. follow-up
51.086,0,female,0,69,1585,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$25-$50k,480519.0,14452.7344,37.5,hispanic,51.0,5,0,0,no,0.699999809,0.5,no dnr,69.0,110.0,18.6992188,130.0,20.0,39.19531,270.0,3.199707,11.5,1.5,150.0,7.519531,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
46.22598,0,male,0,46,1585,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,349052.0,14452.7344,30.0,hispanic,33.0,1,1,0,no,0.5,0.5,no dnr,46.0,61.0,13.5,145.0,8.0,38.39844,155.09375,2.8999023,1.39990234,1.0,129.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.77197,0,male,0,19,1584,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,92775.0,14452.7344,23.0,white,36.0,5,0,0,no,0.699999809,0.5,no dnr,19.0,70.0,18.0976562,60.0,20.0,38.79688,151.65625,2.2998047,1.01,1.09985352,133.0,7.5,135.0,23.0,2502.0,2.2773438,<2 mo. follow-up
50.59497,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,93265.0,49813.9688,42.0,hispanic,118.0,31,1,0,no,0.699999809,0.5,no dnr,5.0,37.0,17.6992188,75.0,40.0,36.89844,143.0,1.5,21.0,3.0,134.0,7.079102,135.0,23.0,2502.0,4.1542969,<2 mo. follow-up
60.56897,0,male,0,13,1584,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,75752.0,36327.7812,15.0,white,17.0,4,0,0,no,0.899999619,0.9,no dnr,13.0,60.0,13.0996094,72.0,10.0,38.39844,205.4375,3.5,1.01,0.69995117,135.0,7.449219,135.0,23.0,2502.0,3.6948242,<2 mo. follow-up
43.21399,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,43810.0,18669.25,26.0,white,59.0,2,0,0,yes,0.099999964,0.001,dnr after sadm,6.0,57.0,7.69921875,120.0,36.0,39.19531,150.0,3.5,1.01,1.89990234,134.0,7.5,135.0,23.0,2502.0,2.7348633,<2 mo. follow-up
82.63098,1,male,0,5,30,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,7920.0,4590.6367,15.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,77.0,19.3984375,70.0,22.0,36.39844,333.3,3.5,1.01,2.29980469,132.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
80.23798,1,female,0,9,258,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,43960.0,22739.5156,25.0,white,21.0,1,0,0,no,0.599999905,0.6,no dnr,9.0,113.0,15.0,60.0,10.0,37.89844,142.5,3.5,1.01,1.09985352,136.0,7.459961,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
26.023,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,166772.0,82111.625,47.0,hispanic,62.0,28,0,0,yes,0.299999952,0.2,dnr after sadm,6.0,40.0,3.29980469,125.0,32.0,36.0,158.0,3.5,1.01,2.89990234,130.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
22.72699,0,female,0,7,1579,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,23778.0,10942.8516,12.0,black,28.0,3,0,0,no,0.699999809,0.5,no dnr,7.0,99.0,6.79980469,112.0,40.0,38.5,140.8125,3.5,1.01,0.79992676,134.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.67599,1,male,0,9,544,Lung Cancer,Cancer,1,17.0,>$50k,22661.0,12761.7266,14.5,white,16.0,1,0,0,metastatic,0.949999809,0.7,no dnr,9.0,104.0,37.296875,78.0,16.0,37.79688,333.3,3.5,1.01,0.89990234,128.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.11798,1,female,0,8,183,Lung Cancer,Cancer,3,12.0,under $11k,12023.0,5635.4844,8.0,black,26.0,1,0,0,metastatic,1.0,0.5,no dnr,8.0,109.0,10.5,78.0,16.0,36.39844,333.3,4.6992188,0.69995117,1.29980469,134.0,7.419922,135.0,23.0,2502.0,2.8193359,<2 mo. follow-up
36.211,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,374053.0,180218.625,44.666657,black,65.0,31,0,0,yes,0.5,0.125,no dnr,17.0,130.0,7.39941406,125.0,14.0,37.5,87.5,3.2998047,18.5976562,2.5,142.0,7.439453,135.0,23.0,2502.0,3.503418,<2 mo. follow-up
29.588,0,male,0,93,1578,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,563075.0,14452.7344,37.25,black,54.0,3,0,0,no,0.699999809,0.5,no dnr,93.0,115.0,1.89990234,120.0,38.0,35.79688,305.0,3.5,3.39990234,5.59960938,137.0,7.389648,135.0,23.0,2502.0,3.7104492,adl>=4 (>=5 if sur)
63.95599,1,male,1,21,21,CHF,COPD/CHF/Cirrhosis,2,9.0,>$50k,68631.0,14452.7344,20.0,hispanic,35.0,1,0,0,no,0.799999714,0.6,dnr after sadm,19.0,68.0,8.09960938,100.0,16.0,36.0,333.3,3.5,2.19970703,1.59985352,125.0,7.419922,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
70.90997,1,male,1,8,8,CHF,COPD/CHF/Cirrhosis,4,18.0,under $11k,13400.0,7033.3555,9.0,white,35.0,1,1,1,no,0.699999809,0.5,no dnr,8.0,93.0,10.0996094,72.0,20.0,36.0,333.3,4.6992188,1.01,2.5,138.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
66.63098,1,female,0,10,229,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,>$50k,14175.0,7477.4492,18.5,white,33.0,1,0,0,yes,0.849999905,0.6,no dnr,10.0,80.0,5.69921875,110.0,22.0,36.0,333.3,3.0,2.59960938,2.0,140.0,7.419922,135.0,23.0,2502.0,3.2807617,no(M2 and SIP pres)
77.17499,1,female,0,9,183,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,14976.0,7870.4492,7.0,white,25.0,2,0,0,no,0.899999619,0.5,no dnr,9.0,82.0,7.79980469,72.0,20.0,36.0,333.3,3.5,6.29980469,1.19995117,138.0,7.419922,135.0,23.0,2502.0,3.434082,<2 mo. follow-up
60.54498,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,283844.0,136717.875,41.0,hispanic,71.0,16,1,0,no,0.75,0.75,dnr after sadm,14.0,107.0,10.5996094,125.0,35.0,38.5,202.0,1.6999512,9.29882812,1.19995117,143.0,7.389648,135.0,23.0,2502.0,2.7592773,<2 mo. follow-up
76.56696,1,male,1,29,29,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,308455.0,14452.7344,40.25,white,66.0,11,1,0,yes,0.199999928,0.1,dnr after sadm,27.0,108.0,10.3984375,145.0,32.0,38.29688,188.5625,1.6999512,7.09960938,1.19995117,136.0,7.489258,135.0,23.0,2502.0,3.4482422,<2 mo. follow-up
76.63495,1,male,0,25,59,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,63938.0,14452.7344,14.25,white,56.0,1,0,0,no,0.799999714,0.5,no dnr,25.0,47.0,14.3984375,95.0,30.0,37.5,184.0,3.5,1.01,1.59985352,134.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
51.20099,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,41580.0,19861.5625,29.0,asian,60.0,1,1,0,no,0.5,0.2,dnr after sadm,6.0,68.0,22.796875,110.0,24.0,37.89844,212.5,1.6999512,4.29980469,3.19970703,133.0,7.349609,135.0,23.0,2502.0,2.6914062,<2 mo. follow-up
20.24399,1,male,0,9,144,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,11528.0,6997.7109,8.5,hispanic,25.0,1,0,0,no,0.799999714,0.6,no dnr,9.0,60.0,8.69921875,70.0,24.0,36.0,333.3,3.5,1.01,1.59985352,128.0,7.419922,135.0,23.0,2502.0,2.8491211,no(M2 and SIP pres)
69.47296,0,female,0,36,1573,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,>$50k,151788.0,14452.7344,16.0,white,45.0,1,0,0,no,0.699999809,0.5,no dnr,36.0,71.0,10.1992188,68.0,20.0,36.80469,333.3,2.5996094,18.5976562,1.59985352,126.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.76099,1,female,1,8,8,Lung Cancer,Cancer,2,12.0,under $11k,18406.0,9426.6562,14.0,white,20.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,5.0,67.0,11.3984375,92.0,20.0,36.39844,368.0,3.5,1.01,0.59997559,130.0,7.429688,135.0,23.0,2502.0,3.887207,<2 mo. follow-up
24.56699,0,female,0,66,1571,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,392270.0,14452.7344,29.75,hispanic,55.0,3,0,0,no,0.199999928,0.008,no dnr,66.0,65.0,10.1992188,130.0,32.0,38.5,166.65625,3.5,0.79992676,8.79882812,137.0,7.369141,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
53.62097,0,female,0,10,1572,Colon Cancer,Cancer,1,12.0,under $11k,28094.0,14153.4141,18.0,white,4.0,1,0,0,metastatic,0.699999809,0.5,no dnr,10.0,80.0,9.69921875,105.0,22.0,38.19531,476.1875,3.5,1.01,1.01,140.0,7.40918,135.0,23.0,2502.0,2.5981445,<2 mo. follow-up
78.88794,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,13.0,>$50k,88377.0,44241.8438,26.0,white,37.0,5,0,0,metastatic,0.0,0.0,dnr after sadm,4.0,73.0,7.19921875,105.0,25.0,38.59375,198.0,3.5,1.01,1.69995117,147.0,7.5,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.40497,1,female,0,14,330,Lung Cancer,Cancer,1,12.0,under $11k,32994.0,16753.8906,15.666664,white,32.0,1,0,0,metastatic,0.199999928,0.0,no dnr,14.0,62.0,7.89941406,75.0,30.0,36.59375,257.125,3.5,1.01,1.79980469,136.0,7.459961,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
74.94299,1,male,1,45,45,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,345855.0,174356.5,38.0,black,30.0,3,1,0,no,0.699999809,0.5,dnr after sadm,43.0,107.0,22.5,105.0,30.0,38.09375,300.0,3.5,1.09985352,1.09985352,131.0,7.519531,135.0,23.0,2502.0,3.6743164,<2 mo. follow-up
72.98798,1,female,1,4,4,Coma,Coma,1,12.0,under $11k,16404.0,8632.5156,22.0,asian,58.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,45.0,28.3984375,185.0,36.0,38.29688,423.3125,3.3999023,0.59997559,1.0,141.0,7.469727,135.0,23.0,2502.0,3.2197266,<2 mo. follow-up
50.28897,1,female,0,4,67,Colon Cancer,Cancer,1,12.0,under $11k,6673.0,3496.5977,10.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,83.0,9.3984375,84.0,20.0,38.0,333.3,3.5,0.59997559,1.39990234,136.0,7.419922,135.0,23.0,2502.0,1.871582,<2 mo. follow-up
87.48297,1,female,0,4,636,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4969.0,2898.3867,5.0,white,18.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,83.0,13.3984375,60.0,18.0,36.79688,333.3,3.5,1.01,1.0,134.0,7.419922,135.0,23.0,2502.0,2.8491211,<2 mo. follow-up
25.95799,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,73645.0,34122.2188,24.0,white,76.0,11,0,0,yes,0.049999982,0.000125,dnr after sadm,4.0,123.0,2.19970703,115.0,32.0,35.29688,56.0,3.5,10.1992188,1.59985352,129.0,7.449219,135.0,23.0,2502.0,2.4125977,<2 mo. follow-up
78.88794,0,female,0,48,1560,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,198860.0,14452.7344,22.75,white,28.0,8,0,0,no,0.699999809,0.5,no dnr,48.0,55.0,19.3984375,90.0,14.0,38.79688,160.0,2.699707,1.01,0.5,128.0,7.5,135.0,23.0,2502.0,2.5380859,no(M2 and SIP pres)
52.30099,1,male,0,4,161,Colon Cancer,Cancer,1,12.0,under $11k,4510.0,2831.8672,9.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,87.0,7.69921875,62.0,20.0,36.19531,333.3,4.6992188,0.5,1.0,134.0,7.419922,135.0,23.0,2502.0,1.5620117,<2 mo. follow-up
49.08698,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,176752.0,82695.1875,30.333328,white,106.0,18,0,0,no,0.099999964,0.001,dnr after sadm,2.0,48.0,37.59375,145.0,28.0,38.29688,118.0,4.7998047,19.296875,4.69921875,142.0,7.389648,135.0,23.0,2502.0,3.0224609,<2 mo. follow-up
54.48599,0,female,0,11,1558,Colon Cancer,Cancer,1,15.0,under $11k,37609.0,18547.4219,26.5,white,32.0,1,0,0,metastatic,0.989999771,0.95,no dnr,11.0,73.0,12.7988281,120.0,30.0,37.0,388.5625,4.0,1.0,1.09985352,133.0,7.329102,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
32.70599,1,female,1,103,103,ARF/MOSF w/Sepsis,ARF/MOSF,0,21.0,under $11k,1233213.0,14452.7344,45.0,white,52.0,1,0,0,no,0.699999809,0.5,no dnr,103.0,122.0,7.29980469,105.0,15.0,36.19531,192.5,4.0,9.5,3.79980469,149.0,7.449219,135.0,23.0,2502.0,3.0,<2 mo. follow-up
40.46799,1,female,0,46,265,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,289233.0,14452.7344,36.75,white,39.0,8,0,0,no,0.5,0.5,no dnr,46.0,42.0,12.8984375,125.0,34.0,38.29688,155.0,2.8999023,0.59997559,0.79992676,135.0,7.509766,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
76.47095,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,203430.0,96371.6875,44.666657,asian,68.0,9,1,0,no,0.5,0.1,dnr after sadm,9.0,67.0,14.3984375,145.0,10.0,39.0,98.32812,2.199707,15.2988281,1.5,153.0,7.489258,135.0,23.0,2502.0,3.0458984,<2 mo. follow-up
64.20496,1,female,1,14,14,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,>$50k,103876.0,48555.0938,30.0,hispanic,60.0,1,0,0,no,0.199999928,0.75,dnr after sadm,13.0,52.0,17.5976562,110.0,38.0,36.0,165.0,2.3999023,2.69970703,1.39990234,135.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
56.07397,0,female,0,25,1552,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,131009.0,60624.0,21.75,white,68.0,14,0,0,no,0.699999809,0.5,no dnr,25.0,40.0,8.59960938,150.0,42.0,36.39844,166.0,3.2998047,5.69921875,1.5,149.0,7.399414,135.0,23.0,2502.0,4.0,SIP>=30
73.01794,0,female,0,21,1551,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,57560.0,28266.1094,16.666656,hispanic,17.0,1,0,0,no,0.949999809,0.95,no dnr,21.0,73.0,13.2988281,65.0,16.0,38.39844,390.0,3.5,1.01,1.0,120.0,7.439453,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.50195,0,female,0,13,1551,Colon Cancer,Cancer,1,12.0,$11-$25k,14005.0,7870.8984,9.0,white,15.0,1,0,0,metastatic,1.0,1.0,no dnr,13.0,104.0,12.8984375,70.0,22.0,36.39844,333.3,3.5,0.79992676,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.77594,0,female,0,12,1551,Colon Cancer,Cancer,1,12.0,under $11k,46753.0,22527.5625,14.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,73.0,15.2988281,105.0,10.0,38.0,223.3125,2.199707,0.19998169,0.69995117,136.0,7.40918,135.0,23.0,2502.0,2.3530273,<2 mo. follow-up
52.30698,0,male,0,8,1548,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,54390.0,26411.8438,15.5,black,42.0,5,0,0,no,0.5,0.5,no dnr,8.0,113.0,14.3984375,105.0,37.0,38.29688,245.6875,2.3999023,6.0,1.29980469,132.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.17099,0,female,0,6,1545,Lung Cancer,Cancer,1,12.0,>$50k,13399.0,7692.7422,12.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,84.0,9.0,108.0,30.0,36.19531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
47.18997,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,160900.0,86296.3125,43.0,other,68.0,3,0,0,no,0.699999809,0.5,no dnr,7.0,60.0,26.0976562,140.0,39.0,37.0,154.28125,3.5,7.89941406,2.19970703,148.0,7.429688,135.0,23.0,2502.0,2.7456055,<2 mo. follow-up
55.25497,1,female,1,7,7,Lung Cancer,Cancer,1,12.0,under $11k,13593.0,6582.4961,14.0,black,25.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,4.0,63.0,9.79882812,120.0,28.0,38.0,333.3,3.5,0.89990234,0.69995117,142.0,7.419922,135.0,23.0,2502.0,4.0058594,<2 mo. follow-up
59.36798,0,male,0,7,1545,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,15494.0,7495.375,15.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,62.0,5.89941406,145.0,24.0,36.5,440.0,3.5,0.69995117,1.29980469,131.0,7.549805,135.0,23.0,2502.0,5.0,<2 mo. follow-up
63.22498,1,male,0,13,95,Colon Cancer,Cancer,1,12.0,under $11k,34247.0,17673.3125,25.0,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,13.0,87.0,10.0,105.0,22.0,38.0,333.3,4.3994141,0.39996338,1.0,132.0,7.419922,135.0,23.0,2502.0,2.1767578,<2 mo. follow-up
54.69699,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,18.0,>$50k,168940.0,85338.75,29.0,white,67.0,56,0,0,yes,0.049999982,0.000125,dnr after sadm,4.0,82.0,0.59997559,115.0,34.0,36.5,171.40625,4.1992188,26.6992188,7.29980469,151.0,7.419922,135.0,23.0,2502.0,2.4682617,<2 mo. follow-up
75.66095,0,male,0,6,1542,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,16067.0,8125.9375,25.0,white,42.0,1,0,0,no,0.949999809,0.5,no dnr,6.0,55.0,9.8984375,70.0,22.0,36.69531,333.3,3.5996094,1.0,2.59960938,135.0,7.419922,135.0,23.0,2502.0,2.421875,no(M2 and SIP pres)
65.09198,1,female,0,17,203,Colon Cancer,Cancer,1,12.0,>$50k,56695.0,29327.0,21.0,white,23.0,1,0,0,metastatic,0.949999809,0.8,no dnr,17.0,120.0,6.79980469,100.0,28.0,37.5,182.0,4.3994141,0.29998779,1.0,139.0,7.359375,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
60.55298,1,male,0,5,297,Lung Cancer,Cancer,1,12.0,under $11k,5619.0,3247.3672,10.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,83.0,4.5,78.0,20.0,36.89844,333.3,4.2998047,0.29998779,1.09985352,139.0,7.419922,135.0,23.0,2502.0,1.7854004,<2 mo. follow-up
30.015,1,male,0,99,635,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,871855.0,14452.7344,27.75,white,64.0,23,0,0,no,0.699999809,0.5,no dnr,99.0,58.0,11.2988281,120.0,6.0,38.39844,290.0,3.699707,16.6992188,5.39941406,141.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
35.92899,1,male,1,20,20,Colon Cancer,Cancer,1,12.0,under $11k,39582.0,21738.4375,7.666664,white,26.0,1,0,0,metastatic,0.5,0.05,dnr after sadm,16.0,85.0,5.09960938,64.0,10.0,36.19531,333.3,4.0996094,1.01,1.79980469,131.0,7.419922,135.0,23.0,2502.0,2.546875,<2 mo. follow-up
54.84998,1,female,0,4,95,Lung Cancer,Cancer,1,16.0,$11-$25k,3278.0,2616.9863,4.0,black,13.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,100.0,7.89941406,80.0,18.0,36.0,333.3,3.5,1.01,0.79992676,136.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
90.32196,1,female,0,27,50,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,106419.0,50455.5938,18.0,white,30.0,3,0,1,no,0.199999928,0.15,dnr after sadm,7.0,68.0,11.0996094,45.0,12.0,37.0,237.5,3.5,1.01,1.0,133.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
84.33899,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,271224.0,129202.75,23.0,white,50.0,45,0,0,no,0.299999952,0.1,dnr after sadm,18.0,110.0,12.7988281,70.0,16.0,35.89844,134.6875,3.5,1.01,5.0,134.0,7.5,135.0,23.0,2502.0,3.4804688,<2 mo. follow-up
57.23999,0,male,0,50,1525,Cirrhosis,COPD/CHF/Cirrhosis,4,19.0,>$50k,410745.0,212786.5,41.0,white,64.0,1,0,0,no,0.599999905,0.6,no dnr,50.0,57.0,2.79980469,110.0,9.0,34.0,257.125,3.0,7.0,2.69970703,150.0,7.459961,135.0,23.0,2502.0,3.9970703,no(M2 and SIP pres)
38.80399,0,female,0,22,1524,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,133255.0,76584.625,26.666656,white,33.0,1,0,0,metastatic,0.699999809,0.5,no dnr,22.0,60.0,6.89941406,120.0,16.0,36.09375,333.3,3.3999023,0.29998779,2.19970703,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
72.46497,1,female,0,5,54,Lung Cancer,Cancer,2,12.0,under $11k,5552.0,3448.8789,10.0,black,12.0,1,1,0,metastatic,0.699999809,0.5,no dnr,5.0,83.0,13.0,74.0,20.0,36.19531,333.3,3.5,1.01,0.79992676,135.0,7.419922,135.0,23.0,2502.0,2.6166992,<2 mo. follow-up
92.60199,1,female,0,16,54,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,50810.0,24484.25,18.333328,white,33.0,1,0,0,no,0.699999809,0.6,no dnr,16.0,120.0,22.296875,115.0,24.0,36.0,388.5625,2.199707,0.89990234,1.59985352,141.0,7.429688,135.0,23.0,2502.0,2.0,<2 mo. follow-up
59.69299,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,71936.0,35045.9688,22.0,white,45.0,15,0,0,metastatic,0.099999964,0.001,dnr after sadm,2.0,73.0,4.29980469,128.0,8.0,38.39844,95.0,3.5,1.01,1.69995117,155.0,7.369141,135.0,23.0,2502.0,3.4375,<2 mo. follow-up
52.767,1,male,0,12,217,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,>$50k,43499.0,20655.6406,12.5,white,30.0,1,0,0,no,0.599999905,0.7,no dnr,12.0,77.0,2.69970703,64.0,22.0,36.79688,333.3,2.699707,5.0,0.89990234,130.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
54.97098,0,female,0,5,1515,COPD,COPD/CHF/Cirrhosis,3,8.0,>$50k,4936.0,3261.3223,9.0,black,15.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,93.0,10.3984375,88.0,24.0,36.39844,272.0,3.5,0.29998779,1.09985352,135.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
62.35699,0,male,0,26,1514,Coma,Coma,0,12.0,under $11k,58097.0,34727.1562,10.25,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,26.0,130.0,12.1992188,110.0,30.0,37.0,260.0,3.5,0.5,0.89990234,146.0,7.579102,135.0,23.0,2502.0,2.0390625,<2 mo. follow-up
82.01196,1,female,0,18,27,COPD,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,45384.0,20617.7188,12.0,white,59.0,1,0,0,no,0.699999809,0.5,no dnr,18.0,63.0,19.3984375,110.0,32.0,36.29688,160.6875,3.8999023,0.19998169,2.0,153.0,7.369141,135.0,23.0,2502.0,2.0,<2 mo. follow-up
53.46997,1,female,0,11,465,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,23440.0,11864.6953,8.5,white,34.0,1,0,0,no,0.5,0.2,no dnr,11.0,77.0,11.6992188,50.0,26.0,36.89844,360.0,3.5,0.39996338,2.5,140.0,7.439453,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
21.092,1,male,1,6,6,Coma,Coma,0,12.0,>$50k,91295.0,43409.4062,36.0,white,51.0,16,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,57.0,26.6992188,130.0,14.0,38.89844,463.3125,3.5,12.5,1.09985352,150.0,7.429688,135.0,23.0,2502.0,2.5375977,<2 mo. follow-up
19.866,1,female,0,22,145,CHF,COPD/CHF/Cirrhosis,1,11.0,under $11k,120028.0,62699.75,22.666656,black,41.0,1,0,0,no,0.699999809,0.5,no dnr,22.0,47.0,11.5996094,120.0,28.0,38.0,333.3,3.199707,3.29980469,0.79992676,128.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.10999,0,female,0,40,1512,ARF/MOSF w/Sepsis,ARF/MOSF,1,21.0,under $11k,546390.0,275272.75,24.25,white,61.0,35,0,0,no,0.899999619,0.8,no dnr,40.0,68.0,31.6992188,110.0,42.0,36.39844,135.53125,2.5,5.39941406,1.5,132.0,7.40918,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
69.66498,1,male,0,4,334,Lung Cancer,Cancer,2,6.0,under $11k,9574.0,4297.7344,10.0,black,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,109.0,12.5,70.0,20.0,36.39844,333.3,4.3994141,0.19998169,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
66.409,0,female,0,11,1511,CHF,COPD/CHF/Cirrhosis,2,14.0,>$50k,43722.0,21538.375,17.0,white,20.0,1,0,0,no,0.799999714,0.6,no dnr,11.0,66.0,7.39941406,75.0,20.0,36.19531,333.3,2.5996094,1.29980469,1.0,131.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
39.84698,1,female,0,17,140,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,47588.0,22880.9062,19.0,white,24.0,3,0,0,metastatic,0.25,0.0156,no dnr,17.0,71.0,6.19921875,120.0,22.0,36.39844,333.3,3.5,1.01,0.29998779,111.0,7.419922,135.0,23.0,2502.0,3.7070312,no(M2 and SIP pres)
66.14099,1,male,1,8,8,COPD,COPD/CHF/Cirrhosis,3,16.0,>$50k,21075.0,9588.3594,11.0,white,38.0,1,1,0,no,0.799999714,0.7,dnr after sadm,1.0,108.0,14.0996094,132.0,32.0,36.59375,247.8125,3.5,1.01,1.0,137.0,7.289062,135.0,23.0,2502.0,4.0595703,<2 mo. follow-up
53.24597,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,231587.0,112461.688,45.0,white,76.0,18,0,0,no,0.399999857,0.1,dnr after sadm,18.0,57.0,24.296875,150.0,37.0,36.0,283.625,3.5,15.5996094,2.29980469,142.0,7.40918,135.0,23.0,2502.0,5.0,<2 mo. follow-up
69.94098,1,male,0,4,352,CHF,COPD/CHF/Cirrhosis,3,18.0,>$50k,5631.0,3324.5644,7.0,white,34.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,60.0,8.0,130.0,24.0,35.59375,323.75,3.5,1.01,1.19995117,138.0,7.539062,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
20.69299,0,male,0,11,1498,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,125185.0,74128.1875,16.5,white,47.0,6,0,0,no,0.989999771,0.98,no dnr,11.0,120.0,16.8984375,145.0,15.0,36.59375,187.75,3.5,0.59997559,8.8984375,134.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.78598,0,female,0,16,1495,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,96189.0,48407.3438,20.0,white,44.0,3,1,0,no,0.699999809,0.5,no dnr,16.0,127.0,22.796875,170.0,32.0,38.29688,328.0,3.5,1.01,1.29980469,153.0,7.359375,135.0,23.0,2502.0,3.5883789,<2 mo. follow-up
35.047,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,155711.0,74268.0,38.0,other,66.0,21,0,0,yes,0.699999809,0.5,dnr after sadm,6.0,65.0,16.3984375,125.0,40.0,36.89844,237.5,3.0996094,17.3984375,2.59960938,139.0,7.339844,135.0,23.0,2502.0,2.3032227,<2 mo. follow-up
72.01398,0,male,0,46,1495,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,173394.0,89319.3125,17.0,white,40.0,12,0,0,no,0.799999714,0.7,no dnr,46.0,110.0,23.296875,85.0,40.0,37.89844,140.8125,3.5,1.01,1.89990234,133.0,7.55957,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
42.823,1,female,1,74,74,MOSF w/Malig,ARF/MOSF,1,15.0,under $11k,393995.0,182175.25,35.75,white,56.0,3,0,0,metastatic,0.5,0.35,no dnr,74.0,67.0,3.29980469,130.0,50.0,39.59375,116.65625,2.5,1.01,1.5,149.0,7.329102,135.0,23.0,2502.0,1.0,Coma or Intub
63.84097,1,female,0,9,380,Colon Cancer,Cancer,1,14.0,$25-$50k,13525.0,7102.8125,11.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,77.0,14.3984375,100.0,20.0,38.19531,333.3,3.5,0.39996338,0.89990234,132.0,7.419922,135.0,23.0,2502.0,2.6625977,<2 mo. follow-up
62.59497,1,female,0,15,107,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,30117.0,16954.0781,11.0,white,24.0,1,0,0,no,0.899999619,0.5,no dnr,15.0,82.0,7.5,78.0,20.0,37.79688,457.125,2.0,4.39941406,1.0,132.0,7.519531,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
70.823,1,female,0,20,26,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,51017.0,26579.4688,16.666656,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,20.0,75.0,6.89941406,70.0,20.0,36.0,333.3,3.5,1.01,2.0,141.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
60.758,1,female,0,11,212,Colon Cancer,Cancer,1,10.0,$25-$50k,24158.0,12792.6641,16.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,117.0,11.0996094,115.0,16.0,36.5,333.3,3.8999023,0.69995117,1.0,142.0,7.419922,135.0,23.0,2502.0,2.5664062,<2 mo. follow-up
76.03296,1,male,0,8,524,Colon Cancer,Cancer,0,17.0,$25-$50k,14594.0,7638.6875,12.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,110.0,13.3984375,104.0,24.0,38.59375,333.3,3.5,1.01,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.42599,1,male,0,4,835,Lung Cancer,Cancer,1,12.0,under $11k,9366.0,3919.8184,10.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,83.0,12.7988281,78.0,20.0,36.39844,333.3,3.5,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.58197,1,male,0,8,168,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,44079.0,24343.4219,12.0,black,23.0,11,0,0,no,0.699999809,0.5,no dnr,8.0,67.0,8.3984375,76.0,20.0,37.89844,333.3,3.5,1.01,1.5,136.0,7.419922,135.0,23.0,2502.0,3.112793,no(M2 and SIP pres)
38.155,1,male,0,21,1050,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,under $11k,143906.0,70408.9375,27.0,white,39.0,10,1,0,no,0.5,0.5,no dnr,21.0,73.0,13.1992188,60.0,10.0,36.59375,142.0,2.5,0.59997559,6.5,131.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
79.97797,1,female,1,37,37,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,214894.0,94687.0,34.75,white,61.0,3,0,0,no,0.699999809,0.5,no dnr,37.0,64.0,25.5,111.0,40.0,36.5,105.0,3.5,0.79992676,2.39990234,129.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.71497,0,female,0,17,1490,CHF,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,76132.0,37674.5625,10.666664,black,31.0,1,0,0,no,0.699999809,0.5,no dnr,17.0,105.0,7.5,110.0,26.0,36.5,333.3,3.5,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.53894,0,female,0,6,1490,Lung Cancer,Cancer,2,14.0,$25-$50k,7769.0,3896.7402,10.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,125.0,9.59960938,88.0,22.0,36.39844,333.3,3.5,1.01,0.79992676,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.439,1,male,0,8,178,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,16863.0,8925.1484,10.5,black,48.0,1,1,0,no,0.799999714,0.7,dnr after sadm,3.0,82.0,2.09960938,60.0,26.0,36.0,366.625,3.5,1.29980469,9.09960938,130.0,7.489258,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
61.02698,0,male,0,10,1488,Colon Cancer,Cancer,1,13.0,under $11k,31943.0,16502.6094,16.5,white,38.0,1,0,0,metastatic,0.949999809,0.75,no dnr,10.0,100.0,10.1992188,128.0,28.0,38.19531,333.3,3.7998047,2.29980469,1.19995117,140.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
66.37097,0,male,0,15,1486,CHF,COPD/CHF/Cirrhosis,0,12.0,$25-$50k,50099.0,25124.25,14.666664,white,42.0,2,0,0,no,0.699999809,0.5,no dnr,15.0,57.0,11.5996094,115.0,24.0,36.59375,333.3,3.5,1.01,1.59985352,130.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
54.08899,1,female,1,9,9,Lung Cancer,Cancer,1,12.0,$11-$25k,23806.0,10995.6953,10.0,white,35.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,4.0,87.0,27.5976562,128.0,30.0,36.19531,136.65625,3.5,1.01,0.79992676,138.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.26398,1,female,0,38,118,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,444915.0,211648.875,20.5,white,41.0,56,0,0,no,0.5,0.3,no dnr,38.0,63.0,12.5,115.0,40.0,36.59375,195.0,3.2998047,1.01,1.09985352,142.0,7.269531,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
31.72099,1,male,0,10,505,MOSF w/Malig,ARF/MOSF,2,20.0,under $11k,58405.0,28456.5938,18.5,white,31.0,5,0,0,metastatic,0.699999809,0.5,no dnr,10.0,73.0,7.5,110.0,28.0,36.29688,149.0625,2.7998047,0.89990234,1.0,134.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.01099,1,male,0,12,45,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,50808.0,23158.7031,25.5,white,27.0,2,0,0,no,0.25,0.1,dnr after sadm,1.0,63.0,15.2988281,100.0,28.0,38.0,277.75,3.5,1.01,1.09985352,148.0,7.519531,135.0,23.0,2502.0,3.0786133,<2 mo. follow-up
83.59497,0,male,0,13,1484,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,>$50k,81350.0,38778.9062,21.0,white,38.0,4,1,0,no,0.699999809,0.5,no dnr,13.0,110.0,14.6992188,130.0,28.0,37.0,195.90625,3.5,1.01,1.0,133.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.64697,1,female,0,59,234,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,528848.0,276147.5,30.25,white,38.0,31,0,0,no,0.699999809,0.5,no dnr,59.0,110.0,18.6992188,110.0,8.0,36.69531,390.0,2.3999023,0.69995117,2.5,127.0,7.399414,135.0,23.0,2502.0,2.7421875,adl>=4 (>=5 if sur)
38.12198,1,female,0,6,956,Lung Cancer,Cancer,1,12.0,under $11k,8624.0,5387.1914,7.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,76.0,4.69921875,82.0,20.0,37.19531,333.3,3.5,0.29998779,0.89990234,138.0,7.419922,135.0,23.0,2502.0,2.1303711,<2 mo. follow-up
79.07495,0,female,0,15,1482,CHF,COPD/CHF/Cirrhosis,1,7.0,under $11k,24141.0,13296.5859,5.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,97.0,5.79980469,76.0,20.0,36.79688,333.3,3.5,1.01,2.69970703,139.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
84.91199,1,male,1,16,16,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,>$50k,30383.0,15251.25,10.333328,white,30.0,1,0,0,no,0.5,0.3,dnr after sadm,10.0,83.0,9.19921875,72.0,20.0,36.0,333.3,2.5,1.01,2.09960938,129.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
74.64795,1,male,1,6,6,Coma,Coma,1,8.0,under $11k,34042.0,17106.8125,42.0,white,27.0,1,0,0,no,0.009999998,1e-06,dnr after sadm,3.0,43.0,33.1953125,70.0,12.0,38.0,205.6875,3.0,1.01,1.0,135.0,7.469727,135.0,23.0,2502.0,2.0,<2 mo. follow-up
56.271,0,male,0,6,1481,Lung Cancer,Cancer,1,16.0,under $11k,15227.0,8136.6094,13.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,75.0,11.1992188,104.0,22.0,38.19531,426.0625,3.5,1.01,0.89990234,134.0,7.369141,135.0,23.0,2502.0,2.3735352,no(M2 and SIP pres)
75.23096,1,male,0,12,992,CHF,COPD/CHF/Cirrhosis,1,20.0,$25-$50k,29545.0,15882.1641,17.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,68.0,6.59960938,70.0,24.0,36.69531,333.3,3.5,1.01,2.29980469,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
40.53098,0,female,0,11,1481,Colon Cancer,Cancer,2,11.0,>$50k,26039.0,13825.3984,12.5,hispanic,5.0,1,0,0,metastatic,0.979999542,0.95,no dnr,11.0,97.0,4.29980469,70.0,14.0,37.89844,333.3,4.3994141,1.19995117,0.79992676,140.0,7.419922,135.0,23.0,2502.0,2.2045898,no(M2 and SIP pres)
74.40094,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,4,15.0,>$50k,22733.0,11903.5234,32.0,white,49.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,57.0,19.3984375,50.0,26.0,38.19531,436.6875,3.5,0.79992676,2.19970703,139.0,7.439453,135.0,23.0,2502.0,3.5600586,<2 mo. follow-up
77.67596,1,female,0,12,59,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,59995.78781114967,14452.7344,23.0,black,23.0,2,0,0,metastatic,0.699999809,0.5,no dnr,12.0,85.0,11.3984375,110.0,20.0,36.89844,260.0,2.5,1.01,1.19995117,134.0,7.449219,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.24597,0,male,0,25,1478,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,162892.0,85360.375,19.25,asian,61.0,21,1,0,no,0.699999809,0.5,no dnr,25.0,117.0,17.8984375,35.0,20.0,36.0,93.875,3.5,1.29980469,4.89941406,131.0,7.529297,135.0,23.0,2502.0,3.1791992,<2 mo. follow-up
38.32999,0,male,0,5,1479,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,6062.0,4049.2051,9.0,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,113.0,8.8984375,72.0,20.0,37.0,333.3,3.5,3.89990234,1.0,141.0,7.419922,135.0,23.0,2502.0,2.1689453,no(M2 and SIP pres)
48.36697,0,male,0,16,1477,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,74504.0,33867.0938,20.333328,white,24.0,3,0,0,no,0.979999542,0.98,no dnr,16.0,80.0,8.29882812,115.0,28.0,39.39844,272.5,2.7998047,0.79992676,1.29980469,141.0,7.509766,135.0,23.0,2502.0,2.2773438,no(M2 and SIP pres)
80.87598,0,female,0,46,1477,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,147296.0,76390.875,21.75,white,43.0,1,0,0,no,0.699999809,0.5,no dnr,46.0,113.0,26.1992188,119.0,24.0,38.19531,177.53125,1.8999023,1.59985352,1.89990234,135.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.38699,1,male,0,3,39,Lung Cancer,Cancer,1,12.0,under $11k,7253.0,3041.6543,9.0,white,15.0,1,0,0,metastatic,0.75,0.15,no dnr,3.0,79.0,12.3984375,82.0,20.0,36.39844,333.3,3.5,1.01,0.89990234,135.0,7.419922,135.0,23.0,2502.0,2.3168945,<2 mo. follow-up
60.03598,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,142731.0,62150.5,43.5,white,50.0,3,1,0,no,0.699999809,0.5,no dnr,10.0,60.0,13.2988281,125.0,8.0,38.5,138.15625,3.5,0.79992676,3.0,137.0,7.569336,135.0,23.0,2502.0,2.7958984,<2 mo. follow-up
71.45197,1,female,0,10,1114,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,29501.0,14482.2031,11.5,white,24.0,1,0,0,no,0.899999619,0.7,no dnr,10.0,87.0,15.1992188,78.0,26.0,36.0,200.0,3.5,1.01,1.0,125.0,7.299805,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
32.95297,0,female,0,8,1461,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,42572.0,22324.5938,23.5,white,50.0,1,0,0,no,0.5,0.5,no dnr,8.0,122.0,5.79980469,110.0,45.0,39.0,194.28125,2.699707,9.29882812,0.5,151.0,7.5,135.0,23.0,2502.0,3.1787109,<2 mo. follow-up
39.63898,0,male,0,48,1460,Cirrhosis,COPD/CHF/Cirrhosis,2,13.0,under $11k,272602.0,133509.5,13.75,white,59.0,1,0,0,no,0.699999809,0.5,no dnr,48.0,71.0,34.3984375,80.0,20.0,36.39844,404.75,2.5,29.5976562,5.89941406,122.0,7.30957,135.0,23.0,2502.0,0.0,SIP>=30
85.11694,1,male,0,7,11,CHF,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,15112.0,7727.9297,12.0,white,42.0,1,0,0,yes,0.75,0.5,dnr after sadm,2.0,66.0,9.19921875,70.0,28.0,36.0,333.3,3.7998047,0.89990234,3.19970703,128.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
68.87299,1,female,1,3,3,Lung Cancer,Cancer,1,18.0,under $11k,9982.0,5144.9805,12.0,white,47.0,1,0,0,metastatic,0.049999982,0.000125,dnr after sadm,1.0,72.0,14.5,124.0,40.0,36.39844,147.5,2.8999023,0.09999084,0.39996338,138.0,7.489258,135.0,23.0,2502.0,3.4711914,<2 mo. follow-up
77.13599,1,male,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,3,19.0,$11-$25k,42561.0,21488.2344,30.0,white,57.0,1,0,0,no,0.099999964,0.001,dnr after sadm,7.0,93.0,10.3984375,96.0,11.0,36.19531,236.71875,2.8999023,9.0,1.89990234,134.0,7.509766,135.0,23.0,2502.0,3.3701172,<2 mo. follow-up
61.99597,0,male,0,9,1458,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,26184.0,13366.4375,13.5,white,31.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,66.0,5.79980469,70.0,26.0,36.0,333.3,3.5,1.29980469,1.39990234,131.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
50.97598,0,male,0,18,1457,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,>$50k,93205.0,41622.8438,25.333328,white,35.0,1,0,0,no,0.099999964,0.001,dnr after sadm,8.0,138.0,14.2988281,120.0,16.0,38.29688,84.0,3.5996094,1.19995117,1.19995117,143.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.45898,1,female,1,132,132,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,1057324.0,483556.25,29.5,white,61.0,4,0,0,no,0.099999964,0.001,dnr after sadm,128.0,63.0,4.59960938,75.0,24.0,36.29688,270.0,3.2998047,29.6992188,5.09960938,137.0,7.469727,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
70.93994,1,male,0,7,1349,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,20186.0,10203.7812,19.0,asian,37.0,1,0,0,no,0.75,0.5,no dnr,7.0,57.0,6.5,60.0,28.0,36.39844,333.3,3.5,1.01,1.29980469,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
89.77399,1,male,0,4,454,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5897.0,3399.334,6.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,120.0,7.89941406,104.0,27.0,36.39844,333.3,3.5,0.19998169,1.19995117,136.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
81.67596,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,125968.0,60127.875,39.333313,white,39.0,1,0,0,no,0.099999964,0.001,dnr after sadm,13.0,58.0,16.0,60.0,10.0,37.19531,74.4375,3.5,1.01,0.89990234,135.0,7.429688,135.0,23.0,2502.0,3.7275391,<2 mo. follow-up
59.10199,1,male,0,8,25,CHF,COPD/CHF/Cirrhosis,3,7.0,$25-$50k,34775.0,17118.25,18.5,hispanic,45.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,55.0,8.09960938,85.0,28.0,36.29688,333.3,3.199707,3.0,1.29980469,134.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
56.64099,1,female,0,8,1022,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,20497.0,11364.9922,9.0,white,22.0,1,0,0,yes,0.699999809,0.5,no dnr,8.0,100.0,10.0996094,100.0,24.0,37.0,271.375,4.5,0.39996338,0.89990234,140.0,7.379883,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
67.37,1,female,0,20,77,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,50138.0,27878.3281,10.333328,white,36.0,1,0,0,no,0.5,0.4,dnr after sadm,6.0,71.0,4.39941406,72.0,20.0,36.39844,333.3,2.5996094,1.89990234,4.69921875,140.0,7.419922,135.0,23.0,2502.0,3.855299,adl>=4 (>=5 if sur)
57.46698,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,150471.0,73386.0625,21.25,asian,41.0,5,0,0,yes,0.799999714,0.75,dnr after sadm,21.0,73.0,15.5996094,120.0,16.0,36.5,83.67188,3.5,3.79980469,0.79992676,141.0,7.449219,135.0,23.0,2502.0,3.2636719,<2 mo. follow-up
68.87897,1,female,0,12,57,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,65136.0,31077.1094,21.5,black,50.0,1,1,0,no,0.599999905,0.4,no dnr,12.0,80.0,25.8984375,115.0,28.0,36.89844,333.3,2.199707,0.39996338,2.0,129.0,7.419922,135.0,23.0,2502.0,3.7280273,<2 mo. follow-up
35.806,0,female,0,5,1448,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,20092.0,10231.5,18.0,white,42.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,50.0,8.69921875,135.0,24.0,35.89844,333.3,3.8999023,0.79992676,1.59985352,134.0,7.419922,135.0,23.0,2502.0,2.1542969,<2 mo. follow-up
35.603,1,male,0,11,814,Colon Cancer,Cancer,1,12.0,under $11k,41788.0,20779.6094,12.5,white,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,79.0,25.5976562,120.0,22.0,39.59375,333.3,3.0996094,0.39996338,0.79992676,133.0,7.419922,135.0,23.0,2502.0,2.9345703,<2 mo. follow-up
43.47699,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,79576.0,37880.3438,44.5,hispanic,68.0,1,0,0,no,0.699999809,0.5,dnr after sadm,8.0,48.0,5.59960938,130.0,20.0,37.5,130.0,2.2998047,21.0976562,1.39990234,130.0,7.589844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.68597,0,male,0,7,1446,CHF,COPD/CHF/Cirrhosis,1,14.0,under $11k,16964.0,9183.4531,16.0,white,30.0,1,0,0,no,0.899999619,0.6,no dnr,7.0,57.0,10.5996094,75.0,24.0,36.29688,333.3,4.3994141,0.5,1.29980469,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
44.60797,1,female,1,9,9,Cirrhosis,COPD/CHF/Cirrhosis,4,8.0,under $11k,214817.0,115186.0,20.0,hispanic,36.0,58,0,0,no,0.199999928,0.05,dnr after sadm,5.0,120.0,12.3984375,115.0,12.0,38.29688,280.0,3.5,9.59960938,0.79992676,137.0,7.489258,135.0,23.0,2502.0,7.0,<2 mo. follow-up
70.04797,0,male,0,14,1445,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,$25-$50k,26738.0,14451.3594,10.0,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,63.0,6.29980469,74.0,20.0,36.39844,266.625,1.5998535,1.09985352,1.19995117,135.0,7.529297,135.0,23.0,2502.0,1.0,<2 mo. follow-up
45.043,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,194716.0,93609.625,31.0,white,74.0,2,0,0,no,0.199999928,0.2,dnr after sadm,12.0,128.0,0.29998779,115.0,38.0,36.0,250.0,2.199707,0.69995117,2.19970703,148.0,7.469727,135.0,23.0,2502.0,4.0,<2 mo. follow-up
60.79398,1,female,0,20,136,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,141714.0,67726.3125,31.333328,white,55.0,10,0,0,no,0.699999809,0.5,no dnr,20.0,59.0,12.8984375,155.0,28.0,38.59375,119.98438,3.5,1.19995117,0.89990234,137.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.88199,1,female,0,3,574,Lung Cancer,Cancer,1,14.0,under $11k,6593.0,2757.2383,9.0,black,5.0,1,0,0,metastatic,0.899999619,0.75,dnr after sadm,1.0,94.0,8.0,88.0,20.0,37.0,333.3,3.5,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,2.2241211,no(M2 and SIP pres)
65.02899,1,female,0,3,35,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3087.0,2025.5361,7.0,black,35.0,1,1,0,metastatic,1.0,0.3,no dnr,3.0,103.0,9.0,68.0,26.0,35.79688,471.375,3.5,1.01,1.5,126.0,7.5,135.0,23.0,2502.0,6.0,<2 mo. follow-up
19.17,0,female,0,30,1440,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,166750.0,79628.75,29.25,hispanic,86.0,1,0,0,yes,0.5,0.1,no dnr,30.0,46.0,16.1992188,170.0,47.0,36.0,31.66406,3.5,1.01,1.59985352,131.0,7.189453,135.0,23.0,2502.0,2.340332,<2 mo. follow-up
72.84296,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,196869.0,94460.75,50.5,white,38.0,16,0,0,no,0.699999809,0.5,no dnr,11.0,50.0,10.1992188,120.0,10.0,36.79688,188.0,3.0,1.01,1.0,127.0,7.489258,135.0,23.0,2502.0,2.65625,<2 mo. follow-up
42.03699,1,male,1,28,28,Cirrhosis,COPD/CHF/Cirrhosis,1,20.0,>$50k,100295.0,48086.9375,16.25,white,59.0,1,0,0,no,0.5,0.5,dnr after sadm,28.0,77.0,6.79980469,82.0,20.0,36.39844,333.3,1.3999023,17.296875,2.0,128.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.806,0,female,0,21,1437,COPD,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,75895.0,34792.25,15.333328,asian,32.0,2,0,0,yes,0.599999905,0.4,no dnr,21.0,128.0,13.6992188,145.0,26.0,37.0,222.84375,3.5,1.01,0.69995117,143.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
49.56097,1,male,1,32,32,Coma,Coma,1,16.0,>$50k,245849.0,101754.438,36.5,black,50.0,17,1,0,no,0.699999809,0.5,dnr after sadm,13.0,102.0,22.3984375,100.0,12.0,38.29688,154.0,3.5,2.09960938,2.19970703,129.0,7.539062,135.0,23.0,2502.0,5.0,<2 mo. follow-up
51.93997,1,male,0,39,1072,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,280893.0,14452.7344,32.0,white,42.0,5,0,0,yes,0.5,0.4,dnr after sadm,9.0,63.0,5.69921875,110.0,18.0,39.19531,172.0,3.5,3.29980469,2.09960938,140.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.24698,1,female,0,4,235,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,6536.0,3746.0566,7.0,white,16.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,87.0,9.19921875,84.0,20.0,36.0,257.125,3.5,0.5,1.19995117,140.0,7.509766,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
73.75494,1,male,0,6,35,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,29426.0,13739.3125,23.0,black,68.0,1,1,0,metastatic,0.049999982,0.000125,dnr after sadm,1.0,50.0,17.3984375,104.0,28.0,38.39844,158.3125,2.0,0.5,2.09960938,153.0,7.199219,135.0,23.0,2502.0,3.8896484,<2 mo. follow-up
47.93198,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,92238.0,45525.5312,45.0,white,83.0,21,0,0,metastatic,0.199999928,0.1,dnr after sadm,4.0,60.0,0.04999542,150.0,40.0,36.29688,167.34375,2.5996094,2.19970703,2.89990234,129.0,7.399414,135.0,23.0,2502.0,3.2519531,<2 mo. follow-up
58.69699,1,female,0,3,1086,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,6849.0,3490.2266,4.0,hispanic,40.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,100.0,5.89941406,80.0,28.0,36.59375,352.375,3.5,1.01,2.19970703,138.0,7.40918,135.0,23.0,2502.0,2.371582,SIP>=30
60.73099,0,male,0,50,1434,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,363112.0,186497.75,28.75,hispanic,56.0,15,0,0,no,0.699999809,0.5,no dnr,50.0,107.0,8.09960938,70.0,24.0,36.29688,315.0,2.7998047,11.8984375,8.19921875,142.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
68.50397,1,male,0,9,338,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,41674.0,19016.3594,23.0,white,32.0,2,0,0,yes,0.699999809,0.6,no dnr,9.0,69.0,3.0,70.0,26.0,38.19531,231.40625,3.5,2.39990234,1.19995117,131.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
41.75497,1,female,1,6,6,Coma,Coma,6,16.0,>$50k,69323.0,33539.1875,36.0,white,60.0,3,1,0,no,0.699999809,0.5,dnr after sadm,6.0,40.0,31.5976562,120.0,26.0,38.59375,260.0,3.5,1.01,3.79980469,146.0,7.599609,135.0,23.0,2502.0,5.0,<2 mo. follow-up
48.14798,0,male,0,4,1432,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,23166.0,11004.8984,11.0,white,9.0,2,0,0,no,0.599999905,0.6,no dnr,4.0,78.0,14.0996094,82.0,18.0,36.79688,86.0,3.5,0.69995117,1.0,138.0,7.40918,135.0,23.0,2502.0,2.1948242,<2 mo. follow-up
48.564,1,male,0,44,181,MOSF w/Malig,ARF/MOSF,2,19.0,under $11k,225659.0,108896.062,20.0,white,49.0,18,0,0,yes,0.699999809,0.5,no dnr,44.0,103.0,0.09999084,110.0,20.0,39.5,208.15625,2.0,1.01,1.39990234,131.0,7.509766,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
45.51398,1,male,1,39,39,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,>$50k,323371.0,183641.75,7.0,asian,46.0,1,0,0,no,0.799999714,0.4,dnr after sadm,39.0,94.0,9.19921875,82.0,18.0,36.19531,333.3,1.8999023,11.1992188,1.39990234,126.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
82.66699,1,female,0,27,128,Coma,Coma,3,12.0,under $11k,130916.0,66110.1875,18.75,white,23.0,5,0,1,yes,0.199999928,0.2,dnr after sadm,3.0,112.0,79.1875,55.0,18.0,38.5,212.5,3.5,1.01,0.69995117,125.0,7.519531,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
42.45599,0,male,0,20,1430,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,>$50k,63445.0,31127.625,16.666656,hispanic,30.0,3,0,0,no,0.989999771,0.99,no dnr,20.0,113.0,9.19921875,110.0,33.0,38.29688,220.0,3.5,0.29998779,0.79992676,137.0,7.469727,135.0,23.0,2502.0,0.0,SIP>=30
70.20898,1,male,0,6,452,Lung Cancer,Cancer,1,16.0,>$50k,9088.0,4997.6172,10.0,white,15.0,1,0,0,metastatic,0.649999619,0.5,no dnr,6.0,111.0,12.1992188,80.0,22.0,36.59375,333.3,3.5,1.01,1.0,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
40.39999,1,male,0,4,130,Lung Cancer,Cancer,3,12.0,under $11k,12693.0,5611.8125,11.0,white,6.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,90.0,6.29980469,104.0,18.0,36.59375,333.3,3.5,1.01,0.89990234,139.0,7.419922,135.0,23.0,2502.0,2.730957,no(M2 and SIP pres)
76.08997,1,male,0,7,240,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,12254.0,6517.3008,8.0,white,19.0,1,0,0,no,0.899999619,0.8,no dnr,7.0,80.0,14.0,120.0,20.0,36.19531,260.0,3.5,1.01,0.79992676,142.0,7.449219,135.0,23.0,2502.0,4.5273972,<2 mo. follow-up
77.85895,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,89858.0,41205.5625,39.0,white,76.0,3,0,0,metastatic,0.25,0.05,dnr before sadm,-1.0,58.0,8.69921875,165.0,16.0,38.79688,91.10938,1.6999512,0.89990234,1.5,143.0,7.40918,135.0,23.0,2502.0,3.6572266,<2 mo. follow-up
71.02295,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,132772.0,59345.3438,30.666656,white,50.0,8,0,0,no,0.099999964,0.001,dnr after sadm,13.0,110.0,10.2988281,140.0,23.0,38.19531,126.3125,3.5,2.0,1.79980469,137.0,7.349609,135.0,23.0,2502.0,2.4824219,<2 mo. follow-up
30.35999,0,male,0,12,1425,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,283773.0,137584.625,44.5,black,38.0,13,0,0,no,0.75,0.75,no dnr,12.0,100.0,17.0,115.0,10.0,37.79688,332.5,2.199707,27.3984375,1.0,136.0,7.389648,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
76.74194,1,male,0,5,349,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,14066.0,7114.2422,14.0,white,38.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,58.0,7.79980469,70.0,20.0,36.5,333.3,3.5,1.01,1.59985352,135.0,7.419922,135.0,23.0,2502.0,2.9550781,no(M2 and SIP pres)
76.97198,0,female,0,6,1424,CHF,COPD/CHF/Cirrhosis,2,13.0,>$50k,11489.0,6593.7188,10.0,black,21.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,85.0,4.69921875,100.0,20.0,36.5,352.375,3.5,1.01,1.59985352,139.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.745,1,female,0,5,328,CHF,COPD/CHF/Cirrhosis,3,16.0,$11-$25k,9478.0,5019.3398,14.0,white,38.0,1,1,0,no,0.949999809,0.8,dnr after sadm,1.0,53.0,11.5,82.0,20.0,36.39844,333.3,3.5,1.01,2.09960938,139.0,7.419922,135.0,23.0,2502.0,2.5449219,adl>=4 (>=5 if sur)
65.93298,1,female,0,4,715,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,10227.0,5117.5234,10.0,asian,30.0,8,0,0,no,0.75,0.5,no dnr,4.0,103.0,8.69921875,134.0,24.0,36.0,260.8125,3.5,1.01,1.0,141.0,7.459961,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
69.98199,1,female,0,15,680,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,65732.0,33516.375,34.0,black,43.0,3,0,0,no,0.059999973,0.000216,no dnr,15.0,63.0,11.1992188,110.0,26.0,36.5,241.65625,3.2998047,2.69970703,1.5,130.0,7.389648,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
82.14099,1,male,0,20,65,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,113460.0,56403.9375,15.0,black,32.0,12,0,0,metastatic,0.799999714,0.5,dnr after sadm,12.0,75.0,9.19921875,70.0,22.0,36.5,107.14062,3.5996094,0.29998779,1.29980469,133.0,7.5,135.0,23.0,2502.0,4.4794922,<2 mo. follow-up
41.06198,0,female,0,4,1419,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,16536.0,8055.3008,6.0,black,9.0,1,0,0,no,0.899999619,0.85,no dnr,4.0,117.0,16.8984375,74.0,24.0,37.0,218.34375,3.5,1.01,1.0,130.0,7.379883,135.0,23.0,2502.0,2.0395508,<2 mo. follow-up
56.34998,1,female,0,3,1344,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,4944.0,2253.7129,6.0,white,12.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,87.0,6.69921875,100.0,24.0,37.0,266.625,3.5,1.01,0.59997559,130.0,7.439453,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
67.72894,1,male,0,9,1325,CHF,COPD/CHF/Cirrhosis,3,18.0,$11-$25k,32258.0,16843.2656,10.0,white,20.0,1,0,0,no,0.959999561,0.92,no dnr,9.0,110.0,7.59960938,65.0,24.0,36.5,333.3,3.5,0.79992676,1.29980469,137.0,7.419922,135.0,23.0,2502.0,2.9853516,<2 mo. follow-up
51.18698,1,male,0,10,1243,Colon Cancer,Cancer,3,12.0,under $11k,30006.0,15566.1562,11.5,white,39.0,1,1,0,metastatic,0.099999964,0.001,no dnr,10.0,120.0,11.3984375,140.0,20.0,39.5,333.3,3.5,0.29998779,1.69995117,135.0,7.419922,135.0,23.0,2502.0,3.5170898,<2 mo. follow-up
48.43799,1,male,1,11,11,MOSF w/Malig,ARF/MOSF,1,15.0,>$50k,275297.0,131152.125,38.5,white,93.0,27,0,0,yes,0.699999809,0.5,dnr after sadm,9.0,58.0,0.59997559,170.0,26.0,39.89844,56.0,2.5996094,0.59997559,3.59960938,150.0,7.329102,135.0,23.0,2502.0,2.2446289,<2 mo. follow-up
63.573,1,female,1,32,32,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,231839.0,99332.375,30.75,white,34.0,7,0,0,metastatic,0.75,0.2,dnr after sadm,18.0,60.0,4.09960938,130.0,23.0,38.69531,107.6875,2.0,0.59997559,0.89990234,125.0,7.419922,135.0,23.0,2502.0,3.2402344,<2 mo. follow-up
56.74197,1,male,0,12,738,Colon Cancer,Cancer,1,18.0,$11-$25k,41129.0,20834.9062,12.5,white,11.0,1,0,0,metastatic,0.949999809,0.85,no dnr,12.0,98.0,10.5996094,82.0,20.0,36.39844,333.3,4.3994141,0.69995117,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.43799,0,male,0,17,1411,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,73122.0,36176.8438,22.333328,white,19.0,2,1,0,no,0.849999905,0.8,no dnr,17.0,67.0,6.29980469,110.0,22.0,36.39844,457.125,3.5,1.01,0.89990234,134.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.59094,1,female,0,124,200,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,352231.25,34.25,white,49.0,11,0,0,no,0.699999809,0.5,no dnr,124.0,68.0,27.5,110.0,12.0,38.5,90.90625,2.3999023,2.39990234,1.09985352,131.0,7.419922,135.0,23.0,2502.0,2.7763672,adl>=4 (>=5 if sur)
56.50098,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,95243.0,48038.875,26.5,white,54.0,15,0,0,no,0.099999964,0.001,dnr after sadm,7.0,123.0,16.8984375,115.0,9.0,37.0,273.3125,3.5996094,11.3984375,5.89941406,137.0,7.439453,135.0,23.0,2502.0,6.0,<2 mo. follow-up
45.22699,0,male,0,29,1406,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,213989.0,110645.438,27.5,white,21.0,4,0,0,no,0.699999809,0.5,no dnr,29.0,122.0,18.5,120.0,6.0,37.29688,504.0,3.5,1.01,0.69995117,132.0,7.489258,135.0,23.0,2502.0,3.4370117,<2 mo. follow-up
54.44498,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,>$50k,61442.0,28589.9844,42.0,white,81.0,2,0,0,no,0.099999964,0.001,no dnr,5.0,30.0,6.79980469,145.0,20.0,39.19531,81.0,2.199707,12.6992188,0.59997559,131.0,7.349609,135.0,23.0,2502.0,2.5195312,<2 mo. follow-up
85.36096,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,51486.0,24927.7031,33.0,white,76.0,9,0,0,no,0.009999998,1e-06,no dnr,3.0,40.0,18.0976562,30.0,25.0,38.0,294.0,3.5,2.5,2.69970703,131.0,7.229492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
46.08099,0,male,0,31,1405,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,170570.0,84744.75,17.0,hispanic,12.0,1,0,0,no,0.699999809,0.5,no dnr,31.0,67.0,9.0,50.0,16.0,37.79688,333.3,3.5,0.19998169,0.89990234,138.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
32.42697,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,382471.0,201105.75,45.5,white,98.0,13,0,0,no,0.099999964,0.001,dnr after sadm,9.0,57.0,39.796875,120.0,36.0,35.09375,205.6875,1.7998047,16.8984375,2.19970703,134.0,7.399414,135.0,23.0,2502.0,4.0322266,<2 mo. follow-up
66.27496,1,male,0,8,879,Colon Cancer,Cancer,1,20.0,>$50k,18606.0,9488.0312,9.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,83.0,13.3984375,68.0,20.0,38.0,333.3,3.199707,1.39990234,1.09985352,135.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
78.53796,1,female,0,6,146,COPD,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,8697.0,5066.1602,7.0,white,28.0,1,0,0,no,0.899999619,0.85,no dnr,6.0,96.0,12.1992188,96.0,22.0,36.0,157.125,3.699707,0.59997559,1.19995117,142.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.95099,1,female,1,43,43,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,449923.0,199117.25,41.75,black,47.0,1,0,0,yes,0.699999809,0.5,no dnr,43.0,63.0,19.3984375,125.0,14.0,39.39844,234.0,2.8999023,1.39990234,6.59960938,144.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
39.81897,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,54871.0,26152.2031,40.0,white,102.0,3,0,0,no,0.099999964,0.001,no dnr,5.0,35.0,18.3984375,130.0,15.0,38.79688,100.0,2.0996094,20.296875,3.0,132.0,7.30957,135.0,23.0,2502.0,3.3813477,<2 mo. follow-up
31.34299,1,female,1,11,11,Coma,Coma,1,12.0,under $11k,148727.0,66520.625,28.0,white,62.0,32,0,0,metastatic,0.699999809,0.5,no dnr,11.0,42.0,20.1992188,140.0,20.0,38.5,68.0,3.5,1.01,2.29980469,132.0,7.339844,135.0,23.0,2502.0,3.6069336,<2 mo. follow-up
73.14697,1,male,0,11,971,CHF,COPD/CHF/Cirrhosis,2,4.0,>$50k,20810.0,13290.375,9.5,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,70.0,8.59960938,65.0,28.0,36.0,333.3,3.5,1.01,2.0,138.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
73.70294,1,male,0,7,166,CHF,COPD/CHF/Cirrhosis,1,24.0,under $11k,14284.0,8644.1797,8.0,white,45.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,77.0,5.29980469,92.0,28.0,38.09375,261.875,3.5,2.29980469,2.19970703,137.0,7.479492,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
71.75397,0,female,0,25,1400,COPD,COPD/CHF/Cirrhosis,1,9.0,under $11k,135615.0,60638.9062,22.5,black,15.0,1,0,0,no,0.599999905,0.5,no dnr,25.0,60.0,15.3984375,110.0,10.0,38.19531,300.0,2.7998047,1.01,0.89990234,137.0,7.439453,135.0,23.0,2502.0,2.8969727,no(M2 and SIP pres)
63.59799,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,51942.0,23758.9062,39.0,white,100.0,1,0,0,yes,0.099999964,0.001,dnr after sadm,2.0,30.0,50.59375,115.0,25.0,38.39844,56.0,2.5,22.796875,5.19921875,129.0,7.579102,135.0,23.0,2502.0,2.206543,<2 mo. follow-up
72.323,1,male,0,18,66,Colon Cancer,Cancer,2,12.0,under $11k,36244.0,20509.875,11.333328,white,19.0,1,1,0,metastatic,0.599999905,0.2,dnr after sadm,9.0,81.0,16.296875,112.0,20.0,39.19531,333.3,3.0996094,1.01,0.79992676,128.0,7.419922,135.0,23.0,2502.0,3.3491211,<2 mo. follow-up
44.12299,1,female,0,28,55,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,293158.0,148681.25,19.25,white,71.0,23,0,0,yes,0.5,0.5,no dnr,28.0,63.0,3.39990234,160.0,21.0,39.19531,348.0,3.5,9.0,4.89941406,135.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
21.74899,0,male,0,23,1396,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,156314.0,88603.3125,26.333328,white,11.0,4,0,0,no,0.699999809,0.5,no dnr,23.0,70.0,10.7988281,105.0,20.0,38.59375,206.09375,3.5,1.01,0.79992676,145.0,7.30957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.85797,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,>$50k,234034.0,109152.25,37.666657,white,34.0,13,0,0,no,0.799999714,0.75,dnr after sadm,17.0,75.0,6.59960938,105.0,28.0,36.5,183.3125,2.0996094,1.01,1.0,144.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.05099,0,female,0,6,1395,Lung Cancer,Cancer,2,12.0,under $11k,9864.0,5061.0352,9.0,black,12.0,1,0,0,metastatic,0.899999619,0.75,no dnr,6.0,79.0,10.2988281,100.0,24.0,37.39844,333.3,3.5,1.01,0.89990234,137.0,7.419922,135.0,23.0,2502.0,2.5302734,no(M2 and SIP pres)
57.84799,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,139623.0,68361.5,58.0,white,104.0,18,0,0,yes,0.069999993,0.000343,no dnr,4.0,48.0,0.04999542,200.0,32.0,39.29688,75.54688,3.5,8.69921875,1.79980469,152.0,7.289062,135.0,23.0,2502.0,5.0,<2 mo. follow-up
72.56097,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,301990.0,138869.5,26.5,white,57.0,21,0,0,yes,0.5,0.125,dnr after sadm,22.0,70.0,15.7988281,110.0,22.0,36.09375,190.0,3.2998047,26.296875,2.39990234,135.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
49.53,0,female,0,4,1392,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,10545.0,5904.1562,10.0,black,21.0,1,1,0,no,1.0,0.95,no dnr,4.0,103.0,6.19921875,86.0,24.0,36.89844,333.3,3.5,1.01,1.39990234,134.0,7.419922,135.0,23.0,2502.0,2.2373047,no(M2 and SIP pres)
60.65399,1,male,1,51,51,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,475387.0,216298.25,35.75,white,52.0,1,1,0,no,0.699999809,0.5,dnr after sadm,44.0,63.0,5.19921875,125.0,8.0,38.89844,114.0,2.3999023,1.5,1.79980469,137.0,7.399414,135.0,23.0,2502.0,3.0224609,<2 mo. follow-up
69.41797,1,male,1,4,4,Lung Cancer,Cancer,1,14.0,$11-$25k,7194.0,3058.4688,12.0,asian,33.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,73.0,9.0,62.0,34.0,39.19531,128.5625,3.0996094,0.29998779,1.09985352,133.0,7.479492,135.0,23.0,2502.0,6.0,<2 mo. follow-up
25.89699,0,male,0,28,1391,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,251227.0,126467.875,22.5,hispanic,36.0,16,0,0,yes,0.75,0.7,no dnr,28.0,153.0,7.09960938,110.0,24.0,35.89844,76.0,2.7998047,0.79992676,2.19970703,136.0,7.389648,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
47.43298,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,169364.0,82586.5,37.0,white,63.0,1,0,0,no,0.099999964,0.001,dnr after sadm,6.0,73.0,5.09960938,115.0,24.0,36.89844,191.65625,2.199707,19.296875,1.69995117,141.0,7.519531,135.0,23.0,2502.0,3.0639648,<2 mo. follow-up
36.29797,0,male,0,15,1385,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,48925.0,26166.5,10.0,white,18.0,2,0,0,no,0.899999619,0.9,no dnr,15.0,97.0,13.5,118.0,16.0,38.0,190.0,3.5,3.19970703,0.79992676,140.0,7.389648,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
63.07999,0,male,0,9,1384,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,29706.0,14753.0078,13.5,hispanic,44.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,51.0,5.29980469,75.0,24.0,36.29688,333.3,2.5,1.19995117,1.29980469,128.0,7.469727,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
61.77399,1,male,0,9,181,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,21076.0,12039.4688,16.0,white,16.0,1,0,0,no,0.899999619,0.85,no dnr,9.0,110.0,6.0,70.0,16.0,36.59375,333.3,3.5996094,0.69995117,1.29980469,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.23297,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,233772.0,97798.75,39.666657,other,34.0,1,1,0,no,0.699999809,0.5,no dnr,19.0,60.0,11.2988281,115.0,8.0,36.39844,230.0,2.7998047,0.79992676,1.39990234,125.0,7.489258,135.0,23.0,2502.0,2.7539062,<2 mo. follow-up
72.42694,1,female,1,9,9,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,69587.0,34518.0,37.5,other,47.0,2,0,0,no,0.5,0.4,dnr after sadm,8.0,103.0,8.3984375,135.0,32.0,37.69531,172.5,3.0996094,4.69921875,1.29980469,153.0,7.40918,135.0,23.0,2502.0,3.1469727,<2 mo. follow-up
80.38599,1,male,0,5,215,Colon Cancer,Cancer,2,8.0,$25-$50k,11109.0,6680.4805,9.0,white,25.0,1,1,0,metastatic,0.899999619,0.3,no dnr,5.0,73.0,5.59960938,72.0,18.0,36.19531,333.3,3.5,1.01,1.09985352,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.12695,1,male,1,3,3,Coma,Coma,1,14.0,under $11k,22541.0,11522.2422,24.0,white,13.0,1,0,1,no,0.699999809,0.5,dnr after sadm,3.0,82.0,9.69921875,50.0,14.0,35.0,430.0,4.0996094,1.01,0.89990234,134.0,7.479492,135.0,23.0,2502.0,4.6728516,<2 mo. follow-up
34.32199,1,female,0,40,150,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,$11-$25k,271769.0,136256.625,26.5,hispanic,39.0,4,1,0,no,0.799999714,0.6,no dnr,40.0,115.0,13.1992188,110.0,16.0,39.5,166.65625,3.5,0.69995117,7.39941406,136.0,7.359375,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
51.491,1,female,1,90,90,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,1056280.0,463356.75,38.0,white,59.0,6,0,0,no,0.699999809,0.5,dnr after sadm,88.0,63.0,39.0,135.0,36.0,37.09375,220.0,3.5,2.69970703,3.69970703,129.0,7.5,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.92499,0,female,0,6,1378,CHF,COPD/CHF/Cirrhosis,3,5.0,under $11k,22303.0,10978.2969,23.0,hispanic,29.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,60.0,7.5,135.0,28.0,36.39844,258.3125,3.5,0.69995117,0.79992676,142.0,7.329102,135.0,23.0,2502.0,3.0,<2 mo. follow-up
71.95599,1,male,0,10,137,CHF,COPD/CHF/Cirrhosis,0,12.0,under $11k,35928.0,18626.0938,18.5,asian,38.0,1,0,0,no,0.949999809,0.6,no dnr,10.0,55.0,6.19921875,105.0,24.0,39.19531,333.3,3.5,1.19995117,1.89990234,133.0,7.419922,135.0,23.0,2502.0,2.6972656,<2 mo. follow-up
60.59097,0,female,0,12,1376,Colon Cancer,Cancer,1,12.0,$25-$50k,35397.0,18058.4375,12.5,white,17.0,1,0,0,metastatic,0.949999809,0.8,no dnr,12.0,81.0,7.5,120.0,22.0,38.39844,333.3,4.6992188,0.5,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
33.09,1,male,1,24,24,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,216416.0,96186.9375,31.666656,asian,37.0,7,0,0,yes,0.099999964,0.001,no dnr,24.0,110.0,3.0,160.0,12.0,35.5,113.84375,3.5,0.5,0.5,135.0,7.469727,135.0,23.0,2502.0,2.6982422,<2 mo. follow-up
74.74896,1,male,0,4,473,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,10758.0,4629.7305,6.0,white,38.0,1,0,0,no,0.899999619,0.6,no dnr,4.0,65.0,5.0,110.0,24.0,36.0,333.3,5.5,0.79992676,1.5,130.0,7.419922,135.0,23.0,2502.0,2.0253906,<2 mo. follow-up
50.90198,1,male,0,13,790,CHF,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,37558.0,23093.8125,15.5,white,21.0,1,0,0,no,0.899999619,0.75,no dnr,13.0,68.0,11.0,110.0,20.0,37.79688,333.3,4.1992188,1.39990234,1.29980469,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.866,1,male,0,14,783,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,68122.0,30441.1719,14.0,white,40.0,1,0,0,no,0.5,0.5,no dnr,14.0,70.0,22.5976562,140.0,20.0,36.0,333.3,4.6992188,1.09985352,1.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.396,0,male,0,6,1375,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,9246.0,5969.9688,10.0,white,16.0,1,0,0,no,0.899999619,0.6,no dnr,6.0,80.0,9.29882812,80.0,20.0,37.09375,357.125,3.5,0.39996338,1.29980469,137.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
63.017,0,male,0,14,1374,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$25-$50k,133878.0,63155.6875,16.666656,white,25.0,5,0,0,no,0.799999714,0.7,no dnr,14.0,57.0,6.89941406,80.0,8.0,37.19531,144.0,2.5996094,0.89990234,0.89990234,137.0,7.449219,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
41.974,0,male,0,53,1373,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,328134.0,14452.7344,35.5,white,73.0,1,0,0,no,0.399999857,0.4,no dnr,53.0,50.0,5.69921875,135.0,30.0,35.09375,56.0,2.7998047,5.59960938,3.09960938,142.0,7.40918,135.0,23.0,2502.0,2.0996094,<2 mo. follow-up
67.88495,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,181177.0,83650.4375,25.0,white,33.0,4,0,0,no,0.5,0.5,no dnr,24.0,73.0,25.796875,110.0,22.0,36.39844,230.0,2.7998047,1.79980469,1.39990234,131.0,7.449219,135.0,23.0,2502.0,2.4399414,<2 mo. follow-up
46.48297,0,female,0,16,1373,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,95454.0,46194.7812,17.333328,white,35.0,5,0,0,no,0.699999809,0.7,no dnr,16.0,75.0,10.2988281,130.0,48.0,38.0,427.0,3.5,1.01,0.79992676,141.0,7.30957,135.0,23.0,2502.0,2.9467773,no(M2 and SIP pres)
64.51697,1,male,0,17,249,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,125379.0,72966.375,24.666656,white,22.0,6,0,0,no,0.699999809,0.5,no dnr,17.0,67.0,8.3984375,100.0,24.0,36.0,333.3,3.5,1.01,1.29980469,129.0,7.419922,135.0,23.0,2502.0,0.4947999,SIP>=30
65.711,1,female,0,44,394,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,497053.0,228884.625,38.75,white,60.0,9,0,0,no,0.699999809,0.5,no dnr,44.0,50.0,13.6992188,95.0,12.0,38.5,106.65625,3.5996094,2.39990234,5.0,144.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.42896,1,male,0,14,413,CHF,COPD/CHF/Cirrhosis,1,12.0,>$50k,79641.0,39536.7812,30.0,white,33.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,53.0,19.3984375,80.0,20.0,36.39844,155.09375,3.5,1.01,1.39990234,137.0,7.259766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
34.05899,0,female,0,36,1368,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,250630.0,105455.062,23.25,black,11.0,2,0,0,no,0.949999809,0.9,no dnr,36.0,103.0,21.8984375,105.0,18.0,38.79688,257.5,3.5,1.01,0.5,133.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
32.40198,1,female,1,18,18,MOSF w/Malig,ARF/MOSF,2,17.0,$25-$50k,262612.0,123059.438,33.666657,white,69.0,12,0,0,yes,0.699999809,0.5,dnr after sadm,8.0,107.0,13.0996094,120.0,28.0,36.79688,142.5,3.5,36.0,3.89990234,142.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
28.30099,0,male,0,37,1366,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,194198.0,119175.312,15.5,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,37.0,67.0,6.29980469,135.0,16.0,36.29688,333.3,3.5,1.01,1.59985352,139.0,7.419922,135.0,23.0,2502.0,2.690918,<2 mo. follow-up
56.323,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,151266.0,68650.875,32.0,white,82.0,14,1,0,no,0.699999809,0.5,no dnr,3.0,0.0,15.3984375,135.0,10.0,38.5,142.0,3.5,1.01,3.19970703,132.0,7.469727,135.0,23.0,2502.0,2.5961914,<2 mo. follow-up
47.98099,0,female,0,4,1364,Lung Cancer,Cancer,2,18.0,under $11k,59995.78781114967,14452.7344,9.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,14.58258953168044,72.0,8.29882812,100.0,20.0,37.19531,333.3,3.5,1.01,0.79992676,136.0,7.419922,135.0,23.0,2502.0,2.5249023,no(M2 and SIP pres)
70.125,1,female,1,11,11,Coma,Coma,0,12.0,under $11k,96471.0,46450.0938,40.5,white,47.0,1,0,0,no,0.699999809,0.5,dnr after sadm,9.0,122.0,37.0,135.0,28.0,38.5,113.32812,3.5,1.01,1.19995117,140.0,7.539062,135.0,23.0,2502.0,2.3598633,<2 mo. follow-up
35.31799,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,212409.0,97678.0625,35.666657,black,36.0,2,0,0,no,0.699999809,0.5,no dnr,18.0,70.0,11.0,130.0,22.0,38.89844,37.0,3.5,1.19995117,0.79992676,134.0,7.199219,135.0,23.0,2502.0,2.6660156,<2 mo. follow-up
52.827,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,>$50k,116166.0,56024.5312,29.5,white,74.0,7,0,0,no,0.699999809,0.5,dnr after sadm,6.0,53.0,12.3984375,110.0,24.0,39.5,333.3,3.5,25.5976562,7.79980469,145.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
68.64899,1,male,0,20,45,CHF,COPD/CHF/Cirrhosis,5,18.0,$11-$25k,75142.0,37775.2188,15.666664,white,50.0,1,0,0,no,0.75,0.6,no dnr,20.0,65.0,20.796875,120.0,30.0,35.79688,253.03125,3.5,0.5,3.29980469,127.0,7.429688,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
69.52795,0,male,0,14,1361,ARF/MOSF w/Sepsis,ARF/MOSF,3,17.0,>$50k,122312.0,61386.375,17.333328,white,39.0,8,0,0,no,0.699999809,0.5,no dnr,14.0,68.0,19.3984375,110.0,40.0,39.5,295.0,2.199707,0.39996338,0.59997559,131.0,7.549805,135.0,23.0,2502.0,0.0,SIP>=30
63.05798,1,male,0,71,1016,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,600192.0,274269.75,45.5,white,62.0,6,1,0,no,0.699999809,0.5,no dnr,71.0,52.0,10.6992188,120.0,38.0,39.09375,198.0,3.5,1.01,2.09960938,140.0,7.449219,135.0,23.0,2502.0,3.199707,<2 mo. follow-up
66.09198,1,male,0,4,54,Lung Cancer,Cancer,1,18.0,>$50k,8272.0,3430.8106,11.0,asian,11.0,1,0,0,metastatic,0.75,0.25,no dnr,4.0,83.0,6.29980469,90.0,20.0,36.59375,333.3,3.5,1.01,0.79992676,132.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
70.48297,1,female,0,9,670,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,19065.0,10006.6484,13.5,white,31.0,1,0,0,no,0.75,0.6,no dnr,9.0,53.0,6.89941406,110.0,22.0,36.19531,333.3,3.5,1.0,0.89990234,134.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.98599,1,female,0,82,433,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,864424.0,14452.7344,32.75,white,33.0,49,0,0,yes,0.699999809,0.5,no dnr,82.0,70.0,8.29882812,115.0,26.0,38.19531,187.5,2.2998047,0.79992676,0.89990234,136.0,7.5,135.0,23.0,2502.0,2.4799805,<2 mo. follow-up
85.862,1,female,1,57,57,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,329169.0,131754.125,30.75,white,52.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,128.0,11.2988281,155.0,14.0,36.19531,155.0,2.699707,1.01,1.79980469,137.0,7.469727,135.0,23.0,2502.0,3.7705078,<2 mo. follow-up
59.81097,1,female,0,63,232,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,401801.0,180741.5,34.75,black,47.0,6,0,0,no,0.149999976,0.1,no dnr,63.0,93.0,28.296875,140.0,30.0,38.5,147.5,1.7998047,0.69995117,0.79992676,129.0,7.469727,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
56.65399,0,female,0,15,1355,Colon Cancer,Cancer,1,12.0,$25-$50k,61711.0,29678.0781,24.666656,black,20.0,1,0,0,metastatic,0.799999714,0.7,no dnr,15.0,80.0,6.79980469,116.0,24.0,38.39844,333.3,3.5996094,4.69921875,0.89990234,136.0,7.419922,135.0,23.0,2502.0,2.2573242,no(M2 and SIP pres)
82.086,0,male,0,7,1354,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,22899.0,11851.4297,12.5,other,46.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,55.0,6.79980469,120.0,24.0,36.29688,333.3,3.5,1.01,2.09960938,135.0,7.419922,135.0,23.0,2502.0,3.9150391,no(M2 and SIP pres)
33.5,0,female,0,33,1353,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,158358.0,76204.125,11.5,hispanic,26.0,2,0,0,no,0.949999809,0.9,no dnr,33.0,117.0,15.6992188,76.0,34.0,36.19531,280.0,1.5998535,0.19998169,0.89990234,130.0,7.379883,135.0,23.0,2502.0,0.0,SIP>=30
72.84094,1,male,0,4,541,Lung Cancer,Cancer,1,12.0,under $11k,10314.0,5952.375,9.0,white,15.0,1,0,0,metastatic,0.899999619,0.7,no dnr,4.0,87.0,5.5,80.0,18.0,36.0,333.3,3.5,1.09985352,1.09985352,129.0,7.419922,135.0,23.0,2502.0,2.465332,<2 mo. follow-up
78.43695,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,106126.0,48244.8438,45.5,white,34.0,3,0,0,no,0.299999952,0.2,no dnr,12.0,67.0,11.1992188,60.0,24.0,38.39844,71.26562,3.5,0.79992676,1.0,128.0,7.329102,135.0,23.0,2502.0,3.5576172,<2 mo. follow-up
78.00995,1,male,0,52,969,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,298193.0,133595.625,25.75,white,31.0,11,0,0,no,0.699999809,0.5,no dnr,52.0,70.0,7.79980469,110.0,34.0,38.69531,267.5,3.5,1.01,0.89990234,130.0,7.459961,135.0,23.0,2502.0,2.7758789,<2 mo. follow-up
67.92596,1,female,0,11,1000,Colon Cancer,Cancer,1,12.0,under $11k,30406.0,15743.8906,19.0,white,24.0,1,0,0,metastatic,0.949999809,0.8,no dnr,11.0,108.0,28.1992188,108.0,20.0,36.59375,333.3,3.2998047,2.09960938,0.69995117,137.0,7.419922,135.0,23.0,2502.0,2.3935547,<2 mo. follow-up
68.55597,1,male,0,5,923,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,11855.0,6571.6523,8.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,93.0,7.69921875,100.0,22.0,35.89844,295.1875,3.5,1.01,1.89990234,139.0,7.429688,135.0,23.0,2502.0,2.421875,<2 mo. follow-up
68.68195,1,male,0,5,222,Lung Cancer,Cancer,1,12.0,$11-$25k,8686.0,4529.3477,8.0,white,29.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,83.0,1.59985352,100.0,24.0,36.39844,333.3,3.0,0.59997559,2.0,138.0,7.419922,135.0,23.0,2502.0,2.6171875,<2 mo. follow-up
33.01297,1,female,0,12,68,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,77603.0,40723.6875,23.0,white,55.0,2,1,0,no,0.899999619,0.8,no dnr,12.0,133.0,10.5,100.0,8.0,38.19531,194.0,3.5,0.5,10.7988281,146.0,7.439453,135.0,23.0,2502.0,2.7485352,<2 mo. follow-up
55.96399,0,male,0,22,1346,Cirrhosis,COPD/CHF/Cirrhosis,4,14.0,$25-$50k,193362.0,100574.375,20.666656,white,26.0,7,0,0,yes,0.799999714,0.6,no dnr,22.0,77.0,12.8984375,110.0,24.0,39.0,333.3,3.5,3.69970703,0.89990234,146.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
79.45496,1,female,0,6,636,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,13703.0,8028.125,6.0,white,16.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,80.0,6.5,50.0,16.0,36.29688,333.3,3.5,1.01,1.19995117,137.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
60.37198,0,male,0,20,1344,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,234608.0,110586.75,33.333313,white,40.0,7,0,0,no,0.849999905,0.85,no dnr,20.0,132.0,7.79980469,110.0,10.0,38.39844,272.6875,2.0,3.0,1.19995117,136.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.65796,1,female,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,477929.0,214188.625,41.5,white,55.0,33,0,0,no,0.699999809,0.5,dnr after sadm,24.0,52.0,14.0,110.0,12.0,36.89844,152.0,3.5,1.01,4.19921875,143.0,7.459961,135.0,23.0,2502.0,2.7861328,<2 mo. follow-up
95.66095,1,female,0,5,661,CHF,COPD/CHF/Cirrhosis,1,10.0,under $11k,12435.0,6208.4922,14.0,white,31.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,89.0,11.5996094,84.0,36.0,38.0,262.9375,3.199707,0.79992676,1.09985352,144.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
61.88098,1,male,1,55,55,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,777314.0,365120.5,48.25,white,78.0,38,0,0,no,0.5,0.5,dnr after sadm,31.0,60.0,19.796875,140.0,30.0,39.0,114.0,2.199707,1.19995117,2.79980469,131.0,7.239258,135.0,23.0,2502.0,3.3334961,<2 mo. follow-up
72.35297,1,female,1,3,3,CHF,COPD/CHF/Cirrhosis,1,13.0,$11-$25k,25184.0,11041.5938,39.0,white,40.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,48.0,7.29980469,0.0,12.0,37.19531,388.0,3.199707,1.29980469,1.39990234,129.0,7.449219,135.0,23.0,2502.0,3.7695312,<2 mo. follow-up
57.93597,1,male,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,29521.0,16122.7266,16.5,white,55.0,1,0,0,no,0.299999952,0.1,dnr after sadm,4.0,73.0,11.7988281,108.0,20.0,36.59375,523.75,2.2998047,11.7988281,1.59985352,130.0,7.429688,135.0,23.0,2502.0,3.8852539,<2 mo. follow-up
47.82498,1,male,0,12,889,Cirrhosis,COPD/CHF/Cirrhosis,4,14.0,under $11k,29605.0,17551.2656,12.5,white,10.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,84.0,2.89990234,80.0,16.0,35.59375,380.0,2.7998047,0.39996338,0.79992676,140.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
70.14899,1,male,0,5,684,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,12331.0,7431.0938,10.0,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,73.0,7.59960938,90.0,18.0,36.0,333.3,3.5,1.09985352,1.09985352,140.0,7.419922,135.0,23.0,2502.0,2.0800781,<2 mo. follow-up
50.44998,1,female,1,6,6,Coma,Coma,2,12.0,under $11k,28491.0,14452.7344,24.0,white,50.0,1,1,0,no,0.049999982,0.000125,dnr after sadm,3.0,63.0,28.0,160.0,30.0,40.89844,336.625,3.5,0.89990234,0.79992676,140.0,7.489258,135.0,23.0,2502.0,2.6328125,<2 mo. follow-up
72.0,1,female,0,13,612,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,40390.0,21526.0,12.5,black,15.0,1,0,0,no,0.75,0.7,no dnr,13.0,83.0,8.8984375,100.0,24.0,37.0,404.75,3.5,0.59997559,0.89990234,138.0,7.459961,135.0,23.0,2502.0,2.5849609,<2 mo. follow-up
65.92999,0,female,0,16,1336,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,60355.0,30505.6719,12.333328,white,29.0,1,1,0,yes,0.989999771,0.98,no dnr,16.0,63.0,7.09960938,50.0,20.0,36.5,333.3,3.5,1.01,2.09960938,140.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
69.77997,0,male,0,21,1333,CHF,COPD/CHF/Cirrhosis,1,16.0,$25-$50k,117036.0,59274.0,22.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,21.0,57.0,8.69921875,50.0,24.0,37.0,486.625,3.199707,1.01,1.29980469,133.0,7.489258,135.0,23.0,2502.0,2.8129883,no(M2 and SIP pres)
59.211,1,female,1,4,4,Lung Cancer,Cancer,3,14.0,>$50k,8126.0,3478.2188,20.0,white,21.0,1,0,0,metastatic,0.009999998,1e-06,dnr after sadm,1.0,60.0,1.29980469,90.0,20.0,37.19531,333.3,3.5,1.01,1.19995117,127.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
32.27698,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,175267.0,79371.5625,23.5,white,35.0,19,0,0,yes,0.199999928,0.1,dnr after sadm,5.0,117.0,11.5,120.0,40.0,36.0,171.40625,2.3999023,1.5,1.19995117,134.0,7.419922,135.0,23.0,2502.0,2.4165039,<2 mo. follow-up
47.63898,1,female,0,9,723,Lung Cancer,Cancer,1,13.0,under $11k,13877.0,7902.1992,8.0,white,16.0,1,0,0,metastatic,0.899999619,0.5,no dnr,9.0,77.0,1.19995117,80.0,20.0,36.59375,333.3,3.5,1.01,0.79992676,136.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
74.26398,1,male,0,10,41,CHF,COPD/CHF/Cirrhosis,3,14.0,>$50k,35636.0,17422.5,18.0,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,40.0,6.79980469,65.0,20.0,36.44531,333.3,3.5,1.01,1.5,131.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.29895,1,male,1,6,6,Coma,Coma,0,14.0,under $11k,37330.0,22028.1719,29.0,white,23.0,1,0,0,no,0.099999964,0.001,dnr after sadm,3.0,62.0,21.6992188,115.0,10.0,38.89844,317.125,3.5,0.5,1.09985352,132.0,7.509766,135.0,23.0,2502.0,2.5908203,<2 mo. follow-up
78.05096,0,male,0,26,1328,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,167412.0,81337.0625,28.0,white,44.0,10,0,0,yes,0.699999809,0.5,no dnr,26.0,52.0,8.3984375,110.0,10.0,38.5,98.75,3.5,1.01,1.39990234,141.0,7.529297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.88599,0,male,0,3,1326,CHF,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,8568.0,4712.4023,8.0,white,17.0,1,0,0,yes,0.649999619,0.5,no dnr,3.0,85.0,10.0996094,65.0,16.0,36.5,333.3,3.5,1.01,1.09985352,139.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
55.37,0,male,0,7,1326,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,30070.0,16821.3906,13.5,white,31.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,80.0,6.79980469,100.0,28.0,35.69531,333.3,4.0,4.09960938,1.29980469,132.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
63.53198,0,male,0,19,1323,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,188077.0,97198.875,16.0,other,34.0,20,1,0,no,0.699999809,0.5,no dnr,19.0,138.0,6.79980469,100.0,28.0,36.39844,254.28125,3.5,1.01,0.59997559,136.0,7.489258,135.0,23.0,2502.0,2.53125,<2 mo. follow-up
72.32599,1,male,0,8,71,Cirrhosis,COPD/CHF/Cirrhosis,3,19.0,$25-$50k,21341.0,13080.7344,7.0,white,43.0,1,1,0,no,0.899999619,0.9,no dnr,8.0,71.0,4.59960938,86.0,16.0,36.39844,423.75,3.2998047,4.0,2.09960938,133.0,7.489258,135.0,23.0,2502.0,3.8486328,adl>=4 (>=5 if sur)
50.64499,1,male,0,4,8,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,27047.0,14579.1094,10.0,white,15.0,7,0,0,no,0.5,0.25,no dnr,4.0,77.0,10.8984375,72.0,22.0,36.19531,333.3,3.5,1.01,1.29980469,130.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
44.37,1,female,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,88231.0,43843.0312,35.0,white,69.0,1,0,0,no,0.699999809,0.5,dnr after sadm,8.0,102.0,38.0,70.0,32.0,36.39844,243.0,2.8999023,42.0,6.79980469,147.0,7.229492,135.0,23.0,2502.0,1.0,<2 mo. follow-up
52.75598,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,25511.0,14848.5469,25.0,white,73.0,1,1,0,no,0.099999964,0.001,no dnr,3.0,38.0,15.3984375,0.0,0.0,38.19531,186.0,3.5,1.01,0.79992676,156.0,7.069336,135.0,23.0,2502.0,3.9453125,<2 mo. follow-up
63.27197,1,male,0,8,60,Lung Cancer,Cancer,1,12.0,under $11k,11532.0,6581.8242,7.5,white,15.0,1,0,0,metastatic,0.799999714,0.512,dnr after sadm,4.0,101.0,8.19921875,78.0,20.0,36.0,333.3,3.5,1.01,0.89990234,131.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
68.20294,1,female,0,44,267,Colon Cancer,Cancer,2,14.0,under $11k,133944.0,62226.3438,22.0,white,21.0,1,1,0,metastatic,0.949999809,0.8,no dnr,44.0,113.0,15.5996094,108.0,28.0,37.19531,333.3,3.5,1.29980469,0.79992676,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.12598,0,male,0,8,1318,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,127395.0,14452.7344,25.0,white,45.0,7,0,0,no,0.699999809,0.5,no dnr,8.0,113.0,13.2988281,140.0,37.0,38.0,181.625,3.5,1.01,1.0,147.0,7.479492,135.0,23.0,2502.0,4.0605469,<2 mo. follow-up
71.11298,1,female,1,4,4,Lung Cancer,Cancer,2,11.0,under $11k,9606.0,4738.4609,15.0,black,65.0,1,1,0,metastatic,0.25,0.15,dnr after sadm,2.0,33.0,21.0976562,124.0,32.0,36.79688,403.3125,3.5,1.01,2.09960938,144.0,7.429688,135.0,23.0,2502.0,3.7338867,<2 mo. follow-up
63.836,0,female,0,9,1315,CHF,COPD/CHF/Cirrhosis,3,12.0,>$50k,31055.0,15986.5625,15.5,white,24.0,1,0,0,no,0.799999714,0.65,no dnr,9.0,70.0,14.7988281,60.0,20.0,35.69531,186.65625,3.5,1.01,1.39990234,136.0,7.299805,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
52.38599,0,male,0,12,1315,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,140565.0,64369.125,26.5,white,42.0,15,0,0,yes,0.699999809,0.5,no dnr,12.0,65.0,1.0,100.0,26.0,39.19531,122.4375,3.5,3.69970703,0.79992676,133.0,7.5,135.0,23.0,2502.0,2.3676758,no(M2 and SIP pres)
86.04199,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,205980.0,99348.6875,36.0,white,50.0,5,0,0,no,0.699999809,0.5,dnr after sadm,12.0,115.0,0.59997559,110.0,12.0,36.89844,231.40625,3.5,1.01,1.19995117,144.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.646,1,female,0,16,262,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,34235.0,21265.7344,15.0,white,22.0,1,1,0,no,0.699999809,0.5,no dnr,16.0,80.0,7.5,60.0,22.0,36.39844,328.5625,3.5,1.01,1.29980469,142.0,7.489258,135.0,23.0,2502.0,3.2436523,no(M2 and SIP pres)
70.034,1,male,0,3,208,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,6528.0,4963.5117,8.0,white,39.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,65.0,8.8984375,85.0,18.0,35.89844,333.3,3.5,1.01,2.59960938,136.0,7.419922,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
65.99896,0,female,0,27,1306,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,53190.0,27477.9375,14.0,white,28.0,1,0,0,no,0.5,0.1,no dnr,27.0,75.0,6.89941406,96.0,24.0,38.19531,333.3,2.2998047,2.69970703,0.69995117,131.0,7.419922,135.0,23.0,2502.0,5.0,SIP>=30
70.59296,1,male,0,6,135,Lung Cancer,Cancer,2,12.0,under $11k,17079.0,11626.0938,8.0,asian,45.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,78.0,0.5,100.0,16.0,36.79688,333.3,2.5,5.19921875,0.69995117,132.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
49.99597,1,female,1,87,87,Coma,Coma,0,14.0,under $11k,712554.0,14452.7344,36.0,white,60.0,21,0,0,no,0.699999809,0.5,dnr after sadm,86.0,48.0,17.296875,140.0,44.0,39.79688,220.0,3.5,4.5,1.39990234,151.0,7.429688,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
62.89899,0,female,0,6,1305,CHF,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,12826.0,8660.6875,12.0,black,26.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,75.0,5.69921875,90.0,20.0,37.0,304.75,3.5,1.01,1.19995117,126.0,7.439453,135.0,23.0,2502.0,2.1884766,no(M2 and SIP pres)
55.87698,1,female,0,14,66,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,55987.0,93.8955,15.666664,white,31.0,1,1,0,yes,0.699999809,0.5,dnr after sadm,2.0,63.0,11.7988281,95.0,10.0,37.69531,187.5,3.699707,0.5,2.0,137.0,7.299805,135.0,23.0,2502.0,3.9853516,<2 mo. follow-up
42.237,1,female,0,9,14,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,41885.0,22365.5781,16.0,white,29.0,6,0,0,no,0.149999976,0.05,no dnr,9.0,100.0,7.29980469,82.0,24.0,35.19531,136.71875,3.5,5.19921875,1.19995117,137.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
49.60999,0,female,0,4,1084,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,>$50k,5215.0,3137.3457,8.0,white,34.0,1,0,0,no,0.899999619,0.74,no dnr,4.0,71.0,4.89941406,64.0,22.0,36.39844,333.3,2.2998047,1.5,1.09985352,139.0,7.419922,104.0,19.0,360.0,1.0,no(M2 and SIP pres)
78.43695,1,female,0,14,86,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,34499.0,18041.7344,14.333328,white,27.0,1,0,0,no,0.399999857,0.2,dnr after sadm,2.0,63.0,14.7988281,72.0,24.0,37.59375,157.125,3.0,0.39996338,1.79980469,140.0,7.339844,74.0,35.0,2600.0,3.0,adl>=4 (>=5 if sur)
55.98599,1,male,1,27,27,CHF,COPD/CHF/Cirrhosis,3,18.0,>$50k,90756.0,45550.0625,21.25,white,25.0,1,0,0,no,0.799999714,0.7,no dnr,27.0,80.0,8.5,74.0,20.0,35.59375,409.5,3.5996094,1.69995117,1.59985352,128.0,7.5,141.0,31.0,1875.0,0.0,<2 mo. follow-up
74.46698,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,161673.0,46653.2188,37.666657,white,22.0,10,0,0,yes,0.75,0.75,dnr after sadm,15.0,118.0,9.59960938,110.0,24.0,39.19531,280.9375,3.2998047,0.29998779,0.59997559,130.0,7.549805,116.0,3.0,3690.0,0.0,<2 mo. follow-up
44.90097,1,female,1,25,25,MOSF w/Malig,ARF/MOSF,4,14.0,>$50k,307552.0,119536.188,36.25,other,65.0,18,1,0,metastatic,0.75,0.5,dnr after sadm,23.0,62.0,16.8984375,95.0,26.0,36.29688,125.0,3.3999023,2.5,2.89990234,144.0,7.479492,433.0,40.0,1240.0,0.0,<2 mo. follow-up
44.383,1,male,0,29,109,ARF/MOSF w/Sepsis,ARF/MOSF,2,20.0,>$50k,246214.0,61128.875,30.5,white,33.0,20,1,0,no,0.199999928,0.1,no dnr,29.0,65.0,7.09960938,80.0,26.0,36.5,300.0,3.5,0.79992676,2.69970703,145.0,7.489258,139.0,29.0,5040.0,2.4560547,<2 mo. follow-up
26.51299,0,female,0,13,1079,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,under $11k,87124.0,28491.8594,29.5,hispanic,47.0,6,0,0,no,0.699999809,0.5,no dnr,13.0,113.0,19.0,135.0,44.0,38.39844,95.375,3.5,2.5,0.69995117,133.0,7.5,114.0,7.0,6500.0,0.0,no(M2 and SIP pres)
70.90796,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,390845.0,51077.6875,36.666657,white,71.0,32,0,0,no,0.009999998,0.01,dnr after sadm,1.0,50.0,26.1992188,120.0,28.0,38.69531,392.5625,3.5,5.5,2.19970703,133.0,7.509766,213.0,65.0,5880.0,3.4643555,<2 mo. follow-up
63.64697,1,male,0,23,157,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,142625.0,60269.375,42.333313,white,37.0,1,0,0,yes,0.75,0.6,no dnr,23.0,65.0,7.09960938,55.0,21.0,37.69531,237.125,2.199707,2.29980469,0.79992676,137.0,7.459961,215.0,12.0,5605.0,6.0,adl>=4 (>=5 if sur)
72.54797,1,female,0,5,354,Colon Cancer,Cancer,0,12.0,under $11k,10862.0,5092.5898,19.0,asian,12.0,1,0,0,metastatic,0.5,0.3,no dnr,5.0,69.0,5.19921875,72.0,20.0,36.39844,333.3,3.2998047,0.19998169,1.09985352,138.0,7.419922,135.0,13.0,2125.0,1.8320312,<2 mo. follow-up
81.24298,0,male,0,26,1076,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,172335.0,78254.0,35.75,white,42.0,1,0,0,no,0.299999952,0.3,no dnr,26.0,60.0,14.5,110.0,12.0,38.69531,92.0,2.5,1.39990234,1.39990234,130.0,7.5,106.0,23.0,5075.0,2.0,no(M2 and SIP pres)
34.59299,1,male,1,13,13,MOSF w/Malig,ARF/MOSF,2,17.0,under $11k,118073.0,45941.9375,38.0,white,33.0,2,0,0,metastatic,0.599999905,0.3,dnr after sadm,7.0,97.0,21.5,146.0,32.0,39.0,280.9375,3.5,1.01,0.59997559,127.0,7.5,119.0,6.0,2159.0,7.0,<2 mo. follow-up
61.39398,1,male,0,11,20,CHF,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,54893.0,23850.4531,31.5,white,25.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,75.0,9.79882812,65.0,20.0,36.0,333.3,3.5,1.59985352,1.79980469,129.0,7.419922,80.0,63.0,2375.0,2.0,<2 mo. follow-up
76.05499,0,male,0,4,1070,CHF,COPD/CHF/Cirrhosis,5,14.0,under $11k,7626.0,4572.4883,9.0,white,25.0,1,0,1,yes,0.599999905,0.5,no dnr,4.0,101.0,6.79980469,114.0,20.0,36.79688,333.3,3.5,0.59997559,1.69995117,139.0,7.419922,161.0,39.0,2390.0,4.5273438,no(M2 and SIP pres)
49.49197,0,female,0,26,1067,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,177889.0,56882.1562,30.0,white,43.0,7,0,0,no,0.849999905,0.85,no dnr,26.0,105.0,13.0,110.0,30.0,39.29688,105.0,4.5,1.01,0.59997559,147.0,7.469727,105.0,25.0,1480.0,7.0,no(M2 and SIP pres)
78.03699,1,male,0,15,74,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,35566.0,19382.1406,20.666656,white,41.0,1,0,0,yes,0.5,0.25,dnr after sadm,1.0,75.0,36.09375,70.0,22.0,36.0,414.25,3.5,1.01,2.5,135.0,7.489258,90.0,71.0,650.0,3.8549805,<2 mo. follow-up
54.02298,1,female,1,46,46,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,676210.0,179056.875,40.5,white,77.0,39,0,0,no,0.699999809,0.5,no dnr,46.0,55.0,12.8984375,115.0,46.0,39.19531,290.0,3.2998047,4.59960938,3.79980469,143.0,7.439453,74.0,95.0,160.0,0.0,<2 mo. follow-up
85.10297,0,female,0,14,1065,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,62841.0,21997.9062,14.333328,white,34.0,5,1,0,no,0.899999619,0.8,dnr before sadm,-4.0,73.0,10.0996094,105.0,24.0,38.0,83.32812,3.5,1.01,1.19995117,128.0,7.469727,353.0,20.0,2978.0,1.0,no(M2 and SIP pres)
52.02197,0,male,0,52,1063,ARF/MOSF w/Sepsis,ARF/MOSF,5,16.0,$11-$25k,593198.0,174370.625,31.75,hispanic,42.0,33,0,0,no,0.699999809,0.5,no dnr,52.0,108.0,3.79980469,55.0,32.0,38.39844,418.3125,3.5,3.59960938,1.5,145.0,7.419922,332.0,81.0,1760.0,7.0,no(M2 and SIP pres)
86.62799,0,male,0,20,1061,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,96480.0,25141.3281,25.333328,white,27.0,9,0,0,no,0.699999809,0.5,no dnr,20.0,98.0,28.8984375,75.0,36.0,36.39844,142.0,3.5,1.01,1.0,150.0,7.519531,357.0,16.0,2502.0,0.0,<2 mo. follow-up
58.95398,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,298234.0,39437.875,34.5,white,56.0,71,0,0,no,0.099999964,0.1,no dnr,11.0,135.0,5.59960938,95.0,10.0,39.09375,170.0,3.5,18.8984375,1.5,153.0,7.439453,182.0,76.0,1880.0,3.206543,<2 mo. follow-up
57.69699,1,male,0,4,320,Lung Cancer,Cancer,1,16.0,>$50k,12827.0,5347.5469,7.0,white,10.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,112.0,11.6992188,80.0,16.0,37.0,333.3,3.2998047,0.29998779,1.0,141.0,7.419922,94.0,14.0,6360.0,0.494751,no(M2 and SIP pres)
59.44397,1,male,1,18,18,Coma,Coma,1,24.0,>$50k,223643.0,93965.8125,54.0,white,33.0,1,1,0,no,0.699999809,0.5,dnr after sadm,17.0,142.0,19.296875,115.0,8.0,38.79688,317.75,3.5,1.89990234,1.09985352,144.0,7.509766,393.0,33.0,3050.0,0.0,<2 mo. follow-up
37.74698,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,$25-$50k,577381.0,99014.5,57.0,white,83.0,28,0,0,no,0.0,0.0,dnr after sadm,13.0,62.0,9.19921875,145.0,12.0,37.89844,280.0,4.8994141,32.6953125,2.59960938,138.0,7.489258,129.0,71.0,12.0,3.0,<2 mo. follow-up
52.99698,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,174687.0,14567.3828,47.0,white,74.0,8,0,0,no,0.5,0.5,dnr after sadm,3.0,42.0,6.79980469,105.0,29.0,35.5,307.5,3.5,6.39941406,8.0,145.0,7.389648,658.0,98.0,0.0,3.7827148,<2 mo. follow-up
76.28497,0,male,0,35,1060,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,141756.0,64223.875,31.0,white,58.0,1,0,0,yes,0.699999809,0.5,no dnr,35.0,72.0,6.29980469,180.0,10.0,36.79688,64.0,2.0,1.01,0.79992676,129.0,7.5,165.0,26.0,3450.0,1.0,adl>=4 (>=5 if sur)
57.53,0,female,0,53,1059,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,261184.0,121786.438,29.0,white,58.0,1,1,0,yes,0.5,0.7,no dnr,53.0,58.0,17.5,130.0,12.0,38.5,325.6875,2.5996094,0.5,4.09960938,125.0,7.429688,841.0,66.0,895.0,7.0,adl>=4 (>=5 if sur)
70.20398,1,male,0,4,245,Lung Cancer,Cancer,1,10.0,$25-$50k,10586.0,3956.8867,13.0,white,10.0,1,0,0,metastatic,1.0,0.5,no dnr,4.0,123.0,9.0,78.0,18.0,36.79688,333.3,3.5,1.01,0.89990234,137.0,7.419922,135.0,5.0,5170.0,0.0,SIP>=30
66.04498,1,male,0,4,385,Lung Cancer,Cancer,1,13.0,>$50k,11532.0,4416.3945,13.0,white,12.0,1,0,0,metastatic,1.0,0.5,no dnr,4.0,79.0,11.5,80.0,16.0,36.79688,333.3,3.5,1.01,1.39990234,135.0,7.419922,135.0,15.0,5250.0,0.0,no(M2 and SIP pres)
42.69397,0,male,0,11,1058,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,76504.0,28285.4219,37.5,white,27.0,3,0,0,no,0.949999809,0.95,no dnr,11.0,103.0,2.39990234,125.0,26.0,39.29688,286.625,2.5,0.5,1.0,130.0,7.449219,123.0,12.0,2000.0,3.315918,<2 mo. follow-up
44.23297,0,male,0,7,1057,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,78031.0,17341.1094,15.0,hispanic,39.0,7,0,0,no,0.949999809,0.95,no dnr,7.0,72.0,19.1992188,75.0,36.0,38.89844,136.71875,2.5,3.79980469,1.29980469,143.0,7.459961,101.0,26.0,4005.0,0.0,no(M2 and SIP pres)
49.892,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,36044.0,13711.9844,14.5,white,55.0,3,0,0,yes,0.0,0.0,no dnr,7.0,70.0,2.29980469,125.0,35.0,37.89844,333.3,3.5,1.01,2.5,140.0,7.419922,135.0,52.0,1350.0,3.0,<2 mo. follow-up
20.523,1,male,0,52,66,MOSF w/Malig,ARF/MOSF,4,12.0,$11-$25k,784726.0,180566.0,34.25,other,57.0,88,1,0,yes,0.5,0.5,dnr after sadm,52.0,110.0,0.04999542,118.0,32.0,36.79688,236.65625,3.5,5.5,0.79992676,142.0,7.439453,251.0,30.0,3890.0,6.0,<2 mo. follow-up
62.5,1,female,0,4,229,Lung Cancer,Cancer,1,9.0,under $11k,10163.0,4479.3477,16.0,white,10.0,1,0,0,metastatic,0.949999809,0.8,no dnr,4.0,113.0,6.5,80.0,20.0,36.0,333.3,3.7998047,1.01,0.89990234,138.0,7.419922,194.0,9.0,5700.0,3.8549805,no(M2 and SIP pres)
37.47598,1,male,1,57,57,CHF,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,270127.0,120381.812,22.75,hispanic,26.0,1,0,0,no,0.699999809,0.5,no dnr,57.0,71.0,14.5996094,55.0,16.0,37.09375,333.3,3.5,2.59960938,1.29980469,131.0,7.419922,99.0,33.0,4275.0,0.0,<2 mo. follow-up
59.45499,1,female,0,91,205,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,>$50k,976623.0,320064.75,33.0,white,57.0,26,0,0,no,0.799999714,0.8,no dnr,91.0,73.0,4.79980469,115.0,30.0,38.59375,312.5,4.5996094,1.59985352,3.69970703,142.0,7.379883,135.0,75.0,238.0,2.0,adl>=4 (>=5 if sur)
66.26099,1,female,0,7,87,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,11494.0,6642.3359,8.5,black,22.0,1,1,0,metastatic,0.849999905,0.5,no dnr,7.0,110.0,9.59960938,109.0,20.0,36.0,442.8125,4.5996094,0.89990234,1.29980469,137.0,7.469727,251.0,23.0,3420.0,4.8818359,<2 mo. follow-up
59.03598,0,male,0,9,1055,CHF,COPD/CHF/Cirrhosis,2,20.0,>$50k,21359.0,10872.9297,19.5,white,51.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,49.0,7.09960938,120.0,16.0,36.39844,333.3,3.5,1.01,2.89990234,132.0,7.419922,100.0,43.0,1770.0,0.0,no(M2 and SIP pres)
60.271,1,male,1,55,55,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$25-$50k,460668.0,190896.5,33.25,white,32.0,1,0,0,yes,0.899999619,0.6,dnr after sadm,37.0,115.0,7.79980469,120.0,20.0,36.89844,333.3,3.5,1.01,1.69995117,143.0,7.419922,154.0,85.0,2850.0,3.0,<2 mo. follow-up
20.99699,1,male,1,3,3,Coma,Coma,3,14.0,under $11k,278242.0,24999.6562,45.0,asian,92.0,40,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,60.0,27.5,85.0,24.0,35.0,54.0,2.3999023,20.5976562,4.09960938,150.0,6.939453,335.0,75.0,110.0,3.309082,<2 mo. follow-up
55.655,0,female,0,12,1053,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,34920.0,19289.2969,20.5,white,43.0,1,0,0,no,0.75,0.75,no dnr,12.0,75.0,8.29882812,116.0,8.0,36.59375,419.0,3.699707,0.19998169,2.0,154.0,7.549805,111.0,63.0,2030.0,5.0,adl>=4 (>=5 if sur)
45.43698,0,female,0,93,1053,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,636886.0,14452.7344,40.25,white,75.0,1,0,0,no,0.399999857,0.5,no dnr,93.0,107.0,0.19998169,140.0,40.0,37.89844,178.0,3.5,3.0,0.5,134.0,7.299805,135.0,23.0,2050.0,2.8330078,<2 mo. follow-up
49.92499,1,male,0,14,935,Colon Cancer,Cancer,1,17.0,>$50k,23578.0,12864.6016,7.333332,white,18.0,1,0,0,metastatic,1.0,0.5,no dnr,14.0,70.0,11.0996094,120.0,20.0,39.59375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,3450.0,0.0,no(M2 and SIP pres)
42.11899,0,female,0,23,1050,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,1086011.0,48990.7812,29.0,hispanic,56.0,147,0,0,no,0.699999809,0.5,no dnr,23.0,72.0,3.89990234,115.0,28.0,38.19531,311.0625,3.5,1.59985352,2.89990234,147.0,7.449219,78.0,64.0,151.0,0.0,no(M2 and SIP pres)
75.08795,1,male,1,4,4,Coma,Coma,4,12.0,under $11k,157000.0,22982.7031,51.0,white,116.0,17,1,0,yes,0.699999809,0.5,no dnr,4.0,32.0,0.04999542,155.0,26.0,38.5,126.25,3.5,1.01,4.59960938,153.0,7.239258,67.0,112.0,0.0,3.8095703,<2 mo. follow-up
44.32599,1,male,0,15,526,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,44950.0,23775.2188,14.333328,black,40.0,1,0,0,no,0.949999809,0.9,no dnr,15.0,73.0,4.89941406,95.0,26.0,37.5,333.3,2.0996094,0.29998779,2.59960938,129.0,7.419922,154.0,51.0,2650.0,0.0,SIP>=30
75.17896,0,male,0,47,1049,ARF/MOSF w/Sepsis,ARF/MOSF,3,15.0,under $11k,191750.0,67892.75,28.75,white,47.0,7,1,0,yes,0.5,0.95,no dnr,47.0,72.0,8.0,100.0,26.0,37.69531,172.5,3.5,1.01,6.19921875,142.0,7.449219,267.0,78.0,935.0,0.0,<2 mo. follow-up
51.452,1,female,0,6,434,Lung Cancer,Cancer,1,12.0,$25-$50k,10606.0,5724.3086,17.0,white,12.0,1,0,0,metastatic,1.0,0.9,no dnr,6.0,73.0,3.39990234,80.0,20.0,36.19531,333.3,3.5,0.09999084,0.69995117,138.0,7.419922,135.0,8.0,6150.0,0.0,no(M2 and SIP pres)
62.37598,1,male,1,14,14,MOSF w/Malig,ARF/MOSF,3,18.0,>$50k,139026.0,47879.5938,29.666656,black,71.0,12,0,0,yes,0.5,0.25,dnr after sadm,11.0,108.0,5.39941406,70.0,12.0,35.89844,153.03125,2.2998047,9.59960938,5.19921875,127.0,7.419922,186.0,101.0,1131.0,4.0,<2 mo. follow-up
54.47498,0,male,0,25,1048,Lung Cancer,Cancer,1,16.0,>$50k,94914.0,44798.6562,15.75,white,6.0,1,0,0,metastatic,0.799999714,0.5,no dnr,25.0,97.0,6.0,76.0,20.0,36.19531,333.3,4.0996094,0.5,1.09985352,138.0,7.419922,165.0,12.0,7500.0,0.0,no(M2 and SIP pres)
52.62997,1,male,0,5,838,Colon Cancer,Cancer,1,12.0,under $11k,12265.0,7544.2812,10.0,white,23.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,101.0,10.0,80.0,22.0,37.79688,333.3,3.7998047,0.39996338,1.09985352,132.0,7.419922,114.0,20.0,1075.0,1.857666,no(M2 and SIP pres)
75.77496,1,female,0,6,716,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,10782.0,6787.6914,15.0,white,9.0,1,0,0,no,0.979999542,0.9,no dnr,6.0,108.0,10.6992188,95.0,22.0,36.39844,333.3,3.5,1.01,0.89990234,137.0,7.419922,135.0,15.0,3450.0,0.494751,<2 mo. follow-up
76.961,0,female,0,17,1045,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,88755.0,37615.1875,32.333313,hispanic,34.0,4,0,0,no,0.75,0.7,no dnr,17.0,78.0,9.09960938,105.0,12.0,36.5,440.0,3.5,1.01,2.0,126.0,7.439453,159.0,30.0,7219.0,3.0,adl>=4 (>=5 if sur)
54.71597,0,female,0,10,1045,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,31403.0,15863.2109,20.0,white,53.0,1,1,0,no,0.299999952,0.25,no dnr,10.0,100.0,26.296875,75.0,15.0,38.0,108.32812,2.3999023,1.39990234,2.19970703,132.0,7.369141,119.0,56.0,970.0,2.0,<2 mo. follow-up
79.70398,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,5,16.0,$11-$25k,56752.0,24689.4531,33.5,white,38.0,1,1,0,yes,0.5,0.3,dnr after sadm,9.0,60.0,22.0,110.0,36.0,36.09375,108.0,2.5996094,1.01,0.5,135.0,7.459961,135.0,16.0,1870.0,3.6772461,<2 mo. follow-up
53.36099,1,male,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,4,18.0,under $11k,314092.0,84356.8125,36.0,white,40.0,7,0,0,no,0.699999809,0.5,dnr after sadm,22.0,97.0,11.5996094,70.0,32.0,36.79688,313.3125,3.0996094,7.79980469,2.69970703,140.0,7.419922,286.0,96.0,7660.0,0.0,<2 mo. follow-up
73.94897,1,male,0,28,57,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,208988.0,79771.75,45.25,asian,54.0,1,1,0,yes,0.149999976,0.05,dnr after sadm,8.0,62.0,6.19921875,115.0,30.0,38.0,127.5,3.5,0.39996338,2.69970703,135.0,7.509766,160.0,64.0,5055.0,3.9243164,<2 mo. follow-up
21.20999,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,73268.0,28876.6094,27.5,hispanic,57.0,2,0,0,no,0.699999809,0.5,no dnr,8.0,112.0,7.19921875,120.0,26.0,38.69531,291.375,1.5998535,13.7988281,0.69995117,140.0,7.459961,135.0,9.0,1325.0,1.0,<2 mo. follow-up
86.35199,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,125804.0,11069.0859,31.0,white,70.0,10,0,0,no,0.25,0.25,dnr before sadm,-3.0,45.0,23.5,75.0,36.0,36.19531,97.0,2.7998047,1.01,2.0,131.0,7.379883,310.0,60.0,1262.0,0.0,<2 mo. follow-up
33.55197,1,male,0,6,442,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26882.0,12281.9531,24.0,black,27.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,113.0,15.6992188,125.0,28.0,39.29688,348.5625,3.5,1.01,1.0,133.0,7.429688,69.0,6.0,2060.0,3.2265625,no(M2 and SIP pres)
64.58295,1,male,0,5,155,Lung Cancer,Cancer,2,12.0,$25-$50k,5751.0,3211.9102,5.0,white,5.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,81.0,5.69921875,84.0,20.0,37.79688,333.3,3.5,1.01,0.79992676,140.0,7.419922,92.0,11.0,2775.0,0.0,<2 mo. follow-up
79.54596,1,female,0,5,580,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,30631.0,13084.1094,42.0,white,34.0,1,1,0,no,0.699999809,0.6,no dnr,5.0,60.0,15.3984375,25.0,32.0,38.29688,333.3,3.0,1.01,0.69995117,146.0,7.419922,189.0,11.0,422.0,3.5649414,<2 mo. follow-up
67.71497,0,female,0,7,1036,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,46447.0,10272.25,14.5,white,25.0,4,0,0,no,0.989999771,0.99,no dnr,7.0,72.0,8.79882812,72.0,22.0,36.5,83.32812,2.3999023,0.69995117,0.89990234,133.0,7.539062,95.0,11.0,2050.0,1.8388672,no(M2 and SIP pres)
48.73599,1,female,0,26,314,Lung Cancer,Cancer,1,12.0,under $11k,117616.0,50040.3438,12.0,white,12.0,1,0,0,metastatic,0.799999714,0.5,no dnr,26.0,73.0,5.0,96.0,24.0,37.5,333.3,3.5,0.19998169,0.89990234,135.0,7.419922,88.0,9.0,4735.0,3.0268555,<2 mo. follow-up
63.79498,1,female,0,8,68,Lung Cancer,Cancer,1,16.0,>$50k,11253.0,7390.0273,9.0,white,13.0,1,0,0,metastatic,0.899999619,0.6,no dnr,8.0,101.0,6.39941406,120.0,24.0,36.19531,333.3,4.1992188,0.39996338,0.89990234,140.0,7.419922,79.0,23.0,2200.0,3.1831055,adl>=4 (>=5 if sur)
88.422,1,male,0,17,930,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,111560.0,36010.375,14.666664,white,56.0,8,0,1,no,0.699999809,0.5,no dnr,17.0,72.0,17.1992188,145.0,36.0,38.69531,148.3125,2.699707,0.39996338,1.09985352,146.0,7.479492,131.0,21.0,1975.0,6.2734375,<2 mo. follow-up
54.38199,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,$11-$25k,508881.0,77303.1875,48.0,white,60.0,35,0,0,yes,0.699999809,0.7,dnr after sadm,16.0,117.0,5.09960938,45.0,27.0,38.0,265.0,3.7998047,29.5,4.89941406,144.0,7.429688,140.0,99.0,619.0,2.0,<2 mo. follow-up
63.62198,0,male,0,9,1027,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,36522.0,18165.5312,22.5,white,24.0,1,0,0,no,0.899999619,0.75,no dnr,9.0,45.0,12.0,115.0,16.0,36.59375,333.3,3.5,1.01,1.0,131.0,7.419922,106.0,16.0,2960.0,1.0,no(M2 and SIP pres)
35.52597,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,190585.0,50592.1562,52.0,white,44.0,12,0,0,yes,0.199999928,0.2,dnr after sadm,6.0,135.0,5.0,120.0,20.0,36.5,153.3125,3.5,1.01,0.79992676,149.0,7.449219,399.0,26.0,1770.0,0.0,<2 mo. follow-up
80.46295,0,male,0,5,1025,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,13833.0,6499.4727,11.0,white,9.0,1,0,0,no,0.929999828,0.75,no dnr,5.0,82.0,5.5,80.0,20.0,36.5,333.3,3.199707,0.79992676,1.19995117,142.0,7.419922,91.0,26.0,2500.0,1.0,no(M2 and SIP pres)
44.02499,1,male,0,6,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,35099.0,14571.9219,38.0,white,39.0,1,0,0,no,0.199999928,0.1,no dnr,6.0,75.0,11.1992188,100.0,10.0,37.5,328.5625,2.0,35.0,1.19995117,136.0,7.429688,106.0,19.0,3520.0,6.0,<2 mo. follow-up
35.26599,0,male,0,11,1023,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,48956.0,23854.9062,15.0,white,19.0,1,0,0,no,0.799999714,0.8,no dnr,11.0,66.0,13.0996094,82.0,16.0,38.39844,245.0,2.7998047,0.09999084,0.79992676,148.0,7.319336,110.0,4.0,2870.0,6.0,SIP>=30
37.25098,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,83192.0,13650.0703,40.0,white,84.0,21,0,0,no,0.0,0.0,dnr after sadm,2.0,42.0,12.0,85.0,24.0,38.79688,70.0,3.699707,37.0,5.59960938,142.0,7.579102,110.0,49.0,0.0,3.012207,<2 mo. follow-up
62.133,1,male,1,13,13,CHF,COPD/CHF/Cirrhosis,4,12.0,>$50k,153171.0,40508.2812,30.0,white,40.0,13,0,0,no,0.699999809,0.7,no dnr,13.0,47.0,11.5,80.0,20.0,36.79688,333.3,3.5,1.01,3.0,132.0,7.419922,135.0,77.0,3885.0,0.494751,<2 mo. follow-up
32.64099,1,female,1,35,35,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,358494.0,126852.438,25.25,white,54.0,13,0,0,yes,0.849999905,0.5,dnr after sadm,34.0,107.0,0.09999084,78.0,20.0,38.0,333.3,3.5,2.0,2.19970703,137.0,7.419922,307.0,70.0,3475.0,0.0,<2 mo. follow-up
76.44098,1,male,0,9,220,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,23486.0,11454.5703,9.5,white,37.0,1,1,0,metastatic,0.899999619,0.8,no dnr,9.0,78.0,21.296875,84.0,16.0,36.0,250.0,3.0,0.39996338,5.5,131.0,7.40918,189.0,69.0,2560.0,0.0,no(M2 and SIP pres)
77.59094,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,355655.0,84230.5625,56.0,white,62.0,28,0,0,no,0.099999964,0.1,dnr after sadm,3.0,57.0,18.0,115.0,32.0,38.5,224.0,3.5,1.79980469,3.5,142.0,7.279297,137.0,73.0,1035.0,3.7192383,<2 mo. follow-up
51.09698,1,male,0,12,112,Lung Cancer,Cancer,2,16.0,under $11k,37350.0,17216.1094,26.0,white,29.0,1,0,0,metastatic,1.0,1.0,no dnr,12.0,65.0,16.5976562,135.0,36.0,37.5,200.0,3.5,1.01,0.89990234,130.0,7.399414,126.0,9.0,2547.0,0.0,<2 mo. follow-up
95.70697,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,>$50k,16032.0,6691.8477,5.0,white,87.0,1,0,1,no,0.699999809,0.5,dnr before sadm,-1.0,65.0,35.09375,115.0,40.0,36.0,374.0,3.5,1.01,1.69995117,137.0,7.299805,395.0,44.0,20.0,6.9287109,<2 mo. follow-up
78.18799,0,female,0,5,1018,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,18497.0,9117.4766,9.0,white,7.0,1,0,1,no,0.899999619,0.9,no dnr,5.0,98.0,10.0,98.0,20.0,37.0,348.5625,3.5,1.01,1.09985352,139.0,7.589844,114.0,8.0,1650.0,4.9316406,<2 mo. follow-up
61.142,1,male,0,29,56,ARF/MOSF w/Sepsis,ARF/MOSF,2,22.0,$25-$50k,365437.0,68879.0,24.25,black,67.0,26,1,0,no,0.799999714,0.6,no dnr,29.0,118.0,10.1992188,65.0,36.0,35.39844,167.5,3.3999023,2.79980469,6.29980469,136.0,7.469727,281.0,101.0,0.0,2.0,<2 mo. follow-up
84.99695,1,male,0,6,9,Coma,Coma,2,12.0,under $11k,19473.0,8654.4922,9.0,white,23.0,1,0,0,yes,0.049999982,0.0,dnr after sadm,2.0,119.0,14.0,82.0,20.0,38.39844,487.5,3.5,1.01,1.39990234,133.0,7.429688,170.0,20.0,850.0,3.3886719,<2 mo. follow-up
84.37195,1,female,0,13,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,64321.0,23580.1406,24.5,white,40.0,3,0,0,no,0.099999964,0.05,dnr after sadm,3.0,58.0,13.6992188,145.0,12.0,39.39844,371.375,2.5,0.5,0.79992676,129.0,7.319336,157.0,30.0,3125.0,3.0,<2 mo. follow-up
77.99298,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,0,21.0,$25-$50k,90070.0,10376.7812,37.0,black,67.0,27,0,0,no,0.699999809,0.5,dnr after sadm,3.0,53.0,21.1992188,65.0,28.0,37.59375,246.65625,3.5,0.79992676,2.59960938,129.0,7.289062,108.0,73.0,162.0,2.6665039,<2 mo. follow-up
79.97797,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,$11-$25k,121331.0,38597.4688,42.0,white,49.0,5,0,0,no,0.099999964,0.05,dnr after sadm,11.0,58.0,9.29882812,70.0,12.0,38.19531,127.5,3.5,2.19970703,4.59960938,129.0,7.40918,97.0,87.0,2631.0,6.0,<2 mo. follow-up
79.06396,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,107076.0,39846.7812,43.5,white,80.0,2,0,0,no,0.199999928,0.2,dnr after sadm,11.0,58.0,26.296875,165.0,22.0,38.0,73.0,2.199707,0.89990234,1.79980469,145.0,7.449219,189.0,38.0,1559.0,0.0,<2 mo. follow-up
45.043,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,30354.0,12436.8125,29.0,white,104.0,1,0,0,no,0.099999964,0.05,dnr after sadm,2.0,5.0,14.5,0.0,5.0,38.79688,120.0,3.2998047,1.79980469,4.39941406,124.0,7.719727,100.0,92.0,275.0,1.6142578,<2 mo. follow-up
50.155,1,male,0,27,489,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,372270.0,82504.6875,28.5,white,40.0,20,0,0,no,0.799999714,0.7,no dnr,27.0,113.0,13.5996094,110.0,6.0,38.29688,267.5,2.7998047,4.19921875,2.69970703,137.0,7.419922,330.0,111.0,3826.0,0.0,adl>=4 (>=5 if sur)
56.211,0,female,0,24,1011,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,135949.0,51641.1562,35.0,white,38.0,4,0,0,no,0.699999809,0.7,no dnr,24.0,65.0,11.5,45.0,14.0,38.5,270.0,2.8999023,1.09985352,3.69970703,139.0,7.459961,89.0,32.0,1965.0,5.0,adl>=4 (>=5 if sur)
51.18698,1,female,0,6,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,56973.0,10217.1094,12.0,white,27.0,6,0,0,metastatic,0.0,0.0,dnr before sadm,-3.0,75.0,13.7988281,126.0,16.0,36.69531,114.28125,3.5,1.01,1.59985352,132.0,7.389648,164.0,13.0,3150.0,2.8598633,<2 mo. follow-up
47.95099,1,male,0,10,77,MOSF w/Malig,ARF/MOSF,3,18.0,$11-$25k,53439.0,16939.0469,23.5,hispanic,51.0,3,0,0,metastatic,0.149999976,0.05,dnr after sadm,4.0,98.0,12.5,110.0,36.0,39.39844,419.0,1.7998047,1.01,1.59985352,134.0,7.369141,157.0,25.0,1450.0,0.0,adl>=4 (>=5 if sur)
100.24597,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,51328.0,17097.4062,50.0,white,111.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,22.0,15.5996094,130.0,26.0,36.5,56.0,2.2998047,12.8984375,2.29980469,145.0,7.359375,49.0,18.0,0.0,4.1796875,<2 mo. follow-up
75.95294,1,male,1,4,4,Coma,Coma,1,17.0,$11-$25k,13525.0,6125.9453,7.0,white,37.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,100.0,100.0,76.0,28.0,40.69531,211.0,3.5,1.01,1.79980469,135.0,7.40918,179.0,32.0,1600.0,3.0849609,<2 mo. follow-up
36.39398,1,male,1,64,64,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,492853.0,180981.875,28.25,black,39.0,8,0,0,no,0.699999809,0.5,no dnr,64.0,65.0,9.29882812,115.0,26.0,36.79688,333.3,3.5,1.01,1.5,150.0,7.419922,153.0,38.0,1467.0,5.0,<2 mo. follow-up
76.21399,0,female,0,7,1003,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,30490.0,8519.5,9.0,white,47.0,2,0,0,no,0.699999809,0.5,no dnr,7.0,107.0,11.1992188,110.0,12.0,36.39844,65.0,3.5,0.19998169,1.19995117,143.0,7.299805,132.0,25.0,1600.0,3.0,no(M2 and SIP pres)
87.05798,1,female,0,40,956,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,202508.0,71926.125,26.5,white,43.0,15,0,0,metastatic,0.849999905,0.85,no dnr,40.0,72.0,18.5976562,115.0,26.0,37.89844,206.09375,3.5,1.01,2.0,131.0,7.5,156.0,55.0,2990.0,5.0,adl>=4 (>=5 if sur)
80.10095,1,female,0,37,47,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,299289.0,109288.875,43.0,white,41.0,5,0,0,yes,0.699999809,0.7,no dnr,37.0,132.0,12.7988281,115.0,28.0,36.79688,117.14062,2.5,0.59997559,0.69995117,136.0,7.399414,152.0,19.0,4355.0,0.0,<2 mo. follow-up
62.724,1,female,1,15,15,Coma,Coma,1,18.0,$11-$25k,109193.0,45729.5938,35.666657,white,21.0,1,0,0,no,0.0,0.0,dnr after sadm,13.0,130.0,10.5,65.0,15.0,38.39844,146.0,3.699707,0.79992676,0.59997559,133.0,7.489258,150.0,5.0,2495.0,2.4272461,<2 mo. follow-up
81.50897,0,male,0,7,1000,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,13004.0,7194.4648,9.0,white,31.0,1,1,1,no,0.799999714,0.4,no dnr,7.0,111.0,6.19921875,80.0,26.0,36.0,333.3,3.5,1.01,1.89990234,140.0,7.419922,135.0,33.0,950.0,4.0,adl>=4 (>=5 if sur)
32.08499,1,male,0,34,877,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,162263.0,71892.875,29.25,hispanic,31.0,1,0,0,no,0.5,0.25,no dnr,34.0,53.0,5.59960938,105.0,16.0,36.5,333.3,3.8999023,1.09985352,1.29980469,134.0,7.419922,103.0,27.0,4955.0,5.0,no(M2 and SIP pres)
71.85498,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,95439.0,26086.2969,42.0,asian,65.0,5,0,0,no,0.099999964,0.05,dnr after sadm,7.0,55.0,11.5996094,105.0,32.0,36.5,134.0,2.3999023,1.59985352,4.29980469,125.0,7.419922,135.0,71.0,2795.0,0.0,<2 mo. follow-up
90.20697,1,female,0,4,476,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,12549.0,5989.2891,11.0,white,48.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,75.0,8.29882812,70.0,22.0,35.89844,134.6875,3.5,1.01,2.69970703,137.0,7.25,390.0,38.0,600.0,0.494751,<2 mo. follow-up
67.92896,1,female,0,15,129,CHF,COPD/CHF/Cirrhosis,0,8.0,under $11k,82258.0,36620.5312,26.0,hispanic,23.0,1,0,0,no,0.5,0.5,dnr after sadm,5.0,57.0,7.09960938,55.0,22.0,36.29688,333.3,3.5,1.01,0.89990234,134.0,7.419922,140.0,15.0,1890.0,1.1667481,SIP>=30
35.76498,0,female,0,14,996,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,$25-$50k,94457.0,38957.1562,27.333328,white,30.0,1,0,0,no,0.599999905,0.7,no dnr,14.0,130.0,16.0,120.0,20.0,39.0,114.28125,2.5996094,0.5,0.59997559,136.0,7.40918,104.0,11.0,3540.0,5.0,no(M2 and SIP pres)
73.75494,1,female,1,28,28,Coma,Coma,1,12.0,under $11k,334890.0,101755.062,38.25,hispanic,62.0,18,0,0,yes,0.089999974,0.000729,dnr after sadm,12.0,125.0,0.04999542,125.0,40.0,38.89844,260.0,2.199707,1.89990234,0.79992676,152.0,7.509766,314.0,17.0,4755.0,5.0,<2 mo. follow-up
54.004,0,female,0,58,991,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,748973.0,14452.7344,46.0,white,84.0,17,1,0,no,0.099999964,0.1,no dnr,58.0,45.0,0.19998169,105.0,32.0,36.89844,202.0,3.2998047,4.5,3.59960938,142.0,7.359375,163.0,95.0,525.0,1.0,adl>=4 (>=5 if sur)
52.51199,0,female,0,15,990,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,69096.0,19972.7031,10.0,white,27.0,5,0,0,yes,0.989999771,0.98,no dnr,15.0,88.0,13.3984375,142.0,20.0,38.19531,256.625,1.3999023,1.01,0.69995117,136.0,7.359375,113.0,5.0,3400.0,3.0,no(M2 and SIP pres)
38.168,0,female,0,23,990,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,$25-$50k,151909.0,61569.8125,31.666656,hispanic,63.0,1,0,0,no,0.5,0.5,no dnr,23.0,102.0,27.1992188,140.0,26.0,38.09375,146.65625,2.0,0.79992676,1.89990234,151.0,7.259766,131.0,21.0,2665.0,2.9682617,SIP>=30
49.02399,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,64403.0,22841.6094,55.0,white,77.0,2,0,0,no,0.199999928,0.1,dnr after sadm,5.0,55.0,26.6992188,105.0,10.0,35.5,186.0,3.2998047,48.5,3.0,139.0,7.279297,164.0,83.0,645.0,0.0,<2 mo. follow-up
47.96198,0,male,0,7,988,COPD,COPD/CHF/Cirrhosis,1,14.0,under $11k,39258.0,16408.9688,20.5,white,38.0,1,0,0,no,0.949999809,0.98,no dnr,7.0,112.0,19.296875,135.0,40.0,37.89844,134.03125,3.3999023,0.79992676,0.79992676,136.0,7.40918,135.0,25.0,3950.0,1.1667481,<2 mo. follow-up
22.91299,0,male,0,25,987,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,59999.0,30400.7031,18.0,black,29.0,1,0,0,no,0.899999619,0.98,no dnr,25.0,65.0,11.0996094,114.0,24.0,37.59375,333.3,2.5996094,0.89990234,1.09985352,141.0,7.419922,156.0,35.0,1330.0,7.0,adl>=4 (>=5 if sur)
68.53894,0,male,0,29,985,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,246417.0,58176.3125,25.25,black,8.0,1,1,0,no,0.699999809,0.5,no dnr,29.0,87.0,8.59960938,115.0,6.0,38.69531,270.0,3.5,1.01,0.79992676,149.0,7.449219,166.0,13.0,2675.0,2.4624023,<2 mo. follow-up
94.80096,1,female,0,5,57,Lung Cancer,Cancer,1,12.0,under $11k,11088.0,5479.2695,16.0,white,36.0,1,0,0,metastatic,0.25,0.05,no dnr,5.0,65.0,15.5,78.0,28.0,35.39844,333.3,3.5,1.01,0.79992676,133.0,7.419922,108.0,28.0,700.0,4.578125,<2 mo. follow-up
47.88498,1,female,0,19,887,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,165774.0,35300.3125,33.0,black,49.0,8,1,0,yes,0.699999809,0.5,no dnr,19.0,52.0,9.59960938,125.0,28.0,38.09375,175.0,2.199707,1.01,1.09985352,144.0,7.419922,290.0,26.0,2761.0,3.1933594,<2 mo. follow-up
52.98599,1,male,0,8,494,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,24044.0,11732.8672,16.0,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,68.0,7.69921875,115.0,28.0,39.09375,333.3,3.5,0.69995117,1.29980469,136.0,7.419922,135.0,12.0,3960.0,1.0,no(M2 and SIP pres)
41.26199,0,male,0,40,982,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,346799.0,97818.8125,31.0,white,70.0,6,0,0,no,0.799999714,0.8,no dnr,40.0,63.0,13.1992188,170.0,40.0,38.5,192.0,2.5,6.39941406,1.0,141.0,7.5,252.0,30.0,2010.0,1.0,no(M2 and SIP pres)
60.96899,0,male,0,14,982,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,$11-$25k,156906.0,81478.125,32.666657,white,36.0,1,0,0,no,0.599999905,0.4,no dnr,14.0,47.0,14.6992188,105.0,30.0,37.69531,158.3125,3.5,1.0,1.29980469,141.0,7.539062,97.0,27.0,4730.0,5.0,no(M2 and SIP pres)
71.84698,0,male,0,30,980,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,210555.0,78092.875,37.25,white,78.0,4,1,0,no,0.199999928,0.2,no dnr,30.0,0.0,6.29980469,0.0,12.0,38.59375,345.0,2.5,0.69995117,4.89941406,133.0,7.399414,476.0,84.0,1941.0,2.0454102,<2 mo. follow-up
84.31799,1,male,0,51,303,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,>$50k,462018.0,154909.25,32.75,asian,34.0,1,0,0,no,0.599999905,0.5,dnr after sadm,45.0,63.0,9.69921875,55.0,18.0,36.09375,191.40625,2.2998047,1.01,1.19995117,137.0,7.259766,135.0,29.0,1870.0,2.8022461,<2 mo. follow-up
38.21799,1,female,1,6,6,Coma,Coma,3,14.0,>$50k,97521.0,18105.5781,34.0,white,75.0,21,0,0,yes,0.75,0.7,dnr after sadm,4.0,118.0,15.8984375,126.0,44.0,37.79688,160.0,2.199707,26.3984375,1.89990234,127.0,7.40918,135.0,24.0,3275.0,5.0,<2 mo. follow-up
79.15698,1,female,1,4,4,Coma,Coma,2,15.0,$25-$50k,16231.0,7312.875,27.0,white,64.0,1,0,0,yes,0.019999996,0.02,dnr after sadm,3.0,32.0,19.0976562,195.0,10.0,35.79688,266.625,3.5,1.01,2.09960938,145.0,7.569336,273.0,19.0,1628.0,3.6679688,<2 mo. follow-up
33.59097,0,male,0,10,979,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,81881.0,19257.6094,12.0,hispanic,40.0,17,0,0,no,0.899999619,0.8,no dnr,10.0,81.0,2.09960938,95.0,16.0,37.59375,40.0,3.5,0.69995117,2.29980469,138.0,7.549805,120.0,38.0,2096.0,1.8388672,no(M2 and SIP pres)
73.61798,1,male,1,21,21,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,86043.0,39136.6875,22.666656,white,29.0,1,0,0,metastatic,0.5,0.0,dnr after sadm,5.0,62.0,5.59960938,64.0,24.0,36.0,247.59375,2.0996094,0.69995117,0.79992676,134.0,7.509766,215.0,15.0,2410.0,5.0,<2 mo. follow-up
98.08899,1,female,1,4,4,Coma,Coma,1,16.0,under $11k,16613.0,7248.9062,25.0,white,16.0,1,0,1,no,0.149999976,0.15,dnr after sadm,1.0,82.0,10.0,135.0,24.0,36.0,190.0,3.5,1.01,0.39996338,139.0,7.549805,155.0,5.0,2525.0,6.3632812,<2 mo. follow-up
65.09497,0,female,0,39,972,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,under $11k,358169.0,103605.875,39.25,white,12.0,15,0,0,no,0.599999905,0.6,no dnr,39.0,103.0,11.0996094,105.0,10.0,39.39844,240.0,3.7998047,1.01,0.69995117,136.0,7.539062,152.0,12.0,4090.0,0.0,adl>=4 (>=5 if sur)
67.39197,1,female,0,26,30,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,213912.0,49587.5625,21.25,black,70.0,25,0,0,no,0.199999928,0.2,dnr after sadm,6.0,142.0,30.0,135.0,40.0,38.89844,576.625,2.3999023,1.0,3.0,143.0,7.239258,286.0,62.0,5785.0,0.0,<2 mo. follow-up
69.77698,0,male,0,11,972,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,88609.0,21318.4688,44.5,white,22.0,5,0,0,yes,0.699999809,0.5,no dnr,11.0,68.0,6.0,55.0,8.0,39.5,165.4375,3.5,1.01,1.0,136.0,7.459961,167.0,17.0,5420.0,2.9160156,<2 mo. follow-up
77.20496,1,female,0,4,310,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,14068.0,6384.2812,25.0,white,46.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,136.0,24.0976562,150.0,24.0,36.39844,553.0,3.5,1.01,1.0,134.0,7.199219,89.0,27.0,790.0,3.659668,<2 mo. follow-up
68.40796,0,female,0,8,971,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,19252.0,10880.3203,11.0,white,40.0,1,0,0,no,0.799999714,0.75,no dnr,8.0,75.0,4.29980469,60.0,28.0,36.59375,339.125,3.5,0.59997559,1.09985352,141.0,7.369141,89.0,21.0,300.0,4.4960938,<2 mo. follow-up
74.25098,1,male,0,34,37,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,205063.0,90528.0625,39.0,white,71.0,1,0,0,no,0.199999928,0.15,dnr after sadm,27.0,52.0,12.0,155.0,10.0,39.59375,280.0,2.5,10.0996094,3.29980469,153.0,7.459961,93.0,100.0,7365.0,3.0,<2 mo. follow-up
35.92599,1,male,1,36,36,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,389403.0,134131.375,33.0,white,79.0,23,0,0,yes,0.699999809,0.7,dnr after sadm,36.0,48.0,2.0,115.0,32.0,39.09375,246.9375,2.0,2.39990234,4.19921875,148.0,7.459961,135.0,101.0,210.0,0.0,<2 mo. follow-up
61.952,1,male,0,51,271,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,451954.0,125566.688,37.0,white,57.0,25,0,0,no,0.199999928,0.2,no dnr,51.0,65.0,32.6953125,115.0,37.0,39.09375,136.65625,3.5,1.01,5.0,143.0,7.469727,181.0,150.0,3060.0,3.0234375,Coma or Intub
75.87695,0,male,0,9,969,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,>$50k,39709.0,17396.3906,32.0,white,25.0,1,0,0,no,0.599999905,0.3,no dnr,9.0,68.0,7.39941406,95.0,8.0,37.69531,243.3125,3.5,1.01,1.29980469,133.0,7.549805,135.0,25.0,4468.0,2.2265625,no(M2 and SIP pres)
50.034,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,60562.0,25240.4688,48.0,white,54.0,1,0,0,yes,0.199999928,0.2,dnr after sadm,5.0,112.0,2.29980469,125.0,26.0,39.0,140.8125,3.5,3.19970703,2.29980469,143.0,7.289062,166.0,36.0,6295.0,3.3105469,<2 mo. follow-up
66.90796,1,female,0,30,53,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,137219.0,57231.9688,21.75,white,24.0,3,0,0,metastatic,0.5,0.3,dnr after sadm,1.0,79.0,6.39941406,110.0,24.0,36.39844,138.75,3.5,1.01,1.0,132.0,7.509766,168.0,10.0,2620.0,5.0,<2 mo. follow-up
38.94299,1,female,1,16,16,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,283724.0,59525.1562,39.0,asian,70.0,22,0,0,no,0.099999964,0.05,no dnr,16.0,118.0,9.0,115.0,34.0,36.5,178.0,3.5,50.09375,3.19970703,151.0,7.579102,261.0,65.0,1200.0,0.0,<2 mo. follow-up
32.07397,0,female,0,99,965,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,793804.0,343271.0,48.5,hispanic,90.0,1,1,0,no,0.699999809,0.7,no dnr,99.0,62.0,2.5,130.0,35.0,33.69531,323.0,2.3999023,21.5,0.39996338,148.0,7.399414,296.0,33.0,2530.0,0.0,Coma or Intub
57.75198,0,female,0,4,964,CHF,COPD/CHF/Cirrhosis,1,11.0,under $11k,10350.0,5801.6016,12.0,black,37.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,78.0,3.69970703,65.0,28.0,36.29688,333.3,3.5,1.01,1.89990234,139.0,7.419922,97.0,66.0,1350.0,1.0,SIP>=30
48.435,1,male,0,10,507,Colon Cancer,Cancer,1,12.0,under $11k,18298.0,9905.8672,18.0,white,11.0,1,0,0,metastatic,0.699999809,0.6,no dnr,10.0,75.0,3.39990234,70.0,20.0,36.39844,333.3,3.5,0.5,1.0,142.0,7.419922,0.0,13.0,3700.0,2.5161133,<2 mo. follow-up
56.50897,1,male,1,4,4,Coma,Coma,1,12.0,$11-$25k,25303.0,9744.8516,33.0,white,33.0,1,0,0,yes,0.099999964,0.0,dnr after sadm,2.0,70.0,7.19921875,65.0,37.0,38.19531,203.3125,2.8999023,0.69995117,1.29980469,148.0,7.639648,126.0,30.0,3155.0,2.1625977,<2 mo. follow-up
48.47098,1,female,0,15,22,Lung Cancer,Cancer,1,17.0,under $11k,41422.0,21064.2656,15.333328,white,19.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,69.0,12.7988281,112.0,24.0,36.19531,366.625,3.3999023,0.19998169,0.69995117,136.0,7.469727,184.0,9.0,2800.0,0.0,<2 mo. follow-up
23.24199,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,636743.0,32527.1719,47.0,white,53.0,85,0,0,yes,0.0,0.0,dnr after sadm,4.0,142.0,2.09960938,65.0,14.0,38.39844,220.0,3.5,47.796875,3.0,141.0,7.389648,135.0,115.0,3750.0,2.65625,<2 mo. follow-up
84.91394,1,male,0,16,33,CHF,COPD/CHF/Cirrhosis,5,16.0,under $11k,42792.0,22130.0781,15.0,white,42.0,1,0,0,yes,0.5,0.25,no dnr,16.0,73.0,10.2988281,74.0,22.0,36.0,204.75,3.5,1.01,1.5,137.0,7.469727,135.0,36.0,1000.0,2.0,<2 mo. follow-up
57.28998,1,male,1,19,19,MOSF w/Malig,ARF/MOSF,2,14.0,>$50k,433153.0,87692.1875,37.333313,white,47.0,46,0,0,yes,0.599999905,0.2,dnr after sadm,19.0,142.0,1.79980469,130.0,36.0,36.0,297.125,3.5,2.0,0.79992676,138.0,7.429688,186.0,34.0,4203.0,0.0,<2 mo. follow-up
62.741,0,male,0,6,958,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,17289.0,10762.1641,11.0,hispanic,45.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,63.0,9.19921875,64.0,12.0,36.0,333.3,2.199707,3.79980469,0.89990234,133.0,7.419922,135.0,23.0,1150.0,1.1667481,no(M2 and SIP pres)
73.91595,1,female,0,19,68,Colon Cancer,Cancer,2,12.0,under $11k,37120.0,19875.8594,11.333328,white,40.0,1,1,0,metastatic,0.299999952,0.1,no dnr,19.0,73.0,8.3984375,118.0,30.0,38.39844,333.3,2.0,2.19970703,0.69995117,133.0,7.419922,139.0,12.0,1410.0,5.0,<2 mo. follow-up
62.34598,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$25-$50k,54050.0,23091.9219,53.0,white,54.0,1,0,0,no,0.599999905,0.6,no dnr,5.0,45.0,24.3984375,75.0,27.0,39.79688,115.0,2.0,1.79980469,1.19995117,146.0,7.55957,145.0,56.0,2540.0,0.0,<2 mo. follow-up
19.765,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,21340.4375,49.0,hispanic,69.0,14,0,0,no,0.25,0.25,no dnr,6.0,45.0,18.796875,145.0,40.0,38.39844,402.8125,3.5,1.01,1.69995117,135.0,7.369141,302.0,71.0,1707.0,2.1357422,<2 mo. follow-up
62.965,1,male,0,11,224,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,32473.0,15833.9297,23.5,white,32.0,1,0,0,no,0.949999809,0.95,no dnr,11.0,115.0,8.5,75.0,20.0,36.0,333.3,3.5,0.19998169,4.69921875,139.0,7.419922,104.0,50.0,1175.0,3.5175781,<2 mo. follow-up
51.98398,1,male,0,10,656,Colon Cancer,Cancer,1,14.0,>$50k,30678.0,13849.9844,18.5,white,25.0,1,0,0,metastatic,0.899999619,0.09,no dnr,10.0,110.0,6.79980469,105.0,10.0,38.39844,333.3,3.5,0.5,1.19995117,140.0,7.419922,169.0,23.0,740.0,0.0,<2 mo. follow-up
78.62,1,female,0,9,249,Lung Cancer,Cancer,1,12.0,under $11k,20276.0,10465.7656,10.5,white,39.0,1,0,0,metastatic,0.5,0.15,dnr after sadm,2.0,77.0,14.0,68.0,26.0,36.59375,323.75,3.5,1.01,1.29980469,126.0,7.579102,100.0,20.0,600.0,1.1667481,<2 mo. follow-up
46.51898,1,female,1,9,9,Coma,Coma,1,12.0,under $11k,79492.0,27622.1875,33.0,black,63.0,5,0,0,yes,0.699999809,0.5,dnr after sadm,9.0,122.0,19.0976562,125.0,27.0,38.59375,205.0,3.5,1.01,5.0,127.0,7.30957,88.0,49.0,3620.0,3.140625,<2 mo. follow-up
60.16699,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,142620.0,47904.9375,57.0,white,83.0,4,0,0,yes,0.5,0.25,dnr after sadm,9.0,48.0,0.39996338,175.0,25.0,39.79688,301.375,1.7998047,0.29998779,0.29998779,143.0,7.489258,154.0,9.0,2310.0,2.0,<2 mo. follow-up
33.01297,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,59995.78781114967,17329.5156,31.0,white,81.0,38,0,0,no,0.699999809,0.5,dnr after sadm,4.0,117.0,4.0,120.0,54.0,38.5,490.0,2.0,28.5,2.59960938,153.0,7.429688,256.0,115.0,2500.0,3.2822266,<2 mo. follow-up
53.71899,1,male,1,73,73,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,651870.0,204370.375,30.5,white,58.0,12,0,0,no,0.799999714,0.8,no dnr,73.0,45.0,13.8984375,105.0,10.0,38.29688,402.5,3.5,1.01,5.39941406,135.0,7.5,235.0,77.0,2.0,0.0,adl>=4 (>=5 if sur)
38.87698,1,male,0,60,135,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,282625.0,14452.7344,26.5,white,41.0,12,0,0,no,0.5,0.5,no dnr,60.0,112.0,12.2988281,125.0,14.0,38.19531,155.0,3.5,0.89990234,2.29980469,142.0,7.509766,291.0,23.0,1405.0,3.0825195,SIP>=30
61.689,1,male,0,9,153,Colon Cancer,Cancer,1,12.0,under $11k,16468.0,9625.2031,21.5,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,83.0,6.09960938,80.0,22.0,38.29688,333.3,3.5,1.01,1.0,135.0,7.419922,135.0,16.0,4520.0,2.4331055,<2 mo. follow-up
69.125,0,female,0,8,942,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,64500.0,9428.2891,17.0,white,34.0,7,0,0,no,0.979999542,0.95,no dnr,8.0,105.0,10.6992188,120.0,28.0,36.0,134.6875,3.5,0.19998169,0.79992676,140.0,7.40918,135.0,23.0,540.0,2.0,no(M2 and SIP pres)
30.98399,0,female,0,19,941,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,175051.0,75655.5,33.666657,white,33.0,2,0,0,no,0.799999714,0.7,no dnr,19.0,115.0,6.09960938,45.0,18.0,39.39844,43.0,3.5,2.09960938,1.09985352,144.0,7.449219,127.0,17.0,2915.0,2.6137695,<2 mo. follow-up
62.75998,0,female,0,107,941,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,under $11k,985215.0,271083.0,38.0,white,67.0,58,1,0,no,0.5,0.4,no dnr,107.0,112.0,6.09960938,125.0,28.0,36.5,305.0,3.8999023,6.0,2.89990234,146.0,7.509766,349.0,59.0,0.0,0.0,<2 mo. follow-up
62.28897,1,male,0,9,532,Colon Cancer,Cancer,1,12.0,under $11k,34721.0,16882.9219,14.5,white,13.0,1,0,0,metastatic,1.0,1.0,no dnr,9.0,63.0,9.0,62.0,20.0,38.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,1900.0,0.0,<2 mo. follow-up
38.94299,1,male,0,12,75,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,147307.0,34028.1875,32.0,white,62.0,17,0,0,no,0.899999619,0.9,no dnr,12.0,108.0,17.6992188,115.0,28.0,36.0,304.0,1.8999023,8.8984375,1.19995117,135.0,7.399414,330.0,22.0,1360.0,5.0,adl>=4 (>=5 if sur)
53.314,0,female,0,71,937,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,517087.0,149585.125,41.0,asian,39.0,11,0,0,no,0.5,0.3,no dnr,71.0,60.0,22.8984375,105.0,26.0,38.79688,257.5,2.8999023,16.0,1.09985352,137.0,7.479492,228.0,19.0,3079.0,3.1201172,SIP>=30
67.63898,1,male,0,9,111,Lung Cancer,Cancer,1,12.0,under $11k,21057.0,11093.6875,13.5,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,9.0,103.0,9.5,76.0,22.0,36.39844,333.3,3.5,1.01,1.09985352,135.0,7.419922,135.0,12.0,2595.0,0.0,SIP>=30
57.34698,0,male,0,16,937,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,139549.0,58391.7188,34.666657,hispanic,54.0,1,1,0,no,0.599999905,0.6,no dnr,16.0,55.0,14.3984375,120.0,36.0,37.0,140.0,2.699707,0.39996338,1.0,136.0,7.399414,508.0,23.0,4170.0,6.0,no(M2 and SIP pres)
40.14798,0,male,0,14,935,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,$11-$25k,172266.0,25485.3281,17.333328,white,33.0,6,0,0,no,0.699999809,0.5,no dnr,14.0,123.0,8.59960938,115.0,24.0,37.0,222.5,3.0996094,3.59960938,0.89990234,145.0,7.449219,154.0,61.0,3550.0,0.0,no(M2 and SIP pres)
60.37,1,female,0,6,443,Colon Cancer,Cancer,1,12.0,>$50k,8439.0,4481.9922,8.0,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,73.0,10.0,80.0,20.0,38.5,333.3,3.5,0.39996338,0.69995117,136.0,7.419922,99.0,6.0,3550.0,0.0,no(M2 and SIP pres)
22.741,0,male,0,20,934,Coma,Coma,0,17.0,$25-$50k,150904.0,61721.625,44.0,hispanic,54.0,1,0,0,no,0.299999952,0.3,no dnr,20.0,115.0,17.6992188,125.0,20.0,39.0,61.0,2.3999023,3.09960938,1.79980469,145.0,7.549805,93.0,32.0,3290.0,0.0,no(M2 and SIP pres)
33.67798,1,female,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,758539.0,233276.0,49.5,black,58.0,14,0,0,no,0.799999714,0.8,no dnr,26.0,118.0,13.2988281,105.0,36.0,37.79688,255.0,3.5,16.796875,3.89990234,147.0,7.469727,350.0,66.0,3025.0,0.0,<2 mo. follow-up
71.29095,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,117388.0,42800.4062,60.0,black,59.0,2,1,0,no,0.5,0.5,no dnr,5.0,55.0,11.8984375,100.0,32.0,38.39844,131.65625,3.5,1.01,7.5,146.0,7.449219,199.0,65.0,753.0,2.4750977,<2 mo. follow-up
59.452,1,female,0,7,756,Colon Cancer,Cancer,1,12.0,under $11k,27070.0,14452.7344,10.5,white,5.0,1,0,0,metastatic,1.0,0.5,no dnr,7.0,97.0,9.59960938,74.0,20.0,38.89844,333.3,3.5,1.01,1.0,135.0,7.419922,135.0,13.0,2025.0,2.0,no(M2 and SIP pres)
74.97894,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,1,18.0,$25-$50k,60987.0,21162.5156,52.0,white,86.0,5,0,0,metastatic,0.199999928,0.05,dnr after sadm,4.0,42.0,13.0996094,105.0,25.0,35.5,121.65625,3.2998047,20.0,2.29980469,135.0,7.489258,178.0,21.0,18.0,2.0,<2 mo. follow-up
75.67999,1,male,1,20,20,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,122270.0,41109.0312,30.666656,white,47.0,11,0,0,yes,0.649999619,0.25,dnr after sadm,6.0,115.0,0.29998779,120.0,6.0,37.79688,205.0,3.5,1.01,1.59985352,140.0,7.5,183.0,29.0,3102.0,0.0,<2 mo. follow-up
65.26196,0,female,0,14,929,Lung Cancer,Cancer,1,12.0,>$50k,35260.0,17061.2188,11.666664,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,14.0,115.0,10.5,100.0,20.0,39.0,333.3,4.1992188,0.29998779,1.0,139.0,7.419922,91.0,13.0,2050.0,1.0,no(M2 and SIP pres)
65.74896,1,female,0,10,689,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,34253.0,17195.6094,25.5,white,17.0,1,0,0,no,0.649999619,0.5,no dnr,10.0,62.0,10.2988281,70.0,22.0,36.19531,333.3,3.2998047,1.89990234,1.29980469,132.0,7.419922,119.0,17.0,5395.0,3.8549805,<2 mo. follow-up
75.97296,1,male,0,13,591,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,51180.0,24631.8281,17.0,white,41.0,1,0,0,no,0.799999714,0.6,no dnr,13.0,68.0,13.3984375,70.0,22.0,39.0,333.3,3.5,1.01,4.0,142.0,7.419922,150.0,34.0,50.0,3.0,<2 mo. follow-up
72.33899,0,female,0,23,923,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,146792.0,47670.3125,24.333328,white,19.0,5,0,0,no,0.949999809,0.9,no dnr,23.0,132.0,19.296875,75.0,16.0,37.69531,293.875,3.5,1.01,0.59997559,135.0,7.389648,149.0,18.0,1615.0,1.0,<2 mo. follow-up
70.62299,1,male,0,15,44,Lung Cancer,Cancer,1,12.0,$25-$50k,48292.0,20661.4688,15.333328,white,15.0,1,0,0,metastatic,0.599999905,0.2,no dnr,15.0,93.0,25.0976562,104.0,20.0,36.59375,333.3,3.2998047,0.29998779,1.29980469,129.0,7.419922,148.0,19.0,3250.0,0.0,<2 mo. follow-up
61.80698,1,female,0,9,566,COPD,COPD/CHF/Cirrhosis,2,20.0,>$50k,17086.0,10877.5703,16.0,white,25.0,1,0,0,yes,0.799999714,0.6,no dnr,9.0,73.0,10.0996094,102.0,32.0,35.79688,266.625,3.5,1.01,1.0,131.0,7.389648,135.0,17.0,2400.0,0.0,<2 mo. follow-up
68.758,1,female,0,9,371,Colon Cancer,Cancer,1,16.0,under $11k,24338.0,13225.6875,19.0,white,25.0,1,0,0,metastatic,0.899999619,0.4,no dnr,9.0,79.0,8.5,76.0,36.0,40.5,333.3,3.5,0.59997559,0.69995117,136.0,7.419922,122.0,4.0,4450.0,0.0,<2 mo. follow-up
32.616,1,female,0,4,119,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,8228.0,4918.0547,6.0,white,25.0,1,0,0,no,0.699999809,0.7,no dnr,4.0,67.0,7.89941406,120.0,26.0,37.5,333.3,3.5,1.01,1.29980469,139.0,7.419922,113.0,14.0,2150.0,0.0,no(M2 and SIP pres)
78.48596,1,male,0,33,37,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,168174.0,67323.0,30.5,white,27.0,5,0,0,no,0.899999619,0.8,no dnr,33.0,115.0,14.0,65.0,36.0,36.79688,320.0,3.5,1.01,0.5,125.0,7.55957,101.0,17.0,1660.0,3.2768555,<2 mo. follow-up
41.64798,1,female,0,6,568,Colon Cancer,Cancer,1,14.0,>$50k,16011.0,7885.75,6.0,white,13.0,1,0,0,metastatic,0.799999714,0.3,no dnr,6.0,77.0,9.0,76.0,22.0,37.69531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,1350.0,0.0,<2 mo. follow-up
55.58398,1,female,0,110,208,MOSF w/Malig,ARF/MOSF,1,11.0,$11-$25k,59995.78781114967,14452.7344,50.5,white,62.0,24,0,0,metastatic,0.5,0.5,no dnr,14.58258953168044,130.0,19.5,125.0,24.0,37.59375,81.10938,1.6999512,7.79980469,0.69995117,126.0,7.349609,188.0,22.0,6865.0,2.9018555,SIP>=30
64.32898,1,male,0,4,71,Lung Cancer,Cancer,1,12.0,under $11k,7735.0,4253.4219,7.0,white,19.0,1,0,0,metastatic,0.899999619,0.8,no dnr,4.0,69.0,14.2988281,66.0,18.0,36.59375,333.3,3.5,1.01,1.19995117,141.0,7.419922,85.0,28.0,2502.0,2.3125,<2 mo. follow-up
77.77698,1,female,1,8,8,Coma,Coma,1,16.0,under $11k,63572.0,26724.9844,41.0,white,69.0,1,1,0,no,0.199999928,0.15,dnr after sadm,7.0,52.0,6.69921875,150.0,20.0,38.09375,164.0,3.0996094,0.5,3.29980469,132.0,7.379883,273.0,70.0,4352.0,1.0,<2 mo. follow-up
82.98999,1,male,0,12,220,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,51711.0,26562.0,22.0,white,29.0,1,0,0,no,0.799999714,0.7,no dnr,12.0,73.0,9.5,60.0,28.0,36.19531,333.3,3.8999023,1.0,1.89990234,139.0,7.419922,113.0,32.0,4750.0,0.0,no(M2 and SIP pres)
72.77496,1,female,0,9,103,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,28137.0,14024.8984,16.5,black,16.0,1,0,0,yes,0.849999905,0.75,no dnr,9.0,115.0,5.09960938,60.0,20.0,36.59375,333.3,3.5,0.79992676,0.79992676,135.0,7.419922,120.0,17.0,1170.0,4.0,adl>=4 (>=5 if sur)
70.04498,1,female,0,18,139,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,119685.0,45163.6875,32.333313,black,34.0,1,1,0,no,0.599999905,0.5,no dnr,18.0,112.0,14.3984375,115.0,26.0,38.0,237.5,3.5,1.01,1.19995117,148.0,7.349609,330.0,22.0,982.0,5.0,adl>=4 (>=5 if sur)
43.93198,0,male,0,9,914,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,57142.0,20929.6562,25.0,white,39.0,2,0,0,no,0.899999619,0.9,no dnr,9.0,118.0,15.1992188,95.0,40.0,38.5,111.65625,3.5,1.01,2.89990234,151.0,7.15918,161.0,16.0,8115.0,1.0,no(M2 and SIP pres)
70.61694,0,female,0,22,913,Coma,Coma,2,14.0,$25-$50k,75372.0,34204.4375,19.0,white,19.0,1,0,0,no,0.149999976,0.1,dnr after sadm,2.0,60.0,9.5,115.0,9.0,38.0,380.0,2.7998047,0.5,0.69995117,139.0,7.419922,150.0,5.0,1940.0,7.0,<2 mo. follow-up
38.07797,0,female,0,4,911,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,51241.0,13257.8125,18.0,white,28.0,4,0,0,metastatic,0.96999979,0.7,no dnr,4.0,67.0,9.3984375,108.0,24.0,35.79688,410.0,2.199707,0.59997559,1.39990234,131.0,7.399414,104.0,37.0,2850.0,2.4296875,<2 mo. follow-up
38.90997,1,female,0,5,232,Cirrhosis,COPD/CHF/Cirrhosis,4,11.0,under $11k,19379.0,9072.9062,23.0,white,22.0,1,0,0,no,0.949999809,0.95,no dnr,5.0,72.0,6.5,75.0,24.0,37.59375,333.3,3.5,6.39941406,0.29998779,136.0,7.419922,89.0,6.0,2519.0,0.0,SIP>=30
27.29099,0,female,0,11,910,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,50203.0,21781.4844,13.0,white,51.0,1,0,0,no,0.75,0.75,no dnr,11.0,107.0,16.796875,125.0,35.0,39.39844,96.0,3.5996094,0.29998779,2.39990234,144.0,7.429688,128.0,28.0,1741.0,3.1616211,<2 mo. follow-up
20.85399,0,male,0,8,909,CHF,COPD/CHF/Cirrhosis,2,15.0,>$50k,20579.0,11638.5703,9.5,hispanic,35.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,52.0,8.69921875,125.0,16.0,36.09375,333.3,3.5,1.0,1.59985352,137.0,7.419922,92.0,30.0,2825.0,0.0,no(M2 and SIP pres)
55.767,1,male,0,10,46,Lung Cancer,Cancer,1,12.0,under $11k,30453.0,12746.4297,18.0,white,45.0,1,0,0,metastatic,0.899999619,0.5,no dnr,10.0,52.0,14.7988281,112.0,32.0,39.69531,333.3,2.0,0.69995117,1.19995117,132.0,7.419922,85.0,19.0,1630.0,3.7163086,<2 mo. follow-up
42.09399,1,female,0,12,219,Lung Cancer,Cancer,1,12.0,under $11k,43422.0,21040.4531,7.5,black,12.0,1,0,0,metastatic,0.949999809,0.6,no dnr,12.0,81.0,14.0,120.0,16.0,36.39844,333.3,4.1992188,0.09999084,1.0,139.0,7.419922,97.0,7.0,2220.0,3.0,<2 mo. follow-up
78.81995,1,female,0,57,437,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,436904.0,161974.25,30.75,white,47.0,6,0,0,no,0.5,0.5,dnr after sadm,11.0,128.0,10.3984375,120.0,12.0,37.59375,143.75,2.7998047,1.01,2.69970703,146.0,7.40918,62.0,58.0,4600.0,6.0,<2 mo. follow-up
65.74695,1,female,0,21,186,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,130357.0,47683.0625,29.666656,white,53.0,3,0,0,yes,0.799999714,0.3,no dnr,21.0,67.0,13.5996094,55.0,8.0,38.0,105.09375,3.5,20.0976562,1.29980469,135.0,7.5,135.0,23.0,4017.0,3.0336914,<2 mo. follow-up
50.01199,1,male,0,5,6,Lung Cancer,Cancer,2,16.0,>$50k,9518.0,4221.1719,10.0,black,26.0,1,0,0,metastatic,0.799999714,0.65,dnr after sadm,2.0,69.0,55.0,76.0,20.0,36.39844,333.3,3.5,1.01,0.69995117,133.0,7.419922,135.0,20.0,2050.0,3.8549805,<2 mo. follow-up
23.24699,1,male,1,23,23,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,419195.0,115365.25,36.333313,white,97.0,19,0,0,yes,0.199999928,0.1,no dnr,23.0,67.0,0.04999542,145.0,42.0,38.39844,144.875,3.5,8.69921875,1.69995117,145.0,7.289062,598.0,69.0,3920.0,0.0,<2 mo. follow-up
38.418,0,male,0,34,905,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,257291.0,14452.7344,22.5,white,28.0,5,0,0,no,0.699999809,0.5,no dnr,34.0,65.0,12.5996094,55.0,16.0,39.0,160.0,3.5,1.01,0.79992676,133.0,7.459961,102.0,20.0,2745.0,2.7998047,<2 mo. follow-up
91.25299,1,female,0,6,440,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,23547.0,9465.8984,21.0,white,40.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,55.0,8.69921875,50.0,16.0,36.0,236.71875,3.5,1.01,1.69995117,125.0,7.139648,109.0,36.0,1475.0,0.0,<2 mo. follow-up
45.31097,1,male,0,11,93,Colon Cancer,Cancer,2,12.0,$11-$25k,32838.0,14494.5859,14.5,white,21.0,1,0,0,metastatic,0.799999714,0.5,no dnr,11.0,125.0,7.89941406,74.0,22.0,38.5,333.3,3.5,2.39990234,0.69995117,140.0,7.419922,111.0,10.0,1800.0,1.0,<2 mo. follow-up
49.16898,1,male,0,8,15,ARF/MOSF w/Sepsis,ARF/MOSF,8,13.0,$25-$50k,59761.0,18474.4688,24.0,white,58.0,2,1,0,no,0.699999809,0.5,dnr after sadm,2.0,55.0,14.7988281,115.0,20.0,36.29688,479.5625,3.0996094,1.01,6.79980469,130.0,7.349609,135.0,43.0,0.0,3.0,<2 mo. follow-up
27.058,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,194402.0,76774.375,52.0,white,111.0,1,0,0,no,0.25,0.25,dnr after sadm,10.0,38.0,5.79980469,165.0,14.0,35.5,118.75,2.8999023,4.69921875,5.5,148.0,7.089844,9.0,28.0,206.0,0.0,<2 mo. follow-up
65.99896,1,male,0,5,62,Colon Cancer,Cancer,1,18.0,$25-$50k,3792.0,2358.4785,9.0,black,17.0,1,0,0,metastatic,0.25,0.05,no dnr,5.0,77.0,6.29980469,64.0,24.0,36.39844,333.3,3.7998047,1.39990234,1.29980469,124.0,7.419922,121.0,15.0,1935.0,0.494751,<2 mo. follow-up
70.03699,1,female,0,9,36,Lung Cancer,Cancer,2,14.0,under $11k,14609.0,7164.4805,8.5,black,26.0,1,1,0,metastatic,0.199999928,0.0,dnr after sadm,1.0,73.0,10.6992188,136.0,32.0,39.09375,333.3,3.5,1.01,0.59997559,126.0,7.419922,162.0,8.0,2200.0,5.0,<2 mo. follow-up
60.504,1,male,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,49985.0,25018.3438,36.0,white,60.0,1,0,0,no,0.299999952,0.15,dnr after sadm,8.0,62.0,15.1992188,60.0,22.0,36.39844,333.3,2.3999023,19.796875,3.39990234,145.0,7.419922,188.0,131.0,700.0,3.0488281,<2 mo. follow-up
29.53299,1,male,0,28,102,MOSF w/Malig,ARF/MOSF,1,17.0,under $11k,102427.0,46724.0,17.5,black,12.0,2,0,0,yes,0.899999619,0.6,no dnr,28.0,81.0,5.59960938,125.0,22.0,36.79688,333.3,3.5,1.01,1.29980469,138.0,7.419922,135.0,12.0,3000.0,0.494751,<2 mo. follow-up
53.07599,0,female,0,7,892,CHF,COPD/CHF/Cirrhosis,4,16.0,>$50k,29187.0,13135.7578,17.0,hispanic,21.0,1,0,0,metastatic,0.799999714,0.6,no dnr,7.0,55.0,8.69921875,100.0,18.0,36.0,333.3,3.5,1.5,0.79992676,135.0,7.419922,86.0,10.0,2080.0,4.0,adl>=4 (>=5 if sur)
67.784,1,female,1,51,51,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,411846.0,147752.125,38.25,white,32.0,6,0,0,no,0.899999619,0.9,dnr after sadm,49.0,65.0,17.1992188,65.0,8.0,37.69531,351.0,2.699707,3.09960938,1.09985352,139.0,7.55957,94.0,9.0,1625.0,2.0,<2 mo. follow-up
53.26199,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,203408.0,78476.3125,62.0,white,86.0,1,0,0,no,0.299999952,0.3,dnr after sadm,7.0,72.0,5.29980469,125.0,12.0,35.39844,85.0,2.8999023,12.0996094,1.59985352,143.0,7.419922,332.0,66.0,140.0,5.0,<2 mo. follow-up
59.17599,1,female,1,5,5,Coma,Coma,0,15.0,$25-$50k,31803.0,13809.9688,32.0,white,55.0,1,0,0,no,0.099999964,0.1,dnr after sadm,3.0,141.0,1.29980469,125.0,32.0,38.59375,207.5,2.0996094,0.59997559,0.69995117,137.0,7.519531,207.0,27.0,1448.0,0.0,<2 mo. follow-up
47.21997,1,male,0,7,426,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,14827.0,8235.9219,7.5,white,23.0,1,1,0,no,0.849999905,0.8,no dnr,7.0,75.0,5.89941406,75.0,32.0,37.5,333.3,3.5,1.01,1.5,138.0,7.419922,102.0,19.0,2100.0,3.0,adl>=4 (>=5 if sur)
54.021,1,male,0,4,116,Lung Cancer,Cancer,2,12.0,under $11k,6533.0,3276.0098,14.0,white,24.0,1,0,0,metastatic,0.5,0.5,no dnr,4.0,65.0,3.89990234,56.0,12.0,38.0,333.3,3.5,0.29998779,0.89990234,140.0,7.419922,135.0,13.0,1225.0,2.4956055,<2 mo. follow-up
81.25397,1,female,0,12,62,Lung Cancer,Cancer,1,12.0,$11-$25k,15945.0,8343.2969,4.0,white,8.0,1,0,0,metastatic,0.399999857,0.05,dnr after sadm,1.0,81.0,9.0,76.0,28.0,36.59375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2800.0,4.0,adl>=4 (>=5 if sur)
91.43896,0,female,0,18,883,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,68103.0,31396.25,25.666656,white,46.0,1,0,0,no,0.399999857,0.1,dnr after sadm,7.0,75.0,9.5,75.0,37.0,36.5,562.75,2.0996094,0.5,1.09985352,134.0,7.599609,202.0,24.0,670.0,6.0,adl>=4 (>=5 if sur)
65.31696,1,male,0,3,312,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,>$50k,80470.0,10313.6797,33.0,white,64.0,4,1,0,no,0.5,0.25,no dnr,3.0,65.0,12.0,65.0,22.0,37.59375,134.53125,2.2998047,1.01,9.3984375,132.0,7.389648,322.0,103.0,0.0,2.0,<2 mo. follow-up
48.94998,0,female,0,5,881,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,12684.0,6731.8086,17.0,hispanic,7.0,1,0,0,no,0.949999809,0.95,no dnr,5.0,107.0,6.89941406,105.0,22.0,36.0,333.3,3.5,1.01,0.79992676,136.0,7.419922,105.0,12.0,2470.0,0.494751,no(M2 and SIP pres)
54.853,1,male,0,37,174,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,272366.0,77111.5625,37.25,white,46.0,10,0,0,no,0.699999809,0.5,no dnr,37.0,72.0,8.5,125.0,26.0,39.39844,174.0,3.5,3.0,1.69995117,142.0,7.489258,122.0,32.0,3411.0,3.4838867,<2 mo. follow-up
75.16797,1,female,0,11,26,MOSF w/Malig,ARF/MOSF,2,14.0,$25-$50k,31213.0,14603.8047,18.0,asian,30.0,1,1,0,metastatic,0.149999976,0.1,dnr after sadm,2.0,109.0,14.1992188,125.0,14.0,36.29688,357.125,3.5,1.01,1.09985352,125.0,7.479492,342.0,15.0,1656.0,4.0,<2 mo. follow-up
70.16296,0,male,0,27,879,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,159568.0,92464.625,19.25,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,27.0,53.0,5.5,105.0,18.0,36.5,333.3,3.5,1.01,2.09960938,134.0,7.419922,107.0,29.0,3490.0,0.0,no(M2 and SIP pres)
91.08795,1,female,0,10,387,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,>$50k,34662.0,18039.8906,13.0,white,27.0,1,0,0,no,0.599999905,0.5,dnr after sadm,1.0,110.0,11.7988281,105.0,33.0,38.0,330.0,3.5,1.01,0.89990234,145.0,7.589844,220.0,11.0,650.0,0.0,<2 mo. follow-up
50.76797,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,19.0,>$50k,312860.0,36578.3438,39.0,white,97.0,47,0,0,no,0.0,0.0,dnr after sadm,2.0,58.0,11.3984375,70.0,35.0,36.79688,109.07812,2.199707,19.796875,3.69970703,148.0,7.609375,206.0,50.0,0.0,0.0,<2 mo. follow-up
29.77399,0,male,0,36,878,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,333521.0,151389.25,33.0,white,77.0,7,0,0,no,0.349999905,0.35,no dnr,36.0,65.0,25.296875,120.0,45.0,36.89844,168.0,2.199707,7.09960938,1.79980469,155.0,7.479492,184.0,53.0,1665.0,0.0,no(M2 and SIP pres)
63.37,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,under $11k,65661.0,26997.4688,66.0,hispanic,88.0,2,1,0,no,0.5,0.5,dnr after sadm,5.0,55.0,6.19921875,55.0,24.0,36.0,80.0,3.2998047,42.0,4.59960938,145.0,7.199219,347.0,56.0,105.0,7.0,<2 mo. follow-up
38.80399,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,407955.0,125929.75,47.0,hispanic,57.0,10,0,0,no,0.399999857,0.4,dnr after sadm,15.0,70.0,1.39990234,65.0,30.0,36.39844,287.5,2.3999023,24.296875,1.29980469,141.0,7.40918,167.0,51.0,1713.0,5.0,<2 mo. follow-up
77.50598,1,female,0,7,13,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,32303.0,13342.4531,10.0,white,26.0,1,0,0,no,0.5,0.2,dnr before sadm,-1.0,70.0,11.2988281,68.0,22.0,37.5,250.0,3.5,1.29980469,0.69995117,145.0,7.429688,135.0,23.0,810.0,4.3789062,<2 mo. follow-up
65.90796,1,female,0,6,115,Colon Cancer,Cancer,1,17.0,>$50k,9327.0,5024.7109,13.0,white,5.0,1,0,0,metastatic,0.899999619,0.6,no dnr,6.0,85.0,9.19921875,82.0,20.0,36.59375,333.3,3.199707,0.59997559,0.79992676,139.0,7.419922,135.0,9.0,2502.0,1.984375,no(M2 and SIP pres)
23.84399,1,female,0,29,105,MOSF w/Malig,ARF/MOSF,1,15.0,$11-$25k,215913.0,73125.5,25.0,hispanic,37.0,6,0,0,yes,0.799999714,0.7,no dnr,29.0,82.0,0.04999542,150.0,24.0,38.39844,333.3,3.5,1.01,0.79992676,137.0,7.419922,135.0,6.0,2250.0,0.0,no(M2 and SIP pres)
58.724,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,20.0,>$50k,461154.0,180363.75,51.666657,white,104.0,5,0,0,no,0.5,0.5,dnr after sadm,19.0,58.0,9.8984375,115.0,26.0,39.0,116.0,2.7998047,8.5,2.09960938,139.0,7.149414,71.0,55.0,160.0,0.0,<2 mo. follow-up
79.71497,0,female,0,24,870,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,241269.0,55635.25,35.0,white,42.0,16,0,0,yes,0.75,0.7,no dnr,24.0,58.0,12.6992188,75.0,30.0,36.39844,268.0,2.699707,0.29998779,1.59985352,132.0,7.419922,164.0,30.0,3510.0,0.0,no(M2 and SIP pres)
48.81897,1,male,1,5,5,Lung Cancer,Cancer,1,16.0,under $11k,14258.0,7296.1016,20.0,black,27.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,101.0,6.59960938,146.0,22.0,38.39844,120.40625,3.199707,0.19998169,0.89990234,141.0,7.429688,144.0,19.0,2600.0,4.0,<2 mo. follow-up
41.98798,0,male,0,16,866,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,501348.0,63796.875,39.0,white,66.0,27,0,0,no,0.599999905,0.6,no dnr,16.0,58.0,11.8984375,135.0,10.0,38.69531,252.5,4.6992188,1.09985352,6.09960938,139.0,7.40918,247.0,90.0,0.0,0.0,SIP>=30
79.04199,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,274616.0,73806.375,44.0,white,54.0,10,0,0,no,0.099999964,0.1,dnr after sadm,9.0,62.0,12.1992188,115.0,14.0,38.39844,105.0,3.5,11.2988281,1.19995117,138.0,7.449219,201.0,32.0,1925.0,0.0,<2 mo. follow-up
44.616,0,male,0,16,866,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,71501.0,34153.9062,25.0,white,28.0,1,0,0,no,0.799999714,0.6,no dnr,16.0,42.0,7.5,105.0,14.0,36.0,333.3,3.0,3.19970703,1.09985352,126.0,7.419922,106.0,19.0,2625.0,5.0,<2 mo. follow-up
24.21899,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,106744.0,14836.7031,31.0,black,91.0,22,0,0,yes,0.019999996,0.0,dnr after sadm,2.0,5.0,5.09960938,0.0,35.0,36.09375,420.0,3.5,1.01,4.89941406,138.0,7.069336,135.0,47.0,88.0,0.0,<2 mo. follow-up
66.146,1,male,1,7,7,CHF,COPD/CHF/Cirrhosis,3,17.0,$25-$50k,44384.0,19614.8125,40.0,white,47.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,52.0,9.8984375,65.0,16.0,36.0,333.3,3.3999023,1.79980469,1.89990234,126.0,7.419922,204.0,51.0,650.0,0.0,<2 mo. follow-up
58.53,0,female,0,5,864,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8325.0,4990.1484,18.0,asian,46.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,53.0,6.79980469,115.0,20.0,36.39844,333.3,3.8999023,2.19970703,2.0,136.0,7.419922,171.0,49.0,4050.0,1.0,<2 mo. follow-up
41.54999,0,male,0,8,864,CHF,COPD/CHF/Cirrhosis,3,21.0,under $11k,31741.0,15434.2344,14.0,white,24.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,55.0,6.89941406,115.0,16.0,36.0,333.3,3.5996094,1.29980469,1.19995117,132.0,7.419922,88.0,13.0,3300.0,0.494751,no(M2 and SIP pres)
75.146,1,female,0,8,746,Colon Cancer,Cancer,1,12.0,under $11k,22930.0,10770.4922,10.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,72.0,10.3984375,84.0,20.0,37.79688,333.3,3.7998047,0.39996338,0.69995117,136.0,7.419922,147.0,7.0,1025.0,2.5004883,<2 mo. follow-up
21.922,0,male,0,37,864,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,407547.0,133430.75,44.0,hispanic,45.0,7,0,0,no,0.5,0.5,no dnr,37.0,67.0,15.3984375,140.0,16.0,38.0,162.5,3.5,0.29998779,0.79992676,135.0,7.5,194.0,39.0,4920.0,2.0605469,no(M2 and SIP pres)
58.09998,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,197978.0,16211.4844,33.0,white,116.0,35,1,0,yes,0.099999964,0.05,dnr after sadm,2.0,37.0,0.19998169,115.0,4.0,36.79688,310.0,3.5,5.59960938,1.89990234,139.0,7.219727,211.0,74.0,114.0,2.9145508,<2 mo. follow-up
89.77997,1,male,1,3,3,Coma,Coma,2,12.0,under $11k,19078.0,8106.625,28.0,white,31.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,78.0,17.296875,80.0,9.0,38.5,237.5,3.5,1.01,1.19995117,149.0,7.449219,107.0,39.0,350.0,5.6455078,<2 mo. follow-up
60.61298,1,male,0,12,754,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,42604.0,23808.5781,16.5,hispanic,38.0,1,0,0,no,0.799999714,0.6,no dnr,12.0,55.0,5.79980469,45.0,16.0,36.19531,333.3,4.1992188,0.5,1.59985352,133.0,7.419922,119.0,25.0,2770.0,0.0,no(M2 and SIP pres)
52.87097,0,male,0,54,861,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$25-$50k,509887.0,150755.75,42.75,white,57.0,10,0,0,no,0.599999905,0.6,no dnr,54.0,125.0,7.89941406,105.0,42.0,38.0,333.3,2.3999023,9.0,0.69995117,135.0,7.419922,184.0,45.0,2080.0,2.0,adl>=4 (>=5 if sur)
94.55194,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,40533.0,16502.4688,43.0,white,83.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,13.0,11.0996094,45.0,8.0,35.59375,202.5,3.2998047,3.19970703,2.0,147.0,7.329102,205.0,49.0,360.0,0.0,<2 mo. follow-up
29.53,0,female,0,32,852,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,89501.0,37115.0,8.75,asian,42.0,1,0,0,no,1.0,1.0,no dnr,32.0,65.0,28.1992188,74.0,22.0,36.59375,612.0,1.0998535,1.01,1.39990234,127.0,7.399414,158.0,38.0,600.0,0.0,SIP>=30
75.10999,1,male,0,4,49,Lung Cancer,Cancer,2,14.0,$25-$50k,8323.0,4449.6875,15.0,asian,42.0,1,0,0,metastatic,0.5,0.15,dnr before sadm,-1.0,73.0,8.29882812,128.0,30.0,35.59375,333.3,3.5,1.01,2.09960938,135.0,7.419922,152.0,31.0,1475.0,1.8388672,<2 mo. follow-up
83.13495,1,male,0,15,95,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,47079.0,21050.375,14.666664,hispanic,48.0,2,0,0,yes,0.199999928,0.05,dnr after sadm,2.0,103.0,25.8984375,130.0,20.0,39.5,372.0,2.3999023,21.796875,1.39990234,140.0,7.419922,135.0,27.0,2900.0,3.7661133,<2 mo. follow-up
38.93799,1,male,1,53,53,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,1045982.0,211981.5,47.25,hispanic,51.0,115,0,0,no,0.5,0.3,dnr after sadm,51.0,78.0,3.29980469,140.0,48.0,38.79688,212.5,1.7998047,0.39996338,1.09985352,146.0,7.369141,150.0,24.0,3970.0,6.0,<2 mo. follow-up
61.70599,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,60681.0,23473.4219,32.0,white,102.0,1,0,0,no,0.799999714,0.7,dnr after sadm,6.0,58.0,15.5,165.0,38.0,38.59375,162.5,3.5,13.0996094,4.69921875,149.0,7.619141,94.0,86.0,70.0,5.0,<2 mo. follow-up
49.32199,1,female,0,15,130,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,>$50k,193938.0,33939.4688,24.333328,white,48.0,12,0,0,no,0.899999619,0.8,no dnr,15.0,56.0,5.19921875,130.0,32.0,36.39844,333.3,3.5,1.01,1.89990234,135.0,7.419922,135.0,58.0,3210.0,0.0,no(M2 and SIP pres)
72.26794,0,male,0,19,848,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,77088.0,32681.6719,27.0,white,35.0,1,0,0,yes,0.899999619,0.9,no dnr,19.0,68.0,7.69921875,55.0,24.0,36.59375,202.84375,3.199707,0.29998779,2.59960938,130.0,7.509766,135.0,55.0,2608.0,1.0,no(M2 and SIP pres)
59.81897,0,female,0,4,846,CHF,COPD/CHF/Cirrhosis,0,11.0,$25-$50k,12972.0,5645.2266,18.0,black,22.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,84.0,16.796875,66.0,26.0,36.79688,323.75,3.5,1.01,1.29980469,139.0,7.389648,107.0,26.0,4000.0,0.0,<2 mo. follow-up
79.98895,0,male,0,6,846,COPD,COPD/CHF/Cirrhosis,2,13.0,$25-$50k,17986.0,7659.9102,20.0,black,41.0,1,0,0,no,0.699999809,0.7,no dnr,6.0,74.0,3.79980469,102.0,20.0,37.59375,195.21875,2.8999023,0.39996338,2.39990234,141.0,7.30957,86.0,30.0,4820.0,0.494751,SIP>=30
67.35699,1,male,0,8,627,CHF,COPD/CHF/Cirrhosis,3,20.0,>$50k,36549.0,17240.5625,25.5,white,33.0,1,0,0,no,0.549999714,0.4,no dnr,8.0,58.0,9.69921875,95.0,14.0,36.09375,333.3,3.0996094,0.79992676,1.5,130.0,7.419922,108.0,24.0,3100.0,3.1831055,no(M2 and SIP pres)
70.29199,0,female,0,9,844,CHF,COPD/CHF/Cirrhosis,4,13.0,under $11k,22123.0,13162.875,8.0,black,18.0,1,1,0,no,0.799999714,0.7,no dnr,9.0,103.0,7.29980469,115.0,24.0,37.0,333.3,3.2998047,1.09985352,1.09985352,140.0,7.419922,135.0,15.0,1970.0,0.0,SIP>=30
77.42096,1,female,1,3,3,Coma,Coma,0,12.0,under $11k,93782.0,9460.7344,30.0,white,55.0,18,0,0,no,0.0,0.0,dnr before sadm,0.0,72.0,41.5,80.0,14.0,35.5,122.5,3.5,0.09999084,0.39996338,119.0,7.599609,127.0,27.0,84.0,3.1269531,<2 mo. follow-up
82.29395,1,male,0,6,529,Coma,Coma,2,12.0,under $11k,39770.0,16190.4453,26.0,white,51.0,2,1,0,no,0.5,0.5,no dnr,6.0,62.0,21.5,65.0,50.0,38.29688,271.375,2.199707,1.01,1.19995117,147.0,7.429688,215.0,30.0,1590.0,2.8618164,<2 mo. follow-up
56.02698,1,male,0,18,295,CHF,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,32470.0,20180.0156,13.0,white,24.0,1,1,0,no,0.949999809,0.9,no dnr,18.0,90.0,10.0996094,120.0,20.0,36.79688,333.3,3.7998047,1.01,3.29980469,141.0,7.419922,105.0,37.0,4130.0,1.1667481,SIP>=30
64.88397,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,221993.0,45616.8125,30.5,white,55.0,12,1,0,no,0.599999905,0.5,no dnr,13.0,48.0,15.6992188,95.0,22.0,36.79688,333.3,3.5,1.01,3.09960938,127.0,7.419922,135.0,60.0,100.0,5.0,<2 mo. follow-up
33.60699,0,male,0,18,842,Coma,Coma,0,16.0,>$50k,53325.0,25504.8125,16.0,asian,37.0,1,0,0,no,0.5,0.3,no dnr,18.0,135.0,18.0976562,150.0,9.0,38.59375,427.5,4.0996094,0.69995117,0.89990234,133.0,7.429688,144.0,15.0,1305.0,0.0,no(M2 and SIP pres)
88.91199,0,female,0,11,841,Coma,Coma,2,17.0,$25-$50k,43891.0,17630.4688,17.0,black,39.0,4,0,1,no,0.5,0.25,no dnr,11.0,131.0,15.0996094,150.0,8.0,38.0,371.375,3.5,1.01,0.89990234,134.0,7.399414,135.0,12.0,1830.0,5.0,adl>=4 (>=5 if sur)
54.81198,0,male,0,54,840,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,653743.0,92126.8125,21.5,black,37.0,80,1,0,no,0.949999809,0.95,no dnr,54.0,111.0,24.5,60.0,10.0,36.69531,520.0,2.0996094,0.19998169,0.79992676,133.0,7.299805,194.0,34.0,3080.0,0.0,no(M2 and SIP pres)
66.49396,0,male,0,7,839,Colon Cancer,Cancer,1,12.0,under $11k,28819.0,12945.9062,11.5,white,13.0,1,0,0,metastatic,1.0,0.9,no dnr,7.0,99.0,9.0,100.0,22.0,38.0,136.71875,3.5,1.01,1.09985352,129.0,7.459961,135.0,11.0,2640.0,2.890625,<2 mo. follow-up
52.22198,1,male,0,16,84,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,73669.0,32506.2969,19.0,asian,29.0,1,0,0,yes,0.799999714,0.5,no dnr,16.0,78.0,5.59960938,115.0,30.0,38.29688,614.25,3.5,1.29980469,1.09985352,128.0,7.479492,145.0,24.0,2260.0,1.0,adl>=4 (>=5 if sur)
72.07397,1,male,0,6,107,CHF,COPD/CHF/Cirrhosis,2,13.0,$11-$25k,22723.0,8480.3125,16.0,white,56.0,2,0,0,no,0.599999905,0.2,no dnr,6.0,68.0,2.5,115.0,28.0,36.0,333.3,3.5,1.01,3.09960938,132.0,7.419922,135.0,48.0,500.0,3.0,no(M2 and SIP pres)
41.95499,0,female,0,44,836,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,495977.0,108496.188,36.5,white,46.0,19,0,0,no,0.5,0.5,no dnr,44.0,68.0,22.296875,120.0,33.0,38.5,141.0,2.2998047,1.79980469,0.5,131.0,7.349609,102.0,10.0,2656.0,3.0,no(M2 and SIP pres)
46.78699,0,male,0,38,833,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,494827.0,124453.375,41.5,hispanic,61.0,15,0,0,no,0.5,0.5,no dnr,38.0,105.0,7.19921875,120.0,10.0,37.79688,435.0,2.8999023,24.0,3.5,145.0,7.479492,180.0,72.0,4645.0,6.0,no(M2 and SIP pres)
74.46399,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,44037.0,17919.9219,42.0,white,77.0,1,1,0,no,0.899999619,0.8,dnr after sadm,5.0,40.0,28.8984375,75.0,36.0,35.19531,64.70312,3.0996094,1.01,6.89941406,125.0,7.479492,254.0,115.0,3345.0,1.0,<2 mo. follow-up
60.06799,1,male,0,122,273,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,838218.0,14452.7344,34.75,asian,57.0,1,0,0,no,0.5,0.3,no dnr,122.0,64.0,9.29882812,134.0,26.0,38.0,333.3,1.7998047,1.89990234,1.69995117,123.0,7.419922,152.0,53.0,1825.0,3.109375,<2 mo. follow-up
63.37,0,male,0,19,825,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,140411.0,28087.625,19.0,hispanic,30.0,21,0,0,no,1.0,0.95,no dnr,19.0,72.0,8.69921875,60.0,34.0,37.89844,333.3,3.5,1.01,0.79992676,126.0,7.419922,135.0,28.0,1585.0,0.0,Coma or Intub
66.77594,1,male,0,7,575,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,13271.0,6757.0,10.5,white,30.0,1,1,0,yes,0.699999809,0.6,no dnr,7.0,77.0,6.59960938,78.0,24.0,36.59375,406.0625,2.8999023,1.01,2.89990234,131.0,7.449219,162.0,53.0,2500.0,3.9477539,<2 mo. follow-up
27.12099,1,female,0,17,364,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,$25-$50k,69535.0,30965.4531,20.0,hispanic,38.0,2,0,0,no,0.299999952,0.1,no dnr,17.0,63.0,5.5,122.0,32.0,35.79688,195.90625,1.7998047,0.19998169,0.69995117,128.0,7.389648,82.0,8.0,3660.0,2.0,<2 mo. follow-up
77.40497,1,female,0,11,243,Colon Cancer,Cancer,2,18.0,>$50k,39468.0,19193.3906,12.5,white,5.0,1,0,0,metastatic,0.949999809,0.5,no dnr,11.0,81.0,18.6992188,76.0,20.0,38.19531,333.3,3.5,1.01,1.0,137.0,7.419922,171.0,8.0,3300.0,0.0,no(M2 and SIP pres)
78.55695,1,male,0,81,82,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,487176.0,14452.7344,42.75,asian,55.0,3,0,1,no,0.75,0.75,no dnr,81.0,55.0,16.1992188,175.0,12.0,39.0,65.0,3.5,1.01,1.09985352,134.0,7.219727,121.0,21.0,1840.0,0.0,adl>=4 (>=5 if sur)
40.84598,0,male,0,14,820,Cirrhosis,COPD/CHF/Cirrhosis,6,13.0,$11-$25k,33793.0,16031.2656,16.0,white,40.0,1,1,0,no,0.799999714,0.33,no dnr,14.0,99.0,7.29980469,130.0,24.0,38.39844,333.3,2.699707,6.39941406,1.69995117,131.0,7.419922,199.0,21.0,740.0,1.1667481,<2 mo. follow-up
66.27496,1,male,0,10,39,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,69356.0,16043.1875,25.5,black,31.0,7,0,0,metastatic,0.5,0.3,no dnr,10.0,130.0,12.7988281,124.0,24.0,36.0,150.0,3.5,1.01,1.29980469,145.0,7.449219,135.0,21.0,2100.0,1.0,<2 mo. follow-up
61.59598,0,male,0,8,818,CHF,COPD/CHF/Cirrhosis,3,15.0,>$50k,32311.0,16214.0234,24.0,white,32.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,55.0,7.09960938,135.0,24.0,36.59375,333.3,3.5,1.01,1.29980469,135.0,7.419922,135.0,13.0,500.0,0.0,<2 mo. follow-up
88.18298,0,female,0,7,817,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,25625.0,13662.4531,11.5,white,22.0,1,0,1,yes,0.5,0.2,no dnr,7.0,70.0,5.89941406,65.0,28.0,36.5,187.75,3.5,1.01,1.19995117,142.0,7.439453,179.0,17.0,1480.0,4.9394531,<2 mo. follow-up
59.48499,1,male,0,12,547,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,52138.0,25009.7969,24.0,white,40.0,1,0,0,no,0.599999905,0.4,no dnr,12.0,63.0,10.8984375,125.0,30.0,36.0,238.09375,3.5,1.39990234,0.79992676,131.0,7.469727,120.0,22.0,1660.0,0.0,no(M2 and SIP pres)
50.66898,1,male,0,21,410,Colon Cancer,Cancer,1,12.0,under $11k,76684.0,33434.1875,20.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,21.0,71.0,7.69921875,72.0,24.0,36.39844,333.3,3.0,0.69995117,1.09985352,134.0,7.419922,85.0,13.0,2400.0,2.7949219,<2 mo. follow-up
29.02399,0,female,0,94,816,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,59995.78781114967,357422.5,52.25,hispanic,92.0,7,0,0,no,0.199999928,0.2,no dnr,94.0,42.0,13.8984375,135.0,25.0,39.09375,128.0,3.5,22.796875,3.79980469,141.0,7.609375,72.0,57.0,0.0,0.0,adl>=4 (>=5 if sur)
76.80194,1,female,1,109,109,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,1226766.0,386508.0,46.25,white,63.0,18,1,0,no,0.5,0.5,dnr after sadm,13.0,55.0,13.2988281,70.0,10.0,38.79688,140.0,3.5,1.01,3.69970703,146.0,7.519531,135.0,67.0,0.0,0.0,Coma or Intub
83.93994,1,male,0,10,327,CHF,COPD/CHF/Cirrhosis,3,14.0,>$50k,79139.0,34448.9375,34.5,white,35.0,1,1,0,no,0.799999714,0.7,no dnr,10.0,62.0,12.1992188,75.0,8.0,38.09375,285.0,3.5,1.01,1.5,138.0,7.429688,255.0,38.0,2674.0,0.0,no(M2 and SIP pres)
91.61896,1,male,0,5,172,Coma,Coma,2,12.0,under $11k,10709.0,5111.0938,12.0,white,17.0,1,0,1,no,0.199999928,0.15,dnr before sadm,-1.0,69.0,10.3984375,80.0,24.0,38.0,333.3,3.5,1.01,1.0,140.0,7.419922,135.0,10.0,1125.0,7.0,adl>=4 (>=5 if sur)
29.76299,1,female,0,42,146,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,under $11k,296857.0,107396.188,38.0,white,62.0,4,1,0,no,0.899999619,0.9,no dnr,42.0,112.0,12.6992188,115.0,35.0,38.09375,92.53125,3.7998047,1.01,7.29980469,147.0,7.269531,212.0,70.0,730.0,0.0,adl>=4 (>=5 if sur)
58.60599,1,female,0,25,103,ARF/MOSF w/Sepsis,ARF/MOSF,3,15.0,>$50k,538323.0,52945.7812,36.5,asian,61.0,48,0,0,no,0.599999905,0.5,no dnr,25.0,57.0,10.0,115.0,34.0,37.79688,323.3125,4.0996094,1.5,2.0,128.0,7.5,156.0,58.0,2708.0,0.0,no(M2 and SIP pres)
40.78,0,male,0,19,814,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,$11-$25k,105330.0,47823.3438,32.0,white,32.0,1,0,0,no,0.799999714,0.8,no dnr,19.0,58.0,5.0,115.0,10.0,38.89844,234.0,3.5,1.59985352,1.09985352,132.0,7.459961,76.0,12.0,3055.0,0.0,no(M2 and SIP pres)
92.64294,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,26196.0,11135.9531,11.5,white,80.0,1,0,1,no,0.099999964,0.1,dnr after sadm,1.0,33.0,27.0,165.0,15.0,36.0,98.32812,3.3999023,1.09985352,1.09985352,139.0,7.469727,135.0,20.0,45.0,0.0,<2 mo. follow-up
45.80197,0,female,0,21,811,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,215484.0,108049.5,44.666657,hispanic,44.0,1,0,0,no,0.699999809,0.5,no dnr,21.0,57.0,22.5,65.0,25.0,39.19531,97.14062,3.3999023,0.59997559,1.09985352,128.0,7.449219,106.0,11.0,4770.0,2.2841797,no(M2 and SIP pres)
54.52399,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,263308.0,42022.6875,52.0,white,70.0,36,0,0,yes,0.099999964,0.05,no dnr,7.0,115.0,0.04999542,175.0,38.0,39.5,495.8125,2.699707,7.39941406,0.59997559,151.0,7.549805,183.0,24.0,2120.0,0.0,<2 mo. follow-up
77.85895,1,male,0,6,294,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,13403.0,7402.2422,9.0,white,21.0,1,0,0,yes,0.799999714,0.7,no dnr,6.0,83.0,6.39941406,76.0,28.0,35.59375,333.3,3.5996094,1.29980469,1.59985352,140.0,7.419922,135.0,25.0,2075.0,3.0351562,<2 mo. follow-up
30.53799,1,male,0,5,235,Lung Cancer,Cancer,1,20.0,>$50k,17851.0,7609.7148,11.0,white,11.0,1,0,0,metastatic,1.0,0.75,no dnr,5.0,101.0,16.6992188,100.0,20.0,36.19531,333.3,3.3999023,0.19998169,0.89990234,135.0,7.419922,86.0,11.0,7800.0,0.494751,<2 mo. follow-up
66.05597,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,283022.0,56063.75,34.666657,white,78.0,14,0,0,no,0.399999857,0.4,dnr after sadm,13.0,108.0,38.8984375,45.0,28.0,36.0,377.75,2.699707,5.19921875,6.79980469,133.0,7.509766,140.0,57.0,30.0,3.1586914,<2 mo. follow-up
49.42398,1,female,0,79,118,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,$25-$50k,809561.0,312729.0,37.25,white,53.0,1,0,0,no,0.099999964,0.5,dnr after sadm,42.0,45.0,5.59960938,105.0,33.0,38.0,304.0,2.0996094,1.5,1.79980469,140.0,7.429688,126.0,66.0,2705.0,0.0,adl>=4 (>=5 if sur)
47.93399,0,female,0,12,809,MOSF w/Malig,ARF/MOSF,2,16.0,$25-$50k,64713.0,27221.6719,16.5,asian,48.0,1,0,0,yes,0.949999809,0.7,no dnr,12.0,85.0,30.1992188,65.0,34.0,36.29688,86.65625,3.5,1.01,3.69970703,131.0,7.389648,119.0,41.0,1535.0,0.0,no(M2 and SIP pres)
77.28998,0,male,0,4,809,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,4408.0,2348.4766,8.0,white,21.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,65.0,5.79980469,68.0,16.0,36.0,333.3,3.5,1.01,1.39990234,130.0,7.419922,135.0,26.0,3220.0,0.494751,no(M2 and SIP pres)
58.14398,1,male,0,10,540,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,32904.0,18238.0312,20.0,hispanic,32.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,57.0,9.09960938,70.0,24.0,36.5,333.3,3.699707,0.59997559,1.79980469,136.0,7.419922,102.0,25.0,4050.0,0.494751,no(M2 and SIP pres)
58.09399,1,male,0,13,47,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,75939.0,27794.0156,35.0,white,44.0,5,0,0,metastatic,0.199999928,0.1,no dnr,13.0,62.0,13.3984375,120.0,20.0,36.39844,333.3,3.5,0.89990234,2.19970703,134.0,7.419922,72.0,54.0,1207.0,0.0,<2 mo. follow-up
69.79895,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$11-$25k,99643.0,26943.4531,34.5,white,90.0,12,0,0,no,0.0,0.0,dnr after sadm,6.0,45.0,17.3984375,115.0,24.0,35.59375,130.96875,2.5,17.796875,2.39990234,129.0,7.459961,97.0,50.0,80.0,0.0,<2 mo. follow-up
24.98299,1,female,0,11,98,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,37548.0,18954.5469,20.5,white,43.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,105.0,7.39941406,125.0,24.0,36.59375,333.3,3.5,3.19970703,3.39990234,132.0,7.419922,102.0,98.0,2920.0,0.0,<2 mo. follow-up
67.98395,1,male,0,9,21,Lung Cancer,Cancer,2,16.0,>$50k,31422.0,15106.75,14.5,white,20.0,1,0,0,metastatic,0.799999714,0.4,no dnr,9.0,64.0,7.59960938,66.0,24.0,36.0,226.65625,3.5,1.01,1.39990234,131.0,7.519531,135.0,16.0,2770.0,1.8388672,<2 mo. follow-up
31.94299,0,female,0,9,804,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,27706.0,14902.0469,14.0,white,21.0,1,0,0,no,0.949999809,0.9,no dnr,9.0,53.0,7.29980469,105.0,16.0,36.39844,333.3,3.7998047,0.19998169,0.79992676,138.0,7.419922,135.0,16.0,2250.0,2.0,<2 mo. follow-up
54.461,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,256932.0,67671.25,53.666657,white,72.0,2,0,0,no,0.5,0.5,no dnr,15.0,107.0,44.796875,135.0,28.0,37.89844,356.625,3.5,12.7988281,3.59960938,142.0,7.519531,191.0,90.0,3875.0,3.0,<2 mo. follow-up
63.91199,0,female,0,3,803,CHF,COPD/CHF/Cirrhosis,3,18.0,>$50k,3241.0,1547.0508,6.0,white,34.0,1,1,0,no,0.949999809,0.65,no dnr,3.0,107.0,9.79882812,68.0,20.0,36.5,333.3,3.3999023,0.19998169,2.39990234,139.0,7.419922,151.0,48.0,875.0,3.1831055,<2 mo. follow-up
58.15698,0,male,0,4,800,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,8082.0,3576.2227,10.0,white,10.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,72.0,11.1992188,75.0,20.0,36.19531,333.3,3.5,0.59997559,1.29980469,139.0,7.419922,112.0,18.0,2390.0,2.4472656,no(M2 and SIP pres)
48.05698,1,female,0,4,202,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,22509.0,9981.5703,26.0,black,41.0,1,1,0,no,0.899999619,0.85,no dnr,4.0,130.0,13.6992188,95.0,28.0,38.19531,323.75,3.5,0.5,3.5,137.0,7.449219,151.0,47.0,2140.0,3.4160156,<2 mo. follow-up
76.23798,1,male,0,7,569,CHF,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,22612.0,11324.4766,20.5,white,25.0,1,1,0,no,0.949999809,0.9,no dnr,7.0,65.0,11.2988281,55.0,20.0,38.09375,173.46875,3.5,1.01,1.29980469,135.0,7.389648,276.0,25.0,1875.0,0.0,<2 mo. follow-up
50.29999,0,female,0,93,798,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,589642.0,179035.25,35.75,hispanic,66.0,7,0,0,no,0.5,0.5,no dnr,93.0,70.0,21.1992188,120.0,26.0,36.09375,115.54688,2.699707,38.09375,1.59985352,131.0,7.469727,212.0,51.0,2786.0,3.1318359,SIP>=30
32.25699,1,male,0,8,427,Colon Cancer,Cancer,1,12.0,under $11k,15115.0,9239.3906,14.5,white,8.0,1,0,0,metastatic,1.0,1.0,no dnr,8.0,78.0,5.5,68.0,20.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2150.0,2.4589844,<2 mo. follow-up
80.87299,0,female,0,13,797,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,47516.0,20618.8281,28.5,white,27.0,1,0,1,no,0.5,0.5,no dnr,13.0,68.0,9.19921875,65.0,28.0,38.5,112.23438,3.5,1.01,0.69995117,138.0,7.329102,179.0,9.0,900.0,7.0,<2 mo. follow-up
35.50198,0,female,0,14,796,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,86275.0,36490.5,25.666656,black,50.0,1,0,0,no,0.299999952,0.3,no dnr,14.0,68.0,2.69970703,115.0,26.0,39.5,118.51562,3.3999023,2.19970703,1.19995117,136.0,7.539062,174.0,24.0,3550.0,3.8613281,no(M2 and SIP pres)
65.32495,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,51732.0,20733.4062,66.0,white,84.0,1,0,0,no,0.199999928,0.1,no dnr,4.0,52.0,8.8984375,175.0,10.0,38.79688,204.0,3.5,22.1992188,4.29980469,140.0,7.319336,78.0,80.0,760.0,3.1479492,<2 mo. follow-up
67.72296,1,male,0,4,158,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,10358.0,5064.6758,14.0,white,23.0,1,0,0,yes,0.799999714,0.7,no dnr,4.0,63.0,5.39941406,80.0,24.0,36.0,333.3,3.5,1.01,1.19995117,136.0,7.419922,100.0,33.0,1620.0,1.1667481,no(M2 and SIP pres)
65.02899,0,female,0,7,795,Coma,Coma,1,12.0,under $11k,64130.0,33178.5938,19.0,white,23.0,1,0,0,yes,0.849999905,0.8,no dnr,7.0,98.0,12.7988281,55.0,28.0,37.89844,300.0,3.5,1.01,0.59997559,138.0,7.5,263.0,14.0,5420.0,0.0,adl>=4 (>=5 if sur)
84.25995,1,male,0,7,14,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,26395.0,10339.2344,12.0,white,39.0,2,0,0,no,0.5,0.2,dnr before sadm,0.0,74.0,7.79980469,118.0,12.0,36.39844,333.3,3.5,1.01,1.59985352,136.0,7.419922,77.0,26.0,970.0,6.0,<2 mo. follow-up
34.47198,0,male,0,4,790,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,19858.0,8356.9141,24.0,white,23.0,1,0,0,no,0.899999619,0.9,no dnr,4.0,83.0,8.69921875,105.0,32.0,36.59375,247.59375,3.5,1.01,0.89990234,135.0,7.5,149.0,16.0,1000.0,2.8930664,<2 mo. follow-up
42.24197,0,male,0,6,789,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,22158.0,11588.9922,26.0,white,24.0,1,0,0,no,1.0,0.99,no dnr,6.0,66.0,7.69921875,115.0,20.0,35.89844,333.3,3.7998047,1.79980469,0.89990234,133.0,7.419922,103.0,17.0,5250.0,0.0,<2 mo. follow-up
44.00299,1,male,0,5,176,Lung Cancer,Cancer,1,12.0,$11-$25k,9377.0,5006.668,16.0,hispanic,12.0,1,0,0,metastatic,0.849999905,0.5,no dnr,5.0,95.0,10.0996094,100.0,22.0,36.5,333.3,3.5,0.19998169,0.79992676,134.0,7.419922,135.0,13.0,1900.0,1.1667481,SIP>=30
87.48798,1,male,0,17,463,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,102946.0,44206.9688,9.666664,white,20.0,1,0,0,yes,0.699999809,0.5,no dnr,17.0,70.0,7.09960938,55.0,20.0,36.0,333.3,3.5,1.01,1.0,127.0,7.419922,182.0,16.0,880.0,4.2802734,<2 mo. follow-up
82.33496,1,female,1,14,14,Coma,Coma,2,14.0,$25-$50k,29987.0,17060.0938,6.666664,white,27.0,1,0,1,no,0.199999928,0.05,dnr after sadm,2.0,113.0,36.09375,116.0,22.0,38.89844,333.3,3.5,1.01,0.89990234,136.0,7.419922,112.0,11.0,425.0,5.5546875,<2 mo. follow-up
56.58298,0,female,0,24,787,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,150141.0,81014.3125,25.333328,white,22.0,1,1,0,no,0.899999619,0.85,no dnr,24.0,72.0,6.5,75.0,16.0,36.19531,333.3,4.0,0.39996338,1.5,136.0,7.419922,87.0,29.0,3225.0,1.0,no(M2 and SIP pres)
18.11899,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,262520.0,47710.1562,51.5,white,74.0,27,0,0,yes,0.039999992,0.0,dnr after sadm,7.0,62.0,0.19998169,130.0,30.0,38.69531,347.8125,1.6999512,1.01,0.89990234,155.0,7.349609,135.0,27.0,5565.0,0.0,<2 mo. follow-up
67.61395,0,female,0,42,784,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,212194.0,79058.5625,27.0,white,33.0,15,0,0,no,0.199999928,0.02,no dnr,42.0,105.0,11.5996094,105.0,8.0,37.89844,308.5625,3.5,1.89990234,2.5,133.0,7.569336,584.0,39.0,4630.0,1.0,SIP>=30
39.53699,0,female,0,9,784,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,50949.0,13308.4609,21.0,white,27.0,3,0,0,yes,0.989999771,0.99,no dnr,9.0,105.0,12.5,75.0,45.0,37.89844,128.5625,3.5,1.01,0.59997559,132.0,7.459961,124.0,7.0,2850.0,0.0,no(M2 and SIP pres)
34.103,1,female,0,53,417,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,401408.0,176795.375,25.75,hispanic,31.0,1,0,0,no,0.849999905,0.75,no dnr,53.0,48.0,11.6992188,120.0,16.0,36.0,423.75,3.5,1.01,0.89990234,131.0,7.469727,107.0,17.0,2725.0,0.0,no(M2 and SIP pres)
85.53595,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,49143.0,20626.4219,25.5,white,50.0,1,0,1,no,0.199999928,0.01,dnr after sadm,3.0,57.0,18.0976562,112.0,40.0,36.29688,171.40625,3.5,1.01,1.79980469,143.0,7.389648,160.0,33.0,1100.0,5.8476562,<2 mo. follow-up
73.26996,1,female,0,6,39,COPD,COPD/CHF/Cirrhosis,3,4.0,under $11k,16373.0,8049.2344,18.0,white,30.0,1,0,0,no,0.5,0.3,no dnr,6.0,62.0,16.0,64.0,24.0,36.19531,209.5,3.5,0.29998779,0.59997559,141.0,7.339844,139.0,11.0,1630.0,2.0,<2 mo. follow-up
48.42697,0,female,0,11,779,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,49165.0,14452.7344,25.0,white,37.0,1,0,0,no,0.949999809,0.95,no dnr,11.0,102.0,14.3984375,105.0,35.0,38.5,156.0,2.3999023,1.01,0.59997559,144.0,7.479492,154.0,8.0,3140.0,3.7768555,<2 mo. follow-up
61.37698,0,male,0,49,779,Cirrhosis,COPD/CHF/Cirrhosis,6,12.0,$25-$50k,341731.0,173828.875,34.5,white,69.0,1,0,0,no,0.099999964,0.0,no dnr,49.0,53.0,14.0,110.0,24.0,36.5,148.96875,3.0,35.0,6.39941406,148.0,7.469727,109.0,71.0,450.0,3.8950195,SIP>=30
41.487,0,male,0,11,777,Colon Cancer,Cancer,1,12.0,under $11k,37940.0,15992.1094,19.0,black,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,108.0,3.5,135.0,24.0,37.89844,333.3,4.5,1.01,1.29980469,139.0,7.419922,90.0,12.0,3021.0,2.1621094,<2 mo. follow-up
66.91595,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,178495.0,43826.0312,29.333328,white,21.0,7,1,0,yes,0.5,0.3,dnr after sadm,15.0,102.0,17.296875,55.0,6.0,39.39844,333.3,3.5,1.01,0.89990234,125.0,7.419922,353.0,14.0,1433.0,3.0839844,<2 mo. follow-up
31.20299,0,male,0,31,776,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,$25-$50k,209845.0,70183.0625,28.0,other,47.0,8,0,0,no,1.0,1.0,no dnr,31.0,115.0,17.6992188,145.0,28.0,40.0,138.0,3.5,2.29980469,0.89990234,130.0,7.459961,113.0,7.0,4995.0,0.0,<2 mo. follow-up
73.00195,0,male,0,8,775,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,50658.0,19138.6406,27.0,white,25.0,1,1,0,no,0.599999905,0.6,no dnr,8.0,62.0,8.19921875,70.0,30.0,38.39844,308.5625,3.5,1.09985352,1.19995117,129.0,7.449219,368.0,18.0,2450.0,1.0,no(M2 and SIP pres)
27.187,0,male,0,14,774,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,110216.0,40231.3125,34.666657,hispanic,71.0,3,1,0,no,0.699999809,0.7,no dnr,14.0,55.0,7.69921875,125.0,10.0,36.0,448.0,2.2998047,0.29998779,4.59960938,133.0,7.40918,597.0,59.0,220.0,1.0,no(M2 and SIP pres)
50.064,0,male,0,7,774,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,13088.0,7913.6211,13.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,55.0,8.5,60.0,16.0,36.0,333.3,3.5,1.01,1.5,127.0,7.419922,135.0,31.0,3900.0,2.3662109,<2 mo. follow-up
41.42599,0,male,0,17,773,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,275961.0,39765.25,31.666656,white,41.0,10,0,0,no,0.799999714,0.8,no dnr,17.0,102.0,21.5976562,125.0,28.0,37.89844,387.5,2.0996094,4.89941406,0.39996338,142.0,7.479492,128.0,19.0,4210.0,2.0,no(M2 and SIP pres)
69.25397,1,female,1,6,6,Coma,Coma,0,16.0,$11-$25k,52100.0,21710.7344,38.0,white,47.0,1,0,0,no,0.299999952,0.15,dnr after sadm,6.0,128.0,19.296875,115.0,8.0,38.0,423.0,3.5,1.01,1.79980469,133.0,7.489258,400.0,39.0,2720.0,0.0,<2 mo. follow-up
64.54498,0,male,0,11,772,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,36225.0,15928.9453,33.5,white,44.0,1,0,0,no,0.75,0.7,no dnr,11.0,50.0,6.09960938,60.0,16.0,36.5,333.3,3.5,1.01,3.09960938,131.0,7.419922,135.0,65.0,1550.0,3.2719727,<2 mo. follow-up
47.30499,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$11-$25k,570603.0,26905.0469,50.0,white,83.0,22,0,0,no,0.199999928,0.7,no dnr,5.0,62.0,5.89941406,145.0,32.0,39.19531,122.09375,2.5,13.6992188,2.5,145.0,7.489258,140.0,115.0,2515.0,4.6552734,<2 mo. follow-up
72.82697,0,male,0,3,763,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,7619.0,3621.5,6.0,black,40.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,77.0,7.29980469,85.0,18.0,36.69531,333.3,3.5,0.79992676,1.89990234,138.0,7.419922,94.0,30.0,200.0,0.0,SIP>=30
78.90497,1,male,0,6,255,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,19787.0,8015.1484,17.0,white,22.0,1,0,0,no,0.989999771,0.9,no dnr,6.0,62.0,6.5,115.0,24.0,36.19531,333.3,3.5,1.01,1.09985352,138.0,7.419922,135.0,12.0,1125.0,0.0,<2 mo. follow-up
53.45697,0,female,0,19,761,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,148758.0,52709.4375,35.666657,black,53.0,4,0,0,no,0.199999928,0.2,no dnr,19.0,62.0,11.7988281,105.0,15.0,38.5,246.65625,2.699707,36.0,3.79980469,134.0,7.5,130.0,61.0,6365.0,0.0,no(M2 and SIP pres)
34.439,0,female,0,7,761,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,53540.0,14613.5,15.5,black,29.0,3,0,0,yes,0.799999714,0.7,no dnr,7.0,118.0,2.39990234,112.0,12.0,36.39844,189.0,3.5,0.59997559,1.29980469,134.0,7.529297,135.0,15.0,2200.0,0.0,<2 mo. follow-up
52.36099,1,male,0,5,168,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,18956.0,9016.3672,18.0,white,41.0,1,0,0,no,0.799999714,0.5,no dnr,5.0,68.0,16.3984375,110.0,22.0,36.5,333.3,4.5996094,1.01,2.59960938,141.0,7.419922,139.0,125.0,4050.0,0.0,no(M2 and SIP pres)
44.13699,1,female,0,13,68,Lung Cancer,Cancer,1,17.0,$25-$50k,84983.0,38717.2812,33.0,white,40.0,1,0,0,metastatic,0.5,0.2,no dnr,13.0,92.0,13.0,110.0,26.0,35.59375,257.125,3.5,1.01,0.59997559,134.0,7.5,128.0,20.0,820.0,3.5,<2 mo. follow-up
77.53595,0,male,0,12,761,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,100611.0,39571.0938,35.0,white,45.0,1,0,0,no,0.799999714,0.7,no dnr,12.0,57.0,18.296875,135.0,10.0,38.19531,164.0,3.5,0.69995117,1.59985352,140.0,7.459961,165.0,22.0,2691.0,4.2373047,<2 mo. follow-up
54.61697,1,male,0,8,300,Lung Cancer,Cancer,1,14.0,$25-$50k,20575.0,10134.0156,14.5,white,32.0,1,0,0,metastatic,0.899999619,0.7,no dnr,8.0,79.0,0.29998779,60.0,22.0,38.0,333.3,3.5,1.01,0.69995117,126.0,7.419922,135.0,11.0,3250.0,2.0,no(M2 and SIP pres)
63.767,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,5,14.0,$25-$50k,177499.0,24227.2344,39.0,white,72.0,10,0,0,yes,0.5,0.1,dnr after sadm,5.0,62.0,14.2988281,95.0,25.0,36.59375,333.3,3.5,54.796875,4.59960938,132.0,7.419922,135.0,78.0,0.0,4.4824219,<2 mo. follow-up
49.21799,1,female,0,4,9,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,21363.0,6401.5273,21.0,white,67.0,2,0,0,yes,0.049999982,0.05,dnr after sadm,2.0,67.0,41.1953125,158.0,34.0,36.39844,280.0,3.5,1.01,1.19995117,131.0,7.5,83.0,25.0,300.0,2.2861328,<2 mo. follow-up
86.83099,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,83218.0,26476.1719,36.5,white,62.0,2,0,0,no,0.25,0.2,dnr after sadm,6.0,37.0,15.5996094,65.0,10.0,38.59375,126.65625,3.5,1.01,3.69970703,131.0,7.479492,135.0,63.0,1088.0,5.0,<2 mo. follow-up
46.56799,1,male,0,9,16,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,95981.0,17189.0625,15.0,white,42.0,10,0,0,no,0.699999809,0.5,no dnr,9.0,70.0,15.5996094,125.0,16.0,36.5,333.3,3.5,1.01,2.09960938,133.0,7.419922,202.0,78.0,4360.0,3.2910156,<2 mo. follow-up
58.431,1,male,0,16,360,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,$25-$50k,97332.0,36308.8125,32.666657,white,64.0,1,1,0,no,0.299999952,0.15,no dnr,16.0,110.0,15.0,115.0,31.0,35.89844,323.3125,2.3999023,3.39990234,2.69970703,131.0,7.379883,356.0,94.0,4225.0,0.0,no(M2 and SIP pres)
74.49396,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,56321.0,6909.1641,15.0,white,56.0,7,0,0,metastatic,0.75,0.5,dnr after sadm,2.0,60.0,39.1953125,120.0,30.0,37.29688,151.0,3.5,0.69995117,1.39990234,142.0,7.369141,244.0,27.0,175.0,3.8999023,<2 mo. follow-up
47.17599,1,female,1,73,73,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,915302.0,14452.7344,39.5,white,63.0,3,0,0,metastatic,0.899999619,0.7,no dnr,73.0,110.0,8.5,125.0,28.0,36.09375,191.09375,3.5,1.5,5.19921875,134.0,7.429688,159.0,63.0,106.0,0.0,<2 mo. follow-up
71.42499,1,female,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,60990.0,23809.3594,36.0,white,62.0,1,1,0,no,0.199999928,0.1,dnr after sadm,3.0,55.0,13.5996094,55.0,26.0,35.69531,120.75,1.2998047,8.69921875,0.59997559,148.0,7.489258,124.0,15.0,2990.0,4.2353516,<2 mo. follow-up
52.84097,0,female,0,40,749,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,283898.0,139695.125,27.75,white,10.0,2,0,0,no,0.899999619,0.8,no dnr,40.0,108.0,11.1992188,105.0,10.0,38.69531,405.0,2.699707,1.59985352,0.69995117,135.0,7.459961,168.0,17.0,2728.0,7.0,<2 mo. follow-up
65.81,1,male,0,4,92,Lung Cancer,Cancer,2,18.0,$25-$50k,14638.0,7570.957,13.0,white,27.0,1,0,0,metastatic,0.099999964,0.1,no dnr,4.0,79.0,7.29980469,136.0,22.0,38.39844,333.3,3.5,1.01,1.29980469,127.0,7.419922,96.0,12.0,720.0,0.0,<2 mo. follow-up
20.991,0,male,0,8,747,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,>$50k,69111.0,22133.0781,22.0,white,63.0,3,0,0,no,1.0,0.9,no dnr,8.0,65.0,17.3984375,95.0,26.0,38.5,135.0,3.5,0.39996338,10.0,146.0,7.439453,155.0,40.0,0.0,0.0,<2 mo. follow-up
79.56696,1,female,1,10,10,Coma,Coma,4,12.0,under $11k,54981.0,17895.0156,28.0,white,17.0,7,1,0,yes,0.0,0.0,dnr after sadm,9.0,107.0,20.8984375,70.0,14.0,38.39844,435.0,3.5,1.01,0.79992676,134.0,7.549805,135.0,10.0,1620.0,3.2192383,<2 mo. follow-up
42.36798,0,male,0,7,747,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,26673.0,13993.6328,15.0,white,31.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,55.0,9.19921875,110.0,20.0,36.19531,333.3,3.699707,0.89990234,1.39990234,128.0,7.419922,103.0,22.0,3225.0,0.0,<2 mo. follow-up
72.06299,0,female,0,4,747,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,6761.0,3211.4473,3.0,hispanic,39.0,1,1,0,no,0.899999619,0.75,no dnr,4.0,123.0,6.39941406,82.0,26.0,36.39844,333.3,2.5,1.01,2.0,138.0,7.419922,242.0,25.0,1600.0,1.0,<2 mo. follow-up
84.04895,0,female,0,15,746,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,63995.0,24024.3125,16.0,white,39.0,3,0,0,no,0.099999964,0.05,dnr after sadm,6.0,62.0,23.6992188,65.0,42.0,36.09375,182.5,3.5,1.0,1.09985352,150.0,7.469727,135.0,54.0,1180.0,4.2011719,<2 mo. follow-up
41.33899,1,male,0,8,664,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,27099.0,13704.3828,14.5,white,19.0,1,0,0,no,1.0,0.9,no dnr,8.0,62.0,7.59960938,115.0,22.0,37.5,333.3,3.5996094,0.29998779,1.39990234,136.0,7.419922,121.0,18.0,3350.0,2.9267578,<2 mo. follow-up
66.22595,1,male,1,82,82,ARF/MOSF w/Sepsis,ARF/MOSF,5,18.0,$25-$50k,837022.0,327682.5,44.0,white,54.0,8,1,0,no,0.199999928,0.1,no dnr,82.0,68.0,6.59960938,110.0,23.0,36.19531,312.5,3.5,26.0,3.0,149.0,7.439453,135.0,116.0,1540.0,2.0,<2 mo. follow-up
67.52899,1,male,0,3,533,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,9941.0,3885.0234,6.0,other,8.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,102.0,6.09960938,70.0,24.0,36.5,202.03125,3.5,1.01,1.39990234,139.0,7.359375,162.0,15.0,2502.0,7.0,<2 mo. follow-up
43.06097,0,male,0,81,741,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,727548.0,204734.375,39.5,hispanic,41.0,25,0,0,no,0.599999905,0.5,no dnr,81.0,65.0,6.09960938,135.0,28.0,37.79688,132.5,3.5,1.09985352,1.19995117,134.0,7.509766,145.0,31.0,4425.0,2.9472656,adl>=4 (>=5 if sur)
23.17,0,male,0,9,728,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,26594.0,9269.4141,10.0,black,18.0,2,0,0,no,0.799999714,0.8,no dnr,9.0,103.0,22.0,96.0,28.0,38.0,155.09375,3.5,1.01,0.79992676,133.0,7.40918,135.0,8.0,2900.0,0.0,<2 mo. follow-up
84.99896,0,male,0,7,728,MOSF w/Malig,ARF/MOSF,2,18.0,under $11k,18968.0,8118.8359,7.0,white,46.0,1,1,0,yes,0.799999714,0.6,no dnr,7.0,75.0,8.3984375,64.0,22.0,36.39844,108.15625,3.5,1.01,4.09960938,134.0,7.15918,276.0,61.0,1200.0,0.494751,<2 mo. follow-up
52.88397,0,male,0,12,727,ARF/MOSF w/Sepsis,ARF/MOSF,3,19.0,>$50k,34829.0,15494.9688,24.5,white,57.0,1,0,0,no,0.799999714,0.7,no dnr,12.0,72.0,21.796875,75.0,28.0,37.5,140.8125,2.5,8.19921875,2.39990234,132.0,7.429688,108.0,58.0,3460.0,2.0,no(M2 and SIP pres)
56.57498,0,male,0,13,727,CHF,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,120213.0,66801.75,31.5,asian,29.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,49.0,4.59960938,65.0,20.0,36.19531,333.3,3.5,1.59985352,1.0,134.0,7.419922,135.0,24.0,2950.0,0.0,no(M2 and SIP pres)
59.02499,1,male,0,12,18,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$11-$25k,84586.0,29856.8594,36.0,white,61.0,1,1,0,no,0.599999905,0.5,no dnr,12.0,68.0,5.19921875,110.0,8.0,36.39844,274.25,3.2998047,2.39990234,6.39941406,142.0,7.549805,424.0,76.0,255.0,7.0,<2 mo. follow-up
35.379,0,female,0,8,725,Colon Cancer,Cancer,1,18.0,>$50k,30835.0,14452.7344,19.0,white,18.0,1,0,0,metastatic,1.0,0.99,no dnr,8.0,78.0,7.19921875,120.0,22.0,39.19531,333.3,2.5996094,0.19998169,0.89990234,139.0,7.419922,79.0,14.0,3730.0,0.0,<2 mo. follow-up
50.59799,0,male,0,22,723,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,178970.0,49564.5312,29.666656,white,34.0,6,0,0,yes,1.0,0.9,no dnr,22.0,128.0,19.6992188,55.0,14.0,38.59375,88.625,3.5,1.01,1.09985352,148.0,7.529297,151.0,32.0,3755.0,2.9150391,adl>=4 (>=5 if sur)
39.52399,0,male,0,4,723,CHF,COPD/CHF/Cirrhosis,2,11.0,under $11k,8793.0,4615.7695,13.0,black,23.0,1,0,0,no,0.949999809,0.8,no dnr,4.0,72.0,4.39941406,115.0,20.0,36.09375,333.3,3.5,1.01,1.39990234,132.0,7.419922,82.0,22.0,5620.0,2.2358398,<2 mo. follow-up
51.702,0,female,0,34,721,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,203761.0,74729.25,39.25,white,47.0,1,1,0,no,0.899999619,0.9,no dnr,34.0,62.0,10.0996094,125.0,43.0,38.69531,154.0,2.7998047,1.01,1.09985352,146.0,7.469727,389.0,20.0,2220.0,1.0,<2 mo. follow-up
74.74896,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,71884.0,26060.8906,33.5,hispanic,77.0,1,1,0,no,0.199999928,0.1,dnr after sadm,3.0,50.0,11.5,50.0,15.0,39.0,308.0,3.5,0.29998779,6.69921875,135.0,7.259766,238.0,53.0,0.0,0.0,<2 mo. follow-up
68.43799,1,male,0,7,108,MOSF w/Malig,ARF/MOSF,1,15.0,>$50k,22713.0,10020.3984,10.5,white,19.0,1,0,0,metastatic,0.5,0.1,no dnr,7.0,68.0,9.5,75.0,22.0,38.59375,130.0,3.5,1.01,1.09985352,133.0,7.439453,173.0,19.0,2825.0,0.0,<2 mo. follow-up
26.754,0,female,0,17,720,Coma,Coma,0,12.0,under $11k,97238.0,41404.5312,28.0,other,27.0,1,0,0,no,0.699999809,0.4,no dnr,17.0,103.0,16.5,115.0,12.0,38.0,445.6875,3.5,1.01,0.59997559,141.0,7.569336,99.0,22.0,1435.0,1.9611816,<2 mo. follow-up
68.60797,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,98679.0,21394.1875,55.0,white,89.0,5,1,0,no,0.0,0.0,dnr after sadm,4.0,52.0,15.8984375,80.0,26.0,36.89844,108.5625,2.5996094,8.69921875,2.29980469,142.0,7.439453,364.0,43.0,0.0,0.0,<2 mo. follow-up
54.61697,1,female,0,28,312,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,144291.0,53110.9062,22.75,white,54.0,1,1,0,yes,0.899999619,0.9,no dnr,28.0,57.0,19.8984375,110.0,6.0,39.09375,222.84375,3.5,1.01,6.19921875,142.0,7.429688,96.0,36.0,5.0,3.8549805,<2 mo. follow-up
91.12695,0,female,0,7,717,CHF,COPD/CHF/Cirrhosis,2,17.0,$11-$25k,13810.0,6750.1758,11.0,white,11.0,1,0,0,no,0.899999619,0.85,no dnr,7.0,104.0,5.29980469,82.0,20.0,37.59375,333.3,3.5,1.01,1.0,140.0,7.419922,135.0,19.0,2705.0,0.0,no(M2 and SIP pres)
75.047,1,female,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,32043.0,12441.5078,36.0,white,29.0,1,0,0,no,0.699999809,0.6,no dnr,5.0,103.0,7.5,75.0,40.0,38.19531,740.0,2.699707,4.0,0.59997559,129.0,7.329102,323.0,7.0,2730.0,6.0,<2 mo. follow-up
65.29999,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,267914.0,78850.4375,42.666657,white,52.0,9,1,0,metastatic,0.5,0.5,dnr after sadm,21.0,43.0,3.29980469,115.0,10.0,38.0,174.53125,2.7998047,0.69995117,7.19921875,142.0,7.489258,95.0,78.0,2502.0,1.0,<2 mo. follow-up
61.49197,0,female,0,39,715,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,270064.0,81985.25,26.25,black,43.0,8,0,0,no,0.899999619,0.9,no dnr,39.0,72.0,19.3984375,115.0,34.0,38.5,292.5,3.5,1.01,1.69995117,148.0,7.55957,110.0,71.0,1118.0,2.1645508,<2 mo. follow-up
73.15796,1,male,0,8,12,Lung Cancer,Cancer,2,12.0,under $11k,30093.0,13114.8672,23.0,white,45.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,1.0,71.0,31.3984375,128.0,32.0,38.09375,347.5625,2.3999023,1.29980469,1.29980469,134.0,7.469727,119.0,23.0,4250.0,4.3505859,<2 mo. follow-up
57.36099,1,female,0,4,16,Lung Cancer,Cancer,0,14.0,$11-$25k,7234.0,3338.7637,9.0,other,22.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,1.0,109.0,4.39941406,96.0,28.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,600.0,5.0,<2 mo. follow-up
49.72998,0,female,0,34,710,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,225448.0,85349.9375,40.5,white,82.0,1,0,0,no,0.299999952,0.3,dnr after sadm,5.0,38.0,42.09375,140.0,24.0,38.09375,193.3125,1.5,0.59997559,7.0,134.0,7.369141,173.0,147.0,4625.0,6.0,adl>=4 (>=5 if sur)
70.12994,1,male,0,7,275,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,24386.0,9793.1484,15.0,white,41.0,1,1,0,no,0.5,0.2,no dnr,7.0,58.0,9.3984375,105.0,20.0,36.69531,333.3,3.5,0.5,1.69995117,136.0,7.419922,361.0,41.0,3780.0,1.0,no(M2 and SIP pres)
61.79898,1,male,0,71,194,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,286496.0,147557.75,19.0,white,46.0,1,0,0,no,0.199999928,0.1,no dnr,71.0,38.0,11.3984375,105.0,22.0,36.09375,333.3,3.5,1.01,1.79980469,133.0,7.419922,135.0,52.0,2800.0,3.3452148,no(M2 and SIP pres)
47.896,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,5,18.0,>$50k,59995.78781114967,70495.6875,41.666657,white,38.0,16,0,0,no,0.5,0.3,dnr after sadm,19.0,113.0,11.7988281,105.0,15.0,39.39844,168.0,3.5,9.19921875,0.5,134.0,7.5,135.0,17.0,2335.0,0.0,<2 mo. follow-up
52.129,0,male,0,12,708,CHF,COPD/CHF/Cirrhosis,2,13.0,$11-$25k,36250.0,17748.6094,22.0,white,38.0,1,0,0,no,0.299999952,0.1,no dnr,12.0,47.0,10.5996094,65.0,24.0,36.29688,333.3,4.2998047,2.59960938,2.0,134.0,7.419922,105.0,24.0,2445.0,0.494751,<2 mo. follow-up
51.461,1,female,1,9,9,Lung Cancer,Cancer,3,12.0,under $11k,38782.0,15543.375,10.5,white,49.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,59.0,10.0,112.0,36.0,36.59375,333.3,3.5,1.01,1.0,141.0,7.419922,112.0,14.0,350.0,3.2802734,<2 mo. follow-up
59.95297,0,male,0,9,705,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,37026.0,16442.4688,16.0,white,59.0,1,0,0,no,0.599999905,0.5,no dnr,9.0,108.0,36.6953125,130.0,28.0,37.89844,333.3,2.3999023,0.59997559,2.39990234,142.0,7.419922,122.0,71.0,510.0,2.0,adl>=4 (>=5 if sur)
77.29999,0,female,0,8,705,Colon Cancer,Cancer,1,12.0,>$50k,23099.0,9433.7266,14.5,white,16.0,1,0,0,metastatic,0.949999809,0.95,no dnr,8.0,71.0,13.0,72.0,14.0,36.19531,333.3,2.5,1.0,0.89990234,140.0,7.419922,135.0,23.0,1050.0,0.494751,<2 mo. follow-up
77.52496,1,male,1,19,19,Coma,Coma,2,10.0,$11-$25k,229171.0,50377.3438,34.333313,white,61.0,5,0,0,no,0.949999809,0.75,dnr after sadm,16.0,55.0,15.1992188,105.0,32.0,35.29688,310.0,3.5,1.0,4.5,144.0,7.619141,151.0,123.0,302.0,1.0,<2 mo. follow-up
50.09399,1,male,0,22,155,CHF,COPD/CHF/Cirrhosis,2,13.0,$25-$50k,172027.0,89110.1875,32.666657,white,36.0,1,0,0,no,0.5,0.5,no dnr,22.0,55.0,5.19921875,75.0,20.0,36.09375,333.3,3.5,1.01,2.69970703,126.0,7.419922,140.0,38.0,2000.0,0.494751,no(M2 and SIP pres)
43.53998,1,female,1,29,29,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,313131.0,120728.75,39.5,white,63.0,1,0,0,no,0.5,0.05,dnr after sadm,23.0,78.0,24.5976562,155.0,12.0,38.0,136.0,3.5,6.59960938,0.59997559,134.0,7.509766,210.0,28.0,1675.0,0.0,<2 mo. follow-up
65.01794,0,male,0,55,704,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,346376.0,128525.562,39.0,white,20.0,7,0,0,no,0.5,0.5,no dnr,55.0,108.0,7.79980469,105.0,18.0,36.69531,127.26562,2.5,0.29998779,1.09985352,139.0,7.419922,93.0,17.0,5930.0,1.0,<2 mo. follow-up
75.55597,1,female,0,6,93,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,128893.0,15698.1953,42.0,white,27.0,10,0,0,no,0.949999809,0.95,no dnr,6.0,68.0,15.2988281,115.0,24.0,36.89844,200.0,2.5996094,1.01,0.79992676,131.0,7.5,155.0,25.0,2165.0,0.0,Coma or Intub
61.76599,0,female,0,6,703,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,33585.0,10267.5391,18.0,black,29.0,3,1,0,yes,0.75,0.75,no dnr,6.0,84.0,6.79980469,75.0,26.0,36.5,217.125,3.5,9.0,0.69995117,134.0,7.439453,135.0,8.0,2350.0,0.0,<2 mo. follow-up
35.47198,1,male,1,28,28,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,687411.0,126430.312,44.5,white,100.0,66,0,0,yes,0.099999964,0.1,dnr after sadm,10.0,55.0,0.59997559,115.0,34.0,39.09375,142.5,1.6999512,14.0,1.79980469,147.0,7.469727,145.0,107.0,1508.0,2.5102539,<2 mo. follow-up
56.36697,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,5,6.0,under $11k,299542.0,26629.2344,42.0,hispanic,87.0,19,0,0,no,0.299999952,0.25,dnr after sadm,6.0,48.0,31.1992188,105.0,30.0,38.5,168.0,3.5,10.0996094,3.0,141.0,7.419922,170.0,73.0,0.0,0.0,<2 mo. follow-up
74.69995,0,female,0,17,700,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,76763.0,28010.2344,19.666656,black,58.0,2,0,0,no,0.699999809,0.5,dnr after sadm,14.0,52.0,8.29882812,65.0,36.0,36.79688,368.5,3.5,1.01,2.5,136.0,7.419922,98.0,48.0,1000.0,1.0,<2 mo. follow-up
46.09198,0,female,0,61,701,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,545065.0,176415.5,31.25,white,101.0,18,0,0,yes,0.199999928,0.1,no dnr,61.0,52.0,0.04999542,165.0,24.0,37.69531,275.5,3.5,3.89990234,3.5,146.0,7.359375,269.0,63.0,0.0,3.6855469,<2 mo. follow-up
53.27899,1,female,0,14,542,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,96262.0,22771.6094,20.333328,white,26.0,4,0,0,yes,0.899999619,0.8,no dnr,14.0,123.0,12.1992188,130.0,28.0,37.89844,337.75,3.0,0.5,1.0,132.0,7.329102,125.0,5.0,3250.0,3.3676758,<2 mo. follow-up
53.06198,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,471833.0,111073.875,44.333313,asian,68.0,10,0,0,no,0.699999809,0.5,no dnr,24.0,63.0,4.89941406,125.0,12.0,36.19531,177.5,3.699707,9.5,2.09960938,142.0,7.299805,438.0,63.0,452.0,2.6240234,<2 mo. follow-up
69.133,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,57562.0,18690.7188,51.0,asian,44.0,4,0,1,no,0.099999964,0.1,dnr after sadm,4.0,68.0,5.39941406,135.0,28.0,38.19531,80.0,3.5,0.59997559,1.19995117,133.0,7.459961,140.0,15.0,3010.0,3.0,<2 mo. follow-up
54.46997,1,male,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,>$50k,658861.0,176627.0,43.25,hispanic,83.0,9,1,0,no,0.699999809,0.5,dnr after sadm,42.0,58.0,7.29980469,115.0,50.0,39.29688,116.0,3.0996094,3.59960938,2.5,163.0,7.419922,180.0,75.0,2151.0,3.0800781,<2 mo. follow-up
45.96298,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,>$50k,402858.0,48769.5625,42.0,white,39.0,25,0,0,no,0.799999714,0.8,dnr after sadm,9.0,118.0,4.09960938,115.0,24.0,38.0,502.8125,2.699707,4.09960938,1.69995117,138.0,7.419922,186.0,120.0,2110.0,3.0,<2 mo. follow-up
38.83099,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,449656.0,76598.4375,54.666657,white,98.0,13,0,0,no,0.5,0.4,dnr after sadm,17.0,45.0,1.39990234,180.0,18.0,39.5,106.0,1.8999023,12.5996094,1.59985352,151.0,7.40918,161.0,86.0,3590.0,0.0,<2 mo. follow-up
48.43799,0,female,0,18,693,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,126356.0,45821.75,28.333328,white,36.0,2,0,0,no,0.849999905,0.85,no dnr,18.0,122.0,16.1992188,145.0,15.0,38.0,134.0,2.199707,0.29998779,1.09985352,145.0,7.319336,125.0,15.0,3975.0,0.0,<2 mo. follow-up
74.88794,0,female,0,26,692,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,367797.0,60647.9375,28.75,white,36.0,20,0,0,no,0.649999619,0.65,dnr after sadm,12.0,68.0,13.0,110.0,36.0,38.39844,167.5,3.199707,1.59985352,0.89990234,148.0,7.389648,178.0,37.0,2360.0,1.0,adl>=4 (>=5 if sur)
68.08795,0,male,0,69,692,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,543761.0,14452.7344,45.25,white,53.0,6,0,0,no,0.799999714,0.8,no dnr,69.0,67.0,18.0976562,75.0,12.0,36.59375,186.65625,3.5,2.39990234,5.0,129.0,7.489258,221.0,63.0,20.0,0.0,adl>=4 (>=5 if sur)
27.30199,0,female,0,16,691,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,147320.0,44378.1875,26.333328,hispanic,22.0,4,0,0,no,0.899999619,0.9,no dnr,16.0,98.0,15.5996094,105.0,48.0,36.79688,197.9375,3.5,0.69995117,1.19995117,135.0,7.419922,177.0,22.0,3405.0,3.5473633,<2 mo. follow-up
64.66296,0,female,0,25,690,CHF,COPD/CHF/Cirrhosis,2,15.0,$11-$25k,82891.0,35861.9375,20.75,white,46.0,1,0,0,no,0.599999905,0.5,no dnr,25.0,58.0,12.1992188,145.0,26.0,36.19531,333.3,2.8999023,0.69995117,1.0,129.0,7.419922,92.0,13.0,1265.0,0.494751,<2 mo. follow-up
74.47998,0,male,0,16,689,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,43115.0,22599.7812,22.333328,hispanic,24.0,1,0,0,no,0.699999809,0.5,no dnr,16.0,73.0,7.5,70.0,28.0,36.0,333.3,3.5,1.01,1.39990234,142.0,7.419922,87.0,22.0,3450.0,0.0,no(M2 and SIP pres)
56.96597,1,male,1,36,36,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,743890.0,136667.25,42.5,white,77.0,62,0,0,yes,0.099999964,0.0,dnr after sadm,35.0,53.0,18.796875,115.0,22.0,39.5,200.0,3.5,24.1992188,3.89990234,137.0,7.549805,97.0,72.0,180.0,2.800293,<2 mo. follow-up
68.32599,0,male,0,7,687,ARF/MOSF w/Sepsis,ARF/MOSF,0,19.0,>$50k,19224.0,7768.3281,7.5,white,28.0,1,0,0,no,0.949999809,0.9,no dnr,7.0,105.0,10.7988281,100.0,30.0,37.79688,333.3,3.5,1.01,1.19995117,130.0,7.419922,247.0,21.0,3350.0,0.494751,no(M2 and SIP pres)
64.02997,1,male,1,30,30,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,193563.0,70496.6875,31.25,white,36.0,1,0,0,no,0.699999809,0.5,dnr after sadm,28.0,62.0,4.5,65.0,22.0,36.5,173.3125,3.5,3.0,2.09960938,132.0,7.469727,110.0,34.0,3465.0,0.0,<2 mo. follow-up
56.01898,1,male,0,60,318,ARF/MOSF w/Sepsis,ARF/MOSF,5,14.0,$25-$50k,59995.78781114967,14452.7344,34.25,hispanic,50.0,18,1,0,no,0.799999714,0.6,no dnr,60.0,112.0,7.29980469,115.0,26.0,38.39844,333.3,2.8999023,4.79980469,2.79980469,136.0,7.419922,168.0,104.0,1000.0,7.0,<2 mo. follow-up
56.42697,1,female,1,60,60,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,59995.78781114967,196988.875,48.0,white,60.0,11,0,0,yes,0.699999809,0.68,dnr after sadm,55.0,128.0,23.1992188,160.0,28.0,38.89844,88.5625,3.5,1.0,1.19995117,145.0,7.40918,292.0,80.0,3495.0,0.0,<2 mo. follow-up
74.97296,0,female,0,4,684,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,5306.0,3045.7793,12.0,black,24.0,1,0,0,no,0.949999809,0.75,no dnr,4.0,101.0,3.79980469,76.0,20.0,36.39844,333.3,3.5,1.01,1.89990234,141.0,7.419922,135.0,39.0,1670.0,4.5273438,<2 mo. follow-up
66.64197,1,female,0,15,181,Lung Cancer,Cancer,1,10.0,under $11k,55841.0,23905.6562,21.666656,white,48.0,1,0,0,metastatic,0.699999809,0.5,no dnr,15.0,46.0,8.8984375,160.0,32.0,36.0,333.3,3.3999023,0.39996338,0.59997559,139.0,7.419922,128.0,6.0,1075.0,0.494751,<2 mo. follow-up
37.25699,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,6,10.0,under $11k,188152.0,63810.8438,59.0,hispanic,82.0,8,0,0,yes,0.25,0.1,dnr after sadm,11.0,65.0,9.8984375,100.0,42.0,34.89844,87.5,3.5,31.5,4.19921875,146.0,7.429688,152.0,75.0,847.0,0.0,<2 mo. follow-up
59.70697,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,770591.0,59998.0625,42.5,white,53.0,80,0,0,no,0.5,0.3,dnr after sadm,9.0,58.0,3.09960938,125.0,35.0,39.5,110.0,3.5,0.79992676,1.09985352,139.0,7.5,135.0,35.0,3805.0,4.0,<2 mo. follow-up
57.91397,1,female,0,34,95,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,376476.0,77035.1875,37.75,white,41.0,14,0,0,no,0.699999809,0.65,no dnr,34.0,120.0,23.0,125.0,12.0,37.59375,130.0,3.5,1.01,1.19995117,136.0,7.449219,294.0,40.0,2770.0,2.0,adl>=4 (>=5 if sur)
79.81396,1,male,0,7,351,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,181788.0,20369.375,34.5,white,55.0,7,0,0,no,0.349999905,0.35,no dnr,7.0,45.0,16.0,95.0,48.0,39.5,133.3125,3.5,6.29980469,1.19995117,152.0,7.479492,165.0,50.0,2496.0,0.0,adl>=4 (>=5 if sur)
80.49298,0,male,0,9,681,CHF,COPD/CHF/Cirrhosis,2,15.0,$25-$50k,27792.0,14040.6328,10.0,white,17.0,1,0,0,no,0.699999809,0.343,no dnr,9.0,78.0,16.0976562,85.0,28.0,38.19531,217.5,3.5,1.01,0.79992676,133.0,7.429688,115.0,10.0,1925.0,2.3549805,<2 mo. follow-up
63.56198,1,female,0,8,27,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,56383.0,19704.25,28.5,black,63.0,1,0,0,no,0.899999619,0.85,no dnr,8.0,85.0,7.69921875,72.0,24.0,36.5,333.3,3.5,1.01,1.39990234,142.0,7.419922,112.0,24.0,1215.0,0.0,<2 mo. follow-up
89.92499,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,215263.0,16649.3125,44.0,asian,69.0,14,0,0,no,0.699999809,0.4,no dnr,3.0,58.0,22.6992188,145.0,32.0,36.29688,227.5,3.2998047,0.39996338,2.69970703,131.0,7.399414,147.0,51.0,1880.0,3.8125,<2 mo. follow-up
75.64996,0,female,0,4,677,Lung Cancer,Cancer,1,12.0,under $11k,9252.0,3596.1035,13.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,60.0,17.0976562,5.0,30.0,37.59375,305.0,2.2998047,4.5,2.59960938,138.0,7.319336,135.0,60.0,13.0,2.3491211,<2 mo. follow-up
52.33398,0,female,0,15,677,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,44858.0,23246.25,21.0,white,35.0,1,1,0,no,0.799999714,0.6,no dnr,15.0,71.0,5.5,80.0,24.0,36.59375,333.3,3.5,1.01,0.89990234,139.0,7.419922,135.0,17.0,2502.0,0.494751,<2 mo. follow-up
41.21298,1,female,0,7,145,Lung Cancer,Cancer,1,14.0,$25-$50k,17155.0,7595.1016,5.0,white,22.0,1,0,0,metastatic,0.599999905,0.3,dnr after sadm,1.0,45.0,5.5,75.0,18.0,36.0,333.3,3.8999023,0.5,1.59985352,135.0,7.419922,186.0,21.0,1700.0,3.0,adl>=4 (>=5 if sur)
62.60898,1,female,0,9,471,Lung Cancer,Cancer,2,12.0,$11-$25k,36914.0,15720.0781,13.5,white,10.0,1,0,0,metastatic,1.0,1.0,no dnr,9.0,71.0,5.59960938,76.0,20.0,36.39844,333.3,3.5,2.0,0.59997559,133.0,7.419922,93.0,4.0,1850.0,3.484375,no(M2 and SIP pres)
71.47198,1,male,0,7,122,CHF,COPD/CHF/Cirrhosis,2,18.0,>$50k,22851.0,11544.6016,17.0,white,44.0,1,0,0,no,0.799999714,0.75,no dnr,7.0,109.0,6.89941406,104.0,22.0,36.39844,460.0,3.5,1.01,0.89990234,134.0,7.399414,183.0,23.0,2075.0,2.0,<2 mo. follow-up
43.129,1,female,0,9,380,Lung Cancer,Cancer,1,12.0,under $11k,32776.0,15275.6172,12.5,white,11.0,1,0,0,metastatic,1.0,0.75,no dnr,9.0,49.0,3.79980469,65.0,20.0,36.29688,333.3,3.5,1.01,2.19970703,126.0,7.419922,135.0,71.0,1575.0,2.9306641,<2 mo. follow-up
45.16098,1,male,1,5,5,Coma,Coma,0,12.0,under $11k,47000.0,16881.7812,48.0,white,48.0,1,0,0,no,0.099999964,0.1,dnr after sadm,4.0,73.0,9.0,80.0,16.0,38.19531,333.3,3.5,1.01,0.69995117,140.0,7.419922,87.0,10.0,2375.0,0.0,<2 mo. follow-up
55.76498,1,female,0,14,109,MOSF w/Malig,ARF/MOSF,1,20.0,$25-$50k,84742.0,36031.0312,21.333328,white,38.0,1,0,0,yes,0.699999809,0.5,no dnr,14.0,132.0,22.5976562,135.0,20.0,38.59375,148.875,3.3999023,0.39996338,2.39990234,148.0,7.359375,401.0,47.0,3975.0,2.9794922,<2 mo. follow-up
70.12695,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,93405.0,33662.875,59.0,white,38.0,1,0,0,no,0.299999952,0.3,dnr after sadm,8.0,62.0,4.59960938,135.0,38.0,39.39844,83.32812,3.5,0.79992676,0.69995117,146.0,7.339844,135.0,25.0,2095.0,2.0,<2 mo. follow-up
70.20697,1,male,0,59,121,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,480909.0,147843.125,35.0,white,37.0,7,1,0,no,0.299999952,0.3,no dnr,59.0,68.0,17.8984375,145.0,24.0,36.69531,222.84375,2.5996094,0.5,0.79992676,131.0,7.439453,235.0,32.0,4750.0,4.0,Coma or Intub
65.87299,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,349615.0,61846.9062,38.666657,white,50.0,15,0,0,no,0.5,0.5,dnr after sadm,14.0,115.0,4.59960938,65.0,26.0,36.0,482.5,2.5,3.39990234,1.59985352,142.0,7.459961,253.0,66.0,2395.0,1.0,<2 mo. follow-up
37.77399,1,female,0,28,93,Lung Cancer,Cancer,1,14.0,>$50k,124501.0,49427.8438,22.75,white,13.0,1,0,0,metastatic,0.799999714,0.5,no dnr,28.0,73.0,5.39941406,115.0,36.0,38.39844,225.0,3.5,1.01,5.5,149.0,7.439453,234.0,125.0,1400.0,0.0,<2 mo. follow-up
27.866,0,female,0,10,670,CHF,COPD/CHF/Cirrhosis,2,18.0,$25-$50k,34964.0,17250.1562,19.5,white,20.0,1,0,0,no,0.949999809,0.7,no dnr,10.0,69.0,7.19921875,74.0,20.0,37.89844,333.3,3.5996094,0.39996338,1.0,135.0,7.419922,84.0,5.0,7025.0,2.0,<2 mo. follow-up
46.51898,1,male,0,107,110,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,466224.0,232577.375,24.0,hispanic,71.0,1,1,0,no,0.25,0.25,no dnr,107.0,67.0,9.5,105.0,20.0,36.19531,333.3,4.1992188,1.0,1.39990234,140.0,7.419922,80.0,17.0,900.0,0.0,<2 mo. follow-up
75.461,1,female,0,5,451,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,22979.0,9299.4453,31.0,black,22.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,56.0,7.89941406,105.0,8.0,36.0,228.875,2.7998047,9.5,2.29980469,155.0,7.459961,184.0,59.0,1965.0,3.3642578,<2 mo. follow-up
66.50494,1,male,1,127,127,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,983206.0,14452.7344,43.0,white,84.0,1,0,0,no,0.949999809,0.65,dnr after sadm,31.0,114.0,7.09960938,70.0,30.0,36.59375,211.09375,3.5,1.01,0.89990234,145.0,7.339844,102.0,18.0,5650.0,2.8105469,Coma or Intub
49.89697,1,female,0,71,308,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,550783.0,250646.0,28.75,black,36.0,1,0,0,no,0.699999809,0.5,no dnr,71.0,45.0,23.1992188,170.0,10.0,38.39844,100.0,3.5,1.01,2.29980469,134.0,7.319336,287.0,33.0,279.0,0.0,adl>=4 (>=5 if sur)
45.08698,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,18.0,under $11k,385690.0,26342.0469,36.5,asian,84.0,37,1,0,no,0.049999982,0.05,dnr after sadm,5.0,77.0,15.8984375,80.0,20.0,36.29688,333.3,3.5,20.5976562,2.19970703,131.0,7.419922,76.0,11.0,2250.0,3.7890625,<2 mo. follow-up
71.849,0,male,0,8,667,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,64436.0,12104.5703,23.0,white,39.0,9,0,0,no,0.299999952,0.3,no dnr,8.0,50.0,9.29882812,25.0,28.0,38.5,295.0,3.5,9.5,2.5,136.0,7.279297,135.0,89.0,1790.0,2.8486328,<2 mo. follow-up
56.88199,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,25415.0,9614.6406,37.0,white,31.0,1,0,0,yes,0.0,0.0,dnr after sadm,4.0,49.0,12.3984375,135.0,16.0,36.69531,211.0,3.5,1.01,1.19995117,137.0,7.089844,135.0,18.0,3013.0,2.9951172,<2 mo. follow-up
39.02298,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,288218.0,98932.75,53.333313,black,74.0,4,0,0,no,0.099999964,0.01,dnr after sadm,18.0,78.0,25.796875,120.0,32.0,36.5,469.375,3.5,1.01,0.5,127.0,7.479492,135.0,13.0,3765.0,2.0,<2 mo. follow-up
56.10999,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,419661.0,141917.875,47.75,white,77.0,5,0,0,no,0.5,0.5,dnr after sadm,26.0,113.0,0.09999084,135.0,12.0,35.79688,265.25,1.7998047,7.5,1.29980469,131.0,7.299805,617.0,30.0,3580.0,2.902832,<2 mo. follow-up
66.26398,0,female,0,12,666,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,210275.0,30875.0625,35.0,asian,21.0,11,0,0,no,0.849999905,0.85,no dnr,12.0,57.0,22.1992188,100.0,31.0,38.5,182.0,3.5,2.79980469,8.09960938,141.0,7.389648,513.0,87.0,12.0,2.4750977,<2 mo. follow-up
67.92596,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,320408.0,67552.125,35.333313,white,78.0,35,0,0,yes,0.099999964,0.05,dnr after sadm,12.0,100.0,16.796875,110.0,10.0,39.0,333.3,3.5,1.0,0.59997559,135.0,7.419922,110.0,25.0,2305.0,2.7646484,<2 mo. follow-up
82.02594,1,male,0,26,311,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,122708.0,45664.9062,23.75,white,63.0,1,0,0,no,0.5,0.125,no dnr,26.0,63.0,9.09960938,108.0,8.0,37.89844,313.3125,3.5,1.01,0.89990234,138.0,7.479492,107.0,25.0,1800.0,3.4726562,Coma or Intub
55.13797,0,male,0,9,663,Lung Cancer,Cancer,3,14.0,under $11k,29367.0,11812.4141,14.5,white,14.0,1,0,0,metastatic,1.0,1.0,no dnr,9.0,48.0,0.5,140.0,34.0,39.79688,120.0,3.5,1.01,0.79992676,157.0,7.379883,135.0,24.0,3935.0,0.0,<2 mo. follow-up
38.771,0,male,0,4,661,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,27652.0,6754.5781,16.0,white,22.0,2,0,0,no,0.799999714,0.75,no dnr,4.0,55.0,18.0976562,175.0,31.0,36.0,260.0,3.5,1.01,1.79980469,137.0,7.469727,179.0,50.0,1337.0,2.1386719,no(M2 and SIP pres)
23.76999,1,female,0,6,37,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,54663.0,14430.6406,44.0,hispanic,55.0,2,0,0,no,0.899999619,0.9,no dnr,6.0,70.0,10.5996094,96.0,20.0,37.59375,309.5,4.0996094,0.29998779,0.79992676,135.0,7.429688,126.0,11.0,2890.0,0.0,<2 mo. follow-up
36.67398,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,288912.0,27184.0625,63.0,black,121.0,9,0,0,no,0.899999619,0.9,no dnr,4.0,103.0,5.0,120.0,34.0,39.0,333.3,2.699707,1.01,0.79992676,143.0,7.419922,135.0,14.0,2616.0,2.5756836,<2 mo. follow-up
89.82599,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,22772.0,8908.125,31.0,white,74.0,1,0,0,no,0.299999952,0.2,dnr after sadm,3.0,77.0,16.3984375,118.0,28.0,36.19531,233.3125,3.5,0.69995117,1.09985352,133.0,7.469727,269.0,15.0,1075.0,3.5668945,<2 mo. follow-up
71.06396,0,male,0,15,656,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,88606.0,28624.5312,26.666656,white,35.0,7,0,0,no,0.75,0.6,no dnr,15.0,40.0,13.2988281,115.0,36.0,38.79688,125.0,3.5,1.01,1.59985352,143.0,7.519531,135.0,29.0,1920.0,1.0,<2 mo. follow-up
84.46796,1,female,1,3,3,Coma,Coma,2,10.0,under $11k,9740.0,4209.6055,17.0,black,78.0,1,0,1,no,0.049999982,0.0,dnr after sadm,1.0,63.0,13.7988281,168.0,40.0,39.59375,178.3125,1.6999512,0.79992676,0.69995117,149.0,7.439453,147.0,32.0,2710.0,5.7636719,<2 mo. follow-up
93.46997,0,female,0,6,654,CHF,COPD/CHF/Cirrhosis,3,12.0,>$50k,13705.0,7081.7773,17.0,white,38.0,1,0,0,yes,0.699999809,0.6,dnr after sadm,2.0,59.0,13.0996094,68.0,24.0,38.19531,90.76562,3.5,1.01,1.59985352,142.0,7.469727,124.0,47.0,1750.0,0.0,SIP>=30
57.48898,1,male,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,49892.0,19744.2812,51.0,white,93.0,1,0,0,yes,0.0,0.0,dnr after sadm,3.0,35.0,33.09375,155.0,30.0,38.59375,65.0,3.5,17.5,4.19921875,135.0,7.109375,151.0,48.0,34.0,3.3417969,<2 mo. follow-up
73.99896,1,female,0,5,415,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,15322.0,6225.7891,17.0,white,23.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,50.0,30.6992188,55.0,36.0,35.5,333.3,3.5,1.29980469,2.29980469,122.0,7.419922,105.0,40.0,209.0,3.0947266,no(M2 and SIP pres)
57.43997,1,female,0,12,91,Colon Cancer,Cancer,1,12.0,$25-$50k,50645.0,22831.8906,25.5,white,32.0,1,0,0,metastatic,0.399999857,0.2,no dnr,12.0,78.0,11.0996094,70.0,20.0,37.89844,223.3125,2.2998047,1.01,1.59985352,137.0,7.419922,102.0,41.0,2540.0,0.0,adl>=4 (>=5 if sur)
70.45599,1,female,1,4,4,Coma,Coma,1,11.0,>$50k,52477.0,15849.2422,34.0,black,45.0,5,0,0,no,0.199999928,0.15,dnr after sadm,4.0,110.0,15.0996094,155.0,44.0,36.59375,680.0,2.5996094,0.89990234,1.59985352,131.0,7.459961,114.0,47.0,15.0,0.0,<2 mo. follow-up
63.88199,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,178201.0,23809.0938,47.0,white,52.0,15,0,0,no,0.5,0.5,no dnr,8.0,70.0,7.39941406,45.0,28.0,36.09375,333.3,3.5,1.01,1.5,139.0,7.419922,90.0,28.0,1175.0,3.230957,<2 mo. follow-up
46.00699,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,3,14.0,$25-$50k,135769.0,16093.7578,49.0,white,68.0,19,0,0,yes,0.049999982,0.05,dnr after sadm,2.0,45.0,22.6992188,125.0,28.0,35.19531,168.0,3.5,4.5,3.69970703,143.0,7.259766,180.0,55.0,10.0,3.2695312,<2 mo. follow-up
63.07999,0,female,0,4,649,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,11751.0,5963.4883,19.0,white,18.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,73.0,11.0996094,102.0,26.0,36.19531,333.3,3.5,1.01,0.89990234,131.0,7.419922,346.0,12.0,3150.0,2.2646484,<2 mo. follow-up
64.34796,0,male,0,6,649,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,under $11k,7934.0,3826.3965,4.0,hispanic,34.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,63.0,3.69970703,136.0,32.0,36.19531,333.3,2.5,1.01,0.79992676,133.0,7.419922,135.0,15.0,1250.0,1.8388672,<2 mo. follow-up
52.02698,1,male,0,19,201,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,>$50k,287368.0,42209.5,34.0,white,84.0,17,0,0,no,0.5,0.5,no dnr,19.0,112.0,14.3984375,140.0,34.0,39.19531,182.5,3.5,1.01,1.29980469,135.0,7.529297,279.0,36.0,1770.0,0.0,no(M2 and SIP pres)
59.75598,0,male,0,6,647,Cirrhosis,COPD/CHF/Cirrhosis,4,14.0,>$50k,29213.0,14474.2109,8.0,white,20.0,1,0,0,no,0.599999905,0.4,no dnr,6.0,113.0,12.5996094,135.0,49.0,39.5,130.0,3.5,1.01,1.39990234,143.0,7.479492,148.0,24.0,1710.0,2.7348633,no(M2 and SIP pres)
72.80194,0,male,0,20,643,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,226908.0,45777.5625,35.333313,white,43.0,8,1,0,no,0.75,0.75,no dnr,20.0,57.0,6.09960938,155.0,25.0,37.39844,118.65625,3.5,1.79980469,0.89990234,131.0,7.419922,135.0,21.0,695.0,2.4453125,<2 mo. follow-up
73.68695,1,male,0,7,11,Lung Cancer,Cancer,2,12.0,under $11k,14124.0,7226.3828,9.0,white,24.0,1,0,0,metastatic,0.009999998,0.0,dnr after sadm,2.0,63.0,9.0,65.0,20.0,36.29688,333.3,3.5,1.01,1.0,133.0,7.419922,462.0,18.0,3600.0,3.9892578,<2 mo. follow-up
70.508,1,female,0,7,45,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,42089.0,9950.7969,13.5,white,20.0,4,0,0,yes,0.699999809,0.5,dnr before sadm,-1.0,75.0,9.8984375,74.0,20.0,36.39844,333.3,3.5,8.5,1.01,134.0,7.419922,135.0,23.0,1430.0,1.9824219,<2 mo. follow-up
55.50198,0,male,0,44,639,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,338671.0,150056.5,40.75,white,46.0,1,0,0,no,0.0,0.0,no dnr,44.0,58.0,22.296875,115.0,44.0,38.09375,330.0,3.5,25.5976562,3.0,142.0,7.5,211.0,136.0,4520.0,0.0,no(M2 and SIP pres)
63.94299,0,female,0,34,637,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,252684.0,66653.875,34.5,hispanic,45.0,4,0,0,no,0.899999619,0.8,no dnr,34.0,67.0,9.79882812,96.0,22.0,38.19531,333.3,3.5,3.39990234,0.69995117,133.0,7.419922,181.0,8.0,2625.0,1.1667481,<2 mo. follow-up
47.47998,0,female,0,30,636,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,339838.0,66693.75,27.5,white,39.0,16,0,0,no,0.899999619,0.9,no dnr,30.0,62.0,12.5,135.0,37.0,38.59375,347.5,3.5,1.01,1.5,152.0,7.589844,304.0,33.0,2712.0,0.494751,<2 mo. follow-up
50.51099,0,female,0,25,636,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,131648.0,43402.2188,23.5,white,24.0,4,0,0,no,0.949999809,0.8,no dnr,25.0,70.0,14.7988281,82.0,22.0,36.39844,333.3,3.0996094,4.29980469,0.79992676,136.0,7.419922,113.0,15.0,800.0,0.494751,<2 mo. follow-up
66.771,1,female,0,9,487,Colon Cancer,Cancer,1,12.0,under $11k,18716.0,8287.7969,10.5,white,16.0,1,0,0,metastatic,1.0,0.8,no dnr,9.0,82.0,9.69921875,96.0,24.0,38.0,333.3,3.5,1.01,2.69970703,138.0,7.419922,135.0,37.0,4250.0,0.494751,<2 mo. follow-up
51.85199,1,male,0,15,57,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,54700.0,25739.7344,11.333328,white,17.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,14.0,52.0,17.8984375,105.0,26.0,38.69531,145.6875,2.5996094,0.89990234,1.29980469,136.0,7.519531,164.0,23.0,3800.0,0.0,<2 mo. follow-up
58.63397,1,female,0,17,572,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,145518.0,34237.9688,25.666656,hispanic,53.0,13,0,0,yes,0.75,0.75,no dnr,17.0,65.0,10.3984375,125.0,24.0,36.59375,186.65625,2.5996094,7.19921875,1.09985352,143.0,7.479492,345.0,54.0,1690.0,0.0,<2 mo. follow-up
74.41797,0,female,0,8,634,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,>$50k,243036.0,22826.3125,48.0,white,50.0,14,0,0,yes,0.799999714,0.7,no dnr,8.0,122.0,1.59985352,65.0,24.0,38.09375,248.96875,3.5,10.1992188,0.79992676,137.0,7.449219,152.0,32.0,5290.0,2.7583008,<2 mo. follow-up
60.01398,0,male,0,15,634,Colon Cancer,Cancer,1,16.0,>$50k,54862.0,23652.125,12.0,white,20.0,1,0,0,metastatic,0.899999619,0.7,no dnr,15.0,99.0,40.796875,120.0,24.0,37.89844,254.65625,3.5,4.09960938,0.79992676,139.0,7.529297,107.0,8.0,3320.0,2.5766602,no(M2 and SIP pres)
34.53799,1,female,1,28,28,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,>$50k,318788.0,148268.875,28.75,hispanic,22.0,1,0,0,no,0.989999771,0.99,no dnr,28.0,72.0,14.0996094,78.0,22.0,38.0,333.3,3.5,1.01,0.79992676,138.0,7.419922,135.0,4.0,1150.0,6.0,<2 mo. follow-up
79.25494,1,male,0,33,411,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,194939.0,77189.125,26.5,white,17.0,3,0,1,no,0.899999619,0.9,dnr after sadm,8.0,100.0,15.8984375,106.0,14.0,36.39844,90.0,3.5,0.5,1.0,135.0,7.459961,177.0,15.0,1200.0,4.1640625,<2 mo. follow-up
59.409,0,male,0,36,628,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,618719.0,256636.625,49.5,white,58.0,2,0,0,no,0.699999809,0.5,no dnr,36.0,62.0,31.6992188,115.0,10.0,35.79688,168.0,3.5,2.69970703,2.59960938,138.0,7.419922,96.0,29.0,3240.0,2.7148438,<2 mo. follow-up
46.31598,1,female,0,11,404,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,123254.0,43014.375,48.5,black,46.0,2,0,0,no,0.949999809,0.95,no dnr,11.0,67.0,28.3984375,115.0,40.0,38.29688,360.0,3.5,1.01,1.89990234,137.0,7.439453,207.0,84.0,2360.0,2.4165039,<2 mo. follow-up
73.10895,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,258088.0,88220.75,47.666657,asian,63.0,4,1,0,no,0.399999857,0.25,no dnr,23.0,78.0,11.0,116.0,24.0,38.39844,333.3,3.199707,1.69995117,1.09985352,138.0,7.419922,142.0,8.0,850.0,3.5952148,<2 mo. follow-up
72.28699,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,235312.0,20672.3125,51.0,white,83.0,14,0,0,no,0.699999809,0.5,dnr after sadm,3.0,69.0,4.89941406,72.0,14.0,37.79688,333.3,2.8999023,3.39990234,0.59997559,135.0,7.419922,93.0,6.0,1950.0,0.0,<2 mo. follow-up
51.72897,0,female,0,6,626,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,11742.0,6274.8945,18.0,white,20.0,1,0,0,no,0.899999619,0.85,no dnr,6.0,107.0,11.0996094,55.0,10.0,36.39844,365.0,2.2998047,1.09985352,0.79992676,132.0,7.459961,148.0,14.0,2655.0,0.494751,no(M2 and SIP pres)
52.89499,0,female,0,15,625,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,>$50k,110588.0,39434.4688,38.0,white,58.0,1,0,0,no,0.099999964,0.1,no dnr,15.0,55.0,11.0996094,105.0,10.0,38.5,250.0,3.0,4.5,3.59960938,148.0,7.539062,212.0,57.0,3988.0,0.0,no(M2 and SIP pres)
44.31799,1,male,0,27,132,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,$11-$25k,500747.0,45473.6562,28.75,white,48.0,23,0,0,no,0.899999619,0.8,no dnr,27.0,72.0,27.0,145.0,40.0,38.79688,202.0,3.5,1.19995117,0.59997559,136.0,7.389648,135.0,10.0,4580.0,2.0,adl>=4 (>=5 if sur)
75.87695,1,male,0,35,406,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,247610.0,92767.625,34.25,white,55.0,1,0,0,no,0.599999905,0.5,dnr after sadm,12.0,35.0,17.296875,185.0,10.0,37.69531,245.0,3.5,1.01,3.89990234,133.0,7.369141,186.0,46.0,3790.0,2.9624023,<2 mo. follow-up
69.46198,0,male,0,16,622,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,$25-$50k,156624.0,50043.9688,35.666657,white,63.0,3,0,0,no,0.5,0.5,no dnr,16.0,156.0,112.1875,135.0,35.0,38.29688,100.0,3.5,1.01,3.5,139.0,7.279297,135.0,73.0,0.0,2.7578125,no(M2 and SIP pres)
42.44998,1,female,0,3,38,Lung Cancer,Cancer,1,17.0,>$50k,10409.0,4667.8398,12.0,white,22.0,1,0,0,metastatic,0.599999905,0.2,no dnr,3.0,70.0,7.0,100.0,26.0,35.89844,333.3,4.0,0.89990234,1.19995117,136.0,7.419922,104.0,13.0,2400.0,2.4477539,<2 mo. follow-up
66.98999,1,female,0,85,385,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,501448.0,14452.7344,44.5,white,33.0,1,1,0,no,0.599999905,0.5,no dnr,85.0,67.0,35.6953125,130.0,28.0,38.59375,345.6875,3.199707,2.39990234,4.5,134.0,7.519531,135.0,166.0,5435.0,2.8271484,<2 mo. follow-up
63.36798,0,male,0,33,618,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,294992.0,85296.0,40.5,white,48.0,5,0,0,no,0.799999714,0.8,no dnr,33.0,115.0,11.1992188,55.0,26.0,36.39844,333.3,2.3999023,10.2988281,1.0,138.0,7.419922,140.0,49.0,2960.0,0.0,no(M2 and SIP pres)
61.741,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,337918.0,41536.5,49.0,white,43.0,11,1,0,no,0.75,0.75,no dnr,10.0,63.0,11.7988281,155.0,25.0,38.0,173.0,3.5,1.01,1.29980469,134.0,7.289062,188.0,24.0,3185.0,3.7597656,<2 mo. follow-up
68.23297,1,male,0,16,196,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,110698.0,44902.375,31.666656,white,51.0,1,0,0,yes,0.5,0.125,no dnr,16.0,67.0,5.59960938,125.0,23.0,38.0,107.04688,3.8999023,4.19921875,3.29980469,139.0,7.399414,231.0,42.0,990.0,2.0,adl>=4 (>=5 if sur)
70.04199,0,male,0,8,615,Colon Cancer,Cancer,1,12.0,$11-$25k,22080.0,9438.75,11.0,white,9.0,1,0,0,metastatic,0.899999619,0.8,no dnr,8.0,115.0,11.6992188,112.0,24.0,36.79688,333.3,3.5,1.01,0.69995117,138.0,7.419922,135.0,7.0,570.0,0.0,no(M2 and SIP pres)
71.36798,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,86494.0,31125.2344,31.5,white,57.0,1,0,0,no,0.199999928,0.9,dnr after sadm,9.0,70.0,7.0,110.0,14.0,36.5,373.3125,3.5,1.69995117,2.09960938,137.0,7.329102,69.0,110.0,2210.0,2.8989258,<2 mo. follow-up
43.25497,0,male,0,11,614,ARF/MOSF w/Sepsis,ARF/MOSF,3,15.0,$25-$50k,186516.0,22284.4531,21.0,white,42.0,9,0,0,no,0.799999714,0.8,no dnr,11.0,62.0,14.6992188,125.0,26.0,38.59375,173.3125,3.5,2.29980469,1.89990234,145.0,7.429688,241.0,38.0,1926.0,1.1667481,no(M2 and SIP pres)
73.90594,1,male,0,4,33,Colon Cancer,Cancer,2,12.0,under $11k,12433.0,5055.2578,21.0,white,15.0,1,0,0,metastatic,0.299999952,0.5,dnr after sadm,3.0,62.0,15.3984375,75.0,6.0,35.39844,87.0,2.3999023,28.0976562,1.39990234,130.0,7.439453,145.0,22.0,3695.0,2.9345703,<2 mo. follow-up
59.19498,1,male,0,8,85,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,31431.0,13725.5938,27.5,white,38.0,1,1,0,no,0.599999905,0.3,no dnr,8.0,140.0,15.0996094,110.0,50.0,38.0,193.3125,3.5,1.01,1.19995117,142.0,7.549805,160.0,22.0,3355.0,4.0,adl>=4 (>=5 if sur)
70.81195,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,213777.0,75374.125,38.5,white,26.0,1,0,0,yes,0.799999714,0.65,dnr after sadm,7.0,115.0,10.5,106.0,24.0,38.5,333.3,3.8999023,1.0,1.0,134.0,7.419922,82.0,9.0,2950.0,2.0,<2 mo. follow-up
73.98499,0,female,0,9,612,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,140801.0,19539.7812,26.0,black,13.0,8,0,0,no,0.699999809,0.5,no dnr,9.0,57.0,34.1953125,110.0,24.0,35.69531,165.28125,3.0996094,3.0,3.29980469,133.0,7.469727,70.0,54.0,4600.0,0.0,adl>=4 (>=5 if sur)
70.41797,0,female,0,8,612,Colon Cancer,Cancer,1,14.0,under $11k,22418.0,10673.7266,8.0,hispanic,17.0,1,0,0,metastatic,1.0,0.95,no dnr,8.0,71.0,15.0,80.0,24.0,35.79688,120.0,3.5,4.09960938,1.69995117,135.0,7.379883,131.0,67.0,1304.0,1.1667481,no(M2 and SIP pres)
79.93195,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,4,18.0,under $11k,207417.0,67940.125,36.666657,white,20.0,4,1,0,no,0.599999905,0.5,dnr after sadm,21.0,84.0,8.3984375,58.0,24.0,35.79688,333.3,2.199707,0.89990234,0.59997559,133.0,7.419922,135.0,10.0,2502.0,6.0,<2 mo. follow-up
66.62299,0,female,0,7,602,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,>$50k,53890.0,10291.6172,6.5,white,10.0,4,0,0,no,0.899999619,0.9,no dnr,7.0,52.0,10.5996094,100.0,22.0,36.5,333.3,2.8999023,1.09985352,1.79980469,127.0,7.419922,118.0,67.0,2310.0,0.0,<2 mo. follow-up
58.69998,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,208373.0,61822.5625,45.666657,white,74.0,6,0,0,no,0.849999905,0.85,dnr after sadm,13.0,68.0,23.0976562,125.0,12.0,37.79688,395.0,3.5,1.01,0.69995117,136.0,7.40918,215.0,10.0,1950.0,1.0,<2 mo. follow-up
29.26999,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,272792.0,110223.438,45.0,hispanic,62.0,7,0,0,no,0.599999905,0.6,dnr after sadm,9.0,105.0,14.5996094,65.0,24.0,38.5,333.3,3.5,1.01,0.79992676,132.0,7.419922,89.0,17.0,2230.0,3.0727539,<2 mo. follow-up
36.26797,0,female,0,22,599,ARF/MOSF w/Sepsis,ARF/MOSF,0,21.0,>$50k,262040.0,85402.5625,39.0,white,26.0,8,0,0,no,0.949999809,0.95,no dnr,22.0,67.0,13.5,100.0,24.0,38.19531,333.3,3.5996094,0.5,0.89990234,136.0,7.419922,135.0,9.0,1600.0,0.0,no(M2 and SIP pres)
97.23999,1,male,0,10,46,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,19291.0,10616.0938,9.0,white,11.0,1,0,1,no,0.799999714,0.06,no dnr,10.0,73.0,10.2988281,83.0,20.0,37.09375,252.375,3.699707,0.5,1.69995117,136.0,7.369141,138.0,19.0,2502.0,6.0,<2 mo. follow-up
44.37198,0,male,0,22,598,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,174634.0,49494.4375,26.666656,white,28.0,17,0,0,yes,0.599999905,0.5,no dnr,22.0,65.0,13.6992188,80.0,27.0,37.69531,300.0,3.5,1.01,0.79992676,135.0,7.419922,135.0,19.0,4165.0,0.0,no(M2 and SIP pres)
62.06198,0,male,0,13,598,Coma,Coma,0,16.0,>$50k,105947.0,42417.3438,43.0,white,61.0,1,0,0,no,0.75,0.7,no dnr,13.0,117.0,8.19921875,108.0,22.0,36.59375,333.3,3.5,1.01,0.69995117,139.0,7.419922,135.0,5.0,2000.0,1.8569336,no(M2 and SIP pres)
57.97699,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,70163.0,13175.4844,28.0,white,81.0,11,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,113.0,25.3984375,155.0,60.0,39.69531,91.42188,1.7998047,0.69995117,0.79992676,135.0,7.349609,262.0,14.0,5101.0,3.3110352,<2 mo. follow-up
75.96698,0,male,0,7,593,COPD,COPD/CHF/Cirrhosis,3,0.0,$11-$25k,21141.0,8768.1953,16.5,white,17.0,1,0,0,yes,0.849999905,0.8,no dnr,7.0,105.0,6.19921875,115.0,10.0,38.0,228.0,3.0,8.79882812,1.59985352,155.0,7.5,259.0,99.0,6920.0,1.8388672,<2 mo. follow-up
71.99695,1,female,0,21,360,Coma,Coma,0,12.0,under $11k,155313.0,52658.3125,29.666656,white,28.0,4,0,0,no,0.5,0.5,no dnr,21.0,105.0,15.5,135.0,26.0,39.0,340.0,3.5,1.01,0.79992676,125.0,7.529297,114.0,16.0,4950.0,2.0209961,<2 mo. follow-up
31.403,0,female,0,14,590,ARF/MOSF w/Sepsis,ARF/MOSF,0,21.0,>$50k,84726.0,31389.7344,25.666656,white,51.0,3,0,0,no,0.799999714,0.8,no dnr,14.0,99.0,11.8984375,76.0,24.0,36.39844,333.3,3.5,1.01,1.19995117,133.0,7.419922,131.0,19.0,1400.0,2.734375,<2 mo. follow-up
59.87097,1,male,0,6,381,Colon Cancer,Cancer,1,12.0,under $11k,20640.0,8659.2891,11.0,white,19.0,1,0,0,metastatic,0.899999619,0.5,no dnr,6.0,102.0,0.04999542,65.0,24.0,36.39844,452.0,3.5,1.5,0.69995117,130.0,7.489258,135.0,16.0,3400.0,2.0478516,no(M2 and SIP pres)
71.12897,1,female,0,8,116,COPD,COPD/CHF/Cirrhosis,1,13.0,$11-$25k,57493.0,14015.8281,16.0,white,34.0,5,0,0,no,0.75,0.75,no dnr,8.0,58.0,14.0996094,115.0,28.0,38.0,415.0,3.5,1.29980469,1.89990234,135.0,7.40918,301.0,30.0,1640.0,3.3452148,Coma or Intub
69.19397,0,male,0,8,586,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,23046.0,12267.5391,16.0,white,32.0,1,0,0,yes,0.899999619,0.75,dnr after sadm,3.0,133.0,19.8984375,155.0,33.0,37.89844,177.53125,2.3999023,18.1992188,2.19970703,144.0,7.449219,135.0,85.0,2665.0,4.0,<2 mo. follow-up
64.02197,0,male,0,12,586,Colon Cancer,Cancer,1,12.0,under $11k,50669.0,19166.1562,29.0,white,26.0,1,0,0,metastatic,1.0,0.65,no dnr,12.0,71.0,9.0,82.0,20.0,36.0,278.25,3.5,1.01,1.0,131.0,7.449219,135.0,18.0,4875.0,3.3325195,<2 mo. follow-up
71.49097,1,male,0,13,146,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,136072.0,23399.875,32.5,black,39.0,12,0,0,no,0.199999928,0.2,no dnr,13.0,75.0,22.5976562,75.0,11.0,38.59375,455.0,3.5,1.01,0.59997559,142.0,7.55957,150.0,15.0,840.0,3.0576172,<2 mo. follow-up
45.19598,1,male,0,27,169,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,481895.0,84690.4375,34.25,white,49.0,29,0,0,no,0.599999905,0.6,no dnr,27.0,62.0,2.19970703,115.0,56.0,36.19531,193.875,3.5,2.59960938,0.79992676,134.0,7.439453,171.0,12.0,8210.0,2.9648438,<2 mo. follow-up
28.627,0,male,0,8,583,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,30279.0,16035.2812,17.5,hispanic,29.0,1,0,0,no,0.5,0.5,no dnr,8.0,85.0,15.2988281,120.0,14.0,38.59375,333.3,3.5,1.01,0.89990234,137.0,7.419922,136.0,12.0,850.0,0.0,<2 mo. follow-up
54.14099,1,male,0,5,64,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,13221.0,6602.8633,16.0,white,37.0,1,0,0,no,0.799999714,0.8,no dnr,5.0,98.0,17.0976562,135.0,39.0,36.5,225.6875,3.5,1.01,1.0,130.0,7.389648,224.0,23.0,2487.0,3.0756836,<2 mo. follow-up
46.04199,1,female,0,6,449,Colon Cancer,Cancer,1,12.0,under $11k,15981.0,6897.0938,11.0,white,12.0,1,0,0,metastatic,0.699999809,0.6,no dnr,6.0,51.0,9.0,95.0,20.0,35.89844,333.3,3.5,1.01,1.69995117,128.0,7.419922,135.0,27.0,2750.0,1.9838867,<2 mo. follow-up
71.19495,0,female,0,12,580,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,141913.0,24841.4375,13.0,white,47.0,28,0,0,yes,0.5,0.3,dnr before sadm,-27.0,72.0,14.0996094,125.0,32.0,37.89844,183.65625,3.2998047,1.01,1.39990234,140.0,7.169922,196.0,13.0,2140.0,0.0,no(M2 and SIP pres)
60.25998,1,female,0,7,525,Lung Cancer,Cancer,1,12.0,under $11k,23886.0,11874.4375,6.5,white,20.0,1,0,0,metastatic,1.0,1.0,no dnr,7.0,50.0,7.19921875,75.0,8.0,36.39844,187.5,3.5,1.01,3.39990234,149.0,7.529297,138.0,93.0,2970.0,3.3417969,<2 mo. follow-up
68.68695,1,male,0,5,257,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,7975.0,4697.3516,12.0,white,19.0,1,0,0,no,0.599999905,0.6,no dnr,5.0,113.0,11.5,110.0,32.0,36.69531,176.0,2.2998047,2.09960938,1.5,132.0,7.449219,173.0,23.0,3785.0,0.494751,no(M2 and SIP pres)
58.741,1,male,0,9,172,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,33382.0,15641.9766,26.5,white,27.0,1,0,0,no,0.899999619,0.7,no dnr,9.0,47.0,8.19921875,105.0,20.0,35.79688,333.3,3.7998047,2.69970703,1.29980469,130.0,7.419922,112.0,17.0,3650.0,4.0,<2 mo. follow-up
71.89294,0,male,0,4,578,CHF,COPD/CHF/Cirrhosis,2,31.0,>$50k,4750.0,2242.2637,8.0,white,22.0,1,0,0,no,1.0,0.9,no dnr,4.0,83.0,8.0,80.0,16.0,37.0,333.3,2.8999023,8.8984375,1.29980469,132.0,7.419922,135.0,21.0,760.0,2.1518555,no(M2 and SIP pres)
62.34399,0,male,0,17,577,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,145561.0,81578.1875,24.666656,white,37.0,1,0,0,yes,0.75,0.7,no dnr,17.0,93.0,6.59960938,126.0,24.0,38.39844,333.3,3.5,0.79992676,0.89990234,140.0,7.419922,113.0,9.0,3975.0,0.0,no(M2 and SIP pres)
60.66299,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,233830.0,57363.3438,52.0,white,97.0,17,0,0,yes,0.099999964,0.1,dnr after sadm,5.0,100.0,0.89990234,110.0,24.0,36.19531,218.34375,3.5,1.01,0.89990234,130.0,7.529297,135.0,17.0,3800.0,2.8022461,<2 mo. follow-up
50.40097,0,male,0,7,576,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,81871.0,11551.2188,15.5,other,20.0,3,0,0,no,0.949999809,0.9,no dnr,7.0,77.0,12.0996094,114.0,24.0,36.0,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,1550.0,1.8530273,<2 mo. follow-up
51.52399,1,female,0,8,17,Lung Cancer,Cancer,1,14.0,under $11k,21235.0,9458.8828,18.5,white,28.0,1,0,0,metastatic,0.0,0.0,dnr before sadm,-1.0,72.0,9.0,75.0,16.0,36.5,333.3,3.5,1.01,1.5,142.0,7.419922,135.0,26.0,3855.0,3.5327148,<2 mo. follow-up
52.71698,1,male,1,8,8,Coma,Coma,1,20.0,>$50k,75660.0,27551.9062,33.0,black,46.0,2,1,0,no,0.5,0.5,dnr after sadm,8.0,50.0,6.19921875,75.0,20.0,36.79688,333.3,3.5,1.01,1.19995117,137.0,7.419922,135.0,35.0,3185.0,0.0,<2 mo. follow-up
64.64899,1,female,0,10,392,Lung Cancer,Cancer,1,12.0,$11-$25k,29507.0,15344.5391,12.0,white,15.0,1,0,0,metastatic,1.0,1.0,no dnr,10.0,73.0,8.09960938,70.0,20.0,36.0,333.3,3.5,1.01,1.59985352,141.0,7.419922,135.0,30.0,3300.0,2.8950195,no(M2 and SIP pres)
73.51996,1,female,0,8,291,Colon Cancer,Cancer,2,12.0,under $11k,13121.0,6902.6875,13.5,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,68.0,35.8984375,120.0,28.0,36.0,333.3,3.5,1.01,1.19995117,136.0,7.419922,135.0,21.0,2790.0,2.8608398,<2 mo. follow-up
63.685,1,female,1,20,20,Coma,Coma,3,11.0,$11-$25k,207959.0,77106.6875,30.666656,white,66.0,2,0,0,yes,0.299999952,0.2,dnr after sadm,18.0,52.0,0.04999542,105.0,10.0,35.69531,131.0,3.5,15.0996094,3.09960938,142.0,7.239258,326.0,32.0,0.0,3.0,<2 mo. follow-up
66.33295,1,male,0,118,181,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,933220.0,373073.0,47.25,white,53.0,3,0,0,no,0.5,0.5,no dnr,118.0,62.0,7.79980469,100.0,36.0,38.29688,315.0,3.5,1.01,0.79992676,136.0,7.449219,135.0,13.0,2430.0,0.0,adl>=4 (>=5 if sur)
38.76498,1,male,0,10,202,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,143626.0,54987.5312,50.0,white,36.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,61.0,5.5,116.0,12.0,36.19531,333.3,3.5,1.01,0.69995117,143.0,7.419922,135.0,9.0,1550.0,0.0,<2 mo. follow-up
65.55798,1,male,0,6,540,Cirrhosis,COPD/CHF/Cirrhosis,3,21.0,$11-$25k,9123.0,4302.4062,10.0,white,34.0,1,1,0,no,1.0,0.9,no dnr,6.0,122.0,110.0,55.0,14.0,38.69531,165.0,3.5,1.01,2.0,143.0,7.469727,281.0,25.0,2380.0,0.494751,no(M2 and SIP pres)
46.56,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,149633.0,33083.8438,46.5,white,85.0,8,0,0,no,0.199999928,0.1,dnr after sadm,6.0,72.0,6.19921875,76.0,20.0,37.79688,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,1850.0,2.0,<2 mo. follow-up
67.89294,1,female,0,20,279,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,269491.0,54600.3438,42.666657,white,37.0,5,0,0,no,0.799999714,0.7,no dnr,20.0,76.0,9.3984375,72.0,20.0,36.0,333.3,3.5,0.39996338,1.09985352,141.0,7.419922,135.0,18.0,1400.0,0.0,no(M2 and SIP pres)
58.24197,1,male,0,6,88,Colon Cancer,Cancer,2,12.0,$11-$25k,11848.0,5331.1211,9.0,white,29.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,92.0,3.39990234,105.0,26.0,36.0,333.3,1.5,17.0,2.09960938,126.0,7.419922,84.0,66.0,875.0,2.4750977,adl>=4 (>=5 if sur)
68.65997,0,male,0,4,567,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,71707.0,10469.6094,40.0,white,25.0,3,0,0,no,0.899999619,0.9,no dnr,4.0,60.0,25.1992188,105.0,28.0,38.0,332.5,3.5,1.01,3.19970703,142.0,7.489258,212.0,49.0,585.0,0.0,<2 mo. follow-up
53.49197,1,female,0,13,15,ARF/MOSF w/Sepsis,ARF/MOSF,3,4.0,under $11k,199060.0,58617.875,42.5,hispanic,71.0,1,0,0,no,0.099999964,0.05,no dnr,13.0,65.0,9.3984375,95.0,6.0,36.29688,455.0,3.5,6.89941406,1.89990234,149.0,7.539062,73.0,53.0,2945.0,5.0,<2 mo. follow-up
70.71295,0,female,0,10,563,Colon Cancer,Cancer,1,12.0,under $11k,35262.0,15618.2266,17.0,white,15.0,1,0,0,metastatic,1.0,0.95,no dnr,10.0,77.0,4.79980469,78.0,20.0,35.69531,333.3,3.8999023,3.0,1.5,138.0,7.419922,111.0,31.0,1825.0,2.4257812,<2 mo. follow-up
68.73895,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,58336.0,22046.9688,39.0,white,101.0,2,1,0,no,0.049999982,0.05,dnr after sadm,4.0,52.0,6.59960938,115.0,40.0,38.59375,270.0,3.5,46.0,3.69970703,143.0,7.449219,340.0,95.0,424.0,2.9160156,<2 mo. follow-up
60.87097,1,male,0,5,187,Colon Cancer,Cancer,3,12.0,under $11k,11670.0,4700.5703,18.0,white,17.0,1,1,0,metastatic,0.899999619,0.2,no dnr,5.0,65.0,6.59960938,75.0,8.0,38.0,333.3,3.2998047,3.0,3.5,135.0,7.419922,106.0,101.0,3360.0,3.1943359,<2 mo. follow-up
77.14398,0,male,0,24,560,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,328863.0,67441.9375,27.333328,white,80.0,1,1,0,yes,0.5,0.5,no dnr,24.0,74.0,9.09960938,110.0,18.0,36.0,333.3,2.0,0.29998779,0.69995117,120.0,7.419922,84.0,8.0,900.0,0.0,adl>=4 (>=5 if sur)
61.92999,0,male,0,6,559,Cirrhosis,COPD/CHF/Cirrhosis,5,8.0,under $11k,7500.0,3849.8496,11.0,hispanic,23.0,1,1,0,no,0.5,0.0,no dnr,6.0,72.0,8.09960938,55.0,20.0,36.19531,91.65625,3.5,0.59997559,1.39990234,138.0,7.419922,135.0,26.0,1636.0,0.494751,no(M2 and SIP pres)
43.05798,0,female,0,15,555,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,94436.0,28478.7031,15.666664,white,19.0,7,0,0,no,0.5,0.1,no dnr,15.0,70.0,26.0976562,110.0,28.0,35.5,302.5,3.5,22.5976562,2.19970703,133.0,7.349609,223.0,77.0,1885.0,2.9926758,no(M2 and SIP pres)
54.47998,1,male,0,6,104,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,19860.0,8709.0,14.0,white,16.0,1,1,0,metastatic,0.049999982,0.01,no dnr,6.0,65.0,8.59960938,75.0,24.0,38.09375,333.3,3.5,0.5,1.19995117,138.0,7.419922,95.0,18.0,4085.0,0.494751,<2 mo. follow-up
80.323,1,female,0,12,49,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,51079.0,21268.8438,32.5,white,70.0,1,1,1,no,0.699999809,0.5,dnr after sadm,3.0,99.0,7.0,79.0,28.0,36.39844,252.375,3.5,1.01,0.79992676,137.0,7.449219,95.0,15.0,1925.0,6.4658203,<2 mo. follow-up
32.28198,1,male,1,13,13,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,226262.0,59380.7188,41.5,hispanic,49.0,13,0,0,yes,0.5,0.3,dnr after sadm,11.0,52.0,28.3984375,70.0,34.0,35.79688,184.0,2.2998047,27.6992188,4.5,145.0,7.449219,207.0,66.0,35.0,0.0,<2 mo. follow-up
44.73099,1,male,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,under $11k,800959.0,216988.875,48.25,white,43.0,50,0,0,no,0.5,0.5,dnr after sadm,33.0,109.0,6.19921875,85.0,28.0,36.59375,313.3125,3.5,1.01,1.0,134.0,7.459961,154.0,16.0,3350.0,0.0,<2 mo. follow-up
49.44598,1,male,0,5,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,53642.0,24402.3594,53.0,hispanic,93.0,1,0,0,yes,0.699999809,0.5,dnr before sadm,0.0,60.0,29.0,120.0,24.0,36.0,120.0,3.5,3.09960938,8.5,142.0,7.429688,146.0,89.0,55.0,4.1162109,<2 mo. follow-up
68.07098,0,male,0,12,547,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,$11-$25k,96931.0,27934.3906,27.0,white,39.0,3,0,0,yes,0.899999619,0.9,no dnr,12.0,71.0,4.69921875,78.0,20.0,36.79688,333.3,3.5,1.59985352,1.19995117,127.0,7.419922,282.0,30.0,2100.0,2.5209961,<2 mo. follow-up
61.71899,0,male,0,28,543,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,205874.0,110087.375,27.5,white,36.0,1,1,0,no,0.919999599,0.85,no dnr,28.0,75.0,20.8984375,104.0,30.0,38.59375,173.3125,3.5,1.09985352,1.01,138.0,7.479492,135.0,23.0,2050.0,1.1667481,<2 mo. follow-up
63.15097,1,male,1,41,41,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,276936.0,104526.0,28.75,white,28.0,3,0,0,no,0.5,0.25,dnr after sadm,40.0,98.0,11.6992188,50.0,20.0,35.5,333.3,3.5,0.89990234,1.29980469,149.0,7.419922,429.0,37.0,2085.0,1.0,<2 mo. follow-up
58.68597,1,female,0,6,389,Lung Cancer,Cancer,1,12.0,$11-$25k,18292.0,8339.8516,20.0,black,10.0,1,0,0,metastatic,1.0,1.0,no dnr,6.0,57.0,44.0,125.0,35.0,36.0,233.3125,3.5,1.01,1.0,136.0,7.449219,415.0,34.0,1870.0,0.0,no(M2 and SIP pres)
65.19598,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,3,18.0,>$50k,59995.78781114967,67778.25,34.666657,white,80.0,8,0,0,no,0.5,0.33,dnr after sadm,11.0,122.0,30.3984375,125.0,12.0,36.59375,300.0,3.5,1.01,4.0,145.0,7.419922,95.0,119.0,694.0,1.0,<2 mo. follow-up
62.81998,1,male,0,19,300,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,62304.0,31476.3438,18.666656,white,23.0,1,1,0,no,0.799999714,0.6,no dnr,19.0,67.0,25.3984375,75.0,10.0,36.09375,375.0,4.0,7.79980469,2.29980469,133.0,7.349609,89.0,46.0,2785.0,0.0,<2 mo. follow-up
90.35699,0,male,0,6,542,CHF,COPD/CHF/Cirrhosis,3,5.0,$11-$25k,9994.0,6418.4141,13.0,white,30.0,1,0,0,no,0.899999619,0.75,no dnr,6.0,66.0,10.5,38.0,24.0,35.29688,333.3,3.7998047,1.79980469,2.0,139.0,7.419922,105.0,29.0,2225.0,0.494751,<2 mo. follow-up
58.98199,0,male,0,8,541,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,267221.0,23775.1719,28.5,asian,26.0,31,0,0,no,0.899999619,0.8,no dnr,8.0,57.0,7.79980469,105.0,12.0,36.59375,163.5,2.3999023,36.3984375,5.19921875,135.0,7.109375,98.0,48.0,240.0,1.0,no(M2 and SIP pres)
79.896,1,male,1,10,10,Coma,Coma,3,12.0,under $11k,73135.0,28528.1875,29.5,white,63.0,1,0,1,no,0.099999964,0.05,dnr after sadm,1.0,127.0,18.6992188,120.0,38.0,38.59375,208.15625,3.5,1.01,1.69995117,130.0,7.489258,135.0,19.0,3186.0,5.7919922,<2 mo. follow-up
77.74396,1,female,1,12,12,CHF,COPD/CHF/Cirrhosis,3,18.0,under $11k,34096.0,16873.2656,16.0,white,20.0,1,1,0,no,0.949999809,0.8,no dnr,12.0,57.0,5.89941406,135.0,22.0,36.89844,333.3,3.5996094,0.79992676,1.19995117,134.0,7.419922,135.0,25.0,3120.0,5.0,<2 mo. follow-up
72.05194,1,male,0,9,340,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,27158.0,13123.1953,26.5,hispanic,26.0,1,1,0,no,0.5,0.5,no dnr,9.0,57.0,7.09960938,65.0,28.0,36.5,333.3,3.5,0.29998779,1.19995117,132.0,7.419922,135.0,13.0,2810.0,3.253418,no(M2 and SIP pres)
61.49799,1,female,0,4,196,Lung Cancer,Cancer,2,12.0,under $11k,6507.0,2927.2148,6.0,white,15.0,1,1,0,metastatic,0.399999857,0.05,no dnr,4.0,97.0,9.0,110.0,22.0,37.89844,333.3,3.5,1.01,1.01,140.0,7.419922,136.0,23.0,3100.0,0.0,<2 mo. follow-up
53.26797,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,309174.0,109134.188,38.0,white,39.0,7,0,0,no,0.699999809,0.5,no dnr,21.0,55.0,27.5976562,95.0,10.0,38.69531,267.5,3.5,13.0,3.69970703,132.0,7.55957,135.0,61.0,0.0,0.494751,<2 mo. follow-up
67.16998,1,male,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,326479.0,129416.938,44.25,white,65.0,2,0,0,no,0.5,0.5,dnr after sadm,22.0,73.0,14.1992188,55.0,24.0,36.5,333.3,2.5996094,0.69995117,1.59985352,135.0,7.419922,165.0,37.0,4220.0,2.9189453,<2 mo. follow-up
86.41998,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,88769.0,34941.5625,21.666656,white,63.0,1,0,0,no,0.5,0.5,dnr after sadm,2.0,65.0,11.8984375,124.0,52.0,39.39844,333.3,3.5,1.01,0.79992676,136.0,7.419922,116.0,22.0,1425.0,4.0419922,<2 mo. follow-up
48.76898,0,male,0,27,534,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,318152.0,72123.125,31.25,white,43.0,4,0,0,no,0.899999619,0.8,no dnr,27.0,70.0,9.0,55.0,20.0,36.0,333.3,3.5,1.01,2.0,139.0,7.419922,117.0,40.0,1745.0,0.0,no(M2 and SIP pres)
41.12799,1,female,0,27,103,Coma,Coma,2,14.0,$25-$50k,141917.0,56199.0625,27.75,white,45.0,1,0,0,no,0.699999809,0.5,dnr after sadm,22.0,107.0,1.89990234,60.0,26.0,38.0,336.625,2.699707,0.69995117,1.59985352,133.0,7.459961,98.0,16.0,2313.0,7.0,<2 mo. follow-up
52.31998,0,male,0,4,531,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,14200.0,8216.9844,17.0,white,18.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,63.0,7.0,75.0,40.0,38.0,67.76562,1.8999023,0.59997559,1.09985352,132.0,7.519531,113.0,26.0,1496.0,2.1513672,no(M2 and SIP pres)
71.75397,0,male,0,38,531,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,198019.0,80928.8125,28.75,white,35.0,6,1,0,no,0.849999905,0.85,no dnr,38.0,71.0,8.09960938,66.0,22.0,35.59375,333.3,3.5,0.79992676,1.0,140.0,7.419922,413.0,18.0,2975.0,5.0,<2 mo. follow-up
64.41595,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,$11-$25k,81959.0,30076.3281,31.0,hispanic,24.0,3,0,0,no,0.699999809,0.5,dnr after sadm,10.0,65.0,10.7988281,70.0,32.0,36.39844,376.1875,3.5,1.01,1.19995117,140.0,7.399414,156.0,24.0,1925.0,7.0,<2 mo. follow-up
56.66299,0,female,0,17,529,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,184814.0,42421.6875,22.0,white,19.0,8,0,0,no,0.699999809,0.5,no dnr,17.0,66.0,12.3984375,64.0,22.0,36.39844,333.3,3.7998047,1.01,0.79992676,136.0,7.419922,260.0,14.0,2350.0,2.5776367,<2 mo. follow-up
20.73099,0,male,0,21,528,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,59732.75,28.333328,hispanic,37.0,12,0,0,no,0.5,0.5,no dnr,21.0,48.0,15.7988281,100.0,24.0,38.0,273.3125,3.5,1.01,1.5,130.0,7.539062,135.0,24.0,1745.0,2.8066406,no(M2 and SIP pres)
77.31097,0,male,0,56,528,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,318057.0,94745.25,26.25,black,32.0,19,0,0,yes,0.849999905,0.8,no dnr,56.0,50.0,9.5,135.0,13.0,39.39844,196.0,1.5998535,1.79980469,0.89990234,135.0,7.369141,236.0,21.0,1800.0,0.0,no(M2 and SIP pres)
56.03299,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,3,18.0,$11-$25k,52414.0,21598.75,34.0,white,77.0,2,0,0,no,0.699999809,0.5,dnr after sadm,3.0,78.0,12.0,115.0,36.0,36.79688,71.65625,3.5,1.01,3.89990234,128.0,7.489258,145.0,73.0,2350.0,0.0,<2 mo. follow-up
76.42999,1,male,0,11,62,Lung Cancer,Cancer,1,12.0,>$50k,29862.0,14500.4219,15.5,white,13.0,1,0,0,metastatic,0.949999809,0.5,no dnr,11.0,70.0,14.6992188,75.0,10.0,38.19531,212.0,3.5,1.59985352,3.09960938,152.0,7.519531,492.0,111.0,2264.0,0.0,adl>=4 (>=5 if sur)
69.58795,1,male,0,5,240,Lung Cancer,Cancer,1,16.0,under $11k,9532.0,4846.543,10.0,other,6.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,65.0,17.5976562,165.0,26.0,38.39844,85.0,3.5,1.01,1.0,132.0,7.359375,253.0,18.0,1440.0,2.340332,<2 mo. follow-up
70.32996,1,female,0,15,28,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,65043.0,28584.9375,21.0,white,46.0,1,0,0,metastatic,0.799999714,0.5,no dnr,15.0,62.0,9.69921875,65.0,20.0,36.19531,333.3,3.8999023,0.59997559,0.89990234,139.0,7.419922,124.0,18.0,1660.0,1.0,<2 mo. follow-up
68.34497,1,female,0,16,236,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,118074.0,28804.5938,18.333328,white,32.0,20,0,0,no,0.799999714,0.8,no dnr,16.0,85.0,20.296875,125.0,30.0,38.59375,315.5,3.5,1.01,2.89990234,147.0,7.429688,101.0,68.0,2545.0,2.8154297,<2 mo. follow-up
76.76099,1,male,0,24,28,CHF,COPD/CHF/Cirrhosis,1,16.0,$25-$50k,82924.0,40077.5312,24.333328,white,34.0,1,0,0,no,0.779999733,0.68,no dnr,24.0,73.0,5.89941406,75.0,10.0,38.29688,186.0,3.5,1.01,1.39990234,152.0,7.339844,135.0,38.0,548.0,2.0,<2 mo. follow-up
58.823,1,female,0,12,440,CHF,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,58144.0,31806.9531,16.5,white,31.0,1,0,0,no,0.799999714,0.7,no dnr,12.0,98.0,19.5,115.0,29.0,38.69531,585.0,3.5,0.69995117,0.59997559,131.0,7.519531,172.0,12.0,3055.0,3.0629883,<2 mo. follow-up
31.79999,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,285267.0,71898.625,40.0,black,57.0,12,1,0,no,0.699999809,0.6,dnr after sadm,21.0,115.0,14.6992188,140.0,24.0,39.29688,402.5,3.5,5.29980469,1.09985352,128.0,7.459961,221.0,18.0,3765.0,2.0,<2 mo. follow-up
55.32898,1,male,0,11,38,CHF,COPD/CHF/Cirrhosis,2,14.0,>$50k,39435.0,17091.9219,25.5,white,27.0,1,0,0,no,0.849999905,0.7,no dnr,11.0,82.0,20.1992188,110.0,26.0,37.39844,137.5,2.2998047,1.01,1.39990234,140.0,7.429688,104.0,12.0,1148.0,0.0,<2 mo. follow-up
55.35098,0,male,0,24,517,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,559190.0,115602.375,38.333313,white,74.0,21,0,0,no,0.5,0.5,no dnr,24.0,65.0,12.0996094,115.0,31.0,37.79688,220.0,2.699707,46.5,7.79980469,138.0,7.5,184.0,96.0,328.0,3.6201172,<2 mo. follow-up
40.05197,1,female,0,11,515,Colon Cancer,Cancer,1,14.0,under $11k,26709.0,12503.6719,15.0,asian,15.0,1,0,0,metastatic,0.399999857,0.2,no dnr,11.0,77.0,13.6992188,80.0,20.0,36.59375,333.3,3.5,1.01,1.19995117,134.0,7.419922,135.0,14.0,2900.0,0.494751,no(M2 and SIP pres)
33.043,0,male,0,62,515,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,584811.0,161002.25,34.75,hispanic,51.0,6,0,0,no,0.5,0.5,no dnr,62.0,83.0,3.0,104.0,22.0,39.19531,333.3,3.5,0.79992676,1.29980469,138.0,7.419922,144.0,15.0,2750.0,3.3510742,no(M2 and SIP pres)
75.20898,1,female,0,7,212,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,16236.0,8621.3047,15.5,hispanic,32.0,1,0,0,no,0.899999619,0.7,no dnr,7.0,67.0,20.5976562,55.0,25.0,36.0,371.0,3.5,0.29998779,1.19995117,129.0,7.609375,289.0,25.0,1466.0,0.0,no(M2 and SIP pres)
59.55099,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,49137.0,22125.8438,13.5,white,17.0,2,0,0,metastatic,0.199999928,0.04,dnr after sadm,1.0,68.0,13.6992188,145.0,32.0,37.69531,344.0,3.5,1.01,0.79992676,140.0,7.539062,133.0,14.0,2183.0,3.3422852,<2 mo. follow-up
65.30298,1,male,1,7,7,Coma,Coma,1,16.0,under $11k,114803.0,25911.7031,36.5,white,51.0,13,1,0,no,0.099999964,0.1,dnr after sadm,7.0,46.0,8.09960938,75.0,22.0,36.5,333.3,3.3999023,2.09960938,1.29980469,130.0,7.419922,108.0,35.0,3113.0,1.0,<2 mo. follow-up
34.31299,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,under $11k,109897.0,21670.1406,18.0,white,74.0,17,0,0,no,0.199999928,0.05,dnr after sadm,1.0,49.0,5.0,55.0,22.0,35.79688,333.3,3.5,1.01,0.69995117,124.0,7.419922,135.0,25.0,3550.0,1.0,<2 mo. follow-up
68.51495,1,female,0,28,163,Coma,Coma,0,16.0,under $11k,269996.0,97231.25,39.0,white,25.0,4,0,0,no,0.75,0.75,no dnr,28.0,60.0,25.5976562,65.0,34.0,38.5,247.5,3.5,0.19998169,5.59960938,136.0,7.469727,135.0,79.0,0.0,0.0,Coma or Intub
70.56494,1,female,0,6,137,Lung Cancer,Cancer,1,20.0,under $11k,13976.0,7062.5586,19.0,white,32.0,1,0,0,metastatic,0.949999809,0.7,no dnr,6.0,63.0,10.3984375,75.0,16.0,36.29688,333.3,3.699707,2.39990234,1.5,126.0,7.419922,94.0,24.0,3625.0,2.3232422,no(M2 and SIP pres)
59.31,1,female,0,16,131,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,45458.0,22102.3906,16.333328,white,26.0,1,0,0,no,0.5,0.4,no dnr,16.0,132.0,2.39990234,125.0,44.0,37.79688,182.0,3.5,1.19995117,4.39941406,140.0,7.339844,356.0,91.0,492.0,4.1611328,<2 mo. follow-up
35.17297,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,194955.0,24154.5312,48.0,hispanic,21.0,40,0,0,yes,0.009999998,0.0,dnr after sadm,4.0,106.0,8.69921875,76.0,14.0,37.5,333.3,3.5,0.29998779,0.79992676,132.0,7.419922,85.0,11.0,1800.0,0.0,<2 mo. follow-up
60.39999,1,male,0,7,499,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,81201.0,10525.8984,15.0,white,22.0,5,0,0,metastatic,0.699999809,0.5,no dnr,7.0,128.0,31.3984375,125.0,25.0,39.0,192.0,2.5,6.09960938,0.79992676,151.0,7.439453,99.0,32.0,6065.0,0.0,adl>=4 (>=5 if sur)
37.96298,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,$11-$25k,569861.0,52801.5938,53.0,white,74.0,28,0,0,no,0.049999982,0.05,dnr after sadm,10.0,63.0,6.69921875,105.0,20.0,36.0,333.3,3.5,1.01,1.89990234,137.0,7.419922,135.0,42.0,1875.0,0.0,<2 mo. follow-up
56.56097,0,male,0,48,494,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,690753.0,141858.875,44.25,white,60.0,36,0,0,no,0.199999928,0.2,no dnr,48.0,72.0,9.79882812,72.0,28.0,36.39844,333.3,3.5,1.01,0.69995117,136.0,7.419922,159.0,7.0,3625.0,2.6245117,<2 mo. follow-up
65.29999,0,female,0,4,494,Lung Cancer,Cancer,2,12.0,under $11k,14436.0,6510.1836,20.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,122.0,6.19921875,145.0,8.0,38.89844,476.1875,3.5,2.89990234,2.39990234,130.0,7.569336,135.0,54.0,2518.0,3.4487305,<2 mo. follow-up
84.08496,0,male,0,12,493,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,29939.0,17392.6406,8.5,white,14.0,1,0,0,no,0.799999714,0.6,no dnr,12.0,117.0,19.5,103.0,24.0,36.19531,333.3,3.5,1.01,1.89990234,134.0,7.419922,175.0,46.0,2502.0,0.0,no(M2 and SIP pres)
71.05798,1,female,0,33,373,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,178983.0,66084.0,27.25,white,58.0,3,0,0,yes,0.799999714,0.7,no dnr,33.0,115.0,1.59985352,35.0,50.0,37.59375,72.5,3.5,5.19921875,0.79992676,137.0,7.419922,192.0,32.0,1075.0,0.0,no(M2 and SIP pres)
36.33099,1,male,1,15,15,Coma,Coma,0,12.0,under $11k,191073.0,76378.6875,55.333313,white,81.0,2,0,0,no,0.099999964,0.1,dnr after sadm,10.0,120.0,12.7988281,125.0,30.0,39.19531,333.3,3.5,0.89990234,0.69995117,131.0,7.419922,146.0,14.0,2795.0,2.7856445,<2 mo. follow-up
78.26996,1,female,0,6,263,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,155711.0,10424.0391,31.0,white,47.0,20,1,0,yes,0.5,0.4,no dnr,6.0,73.0,0.19998169,72.0,24.0,38.19531,333.3,3.5,1.01,0.59997559,132.0,7.419922,135.0,6.0,2150.0,2.0,Coma or Intub
83.49597,0,male,0,21,491,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,174489.0,53113.5938,30.0,white,34.0,5,0,0,yes,0.5,0.5,no dnr,21.0,103.0,7.09960938,67.0,24.0,36.09375,220.0,3.5,0.39996338,1.0,140.0,7.359375,169.0,18.0,2502.0,4.5117188,<2 mo. follow-up
48.58298,0,male,0,30,489,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,222936.0,110012.125,34.0,white,28.0,1,0,0,no,0.799999714,0.8,no dnr,30.0,68.0,9.8984375,98.0,24.0,36.19531,333.3,2.3999023,7.39941406,0.59997559,143.0,7.419922,103.0,3.0,3800.0,3.1904297,<2 mo. follow-up
63.33499,1,male,0,10,467,Colon Cancer,Cancer,1,16.0,>$50k,43200.0,20651.7812,11.5,white,14.0,1,0,0,metastatic,1.0,0.5,no dnr,10.0,105.0,9.3984375,50.0,26.0,39.0,480.0,3.5,1.01,0.69995117,132.0,7.509766,271.0,10.0,2570.0,1.0,<2 mo. follow-up
34.53497,1,female,1,18,18,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,437598.0,107912.312,44.0,hispanic,93.0,28,0,0,yes,0.349999905,0.25,dnr after sadm,10.0,110.0,4.59960938,62.0,24.0,36.79688,333.3,3.5,1.01,1.29980469,138.0,7.419922,366.0,33.0,4400.0,4.1826172,<2 mo. follow-up
53.69699,0,male,0,21,488,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,155191.0,91163.625,25.666656,white,16.0,1,0,0,no,0.699999809,0.5,no dnr,21.0,65.0,8.8984375,125.0,10.0,38.39844,176.0,3.0996094,32.0,4.79980469,141.0,7.419922,178.0,61.0,12.0,0.0,<2 mo. follow-up
46.89099,0,female,0,10,489,CHF,COPD/CHF/Cirrhosis,6,12.0,$11-$25k,108058.0,65461.0312,38.5,white,56.0,1,0,0,no,0.949999809,0.93,no dnr,10.0,108.0,2.09960938,135.0,26.0,38.29688,142.0,3.5,0.59997559,5.79980469,132.0,7.299805,135.0,50.0,1045.0,0.0,<2 mo. follow-up
66.89099,0,male,0,22,487,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,223592.0,14452.7344,29.0,white,38.0,12,0,0,no,0.799999714,0.75,no dnr,22.0,107.0,18.0976562,66.0,24.0,38.0,333.3,3.5,1.01,0.89990234,136.0,7.419922,170.0,6.0,1175.0,3.0917969,<2 mo. follow-up
31.17599,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,$11-$25k,558904.0,144282.875,50.333313,hispanic,95.0,22,0,0,no,0.699999809,0.5,dnr after sadm,14.0,70.0,9.0,70.0,20.0,36.5,521.625,3.5,0.89990234,1.79980469,131.0,7.429688,157.0,19.0,2050.0,7.0,<2 mo. follow-up
77.55499,1,female,0,25,33,Coma,Coma,2,12.0,under $11k,168806.0,38366.5625,24.75,white,47.0,7,1,0,no,0.399999857,0.3,dnr after sadm,4.0,43.0,14.8984375,125.0,10.0,38.0,360.0,1.3999023,0.59997559,2.59960938,133.0,7.319336,398.0,36.0,5960.0,3.0,<2 mo. follow-up
36.70099,1,female,1,6,6,Coma,Coma,3,14.0,$11-$25k,139607.0,32443.6719,50.0,white,97.0,11,0,0,yes,0.199999928,0.2,no dnr,6.0,53.0,1.79980469,125.0,30.0,34.79688,445.6875,3.5,0.29998779,2.39990234,134.0,7.389648,211.0,18.0,34.0,3.4394531,<2 mo. follow-up
52.24899,0,male,0,25,480,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,154101.0,60022.8125,26.5,white,38.0,7,0,0,no,0.899999619,0.9,no dnr,25.0,112.0,10.2988281,120.0,40.0,35.89844,332.0,3.5,1.01,1.79980469,138.0,7.469727,135.0,48.0,3240.0,0.0,<2 mo. follow-up
80.23499,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,22474.0,9052.9141,29.0,other,47.0,1,0,0,metastatic,0.099999964,0.0,no dnr,5.0,67.0,0.5,120.0,24.0,38.19531,333.3,2.3999023,1.09985352,1.19995117,135.0,7.419922,226.0,33.0,5400.0,3.253418,<2 mo. follow-up
47.49298,1,male,0,7,404,Colon Cancer,Cancer,2,12.0,>$50k,32899.0,15341.8359,6.5,white,7.0,1,0,0,metastatic,1.0,0.9,no dnr,7.0,62.0,12.5,65.0,29.0,37.89844,66.25,3.5,1.01,1.29980469,142.0,7.489258,126.0,31.0,2175.0,0.0,no(M2 and SIP pres)
64.75,0,male,0,18,477,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,>$50k,161773.0,34648.2188,23.333328,white,38.0,20,0,0,yes,0.799999714,0.8,no dnr,18.0,70.0,9.09960938,125.0,20.0,36.5,333.3,3.5,1.01,1.29980469,130.0,7.419922,135.0,26.0,4940.0,3.2602539,<2 mo. follow-up
39.78098,0,male,0,13,476,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,87541.0,17153.9219,19.5,white,36.0,6,0,0,yes,0.949999809,0.95,no dnr,13.0,102.0,11.0996094,80.0,24.0,36.39844,333.3,3.5,1.29980469,1.19995117,136.0,7.419922,161.0,16.0,1425.0,0.494751,<2 mo. follow-up
79.70398,1,female,0,5,335,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,28450.0,12693.6328,35.0,white,50.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,65.0,0.04999542,145.0,12.0,36.19531,421.25,1.8999023,5.59960938,3.19970703,148.0,7.5,374.0,90.0,1356.0,0.0,no(M2 and SIP pres)
64.25696,0,male,0,8,474,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,52715.0,16607.4531,17.0,white,28.0,3,1,0,no,0.899999619,0.75,no dnr,8.0,62.0,7.39941406,70.0,14.0,36.19531,333.3,3.5,1.01,1.5,137.0,7.419922,135.0,13.0,2095.0,0.0,no(M2 and SIP pres)
48.375,1,female,0,10,106,Lung Cancer,Cancer,1,19.0,>$50k,19535.0,10733.4609,10.0,white,11.0,1,0,0,metastatic,0.849999905,0.5,no dnr,10.0,48.0,15.8984375,145.0,8.0,38.09375,130.0,3.2998047,1.69995117,0.79992676,146.0,7.5,198.0,20.0,4120.0,0.494751,<2 mo. follow-up
52.293,1,male,0,11,440,Colon Cancer,Cancer,1,18.0,>$50k,24621.0,12094.4141,14.0,white,14.0,1,0,0,metastatic,0.75,0.1,no dnr,11.0,140.0,12.0996094,65.0,34.0,38.19531,159.15625,4.5996094,1.59985352,0.79992676,132.0,7.419922,180.0,28.0,1635.0,0.0,<2 mo. follow-up
69.91595,0,male,0,28,472,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,269095.0,69369.1875,37.5,white,73.0,8,1,0,yes,0.699999809,0.5,no dnr,28.0,130.0,12.0996094,145.0,26.0,39.39844,334.0,2.0996094,34.0,2.59960938,156.0,7.609375,648.0,96.0,1775.0,3.4599609,<2 mo. follow-up
60.20499,0,female,0,17,472,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,189109.0,46810.6562,25.0,asian,64.0,25,0,0,yes,0.5,0.25,no dnr,17.0,72.0,19.5976562,115.0,32.0,37.5,197.9375,3.5,1.01,1.69995117,155.0,7.539062,468.0,69.0,2455.0,0.0,no(M2 and SIP pres)
60.91699,1,female,0,5,254,Lung Cancer,Cancer,1,16.0,under $11k,13116.0,6205.8125,12.0,white,11.0,1,0,0,metastatic,0.799999714,0.4,no dnr,5.0,128.0,6.5,120.0,36.0,38.59375,127.5,2.2998047,36.0,3.0,129.0,7.539062,135.0,69.0,213.0,2.2416992,no(M2 and SIP pres)
53.75198,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,345497.0,81596.1875,56.0,white,88.0,8,0,0,no,0.899999619,0.8,no dnr,15.0,67.0,22.796875,130.0,10.0,37.89844,200.0,3.5,0.79992676,0.89990234,138.0,7.479492,227.0,16.0,1245.0,2.5043945,<2 mo. follow-up
30.53799,0,male,0,9,468,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,130205.0,21199.2188,24.0,white,20.0,28,0,0,no,0.799999714,0.8,no dnr,9.0,82.0,1.5,115.0,30.0,37.59375,176.1875,3.5,1.01,1.0,123.0,7.479492,173.0,26.0,1700.0,1.0,<2 mo. follow-up
73.84796,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,5,18.0,$11-$25k,77209.0,27299.3438,34.0,hispanic,80.0,2,1,0,no,0.5,0.4,dnr after sadm,8.0,94.0,6.29980469,106.0,24.0,36.59375,333.3,4.1992188,0.5,1.09985352,138.0,7.419922,78.0,16.0,1900.0,4.2841797,<2 mo. follow-up
63.93399,1,female,1,10,10,Colon Cancer,Cancer,1,14.0,under $11k,39476.0,16393.5781,14.5,white,30.0,1,0,0,metastatic,0.5,0.0,dnr after sadm,8.0,131.0,6.29980469,116.0,25.0,38.19531,197.125,3.5,1.01,2.29980469,147.0,7.459961,135.0,23.0,5658.0,6.0,<2 mo. follow-up
71.69299,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,164001.0,23916.8125,38.5,white,47.0,29,0,0,no,0.099999964,0.1,dnr after sadm,2.0,137.0,11.8984375,75.0,24.0,38.89844,333.3,3.5,1.39990234,4.69921875,126.0,7.419922,135.0,90.0,5200.0,5.0,<2 mo. follow-up
69.56897,0,male,0,10,462,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,35691.0,16373.8594,16.0,black,30.0,1,1,0,no,0.899999619,0.7,no dnr,10.0,117.0,11.6992188,175.0,16.0,36.09375,157.125,3.5,1.01,2.09960938,138.0,7.269531,184.0,43.0,1699.0,5.0,<2 mo. follow-up
71.12396,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,227604.0,49044.9688,45.0,black,92.0,12,0,0,no,0.099999964,0.05,dnr after sadm,2.0,111.0,8.0,110.0,30.0,36.39844,197.5,3.5,1.01,0.79992676,136.0,7.449219,265.0,14.0,1150.0,3.0898438,<2 mo. follow-up
65.52997,0,female,0,13,463,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,32728.0,18566.0,15.5,black,11.0,1,0,0,no,0.75,0.7,no dnr,13.0,75.0,8.8984375,78.0,22.0,36.79688,333.3,3.5,1.01,0.79992676,138.0,7.419922,135.0,23.0,3100.0,0.0,<2 mo. follow-up
60.65997,1,female,0,16,51,Coma,Coma,1,12.0,under $11k,59110.0,27980.5625,12.0,hispanic,15.0,1,0,0,metastatic,0.0,0.0,dnr before sadm,-1.0,103.0,6.69921875,78.0,22.0,38.5,333.3,3.5,0.5,1.0,140.0,7.419922,86.0,11.0,1050.0,2.8994141,<2 mo. follow-up
75.16199,0,male,0,12,461,CHF,COPD/CHF/Cirrhosis,2,20.0,>$50k,43004.0,18532.2344,26.5,white,42.0,1,0,0,no,0.949999809,0.9,no dnr,12.0,50.0,9.0,95.0,32.0,37.5,367.5,1.7998047,10.1992188,2.19970703,142.0,7.439453,200.0,112.0,3425.0,0.0,no(M2 and SIP pres)
60.72299,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,165860.0,56255.9062,38.666657,white,73.0,4,0,0,no,0.75,0.7,dnr after sadm,11.0,143.0,0.04999542,135.0,36.0,35.5,540.0,3.0,1.01,1.5,135.0,7.55957,135.0,29.0,2480.0,3.6044922,<2 mo. follow-up
54.67499,1,male,0,10,250,Colon Cancer,Cancer,1,16.0,>$50k,32539.0,14322.4609,14.5,white,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,10.0,73.0,5.19921875,76.0,24.0,36.39844,333.3,3.5,1.01,1.09985352,136.0,7.419922,135.0,3.0,2400.0,2.9594727,<2 mo. follow-up
56.00299,0,male,0,24,460,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,130715.0,66234.25,18.666656,white,22.0,1,0,0,no,0.799999714,0.7,no dnr,24.0,68.0,46.5,150.0,40.0,39.29688,130.0,3.0,16.0976562,2.29980469,150.0,7.539062,300.0,63.0,2420.0,0.0,<2 mo. follow-up
58.54599,0,female,0,6,460,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,11516.0,7043.5547,12.0,white,24.0,1,1,0,yes,1.0,0.7,no dnr,6.0,72.0,7.79980469,135.0,10.0,36.69531,391.8125,3.5,0.39996338,0.69995117,136.0,7.519531,103.0,7.0,5660.0,3.3901367,<2 mo. follow-up
78.27496,1,female,1,7,7,Coma,Coma,0,12.0,under $11k,63413.0,19578.7656,38.0,asian,38.0,8,0,0,no,0.199999928,0.5,no dnr,7.0,52.0,12.8984375,120.0,40.0,39.79688,148.875,3.3999023,1.01,3.59960938,143.0,7.459961,135.0,87.0,73.0,2.3945312,<2 mo. follow-up
79.07495,1,female,0,8,183,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,14921.0,9544.6016,18.5,white,34.0,1,1,0,yes,0.599999905,0.4,dnr before sadm,-1.0,69.0,9.69921875,120.0,16.0,36.79688,333.3,1.7998047,1.01,0.59997559,140.0,7.419922,135.0,16.0,2502.0,3.0,no(M2 and SIP pres)
71.146,1,male,0,3,402,CHF,COPD/CHF/Cirrhosis,3,19.0,>$50k,8208.0,4140.8594,15.0,white,35.0,1,1,0,no,0.799999714,0.7,no dnr,3.0,52.0,22.296875,125.0,24.0,36.19531,333.3,3.0996094,1.01,1.79980469,138.0,7.419922,135.0,47.0,1925.0,2.4311523,no(M2 and SIP pres)
47.20898,0,male,0,16,458,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,120554.0,50712.9062,21.0,white,24.0,1,0,0,no,0.949999809,0.92,no dnr,16.0,163.0,17.0,116.0,22.0,36.0,300.0,3.5,1.01,1.19995117,139.0,7.379883,282.0,26.0,1925.0,0.0,<2 mo. follow-up
52.97198,1,male,0,5,74,CHF,COPD/CHF/Cirrhosis,2,9.0,$25-$50k,109462.0,9459.1641,36.0,white,27.0,18,0,0,no,0.699999809,0.55,no dnr,5.0,52.0,44.5,150.0,14.0,38.29688,225.4375,3.0,25.796875,4.89941406,142.0,7.419922,94.0,76.0,28.0,3.0,SIP>=30
59.28299,1,female,1,31,31,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,263478.0,96814.8125,26.75,black,47.0,4,0,0,yes,0.599999905,0.6,dnr after sadm,26.0,105.0,6.19921875,105.0,24.0,36.79688,333.3,3.5,1.01,1.09985352,139.0,7.419922,92.0,14.0,4950.0,5.0,<2 mo. follow-up
66.92096,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,259419.0,10136.9922,29.0,hispanic,116.0,41,1,0,no,0.199999928,0.2,no dnr,3.0,103.0,20.1992188,105.0,20.0,36.79688,333.3,3.5,1.01,0.69995117,141.0,7.419922,172.0,9.0,1750.0,0.0,<2 mo. follow-up
44.89297,1,female,0,7,174,Colon Cancer,Cancer,1,12.0,>$50k,59995.78781114967,6676.3672,10.0,white,14.0,1,0,0,metastatic,0.899999619,0.3,no dnr,7.0,55.0,12.7988281,75.0,12.0,38.29688,333.3,3.3999023,0.89990234,1.69995117,138.0,7.419922,128.0,30.0,1920.0,0.494751,<2 mo. follow-up
52.323,0,male,0,13,454,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,108450.0,65760.8125,34.0,white,40.0,1,0,0,no,0.899999619,0.85,no dnr,13.0,55.0,11.2988281,35.0,10.0,35.0,262.5,1.8999023,20.5,1.69995117,138.0,7.40918,229.0,55.0,2211.0,3.3037109,no(M2 and SIP pres)
41.60699,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,590617.0,62744.5312,37.5,hispanic,84.0,15,0,0,no,0.099999964,0.05,dnr after sadm,12.0,83.0,10.8984375,76.0,16.0,36.59375,333.3,2.5996094,1.0,0.89990234,137.0,7.419922,100.0,11.0,2840.0,2.734375,<2 mo. follow-up
53.50299,0,male,0,17,453,CHF,COPD/CHF/Cirrhosis,2,14.0,>$50k,150298.0,90096.0,30.333328,white,31.0,1,0,0,no,0.799999714,0.7,no dnr,17.0,63.0,12.6992188,125.0,26.0,39.09375,333.3,3.699707,1.29980469,1.29980469,138.0,7.419922,154.0,14.0,2670.0,0.0,<2 mo. follow-up
73.24799,1,male,0,7,24,Cirrhosis,COPD/CHF/Cirrhosis,2,18.0,under $11k,12039.0,6354.4219,8.0,white,45.0,1,0,0,no,0.299999952,0.3,dnr after sadm,2.0,107.0,6.89941406,75.0,20.0,36.0,333.3,3.5,1.01,1.89990234,142.0,7.419922,167.0,40.0,2850.0,2.6772461,<2 mo. follow-up
74.17395,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,322777.0,102572.188,40.0,white,54.0,7,1,0,no,0.899999619,0.9,dnr after sadm,22.0,42.0,23.3984375,105.0,10.0,36.29688,316.0,3.5,1.01,2.0,135.0,7.25,135.0,40.0,2650.0,2.5429688,<2 mo. follow-up
57.49799,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,3,17.0,>$50k,347324.0,14452.7344,36.0,white,58.0,21,0,0,no,0.199999928,0.05,dnr after sadm,6.0,70.0,6.19921875,70.0,20.0,36.5,333.3,3.5,1.01,2.79980469,139.0,7.419922,135.0,59.0,1175.0,0.0,<2 mo. follow-up
72.20294,1,male,0,9,146,Lung Cancer,Cancer,1,18.0,$11-$25k,38812.0,18041.3594,9.5,white,23.0,1,0,0,metastatic,0.649999619,0.4,no dnr,9.0,72.0,6.39941406,75.0,22.0,37.0,333.3,3.5,1.01,2.39990234,131.0,7.419922,153.0,77.0,600.0,3.4951172,no(M2 and SIP pres)
57.98199,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,461451.0,14452.7344,39.75,asian,55.0,4,0,0,no,0.099999964,0.5,dnr after sadm,31.0,75.0,12.8984375,75.0,22.0,38.0,145.0,2.699707,3.59960938,1.09985352,132.0,7.619141,160.0,28.0,3700.0,2.9321289,<2 mo. follow-up
54.88599,0,male,0,10,443,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,39274.0,19644.2188,20.0,black,19.0,1,1,0,no,0.799999714,0.8,no dnr,10.0,65.0,14.1992188,65.0,16.0,35.59375,333.3,3.5,1.01,1.59985352,125.0,7.419922,135.0,35.0,3550.0,0.0,no(M2 and SIP pres)
31.84099,0,female,0,9,441,Colon Cancer,Cancer,1,12.0,under $11k,34588.0,15645.4297,12.0,white,23.0,1,0,0,metastatic,1.0,0.9,no dnr,9.0,82.0,0.59997559,115.0,12.0,39.0,333.3,3.5,0.59997559,1.89990234,136.0,7.419922,261.0,46.0,2915.0,0.494751,<2 mo. follow-up
55.43298,0,female,0,9,441,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,35245.0,16080.6328,18.0,white,33.0,1,0,0,no,0.899999619,0.8,no dnr,9.0,0.0,24.1992188,0.0,0.0,36.19531,274.25,1.1999512,10.0996094,2.79980469,142.0,7.349609,135.0,92.0,14.0,6.0,SIP>=30
86.55396,1,male,0,10,37,Coma,Coma,1,7.0,under $11k,139613.0,27035.8438,40.0,white,39.0,6,0,0,no,0.699999809,0.5,no dnr,10.0,65.0,17.796875,104.0,32.0,36.79688,148.3125,3.5,1.01,1.0,144.0,7.489258,118.0,21.0,2075.0,0.0,<2 mo. follow-up
36.89297,1,female,0,54,64,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,556242.0,116165.5,21.75,black,30.0,44,0,0,no,0.949999809,0.95,no dnr,54.0,83.0,2.5,80.0,22.0,35.79688,333.3,4.1992188,0.79992676,0.79992676,133.0,7.419922,135.0,3.0,3000.0,5.0,<2 mo. follow-up
68.51196,1,male,0,58,240,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,265912.0,14452.7344,27.25,black,61.0,4,0,0,no,0.699999809,0.6,no dnr,58.0,55.0,6.5,115.0,16.0,35.89844,333.3,3.5,1.01,1.79980469,137.0,7.419922,135.0,26.0,1375.0,5.0,SIP>=30
34.23999,0,female,0,18,436,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,120821.0,55423.3438,25.333328,white,18.0,1,0,0,no,0.949999809,0.9,no dnr,18.0,58.0,10.5996094,115.0,31.0,38.19531,162.5,3.8999023,31.0,4.19921875,135.0,7.489258,174.0,83.0,0.0,0.494751,no(M2 and SIP pres)
75.28296,1,female,0,50,235,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,542002.0,152701.875,39.0,white,56.0,11,1,0,no,0.699999809,0.5,no dnr,50.0,55.0,8.69921875,70.0,20.0,36.09375,333.3,3.3999023,1.0,1.59985352,135.0,7.419922,135.0,38.0,2425.0,2.8818359,<2 mo. follow-up
77.54999,0,female,0,51,434,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,382453.0,145990.75,43.5,white,62.0,10,0,0,no,0.199999928,0.2,no dnr,51.0,67.0,14.7988281,74.0,22.0,36.19531,333.3,3.2998047,3.89990234,3.09960938,136.0,7.419922,85.0,80.0,590.0,2.7924805,<2 mo. follow-up
30.97899,0,male,0,39,435,Coma,Coma,0,12.0,under $11k,229100.0,103634.5,26.75,hispanic,35.0,1,0,0,no,0.75,0.75,no dnr,39.0,75.0,14.2988281,120.0,44.0,39.0,157.125,2.199707,0.79992676,1.69995117,139.0,7.509766,438.0,32.0,2635.0,0.0,no(M2 and SIP pres)
63.63898,1,female,1,55,55,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,902281.0,191182.375,37.0,hispanic,65.0,39,0,0,no,0.099999964,0.1,dnr after sadm,46.0,57.0,23.8984375,105.0,9.0,36.59375,256.0,3.5,38.3984375,3.29980469,138.0,7.439453,109.0,66.0,1965.0,3.065918,<2 mo. follow-up
46.935,0,female,0,28,432,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,160986.0,14452.7344,18.25,white,28.0,2,0,0,yes,0.949999809,0.9,no dnr,28.0,75.0,10.5996094,60.0,14.0,36.0,333.3,3.5,1.01,0.69995117,133.0,7.419922,202.0,22.0,2502.0,4.4863281,<2 mo. follow-up
45.27597,1,female,0,14,46,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,76227.0,28078.3281,17.666656,black,73.0,1,1,0,no,0.5,0.4,no dnr,14.0,75.0,11.2988281,75.0,25.0,38.19531,215.0,2.2998047,2.09960938,1.69995117,134.0,7.509766,135.0,30.0,1651.0,3.1689453,<2 mo. follow-up
39.86899,1,male,1,30,30,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,497787.0,114284.062,34.0,white,78.0,37,0,0,yes,0.049999982,0.0,dnr after sadm,29.0,62.0,6.5,115.0,24.0,36.5,333.3,3.5,1.01,0.79992676,136.0,7.419922,188.0,19.0,3600.0,2.5600586,<2 mo. follow-up
65.73596,0,male,0,23,430,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,195264.0,97759.1875,39.666657,white,63.0,1,0,0,no,0.699999809,0.6,no dnr,23.0,71.0,4.19921875,120.0,24.0,38.39844,333.3,3.699707,2.39990234,0.59997559,139.0,7.419922,138.0,6.0,3350.0,3.4580078,no(M2 and SIP pres)
49.34198,1,female,1,17,17,Coma,Coma,2,22.0,$25-$50k,201340.0,37985.2188,36.333313,hispanic,23.0,34,0,0,no,0.5,0.5,dnr after sadm,7.0,115.0,31.796875,95.0,16.0,36.79688,524.0,3.5,1.01,1.19995117,155.0,6.959961,651.0,14.0,2400.0,5.0,<2 mo. follow-up
59.35397,1,female,0,9,218,Colon Cancer,Cancer,1,18.0,under $11k,30984.0,14547.3594,14.0,white,16.0,1,0,0,metastatic,1.0,0.9,no dnr,9.0,108.0,11.0,135.0,10.0,37.0,227.5,3.5,1.01,2.19970703,153.0,7.509766,125.0,59.0,1852.0,0.0,no(M2 and SIP pres)
73.52795,0,female,0,5,424,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5988.0,3484.082,6.0,white,6.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,97.0,16.296875,140.0,28.0,36.59375,226.65625,3.5,1.01,0.59997559,137.0,7.529297,135.0,3.0,2416.0,2.5693359,<2 mo. follow-up
71.18695,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,3,20.0,>$50k,201762.0,29839.5781,56.5,asian,75.0,9,1,0,no,0.399999857,0.1,dnr after sadm,6.0,52.0,4.89941406,60.0,24.0,33.39844,333.3,3.5,1.01,4.19921875,144.0,7.419922,117.0,43.0,759.0,1.0,<2 mo. follow-up
60.22198,1,male,0,16,19,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,53341.0,26078.8125,26.0,black,33.0,1,1,0,no,0.799999714,0.5,no dnr,16.0,65.0,11.5,70.0,24.0,35.89844,333.3,3.5,1.01,0.89990234,134.0,7.419922,104.0,18.0,2675.0,3.3642578,<2 mo. follow-up
75.29895,1,male,0,54,239,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,361878.0,102817.562,32.5,white,72.0,24,0,0,yes,0.5,0.45,no dnr,54.0,60.0,15.2988281,110.0,10.0,36.5,112.0,3.5,1.01,5.19921875,136.0,7.519531,165.0,130.0,1136.0,0.0,adl>=4 (>=5 if sur)
66.53497,1,male,0,7,172,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,22157.0,10879.25,17.5,asian,33.0,1,0,0,no,0.599999905,0.5,no dnr,7.0,62.0,31.1992188,155.0,22.0,38.29688,93.84375,1.5998535,0.29998779,0.69995117,135.0,7.389648,175.0,21.0,4280.0,2.8154297,<2 mo. follow-up
20.29599,1,female,1,40,40,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,355578.0,14452.7344,35.25,hispanic,67.0,2,0,0,metastatic,0.899999619,0.9,no dnr,40.0,122.0,21.1992188,155.0,10.0,38.0,333.3,3.7998047,0.5,1.19995117,143.0,7.419922,122.0,8.0,2397.0,1.0,<2 mo. follow-up
68.82098,0,female,0,7,419,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,21750.0,11069.8047,13.5,white,52.0,1,1,0,no,0.799999714,0.5,no dnr,7.0,113.0,38.59375,105.0,9.0,38.0,342.5,4.0996094,15.3984375,4.39941406,133.0,7.449219,123.0,170.0,0.0,6.0,<2 mo. follow-up
60.29797,0,female,0,11,415,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,51183.0,23294.4844,22.0,white,56.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,82.0,13.7988281,120.0,32.0,39.59375,590.0,3.7998047,1.01,0.79992676,136.0,7.469727,135.0,8.0,2735.0,2.7836914,<2 mo. follow-up
87.35394,1,female,0,4,210,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,11602.0,5440.957,9.0,white,27.0,1,0,1,no,0.949999809,0.85,dnr after sadm,1.0,47.0,20.5,154.0,38.0,35.59375,138.75,3.5,0.79992676,7.69921875,152.0,7.429688,224.0,125.0,0.0,5.25,no(M2 and SIP pres)
58.32999,1,female,0,13,147,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,57209.0,19964.7031,14.5,white,57.0,6,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,113.0,14.2988281,150.0,30.0,36.39844,161.21875,3.7998047,0.59997559,6.19921875,130.0,7.40918,408.0,62.0,0.0,6.0,adl>=4 (>=5 if sur)
79.12897,1,female,0,9,59,COPD,COPD/CHF/Cirrhosis,3,13.0,under $11k,25770.0,11566.8984,12.5,white,31.0,1,0,0,no,0.899999619,0.5,no dnr,9.0,52.0,0.04999542,115.0,14.0,37.5,226.0625,3.5,18.5,2.09960938,134.0,7.399414,111.0,58.0,3149.0,1.8388672,<2 mo. follow-up
41.09799,0,male,0,8,411,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,43026.0,18923.1094,20.5,hispanic,47.0,2,0,0,no,0.899999619,0.9,no dnr,8.0,57.0,13.3984375,140.0,10.0,36.39844,230.0,3.0996094,2.0,2.89990234,151.0,7.439453,153.0,108.0,2420.0,0.0,<2 mo. follow-up
72.13995,1,male,1,7,7,Lung Cancer,Cancer,3,12.0,$11-$25k,30670.0,13482.5156,26.5,black,39.0,1,1,0,metastatic,0.299999952,0.1,dnr after sadm,2.0,130.0,8.19921875,110.0,6.0,37.5,370.0,2.5996094,0.89990234,0.89990234,144.0,7.579102,333.0,8.0,3020.0,1.0,<2 mo. follow-up
40.74698,0,male,0,64,408,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,310749.0,128527.625,31.0,white,83.0,2,0,0,no,0.5,0.4,no dnr,64.0,69.0,7.5,74.0,16.0,36.39844,333.3,3.5,0.59997559,1.09985352,135.0,7.419922,78.0,12.0,1525.0,0.0,adl>=4 (>=5 if sur)
66.67798,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,192030.0,43920.3438,24.666656,hispanic,16.0,41,0,0,yes,0.5,0.1,dnr after sadm,18.0,89.0,8.0,86.0,22.0,36.79688,392.0,3.5,1.01,0.89990234,132.0,7.399414,135.0,13.0,2502.0,1.0,<2 mo. follow-up
32.008,1,male,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,348165.0,14452.7344,25.25,hispanic,36.0,25,0,0,no,0.5,0.3,dnr after sadm,5.0,52.0,18.5,135.0,16.0,38.09375,98.5625,2.8999023,33.5,2.69970703,144.0,7.489258,249.0,76.0,3850.0,3.8959961,<2 mo. follow-up
62.32397,1,female,1,66,66,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,916502.0,14452.7344,41.0,white,64.0,27,0,0,no,0.899999619,0.8,dnr after sadm,64.0,65.0,11.6992188,80.0,24.0,35.89844,333.3,3.5,1.29980469,2.0,137.0,7.419922,147.0,79.0,4330.0,3.0,adl>=4 (>=5 if sur)
54.96799,0,male,0,43,403,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,347848.0,94807.5,30.5,white,46.0,18,0,0,metastatic,0.549999714,0.5,no dnr,43.0,70.0,36.296875,170.0,47.0,37.59375,124.48438,3.5,1.01,1.79980469,149.0,7.469727,279.0,43.0,1494.0,1.0,SIP>=30
40.82098,0,male,0,12,403,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,58518.0,25931.4062,36.5,white,48.0,1,1,0,no,0.5,0.5,no dnr,12.0,62.0,5.79980469,105.0,16.0,36.0,333.3,3.5,1.01,1.79980469,133.0,7.419922,202.0,71.0,2120.0,0.0,no(M2 and SIP pres)
69.48096,0,female,0,11,399,Colon Cancer,Cancer,1,11.0,under $11k,30978.0,13760.3516,15.0,hispanic,15.0,1,0,0,metastatic,1.0,0.9,no dnr,11.0,32.0,0.04999542,155.0,22.0,39.0,333.3,3.5,1.19995117,1.09985352,133.0,7.419922,135.0,10.0,7750.0,0.0,<2 mo. follow-up
58.793,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,234692.0,24678.2344,48.0,white,111.0,42,0,0,yes,0.5,0.5,dnr after sadm,4.0,111.0,10.1992188,104.0,34.0,36.0,122.5,3.5,1.01,0.89990234,138.0,7.30957,135.0,22.0,49.0,1.9633789,<2 mo. follow-up
52.22699,0,female,0,22,398,Coma,Coma,1,7.0,under $11k,192402.0,48440.875,24.666656,white,27.0,8,0,0,no,0.699999809,0.5,no dnr,22.0,72.0,6.59960938,115.0,12.0,38.29688,547.5,3.5,1.01,4.09960938,143.0,7.119141,395.0,50.0,2535.0,2.2666016,no(M2 and SIP pres)
94.54895,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,88695.0,36447.625,32.0,black,37.0,1,0,0,no,0.149999976,0.05,dnr after sadm,7.0,107.0,13.7988281,64.0,24.0,36.79688,195.21875,3.5996094,1.01,0.89990234,140.0,7.349609,175.0,13.0,1500.0,6.0,<2 mo. follow-up
49.70599,0,male,0,73,396,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,910119.0,177845.75,45.75,hispanic,59.0,32,0,0,no,0.299999952,0.3,no dnr,73.0,132.0,15.7988281,110.0,46.0,36.79688,190.46875,3.5,1.01,1.89990234,142.0,7.509766,114.0,38.0,2200.0,0.0,no(M2 and SIP pres)
77.06494,1,male,0,8,66,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26899.0,11858.2734,18.5,white,25.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,137.0,5.89941406,65.0,24.0,36.0,247.59375,3.5,1.01,0.79992676,135.0,7.469727,92.0,19.0,2200.0,5.4121094,<2 mo. follow-up
65.95996,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,68139.0,26086.8594,35.0,white,60.0,1,0,0,yes,0.199999928,0.5,no dnr,8.0,62.0,17.5,55.0,0.0,36.19531,206.65625,3.5,1.29980469,2.39990234,142.0,7.40918,139.0,39.0,5210.0,6.0,<2 mo. follow-up
42.82797,0,male,0,14,394,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,>$50k,85800.0,32954.5312,33.0,white,55.0,1,0,0,no,0.5,0.5,no dnr,14.0,78.0,7.79980469,125.0,28.0,36.09375,333.3,3.5,0.39996338,1.39990234,135.0,7.419922,199.0,46.0,1687.0,0.0,no(M2 and SIP pres)
86.71594,0,female,0,11,394,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,25502.0,11281.9609,14.0,white,20.0,1,0,0,no,0.949999809,0.85,no dnr,11.0,35.0,13.0,120.0,26.0,38.5,128.0,3.8999023,2.09960938,7.89941406,138.0,7.429688,119.0,88.0,0.0,0.0,no(M2 and SIP pres)
68.07397,1,male,0,9,43,COPD,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,66904.0,19334.0625,27.0,white,24.0,5,0,0,yes,0.5,0.2,no dnr,9.0,73.0,6.29980469,75.0,22.0,36.5,260.0,3.5,1.09985352,1.0,134.0,7.5,135.0,6.0,2622.0,6.0,<2 mo. follow-up
50.56299,0,male,0,31,391,Coma,Coma,1,16.0,>$50k,232891.0,96200.25,39.0,white,15.0,4,0,0,no,0.5,0.5,no dnr,31.0,102.0,20.8984375,125.0,54.0,38.59375,435.0,3.5,1.01,1.09985352,145.0,7.25,100.0,13.0,5400.0,2.1708984,<2 mo. follow-up
60.54498,1,male,1,31,31,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,239928.0,76509.625,26.5,white,41.0,19,0,0,yes,0.199999928,0.15,dnr after sadm,12.0,108.0,22.0,125.0,35.0,36.39844,333.3,3.5,11.3984375,2.09960938,146.0,7.519531,220.0,73.0,3100.0,4.0,<2 mo. follow-up
45.81497,0,female,0,168,391,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,1161504.0,14452.7344,40.25,hispanic,86.0,1,0,0,no,0.299999952,0.15,no dnr,168.0,67.0,5.69921875,145.0,36.0,39.59375,291.8125,3.5,1.01,1.19995117,135.0,7.5,108.0,20.0,1561.0,0.0,no(M2 and SIP pres)
81.57397,1,male,0,9,64,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,19878.0,11246.7969,12.5,white,17.0,1,0,0,yes,0.899999619,0.75,no dnr,9.0,62.0,6.5,115.0,27.0,38.5,192.0,3.5,1.01,1.09985352,131.0,7.369141,502.0,20.0,4590.0,1.8388672,adl>=4 (>=5 if sur)
83.35895,1,female,1,5,5,Coma,Coma,2,12.0,$25-$50k,22522.0,9069.2344,27.0,white,32.0,1,1,0,no,0.149999976,0.1,dnr after sadm,2.0,107.0,6.19921875,100.0,20.0,38.19531,333.3,4.2998047,0.39996338,1.0,140.0,7.419922,102.0,14.0,1445.0,7.0,<2 mo. follow-up
79.65796,1,male,0,5,84,Lung Cancer,Cancer,1,11.0,under $11k,10991.0,5674.75,10.0,black,23.0,1,0,0,metastatic,0.799999714,0.4,dnr after sadm,1.0,38.0,1.0,145.0,40.0,39.19531,78.75,3.5,10.0,2.69970703,130.0,7.5,117.0,81.0,1315.0,5.0,adl>=4 (>=5 if sur)
18.502,0,female,0,44,386,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,327791.0,124510.062,37.25,hispanic,43.0,3,0,0,no,0.599999905,0.6,no dnr,44.0,115.0,15.0996094,125.0,20.0,38.5,333.3,5.6992188,1.01,0.69995117,149.0,7.419922,151.0,20.0,3865.0,2.4863281,SIP>=30
62.52197,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$11-$25k,279274.0,61933.125,56.5,hispanic,51.0,12,0,0,yes,0.149999976,0.05,dnr after sadm,11.0,48.0,15.2988281,105.0,6.0,36.19531,303.3125,3.2998047,1.09985352,2.5,142.0,7.399414,169.0,43.0,2025.0,7.0,<2 mo. follow-up
66.15198,0,male,0,22,384,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,80163.0,36860.3125,22.0,black,52.0,2,1,0,no,0.949999809,0.85,no dnr,22.0,115.0,2.29980469,125.0,28.0,38.79688,356.0,3.5,17.5976562,1.09985352,136.0,7.379883,243.0,34.0,5026.0,4.0,adl>=4 (>=5 if sur)
86.37097,0,male,0,4,383,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,9019.0,5309.8047,20.0,white,31.0,1,0,1,no,0.899999619,0.75,dnr after sadm,2.0,70.0,7.5,65.0,20.0,36.0,266.625,3.5,1.01,0.79992676,143.0,7.5,322.0,16.0,1350.0,5.9873047,<2 mo. follow-up
59.31,1,female,0,11,242,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,63881.0,27277.3281,29.5,white,55.0,1,0,0,yes,0.899999619,0.7,no dnr,11.0,62.0,2.29980469,105.0,31.0,39.29688,162.0,2.199707,2.29980469,1.59985352,151.0,7.549805,148.0,78.0,2126.0,5.0,SIP>=30
68.34198,1,male,1,24,24,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,59995.78781114967,14452.7344,33.666657,white,29.0,12,0,0,no,0.75,0.75,no dnr,14.58258953168044,58.0,15.1992188,90.0,12.0,36.29688,333.3,3.5,8.0,5.79980469,145.0,7.419922,135.0,130.0,2145.0,1.0,<2 mo. follow-up
26.14099,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,3,14.0,under $11k,87952.0,30212.125,44.5,hispanic,59.0,3,0,0,yes,0.849999905,0.85,dnr after sadm,7.0,75.0,23.5,76.0,20.0,37.0,242.84375,3.5,1.01,1.09985352,132.0,7.439453,136.0,24.0,4200.0,0.0,<2 mo. follow-up
51.26099,1,male,0,49,205,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,230224.0,96777.375,30.5,white,39.0,4,0,1,no,0.799999714,0.4,dnr before sadm,0.0,102.0,17.296875,95.0,20.0,36.0,116.3125,3.199707,1.39990234,1.5,136.0,7.419922,180.0,39.0,2295.0,5.6826172,<2 mo. follow-up
67.09399,0,female,0,68,381,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,433012.0,163304.625,36.25,white,21.0,2,0,0,yes,1.0,1.0,no dnr,68.0,125.0,14.3984375,55.0,8.0,38.89844,322.5,3.5,1.01,0.69995117,134.0,7.469727,315.0,15.0,2055.0,4.0,<2 mo. follow-up
60.26599,0,female,0,5,380,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,13646.0,7869.8555,19.0,black,8.0,1,0,0,no,0.75,0.6,no dnr,5.0,65.0,15.0,125.0,40.0,38.89844,262.8125,3.5,1.01,0.79992676,152.0,7.519531,244.0,30.0,2795.0,0.494751,<2 mo. follow-up
72.375,1,female,0,11,309,COPD,COPD/CHF/Cirrhosis,4,18.0,>$50k,53913.0,20428.3906,20.0,white,44.0,3,0,0,no,0.649999619,0.65,no dnr,11.0,46.0,30.796875,170.0,48.0,36.39844,255.0,3.5,0.89990234,5.09960938,140.0,7.359375,158.0,89.0,349.0,5.0234375,<2 mo. follow-up
47.60599,0,female,0,20,365,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,174923.0,31521.7031,19.333328,white,34.0,13,0,0,yes,0.849999905,0.7,no dnr,20.0,83.0,6.29980469,100.0,22.0,38.0,333.3,3.5,1.01,1.5,138.0,7.419922,135.0,22.0,2850.0,0.0,<2 mo. follow-up
65.25397,1,female,0,17,142,Coma,Coma,1,18.0,$25-$50k,149859.0,38738.5938,32.666657,white,26.0,5,0,0,no,0.549999714,0.5,no dnr,17.0,58.0,14.7988281,75.0,38.0,37.89844,526.5,3.5,1.01,0.79992676,141.0,7.389648,144.0,11.0,1150.0,0.0,adl>=4 (>=5 if sur)
54.103,1,male,0,52,227,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,467237.0,167344.375,51.75,white,80.0,1,0,0,no,0.049999982,0.05,no dnr,52.0,63.0,6.59960938,78.0,20.0,37.89844,333.3,3.5,1.01,1.29980469,138.0,7.419922,152.0,21.0,1500.0,0.0,<2 mo. follow-up
65.71698,1,female,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,3,18.0,>$50k,460259.0,173739.375,49.0,asian,31.0,1,0,0,no,0.699999809,0.7,no dnr,41.0,65.0,14.1992188,140.0,15.0,39.5,182.21875,1.7998047,3.0,0.5,141.0,7.389648,236.0,8.0,3835.0,1.0,<2 mo. follow-up
83.06598,0,female,0,17,362,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,118843.0,29307.4219,22.666656,black,26.0,16,0,0,metastatic,0.5,0.15,no dnr,17.0,72.0,3.0,70.0,31.0,38.09375,135.0,3.5,2.79980469,0.89990234,148.0,7.539062,398.0,41.0,4700.0,1.0,<2 mo. follow-up
85.45099,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,under $11k,65216.0,14452.7344,33.5,white,60.0,1,0,0,yes,0.299999952,0.3,no dnr,7.0,78.0,10.8984375,125.0,22.0,38.19531,122.4375,3.5,0.29998779,4.89941406,133.0,7.319336,373.0,117.0,1475.0,4.5664062,<2 mo. follow-up
74.37396,0,male,0,10,360,CHF,COPD/CHF/Cirrhosis,4,6.0,$11-$25k,23855.0,14452.7344,11.5,white,19.0,1,0,0,no,0.799999714,0.5,no dnr,10.0,75.0,9.29882812,64.0,12.0,36.59375,333.3,3.3999023,1.19995117,1.59985352,134.0,7.419922,97.0,24.0,2950.0,0.0,no(M2 and SIP pres)
67.81696,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,56904.0,22632.4375,30.5,white,70.0,2,1,0,yes,0.099999964,0.0,dnr after sadm,2.0,113.0,0.04999542,130.0,11.0,39.09375,333.3,1.8999023,1.01,0.5,135.0,7.419922,114.0,15.0,4684.0,7.0,<2 mo. follow-up
76.099,0,female,0,9,356,COPD,COPD/CHF/Cirrhosis,4,19.0,$11-$25k,53633.0,15800.9922,16.5,white,54.0,6,0,0,metastatic,0.599999905,0.5,no dnr,9.0,75.0,15.7988281,115.0,10.0,36.39844,222.5,3.5,4.19921875,0.79992676,133.0,7.419922,135.0,20.0,2420.0,0.0,no(M2 and SIP pres)
63.978,1,female,0,11,185,Colon Cancer,Cancer,1,13.0,$11-$25k,21967.0,11803.8203,13.5,white,19.0,1,0,0,metastatic,0.799999714,0.5,no dnr,11.0,73.0,0.59997559,70.0,14.0,39.09375,153.03125,3.5,3.19970703,1.59985352,141.0,7.399414,135.0,30.0,3295.0,1.1667481,<2 mo. follow-up
80.50397,1,male,1,4,4,Coma,Coma,2,12.0,under $11k,23637.0,9525.2812,23.0,white,20.0,1,1,1,no,0.899999619,0.9,dnr before sadm,-1.0,48.0,10.8984375,55.0,10.0,36.19531,41.0,3.5,1.01,0.89990234,134.0,7.549805,109.0,20.0,2460.0,4.5996094,<2 mo. follow-up
60.69299,0,male,0,3,355,CHF,COPD/CHF/Cirrhosis,2,15.0,under $11k,8561.0,3575.4902,28.0,white,19.0,1,0,0,no,0.899999619,0.8,no dnr,3.0,72.0,21.296875,115.0,24.0,38.19531,272.0,3.5,1.01,0.69995117,135.0,7.30957,173.0,7.0,2180.0,0.0,no(M2 and SIP pres)
72.01898,1,male,0,24,58,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,136226.0,57056.75,36.333313,white,41.0,2,0,0,no,0.849999905,0.8,no dnr,24.0,78.0,5.29980469,80.0,20.0,36.0,333.3,3.5,1.01,1.09985352,139.0,7.419922,110.0,16.0,3800.0,0.0,<2 mo. follow-up
54.73798,0,male,0,17,352,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,156205.0,84656.0,34.333313,white,31.0,1,0,0,no,0.599999905,0.5,no dnr,17.0,62.0,13.1992188,115.0,35.0,37.89844,103.32812,3.5,1.01,0.39996338,126.0,7.319336,135.0,2.0,1000.0,1.0,no(M2 and SIP pres)
45.85898,0,female,0,34,352,Coma,Coma,0,12.0,under $11k,502025.0,102793.438,31.5,white,34.0,31,0,0,no,0.5,0.4,no dnr,34.0,106.0,17.5976562,105.0,26.0,36.89844,301.0,3.5,1.01,0.39996338,143.0,7.619141,209.0,28.0,1590.0,0.0,adl>=4 (>=5 if sur)
63.53998,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,647638.0,142198.625,51.0,hispanic,83.0,27,0,0,no,0.049999982,0.02,dnr after sadm,21.0,120.0,10.2988281,120.0,25.0,37.79688,210.0,3.5,1.01,1.19995117,142.0,7.5,135.0,15.0,3445.0,0.0,<2 mo. follow-up
84.70599,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,3,19.0,>$50k,26000.0,11751.9062,17.0,white,51.0,1,0,1,yes,0.699999809,0.4,dnr after sadm,2.0,67.0,15.8984375,175.0,14.0,39.19531,135.6875,4.1992188,9.59960938,2.79980469,156.0,7.459961,196.0,83.0,6910.0,5.8369141,<2 mo. follow-up
63.017,1,male,0,9,31,Lung Cancer,Cancer,1,27.0,>$50k,26494.0,13606.3359,13.0,white,8.0,1,0,0,metastatic,1.0,0.6,no dnr,9.0,132.0,21.296875,105.0,24.0,38.0,288.5625,2.2998047,1.0,0.79992676,130.0,7.439453,135.0,24.0,6603.0,0.494751,<2 mo. follow-up
30.741,0,female,0,56,346,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,364515.0,188889.25,34.75,black,62.0,1,0,0,no,0.599999905,0.4,no dnr,56.0,68.0,12.6992188,95.0,29.0,36.79688,250.0,3.5,1.01,1.0,137.0,7.5,147.0,22.0,2028.0,0.0,no(M2 and SIP pres)
29.10899,1,female,0,8,29,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,44220.0,16745.4844,24.0,white,32.0,2,0,0,no,0.75,0.7,no dnr,8.0,60.0,19.296875,135.0,20.0,37.0,70.0,2.5996094,1.01,2.5,131.0,7.239258,92.0,80.0,1109.0,3.0449219,<2 mo. follow-up
59.31,0,male,0,5,346,Colon Cancer,Cancer,1,15.0,>$50k,59995.78781114967,14452.7344,11.0,white,11.0,1,0,0,metastatic,1.0,0.95,no dnr,14.58258953168044,69.0,8.5,105.0,24.0,36.0,333.3,4.1992188,0.79992676,1.19995117,142.0,7.419922,117.0,18.0,1810.0,1.8730469,no(M2 and SIP pres)
49.76898,1,female,1,86,86,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,59995.78781114967,14452.7344,47.0,white,46.0,15,0,0,no,0.5,0.5,dnr after sadm,46.0,45.0,7.89941406,125.0,28.0,37.79688,322.8125,2.5996094,1.01,8.19921875,143.0,7.40918,293.0,58.0,0.0,3.3203125,adl>=4 (>=5 if sur)
47.978,0,male,0,6,345,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,23716.0,9634.25,34.0,white,47.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,122.0,9.5,120.0,30.0,38.0,75.5,3.5,1.01,0.89990234,132.0,7.519531,135.0,19.0,2560.0,2.3818359,<2 mo. follow-up
65.17999,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,>$50k,218454.0,27713.5,55.0,white,81.0,11,1,0,no,0.099999964,0.1,dnr after sadm,4.0,73.0,10.0,136.0,20.0,38.59375,333.3,3.5,0.09999084,0.69995117,135.0,7.419922,135.0,13.0,4500.0,1.0,<2 mo. follow-up
69.92694,1,male,0,20,308,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,94568.0,38181.5312,32.0,white,57.0,1,0,0,yes,0.599999905,0.4,no dnr,20.0,83.0,17.8984375,95.0,24.0,38.29688,150.0,3.5,0.69995117,1.29980469,149.0,7.5,431.0,37.0,3850.0,3.5058594,SIP>=30
66.57599,1,male,1,5,5,Colon Cancer,Cancer,1,12.0,$25-$50k,4971.0,3593.7559,12.0,white,66.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,64.0,13.8984375,64.0,24.0,36.79688,81.65625,2.7998047,20.3984375,2.39990234,131.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.23999,1,male,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,16101.0,9690.9844,17.0,white,68.0,12,0,0,no,0.899999619,0.8,dnr after sadm,4.0,67.0,15.0,92.0,20.0,34.69531,333.3,2.3999023,30.5976562,4.59960938,117.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.13599,1,male,0,8,14,Colon Cancer,Cancer,1,12.0,under $11k,7688.0,2069.8438,7.5,white,26.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,90.0,10.3984375,90.0,25.0,37.0,333.3,2.5996094,0.79992676,1.79980469,139.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
71.18994,1,male,0,4,211,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,3214.0,2426.2617,11.0,black,26.0,1,0,0,yes,0.989999771,0.98,no dnr,4.0,107.0,15.2988281,78.0,28.0,36.29688,400.0,3.5,1.01,1.59985352,142.0,7.449219,135.0,23.0,2502.0,2.578125,SIP>=30
59.59799,1,male,0,7,37,Lung Cancer,Cancer,2,15.0,under $11k,7063.0,5217.0,11.0,white,17.0,1,0,0,metastatic,0.899999619,0.5,no dnr,7.0,82.0,18.0,92.0,32.0,38.0,308.0,3.0996094,0.89990234,0.79992676,124.0,7.479492,135.0,23.0,2502.0,3.402832,<2 mo. follow-up
65.81,0,male,0,8,2029,CHF,COPD/CHF/Cirrhosis,1,15.0,under $11k,7104.0,5181.7969,9.5,black,26.0,1,0,0,no,1.0,1.0,no dnr,8.0,113.0,5.39941406,100.0,20.0,37.59375,380.9375,4.5,1.01,1.79980469,143.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.88495,0,female,0,8,2028,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,7143.0,5452.7578,8.0,white,48.0,1,0,0,no,0.949999809,0.75,dnr after sadm,1.0,60.0,11.1992188,64.0,25.0,36.0,252.0,4.0,0.59997559,5.39941406,129.0,7.5,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
42.70499,1,male,0,5,17,Lung Cancer,Cancer,1,14.0,$11-$25k,6662.0,4805.4062,20.0,white,11.0,1,0,0,metastatic,0.699999809,0.3,no dnr,5.0,73.0,7.5,72.0,24.0,36.19531,333.3,2.699707,0.19998169,0.69995117,136.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
79.35095,1,male,0,10,31,CHF,COPD/CHF/Cirrhosis,4,7.0,under $11k,10774.0,8725.1875,8.0,white,28.0,1,1,0,yes,0.799999714,0.5,no dnr,10.0,101.0,10.6992188,74.0,16.0,36.09375,155.09375,4.2998047,1.01,1.89990234,131.0,7.359375,135.0,23.0,2502.0,1.0,<2 mo. follow-up
34.14398,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,44464.0,19419.25,43.333313,white,71.0,1,0,0,no,0.829999924,0.83,dnr after sadm,13.0,45.0,17.0976562,158.0,40.0,37.5,121.65625,2.7998047,3.5,1.39990234,145.0,7.539062,135.0,23.0,2502.0,4.1367188,<2 mo. follow-up
85.12799,1,female,0,8,101,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,11331.0,6966.8047,12.5,hispanic,41.0,3,0,0,no,0.899999619,0.8,no dnr,8.0,76.0,7.09960938,102.0,24.0,36.59375,209.5,3.0996094,0.39996338,0.89990234,134.0,7.5,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
80.33398,0,male,0,9,2027,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,15306.0,9417.1719,16.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,56.0,14.1992188,75.0,20.0,37.0,337.0,3.5996094,1.01,1.19995117,142.0,7.399414,135.0,23.0,2502.0,2.8393555,<2 mo. follow-up
62.84497,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,79451.0,59804.6562,51.0,white,59.0,20,0,0,no,0.699999809,0.5,dnr after sadm,5.0,40.0,18.0976562,158.0,28.0,37.59375,240.0,3.5,1.01,4.5,135.0,7.439453,135.0,23.0,2502.0,2.3706055,<2 mo. follow-up
56.91199,1,male,0,14,40,Lung Cancer,Cancer,1,15.0,$25-$50k,13620.0,12023.5703,9.333328,white,41.0,1,0,0,metastatic,0.5,0.1,dnr before sadm,-1.0,60.0,7.09960938,140.0,40.0,38.29688,304.75,3.0,0.59997559,0.79992676,136.0,7.439453,135.0,23.0,2502.0,2.0,<2 mo. follow-up
44.47897,1,female,0,22,111,Lung Cancer,Cancer,1,13.0,$25-$50k,25121.0,20401.625,13.0,white,28.0,1,0,0,metastatic,0.5,0.4,dnr after sadm,1.0,67.0,8.09960938,107.0,8.0,36.29688,381.625,2.3999023,0.39996338,1.39990234,136.0,7.339844,135.0,23.0,2502.0,3.9077148,adl>=4 (>=5 if sur)
29.13599,1,male,0,15,59,MOSF w/Malig,ARF/MOSF,1,18.0,under $11k,20860.0,16367.9531,9.666664,white,42.0,1,0,0,yes,0.199999928,0.05,dnr after sadm,1.0,67.0,27.8984375,112.0,24.0,38.29688,333.3,1.8999023,3.69970703,1.09985352,118.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
82.06396,0,male,0,4,2024,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,3265.0,2432.3867,14.0,white,37.0,1,1,0,no,0.599999905,0.5,no dnr,4.0,70.0,16.8984375,80.0,20.0,36.09375,290.4375,3.5,1.01,1.5,135.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.63699,0,male,0,12,2024,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,10749.0,8246.9922,12.0,white,40.0,1,0,0,no,0.5,0.2,no dnr,12.0,79.0,10.0996094,124.0,42.0,40.09375,227.5,4.0996094,1.0,1.19995117,132.0,7.489258,135.0,23.0,2502.0,2.4262695,<2 mo. follow-up
90.89099,1,female,0,16,64,Colon Cancer,Cancer,2,11.0,under $11k,13201.0,10254.375,6.0,other,27.0,1,1,0,metastatic,0.5,0.1,dnr after sadm,1.0,81.0,7.0,80.0,20.0,36.5,323.75,3.5996094,0.89990234,1.59985352,135.0,7.30957,135.0,23.0,2502.0,2.0,<2 mo. follow-up
70.80396,1,female,0,12,18,Lung Cancer,Cancer,4,12.0,under $11k,13253.0,10580.3281,7.5,white,33.0,1,0,0,metastatic,0.699999809,0.1,dnr after sadm,1.0,73.0,11.7988281,120.0,28.0,36.09375,395.1875,3.3999023,0.5,1.19995117,135.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
82.11896,0,female,0,3,2022,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,3189.0,2218.0117,12.0,white,23.0,1,1,1,no,1.0,0.75,no dnr,3.0,92.0,6.29980469,60.0,24.0,36.29688,333.3,3.5,1.01,1.59985352,136.0,7.419922,135.0,23.0,2502.0,3.9838867,no(M2 and SIP pres)
30.03999,0,male,0,12,2022,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,17692.0,9315.7969,16.5,black,12.0,1,0,0,no,0.849999905,0.85,no dnr,12.0,89.0,9.69921875,102.0,24.0,38.69531,333.3,2.2998047,0.39996338,0.5,146.0,7.419922,135.0,23.0,2502.0,2.2026367,adl>=4 (>=5 if sur)
83.65796,1,female,0,9,744,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,6931.0,5280.9766,5.5,white,25.0,1,0,0,no,0.5,0.125,dnr after sadm,1.0,95.0,18.6992188,104.0,25.0,37.29688,504.0625,3.5,1.01,1.19995117,146.0,7.5,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
77.66699,1,male,1,20,20,CHF,COPD/CHF/Cirrhosis,3,15.0,under $11k,16398.0,13352.3125,5.333332,white,42.0,1,1,0,no,0.799999714,0.512,no dnr,20.0,69.0,9.8984375,74.0,16.0,36.79688,204.0,4.1992188,1.01,2.29980469,137.0,7.419922,135.0,23.0,2502.0,2.9882812,<2 mo. follow-up
93.75494,1,female,0,13,102,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,10622.0,8300.2734,14.5,white,53.0,1,0,0,no,0.949999809,0.9,dnr after sadm,1.0,66.0,5.09960938,140.0,36.0,38.69531,333.3,3.7998047,1.01,1.79980469,136.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
63.48499,1,female,0,23,52,Lung Cancer,Cancer,1,12.0,$11-$25k,22166.0,18582.3438,13.333328,black,28.0,1,0,0,metastatic,0.649999619,0.35,dnr after sadm,1.0,53.0,20.296875,112.0,20.0,37.29688,333.3,2.699707,0.5,0.79992676,133.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
58.63898,0,male,0,15,2019,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,17714.0,11645.3594,20.333328,white,42.0,1,0,0,yes,0.5,0.02,no dnr,15.0,49.0,14.5,118.0,32.0,36.19531,243.3125,3.2998047,1.29980469,1.09985352,124.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.10095,1,female,0,42,1115,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,42058.0,28787.5156,14.5,white,39.0,1,1,0,no,0.699999809,0.5,no dnr,42.0,65.0,18.3984375,44.0,24.0,37.29688,388.0,2.199707,1.09985352,1.89990234,142.0,7.329102,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
51.52399,0,female,0,10,2017,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9931.0,5960.7148,18.5,white,21.0,1,0,0,no,0.989999771,0.98,no dnr,10.0,63.0,3.59960938,98.0,40.0,39.09375,302.5,3.0,0.39996338,0.59997559,136.0,7.439453,135.0,23.0,2502.0,2.4150391,<2 mo. follow-up
95.56494,1,female,0,5,1668,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,4417.0,3155.0312,10.0,white,56.0,1,1,0,no,0.949999809,0.9,no dnr,5.0,77.0,12.6992188,160.0,28.0,36.69531,460.0,4.0,1.19995117,1.69995117,144.0,7.459961,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
55.42499,1,female,0,11,93,Lung Cancer,Cancer,1,13.0,under $11k,10085.0,7489.4961,12.5,white,14.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,2.0,73.0,8.0,104.0,24.0,37.0,333.3,2.5996094,0.89990234,0.79992676,128.0,7.419922,135.0,23.0,2502.0,3.2207031,no(M2 and SIP pres)
53.42099,0,male,0,9,2016,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,14593.0,8761.5156,14.0,white,13.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,83.0,13.5996094,78.0,32.0,38.29688,333.3,2.7998047,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
84.33099,0,male,0,12,2016,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,17909.0,13563.3047,22.0,white,34.0,1,0,0,no,0.599999905,0.5,no dnr,12.0,75.0,10.3984375,68.0,16.0,38.5,108.0,3.7998047,0.29998779,1.39990234,142.0,7.40918,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
57.23199,1,female,0,5,236,Lung Cancer,Cancer,1,9.0,$11-$25k,4652.0,3553.2793,16.0,asian,10.0,1,0,0,metastatic,0.899999619,0.7,no dnr,5.0,107.0,7.5,100.0,18.0,36.89844,333.3,4.1992188,1.01,0.89990234,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.74597,0,female,0,45,2015,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,94302.0,24157.2031,34.0,white,44.0,1,0,0,no,0.299999952,0.3,no dnr,45.0,103.0,3.09960938,158.0,10.0,39.59375,200.0,2.199707,3.59960938,0.69995117,132.0,7.279297,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
87.20099,1,female,0,23,217,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,21775.0,14229.2656,10.0,white,31.0,1,0,0,no,0.799999714,0.8,no dnr,23.0,67.0,8.19921875,88.0,24.0,38.0,453.0,3.5,1.01,1.59985352,139.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.29596,1,female,1,7,7,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,11442.0,3974.5703,26.0,white,20.0,1,0,0,no,0.299999952,0.1,no dnr,7.0,98.0,5.0,40.0,24.0,38.0,200.0,3.5,0.5,0.59997559,141.0,7.359375,135.0,23.0,2502.0,2.0,<2 mo. follow-up
78.26099,1,male,0,9,176,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,13574.0,10652.4219,18.5,white,31.0,1,0,0,no,0.5,0.3,dnr before sadm,-1.0,75.0,7.0,103.0,20.0,38.0,127.5,3.5,1.01,1.09985352,128.0,7.509766,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
75.99695,1,male,0,39,1423,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,81626.0,562.814,29.25,white,37.0,4,0,0,no,0.699999809,0.5,no dnr,39.0,112.0,9.29882812,83.0,18.0,38.39844,196.0,3.0,1.01,3.79980469,139.0,7.399414,135.0,23.0,2502.0,1.1668997,adl>=4 (>=5 if sur)
60.86798,1,male,0,128,476,ARF/MOSF w/Sepsis,ARF/MOSF,2,4.0,under $11k,259334.0,74035.125,25.25,white,48.0,12,0,0,no,0.699999809,0.6,no dnr,128.0,129.0,10.2988281,114.0,28.0,37.19531,376.625,3.5,1.01,10.8984375,134.0,7.339844,135.0,23.0,2502.0,2.0,<2 mo. follow-up
57.11697,1,male,0,5,375,Lung Cancer,Cancer,1,12.0,>$50k,8150.0,5800.4766,15.0,white,9.0,1,0,0,metastatic,0.799999714,0.4,no dnr,5.0,93.0,6.69921875,84.0,20.0,38.0,333.3,3.5,0.39996338,1.0,142.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
67.38898,1,male,0,5,38,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,6146.0,3244.582,6.0,white,13.0,2,0,0,no,0.599999905,0.4,no dnr,5.0,80.0,9.0,80.0,24.0,36.69531,333.3,3.5,1.01,1.29980469,144.0,7.419922,135.0,23.0,2502.0,4.5273972,<2 mo. follow-up
71.90094,0,male,0,9,2010,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,27244.0,20179.2031,21.0,white,31.0,6,0,0,yes,0.699999809,0.5,no dnr,9.0,75.0,6.69921875,58.0,12.0,36.0,214.28125,3.5,0.39996338,1.89990234,137.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
21.20999,0,male,0,5,2009,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,6719.0,3303.125,7.0,white,45.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,129.0,8.29882812,70.0,26.0,36.19531,306.625,3.0996094,0.29998779,12.3984375,156.0,7.239258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.67297,1,male,1,3,3,Coma,Coma,0,17.0,$11-$25k,6521.0,2071.1094,22.0,black,81.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,33.0,5.09960938,0.0,0.0,35.19531,211.65625,3.199707,0.5,2.39990234,145.0,7.379883,135.0,23.0,2502.0,2.2983398,<2 mo. follow-up
71.45197,0,female,0,5,2008,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,4995.0,4014.6133,7.0,black,26.0,1,0,0,no,0.899999619,0.7,no dnr,5.0,110.0,4.59960938,66.0,20.0,36.79688,176.65625,3.5,0.29998779,1.5,141.0,7.179688,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
76.15094,1,male,1,26,26,Lung Cancer,Cancer,1,12.0,under $11k,16484.0,13867.6016,3.75,white,18.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,1.0,77.0,9.5,100.0,22.0,36.69531,333.3,2.699707,0.39996338,0.69995117,128.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
64.99396,0,male,0,6,2005,CHF,COPD/CHF/Cirrhosis,1,17.0,$11-$25k,7826.0,3351.7012,7.0,white,24.0,1,0,0,no,0.799999714,0.75,no dnr,6.0,73.0,4.0,114.0,20.0,36.19531,333.3,3.5,1.01,1.29980469,137.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
37.81,0,male,0,17,2005,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,57170.0,420.3059,36.0,white,81.0,6,0,0,no,0.599999905,0.6,no dnr,17.0,47.0,17.8984375,147.0,40.0,38.89844,80.0,2.2998047,1.01,2.29980469,138.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.01498,0,male,0,8,2004,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,under $11k,9923.0,6147.9219,13.0,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,73.0,7.59960938,50.0,16.0,36.79688,309.5,4.6992188,1.29980469,0.59997559,135.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
62.84698,1,male,1,29,29,MOSF w/Malig,ARF/MOSF,2,14.0,under $11k,46029.0,28832.4688,16.0,white,49.0,8,1,0,metastatic,0.599999905,0.216,dnr after sadm,22.0,63.0,32.3984375,66.0,28.0,36.79688,200.0,2.8999023,1.09985352,4.09960938,128.0,7.399414,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
74.77899,1,male,0,7,1769,CHF,COPD/CHF/Cirrhosis,1,9.0,under $11k,10348.0,9178.2422,8.0,white,27.0,3,0,0,no,0.799999714,0.7,no dnr,7.0,65.0,11.1992188,68.0,22.0,36.0,333.3,3.5,1.01,1.59985352,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.67694,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,27784.0,20989.0,38.0,white,34.0,8,1,0,no,0.399999857,0.2,dnr after sadm,1.0,73.0,12.2988281,77.0,22.0,36.29688,296.625,3.5,0.29998779,2.39990234,137.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
24.78,0,female,0,13,1999,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,20322.0,12712.5781,16.0,black,23.0,6,0,0,no,0.989999771,0.99,no dnr,13.0,60.0,13.1992188,115.0,28.0,37.0,204.0625,3.5,1.01,0.59997559,137.0,7.459961,135.0,23.0,2502.0,4.0,<2 mo. follow-up
72.95294,1,male,0,16,29,Lung Cancer,Cancer,1,14.0,$11-$25k,13340.0,11943.1562,7.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,62.0,7.69921875,62.0,16.0,36.5,333.3,3.5996094,0.69995117,0.79992676,132.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
31.56699,0,male,0,43,1998,ARF/MOSF w/Sepsis,ARF/MOSF,3,18.0,under $11k,46374.0,29131.6406,13.25,white,42.0,1,0,0,yes,1.0,0.99,no dnr,43.0,57.0,17.6992188,130.0,34.0,39.59375,167.34375,2.699707,0.79992676,1.5,138.0,7.379883,135.0,23.0,2502.0,1.0,<2 mo. follow-up
56.961,0,male,0,17,1998,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,$25-$50k,19128.0,13759.375,13.666664,white,26.0,1,0,0,no,0.799999714,0.7,no dnr,17.0,71.0,6.0,77.0,32.0,37.0,306.625,2.5,2.5,0.79992676,135.0,7.429688,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
85.31995,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,10257.0,7788.1328,35.0,white,52.0,1,1,0,no,0.099999964,0.001,dnr after sadm,2.0,57.0,11.7988281,155.0,8.0,38.69531,310.0,3.199707,0.39996338,1.5,140.0,7.259766,135.0,23.0,2502.0,4.0,<2 mo. follow-up
65.70599,1,female,1,4,4,Colon Cancer,Cancer,1,12.0,under $11k,2924.0,2225.625,7.0,white,79.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,53.0,0.29998779,112.0,30.0,36.69531,661.625,1.6999512,1.09985352,1.39990234,141.0,7.289062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
87.19196,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,15135.0,13666.3828,31.0,white,68.0,3,1,0,no,0.0,0.0,dnr after sadm,1.0,30.0,23.6992188,55.0,10.0,37.59375,197.5,3.5,1.01,2.5,130.0,7.289062,135.0,23.0,2502.0,6.0,<2 mo. follow-up
73.35199,0,male,0,12,1994,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,16690.0,13542.2344,20.5,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,73.0,8.29882812,88.0,32.0,38.19531,350.0,2.699707,1.01,0.89990234,146.0,7.439453,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
88.89795,1,female,0,14,21,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,15777.0,8660.6016,15.0,white,42.0,1,1,0,no,0.5,0.5,dnr after sadm,1.0,56.0,6.59960938,51.0,12.0,37.59375,247.59375,2.5,0.29998779,0.39996338,140.0,7.429688,135.0,23.0,2502.0,6.0,<2 mo. follow-up
68.26294,1,male,0,7,20,Lung Cancer,Cancer,2,12.0,under $11k,5599.0,4413.5742,21.0,white,36.0,1,1,0,metastatic,0.5,0.1,dnr before sadm,-1.0,77.0,13.1992188,110.0,28.0,36.0,333.3,2.8999023,0.59997559,1.0,135.0,7.419922,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
72.47595,0,male,0,38,1993,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,55572.0,46378.6875,26.75,white,38.0,1,1,0,no,0.5,0.4,dnr after sadm,28.0,61.0,6.09960938,97.0,9.0,38.39844,156.0,3.5,1.01,2.5,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.54999,1,female,0,13,25,Lung Cancer,Cancer,1,15.0,$11-$25k,10349.0,7812.418,10.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,83.0,8.0,90.0,20.0,37.0,333.3,3.3999023,0.29998779,0.79992676,134.0,7.419922,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
77.32495,1,male,0,7,34,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,12638.0,8273.2656,19.0,white,48.0,3,0,0,yes,0.0,0.0,no dnr,7.0,107.0,100.0,82.0,30.0,37.69531,122.5,3.5,1.5,1.5,146.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
73.91095,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,46732.0,21987.5,33.666657,white,31.0,1,0,0,no,0.5,0.4,dnr after sadm,13.0,77.0,9.69921875,80.0,30.0,38.39844,166.0,3.5,1.01,1.09985352,133.0,7.349609,135.0,23.0,2502.0,2.5981445,<2 mo. follow-up
61.43997,0,female,0,12,1990,Cirrhosis,COPD/CHF/Cirrhosis,4,11.0,under $11k,9601.0,7848.5742,9.0,black,35.0,1,0,0,no,0.899999619,0.8,no dnr,12.0,77.0,6.19921875,94.0,16.0,36.0,333.3,3.5,1.01,18.3984375,137.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
74.33795,1,male,0,8,85,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,6024.0,4765.9258,8.0,white,36.0,1,0,0,no,0.799999714,0.4,dnr after sadm,1.0,81.0,9.5,84.0,32.0,37.29688,195.21875,3.5,1.01,1.0,142.0,7.319336,135.0,23.0,2502.0,3.0766602,adl>=4 (>=5 if sur)
51.461,0,female,0,27,1989,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,30321.0,23567.2188,9.75,white,64.0,1,0,0,no,0.699999809,0.5,no dnr,27.0,73.0,8.578125,140.0,22.0,38.59375,384.0,2.199707,17.6992188,1.59985352,135.0,7.379883,135.0,23.0,2502.0,3.5332031,SIP>=30
61.98499,0,male,0,5,1988,Colon Cancer,Cancer,1,20.0,$11-$25k,3503.0,2697.7246,4.0,white,16.0,1,0,0,metastatic,0.5,0.1,no dnr,5.0,93.0,10.5996094,60.0,20.0,37.0,333.3,3.5,1.01,1.29980469,138.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
89.36597,1,male,0,5,167,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4119.0,3051.9258,12.0,white,30.0,1,0,0,no,0.899999619,0.5,dnr after sadm,2.0,73.0,4.89941406,74.0,28.0,36.09375,276.0,3.5,1.01,1.29980469,144.0,7.419922,135.0,23.0,2502.0,4.5273972,adl>=4 (>=5 if sur)
85.85596,1,male,0,12,69,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,10144.0,7912.125,14.5,white,49.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,105.0,3.29980469,78.0,22.0,35.89844,233.3125,3.5,1.01,3.0,140.0,7.289062,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
83.69299,1,female,0,7,1237,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,8571.0,7353.4258,23.0,white,21.0,1,0,1,no,0.699999809,0.5,dnr before sadm,-1.0,60.0,9.3984375,64.0,24.0,38.29688,266.625,3.5,1.01,0.59997559,142.0,7.449219,135.0,23.0,2502.0,4.7822266,adl>=4 (>=5 if sur)
50.36798,1,male,0,7,427,Lung Cancer,Cancer,1,20.0,>$50k,10558.0,7541.6172,12.0,white,11.0,1,0,0,metastatic,0.779999733,0.1,no dnr,7.0,103.0,11.0996094,96.0,24.0,38.19531,333.3,3.8999023,1.01,1.19995117,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.435,0,male,0,3,1985,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,2722.0,1893.0508,5.0,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,92.0,10.6992188,74.0,20.0,36.39844,388.0,3.5,1.01,2.59960938,136.0,7.419922,135.0,23.0,2502.0,1.9543457,no(M2 and SIP pres)
81.57196,1,female,1,33,33,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,42506.0,25386.0312,16.25,white,41.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,26.0,113.0,6.89941406,134.0,42.0,38.59375,304.0,2.699707,0.59997559,0.89990234,132.0,7.40918,135.0,23.0,2502.0,3.2646484,<2 mo. follow-up
75.16498,1,male,0,18,39,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,19845.0,14452.7344,12.0,white,25.0,1,0,0,yes,0.799999714,0.6,dnr before sadm,-1.0,83.0,6.69921875,60.0,24.0,36.19531,188.3125,3.199707,1.09985352,2.19970703,141.0,7.339844,135.0,23.0,2502.0,3.3955078,<2 mo. follow-up
28.411,0,female,0,11,1982,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,15781.0,8793.8828,16.5,white,36.0,1,0,0,no,0.949999809,0.94,no dnr,11.0,57.0,8.3984375,117.0,44.0,38.39844,177.5,3.5996094,0.39996338,0.69995117,137.0,7.399414,135.0,23.0,2502.0,2.3706055,no(M2 and SIP pres)
75.80298,1,female,0,15,265,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,20469.0,11248.2812,20.333328,white,54.0,1,1,0,no,0.699999809,0.5,no dnr,15.0,130.0,20.0,126.0,36.0,38.59375,289.0,3.5,1.01,1.79980469,143.0,7.399414,135.0,23.0,2502.0,3.3759766,adl>=4 (>=5 if sur)
40.77798,0,male,0,10,1983,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,$11-$25k,15497.0,6732.6719,24.5,white,50.0,1,1,0,no,0.949999809,0.8,no dnr,10.0,61.0,15.0,110.0,26.0,36.29688,386.625,2.2998047,1.01,2.0,136.0,7.269531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.10699,1,male,0,11,220,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,40364.0,27025.0312,20.5,white,32.0,6,1,0,no,0.899999619,0.7,no dnr,11.0,106.0,7.29980469,62.0,6.0,34.79688,341.0,3.5,1.01,1.19995117,134.0,7.509766,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
81.40997,1,female,0,11,158,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15727.0,13627.2422,26.5,white,22.0,1,0,0,no,0.699999809,0.4,no dnr,11.0,61.0,5.19921875,89.0,11.0,36.39844,210.1875,3.5,1.01,1.19995117,139.0,7.439453,135.0,23.0,2502.0,2.9394531,adl>=4 (>=5 if sur)
83.51495,1,female,1,9,9,Coma,Coma,2,12.0,under $11k,21857.0,9337.4766,34.5,white,49.0,3,0,0,no,0.0,0.0,dnr after sadm,6.0,133.0,18.796875,105.0,38.0,37.29688,208.0,2.8999023,1.01,2.29980469,133.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
46.27798,0,male,0,5,1979,Lung Cancer,Cancer,1,16.0,$25-$50k,6112.0,4393.9492,15.0,white,10.0,1,0,0,metastatic,0.949999809,0.9,no dnr,5.0,93.0,8.69921875,110.0,20.0,36.19531,333.3,3.2998047,1.01,0.89990234,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.06494,1,male,0,6,173,Lung Cancer,Cancer,1,12.0,$11-$25k,9324.0,6639.1523,18.0,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,87.0,7.79980469,70.0,20.0,37.0,333.3,3.199707,0.5,1.19995117,140.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
71.84399,0,female,0,142,1978,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,247553.0,14452.7344,34.25,white,36.0,33,0,0,no,0.899999619,0.9,dnr after sadm,17.0,108.0,13.2988281,112.0,37.0,40.19531,308.0,3.5,1.01,0.69995117,145.0,7.459961,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
57.85599,0,female,0,4,1978,Lung Cancer,Cancer,1,11.0,$11-$25k,6191.0,4342.793,18.0,black,7.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,99.0,6.09960938,80.0,20.0,36.59375,333.3,3.5,1.01,1.19995117,144.0,7.419922,135.0,23.0,2502.0,1.9558106,no(M2 and SIP pres)
91.35394,1,female,0,10,287,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,9472.0,5058.6484,14.5,black,41.0,1,0,1,no,0.5,0.3,dnr after sadm,1.0,77.0,7.69921875,104.0,26.0,37.29688,593.25,1.7998047,0.69995117,1.39990234,156.0,7.419922,135.0,23.0,2502.0,6.2675781,adl>=4 (>=5 if sur)
84.32599,1,male,0,11,589,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8797.0,6918.1875,15.0,white,32.0,1,0,0,no,0.699999809,0.343,no dnr,11.0,82.0,8.69921875,58.0,28.0,37.0,360.0,3.5,1.01,3.39990234,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.74097,1,male,0,8,25,Colon Cancer,Cancer,1,12.0,$11-$25k,6911.0,5281.0781,8.0,white,43.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,1.0,96.0,13.1992188,94.0,18.0,37.5,333.3,2.3999023,25.5976562,1.29980469,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.75995,1,male,1,37,37,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,35881.0,29816.2656,12.5,white,46.0,1,0,0,no,0.799999714,0.7,dnr after sadm,23.0,44.0,7.89941406,76.0,24.0,35.79688,376.1875,3.5,1.01,1.59985352,136.0,7.5,135.0,23.0,2502.0,3.0,<2 mo. follow-up
50.59,0,male,0,26,1973,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,>$50k,49205.0,44503.75,28.25,white,67.0,1,0,0,no,0.299999952,0.3,no dnr,26.0,43.0,3.79980469,78.0,10.0,36.19531,142.0,2.0996094,0.39996338,7.0,132.0,7.089844,135.0,23.0,2502.0,0.0,SIP>=30
73.336,1,female,0,25,1944,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,50127.0,37894.8438,24.75,white,36.0,7,0,0,no,0.799999714,0.8,no dnr,25.0,109.0,12.2988281,66.0,26.0,38.19531,147.5,3.0996094,2.39990234,1.39990234,135.0,7.489258,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
82.60394,1,female,0,31,1471,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,38687.0,27226.2812,12.25,white,49.0,2,0,0,yes,0.899999619,0.8,no dnr,31.0,57.0,8.0,49.0,22.0,36.39844,300.0,3.3999023,0.5,2.29980469,134.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.49597,0,male,0,10,1971,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,12827.0,10778.3125,25.5,white,32.0,1,1,0,no,0.959999561,0.95,no dnr,10.0,116.0,5.0,51.0,24.0,36.59375,148.96875,2.199707,1.29980469,2.19970703,138.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.34094,1,male,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,2,4.0,under $11k,4338.0,3098.4258,11.0,white,38.0,1,0,0,no,0.599999905,0.3,dnr after sadm,4.0,87.0,15.0,124.0,23.0,38.79688,246.40625,3.199707,7.19921875,1.09985352,136.0,7.529297,135.0,23.0,2502.0,2.7255859,<2 mo. follow-up
39.896,1,male,0,5,1001,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,5221.0,3690.5723,8.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,93.0,5.09960938,104.0,28.0,37.29688,333.3,1.7998047,1.0,1.29980469,136.0,7.419922,135.0,23.0,2502.0,1.8635254,<2 mo. follow-up
70.83899,1,male,0,10,1227,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,15529.0,6593.3281,18.0,white,39.0,1,1,0,no,0.799999714,0.75,no dnr,10.0,53.0,4.79980469,52.0,28.0,36.59375,200.0,3.5996094,0.19998169,0.79992676,137.0,7.429688,135.0,23.0,2502.0,0.4947999,SIP>=30
66.61694,1,male,0,24,31,Colon Cancer,Cancer,1,12.0,under $11k,21410.0,19480.0312,10.333328,white,22.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,4.0,86.0,2.69970703,60.0,8.0,36.89844,333.3,3.3999023,0.59997559,0.89990234,141.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
45.06998,1,female,0,11,256,Lung Cancer,Cancer,1,16.0,$25-$50k,11897.0,8689.2031,13.5,white,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,11.0,81.0,9.3984375,80.0,20.0,37.79688,333.3,2.5996094,1.01,0.89990234,136.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
54.28299,1,female,0,10,335,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,15118.0,6624.2617,22.5,white,52.0,1,0,0,no,0.799999714,0.65,no dnr,10.0,50.0,10.0,155.0,40.0,37.29688,95.0,3.0,1.79980469,0.89990234,140.0,7.289062,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.44897,1,male,1,172,172,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,357428.0,306873.5,42.0,white,60.0,14,0,0,no,0.199999928,0.09,no dnr,172.0,107.0,15.6992188,88.0,18.0,37.5,188.3125,2.0996094,7.79980469,7.0,134.0,7.40918,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
87.09698,1,female,0,27,71,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,42836.0,33844.75,21.5,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,27.0,104.0,24.5976562,80.0,34.0,38.0,355.0625,3.5,0.59997559,0.89990234,130.0,7.40918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
90.81195,1,female,0,11,72,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,40846.0,6658.1758,13.0,white,30.0,1,1,0,no,0.899999619,0.5,no dnr,11.0,111.0,8.3984375,48.0,16.0,36.89844,293.3125,3.699707,0.39996338,1.69995117,138.0,7.429688,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
46.72699,1,female,0,4,452,Cirrhosis,COPD/CHF/Cirrhosis,3,9.0,under $11k,2666.0,2077.2012,11.0,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,77.0,9.8984375,80.0,20.0,37.59375,333.3,3.5,1.09985352,0.89990234,143.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
65.20197,1,male,1,14,14,Cirrhosis,COPD/CHF/Cirrhosis,5,14.0,under $11k,14254.0,11676.5625,7.666664,white,43.0,1,0,1,no,0.699999809,0.09,dnr after sadm,2.0,77.0,13.1992188,54.0,24.0,35.69531,182.59375,2.2998047,3.0,0.79992676,142.0,7.469727,135.0,23.0,2502.0,4.0,<2 mo. follow-up
48.94998,1,male,0,25,161,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,34640.0,29713.7656,24.0,white,34.0,1,1,0,no,0.699999809,0.5,no dnr,25.0,43.0,6.09960938,69.0,20.0,36.09375,480.0,4.5996094,0.89990234,1.39990234,133.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.70599,0,female,0,7,1957,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9764.0,4184.7578,28.0,white,42.0,1,0,1,no,0.599999905,0.5,dnr after sadm,1.0,78.0,8.09960938,73.0,28.0,37.5,204.0,3.8999023,1.01,2.79980469,147.0,6.959961,135.0,23.0,2502.0,5.0,<2 mo. follow-up
60.31497,1,female,0,23,49,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,26095.0,19613.9844,15.0,black,25.0,1,0,0,no,0.699999809,0.6,no dnr,23.0,69.0,8.59960938,76.0,24.0,36.89844,333.3,4.0996094,1.39990234,1.29980469,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.64099,1,female,0,9,56,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,8667.0,6495.2734,10.0,white,35.0,1,0,0,no,0.899999619,0.8,no dnr,9.0,93.0,11.5,84.0,22.0,36.69531,191.28125,3.199707,1.01,1.59985352,136.0,7.369141,135.0,23.0,2502.0,4.3330078,<2 mo. follow-up
67.47998,1,female,0,8,266,Colon Cancer,Cancer,2,11.0,under $11k,7020.0,5177.6289,11.5,white,23.0,1,1,0,metastatic,0.799999714,0.25,no dnr,8.0,96.0,6.29980469,80.0,20.0,37.59375,333.3,2.8999023,0.5,1.5,139.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
77.758,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,17610.0,10376.9688,18.333328,white,68.0,1,0,0,no,0.399999857,0.0,dnr after sadm,7.0,49.0,7.19921875,94.0,36.0,34.19531,320.0,3.5996094,1.59985352,6.5,136.0,7.429688,135.0,23.0,2502.0,5.0,<2 mo. follow-up
36.27698,0,female,0,11,1953,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,20110.0,8962.0156,28.0,white,29.0,1,0,0,no,0.599999905,0.6,no dnr,11.0,54.0,18.296875,76.0,14.0,35.79688,195.0,2.7998047,0.59997559,0.79992676,139.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.75,0,male,0,23,1952,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,25860.0,17224.5469,14.0,white,29.0,2,1,0,yes,0.949999809,0.85,no dnr,23.0,100.0,11.3984375,100.0,26.0,37.79688,322.5,2.8999023,1.19995117,1.29980469,148.0,7.359375,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
68.323,1,female,0,17,223,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,33471.0,19604.7969,14.666664,white,37.0,3,1,0,yes,0.899999619,0.8,no dnr,17.0,67.0,9.59960938,122.0,26.0,37.79688,227.5,3.5,1.01,1.09985352,132.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.63599,0,female,0,14,1951,COPD,COPD/CHF/Cirrhosis,1,7.0,under $11k,10530.0,7928.7734,10.333328,white,40.0,1,0,0,no,0.899999619,0.85,no dnr,14.0,63.0,8.69921875,76.0,30.0,36.29688,240.0,3.5,1.01,1.19995117,143.0,7.339844,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
70.76495,1,male,0,10,252,COPD,COPD/CHF/Cirrhosis,1,11.0,$11-$25k,8711.0,6830.3867,13.0,white,24.0,1,0,0,no,0.949999809,0.8,no dnr,10.0,83.0,10.6992188,108.0,32.0,36.09375,188.5625,3.5,1.01,1.0,141.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
89.487,0,female,0,3,1950,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3584.0,2357.1133,14.0,white,22.0,1,0,0,no,0.899999619,0.7,no dnr,3.0,100.0,14.3984375,86.0,18.0,37.29688,200.0,3.5,1.01,0.59997559,138.0,7.329102,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.80298,1,female,0,3,221,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,3057.0,1528.8027,7.0,white,24.0,1,0,0,no,0.799999714,0.5,dnr after sadm,2.0,90.0,7.5,110.0,25.0,37.59375,208.0,3.5,1.01,0.5,139.0,7.349609,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
72.59698,1,male,0,14,291,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17419.0,10273.3359,19.666656,white,28.0,1,0,0,no,1.0,0.99,no dnr,14.0,63.0,4.29980469,102.0,28.0,37.5,365.0,2.7998047,1.01,1.69995117,139.0,7.399414,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
79.62994,1,female,0,12,1398,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,11895.0,6759.8086,11.5,white,32.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,75.0,11.0996094,101.0,26.0,37.19531,141.65625,3.5,1.01,0.79992676,147.0,7.139648,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
71.54297,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,31316.0,16828.9375,29.5,white,55.0,5,0,0,yes,0.149999976,0.12,dnr after sadm,5.0,60.0,1.29980469,136.0,32.0,36.0,371.375,1.6999512,0.09999084,1.79980469,145.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
42.78998,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,19185.0,9497.8828,37.0,white,86.0,3,0,0,yes,0.0,0.0,dnr after sadm,4.0,49.0,3.89990234,128.0,28.0,34.5,436.0,3.5,8.5,3.89990234,138.0,7.209961,135.0,23.0,2502.0,2.5180664,<2 mo. follow-up
73.91895,1,female,0,6,46,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,4780.0,3638.6152,10.0,white,31.0,1,1,0,no,0.899999619,0.8,no dnr,6.0,97.0,9.0,76.0,24.0,37.69531,256.625,3.5,1.01,2.79980469,139.0,7.439453,135.0,23.0,2502.0,5.0,<2 mo. follow-up
67.37598,0,male,0,13,1945,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,21696.0,18037.2969,24.0,white,59.0,1,1,0,no,0.949999809,1.0,no dnr,13.0,75.0,11.5,150.0,8.0,38.59375,121.65625,3.5,0.89990234,2.0,134.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.06995,1,female,0,6,12,CHF,COPD/CHF/Cirrhosis,1,10.0,under $11k,3634.0,2929.1738,9.0,white,31.0,1,0,0,no,0.5,0.3,no dnr,6.0,117.0,9.5,74.0,16.0,36.29688,333.3,4.1992188,0.5,2.89990234,135.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.10095,1,male,0,22,56,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,24014.0,18220.5156,17.0,white,35.0,1,0,0,no,0.25,0.1,dnr after sadm,3.0,70.0,3.29980469,72.0,20.0,36.29688,333.3,3.199707,1.01,5.29980469,128.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
96.422,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17637.0,7842.3086,26.5,white,52.0,3,0,0,no,0.5,0.5,dnr after sadm,8.0,51.0,20.5976562,80.0,28.0,36.09375,250.0,2.7998047,1.01,3.09960938,128.0,7.419922,135.0,23.0,2502.0,4.890625,<2 mo. follow-up
70.034,1,female,0,47,1687,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,69542.0,49621.9688,20.25,white,32.0,1,1,0,no,0.899999619,0.9,no dnr,47.0,111.0,13.0996094,80.0,32.0,35.89844,333.3,4.0,1.01,1.59985352,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.51697,1,male,0,6,197,Lung Cancer,Cancer,2,12.0,under $11k,8659.0,6245.7969,12.0,white,16.0,1,0,0,metastatic,0.899999619,0.5,no dnr,6.0,80.0,7.09960938,86.0,20.0,37.5,333.3,4.1992188,1.01,1.29980469,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
91.67694,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,14107.0,5900.5625,32.0,white,55.0,1,1,0,yes,0.099999964,0.001,dnr after sadm,4.0,46.0,15.0996094,50.0,26.0,37.69531,185.0,3.199707,0.69995117,3.09960938,136.0,7.289062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
36.53699,0,male,0,62,1941,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,117256.0,31268.7656,28.0,white,33.0,3,0,0,no,0.699999809,0.5,no dnr,62.0,108.0,8.8984375,110.0,8.0,39.29688,202.0,1.8999023,1.89990234,1.19995117,133.0,7.389648,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
81.284,0,female,0,6,1939,CHF,COPD/CHF/Cirrhosis,1,12.0,>$50k,5025.0,3666.4121,8.0,white,31.0,1,0,0,no,0.899999619,0.5,dnr before sadm,0.0,105.0,7.89941406,58.0,28.0,36.29688,304.75,3.699707,1.01,1.0,142.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.16498,0,male,0,13,1938,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,17918.0,11141.7109,16.5,white,30.0,1,0,0,no,0.949999809,0.85,no dnr,13.0,73.0,5.79980469,68.0,27.0,37.79688,266.625,2.5996094,1.01,1.5,138.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.64499,1,female,0,9,13,Colon Cancer,Cancer,1,12.0,under $11k,9016.0,2677.668,10.0,white,32.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,1.0,80.0,8.8984375,70.0,25.0,37.0,333.3,2.7998047,29.0,0.69995117,142.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
39.31299,0,female,0,12,1938,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,24390.0,15204.3672,24.5,white,73.0,2,0,0,yes,0.699999809,0.5,no dnr,12.0,135.0,7.19921875,150.0,42.0,37.5,285.6875,2.699707,2.59960938,3.09960938,144.0,7.299805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.24799,1,female,1,47,47,Lung Cancer,Cancer,1,12.0,under $11k,41185.0,32064.5625,8.0,white,24.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,7.0,93.0,18.1992188,72.0,26.0,37.0,333.3,4.0,0.69995117,1.19995117,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
41.02698,1,male,1,47,47,Cirrhosis,COPD/CHF/Cirrhosis,2,18.0,>$50k,57856.0,41057.1875,10.75,white,58.0,1,0,0,no,0.5,0.3,dnr after sadm,38.0,73.0,15.0,110.0,24.0,37.0,333.3,2.8999023,50.6953125,5.0,135.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
77.96594,0,female,0,16,1937,COPD,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,14553.0,10891.6562,15.666664,white,35.0,1,1,0,no,0.799999714,0.6,dnr after sadm,4.0,95.0,10.2988281,94.0,28.0,37.79688,277.75,3.5,1.01,2.5,142.0,7.429688,135.0,23.0,2502.0,3.0,SIP>=30
62.63898,1,male,0,18,91,Lung Cancer,Cancer,1,16.0,$11-$25k,26939.0,20709.8594,14.666664,black,23.0,1,0,0,metastatic,0.799999714,0.3,dnr after sadm,7.0,135.0,9.79882812,48.0,15.0,36.5,333.3,4.0,0.59997559,1.09985352,133.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
68.27698,1,male,0,6,111,Colon Cancer,Cancer,1,16.0,under $11k,5046.0,3617.6836,6.0,white,28.0,1,0,0,metastatic,0.899999619,0.2,no dnr,6.0,97.0,20.0,72.0,20.0,37.19531,333.3,3.7998047,0.39996338,2.19970703,136.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
68.64099,1,female,0,19,470,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,50918.0,32448.8281,23.333328,white,41.0,5,0,0,metastatic,0.599999905,0.3,no dnr,19.0,74.0,14.5996094,117.0,41.0,38.29688,415.0,3.5,1.01,0.89990234,146.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.43298,1,male,1,5,5,COPD,COPD/CHF/Cirrhosis,2,20.0,under $11k,5135.0,3777.4356,12.0,white,47.0,1,0,0,metastatic,0.199999928,0.5,dnr after sadm,2.0,115.0,29.8984375,80.0,40.0,36.0,210.0,3.199707,1.01,0.89990234,149.0,7.529297,135.0,23.0,2502.0,0.0,<2 mo. follow-up
86.65295,1,male,0,7,103,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,4723.0,3616.1152,9.0,white,43.0,1,0,1,no,0.899999619,0.8,no dnr,7.0,71.0,6.5,80.0,42.0,35.79688,252.375,4.0,1.59985352,1.69995117,143.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.409,1,male,0,12,1563,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,9601.0,7057.1562,6.0,white,19.0,1,0,0,yes,0.949999809,0.9,no dnr,12.0,97.0,10.3984375,69.0,27.0,36.0,333.3,3.5,1.01,1.29980469,144.0,7.419922,135.0,23.0,2502.0,2.5053711,<2 mo. follow-up
71.79999,1,male,0,14,511,ARF/MOSF w/Sepsis,ARF/MOSF,1,21.0,under $11k,31459.0,15559.6328,17.0,white,32.0,9,0,0,no,0.899999619,0.6,no dnr,14.0,53.0,11.8984375,49.0,24.0,37.39844,280.9375,3.5,1.01,1.0,138.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.85999,1,male,0,10,1478,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,8570.0,6200.0781,13.0,black,22.0,1,0,0,no,0.979999542,0.9,no dnr,10.0,103.0,14.3984375,80.0,22.0,37.79688,333.3,3.5,1.01,1.39990234,142.0,7.389648,135.0,23.0,2502.0,2.5110989,no(M2 and SIP pres)
76.06,1,male,1,15,15,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,35239.0,11708.6641,38.333313,white,36.0,1,0,0,no,0.949999809,0.75,dnr after sadm,14.0,61.0,9.79882812,118.0,12.0,38.19531,111.65625,2.8999023,1.29980469,1.59985352,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.672,1,male,0,10,1815,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,10477.0,5305.0938,14.5,white,37.0,1,1,0,no,0.899999619,0.8,dnr after sadm,1.0,109.0,10.2988281,111.0,32.0,37.89844,420.0,2.7998047,0.79992676,0.89990234,143.0,7.399414,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
30.55199,1,male,0,32,304,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,76135.0,41028.2812,22.0,black,29.0,1,0,0,no,0.549999714,0.45,no dnr,32.0,63.0,15.1992188,126.0,20.0,38.19531,392.0,2.0996094,3.79980469,1.0,140.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.396,0,female,0,5,1921,COPD,COPD/CHF/Cirrhosis,2,5.0,under $11k,4530.0,3147.0176,6.0,black,45.0,1,0,0,no,0.989999771,0.95,no dnr,5.0,51.0,14.3984375,92.0,24.0,37.0,185.6875,3.5,1.01,1.29980469,134.0,7.289062,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
56.00299,1,female,0,8,409,Lung Cancer,Cancer,2,12.0,>$50k,10614.0,7028.1914,16.0,white,15.0,1,0,0,metastatic,0.949999809,0.75,no dnr,8.0,116.0,6.0,74.0,28.0,36.69531,333.3,3.2998047,1.01,0.59997559,139.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
76.33698,1,female,0,13,104,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,9457.0,6602.0273,11.5,white,31.0,1,0,0,no,0.899999619,0.8,no dnr,13.0,87.0,9.59960938,122.0,36.0,38.5,340.0,3.5,1.01,0.89990234,143.0,7.419922,135.0,23.0,2502.0,3.0761719,no(M2 and SIP pres)
59.21399,0,female,0,12,1919,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,33298.0,22645.9688,19.0,black,37.0,4,1,0,no,0.699999809,0.5,no dnr,12.0,105.0,13.5,100.0,40.0,38.59375,130.0,3.5,1.01,1.79980469,138.0,7.479492,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.34595,0,female,0,7,1916,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,4751.0,3376.4043,9.0,white,20.0,1,0,0,no,0.949999809,0.92,dnr after sadm,1.0,97.0,10.5,100.0,32.0,36.59375,303.3125,3.5,1.01,1.09985352,139.0,7.349609,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
61.48099,0,female,0,25,1916,CHF,COPD/CHF/Cirrhosis,2,4.0,$11-$25k,21507.0,14395.5781,12.75,white,41.0,1,1,0,no,0.899999619,0.8,no dnr,25.0,105.0,8.79882812,98.0,32.0,37.09375,255.53125,3.5,1.01,1.0,140.0,7.459961,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
63.27399,1,male,0,8,1244,CHF,COPD/CHF/Cirrhosis,4,10.0,$11-$25k,7418.0,4707.8086,10.0,white,27.0,1,1,0,metastatic,1.0,0.9,no dnr,8.0,63.0,9.19921875,100.0,25.0,36.59375,466.625,3.699707,1.09985352,1.29980469,135.0,7.40918,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
79.64996,0,male,0,6,1915,COPD,COPD/CHF/Cirrhosis,2,15.0,under $11k,4776.0,3234.5801,13.0,white,10.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,85.0,7.29980469,86.0,20.0,36.79688,588.25,3.5,1.01,0.89990234,145.0,7.439453,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
62.51599,1,female,0,72,135,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,134421.0,35840.0625,27.5,black,40.0,1,1,0,no,0.899999619,0.75,no dnr,72.0,143.0,7.19921875,130.0,32.0,38.19531,262.9375,3.5,1.01,1.19995117,141.0,7.299805,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
57.60999,1,male,0,12,235,Lung Cancer,Cancer,1,12.0,$25-$50k,14797.0,9158.2656,15.5,white,14.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,2.0,81.0,2.79980469,78.0,22.0,35.69531,333.3,3.5,0.5,1.09985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
85.50598,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,24531.0,8586.1094,26.666656,white,47.0,1,0,0,no,0.899999619,0.8,dnr after sadm,14.0,107.0,10.5996094,55.0,44.0,38.19531,134.6875,3.5,1.01,1.89990234,143.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.29297,1,male,0,6,10,CHF,COPD/CHF/Cirrhosis,2,15.0,$11-$25k,4825.0,3000.5684,9.0,white,40.0,1,1,0,no,0.949999809,0.75,no dnr,6.0,63.0,8.59960938,61.0,20.0,36.09375,319.0,3.699707,0.39996338,2.19970703,138.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
88.28699,0,female,0,9,1910,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,7485.0,4946.9727,8.0,white,27.0,1,1,0,no,0.899999619,0.9,no dnr,9.0,69.0,5.5,80.0,14.0,36.09375,484.0,3.5,1.01,0.69995117,129.0,7.349609,135.0,23.0,2502.0,6.0,SIP>=30
80.32898,1,female,0,6,77,Colon Cancer,Cancer,2,10.0,under $11k,6066.0,3936.1367,14.0,white,45.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,123.0,7.09960938,60.0,42.0,38.19531,333.3,2.7998047,0.59997559,4.09960938,144.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
25.92999,0,male,0,9,1909,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,31526.0,33885.3438,10.5,white,51.0,5,0,0,no,0.699999809,0.5,no dnr,9.0,145.0,15.7988281,120.0,20.0,36.09375,136.0,3.5,1.01,12.1992188,135.0,7.199219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
85.15796,1,female,0,7,41,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,5272.0,3606.2617,6.0,white,39.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,55.0,6.59960938,62.0,40.0,35.39844,428.5625,3.5,1.01,1.29980469,138.0,7.489258,135.0,23.0,2502.0,3.1811523,<2 mo. follow-up
40.375,0,male,0,4,1909,COPD,COPD/CHF/Cirrhosis,0,10.0,under $11k,3558.0,1725.0977,5.0,hispanic,10.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,83.0,9.8984375,80.0,20.0,36.69531,130.0,4.1992188,0.39996338,1.0,143.0,6.969727,135.0,23.0,2502.0,1.0,SIP>=30
65.53595,1,male,0,50,991,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,38225.0,26093.1875,12.25,white,24.0,2,0,0,no,0.949999809,0.9,no dnr,50.0,53.0,12.3984375,77.0,24.0,39.29688,185.6875,2.5,0.29998779,1.0,143.0,7.419922,135.0,23.0,2502.0,3.0,SIP>=30
59.35098,1,female,0,13,57,Lung Cancer,Cancer,1,16.0,>$50k,14557.0,9539.7266,10.0,white,10.0,1,0,0,metastatic,0.799999714,0.5,no dnr,13.0,100.0,6.09960938,108.0,24.0,36.79688,333.3,2.8999023,0.29998779,0.69995117,145.0,7.419922,135.0,23.0,2502.0,3.0551758,<2 mo. follow-up
69.95996,0,female,0,23,1907,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,33506.0,29262.4844,18.666656,white,39.0,7,1,0,no,0.799999714,0.7,no dnr,23.0,113.0,8.29882812,63.0,26.0,38.09375,175.5,2.5,0.69995117,2.59960938,153.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.35394,1,male,0,8,100,CHF,COPD/CHF/Cirrhosis,3,16.0,under $11k,6006.0,4201.6367,8.5,white,23.0,1,0,0,yes,0.899999619,0.5,no dnr,8.0,80.0,11.5996094,68.0,24.0,36.29688,333.3,3.5996094,0.5,1.5,134.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
62.17697,0,female,0,5,1907,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,5648.0,3686.043,13.0,black,50.0,1,1,0,no,0.949999809,0.9,no dnr,5.0,63.0,10.3984375,104.0,28.0,36.79688,333.3,2.0996094,0.29998779,2.39990234,146.0,7.419922,135.0,23.0,2502.0,4.5273972,no(M2 and SIP pres)
64.63196,1,female,0,14,33,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,14478.0,8823.1172,19.333328,white,56.0,1,0,0,metastatic,0.599999905,0.45,dnr after sadm,6.0,43.0,6.59960938,120.0,38.0,34.79688,418.5,3.5996094,1.01,1.29980469,126.0,7.489258,135.0,23.0,2502.0,1.0,<2 mo. follow-up
77.98798,1,female,1,15,15,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,28654.0,8108.0273,33.0,white,24.0,1,0,0,no,0.5,0.25,dnr after sadm,7.0,50.0,9.59960938,112.0,8.0,38.39844,332.5,3.199707,1.01,0.5,136.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
25.782,0,male,0,7,1906,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,9020.0,3857.5996,15.0,other,11.0,1,0,0,no,1.0,0.95,no dnr,7.0,73.0,5.5,76.0,24.0,39.09375,333.3,2.7998047,0.19998169,1.29980469,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
92.95599,1,female,1,11,11,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,16444.0,5627.5742,18.5,white,31.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,10.0,68.0,8.59960938,68.0,24.0,36.79688,422.1875,3.5,1.01,1.79980469,145.0,7.379883,135.0,23.0,2502.0,2.0,<2 mo. follow-up
81.56897,1,female,0,8,396,CHF,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,6537.0,4397.2109,10.5,white,33.0,1,0,0,no,0.989999771,0.98,no dnr,8.0,69.0,10.6992188,78.0,22.0,36.09375,252.0,3.5,0.89990234,1.69995117,140.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.06195,1,female,0,5,120,Lung Cancer,Cancer,1,12.0,under $11k,3867.0,2508.041,6.0,white,23.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,107.0,9.79882812,98.0,28.0,36.59375,333.3,3.2998047,0.59997559,1.19995117,142.0,7.419922,135.0,23.0,2502.0,2.2426758,no(M2 and SIP pres)
72.047,1,female,0,10,389,Colon Cancer,Cancer,1,16.0,$25-$50k,7914.0,5386.832,8.5,black,22.0,1,0,0,metastatic,0.299999952,0.2,no dnr,10.0,73.0,2.39990234,76.0,20.0,37.0,333.3,3.5,0.89990234,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.97894,1,female,0,7,777,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,8999.0,5357.5039,16.0,white,45.0,1,0,0,metastatic,0.949999809,0.75,no dnr,7.0,105.0,17.5976562,130.0,26.0,36.0,332.0,3.2998047,1.01,6.29980469,137.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
70.44995,1,male,1,17,17,Coma,Coma,2,20.0,under $11k,25671.0,19454.9688,15.333328,white,23.0,2,1,0,no,0.099999964,0.001,dnr after sadm,2.0,81.0,10.7988281,104.0,38.0,39.0,345.0,3.5,1.01,1.39990234,139.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.95099,1,female,1,38,38,Colon Cancer,Cancer,1,12.0,under $11k,33734.0,22634.6719,8.75,white,26.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,5.0,73.0,10.1992188,78.0,16.0,36.5,333.3,3.5996094,0.39996338,1.59985352,137.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
75.33197,1,female,1,60,60,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,180272.0,73283.0625,41.0,white,76.0,1,0,0,no,0.699999809,0.5,dnr after sadm,45.0,44.0,43.09375,105.0,14.0,36.09375,265.0,1.5,4.59960938,7.59960938,128.0,7.329102,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.646,1,female,0,20,38,COPD,COPD/CHF/Cirrhosis,2,16.0,>$50k,12745.0,9543.7656,6.0,white,22.0,1,0,1,no,0.799999714,0.5,dnr after sadm,1.0,84.0,5.29980469,76.0,30.0,36.59375,238.09375,3.5,0.5,0.39996338,144.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
81.28699,1,male,0,12,137,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,12674.0,6361.8516,17.5,white,33.0,1,0,1,no,0.899999619,0.75,no dnr,12.0,74.0,10.8984375,60.0,22.0,36.59375,408.0,3.2998047,0.59997559,2.5,137.0,7.459961,135.0,23.0,2502.0,5.4804688,<2 mo. follow-up
93.91394,1,female,1,7,7,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,13570.0,11662.1562,20.5,white,55.0,1,0,0,no,0.0,0.0,dnr after sadm,1.0,42.0,13.1992188,127.0,26.0,38.29688,234.0,3.5,1.01,1.39990234,140.0,7.269531,135.0,23.0,2502.0,4.0,<2 mo. follow-up
80.72296,1,female,0,8,108,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,7633.0,4950.8477,15.0,white,56.0,1,0,1,no,0.799999714,0.7,dnr after sadm,1.0,112.0,7.0,160.0,28.0,38.19531,161.65625,4.0996094,1.01,2.59960938,141.0,7.089844,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
60.35599,1,male,1,9,9,Colon Cancer,Cancer,1,12.0,under $11k,13863.0,8505.2422,16.0,white,82.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,49.0,8.19921875,130.0,36.0,35.09375,333.3,2.3999023,20.1992188,2.79980469,137.0,7.419922,135.0,23.0,2502.0,2.2954102,<2 mo. follow-up
60.34497,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,86807.0,67231.1875,36.0,white,37.0,8,1,0,no,0.799999714,0.8,no dnr,18.0,51.0,11.5996094,102.0,8.0,38.79688,168.0,3.5,1.01,1.29980469,147.0,7.259766,135.0,23.0,2502.0,4.0,<2 mo. follow-up
93.77399,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15581.0,6194.3398,23.5,white,44.0,1,0,1,no,0.049999982,0.000125,dnr after sadm,2.0,50.0,3.89990234,60.0,25.0,36.69531,155.0,3.0,0.29998779,0.89990234,145.0,7.359375,135.0,23.0,2502.0,5.1074219,<2 mo. follow-up
70.82794,1,female,0,13,321,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,14896.0,7133.4609,22.0,white,41.0,1,0,0,metastatic,0.199999928,0.04,dnr after sadm,2.0,56.0,14.2988281,102.0,40.0,38.09375,114.0,2.7998047,0.59997559,0.59997559,138.0,7.429688,135.0,23.0,2502.0,2.4926758,<2 mo. follow-up
69.76898,1,female,1,9,9,Lung Cancer,Cancer,2,12.0,under $11k,9542.0,6106.1094,15.5,white,41.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,2.0,70.0,67.296875,116.0,38.0,36.79688,338.0625,2.8999023,0.39996338,0.89990234,143.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
46.349,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,100904.0,64948.5938,50.0,white,73.0,23,0,0,no,0.699999809,0.5,dnr after sadm,8.0,57.0,23.796875,102.0,12.0,37.0,268.3125,2.3999023,39.296875,3.89990234,138.0,7.419922,135.0,23.0,2502.0,2.762207,<2 mo. follow-up
61.14697,1,female,0,12,161,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,23298.0,13658.8594,21.0,white,42.0,4,1,0,no,0.699999809,0.5,no dnr,12.0,120.0,11.0,62.0,30.0,38.0,234.6875,3.0,1.01,6.19921875,140.0,7.319336,135.0,23.0,2502.0,2.2729492,<2 mo. follow-up
51.13998,0,male,0,6,1890,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,7438.0,2830.9902,15.0,white,21.0,1,0,0,no,0.979999542,0.97,no dnr,6.0,63.0,7.09960938,75.0,28.0,36.39844,256.0,3.5,0.5,0.89990234,139.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
59.69598,1,male,0,30,122,Colon Cancer,Cancer,2,12.0,under $11k,40846.0,25642.7969,10.75,white,22.0,1,0,0,metastatic,0.699999809,0.5,no dnr,30.0,56.0,8.0,80.0,15.0,36.69531,333.3,3.699707,0.39996338,1.09985352,145.0,7.419922,135.0,23.0,2502.0,2.3588867,<2 mo. follow-up
73.31995,0,female,0,25,1887,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,28079.0,14801.8203,12.333328,white,33.0,1,0,0,no,1.0,0.95,no dnr,25.0,99.0,10.0996094,102.0,42.0,38.09375,144.875,2.5,0.5,0.79992676,142.0,7.419922,135.0,23.0,2502.0,2.4248047,<2 mo. follow-up
35.76199,0,male,0,12,1886,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,14027.0,6408.0898,21.5,white,25.0,1,0,0,no,0.899999619,0.9,no dnr,12.0,53.0,14.5,106.0,22.0,38.0,212.21875,2.2998047,1.5,1.09985352,138.0,7.469727,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
77.35797,1,female,0,19,896,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,28820.0,13814.8125,21.666656,white,57.0,1,1,0,no,0.5,0.5,dnr after sadm,1.0,37.0,10.5,92.0,40.0,37.59375,170.0,2.5,0.39996338,1.09985352,153.0,7.399414,135.0,23.0,2502.0,3.2709961,no(M2 and SIP pres)
83.57794,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,65318.0,51210.2188,47.0,white,72.0,15,0,0,yes,0.699999809,0.5,dnr after sadm,11.0,67.0,19.1992188,130.0,34.0,38.79688,74.0,1.7998047,1.01,2.79980469,133.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
82.80096,1,female,0,20,368,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,35464.0,29197.8125,19.666656,white,32.0,1,0,0,no,0.899999619,0.7,no dnr,20.0,64.0,13.5,54.0,24.0,37.39844,190.0,3.5,1.01,1.69995117,134.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
58.82498,1,male,0,5,1625,Lung Cancer,Cancer,1,12.0,under $11k,5670.0,3605.0137,15.0,black,13.0,1,0,0,metastatic,0.949999809,0.75,no dnr,5.0,103.0,3.39990234,64.0,20.0,36.59375,333.3,3.7998047,0.19998169,1.0,141.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
77.56097,0,female,0,7,1883,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5333.0,3607.3574,13.0,hispanic,22.0,1,0,0,yes,0.949999809,0.95,no dnr,7.0,107.0,7.79980469,78.0,24.0,35.79688,333.3,3.5,0.89990234,1.39990234,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
53.70297,1,female,0,47,1794,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,91986.0,72924.0625,34.25,white,36.0,3,1,0,no,0.699999809,0.65,no dnr,47.0,65.0,18.296875,150.0,10.0,38.29688,164.0,3.5,1.01,0.59997559,137.0,7.509766,135.0,23.0,2502.0,1.0,SIP>=30
78.43695,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,14.0,$25-$50k,17635.0,6980.957,40.0,white,61.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,5.0,49.0,1.39990234,140.0,24.0,39.0,138.0,1.7998047,1.59985352,1.09985352,144.0,7.319336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.68997,1,male,0,10,858,COPD,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,11201.0,6830.2617,13.5,white,32.0,1,0,0,no,0.989999771,0.9,no dnr,10.0,110.0,13.0996094,120.0,30.0,36.69531,192.84375,3.5,0.69995117,0.89990234,137.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
44.30399,1,female,1,21,21,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,56112.0,21248.1875,30.0,black,38.0,1,0,0,no,0.099999964,0.001,dnr after sadm,20.0,59.0,12.3984375,139.0,21.0,39.09375,432.0,3.2998047,5.89941406,0.89990234,138.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
82.09399,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,15079.0,5353.8984,54.0,white,96.0,2,1,0,no,0.0,0.0,dnr after sadm,5.0,0.0,11.5,0.0,0.0,35.59375,306.0,3.5,0.69995117,2.29980469,135.0,7.269531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
44.48199,0,female,0,7,1880,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,13559.0,6085.4531,20.0,white,26.0,3,0,0,no,0.75,0.4,no dnr,7.0,51.0,10.5,122.0,20.0,37.0,352.375,3.5,1.01,0.59997559,135.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.086,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,38936.0,31189.4219,35.333313,white,34.0,3,0,0,metastatic,0.5,0.05,dnr after sadm,14.0,55.0,13.1992188,118.0,12.0,38.5,101.42188,3.5,1.01,0.69995117,141.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.93399,1,male,0,18,926,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,39951.0,23115.0156,29.666656,white,62.0,15,1,0,no,0.25,0.5,no dnr,18.0,49.0,10.7988281,122.0,38.0,38.79688,174.0,2.5996094,0.89990234,5.19921875,139.0,7.349609,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
73.336,1,male,1,6,6,Lung Cancer,Cancer,2,8.0,under $11k,6528.0,4465.707,18.0,white,19.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,79.0,4.69921875,100.0,24.0,36.79688,433.3125,3.3999023,0.59997559,0.79992676,134.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.21799,0,male,0,5,1875,Lung Cancer,Cancer,1,7.0,under $11k,6209.0,3865.9766,22.0,white,15.0,1,0,0,metastatic,1.0,0.5,no dnr,5.0,106.0,6.59960938,88.0,20.0,36.79688,333.3,3.8999023,0.89990234,1.19995117,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.58899,1,male,0,20,61,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,20287.0,12675.5625,17.333328,white,34.0,1,1,0,no,0.799999714,0.6,dnr after sadm,8.0,75.0,6.59960938,80.0,24.0,36.59375,490.0,3.5996094,1.29980469,1.5,130.0,7.459961,135.0,23.0,2502.0,2.5820312,<2 mo. follow-up
73.73297,0,male,0,18,1873,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,35954.0,25675.9688,27.333328,white,55.0,1,1,0,no,0.75,0.6,no dnr,18.0,105.0,9.8984375,112.0,28.0,39.09375,332.0,2.3999023,1.01,2.0,143.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.01599,1,male,0,22,130,MOSF w/Malig,ARF/MOSF,1,14.0,$11-$25k,43814.0,19164.0,36.333313,white,36.0,7,0,0,metastatic,0.699999809,0.5,dnr after sadm,16.0,48.0,4.0,118.0,34.0,38.0,372.0,3.5,1.5,1.29980469,148.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
43.26898,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,11032.0,4530.9414,47.0,white,89.0,1,0,0,no,0.009999998,1e-06,no dnr,4.0,43.0,28.0,140.0,26.0,39.0,72.0,2.2998047,4.0,3.79980469,137.0,7.279297,135.0,23.0,2502.0,2.1391602,<2 mo. follow-up
61.63397,0,male,0,11,1867,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,13547.0,7884.6055,10.5,white,39.0,1,0,0,no,0.899999619,0.8,no dnr,11.0,85.0,7.19921875,160.0,24.0,36.09375,333.3,3.5,2.39990234,1.59985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.30194,1,male,0,5,130,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,3822.0,2581.4356,13.0,white,36.0,1,0,0,no,0.899999619,0.5,dnr after sadm,1.0,71.0,10.3984375,54.0,24.0,35.59375,290.0,3.5,1.01,2.39990234,139.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
83.01996,1,female,0,20,1577,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,21266.0,11367.5859,19.0,white,50.0,2,0,0,no,0.899999619,0.8,no dnr,20.0,53.0,17.5,68.0,32.0,36.5,156.0,2.5996094,1.19995117,0.59997559,140.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
49.28699,0,female,0,31,1866,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,106935.0,81057.125,25.75,black,57.0,36,0,0,no,0.849999905,0.9,no dnr,31.0,75.0,17.3984375,112.0,0.0,38.5,146.0,3.5,1.01,3.19970703,149.0,7.389648,135.0,23.0,2502.0,2.0,SIP>=30
65.46198,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,68682.0,57570.2188,42.666657,white,47.0,3,1,0,no,0.099999964,0.001,dnr after sadm,9.0,63.0,16.5,75.0,20.0,38.59375,140.0,3.5,1.29980469,5.69921875,137.0,7.349609,135.0,23.0,2502.0,1.0,<2 mo. follow-up
75.63898,1,male,0,7,322,CHF,COPD/CHF/Cirrhosis,2,7.0,$25-$50k,5284.0,3609.7305,5.0,white,26.0,1,0,0,no,0.75,0.75,no dnr,7.0,105.0,5.39941406,68.0,24.0,37.0,235.0,3.5,1.01,2.5,142.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
54.43698,0,male,0,8,1864,CHF,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,12503.0,7265.9961,25.0,white,25.0,1,1,0,no,0.5,0.125,no dnr,8.0,75.0,10.0,106.0,24.0,36.39844,300.0,3.5,1.01,1.39990234,138.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
49.61499,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,42791.0,33042.8438,46.5,white,58.0,5,0,0,metastatic,0.5,0.1,dnr after sadm,8.0,55.0,23.1992188,150.0,10.0,39.19531,140.0,1.8999023,1.01,0.5,146.0,7.359375,135.0,23.0,2502.0,2.5019531,<2 mo. follow-up
40.68698,1,female,1,18,18,Lung Cancer,Cancer,1,14.0,>$50k,26951.0,17289.8281,15.666664,asian,22.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,5.0,83.0,5.79980469,80.0,28.0,36.29688,333.3,2.7998047,1.89990234,1.69995117,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
41.448,0,male,0,13,1861,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,>$50k,15982.0,8234.9922,13.5,white,42.0,1,0,0,no,0.899999619,0.8,no dnr,13.0,57.0,9.5,60.0,40.0,36.19531,333.3,2.0996094,2.69970703,0.59997559,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.34296,0,male,0,7,1859,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,5532.0,3669.9375,9.0,black,27.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,100.0,6.69921875,60.0,20.0,37.0,242.84375,3.5,0.79992676,1.69995117,139.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
69.35797,1,female,0,6,1471,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,4764.0,3248.6406,10.0,white,25.0,1,0,0,no,0.75,0.75,no dnr,6.0,98.0,8.29882812,80.0,24.0,37.0,259.25,3.5,1.01,1.39990234,140.0,7.469727,135.0,23.0,2502.0,4.0,SIP>=30
54.43399,1,male,0,5,11,Lung Cancer,Cancer,1,12.0,under $11k,4818.0,3069.916,12.0,black,16.0,1,0,0,metastatic,0.699999809,0.5,dnr before sadm,-1.0,100.0,13.3984375,120.0,20.0,37.79688,333.3,3.199707,0.59997559,0.89990234,142.0,7.419922,135.0,23.0,2502.0,2.2055664,<2 mo. follow-up
75.07996,1,female,0,21,52,COPD,COPD/CHF/Cirrhosis,1,5.0,under $11k,39957.0,32404.2969,40.333313,white,24.0,1,0,0,no,0.189999938,0.19,dnr after sadm,6.0,117.0,11.5,64.0,6.0,38.39844,206.65625,3.0,1.01,1.59985352,142.0,7.349609,135.0,23.0,2502.0,1.0,<2 mo. follow-up
54.66397,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,96588.0,50266.9688,43.0,white,87.0,23,0,0,no,0.5,0.3,no dnr,8.0,57.0,3.09960938,140.0,26.0,35.79688,160.0,3.0,33.0,3.69970703,132.0,7.379883,135.0,23.0,2502.0,1.9960938,<2 mo. follow-up
72.40497,0,male,0,10,1855,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,48378.0,31511.7344,28.5,white,33.0,7,1,0,no,0.929999828,0.9,no dnr,10.0,69.0,12.6992188,110.0,28.0,39.0,220.0,3.5,1.01,0.89990234,143.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.12695,1,female,0,16,1013,COPD,COPD/CHF/Cirrhosis,1,9.0,under $11k,53401.0,33741.6562,14.333328,white,33.0,1,0,0,no,0.799999714,0.4,no dnr,16.0,87.0,6.69921875,70.0,26.0,35.19531,217.375,3.5,0.39996338,1.5,144.0,7.329102,135.0,23.0,2502.0,7.0,SIP>=30
65.05096,1,male,0,8,177,Lung Cancer,Cancer,2,16.0,$25-$50k,6174.0,4199.1641,5.0,white,9.0,1,0,0,metastatic,0.5,0.3,no dnr,8.0,85.0,4.79980469,72.0,18.0,36.29688,333.3,3.5996094,0.79992676,0.79992676,147.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
62.35498,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,2,20.0,under $11k,45424.0,36292.4062,29.75,white,55.0,1,1,0,no,0.5,0.5,dnr after sadm,26.0,55.0,2.19970703,105.0,28.0,38.69531,179.5625,3.2998047,0.69995117,2.29980469,132.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
51.767,1,female,1,9,9,Colon Cancer,Cancer,1,12.0,under $11k,6608.0,4792.4727,11.5,white,38.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,70.0,15.1992188,128.0,22.0,36.59375,333.3,2.5,12.2988281,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.64099,1,male,0,22,1489,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,30733.0,16213.8359,16.0,white,42.0,4,1,0,no,0.949999809,0.85,no dnr,22.0,74.0,12.7988281,76.0,24.0,36.09375,217.5,2.0,1.69995117,3.89990234,131.0,7.339844,135.0,23.0,2502.0,1.0,<2 mo. follow-up
87.70996,0,female,0,27,1848,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,46354.0,16436.5938,31.75,white,47.0,1,0,1,no,0.5,0.25,no dnr,27.0,61.0,17.5976562,107.0,28.0,36.19531,124.48438,3.3999023,0.79992676,2.5,136.0,7.299805,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
80.159,1,male,0,82,1199,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$25-$50k,131511.0,100763.688,29.0,white,46.0,14,1,0,no,0.949999809,0.9,dnr after sadm,30.0,80.0,18.0,80.0,32.0,38.09375,98.0,3.5,1.01,1.89990234,141.0,7.399414,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
57.51999,1,female,0,6,106,Lung Cancer,Cancer,1,12.0,$11-$25k,6630.0,4241.5977,15.0,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,6.0,83.0,6.89941406,104.0,24.0,36.69531,333.3,3.8999023,0.5,1.09985352,142.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
74.51599,1,male,1,4,4,Lung Cancer,Cancer,1,14.0,under $11k,3122.0,2082.5606,14.0,white,37.0,1,0,0,metastatic,0.5,0.0,dnr after sadm,1.0,100.0,7.89941406,60.0,5.0,36.09375,333.3,3.699707,0.69995117,1.29980469,147.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
67.034,1,male,0,13,245,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,25793.0,11789.1562,17.0,white,29.0,1,0,0,no,0.949999809,0.8,no dnr,13.0,70.0,13.2988281,54.0,26.0,36.69531,240.0,3.3999023,0.59997559,1.19995117,137.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.53894,0,male,0,10,1846,CHF,COPD/CHF/Cirrhosis,1,19.0,>$50k,10474.0,6287.6641,14.0,white,21.0,1,0,0,no,0.75,0.5,no dnr,10.0,85.0,5.59960938,92.0,22.0,37.19531,385.6875,3.5,1.01,1.5,136.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.44397,1,female,0,7,181,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5718.0,3549.4473,15.0,white,37.0,1,1,0,no,0.909999847,0.91,no dnr,7.0,117.0,8.09960938,70.0,20.0,36.09375,211.09375,2.7998047,1.01,3.5,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.27698,1,male,0,7,30,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,6045.0,3920.6856,17.0,white,36.0,1,0,0,no,0.949999809,0.75,no dnr,7.0,65.0,11.3984375,64.0,22.0,37.59375,197.5,3.5,1.01,1.69995117,145.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
84.41595,0,male,0,8,1843,COPD,COPD/CHF/Cirrhosis,2,4.0,under $11k,11238.0,8764.9141,21.0,white,41.0,2,0,0,no,0.799999714,0.7,no dnr,8.0,57.0,8.19921875,61.0,34.0,37.59375,197.5,3.0,0.89990234,1.69995117,135.0,7.40918,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
82.09399,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,13125.0,9268.6562,32.0,white,59.0,4,0,1,yes,0.099999964,0.001,dnr after sadm,2.0,68.0,13.3984375,85.0,40.0,37.19531,185.6875,2.3999023,0.69995117,2.0,132.0,7.529297,135.0,23.0,2502.0,5.2265625,<2 mo. follow-up
78.25598,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,7774.0,2277.2676,12.0,white,43.0,3,0,0,no,0.0,0.0,no dnr,4.0,67.0,9.0,128.0,4.0,41.09375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,1.7348633,<2 mo. follow-up
81.56299,0,female,0,14,1842,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15296.0,8135.9922,13.666664,white,29.0,2,1,0,no,0.949999809,0.9,no dnr,14.0,54.0,7.5,59.0,24.0,38.69531,330.0,3.5,1.01,0.79992676,129.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.306,1,female,0,32,830,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,74086.0,60316.625,29.5,white,56.0,7,0,0,no,0.019999996,8e-06,dnr after sadm,1.0,41.0,34.3984375,210.0,24.0,38.39844,96.25,3.0,1.01,1.39990234,144.0,7.30957,135.0,23.0,2502.0,2.1899414,<2 mo. follow-up
70.68896,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,49259.0,22383.4375,42.0,white,52.0,1,0,0,no,0.799999714,0.8,dnr after sadm,14.0,46.0,14.0,126.0,10.0,36.59375,153.03125,2.7998047,0.59997559,4.5,140.0,7.229492,135.0,23.0,2502.0,2.0,<2 mo. follow-up
89.31396,1,male,1,28,28,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,26630.0,16067.7109,11.5,white,47.0,2,0,1,no,0.599999905,0.3,dnr before sadm,-1.0,123.0,10.8984375,62.0,28.0,38.09375,286.625,3.0996094,1.01,1.79980469,148.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.58099,0,male,0,6,1839,Colon Cancer,Cancer,1,12.0,under $11k,5187.0,3958.7441,10.0,white,30.0,1,0,0,metastatic,0.75,0.4,dnr after sadm,3.0,93.0,12.7988281,98.0,24.0,36.59375,333.3,2.5,10.3984375,1.0,133.0,7.419922,135.0,23.0,2502.0,3.1831989,no(M2 and SIP pres)
92.29797,1,female,0,29,41,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,19765.0,14352.9297,8.25,white,38.0,1,0,0,no,0.799999714,0.55,dnr after sadm,1.0,97.0,15.2988281,80.0,24.0,36.19531,233.3125,3.2998047,1.0,2.39990234,144.0,7.419922,135.0,23.0,2502.0,3.9008789,<2 mo. follow-up
74.409,1,male,0,12,69,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,26899.0,17381.4844,32.5,white,25.0,2,0,0,no,0.799999714,0.6,dnr after sadm,2.0,47.0,12.0996094,67.0,20.0,38.89844,320.0,3.5,1.01,1.09985352,137.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
88.172,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,6992.0,2529.5703,34.0,white,73.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,0.0,10.6992188,0.0,30.0,36.39844,312.5,3.5,1.29980469,5.59960938,126.0,7.389648,135.0,23.0,2502.0,1.8625488,<2 mo. follow-up
82.32697,1,male,1,6,6,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,15828.0,5706.2148,46.0,white,58.0,1,1,1,no,0.0,0.0,dnr after sadm,5.0,42.0,17.3984375,104.0,32.0,36.39844,218.0,3.5,1.59985352,2.69970703,145.0,7.329102,135.0,23.0,2502.0,6.0,<2 mo. follow-up
95.41394,1,female,0,16,944,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,21600.0,8630.2812,23.0,white,58.0,1,0,0,no,0.299999952,0.3,no dnr,16.0,57.0,8.19921875,77.0,40.0,38.89844,90.0,3.5,0.69995117,1.59985352,148.0,7.069336,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
76.12598,0,male,0,5,1826,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,4546.0,2898.5039,11.0,white,33.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,107.0,3.29980469,80.0,21.0,37.19531,230.0,3.5,1.01,1.09985352,131.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
86.49097,1,male,0,114,294,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,under $11k,110134.0,74480.9375,9.25,white,34.0,1,0,1,no,0.75,0.75,no dnr,114.0,131.0,8.59960938,78.0,28.0,36.69531,85.0,2.5996094,0.59997559,0.69995117,140.0,7.529297,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
70.21796,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,27165.0,17051.6719,10.0,white,44.0,1,0,0,no,0.699999809,0.5,dnr after sadm,9.0,80.0,3.0,100.0,26.0,35.0,404.75,2.199707,1.89990234,8.19921875,135.0,7.539062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.84796,1,female,0,19,126,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,27437.0,11603.9375,21.666656,hispanic,19.0,1,0,0,yes,0.75,0.5,dnr after sadm,3.0,50.0,15.0,63.0,10.0,38.0,225.0,3.7998047,0.19998169,0.59997559,137.0,7.379883,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
48.909,1,male,0,111,410,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,162243.0,92695.5,42.0,white,53.0,1,0,0,no,0.5,0.5,no dnr,111.0,47.0,18.296875,121.0,10.0,33.29688,249.0,2.5996094,1.39990234,1.19995117,138.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.65295,1,male,0,8,231,Colon Cancer,Cancer,3,5.0,$25-$50k,8013.0,4871.3359,2.5,white,25.0,1,0,0,metastatic,0.75,0.5,no dnr,8.0,77.0,8.69921875,60.0,28.0,37.89844,333.3,3.5,1.01,1.0,143.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
39.12698,0,female,0,18,1823,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,19532.0,14328.2969,16.666656,white,31.0,1,0,0,no,0.989999771,0.95,no dnr,18.0,68.0,17.3984375,144.0,28.0,38.39844,424.0,3.5,1.01,1.19995117,136.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.21295,1,female,1,9,9,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,19470.0,5971.9727,29.5,white,71.0,1,0,0,no,0.5,0.4,no dnr,9.0,53.0,21.8984375,165.0,38.0,36.89844,203.6875,4.0996094,1.01,2.39990234,134.0,7.399414,135.0,23.0,2502.0,1.0,<2 mo. follow-up
19.75099,0,male,0,6,1822,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,8945.0,3473.5801,21.0,black,13.0,2,0,0,no,0.989999771,0.99,no dnr,6.0,113.0,14.5996094,112.0,24.0,37.09375,245.0,3.5,1.01,0.89990234,137.0,7.389648,135.0,23.0,2502.0,1.6252441,no(M2 and SIP pres)
65.87799,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,10435.0,3580.7969,33.0,white,59.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,47.0,15.0996094,110.0,22.0,39.19531,150.0,2.0,2.5,1.59985352,145.0,7.329102,135.0,23.0,2502.0,2.1923828,<2 mo. follow-up
85.89996,1,female,0,11,358,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9867.0,6423.6914,12.0,white,31.0,1,0,1,no,0.5,0.1,dnr after sadm,2.0,57.0,8.69921875,64.0,20.0,37.39844,333.3,2.699707,1.79980469,0.79992676,142.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
77.73895,1,male,1,121,121,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,$25-$50k,298360.0,198960.125,13.5,white,44.0,1,0,0,no,0.989999771,0.9,dnr after sadm,120.0,132.0,10.3984375,115.0,8.0,38.19531,141.65625,3.5996094,1.01,2.59960938,138.0,7.369141,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
88.03595,0,female,0,17,1820,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,15815.0,12376.2344,12.333328,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,17.0,71.0,5.5,76.0,45.0,38.5,388.0,3.5,0.5,1.69995117,137.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.66595,1,female,0,7,126,COPD,COPD/CHF/Cirrhosis,1,14.0,>$50k,7804.0,6189.3398,20.0,white,20.0,1,0,0,no,0.899999619,0.7,no dnr,7.0,71.0,7.29980469,74.0,20.0,36.29688,542.75,3.7998047,1.01,1.29980469,137.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.31897,1,female,0,4,19,Lung Cancer,Cancer,1,12.0,$25-$50k,4416.0,2761.2207,17.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,60.0,5.19921875,80.0,20.0,37.79688,333.3,3.5,1.09985352,0.59997559,135.0,7.419922,135.0,23.0,2502.0,1.9909668,<2 mo. follow-up
69.14398,1,male,0,9,58,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,10137.0,5123.7227,12.5,white,16.0,1,0,0,no,0.949999809,0.65,no dnr,9.0,83.0,6.5,76.0,32.0,36.19531,337.0,4.0,0.5,0.79992676,137.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
80.87097,1,female,0,9,1174,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,10512.0,4263.2422,16.5,white,49.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,77.0,17.296875,134.0,28.0,36.5,190.46875,3.5,1.01,0.89990234,136.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.67596,1,male,0,7,45,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,11472.0,7616.8633,19.0,white,36.0,3,0,0,no,0.799999714,0.8,no dnr,7.0,67.0,10.5996094,62.0,26.0,36.09375,471.625,2.8999023,1.0,1.79980469,134.0,7.509766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
90.11597,1,female,0,12,27,COPD,COPD/CHF/Cirrhosis,1,5.0,under $11k,10945.0,6067.9414,9.5,white,28.0,1,0,0,no,0.899999619,0.7,dnr after sadm,1.0,93.0,5.39941406,82.0,28.0,37.0,285.6875,3.5,1.01,1.09985352,144.0,7.269531,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
91.88995,0,female,0,7,1813,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,5870.0,3882.2109,17.0,white,35.0,1,0,0,no,0.199999928,0.1,dnr after sadm,1.0,75.0,8.69921875,60.0,24.0,36.69531,400.0,4.5996094,1.01,1.89990234,135.0,7.259766,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
85.29498,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,under $11k,22704.0,10671.1172,39.0,black,41.0,10,0,0,no,0.099999964,0.001,dnr after sadm,3.0,63.0,19.1992188,138.0,46.0,39.29688,173.3125,3.199707,1.19995117,0.79992676,132.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.06195,1,male,0,16,36,CHF,COPD/CHF/Cirrhosis,3,6.0,under $11k,12894.0,8858.2969,9.666664,white,35.0,1,0,0,no,0.799999714,0.6,no dnr,16.0,65.0,5.19921875,98.0,32.0,36.19531,333.3,3.2998047,0.5,1.59985352,134.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
77.36896,1,male,1,75,75,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,$11-$25k,159774.0,82870.6875,36.75,white,45.0,15,0,0,no,0.949999809,0.8,dnr after sadm,68.0,43.0,5.69921875,189.0,16.0,36.59375,153.03125,2.2998047,1.01,0.79992676,136.0,7.399414,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
57.47598,1,female,0,17,59,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,27525.0,15043.7344,25.333328,hispanic,30.0,7,0,0,metastatic,0.799999714,0.5,no dnr,17.0,111.0,6.19921875,110.0,26.0,36.79688,250.0,3.5,1.01,1.29980469,149.0,7.519531,135.0,23.0,2502.0,0.4947999,adl>=4 (>=5 if sur)
75.12097,0,female,0,121,1809,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,171895.0,117669.438,27.75,white,66.0,1,1,0,no,0.599999905,0.4,no dnr,121.0,53.0,15.5996094,160.0,8.0,36.39844,248.0,3.3999023,1.79980469,2.0,146.0,7.209961,135.0,23.0,2502.0,5.0,SIP>=30
36.16397,0,male,0,44,1810,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,90237.0,73488.125,40.25,white,22.0,3,0,0,no,0.699999809,0.5,no dnr,44.0,127.0,11.0,102.0,14.0,38.5,191.65625,3.5,1.01,0.89990234,134.0,7.449219,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
76.10999,1,male,0,11,833,ARF/MOSF w/Sepsis,ARF/MOSF,2,0.0,under $11k,21743.0,18019.5156,35.0,white,36.0,2,0,1,no,0.75,0.25,no dnr,11.0,113.0,12.7988281,70.0,28.0,38.79688,103.0,3.5,1.01,1.39990234,143.0,7.489258,135.0,23.0,2502.0,5.4404297,adl>=4 (>=5 if sur)
87.13995,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,19842.0,5105.0781,34.0,white,46.0,1,0,0,yes,0.099999964,0.001,dnr after sadm,4.0,43.0,7.09960938,114.0,12.0,38.19531,285.0,4.0,1.19995117,2.09960938,143.0,7.439453,135.0,23.0,2502.0,3.121582,<2 mo. follow-up
76.80194,1,female,0,13,713,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,32927.0,20705.5312,27.0,white,33.0,5,1,0,no,0.799999714,0.65,no dnr,13.0,72.0,16.0976562,102.0,28.0,38.09375,177.53125,3.5,1.01,1.39990234,138.0,7.509766,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
85.62097,1,female,0,17,1057,CHF,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,13883.0,8324.8047,7.666664,white,46.0,1,0,0,no,0.979999542,1.0,no dnr,17.0,53.0,5.69921875,69.0,30.0,38.0,126.51562,3.5,0.59997559,1.69995117,136.0,7.369141,135.0,23.0,2502.0,0.0,SIP>=30
82.83099,1,female,0,5,139,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,7412.0,3651.3867,15.0,white,45.0,1,0,0,no,0.899999619,0.6,dnr after sadm,2.0,65.0,9.0,71.0,35.0,36.89844,220.0,3.7998047,0.5,3.0,140.0,7.379883,135.0,23.0,2502.0,4.5273972,adl>=4 (>=5 if sur)
67.26099,1,female,0,8,49,COPD,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,9286.0,5743.0938,8.5,black,20.0,1,0,0,no,0.899999619,0.85,no dnr,8.0,113.0,6.89941406,90.0,24.0,37.79688,421.625,3.2998047,0.29998779,1.5,144.0,7.379883,135.0,23.0,2502.0,1.0,<2 mo. follow-up
78.07794,1,female,0,19,355,COPD,COPD/CHF/Cirrhosis,2,15.0,$25-$50k,13959.0,9974.7891,8.0,white,32.0,1,0,0,no,0.799999714,0.6,dnr after sadm,1.0,67.0,4.69921875,80.0,20.0,36.69531,220.0,3.5,1.01,0.79992676,133.0,7.5,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
48.05698,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,19.0,>$50k,9250.0,2868.1894,30.0,white,56.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,49.0,1.5,124.0,44.0,34.59375,145.0,2.7998047,0.59997559,0.69995117,130.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.75195,1,female,0,20,179,Lung Cancer,Cancer,2,12.0,under $11k,19308.0,13598.2031,7.666664,white,15.0,1,0,0,metastatic,0.799999714,0.7,no dnr,20.0,103.0,12.8984375,76.0,16.0,36.69531,333.3,3.3999023,0.5,0.89990234,141.0,7.419922,135.0,23.0,2502.0,2.953125,<2 mo. follow-up
85.06494,1,female,0,13,82,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15635.0,7769.6562,18.0,white,35.0,1,1,0,no,0.899999619,0.8,no dnr,13.0,50.0,11.8984375,85.0,20.0,37.89844,235.0,3.5996094,0.5,0.79992676,133.0,7.319336,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
43.21399,1,female,0,10,322,Cirrhosis,COPD/CHF/Cirrhosis,2,21.0,>$50k,22535.0,9573.2734,22.5,white,62.0,1,0,0,no,0.599999905,0.33,no dnr,10.0,58.0,11.2988281,132.0,56.0,38.89844,261.875,2.3999023,2.59960938,0.39996338,145.0,7.509766,135.0,23.0,2502.0,3.0,<2 mo. follow-up
61.862,1,female,0,96,1362,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,139856.0,89639.3125,35.0,black,62.0,1,1,0,no,0.699999809,0.65,dnr after sadm,6.0,53.0,11.8984375,69.0,32.0,38.69531,316.0,2.7998047,1.01,6.69921875,137.0,7.229492,135.0,23.0,2502.0,2.0,SIP>=30
55.64099,1,male,0,11,49,Lung Cancer,Cancer,1,14.0,under $11k,12424.0,7868.0664,22.0,white,17.0,1,0,0,metastatic,0.5,0.25,no dnr,11.0,103.0,7.0,88.0,16.0,37.79688,333.3,3.5,0.39996338,1.19995117,133.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.35199,1,male,0,5,118,Lung Cancer,Cancer,1,12.0,$25-$50k,5977.0,3633.5742,11.0,white,53.0,1,0,0,metastatic,0.5,0.2,no dnr,5.0,70.0,0.79992676,100.0,26.0,38.79688,328.5625,3.5,1.01,1.5,133.0,7.479492,135.0,23.0,2502.0,2.2036133,no(M2 and SIP pres)
55.66098,1,female,0,12,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,30821.0,22212.0469,33.0,white,31.0,4,0,0,no,0.5,0.2,no dnr,12.0,53.0,13.5996094,109.0,32.0,39.09375,118.32812,3.5,1.01,0.79992676,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
27.228,0,male,0,100,1790,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,95692.0,65816.625,14.75,white,16.0,2,0,0,no,0.949999809,0.8,no dnr,100.0,106.0,13.8984375,135.0,22.0,37.89844,236.65625,3.5,1.01,1.09985352,145.0,7.439453,135.0,23.0,2502.0,2.6665039,<2 mo. follow-up
64.76898,0,female,0,44,1790,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,67778.0,34829.25,26.75,white,60.0,1,1,0,no,0.299999952,0.25,no dnr,44.0,59.0,16.1992188,67.0,32.0,38.09375,185.6875,2.7998047,0.39996338,8.8984375,144.0,7.459961,135.0,23.0,2502.0,0.0,SIP>=30
89.05695,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,under $11k,21707.0,9177.0938,20.0,white,41.0,4,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,59.0,8.5,115.0,36.0,38.39844,235.0,3.7998047,1.01,1.19995117,150.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
75.625,1,male,0,35,300,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,33324.0,21974.6406,7.75,black,21.0,1,0,0,no,0.899999619,0.9,dnr after sadm,16.0,72.0,8.59960938,73.0,16.0,36.0,237.125,3.199707,0.39996338,1.0,135.0,7.399414,135.0,23.0,2502.0,5.1994972,<2 mo. follow-up
51.56998,1,female,0,8,1286,COPD,COPD/CHF/Cirrhosis,1,14.0,$25-$50k,7933.0,5171.043,10.0,white,18.0,1,0,0,no,0.979999542,0.98,no dnr,8.0,73.0,12.6992188,110.0,25.0,38.29688,329.625,3.5,0.69995117,0.69995117,146.0,7.399414,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
76.18896,1,female,0,46,283,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,58865.0,32778.4062,19.5,white,21.0,1,0,0,no,0.299999952,0.1,dnr after sadm,5.0,57.0,10.1992188,63.0,6.0,38.19531,294.25,3.7998047,0.39996338,0.69995117,132.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.66498,0,female,0,4,1783,Lung Cancer,Cancer,3,15.0,under $11k,3253.0,2141.6816,11.0,white,22.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,117.0,6.5,72.0,28.0,36.39844,333.3,3.5,1.01,1.09985352,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
89.62598,0,female,0,6,1781,COPD,COPD/CHF/Cirrhosis,2,16.0,>$50k,6769.0,4204.9414,9.0,white,51.0,1,0,0,no,1.0,0.8,no dnr,6.0,93.0,15.3984375,80.0,40.0,36.09375,220.0,3.3999023,0.5,1.69995117,139.0,7.469727,135.0,23.0,2502.0,5.0,SIP>=30
71.77295,1,male,0,7,28,Colon Cancer,Cancer,2,12.0,$25-$50k,6365.0,4270.9492,13.0,white,29.0,1,1,0,metastatic,0.049999982,0.000125,dnr after sadm,3.0,103.0,2.39990234,76.0,20.0,37.79688,333.3,2.199707,0.5,0.89990234,142.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
77.72998,0,female,0,3,1780,COPD,COPD/CHF/Cirrhosis,1,16.0,under $11k,2752.0,1723.9951,16.0,white,20.0,1,0,0,no,0.949999809,0.85,no dnr,3.0,120.0,7.59960938,60.0,24.0,36.19531,380.0,3.5,1.01,1.09985352,144.0,7.469727,135.0,23.0,2502.0,2.2114258,<2 mo. follow-up
52.961,1,male,1,7,7,Lung Cancer,Cancer,1,12.0,under $11k,8388.0,5345.3594,12.0,black,15.0,1,0,0,metastatic,0.049999982,0.000125,dnr before sadm,-1.0,83.0,32.1953125,112.0,16.0,37.39844,333.3,2.7998047,1.09985352,0.69995117,142.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
62.25098,0,female,0,5,1779,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,5801.0,3634.0312,7.0,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,110.0,17.296875,100.0,20.0,36.69531,176.65625,3.8999023,0.39996338,1.19995117,143.0,7.30957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.54797,0,female,0,18,1778,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,35637.0,15254.7578,20.666656,white,34.0,1,0,0,no,0.799999714,0.6,no dnr,18.0,147.0,8.19921875,115.0,6.0,37.79688,140.0,4.1992188,1.5,1.39990234,148.0,7.299805,135.0,23.0,2502.0,1.0,<2 mo. follow-up
71.30695,0,female,0,19,1777,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,35785.0,29547.8125,27.0,white,49.0,5,1,0,no,0.75,0.7,dnr after sadm,4.0,68.0,10.1992188,103.0,32.0,38.39844,61.0,3.5,1.01,1.59985352,134.0,7.489258,135.0,23.0,2502.0,5.0,SIP>=30
70.15497,1,male,0,4,51,Lung Cancer,Cancer,1,14.0,$11-$25k,4469.0,2853.1348,9.0,white,10.0,1,0,0,metastatic,0.5,0.1,no dnr,4.0,80.0,20.296875,90.0,20.0,37.79688,333.3,3.2998047,0.5,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.98798,1,male,0,7,225,MOSF w/Malig,ARF/MOSF,1,14.0,$11-$25k,20414.0,7250.3516,30.0,white,56.0,1,0,0,yes,0.75,0.5,no dnr,7.0,52.0,5.5,110.0,12.0,38.89844,145.0,1.6999512,1.69995117,1.89990234,131.0,7.30957,135.0,23.0,2502.0,0.0,SIP>=30
75.737,1,female,0,7,1215,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,11378.0,6638.8867,16.0,white,18.0,1,0,0,no,0.989999771,0.97,no dnr,7.0,77.0,13.0996094,100.0,20.0,37.19531,295.1875,3.5,1.01,0.89990234,139.0,7.439453,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
57.09198,0,male,0,15,1775,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,40735.0,20608.4844,26.666656,white,28.0,1,1,0,no,0.899999619,0.95,no dnr,15.0,58.0,6.69921875,110.0,24.0,38.59375,280.0,3.5,1.01,0.89990234,136.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.55896,1,male,0,7,928,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,9225.0,6452.3867,11.0,white,46.0,1,0,0,no,0.899999619,0.75,no dnr,7.0,107.0,16.796875,60.0,25.0,36.69531,117.5,3.5,1.01,1.5,144.0,7.279297,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
53.54999,1,male,0,22,904,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,47802.0,29025.8438,19.666656,white,29.0,1,1,0,no,0.989999771,0.99,no dnr,22.0,77.0,7.5,63.0,24.0,36.69531,170.0,3.5,1.01,1.89990234,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.58698,1,male,0,6,359,Lung Cancer,Cancer,1,13.0,>$50k,7248.0,4762.5352,12.0,white,18.0,1,0,0,metastatic,0.899999619,0.65,no dnr,6.0,100.0,3.0,100.0,20.0,35.59375,333.3,3.0996094,0.19998169,1.09985352,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
89.16095,1,male,1,62,62,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,74657.0,46843.25,14.75,white,55.0,1,0,0,no,0.849999905,0.75,dnr after sadm,57.0,47.0,9.09960938,72.0,26.0,38.39844,203.3125,3.5,1.01,2.5,138.0,7.269531,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
85.45697,1,male,0,11,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,31884.0,20765.8125,32.5,white,50.0,8,0,1,yes,0.799999714,0.65,dnr after sadm,10.0,46.0,10.1992188,105.0,28.0,36.29688,346.625,2.2998047,1.29980469,1.5,138.0,7.269531,135.0,23.0,2502.0,4.0,<2 mo. follow-up
66.53296,0,male,0,9,1771,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,14115.0,6797.5898,18.0,white,33.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,55.0,7.0,68.0,24.0,38.79688,252.5,2.8999023,0.29998779,1.5,141.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.34998,1,female,1,6,6,Colon Cancer,Cancer,1,12.0,under $11k,4814.0,3547.2793,12.0,white,25.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,93.0,11.7988281,100.0,20.0,36.09375,333.3,1.8999023,4.39941406,0.89990234,146.0,7.419922,135.0,23.0,2502.0,2.1054688,<2 mo. follow-up
91.23895,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,49254.0,17402.25,38.333313,white,41.0,1,0,0,yes,0.049999982,0.000125,dnr after sadm,16.0,47.0,8.79882812,47.0,8.0,36.89844,230.0,3.5,0.5,1.29980469,137.0,7.369141,135.0,23.0,2502.0,3.5141602,<2 mo. follow-up
52.43799,1,male,0,4,63,Lung Cancer,Cancer,3,12.0,under $11k,3754.0,2510.0801,7.0,white,15.0,1,0,0,metastatic,0.5,0.1,no dnr,4.0,90.0,10.5,90.0,20.0,37.79688,342.8125,4.0996094,2.09960938,1.29980469,136.0,7.489258,135.0,23.0,2502.0,2.921875,<2 mo. follow-up
69.68695,0,female,0,6,1768,Lung Cancer,Cancer,2,16.0,>$50k,7594.0,4807.0508,13.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,97.0,4.09960938,100.0,20.0,38.19531,280.9375,3.5,1.01,1.0,144.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.01099,1,female,0,40,1608,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,$25-$50k,65515.0,35741.6875,21.25,white,30.0,4,0,1,no,0.5,0.5,no dnr,40.0,53.0,11.1992188,70.0,8.0,38.59375,182.0,3.5,1.01,1.09985352,157.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.00995,1,male,1,26,26,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,55591.0,25233.4688,15.5,white,40.0,1,0,0,no,0.5,0.4,dnr after sadm,20.0,117.0,16.8984375,70.0,20.0,35.59375,169.5625,3.5996094,0.39996338,1.69995117,146.0,7.319336,135.0,23.0,2502.0,2.7246094,<2 mo. follow-up
66.57599,1,male,0,32,58,Lung Cancer,Cancer,1,10.0,$11-$25k,28609.0,21191.9844,9.75,hispanic,11.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,87.0,13.3984375,60.0,20.0,37.0,333.3,3.5996094,0.59997559,0.89990234,133.0,7.419922,135.0,23.0,2502.0,2.8164062,<2 mo. follow-up
71.55096,1,male,0,4,42,Lung Cancer,Cancer,1,13.0,under $11k,4155.0,2700.1113,6.0,white,33.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,60.0,12.5996094,110.0,25.0,36.79688,323.75,3.0996094,0.39996338,1.0,143.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
93.63196,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,20328.0,6779.9258,34.0,white,51.0,1,0,1,yes,0.5,0.1,dnr after sadm,6.0,55.0,12.0996094,62.0,36.0,36.79688,177.5,3.5,0.79992676,2.19970703,139.0,7.379883,135.0,23.0,2502.0,6.0,<2 mo. follow-up
55.51498,1,male,0,3,410,Lung Cancer,Cancer,3,8.0,$11-$25k,4136.0,2525.0195,6.0,white,9.0,1,0,0,metastatic,1.0,0.9,no dnr,3.0,100.0,11.6992188,92.0,20.0,36.69531,333.3,3.5,1.01,0.79992676,137.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
84.80499,1,female,0,13,35,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,13374.0,9147.9844,10.0,white,40.0,1,1,1,no,0.899999619,0.5,dnr after sadm,10.0,107.0,6.0,80.0,20.0,35.59375,276.0,3.0,0.5,2.39990234,136.0,7.5,135.0,23.0,2502.0,7.0,<2 mo. follow-up
46.08398,0,female,0,10,1761,Lung Cancer,Cancer,1,12.0,under $11k,9901.0,7630.4258,3.0,black,6.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,93.0,12.6992188,76.0,16.0,36.69531,333.3,3.5996094,0.39996338,1.0,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.99597,0,male,0,11,1759,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,14066.0,7690.0742,19.0,black,21.0,1,0,0,no,1.0,0.95,no dnr,11.0,64.0,11.6992188,110.0,25.0,38.09375,179.5625,3.5,1.01,0.79992676,136.0,7.449219,135.0,23.0,2502.0,2.565918,<2 mo. follow-up
44.89499,0,female,0,63,1757,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,176328.0,64412.5625,50.75,white,70.0,1,0,0,no,0.149999976,0.00337,no dnr,63.0,53.0,41.1953125,130.0,22.0,36.39844,50.0,1.8999023,1.19995117,1.5,129.0,7.279297,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
67.75098,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,46516.0,22635.3438,43.0,white,63.0,10,0,0,yes,0.75,0.5,dnr after sadm,8.0,57.0,12.1992188,145.0,14.0,36.89844,211.65625,3.5,0.5,11.7988281,138.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
75.159,1,female,1,6,6,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,24431.0,10405.8281,39.0,white,58.0,4,0,0,no,0.049999982,0.000125,dnr after sadm,6.0,43.0,29.3984375,127.0,24.0,34.59375,195.0,2.7998047,1.01,1.19995117,132.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.59094,1,male,0,6,816,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,5894.0,3981.5547,15.0,white,48.0,1,1,0,no,0.799999714,0.6,no dnr,6.0,63.0,11.0,80.0,25.0,35.59375,224.0,3.5,1.59985352,2.19970703,135.0,7.489258,135.0,23.0,2502.0,0.0,SIP>=30
31.76999,1,male,0,23,72,Lung Cancer,Cancer,2,12.0,under $11k,33867.0,22225.9375,18.666656,white,20.0,1,0,0,metastatic,0.799999714,0.25,no dnr,23.0,72.0,16.796875,124.0,20.0,39.39844,333.3,3.5,1.01,0.59997559,133.0,7.419922,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
74.83398,1,female,1,7,7,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,10763.0,6619.1445,15.0,white,47.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,70.0,11.8984375,100.0,50.0,36.09375,263.3125,2.199707,0.39996338,0.79992676,142.0,7.429688,135.0,23.0,2502.0,4.0,<2 mo. follow-up
74.66699,1,male,0,25,1323,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,46033.0,19954.7188,30.0,white,67.0,1,1,0,no,0.5,0.5,no dnr,25.0,52.0,13.0,113.0,32.0,37.59375,120.0,2.0996094,0.39996338,2.0,150.0,7.479492,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
69.68097,0,female,0,6,1753,Lung Cancer,Cancer,1,20.0,>$50k,6840.0,4699.6172,14.0,white,17.0,1,0,0,metastatic,0.949999809,0.75,no dnr,6.0,77.0,9.0,74.0,20.0,36.79688,333.3,3.199707,0.29998779,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.66895,1,male,0,8,64,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20399.0,17433.4219,18.5,white,27.0,5,0,0,no,0.899999619,0.7,no dnr,8.0,108.0,5.59960938,78.0,24.0,36.59375,173.3125,2.699707,1.01,1.79980469,140.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
70.09698,0,male,0,4,1750,COPD,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,6388.0,3125.3809,9.0,white,16.0,1,0,0,no,0.96999979,0.97,no dnr,4.0,60.0,10.0996094,60.0,20.0,36.09375,361.875,3.5,1.01,1.09985352,144.0,7.319336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
79.05499,1,female,0,9,68,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,9388.0,6350.4453,11.0,white,43.0,1,0,0,metastatic,0.099999964,0.001,dnr before sadm,-1.0,97.0,0.59997559,76.0,32.0,36.09375,190.0,3.0996094,0.69995117,0.59997559,147.0,7.389648,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
69.06195,0,female,0,9,1749,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,12943.0,5987.9141,12.5,white,33.0,1,0,0,no,0.899999619,0.8,no dnr,9.0,69.0,9.3984375,72.0,24.0,37.89844,348.0,3.0996094,1.09985352,4.09960938,143.0,7.30957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.29596,0,female,0,23,1748,CHF,COPD/CHF/Cirrhosis,4,13.0,under $11k,47413.0,27751.4062,16.333328,white,38.0,1,0,0,no,0.899999619,0.75,no dnr,23.0,47.0,5.29980469,121.0,24.0,37.79688,333.3,3.8999023,0.29998779,1.29980469,146.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.30298,0,male,0,17,1748,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,37775.0,27634.4375,21.666656,other,26.0,1,0,0,no,0.699999809,0.5,no dnr,17.0,68.0,10.0,65.0,32.0,39.09375,177.5,3.0996094,0.79992676,1.29980469,141.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
90.073,1,female,0,8,240,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,9664.0,7518.3672,9.0,white,27.0,1,0,0,yes,0.799999714,0.6,dnr before sadm,-1.0,120.0,4.79980469,59.0,16.0,36.19531,425.0,3.5996094,0.19998169,1.5,132.0,7.369141,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
72.59698,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,$11-$25k,65724.0,42684.0,50.0,white,61.0,11,0,0,no,0.399999857,0.2,no dnr,3.0,50.0,28.0976562,120.0,12.0,36.69531,100.0,2.5996094,1.01,3.5,129.0,7.30957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
89.28094,1,male,0,11,215,MOSF w/Malig,ARF/MOSF,4,8.0,under $11k,15407.0,7858.9844,16.5,white,68.0,1,1,0,yes,0.199999928,0.1,dnr after sadm,2.0,50.0,45.0,116.0,28.0,36.09375,199.96875,3.0,1.01,5.79980469,140.0,7.299805,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
78.39795,1,male,0,5,1112,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,7293.0,5625.7344,13.0,hispanic,23.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,117.0,8.79882812,65.0,24.0,37.19531,283.3125,3.5,1.01,1.79980469,138.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
63.44098,1,female,0,7,347,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,13301.0,7643.9961,36.0,white,49.0,1,1,0,no,0.75,0.5,no dnr,7.0,53.0,14.1992188,100.0,24.0,37.69531,355.0,3.5996094,0.79992676,4.39941406,136.0,7.429688,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
70.90997,1,male,0,7,1069,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,14078.0,10750.4922,34.0,white,37.0,2,1,0,no,0.699999809,0.5,no dnr,7.0,57.0,9.5,112.0,26.0,38.59375,224.46875,3.5,1.01,1.0,136.0,7.519531,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
48.48499,0,male,0,8,1738,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,9580.0,5006.9414,14.0,white,26.0,1,0,0,no,0.799999714,0.8,no dnr,8.0,63.0,6.0,58.0,26.0,35.59375,428.5625,3.0,3.0,0.5,128.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.75897,0,male,0,67,1737,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,101328.0,73976.6875,31.75,black,54.0,5,0,0,no,0.799999714,0.7,no dnr,67.0,153.0,12.2988281,130.0,8.0,37.79688,145.0,3.5,1.01,2.19970703,134.0,7.40918,135.0,23.0,2502.0,0.0,SIP>=30
84.57495,1,male,0,15,16,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,19696.0,12471.5234,19.666656,white,38.0,1,0,0,no,0.899999619,0.9,dnr after sadm,9.0,107.0,8.19921875,64.0,32.0,36.09375,333.3,3.7998047,1.5,2.09960938,145.0,7.419922,135.0,23.0,2502.0,3.3823242,<2 mo. follow-up
88.50696,1,male,1,10,10,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,8194.0,5980.1562,8.5,white,31.0,1,0,1,no,0.899999619,0.8,dnr after sadm,1.0,83.0,7.89941406,80.0,25.0,37.79688,390.4375,3.8999023,1.69995117,2.29980469,133.0,7.459961,135.0,23.0,2502.0,6.0,<2 mo. follow-up
71.82495,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,52016.0,39866.4688,24.5,white,40.0,26,1,0,no,0.699999809,0.5,dnr after sadm,1.0,77.0,11.6992188,70.0,32.0,39.39844,119.0,2.3999023,0.29998779,1.79980469,138.0,7.30957,135.0,23.0,2502.0,3.0,<2 mo. follow-up
61.19098,1,male,0,15,402,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,27367.0,12431.9375,21.0,white,22.0,1,0,0,no,0.899999619,0.9,no dnr,15.0,100.0,16.0,80.0,25.0,36.09375,273.3125,4.0,0.79992676,1.39990234,136.0,7.429688,135.0,23.0,2502.0,3.9931641,no(M2 and SIP pres)
89.04297,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,58008.0,38696.375,36.0,hispanic,50.0,14,0,0,no,0.5,0.5,dnr after sadm,6.0,59.0,12.5,120.0,33.0,38.59375,168.0,3.5,0.39996338,1.0,146.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
58.50198,0,male,0,12,1735,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,18372.0,13234.2969,22.5,white,30.0,1,1,0,no,0.799999714,0.8,no dnr,12.0,77.0,3.19970703,70.0,20.0,39.59375,242.84375,2.7998047,4.29980469,0.59997559,136.0,7.509766,135.0,23.0,2502.0,2.262207,no(M2 and SIP pres)
81.02698,0,female,0,10,1733,COPD,COPD/CHF/Cirrhosis,2,9.0,>$50k,11976.0,8376.7734,10.5,white,46.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,53.0,5.69921875,80.0,20.0,36.09375,266.625,3.5,1.01,0.89990234,141.0,7.479492,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
76.10699,0,female,0,14,1733,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,27917.0,21123.0625,32.333313,white,23.0,1,0,0,no,0.799999714,0.8,no dnr,14.0,107.0,13.6992188,78.0,8.0,37.69531,237.5,3.199707,0.29998779,1.59985352,138.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.91498,1,female,0,17,78,COPD,COPD/CHF/Cirrhosis,2,18.0,$11-$25k,21983.0,14240.3828,13.0,white,36.0,1,0,0,metastatic,0.699999809,0.5,no dnr,17.0,103.0,1.79980469,80.0,25.0,36.09375,252.375,3.5,1.01,1.09985352,142.0,7.479492,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
75.41394,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,45105.0,22974.0938,34.5,white,29.0,12,0,0,metastatic,0.5,0.4,dnr after sadm,7.0,63.0,15.0,112.0,22.0,38.79688,185.0,3.5,1.01,1.29980469,141.0,7.389648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
90.08398,1,female,0,15,323,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,18263.0,11832.4766,11.333328,white,25.0,1,0,0,no,0.599999905,0.15,no dnr,15.0,97.0,3.79980469,70.0,20.0,37.0,162.84375,3.5,1.01,1.59985352,150.0,7.379883,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
78.96796,0,female,0,13,1732,ARF/MOSF w/Sepsis,ARF/MOSF,2,0.0,$11-$25k,16741.0,12578.8281,16.0,white,44.0,1,1,0,no,0.899999619,0.75,no dnr,13.0,58.0,7.69921875,65.0,24.0,35.59375,136.71875,3.5,0.69995117,1.39990234,133.0,7.519531,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
69.66199,1,female,0,22,43,Lung Cancer,Cancer,2,12.0,under $11k,41995.0,27412.6562,8.666664,white,37.0,1,0,0,metastatic,0.949999809,0.8,no dnr,22.0,117.0,9.29882812,80.0,25.0,36.5,340.0,3.199707,0.39996338,1.09985352,136.0,7.5,135.0,23.0,2502.0,3.0629883,<2 mo. follow-up
47.866,0,male,0,8,1731,CHF,COPD/CHF/Cirrhosis,2,9.0,>$50k,9214.0,5951.7148,11.0,white,19.0,1,0,0,no,0.899999619,0.6,no dnr,8.0,70.0,5.09960938,80.0,16.0,36.69531,333.3,4.0,0.89990234,1.59985352,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.20099,0,male,0,7,1729,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,9812.0,4801.6211,19.0,white,28.0,1,0,0,no,0.899999619,0.9,no dnr,7.0,77.0,19.0976562,68.0,30.0,38.89844,159.15625,3.5,1.01,1.29980469,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.30396,0,male,0,16,1728,Coma,Coma,1,16.0,>$50k,15716.0,12380.3438,10.0,white,31.0,1,0,0,yes,0.799999714,0.9,no dnr,16.0,77.0,8.8984375,62.0,28.0,37.79688,352.0,4.1992188,1.5,1.29980469,134.0,7.539062,135.0,23.0,2502.0,2.2578125,<2 mo. follow-up
78.95099,0,female,0,13,1728,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,19168.0,14840.7812,19.5,black,36.0,1,0,0,no,0.899999619,0.75,no dnr,13.0,117.0,7.44921875,150.0,26.0,36.09375,448.0,3.5,1.01,1.09985352,134.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.56,0,male,0,32,1728,Coma,Coma,1,18.0,>$50k,44236.0,25587.5156,22.25,black,47.0,2,0,0,no,0.699999809,0.6,dnr after sadm,7.0,135.0,14.5,140.0,28.0,38.29688,126.51562,3.2998047,1.01,1.79980469,146.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.25397,0,male,0,16,1727,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,54799.0,29236.5469,30.666656,white,38.0,2,1,0,no,0.899999619,0.9,no dnr,16.0,49.0,12.5996094,76.0,24.0,38.39844,123.32812,3.5,1.01,1.29980469,132.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.32898,1,female,1,15,15,Coma,Coma,3,12.0,under $11k,75051.0,64077.8125,34.333313,white,46.0,13,1,0,no,0.75,0.25,dnr after sadm,14.0,67.0,16.5976562,110.0,32.0,38.79688,346.0,2.3999023,1.01,1.0,148.0,7.459961,135.0,23.0,2502.0,2.871582,<2 mo. follow-up
55.431,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19018.0,6998.5195,26.0,white,42.0,1,0,0,yes,0.799999714,0.8,dnr after sadm,6.0,130.0,1.39990234,140.0,12.0,38.29688,121.42188,2.5996094,1.5,0.69995117,140.0,7.399414,135.0,23.0,2502.0,2.7421875,<2 mo. follow-up
47.26898,0,male,0,3,1723,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,4884.0,2802.9844,20.0,white,29.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,80.0,12.2988281,80.0,30.0,36.69531,456.0,2.7998047,2.59960938,0.69995117,134.0,7.349609,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
64.77795,1,male,0,19,129,Lung Cancer,Cancer,1,10.0,under $11k,25747.0,15204.4766,15.0,white,29.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,3.0,81.0,14.5996094,110.0,32.0,34.79688,267.3125,2.5996094,0.69995117,0.59997559,135.0,7.439453,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
75.72894,1,male,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,168004.0,99285.125,28.75,white,47.0,55,0,0,no,0.5,0.1,no dnr,34.0,70.0,6.5,80.0,38.0,36.59375,157.0,2.3999023,1.01,1.69995117,150.0,7.359375,135.0,23.0,2502.0,2.6513672,<2 mo. follow-up
83.61896,1,male,0,19,51,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,23847.0,18103.2031,10.666664,white,38.0,2,0,0,no,0.799999714,0.7,dnr after sadm,9.0,65.0,10.1992188,65.0,26.0,35.79688,240.0,3.0,0.59997559,1.69995117,138.0,7.5,135.0,23.0,2502.0,2.0,<2 mo. follow-up
83.59796,1,male,1,6,6,Coma,Coma,2,12.0,under $11k,8071.0,5081.8008,17.0,white,20.0,1,0,0,no,0.009999998,1e-06,dnr before sadm,-1.0,93.0,12.3984375,100.0,20.0,38.29688,488.3125,3.699707,0.59997559,1.5,144.0,7.40918,135.0,23.0,2502.0,2.5795898,<2 mo. follow-up
82.46399,1,female,0,8,51,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,7544.0,5190.9688,6.0,white,34.0,1,0,0,yes,0.0,0.0,dnr after sadm,4.0,73.0,6.79980469,70.0,20.0,35.59375,508.0,3.199707,0.59997559,2.39990234,141.0,7.339844,135.0,23.0,2502.0,3.9868164,<2 mo. follow-up
73.62097,1,male,0,5,80,Colon Cancer,Cancer,1,12.0,under $11k,5234.0,3463.6504,10.0,white,26.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,40.0,12.7988281,80.0,20.0,38.79688,333.3,2.8999023,1.19995117,1.0,137.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
47.35098,1,female,0,6,374,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,7408.0,3852.2246,34.0,white,37.0,1,1,0,no,0.949999809,0.8,no dnr,6.0,68.0,12.1992188,78.0,28.0,36.29688,187.75,3.5,1.01,3.5,136.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
79.06598,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,46932.0,35811.0312,45.0,white,54.0,16,0,0,yes,0.049999982,0.000125,dnr before sadm,0.0,63.0,17.0,100.0,7.0,35.59375,266.625,3.5996094,2.89990234,2.59960938,127.0,7.269531,135.0,23.0,2502.0,3.0,<2 mo. follow-up
77.21594,1,male,0,27,913,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,46000.0,23963.8438,21.5,white,35.0,3,0,0,no,0.199999928,0.1,dnr after sadm,1.0,44.0,9.3984375,107.0,8.0,36.19531,214.0,3.5,1.01,1.19995117,136.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.06198,0,male,0,8,1719,Cirrhosis,COPD/CHF/Cirrhosis,3,19.0,>$50k,10061.0,5333.6562,13.0,white,27.0,1,0,0,no,0.5,0.6,no dnr,8.0,69.0,5.29980469,112.0,22.0,37.89844,333.3,3.8999023,3.09960938,0.79992676,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.92297,0,female,0,7,1718,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,8348.0,5407.6719,11.0,white,32.0,1,0,0,no,0.949999809,0.85,no dnr,7.0,77.0,8.0,80.0,25.0,36.69531,271.375,3.5,1.01,1.0,139.0,7.379883,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
77.93298,0,male,0,13,1717,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,18693.0,9089.9141,23.0,white,46.0,1,0,0,no,0.799999714,0.8,no dnr,13.0,57.0,9.5,69.0,20.0,36.79688,206.09375,2.2998047,0.69995117,5.39941406,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
81.07898,1,female,0,31,42,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,55945.0,26017.2031,28.5,white,46.0,1,0,0,no,0.599999905,0.5,no dnr,31.0,53.0,12.3984375,64.0,42.0,36.89844,150.0,3.699707,0.79992676,1.09985352,145.0,7.30957,135.0,23.0,2502.0,4.0,<2 mo. follow-up
28.25699,0,female,0,7,1714,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,22529.0,11484.4844,22.0,white,24.0,6,0,0,no,0.899999619,0.9,no dnr,7.0,138.0,12.7988281,102.0,28.0,38.19531,166.65625,3.0,1.29980469,0.89990234,138.0,7.479492,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
77.30597,1,male,0,10,1037,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,11137.0,8727.0391,12.0,white,33.0,1,0,1,no,0.899999619,0.75,no dnr,10.0,100.0,5.0,59.0,22.0,35.59375,333.3,3.0,0.39996338,2.59960938,142.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
83.51294,1,male,0,5,69,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,4691.0,3171.3438,7.0,white,37.0,1,1,1,no,0.799999714,0.7,dnr after sadm,3.0,93.0,8.29882812,70.0,25.0,36.09375,396.0,3.699707,0.89990234,2.09960938,142.0,7.299805,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
68.24097,1,female,0,6,64,CHF,COPD/CHF/Cirrhosis,3,15.0,under $11k,5608.0,3866.9336,14.0,white,35.0,1,1,0,no,0.799999714,0.7,no dnr,6.0,73.0,3.79980469,60.0,20.0,37.19531,347.5625,3.5,2.39990234,1.19995117,136.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
78.245,1,female,1,42,42,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,69147.0,33901.3438,22.75,white,28.0,1,0,0,no,0.949999809,0.75,dnr after sadm,17.0,53.0,17.296875,107.0,8.0,35.59375,320.0,3.5,0.5,1.09985352,143.0,7.369141,135.0,23.0,2502.0,2.0,<2 mo. follow-up
60.77197,1,male,0,7,248,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,8159.0,4635.6094,12.0,white,25.0,2,1,0,no,0.75,0.7,no dnr,7.0,111.0,7.19921875,64.0,20.0,36.39844,336.625,4.5996094,1.09985352,1.79980469,141.0,7.549805,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
67.96997,1,male,0,11,1134,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,27302.0,15819.0,16.5,black,34.0,4,1,0,metastatic,0.799999714,0.7,no dnr,11.0,145.0,17.3984375,70.0,24.0,38.19531,193.875,2.8999023,1.01,5.5,138.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.38098,0,male,0,17,1708,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,25486.0,14188.5703,15.333328,white,21.0,2,0,0,no,0.799999714,0.7,no dnr,17.0,115.0,6.5,59.0,24.0,37.89844,486.0,2.5,0.5,1.69995117,141.0,7.509766,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
61.56299,0,male,0,4,1708,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,7588.0,3814.6152,4.0,white,16.0,1,1,0,no,1.0,1.0,no dnr,4.0,103.0,7.79980469,70.0,20.0,36.09375,447.5625,3.0996094,0.69995117,1.09985352,140.0,7.579102,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.23199,0,female,0,32,1707,Colon Cancer,Cancer,2,12.0,under $11k,37893.0,26417.5156,14.0,black,35.0,1,1,0,metastatic,0.75,0.5,dnr after sadm,9.0,100.0,0.79992676,80.0,15.0,37.79688,333.3,2.699707,1.89990234,0.69995117,140.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
89.32794,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,86069.0,34868.0,50.0,white,61.0,1,0,0,no,0.299999952,0.28,dnr after sadm,16.0,53.0,4.09960938,230.0,12.0,39.69531,142.0,2.0996094,5.39941406,1.0,146.0,7.349609,135.0,23.0,2502.0,3.0795898,<2 mo. follow-up
84.35297,0,male,0,16,1705,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19014.0,11332.1406,9.666664,white,24.0,1,0,0,no,0.5,0.4,no dnr,16.0,65.0,14.3984375,68.0,26.0,38.09375,385.125,3.0,0.59997559,0.5,133.0,7.439453,135.0,23.0,2502.0,3.1708984,<2 mo. follow-up
73.63397,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,$11-$25k,21516.0,13772.5234,5.5,white,31.0,9,1,0,yes,0.5,0.1,no dnr,11.0,120.0,17.5,90.0,35.0,37.69531,333.3,3.199707,1.01,1.09985352,145.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
87.41699,0,female,0,19,1703,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,25572.0,13947.4531,12.333328,white,38.0,1,0,0,metastatic,0.899999619,0.7,dnr after sadm,1.0,70.0,13.3984375,59.0,28.0,36.09375,404.0,2.3999023,0.79992676,1.5,130.0,7.459961,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
75.34296,0,female,0,89,1701,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,81770.0,57706.5312,8.75,white,27.0,1,0,0,no,0.799999714,0.5,dnr after sadm,16.0,58.0,5.5,98.0,24.0,36.69531,196.40625,3.8999023,0.79992676,0.59997559,130.0,7.389648,135.0,23.0,2502.0,3.2998047,<2 mo. follow-up
78.53497,1,female,0,10,14,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,10645.0,7270.207,11.0,white,15.0,1,0,0,no,0.099999964,0.001,dnr before sadm,-1.0,77.0,10.0,70.0,20.0,36.59375,195.0,3.5,1.01,0.5,137.0,7.179688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
67.06396,1,female,0,10,194,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,15291.0,7507.1133,18.0,hispanic,37.0,1,1,0,no,0.5,0.3,no dnr,10.0,62.0,11.5,68.0,16.0,36.79688,392.0,3.5,0.39996338,4.39941406,133.0,7.339844,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
76.28497,1,male,0,10,1335,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,12633.0,6874.457,12.0,white,39.0,1,0,0,no,0.799999714,0.6,no dnr,10.0,58.0,13.0996094,60.0,24.0,36.59375,285.6875,2.2998047,0.59997559,1.5,139.0,7.319336,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
95.58099,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,4.0,under $11k,27548.0,17302.7969,10.333328,black,50.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,22.0,58.0,4.0,78.0,30.0,34.89844,416.625,2.0996094,0.29998779,1.39990234,144.0,7.429688,135.0,23.0,2502.0,5.0,<2 mo. follow-up
60.79398,1,male,0,25,323,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,26174.0,17180.8281,12.333328,black,32.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,80.0,6.09960938,100.0,25.0,35.59375,333.3,3.5,1.01,1.89990234,149.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
52.28497,1,male,0,7,617,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,10612.0,7649.7734,21.0,white,27.0,1,1,0,no,0.949999809,0.9,no dnr,7.0,104.0,17.3984375,101.0,28.0,36.29688,257.125,3.5,1.01,0.69995117,138.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
58.32199,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,75398.0,51512.75,15.666664,white,22.0,27,0,0,no,0.599999905,0.45,dnr after sadm,4.0,55.0,10.5,58.0,24.0,38.79688,333.3,3.5,1.01,1.09985352,133.0,7.369141,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
83.46899,1,female,0,7,76,COPD,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,7015.0,4895.7891,11.0,white,22.0,1,0,0,no,0.899999619,0.8,dnr after sadm,1.0,107.0,6.69921875,60.0,25.0,35.59375,404.3125,3.5,1.01,0.59997559,138.0,7.399414,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.46997,1,female,1,142,142,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,216883.0,123592.312,33.75,white,28.0,1,0,0,no,0.899999619,0.8,dnr after sadm,115.0,61.0,17.0,128.0,10.0,36.0,132.5,2.2998047,0.89990234,1.0,136.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
77.008,0,male,0,8,1690,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,11872.0,6965.2148,9.5,white,23.0,1,0,0,no,0.949999809,0.8,no dnr,8.0,80.0,10.2988281,80.0,20.0,35.59375,357.125,3.5,1.01,1.5,139.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
85.37195,1,male,1,9,9,Coma,Coma,1,16.0,$25-$50k,18329.0,7512.7578,31.0,white,52.0,1,0,1,no,0.5,0.2,dnr after sadm,2.0,123.0,8.19921875,136.0,34.0,38.0,84.0,3.3999023,1.0,1.79980469,143.0,7.439453,135.0,23.0,2502.0,4.3955078,<2 mo. follow-up
83.16199,1,male,0,14,29,Lung Cancer,Cancer,1,15.0,under $11k,18052.0,12468.0547,8.333328,white,33.0,1,0,0,metastatic,0.399999857,0.3,dnr after sadm,1.0,123.0,6.5,110.0,20.0,36.39844,228.0,3.5,1.01,1.09985352,136.0,7.459961,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
65.91595,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,14437.0,9101.7734,38.0,white,89.0,1,1,0,no,0.699999809,0.5,dnr after sadm,3.0,30.0,13.6992188,0.0,0.0,38.79688,255.0,3.5,1.01,6.29980469,137.0,7.289062,135.0,23.0,2502.0,2.0917969,<2 mo. follow-up
79.22498,1,male,0,9,1453,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$11-$25k,12608.0,8627.8359,11.5,white,25.0,1,0,0,no,0.899999619,0.75,no dnr,9.0,103.0,5.29980469,60.0,20.0,35.79688,328.0,2.5,0.59997559,1.5,137.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.09998,0,male,0,13,1687,COPD,COPD/CHF/Cirrhosis,4,14.0,under $11k,14896.0,10624.0078,8.0,white,27.0,1,0,0,yes,0.699999809,0.2,no dnr,13.0,80.0,5.5,100.0,25.0,36.29688,147.5,3.8999023,1.01,1.39990234,140.0,7.339844,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
59.88797,1,female,0,13,340,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,18408.0,9522.8906,18.0,white,50.0,1,0,0,yes,0.799999714,0.04,no dnr,13.0,50.0,24.1992188,74.0,12.0,36.29688,333.3,3.3999023,0.5,3.09960938,143.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
59.27197,0,female,0,9,1683,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,9120.0,6131.0703,6.0,white,26.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,73.0,7.89941406,70.0,20.0,36.09375,304.75,3.699707,1.09985352,1.39990234,143.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
63.25299,1,male,0,3,43,Colon Cancer,Cancer,1,12.0,$25-$50k,4324.0,2529.5195,9.0,white,24.0,1,0,0,metastatic,0.299999952,0.2,no dnr,3.0,103.0,10.5996094,100.0,20.0,36.69531,333.3,3.199707,6.39941406,0.69995117,131.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
69.125,1,female,0,6,765,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,6270.0,4137.7578,14.0,white,29.0,1,0,0,no,0.949999809,0.8,no dnr,6.0,113.0,6.5,70.0,20.0,36.69531,396.0,3.5,1.01,4.0,136.0,7.329102,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
71.461,1,female,0,7,266,Lung Cancer,Cancer,1,23.0,$25-$50k,9665.0,6271.7461,13.0,white,27.0,1,0,0,metastatic,0.899999619,0.7,no dnr,7.0,107.0,8.29882812,108.0,32.0,37.89844,333.3,3.0996094,0.5,1.09985352,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
87.24194,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,18381.0,6058.1445,27.5,white,56.0,1,0,1,no,0.5,0.4,dnr after sadm,2.0,47.0,9.59960938,66.0,10.0,37.69531,220.0,2.699707,0.69995117,4.29980469,142.0,7.269531,135.0,23.0,2502.0,7.0,<2 mo. follow-up
57.79898,0,male,0,55,1681,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,129188.0,48944.9688,33.0,white,26.0,3,0,0,yes,0.5,0.5,no dnr,55.0,49.0,15.7988281,50.0,10.0,38.09375,155.0,3.5,0.39996338,0.59997559,130.0,7.399414,135.0,23.0,2502.0,2.171875,no(M2 and SIP pres)
72.62695,1,male,0,11,1643,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,15794.0,7943.2148,14.5,white,34.0,1,0,0,no,0.949999809,0.7,dnr after sadm,6.0,130.0,11.1992188,109.0,40.0,36.69531,416.0,3.5,1.01,1.29980469,134.0,7.369141,135.0,23.0,2502.0,0.0,SIP>=30
69.21594,1,male,0,5,422,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5314.0,3484.1719,8.0,white,45.0,1,1,0,no,0.799999714,0.7,no dnr,5.0,73.0,7.19921875,80.0,25.0,37.19531,248.0,3.5,0.69995117,2.89990234,137.0,7.459961,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
49.87299,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,35115.0,16667.8594,36.0,white,38.0,10,0,0,metastatic,0.299999952,0.2,dnr after sadm,7.0,43.0,2.69970703,128.0,32.0,35.89844,205.0,2.5,0.59997559,0.59997559,136.0,7.389648,135.0,23.0,2502.0,2.5141602,<2 mo. follow-up
81.19098,0,male,0,61,1676,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,$25-$50k,68286.0,44503.1875,15.5,white,48.0,1,1,0,no,0.899999619,0.6,no dnr,61.0,57.0,7.09960938,51.0,24.0,37.89844,496.0,2.5,0.39996338,3.59960938,150.0,7.459961,135.0,23.0,2502.0,1.1668997,SIP>=30
50.19598,0,female,0,23,1676,Cirrhosis,COPD/CHF/Cirrhosis,2,2.0,>$50k,31479.0,20222.6562,11.666664,white,33.0,1,0,0,no,1.0,1.0,no dnr,23.0,103.0,12.1992188,80.0,20.0,36.09375,333.3,3.699707,0.69995117,3.79980469,125.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
69.12299,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,53798.0,40329.6875,36.0,white,48.0,4,1,0,no,0.799999714,0.7,dnr after sadm,8.0,110.0,6.69921875,70.0,12.0,38.29688,107.14062,3.5,1.01,6.19921875,142.0,7.429688,135.0,23.0,2502.0,4.0,<2 mo. follow-up
82.35699,1,female,0,241,1231,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,209565.0,143218.5,11.0,black,27.0,1,0,0,no,0.5,0.25,dnr after sadm,1.0,137.0,21.8984375,100.0,20.0,37.79688,323.75,3.5996094,1.0,1.19995117,135.0,7.399414,135.0,23.0,2502.0,3.0576172,<2 mo. follow-up
52.57797,1,female,0,7,118,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,7638.0,5049.6445,4.0,white,27.0,1,0,0,no,0.899999619,0.8,no dnr,7.0,67.0,6.79980469,70.0,15.0,37.0,180.9375,2.7998047,0.79992676,1.09985352,138.0,7.379883,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
71.79498,1,male,0,25,97,COPD,COPD/CHF/Cirrhosis,2,18.0,$11-$25k,46839.0,22876.9062,28.0,white,13.0,1,0,0,no,0.599999905,0.5,dnr after sadm,10.0,61.0,11.1992188,68.0,10.0,37.69531,152.5,3.199707,0.69995117,0.69995117,136.0,7.419922,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
38.66699,0,female,0,21,1670,Cirrhosis,COPD/CHF/Cirrhosis,1,9.0,under $11k,46790.0,20298.0625,41.0,black,63.0,1,0,0,no,0.399999857,0.4,no dnr,21.0,43.0,29.0976562,43.0,8.0,35.59375,217.0,2.3999023,11.0996094,0.5,137.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.85394,1,female,0,7,902,COPD,COPD/CHF/Cirrhosis,0,17.0,under $11k,8190.0,5374.0156,11.0,white,24.0,1,0,0,no,1.0,1.0,no dnr,7.0,63.0,7.89941406,80.0,20.0,36.69531,261.875,3.5,1.01,0.79992676,133.0,7.369141,135.0,23.0,2502.0,2.0913086,<2 mo. follow-up
70.45898,0,female,0,14,1669,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,21065.0,11537.9062,14.666664,white,36.0,1,0,0,no,0.899999619,0.9,no dnr,14.0,61.0,8.8984375,65.0,36.0,38.29688,256.625,3.0,1.19995117,1.5,137.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.435,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,5085.0,3324.0449,12.0,white,39.0,1,0,1,no,0.5,0.25,dnr after sadm,1.0,77.0,7.59960938,120.0,40.0,39.09375,140.0,3.5,1.01,0.89990234,139.0,7.349609,135.0,23.0,2502.0,5.7724609,<2 mo. follow-up
83.30194,1,female,0,12,35,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,25474.0,18161.7188,33.5,white,60.0,2,0,0,no,0.799999714,0.8,no dnr,12.0,59.0,14.5996094,160.0,24.0,38.5,256.625,3.5,0.69995117,2.39990234,141.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.42896,1,male,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,93900.0,58769.0312,23.75,white,55.0,32,1,0,no,0.699999809,0.5,dnr after sadm,32.0,49.0,16.3984375,131.0,32.0,36.39844,187.75,2.0996094,0.79992676,1.29980469,155.0,7.379883,135.0,23.0,2502.0,5.0,<2 mo. follow-up
90.57599,1,female,1,9,9,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,9106.0,6112.6406,14.0,white,35.0,1,0,0,no,0.949999809,0.85,dnr after sadm,3.0,73.0,5.5,60.0,25.0,35.39844,333.3,3.699707,1.01,1.69995117,142.0,7.419922,135.0,23.0,2502.0,3.7075195,<2 mo. follow-up
54.237,1,female,0,3,722,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,3979.0,2404.7246,6.0,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,80.0,6.59960938,80.0,20.0,36.39844,504.75,2.0996094,6.5,0.79992676,129.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.10199,0,male,0,4,1663,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,3464.0,2371.1113,2.0,white,22.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,117.0,5.0,50.0,20.0,36.69531,336.625,3.5,1.01,1.69995117,141.0,7.429688,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
66.92096,0,female,0,8,1661,COPD,COPD/CHF/Cirrhosis,1,16.0,>$50k,13139.0,6770.543,16.5,white,31.0,1,0,0,no,0.979999542,0.9,no dnr,8.0,56.0,6.59960938,109.0,8.0,37.89844,180.0,2.3999023,1.01,0.59997559,141.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.487,1,female,0,7,14,Colon Cancer,Cancer,1,12.0,under $11k,8837.0,5661.6797,7.5,black,14.0,1,0,0,metastatic,0.199999928,0.0,dnr before sadm,-1.0,109.0,9.5,72.0,20.0,36.09375,333.3,2.5,0.39996338,1.0,134.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
66.52399,1,female,0,15,230,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,26499.0,10231.5625,25.0,black,56.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,49.0,11.7988281,129.0,40.0,38.59375,175.0,4.0996094,2.5,1.69995117,147.0,7.479492,135.0,23.0,2502.0,2.737793,no(M2 and SIP pres)
41.12299,1,male,0,59,897,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,78089.0,47791.0625,16.5,black,33.0,3,0,0,no,0.25,0.25,dnr after sadm,5.0,121.0,13.6992188,63.0,32.0,39.29688,416.625,2.0,1.5,2.0,142.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
64.81299,1,male,0,9,29,CHF,COPD/CHF/Cirrhosis,0,10.0,under $11k,12726.0,8069.832,16.5,white,46.0,1,0,0,no,0.5,0.2,dnr after sadm,7.0,70.0,8.69921875,60.0,20.0,35.59375,323.75,3.5,1.01,5.19921875,125.0,7.259766,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
82.15698,1,female,0,26,116,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,40355.0,18819.2812,20.0,white,50.0,1,1,0,no,0.699999809,0.5,dnr after sadm,6.0,59.0,5.39941406,60.0,26.0,37.69531,276.625,3.699707,1.01,2.19970703,142.0,7.449219,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
83.16199,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,19.0,under $11k,13316.0,8379.6406,57.0,white,65.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,43.0,9.5,120.0,38.0,38.39844,123.32812,4.0996094,1.09985352,2.59960938,141.0,7.339844,135.0,23.0,2502.0,2.8325195,<2 mo. follow-up
68.19995,0,female,0,43,1652,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,83351.0,57514.5,32.5,white,63.0,1,0,0,no,0.049999982,0.000125,no dnr,43.0,49.0,8.3984375,145.0,10.0,38.59375,105.0,3.2998047,0.69995117,3.29980469,137.0,7.369141,135.0,23.0,2502.0,2.0317383,adl>=4 (>=5 if sur)
47.58899,1,male,0,7,190,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,$25-$50k,6175.0,4326.5781,9.0,white,19.0,1,0,0,no,1.0,0.9,no dnr,7.0,80.0,5.29980469,80.0,20.0,37.0,333.3,3.5,5.0,0.79992676,131.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.05896,0,female,0,10,1650,Colon Cancer,Cancer,1,12.0,$25-$50k,9658.0,6682.3438,8.0,white,40.0,1,0,0,metastatic,0.699999809,0.3,no dnr,10.0,100.0,6.79980469,80.0,20.0,36.09375,333.3,2.699707,2.79980469,10.3984375,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.83496,1,female,1,9,9,Coma,Coma,0,18.0,$11-$25k,14380.0,5589.5703,12.5,asian,23.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,56.0,9.79882812,47.0,6.0,38.09375,393.3125,2.5996094,1.01,0.79992676,136.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
34.51297,1,male,0,61,1232,Coma,Coma,2,12.0,under $11k,123827.0,33595.5938,23.0,white,51.0,7,0,0,yes,1.0,1.0,no dnr,61.0,57.0,2.0,58.0,12.0,33.5,178.0,2.2998047,1.01,1.39990234,142.0,7.40918,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
85.54999,1,male,0,11,105,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,11059.0,8758.3984,11.0,white,39.0,1,0,0,no,0.799999714,0.6,dnr after sadm,1.0,63.0,8.59960938,66.0,24.0,35.59375,319.0,3.5,1.01,3.19970703,129.0,7.449219,135.0,23.0,2502.0,4.5273438,no(M2 and SIP pres)
75.10999,0,male,0,17,1645,Colon Cancer,Cancer,1,16.0,>$50k,17967.0,12273.4141,8.333328,white,24.0,1,0,0,metastatic,1.0,0.6,no dnr,17.0,80.0,5.29980469,60.0,25.0,38.89844,333.3,2.8999023,1.0,1.29980469,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.25098,0,male,0,10,1642,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,21914.0,15529.125,28.0,white,36.0,1,0,0,yes,0.899999619,0.8,no dnr,10.0,57.0,17.5,117.0,8.0,38.29688,125.0,3.5,1.01,1.19995117,139.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.35895,0,female,0,6,1642,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,6528.0,4329.5859,12.0,white,35.0,1,0,0,yes,1.0,0.9,no dnr,6.0,70.0,4.29980469,80.0,35.0,37.0,211.09375,3.5,1.01,1.09985352,140.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.10397,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,18313.0,8718.0938,49.0,white,62.0,2,0,0,yes,0.199999928,0.1,dnr after sadm,4.0,60.0,0.09999084,120.0,8.0,36.59375,182.84375,2.199707,1.01,1.69995117,138.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
83.461,1,male,1,87,87,ARF/MOSF w/Sepsis,ARF/MOSF,4,20.0,$25-$50k,177467.0,141714.75,37.25,white,71.0,1,1,0,no,0.0,0.0,dnr after sadm,87.0,43.0,3.19970703,120.0,32.0,36.5,231.65625,2.199707,0.79992676,2.89990234,128.0,7.319336,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
75.33197,1,female,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,88774.0,49328.5625,18.25,white,37.0,21,1,0,no,0.899999619,0.9,dnr after sadm,24.0,64.0,19.5,110.0,26.0,36.09375,253.03125,3.5,0.39996338,1.39990234,126.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
84.47894,0,male,0,11,1637,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,12504.0,8726.3828,10.5,white,29.0,1,0,0,yes,0.75,0.5,no dnr,11.0,105.0,10.1992188,68.0,24.0,36.89844,333.3,3.5,0.5,1.79980469,138.0,7.429688,135.0,23.0,2502.0,4.2509766,no(M2 and SIP pres)
85.48096,1,female,0,5,1096,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,5872.0,3718.6934,8.0,white,23.0,1,0,0,no,0.799999714,0.6,no dnr,5.0,67.0,21.296875,70.0,20.0,36.69531,332.0,3.5,1.01,1.29980469,144.0,7.339844,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
64.06,1,female,0,3,93,Lung Cancer,Cancer,1,14.0,$11-$25k,4562.0,3148.3848,11.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,75.0,7.79980469,100.0,18.0,36.89844,333.3,3.8999023,0.39996338,0.69995117,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.896,1,female,1,33,33,Colon Cancer,Cancer,1,14.0,under $11k,39582.0,26151.2344,14.0,white,19.0,1,0,0,metastatic,0.949999809,0.7,dnr before sadm,0.0,127.0,8.09960938,60.0,22.0,37.69531,333.3,4.0996094,0.39996338,1.39990234,139.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
65.29797,1,male,0,13,30,Colon Cancer,Cancer,1,14.0,$25-$50k,13669.0,9362.3203,13.5,white,12.0,1,0,0,metastatic,0.5,0.15,dnr after sadm,5.0,60.0,12.2988281,90.0,20.0,36.69531,333.3,3.5,1.01,0.79992676,140.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
80.77496,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,82763.0,62808.2188,26.666656,white,41.0,20,0,0,yes,0.199999928,0.05,dnr after sadm,4.0,53.0,18.5976562,73.0,22.0,38.39844,383.3125,3.5,0.89990234,7.39941406,139.0,7.359375,135.0,23.0,2502.0,6.0,<2 mo. follow-up
74.46698,1,female,1,36,36,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,46365.0,32123.8594,14.0,white,54.0,2,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,47.0,3.39990234,154.0,52.0,36.29688,284.0,3.5,1.01,0.59997559,139.0,7.369141,135.0,23.0,2502.0,3.8374023,<2 mo. follow-up
74.875,1,female,0,15,81,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,18145.0,9994.9297,10.333328,black,31.0,1,1,0,no,0.799999714,0.3,no dnr,15.0,62.0,7.09960938,70.0,32.0,37.89844,620.0,4.1992188,1.01,0.89990234,154.0,7.379883,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
46.448,0,male,0,93,1629,Coma,Coma,0,12.0,under $11k,102951.0,61589.5312,32.0,white,46.0,1,0,0,no,0.5,0.5,dnr after sadm,5.0,39.0,8.79882812,130.0,8.0,34.0,162.5,2.5996094,1.01,0.79992676,144.0,7.379883,135.0,23.0,2502.0,1.6599121,<2 mo. follow-up
36.36099,0,male,0,19,1631,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,49378.0,20026.4531,27.666656,white,49.0,6,0,0,no,0.5,0.5,no dnr,19.0,57.0,8.5,100.0,34.0,39.29688,171.65625,2.2998047,5.0,0.79992676,148.0,7.439453,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
84.758,1,female,0,16,201,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,55554.0,41568.0312,24.0,white,32.0,8,0,0,no,0.899999619,0.9,dnr after sadm,1.0,70.0,5.79980469,100.0,9.0,37.89844,343.0,3.5,1.01,1.0,132.0,7.449219,135.0,23.0,2502.0,3.980957,<2 mo. follow-up
73.09497,1,male,0,4,629,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,3231.0,2033.0977,9.0,white,19.0,1,0,1,no,0.899999619,0.8,no dnr,4.0,110.0,9.29882812,60.0,20.0,37.0,324.0,4.3994141,0.29998779,1.09985352,140.0,7.379883,135.0,23.0,2502.0,4.6621094,<2 mo. follow-up
87.836,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,7485.0,2813.8379,21.0,white,42.0,1,1,0,no,0.0,0.0,dnr after sadm,3.0,57.0,14.2988281,111.0,14.0,37.89844,376.625,3.7998047,1.01,1.19995117,139.0,7.469727,135.0,23.0,2502.0,4.0,<2 mo. follow-up
65.21796,1,male,1,17,17,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,56488.0,25246.2031,45.0,white,67.0,1,0,0,no,0.699999809,0.5,dnr after sadm,6.0,45.0,11.3984375,120.0,8.0,37.69531,104.0,2.3999023,1.89990234,2.89990234,136.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
39.159,1,male,1,6,6,Lung Cancer,Cancer,2,14.0,$11-$25k,8814.0,5570.7383,27.0,white,56.0,1,0,0,metastatic,0.009999998,1e-06,dnr after sadm,3.0,52.0,31.0976562,140.0,28.0,38.19531,121.65625,1.8999023,0.5,0.59997559,139.0,7.449219,135.0,23.0,2502.0,3.0,<2 mo. follow-up
61.23999,1,female,1,28,28,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,under $11k,104725.0,64707.5,48.75,black,21.0,3,1,0,no,0.799999714,0.6,no dnr,28.0,129.0,6.79980469,70.0,16.0,36.09375,333.3,2.199707,1.01,0.79992676,143.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
85.05396,1,male,0,156,420,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,143520.0,94672.4375,20.0,white,57.0,1,1,1,no,0.649999619,0.5,dnr after sadm,1.0,50.0,6.59960938,48.0,37.0,38.09375,237.5,3.5,1.01,3.0,144.0,7.30957,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
80.54999,1,female,0,27,59,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,51714.0,39208.5,20.5,white,53.0,10,1,0,no,0.899999619,0.8,dnr after sadm,1.0,63.0,9.0,39.0,28.0,36.09375,333.3,3.5,1.01,2.09960938,134.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
73.30298,1,male,1,45,45,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,73250.0,31503.1719,22.75,white,43.0,1,0,0,yes,0.5,0.5,dnr after sadm,32.0,57.0,9.09960938,132.0,38.0,36.5,250.0,3.5,1.01,0.69995117,137.0,7.379883,135.0,23.0,2502.0,2.6767578,<2 mo. follow-up
66.89899,1,female,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,87649.0,76678.5625,39.75,white,52.0,2,1,0,no,0.699999809,0.7,no dnr,33.0,130.0,11.8984375,110.0,24.0,39.09375,138.0,3.5,1.01,3.0,145.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.04498,0,male,0,23,1621,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,102951.0,18028.2969,18.666656,white,39.0,1,0,0,no,0.799999714,0.7,no dnr,23.0,77.0,9.19921875,80.0,25.0,36.69531,203.3125,3.199707,0.79992676,1.19995117,135.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
91.00098,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,25116.0,12177.7344,40.0,white,53.0,12,0,0,no,0.299999952,0.15,dnr after sadm,2.0,41.0,17.796875,67.0,27.0,35.69531,320.0,3.5,1.01,2.79980469,121.0,7.469727,135.0,23.0,2502.0,3.0,<2 mo. follow-up
70.86694,1,female,0,13,1269,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20128.0,14848.0938,26.0,white,22.0,1,0,0,no,0.849999905,0.75,no dnr,13.0,57.0,10.5996094,52.0,22.0,39.29688,171.40625,2.5,1.89990234,0.79992676,139.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
80.80798,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,21600.0,16596.6094,42.5,white,90.0,2,0,0,yes,0.039999992,6.4e-05,dnr after sadm,6.0,40.0,99.0,174.0,48.0,36.29688,95.0,2.0996094,1.01,1.39990234,146.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
39.01398,0,male,0,54,1619,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,143863.0,52669.7188,39.5,white,75.0,1,0,0,no,0.949999809,0.95,no dnr,54.0,47.0,12.5,120.0,46.0,36.59375,145.0,2.7998047,4.69921875,6.19921875,134.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
96.29297,1,male,0,11,327,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,23315.0,14476.0781,31.0,white,35.0,1,0,0,yes,0.949999809,0.9,no dnr,11.0,115.0,3.59960938,59.0,24.0,37.69531,409.5,3.199707,1.01,3.89990234,138.0,7.379883,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
60.96399,0,female,0,7,1616,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,7831.0,5228.7148,7.0,white,15.0,1,1,0,no,0.949999809,0.8,no dnr,7.0,60.0,10.6992188,60.0,20.0,36.69531,360.0,3.5,1.01,1.19995117,135.0,7.399414,135.0,23.0,2502.0,3.1831989,SIP>=30
57.892,1,male,0,4,152,Lung Cancer,Cancer,2,12.0,under $11k,3803.0,2349.0977,12.0,black,21.0,1,0,0,metastatic,0.5,0.3,no dnr,4.0,71.0,4.79980469,110.0,24.0,37.09375,266.625,3.5,1.01,1.09985352,139.0,7.489258,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
79.43097,1,female,0,46,60,Colon Cancer,Cancer,2,19.0,$11-$25k,41940.0,31571.2969,3.25,white,17.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,87.0,5.29980469,109.0,20.0,36.09375,333.3,2.8999023,1.0,0.89990234,131.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
84.25494,1,male,0,5,1578,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4931.0,3273.2148,9.0,white,24.0,1,0,0,no,0.979999542,0.8,no dnr,5.0,73.0,9.59960938,80.0,20.0,36.69531,392.0,3.5,1.01,1.89990234,135.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.97897,0,male,0,9,1606,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,42691.0,24151.6406,11.5,black,18.0,19,0,0,no,0.949999809,0.9,no dnr,9.0,125.0,14.6992188,119.0,24.0,36.29688,292.0,3.5,1.01,0.59997559,139.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
75.34296,1,male,0,12,60,Colon Cancer,Cancer,1,12.0,under $11k,15764.0,10021.3438,12.0,white,27.0,1,0,0,metastatic,0.5,0.125,no dnr,12.0,67.0,9.59960938,80.0,20.0,40.0,333.3,3.7998047,1.01,1.09985352,138.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.20697,1,female,0,14,28,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,27314.0,13883.3828,31.0,white,61.0,1,0,0,yes,0.599999905,0.1,dnr after sadm,2.0,40.0,0.29998779,180.0,22.0,35.59375,381.625,4.0,0.89990234,0.69995117,135.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
75.45197,1,male,1,24,24,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,27479.0,20806.5469,19.666656,white,68.0,1,1,0,no,0.899999619,0.8,dnr after sadm,20.0,44.0,8.69921875,64.0,26.0,35.59375,276.1875,3.5,0.59997559,2.59960938,137.0,7.569336,135.0,23.0,2502.0,2.0,<2 mo. follow-up
74.17096,0,female,0,5,1604,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,24406.0,16957.9062,43.0,white,14.0,4,0,0,no,0.299999952,0.2,no dnr,5.0,66.0,7.39941406,60.0,10.0,38.79688,180.0,2.7998047,1.01,1.0,143.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.31799,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,91472.0,62769.8438,41.333313,white,33.0,5,0,0,no,0.75,0.7,dnr after sadm,21.0,66.0,15.0,51.0,10.0,39.09375,161.65625,3.5,1.5,2.29980469,141.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
61.06998,0,female,0,10,1599,COPD,COPD/CHF/Cirrhosis,2,12.0,>$50k,37517.0,25528.4062,29.0,white,29.0,5,0,0,no,0.989999771,0.99,no dnr,10.0,67.0,12.8984375,70.0,10.0,36.39844,118.0,3.5,1.01,0.59997559,142.0,7.489258,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
76.57996,1,male,0,17,44,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,46322.0,35720.125,26.0,white,69.0,4,0,0,yes,0.399999857,0.1,no dnr,17.0,56.0,15.2988281,110.0,12.0,38.29688,170.0,2.8999023,13.8984375,3.09960938,137.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
91.47198,1,female,0,25,71,MOSF w/Malig,ARF/MOSF,2,17.0,>$50k,58579.0,34724.0312,22.333328,white,50.0,10,0,0,yes,0.299999952,0.2,dnr after sadm,9.0,53.0,1.59985352,120.0,26.0,36.19531,390.0,3.5,1.01,1.0,138.0,7.5,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
22.31099,0,male,0,53,1596,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,69109.0,56255.5,17.0,white,15.0,4,0,0,no,0.199999928,0.5,no dnr,53.0,110.0,9.29882812,120.0,10.0,39.0,434.6875,3.5,1.01,0.89990234,135.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.40799,0,female,0,11,1598,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26252.0,17970.7188,28.0,white,10.0,1,0,0,no,0.849999905,0.6,no dnr,11.0,63.0,11.0,96.0,12.0,37.89844,282.125,2.5996094,0.89990234,0.79992676,138.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.15497,1,male,0,19,33,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,84411.0,47659.9375,24.0,white,59.0,33,0,0,no,0.5,0.125,no dnr,19.0,45.0,19.5,38.0,24.0,34.79688,200.0,2.0,1.89990234,1.89990234,146.0,7.489258,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.95599,1,male,0,9,965,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,16094.0,9747.75,16.5,white,51.0,1,0,0,no,0.899999619,0.7,no dnr,9.0,42.0,5.69921875,80.0,24.0,37.5,359.25,3.8999023,1.09985352,8.09960938,135.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
30.021,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,257474.0,150595.625,35.333313,white,43.0,80,0,0,no,0.299999952,0.4,dnr after sadm,20.0,73.0,0.19998169,104.0,32.0,38.19531,333.3,2.3999023,1.01,0.69995117,141.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.72699,0,female,0,25,1590,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,57971.0,30666.6406,15.666664,white,42.0,1,1,0,no,0.899999619,0.9,no dnr,25.0,69.0,5.19921875,52.0,28.0,36.39844,169.375,3.199707,1.01,4.79980469,145.0,7.349609,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.45996,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,21265.0,6894.4297,32.5,white,62.0,1,0,1,no,0.199999928,0.15,dnr after sadm,3.0,43.0,21.5,111.0,42.0,38.69531,275.0,2.3999023,0.09999084,0.79992676,144.0,7.289062,135.0,23.0,2502.0,7.0,<2 mo. follow-up
59.737,1,male,0,5,22,Lung Cancer,Cancer,1,14.0,$25-$50k,8897.0,5825.3672,13.0,white,21.0,1,0,0,metastatic,0.699999809,0.7,no dnr,5.0,117.0,6.5,120.0,25.0,36.09375,333.3,3.199707,1.01,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.28497,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,63906.0,40457.0,52.0,white,46.0,24,0,0,no,0.5,0.3,dnr after sadm,1.0,49.0,16.0976562,116.0,28.0,35.79688,163.25,2.699707,1.59985352,1.69995117,149.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.46799,1,male,1,21,21,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,110493.0,14452.7344,46.666657,white,66.0,22,0,0,yes,0.019999996,8e-06,dnr after sadm,20.0,49.0,36.1953125,116.0,10.0,35.39844,142.84375,2.3999023,1.89990234,6.09960938,148.0,7.279297,135.0,23.0,2502.0,2.0361328,<2 mo. follow-up
86.17096,0,female,0,95,1583,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,215811.0,79855.875,40.25,white,42.0,3,0,0,no,0.699999809,0.9,no dnr,95.0,50.0,12.5996094,38.0,24.0,38.89844,96.65625,3.199707,0.79992676,0.79992676,137.0,7.419922,135.0,23.0,2502.0,3.4326172,<2 mo. follow-up
79.98395,1,male,1,6,6,COPD,COPD/CHF/Cirrhosis,2,14.0,>$50k,18895.0,7076.6055,45.0,white,68.0,1,0,0,no,0.699999809,0.6,dnr after sadm,6.0,45.0,11.6992188,150.0,35.0,35.89844,213.3125,2.3999023,0.79992676,1.69995117,138.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.65598,0,male,0,11,1580,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,16865.0,9048.6797,14.5,hispanic,47.0,1,0,0,no,0.989999771,0.99,no dnr,11.0,60.0,9.69921875,69.0,40.0,38.89844,333.3,2.2998047,2.89990234,1.39990234,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.51794,0,female,0,18,1579,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,23680.0,17051.9375,9.0,white,58.0,1,1,1,no,1.0,0.1,no dnr,18.0,78.0,12.0,100.0,38.0,37.59375,93.0,3.0,3.29980469,1.5,137.0,7.349609,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
83.50696,0,female,0,7,1579,Colon Cancer,Cancer,2,12.0,under $11k,8183.0,5498.0977,8.0,white,18.0,1,0,0,metastatic,0.899999619,0.6,no dnr,7.0,103.0,6.89941406,60.0,20.0,36.09375,333.3,4.3994141,0.69995117,1.19995117,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.22198,0,male,0,4,1578,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,4646.0,3037.4551,15.0,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,80.0,7.39941406,90.0,25.0,36.19531,333.3,4.0,1.01,1.69995117,141.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
64.72296,1,female,0,13,1257,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,20184.0,9861.875,16.5,white,39.0,1,1,0,no,0.899999619,0.9,no dnr,13.0,57.0,14.6992188,101.0,36.0,36.19531,116.3125,3.0,0.5,0.79992676,136.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
87.04199,1,female,0,13,150,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,17585.0,8647.2109,18.0,white,72.0,1,0,1,no,0.699999809,0.5,no dnr,13.0,52.0,17.0,116.0,30.0,37.89844,125.70312,2.7998047,0.29998779,2.39990234,145.0,7.449219,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
81.85895,1,female,0,15,1467,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,25693.0,18750.5312,15.333328,white,20.0,1,0,0,no,0.949999809,0.8,no dnr,15.0,110.0,10.8984375,110.0,14.0,37.79688,240.0,3.5,1.01,0.79992676,143.0,7.40918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
74.61694,1,female,1,9,9,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,19026.0,6393.8477,13.0,white,43.0,1,0,1,no,0.5,0.3,dnr after sadm,8.0,65.0,12.8984375,120.0,35.0,36.59375,262.5,3.5,0.69995117,0.59997559,141.0,7.379883,135.0,23.0,2502.0,5.2617188,<2 mo. follow-up
53.59299,1,female,0,6,1344,Lung Cancer,Cancer,1,15.0,under $11k,7058.0,4624.3828,15.0,white,14.0,1,0,0,metastatic,0.949999809,0.8,no dnr,6.0,103.0,13.6992188,100.0,20.0,36.79688,333.3,4.0996094,0.29998779,1.0,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
57.84497,1,male,0,22,774,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,29955.0,20794.0781,16.0,white,28.0,1,0,0,no,0.949999809,0.9,no dnr,22.0,80.0,4.89941406,127.0,25.0,35.89844,342.8125,3.699707,2.09960938,1.19995117,146.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.60596,1,male,0,15,1550,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,18683.0,11155.7188,11.666664,white,28.0,1,0,0,no,0.949999809,0.9,no dnr,15.0,109.0,11.5,73.0,26.0,39.69531,333.3,4.0,1.09985352,1.39990234,133.0,7.419922,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
43.38898,0,male,0,17,1568,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,25196.0,13795.8359,13.333328,black,20.0,1,0,0,no,0.899999619,0.9,no dnr,17.0,65.0,6.09960938,110.0,20.0,37.89844,420.0,3.199707,1.39990234,0.69995117,139.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.34799,1,male,0,18,113,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,29852.0,14541.1406,20.0,white,31.0,1,0,0,yes,0.299999952,0.1,no dnr,18.0,55.0,13.1992188,68.0,13.0,35.59375,128.3125,3.699707,1.29980469,0.89990234,140.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
78.67798,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,19026.0,6859.6016,37.5,white,49.0,1,1,0,no,0.699999809,0.6,no dnr,7.0,59.0,7.39941406,60.0,8.0,37.69531,390.0,2.0996094,0.69995117,3.5,147.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
75.52899,0,female,0,13,1570,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,13975.0,9379.8125,12.0,white,38.0,1,0,0,no,0.199999928,0.5,no dnr,13.0,73.0,4.19921875,80.0,20.0,37.0,224.0,3.5,1.01,2.39990234,136.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.59198,0,male,0,27,1570,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,57841.0,33688.0625,19.75,white,34.0,1,0,0,no,0.399999857,0.4,no dnr,27.0,113.0,22.296875,136.0,10.0,39.39844,275.5,2.5,2.0,2.0,147.0,7.349609,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
82.63696,1,female,0,88,137,COPD,COPD/CHF/Cirrhosis,3,15.0,under $11k,87279.0,55067.1875,8.75,white,34.0,6,0,0,no,0.849999905,0.8,dnr after sadm,1.0,60.0,9.09960938,74.0,34.0,36.5,192.5625,3.7998047,0.5,0.89990234,139.0,7.489258,135.0,23.0,2502.0,1.8389997,adl>=4 (>=5 if sur)
68.87097,0,female,0,6,1564,Lung Cancer,Cancer,2,12.0,under $11k,8578.0,5081.6016,7.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,83.0,4.5,100.0,20.0,38.09375,333.3,3.2998047,0.69995117,0.79992676,136.0,7.539062,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.11597,1,male,0,22,135,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,27727.0,15532.4844,18.333328,white,34.0,1,0,1,no,0.699999809,0.5,dnr after sadm,2.0,53.0,14.5,63.0,24.0,36.09375,103.32812,3.199707,0.79992676,1.09985352,145.0,7.479492,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
70.21997,1,female,1,4,4,Coma,Coma,1,14.0,>$50k,14317.0,6209.9922,49.0,white,90.0,1,1,0,no,0.699999809,0.5,dnr after sadm,3.0,42.0,11.8984375,108.0,9.0,32.29688,54.0,2.199707,4.39941406,2.79980469,136.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.92999,0,male,0,45,1561,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,88955.0,50380.625,27.25,white,50.0,1,0,0,no,0.799999714,0.8,no dnr,45.0,57.0,10.5,170.0,28.0,38.69531,138.0,3.5,1.01,1.0,142.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.97598,0,male,0,74,1560,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,74681.0,47597.1562,8.25,black,15.0,1,1,0,yes,0.699999809,0.5,no dnr,74.0,82.0,10.0996094,106.0,26.0,36.0,225.0,2.5,0.29998779,0.89990234,134.0,7.449219,135.0,23.0,2502.0,3.2895508,no(M2 and SIP pres)
43.047,0,female,0,5,1560,COPD,COPD/CHF/Cirrhosis,1,18.0,under $11k,6616.0,4769.8359,8.0,white,31.0,1,0,0,no,0.979999542,0.98,no dnr,5.0,107.0,9.79882812,70.0,25.0,35.59375,214.28125,3.5,1.01,1.0,143.0,7.429688,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
54.793,1,female,1,27,27,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,48801.0,29029.0938,20.5,white,64.0,1,0,0,yes,0.599999905,0.5,dnr after sadm,22.0,123.0,0.09999084,170.0,38.0,39.59375,333.3,2.5,0.69995117,1.09985352,144.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
59.64398,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,20609.0,14452.7344,37.5,hispanic,35.0,1,0,0,metastatic,0.149999976,0.08,dnr after sadm,5.0,45.0,6.29980469,112.0,38.0,37.89844,118.32812,3.0996094,1.01,0.59997559,138.0,7.30957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.45795,0,female,0,55,1556,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,207683.0,103477.188,37.5,white,56.0,15,0,0,no,0.699999809,0.5,dnr after sadm,9.0,123.0,7.39941406,101.0,8.0,38.59375,79.0,3.0,1.01,2.19970703,154.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
75.65198,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,32199.0,21257.1094,47.0,white,25.0,16,0,0,no,0.699999809,0.5,dnr after sadm,1.0,68.0,9.69921875,125.0,20.0,39.39844,132.0,3.5,1.01,0.69995117,139.0,7.419922,135.0,23.0,2502.0,2.5561523,<2 mo. follow-up
79.27698,0,female,0,12,1556,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,14304.0,8597.7031,18.5,white,27.0,1,0,0,no,0.75,0.5,dnr after sadm,1.0,60.0,16.296875,100.0,20.0,37.79688,311.625,3.2998047,0.69995117,1.69995117,135.0,7.399414,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
73.51996,1,female,0,5,32,Lung Cancer,Cancer,3,12.0,under $11k,6003.0,3975.2188,4.0,white,14.0,1,1,0,metastatic,0.899999619,0.8,dnr after sadm,3.0,100.0,21.8984375,80.0,20.0,36.69531,333.3,3.5,0.69995117,0.59997559,136.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
41.52197,1,male,0,12,97,Lung Cancer,Cancer,2,11.0,under $11k,15020.0,9517.5469,10.5,white,14.0,1,1,0,metastatic,0.75,0.1,no dnr,12.0,101.0,6.5,72.0,14.0,35.89844,333.3,4.0,0.89990234,1.0,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
81.25098,1,female,0,38,78,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,45228.0,32094.3125,17.0,white,49.0,1,0,0,no,0.099999964,0.001,dnr after sadm,1.0,67.0,4.39941406,63.0,38.0,36.69531,257.125,3.2998047,0.39996338,3.39990234,144.0,7.259766,135.0,23.0,2502.0,4.5458984,SIP>=30
46.59497,0,male,0,17,1551,Cirrhosis,COPD/CHF/Cirrhosis,2,15.0,under $11k,21756.0,11337.4766,11.333328,white,66.0,2,0,0,no,0.099999964,0.001,dnr after sadm,7.0,57.0,12.0996094,118.0,24.0,36.09375,328.5625,2.8999023,36.5,5.39941406,136.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
77.52496,1,male,0,10,246,MOSF w/Malig,ARF/MOSF,1,18.0,under $11k,16099.0,8107.6133,17.0,white,63.0,1,0,0,yes,0.899999619,0.7,no dnr,10.0,110.0,0.89990234,110.0,28.0,36.09375,270.0,2.8999023,3.79980469,1.69995117,136.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.71997,0,male,0,8,1550,ARF/MOSF w/Sepsis,ARF/MOSF,0,22.0,under $11k,16069.0,6561.6797,16.0,white,45.0,1,0,0,no,0.989999771,0.9,no dnr,8.0,135.0,11.0996094,142.0,68.0,37.79688,205.0,3.3999023,1.59985352,1.09985352,142.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.73499,1,male,0,58,1236,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,>$50k,61059.0,35104.8438,6.75,white,36.0,9,0,0,no,0.699999809,0.5,no dnr,58.0,61.0,7.09960938,52.0,28.0,37.89844,151.0,3.5,1.01,1.59985352,134.0,7.369141,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
77.53296,0,female,0,7,1550,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,10496.0,5027.7578,19.0,white,57.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,67.0,26.0976562,132.0,42.0,36.19531,223.78125,3.8999023,1.01,1.0,138.0,7.329102,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
85.20496,1,male,0,7,299,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,21089.0,11513.1719,17.0,white,36.0,11,0,0,yes,0.899999619,0.5,no dnr,7.0,56.0,5.19921875,70.0,25.0,36.09375,175.5,3.5,1.01,1.0,140.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.61398,0,female,0,5,1547,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,11252.0,4251.1133,13.0,white,18.0,2,0,0,no,0.5,0.5,no dnr,5.0,63.0,6.69921875,72.0,24.0,37.79688,137.5,3.5,0.5,0.89990234,143.0,7.569336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.78094,1,female,0,12,49,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,30913.0,15681.8906,20.5,white,62.0,14,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,51.0,58.1953125,59.0,26.0,35.29688,197.5,3.0996094,2.19970703,2.0,132.0,7.40918,135.0,23.0,2502.0,2.9829102,<2 mo. follow-up
74.95697,1,male,1,48,48,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,131184.0,100893.625,39.25,white,30.0,3,0,0,no,0.799999714,0.8,dnr after sadm,18.0,123.0,10.1992188,80.0,6.0,36.29688,121.65625,3.5,1.01,1.5,138.0,7.479492,135.0,23.0,2502.0,2.1328125,<2 mo. follow-up
74.32196,1,male,0,4,234,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,3623.0,2212.6562,5.0,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,97.0,11.5,70.0,32.0,37.09375,400.0,4.0,0.69995117,2.0,142.0,7.489258,135.0,23.0,2502.0,1.0,SIP>=30
64.19696,1,female,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,104074.0,35145.8438,41.5,white,39.0,1,0,0,yes,0.75,0.6,dnr after sadm,9.0,46.0,19.1992188,123.0,12.0,39.09375,175.0,3.5996094,1.01,0.29998779,137.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
58.65799,1,male,0,17,153,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,21228.0,11682.9922,11.0,white,18.0,1,0,0,no,0.949999809,0.95,no dnr,17.0,73.0,11.0996094,80.0,20.0,35.59375,196.65625,4.3994141,1.01,1.09985352,141.0,7.359375,135.0,23.0,2502.0,0.0,SIP>=30
93.34998,1,male,0,17,462,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,22396.0,12064.6797,12.0,white,28.0,1,1,0,no,0.5,0.4,no dnr,17.0,70.0,7.5,58.0,8.0,36.09375,325.0,3.5,1.69995117,1.69995117,143.0,7.369141,135.0,23.0,2502.0,4.5322266,<2 mo. follow-up
67.10199,1,male,1,22,22,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,26499.0,16922.2969,13.0,white,29.0,1,0,0,no,0.799999714,0.6,no dnr,22.0,117.0,11.7988281,100.0,20.0,36.09375,368.0,4.0,0.79992676,2.79980469,135.0,7.519531,135.0,23.0,2502.0,2.0,<2 mo. follow-up
51.45499,0,female,0,14,1543,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,36074.0,15445.6406,31.333328,white,26.0,3,1,0,no,0.949999809,0.95,no dnr,14.0,67.0,6.79980469,62.0,8.0,36.09375,141.40625,2.5996094,1.39990234,0.59997559,134.0,7.389648,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
65.08698,0,male,0,5,1543,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5422.0,2610.7871,14.0,white,13.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,83.0,7.79980469,100.0,20.0,37.79688,648.125,3.5,1.01,1.19995117,136.0,7.40918,135.0,23.0,2502.0,2.5957031,<2 mo. follow-up
84.48199,1,male,1,106,106,COPD,COPD/CHF/Cirrhosis,1,6.0,$11-$25k,227626.0,151603.0,25.75,white,29.0,3,0,0,no,1.0,1.0,no dnr,106.0,107.0,16.3984375,120.0,32.0,37.79688,223.0,3.5,1.01,1.29980469,146.0,7.389648,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
42.82797,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,16096.0,8934.75,40.0,black,92.0,1,0,0,no,0.0,0.0,no dnr,4.0,40.0,32.1953125,135.0,37.0,35.69531,125.0,2.199707,5.69921875,8.29882812,143.0,7.269531,135.0,23.0,2502.0,1.9831543,<2 mo. follow-up
80.45697,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,12819.0,7515.3398,23.5,white,71.0,1,0,0,yes,0.099999964,0.001,dnr after sadm,2.0,46.0,0.09999084,128.0,35.0,36.29688,190.0,3.3999023,2.09960938,0.89990234,127.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
58.28598,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,34635.0,20541.2812,46.0,white,72.0,3,1,0,no,0.699999809,0.5,dnr after sadm,3.0,43.0,35.5,120.0,14.0,40.39844,106.65625,2.0996094,1.01,2.39990234,131.0,7.399414,135.0,23.0,2502.0,2.4492188,<2 mo. follow-up
67.01196,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,94528.0,71583.0625,45.666657,white,54.0,10,1,0,no,0.849999905,0.85,no dnr,19.0,55.0,21.3984375,120.0,12.0,38.59375,186.0,3.5,1.01,4.19921875,140.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.03998,1,female,0,12,151,Lung Cancer,Cancer,2,12.0,under $11k,12519.0,7553.4453,6.5,white,21.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,77.0,5.79980469,70.0,25.0,36.09375,333.3,3.7998047,1.39990234,0.69995117,143.0,7.419922,135.0,23.0,2502.0,2.9023438,<2 mo. follow-up
99.28497,1,male,1,53,53,CHF,COPD/CHF/Cirrhosis,3,17.0,under $11k,118924.0,35281.5938,34.5,white,43.0,1,0,1,no,0.299999952,0.2,no dnr,53.0,45.0,13.1992188,70.0,10.0,36.39844,212.5,3.5,1.69995117,2.29980469,132.0,7.489258,135.0,23.0,2502.0,7.0,<2 mo. follow-up
52.504,1,female,0,11,927,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,15466.0,7561.2266,13.0,white,22.0,1,0,0,yes,1.0,0.95,no dnr,11.0,71.0,19.3984375,140.0,24.0,36.09375,288.0,3.5,1.01,0.89990234,143.0,7.329102,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
68.99097,1,female,1,8,8,Colon Cancer,Cancer,1,6.0,$25-$50k,9864.0,6236.082,18.0,white,36.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,1.0,53.0,7.69921875,72.0,10.0,35.79688,333.3,2.5,0.59997559,1.09985352,137.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
59.49298,1,female,0,26,668,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,40197.0,20480.5469,18.0,black,40.0,1,0,0,no,1.0,0.8,no dnr,26.0,137.0,18.0976562,119.0,32.0,35.79688,273.4375,5.0,0.59997559,1.5,138.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
86.61694,1,male,0,13,1494,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,16228.0,8260.2891,16.5,white,42.0,1,0,0,no,1.0,0.7,no dnr,13.0,53.0,12.6992188,66.0,32.0,36.09375,280.0,4.5,1.79980469,1.29980469,143.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
26.56,1,female,1,15,15,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,97294.0,45422.125,54.666657,white,34.0,6,0,0,yes,0.199999928,0.2,dnr after sadm,15.0,49.0,5.5,118.0,10.0,36.39844,137.5,2.199707,1.29980469,0.69995117,144.0,7.399414,135.0,23.0,2502.0,2.1289062,<2 mo. follow-up
51.39999,0,male,0,15,1531,Coma,Coma,1,12.0,$25-$50k,28600.0,11534.4531,29.0,white,46.0,1,0,0,no,0.75,0.7,no dnr,15.0,47.0,4.19921875,126.0,10.0,38.29688,88.0,3.5,2.0,0.59997559,133.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
70.62598,1,female,0,29,1114,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,82196.0,63520.0625,24.75,white,32.0,8,1,0,no,0.799999714,0.2,no dnr,29.0,71.0,7.09960938,62.0,24.0,36.69531,266.625,3.5,0.39996338,3.89990234,141.0,7.489258,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
44.17499,1,male,0,35,51,Colon Cancer,Cancer,2,13.0,$11-$25k,45066.0,26888.6406,19.5,white,23.0,1,0,0,metastatic,0.75,0.3,no dnr,35.0,66.0,9.3984375,116.0,24.0,38.89844,504.75,2.0996094,1.0,0.59997559,134.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
75.01996,1,male,0,12,33,MOSF w/Malig,ARF/MOSF,3,12.0,$25-$50k,24165.0,8863.8125,39.5,white,37.0,1,0,0,metastatic,0.199999928,0.1,no dnr,12.0,57.0,5.09960938,51.0,10.0,38.0,150.0,4.0996094,0.89990234,1.69995117,144.0,7.149414,135.0,23.0,2502.0,3.0,<2 mo. follow-up
69.09796,0,male,0,7,1528,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,18468.0,13271.6875,19.0,white,28.0,3,0,1,no,0.949999809,0.85,no dnr,7.0,63.0,7.39941406,100.0,9.0,36.29688,113.0,2.8999023,1.0,1.29980469,135.0,7.489258,135.0,23.0,2502.0,4.8164062,<2 mo. follow-up
79.66095,0,female,0,8,1527,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,26312.0,13002.9297,18.0,white,29.0,2,0,0,no,0.929999828,0.85,no dnr,8.0,54.0,10.0,67.0,16.0,38.0,236.71875,2.5,1.01,0.89990234,142.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
81.23798,1,male,0,4,204,CHF,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,3806.0,2219.1094,7.0,white,20.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,83.0,11.0,60.0,20.0,35.59375,336.0,3.5,1.01,1.89990234,142.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.30695,1,female,0,18,207,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,31908.0,23415.7656,31.666656,white,44.0,1,1,0,yes,0.5,0.4,no dnr,18.0,64.0,15.8984375,72.0,30.0,39.19531,68.0,3.5,1.01,1.19995117,133.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
82.39294,0,male,0,8,1524,MOSF w/Malig,ARF/MOSF,3,9.0,$11-$25k,9332.0,5003.9336,8.0,white,44.0,1,1,0,yes,0.949999809,0.8,no dnr,8.0,73.0,8.8984375,70.0,25.0,37.79688,188.0,3.199707,1.01,1.09985352,142.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.00098,1,female,1,16,16,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,20870.0,11380.0078,15.0,white,57.0,1,0,0,yes,0.299999952,0.1,dnr after sadm,2.0,103.0,6.69921875,70.0,30.0,37.79688,100.0,3.0996094,0.29998779,1.59985352,132.0,7.459961,135.0,23.0,2502.0,6.0,<2 mo. follow-up
91.03894,1,male,0,17,87,COPD,COPD/CHF/Cirrhosis,1,10.0,$11-$25k,27902.0,12191.4844,13.0,white,41.0,1,0,0,no,0.5,0.3,dnr after sadm,3.0,97.0,9.59960938,120.0,50.0,37.19531,175.5,3.2998047,1.01,1.29980469,144.0,7.379883,135.0,23.0,2502.0,3.0,SIP>=30
48.78,1,female,0,7,84,Lung Cancer,Cancer,1,10.0,under $11k,10689.0,6053.1328,13.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,61.0,5.0,120.0,24.0,36.89844,333.3,3.199707,0.29998779,0.69995117,145.0,7.469727,135.0,23.0,2502.0,0.0,SIP>=30
76.18597,1,male,0,10,37,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,25469.0,20858.3125,16.0,black,47.0,7,0,0,no,0.649999619,0.5,dnr after sadm,1.0,54.0,10.3984375,71.0,24.0,35.0,432.0,3.5,0.5,2.39990234,125.0,7.509766,135.0,23.0,2502.0,2.0,<2 mo. follow-up
84.62994,1,female,0,5,24,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,6414.0,3839.3555,13.0,white,36.0,1,0,0,no,0.5,0.4,dnr before sadm,-1.0,80.0,9.8984375,60.0,30.0,36.09375,190.46875,3.5996094,1.01,1.19995117,138.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
93.62897,1,female,0,4,624,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4975.0,2718.4961,8.0,white,25.0,1,0,0,no,0.75,0.6,dnr after sadm,1.0,67.0,5.79980469,70.0,20.0,36.09375,333.3,3.5,1.01,0.89990234,132.0,7.389648,135.0,23.0,2502.0,4.3154297,<2 mo. follow-up
86.18799,1,female,1,23,23,Lung Cancer,Cancer,1,12.0,under $11k,26902.0,16868.9062,9.666664,black,27.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,2.0,100.0,8.69921875,100.0,25.0,36.09375,333.3,3.0,0.39996338,0.69995117,131.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
76.53894,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,56726.0,19535.5,33.666657,white,50.0,3,0,0,metastatic,0.5,0.1,dnr after sadm,11.0,50.0,9.79882812,48.0,42.0,38.0,170.0,3.199707,1.01,0.69995117,134.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
80.79095,0,female,0,8,1521,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,21055.0,10767.7969,10.0,white,15.0,6,0,0,no,0.949999809,0.8,no dnr,8.0,83.0,12.8984375,80.0,20.0,38.0,390.0,3.5,1.01,0.89990234,144.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
49.85397,1,male,0,14,54,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,31619.0,9491.9141,35.333313,white,39.0,1,0,0,yes,0.299999952,0.3,no dnr,14.0,43.0,11.3984375,114.0,10.0,39.29688,154.0,2.2998047,0.59997559,0.29998779,147.0,7.389648,135.0,23.0,2502.0,2.3754883,<2 mo. follow-up
94.10797,1,female,0,23,27,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,21424.0,12836.1719,13.333328,white,24.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,70.0,9.29882812,80.0,20.0,36.69531,295.0,3.5,0.39996338,1.09985352,140.0,7.299805,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
97.83997,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,49040.0,36014.4375,39.5,white,47.0,7,0,1,no,0.199999928,0.2,dnr after sadm,6.0,103.0,8.19921875,105.0,48.0,37.59375,124.0,2.0,1.0,1.29980469,142.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.51294,1,male,0,7,803,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,8567.0,6116.7656,20.0,white,19.0,1,0,0,yes,0.899999619,0.9,no dnr,7.0,72.0,8.8984375,60.0,16.0,36.19531,140.0,5.1992188,1.79980469,1.09985352,137.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
29.618,0,female,0,23,1512,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,69945.0,27965.0312,25.0,white,25.0,13,0,0,no,0.979999542,0.98,no dnr,23.0,58.0,6.5,124.0,8.0,38.09375,353.3125,3.5996094,1.01,0.59997559,136.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.10095,1,male,0,5,833,CHF,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,4571.0,2801.9727,7.0,white,45.0,1,1,0,no,0.799999714,0.7,no dnr,5.0,120.0,11.3984375,80.0,25.0,35.59375,333.3,4.1992188,0.59997559,2.79980469,139.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
43.16998,0,male,0,34,1514,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,97562.0,64663.4688,33.5,white,35.0,3,1,0,no,0.5,0.5,no dnr,34.0,60.0,12.3984375,58.0,12.0,39.59375,97.14062,3.5,0.59997559,1.5,146.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.01599,1,female,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,105850.0,78684.0,38.25,white,46.0,9,1,0,no,0.049999982,0.000125,dnr before sadm,-3.0,62.0,13.0,62.0,8.0,37.79688,153.3125,3.5,1.01,4.5,128.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.26099,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,13516.0,6553.5938,19.0,black,56.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,4.0,53.0,19.5976562,74.0,22.0,37.69531,386.625,2.5996094,8.59960938,2.89990234,149.0,7.359375,135.0,23.0,2502.0,2.0,<2 mo. follow-up
54.33499,1,female,0,12,1021,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,18839.0,7886.2734,22.0,black,43.0,2,1,0,no,1.0,1.0,no dnr,12.0,45.0,10.7988281,118.0,28.0,39.09375,490.4375,2.699707,1.01,1.89990234,153.0,7.40918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
85.16095,1,female,1,25,25,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,27344.0,17588.2812,11.666664,white,52.0,1,1,0,no,0.5,0.3,dnr after sadm,5.0,57.0,7.0,56.0,20.0,34.79688,396.0,3.3999023,1.5,2.89990234,142.0,7.419922,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
52.19199,1,female,0,16,1059,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,20742.0,10266.4219,11.666664,white,31.0,1,0,0,no,0.949999809,0.9,no dnr,16.0,103.0,9.59960938,66.0,22.0,36.0,403.6875,3.2998047,0.5,12.3984375,143.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.72095,0,male,0,6,1507,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,6934.0,3570.0644,9.0,white,27.0,1,1,0,no,0.989999771,0.99,no dnr,6.0,120.0,8.19921875,80.0,20.0,37.5,309.0,4.3994141,0.29998779,1.5,142.0,7.279297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
88.32898,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,21473.0,7042.2812,45.5,white,35.0,2,0,0,no,0.299999952,0.3,no dnr,8.0,40.0,13.3984375,55.0,10.0,37.19531,192.5,2.5,1.01,1.39990234,133.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.82599,0,female,0,28,1503,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,59663.0,27647.4062,21.25,white,30.0,7,0,0,no,0.699999809,0.4,dnr before sadm,-4.0,60.0,5.79980469,49.0,24.0,36.19531,300.0,2.7998047,1.01,1.89990234,137.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
82.35498,1,female,0,7,252,Coma,Coma,2,18.0,$25-$50k,5849.0,3759.3828,8.0,white,17.0,1,0,1,no,0.5,0.25,dnr after sadm,1.0,113.0,6.29980469,60.0,20.0,36.39844,333.3,3.5,1.01,1.0,139.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
87.61096,1,male,0,87,129,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,77925.0,50186.2812,8.75,white,36.0,1,1,0,no,0.399999857,0.2,dnr after sadm,1.0,107.0,9.3984375,60.0,20.0,36.59375,218.5,3.5,1.01,2.09960938,145.0,7.479492,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
50.81497,0,female,0,6,1501,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,6782.0,4035.1836,13.0,black,39.0,1,1,0,no,0.979999542,0.95,no dnr,6.0,73.0,4.5,70.0,20.0,36.69531,333.3,2.7998047,0.29998779,5.69921875,139.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
34.54099,0,female,0,21,1500,ARF/MOSF w/Sepsis,ARF/MOSF,0,19.0,under $11k,55377.0,22339.2344,32.0,white,32.0,1,0,0,no,0.979999542,0.98,no dnr,21.0,63.0,7.79980469,142.0,14.0,38.39844,202.0,3.0996094,0.79992676,1.29980469,139.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.08795,1,female,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,43926.0,24020.4688,17.5,black,67.0,1,0,0,no,0.599999905,0.4,dnr after sadm,1.0,43.0,26.0976562,120.0,24.0,34.69531,504.0,2.2998047,0.29998779,6.29980469,149.0,7.359375,135.0,23.0,2502.0,7.0,<2 mo. follow-up
67.53198,1,female,0,15,283,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,25469.0,9964.6797,22.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,52.0,5.29980469,64.0,8.0,37.79688,195.0,3.0,1.01,0.69995117,134.0,7.179688,135.0,23.0,2502.0,2.0639648,<2 mo. follow-up
64.13696,1,male,0,19,1106,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,50784.0,39553.5312,30.0,white,43.0,6,1,0,yes,0.949999809,0.9,no dnr,19.0,70.0,13.0,125.0,33.0,38.19531,296.0,3.5,1.01,1.09985352,135.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
89.83698,1,female,0,8,63,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,11439.0,5436.3047,8.5,white,40.0,2,0,0,no,0.699999809,0.5,no dnr,8.0,123.0,5.59960938,80.0,30.0,36.19531,118.32812,3.0,0.39996338,3.89990234,144.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
57.20697,0,male,0,12,1497,Colon Cancer,Cancer,2,14.0,$25-$50k,18587.0,10156.1484,11.5,white,21.0,1,0,0,metastatic,0.989999771,0.5,no dnr,12.0,77.0,5.69921875,70.0,15.0,36.09375,333.3,4.6992188,0.5,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
84.50897,1,male,1,13,13,Coma,Coma,2,6.0,under $11k,29340.0,11978.5312,32.0,white,46.0,1,0,0,no,0.25,0.15,dnr after sadm,9.0,69.0,7.39941406,158.0,30.0,38.19531,420.0,2.3999023,0.5,1.29980469,149.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.91998,1,female,0,11,13,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,16313.0,7441.9102,18.5,white,23.0,1,0,1,no,0.899999619,0.5,dnr after sadm,8.0,67.0,8.69921875,128.0,8.0,37.79688,206.65625,3.5,1.01,0.5,135.0,7.40918,135.0,23.0,2502.0,4.3994141,<2 mo. follow-up
70.23999,0,female,0,15,1490,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,19161.0,13954.1172,16.333328,white,31.0,1,1,0,no,0.699999809,0.3,no dnr,15.0,64.0,8.19921875,64.0,20.0,38.09375,130.59375,3.5,1.01,1.19995117,135.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
44.04898,1,female,0,6,39,Colon Cancer,Cancer,1,12.0,$25-$50k,7996.0,4786.5938,20.0,black,24.0,1,0,0,metastatic,0.5,0.2,no dnr,6.0,103.0,17.6992188,120.0,24.0,39.39844,333.3,2.2998047,1.19995117,0.69995117,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
84.70898,1,male,0,10,498,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,22238.0,12097.125,8.5,white,35.0,10,0,0,no,0.599999905,0.5,no dnr,10.0,117.0,10.6992188,70.0,26.0,36.19531,471.625,3.8999023,0.5,2.79980469,145.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
22.61699,0,female,0,19,1487,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,77442.0,32460.3125,19.666656,white,18.0,24,0,0,no,0.949999809,0.95,no dnr,19.0,63.0,5.79980469,126.0,8.0,38.19531,503.3125,3.5,1.01,0.5,135.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
61.07898,1,male,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,106796.0,36357.6562,33.25,white,24.0,1,0,0,no,0.649999619,0.5,no dnr,34.0,47.0,6.39941406,66.0,6.0,36.09375,253.3125,2.699707,0.39996338,0.39996338,136.0,7.349609,135.0,23.0,2502.0,2.4936523,<2 mo. follow-up
70.36597,1,female,0,6,1339,Lung Cancer,Cancer,1,12.0,under $11k,6223.0,3822.707,19.0,white,9.0,1,0,0,metastatic,0.899999619,0.8,no dnr,6.0,83.0,5.09960938,84.0,20.0,36.69531,333.3,3.5,1.01,0.89990234,144.0,7.419922,135.0,23.0,2502.0,2.637207,<2 mo. follow-up
38.448,1,female,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,88669.0,31513.9062,32.5,white,40.0,1,0,0,no,0.799999714,0.8,dnr after sadm,29.0,119.0,4.59960938,64.0,20.0,37.79688,204.75,3.199707,0.09999084,3.59960938,142.0,7.359375,135.0,23.0,2502.0,1.8059082,<2 mo. follow-up
43.23898,0,male,0,11,1482,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$11-$25k,40025.0,30081.8594,34.5,white,30.0,4,0,0,no,0.799999714,0.7,no dnr,11.0,70.0,16.5976562,70.0,38.0,39.29688,190.0,3.5,1.39990234,0.89990234,134.0,7.339844,135.0,23.0,2502.0,1.980957,no(M2 and SIP pres)
69.45898,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,54062.0,41957.7812,56.0,white,62.0,10,1,0,no,0.75,0.6,no dnr,7.0,45.0,19.296875,120.0,46.0,39.09375,248.0,2.2998047,1.01,1.19995117,149.0,7.519531,135.0,23.0,2502.0,2.4765625,<2 mo. follow-up
80.37195,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,28526.0,9979.5781,40.0,white,30.0,4,0,0,no,0.0,0.0,no dnr,7.0,61.0,13.0996094,133.0,12.0,38.69531,215.0,1.7998047,0.5,0.79992676,142.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.93198,1,female,0,10,792,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,25230.0,10519.9688,28.0,black,57.0,3,1,0,no,0.899999619,0.9,no dnr,10.0,61.0,10.0,110.0,6.0,36.59375,216.0,2.5,0.29998779,2.79980469,134.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.10797,0,male,0,226,1480,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,421711.0,264855.0,42.5,white,50.0,1,0,0,no,0.75,0.75,no dnr,226.0,51.0,15.6992188,140.0,43.0,38.89844,202.5,2.199707,1.59985352,0.89990234,153.0,7.439453,135.0,23.0,2502.0,2.1748047,adl>=4 (>=5 if sur)
50.64499,1,male,0,7,706,Cirrhosis,COPD/CHF/Cirrhosis,3,17.0,under $11k,8764.0,5128.2109,10.0,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,97.0,5.29980469,80.0,20.0,37.0,333.3,2.8999023,1.89990234,1.5,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.48599,1,female,1,9,9,Colon Cancer,Cancer,1,12.0,under $11k,7395.0,4865.1836,9.0,white,47.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,70.0,22.0,110.0,22.0,35.59375,333.3,2.199707,14.0,0.69995117,134.0,7.419922,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
54.32999,0,male,0,9,1477,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,46721.0,35097.75,9.0,white,23.0,17,0,0,no,1.0,1.0,no dnr,9.0,75.0,13.3984375,110.0,30.0,38.29688,178.0,3.5,1.01,0.69995117,134.0,7.349609,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.65594,1,female,0,14,108,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,32779.0,12959.2578,34.666657,white,34.0,4,0,0,yes,0.75,0.5,no dnr,14.0,58.0,5.19921875,137.0,30.0,38.39844,230.0,3.3999023,1.01,0.5,134.0,7.399414,135.0,23.0,2502.0,2.0800781,no(M2 and SIP pres)
84.16998,1,female,1,6,6,Coma,Coma,2,12.0,under $11k,9943.0,3755.8301,28.0,white,30.0,1,0,0,no,0.099999964,0.001,dnr before sadm,0.0,69.0,13.3984375,112.0,24.0,38.89844,120.0,4.0,1.09985352,1.69995117,144.0,7.429688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.47595,1,male,0,6,68,Lung Cancer,Cancer,2,16.0,>$50k,6831.0,4204.0312,11.0,white,17.0,1,0,0,metastatic,0.75,0.0,no dnr,6.0,109.0,7.19921875,96.0,16.0,35.89844,333.3,3.2998047,1.39990234,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.211,1,male,0,33,137,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,67530.0,49720.875,28.5,white,36.0,3,0,0,no,0.5,0.25,no dnr,33.0,118.0,9.5,68.0,12.0,38.0,67.5,3.5,0.29998779,6.79980469,136.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
65.59094,0,female,0,19,1475,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,33458.0,13394.7031,17.666656,white,34.0,4,0,0,no,0.899999619,0.9,no dnr,19.0,53.0,7.79980469,80.0,38.0,39.69531,126.65625,3.2998047,0.29998779,0.59997559,138.0,7.509766,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
52.62097,1,male,1,17,17,MOSF w/Malig,ARF/MOSF,1,20.0,>$50k,97248.0,46806.2188,45.666657,white,60.0,6,0,0,yes,0.049999982,0.000125,dnr after sadm,2.0,46.0,80.59375,72.0,28.0,37.89844,87.14062,2.8999023,1.79980469,3.69970703,125.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.32898,1,female,0,31,32,Lung Cancer,Cancer,2,12.0,under $11k,36321.0,23353.5781,13.0,white,15.0,1,0,0,metastatic,0.899999619,0.5,dnr after sadm,13.0,103.0,8.5,70.0,20.0,35.69531,333.3,4.0996094,0.59997559,0.59997559,137.0,7.419922,135.0,23.0,2502.0,2.2285156,<2 mo. follow-up
68.81,1,female,1,3,3,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3666.0,2116.4824,21.0,white,37.0,1,0,0,metastatic,0.019999996,8e-06,dnr after sadm,1.0,60.0,12.3984375,120.0,20.0,35.59375,219.03125,3.5,1.01,0.59997559,131.0,7.30957,135.0,23.0,2502.0,4.0,<2 mo. follow-up
61.62097,1,female,0,6,314,Lung Cancer,Cancer,1,12.0,>$50k,6666.0,3844.1074,10.0,white,11.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,97.0,4.39941406,100.0,20.0,36.09375,333.3,4.5996094,1.01,0.69995117,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.56897,0,male,0,19,1460,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,29690.0,15245.2891,16.0,white,35.0,4,0,0,no,0.899999619,0.8,no dnr,19.0,53.0,5.39941406,63.0,30.0,38.59375,220.0,3.5,0.5,0.79992676,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.85596,1,male,1,10,10,Coma,Coma,1,12.0,$25-$50k,17288.0,6808.6406,25.5,white,14.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,5.0,71.0,11.0,114.0,8.0,38.5,232.5,3.699707,0.69995117,0.79992676,135.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
84.27698,1,male,0,22,495,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,53017.0,33306.75,25.333328,white,42.0,3,0,0,no,0.799999714,0.8,no dnr,22.0,63.0,29.796875,60.0,6.0,35.59375,166.0,3.5,1.01,1.79980469,138.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
51.92297,0,female,0,13,1458,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,30647.0,14629.6094,14.5,white,16.0,1,0,0,no,0.989999771,0.98,no dnr,13.0,100.0,6.89941406,65.0,16.0,38.19531,198.0,2.8999023,0.79992676,0.69995117,139.0,7.279297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.90594,1,male,0,12,1068,CHF,COPD/CHF/Cirrhosis,1,13.0,under $11k,19699.0,12867.1562,21.5,white,40.0,1,0,0,no,0.949999809,0.9,no dnr,12.0,129.0,12.0,100.0,12.0,36.19531,270.0,3.5,1.01,2.19970703,139.0,7.429688,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
59.09097,1,male,0,11,18,Lung Cancer,Cancer,1,12.0,under $11k,13003.0,7888.3828,12.0,white,14.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,87.0,10.0,100.0,25.0,36.69531,333.3,2.8999023,0.5,0.69995117,134.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
83.35095,1,female,0,11,65,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,13550.0,8018.4453,17.0,white,37.0,1,0,0,no,0.799999714,0.75,no dnr,11.0,110.0,7.69921875,70.0,25.0,36.59375,333.3,3.5,0.89990234,2.09960938,140.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
63.59198,1,male,0,8,91,Colon Cancer,Cancer,1,17.0,>$50k,12101.0,7983.332,3.5,black,23.0,1,0,0,metastatic,0.299999952,0.1,no dnr,8.0,117.0,18.5,80.0,20.0,35.19531,333.3,2.7998047,4.39941406,0.69995117,131.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
21.28099,0,female,0,22,1459,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,32860.0,20276.2344,20.0,black,27.0,2,0,0,no,0.899999619,0.8,no dnr,22.0,68.0,17.0976562,136.0,30.0,40.29688,359.25,3.5,1.01,0.69995117,141.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
89.10095,1,male,1,90,90,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,116854.0,92010.6875,32.0,white,44.0,1,0,0,no,0.799999714,0.75,no dnr,90.0,53.0,21.5976562,110.0,24.0,38.09375,156.0,3.2998047,0.69995117,1.29980469,128.0,7.369141,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
74.65796,0,female,0,23,1454,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,26459.0,14287.1172,13.666664,white,63.0,1,0,0,no,0.849999905,0.8,no dnr,23.0,53.0,31.3984375,120.0,36.0,36.09375,392.5625,2.8999023,0.39996338,2.29980469,128.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.935,1,male,0,16,81,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,28416.0,15437.4375,14.666664,white,19.0,1,0,0,no,0.5,0.3,dnr after sadm,1.0,73.0,18.1992188,98.0,22.0,36.29688,294.25,2.199707,0.59997559,0.89990234,139.0,7.399414,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
40.099,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,27665.0,9428.0156,39.0,black,68.0,1,0,0,no,0.699999809,0.7,dnr after sadm,5.0,55.0,23.296875,106.0,42.0,38.09375,160.0,2.0,25.6992188,1.89990234,143.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.09698,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,41196.0,27988.9375,49.0,white,60.0,8,0,0,no,0.049999982,0.000125,dnr after sadm,6.0,52.0,26.796875,113.0,8.0,40.09375,317.0,3.5,1.01,2.0,145.0,7.549805,135.0,23.0,2502.0,2.090332,<2 mo. follow-up
65.62396,1,male,0,22,377,Lung Cancer,Cancer,1,8.0,under $11k,37795.0,20885.0156,19.666656,white,54.0,1,0,0,metastatic,0.849999905,0.75,dnr after sadm,20.0,73.0,0.89990234,140.0,24.0,38.29688,333.3,2.8999023,1.01,1.39990234,134.0,7.489258,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
39.61899,1,female,0,7,111,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,12213.0,5289.6758,21.0,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,43.0,4.59960938,74.0,20.0,38.39844,466.625,2.0996094,0.39996338,0.39996338,132.0,7.469727,135.0,23.0,2502.0,3.4155273,<2 mo. follow-up
96.70599,1,male,0,7,93,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,7407.0,4494.0625,11.0,white,26.0,1,0,1,no,0.75,0.75,dnr before sadm,-1.0,103.0,3.29980469,70.0,25.0,37.0,417.125,3.0996094,0.29998779,1.19995117,138.0,7.379883,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
88.159,1,male,0,40,43,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,59176.0,42419.75,23.5,white,21.0,1,0,1,no,0.099999964,0.001,dnr after sadm,2.0,60.0,7.89941406,69.0,10.0,38.79688,232.5,2.5,1.09985352,0.89990234,140.0,7.399414,135.0,23.0,2502.0,1.0,<2 mo. follow-up
73.08698,1,male,0,20,48,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,19910.0,12320.1172,13.0,white,36.0,1,1,0,yes,0.399999857,0.2,dnr after sadm,1.0,83.0,11.8984375,80.0,25.0,36.69531,305.0,3.0996094,1.09985352,2.29980469,134.0,7.40918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
74.55695,0,male,0,28,1449,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,50568.0,32572.0625,23.75,white,42.0,2,0,0,no,0.699999809,0.6,no dnr,28.0,52.0,11.5,64.0,10.0,38.19531,191.40625,3.5,1.09985352,1.89990234,138.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
76.271,0,female,0,33,1449,MOSF w/Malig,ARF/MOSF,3,16.0,under $11k,79339.0,59362.0,34.25,white,53.0,9,1,0,yes,0.699999809,0.5,dnr after sadm,2.0,62.0,7.39941406,113.0,26.0,38.5,59.0,2.199707,1.01,1.19995117,130.0,7.459961,135.0,23.0,2502.0,1.0,SIP>=30
85.39398,1,female,0,9,194,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,10243.0,7546.2773,16.0,white,19.0,1,0,0,no,0.5,0.2,no dnr,9.0,100.0,10.5996094,65.0,24.0,38.69531,288.0,3.5,0.89990234,0.59997559,132.0,7.469727,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
65.77698,1,male,0,10,31,Lung Cancer,Cancer,1,12.0,under $11k,13376.0,8313.875,14.0,white,29.0,1,0,0,metastatic,0.899999619,0.85,no dnr,10.0,73.0,9.8984375,110.0,15.0,35.59375,333.3,1.8999023,1.01,0.89990234,137.0,7.419922,135.0,23.0,2502.0,3.2402344,<2 mo. follow-up
95.00098,1,male,0,33,855,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,51385.0,38111.875,15.0,white,37.0,1,0,0,no,0.699999809,0.5,dnr after sadm,25.0,109.0,5.0,68.0,24.0,36.29688,230.0,3.0996094,0.39996338,10.2988281,144.0,7.15918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
95.65796,1,male,0,6,287,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,12752.0,6904.0234,18.0,white,24.0,3,0,0,yes,0.799999714,0.6,no dnr,6.0,97.0,7.39941406,100.0,25.0,36.69531,386.625,2.699707,1.01,1.0,141.0,7.469727,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
81.93597,1,male,0,17,188,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,23223.0,16159.3828,21.0,white,34.0,1,1,0,no,0.75,0.6,no dnr,17.0,69.0,14.2988281,70.0,28.0,38.0,450.0,3.5996094,1.0,1.69995117,136.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
31.034,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,71576.0,25119.9688,42.0,white,48.0,1,0,0,no,0.5,0.5,dnr after sadm,21.0,50.0,13.0,122.0,8.0,33.39844,240.0,2.699707,0.39996338,0.59997559,138.0,7.419922,135.0,23.0,2502.0,2.3056641,<2 mo. follow-up
85.52997,1,female,0,17,31,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,76341.0,44854.9688,11.333328,white,39.0,52,0,1,no,0.699999809,0.5,no dnr,17.0,121.0,17.3984375,118.0,30.0,37.79688,276.0,3.5996094,0.39996338,0.5,135.0,7.269531,135.0,23.0,2502.0,1.0,<2 mo. follow-up
84.42395,1,female,0,7,837,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,8777.0,3951.0606,13.0,white,32.0,1,1,0,no,0.399999857,0.1,no dnr,7.0,68.0,8.59960938,58.0,28.0,37.79688,402.0,3.5,0.69995117,1.0,136.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
43.62997,0,female,0,34,1442,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,>$50k,44202.0,24045.0938,17.5,white,37.0,1,0,0,no,0.949999809,0.95,no dnr,34.0,53.0,11.1992188,110.0,26.0,38.89844,557.125,2.0996094,0.69995117,0.79992676,132.0,7.399414,135.0,23.0,2502.0,5.1994972,SIP>=30
59.48798,0,male,0,33,1444,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,54994.0,34875.8125,30.75,black,58.0,1,0,0,no,0.899999619,0.9,no dnr,33.0,60.0,30.0,135.0,44.0,38.69531,97.5,2.2998047,0.79992676,0.79992676,132.0,7.40918,135.0,23.0,2502.0,2.6298828,SIP>=30
36.22699,1,male,0,16,314,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,37450.0,17838.1719,16.333328,white,14.0,1,0,0,no,0.699999809,0.5,no dnr,16.0,111.0,11.3984375,120.0,22.0,38.69531,201.0,4.0,1.0,1.19995117,136.0,7.539062,135.0,23.0,2502.0,2.453125,no(M2 and SIP pres)
86.68896,1,male,0,31,1298,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,63310.0,33241.6875,15.0,white,50.0,10,1,0,no,0.199999928,0.1,no dnr,31.0,113.0,25.0976562,70.0,40.0,38.5,333.3,2.5,1.09985352,2.0,142.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
84.15594,1,male,0,15,1408,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,under $11k,21427.0,10362.7969,15.333328,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,67.0,6.5,60.0,24.0,38.69531,108.32812,4.5996094,0.69995117,1.29980469,123.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.54895,1,male,0,3,479,Lung Cancer,Cancer,2,11.0,under $11k,2752.0,1697.4912,8.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,83.0,3.69970703,80.0,20.0,36.69531,333.3,3.5,1.01,0.79992676,131.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
86.80597,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,>$50k,46091.0,40561.875,29.333328,white,60.0,1,0,0,no,0.199999928,0.1,dnr after sadm,2.0,43.0,9.5,66.0,12.0,38.09375,150.0,2.7998047,0.59997559,5.69921875,136.0,7.30957,135.0,23.0,2502.0,1.0,<2 mo. follow-up
73.82599,1,male,0,10,26,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,10333.0,6035.9219,10.0,white,33.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,70.0,10.5996094,108.0,25.0,36.69531,323.75,3.5,1.01,1.59985352,138.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.92999,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,48246.0,18903.375,40.333313,white,34.0,1,0,0,no,0.5,0.5,no dnr,19.0,111.0,14.6992188,115.0,28.0,37.89844,150.0,2.3999023,1.01,1.0,149.0,7.369141,135.0,23.0,2502.0,2.6669922,<2 mo. follow-up
55.06897,1,male,0,4,614,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,8824.0,2768.0117,25.0,other,25.0,1,0,0,yes,0.899999619,0.9,no dnr,4.0,63.0,12.1992188,103.0,12.0,38.29688,187.75,3.0996094,1.01,1.39990234,142.0,7.439453,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
72.91199,1,male,0,4,18,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3901.0,2315.2656,6.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,73.0,10.0,80.0,20.0,36.69531,102.5,3.5,0.59997559,1.09985352,135.0,7.439453,135.0,23.0,2502.0,2.3696289,<2 mo. follow-up
84.72595,1,female,0,19,79,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,29354.0,22675.0,20.666656,white,46.0,1,0,0,no,0.149999976,0.05,dnr after sadm,2.0,50.0,10.0,48.0,8.0,36.29688,248.5625,3.5,1.01,1.5,146.0,7.489258,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
41.43698,1,female,0,7,61,MOSF w/Malig,ARF/MOSF,1,18.0,>$50k,23016.0,13218.8906,27.0,white,32.0,3,0,0,yes,0.799999714,0.5,no dnr,7.0,76.0,0.29998779,80.0,24.0,36.09375,333.3,2.5,1.09985352,1.19995117,139.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
55.97299,0,male,0,15,1433,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,20538.0,10286.8125,12.0,other,30.0,1,0,0,no,0.989999771,0.99,no dnr,15.0,63.0,9.3984375,115.0,40.0,36.09375,128.3125,3.0,1.0,0.89990234,135.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
85.01294,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,12527.0,4269.3672,29.0,white,62.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,49.0,0.79992676,75.0,8.0,36.0,366.625,2.0,0.29998779,1.29980469,129.0,7.299805,135.0,23.0,2502.0,3.8486328,<2 mo. follow-up
76.09296,1,male,0,7,499,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,9274.0,5036.4609,14.0,white,29.0,1,0,0,yes,1.0,1.0,no dnr,7.0,97.0,7.5,70.0,20.0,36.09375,223.78125,3.5,0.79992676,1.29980469,136.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.70898,1,female,0,4,375,Colon Cancer,Cancer,3,12.0,under $11k,4285.0,2603.9785,12.0,white,12.0,1,1,0,metastatic,0.75,0.2,no dnr,4.0,83.0,7.59960938,80.0,20.0,38.89844,333.3,4.0,0.39996338,0.69995117,136.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
79.96399,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,31577.0,17898.6719,15.333328,white,34.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,1.0,83.0,9.09960938,80.0,20.0,35.59375,180.0,2.199707,1.01,0.59997559,135.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.60394,0,female,0,21,1426,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,54833.0,28931.3906,24.666656,white,31.0,6,1,0,no,1.0,1.0,no dnr,21.0,120.0,10.7988281,68.0,8.0,38.09375,232.5,3.5,0.69995117,3.29980469,145.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.73395,1,female,0,7,73,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,9907.0,4264.9141,20.0,white,31.0,1,0,0,no,0.299999952,0.2,no dnr,7.0,113.0,6.69921875,54.0,12.0,35.89844,642.75,2.699707,3.5,0.79992676,142.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
84.68396,1,female,0,21,741,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,28225.0,11972.6172,11.0,white,50.0,2,1,0,no,0.599999905,0.5,dnr after sadm,2.0,77.0,10.8984375,132.0,26.0,36.09375,120.0,3.5,0.79992676,2.5,141.0,7.30957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.59799,0,male,0,7,1424,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,15332.0,8985.8438,11.0,white,25.0,1,1,0,no,0.899999619,0.6,no dnr,7.0,63.0,10.1992188,70.0,28.0,36.59375,333.3,3.5996094,0.79992676,1.0,139.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
86.75397,1,female,1,35,35,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,87011.0,26562.7031,32.5,white,66.0,1,0,0,no,0.849999905,0.7,dnr after sadm,10.0,51.0,17.0,65.0,38.0,36.19531,146.40625,3.5,0.19998169,2.79980469,142.0,7.30957,135.0,23.0,2502.0,2.0,<2 mo. follow-up
77.65094,1,male,0,21,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,29557.0,14287.6953,23.333328,white,42.0,1,0,1,no,0.75,0.6,no dnr,21.0,71.0,9.3984375,63.0,8.0,37.79688,108.23438,2.5996094,0.79992676,2.79980469,139.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
78.87195,0,male,0,30,1421,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,59878.0,45923.1562,24.75,white,23.0,4,0,0,no,0.75,0.75,no dnr,30.0,117.0,7.5,50.0,8.0,38.39844,128.0,3.5,1.01,1.09985352,144.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
83.20294,0,female,0,7,1421,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,8495.0,4689.9648,12.0,white,30.0,1,1,0,no,0.949999809,0.8,no dnr,7.0,77.0,8.29882812,70.0,20.0,36.09375,304.75,3.3999023,1.01,1.0,141.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
85.30597,1,female,0,12,294,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,23144.0,17423.9844,26.5,white,47.0,1,0,0,yes,0.979999542,0.941,no dnr,12.0,60.0,41.0,80.0,31.0,36.79688,114.0,3.5,1.01,1.0,134.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.23999,0,male,0,5,1420,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,4915.0,2881.0078,9.0,white,26.0,1,0,0,yes,0.799999714,0.6,no dnr,5.0,73.0,6.09960938,80.0,20.0,36.09375,333.3,3.5,1.01,1.59985352,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
86.13599,1,female,0,9,1027,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,9257.0,5256.9336,12.5,white,25.0,1,0,0,no,0.899999619,0.85,no dnr,9.0,103.0,9.0,80.0,20.0,36.09375,544.0,3.699707,1.01,1.69995117,139.0,7.489258,135.0,23.0,2502.0,3.1557617,<2 mo. follow-up
85.51398,1,female,0,8,625,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,6524.0,4043.3086,8.5,white,20.0,1,0,0,no,0.949999809,0.5,dnr after sadm,3.0,83.0,4.79980469,70.0,20.0,36.69531,408.3125,3.8999023,1.01,1.69995117,138.0,7.389648,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
35.96997,0,female,0,5,1418,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,7688.0,3634.7578,15.0,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,73.0,15.0996094,80.0,20.0,37.79688,125.0,2.699707,0.29998779,0.89990234,143.0,7.429688,135.0,23.0,2502.0,2.6083984,<2 mo. follow-up
79.86896,0,female,0,16,1418,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,18921.0,9482.1172,13.333328,white,45.0,1,1,0,no,0.75,0.75,dnr after sadm,3.0,49.0,5.79980469,74.0,28.0,36.59375,230.59375,2.7998047,1.01,1.09985352,128.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.91595,0,male,0,12,1415,Coma,Coma,4,12.0,$11-$25k,29515.0,14788.8281,24.5,white,21.0,4,0,0,no,0.899999619,0.8,no dnr,12.0,123.0,7.89941406,102.0,10.0,36.79688,333.3,3.2998047,0.29998779,1.0,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.37,1,male,0,35,150,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,under $11k,71015.0,43051.8438,23.5,white,53.0,3,0,0,no,0.75,0.75,no dnr,35.0,55.0,18.796875,63.0,28.0,36.0,428.0,2.0996094,0.5,1.39990234,135.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.91498,1,male,0,10,141,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,10359.0,6967.9688,12.5,white,38.0,1,1,0,no,0.899999619,0.7,no dnr,10.0,73.0,7.89941406,70.0,20.0,36.69531,333.3,3.3999023,0.79992676,2.19970703,129.0,7.419922,135.0,23.0,2502.0,4.5273972,SIP>=30
61.25897,1,female,0,13,128,Lung Cancer,Cancer,1,19.0,under $11k,13490.0,8014.7656,7.0,black,19.0,1,0,0,metastatic,0.399999857,0.5,dnr after sadm,1.0,87.0,9.0,110.0,10.0,36.69531,404.75,3.0,1.01,0.59997559,131.0,7.449219,135.0,23.0,2502.0,1.1668997,SIP>=30
68.52295,1,male,0,9,17,Lung Cancer,Cancer,1,7.0,under $11k,9748.0,6052.6523,15.0,white,12.0,1,0,0,metastatic,0.5,0.02,dnr after sadm,1.0,97.0,5.39941406,100.0,20.0,36.09375,333.3,3.5996094,1.01,1.0,144.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
86.64795,1,male,0,8,17,COPD,COPD/CHF/Cirrhosis,3,20.0,>$50k,8987.0,5409.3164,8.5,white,28.0,1,0,0,no,0.599999905,0.4,dnr after sadm,2.0,90.0,13.3984375,80.0,30.0,36.09375,204.0,3.699707,0.59997559,1.69995117,146.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
67.43298,1,male,0,20,414,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,29192.0,17898.7812,10.0,white,36.0,5,0,0,no,0.599999905,0.5,no dnr,20.0,53.0,7.89941406,60.0,22.0,35.89844,532.0,3.5,1.01,1.59985352,136.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
85.06195,1,female,1,14,14,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,38155.0,26735.8125,30.333328,white,38.0,1,0,0,no,0.899999619,0.7,dnr after sadm,13.0,68.0,12.5996094,120.0,8.0,38.69531,163.3125,2.5,0.5,0.59997559,142.0,7.479492,135.0,23.0,2502.0,4.5273972,<2 mo. follow-up
55.42499,1,male,0,6,105,Lung Cancer,Cancer,1,12.0,under $11k,7515.0,4379.293,17.0,black,10.0,1,0,0,metastatic,0.599999905,0.1,no dnr,6.0,100.0,4.09960938,100.0,20.0,36.09375,333.3,3.2998047,1.01,1.0,144.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.63794,1,male,0,5,196,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,6801.0,4078.2344,17.0,white,33.0,1,0,0,yes,0.899999619,0.6,no dnr,5.0,53.0,15.8984375,70.0,20.0,35.59375,333.3,3.699707,1.01,1.39990234,140.0,7.419922,135.0,23.0,2502.0,3.1088867,no(M2 and SIP pres)
68.03595,1,male,0,18,118,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,27335.0,13538.8984,21.0,white,33.0,2,0,0,metastatic,0.899999619,0.8,dnr after sadm,7.0,57.0,5.09960938,82.0,28.0,38.29688,98.32812,3.5,1.01,0.79992676,139.0,7.469727,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
62.198,1,female,0,32,1258,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,62019.0,41464.5938,20.25,white,41.0,8,1,0,no,0.75,0.5,no dnr,32.0,45.0,20.8984375,132.0,8.0,41.29688,162.5,2.699707,1.01,1.0,139.0,7.509766,135.0,23.0,2502.0,3.1210938,SIP>=30
87.72296,1,female,0,13,390,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,16386.0,7860.3008,8.5,white,26.0,2,1,0,no,0.799999714,0.6,dnr after sadm,5.0,61.0,10.2988281,58.0,16.0,37.79688,333.3,3.5,1.01,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.24197,1,male,0,6,42,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,9470.0,5086.2266,8.0,black,9.0,1,0,0,metastatic,0.5,0.3,no dnr,6.0,83.0,5.5,80.0,20.0,36.09375,316.0,3.199707,0.69995117,1.0,139.0,7.429688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.80396,1,female,0,8,385,Lung Cancer,Cancer,2,12.0,$11-$25k,9066.0,5457.0195,7.0,white,13.0,1,0,0,metastatic,0.899999619,0.5,no dnr,8.0,66.0,6.09960938,104.0,24.0,37.39844,333.3,3.7998047,1.01,1.0,142.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
56.71198,0,male,0,6,1409,COPD,COPD/CHF/Cirrhosis,4,6.0,under $11k,6969.0,4062.6348,13.0,white,18.0,1,0,0,no,0.979999542,0.95,no dnr,6.0,97.0,14.0996094,70.0,30.0,36.09375,232.0,3.5,1.01,1.0,141.0,7.359375,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
32.58899,1,male,0,18,1001,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,40281.0,13931.6719,27.333328,white,20.0,1,0,0,no,0.949999809,0.95,no dnr,18.0,113.0,12.5996094,110.0,32.0,38.69531,130.0,3.5,1.0,0.89990234,139.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.83496,1,female,0,14,81,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,20707.0,16171.3594,25.333328,hispanic,41.0,1,1,0,no,0.199999928,0.2,no dnr,14.0,64.0,11.7988281,110.0,8.0,37.89844,248.3125,3.2998047,0.39996338,2.0,134.0,7.439453,135.0,23.0,2502.0,4.0,SIP>=30
93.02399,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,24818.0,14741.2734,39.0,white,46.0,3,1,0,no,0.099999964,0.001,dnr after sadm,3.0,47.0,10.8984375,68.0,10.0,37.89844,210.1875,3.0,1.0,2.39990234,132.0,7.369141,135.0,23.0,2502.0,3.2661133,<2 mo. follow-up
52.27698,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,14.0,$11-$25k,15833.0,5548.2305,41.0,white,70.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,4.0,43.0,14.1992188,140.0,36.0,36.29688,145.0,1.5,0.39996338,0.39996338,141.0,7.259766,135.0,23.0,2502.0,5.0,<2 mo. follow-up
66.50195,1,male,0,9,165,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,17841.0,9923.0312,12.0,white,20.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,1.0,93.0,8.59960938,120.0,20.0,36.09375,142.5,3.8999023,0.59997559,0.89990234,139.0,7.429688,135.0,23.0,2502.0,4.4257812,<2 mo. follow-up
47.258,1,male,0,26,27,Lung Cancer,Cancer,1,12.0,under $11k,30794.0,19494.3906,8.75,white,11.0,1,0,0,metastatic,0.5,0.125,dnr after sadm,9.0,93.0,9.0,110.0,20.0,37.0,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.20294,1,male,0,13,109,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,15884.0,10151.2031,10.0,white,31.0,1,1,0,no,0.989999771,0.3,no dnr,13.0,70.0,7.79980469,70.0,20.0,35.0,333.3,3.0996094,0.89990234,1.5,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.81699,1,female,0,4,734,Lung Cancer,Cancer,1,12.0,$25-$50k,11059.0,6199.6445,12.0,white,11.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,74.0,7.5,80.0,16.0,36.89844,333.3,4.0,0.39996338,1.0,141.0,7.419922,135.0,23.0,2502.0,0.4947999,SIP>=30
64.29596,0,female,0,15,1396,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,26732.0,12994.8281,14.0,white,26.0,4,0,0,no,0.699999809,0.5,no dnr,15.0,55.0,7.89941406,70.0,28.0,38.29688,197.5,3.2998047,0.39996338,0.59997559,141.0,7.359375,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
62.987,1,female,0,14,19,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,35581.0,17470.0312,33.333313,black,41.0,7,0,0,no,0.399999857,0.064,dnr after sadm,3.0,40.0,3.0,66.0,10.0,36.29688,219.0,2.7998047,6.89941406,0.69995117,135.0,7.319336,135.0,23.0,2502.0,3.4702148,<2 mo. follow-up
44.42697,1,female,0,35,132,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,58145.0,23774.0,31.0,black,45.0,1,1,0,no,0.199999928,0.1,dnr after sadm,28.0,130.0,15.0996094,111.0,10.0,39.19531,142.5,2.5996094,0.19998169,6.0,142.0,7.479492,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.715,1,male,0,5,892,Colon Cancer,Cancer,2,20.0,under $11k,4972.0,2736.0762,8.0,white,18.0,1,1,0,metastatic,0.989999771,0.9,no dnr,5.0,103.0,5.39941406,80.0,20.0,36.09375,333.3,3.5,1.01,0.89990234,134.0,7.419922,135.0,23.0,2502.0,2.0,SIP>=30
20.04399,1,female,1,8,8,Coma,Coma,0,12.0,under $11k,26400.0,9856.6875,32.5,white,64.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,160.0,30.6992188,173.0,12.0,40.39844,217.5,2.8999023,0.5,3.0,134.0,7.469727,135.0,23.0,2502.0,2.3530273,<2 mo. follow-up
76.38098,0,male,0,59,1390,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,91340.0,62352.2188,17.0,white,43.0,10,1,0,no,0.899999619,0.8,dnr after sadm,13.0,80.0,8.0,110.0,36.0,39.39844,161.0,3.5,1.01,1.29980469,145.0,7.489258,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
83.05298,0,male,0,9,1387,COPD,COPD/CHF/Cirrhosis,3,19.0,$11-$25k,11650.0,5398.1602,17.5,white,57.0,1,1,0,no,0.799999714,0.75,no dnr,9.0,51.0,6.19921875,53.0,16.0,36.89844,237.03125,4.0996094,0.39996338,2.0,142.0,7.5,135.0,23.0,2502.0,0.0,SIP>=30
44.42999,0,male,0,15,1388,ARF/MOSF w/Sepsis,ARF/MOSF,2,5.0,under $11k,23510.0,12153.7891,15.666664,white,22.0,1,0,0,no,0.989999771,0.99,no dnr,15.0,103.0,8.29882812,68.0,24.0,38.59375,148.0,3.199707,1.79980469,1.09985352,145.0,7.379883,135.0,23.0,2502.0,2.5110989,SIP>=30
74.86896,1,female,1,4,4,Coma,Coma,2,14.0,under $11k,4332.0,2538.168,3.0,white,37.0,1,0,0,metastatic,0.049999982,0.000125,dnr after sadm,1.0,123.0,12.3984375,80.0,40.0,35.39844,385.0,3.5,1.01,1.0,132.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.77298,0,male,0,3,1384,COPD,COPD/CHF/Cirrhosis,6,14.0,under $11k,5000.0,2686.8398,17.0,hispanic,34.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,83.0,7.69921875,104.0,30.0,36.69531,271.375,4.0,0.69995117,1.5,141.0,7.399414,135.0,23.0,2502.0,2.9560547,no(M2 and SIP pres)
86.51099,1,female,0,7,15,Coma,Coma,1,12.0,under $11k,5779.0,3547.0391,4.0,white,17.0,1,0,0,no,0.199999928,0.1,dnr before sadm,-1.0,97.0,19.296875,70.0,20.0,38.19531,333.3,3.5,1.01,0.89990234,138.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
76.88397,1,male,0,12,1024,COPD,COPD/CHF/Cirrhosis,1,7.0,under $11k,19659.0,8682.5469,19.0,other,35.0,1,0,0,no,0.399999857,0.2,dnr before sadm,-1.0,83.0,7.89941406,100.0,25.0,36.09375,150.0,3.5,1.01,1.09985352,138.0,7.30957,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
73.89996,1,female,0,22,174,Lung Cancer,Cancer,3,12.0,under $11k,32118.0,18400.0938,9.333328,white,18.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,5.0,103.0,2.39990234,60.0,20.0,36.09375,333.3,3.5,1.01,0.79992676,141.0,7.419922,135.0,23.0,2502.0,4.0,SIP>=30
41.57999,1,female,0,17,681,MOSF w/Malig,ARF/MOSF,1,18.0,>$50k,35673.0,20488.1875,21.333328,white,71.0,1,0,0,metastatic,0.979999542,0.85,no dnr,17.0,53.0,0.09999084,124.0,35.0,38.5,228.0,2.199707,2.89990234,0.89990234,145.0,7.389648,135.0,23.0,2502.0,0.0,SIP>=30
87.79498,1,female,0,12,716,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,13337.0,7492.2266,15.5,white,49.0,1,0,0,no,0.899999619,0.75,dnr before sadm,-1.0,117.0,4.5,70.0,40.0,36.09375,233.3125,3.5,1.01,1.59985352,142.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
23.379,0,female,0,10,1378,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,17374.0,9278.9297,13.5,white,22.0,4,0,0,no,0.989999771,0.99,no dnr,10.0,77.0,14.2988281,110.0,30.0,38.89844,120.0,2.7998047,1.01,0.79992676,138.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.12897,1,female,1,8,8,Coma,Coma,1,16.0,under $11k,23860.0,11709.4297,26.5,white,50.0,7,0,0,no,0.0,0.0,dnr after sadm,3.0,53.0,9.29882812,110.0,35.0,35.0,140.0,3.0,1.01,1.19995117,148.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
94.26996,1,female,1,5,5,Coma,Coma,2,12.0,>$50k,5610.0,3407.0137,18.0,white,51.0,1,0,0,yes,0.0,0.0,dnr after sadm,1.0,43.0,32.8984375,70.0,30.0,35.59375,552.0,3.0996094,0.69995117,1.79980469,151.0,7.609375,135.0,23.0,2502.0,7.0,<2 mo. follow-up
60.71698,0,male,0,25,1377,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,83838.0,49739.8125,38.0,white,39.0,2,1,0,no,0.899999619,0.9,no dnr,25.0,63.0,14.1992188,67.0,28.0,38.89844,96.65625,3.699707,0.89990234,1.5,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.97797,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,37408.0,28155.8281,47.0,white,89.0,6,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,33.0,15.5996094,140.0,18.0,39.19531,186.65625,1.8999023,1.09985352,6.79980469,129.0,7.389648,135.0,23.0,2502.0,2.7636719,<2 mo. follow-up
94.06195,1,male,1,44,44,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,60663.0,31748.0469,18.0,white,53.0,1,0,0,no,0.25,0.1,no dnr,44.0,47.0,10.7988281,59.0,28.0,36.59375,519.0,2.3999023,0.69995117,3.29980469,145.0,7.349609,135.0,23.0,2502.0,7.0,<2 mo. follow-up
74.42798,1,female,0,6,719,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,6553.0,3672.4277,6.0,white,32.0,1,1,0,no,0.949999809,0.75,no dnr,6.0,73.0,5.5,60.0,15.0,35.59375,257.125,3.0996094,0.59997559,1.29980469,143.0,7.479492,135.0,23.0,2502.0,2.1777344,no(M2 and SIP pres)
72.70898,1,male,0,19,1020,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,32712.0,22892.3594,22.0,white,32.0,2,0,0,no,0.75,0.6,no dnr,19.0,105.0,11.3984375,81.0,10.0,38.19531,150.0,3.7998047,0.59997559,2.0,133.0,7.449219,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
76.849,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,43883.0,32881.8125,32.0,white,39.0,9,0,1,yes,0.099999964,0.001,dnr after sadm,6.0,57.0,12.6992188,80.0,28.0,38.69531,157.125,3.5,1.01,0.69995117,138.0,7.479492,135.0,23.0,2502.0,3.0,<2 mo. follow-up
76.435,1,male,0,11,472,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,12933.0,6387.9922,14.5,white,55.0,1,1,0,yes,0.799999714,0.5,dnr before sadm,-1.0,53.0,10.1992188,70.0,25.0,36.09375,113.32812,3.5,1.01,2.29980469,137.0,7.369141,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
77.74896,1,male,0,26,328,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,37301.0,18901.2188,21.0,white,53.0,1,0,0,no,0.75,0.75,no dnr,26.0,60.0,21.296875,140.0,12.0,36.39844,143.75,3.5,1.01,3.39990234,147.0,7.459961,135.0,23.0,2502.0,3.675293,no(M2 and SIP pres)
24.36699,1,male,1,9,9,Coma,Coma,0,16.0,under $11k,32558.0,21909.3125,41.0,white,30.0,1,0,0,no,0.899999619,0.9,dnr after sadm,8.0,125.0,5.09960938,150.0,14.0,39.39844,196.0,2.5,0.59997559,0.69995117,145.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
33.33899,0,female,0,8,1371,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,9397.0,4952.1719,12.0,hispanic,16.0,1,1,0,no,0.989999771,0.99,no dnr,8.0,83.0,7.0,70.0,20.0,36.09375,300.0,3.2998047,1.0,0.89990234,135.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
67.948,0,female,0,3,1369,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,3707.0,2003.1494,19.0,white,11.0,1,0,0,no,0.899999619,0.6,no dnr,3.0,80.0,6.69921875,70.0,20.0,37.39844,240.0,4.2998047,1.01,1.09985352,144.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
78.38495,0,female,0,42,1369,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,55119.0,31046.0312,13.5,white,37.0,1,0,0,no,0.5,0.4,dnr after sadm,3.0,61.0,11.5,55.0,12.0,36.09375,486.1875,2.8999023,0.5,1.89990234,148.0,7.369141,135.0,23.0,2502.0,3.2392578,<2 mo. follow-up
70.00696,0,female,0,33,1368,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,52072.0,24351.1875,21.25,white,65.0,1,0,0,yes,0.899999619,0.9,no dnr,33.0,44.0,37.8984375,78.0,40.0,38.59375,228.5625,1.8999023,1.29980469,1.39990234,139.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
85.85394,1,female,0,13,48,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,16619.0,9151.375,14.5,white,43.0,1,1,0,no,0.699999809,0.7,no dnr,13.0,53.0,4.19921875,70.0,30.0,36.69531,105.0,3.5,1.01,0.89990234,142.0,7.349609,135.0,23.0,2502.0,5.0,<2 mo. follow-up
95.50995,1,male,1,8,8,Coma,Coma,1,15.0,$11-$25k,8418.0,4959.6328,14.0,white,29.0,1,0,0,yes,0.009999998,1e-06,dnr before sadm,-1.0,83.0,34.796875,100.0,30.0,38.59375,333.3,4.1992188,1.09985352,1.39990234,136.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
61.57199,0,female,0,13,1367,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,17562.0,9151.3125,18.5,white,36.0,1,1,0,no,0.949999809,0.95,no dnr,13.0,53.0,8.0,69.0,30.0,38.79688,264.0,3.199707,0.39996338,0.89990234,139.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
76.67096,1,male,1,26,26,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,28454.0,17808.5312,14.75,white,22.0,1,0,0,no,0.899999619,0.75,dnr after sadm,10.0,73.0,8.3984375,76.0,24.0,36.59375,333.3,3.2998047,1.5,1.29980469,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
65.88599,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,50062.0,30376.6094,29.333328,white,55.0,1,0,0,no,0.5,0.7,dnr after sadm,19.0,45.0,11.0,72.0,38.0,38.5,244.4375,2.699707,1.09985352,2.5,141.0,7.40918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
80.27698,0,female,0,4,1362,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,4464.0,2597.1328,13.0,white,21.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,107.0,11.3984375,60.0,20.0,35.59375,332.0,3.5,1.01,1.0,140.0,7.359375,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
80.47095,0,male,0,9,1361,CHF,COPD/CHF/Cirrhosis,3,19.0,under $11k,10981.0,5523.8789,5.0,white,21.0,1,1,0,no,0.899999619,0.9,no dnr,9.0,83.0,7.0,60.0,15.0,36.69531,410.0,4.0,0.5,1.69995117,138.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
85.06494,0,male,0,17,1359,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,$11-$25k,21711.0,11713.5469,17.0,white,35.0,1,0,1,no,0.149999976,0.05,dnr after sadm,5.0,113.0,5.89941406,110.0,30.0,38.09375,306.625,2.199707,1.89990234,0.89990234,144.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
78.32196,1,male,0,12,1201,COPD,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,16940.0,8582.7422,16.0,white,46.0,1,0,0,no,0.699999809,0.6,no dnr,12.0,128.0,12.5,59.0,36.0,37.09375,172.5,3.3999023,0.29998779,3.39990234,138.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
52.26797,1,female,0,4,11,Lung Cancer,Cancer,1,12.0,under $11k,3133.0,1922.8633,2.0,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,83.0,11.3984375,100.0,20.0,36.09375,333.3,3.2998047,0.5,0.79992676,138.0,7.419922,135.0,23.0,2502.0,2.1723633,<2 mo. follow-up
50.20898,1,female,0,14,108,Lung Cancer,Cancer,1,14.0,$25-$50k,17041.0,10160.3672,5.333332,white,9.0,1,0,0,metastatic,0.899999619,0.09,dnr after sadm,6.0,80.0,9.5,72.0,20.0,36.79688,333.3,4.6992188,0.39996338,0.5,135.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
63.228,1,male,1,11,11,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,33619.0,13934.8281,50.5,white,65.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,8.0,53.0,2.89990234,56.0,12.0,38.39844,63.0,3.0,2.19970703,3.39990234,138.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.58899,1,male,0,13,692,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,$25-$50k,52123.0,13483.3047,17.0,white,24.0,1,0,0,no,0.899999619,0.6,no dnr,13.0,70.0,15.1992188,70.0,22.0,38.5,484.0,3.3999023,0.89990234,1.5,136.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.06897,1,female,0,10,114,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,12777.0,7161.125,9.5,white,17.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,87.0,11.3984375,80.0,20.0,36.69531,271.375,3.5,1.01,1.19995117,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.39996,1,male,0,50,90,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,61748.0,37880.6562,10.75,white,49.0,1,0,0,no,0.799999714,0.6,dnr after sadm,16.0,73.0,4.89941406,137.0,40.0,36.09375,333.3,3.2998047,1.39990234,2.29980469,150.0,7.449219,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
33.922,1,male,0,17,299,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,25613.0,10798.6406,17.333328,white,44.0,1,0,0,no,0.699999809,0.4,no dnr,17.0,65.0,16.5,130.0,24.0,38.09375,284.0,2.2998047,8.29882812,0.79992676,141.0,7.549805,135.0,23.0,2502.0,2.7705078,<2 mo. follow-up
63.29398,1,male,0,11,498,ARF/MOSF w/Sepsis,ARF/MOSF,5,19.0,under $11k,21501.0,10837.3281,27.0,white,40.0,1,1,0,no,0.699999809,0.6,no dnr,11.0,63.0,5.59960938,80.0,14.0,36.79688,207.5,2.7998047,0.5,5.89941406,135.0,7.359375,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
96.42694,1,female,0,5,1050,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,5218.0,3066.8047,15.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,103.0,14.1992188,80.0,20.0,36.69531,251.65625,3.5,1.29980469,1.39990234,144.0,7.329102,135.0,23.0,2502.0,3.3037109,no(M2 and SIP pres)
69.43994,1,male,1,5,5,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,18031.0,7176.5977,34.0,white,48.0,4,0,0,no,0.089999974,0.000729,no dnr,5.0,50.0,26.0,105.0,24.0,38.0,118.875,3.5,1.01,1.59985352,136.0,7.259766,135.0,23.0,2502.0,2.7158203,<2 mo. follow-up
63.625,0,female,0,8,1349,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,11290.0,5561.3125,9.0,white,9.0,1,0,0,no,0.5,0.3,dnr after sadm,1.0,93.0,8.59960938,100.0,20.0,36.69531,344.4375,3.5,1.01,0.79992676,142.0,7.319336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
69.30597,0,male,0,15,1349,Coma,Coma,1,8.0,$11-$25k,28125.0,19160.1094,15.666664,black,49.0,1,0,0,yes,0.049999982,0.000125,no dnr,15.0,74.0,10.5,74.0,42.0,36.39844,124.0,3.3999023,2.19970703,1.5,138.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
85.51996,1,male,0,8,349,ARF/MOSF w/Sepsis,ARF/MOSF,5,8.0,under $11k,10072.0,5087.5469,12.0,white,37.0,1,1,0,metastatic,0.899999619,0.8,no dnr,8.0,61.0,14.7988281,58.0,30.0,36.09375,314.25,3.0996094,1.01,1.09985352,140.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
81.44299,0,female,0,16,1347,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,52123.0,35130.2812,24.666656,white,29.0,9,0,0,yes,0.5,0.4,dnr after sadm,9.0,61.0,15.0,69.0,24.0,38.29688,106.65625,2.699707,0.69995117,1.39990234,135.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.44098,0,female,0,9,1344,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,$25-$50k,17626.0,7756.8359,13.5,black,35.0,3,1,0,yes,0.949999809,0.93,no dnr,9.0,69.0,10.8984375,70.0,14.0,36.19531,128.0,3.2998047,1.29980469,3.69970703,141.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.978,1,female,0,35,269,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,79417.0,48618.5312,27.0,white,40.0,14,1,0,no,0.949999809,0.9,no dnr,35.0,77.0,16.5,80.0,4.0,36.39844,268.0,3.5,1.01,0.69995117,139.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
38.80399,1,male,0,3,115,Colon Cancer,Cancer,1,10.0,$25-$50k,4218.0,2412.7617,12.0,white,18.0,1,0,0,metastatic,0.899999619,0.9,no dnr,3.0,99.0,9.0,120.0,26.0,37.89844,333.3,3.5996094,0.89990234,0.69995117,136.0,7.419922,135.0,23.0,2502.0,1.734375,no(M2 and SIP pres)
72.40497,1,female,0,10,761,MOSF w/Malig,ARF/MOSF,5,12.0,under $11k,16955.0,6938.1562,15.0,white,35.0,1,1,0,yes,0.979999542,0.8,no dnr,10.0,113.0,93.890625,85.0,34.0,38.09375,232.25,4.1992188,0.19998169,0.89990234,140.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.10095,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,16.0,under $11k,29317.0,17072.7812,25.0,white,37.0,3,0,0,yes,0.009999998,1e-06,dnr after sadm,1.0,100.0,63.0,80.0,32.0,35.69531,161.21875,3.5,1.01,1.5,146.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.27399,1,male,0,8,303,Colon Cancer,Cancer,2,16.0,>$50k,7562.0,4552.8359,2.5,white,14.0,1,0,0,metastatic,0.979999542,0.8,no dnr,8.0,97.0,4.59960938,80.0,20.0,36.69531,333.3,3.5,1.01,1.19995117,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
67.03595,1,male,1,8,8,Colon Cancer,Cancer,1,8.0,under $11k,16195.0,9882.6484,24.0,white,44.0,1,0,0,metastatic,0.199999928,0.02,dnr after sadm,7.0,117.0,19.5976562,110.0,30.0,35.69531,316.3125,2.699707,9.5,1.29980469,136.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
43.66098,1,male,0,11,282,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,19138.0,9625.2031,10.5,white,38.0,3,0,0,no,0.899999619,0.8,no dnr,11.0,133.0,5.29980469,80.0,20.0,36.69531,333.3,2.199707,1.01,5.29980469,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
66.04498,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,11598.0,3684.0996,52.0,white,91.0,1,1,0,metastatic,0.0,0.0,dnr after sadm,3.0,33.0,23.796875,40.0,44.0,36.39844,105.0,2.199707,2.19970703,4.19921875,127.0,7.389648,135.0,23.0,2502.0,2.175293,<2 mo. follow-up
83.06396,1,male,0,12,65,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,17204.0,10102.1719,13.5,white,44.0,1,0,0,yes,0.5,0.33,dnr after sadm,4.0,68.0,13.2988281,60.0,20.0,35.59375,333.3,3.5,2.0,2.29980469,131.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
89.67297,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,3,30.0,$25-$50k,19612.0,5866.1602,29.0,white,44.0,2,0,0,yes,0.5,0.4,dnr after sadm,1.0,120.0,19.3984375,78.0,28.0,37.89844,170.0,3.5,0.89990234,4.19921875,136.0,7.389648,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
84.51996,1,female,0,5,1244,CHF,COPD/CHF/Cirrhosis,4,13.0,$11-$25k,5884.0,4059.6016,10.0,white,30.0,1,0,0,yes,0.949999809,0.95,no dnr,5.0,117.0,9.29882812,45.0,28.0,36.69531,223.3125,3.199707,0.39996338,1.19995117,143.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.88794,1,male,0,6,243,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,4909.0,3153.375,14.0,white,34.0,1,1,0,no,0.979999542,0.95,no dnr,6.0,83.0,5.39941406,70.0,20.0,35.59375,333.3,3.5,1.01,2.19970703,133.0,7.419922,135.0,23.0,2502.0,3.855299,SIP>=30
75.67395,1,female,0,47,54,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,61867.0,35709.0,18.25,white,68.0,1,0,0,no,0.75,0.6,dnr after sadm,3.0,45.0,25.1992188,160.0,48.0,39.29688,342.8125,2.5,0.79992676,1.89990234,142.0,7.269531,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
100.13098,1,female,0,5,1082,CHF,COPD/CHF/Cirrhosis,3,4.0,under $11k,4485.0,2759.3106,6.0,black,23.0,1,0,0,yes,0.699999809,0.6,no dnr,5.0,77.0,6.0,60.0,15.0,36.09375,333.3,3.699707,1.01,1.09985352,141.0,7.419922,135.0,23.0,2502.0,3.3823242,no(M2 and SIP pres)
41.771,1,male,1,21,21,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,97144.0,72525.5625,44.333313,hispanic,37.0,1,0,0,no,0.599999905,0.5,dnr after sadm,20.0,70.0,11.1992188,70.0,10.0,38.09375,162.0,1.6999512,5.5,0.79992676,132.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
54.36798,0,male,0,14,1324,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,35856.0,23739.0781,31.333328,white,64.0,4,0,0,no,0.599999905,0.6,no dnr,14.0,61.0,7.59960938,150.0,52.0,39.29688,102.5,2.5,0.39996338,1.19995117,134.0,7.229492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.43896,1,female,0,19,34,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,25724.0,12041.1484,18.333328,white,30.0,1,0,0,yes,0.599999905,0.5,dnr after sadm,7.0,100.0,12.2988281,100.0,15.0,36.09375,355.0,3.7998047,0.29998779,2.59960938,141.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.10297,0,male,0,4,1321,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,6726.0,2813.3965,15.0,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,63.0,10.7988281,54.0,14.0,36.29688,219.03125,3.5,1.39990234,1.09985352,142.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.30096,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,4,9.0,under $11k,63943.0,28989.6094,48.5,black,74.0,15,1,0,no,0.699999809,0.5,dnr after sadm,9.0,63.0,30.0976562,119.0,38.0,35.19531,151.65625,2.199707,1.0,7.79980469,132.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.81,1,female,1,10,10,Coma,Coma,4,12.0,under $11k,20721.0,7335.1953,31.5,white,60.0,1,1,1,no,0.099999964,0.001,dnr after sadm,9.0,43.0,22.3984375,120.0,28.0,38.69531,324.4375,2.199707,1.01,3.69970703,142.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
75.258,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,34405.0,13343.0625,42.5,white,36.0,5,0,0,yes,0.5,0.5,dnr after sadm,5.0,44.0,21.3984375,108.0,16.0,38.19531,135.0,3.5,1.01,1.19995117,145.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
74.72699,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,35196.0,12690.6484,40.5,white,70.0,5,1,0,no,0.199999928,0.2,dnr after sadm,2.0,49.0,14.2988281,120.0,34.0,38.29688,148.3125,2.8999023,0.19998169,3.39990234,136.0,7.359375,135.0,23.0,2502.0,2.5004883,<2 mo. follow-up
66.97095,0,female,0,18,1315,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,26628.0,12572.0234,12.0,white,18.0,1,0,0,no,0.699999809,0.6,no dnr,18.0,62.0,8.3984375,110.0,8.0,37.89844,162.5,3.7998047,0.89990234,0.89990234,143.0,7.349609,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
87.86298,0,female,0,15,1314,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,28359.0,18643.0156,15.333328,white,63.0,2,0,0,no,0.849999905,0.5,dnr before sadm,-1.0,53.0,5.19921875,66.0,36.0,35.59375,188.0,3.5996094,0.79992676,7.19921875,137.0,7.329102,135.0,23.0,2502.0,3.1831989,no(M2 and SIP pres)
87.06097,1,female,0,8,1109,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,9141.0,5488.5938,10.5,white,22.0,1,0,0,no,0.799999714,0.6,dnr after sadm,1.0,83.0,6.79980469,60.0,20.0,36.09375,185.6875,3.5,0.19998169,1.29980469,142.0,7.269531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.745,0,female,0,9,1313,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,14478.0,4920.8438,26.0,black,29.0,1,0,0,yes,0.75,0.5,no dnr,9.0,42.0,11.1992188,112.0,16.0,38.09375,524.0,2.7998047,1.19995117,1.0,144.0,7.399414,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
52.86499,1,female,0,11,23,Lung Cancer,Cancer,1,11.0,>$50k,20940.0,11508.2656,15.5,white,11.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,3.0,80.0,15.7988281,70.0,30.0,37.69531,333.3,2.8999023,0.19998169,0.79992676,141.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
69.04895,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,49859.0,28440.2969,34.0,white,52.0,6,1,0,no,0.599999905,0.55,dnr after sadm,11.0,63.0,8.69921875,110.0,8.0,36.19531,130.0,2.8999023,0.89990234,8.09960938,134.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.31097,1,female,0,18,92,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,56614.0,41906.9375,22.0,white,34.0,13,0,0,no,0.399999857,0.3,no dnr,18.0,62.0,7.5,69.0,24.0,36.79688,163.25,3.7998047,1.01,3.09960938,134.0,7.429688,135.0,23.0,2502.0,3.1831989,no(M2 and SIP pres)
71.86896,0,male,0,121,1307,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,>$50k,195312.0,104546.312,28.5,white,47.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,59.0,4.0,62.0,5.0,39.09375,195.0,2.199707,0.5,0.5,131.0,7.469727,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
67.92096,1,male,0,9,210,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,12316.0,7214.0312,14.5,white,20.0,1,0,0,yes,0.5,0.3,no dnr,9.0,77.0,22.1992188,80.0,25.0,36.09375,367.5,3.5,1.19995117,0.89990234,141.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.24298,1,male,0,4,583,COPD,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,4298.0,2533.3926,15.0,white,17.0,1,0,0,yes,1.0,0.9,no dnr,4.0,87.0,12.3984375,80.0,20.0,36.09375,395.0,3.5,1.01,1.69995117,139.0,7.329102,135.0,23.0,2502.0,2.8388672,no(M2 and SIP pres)
66.97095,0,female,0,9,1305,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,11884.0,5305.3516,14.5,black,50.0,1,1,0,yes,0.899999619,0.9,dnr before sadm,-1.0,47.0,9.79882812,98.0,11.0,36.29688,486.625,4.5,0.5,0.5,168.0,7.319336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
31.05299,0,female,0,50,1305,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,238115.0,116004.25,43.5,white,77.0,1,0,0,yes,0.699999809,0.5,no dnr,50.0,51.0,0.89990234,134.0,12.0,38.29688,132.0,1.7998047,1.79980469,2.0,145.0,7.339844,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
63.452,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,30733.0,10592.25,31.5,white,34.0,7,0,0,no,0.96999979,0.98,no dnr,8.0,76.0,12.0996094,104.0,32.0,39.29688,116.65625,2.7998047,1.01,0.79992676,132.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.29999,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,148632.0,93047.125,58.333313,white,69.0,4,0,0,no,0.25,0.2,dnr after sadm,19.0,50.0,39.296875,110.0,8.0,33.69531,61.0,3.5,3.29980469,1.29980469,132.0,7.349609,135.0,23.0,2502.0,2.4887695,<2 mo. follow-up
55.78897,1,male,0,16,82,Lung Cancer,Cancer,2,12.0,under $11k,19538.0,11818.8594,19.666656,white,23.0,1,0,0,metastatic,0.149999976,0.05,no dnr,16.0,113.0,7.29980469,96.0,32.0,38.69531,171.65625,3.0996094,0.39996338,1.09985352,139.0,7.5,135.0,23.0,2502.0,3.2353516,<2 mo. follow-up
87.25494,1,female,0,10,348,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,16061.0,10449.7344,19.5,white,31.0,1,0,0,no,0.5,0.1,no dnr,10.0,67.0,8.59960938,100.0,16.0,36.89844,333.3,3.5,1.01,1.19995117,138.0,7.419922,135.0,19.0,750.0,2.0,no(M2 and SIP pres)
46.30298,1,female,0,4,333,Lung Cancer,Cancer,1,12.0,$25-$50k,14642.0,7322.0742,11.0,white,5.0,1,0,0,metastatic,0.899999619,0.7,no dnr,4.0,73.0,13.5,105.0,23.0,38.19531,100.0,3.5,1.01,3.69970703,127.0,7.389648,135.0,78.0,3100.0,2.7387695,no(M2 and SIP pres)
83.67096,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,12886.0,2669.707,24.0,white,45.0,1,0,0,no,0.75,0.7,dnr after sadm,4.0,50.0,12.0996094,105.0,16.0,36.09375,333.3,3.5996094,1.19995117,1.29980469,125.0,7.419922,135.0,39.0,5180.0,1.1667481,<2 mo. follow-up
49.69498,0,male,0,10,1090,ARF/MOSF w/Sepsis,ARF/MOSF,4,9.0,under $11k,15399.0,9213.6016,18.5,black,51.0,1,0,0,no,0.949999809,0.92,no dnr,10.0,102.0,14.7988281,130.0,30.0,39.0,155.0,3.5,1.01,0.5,130.0,7.5,147.0,13.0,1530.0,0.0,SIP>=30
82.237,1,female,0,14,245,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,41176.0,18947.2656,22.0,white,29.0,3,0,0,yes,0.899999619,0.7,no dnr,14.0,68.0,0.79992676,120.0,18.0,38.09375,152.0,2.0996094,6.29980469,2.5,127.0,7.289062,215.0,77.0,2010.0,1.0,SIP>=30
74.40399,1,female,0,8,805,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,>$50k,12160.0,6177.9922,10.5,white,22.0,1,0,0,no,0.919999599,0.7,no dnr,8.0,63.0,21.0,124.0,36.0,36.0,319.0,2.699707,0.59997559,1.19995117,147.0,7.359375,226.0,44.0,1027.0,2.5107422,no(M2 and SIP pres)
85.224,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,6,20.0,>$50k,67876.0,49520.2188,29.666656,white,57.0,14,1,0,yes,0.299999952,0.3,dnr after sadm,4.0,81.0,9.59960938,100.0,20.0,38.39844,333.3,3.5,1.01,0.79992676,132.0,7.419922,108.0,12.0,2650.0,7.0,<2 mo. follow-up
87.60797,1,female,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,93347.0,58623.625,15.25,white,45.0,17,0,0,no,0.799999714,0.6,dnr after sadm,24.0,112.0,6.29980469,115.0,10.0,35.0,230.0,2.3999023,16.0976562,1.79980469,145.0,7.449219,296.0,34.0,1494.0,1.0,<2 mo. follow-up
68.18896,0,female,0,37,1088,COPD,COPD/CHF/Cirrhosis,3,14.0,under $11k,81038.0,25616.6562,25.25,white,20.0,1,0,0,no,0.75,0.7,no dnr,37.0,55.0,6.5,45.0,10.0,36.29688,333.3,3.5,1.01,0.39996338,141.0,7.419922,135.0,16.0,1775.0,3.0,no(M2 and SIP pres)
58.46698,0,male,0,5,1088,Cirrhosis,COPD/CHF/Cirrhosis,4,19.0,>$50k,6816.0,3522.6035,7.0,white,40.0,1,0,0,no,0.899999619,0.75,no dnr,5.0,79.0,11.6992188,72.0,16.0,38.0,333.3,3.5,0.69995117,0.89990234,138.0,7.419922,135.0,23.0,3900.0,1.0,SIP>=30
72.62396,1,female,0,27,37,Lung Cancer,Cancer,3,8.0,under $11k,29597.0,17250.1875,8.75,white,18.0,1,0,0,metastatic,0.149999976,0.04,dnr after sadm,2.0,127.0,7.79980469,130.0,52.0,38.5,333.3,2.0,0.89990234,0.5,131.0,7.419922,191.0,16.0,4185.0,0.0,<2 mo. follow-up
85.05096,0,male,0,19,1086,COPD,COPD/CHF/Cirrhosis,1,19.0,under $11k,27225.0,13628.3281,11.0,white,26.0,1,0,0,no,0.949999809,0.8,no dnr,19.0,58.0,6.0,125.0,28.0,38.09375,150.0,3.5,1.01,1.39990234,133.0,7.489258,135.0,28.0,3400.0,0.0,no(M2 and SIP pres)
88.86798,1,female,0,5,8,Coma,Coma,0,12.0,under $11k,4313.0,2654.1602,6.0,white,18.0,1,0,0,no,0.009999998,0.01,dnr before sadm,-1.0,53.0,42.09375,75.0,12.0,38.89844,67.0,3.5,8.09960938,5.5,155.0,7.419922,391.0,98.0,2502.0,3.0161133,<2 mo. follow-up
73.39899,1,male,0,3,135,Cirrhosis,COPD/CHF/Cirrhosis,5,10.0,under $11k,5160.0,2640.3477,15.0,hispanic,38.0,1,1,0,no,0.5,0.3,dnr after sadm,2.0,68.0,0.79992676,120.0,24.0,38.0,297.125,2.3999023,0.79992676,2.09960938,141.0,7.429688,74.0,21.0,4070.0,2.5107422,adl>=4 (>=5 if sur)
90.28296,1,male,1,5,5,Coma,Coma,1,8.0,under $11k,18727.0,7006.1328,38.0,white,45.0,4,0,0,no,0.0,0.0,dnr after sadm,2.0,67.0,6.39941406,46.0,22.0,36.89844,251.0,3.5,1.01,1.89990234,137.0,7.439453,126.0,28.0,1370.0,3.4916992,<2 mo. follow-up
69.125,0,female,0,9,1080,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,8771.0,4925.7344,6.5,black,9.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,93.0,6.5,80.0,20.0,36.09375,333.3,3.5,1.01,1.0,139.0,7.419922,107.0,17.0,6050.0,1.0,no(M2 and SIP pres)
58.987,1,female,0,7,11,Colon Cancer,Cancer,1,16.0,$25-$50k,6447.0,3819.7754,5.0,white,23.0,1,0,0,metastatic,0.199999928,0.02,dnr after sadm,1.0,50.0,8.09960938,50.0,28.0,38.09375,171.40625,4.3994141,0.79992676,1.39990234,139.0,7.449219,109.0,27.0,440.0,3.0,<2 mo. follow-up
73.15796,1,female,0,11,679,COPD,COPD/CHF/Cirrhosis,2,16.0,under $11k,18381.0,7921.2852,17.5,white,54.0,1,0,0,no,0.849999905,0.8,no dnr,11.0,107.0,11.0996094,80.0,25.0,36.09375,375.0,2.5,1.01,8.09960938,130.0,7.359375,191.0,69.0,110.0,1.8388672,SIP>=30
93.04895,0,male,0,8,1078,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,16645.0,7173.9883,16.5,white,43.0,3,1,0,yes,0.899999619,0.75,no dnr,8.0,73.0,14.6992188,72.0,20.0,35.79688,422.1875,3.2998047,1.01,2.29980469,142.0,7.429688,126.0,44.0,2140.0,1.0,no(M2 and SIP pres)
62.31097,1,female,1,19,19,Coma,Coma,3,12.0,under $11k,47340.0,29971.7969,30.0,black,45.0,1,1,0,yes,0.899999619,0.9,dnr after sadm,13.0,107.0,4.59960938,80.0,20.0,36.79688,333.3,2.3999023,1.5,0.79992676,141.0,7.419922,70.0,7.0,650.0,7.0,<2 mo. follow-up
78.87195,1,female,0,30,55,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,63298.0,26520.2656,23.25,white,81.0,1,1,0,no,0.25,0.05,dnr after sadm,16.0,67.0,9.8984375,70.0,8.0,35.89844,267.5,2.0996094,1.01,5.29980469,133.0,7.359375,163.0,97.0,39.0,6.0,<2 mo. follow-up
48.77798,1,female,0,5,150,Lung Cancer,Cancer,2,12.0,under $11k,7376.0,3867.5684,13.0,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,63.0,12.3984375,70.0,34.0,35.59375,315.0,3.5,1.01,1.89990234,135.0,7.379883,258.0,90.0,775.0,2.5107422,SIP>=30
75.15399,1,female,0,11,300,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,51018.0,25412.875,29.0,white,35.0,8,0,0,no,0.949999809,0.95,no dnr,11.0,53.0,11.0996094,62.0,10.0,38.19531,410.0,2.7998047,0.19998169,0.69995117,128.0,7.40918,96.0,14.0,2820.0,0.0,no(M2 and SIP pres)
95.33496,1,female,0,11,1053,COPD,COPD/CHF/Cirrhosis,1,12.0,>$50k,18790.0,8041.3633,25.0,white,10.0,1,0,0,no,0.799999714,0.5,dnr after sadm,2.0,60.0,4.29980469,80.0,15.0,36.69531,333.3,2.2998047,7.69921875,1.0,133.0,7.419922,76.0,23.0,1150.0,4.0,no(M2 and SIP pres)
43.44998,1,male,0,16,251,MOSF w/Malig,ARF/MOSF,3,14.0,$25-$50k,67444.0,43043.2188,38.333313,white,83.0,8,0,0,metastatic,0.5,0.2,no dnr,16.0,103.0,9.0,96.0,12.0,36.59375,333.3,3.2998047,0.39996338,0.59997559,132.0,7.419922,168.0,8.0,2502.0,0.0,<2 mo. follow-up
77.81494,1,male,1,3,3,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,5391.0,3145.9785,24.0,white,79.0,1,0,1,no,0.699999809,0.5,dnr after sadm,3.0,100.0,14.5996094,100.0,25.0,36.69531,323.75,3.8999023,1.01,1.09985352,140.0,7.329102,181.0,18.0,1700.0,6.0683594,<2 mo. follow-up
64.85394,1,male,1,14,14,MOSF w/Malig,ARF/MOSF,4,16.0,>$50k,57305.0,20685.6875,27.666656,white,55.0,3,0,0,yes,0.299999952,0.15,dnr after sadm,8.0,70.0,12.2988281,100.0,30.0,39.39844,333.3,3.5,1.01,0.79992676,139.0,7.419922,143.0,11.0,2502.0,1.0,<2 mo. follow-up
73.17999,0,male,0,9,1072,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,15118.0,8541.5078,11.5,white,23.0,1,0,0,no,1.0,0.9,no dnr,9.0,67.0,11.5,100.0,20.0,36.09375,292.0,2.699707,0.79992676,1.5,130.0,7.479492,305.0,49.0,935.0,0.0,no(M2 and SIP pres)
77.24298,0,male,0,6,1071,COPD,COPD/CHF/Cirrhosis,2,15.0,$25-$50k,9213.0,4534.9688,9.0,white,29.0,1,0,0,no,0.599999905,0.25,dnr before sadm,0.0,63.0,2.19970703,60.0,15.0,40.29688,317.5,3.0996094,1.01,2.5,145.0,7.479492,215.0,64.0,1205.0,0.0,no(M2 and SIP pres)
91.16797,1,female,1,11,11,COPD,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,22895.0,6213.3398,24.5,white,33.0,1,0,0,no,0.5,0.5,dnr after sadm,6.0,67.0,6.59960938,80.0,20.0,36.09375,173.3125,3.5,1.01,0.79992676,136.0,7.259766,106.0,6.0,2502.0,6.0,<2 mo. follow-up
45.10599,0,male,0,46,1071,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,132956.0,95915.0,41.5,white,30.0,2,0,0,yes,0.5,0.5,no dnr,46.0,77.0,2.19970703,130.0,20.0,36.09375,333.3,3.5,1.01,0.89990234,135.0,7.419922,99.0,4.0,2502.0,0.0,adl>=4 (>=5 if sur)
73.61798,1,female,0,12,67,Lung Cancer,Cancer,4,14.0,$25-$50k,21745.0,12838.8906,16.0,white,30.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,3.0,57.0,10.0,67.0,5.0,36.29688,210.0,2.7998047,0.19998169,0.69995117,149.0,7.459961,162.0,14.0,501.0,4.0,<2 mo. follow-up
87.45197,0,female,0,27,1068,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,40903.0,25369.1562,15.5,white,43.0,3,1,0,no,0.799999714,0.8,no dnr,27.0,53.0,5.79980469,56.0,16.0,36.79688,362.9375,2.7998047,0.29998779,3.19970703,137.0,7.379883,339.0,64.0,1705.0,1.0,no(M2 and SIP pres)
72.10999,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,82805.0,30254.5,46.666657,white,43.0,15,1,1,no,0.5,0.4,dnr after sadm,14.0,50.0,13.5,68.0,30.0,36.09375,396.625,3.5,0.29998779,1.5,150.0,7.389648,306.0,22.0,855.0,5.9599609,<2 mo. follow-up
67.01196,1,male,0,5,27,Colon Cancer,Cancer,1,13.0,$11-$25k,4505.0,2691.5371,10.0,white,24.0,1,0,0,metastatic,0.899999619,0.3,no dnr,5.0,57.0,78.796875,67.0,11.0,35.69531,509.5,1.8999023,0.39996338,4.79980469,138.0,7.329102,150.0,111.0,353.0,0.0,<2 mo. follow-up
67.258,1,female,0,4,99,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,4037.0,2270.6152,15.0,white,32.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,77.0,6.69921875,80.0,20.0,39.39844,333.3,2.699707,0.5,0.59997559,135.0,7.419922,118.0,3.0,2502.0,2.0,no(M2 and SIP pres)
63.59198,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,55293.0,29078.8281,34.0,white,47.0,1,0,0,no,0.699999809,0.7,dnr after sadm,11.0,63.0,11.1992188,60.0,8.0,36.19531,116.0,3.5,1.01,1.39990234,150.0,7.439453,158.0,43.0,3081.0,0.494751,<2 mo. follow-up
38.81198,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,$25-$50k,46577.0,28459.8281,42.0,white,54.0,2,0,0,no,0.0,0.0,dnr after sadm,9.0,111.0,7.5,50.0,8.0,35.79688,362.5,3.5,1.01,0.79992676,146.0,7.379883,83.0,10.0,3226.0,0.0,<2 mo. follow-up
72.03595,1,female,0,10,816,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,18033.0,10641.3906,18.5,white,37.0,1,1,0,no,0.75,0.75,no dnr,10.0,40.0,0.5,135.0,30.0,36.69531,110.0,1.5,3.69970703,1.0,142.0,7.429688,156.0,30.0,2810.0,1.0,SIP>=30
94.04199,1,female,0,13,74,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,12115.0,7034.9492,6.5,white,51.0,1,0,0,no,0.199999928,0.05,dnr after sadm,1.0,43.0,6.59960938,71.0,38.0,35.59375,309.5,3.699707,0.89990234,2.5,137.0,7.419922,39.0,139.0,364.0,6.0,SIP>=30
58.29398,1,female,0,7,143,Lung Cancer,Cancer,1,16.0,>$50k,9432.0,5565.1484,6.5,white,8.0,1,0,0,metastatic,0.949999809,0.5,no dnr,7.0,52.0,3.39990234,72.0,14.0,39.89844,95.70312,1.5,0.5,1.29980469,142.0,7.469727,288.0,39.0,1095.0,0.494751,SIP>=30
79.76996,1,male,0,13,224,CHF,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,13059.0,7513.8086,12.0,white,43.0,1,0,0,no,0.799999714,0.2,dnr after sadm,1.0,63.0,3.0,50.0,25.0,37.5,352.375,4.3994141,0.39996338,1.39990234,139.0,7.439453,86.0,11.0,1025.0,1.0,no(M2 and SIP pres)
93.5,0,female,0,11,1059,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,17669.0,7677.5938,17.5,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,100.0,8.69921875,100.0,20.0,36.09375,246.0,3.3999023,0.39996338,1.89990234,137.0,7.269531,211.0,34.0,1175.0,3.5712891,<2 mo. follow-up
64.98596,0,male,0,11,1058,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,15358.0,8118.6953,13.0,white,34.0,1,0,0,no,0.949999809,0.9,no dnr,11.0,63.0,10.8984375,49.0,36.0,35.79688,215.0,2.5,0.5,1.09985352,138.0,7.399414,122.0,24.0,2900.0,3.2094727,<2 mo. follow-up
79.21997,1,male,1,13,13,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,26546.0,19413.3125,23.0,white,46.0,1,0,0,yes,0.949999809,0.7,no dnr,13.0,60.0,12.5,130.0,8.0,38.5,276.0,2.2998047,0.69995117,1.0,144.0,7.439453,148.0,11.0,3310.0,0.0,<2 mo. follow-up
73.16095,1,female,0,16,71,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,31648.0,9778.0625,33.0,white,34.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,69.0,10.3984375,97.0,22.0,36.69531,148.5625,2.7998047,0.29998779,6.5,136.0,7.319336,82.0,37.0,2502.0,6.0,adl>=4 (>=5 if sur)
64.53094,1,female,0,5,31,Colon Cancer,Cancer,1,12.0,under $11k,6520.0,3431.6211,15.0,white,13.0,1,0,0,metastatic,0.789999962,0.25,no dnr,5.0,127.0,15.3984375,70.0,30.0,37.89844,280.0,2.2998047,1.01,0.69995117,153.0,7.379883,299.0,31.0,2035.0,0.0,<2 mo. follow-up
96.02496,1,male,0,6,153,CHF,COPD/CHF/Cirrhosis,2,0.0,$11-$25k,5425.0,3100.5625,11.0,white,16.0,1,0,0,no,0.799999714,0.5,no dnr,6.0,52.0,11.7988281,63.0,10.0,38.59375,70.0,2.5996094,0.5,1.59985352,136.0,7.469727,270.0,35.0,2215.0,1.0,no(M2 and SIP pres)
79.61395,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,3,17.0,$11-$25k,49723.0,19671.1875,33.0,white,40.0,7,0,1,no,0.5,0.5,dnr after sadm,5.0,97.0,7.79980469,80.0,20.0,36.69531,333.3,3.0996094,1.69995117,1.09985352,138.0,7.419922,88.0,23.0,300.0,1.0,<2 mo. follow-up
80.383,1,male,0,21,71,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,65194.0,34252.8438,18.0,white,49.0,16,0,0,no,0.199999928,0.2,no dnr,21.0,67.0,12.0,70.0,20.0,36.09375,280.9375,2.699707,1.01,1.0,139.0,7.519531,103.0,13.0,1475.0,3.8051758,<2 mo. follow-up
72.82098,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,9040.0,2867.6523,42.0,white,77.0,1,0,0,yes,0.089999974,0.09,dnr after sadm,3.0,115.0,30.5976562,130.0,38.0,36.69531,142.84375,3.199707,0.5,0.69995117,145.0,7.479492,259.0,25.0,1485.0,2.3725586,<2 mo. follow-up
62.17899,1,male,0,7,840,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,12723.0,4000.0977,13.5,white,24.0,1,1,0,no,0.849999905,0.8,no dnr,7.0,69.0,14.0996094,82.0,32.0,38.09375,71.0,2.2998047,1.01,2.29980469,136.0,7.389648,151.0,31.0,1975.0,2.1552734,<2 mo. follow-up
91.59998,0,female,0,5,1051,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,6892.0,3620.3379,19.0,white,44.0,1,0,1,no,0.75,0.5,dnr before sadm,-1.0,110.0,6.79980469,80.0,24.0,38.09375,220.0,3.0,0.79992676,6.0,140.0,7.329102,106.0,75.0,855.0,6.7988281,<2 mo. follow-up
63.70398,0,female,0,7,1052,COPD,COPD/CHF/Cirrhosis,1,13.0,under $11k,14808.0,8494.9297,11.5,white,25.0,1,0,0,no,0.949999809,0.95,dnr after sadm,3.0,70.0,11.7988281,80.0,25.0,37.0,344.0,4.0,1.09985352,1.5,134.0,7.549805,127.0,61.0,700.0,1.1667481,no(M2 and SIP pres)
49.94098,0,male,0,6,1052,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6022.0,3451.0117,9.0,white,37.0,1,0,0,no,0.699999809,0.6,no dnr,6.0,73.0,6.5,70.0,20.0,36.69531,333.3,3.5,0.5,0.5,139.0,7.419922,101.0,12.0,2502.0,2.3305664,<2 mo. follow-up
80.65698,1,female,1,16,16,Coma,Coma,1,12.0,under $11k,52292.0,35646.375,28.666656,white,62.0,1,1,0,no,0.5,0.4,dnr after sadm,13.0,107.0,6.59960938,50.0,25.0,36.09375,186.1875,3.5,1.01,4.5,138.0,7.5,179.0,70.0,1900.0,0.0,<2 mo. follow-up
73.185,1,male,0,13,23,COPD,COPD/CHF/Cirrhosis,2,12.0,>$50k,21289.0,9521.3359,11.0,white,22.0,1,0,0,no,0.799999714,0.5,dnr after sadm,2.0,58.0,14.0996094,107.0,28.0,39.09375,330.0,3.5,1.01,0.79992676,134.0,7.40918,252.0,16.0,1500.0,0.0,<2 mo. follow-up
92.35297,1,female,0,5,1037,CHF,COPD/CHF/Cirrhosis,4,18.0,$25-$50k,4530.0,2524.7617,5.0,white,44.0,1,0,0,yes,0.75,0.4,no dnr,5.0,77.0,15.2988281,80.0,20.0,36.69531,200.0,3.5,1.01,1.09985352,137.0,7.40918,169.0,26.0,1250.0,3.0,no(M2 and SIP pres)
71.06897,0,female,0,8,1048,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,9867.0,5391.0859,11.0,white,11.0,1,0,1,no,0.989999771,0.98,no dnr,8.0,107.0,14.1992188,110.0,26.0,36.5,313.0,3.5,1.01,1.0,137.0,7.429688,246.0,28.0,607.0,5.0332031,<2 mo. follow-up
70.69098,1,female,1,17,17,Colon Cancer,Cancer,1,12.0,under $11k,15326.0,9194.1484,7.333332,white,35.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,3.0,58.0,11.6992188,74.0,8.0,37.89844,180.0,3.3999023,1.01,1.19995117,142.0,7.389648,151.0,24.0,2885.0,7.0,<2 mo. follow-up
81.45898,1,female,0,24,541,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,38340.0,16256.4531,22.666656,white,37.0,1,1,0,no,0.599999905,0.6,no dnr,24.0,78.0,12.1992188,76.0,16.0,37.79688,333.3,3.199707,0.39996338,1.09985352,138.0,7.419922,83.0,19.0,2502.0,2.0,no(M2 and SIP pres)
56.85999,0,female,0,22,1047,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,31629.0,14054.8281,15.333328,white,40.0,1,0,0,no,0.75,0.6,no dnr,22.0,60.0,5.59960938,80.0,20.0,36.09375,333.3,3.5,1.01,1.19995117,129.0,7.419922,109.0,18.0,2502.0,1.0,no(M2 and SIP pres)
53.43698,1,female,1,4,4,Lung Cancer,Cancer,1,12.0,under $11k,4094.0,2367.0938,11.0,white,59.0,1,0,0,metastatic,0.0,0.0,dnr before sadm,-1.0,65.0,16.5976562,126.0,20.0,36.89844,140.0,2.199707,0.29998779,0.89990234,149.0,7.40918,265.0,35.0,2447.0,2.5229492,<2 mo. follow-up
34.72098,0,male,0,5,1042,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,$11-$25k,8854.0,3487.0508,24.0,white,12.0,1,0,0,no,0.899999619,0.9,no dnr,5.0,133.0,26.296875,134.0,22.0,36.09375,236.71875,3.3999023,1.39990234,4.5,147.0,7.389648,111.0,125.0,1355.0,1.6228027,no(M2 and SIP pres)
49.65399,0,female,0,32,1041,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,45260.0,21936.75,20.25,white,32.0,1,1,0,yes,0.949999809,0.9,dnr after sadm,2.0,43.0,5.89941406,111.0,15.0,38.59375,336.0,2.3999023,1.19995117,5.39941406,151.0,7.389648,99.0,70.0,285.0,6.0,adl>=4 (>=5 if sur)
46.78198,1,male,0,7,993,COPD,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,7958.0,4409.9375,5.5,hispanic,18.0,1,0,0,no,0.979999542,0.96,no dnr,7.0,109.0,6.89941406,65.0,20.0,36.59375,524.0,3.5,1.01,1.69995117,139.0,7.509766,224.0,30.0,2100.0,0.0,no(M2 and SIP pres)
63.836,0,male,0,4,1039,Lung Cancer,Cancer,1,12.0,under $11k,17745.0,8744.4062,12.0,white,12.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,77.0,3.79980469,80.0,25.0,35.59375,333.3,3.2998047,1.59985352,2.09960938,138.0,7.419922,92.0,53.0,825.0,2.2768555,<2 mo. follow-up
76.47894,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,26124.0,8544.6719,44.0,white,48.0,1,0,0,yes,0.299999952,0.3,no dnr,8.0,110.0,16.3984375,70.0,25.0,36.69531,180.0,3.2998047,1.01,0.5,136.0,7.399414,167.0,17.0,1590.0,0.0,<2 mo. follow-up
66.04498,0,female,0,76,1038,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,162830.0,148262.375,38.25,white,68.0,1,0,0,no,0.899999619,0.85,no dnr,76.0,70.0,6.5,80.0,25.0,36.69531,319.0,4.1992188,1.19995117,1.59985352,134.0,7.529297,106.0,24.0,1500.0,1.987793,adl>=4 (>=5 if sur)
65.487,1,male,0,24,231,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,40260.0,22924.5312,19.666656,white,42.0,1,0,0,no,0.299999952,0.2,dnr after sadm,17.0,47.0,16.0,70.0,10.0,40.19531,382.0,3.699707,2.5,2.19970703,145.0,7.459961,219.0,60.0,1072.0,1.0,SIP>=30
74.98999,0,female,0,11,1034,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,51049.0,32962.1562,24.5,white,48.0,5,0,0,no,0.5,0.45,no dnr,11.0,100.0,9.3984375,100.0,30.0,36.09375,385.125,3.199707,1.01,0.69995117,141.0,7.239258,155.0,19.0,775.0,0.0,no(M2 and SIP pres)
71.00897,1,female,1,20,20,Coma,Coma,3,12.0,under $11k,24582.0,16148.7969,20.0,white,21.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,57.0,27.796875,80.0,20.0,36.09375,252.375,3.5,1.01,1.09985352,132.0,7.459961,90.0,30.0,1100.0,6.0,<2 mo. follow-up
82.26099,1,male,0,38,397,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,79617.0,28075.9219,33.75,white,61.0,1,0,0,yes,0.5,0.3,dnr after sadm,8.0,107.0,4.79980469,100.0,20.0,36.09375,498.3125,3.8999023,0.29998779,0.89990234,135.0,7.359375,90.0,18.0,2502.0,3.0,adl>=4 (>=5 if sur)
77.06494,1,female,0,4,381,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,4731.0,2831.1074,16.0,white,13.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,67.0,20.1992188,90.0,20.0,36.5,404.75,3.7998047,4.09960938,1.79980469,143.0,7.549805,89.0,44.0,2502.0,3.0,no(M2 and SIP pres)
79.91498,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,35208.0,28682.25,27.5,white,61.0,5,1,0,no,0.0,0.0,dnr after sadm,3.0,41.0,15.3984375,109.0,28.0,37.69531,436.625,3.0,0.59997559,1.69995117,138.0,7.369141,82.0,36.0,2340.0,3.675293,<2 mo. follow-up
80.05499,0,female,0,27,1033,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,63531.0,30828.3438,19.25,white,17.0,9,0,0,no,0.699999809,0.65,no dnr,27.0,51.0,17.5,84.0,29.0,36.29688,122.4375,3.699707,1.01,1.29980469,136.0,7.359375,200.0,21.0,3070.0,0.0,no(M2 and SIP pres)
72.25494,1,male,0,7,9,Lung Cancer,Cancer,2,12.0,under $11k,5886.0,3460.0781,5.5,black,10.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,40.0,15.6992188,144.0,4.0,37.19531,105.0,3.5,1.01,0.89990234,141.0,7.289062,209.0,13.0,2502.0,3.1450195,<2 mo. follow-up
41.172,1,female,0,10,26,Colon Cancer,Cancer,1,12.0,$25-$50k,15770.0,8478.8047,17.5,white,44.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,6.0,63.0,7.59960938,72.0,16.0,38.29688,305.0,3.3999023,0.89990234,0.69995117,141.0,7.419922,107.0,15.0,4640.0,2.0,<2 mo. follow-up
64.04395,1,male,0,3,129,Colon Cancer,Cancer,2,12.0,under $11k,2867.0,1655.6846,22.610928270087555,white,32.0,1,1,0,metastatic,0.699999809,0.1,no dnr,3.0,109.0,7.09960938,129.0,22.0,39.39844,246.65625,3.5,0.59997559,1.19995117,146.0,7.289062,418.0,23.0,3230.0,0.494751,no(M2 and SIP pres)
30.29999,0,female,0,12,1031,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,>$50k,47058.0,21754.5938,16.0,black,74.0,1,0,0,yes,0.849999905,0.75,no dnr,12.0,107.0,8.29882812,110.0,20.0,37.79688,247.59375,3.5,0.89990234,1.19995117,141.0,7.399414,106.0,13.0,2502.0,0.0,no(M2 and SIP pres)
79.49896,1,female,0,5,83,Colon Cancer,Cancer,2,14.0,under $11k,6147.0,3362.3672,9.0,white,19.0,1,0,0,metastatic,0.299999952,0.0,dnr after sadm,1.0,77.0,6.89941406,80.0,20.0,37.0,333.3,4.0,0.29998779,0.89990234,135.0,7.419922,98.0,8.0,4300.0,2.4311523,adl>=4 (>=5 if sur)
83.00598,1,female,0,28,48,Coma,Coma,1,12.0,under $11k,23863.0,14685.375,6.0,white,21.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,1.0,67.0,26.296875,72.0,23.0,39.09375,123.32812,2.199707,1.01,2.89990234,135.0,7.359375,147.0,63.0,2535.0,3.2202148,<2 mo. follow-up
75.21399,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,6,9.0,under $11k,14546.0,5461.0391,24.0,white,59.0,4,0,1,yes,0.0,0.0,dnr after sadm,1.0,40.0,15.5,110.0,50.0,38.19531,144.0,3.5,5.09960938,0.69995117,139.0,7.509766,113.0,16.0,778.0,5.1630859,<2 mo. follow-up
62.09198,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,102751.0,54442.6875,44.0,white,43.0,16,0,0,no,0.299999952,0.25,no dnr,5.0,107.0,7.89941406,100.0,20.0,35.59375,261.875,3.8999023,1.39990234,3.09960938,132.0,7.5,89.0,45.0,1650.0,1.8996582,<2 mo. follow-up
80.24896,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,28091.0,16275.4766,35.0,white,43.0,3,0,0,no,0.049999982,0.05,no dnr,6.0,127.0,14.1992188,180.0,36.0,38.09375,138.0,2.8999023,1.01,0.59997559,134.0,7.5,173.0,9.0,2540.0,2.2250977,<2 mo. follow-up
86.38995,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,17556.0,7838.75,33.0,white,41.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,123.0,16.8984375,120.0,24.0,38.5,240.0,3.5,1.01,0.69995117,148.0,7.429688,121.0,13.0,810.0,3.9760742,<2 mo. follow-up
91.25299,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,12313.0,7960.0508,35.0,white,49.0,1,1,0,no,0.5,0.25,dnr after sadm,4.0,55.0,9.79882812,120.0,6.0,38.0,218.0,2.199707,1.01,1.89990234,148.0,7.40918,79.0,41.0,632.0,3.5063477,<2 mo. follow-up
70.78198,1,female,0,20,31,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,29158.0,14752.7422,16.666656,white,20.0,1,1,0,no,0.5,0.5,no dnr,20.0,73.0,11.2988281,80.0,20.0,37.79688,333.3,3.5,0.39996338,1.0,138.0,7.419922,130.0,19.0,2502.0,0.0,<2 mo. follow-up
82.034,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,27756.0,7517.25,23.0,black,76.0,4,0,0,no,0.5,0.4,dnr after sadm,2.0,66.0,6.39941406,70.0,40.0,36.09375,80.0,2.699707,0.5,3.39990234,138.0,7.439453,247.0,85.0,860.0,5.0,<2 mo. follow-up
82.55396,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,58079.0,57121.4375,26.666656,white,68.0,9,0,1,no,0.899999619,0.75,dnr after sadm,10.0,107.0,7.69921875,80.0,24.0,38.0,333.3,3.5,1.01,1.0,135.0,7.419922,275.0,16.0,975.0,5.2138672,<2 mo. follow-up
84.01898,1,male,0,3,887,CHF,COPD/CHF/Cirrhosis,4,14.0,$25-$50k,3200.0,1747.9268,22.610928270087555,white,34.0,1,0,0,no,0.899999619,0.8,no dnr,3.0,100.0,11.0996094,100.0,20.0,37.0,333.3,3.5,1.01,0.59997559,136.0,7.419922,172.0,11.0,2502.0,2.7324219,no(M2 and SIP pres)
80.02698,1,female,0,18,792,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,29207.0,11660.3984,24.333328,white,40.0,2,0,0,no,0.599999905,0.6,no dnr,18.0,103.0,33.0,60.0,15.0,37.0,333.3,3.0996094,1.5,0.79992676,152.0,7.539062,176.0,13.0,54.5,0.0,no(M2 and SIP pres)
75.31598,1,female,0,30,68,Coma,Coma,0,12.0,under $11k,34680.0,20164.875,17.5,black,19.0,1,0,0,no,0.25,0.1,dnr after sadm,2.0,57.0,11.5996094,80.0,20.0,37.29688,333.3,3.5,1.19995117,1.19995117,133.0,7.419922,328.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
76.487,1,male,0,12,78,Cirrhosis,COPD/CHF/Cirrhosis,5,15.0,under $11k,17185.0,9153.4531,9.0,white,28.0,1,0,0,yes,0.75,0.6,dnr after sadm,1.0,57.0,2.59960938,114.0,32.0,37.79688,333.3,3.2998047,4.59960938,2.19970703,135.0,7.419922,98.0,31.0,350.0,0.0,SIP>=30
68.97998,1,male,0,3,387,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,4894.0,2226.7188,22.610928270087555,white,34.0,1,0,0,yes,0.799999714,0.75,no dnr,3.0,83.0,14.5,100.0,25.0,36.09375,333.3,2.699707,1.01,0.89990234,135.0,7.419922,157.0,24.0,2502.0,2.0,SIP>=30
67.45795,1,female,0,8,121,Lung Cancer,Cancer,1,14.0,under $11k,8469.0,4488.4531,12.5,white,26.0,1,0,0,metastatic,0.299999952,0.1,no dnr,8.0,99.0,26.8984375,68.0,20.0,37.69531,281.625,3.0,0.5,0.89990234,141.0,7.269531,171.0,20.0,2502.0,0.0,SIP>=30
64.30096,0,female,0,5,1020,Colon Cancer,Cancer,2,16.0,>$50k,5613.0,3166.1211,13.0,white,15.0,1,0,0,metastatic,0.899999619,0.6,no dnr,5.0,49.0,13.5996094,121.0,36.0,37.69531,316.625,3.199707,3.29980469,5.09960938,145.0,7.379883,155.0,8.798828,860.0,0.0,no(M2 and SIP pres)
87.25299,1,female,0,14,1006,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,22466.0,10451.4688,10.0,white,29.0,2,0,0,no,0.75,0.7,no dnr,14.0,60.0,13.6992188,120.0,44.0,38.19531,231.65625,3.5,0.59997559,1.09985352,150.0,7.329102,233.0,23.0,1166.0,0.0,SIP>=30
73.92694,1,male,0,9,93,CHF,COPD/CHF/Cirrhosis,6,16.0,under $11k,14982.0,7797.0742,7.5,white,45.0,1,0,0,no,0.759999752,0.6,dnr before sadm,-1.0,73.0,9.69921875,65.0,8.0,38.59375,122.5,3.5,1.01,1.39990234,143.0,7.179688,265.0,36.0,1005.0,0.0,SIP>=30
81.85095,1,male,0,20,726,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,52814.0,30049.1719,40.666657,white,59.0,1,0,0,no,0.099999964,0.05,no dnr,20.0,47.0,9.59960938,70.0,24.0,37.89844,162.84375,1.8999023,1.01,0.69995117,139.0,7.319336,178.0,19.0,1255.0,0.0,no(M2 and SIP pres)
72.52594,0,female,0,26,1018,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,64956.0,24196.6562,27.0,black,22.0,1,1,0,no,0.019999996,0.0,no dnr,26.0,55.0,9.8984375,112.0,40.0,38.19531,165.28125,4.1992188,0.59997559,1.09985352,136.0,7.30957,282.0,24.0,1930.0,0.0,adl>=4 (>=5 if sur)
72.35895,1,male,0,20,446,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,33427.0,13770.5,18.666656,white,25.0,2,0,0,no,0.799999714,0.8,no dnr,20.0,109.0,10.5996094,82.0,20.0,37.79688,373.3125,2.3999023,0.89990234,1.19995117,141.0,7.399414,101.0,28.0,2350.0,0.0,no(M2 and SIP pres)
83.49896,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,30052.0,14490.6094,15.0,white,72.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,1.0,111.0,7.0,58.0,28.0,33.79688,388.0,2.3999023,4.5,5.5,135.0,7.25,80.0,56.0,48.0,2.0,<2 mo. follow-up
77.35797,0,male,0,8,1015,MOSF w/Malig,ARF/MOSF,2,12.0,>$50k,12651.0,5684.1094,19.0,white,34.0,1,1,0,yes,0.899999619,0.9,no dnr,8.0,57.0,6.09960938,120.0,40.0,37.69531,94.0,3.5,1.01,1.39990234,148.0,7.379883,140.0,66.0,758.0,2.0,no(M2 and SIP pres)
61.81198,0,female,0,20,1015,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,48864.0,32935.75,28.666656,white,41.0,1,1,0,no,0.899999619,0.85,no dnr,20.0,107.0,3.89990234,60.0,20.0,36.69531,447.5625,4.0996094,1.01,5.09960938,138.0,7.379883,79.0,42.0,1850.0,2.0,no(M2 and SIP pres)
85.172,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,20.0,>$50k,12742.0,8474.7344,36.0,white,69.0,1,0,0,yes,0.049999982,0.0,dnr before sadm,-1.0,66.0,17.3984375,120.0,33.0,37.69531,135.0,3.199707,1.01,1.29980469,140.0,7.449219,118.0,43.0,1340.0,2.7807617,<2 mo. follow-up
77.63995,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,19449.0,6839.2773,19.0,black,49.0,3,1,0,no,0.699999809,0.5,dnr after sadm,6.0,100.0,9.0,80.0,30.0,39.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,600.0,3.6835938,<2 mo. follow-up
69.33899,1,male,0,16,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,54183.0,16196.5078,39.666657,white,39.0,4,0,0,no,0.5,0.5,no dnr,16.0,103.0,5.59960938,80.0,20.0,37.79688,423.75,2.199707,1.79980469,1.29980469,145.0,7.469727,109.0,26.0,500.0,1.0,<2 mo. follow-up
35.116,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,3,20.0,under $11k,38566.0,14847.1406,31.0,black,43.0,1,0,0,no,0.799999714,0.8,dnr after sadm,4.0,76.0,6.89941406,72.0,26.0,36.5,304.0,3.699707,1.01,1.09985352,143.0,7.469727,96.0,10.0,1490.0,6.0,<2 mo. follow-up
91.93396,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,95204.0,62915.8125,35.0,white,58.0,17,0,0,no,0.149999976,0.1,dnr after sadm,1.0,65.0,6.29980469,108.0,26.0,37.09375,146.9375,3.5,1.01,1.01,140.0,7.329102,96.0,17.0,1800.0,2.0,<2 mo. follow-up
81.29999,0,female,0,7,1011,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,7211.0,4100.0664,5.0,white,34.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,83.0,2.39990234,60.0,20.0,36.29688,333.3,2.5,1.09985352,0.89990234,141.0,7.419922,89.0,4.0,950.0,3.7529297,SIP>=30
57.61298,1,female,0,4,772,Lung Cancer,Cancer,1,14.0,>$50k,13214.0,6605.2031,16.0,white,5.0,1,0,0,metastatic,0.899999619,0.7,no dnr,4.0,101.0,18.296875,69.0,20.0,36.29688,249.0,3.8999023,1.01,1.5,140.0,7.179688,203.0,47.0,2650.0,0.494751,no(M2 and SIP pres)
83.74799,1,female,0,5,951,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,5225.0,2941.1777,12.0,white,31.0,1,0,0,yes,0.799999714,0.5,no dnr,5.0,67.0,17.0,100.0,25.0,36.39844,264.0,3.3999023,1.09985352,2.59960938,136.0,7.429688,145.0,77.0,2502.0,0.494751,no(M2 and SIP pres)
81.50897,0,male,0,17,1007,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,>$50k,23306.0,12391.3984,12.333328,white,38.0,1,0,1,no,0.75,0.75,no dnr,17.0,37.0,8.3984375,56.0,8.0,38.59375,63.0,3.0996094,1.29980469,2.19970703,136.0,7.339844,109.0,37.0,1530.0,6.0,adl>=4 (>=5 if sur)
74.26697,1,male,0,19,199,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,26839.0,13803.5078,12.0,white,36.0,1,0,0,no,0.799999714,0.8,no dnr,19.0,43.0,6.09960938,105.0,8.0,38.39844,317.5,3.5,0.39996338,0.5,147.0,7.399414,276.0,10.0,2975.0,0.494751,adl>=4 (>=5 if sur)
75.98596,1,male,0,39,122,Lung Cancer,Cancer,2,12.0,under $11k,51147.0,27488.625,10.0,white,20.0,1,0,0,metastatic,0.899999619,0.6,dnr after sadm,26.0,110.0,8.5,60.0,36.0,38.89844,254.0,2.7998047,1.01,0.79992676,134.0,7.419922,120.0,16.0,2400.0,2.6210938,<2 mo. follow-up
87.59497,1,female,1,23,23,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,53912.0,18908.0312,23.333328,white,29.0,1,0,0,no,0.5,0.2,no dnr,23.0,56.0,0.69995117,102.0,30.0,39.19531,251.65625,3.5,1.0,2.39990234,135.0,7.5,93.0,44.0,780.0,7.0,<2 mo. follow-up
80.77197,1,female,0,9,248,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,12938.0,6714.7852,10.5,white,21.0,1,0,0,no,0.899999619,0.7,no dnr,9.0,55.0,4.69921875,55.0,38.0,35.19531,280.0,3.3999023,0.79992676,0.89990234,139.0,7.539062,196.0,10.0,2050.0,0.0,SIP>=30
79.36499,1,female,0,10,39,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15161.0,11720.0547,16.0,white,31.0,1,0,0,no,0.399999857,0.3,dnr after sadm,1.0,63.0,15.2988281,60.0,8.0,37.79688,68.75,3.5,2.0,1.19995117,135.0,7.439453,213.0,47.0,2500.0,2.8666992,<2 mo. follow-up
42.98199,1,male,0,8,50,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,8715.0,4783.1445,10.5,white,43.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,58.0,2.29980469,134.0,40.0,39.09375,484.0,3.5,1.01,3.69970703,136.0,7.439453,80.0,108.0,1935.0,2.0,<2 mo. follow-up
51.64999,0,female,0,14,1004,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,33418.0,11204.1328,22.666656,white,37.0,1,0,0,no,0.899999619,0.9,no dnr,14.0,52.0,10.5996094,70.0,8.0,38.09375,196.0,2.2998047,1.01,1.89990234,145.0,7.429688,315.0,37.0,1610.0,0.0,no(M2 and SIP pres)
78.64496,0,female,0,8,1003,Colon Cancer,Cancer,2,12.0,under $11k,7249.0,4118.5742,2.0,white,11.0,1,1,0,metastatic,0.799999714,0.4,no dnr,8.0,65.0,12.5,150.0,14.0,35.39844,333.3,3.5,0.79992676,1.69995117,144.0,7.419922,145.0,21.0,4345.0,1.0,adl>=4 (>=5 if sur)
55.48297,1,male,0,4,692,Lung Cancer,Cancer,1,12.0,>$50k,15966.0,8098.7812,14.0,white,5.0,1,0,0,metastatic,0.949999809,0.6,no dnr,4.0,142.0,15.0996094,50.0,24.0,36.19531,333.3,2.199707,1.89990234,3.09960938,141.0,7.419922,167.0,46.0,1990.0,1.9882812,no(M2 and SIP pres)
39.784,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,23300.0,8672.8906,52.0,white,77.0,1,0,0,no,0.5,0.5,no dnr,5.0,73.0,22.5976562,110.0,14.0,36.69531,190.0,1.3999023,1.01,4.0,129.0,7.369141,77.0,62.0,1460.0,0.0,<2 mo. follow-up
68.31195,1,female,1,10,10,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,11437.0,6671.9297,16.5,white,51.0,1,0,0,no,0.099999964,0.0,dnr after sadm,2.0,107.0,11.3984375,70.0,20.0,37.79688,171.40625,3.5,1.01,1.69995117,143.0,7.389648,107.0,31.0,2502.0,6.0,<2 mo. follow-up
42.74597,0,male,0,9,998,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,>$50k,11712.0,5439.4219,10.0,white,33.0,1,0,0,yes,0.949999809,0.75,no dnr,9.0,85.0,3.59960938,72.0,16.0,37.39844,333.3,3.5996094,0.89990234,0.89990234,137.0,7.419922,114.0,9.0,3200.0,0.0,no(M2 and SIP pres)
82.70496,1,female,0,7,473,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,7815.0,3563.9981,5.5,white,29.0,1,0,0,no,0.5,0.3,no dnr,7.0,103.0,6.79980469,100.0,25.0,36.69531,229.625,3.5,1.01,1.19995117,137.0,7.379883,92.0,24.0,1575.0,1.1667481,no(M2 and SIP pres)
65.10095,1,female,0,12,518,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,19496.0,11600.2734,17.5,hispanic,14.0,1,0,0,no,0.949999809,0.95,no dnr,12.0,120.0,10.0996094,51.0,26.0,37.89844,242.84375,3.199707,0.29998779,1.59985352,149.0,7.459961,86.0,44.0,2502.0,0.494751,<2 mo. follow-up
77.68097,1,female,0,7,26,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,7278.0,4078.0527,6.5,white,35.0,1,0,0,no,0.799999714,0.6,dnr before sadm,-1.0,67.0,10.5,80.0,20.0,36.09375,256.0,3.2998047,1.01,1.59985352,140.0,7.459961,95.0,23.0,5000.0,2.0,<2 mo. follow-up
47.12097,1,male,0,8,212,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,18732.0,7620.1289,24.5,white,44.0,1,0,0,no,0.769999981,0.8,no dnr,8.0,107.0,7.29980469,100.0,25.0,38.89844,333.3,4.3994141,0.89990234,0.79992676,136.0,7.419922,197.0,13.0,1950.0,2.0,SIP>=30
50.60098,0,male,0,4,996,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5799.0,3000.6602,15.0,white,8.0,1,0,0,no,0.899999619,0.85,no dnr,4.0,65.0,9.3984375,72.0,8.0,36.59375,197.5,2.7998047,0.39996338,1.0,137.0,7.369141,132.0,49.0,1020.0,2.1162109,<2 mo. follow-up
89.70795,1,female,1,4,4,Coma,Coma,3,12.0,under $11k,4730.0,2593.6152,11.0,white,41.0,1,1,1,yes,0.699999809,0.5,dnr before sadm,-1.0,93.0,10.1992188,80.0,20.0,36.09375,285.6875,3.5,1.01,1.29980469,143.0,7.40918,109.0,31.0,575.0,5.0732422,<2 mo. follow-up
44.58899,1,male,0,13,67,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$11-$25k,43026.0,29745.9531,36.5,white,41.0,1,0,0,no,0.849999905,0.8,no dnr,13.0,102.0,5.29980469,73.0,30.0,37.59375,176.65625,3.5,0.29998779,1.0,134.0,7.369141,508.0,26.0,1760.0,0.0,no(M2 and SIP pres)
23.33499,1,female,1,22,22,MOSF w/Malig,ARF/MOSF,3,13.0,under $11k,118566.0,40615.4688,44.333313,white,59.0,1,0,0,yes,0.899999619,0.6,dnr after sadm,21.0,47.0,6.59960938,120.0,35.0,36.69531,333.3,3.5,1.01,1.29980469,138.0,7.419922,99.0,21.0,2502.0,0.0,<2 mo. follow-up
57.629,0,female,0,17,994,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,36754.0,14798.7344,30.666656,white,40.0,1,0,0,no,0.5,0.35,no dnr,17.0,58.0,21.1992188,99.0,24.0,37.0,132.5,3.5,0.5,0.79992676,137.0,7.329102,230.0,10.0,1990.0,0.0,no(M2 and SIP pres)
83.75397,1,female,0,11,128,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,21739.0,7108.4688,28.5,white,33.0,1,1,1,no,0.799999714,0.5,no dnr,11.0,113.0,9.0,68.0,20.0,36.19531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,1100.0,6.5097656,<2 mo. follow-up
44.64297,1,male,0,14,39,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,39916.0,29562.3125,27.333328,black,45.0,1,0,0,no,0.5,0.5,no dnr,14.0,97.0,6.09960938,64.0,16.0,36.69531,333.3,3.5,0.89990234,1.29980469,141.0,7.419922,189.0,16.0,2502.0,4.0,<2 mo. follow-up
89.23999,1,female,0,6,666,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,5975.0,3379.2207,6.0,white,35.0,1,0,0,yes,0.949999809,0.9,dnr before sadm,-1.0,55.0,25.796875,139.0,26.0,39.29688,67.0,1.8999023,0.79992676,0.89990234,144.0,7.319336,72.0,42.0,1193.0,0.0,SIP>=30
40.73599,0,male,0,11,991,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,20281.0,9646.7969,13.0,white,50.0,2,0,0,no,0.5,0.3,no dnr,11.0,43.0,80.0,50.0,20.0,37.79688,333.3,3.0,0.59997559,2.5,139.0,7.419922,100.0,115.0,625.0,2.8046875,<2 mo. follow-up
89.5,0,female,0,7,990,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,14752.0,8761.9141,13.0,white,33.0,1,0,0,no,0.799999714,0.7,no dnr,7.0,71.0,5.29980469,110.0,21.0,37.5,333.3,3.3999023,3.79980469,1.0,138.0,7.419922,92.0,20.0,1850.0,2.0,no(M2 and SIP pres)
83.98395,0,female,0,7,989,ARF/MOSF w/Sepsis,ARF/MOSF,5,8.0,under $11k,13372.0,8229.1406,13.0,white,36.0,1,0,1,no,0.25,0.2,dnr after sadm,2.0,59.0,10.3984375,68.0,26.0,36.39844,320.0,3.699707,0.79992676,1.09985352,134.0,7.30957,103.0,19.0,2030.0,6.015625,no(M2 and SIP pres)
77.92694,1,female,0,17,684,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,25184.0,17107.1406,15.666664,white,47.0,1,0,0,no,0.75,0.75,no dnr,17.0,122.0,6.69921875,76.0,16.0,36.89844,151.65625,4.0996094,1.01,1.09985352,140.0,7.459961,96.0,18.0,3570.0,0.0,no(M2 and SIP pres)
64.28198,0,female,0,12,986,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,18119.0,9395.9844,12.5,white,45.0,1,1,0,no,0.899999619,0.9,no dnr,12.0,109.0,13.0,100.0,34.0,37.69531,251.84375,3.7998047,1.01,1.09985352,137.0,7.329102,250.0,34.0,1100.0,1.0,SIP>=30
61.823,1,female,0,42,315,Coma,Coma,0,18.0,>$50k,73012.0,27574.4219,31.25,hispanic,42.0,1,0,0,no,0.299999952,0.3,no dnr,42.0,52.0,1.09985352,64.0,30.0,36.29688,333.3,2.5,7.89941406,0.59997559,139.0,7.419922,110.0,15.0,1040.0,0.0,Coma or Intub
28.25999,0,female,0,10,984,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,30418.0,13484.6328,20.5,white,25.0,6,0,0,no,0.899999619,0.9,no dnr,10.0,83.0,5.69921875,60.0,20.0,35.59375,239.125,4.0,0.5,0.89990234,138.0,7.369141,171.0,11.0,2502.0,0.0,no(M2 and SIP pres)
83.11798,1,female,0,18,97,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,24810.0,11643.9219,18.333328,white,62.0,1,1,0,no,0.5,0.4,no dnr,18.0,77.0,26.0976562,60.0,32.0,36.09375,361.875,3.2998047,1.29980469,2.39990234,145.0,7.489258,330.0,37.0,2502.0,0.0,SIP>=30
59.41998,1,female,0,9,785,Colon Cancer,Cancer,1,19.0,under $11k,14652.0,7374.5117,4.0,white,26.0,1,0,0,metastatic,1.0,0.8,no dnr,9.0,57.0,13.1992188,120.0,12.0,39.19531,266.0,4.6992188,0.39996338,0.79992676,138.0,7.399414,129.0,8.0,1180.0,0.0,no(M2 and SIP pres)
67.06396,0,female,0,14,982,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,36505.0,24395.2812,24.0,white,42.0,1,0,0,no,0.849999905,0.8,no dnr,14.0,126.0,8.19921875,134.0,25.0,38.09375,152.0,3.3999023,2.0,3.39990234,130.0,7.389648,167.0,58.0,1971.0,1.0,no(M2 and SIP pres)
78.94598,1,male,0,20,552,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,67914.0,41837.125,31.666656,white,50.0,3,1,0,no,0.699999809,0.343,no dnr,20.0,48.0,15.2988281,106.0,8.0,36.19531,113.75,2.5,6.29980469,1.39990234,149.0,7.469727,165.0,18.0,2235.0,2.6767578,<2 mo. follow-up
43.42499,0,male,0,6,980,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,6695.0,3467.9668,14.0,black,10.0,1,0,0,no,0.949999809,0.9,no dnr,6.0,51.0,14.7988281,68.0,8.0,38.59375,262.5,2.699707,0.29998779,0.89990234,140.0,7.40918,321.0,26.0,1080.0,2.5107422,SIP>=30
46.80099,1,male,0,18,55,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,under $11k,26374.0,14535.5391,12.0,white,56.0,1,0,0,no,0.5,0.3,dnr after sadm,15.0,66.0,7.89941406,108.0,26.0,35.89844,286.625,2.3999023,1.01,1.79980469,126.0,7.5,184.0,45.0,2500.0,2.5107422,<2 mo. follow-up
71.31799,1,male,0,9,135,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,12882.0,6878.3906,6.0,white,33.0,1,1,0,no,0.5,0.5,dnr before sadm,0.0,93.0,5.59960938,60.0,15.0,36.09375,318.3125,4.3994141,1.01,2.0,139.0,7.359375,108.0,34.0,370.0,0.0,no(M2 and SIP pres)
62.29398,1,female,0,20,78,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,34399.0,15657.6719,14.333328,white,19.0,1,0,0,no,0.879999638,0.77,dnr before sadm,-1.0,67.0,16.796875,80.0,20.0,38.39844,333.3,2.0,15.5996094,1.5,142.0,7.419922,65.0,33.0,1370.0,3.7045898,<2 mo. follow-up
41.008,0,male,0,7,974,Cirrhosis,COPD/CHF/Cirrhosis,4,15.0,under $11k,16407.0,7312.7578,8.0,white,34.0,1,0,0,no,0.899999619,0.7,no dnr,7.0,110.0,5.89941406,60.0,16.0,36.19531,297.125,4.6992188,0.59997559,2.29980469,144.0,7.419922,107.0,45.0,1795.0,0.494751,no(M2 and SIP pres)
53.03198,0,male,0,10,973,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,$25-$50k,19707.0,7497.7969,23.5,white,40.0,2,0,0,no,0.949999809,0.95,no dnr,10.0,62.0,7.19921875,42.0,16.0,36.09375,319.0,3.5,1.01,1.5,139.0,7.379883,125.0,35.0,1170.0,0.0,no(M2 and SIP pres)
95.60596,0,female,0,8,972,ARF/MOSF w/Sepsis,ARF/MOSF,1,4.0,under $11k,10736.0,4586.8047,10.5,white,19.0,1,0,0,yes,0.5,0.4,dnr before sadm,-1.0,74.0,10.3984375,62.0,10.0,38.09375,373.3125,2.7998047,0.5,5.69921875,132.0,7.229492,104.0,78.0,1510.0,1.0,no(M2 and SIP pres)
62.88599,1,female,0,4,332,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,12771.0,4837.4727,14.0,white,30.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,127.0,10.2988281,120.0,35.0,40.0,204.75,3.3999023,0.59997559,1.09985352,139.0,7.429688,151.0,12.0,2300.0,4.0,no(M2 and SIP pres)
62.12698,0,female,0,23,971,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,52812.0,38622.9062,33.666657,hispanic,23.0,2,1,0,no,0.799999714,0.6,no dnr,23.0,153.0,14.5996094,125.0,36.0,39.59375,438.0625,2.8999023,1.01,1.19995117,134.0,7.5,220.0,16.0,1055.0,0.0,adl>=4 (>=5 if sur)
50.82498,1,female,0,7,49,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,23926.0,13897.9531,6.5,black,29.0,7,0,0,yes,0.649999619,0.35,dnr before sadm,0.0,111.0,14.0,110.0,44.0,37.89844,136.65625,3.5,1.01,0.59997559,141.0,7.399414,93.0,18.0,3400.0,6.0,<2 mo. follow-up
77.26495,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,28082.0,10635.9766,38.5,white,63.0,1,0,0,no,0.299999952,0.3,dnr after sadm,5.0,55.0,12.3984375,114.0,30.0,38.69531,136.71875,3.7998047,0.69995117,2.69970703,136.0,7.459961,262.0,61.0,1156.0,4.0,<2 mo. follow-up
44.92297,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,23066.0,7157.0508,39.0,white,48.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,7.0,103.0,16.296875,120.0,25.0,38.89844,333.3,3.5,1.01,0.79992676,135.0,7.419922,154.0,11.0,1795.0,2.4384766,<2 mo. follow-up
49.85397,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,24.0,>$50k,39151.0,16444.9531,39.5,white,46.0,6,0,0,metastatic,0.25,0.15,dnr after sadm,5.0,57.0,11.7988281,120.0,26.0,39.19531,128.0,2.7998047,0.59997559,0.79992676,133.0,7.419922,128.0,9.0,2279.0,0.0,<2 mo. follow-up
88.81598,0,female,0,4,965,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,8938.0,4971.3711,13.0,white,19.0,1,1,1,no,0.799999714,0.5,no dnr,4.0,43.0,17.296875,130.0,14.0,38.69531,140.0,3.5,1.01,1.79980469,136.0,7.30957,189.0,27.0,1300.0,6.2636719,adl>=4 (>=5 if sur)
90.76794,1,female,0,15,742,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,27955.0,10796.5703,21.333328,white,41.0,1,0,0,no,0.5,0.4,dnr after sadm,3.0,80.0,6.39941406,80.0,20.0,35.59375,347.5625,2.2998047,0.79992676,1.19995117,139.0,7.369141,113.0,14.0,3400.0,2.0,adl>=4 (>=5 if sur)
94.07495,1,female,0,10,726,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,13122.0,7737.0781,18.0,white,25.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,50.0,13.5996094,110.0,20.0,36.09375,333.3,2.199707,11.2988281,0.69995117,130.0,7.419922,157.0,13.0,850.0,1.0,<2 mo. follow-up
61.91397,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,69577.0,26139.0625,37.0,white,61.0,9,0,0,no,0.299999952,0.3,dnr after sadm,18.0,73.0,2.79980469,80.0,20.0,36.09375,333.3,2.0,3.5,0.69995117,131.0,7.419922,294.0,13.0,2502.0,7.0,<2 mo. follow-up
68.60797,0,female,0,19,961,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,>$50k,85343.0,46375.0312,23.0,white,53.0,8,0,0,no,0.799999714,0.8,no dnr,19.0,100.0,12.3984375,108.0,32.0,36.59375,225.6875,3.5,1.01,0.69995117,141.0,7.379883,202.0,10.0,2280.0,0.0,<2 mo. follow-up
62.327,1,male,1,4,4,Lung Cancer,Cancer,2,12.0,under $11k,4703.0,2592.9492,9.0,white,37.0,1,1,0,metastatic,0.049999982,0.01,dnr before sadm,-1.0,57.0,8.19921875,74.0,24.0,37.79688,333.3,3.5,1.01,1.29980469,130.0,7.419922,169.0,39.0,900.0,2.7363281,<2 mo. follow-up
77.86694,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,7696.0,3119.4824,33.0,white,80.0,1,1,0,yes,0.099999964,0.07,dnr after sadm,2.0,60.0,8.79882812,52.0,50.0,38.79688,171.0,2.5996094,0.69995117,0.89990234,141.0,7.369141,96.0,14.0,3450.0,3.5195312,<2 mo. follow-up
32.84598,0,female,0,30,956,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,79142.0,31164.3906,27.75,hispanic,29.0,3,0,0,no,0.899999619,0.9,no dnr,30.0,100.0,12.8984375,70.0,20.0,35.89844,357.125,3.7998047,1.09985352,0.69995117,125.0,7.509766,237.0,14.0,2502.0,0.0,no(M2 and SIP pres)
70.70795,0,male,0,35,956,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,165432.0,96053.8125,25.25,white,15.0,28,0,0,yes,0.699999809,0.5,no dnr,35.0,105.0,10.7988281,180.0,20.0,37.89844,640.0,3.0996094,1.39990234,0.79992676,143.0,7.269531,102.0,6.0,2750.0,0.0,SIP>=30
58.81198,1,female,0,6,152,Lung Cancer,Cancer,2,18.0,under $11k,6654.0,3721.7891,11.0,white,6.0,1,0,0,metastatic,0.949999809,0.75,no dnr,6.0,117.0,11.5,80.0,9.0,39.29688,185.0,3.5,1.01,1.29980469,144.0,7.489258,110.0,15.0,1273.0,0.0,no(M2 and SIP pres)
74.11096,0,female,0,48,954,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,99474.0,24398.5625,26.5,white,48.0,2,0,0,no,0.899999619,0.7,no dnr,48.0,83.0,3.0,100.0,20.0,36.69531,333.3,3.5,1.01,3.5,142.0,7.419922,70.0,66.0,1100.0,7.0,adl>=4 (>=5 if sur)
65.89197,1,female,0,5,39,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,13944.0,4423.6641,33.0,white,26.0,2,1,0,yes,0.699999809,0.5,no dnr,5.0,109.0,24.1992188,113.0,24.0,36.39844,356.0,1.5998535,26.796875,3.89990234,150.0,7.419922,153.0,147.0,1600.0,2.152832,<2 mo. follow-up
83.40295,1,male,0,18,140,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,44009.0,24023.8906,24.0,white,34.0,1,0,0,no,0.899999619,0.75,no dnr,18.0,54.0,9.5,145.0,12.0,38.79688,161.65625,2.5996094,0.29998779,0.69995117,153.0,7.349609,144.0,26.0,3155.0,3.1352539,<2 mo. follow-up
72.099,1,female,0,3,98,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,6312.0,1674.8115,22.610928270087555,white,36.0,2,0,0,yes,0.699999809,0.5,no dnr,3.0,54.0,4.69921875,76.0,28.0,38.19531,107.5,2.5996094,1.0,0.69995117,141.0,7.439453,221.0,26.0,4745.0,1.8388672,adl>=4 (>=5 if sur)
72.81,1,female,0,6,858,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$11-$25k,9466.0,4703.8672,18.0,white,51.0,1,1,0,yes,0.849999905,0.65,no dnr,6.0,110.0,7.69921875,70.0,20.0,35.89844,114.0,3.5996094,1.01,1.19995117,146.0,7.259766,90.0,23.0,2631.0,2.3208008,no(M2 and SIP pres)
68.99896,1,female,0,8,32,Lung Cancer,Cancer,3,16.0,>$50k,11272.0,6130.332,9.5,white,23.0,1,0,0,metastatic,0.5,0.2,no dnr,8.0,137.0,7.0,56.0,50.0,37.89844,293.3125,3.5,1.01,0.79992676,141.0,7.399414,166.0,20.0,1610.0,2.0,<2 mo. follow-up
89.46997,1,male,0,14,611,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,>$50k,43497.0,23069.7344,10.0,white,32.0,5,0,0,no,0.699999809,0.7,dnr after sadm,1.0,97.0,10.3984375,60.0,20.0,36.09375,131.65625,3.5,1.01,1.59985352,143.0,7.30957,94.0,40.0,1600.0,1.0,no(M2 and SIP pres)
45.741,1,male,0,23,121,Coma,Coma,3,8.0,under $11k,35265.0,16548.5625,22.333328,white,50.0,1,1,1,no,0.5,0.5,no dnr,23.0,139.0,10.5996094,104.0,60.0,38.29688,297.5,2.0,0.29998779,7.29980469,140.0,7.359375,121.0,69.0,1150.0,7.0,adl>=4 (>=5 if sur)
62.11899,0,male,0,9,947,COPD,COPD/CHF/Cirrhosis,3,17.0,$25-$50k,12604.0,6835.1055,11.0,white,17.0,1,0,0,yes,0.949999809,0.95,no dnr,9.0,55.0,12.3984375,72.0,24.0,36.69531,240.0,3.3999023,1.01,2.19970703,145.0,7.529297,105.0,43.0,3990.0,1.0,no(M2 and SIP pres)
86.75995,1,female,0,102,238,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,108592.0,62537.4062,12.25,white,44.0,1,0,1,no,0.599999905,0.6,dnr after sadm,12.0,73.0,4.39941406,130.0,30.0,36.09375,333.3,2.0,1.01,1.09985352,145.0,7.419922,281.0,25.0,2502.0,2.0,<2 mo. follow-up
82.12994,1,female,0,17,52,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,44671.0,14975.4922,19.0,white,55.0,14,0,0,no,0.75,0.66,dnr after sadm,6.0,39.0,13.5996094,125.0,34.0,38.39844,148.96875,3.0996094,1.39990234,2.59960938,136.0,7.359375,110.0,94.0,107.0,1.0,<2 mo. follow-up
64.01398,0,female,0,10,944,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,12940.0,7034.8008,12.5,black,30.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,121.0,10.8984375,106.0,12.0,38.29688,157.0,3.5,0.29998779,0.79992676,143.0,7.399414,145.0,12.0,1625.0,1.0,no(M2 and SIP pres)
41.66498,0,male,0,23,943,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,71676.0,39046.6875,33.0,black,47.0,7,1,0,no,0.799999714,0.8,no dnr,23.0,107.0,6.59960938,110.0,10.0,39.19531,190.0,3.5,1.01,1.19995117,149.0,7.439453,136.0,18.0,4890.0,0.0,no(M2 and SIP pres)
73.599,1,male,1,52,52,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,179085.0,108960.0,31.5,white,34.0,20,0,0,metastatic,0.949999809,0.7,dnr after sadm,39.0,81.0,6.79980469,76.0,20.0,37.39844,333.3,3.5,1.01,0.59997559,137.0,7.419922,115.0,10.0,4202.0,0.0,<2 mo. follow-up
76.08795,1,male,0,22,34,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,45370.0,20808.0156,27.333328,black,35.0,1,0,0,no,0.849999905,0.6,dnr after sadm,7.0,47.0,5.79980469,60.0,42.0,36.09375,80.0,2.8999023,0.39996338,0.29998779,141.0,7.399414,102.0,3.0,3195.0,0.0,<2 mo. follow-up
84.13995,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,51665.0,23915.7656,65.0,white,68.0,3,0,0,no,0.25,0.25,no dnr,6.0,70.0,2.5,108.0,15.0,36.69531,333.3,2.0,0.89990234,0.39996338,137.0,7.419922,155.0,11.0,3000.0,0.0,<2 mo. follow-up
41.314,1,female,0,10,397,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,10240.0,5688.7188,9.5,white,23.0,1,0,0,no,0.949999809,0.8,no dnr,10.0,77.0,5.69921875,60.0,20.0,36.09375,333.3,3.8999023,0.59997559,2.79980469,139.0,7.419922,115.0,70.0,1200.0,1.8388672,<2 mo. follow-up
68.81598,1,male,1,16,16,CHF,COPD/CHF/Cirrhosis,5,16.0,$25-$50k,22629.0,12613.125,16.333328,white,39.0,1,1,0,no,0.899999619,0.7,dnr after sadm,14.0,72.0,18.3984375,68.0,16.0,35.89844,333.3,1.6999512,1.01,0.69995117,137.0,7.419922,68.0,15.0,310.0,3.0,<2 mo. follow-up
53.46997,0,female,0,12,941,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,23618.0,10149.8594,19.0,white,41.0,1,1,0,no,0.349999905,0.27,no dnr,12.0,77.0,5.69921875,60.0,20.0,35.59375,548.0,3.3999023,0.29998779,2.89990234,136.0,7.299805,54.0,63.0,780.0,0.0,SIP>=30
57.35498,1,male,0,16,44,Lung Cancer,Cancer,2,10.0,under $11k,27340.0,14559.7422,15.666664,white,23.0,1,0,0,metastatic,0.899999619,0.5,dnr after sadm,1.0,77.0,8.19921875,70.0,25.0,36.09375,333.3,3.5,0.39996338,0.69995117,132.0,7.419922,94.0,10.0,1550.0,1.0,<2 mo. follow-up
79.15094,1,female,0,36,102,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,53562.0,14452.7344,19.25,white,30.0,2,1,1,yes,0.299999952,0.3,dnr after sadm,5.0,123.0,12.5,67.0,25.0,36.09375,170.0,3.5,1.01,1.89990234,138.0,7.449219,92.0,27.0,2170.0,5.0,adl>=4 (>=5 if sur)
77.133,0,female,0,6,939,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,7707.0,3549.8262,14.0,white,14.0,1,0,0,no,0.899999619,0.85,no dnr,6.0,103.0,10.5,44.0,6.0,37.89844,214.0,3.5,0.5,2.69970703,145.0,7.399414,440.0,81.0,615.0,0.0,no(M2 and SIP pres)
63.72299,1,male,0,9,52,Cirrhosis,COPD/CHF/Cirrhosis,2,9.0,under $11k,12741.0,6802.207,17.5,white,55.0,1,0,0,no,0.599999905,0.4,dnr after sadm,4.0,107.0,12.0,80.0,25.0,35.59375,333.3,3.5,1.01,1.09985352,136.0,7.419922,181.0,18.0,5800.0,0.0,<2 mo. follow-up
72.30896,0,male,0,7,939,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$11-$25k,32851.0,14498.5859,13.0,white,31.0,4,0,0,yes,0.75,0.5,no dnr,7.0,77.0,11.1992188,80.0,20.0,36.09375,476.1875,2.5,0.59997559,4.19921875,147.0,7.40918,77.0,107.0,400.0,0.0,no(M2 and SIP pres)
56.20798,0,female,0,19,939,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,58257.0,36612.6875,19.333328,white,31.0,5,0,0,yes,0.599999905,0.5,no dnr,19.0,49.0,18.796875,120.0,44.0,36.39844,173.46875,3.5996094,1.01,1.89990234,135.0,7.429688,92.0,46.0,1520.0,2.831543,<2 mo. follow-up
90.448,1,female,0,11,872,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,23279.0,14248.1094,23.0,white,23.0,1,0,0,no,0.799999714,0.6,no dnr,11.0,77.0,12.3984375,120.0,25.0,38.59375,368.0,3.5,0.69995117,1.0,136.0,7.419922,103.0,11.0,850.0,1.0,no(M2 and SIP pres)
68.08795,0,male,0,14,938,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,24806.0,12282.0547,14.666664,white,16.0,1,1,0,no,0.949999809,0.8,no dnr,14.0,55.0,12.0,98.0,10.0,36.09375,78.75,2.8999023,1.29980469,7.69921875,135.0,7.349609,163.0,50.0,3800.0,2.7832031,<2 mo. follow-up
79.51495,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,$11-$25k,38930.0,17790.625,44.0,white,39.0,13,0,0,yes,0.099999964,0.05,dnr after sadm,4.0,77.0,5.59960938,70.0,35.0,38.0,204.0,3.5,1.01,0.69995117,131.0,7.399414,168.0,19.0,948.0,3.2685547,<2 mo. follow-up
42.62299,0,female,0,6,937,Lung Cancer,Cancer,1,13.0,under $11k,7367.0,4045.7656,11.0,white,11.0,1,0,0,metastatic,0.989999771,0.8,no dnr,6.0,57.0,19.796875,70.0,20.0,36.09375,433.3125,2.199707,0.5,1.39990234,142.0,7.479492,93.0,41.0,2502.0,3.0,<2 mo. follow-up
83.99695,0,male,0,6,937,CHF,COPD/CHF/Cirrhosis,5,7.0,under $11k,7790.0,4020.8164,14.0,white,29.0,1,1,0,yes,0.699999809,0.5,no dnr,6.0,47.0,21.0,134.0,10.0,34.79688,62.0,2.0,0.19998169,2.29980469,136.0,7.399414,165.0,34.0,2948.0,0.0,no(M2 and SIP pres)
33.89697,0,male,0,24,936,Coma,Coma,1,12.0,under $11k,46364.0,30283.7969,30.666656,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,24.0,47.0,8.59960938,100.0,20.0,36.09375,333.3,4.0,1.59985352,0.79992676,135.0,7.439453,107.0,15.0,1100.0,1.9265137,<2 mo. follow-up
71.51495,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,18491.0,8120.4453,14.5,white,77.0,3,0,0,no,0.75,0.3,dnr after sadm,1.0,77.0,9.29882812,80.0,25.0,36.69531,333.3,2.7998047,3.69970703,1.19995117,127.0,7.419922,197.0,28.0,800.0,2.0,<2 mo. follow-up
82.87994,1,male,0,8,225,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,8872.0,4778.4258,14.5,white,39.0,1,0,0,no,0.899999619,0.6,dnr after sadm,1.0,103.0,6.19921875,49.0,24.0,38.39844,152.5,3.0996094,9.19921875,0.5,149.0,7.399414,331.0,15.0,1260.0,3.8188477,no(M2 and SIP pres)
31.806,0,female,0,13,929,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,21303.0,8634.6562,16.0,black,39.0,1,0,0,no,0.949999809,0.95,no dnr,13.0,71.0,11.5,84.0,16.0,38.39844,333.3,2.3999023,0.29998779,0.69995117,131.0,7.419922,134.0,9.0,1800.0,0.0,<2 mo. follow-up
83.995,0,male,0,5,929,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4725.0,2720.9766,7.0,white,33.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,60.0,23.0,60.0,30.0,38.19531,178.3125,2.0996094,1.01,1.0,129.0,7.449219,276.0,17.0,2495.0,1.0,no(M2 and SIP pres)
43.64398,1,male,1,15,15,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,61249.0,20110.8438,40.333313,white,30.0,3,0,0,no,0.299999952,0.3,dnr after sadm,14.0,100.0,6.79980469,80.0,20.0,37.19531,478.3125,3.2998047,0.19998169,1.09985352,137.0,7.419922,189.0,19.0,1150.0,0.0,<2 mo. follow-up
54.103,0,male,0,66,928,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,149841.0,64629.4375,23.0,white,40.0,11,0,0,no,0.299999952,0.3,no dnr,66.0,63.0,13.5,70.0,20.0,36.59375,333.3,1.7998047,6.5,2.79980469,137.0,7.419922,132.0,82.0,980.0,1.0,SIP>=30
60.40799,1,male,0,3,342,CHF,COPD/CHF/Cirrhosis,6,11.0,$25-$50k,3982.0,2106.6113,22.610928270087555,white,22.0,1,0,0,no,0.899999619,0.75,no dnr,3.0,62.0,9.79882812,55.0,28.0,36.39844,121.65625,2.8999023,1.01,1.19995117,137.0,7.469727,123.0,25.0,1905.0,0.494751,no(M2 and SIP pres)
83.56195,0,female,0,8,926,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,37685.0,18763.4062,12.5,white,22.0,4,0,0,yes,0.799999714,0.7,no dnr,8.0,63.0,10.2988281,97.0,28.0,38.29688,136.71875,3.5,1.01,0.39996338,136.0,7.469727,88.0,12.0,920.0,2.0,no(M2 and SIP pres)
82.35999,0,male,0,10,925,ARF/MOSF w/Sepsis,ARF/MOSF,1,24.0,>$50k,56254.0,30071.8281,22.5,white,25.0,13,0,0,no,0.899999619,0.7,no dnr,10.0,110.0,14.7988281,67.0,24.0,36.09375,173.3125,4.0996094,0.59997559,1.89990234,135.0,7.369141,88.0,35.0,2380.0,0.0,no(M2 and SIP pres)
61.90598,1,male,0,26,28,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$11-$25k,43792.0,18118.8438,14.75,white,57.0,1,0,0,no,0.899999619,0.7,no dnr,26.0,81.0,7.09960938,116.0,24.0,38.0,144.875,3.5,1.01,0.79992676,134.0,7.479492,185.0,7.0,1850.0,1.0,<2 mo. follow-up
54.784,0,female,0,4,922,Lung Cancer,Cancer,1,12.0,$11-$25k,15991.0,7817.5508,13.0,white,16.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,113.0,15.5,126.0,38.0,36.29688,230.0,2.0,1.01,0.59997559,142.0,7.429688,231.0,7.0,1421.0,0.0,no(M2 and SIP pres)
74.85297,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,44102.0,15078.0781,10.0,white,84.0,7,0,0,no,0.0,0.0,dnr after sadm,2.0,77.0,8.09960938,76.0,18.0,36.79688,333.3,3.3999023,0.39996338,1.0,142.0,7.419922,100.0,7.0,3250.0,4.2832031,<2 mo. follow-up
73.18799,1,female,0,28,753,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,45490.0,24600.6406,8.75,white,52.0,1,1,0,no,0.799999714,0.8,no dnr,28.0,77.0,7.09960938,50.0,25.0,36.09375,261.875,3.5,0.89990234,1.59985352,145.0,7.439453,114.0,25.0,2502.0,5.0,SIP>=30
54.16599,0,female,0,75,919,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,193965.0,73248.25,38.5,white,43.0,1,0,0,no,0.5,0.5,no dnr,75.0,77.0,14.0996094,108.0,22.0,38.69531,212.5,2.8999023,1.89990234,0.89990234,142.0,7.419922,100.0,27.0,1875.0,0.0,adl>=4 (>=5 if sur)
81.97095,0,male,0,41,919,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,under $11k,141760.0,122821.688,24.75,white,51.0,17,0,0,no,0.799999714,0.8,no dnr,41.0,131.0,18.0,66.0,4.0,38.39844,379.0,3.0996094,1.09985352,11.2988281,137.0,7.229492,135.0,72.0,375.0,2.3037109,no(M2 and SIP pres)
95.05298,1,male,0,12,873,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,20485.0,7978.0625,20.0,white,41.0,3,0,0,no,0.049999982,0.05,no dnr,12.0,67.0,6.09960938,80.0,25.0,36.09375,188.0,3.5,1.01,1.29980469,142.0,7.349609,103.0,24.0,2250.0,0.0,no(M2 and SIP pres)
89.84796,0,male,0,42,918,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,50121.0,27595.3594,6.0,white,24.0,6,1,1,no,0.199999928,0.1,dnr before sadm,0.0,59.0,22.0976562,132.0,34.0,37.59375,142.84375,4.1992188,0.39996338,0.89990234,137.0,7.399414,153.0,10.0,1450.0,5.8251953,<2 mo. follow-up
20.821,0,male,0,19,917,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,92095.0,73341.125,26.333328,white,38.0,3,0,0,no,0.799999714,0.8,no dnr,19.0,73.0,4.89941406,70.0,25.0,36.09375,390.4375,3.5,1.01,1.5,141.0,7.5,103.0,35.0,800.0,6.0,adl>=4 (>=5 if sur)
76.91699,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,5.0,$11-$25k,10552.0,4853.0273,7.5,black,60.0,1,1,1,no,0.099999964,0.0,dnr after sadm,2.0,113.0,6.29980469,43.0,12.0,36.19531,105.0,3.5,3.29980469,0.69995117,144.0,7.5,145.0,14.0,3660.0,6.0,<2 mo. follow-up
85.336,1,male,0,11,110,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,12972.0,7308.043,18.5,white,22.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,73.0,15.5996094,135.0,28.0,40.19531,230.0,2.0996094,0.39996338,0.5,158.0,7.379883,148.0,3.299805,1870.0,3.0,adl>=4 (>=5 if sur)
87.75397,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,53522.0,34284.5938,49.0,white,63.0,7,0,0,yes,0.099999964,0.05,dnr after sadm,1.0,76.0,20.796875,70.0,28.0,36.09375,333.3,3.0,1.01,1.09985352,141.0,7.419922,116.0,21.0,2502.0,0.0,<2 mo. follow-up
70.28894,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,24749.0,13033.4609,59.0,white,91.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,122.0,13.5996094,71.0,24.0,38.19531,144.875,3.5,1.01,0.69995117,141.0,7.509766,116.0,32.0,3066.0,2.7548828,<2 mo. follow-up
60.40198,0,female,0,5,912,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,5828.0,3155.9629,12.0,black,18.0,1,0,0,no,0.989999771,0.99,no dnr,5.0,50.0,12.1992188,61.0,28.0,38.09375,143.3125,2.5996094,1.89990234,1.0,138.0,7.439453,112.0,9.0,5625.0,0.494751,no(M2 and SIP pres)
74.11597,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,55886.0,33183.25,39.0,white,31.0,3,0,0,yes,0.199999928,0.1,dnr after sadm,10.0,62.0,8.69921875,64.0,12.0,37.79688,376.1875,1.7998047,11.6992188,1.59985352,138.0,7.399414,98.0,37.0,2502.0,3.237793,<2 mo. follow-up
87.633,1,male,0,34,181,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,56611.0,29262.4375,13.25,white,20.0,1,0,0,metastatic,0.899999619,0.75,no dnr,34.0,83.0,3.5,80.0,30.0,37.0,333.3,4.5996094,0.39996338,0.89990234,138.0,7.419922,91.0,9.0,4900.0,2.0,SIP>=30
83.08295,1,female,1,4,4,Coma,Coma,2,12.0,under $11k,5078.0,1799.9971,8.0,white,22.0,1,0,0,yes,0.0,0.0,dnr after sadm,1.0,34.0,18.3984375,41.0,8.0,35.39844,238.0,3.5,1.01,2.39990234,137.0,7.399414,292.0,27.0,340.0,1.0,<2 mo. follow-up
78.63898,1,female,0,14,140,Lung Cancer,Cancer,2,12.0,under $11k,23239.0,11915.2344,10.0,white,25.0,1,0,0,metastatic,0.799999714,0.4,dnr after sadm,1.0,70.0,5.39941406,80.0,25.0,36.09375,233.3125,3.699707,0.59997559,6.69921875,139.0,7.319336,201.0,83.0,3105.0,0.0,no(M2 and SIP pres)
91.92297,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,27153.0,7410.3867,40.5,white,32.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,141.0,22.0976562,123.0,34.0,38.0,155.0,3.2998047,0.59997559,0.79992676,141.0,7.5,172.0,13.0,1730.0,2.0,<2 mo. follow-up
79.01196,1,male,0,9,337,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,18246.0,13885.0781,20.5,white,34.0,1,0,0,yes,1.0,1.0,no dnr,9.0,63.0,8.29882812,80.0,30.0,37.79688,257.125,2.199707,1.01,3.89990234,142.0,7.339844,207.0,116.0,1720.0,0.0,adl>=4 (>=5 if sur)
31.82999,1,male,0,6,394,CHF,COPD/CHF/Cirrhosis,3,15.0,under $11k,8811.0,5220.5625,20.0,white,30.0,1,0,0,no,0.849999905,0.75,no dnr,6.0,115.0,14.0,120.0,28.0,38.29688,333.3,3.5,1.01,6.29980469,138.0,7.419922,102.0,83.0,3330.0,0.494751,no(M2 and SIP pres)
66.06995,1,male,0,6,62,Lung Cancer,Cancer,1,9.0,under $11k,9945.0,6046.1016,13.0,white,16.0,1,0,0,metastatic,0.799999714,0.4,no dnr,6.0,76.0,5.89941406,80.0,24.0,36.69531,333.3,3.3999023,2.0,1.0,143.0,7.419922,110.0,15.0,410.0,0.0,<2 mo. follow-up
68.75299,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,59995.78781114967,14452.7344,39.0,white,74.0,22,0,0,no,0.099999964,0.1,no dnr,8.0,110.0,7.69921875,120.0,34.0,37.79688,224.0,1.8999023,0.69995117,0.5,135.0,7.449219,137.0,5.0,3565.0,1.0,<2 mo. follow-up
91.81696,1,female,0,9,315,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,13455.0,5766.6562,13.5,white,37.0,2,1,1,no,0.849999905,0.5,dnr after sadm,3.0,68.0,11.5996094,70.0,28.0,37.69531,342.8125,3.5996094,1.09985352,13.0996094,152.0,7.439453,151.0,178.0,241.0,7.0,adl>=4 (>=5 if sur)
71.59796,1,female,0,18,532,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,36646.0,14415.6328,19.0,black,40.0,1,0,0,no,0.899999619,0.8,no dnr,18.0,67.0,20.1992188,100.0,40.0,38.29688,333.3,3.5,0.5,1.0,139.0,7.419922,161.0,14.0,2502.0,3.0,no(M2 and SIP pres)
40.60199,0,male,0,11,904,Cirrhosis,COPD/CHF/Cirrhosis,6,12.0,under $11k,11743.0,6783.0039,8.5,black,18.0,1,0,0,no,0.599999905,0.4,dnr after sadm,5.0,60.0,8.69921875,120.0,14.0,34.29688,158.0,1.7998047,1.01,1.69995117,132.0,7.40918,215.0,50.0,2535.0,3.7875977,SIP>=30
55.85199,0,female,0,110,903,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,340910.0,190980.5,32.75,white,34.0,1,0,0,no,0.799999714,0.8,no dnr,110.0,33.0,0.5,150.0,12.0,38.69531,60.0,4.1992188,1.19995117,1.69995117,140.0,7.319336,159.0,22.0,450.0,1.9328613,no(M2 and SIP pres)
64.51495,0,male,0,11,901,Lung Cancer,Cancer,3,12.0,under $11k,14429.0,8822.6641,11.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,113.0,7.5,70.0,25.0,36.69531,280.9375,3.5,1.01,1.0,141.0,7.369141,153.0,19.0,2502.0,3.1210938,<2 mo. follow-up
67.409,0,male,0,13,900,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,49973.0,14452.7344,25.5,white,26.0,6,1,0,yes,0.799999714,0.8,no dnr,13.0,68.0,9.3984375,74.0,8.0,38.09375,145.0,2.0996094,1.01,1.29980469,144.0,7.5,123.0,30.0,3263.0,0.0,no(M2 and SIP pres)
77.74695,0,female,0,4,898,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,3228.0,1775.8408,11.0,white,28.0,1,1,0,no,0.799999714,0.6,no dnr,4.0,80.0,16.6992188,80.0,20.0,36.09375,261.875,3.8999023,0.79992676,1.5,140.0,7.339844,80.0,35.0,2502.0,2.0966797,no(M2 and SIP pres)
85.91895,1,female,0,15,133,CHF,COPD/CHF/Cirrhosis,4,16.0,>$50k,16137.0,9039.2656,6.0,white,36.0,1,1,1,no,0.699999809,0.5,dnr after sadm,2.0,103.0,9.59960938,80.0,20.0,38.89844,402.0,3.5,1.01,1.5,137.0,7.439453,170.0,25.0,1885.0,3.0,adl>=4 (>=5 if sur)
40.17499,0,female,0,6,898,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,9842.0,4744.2148,14.0,white,6.0,1,0,0,no,0.899999619,0.9,no dnr,6.0,76.0,5.09960938,64.0,12.0,36.39844,333.3,4.2998047,0.29998779,1.09985352,137.0,7.419922,93.0,23.0,2502.0,1.0,no(M2 and SIP pres)
78.448,1,female,0,10,315,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19295.0,9187.2734,21.5,white,34.0,1,1,0,no,0.599999905,0.4,no dnr,10.0,49.0,13.0996094,117.0,8.0,38.29688,198.0,2.5,0.79992676,0.79992676,134.0,7.429688,93.0,11.0,2277.0,2.5576172,SIP>=30
85.55798,1,female,1,5,5,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,12845.0,4185.3398,36.0,white,51.0,1,1,0,metastatic,0.199999928,0.1,dnr after sadm,3.0,113.0,15.6992188,70.0,14.0,39.09375,409.5,3.5,1.01,2.09960938,136.0,7.399414,281.0,38.0,1270.0,6.0,<2 mo. follow-up
86.89398,1,female,0,31,404,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,50008.0,25600.2812,18.75,white,36.0,4,1,0,no,0.699999809,0.5,dnr after sadm,8.0,80.0,10.2988281,110.0,30.0,36.09375,237.5,3.7998047,1.09985352,1.39990234,135.0,7.449219,87.0,24.0,1879.0,4.1533203,adl>=4 (>=5 if sur)
67.26099,1,male,1,7,7,Lung Cancer,Cancer,2,12.0,under $11k,17966.0,9470.0312,22.0,white,77.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,5.0,100.0,24.6992188,80.0,25.0,36.09375,436.0,3.199707,1.01,1.0,129.0,7.429688,124.0,14.0,2502.0,2.7294922,<2 mo. follow-up
68.94696,1,male,0,7,133,MOSF w/Malig,ARF/MOSF,2,8.0,$11-$25k,16339.0,8028.6094,16.0,black,42.0,1,0,0,metastatic,0.799999714,0.6,no dnr,7.0,70.0,12.1992188,120.0,10.0,36.29688,96.25,2.2998047,0.79992676,4.89941406,132.0,7.219727,103.0,50.0,0.0,4.0,no(M2 and SIP pres)
74.92999,1,male,0,4,48,Lung Cancer,Cancer,1,7.0,under $11k,6121.0,3628.7383,5.0,white,18.0,1,0,0,metastatic,0.699999809,0.1,no dnr,4.0,65.0,10.5996094,56.0,30.0,38.69531,183.65625,2.3999023,1.01,1.09985352,135.0,7.389648,306.0,28.0,1350.0,3.0,<2 mo. follow-up
85.99298,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,10742.0,4711.6367,14.5,white,34.0,1,0,0,no,0.199999928,0.1,dnr after sadm,2.0,67.0,13.5,60.0,6.0,38.79688,136.65625,4.0996094,0.79992676,2.0,142.0,7.419922,157.0,24.0,645.0,0.0,<2 mo. follow-up
87.82196,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,32606.0,13760.4141,31.0,white,55.0,10,0,0,no,0.199999928,0.2,dnr after sadm,3.0,83.0,3.89990234,80.0,20.0,36.09375,333.3,1.5,1.69995117,0.89990234,129.0,7.419922,125.0,11.0,2502.0,6.0,<2 mo. follow-up
88.53699,1,female,0,16,82,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,26190.0,17459.5625,17.0,white,35.0,1,0,0,no,0.699999809,0.7,dnr after sadm,10.0,110.0,8.5,110.0,14.0,38.39844,314.0,2.7998047,0.39996338,0.5,150.0,7.339844,300.0,25.0,1335.0,4.0,<2 mo. follow-up
63.064,1,female,0,5,865,COPD,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,4934.0,2945.0371,9.0,white,27.0,1,0,0,no,1.0,0.98,no dnr,5.0,80.0,6.09960938,100.0,20.0,37.39844,333.3,3.5,0.39996338,1.0,136.0,7.419922,111.0,10.0,600.0,1.8388672,no(M2 and SIP pres)
71.15094,1,female,0,100,833,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,179736.0,94621.375,22.75,white,38.0,15,1,0,no,0.899999619,0.9,no dnr,100.0,105.0,9.8984375,102.0,24.0,38.5,171.40625,2.5996094,1.19995117,1.19995117,137.0,7.5,200.0,24.0,3400.0,3.0981445,adl>=4 (>=5 if sur)
41.16098,1,female,0,10,214,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,21183.0,8702.5938,17.0,white,53.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,3.0,73.0,9.59960938,60.0,20.0,36.09375,358.3125,3.5,1.01,1.79980469,137.0,7.349609,222.0,30.0,1850.0,1.0,no(M2 and SIP pres)
45.43198,0,female,0,23,886,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,123970.0,67890.6875,25.333328,black,42.0,10,0,0,no,0.949999809,0.95,no dnr,23.0,100.0,15.0996094,80.0,20.0,38.29688,626.625,3.5,0.59997559,3.89990234,132.0,7.359375,277.0,86.0,950.0,2.7319336,<2 mo. follow-up
91.13794,1,female,0,5,407,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,5236.0,2960.1621,7.0,white,18.0,1,0,1,no,0.399999857,0.2,dnr before sadm,-1.0,117.0,5.59960938,72.0,20.0,38.19531,218.3125,3.699707,0.39996338,0.89990234,133.0,7.349609,85.0,10.0,2100.0,6.0927734,<2 mo. follow-up
81.13599,0,female,0,36,885,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,38685.0,22244.0469,7.5,white,24.0,1,0,0,yes,0.799999714,0.7,dnr after sadm,2.0,60.0,9.79882812,62.0,24.0,38.39844,480.0,2.699707,1.79980469,1.19995117,149.0,7.449219,719.0,63.0,700.0,0.0,<2 mo. follow-up
58.349,1,female,0,11,158,MOSF w/Malig,ARF/MOSF,1,14.0,$11-$25k,12365.0,5889.5469,14.5,white,9.0,1,0,0,metastatic,0.899999619,0.5,no dnr,11.0,53.0,8.8984375,96.0,33.0,35.79688,136.71875,2.5996094,1.59985352,1.89990234,138.0,7.419922,187.0,41.0,1855.0,0.0,no(M2 and SIP pres)
90.48596,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,14422.0,5378.875,20.5,white,46.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,133.0,9.29882812,82.0,24.0,36.79688,432.0,3.5,0.5,1.79980469,147.0,7.379883,247.0,29.0,1435.0,3.0,<2 mo. follow-up
45.95798,0,male,0,15,882,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,31723.0,21983.0938,23.666656,white,31.0,1,0,0,yes,0.699999809,0.5,no dnr,15.0,111.0,0.09999084,140.0,28.0,36.29688,380.0,2.0,0.79992676,3.5,142.0,7.359375,235.0,69.0,2250.0,0.0,no(M2 and SIP pres)
78.58698,0,male,0,24,879,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,31302.0,15784.8203,24.666656,white,68.0,1,1,1,no,0.799999714,0.5,dnr before sadm,-1.0,80.0,2.29980469,68.0,16.0,36.09375,556.0,2.2998047,2.39990234,2.0,154.0,7.459961,90.0,33.0,1920.0,7.0,adl>=4 (>=5 if sur)
53.12799,0,female,0,45,879,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,92751.0,57897.0,15.0,black,38.0,10,0,0,no,0.899999619,0.9,no dnr,45.0,76.0,11.7988281,72.0,16.0,36.5,333.3,3.0996094,0.39996338,1.09985352,138.0,7.419922,127.0,22.0,2502.0,0.0,no(M2 and SIP pres)
82.04797,0,female,0,9,879,CHF,COPD/CHF/Cirrhosis,6,6.0,under $11k,16409.0,12120.5391,30.5,white,39.0,1,0,0,yes,0.849999905,0.85,no dnr,9.0,107.0,18.1992188,68.0,30.0,36.69531,333.3,3.0996094,1.09985352,3.69970703,150.0,7.419922,179.0,99.0,2003.0,0.494751,no(M2 and SIP pres)
47.95297,1,female,1,7,7,Lung Cancer,Cancer,1,12.0,$11-$25k,12930.0,6180.0547,20.0,black,17.0,1,0,0,metastatic,0.099999964,0.1,dnr after sadm,2.0,51.0,7.09960938,50.0,6.0,35.59375,74.0,3.5,1.01,3.0,135.0,7.339844,72.0,105.0,1024.0,0.0,<2 mo. follow-up
73.758,0,female,0,14,877,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,46212.0,15088.2344,25.0,white,40.0,7,0,0,yes,0.599999905,0.6,dnr after sadm,8.0,61.0,11.1992188,62.0,24.0,38.29688,120.0,3.7998047,1.01,2.29980469,138.0,7.419922,142.0,43.0,1072.0,1.0,no(M2 and SIP pres)
88.23297,0,female,0,5,877,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,8650.0,3403.5019,19.0,white,22.0,1,0,0,no,1.0,0.95,no dnr,5.0,83.0,11.3984375,100.0,25.0,36.09375,333.3,3.5,1.01,1.59985352,135.0,7.419922,97.0,47.0,2100.0,0.494751,no(M2 and SIP pres)
61.74899,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,13353.0,6758.6875,20.0,white,54.0,6,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,12.8984375,100.0,24.0,37.39844,363.25,2.3999023,1.01,2.09960938,135.0,7.389648,234.0,37.0,1145.0,2.3730469,<2 mo. follow-up
88.00299,1,female,0,76,89,Coma,Coma,1,14.0,under $11k,102276.0,55993.5,20.5,white,17.0,1,0,1,no,0.5,0.3,dnr after sadm,27.0,57.0,0.79992676,128.0,36.0,39.39844,328.0,2.5996094,0.59997559,0.79992676,136.0,7.489258,112.0,10.0,2100.0,1.0,<2 mo. follow-up
76.92798,1,female,0,7,135,Lung Cancer,Cancer,1,12.0,under $11k,14385.0,6852.5547,4.5,white,35.0,1,0,0,metastatic,0.899999619,0.6,no dnr,7.0,50.0,21.0,110.0,8.0,38.19531,195.0,3.5,1.01,2.89990234,141.0,7.40918,68.0,17.0,2100.0,2.375,no(M2 and SIP pres)
67.31299,1,female,0,9,590,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,13149.0,5712.6484,15.5,white,29.0,1,0,0,no,0.799999714,0.65,no dnr,9.0,67.0,8.09960938,60.0,15.0,36.09375,403.3125,3.5,1.01,1.29980469,139.0,7.359375,119.0,21.0,2502.0,0.0,no(M2 and SIP pres)
76.14197,0,female,0,6,875,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,7858.0,4060.5547,7.0,white,18.0,1,0,0,no,1.0,1.0,no dnr,6.0,70.0,16.3984375,80.0,30.0,37.0,333.3,4.0,0.89990234,0.89990234,134.0,7.419922,111.0,8.0,1050.0,1.1667481,no(M2 and SIP pres)
66.63898,1,female,0,6,163,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,7222.0,3841.3008,7.0,black,13.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,71.0,3.69970703,74.0,20.0,38.09375,419.0,3.5,1.01,0.59997559,139.0,7.449219,101.0,3.0,3900.0,0.0,<2 mo. follow-up
79.50696,1,female,0,4,207,CHF,COPD/CHF/Cirrhosis,4,14.0,$11-$25k,4092.0,2277.5312,8.0,white,36.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,52.0,13.5996094,107.0,24.0,37.79688,230.59375,3.3999023,1.01,2.0,141.0,7.40918,388.0,52.0,1780.0,0.494751,no(M2 and SIP pres)
44.06299,1,male,0,10,193,MOSF w/Malig,ARF/MOSF,1,13.0,$11-$25k,106706.0,53907.25,25.5,black,43.0,27,0,0,yes,0.75,0.5,no dnr,10.0,56.0,7.39941406,117.0,8.0,38.09375,442.5,3.5,1.01,1.0,138.0,7.439453,97.0,12.0,2111.0,1.1667481,no(M2 and SIP pres)
54.56497,1,female,1,27,27,Coma,Coma,3,13.0,>$50k,90807.0,75018.625,42.0,white,48.0,6,0,0,no,0.009999998,0.01,no dnr,27.0,49.0,15.5996094,70.0,24.0,40.09375,120.0,3.0996094,0.5,2.79980469,156.0,7.199219,355.0,85.0,1980.0,0.0,<2 mo. follow-up
70.49097,0,male,0,37,873,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,under $11k,129379.0,49179.8125,36.25,white,31.0,5,1,0,no,0.5,0.4,no dnr,37.0,113.0,21.796875,120.0,34.0,38.79688,293.875,3.5,1.01,0.79992676,148.0,7.519531,150.0,10.0,1265.0,0.0,no(M2 and SIP pres)
50.12997,1,male,0,32,272,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,103700.0,53768.3438,28.5,other,48.0,12,0,0,yes,0.699999809,0.5,no dnr,32.0,45.0,10.6992188,75.0,14.0,38.0,363.3125,3.5,1.29980469,2.69970703,141.0,7.619141,173.0,47.0,3105.0,1.0,no(M2 and SIP pres)
76.85699,1,female,0,16,456,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$11-$25k,26843.0,12188.6875,11.333328,white,20.0,3,0,0,no,0.799999714,0.8,no dnr,16.0,69.0,11.7988281,100.0,24.0,36.59375,333.3,3.5996094,0.69995117,0.69995117,137.0,7.419922,129.0,7.0,1800.0,0.0,SIP>=30
67.42499,1,female,0,15,252,Colon Cancer,Cancer,1,12.0,$11-$25k,20324.0,11267.1641,14.0,white,12.0,1,0,0,metastatic,0.929999828,0.7,no dnr,15.0,53.0,10.2988281,113.0,14.0,38.29688,166.65625,2.0996094,1.01,0.89990234,138.0,7.379883,140.0,18.0,2130.0,0.0,no(M2 and SIP pres)
76.19696,1,male,0,8,95,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,18925.0,10816.7031,15.5,white,64.0,2,0,0,yes,0.899999619,0.5,no dnr,8.0,127.0,15.2988281,49.0,29.0,36.09375,286.625,3.5996094,1.39990234,0.79992676,137.0,7.40918,136.0,15.0,2210.0,3.8549805,adl>=4 (>=5 if sur)
63.81699,0,female,0,14,869,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,18628.0,9706.6719,7.0,white,26.0,1,0,0,no,0.799999714,0.8,dnr before sadm,-1.0,50.0,29.1992188,110.0,32.0,36.59375,270.0,2.2998047,1.01,1.0,145.0,7.289062,122.0,30.0,995.0,3.0,SIP>=30
76.01398,1,female,0,6,123,COPD,COPD/CHF/Cirrhosis,5,8.0,under $11k,8725.0,4444.0039,19.0,white,20.0,1,1,0,no,0.799999714,0.6,dnr before sadm,0.0,67.0,7.5,70.0,20.0,38.39844,663.25,3.5,1.01,0.69995117,141.0,7.469727,89.0,16.0,750.0,5.0,SIP>=30
67.63898,0,female,0,11,868,COPD,COPD/CHF/Cirrhosis,2,18.0,under $11k,17103.0,8721.7734,13.5,white,22.0,1,0,0,no,0.989999771,0.97,no dnr,11.0,70.0,12.0,80.0,25.0,36.69531,333.3,3.5,1.01,2.79980469,137.0,7.419922,104.0,66.0,2502.0,1.1667481,no(M2 and SIP pres)
44.58298,1,female,0,24,122,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,39887.0,14321.3672,29.333328,black,44.0,1,0,0,no,0.699999809,0.5,no dnr,24.0,71.0,16.6992188,80.0,30.0,38.09375,260.0,3.7998047,1.09985352,1.29980469,137.0,7.289062,166.0,26.0,3500.0,2.9350586,no(M2 and SIP pres)
73.42896,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,103441.0,55695.25,51.0,white,29.0,12,1,0,no,0.399999857,0.1,dnr after sadm,3.0,87.0,18.5,80.0,20.0,36.69531,488.3125,3.5,1.01,1.09985352,138.0,7.359375,137.0,26.0,600.0,2.2182617,<2 mo. follow-up
61.366,1,female,0,26,527,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,66701.0,42294.8125,32.5,white,69.0,1,0,0,no,0.799999714,0.7,no dnr,26.0,83.0,15.7988281,80.0,20.0,36.39844,248.0,4.0996094,0.39996338,0.89990234,137.0,7.389648,170.0,20.0,2400.0,0.0,no(M2 and SIP pres)
82.92999,1,female,0,14,167,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,20326.0,13601.4219,9.666664,white,29.0,1,0,0,no,0.75,0.6,no dnr,14.0,73.0,7.19921875,60.0,15.0,35.79688,333.3,3.5,1.01,2.0,142.0,7.419922,105.0,41.0,1275.0,0.0,no(M2 and SIP pres)
83.88196,0,female,0,35,864,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,83738.0,31256.8594,38.25,black,43.0,5,0,0,no,0.199999928,0.2,no dnr,35.0,111.0,2.79980469,105.0,38.0,36.69531,151.65625,2.5996094,1.69995117,3.79980469,145.0,7.40918,340.0,73.0,3525.0,0.0,no(M2 and SIP pres)
68.50397,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,36125.0,14889.1406,46.0,white,70.0,1,0,0,no,0.299999952,0.3,dnr after sadm,6.0,67.0,22.5,120.0,40.0,35.69531,190.0,3.5,1.01,0.89990234,145.0,7.469727,140.0,8.0,596.0,0.0,<2 mo. follow-up
74.91595,0,male,0,5,862,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,6488.0,2851.5176,19.0,white,7.0,1,0,0,no,0.699999809,0.6,no dnr,5.0,64.0,22.1992188,72.0,8.0,36.39844,122.0,3.5,1.01,1.09985352,132.0,7.429688,263.0,18.0,1655.0,1.0,<2 mo. follow-up
41.26797,1,male,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,54511.0,24352.5781,25.75,white,53.0,1,1,0,no,0.5,0.5,dnr after sadm,11.0,51.0,0.89990234,108.0,31.0,35.59375,245.6875,2.5,1.0,1.0,141.0,7.40918,133.0,17.0,2000.0,0.0,<2 mo. follow-up
90.18799,0,female,0,31,862,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,56886.0,43806.9062,17.25,white,32.0,10,0,0,no,0.899999619,0.9,no dnr,31.0,110.0,15.0,80.0,20.0,37.19531,169.375,3.0,1.01,1.69995117,139.0,7.299805,103.0,30.0,3175.0,0.0,no(M2 and SIP pres)
62.80899,1,male,1,53,53,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,110359.0,65038.4375,24.75,white,32.0,4,0,0,no,0.5,0.3,no dnr,53.0,83.0,2.79980469,72.0,18.0,36.29688,333.3,2.8999023,0.59997559,1.0,133.0,7.419922,94.0,9.0,2500.0,0.0,<2 mo. follow-up
81.862,0,male,0,7,859,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,$11-$25k,13348.0,5834.8086,11.0,white,43.0,1,0,0,yes,0.949999809,0.9,no dnr,7.0,53.0,10.8984375,80.0,15.0,38.89844,333.3,1.8999023,1.01,13.1992188,141.0,7.419922,96.0,52.0,0.0,1.0,no(M2 and SIP pres)
92.59998,1,male,0,4,424,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4591.0,2519.8281,15.0,white,25.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,63.0,14.5996094,120.0,30.0,36.69531,216.65625,3.699707,0.5,0.79992676,145.0,7.359375,100.0,9.0,2502.0,0.494751,SIP>=30
63.23297,1,male,0,17,200,Colon Cancer,Cancer,2,9.0,under $11k,21338.0,12039.3906,14.666664,white,23.0,1,0,0,metastatic,0.949999809,0.5,dnr after sadm,10.0,103.0,14.8984375,80.0,20.0,36.09375,142.84375,3.5,1.01,1.0,136.0,7.339844,115.0,39.0,2300.0,0.0,no(M2 and SIP pres)
37.16599,0,male,0,35,857,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,41987.0,22330.9375,12.0,white,85.0,1,0,0,no,0.5,0.4,no dnr,35.0,97.0,14.0,80.0,25.0,36.69531,204.75,3.5,1.01,1.09985352,143.0,7.369141,131.0,16.0,2502.0,3.0,no(M2 and SIP pres)
75.409,0,male,0,8,856,ARF/MOSF w/Sepsis,ARF/MOSF,4,9.0,under $11k,33492.0,15391.3984,9.5,white,15.0,15,1,0,no,0.899999619,0.85,no dnr,8.0,66.0,6.39941406,116.0,8.0,36.09375,222.0,3.0,1.19995117,3.79980469,142.0,7.209961,112.0,58.0,4150.0,0.494751,no(M2 and SIP pres)
72.534,1,male,0,5,29,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,6225.0,3391.3731,16.0,white,27.0,1,0,0,yes,0.299999952,0.1,no dnr,5.0,61.0,23.1992188,130.0,10.0,38.69531,270.0,3.5,1.01,1.19995117,147.0,7.389648,155.0,46.0,2159.0,4.0,<2 mo. follow-up
80.66296,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,67475.0,23792.2969,56.0,white,52.0,1,0,0,no,0.099999964,0.1,dnr after sadm,16.0,69.0,12.0996094,125.0,28.0,35.59375,149.0,3.699707,1.01,6.19921875,123.0,7.179688,159.0,89.0,1395.0,2.2944336,<2 mo. follow-up
75.90698,0,male,0,21,855,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,61597.0,38251.2812,46.0,white,52.0,1,0,0,no,0.049999982,0.05,no dnr,21.0,63.0,7.59960938,64.0,26.0,36.59375,285.0,3.5,1.01,1.0,141.0,7.399414,130.0,23.0,1350.0,0.0,SIP>=30
88.99396,1,male,0,10,293,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,16074.0,6716.0938,16.0,white,41.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,55.0,33.0,76.0,11.0,36.19531,88.0,2.0,1.01,0.69995117,147.0,7.379883,116.0,11.0,3531.0,0.494751,no(M2 and SIP pres)
52.73398,0,male,0,59,853,Coma,Coma,1,12.0,under $11k,70943.0,41053.25,19.0,white,41.0,2,0,0,no,0.5,0.5,dnr after sadm,54.0,45.0,2.09960938,118.0,20.0,38.69531,98.75,3.5996094,4.0,2.5,138.0,7.279297,121.0,54.0,1300.0,1.7128906,<2 mo. follow-up
80.37195,1,female,0,21,120,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$25-$50k,42111.0,29083.7656,35.666657,white,31.0,1,0,0,no,0.849999905,0.8,no dnr,21.0,107.0,7.0,70.0,20.0,36.09375,206.65625,3.7998047,0.89990234,1.29980469,144.0,7.469727,95.0,16.0,2200.0,2.8959961,SIP>=30
80.24097,1,female,0,16,419,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26305.0,11489.6016,16.0,white,46.0,2,0,0,yes,0.899999619,0.9,no dnr,16.0,43.0,5.89941406,117.0,42.0,39.19531,108.0,2.5996094,0.5,1.29980469,136.0,7.439453,215.0,19.0,3770.0,0.0,no(M2 and SIP pres)
50.46698,0,male,0,8,851,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,11153.0,4478.0234,18.0,black,13.0,1,0,0,yes,0.699999809,0.6,no dnr,8.0,60.0,15.8984375,60.0,24.0,36.29688,91.65625,2.2998047,1.01,1.69995117,139.0,7.429688,113.0,34.0,3075.0,0.0,no(M2 and SIP pres)
70.20898,1,male,0,14,279,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,18113.0,10003.5156,5.333332,white,37.0,1,0,0,no,0.799999714,0.6,no dnr,14.0,103.0,5.19921875,68.0,22.0,37.69531,263.3125,3.5,1.01,3.5,131.0,7.40918,245.0,65.0,2395.0,2.0,SIP>=30
79.71497,1,female,0,19,26,COPD,COPD/CHF/Cirrhosis,7,12.0,under $11k,18665.0,11108.2734,10.0,white,31.0,1,1,1,yes,0.5,0.2,dnr before sadm,-1.0,59.0,10.5996094,69.0,20.0,36.69531,178.3125,3.5996094,1.79980469,2.39990234,138.0,7.15918,85.0,33.0,850.0,7.0,<2 mo. follow-up
38.39798,0,male,0,127,850,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,308151.0,174160.875,48.25,white,44.0,14,0,1,no,0.5,0.5,no dnr,127.0,103.0,5.59960938,70.0,20.0,36.69531,333.3,3.5,1.01,1.69995117,143.0,7.419922,103.0,32.0,1310.0,3.0,adl>=4 (>=5 if sur)
72.487,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,86066.0,48466.7188,37.0,black,67.0,23,0,1,no,0.699999809,0.5,dnr before sadm,0.0,63.0,6.09960938,80.0,20.0,36.09375,333.3,3.5,1.59985352,1.89990234,135.0,7.419922,98.0,27.0,2000.0,4.9462891,<2 mo. follow-up
71.17896,1,female,0,12,408,Lung Cancer,Cancer,2,16.0,$25-$50k,17762.0,11561.0938,27.5,black,26.0,1,1,0,metastatic,0.75,0.5,no dnr,12.0,56.0,26.0976562,72.0,28.0,36.09375,333.3,1.2998047,24.3984375,2.39990234,112.0,7.419922,477.0,28.0,1040.0,0.0,no(M2 and SIP pres)
63.767,0,female,0,26,848,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59345.0,33678.8438,28.75,white,20.0,2,1,0,no,0.5,0.75,no dnr,26.0,80.0,6.19921875,80.0,20.0,36.09375,266.625,2.5,1.01,0.89990234,134.0,7.5,124.0,11.0,1100.0,0.0,no(M2 and SIP pres)
91.98395,1,female,0,3,658,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,5355.0,2215.8594,22.610928270087555,white,10.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,107.0,8.29882812,80.0,15.0,36.09375,484.0,2.5,1.01,2.39990234,138.0,7.339844,192.0,36.0,1300.0,2.6958008,no(M2 and SIP pres)
70.87994,1,male,0,6,42,Lung Cancer,Cancer,3,12.0,under $11k,5514.0,3357.1543,11.0,white,31.0,1,0,0,metastatic,0.799999714,0.3,no dnr,6.0,119.0,9.59960938,140.0,12.0,34.59375,150.0,2.199707,1.01,0.79992676,144.0,7.429688,90.0,54.0,2955.0,5.0,<2 mo. follow-up
77.65399,0,female,0,10,844,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,14591.0,6149.5938,15.0,white,25.0,1,1,0,no,0.899999619,0.8,no dnr,10.0,53.0,13.1992188,72.0,10.0,38.29688,80.0,2.5996094,1.01,2.59960938,130.0,7.319336,121.0,62.0,2362.0,3.1147461,<2 mo. follow-up
59.58398,1,male,0,48,258,MOSF w/Malig,ARF/MOSF,1,20.0,>$50k,106109.0,59733.1875,24.5,white,58.0,1,0,0,metastatic,0.899999619,0.8,no dnr,48.0,61.0,7.5,112.0,40.0,37.59375,122.4375,3.199707,1.01,0.89990234,141.0,7.399414,139.0,39.0,1130.0,0.0,no(M2 and SIP pres)
42.69998,0,male,0,4,845,COPD,COPD/CHF/Cirrhosis,3,14.0,under $11k,6088.0,1507.1191,5.0,hispanic,27.0,1,0,0,no,0.979999542,0.96,no dnr,4.0,107.0,12.3984375,111.0,36.0,38.79688,156.0,3.699707,1.01,0.89990234,145.0,7.459961,105.0,31.0,1640.0,0.494751,<2 mo. follow-up
40.745,0,male,0,12,843,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,$11-$25k,21615.0,8890.4766,16.0,white,34.0,1,0,0,no,0.699999809,0.65,no dnr,12.0,60.0,20.796875,114.0,32.0,37.89844,220.0,3.5,1.01,1.19995117,134.0,7.479492,116.0,23.0,2878.0,0.494751,<2 mo. follow-up
84.58899,1,male,0,7,273,CHF,COPD/CHF/Cirrhosis,2,17.0,$25-$50k,12772.0,5564.2031,14.0,white,22.0,1,0,0,no,0.75,0.5,no dnr,7.0,53.0,22.5976562,69.0,28.0,38.0,234.28125,3.0996094,0.5,6.69921875,127.0,7.369141,162.0,84.0,2260.0,0.0,no(M2 and SIP pres)
38.21997,1,female,0,65,781,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,165549.0,97381.375,24.0,black,64.0,9,0,0,no,0.699999809,0.6,no dnr,65.0,113.0,6.89941406,65.0,13.0,36.29688,333.3,3.699707,0.5,0.89990234,139.0,7.419922,176.0,11.0,2400.0,2.4521484,no(M2 and SIP pres)
66.57098,1,female,0,17,251,MOSF w/Malig,ARF/MOSF,2,8.0,under $11k,21336.0,10116.6641,10.666664,hispanic,38.0,1,0,0,yes,1.0,0.9,no dnr,17.0,83.0,6.09960938,80.0,20.0,36.09375,333.3,3.2998047,1.69995117,1.59985352,138.0,7.419922,65.0,30.0,300.0,0.0,no(M2 and SIP pres)
72.09296,1,female,1,66,66,Coma,Coma,2,12.0,$11-$25k,92723.0,53217.9375,19.0,black,37.0,15,1,0,no,0.799999714,0.75,dnr after sadm,12.0,93.0,8.69921875,70.0,20.0,36.09375,333.3,3.5,0.39996338,6.5,133.0,7.419922,111.0,97.0,1200.0,2.0,<2 mo. follow-up
42.99799,0,male,0,23,839,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,58702.0,33407.1562,26.0,white,52.0,9,0,0,no,0.5,0.5,no dnr,23.0,55.0,16.8984375,78.0,10.0,35.0,65.0,2.0,0.59997559,0.59997559,137.0,7.389648,144.0,4.0,1906.0,0.0,<2 mo. follow-up
68.88196,1,male,0,7,177,COPD,COPD/CHF/Cirrhosis,4,13.0,$11-$25k,8507.0,4556.7773,7.0,white,47.0,1,1,0,metastatic,0.799999714,0.6,no dnr,7.0,60.0,11.5996094,80.0,36.0,33.79688,96.65625,2.5,2.09960938,2.39990234,149.0,7.529297,85.0,54.0,1735.0,0.0,no(M2 and SIP pres)
70.20398,0,female,0,6,837,COPD,COPD/CHF/Cirrhosis,4,11.0,$11-$25k,6931.0,3673.6504,13.0,white,29.0,1,0,0,no,0.949999809,0.9,no dnr,6.0,107.0,4.59960938,69.0,28.0,38.19531,333.3,3.5,1.01,1.5,134.0,7.419922,333.0,17.0,3480.0,1.8388672,no(M2 and SIP pres)
92.33899,1,female,0,24,147,ARF/MOSF w/Sepsis,ARF/MOSF,3,18.0,under $11k,34012.0,20204.1719,22.666656,white,51.0,1,1,0,no,0.75,0.75,no dnr,24.0,52.0,8.5,81.0,8.0,38.89844,295.0,3.5,1.01,1.09985352,139.0,7.419922,101.0,18.0,2212.0,0.494751,SIP>=30
85.34399,0,female,0,30,836,Coma,Coma,2,12.0,under $11k,41743.0,23544.8438,17.0,white,30.0,1,0,0,yes,0.299999952,0.1,dnr after sadm,1.0,93.0,6.79980469,60.0,20.0,37.59375,318.0,3.5,1.01,1.0,141.0,7.5,95.0,26.0,2502.0,3.0,adl>=4 (>=5 if sur)
87.71497,1,male,1,3,3,Coma,Coma,0,12.0,under $11k,7018.0,5242.0508,17.0,white,89.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,80.0,20.5976562,110.0,25.0,37.79688,333.3,2.5996094,1.01,1.19995117,133.0,7.419922,93.0,21.0,1475.0,2.1518555,<2 mo. follow-up
49.155,1,male,0,21,32,Cirrhosis,COPD/CHF/Cirrhosis,7,16.0,>$50k,46039.0,26825.8281,22.666656,white,46.0,1,1,0,no,0.799999714,0.75,dnr after sadm,13.0,60.0,22.1992188,108.0,30.0,38.59375,135.0,2.8999023,1.39990234,1.0,136.0,7.319336,164.0,26.0,2140.0,3.0,<2 mo. follow-up
87.44397,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,7418.0,2254.0938,17.0,white,69.0,1,0,0,yes,0.0,0.0,dnr after sadm,1.0,45.0,7.69921875,54.0,26.0,38.79688,170.0,2.0,7.39941406,0.89990234,139.0,7.379883,88.0,40.0,2450.0,2.8549805,<2 mo. follow-up
71.74799,0,female,0,16,829,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,68313.0,34881.2188,26.0,white,37.0,1,1,0,no,0.599999905,0.5,no dnr,16.0,74.0,6.0,72.0,24.0,36.79688,176.1875,3.5,1.01,0.79992676,137.0,7.289062,98.0,8.0,1650.0,0.0,no(M2 and SIP pres)
32.75598,0,female,0,16,828,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,under $11k,22857.0,12762.8438,21.0,white,40.0,1,0,0,no,0.989999771,0.99,no dnr,16.0,147.0,11.2988281,78.0,6.0,38.39844,89.0,3.199707,0.69995117,1.19995117,147.0,7.339844,149.0,31.0,2090.0,1.0,SIP>=30
80.22498,1,female,0,8,23,Lung Cancer,Cancer,1,12.0,under $11k,7970.0,4700.3672,2.0,white,37.0,1,0,0,metastatic,0.799999714,0.3,dnr after sadm,1.0,77.0,6.79980469,80.0,25.0,36.39844,136.65625,4.0996094,0.79992676,1.39990234,141.0,7.319336,104.0,23.0,2720.0,6.0,<2 mo. follow-up
79.65796,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,9602.0,6555.2578,8.0,white,59.0,1,1,0,metastatic,0.099999964,0.0,dnr after sadm,1.0,127.0,15.0,110.0,8.0,36.39844,194.0,2.0,1.01,6.19921875,137.0,7.419922,73.0,44.0,95.0,3.0,<2 mo. follow-up
74.72095,0,male,0,4,824,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,5136.0,2833.5059,9.0,white,29.0,1,1,0,no,0.199999928,0.1,no dnr,4.0,61.0,9.69921875,108.0,32.0,36.69531,266.625,2.2998047,1.09985352,1.29980469,143.0,7.55957,145.0,21.0,1160.0,2.1064453,no(M2 and SIP pres)
68.50696,1,female,0,12,41,Lung Cancer,Cancer,1,12.0,under $11k,12682.0,7578.1133,7.5,white,16.0,1,0,0,metastatic,0.699999809,0.2,no dnr,12.0,67.0,8.8984375,76.0,24.0,36.59375,306.0625,3.5,1.01,2.29980469,139.0,7.419922,298.0,33.0,928.0,2.2397461,<2 mo. follow-up
59.79498,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,33532.0,22360.375,35.0,black,67.0,2,1,0,no,0.599999905,0.4,dnr after sadm,5.0,48.0,55.59375,70.0,0.0,38.19531,128.0,3.5,1.01,0.79992676,131.0,7.419922,144.0,9.0,4675.0,3.2382812,<2 mo. follow-up
92.32599,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,21252.0,14635.0859,35.0,white,60.0,1,0,1,no,0.25,0.25,dnr before sadm,0.0,101.0,7.59960938,60.0,28.0,36.09375,163.3125,3.699707,0.59997559,0.89990234,139.0,7.469727,227.0,12.0,1850.0,6.1230469,<2 mo. follow-up
73.63696,0,female,0,9,821,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,8924.0,5092.6602,10.0,white,20.0,1,1,0,no,0.899999619,0.75,no dnr,9.0,83.0,6.09960938,100.0,25.0,35.59375,271.375,3.5,1.01,1.19995117,142.0,7.419922,103.0,28.0,800.0,2.0,SIP>=30
82.57397,0,male,0,14,821,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$11-$25k,52314.0,27385.3438,13.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,115.0,12.5996094,156.0,14.0,36.29688,252.375,2.699707,1.01,2.39990234,139.0,7.469727,146.0,55.0,1913.0,3.1118164,no(M2 and SIP pres)
61.728,0,male,0,9,821,CHF,COPD/CHF/Cirrhosis,4,13.0,$11-$25k,12263.0,6591.2969,18.5,white,16.0,1,0,0,yes,0.899999619,0.8,no dnr,9.0,135.0,13.8984375,60.0,25.0,37.79688,238.09375,3.5,0.59997559,1.29980469,136.0,7.319336,108.0,25.0,2170.0,0.0,no(M2 and SIP pres)
81.021,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,71731.0,48839.4062,28.5,white,49.0,13,0,0,yes,0.099999964,0.1,no dnr,7.0,33.0,19.3984375,68.0,44.0,40.0,347.0,3.5,1.01,2.19970703,136.0,7.419922,547.0,39.0,64.0,0.0,<2 mo. follow-up
79.68195,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,44745.0,26816.8125,42.5,white,35.0,1,0,0,yes,0.799999714,0.6,dnr after sadm,4.0,100.0,12.5,70.0,25.0,36.69531,428.5625,2.3999023,7.29980469,1.39990234,126.0,7.549805,335.0,43.0,2020.0,2.4433594,<2 mo. follow-up
75.18695,0,female,0,5,819,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,7456.0,4245.8906,14.0,black,16.0,1,0,0,no,1.0,1.0,no dnr,5.0,46.0,15.8984375,109.0,8.0,35.89844,238.09375,3.0996094,1.01,1.59985352,135.0,7.419922,204.0,26.0,253.0,0.0,no(M2 and SIP pres)
62.26099,1,male,0,14,120,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,39981.0,21077.875,8.333328,white,25.0,3,0,0,metastatic,0.5,0.1,dnr after sadm,2.0,111.0,7.19921875,69.0,36.0,38.29688,196.65625,3.199707,1.01,2.79980469,136.0,7.15918,272.0,36.0,2115.0,0.0,no(M2 and SIP pres)
66.51294,0,female,0,5,818,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,4732.0,2705.3906,10.0,white,25.0,1,0,0,yes,0.899999619,0.8,no dnr,5.0,63.0,14.0,130.0,35.0,36.59375,150.0,2.2998047,0.19998169,0.79992676,145.0,7.519531,111.0,12.0,1180.0,3.8969727,<2 mo. follow-up
70.20099,0,female,0,11,817,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,22622.0,13765.7031,11.0,white,29.0,1,0,0,no,0.949999809,0.95,no dnr,11.0,100.0,8.5,110.0,25.0,36.69531,333.3,3.3999023,1.01,1.09985352,137.0,7.419922,209.0,28.0,800.0,0.0,no(M2 and SIP pres)
75.66296,1,female,0,24,74,Lung Cancer,Cancer,2,16.0,>$50k,30159.0,16960.3906,7.666664,white,17.0,1,1,0,metastatic,0.899999619,0.5,dnr after sadm,16.0,73.0,6.59960938,120.0,35.0,35.0,457.125,2.8999023,1.0,2.5,142.0,7.529297,227.0,61.0,550.0,3.0,adl>=4 (>=5 if sur)
73.06,0,female,0,10,816,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,31491.0,16079.4531,30.5,white,21.0,3,0,0,yes,1.0,1.0,no dnr,10.0,80.0,6.09960938,80.0,25.0,36.69531,276.1875,3.5,1.01,1.79980469,139.0,7.449219,116.0,41.0,2502.0,1.0,no(M2 and SIP pres)
81.73297,1,female,0,13,47,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,28287.0,21679.875,25.0,white,45.0,1,0,1,yes,0.299999952,0.3,dnr after sadm,3.0,87.0,13.5996094,68.0,20.0,36.5,333.3,4.2998047,0.69995117,0.89990234,139.0,7.419922,124.0,20.0,1750.0,5.3720703,<2 mo. follow-up
84.82098,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,>$50k,45150.0,35746.5,32.5,white,46.0,1,0,1,no,0.799999714,0.8,dnr after sadm,7.0,53.0,14.7988281,106.0,10.0,39.29688,108.32812,2.2998047,0.59997559,8.19921875,147.0,7.429688,109.0,40.0,0.0,6.0,<2 mo. follow-up
49.82898,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,32057.0,18602.5156,12.0,black,34.0,3,0,1,metastatic,0.0,0.0,dnr after sadm,1.0,163.0,5.39941406,150.0,37.0,38.0,72.0,2.5,0.59997559,0.79992676,142.0,7.369141,163.0,31.0,1625.0,4.8066406,<2 mo. follow-up
68.31995,0,male,0,7,813,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15734.0,11297.625,9.5,white,24.0,1,0,0,no,0.899999619,0.9,no dnr,7.0,103.0,9.3984375,60.0,20.0,36.09375,333.3,3.5,1.01,1.39990234,140.0,7.419922,129.0,44.0,2275.0,1.0,no(M2 and SIP pres)
47.87399,0,male,0,28,813,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,124925.0,87454.0625,39.5,white,55.0,1,0,0,no,0.099999964,0.1,no dnr,28.0,56.0,4.39941406,48.0,22.0,36.09375,333.3,3.0996094,0.59997559,1.09985352,143.0,7.419922,106.0,14.0,1370.0,1.0,no(M2 and SIP pres)
70.35199,1,female,0,17,118,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,100587.0,59188.5625,11.333328,hispanic,37.0,48,1,0,no,0.699999809,0.7,no dnr,17.0,83.0,7.0,80.0,35.0,35.59375,366.625,3.5,0.39996338,1.19995117,136.0,7.429688,107.0,14.0,2980.0,1.0,no(M2 and SIP pres)
85.63196,0,male,0,19,811,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,55663.0,14452.7344,21.333328,white,58.0,7,0,0,yes,0.799999714,0.7,no dnr,19.0,69.0,15.0996094,66.0,20.0,36.09375,111.65625,2.0996094,1.01,3.29980469,139.0,7.439453,432.0,129.0,2400.0,2.5107422,<2 mo. follow-up
64.08197,1,male,0,17,221,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,37130.0,24575.8281,19.0,black,45.0,2,1,0,yes,0.799999714,0.7,no dnr,17.0,63.0,7.09960938,120.0,42.0,36.89844,135.0,3.199707,1.19995117,0.79992676,146.0,7.429688,131.0,17.0,1010.0,0.0,no(M2 and SIP pres)
77.59296,1,male,0,14,17,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,37632.0,24508.875,13.666664,white,42.0,9,1,0,yes,0.25,0.05,dnr after sadm,1.0,101.0,4.89941406,55.0,25.0,36.19531,266.625,4.3994141,0.5,0.69995117,144.0,7.439453,117.0,15.0,3200.0,1.0,<2 mo. follow-up
76.78595,0,female,0,5,808,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,8474.0,5556.4961,10.0,white,30.0,1,0,0,no,0.989999771,0.9,no dnr,5.0,105.0,16.0,80.0,28.0,36.29688,138.3125,2.5996094,0.79992676,0.69995117,142.0,7.40918,136.0,20.0,1550.0,1.78125,no(M2 and SIP pres)
74.32996,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,$11-$25k,27511.0,17544.0156,14.333328,white,32.0,1,1,1,yes,0.099999964,0.0,dnr after sadm,3.0,100.0,9.0,90.0,25.0,36.09375,242.84375,3.5,0.29998779,1.09985352,133.0,7.359375,163.0,22.0,2502.0,5.7832031,<2 mo. follow-up
58.34598,1,male,0,13,690,Colon Cancer,Cancer,2,16.0,>$50k,20169.0,11726.9375,15.5,white,16.0,1,0,0,metastatic,0.899999619,0.7,no dnr,13.0,82.0,27.3984375,70.0,24.0,36.09375,197.125,2.699707,0.5,1.09985352,138.0,7.369141,86.0,22.0,1600.0,0.0,no(M2 and SIP pres)
52.98599,1,female,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,>$50k,165799.0,115003.688,38.5,white,66.0,1,1,0,no,0.099999964,0.05,dnr after sadm,25.0,93.0,6.09960938,60.0,15.0,37.0,333.3,2.7998047,1.01,0.69995117,134.0,7.419922,249.0,25.0,2502.0,4.0,<2 mo. follow-up
42.17899,0,male,0,28,802,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,95443.0,63887.2812,23.0,black,49.0,14,1,0,no,0.949999809,0.9,no dnr,28.0,110.0,4.89941406,110.0,32.0,38.29688,183.3125,3.5,1.01,0.89990234,143.0,7.489258,121.0,9.0,4685.0,0.0,SIP>=30
70.11896,0,female,0,35,799,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,72087.0,49218.4688,29.0,white,63.0,1,0,0,no,0.25,0.15,no dnr,35.0,79.0,10.8984375,140.0,38.0,38.09375,269.375,2.7998047,0.59997559,1.19995117,138.0,7.379883,167.0,33.0,600.0,0.0,<2 mo. follow-up
72.46497,1,male,0,13,31,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$25-$50k,20845.0,12817.9688,14.0,white,44.0,1,0,0,yes,0.799999714,0.6,no dnr,13.0,48.0,10.3984375,134.0,10.0,38.29688,170.0,3.5,1.01,1.29980469,143.0,7.359375,121.0,32.0,505.0,0.0,<2 mo. follow-up
66.00397,1,female,0,8,30,MOSF w/Malig,ARF/MOSF,5,13.0,$11-$25k,20343.0,14605.9766,20.5,hispanic,42.0,1,1,0,metastatic,0.099999964,0.0,dnr after sadm,3.0,97.0,24.5,100.0,5.0,37.79688,111.65625,3.5,1.01,1.09985352,137.0,7.449219,136.0,29.0,2502.0,3.0,<2 mo. follow-up
72.38098,1,male,0,17,89,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,71071.0,36104.8125,15.0,white,44.0,7,0,0,no,0.799999714,0.75,no dnr,17.0,129.0,5.0,106.0,34.0,38.19531,360.0,3.199707,1.39990234,1.19995117,142.0,7.449219,95.0,24.0,3710.0,0.0,no(M2 and SIP pres)
74.875,1,female,0,7,190,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,7262.0,3990.8398,12.0,other,11.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,47.0,18.5976562,113.0,34.0,38.79688,53.0,2.2998047,0.89990234,0.89990234,143.0,7.369141,154.0,17.0,1968.0,1.0,no(M2 and SIP pres)
75.03094,0,female,0,27,794,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,59400.0,40212.1562,19.5,white,33.0,1,0,0,no,0.649999619,0.65,no dnr,27.0,99.0,24.1992188,70.0,16.0,36.39844,334.25,3.5,0.79992676,7.79980469,137.0,7.359375,160.0,47.0,5.0,2.7119141,<2 mo. follow-up
30.752,0,female,0,39,793,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,107237.0,49841.0312,12.25,white,22.0,3,0,0,no,0.899999619,0.729,no dnr,39.0,57.0,6.0,144.0,36.0,40.19531,111.65625,3.5,1.01,1.29980469,134.0,7.40918,169.0,21.0,3775.0,2.9794922,<2 mo. follow-up
93.008,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,30466.0,23195.1875,27.5,white,38.0,1,0,0,no,0.799999714,0.7,dnr after sadm,5.0,56.0,10.2988281,68.0,30.0,36.09375,450.0,3.0996094,1.01,1.59985352,143.0,7.339844,112.0,58.0,950.0,7.0,<2 mo. follow-up
43.92297,0,female,0,5,793,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,8939.0,5789.7773,12.0,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,120.0,14.2988281,74.0,38.0,38.09375,333.3,2.699707,0.29998779,3.79980469,142.0,7.419922,207.0,58.0,3100.0,1.7971191,no(M2 and SIP pres)
64.52795,0,female,0,7,792,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,13593.0,7954.3398,10.0,white,27.0,1,0,0,no,0.899999619,0.9,no dnr,7.0,97.0,6.89941406,80.0,20.0,37.79688,261.875,3.5,1.01,0.89990234,143.0,7.399414,87.0,21.0,250.0,0.0,no(M2 and SIP pres)
73.89496,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,32243.0,18343.7344,25.0,white,111.0,1,0,0,metastatic,0.699999809,0.5,dnr before sadm,-1.0,76.0,5.39941406,58.0,28.0,36.59375,361.875,2.8999023,0.89990234,1.09985352,135.0,7.439453,133.0,39.0,492.0,2.4311523,<2 mo. follow-up
47.16498,0,male,0,11,791,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,>$50k,23887.0,18863.2188,12.0,white,45.0,1,0,0,no,0.799999714,0.8,no dnr,11.0,103.0,4.69921875,60.0,15.0,36.69531,333.3,3.5,0.59997559,1.19995117,138.0,7.419922,114.0,20.0,2502.0,0.0,no(M2 and SIP pres)
82.409,1,male,0,46,118,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,133174.0,77660.5,31.25,white,32.0,1,0,0,yes,0.989999771,0.95,dnr after sadm,22.0,150.0,31.0,102.0,38.0,36.29688,184.0,2.0,1.39990234,1.5,127.0,7.40918,323.0,37.0,1810.0,0.0,no(M2 and SIP pres)
65.58197,1,female,0,73,624,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,194085.0,124043.188,29.75,white,49.0,2,0,0,no,0.25,0.25,no dnr,73.0,119.0,8.0,119.0,28.0,39.59375,333.3,3.199707,1.59985352,7.09960938,140.0,7.419922,151.0,22.0,0.0,2.0,adl>=4 (>=5 if sur)
52.89499,1,female,0,34,112,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,64598.0,38731.9062,16.5,white,64.0,1,0,0,no,0.5,0.3,dnr after sadm,3.0,47.0,3.79980469,108.0,26.0,36.39844,120.0,2.0,1.01,3.89990234,136.0,7.419922,179.0,50.0,2030.0,5.0,adl>=4 (>=5 if sur)
79.85199,1,female,0,28,525,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,38248.0,22160.5938,14.75,white,30.0,1,0,0,metastatic,0.799999714,0.75,dnr after sadm,4.0,52.0,10.0996094,138.0,24.0,35.0,95.0,3.199707,1.01,1.39990234,139.0,7.439453,132.0,38.0,1550.0,1.0,SIP>=30
83.20898,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,23733.0,15129.2266,35.0,white,51.0,8,0,0,no,0.299999952,0.2,dnr after sadm,1.0,113.0,12.0,114.0,28.0,37.59375,75.0,3.5,1.01,0.69995117,134.0,7.199219,256.0,7.0,2275.0,0.0,<2 mo. follow-up
74.45898,1,female,1,65,65,Coma,Coma,2,9.0,under $11k,268852.0,152357.875,42.5,white,42.0,1,0,0,no,0.699999809,0.5,no dnr,65.0,55.0,6.09960938,49.0,16.0,36.79688,146.9375,3.0996094,1.01,2.69970703,139.0,7.419922,103.0,29.0,1365.0,1.9885254,<2 mo. follow-up
53.75497,1,female,0,14,82,Cirrhosis,COPD/CHF/Cirrhosis,4,4.0,under $11k,20960.0,11320.4219,12.666664,white,41.0,1,1,0,no,0.599999905,0.5,no dnr,14.0,93.0,4.39941406,80.0,20.0,36.69531,246.65625,3.5,1.01,1.19995117,140.0,7.439453,87.0,30.0,1800.0,6.0,<2 mo. follow-up
89.60699,1,female,0,6,211,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,11821.0,14452.7344,23.0,white,61.0,1,0,0,yes,0.5,0.2,no dnr,6.0,53.0,8.19921875,68.0,8.0,36.69531,200.0,3.0,1.29980469,0.69995117,142.0,7.389648,111.0,32.0,1050.0,1.8388672,adl>=4 (>=5 if sur)
76.35297,1,male,0,6,622,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,78784.0,41778.3438,14.0,white,34.0,26,0,0,yes,0.899999619,0.7,dnr after sadm,1.0,103.0,4.69921875,120.0,28.0,38.79688,343.3125,3.5,1.09985352,0.69995117,132.0,7.399414,117.0,6.0,3525.0,0.0,no(M2 and SIP pres)
68.42999,1,male,1,52,52,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,229885.0,137699.125,50.25,white,63.0,2,0,0,yes,0.599999905,0.6,dnr after sadm,14.0,63.0,8.09960938,75.0,10.0,36.19531,230.0,2.7998047,0.69995117,1.09985352,143.0,7.269531,196.0,53.0,850.0,2.0,<2 mo. follow-up
78.44995,1,male,0,9,107,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,25633.0,15443.7422,10.5,white,33.0,6,0,0,yes,0.299999952,0.05,no dnr,9.0,97.0,6.59960938,60.0,20.0,36.09375,224.0,3.5,1.01,0.69995117,141.0,7.299805,183.0,7.0,2502.0,0.0,no(M2 and SIP pres)
73.37994,0,female,0,4,782,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,4327.0,2242.1426,16.0,white,29.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,80.0,13.5,180.0,20.0,36.09375,260.0,3.5,1.01,0.69995117,138.0,7.419922,82.0,8.0,850.0,0.494751,no(M2 and SIP pres)
73.89697,1,male,0,9,29,CHF,COPD/CHF/Cirrhosis,2,17.0,$25-$50k,13112.0,7688.0469,13.0,white,29.0,1,0,0,no,0.949999809,0.9,no dnr,9.0,39.0,31.3984375,118.0,28.0,37.29688,70.0,1.5,0.59997559,2.5,136.0,7.109375,230.0,51.0,50.0,1.0,<2 mo. follow-up
41.91898,0,male,0,21,780,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,86133.0,59003.0312,40.333313,white,28.0,1,0,0,no,0.699999809,0.7,no dnr,21.0,65.0,17.5976562,116.0,16.0,37.89844,333.3,2.0996094,2.09960938,1.09985352,132.0,7.419922,109.0,29.0,450.0,0.0,no(M2 and SIP pres)
81.16595,1,male,0,28,32,Lung Cancer,Cancer,2,24.0,$25-$50k,32597.0,18775.0156,9.25,white,22.0,1,1,0,metastatic,0.799999714,0.3,dnr after sadm,7.0,107.0,7.29980469,72.0,24.0,36.89844,262.9375,3.5,1.01,2.19970703,139.0,7.40918,129.0,54.0,1450.0,4.0,<2 mo. follow-up
22.63399,0,male,0,154,779,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,489823.0,279177.75,51.5,white,50.0,1,0,0,no,0.599999905,0.5,no dnr,154.0,127.0,20.296875,130.0,40.0,38.19531,132.0,2.0996094,1.01,0.59997559,146.0,7.439453,111.0,9.0,1016.0,0.0,Coma or Intub
84.49298,1,female,0,86,206,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,183705.0,14452.7344,37.25,white,54.0,1,1,0,metastatic,0.799999714,0.5,no dnr,86.0,111.0,17.6992188,105.0,16.0,35.59375,195.21875,3.7998047,0.59997559,4.69921875,132.0,7.489258,119.0,23.0,0.0,3.7641602,adl>=4 (>=5 if sur)
18.754,0,female,0,8,777,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,15711.0,11459.125,16.0,other,38.0,1,0,0,no,0.979999542,0.98,no dnr,8.0,124.0,16.0976562,50.0,24.0,38.5,105.0,3.5,1.01,1.5,142.0,7.399414,172.0,35.0,1664.0,1.0,no(M2 and SIP pres)
77.05695,1,male,0,11,70,MOSF w/Malig,ARF/MOSF,3,16.0,under $11k,23606.0,13628.6641,13.0,white,37.0,6,1,0,yes,0.599999905,0.5,no dnr,11.0,52.0,7.0,120.0,29.0,36.79688,95.90625,3.5,1.01,0.89990234,131.0,7.489258,95.0,17.0,4300.0,0.0,no(M2 and SIP pres)
82.86395,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26475.0,15379.2031,24.0,white,52.0,1,1,0,no,0.199999928,0.2,dnr after sadm,2.0,63.0,16.3984375,60.0,4.0,36.59375,65.0,3.5,0.29998779,0.79992676,145.0,7.329102,253.0,15.0,2275.0,3.0263672,<2 mo. follow-up
64.81598,0,female,0,79,776,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,227656.0,150149.0,41.0,white,24.0,8,0,0,no,0.799999714,0.75,no dnr,79.0,67.0,7.29980469,80.0,20.0,37.0,271.375,2.8999023,6.5,1.5,140.0,7.469727,183.0,21.0,1200.0,5.0,adl>=4 (>=5 if sur)
91.25,1,female,0,7,10,Lung Cancer,Cancer,3,12.0,under $11k,6621.0,3815.6055,3.0,white,43.0,1,0,0,metastatic,0.599999905,0.2,dnr after sadm,3.0,59.0,5.0,120.0,24.0,35.79688,261.875,3.5,1.01,3.79980469,139.0,7.279297,88.0,86.0,490.0,3.0,<2 mo. follow-up
73.54999,1,male,0,16,43,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,37467.0,26889.4062,17.0,white,61.0,1,0,0,metastatic,0.849999905,0.6,dnr after sadm,14.0,77.0,8.69921875,70.0,25.0,36.69531,305.0,2.2998047,1.09985352,1.09985352,140.0,7.479492,106.0,14.0,4745.0,1.0,<2 mo. follow-up
84.64899,1,female,1,3,3,Coma,Coma,1,12.0,under $11k,10739.0,5883.5078,34.0,white,64.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,60.0,14.6992188,1.0,40.0,36.89844,100.0,2.0,1.89990234,2.09960938,136.0,7.449219,172.0,26.0,972.0,3.4047852,<2 mo. follow-up
34.45898,0,male,0,3,773,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3212.0,1865.0439,22.610928270087555,black,19.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,51.0,4.5,79.0,25.0,36.09375,333.3,3.5,0.5,1.19995117,138.0,7.419922,101.0,16.0,750.0,1.7236328,no(M2 and SIP pres)
94.28894,0,female,0,18,772,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,4854.0,35284.0938,24.333328,white,25.0,1,0,0,no,0.699999809,0.6,no dnr,18.0,120.0,7.69921875,70.0,20.0,35.59375,333.3,3.5,1.01,1.09985352,137.0,7.419922,250.0,21.0,1000.0,1.0,adl>=4 (>=5 if sur)
65.65594,0,female,0,5,771,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,>$50k,14770.0,10889.8672,19.0,white,24.0,3,0,0,no,1.0,1.0,no dnr,5.0,105.0,12.0,60.0,24.0,36.59375,333.3,3.7998047,1.79980469,1.89990234,139.0,7.419922,124.0,44.0,1175.0,1.9521484,no(M2 and SIP pres)
77.14697,0,male,0,3,769,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,6100.0,3419.4824,22.610928270087555,white,51.0,1,0,0,no,1.0,0.9,no dnr,3.0,79.0,12.5996094,106.0,30.0,38.09375,106.65625,2.699707,0.19998169,0.69995117,133.0,7.389648,101.0,13.0,7130.0,0.0,no(M2 and SIP pres)
63.17899,1,male,0,3,426,CHF,COPD/CHF/Cirrhosis,4,22.0,>$50k,4222.0,2193.7207,22.610928270087555,white,19.0,1,0,0,yes,0.849999905,0.5,no dnr,3.0,73.0,8.0,80.0,16.0,36.09375,333.3,3.199707,1.01,1.29980469,142.0,7.419922,61.0,27.0,1770.0,2.1157227,no(M2 and SIP pres)
69.42395,1,male,0,6,256,Lung Cancer,Cancer,2,10.0,under $11k,7165.0,4281.4922,23.0,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,56.0,12.0,130.0,14.0,40.09375,58.0,2.2998047,0.69995117,0.79992676,136.0,7.369141,119.0,8.0,2320.0,1.8388672,no(M2 and SIP pres)
83.23596,0,female,0,8,768,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,6498.0,11080.0312,26.0,white,28.0,1,0,1,no,0.699999809,0.65,dnr before sadm,0.0,53.0,8.09960938,60.0,8.0,38.0,278.0,2.5996094,1.01,0.69995117,149.0,7.459961,169.0,19.0,349.0,7.0,adl>=4 (>=5 if sur)
24.474,0,female,0,22,767,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,84800.0,62121.2188,42.0,hispanic,32.0,2,0,0,no,0.649999619,0.65,no dnr,22.0,67.0,12.7988281,112.0,58.0,38.89844,169.375,3.5,1.01,0.59997559,141.0,7.439453,121.0,2.0,1375.0,1.0,SIP>=30
34.47198,0,female,0,24,767,ARF/MOSF w/Sepsis,ARF/MOSF,4,17.0,$25-$50k,89616.0,51243.75,36.333313,white,51.0,2,1,0,yes,0.699999809,0.5,no dnr,24.0,80.0,21.0976562,70.0,20.0,36.09375,321.0,3.2998047,1.01,6.5,134.0,7.289062,599.0,91.0,1315.0,0.0,no(M2 and SIP pres)
37.02698,0,male,0,6,766,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,7813.0,4125.1992,14.0,white,13.0,1,0,0,no,0.949999809,0.8,no dnr,6.0,65.0,12.0,131.0,52.0,38.59375,368.0,2.7998047,0.59997559,1.89990234,150.0,7.419922,168.0,78.0,1445.0,1.8041992,no(M2 and SIP pres)
85.06494,1,male,0,12,94,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$25-$50k,34245.0,20162.6406,21.5,white,38.0,3,0,0,yes,0.799999714,0.7,no dnr,12.0,96.0,9.19921875,68.0,10.0,36.79688,93.75,2.3999023,0.39996338,0.59997559,130.0,7.399414,82.0,17.0,2030.0,0.0,adl>=4 (>=5 if sur)
89.74097,0,female,0,9,765,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,17130.0,10323.2422,10.0,white,28.0,1,0,0,no,0.899999619,0.9,dnr after sadm,1.0,60.0,14.7988281,110.0,30.0,36.59375,195.625,3.5,1.01,0.69995117,144.0,7.449219,83.0,22.0,2502.0,0.0,no(M2 and SIP pres)
54.09399,1,female,0,20,62,Lung Cancer,Cancer,4,14.0,$11-$25k,16905.0,10727.7969,7.333332,white,13.0,1,1,0,metastatic,0.199999928,0.05,dnr before sadm,-1.0,110.0,15.5,146.0,11.0,36.19531,268.0,4.7998047,0.39996338,2.19970703,142.0,7.329102,111.0,47.0,1275.0,7.0,adl>=4 (>=5 if sur)
51.38898,1,male,0,17,183,Lung Cancer,Cancer,4,13.0,$11-$25k,41738.0,21054.7188,13.666664,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,17.0,51.0,4.89941406,60.0,6.0,35.19531,130.59375,2.8999023,0.5,2.29980469,141.0,7.099609,204.0,80.0,1090.0,0.0,no(M2 and SIP pres)
67.49597,1,female,0,10,123,Lung Cancer,Cancer,2,12.0,$25-$50k,13784.0,8026.0547,10.5,white,35.0,1,0,0,metastatic,0.5,0.15,dnr before sadm,-1.0,113.0,4.09960938,60.0,25.0,36.69531,333.3,4.5,1.01,1.29980469,143.0,7.419922,60.0,13.0,2502.0,0.0,no(M2 and SIP pres)
34.793,0,female,0,7,761,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,10315.0,6516.2422,11.0,black,45.0,1,0,0,no,0.899999619,0.9,no dnr,7.0,122.0,12.2988281,102.0,8.0,37.79688,250.0,3.2998047,1.01,0.79992676,134.0,7.449219,155.0,23.0,1035.0,0.0,no(M2 and SIP pres)
78.086,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,$11-$25k,43260.0,31237.7344,49.0,white,26.0,1,1,0,no,0.25,0.0,dnr after sadm,9.0,73.0,19.0,68.0,26.0,36.09375,134.6875,3.5,1.01,0.79992676,135.0,7.40918,106.0,14.0,1970.0,6.0,<2 mo. follow-up
54.79797,1,male,1,30,30,Lung Cancer,Cancer,1,12.0,under $11k,43582.0,24543.3906,14.5,white,17.0,1,0,0,metastatic,0.5,0.1,no dnr,30.0,159.0,9.09960938,128.0,42.0,36.59375,333.3,4.5996094,0.79992676,2.0,141.0,7.419922,91.0,33.0,3748.0,2.8334961,<2 mo. follow-up
75.12897,1,male,0,8,51,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,16763.0,9901.5234,17.0,white,34.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,93.0,8.0,110.0,20.0,35.59375,218.3125,4.2998047,1.01,1.29980469,142.0,7.459961,76.0,23.0,3800.0,4.0,<2 mo. follow-up
71.51794,0,female,0,20,759,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,41046.0,27401.8438,12.0,white,43.0,3,0,1,no,0.799999714,0.6,no dnr,20.0,73.0,6.09960938,80.0,20.0,37.79688,333.3,3.5,1.01,0.79992676,138.0,7.419922,71.0,6.0,3000.0,1.0,no(M2 and SIP pres)
77.88098,1,female,0,15,38,Lung Cancer,Cancer,1,11.0,under $11k,19490.0,10861.7734,9.666664,white,32.0,1,0,0,metastatic,0.25,0.5,dnr after sadm,3.0,63.0,14.5996094,98.0,30.0,38.19531,242.5,3.199707,1.01,1.39990234,144.0,7.419922,174.0,41.0,2280.0,1.0,<2 mo. follow-up
76.96594,1,male,0,11,23,ARF/MOSF w/Sepsis,ARF/MOSF,0,3.0,under $11k,22398.0,13414.8828,24.0,white,38.0,1,0,0,no,0.5,0.5,no dnr,11.0,131.0,25.1992188,103.0,14.0,38.09375,76.25,2.699707,0.5,0.69995117,144.0,7.469727,144.0,11.0,4815.0,2.5927734,<2 mo. follow-up
56.06299,1,male,0,4,343,Lung Cancer,Cancer,4,1.0,$11-$25k,18205.0,9173.8828,11.0,white,17.0,1,1,0,metastatic,0.75,0.4,no dnr,4.0,121.0,25.1992188,71.0,12.0,35.0,111.42188,2.699707,2.69970703,4.29980469,146.0,7.489258,98.0,76.0,2922.0,0.494751,no(M2 and SIP pres)
43.87698,0,female,0,9,753,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,19006.0,12625.0234,14.5,white,36.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,108.0,11.5996094,84.0,20.0,36.39844,400.0,4.3994141,1.01,0.39996338,138.0,7.539062,122.0,2.0,3900.0,1.0,<2 mo. follow-up
73.80396,1,female,0,24,60,Colon Cancer,Cancer,1,12.0,under $11k,34604.0,22847.0469,20.666656,white,31.0,1,0,0,metastatic,0.099999964,0.1,dnr after sadm,20.0,49.0,7.0,63.0,28.0,38.39844,333.3,3.5,1.01,1.59985352,142.0,7.419922,84.0,21.0,1935.0,2.5986328,<2 mo. follow-up
76.20294,1,male,0,7,24,Lung Cancer,Cancer,5,9.0,$25-$50k,14896.0,7059.4922,4.5,white,18.0,1,1,0,metastatic,0.199999928,0.0,no dnr,7.0,70.0,6.0,62.0,14.0,36.69531,203.3125,4.0,1.0,1.39990234,142.0,7.189453,106.0,42.0,1710.0,3.8549805,<2 mo. follow-up
71.63599,1,male,0,7,366,Lung Cancer,Cancer,1,10.0,$11-$25k,15393.0,8254.8359,6.5,white,14.0,1,0,0,metastatic,0.799999714,0.2,no dnr,7.0,113.0,7.19921875,100.0,20.0,36.09375,333.3,3.5,0.39996338,0.89990234,136.0,7.419922,286.0,14.0,2502.0,6.0,<2 mo. follow-up
73.18298,0,female,0,12,750,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,26832.0,14452.7344,21.5,white,33.0,1,1,0,no,0.799999714,0.7,no dnr,12.0,69.0,11.8984375,108.0,20.0,38.59375,333.3,3.5,0.69995117,0.89990234,137.0,7.419922,81.0,7.0,2850.0,0.0,no(M2 and SIP pres)
70.90997,0,female,0,24,749,Coma,Coma,0,6.0,>$50k,48963.0,27923.0,20.666656,white,24.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,77.0,15.3984375,120.0,25.0,36.09375,333.3,3.5,1.01,1.0,138.0,7.419922,123.0,20.0,700.0,0.0,adl>=4 (>=5 if sur)
73.125,1,female,1,82,82,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,282678.0,170951.875,35.25,white,72.0,1,1,0,no,0.5,0.3,dnr after sadm,82.0,53.0,10.5996094,59.0,36.0,36.69531,100.0,2.7998047,0.59997559,0.79992676,133.0,7.5,84.0,14.0,500.0,3.0,SIP>=30
68.78296,1,female,0,16,604,Coma,Coma,3,6.0,under $11k,31924.0,20235.625,18.333328,black,42.0,1,1,0,no,0.399999857,0.3,no dnr,16.0,61.0,15.7988281,135.0,8.0,37.69531,175.0,2.5,0.39996338,1.0,142.0,7.359375,301.0,19.0,5240.0,1.0,no(M2 and SIP pres)
71.625,0,male,0,9,746,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,11909.0,6340.0938,11.0,white,22.0,1,0,0,yes,1.0,0.75,no dnr,9.0,97.0,6.39941406,120.0,20.0,39.39844,276.1875,3.5,1.01,0.89990234,139.0,7.479492,124.0,13.0,2502.0,0.0,no(M2 and SIP pres)
76.96399,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,114257.0,63974.1562,47.333313,white,50.0,1,1,0,no,0.5,0.5,dnr after sadm,23.0,78.0,29.296875,68.0,10.0,35.69531,528.5,2.8999023,1.29980469,1.09985352,139.0,7.339844,289.0,33.0,2260.0,0.0,<2 mo. follow-up
45.40698,1,female,0,62,182,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,241277.0,146111.75,46.5,white,53.0,12,0,0,metastatic,0.009999998,0.0,dnr after sadm,21.0,57.0,7.5,100.0,28.0,36.89844,369.0,3.0996094,1.01,0.69995117,139.0,7.5,97.0,5.0,370.0,0.0,SIP>=30
89.64496,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,62130.0,34845.0,47.5,white,45.0,5,0,0,no,0.5,0.4,dnr after sadm,10.0,77.0,9.09960938,128.0,36.0,36.69531,333.3,3.5,0.39996338,0.69995117,143.0,7.419922,104.0,13.0,1050.0,0.0,<2 mo. follow-up
86.26697,1,male,0,9,25,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,9107.0,5198.6875,13.5,white,44.0,1,0,0,no,0.099999964,0.01,dnr before sadm,-1.0,79.0,15.3984375,63.0,32.0,38.69531,316.0,3.3999023,1.59985352,0.79992676,136.0,7.509766,203.0,46.0,1910.0,3.0,<2 mo. follow-up
80.30695,1,female,0,46,299,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,53620.0,32645.9688,18.5,white,38.0,1,0,0,no,0.199999928,0.0,dnr after sadm,2.0,71.0,9.79882812,88.0,26.0,37.69531,333.3,3.5,0.5,1.19995117,134.0,7.419922,169.0,13.0,7650.0,3.0,no(M2 and SIP pres)
59.06598,0,female,0,4,741,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,>$50k,6445.0,4533.3242,4.0,white,24.0,1,0,0,no,0.75,0.75,no dnr,4.0,57.0,3.89990234,115.0,25.0,38.0,338.0625,3.0,1.09985352,0.5,134.0,7.549805,126.0,3.0,3550.0,0.0,no(M2 and SIP pres)
78.05597,1,female,0,23,122,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,45659.0,28706.2969,24.666656,white,61.0,1,0,0,no,0.5,0.7,no dnr,23.0,63.0,18.8984375,76.0,26.0,36.19531,333.3,2.0,1.01,0.79992676,143.0,7.419922,159.0,15.0,750.0,1.1667481,no(M2 and SIP pres)
76.04095,0,male,0,4,726,COPD,COPD/CHF/Cirrhosis,3,20.0,$11-$25k,10911.0,8963.7969,21.0,white,21.0,1,0,0,no,0.099999964,0.05,dnr after sadm,2.0,77.0,6.19921875,80.0,20.0,36.09375,333.3,3.2998047,0.59997559,1.0,138.0,7.419922,73.0,23.0,2502.0,0.494751,SIP>=30
78.06696,1,female,0,16,17,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,33427.0,18798.0781,16.0,white,8.0,1,0,0,no,0.899999619,0.75,no dnr,16.0,73.0,5.09960938,100.0,24.0,36.79688,333.3,3.5,1.01,1.09985352,143.0,7.419922,92.0,19.0,3500.0,2.6274414,<2 mo. follow-up
67.17297,1,male,1,56,56,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,214919.0,133772.875,44.25,white,39.0,1,1,0,metastatic,0.5,0.0,dnr after sadm,27.0,58.0,6.29980469,73.0,40.0,38.29688,175.0,3.5,1.01,1.19995117,134.0,7.429688,171.0,19.0,2094.0,0.0,<2 mo. follow-up
61.88599,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,22855.0,12007.4844,51.0,white,53.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,68.0,12.5996094,66.0,10.0,38.5,158.0,2.7998047,0.59997559,0.5,138.0,7.449219,118.0,21.0,2184.0,2.1313477,<2 mo. follow-up
76.07397,1,male,0,7,32,COPD,COPD/CHF/Cirrhosis,2,17.0,under $11k,12470.0,7309.4531,5.0,white,23.0,1,0,0,yes,0.5,0.2,dnr after sadm,1.0,58.0,3.69970703,67.0,28.0,38.5,211.65625,1.7998047,1.01,5.0,139.0,7.299805,94.0,109.0,215.0,7.0,<2 mo. follow-up
69.81195,0,female,0,6,724,COPD,COPD/CHF/Cirrhosis,2,12.0,>$50k,8025.0,4081.2266,8.0,white,10.0,1,0,0,no,0.599999905,0.6,dnr after sadm,3.0,62.0,8.3984375,64.0,31.0,37.89844,277.5,3.5,1.0,3.19970703,140.0,7.339844,247.0,58.0,1194.0,0.0,no(M2 and SIP pres)
90.073,1,male,1,7,7,Coma,Coma,1,8.0,under $11k,9079.0,5025.3203,11.0,white,53.0,1,0,0,no,0.329999924,0.33,dnr after sadm,7.0,73.0,11.1992188,70.0,15.0,37.79688,290.4375,3.5,1.01,1.69995117,132.0,7.459961,66.0,15.0,2000.0,7.0,<2 mo. follow-up
74.68298,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,31918.0,24692.5,36.0,white,22.0,1,0,0,yes,0.75,0.65,dnr after sadm,5.0,63.0,22.6992188,117.0,10.0,39.39844,91.0,3.0,1.79980469,1.69995117,147.0,7.419922,181.0,52.0,1535.0,0.0,<2 mo. follow-up
66.23096,0,male,0,6,722,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,16752.0,11609.2812,17.0,white,20.0,1,0,0,no,1.0,1.0,no dnr,6.0,67.0,11.1992188,140.0,16.0,36.5,93.32812,2.7998047,5.09960938,0.69995117,141.0,7.439453,55.0,11.0,1516.0,0.494751,no(M2 and SIP pres)
72.31995,1,female,1,23,23,MOSF w/Malig,ARF/MOSF,2,10.0,$11-$25k,67687.0,38645.4062,31.666656,other,62.0,4,0,0,yes,0.5,0.25,dnr after sadm,5.0,65.0,11.3984375,70.0,8.0,36.19531,178.0,2.3999023,0.59997559,2.0,135.0,7.479492,69.0,43.0,1745.0,6.0,<2 mo. follow-up
49.59299,0,female,0,10,717,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,23496.0,18205.4531,19.5,black,65.0,1,0,0,no,0.699999809,0.7,no dnr,10.0,110.0,9.79882812,100.0,25.0,36.09375,326.625,4.0,1.01,7.0,144.0,7.199219,128.0,127.0,650.0,0.0,no(M2 and SIP pres)
72.49298,1,female,0,20,24,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,40801.0,26217.1719,33.0,white,42.0,1,0,0,yes,0.5,0.1,dnr before sadm,0.0,63.0,13.3984375,72.0,22.0,36.69531,446.625,2.3999023,1.39990234,3.0,130.0,7.389648,107.0,138.0,2230.0,6.0,<2 mo. follow-up
75.35095,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,24854.0,17060.5,20.5,black,57.0,1,1,1,no,0.599999905,0.4,dnr after sadm,1.0,143.0,8.8984375,80.0,20.0,36.09375,304.75,3.5,1.19995117,1.59985352,142.0,7.459961,76.0,19.0,3500.0,6.2792969,<2 mo. follow-up
65.69495,1,female,0,6,45,Lung Cancer,Cancer,1,12.0,$11-$25k,11757.0,5935.3398,14.0,white,13.0,1,0,0,metastatic,0.75,0.5,no dnr,6.0,59.0,29.1992188,60.0,22.0,35.89844,233.3125,3.199707,0.29998779,2.09960938,128.0,7.379883,154.0,65.0,3000.0,0.0,<2 mo. follow-up
53.89499,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,36722.0,26371.9219,34.5,white,46.0,1,0,0,metastatic,0.449999809,0.1,dnr after sadm,5.0,77.0,8.69921875,62.0,24.0,36.09375,217.375,3.3999023,0.5,1.39990234,131.0,7.359375,176.0,39.0,3175.0,6.0,<2 mo. follow-up
71.59998,1,female,0,11,358,COPD,COPD/CHF/Cirrhosis,2,18.0,$25-$50k,15622.0,8136.7266,14.5,white,28.0,1,0,0,no,0.949999809,0.8,no dnr,11.0,73.0,5.5,60.0,20.0,36.69531,333.3,3.5,0.59997559,1.19995117,137.0,7.419922,102.0,13.0,2600.0,0.0,no(M2 and SIP pres)
49.495,0,female,0,13,710,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,45617.0,25077.0781,29.5,black,30.0,1,0,0,no,0.949999809,0.9,no dnr,13.0,47.0,13.7988281,176.0,8.0,38.39844,190.0,2.5996094,0.89990234,0.79992676,146.0,7.379883,251.0,16.0,4505.0,1.0,no(M2 and SIP pres)
90.27795,1,female,0,15,42,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,29200.0,18691.5781,17.333328,white,37.0,1,0,0,no,0.599999905,0.5,dnr after sadm,1.0,68.0,7.0,80.0,20.0,35.89844,180.0,2.0,6.09960938,0.89990234,132.0,7.299805,117.0,24.0,1425.0,6.0,<2 mo. follow-up
77.14697,1,male,0,15,606,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,74562.0,39255.3125,33.333313,white,25.0,5,0,0,no,0.599999905,0.216,no dnr,15.0,48.0,17.0,142.0,26.0,39.0,196.65625,3.0,0.89990234,1.5,136.0,7.429688,370.0,35.0,2221.0,2.800293,<2 mo. follow-up
71.64996,1,male,0,20,196,COPD,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,26614.0,14004.4609,16.0,white,27.0,1,1,0,yes,1.0,1.0,dnr after sadm,15.0,97.0,11.8984375,80.0,20.0,35.0,233.3125,3.5,1.01,1.09985352,139.0,7.399414,139.0,39.0,550.0,3.0,SIP>=30
70.17395,0,male,0,13,709,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,30650.0,20517.8594,27.0,white,34.0,1,0,1,no,0.699999809,0.5,no dnr,13.0,93.0,9.0,97.0,24.0,36.79688,304.3125,3.5,1.01,0.89990234,141.0,7.399414,112.0,29.0,2502.0,7.0,adl>=4 (>=5 if sur)
44.32898,1,female,0,9,116,MOSF w/Malig,ARF/MOSF,2,18.0,$25-$50k,22641.0,14706.6016,29.0,white,19.0,1,0,0,metastatic,0.599999905,0.3,no dnr,9.0,53.0,20.5,80.0,30.0,37.79688,333.3,3.5,1.01,2.5,151.0,7.419922,135.0,64.0,550.0,0.494751,no(M2 and SIP pres)
89.99896,1,female,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,165741.0,14452.7344,36.5,white,48.0,1,0,0,no,0.599999905,0.6,dnr after sadm,1.0,42.0,14.5996094,76.0,8.0,36.59375,230.0,3.5,0.59997559,1.5,138.0,7.429688,154.0,14.0,3885.0,5.0,<2 mo. follow-up
62.42798,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,3.0,under $11k,34412.0,22751.5938,44.0,black,87.0,1,0,0,no,0.5,0.5,dnr after sadm,7.0,70.0,11.1992188,70.0,26.0,37.0,486.625,3.699707,0.39996338,1.0,141.0,7.339844,95.0,11.0,1800.0,6.0,<2 mo. follow-up
64.71198,1,male,0,14,84,ARF/MOSF w/Sepsis,ARF/MOSF,4,25.0,>$50k,36616.0,21484.0,22.666656,white,35.0,1,1,0,no,0.899999619,0.8,no dnr,14.0,67.0,1.0,100.0,12.0,35.29688,351.0,1.8999023,4.0,1.79980469,144.0,7.379883,107.0,29.0,845.0,0.0,no(M2 and SIP pres)
78.75995,0,female,0,18,706,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,61702.0,41052.375,12.666664,white,37.0,14,1,0,no,0.699999809,0.6,no dnr,18.0,111.0,12.6992188,128.0,50.0,38.29688,261.875,3.0,1.01,7.79980469,140.0,7.369141,126.0,82.0,1600.0,0.0,no(M2 and SIP pres)
86.70197,0,male,0,14,705,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,56348.0,32967.5312,12.666664,white,26.0,11,0,1,yes,0.899999619,0.8,no dnr,14.0,63.0,0.09999084,109.0,28.0,36.0,144.0,2.199707,0.69995117,0.69995117,146.0,7.439453,118.0,16.0,3950.0,2.0,adl>=4 (>=5 if sur)
67.33496,1,female,0,14,94,MOSF w/Malig,ARF/MOSF,1,15.0,$25-$50k,37386.0,27409.5781,19.333328,white,63.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,7.0,50.0,7.79980469,60.0,25.0,39.29688,472.5,2.699707,1.01,8.5,144.0,7.349609,76.0,63.0,40.0,0.0,no(M2 and SIP pres)
85.97095,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,40860.0,23068.5469,46.0,white,58.0,6,1,0,no,0.5,0.5,dnr after sadm,5.0,105.0,9.0,70.0,20.0,36.19531,264.0,3.5,1.01,1.01,140.0,7.369141,135.0,23.0,3300.0,2.0,<2 mo. follow-up
79.01398,1,male,1,58,58,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,234205.0,136209.5,38.75,white,55.0,6,1,0,no,0.5,0.3,dnr after sadm,44.0,93.0,3.79980469,100.0,20.0,36.59375,333.3,3.5,1.01,1.39990234,140.0,7.419922,118.0,35.0,2502.0,2.0,<2 mo. follow-up
50.155,0,male,0,8,702,ARF/MOSF w/Sepsis,ARF/MOSF,2,4.0,under $11k,16569.0,11694.7969,12.5,black,69.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,53.0,6.79980469,126.0,38.0,37.59375,93.32812,3.699707,0.89990234,1.39990234,147.0,7.429688,84.0,28.0,2480.0,3.0,adl>=4 (>=5 if sur)
77.06,0,male,0,10,699,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,24721.0,16660.7188,19.0,white,47.0,1,0,0,no,0.799999714,0.6,no dnr,10.0,100.0,5.5,80.0,20.0,37.79688,333.3,3.5,1.01,3.5,138.0,7.419922,179.0,90.0,2502.0,3.6118164,<2 mo. follow-up
81.25897,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,17124.0,11060.8125,20.0,white,69.0,1,0,0,yes,0.099999964,0.05,dnr before sadm,0.0,125.0,5.69921875,62.0,30.0,36.5,205.0,3.5,1.01,1.39990234,142.0,7.489258,98.0,21.0,1350.0,2.9545898,<2 mo. follow-up
75.58099,1,female,0,12,186,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,16291.0,10785.2656,19.0,black,37.0,1,1,0,yes,0.899999619,0.8,no dnr,12.0,65.0,5.39941406,64.0,16.0,38.09375,285.6875,3.5,1.01,2.0,140.0,7.379883,103.0,26.0,690.0,7.0,adl>=4 (>=5 if sur)
48.97998,0,female,0,13,695,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,65038.0,36985.9375,16.5,white,27.0,16,0,0,no,0.799999714,0.8,no dnr,13.0,119.0,14.8984375,62.0,24.0,38.79688,167.34375,3.5,1.01,2.29980469,140.0,7.369141,125.0,31.0,1965.0,0.0,no(M2 and SIP pres)
53.75497,0,male,0,19,695,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,29567.0,15931.1328,11.333328,white,29.0,1,0,0,no,0.799999714,0.5,no dnr,19.0,110.0,6.09960938,80.0,20.0,36.09375,200.0,3.5,1.01,1.39990234,141.0,7.429688,104.0,25.0,2502.0,0.0,no(M2 and SIP pres)
85.46497,1,male,0,27,472,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,76784.0,52937.0625,33.25,white,51.0,1,0,0,yes,0.899999619,0.88,no dnr,27.0,50.0,6.79980469,98.0,26.0,39.29688,235.0,2.8999023,1.19995117,1.09985352,141.0,7.419922,283.0,38.0,2155.0,1.0,adl>=4 (>=5 if sur)
88.20294,1,female,0,10,279,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,20010.0,13632.3438,17.5,white,47.0,1,0,0,no,0.899999619,0.8,dnr after sadm,2.0,35.0,11.8984375,182.0,40.0,38.89844,154.28125,3.5,1.01,4.79980469,135.0,7.289062,319.0,82.0,625.0,6.0,<2 mo. follow-up
84.09296,0,male,0,8,693,ARF/MOSF w/Sepsis,ARF/MOSF,3,21.0,$25-$50k,18630.0,10353.1406,14.5,white,21.0,1,0,0,yes,0.599999905,0.4,dnr after sadm,1.0,66.0,4.5,62.0,16.0,36.59375,356.0,3.199707,5.0,0.59997559,141.0,7.369141,130.0,8.0,4530.0,6.0,SIP>=30
83.29895,1,female,0,4,594,CHF,COPD/CHF/Cirrhosis,3,15.0,under $11k,5048.0,2602.3965,10.0,white,37.0,1,1,0,no,0.989999771,0.78,no dnr,4.0,68.0,27.0976562,83.0,24.0,38.0,348.0,3.5,1.01,0.89990234,141.0,7.40918,132.0,24.0,3100.0,0.494751,SIP>=30
73.04596,0,female,0,67,692,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,211782.0,126372.188,44.75,white,50.0,1,0,0,no,0.25,0.25,no dnr,67.0,106.0,14.5996094,62.0,10.0,37.89844,168.3125,2.0,0.29998779,2.29980469,138.0,7.209961,198.0,42.0,1350.0,7.0,<2 mo. follow-up
64.77795,0,female,0,36,691,CHF,COPD/CHF/Cirrhosis,9,11.0,under $11k,51994.0,30648.0625,13.25,white,34.0,1,1,0,no,0.799999714,0.7,dnr after sadm,27.0,47.0,16.796875,144.0,28.0,39.19531,168.3125,1.5,0.59997559,2.0,132.0,7.289062,102.0,61.0,4030.0,3.0,adl>=4 (>=5 if sur)
85.75995,1,female,0,11,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17840.0,11800.1875,21.0,white,45.0,2,0,0,no,0.299999952,0.1,dnr after sadm,2.0,72.0,13.7988281,114.0,28.0,35.89844,258.3125,3.0996094,1.01,1.5,145.0,7.469727,221.0,29.0,2275.0,2.0,<2 mo. follow-up
78.05597,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,53410.0,30021.2031,51.0,white,99.0,2,1,0,metastatic,0.5,0.125,dnr after sadm,2.0,81.0,18.5,82.0,28.0,38.19531,218.34375,3.0,0.59997559,1.0,133.0,7.459961,201.0,41.0,2855.0,3.237793,<2 mo. follow-up
75.63599,1,male,0,10,185,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,26626.0,18746.7031,20.0,white,23.0,1,0,0,no,0.899999619,0.85,no dnr,10.0,111.0,7.29980469,80.0,25.0,38.79688,316.0,3.5,1.5,1.29980469,145.0,7.429688,121.0,42.0,3815.0,0.0,no(M2 and SIP pres)
71.78094,1,male,0,25,129,COPD,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,46370.0,28051.75,15.5,white,58.0,3,0,0,yes,0.299999952,0.1,no dnr,25.0,101.0,0.19998169,118.0,22.0,34.79688,333.3,2.199707,2.69970703,0.79992676,141.0,7.419922,87.0,31.0,1550.0,0.0,<2 mo. follow-up
21.20699,0,female,0,10,685,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,31912.0,24281.7812,21.0,white,43.0,3,0,0,no,1.0,1.0,no dnr,10.0,124.0,10.0,160.0,37.0,39.09375,356.0,2.699707,4.09960938,1.0,149.0,7.459961,89.0,28.0,1596.0,0.0,no(M2 and SIP pres)
31.45499,1,female,0,7,198,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,12363.0,8496.1641,7.5,black,38.0,1,1,0,no,0.599999905,0.5,no dnr,7.0,131.0,11.0,103.0,10.0,37.69531,96.0,3.0,1.29980469,2.69970703,144.0,7.429688,392.0,53.0,924.0,2.0649414,adl>=4 (>=5 if sur)
35.60797,0,female,0,19,685,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,55312.0,30751.875,23.0,white,24.0,1,0,0,no,1.0,0.95,no dnr,19.0,139.0,9.0,106.0,28.0,35.59375,219.03125,3.2998047,0.5,8.3984375,137.0,7.449219,92.0,53.0,325.0,0.0,no(M2 and SIP pres)
76.18896,0,female,0,3,685,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,4601.0,2396.1289,22.610928270087555,white,8.0,1,0,1,yes,0.699999809,0.5,dnr before sadm,-1.0,65.0,12.5,60.0,30.0,37.69531,126.51562,3.0996094,1.01,1.5,140.0,7.429688,210.0,52.0,800.0,4.1923828,<2 mo. follow-up
83.07495,1,female,0,17,29,Coma,Coma,1,14.0,$11-$25k,25394.0,15203.2812,13.666664,white,18.0,1,0,0,metastatic,0.5,0.2,dnr before sadm,-1.0,38.0,39.3984375,52.0,14.0,38.69531,354.0,2.7998047,0.39996338,7.79980469,130.0,7.329102,63.0,63.0,0.0,2.0,<2 mo. follow-up
81.00995,1,male,0,10,16,Lung Cancer,Cancer,1,16.0,under $11k,12735.0,6927.9883,14.0,white,24.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,2.0,72.0,10.5996094,103.0,12.0,36.39844,241.65625,2.699707,0.39996338,0.69995117,143.0,7.40918,292.0,26.0,1375.0,3.0,<2 mo. follow-up
52.11798,0,male,0,37,682,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,141717.0,95230.0,39.0,black,43.0,3,1,0,no,0.299999952,0.3,no dnr,37.0,53.0,6.5,60.0,24.0,36.59375,161.21875,2.7998047,1.01,0.69995117,135.0,7.469727,99.0,7.0,1275.0,2.0546875,<2 mo. follow-up
89.547,1,female,0,12,141,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,16186.0,8523.2422,15.5,white,42.0,1,0,0,no,0.599999905,0.5,no dnr,12.0,75.0,14.0,74.0,24.0,35.89844,276.1875,3.5,1.01,1.5,136.0,7.449219,106.0,22.0,3750.0,3.0,adl>=4 (>=5 if sur)
90.03094,1,male,0,14,32,CHF,COPD/CHF/Cirrhosis,3,12.0,>$50k,19286.0,9880.3359,7.0,white,23.0,1,0,0,no,0.699999809,0.6,dnr after sadm,6.0,83.0,11.2988281,100.0,20.0,35.39844,333.3,2.0996094,3.69970703,0.89990234,131.0,7.419922,96.0,11.0,750.0,0.0,<2 mo. follow-up
78.00696,1,female,0,9,212,Colon Cancer,Cancer,2,8.0,$11-$25k,9633.0,5673.2227,13.5,white,10.0,1,0,0,metastatic,0.899999619,0.9,no dnr,9.0,57.0,11.6992188,70.0,10.0,38.19531,176.0,2.2998047,0.5,2.69970703,132.0,7.359375,141.0,63.0,2170.0,1.0,no(M2 and SIP pres)
74.771,1,female,1,29,29,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,144316.0,96597.3125,39.5,hispanic,52.0,1,0,0,yes,0.299999952,0.2,dnr after sadm,15.0,54.0,117.0,118.0,30.0,38.19531,333.3,3.5,1.01,0.5,137.0,7.429688,105.0,23.0,930.0,0.0,<2 mo. follow-up
79.82794,0,female,0,10,680,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,16884.0,9903.6406,16.0,white,33.0,1,0,0,no,0.949999809,0.9,no dnr,10.0,57.0,8.79882812,60.0,20.0,38.29688,141.65625,3.0,1.0,1.19995117,137.0,7.379883,129.0,17.0,4600.0,0.494751,no(M2 and SIP pres)
48.55899,0,male,0,4,680,CHF,COPD/CHF/Cirrhosis,4,14.0,$25-$50k,4980.0,2690.5996,9.0,white,17.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,100.0,3.69970703,60.0,25.0,36.09375,333.3,3.5,1.01,2.79980469,143.0,7.419922,89.0,70.0,1600.0,2.184082,no(M2 and SIP pres)
68.65399,1,male,0,38,158,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,98707.0,14452.7344,34.5,black,32.0,1,1,0,no,0.899999619,0.7,no dnr,38.0,60.0,10.0,110.0,12.0,38.5,180.0,2.2998047,0.59997559,2.19970703,148.0,7.359375,106.0,46.0,2044.0,0.0,adl>=4 (>=5 if sur)
20.05199,0,female,0,13,678,Cirrhosis,COPD/CHF/Cirrhosis,1,13.0,under $11k,27570.0,16774.4219,11.5,asian,37.0,1,0,0,no,0.599999905,0.5,no dnr,13.0,82.0,17.0,120.0,30.0,38.09375,135.0,3.5,1.01,1.0,137.0,7.449219,373.0,30.0,1500.0,0.0,<2 mo. follow-up
51.86298,0,male,0,49,677,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,193178.0,116287.625,48.0,white,62.0,11,0,0,no,0.199999928,0.1,no dnr,49.0,63.0,4.79980469,38.0,26.0,36.19531,333.3,3.5,0.69995117,1.89990234,140.0,7.419922,98.0,78.0,1890.0,0.0,no(M2 and SIP pres)
85.85895,0,male,0,10,677,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,14731.0,8202.5156,16.5,white,24.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,73.0,2.59960938,180.0,4.0,36.59375,140.0,2.2998047,4.39941406,2.69970703,136.0,7.359375,97.0,49.0,750.0,7.0,adl>=4 (>=5 if sur)
72.24597,1,female,0,7,27,Lung Cancer,Cancer,4,12.0,$11-$25k,10505.0,5559.7383,7.0,white,41.0,1,1,0,metastatic,0.799999714,0.6,no dnr,7.0,77.0,8.19921875,73.0,8.0,37.69531,165.0,3.5,1.01,1.0,140.0,7.429688,102.0,22.0,4000.0,0.0,<2 mo. follow-up
70.26996,1,female,0,16,259,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,15786.0,9205.1953,12.0,white,26.0,1,1,0,yes,0.599999905,0.5,dnr after sadm,5.0,131.0,13.0996094,120.0,7.0,38.0,240.8125,3.5,0.59997559,2.5,143.0,7.269531,114.0,52.0,399.0,0.0,<2 mo. follow-up
74.87195,1,female,0,4,5,Lung Cancer,Cancer,1,12.0,under $11k,4868.0,2726.8789,7.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,112.0,10.6992188,118.0,40.0,39.19531,266.625,2.3999023,1.79980469,1.69995117,141.0,7.459961,144.0,14.0,3100.0,2.9086914,<2 mo. follow-up
59.65198,0,male,0,17,675,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$11-$25k,70523.0,37017.0938,34.333313,white,29.0,3,1,0,no,0.699999809,0.5,no dnr,17.0,123.0,9.09960938,80.0,20.0,37.59375,433.3125,3.2998047,0.89990234,5.19921875,122.0,7.289062,943.0,64.0,2502.0,2.5571289,no(M2 and SIP pres)
66.34595,0,female,0,11,675,COPD,COPD/CHF/Cirrhosis,3,14.0,>$50k,12506.0,6952.1836,11.5,white,27.0,1,0,0,yes,1.0,1.0,no dnr,11.0,108.0,7.5,114.0,8.0,38.39844,185.0,3.0,1.01,0.59997559,139.0,7.40918,75.0,9.0,4895.0,2.0,no(M2 and SIP pres)
58.60898,1,female,0,24,674,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,76228.0,58941.125,30.0,white,49.0,1,0,0,no,0.699999809,0.6,no dnr,24.0,83.0,14.5996094,80.0,20.0,36.69531,412.0,3.8999023,0.29998779,0.89990234,146.0,7.329102,124.0,31.0,2502.0,4.0,no(M2 and SIP pres)
83.13794,1,female,0,10,326,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,13636.0,7885.5391,12.0,white,46.0,1,0,1,no,0.949999809,0.8,no dnr,10.0,75.0,9.0,67.0,20.0,36.19531,333.3,3.5,1.01,1.39990234,136.0,7.419922,108.0,17.0,1475.0,5.3701172,adl>=4 (>=5 if sur)
93.89496,1,male,0,7,114,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,8276.0,4589.8164,4.0,white,18.0,1,0,0,yes,0.649999619,0.5,no dnr,7.0,117.0,7.19921875,100.0,20.0,38.69531,420.0,4.1992188,0.5,0.79992676,132.0,7.539062,133.0,11.0,1200.0,4.4140625,<2 mo. follow-up
63.55899,0,male,0,4,670,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,3814.0,2211.6289,9.0,white,26.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,113.0,12.0996094,80.0,20.0,36.69531,333.3,3.5996094,1.19995117,1.59985352,140.0,7.419922,110.0,51.0,2502.0,2.5107422,no(M2 and SIP pres)
88.10699,0,male,0,11,670,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,11812.0,6656.2422,11.0,white,20.0,1,0,0,no,0.75,0.6,no dnr,11.0,123.0,17.8984375,70.0,12.0,36.79688,160.0,2.199707,1.01,1.89990234,148.0,7.389648,362.0,52.0,2360.0,1.0,no(M2 and SIP pres)
88.65198,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,34155.0,21667.0938,31.0,white,54.0,1,1,1,no,0.199999928,0.1,dnr after sadm,1.0,107.0,12.3984375,80.0,25.0,36.09375,272.0,3.5,0.59997559,2.09960938,144.0,7.319336,103.0,50.0,1400.0,6.1611328,<2 mo. follow-up
78.18195,1,female,0,13,27,Lung Cancer,Cancer,2,11.0,under $11k,11763.0,7217.9141,11.0,white,19.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,1.0,97.0,7.79980469,80.0,25.0,36.09375,460.0,3.5,1.01,1.39990234,136.0,7.469727,184.0,39.0,1250.0,6.0,<2 mo. follow-up
76.01398,0,male,0,7,669,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,10143.0,5317.5781,7.0,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,83.0,24.6992188,80.0,15.0,36.09375,333.3,2.5996094,0.69995117,0.79992676,134.0,7.419922,148.0,11.0,982.0,1.1667481,no(M2 and SIP pres)
91.71796,0,female,0,19,668,ARF/MOSF w/Sepsis,ARF/MOSF,4,6.0,under $11k,52128.0,38784.875,26.333328,white,57.0,2,1,0,no,0.699999809,0.6,dnr after sadm,11.0,43.0,15.5,113.0,16.0,37.79688,154.0,1.8999023,0.09999084,0.89990234,146.0,7.299805,186.0,14.0,1338.0,2.0,adl>=4 (>=5 if sur)
60.78,0,male,0,14,668,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,46709.0,28562.625,13.333328,white,49.0,4,0,0,yes,0.75,0.75,no dnr,14.0,59.0,10.0996094,78.0,28.0,37.89844,150.0,3.699707,0.69995117,1.0,142.0,7.459961,114.0,26.0,2064.0,0.0,no(M2 and SIP pres)
48.87299,1,female,0,9,392,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,54664.0,28733.1094,24.0,white,32.0,4,0,0,no,0.979999542,0.98,no dnr,9.0,104.0,9.3984375,108.0,22.0,36.59375,333.3,3.5,1.01,1.29980469,140.0,7.419922,133.0,23.0,2990.0,0.0,no(M2 and SIP pres)
49.45398,0,female,0,4,664,Lung Cancer,Cancer,2,12.0,$25-$50k,12241.0,6169.6445,11.0,white,12.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,49.0,5.69921875,107.0,28.0,38.89844,287.5,3.5,0.59997559,1.39990234,142.0,7.429688,110.0,35.0,2710.0,0.494751,no(M2 and SIP pres)
75.33698,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,30832.0,21063.1719,46.5,white,57.0,1,0,0,no,0.299999952,0.2,dnr after sadm,2.0,72.0,15.0996094,128.0,14.0,36.29688,333.3,2.0,4.09960938,0.59997559,131.0,7.419922,164.0,10.0,1200.0,6.0,<2 mo. follow-up
36.44897,0,female,0,6,661,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,9396.0,6253.5547,12.0,white,30.0,1,0,0,no,0.899999619,0.7,no dnr,6.0,60.0,29.796875,150.0,12.0,36.09375,66.0,1.6999512,1.09985352,0.79992676,145.0,7.329102,309.0,11.0,965.0,0.494751,<2 mo. follow-up
74.48297,1,male,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,53352.0,38328.8125,18.5,white,45.0,2,0,0,yes,0.699999809,0.0,dnr after sadm,1.0,57.0,5.0,80.0,20.0,36.29688,261.875,2.7998047,1.01,1.0,144.0,7.389648,105.0,9.0,2502.0,0.0,<2 mo. follow-up
90.84998,1,female,0,8,369,CHF,COPD/CHF/Cirrhosis,5,16.0,$25-$50k,13773.0,7660.4609,17.0,white,30.0,1,1,0,yes,0.699999809,0.5,no dnr,8.0,80.0,16.8984375,80.0,20.0,36.09375,300.0,3.2998047,1.09985352,1.09985352,133.0,7.459961,158.0,47.0,500.0,0.0,no(M2 and SIP pres)
58.70999,1,male,0,21,231,Lung Cancer,Cancer,2,12.0,under $11k,46753.0,22374.1719,14.333328,white,20.0,1,0,0,metastatic,0.899999619,0.5,no dnr,21.0,103.0,6.69921875,70.0,20.0,35.59375,333.3,3.5,1.01,2.29980469,138.0,7.419922,151.0,79.0,3050.0,4.5273438,<2 mo. follow-up
79.76495,0,female,0,4,660,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4730.0,2543.9805,9.0,white,43.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,77.0,3.5,90.0,20.0,37.79688,290.4375,3.5,1.01,0.59997559,143.0,7.509766,107.0,11.0,2502.0,2.4296875,no(M2 and SIP pres)
61.133,0,male,0,4,658,CHF,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,4455.0,2464.0703,7.0,white,26.0,1,0,0,no,0.989999771,0.99,no dnr,4.0,60.0,16.8984375,120.0,12.0,38.39844,186.0,3.5,1.01,1.19995117,138.0,7.429688,196.0,12.0,1138.0,0.494751,no(M2 and SIP pres)
92.28497,1,male,0,15,43,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,32367.0,22582.9531,15.0,white,56.0,1,0,1,yes,0.5,0.3,dnr before sadm,-1.0,109.0,9.79882812,104.0,12.0,37.59375,168.0,1.8999023,3.79980469,1.09985352,143.0,7.379883,137.0,25.0,3430.0,1.0,<2 mo. follow-up
74.32996,0,male,0,19,657,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,78641.0,41373.7188,15.0,white,52.0,1,0,0,no,0.799999714,0.8,no dnr,19.0,103.0,7.5,100.0,25.0,36.09375,304.75,4.2998047,1.01,1.0,142.0,7.429688,118.0,21.0,2575.0,0.0,no(M2 and SIP pres)
89.00195,0,male,0,9,657,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,16165.0,8656.2188,14.5,white,28.0,1,0,0,no,0.75,0.6,no dnr,9.0,75.0,14.2988281,120.0,22.0,36.59375,295.1875,2.8999023,0.59997559,2.39990234,133.0,7.5,114.0,38.0,2200.0,0.0,no(M2 and SIP pres)
74.71295,0,female,0,5,657,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,6499.0,3311.8633,12.0,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,46.0,13.3984375,128.0,32.0,36.09375,216.0,3.5,1.01,0.69995117,127.0,7.289062,268.0,19.0,1610.0,0.494751,no(M2 and SIP pres)
83.68195,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,16292.0,12585.8359,30.0,white,17.0,1,0,0,no,0.199999928,0.05,dnr after sadm,3.0,53.0,31.5,65.0,22.0,36.09375,98.32812,3.0,0.5,0.89990234,140.0,7.469727,80.0,36.0,725.0,1.0,<2 mo. follow-up
84.71698,1,female,1,10,10,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,under $11k,11188.0,6340.8047,10.0,white,30.0,1,0,0,no,0.199999928,0.1,no dnr,10.0,59.0,9.8984375,68.0,25.0,36.09375,262.9375,3.5,1.01,1.69995117,150.0,7.389648,131.0,69.0,1070.0,0.0,<2 mo. follow-up
75.05499,1,female,0,7,56,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,10896.0,5416.8984,9.0,white,37.0,1,0,0,no,0.899999619,0.6,no dnr,7.0,97.0,3.59960938,56.0,20.0,36.29688,320.0,3.199707,1.01,0.89990234,141.0,7.399414,89.0,26.0,725.0,1.0,<2 mo. follow-up
75.51294,1,male,0,6,9,Colon Cancer,Cancer,4,10.0,$11-$25k,10102.0,5214.3555,12.0,white,46.0,1,1,0,metastatic,0.599999905,0.5,dnr after sadm,3.0,93.0,9.79882812,80.0,20.0,37.0,340.0,3.5,1.01,0.89990234,146.0,7.389648,110.0,37.0,58.695312,1.0,<2 mo. follow-up
69.95197,0,female,0,6,651,CHF,COPD/CHF/Cirrhosis,6,12.0,$25-$50k,8304.0,5138.1016,16.0,white,26.0,1,1,0,no,0.799999714,0.75,no dnr,6.0,70.0,6.19921875,80.0,20.0,36.09375,383.3125,2.5996094,0.69995117,1.29980469,148.0,7.439453,120.0,36.0,1650.0,1.0,no(M2 and SIP pres)
42.198,1,male,0,4,24,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,under $11k,8124.0,5598.8945,22.0,other,65.0,1,0,0,no,0.699999809,0.65,dnr after sadm,2.0,53.0,21.3984375,125.0,34.0,38.29688,125.0,3.0,1.0,2.39990234,152.0,7.439453,420.0,55.0,2661.0,2.9926758,<2 mo. follow-up
52.099,1,male,0,19,634,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,32432.0,17322.9219,15.0,white,52.0,1,0,0,no,0.75,0.6,dnr after sadm,13.0,100.0,13.5996094,100.0,20.0,36.09375,268.0,2.2998047,1.01,0.89990234,141.0,7.459961,137.0,15.0,2502.0,5.0,no(M2 and SIP pres)
96.55298,1,female,0,5,448,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,4872.0,2651.5586,7.0,white,19.0,1,0,0,no,0.699999809,0.6,dnr after sadm,1.0,103.0,18.796875,90.0,25.0,36.09375,333.3,3.5,1.01,1.39990234,138.0,7.419922,188.0,29.0,2502.0,1.1667481,no(M2 and SIP pres)
60.57999,0,male,0,6,650,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,17258.0,12425.8438,22.0,white,57.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,123.0,5.79980469,69.0,42.0,39.39844,166.0,2.3999023,1.01,1.69995117,149.0,7.459961,245.0,50.0,1415.0,0.0,SIP>=30
77.54999,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,121358.0,90567.5,37.0,white,78.0,1,0,0,no,0.5,0.5,dnr after sadm,14.0,121.0,12.7988281,107.0,24.0,38.59375,333.3,3.3999023,1.01,8.8984375,133.0,7.419922,116.0,106.0,200.0,0.0,<2 mo. follow-up
87.93994,1,female,0,8,108,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,10547.0,6321.6562,6.0,white,33.0,1,1,1,no,0.699999809,0.5,dnr before sadm,-1.0,123.0,9.0,121.0,24.0,35.69531,333.3,3.5,1.01,0.89990234,141.0,7.419922,161.0,18.0,2425.0,6.0,<2 mo. follow-up
80.82098,1,male,0,33,160,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,66466.0,41180.625,22.5,black,35.0,2,1,1,yes,0.5,0.4,dnr after sadm,16.0,55.0,7.69921875,72.0,35.0,36.89844,171.65625,3.5,1.01,0.69995117,140.0,7.419922,112.0,16.0,1470.0,0.0,adl>=4 (>=5 if sur)
52.405,1,male,0,15,244,MOSF w/Malig,ARF/MOSF,2,14.0,under $11k,73204.0,51713.1562,24.666656,white,38.0,5,0,0,yes,0.099999964,0.0,no dnr,15.0,63.0,6.69921875,64.0,20.0,36.59375,333.3,4.0,1.01,1.0,142.0,7.419922,106.0,9.0,3625.0,0.0,no(M2 and SIP pres)
41.202,0,female,0,32,646,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,129721.0,82183.5,38.0,white,71.0,1,0,0,no,0.75,0.75,no dnr,32.0,44.0,21.8984375,105.0,10.0,38.5,92.0,2.699707,1.01,2.59960938,137.0,7.419922,173.0,55.0,953.0,2.3608398,<2 mo. follow-up
66.28595,1,female,0,12,43,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,16697.0,9707.1875,8.5,white,35.0,1,0,0,no,0.75,0.5,dnr after sadm,1.0,47.0,6.5,80.0,20.0,36.09375,504.75,3.0,0.29998779,0.79992676,131.0,7.479492,72.0,3.0,1200.0,1.0,<2 mo. follow-up
87.06396,1,female,0,4,70,COPD,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,5038.0,2673.8769,9.0,white,18.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,100.0,6.79980469,61.0,24.0,36.09375,159.0625,4.2998047,0.29998779,1.09985352,133.0,7.299805,229.0,15.0,1500.0,3.1762695,adl>=4 (>=5 if sur)
29.23999,0,male,0,3,643,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,5007.0,2405.1856,22.610928270087555,white,33.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,120.0,10.5,78.0,4.0,38.69531,151.0,3.5,1.01,0.89990234,143.0,7.439453,130.0,21.0,1730.0,1.826416,no(M2 and SIP pres)
62.25299,0,male,0,16,642,ARF/MOSF w/Sepsis,ARF/MOSF,4,19.0,under $11k,47166.0,34499.5625,29.666656,white,48.0,1,1,0,no,0.5,0.5,no dnr,16.0,72.0,6.59960938,80.0,20.0,36.59375,385.6875,3.5,1.01,1.59985352,131.0,7.429688,118.0,40.0,1730.0,3.0,SIP>=30
68.75598,0,male,0,16,642,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,39370.0,21827.7031,18.0,white,16.0,3,0,0,no,0.699999809,0.6,no dnr,16.0,78.0,5.0,92.0,12.0,35.39844,333.3,3.2998047,0.19998169,0.59997559,140.0,7.419922,131.0,5.0,2502.0,1.0,no(M2 and SIP pres)
47.379,1,male,0,5,216,Colon Cancer,Cancer,1,12.0,under $11k,5139.0,3095.4082,11.0,white,14.0,1,0,0,metastatic,0.949999809,0.5,no dnr,5.0,107.0,12.3984375,60.0,20.0,35.39844,290.4375,3.5,1.01,1.69995117,142.0,7.369141,53.0,43.0,1300.0,2.2407227,<2 mo. follow-up
51.64398,0,male,0,16,640,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,>$50k,54163.0,35252.0,35.666657,white,103.0,1,0,0,yes,0.199999928,0.2,no dnr,16.0,83.0,11.2988281,120.0,20.0,38.19531,333.3,3.699707,2.29980469,1.39990234,133.0,7.419922,97.0,20.0,2400.0,2.3583984,no(M2 and SIP pres)
53.02899,1,male,0,6,36,Lung Cancer,Cancer,2,12.0,$11-$25k,10443.0,5390.8398,10.0,black,28.0,1,0,0,metastatic,1.0,0.5,no dnr,6.0,49.0,10.6992188,60.0,10.0,39.0,220.0,2.0996094,0.69995117,4.69921875,160.0,7.349609,150.0,82.0,2000.0,0.494751,<2 mo. follow-up
90.42798,0,female,0,4,637,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,3956.0,2251.0762,8.0,white,15.0,1,1,0,no,0.949999809,0.85,no dnr,4.0,111.0,11.0996094,117.0,26.0,36.19531,127.0,3.5,1.01,1.89990234,142.0,7.449219,103.0,58.0,1480.0,0.494751,no(M2 and SIP pres)
76.54797,0,male,0,7,637,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,7034.0,4044.625,10.0,white,24.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,97.0,6.29980469,76.0,24.0,36.59375,115.0,4.1992188,0.89990234,1.5,137.0,7.199219,106.0,26.0,900.0,0.0,no(M2 and SIP pres)
80.75,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,45475.0,29121.9219,29.0,black,41.0,16,1,0,no,0.199999928,0.1,dnr after sadm,1.0,73.0,7.5,100.0,25.0,36.09375,217.375,3.5,1.01,0.89990234,141.0,7.369141,139.0,16.0,2502.0,0.0,<2 mo. follow-up
49.68698,0,male,0,23,633,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,48180.0,28100.25,24.0,white,47.0,1,0,0,no,0.779999733,0.6,no dnr,23.0,125.0,13.3984375,61.0,8.0,38.19531,242.5,3.5996094,1.01,0.79992676,140.0,7.589844,112.0,14.0,1560.0,0.494751,no(M2 and SIP pres)
79.78894,0,female,0,19,632,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,76279.0,43290.6875,28.333328,white,33.0,19,0,0,no,0.699999809,0.7,no dnr,19.0,100.0,9.09960938,60.0,20.0,37.0,333.3,2.3999023,0.89990234,1.29980469,143.0,7.419922,114.0,16.0,280.0,1.0,no(M2 and SIP pres)
53.58499,0,male,0,8,632,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,>$50k,12397.0,6571.5312,12.5,white,31.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,80.0,4.29980469,70.0,30.0,36.09375,228.5625,3.8999023,1.09985352,1.19995117,140.0,7.379883,152.0,35.0,1075.0,0.0,no(M2 and SIP pres)
91.01996,1,female,0,6,96,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,11767.0,6400.082,18.0,white,21.0,1,0,1,no,0.899999619,0.9,dnr before sadm,-1.0,73.0,7.29980469,80.0,20.0,35.59375,333.3,2.3999023,1.01,1.69995117,132.0,7.419922,351.0,61.0,1125.0,5.1376953,SIP>=30
74.70996,1,female,1,5,5,Coma,Coma,1,8.0,$11-$25k,18728.0,13579.5156,31.0,white,30.0,2,0,0,yes,0.0,0.0,dnr after sadm,4.0,80.0,11.3984375,80.0,25.0,36.69531,276.0,3.5,1.01,1.0,136.0,7.479492,227.0,20.0,2525.0,2.4985352,<2 mo. follow-up
59.82498,1,female,0,12,18,Colon Cancer,Cancer,4,12.0,under $11k,15538.0,8949.1797,11.0,white,38.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,53.0,11.8984375,100.0,15.0,38.29688,333.3,1.7998047,0.59997559,7.29980469,138.0,7.419922,69.0,68.0,0.0,3.4794922,<2 mo. follow-up
79.49597,0,female,0,15,629,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,37583.0,23426.4375,20.333328,white,52.0,1,0,0,no,0.5,0.5,no dnr,15.0,57.0,11.6992188,80.0,20.0,36.09375,333.3,2.3999023,7.39941406,1.5,137.0,7.419922,227.0,51.0,2502.0,0.494751,no(M2 and SIP pres)
35.17599,1,male,0,18,196,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,86623.0,45066.5312,21.0,white,52.0,10,0,0,yes,0.399999857,0.2,no dnr,18.0,107.0,3.0,70.0,30.0,36.09375,333.3,3.5,1.01,0.89990234,140.0,7.419922,98.0,16.0,1800.0,4.0,no(M2 and SIP pres)
66.58496,1,male,0,31,196,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,124293.0,70849.0625,40.0,white,42.0,1,0,0,no,0.799999714,0.7,no dnr,31.0,49.0,9.8984375,70.0,16.0,36.09375,371.375,3.5,0.59997559,14.5,135.0,7.339844,88.0,83.0,0.0,1.0,adl>=4 (>=5 if sur)
86.10797,0,male,0,13,625,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26338.0,17204.7031,27.0,white,40.0,3,0,0,no,0.949999809,0.85,dnr after sadm,1.0,111.0,27.1992188,119.0,10.0,36.0,66.0,2.2998047,0.59997559,7.19921875,135.0,7.489258,184.0,79.0,345.0,1.0,no(M2 and SIP pres)
75.44696,0,female,0,32,622,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,87543.0,62266.3438,33.0,white,46.0,1,0,1,no,0.5,0.5,dnr after sadm,4.0,50.0,6.09960938,60.0,20.0,35.59375,333.3,3.5,1.01,1.39990234,136.0,7.419922,145.0,42.0,2502.0,3.8095703,<2 mo. follow-up
89.09198,0,male,0,7,623,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,14379.0,9627.0469,8.5,black,34.0,1,0,0,yes,0.899999619,0.9,no dnr,7.0,109.0,12.3984375,72.0,4.0,38.79688,295.0,2.199707,1.01,1.29980469,139.0,7.429688,274.0,19.0,2160.0,3.8432617,<2 mo. follow-up
85.70795,0,male,0,18,623,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,55561.0,31941.0,33.666657,white,36.0,1,0,0,no,0.699999809,0.7,no dnr,18.0,113.0,13.1992188,110.0,10.0,36.09375,91.42188,2.0996094,1.01,0.59997559,137.0,7.429688,180.0,20.0,8550.0,5.0,adl>=4 (>=5 if sur)
77.23798,1,male,1,29,29,MOSF w/Malig,ARF/MOSF,3,15.0,$11-$25k,84604.0,49319.5625,17.0,hispanic,29.0,8,0,0,yes,0.799999714,0.1,dnr after sadm,1.0,51.0,2.59960938,155.0,10.0,38.19531,125.0,1.5998535,1.0,0.79992676,143.0,7.259766,73.0,21.0,2640.0,1.0,<2 mo. follow-up
49.875,1,male,0,16,235,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,57210.0,34996.625,30.666656,white,34.0,1,0,0,no,0.699999809,0.7,no dnr,16.0,73.0,9.29882812,70.0,25.0,36.69531,260.0,3.5,1.01,0.79992676,141.0,7.359375,213.0,27.0,600.0,0.0,SIP>=30
88.487,1,female,0,6,498,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,5350.0,3153.6074,15.0,white,19.0,1,0,0,no,0.949999809,0.6,no dnr,6.0,73.0,11.0996094,70.0,20.0,36.09375,678.25,3.5,1.01,1.19995117,142.0,7.279297,155.0,38.0,2502.0,1.8388672,no(M2 and SIP pres)
63.064,0,male,0,20,618,COPD,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,44135.0,30358.0156,22.666656,white,24.0,1,0,0,no,0.899999619,0.7,dnr after sadm,1.0,57.0,14.5996094,124.0,10.0,39.09375,368.3125,4.3994141,0.5,1.0,136.0,7.5,137.0,11.0,2502.0,0.0,SIP>=30
77.84296,0,male,0,10,618,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,16510.0,11070.5391,20.0,white,45.0,1,1,0,no,0.899999619,0.8,no dnr,10.0,67.0,7.5,73.0,12.0,36.29688,152.0,3.0996094,0.39996338,5.59960938,131.0,7.389648,317.0,146.0,2745.0,0.0,no(M2 and SIP pres)
35.13998,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,15.0,>$50k,134773.0,77402.1875,45.5,white,77.0,22,0,0,yes,0.5,0.4,dnr after sadm,7.0,118.0,8.8984375,68.0,24.0,39.0,366.625,3.5,1.01,1.39990234,140.0,7.459961,96.0,26.0,2100.0,1.0,<2 mo. follow-up
77.862,1,female,0,17,448,ARF/MOSF w/Sepsis,ARF/MOSF,3,15.0,$11-$25k,50395.0,29363.4375,23.333328,white,35.0,1,1,0,yes,0.799999714,0.65,no dnr,17.0,69.0,6.29980469,72.0,20.0,35.79688,333.3,3.5,0.5,1.19995117,142.0,7.419922,106.0,14.0,2875.0,0.0,no(M2 and SIP pres)
79.59198,0,female,0,24,615,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,81465.0,45749.0625,39.0,white,54.0,4,0,0,no,0.799999714,0.8,no dnr,24.0,111.0,0.39996338,170.0,28.0,36.19531,135.0,2.2998047,2.09960938,7.79980469,135.0,7.349609,90.0,103.0,1660.0,3.0,no(M2 and SIP pres)
66.10297,1,female,0,3,204,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,7201.0,5917.7344,22.610928270087555,black,46.0,1,1,0,no,0.799999714,0.7,no dnr,3.0,87.0,7.09960938,80.0,20.0,36.69531,333.3,3.5,0.39996338,3.5,142.0,7.419922,88.0,70.0,1375.0,0.494751,no(M2 and SIP pres)
53.55499,0,female,0,21,614,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,65863.0,47683.4688,34.0,white,35.0,1,1,0,no,0.899999619,0.9,no dnr,21.0,97.0,7.79980469,70.0,25.0,36.09375,333.3,3.5,1.01,0.79992676,139.0,7.419922,162.0,13.0,1600.0,1.0,SIP>=30
61.952,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,42843.0,32285.8125,22.333328,white,60.0,1,0,0,no,0.049999982,0.0,dnr after sadm,8.0,70.0,3.79980469,80.0,20.0,35.59375,333.3,3.8999023,1.01,1.79980469,137.0,7.419922,112.0,33.0,2502.0,2.3276367,<2 mo. follow-up
84.57794,0,male,0,13,613,CHF,COPD/CHF/Cirrhosis,2,22.0,under $11k,14980.0,8515.0,10.5,white,31.0,1,0,0,no,0.799999714,0.5,no dnr,13.0,63.0,30.0976562,75.0,24.0,36.19531,333.3,2.5,1.01,5.09960938,134.0,7.419922,303.0,300.0,2155.0,4.0,SIP>=30
81.06494,1,male,0,6,36,CHF,COPD/CHF/Cirrhosis,4,12.0,>$50k,5775.0,3203.0195,17.0,white,17.0,1,0,0,no,0.849999905,0.8,no dnr,6.0,111.0,13.0,110.0,34.0,39.59375,162.0,3.5,1.01,1.5,135.0,7.439453,158.0,37.0,3650.0,0.494751,<2 mo. follow-up
58.168,1,female,0,5,347,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,6601.0,3433.3731,18.0,black,35.0,1,1,0,yes,0.849999905,0.85,no dnr,5.0,110.0,5.69921875,44.0,34.0,36.19531,79.0,2.5996094,0.69995117,1.89990234,138.0,7.359375,132.0,27.0,1675.0,1.1667481,no(M2 and SIP pres)
71.64398,1,male,0,17,48,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,49989.0,27934.75,24.0,white,37.0,3,0,0,yes,0.899999619,0.7,no dnr,17.0,56.0,10.5,70.0,6.0,37.79688,232.5,2.0,0.19998169,1.19995117,143.0,7.479492,152.0,21.0,3200.0,2.9536133,<2 mo. follow-up
63.76999,1,male,0,18,548,ARF/MOSF w/Sepsis,ARF/MOSF,0,22.0,>$50k,69599.0,35332.0312,22.333328,white,33.0,1,0,0,no,0.899999619,0.9,no dnr,18.0,83.0,6.0,80.0,20.0,38.29688,333.3,3.0,4.5,1.69995117,133.0,7.419922,95.0,39.0,800.0,0.0,no(M2 and SIP pres)
58.60397,1,male,0,37,563,MOSF w/Malig,ARF/MOSF,5,22.0,$25-$50k,141401.0,91900.25,35.25,white,48.0,3,0,0,yes,0.599999905,0.5,no dnr,37.0,112.0,8.3984375,76.0,22.0,36.0,333.3,3.5,1.01,1.19995117,137.0,7.419922,93.0,25.0,1325.0,1.0,adl>=4 (>=5 if sur)
44.49597,1,female,0,6,16,Lung Cancer,Cancer,2,12.0,$25-$50k,5962.0,3463.832,6.0,black,50.0,1,0,0,metastatic,0.149999976,0.01,dnr after sadm,2.0,116.0,16.796875,118.0,32.0,39.09375,250.0,4.0,1.01,0.79992676,145.0,7.40918,315.0,18.0,887.0,2.5405273,<2 mo. follow-up
48.37799,1,male,0,40,74,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,149618.0,74711.5,26.25,white,49.0,4,0,0,yes,0.5,0.2,no dnr,40.0,45.0,13.5,100.0,20.0,38.29688,333.3,2.3999023,0.19998169,1.0,134.0,7.419922,77.0,17.0,800.0,0.0,<2 mo. follow-up
74.73199,1,male,0,19,501,COPD,COPD/CHF/Cirrhosis,5,7.0,under $11k,24493.0,13656.2188,13.666664,white,54.0,1,1,0,yes,0.5,0.45,no dnr,19.0,119.0,14.0,118.0,11.0,36.79688,238.09375,1.8999023,0.59997559,1.19995117,113.0,7.349609,1092.0,35.0,2370.0,3.0,<2 mo. follow-up
77.82599,0,female,0,18,600,Coma,Coma,0,12.0,under $11k,31427.0,17934.3906,15.666664,white,26.0,1,0,0,no,0.25,0.1,dnr after sadm,1.0,121.0,26.0976562,156.0,40.0,40.19531,333.3,3.2998047,0.39996338,0.79992676,132.0,7.419922,130.0,10.0,4750.0,6.0,adl>=4 (>=5 if sur)
78.70795,1,female,0,15,189,COPD,COPD/CHF/Cirrhosis,2,18.0,$11-$25k,17883.0,9741.2891,11.666664,white,26.0,1,0,0,no,0.899999619,0.8,dnr after sadm,7.0,59.0,11.7988281,62.0,28.0,38.5,302.0,3.5996094,1.01,2.0,136.0,7.40918,95.0,60.0,2713.0,1.8388672,adl>=4 (>=5 if sur)
82.80096,1,male,0,9,165,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,$11-$25k,8501.0,4951.0508,10.5,white,37.0,1,0,1,yes,0.5,0.2,dnr before sadm,0.0,59.0,6.69921875,66.0,28.0,37.29688,333.3,2.199707,0.59997559,1.79980469,134.0,7.419922,196.0,88.0,2350.0,5.0,adl>=4 (>=5 if sur)
83.23297,1,female,0,15,400,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,24143.0,15879.9141,14.666664,white,29.0,1,0,1,no,0.799999714,0.8,dnr after sadm,1.0,113.0,14.3984375,152.0,36.0,36.39844,96.65625,3.199707,1.09985352,0.89990234,142.0,7.5,108.0,19.0,5065.0,6.0,adl>=4 (>=5 if sur)
71.81696,0,male,0,9,598,COPD,COPD/CHF/Cirrhosis,4,14.0,$11-$25k,21997.0,12084.0312,17.0,white,25.0,1,1,0,no,0.699999809,0.65,no dnr,9.0,47.0,14.0996094,58.0,10.0,37.79688,87.5,2.7998047,0.79992676,1.0,139.0,7.389648,228.0,21.0,848.0,0.0,no(M2 and SIP pres)
74.13794,0,female,0,16,593,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,27806.0,19504.6719,13.333328,white,37.0,1,0,0,no,0.799999714,0.8,dnr after sadm,1.0,107.0,15.2988281,112.0,27.0,36.69531,242.84375,3.5,1.01,1.19995117,140.0,7.439453,150.0,20.0,1670.0,6.0,adl>=4 (>=5 if sur)
93.21295,0,female,0,10,592,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,10108.0,5805.0742,11.5,white,47.0,1,0,0,no,0.799999714,0.7,dnr before sadm,-1.0,113.0,5.79980469,50.0,24.0,37.79688,371.375,2.0996094,4.29980469,1.0,142.0,7.479492,85.0,27.0,2502.0,1.0,no(M2 and SIP pres)
71.34296,0,female,0,8,591,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,18782.0,14517.0781,17.0,white,31.0,1,1,1,no,0.949999809,0.9,dnr before sadm,-1.0,60.0,10.8984375,71.0,7.0,37.79688,164.0,3.199707,0.5,1.19995117,145.0,7.489258,103.0,28.0,880.0,6.0,<2 mo. follow-up
62.76797,0,female,0,10,587,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,14804.0,10534.9922,13.5,white,48.0,1,0,0,no,0.979999542,0.95,no dnr,10.0,112.0,3.79980469,80.0,16.0,38.09375,314.25,3.0,1.01,1.59985352,142.0,7.229492,145.0,27.0,3050.0,0.0,no(M2 and SIP pres)
77.38794,1,male,0,62,65,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,276475.0,14452.7344,28.0,white,45.0,15,1,0,no,0.799999714,0.5,dnr after sadm,56.0,63.0,8.0,109.0,24.0,37.59375,225.0,2.7998047,1.01,1.39990234,133.0,7.279297,171.0,27.0,3893.0,2.0,adl>=4 (>=5 if sur)
44.65698,1,female,0,43,431,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,162599.0,101252.0,34.25,white,92.0,28,0,0,no,0.599999905,0.5,no dnr,43.0,83.0,7.79980469,62.0,22.0,35.79688,333.3,3.5,1.01,1.89990234,140.0,7.419922,97.0,51.0,2000.0,0.0,SIP>=30
50.73798,1,male,0,19,350,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,59439.0,34156.6875,42.333313,white,45.0,1,1,0,no,0.299999952,0.2,dnr after sadm,6.0,68.0,12.2988281,70.0,8.0,36.0,154.0,3.5,1.01,0.69995117,147.0,7.349609,149.0,18.0,846.0,0.0,no(M2 and SIP pres)
73.40497,0,female,0,34,583,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,59995.78781114967,14452.7344,12.25,white,33.0,1,0,0,no,0.699999809,0.55,no dnr,34.0,113.0,13.1992188,110.0,28.0,36.09375,266.625,3.199707,8.19921875,0.89990234,140.0,7.469727,131.0,13.0,1760.0,0.0,<2 mo. follow-up
79.66296,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,62999.0,40298.4688,30.0,white,25.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,6.0,53.0,0.09999084,145.0,22.0,38.39844,152.84375,2.0,0.69995117,0.79992676,150.0,7.329102,245.0,35.0,4700.0,0.0,<2 mo. follow-up
69.08099,1,male,1,14,14,Coma,Coma,0,12.0,under $11k,20163.0,13435.8359,9.0,white,28.0,1,0,0,no,0.299999952,0.25,dnr after sadm,2.0,49.0,11.7988281,67.0,12.0,36.69531,167.5,2.699707,1.19995117,1.5,136.0,7.359375,184.0,31.0,2311.0,2.0917969,<2 mo. follow-up
27.584,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,19892.0,12599.1016,46.0,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,51.0,14.0,120.0,46.0,38.5,235.0,2.3999023,0.69995117,1.79980469,143.0,7.349609,152.0,38.0,2304.0,2.0629883,<2 mo. follow-up
86.26996,1,female,0,7,565,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,$11-$25k,9650.0,5775.1953,6.0,white,32.0,1,0,0,no,0.899999619,0.8,dnr after sadm,1.0,113.0,7.59960938,70.0,16.0,36.69531,603.25,3.5,1.01,7.79980469,142.0,7.109375,225.0,33.0,0.0,4.5273438,SIP>=30
61.35199,0,female,0,54,575,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,234324.0,137719.875,42.75,white,25.0,4,0,0,no,0.199999928,0.2,no dnr,54.0,70.0,17.5,144.0,11.0,39.79688,200.0,2.199707,0.19998169,0.69995117,141.0,7.319336,164.0,12.0,3780.0,0.0,adl>=4 (>=5 if sur)
77.758,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,146557.0,89139.1875,42.0,black,44.0,12,0,0,no,0.199999928,0.1,dnr after sadm,24.0,77.0,15.1992188,124.0,36.0,38.09375,253.03125,2.8999023,1.09985352,1.89990234,134.0,7.319336,224.0,81.0,1225.0,2.7324219,<2 mo. follow-up
80.35297,1,male,0,21,176,Coma,Coma,2,15.0,$11-$25k,29080.0,20074.9531,19.0,white,33.0,1,0,1,no,0.949999809,0.75,dnr after sadm,2.0,77.0,5.59960938,60.0,20.0,36.09375,333.3,3.5,1.01,2.39990234,133.0,7.419922,82.0,61.0,2502.0,7.0,adl>=4 (>=5 if sur)
84.22699,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,36814.0,20278.5469,16.0,white,22.0,13,0,0,yes,0.099999964,0.0,dnr after sadm,1.0,102.0,12.5996094,80.0,20.0,36.09375,333.3,3.5,1.01,1.79980469,136.0,7.419922,163.0,36.0,2502.0,2.5117188,<2 mo. follow-up
82.63397,1,female,0,22,30,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,82585.0,45284.7188,33.666657,white,54.0,1,0,0,yes,0.199999928,0.15,no dnr,22.0,68.0,11.5996094,150.0,24.0,40.0,136.65625,4.5,0.5,3.29980469,138.0,7.519531,146.0,55.0,1040.0,2.0,<2 mo. follow-up
59.03098,0,female,0,4,570,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3748.0,2022.1465,15.0,white,33.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,110.0,4.5,80.0,20.0,36.09375,338.0625,3.5,1.01,9.09960938,141.0,7.289062,78.0,119.0,1950.0,2.1147461,<2 mo. follow-up
49.95499,1,female,0,4,148,Lung Cancer,Cancer,1,14.0,under $11k,12992.0,6650.6328,16.0,black,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,107.0,24.5,80.0,26.0,37.09375,77.0,3.5,1.01,0.5,134.0,7.439453,144.0,11.0,690.0,2.1118164,no(M2 and SIP pres)
70.02594,0,male,0,5,569,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,18838.0,11435.375,10.0,white,40.0,8,0,0,no,0.699999809,0.5,no dnr,5.0,67.0,8.29882812,57.0,8.0,38.19531,156.0,4.5996094,0.59997559,1.0,140.0,7.329102,107.0,10.0,1410.0,3.2270508,<2 mo. follow-up
50.87198,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,60732.0,36637.6875,14.666664,white,27.0,20,1,1,no,0.799999714,0.8,dnr after sadm,7.0,47.0,15.1992188,77.0,9.0,36.0,154.53125,2.7998047,0.29998779,2.79980469,134.0,7.349609,113.0,48.0,2015.0,4.7675781,<2 mo. follow-up
73.03198,0,male,0,29,564,Coma,Coma,2,12.0,under $11k,83542.0,46609.1562,12.75,white,52.0,7,1,0,no,0.0,0.0,no dnr,29.0,73.0,12.5996094,72.0,4.0,36.29688,333.3,2.5996094,0.29998779,0.89990234,138.0,7.419922,143.0,31.0,260.0,3.7890625,<2 mo. follow-up
75.96997,1,female,0,6,140,Colon Cancer,Cancer,3,13.0,under $11k,9781.0,5472.5625,16.0,white,11.0,1,0,0,metastatic,0.599999905,0.1,dnr after sadm,1.0,133.0,11.7988281,140.0,40.0,37.89844,235.0,3.5,1.01,0.89990234,141.0,7.279297,138.0,16.0,3239.0,1.1667481,SIP>=30
100.849,1,female,0,6,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,10535.0,5857.9258,26.0,white,27.0,1,0,1,no,0.699999809,0.5,dnr after sadm,3.0,57.0,20.296875,70.0,25.0,36.69531,277.75,3.5,1.01,2.09960938,132.0,7.399414,407.0,65.0,1350.0,1.0,<2 mo. follow-up
89.56097,1,male,0,7,32,COPD,COPD/CHF/Cirrhosis,7,12.0,under $11k,10879.0,7056.1211,9.0,white,51.0,1,1,0,yes,0.5,0.3,dnr before sadm,-1.0,67.0,15.0996094,70.0,20.0,39.39844,233.3125,4.2998047,0.5,2.39990234,144.0,7.219727,176.0,36.0,3600.0,5.0,<2 mo. follow-up
76.45197,0,male,0,3,563,CHF,COPD/CHF/Cirrhosis,5,16.0,$11-$25k,3710.0,2018.0147,22.610928270087555,white,39.0,1,1,0,yes,0.699999809,0.5,no dnr,3.0,60.0,6.59960938,60.0,25.0,37.79688,232.0,3.5,1.01,1.19995117,142.0,7.359375,98.0,21.0,2502.0,0.494751,no(M2 and SIP pres)
86.71295,1,female,0,5,417,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,10759.0,7902.1875,17.0,black,36.0,1,0,0,no,1.0,1.0,no dnr,5.0,100.0,9.79882812,100.0,20.0,35.89844,113.32812,3.5,1.01,1.59985352,143.0,7.259766,208.0,41.0,900.0,0.494751,no(M2 and SIP pres)
88.099,1,female,1,4,4,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,6003.0,3062.8555,16.0,white,40.0,1,0,0,yes,0.049999982,0.0,dnr before sadm,-1.0,67.0,24.8984375,160.0,30.0,40.0,157.5,3.5,1.01,1.89990234,140.0,7.489258,166.0,78.0,2510.0,4.3720703,<2 mo. follow-up
73.08997,0,male,0,3,560,Colon Cancer,Cancer,1,15.0,>$50k,3504.0,14452.7344,22.610928270087555,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,51.0,16.3984375,65.0,24.0,35.59375,333.3,2.699707,0.39996338,0.69995117,147.0,7.419922,88.0,22.0,3020.0,1.6003418,no(M2 and SIP pres)
41.06,1,male,1,11,11,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,34565.0,22094.8281,14.5,white,11.0,1,0,0,no,0.5,0.3,dnr after sadm,11.0,66.0,10.8984375,66.0,22.0,36.59375,73.0,3.8999023,1.01,1.69995117,139.0,7.459961,132.0,31.0,3420.0,1.0,<2 mo. follow-up
79.38696,0,female,0,8,559,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,10367.0,6241.707,11.5,white,24.0,1,0,0,no,0.929999828,0.9,no dnr,8.0,60.0,16.296875,106.0,24.0,36.89844,250.0,2.699707,0.5,0.69995117,151.0,7.349609,222.0,35.0,1060.0,3.1455078,<2 mo. follow-up
88.04095,1,female,0,12,129,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,14197.0,7723.1719,16.5,white,26.0,1,0,0,no,0.75,0.65,no dnr,12.0,105.0,10.0,85.0,20.0,36.0,333.3,4.0996094,0.29998779,1.29980469,133.0,7.419922,164.0,9.0,2502.0,1.0,no(M2 and SIP pres)
72.02496,0,male,0,14,557,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,under $11k,26558.0,15732.0469,12.666664,white,34.0,1,1,0,yes,0.949999809,0.9,no dnr,14.0,73.0,9.59960938,70.0,20.0,36.69531,333.3,3.5,1.01,2.59960938,140.0,7.419922,168.0,53.0,275.0,1.0,SIP>=30
63.95599,1,female,0,15,78,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$25-$50k,23886.0,16045.0391,13.666664,black,71.0,1,0,0,no,0.75,0.7,no dnr,15.0,111.0,11.1992188,70.0,12.0,36.09375,312.0,2.5,1.01,0.59997559,137.0,7.5,147.0,23.0,980.0,0.0,SIP>=30
59.129,1,male,0,20,94,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,71912.0,14452.7344,36.333313,white,42.0,1,1,0,no,0.599999905,0.55,no dnr,20.0,51.0,12.6992188,76.0,24.0,36.09375,612.0,2.8999023,0.29998779,2.59960938,146.0,7.119141,86.0,41.0,2000.0,0.0,no(M2 and SIP pres)
44.78,0,male,0,7,552,Colon Cancer,Cancer,1,17.0,>$50k,9059.0,4849.8164,6.0,black,16.0,1,0,0,metastatic,0.989999771,0.75,no dnr,7.0,107.0,10.2988281,80.0,26.0,36.29688,176.65625,3.0996094,0.39996338,3.89990234,143.0,7.419922,193.0,90.0,521.0,0.0,no(M2 and SIP pres)
33.73898,1,female,1,37,37,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,>$50k,156416.0,93311.875,33.25,white,39.0,1,0,0,no,0.899999619,0.9,dnr after sadm,35.0,49.0,5.19921875,138.0,52.0,38.09375,131.0,1.8999023,1.01,2.39990234,138.0,7.259766,160.0,52.0,1937.0,0.0,<2 mo. follow-up
63.39798,0,female,0,8,551,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,10480.0,6736.8789,5.5,white,63.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,48.0,18.0976562,131.0,14.0,39.19531,140.0,2.699707,1.01,1.39990234,148.0,7.349609,164.0,19.0,2095.0,1.1667481,no(M2 and SIP pres)
74.58997,0,female,0,23,551,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,30041.0,16481.7656,13.333328,white,36.0,1,0,1,no,0.5,0.3,dnr after sadm,1.0,60.0,14.7988281,80.0,13.0,36.69531,405.0,3.2998047,0.89990234,1.39990234,151.0,7.469727,92.0,67.0,3775.0,5.7011719,adl>=4 (>=5 if sur)
43.93399,0,female,0,11,551,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,40720.0,28689.8125,32.5,black,22.0,1,1,0,no,0.699999809,0.65,no dnr,11.0,46.0,8.5,71.0,24.0,36.09375,217.5,3.699707,0.89990234,1.69995117,143.0,7.419922,119.0,19.0,3835.0,0.0,no(M2 and SIP pres)
74.54095,1,male,1,17,17,Colon Cancer,Cancer,2,17.0,under $11k,28086.0,16028.0312,18.666656,white,37.0,1,1,0,metastatic,0.5,0.2,dnr after sadm,16.0,64.0,6.5,55.0,15.0,36.39844,376.625,3.5,0.5,0.89990234,136.0,7.449219,314.0,15.0,380.0,1.0,<2 mo. follow-up
61.76297,1,female,1,7,7,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,9606.0,4910.543,8.0,white,17.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,51.0,9.8984375,126.0,20.0,39.09375,85.70312,2.5,1.59985352,0.69995117,149.0,7.369141,404.0,11.0,6020.0,3.3886719,<2 mo. follow-up
31.75899,0,female,0,9,550,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,>$50k,13281.0,9716.3906,14.5,white,25.0,1,0,0,yes,1.0,0.98,no dnr,9.0,103.0,6.79980469,80.0,20.0,36.09375,185.0,3.5,1.01,1.79980469,136.0,7.329102,124.0,42.0,785.0,0.0,no(M2 and SIP pres)
80.73395,1,female,0,13,485,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,13755.0,8092.8984,6.5,white,34.0,1,1,0,yes,0.899999619,0.75,no dnr,13.0,70.0,10.5,100.0,12.0,38.5,150.0,2.199707,0.5,1.0,137.0,7.389648,110.0,13.0,2660.0,5.0,no(M2 and SIP pres)
57.44299,0,male,0,6,544,CHF,COPD/CHF/Cirrhosis,5,12.0,>$50k,16060.0,9673.1953,26.0,white,36.0,1,1,0,no,0.899999619,0.65,no dnr,6.0,63.0,24.296875,80.0,8.0,36.89844,191.65625,1.6999512,1.01,1.39990234,132.0,7.489258,279.0,30.0,4375.0,0.494751,no(M2 and SIP pres)
90.409,1,female,0,9,47,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,15787.0,9226.8359,15.0,white,38.0,1,0,0,no,0.599999905,0.5,dnr after sadm,1.0,105.0,7.39941406,71.0,20.0,36.29688,333.3,3.199707,0.69995117,1.69995117,142.0,7.419922,116.0,29.0,2502.0,4.7402344,<2 mo. follow-up
64.47595,1,male,0,55,215,Coma,Coma,3,12.0,under $11k,69165.0,43183.8125,15.5,white,34.0,1,0,0,no,0.199999928,0.1,no dnr,55.0,46.0,14.5,59.0,12.0,38.59375,423.3125,2.2998047,1.01,0.69995117,142.0,7.329102,174.0,19.0,2250.0,2.9770508,adl>=4 (>=5 if sur)
91.55896,1,female,1,11,11,Coma,Coma,1,6.0,under $11k,10485.0,6151.1875,20.0,white,43.0,1,0,1,no,0.099999964,0.02,dnr before sadm,0.0,115.0,12.2988281,69.0,28.0,35.79688,148.3125,3.5,1.01,0.89990234,134.0,7.429688,107.0,10.0,1300.0,7.0,<2 mo. follow-up
73.69995,1,male,0,14,212,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,25804.0,15467.3672,10.0,white,38.0,1,1,0,metastatic,0.049999982,0.02,dnr after sadm,5.0,73.0,26.0,110.0,12.0,36.0,70.0,2.2998047,0.5,1.59985352,143.0,7.469727,149.0,20.0,949.0,3.7792969,no(M2 and SIP pres)
72.41095,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,67720.0,48275.4062,35.333313,white,84.0,4,1,0,no,0.299999952,0.2,dnr after sadm,14.0,103.0,6.29980469,80.0,20.0,36.09375,333.3,4.3994141,0.59997559,5.89941406,135.0,7.419922,91.0,82.0,975.0,1.1667481,<2 mo. follow-up
46.06699,0,male,0,12,538,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,25496.0,16835.1719,14.0,hispanic,28.0,1,1,0,no,1.0,1.0,no dnr,12.0,93.0,6.59960938,96.0,28.0,36.5,333.3,3.5,1.01,0.59997559,137.0,7.419922,96.0,11.0,2220.0,0.0,no(M2 and SIP pres)
87.63599,1,female,0,15,150,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,25788.0,16038.0859,16.333328,white,29.0,1,1,0,no,0.0,0.0,no dnr,15.0,117.0,13.2988281,80.0,25.0,37.79688,333.3,2.0996094,0.39996338,4.29980469,145.0,7.419922,118.0,116.0,2050.0,1.0,adl>=4 (>=5 if sur)
72.46295,1,female,0,10,291,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,15090.0,8748.4688,17.0,white,49.0,1,1,0,yes,0.699999809,0.6,no dnr,10.0,79.0,6.59960938,117.0,25.0,38.09375,333.3,3.5,0.29998779,0.5,130.0,7.419922,307.0,2.0,2675.0,2.0,no(M2 and SIP pres)
76.71497,1,male,0,14,517,CHF,COPD/CHF/Cirrhosis,5,16.0,>$50k,20323.0,11287.5625,9.666664,white,40.0,1,0,0,no,0.699999809,0.6,no dnr,14.0,52.0,7.89941406,106.0,10.0,38.5,333.3,3.5,21.0,1.09985352,138.0,7.419922,330.0,23.0,735.0,6.0,no(M2 and SIP pres)
69.75995,0,male,0,19,534,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,54999.0,36966.5938,23.666656,white,48.0,1,0,0,no,0.299999952,0.1,dnr after sadm,13.0,87.0,15.8984375,80.0,20.0,37.0,333.3,3.3999023,0.5,1.09985352,139.0,7.419922,196.0,17.0,1500.0,0.0,no(M2 and SIP pres)
90.84198,1,female,0,7,171,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,8074.0,4425.0781,10.0,white,31.0,1,1,1,yes,0.899999619,0.6,dnr before sadm,0.0,72.0,10.8984375,72.0,24.0,36.19531,225.6875,3.5,1.01,1.89990234,141.0,7.399414,133.0,58.0,2300.0,4.0,adl>=4 (>=5 if sur)
57.133,0,female,0,7,532,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,17320.0,11057.3828,18.0,white,46.0,1,1,0,no,0.799999714,0.7,no dnr,7.0,83.0,7.89941406,70.0,30.0,36.09375,190.46875,3.5996094,0.79992676,1.0,142.0,7.459961,117.0,27.0,500.0,0.0,no(M2 and SIP pres)
79.64697,1,male,0,6,270,CHF,COPD/CHF/Cirrhosis,5,14.0,$11-$25k,7423.0,3945.709,7.0,white,28.0,1,1,0,metastatic,0.75,0.5,dnr after sadm,2.0,65.0,7.09960938,60.0,18.0,36.19531,333.3,3.5,1.01,2.29980469,134.0,7.419922,283.0,51.0,1700.0,1.0,adl>=4 (>=5 if sur)
84.15594,0,female,0,13,526,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,30009.0,19574.5,31.0,white,32.0,1,1,0,no,0.949999809,0.75,dnr after sadm,11.0,109.0,23.5,50.0,10.0,36.39844,224.4375,3.5,1.39990234,1.09985352,140.0,7.529297,167.0,18.0,2675.0,5.0,adl>=4 (>=5 if sur)
74.74896,1,male,1,7,7,Coma,Coma,2,16.0,under $11k,22690.0,13871.0312,13.0,white,47.0,1,0,0,no,0.199999928,0.1,dnr after sadm,5.0,69.0,5.29980469,65.0,24.0,36.59375,161.65625,3.5,1.01,3.0,139.0,7.189453,99.0,42.0,1500.0,1.0,<2 mo. follow-up
89.71399,0,male,0,22,524,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,under $11k,48745.0,34818.8125,42.0,white,52.0,1,0,0,yes,0.099999964,0.1,no dnr,22.0,113.0,14.0,70.0,20.0,38.29688,247.59375,2.8999023,0.59997559,1.0,130.0,7.519531,171.0,17.0,6625.0,0.0,no(M2 and SIP pres)
63.51297,0,female,0,37,523,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,193988.0,14452.7344,36.75,white,63.0,10,0,0,no,0.799999714,0.7,dnr after sadm,14.0,53.0,8.8984375,120.0,20.0,37.0,196.28125,3.5,1.01,1.09985352,148.0,7.269531,136.0,43.0,2502.0,1.0,adl>=4 (>=5 if sur)
75.92096,0,male,0,7,522,COPD,COPD/CHF/Cirrhosis,2,13.0,$11-$25k,17128.0,10540.1797,14.0,white,38.0,1,0,0,no,0.849999905,0.75,no dnr,7.0,100.0,14.0,70.0,30.0,36.09375,428.5625,4.1992188,0.69995117,1.19995117,139.0,7.539062,118.0,12.0,2502.0,0.0,no(M2 and SIP pres)
67.38696,0,female,0,13,521,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,50514.0,30673.5781,15.5,white,22.0,16,1,0,no,0.799999714,0.95,dnr after sadm,2.0,87.0,9.5,80.0,20.0,36.09375,333.3,2.5996094,1.01,1.09985352,132.0,7.419922,81.0,23.0,2502.0,6.0,no(M2 and SIP pres)
92.57196,1,male,0,6,24,Colon Cancer,Cancer,1,7.0,$11-$25k,5912.0,3369.0644,6.0,white,25.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,72.0,13.1992188,66.0,22.0,36.69531,333.3,3.5,1.0,0.69995117,134.0,7.419922,132.0,8.0,2502.0,3.6606445,<2 mo. follow-up
78.97296,0,male,0,9,520,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,45546.0,27270.8125,13.0,white,40.0,6,0,0,metastatic,0.5,0.5,no dnr,9.0,77.0,5.0,110.0,20.0,36.09375,392.5625,3.5,1.01,1.19995117,135.0,7.449219,112.0,21.0,1100.0,0.0,no(M2 and SIP pres)
65.711,0,male,0,10,517,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,20463.0,14977.1953,16.5,white,51.0,1,1,0,no,0.799999714,0.6,no dnr,10.0,87.0,5.19921875,80.0,25.0,36.09375,333.3,3.5,1.5,1.69995117,143.0,7.419922,111.0,46.0,2502.0,1.0,no(M2 and SIP pres)
71.11597,1,male,1,12,12,Lung Cancer,Cancer,5,0.0,under $11k,15720.0,8923.6016,16.5,white,28.0,1,0,0,metastatic,0.649999619,0.4,no dnr,12.0,63.0,13.3984375,114.0,20.0,36.09375,177.53125,2.5996094,0.39996338,3.59960938,142.0,7.379883,157.0,79.0,3550.0,6.0,<2 mo. follow-up
79.67694,1,male,0,11,96,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,11104.0,6684.3984,6.0,white,40.0,1,0,0,no,0.399999857,0.1,no dnr,11.0,46.0,15.1992188,71.0,16.0,35.39844,168.5625,2.5,2.0,5.59960938,128.0,7.289062,83.0,56.0,0.0,0.0,adl>=4 (>=5 if sur)
78.34399,0,male,0,42,515,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,171445.0,92540.1875,52.25,white,51.0,1,1,0,no,0.099999964,0.1,no dnr,42.0,43.0,10.3984375,107.0,14.0,38.29688,130.0,2.0,1.01,1.69995117,136.0,7.40918,284.0,16.0,8404.0,2.3637695,no(M2 and SIP pres)
77.85895,0,male,0,15,514,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,$25-$50k,42725.0,28351.5156,28.333328,white,58.0,1,1,0,yes,0.5,0.2,no dnr,15.0,77.0,13.8984375,70.0,20.0,37.89844,333.3,3.2998047,1.29980469,1.29980469,135.0,7.419922,130.0,12.0,1300.0,3.6811523,<2 mo. follow-up
75.88196,1,male,0,14,268,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,38838.0,28448.0156,27.333328,white,56.0,1,0,0,no,0.799999714,0.8,no dnr,14.0,55.0,2.59960938,105.0,20.0,36.79688,420.0,1.5,0.79992676,0.59997559,141.0,7.429688,86.0,13.0,1900.0,0.0,<2 mo. follow-up
79.63599,0,male,0,10,513,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,17408.0,10100.2578,17.5,white,32.0,1,1,0,no,0.899999619,0.5,no dnr,10.0,57.0,23.3984375,70.0,25.0,36.69531,195.21875,3.5,1.01,2.0,145.0,7.359375,224.0,50.0,1780.0,0.0,adl>=4 (>=5 if sur)
53.952,1,male,0,4,464,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,13302.0,10411.4531,16.0,black,47.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,117.0,17.8984375,100.0,20.0,38.29688,130.0,3.5,1.01,0.89990234,151.0,7.149414,121.0,26.0,30.0,2.2719727,no(M2 and SIP pres)
83.81396,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,27338.0,19948.9062,34.5,white,61.0,1,0,1,no,0.699999809,0.7,dnr after sadm,1.0,137.0,16.5,66.0,10.0,36.89844,120.0,3.5996094,0.79992676,0.69995117,136.0,7.379883,315.0,15.0,2680.0,6.0,<2 mo. follow-up
56.63498,0,female,0,26,506,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,119068.0,69944.5625,38.5,white,48.0,1,0,0,no,0.799999714,0.87,no dnr,26.0,62.0,10.1992188,72.0,12.0,35.69531,333.3,3.5,1.01,1.19995117,130.0,7.419922,105.0,20.0,850.0,0.0,<2 mo. follow-up
72.94196,1,female,1,5,5,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,16909.0,10511.6953,17.0,white,74.0,1,0,0,yes,0.099999964,0.05,no dnr,5.0,97.0,12.1992188,110.0,25.0,35.79688,420.0,3.199707,0.39996338,0.69995117,144.0,7.449219,158.0,11.0,2502.0,2.9960938,<2 mo. follow-up
70.07495,1,male,0,7,152,Lung Cancer,Cancer,3,19.0,$11-$25k,8271.0,4555.8086,3.5,white,16.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,4.0,79.0,6.0,70.0,24.0,36.29688,136.71875,3.0,0.39996338,1.0,138.0,7.479492,146.0,17.0,1850.0,0.0,<2 mo. follow-up
70.21497,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,55557.0,39851.4688,41.5,white,35.0,1,0,0,no,0.899999619,0.9,dnr after sadm,10.0,107.0,3.79980469,80.0,20.0,36.69531,333.3,3.5,1.01,4.59960938,135.0,7.419922,105.0,53.0,825.0,1.0,<2 mo. follow-up
44.65997,0,female,0,25,499,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,94668.0,63825.6875,33.0,black,32.0,4,0,0,no,0.599999905,0.6,no dnr,25.0,117.0,6.5,82.0,20.0,35.89844,309.5,3.5,1.01,3.5,142.0,7.389648,226.0,55.0,5860.0,0.0,no(M2 and SIP pres)
70.44995,0,female,0,7,499,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,6921.0,3909.4043,5.0,white,12.0,1,0,0,yes,0.899999619,0.9,no dnr,7.0,67.0,6.79980469,64.0,12.0,36.39844,155.09375,3.5,0.39996338,2.39990234,141.0,7.329102,90.0,64.0,2360.0,2.3833008,<2 mo. follow-up
64.89294,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,37234.0,18465.0625,64.0,white,47.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,64.0,6.5,63.0,30.0,38.19531,126.65625,3.5996094,1.09985352,1.39990234,143.0,7.399414,86.0,30.0,1885.0,2.4599609,<2 mo. follow-up
66.37598,1,female,0,7,33,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,8253.0,4674.8828,6.0,black,32.0,1,0,1,no,0.599999905,0.3,no dnr,7.0,60.0,17.5,40.0,20.0,35.79688,333.3,3.5,1.01,2.29980469,150.0,7.419922,98.0,93.0,925.0,6.0,<2 mo. follow-up
71.80798,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,$11-$25k,11112.0,5896.1367,6.5,white,26.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,1.0,107.0,11.5996094,116.0,28.0,35.29688,286.625,2.3999023,1.01,0.69995117,130.0,7.419922,260.0,21.0,2502.0,5.0,<2 mo. follow-up
77.32794,1,male,1,14,14,MOSF w/Malig,ARF/MOSF,2,16.0,$25-$50k,38514.0,14452.7344,11.0,white,62.0,1,0,0,yes,0.299999952,0.05,dnr after sadm,12.0,75.0,19.6992188,108.0,32.0,35.0,240.0,1.7998047,2.39990234,4.39941406,131.0,7.30957,214.0,67.0,285.0,0.0,<2 mo. follow-up
64.63196,0,female,0,11,495,Lung Cancer,Cancer,1,13.0,$25-$50k,13459.0,7567.1641,13.0,white,24.0,1,0,0,metastatic,0.5,0.05,no dnr,11.0,60.0,6.19921875,75.0,22.0,36.59375,714.25,3.199707,0.5,0.59997559,137.0,7.069336,400.0,10.0,9000.0,1.0,no(M2 and SIP pres)
29.29799,0,male,0,13,492,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,59995.78781114967,14452.7344,39.0,white,38.0,7,0,0,no,0.799999714,0.8,no dnr,14.58258953168044,116.0,10.6992188,74.0,20.0,38.19531,272.0,3.699707,1.09985352,0.89990234,150.0,7.449219,209.0,30.0,690.0,0.0,no(M2 and SIP pres)
74.06195,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,87620.0,55738.7812,38.5,white,49.0,1,0,0,no,0.099999964,0.05,dnr after sadm,22.0,64.0,19.6992188,60.0,24.0,37.39844,76.65625,3.5,1.01,1.89990234,135.0,7.269531,331.0,40.0,3310.0,1.0,<2 mo. follow-up
63.22198,1,male,0,8,225,Cirrhosis,COPD/CHF/Cirrhosis,4,13.0,under $11k,11623.0,6085.7773,5.5,white,13.0,1,1,0,no,0.75,0.5,no dnr,8.0,43.0,11.6992188,70.0,20.0,35.59375,135.0,3.5,1.01,2.0,139.0,7.439453,93.0,54.0,1075.0,3.0,no(M2 and SIP pres)
83.65198,0,female,0,9,492,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,21889.0,14486.3828,15.5,white,34.0,1,0,0,no,1.0,1.0,no dnr,9.0,76.0,17.5,114.0,28.0,36.39844,322.1875,2.0,2.39990234,0.79992676,141.0,7.439453,101.0,21.0,910.0,3.1210938,no(M2 and SIP pres)
70.08899,0,female,0,8,491,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,8502.0,4805.1172,9.5,white,35.0,1,1,0,no,0.599999905,0.4,no dnr,8.0,107.0,10.3984375,90.0,20.0,37.0,220.0,3.5,1.01,1.5,140.0,7.449219,179.0,23.0,800.0,0.0,no(M2 and SIP pres)
82.57098,0,female,0,5,490,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5274.0,2972.1348,20.0,white,32.0,1,1,0,no,0.799999714,0.65,no dnr,5.0,117.0,18.0976562,140.0,30.0,40.19531,162.5,4.0,0.59997559,1.09985352,141.0,7.459961,151.0,19.0,1625.0,2.0,no(M2 and SIP pres)
74.21796,1,male,0,7,207,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,10267.0,5255.0938,5.0,white,50.0,1,1,0,no,0.909999847,0.9,no dnr,7.0,55.0,14.5996094,80.0,8.0,37.69531,374.25,2.199707,0.69995117,1.59985352,136.0,7.319336,261.0,44.0,1970.0,1.0,SIP>=30
56.698,0,female,0,6,484,COPD,COPD/CHF/Cirrhosis,2,13.0,$25-$50k,11830.0,8260.5078,16.0,white,14.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,100.0,8.5,70.0,20.0,36.09375,333.3,3.0996094,0.59997559,1.79980469,135.0,7.419922,276.0,30.0,1350.0,0.0,no(M2 and SIP pres)
55.34,1,male,0,16,49,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,30451.0,18925.0469,19.333328,white,24.0,1,0,0,no,0.899999619,0.8,no dnr,16.0,62.0,6.79980469,119.0,30.0,36.69531,240.0,3.5,1.01,0.79992676,138.0,7.429688,312.0,25.0,1775.0,0.0,<2 mo. follow-up
63.71799,0,female,0,4,482,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,6560.0,3361.3398,11.0,white,16.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,111.0,12.0,73.0,30.0,39.89844,166.0,3.5996094,0.79992676,2.09960938,148.0,7.439453,141.0,56.0,1660.0,2.0039062,no(M2 and SIP pres)
70.54895,0,female,0,9,481,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,14419.0,7425.9219,14.5,white,27.0,1,1,0,no,0.799999714,0.7,no dnr,9.0,48.0,16.8984375,105.0,12.0,38.09375,59.0,3.7998047,1.29980469,2.19970703,138.0,7.359375,183.0,71.0,5380.0,1.0,no(M2 and SIP pres)
64.82996,0,male,0,8,477,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,16287.0,9790.8906,20.5,white,17.0,1,0,0,no,0.899999619,0.85,no dnr,8.0,63.0,3.5,110.0,16.0,38.59375,238.0,2.0,1.01,3.59960938,133.0,7.389648,115.0,61.0,0.0,2.6801758,<2 mo. follow-up
67.797,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,3,12.0,$25-$50k,99187.0,60955.6562,46.0,white,58.0,16,0,0,yes,0.199999928,0.2,no dnr,10.0,76.0,14.7988281,72.0,25.0,36.19531,356.0,3.7998047,0.69995117,2.0,137.0,7.089844,123.0,25.0,1320.0,0.0,<2 mo. follow-up
78.836,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,140610.0,73381.8125,61.666657,white,81.0,8,0,0,no,0.699999809,0.5,dnr after sadm,14.0,61.0,15.6992188,79.0,30.0,38.19531,333.3,3.5,1.01,0.59997559,136.0,7.419922,132.0,6.0,1550.0,0.0,<2 mo. follow-up
76.49597,0,male,0,3,473,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,3392.0,1745.9248,22.610928270087555,white,30.0,1,0,0,yes,0.699999809,0.5,no dnr,3.0,72.0,11.6992188,64.0,20.0,36.29688,333.3,3.5996094,1.09985352,0.89990234,136.0,7.419922,96.0,21.0,600.0,0.494751,no(M2 and SIP pres)
61.40198,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,54985.0,30964.4375,30.0,white,87.0,16,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,104.0,10.0,60.0,12.0,36.29688,108.32812,3.5,1.01,1.29980469,137.0,7.399414,97.0,40.0,1400.0,2.2880859,<2 mo. follow-up
64.51996,0,male,0,6,472,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,11983.0,7241.2617,21.0,white,48.0,1,0,0,no,0.989999771,0.95,no dnr,6.0,55.0,11.0,71.0,14.0,36.09375,600.0,3.699707,0.69995117,6.79980469,138.0,7.389648,197.0,55.0,390.0,0.0,no(M2 and SIP pres)
62.155,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,32587.0,19519.9062,43.0,white,60.0,3,0,0,no,0.699999809,0.5,dnr after sadm,5.0,77.0,12.0996094,130.0,30.0,39.0,357.125,2.7998047,0.59997559,0.89990234,136.0,7.469727,140.0,9.0,1750.0,1.0,<2 mo. follow-up
65.98499,1,male,0,9,43,Lung Cancer,Cancer,1,8.0,under $11k,16239.0,8887.7891,17.5,white,24.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,1.0,70.0,9.0,80.0,20.0,34.39844,333.3,3.5,1.01,1.39990234,126.0,7.419922,115.0,38.0,350.0,3.0,<2 mo. follow-up
64.95599,1,male,0,6,77,Lung Cancer,Cancer,2,10.0,$11-$25k,6889.0,3987.8144,8.0,white,12.0,1,0,0,metastatic,0.649999619,0.25,no dnr,6.0,54.0,18.296875,121.0,10.0,38.79688,165.0,2.699707,0.89990234,1.39990234,146.0,7.489258,264.0,23.0,3751.0,2.0,no(M2 and SIP pres)
73.77997,1,female,0,5,166,Colon Cancer,Cancer,1,12.0,under $11k,7095.0,5031.3672,10.0,white,20.0,1,0,0,metastatic,0.799999714,0.7,no dnr,5.0,57.0,16.0,138.0,40.0,38.09375,182.0,2.5996094,1.29980469,0.89990234,139.0,7.449219,250.0,24.0,1515.0,2.0170898,<2 mo. follow-up
48.83197,1,female,0,12,59,Lung Cancer,Cancer,2,12.0,>$50k,19926.0,10830.2578,21.5,white,14.0,1,0,0,metastatic,0.5,0.3,no dnr,12.0,55.0,10.0996094,49.0,10.0,38.79688,84.4375,2.8999023,1.0,6.69921875,139.0,7.359375,114.0,112.0,2395.0,1.0,<2 mo. follow-up
99.198,0,female,0,9,469,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,9626.0,5471.4766,7.0,white,24.0,1,0,0,yes,0.799999714,0.7,dnr after sadm,2.0,75.0,37.6953125,66.0,22.0,36.39844,187.5,3.199707,0.39996338,1.59985352,140.0,7.369141,181.0,29.0,4525.0,2.0,no(M2 and SIP pres)
41.46198,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,17453.0,10567.6562,35.0,white,99.0,1,0,0,yes,0.049999982,0.05,dnr after sadm,3.0,72.0,10.0996094,65.0,20.0,35.79688,148.3125,3.3999023,0.39996338,1.89990234,135.0,7.239258,191.0,49.0,1560.0,2.0996094,<2 mo. follow-up
68.90594,1,female,0,14,94,Lung Cancer,Cancer,3,12.0,$11-$25k,26221.0,13905.5938,13.333328,white,35.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,2.0,140.0,7.59960938,114.0,24.0,36.59375,355.0,3.5,0.69995117,21.5,136.0,7.219727,187.0,174.0,625.0,0.0,<2 mo. follow-up
68.06799,0,female,0,4,466,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,6274.0,14452.7344,5.0,white,33.0,1,1,0,no,0.799999714,0.6,no dnr,4.0,42.0,15.8984375,70.0,37.0,39.39844,102.84375,2.2998047,1.09985352,1.39990234,148.0,7.449219,78.0,51.0,4460.0,3.6503906,<2 mo. follow-up
72.00494,0,female,0,26,465,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,66389.0,43857.75,22.75,white,51.0,1,1,0,no,0.899999619,0.9,no dnr,26.0,107.0,14.1992188,100.0,12.0,38.29688,241.0,3.0,5.79980469,4.5,144.0,7.429688,163.0,39.0,859.0,2.0,no(M2 and SIP pres)
69.21796,0,male,0,19,463,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,75486.0,45836.7188,22.333328,white,35.0,9,0,0,no,0.5,0.5,no dnr,19.0,51.0,5.89941406,116.0,10.0,38.79688,55.0,3.5,1.01,2.29980469,131.0,7.25,253.0,29.0,765.0,0.0,no(M2 and SIP pres)
59.63599,1,male,0,4,52,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,5450.0,2994.2324,17.0,black,31.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,60.0,7.89941406,80.0,20.0,36.09375,333.3,4.0,0.59997559,0.79992676,130.0,7.419922,412.0,15.0,2502.0,0.494751,<2 mo. follow-up
86.13794,1,female,0,18,20,Colon Cancer,Cancer,2,12.0,under $11k,15685.0,9282.5547,5.0,black,20.0,1,0,0,metastatic,0.199999928,0.01,dnr after sadm,2.0,195.0,18.296875,180.0,33.0,38.09375,102.84375,3.5,1.01,1.39990234,137.0,7.30957,150.0,16.0,3275.0,0.494751,<2 mo. follow-up
85.00195,0,male,0,21,460,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,43153.0,29686.2969,19.333328,white,42.0,5,0,0,no,0.5,0.5,no dnr,21.0,55.0,14.3984375,80.0,42.0,38.39844,153.3125,3.5,1.01,0.79992676,141.0,7.399414,115.0,14.0,1081.0,1.0,no(M2 and SIP pres)
52.25198,1,female,0,17,173,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,37267.0,24023.6406,18.0,white,41.0,1,0,0,yes,1.0,0.5,dnr after sadm,9.0,127.0,6.69921875,114.0,16.0,38.59375,91.25,2.0996094,0.19998169,0.79992676,141.0,7.439453,112.0,11.0,2780.0,0.494751,no(M2 and SIP pres)
74.81494,1,female,1,8,8,Coma,Coma,3,12.0,under $11k,41314.0,29420.4844,35.0,white,66.0,3,1,1,no,0.199999928,0.2,dnr after sadm,4.0,117.0,7.69921875,80.0,20.0,36.09375,366.625,3.2998047,1.01,0.79992676,139.0,7.40918,92.0,14.0,750.0,4.53125,<2 mo. follow-up
80.99896,1,male,1,7,7,Lung Cancer,Cancer,1,14.0,$25-$50k,10073.0,5477.4531,13.5,white,29.0,1,0,0,metastatic,0.899999619,0.5,dnr after sadm,1.0,60.0,13.6992188,130.0,12.0,39.39844,58.0,3.5,0.69995117,2.89990234,141.0,7.25,128.0,30.0,2226.0,2.6552734,<2 mo. follow-up
69.19397,1,female,0,19,200,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,52004.0,33686.25,24.0,white,36.0,4,0,0,yes,0.799999714,0.5,dnr after sadm,1.0,57.0,6.59960938,100.0,25.0,36.19531,304.0,3.2998047,1.79980469,1.09985352,142.0,7.479492,109.0,14.0,2502.0,2.5107422,adl>=4 (>=5 if sur)
73.69495,1,female,1,8,8,Lung Cancer,Cancer,2,12.0,under $11k,25491.0,10699.6172,15.5,white,22.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,3.0,70.0,11.3984375,90.0,20.0,36.09375,333.3,2.199707,1.89990234,0.89990234,132.0,7.419922,158.0,25.0,2502.0,0.0,<2 mo. follow-up
75.27399,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,59995.78781114967,14452.7344,48.0,white,68.0,1,1,0,no,0.25,0.25,no dnr,14.58258953168044,63.0,1.59985352,45.0,32.0,36.09375,412.0,2.3999023,1.29980469,1.79980469,135.0,7.40918,216.0,41.0,685.0,0.0,<2 mo. follow-up
42.60898,1,female,0,97,98,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,460909.0,14452.7344,33.0,white,50.0,7,0,0,no,0.599999905,0.6,dnr after sadm,93.0,97.0,11.6992188,80.0,25.0,36.69531,333.3,2.3999023,0.29998779,0.79992676,132.0,7.419922,528.0,13.0,2900.0,1.0,adl>=4 (>=5 if sur)
67.37897,0,male,0,9,453,COPD,COPD/CHF/Cirrhosis,6,11.0,under $11k,14515.0,9983.3281,13.5,white,43.0,1,1,0,no,0.899999619,0.6,no dnr,9.0,77.0,14.2988281,130.0,12.0,38.89844,354.0,2.0,1.01,0.79992676,140.0,7.479492,154.0,22.0,3680.0,0.0,no(M2 and SIP pres)
82.034,1,female,0,4,28,Colon Cancer,Cancer,1,12.0,under $11k,3777.0,2087.0606,3.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,110.0,8.79882812,110.0,14.0,37.89844,192.5,1.8999023,0.59997559,6.89941406,136.0,7.429688,164.0,87.0,1490.0,2.8754883,<2 mo. follow-up
75.87396,1,male,0,109,218,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,269854.0,14452.7344,43.75,white,64.0,4,1,0,yes,0.25,0.2,no dnr,109.0,81.0,6.69921875,80.0,20.0,36.89844,333.3,3.3999023,4.69921875,0.79992676,136.0,7.419922,93.0,17.0,2502.0,2.4067383,SIP>=30
75.69598,0,male,0,26,450,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,50793.0,30239.1094,18.75,white,42.0,3,0,0,no,0.899999619,0.9,no dnr,26.0,103.0,17.0976562,64.0,22.0,38.0,434.5625,3.3999023,3.5,4.09960938,153.0,7.469727,75.0,137.0,3040.0,0.0,no(M2 and SIP pres)
89.72998,1,female,0,5,100,COPD,COPD/CHF/Cirrhosis,6,14.0,under $11k,5463.0,3171.1406,7.0,white,23.0,1,0,0,no,0.199999928,0.0,dnr after sadm,1.0,70.0,12.0996094,60.0,20.0,36.5,333.3,3.199707,1.01,2.19970703,131.0,7.419922,99.0,54.0,1675.0,1.1667481,adl>=4 (>=5 if sur)
70.073,1,female,0,9,154,Colon Cancer,Cancer,2,15.0,$11-$25k,17889.0,11542.8047,15.0,white,21.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,2.0,73.0,3.69970703,60.0,20.0,35.59375,333.3,3.2998047,1.01,1.5,140.0,7.419922,203.0,32.0,1350.0,0.0,no(M2 and SIP pres)
66.32196,1,female,1,21,21,Cirrhosis,COPD/CHF/Cirrhosis,6,12.0,under $11k,40175.0,23565.5156,14.0,white,47.0,1,1,0,metastatic,0.75,0.1,dnr after sadm,2.0,73.0,6.5,80.0,25.0,36.09375,242.84375,3.5996094,0.5,2.39990234,143.0,7.539062,50.0,68.0,2100.0,4.5820312,<2 mo. follow-up
90.75995,1,male,0,11,22,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,18985.0,12499.0547,17.5,white,54.0,1,1,0,no,0.699999809,0.5,dnr before sadm,-1.0,123.0,9.0,104.0,28.0,36.19531,200.0,2.3999023,0.59997559,4.09960938,137.0,7.449219,166.0,76.0,1800.0,4.5380859,<2 mo. follow-up
71.13495,0,female,0,4,446,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,15780.0,11261.8438,11.0,white,24.0,3,0,1,no,0.399999857,0.3,no dnr,4.0,77.0,13.5,60.0,24.0,36.09375,145.0,3.5,0.59997559,0.69995117,141.0,7.359375,144.0,14.0,1700.0,6.0,adl>=4 (>=5 if sur)
57.92499,0,female,0,9,446,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,8734.0,5139.0586,7.5,hispanic,33.0,1,1,0,no,0.989999771,0.99,no dnr,9.0,65.0,11.5,106.0,28.0,37.79688,333.3,3.5,1.01,1.0,136.0,7.419922,130.0,14.0,1150.0,3.0,SIP>=30
89.47296,1,male,0,13,43,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,44299.0,26925.4062,25.5,white,24.0,12,0,1,yes,0.799999714,0.7,no dnr,13.0,83.0,16.0,80.0,20.0,36.09375,214.8125,3.8999023,0.89990234,0.69995117,142.0,7.389648,102.0,20.0,2502.0,7.0,<2 mo. follow-up
68.17499,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,24260.0,16137.75,25.5,white,66.0,1,0,1,yes,0.5,0.2,no dnr,11.0,77.0,6.5,80.0,25.0,36.29688,288.0,2.8999023,1.01,1.0,136.0,7.469727,208.0,23.0,2502.0,1.0,<2 mo. follow-up
79.80597,0,female,0,13,443,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,34574.0,14452.7344,29.5,white,42.0,1,0,0,no,1.0,0.9,dnr after sadm,2.0,107.0,6.89941406,100.0,26.0,35.39844,333.3,4.0,1.01,1.09985352,139.0,7.419922,106.0,19.0,3250.0,1.0,no(M2 and SIP pres)
63.198,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,34958.0,24062.5781,23.5,white,61.0,2,1,0,yes,0.299999952,0.5,dnr after sadm,6.0,119.0,0.19998169,124.0,38.0,38.59375,121.65625,2.2998047,1.19995117,1.39990234,151.0,7.419922,145.0,27.0,3455.0,2.0,<2 mo. follow-up
81.21796,0,female,0,13,440,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,30348.0,16742.7344,28.5,white,18.0,1,0,0,no,0.599999905,0.5,dnr before sadm,-1.0,62.0,14.3984375,180.0,12.0,38.0,197.5,3.5,1.01,4.79980469,140.0,7.449219,179.0,45.0,540.0,4.0,SIP>=30
56.556,0,female,0,7,437,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,11227.0,14452.7344,6.5,white,36.0,1,1,0,no,0.899999619,0.75,no dnr,7.0,53.0,20.8984375,120.0,8.0,32.59375,48.0,1.0,1.01,1.19995117,130.0,7.379883,147.0,13.0,419.0,0.0,<2 mo. follow-up
91.01996,0,female,0,9,438,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,18010.0,14452.7344,14.0,white,26.0,1,0,0,no,0.849999905,0.614,dnr after sadm,1.0,127.0,11.1992188,80.0,20.0,36.09375,333.3,3.5996094,1.01,3.89990234,142.0,7.419922,124.0,56.0,2502.0,2.0,adl>=4 (>=5 if sur)
40.67599,0,female,0,28,437,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,>$50k,89921.0,67147.9375,34.75,white,45.0,1,0,0,no,0.649999619,0.65,no dnr,28.0,38.0,1.0,140.0,32.0,36.29688,193.3125,3.5,1.01,2.59960938,146.0,7.389648,146.0,82.0,0.0,0.0,no(M2 and SIP pres)
81.00195,0,male,0,43,436,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,79981.0,45042.25,17.75,white,34.0,1,0,0,no,0.599999905,0.55,dnr after sadm,33.0,71.0,11.2988281,110.0,22.0,35.59375,200.0,3.0,0.79992676,1.79980469,136.0,7.469727,102.0,45.0,3925.0,1.0,no(M2 and SIP pres)
85.80194,1,male,0,13,31,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20685.0,12158.5781,16.5,white,42.0,1,0,1,no,0.799999714,0.7,dnr before sadm,-1.0,47.0,12.0996094,144.0,16.0,38.09375,100.0,1.7998047,0.39996338,1.09985352,137.0,7.359375,91.0,20.0,2760.0,6.0,<2 mo. follow-up
73.24298,1,female,0,11,153,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,14628.0,7396.7266,5.0,white,32.0,1,0,0,no,0.799999714,0.6,dnr before sadm,-1.0,57.0,9.0,120.0,20.0,36.19531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,2.0,SIP>=30
83.20099,1,male,0,8,35,Lung Cancer,Cancer,3,12.0,under $11k,8584.0,4957.8984,10.5,white,13.0,1,1,0,metastatic,0.599999905,0.4,no dnr,8.0,67.0,9.29882812,87.0,16.0,36.09375,333.3,3.5,1.01,0.69995117,132.0,7.419922,147.0,14.0,2502.0,7.0,<2 mo. follow-up
65.34399,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,65291.0,14452.7344,21.0,white,57.0,1,1,0,yes,0.5,0.0,dnr after sadm,24.0,90.0,12.8984375,100.0,20.0,37.19531,290.4375,3.5,1.01,0.79992676,139.0,7.449219,126.0,17.0,2502.0,0.0,<2 mo. follow-up
70.47998,1,male,0,33,190,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,124697.0,14452.7344,28.75,white,56.0,2,0,0,yes,0.199999928,0.05,no dnr,33.0,107.0,4.39941406,70.0,20.0,36.69531,304.75,2.5996094,0.29998779,1.0,143.0,7.449219,122.0,14.0,445.0,2.5854492,Coma or Intub
31.17899,1,male,1,17,17,MOSF w/Malig,ARF/MOSF,2,14.0,$25-$50k,120808.0,14452.7344,47.0,white,57.0,1,0,0,yes,0.5,0.5,dnr after sadm,12.0,85.0,9.59960938,60.0,18.0,36.5,333.3,2.3999023,0.59997559,0.69995117,141.0,7.419922,208.0,14.0,3600.0,0.0,<2 mo. follow-up
46.55399,0,male,0,11,429,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$11-$25k,41692.0,20516.0469,19.0,white,32.0,2,0,0,yes,0.989999771,0.99,no dnr,11.0,73.0,6.69921875,80.0,20.0,36.69531,483.3125,3.5,1.01,1.19995117,139.0,7.349609,97.0,30.0,625.0,0.0,no(M2 and SIP pres)
78.45898,1,male,0,7,347,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,$11-$25k,13683.0,9479.7422,4.0,white,33.0,3,0,0,yes,0.799999714,0.75,no dnr,7.0,111.0,0.09999084,130.0,16.0,35.59375,145.0,2.0,2.69970703,3.0,130.0,7.259766,116.0,67.0,243.0,0.0,no(M2 and SIP pres)
83.59198,0,female,0,10,428,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,16860.0,9524.4922,17.5,white,29.0,1,1,0,no,0.899999619,0.8,no dnr,10.0,71.0,15.5996094,64.0,8.0,36.69531,160.0,2.699707,0.39996338,1.19995117,141.0,7.459961,156.0,22.0,1020.0,1.1667481,no(M2 and SIP pres)
79.75598,0,male,0,10,428,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,17840.0,12445.2969,16.5,white,29.0,1,0,0,yes,0.5,0.3,dnr after sadm,1.0,38.0,6.5,120.0,15.0,36.69531,419.0,3.0996094,1.01,1.0,132.0,7.449219,92.0,9.0,2502.0,1.0,adl>=4 (>=5 if sur)
78.76794,0,male,0,8,428,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,under $11k,18086.0,12766.6875,21.5,white,34.0,1,1,1,no,0.799999714,0.7,no dnr,8.0,97.0,10.6992188,70.0,25.0,36.79688,333.3,3.5,1.01,2.79980469,141.0,7.419922,154.0,46.0,1750.0,2.0,adl>=4 (>=5 if sur)
28.44099,0,male,0,5,426,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,11832.0,8365.3359,22.0,white,24.0,1,0,0,no,1.0,1.0,no dnr,5.0,49.0,8.3984375,53.0,36.0,35.79688,169.375,3.5,1.01,1.69995117,134.0,7.439453,57.0,26.0,3025.0,2.2167969,<2 mo. follow-up
41.69199,1,male,0,4,295,Lung Cancer,Cancer,2,15.0,$11-$25k,16184.0,14452.7344,16.0,white,20.0,1,0,0,metastatic,1.0,0.8,no dnr,4.0,102.0,10.5996094,70.0,30.0,36.89844,121.65625,3.5,7.29980469,1.0,142.0,7.459961,91.0,16.0,3955.0,1.597168,no(M2 and SIP pres)
69.76294,0,female,0,7,425,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,8789.0,4800.1484,5.0,white,16.0,1,0,0,no,0.699999809,0.7,no dnr,7.0,80.0,4.19921875,70.0,20.0,36.09375,333.3,1.6999512,3.29980469,1.19995117,132.0,7.419922,88.0,32.0,2502.0,1.0,no(M2 and SIP pres)
82.14099,1,female,0,7,10,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,12928.0,7280.9922,18.0,white,47.0,1,0,1,yes,0.699999809,0.5,dnr after sadm,1.0,100.0,13.3984375,112.0,20.0,36.09375,333.3,2.199707,1.01,0.69995117,141.0,7.419922,78.0,8.0,2502.0,5.5888672,<2 mo. follow-up
73.28998,1,female,0,9,163,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,22415.0,14768.2969,21.5,white,28.0,1,0,0,no,0.75,0.65,no dnr,9.0,80.0,12.7988281,60.0,28.0,36.69531,78.32812,2.0,1.01,0.79992676,148.0,7.439453,120.0,30.0,2125.0,0.0,no(M2 and SIP pres)
70.70197,1,female,0,6,123,Lung Cancer,Cancer,1,18.0,>$50k,8339.0,4873.0,9.0,white,9.0,1,0,0,metastatic,0.599999905,0.2,no dnr,6.0,103.0,15.3984375,121.0,6.0,37.79688,520.0,2.5,0.79992676,10.0996094,147.0,7.339844,185.0,67.0,2870.0,0.0,no(M2 and SIP pres)
50.52399,0,female,0,47,421,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,176139.0,120280.312,29.0,white,58.0,7,0,0,no,0.849999905,0.75,no dnr,47.0,130.0,19.8984375,79.0,44.0,37.69531,97.95312,2.5,0.5,3.29980469,148.0,7.449219,185.0,56.0,1160.0,2.6069336,<2 mo. follow-up
91.68799,1,male,0,7,18,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,9399.0,5090.8633,7.5,black,31.0,1,0,1,yes,0.699999809,0.2,no dnr,7.0,77.0,61.296875,80.0,30.0,37.0,333.3,3.5,1.01,1.0,143.0,7.419922,435.0,18.0,2502.0,7.0732422,<2 mo. follow-up
54.95398,1,female,0,14,58,Lung Cancer,Cancer,2,9.0,under $11k,15766.0,9523.3125,4.333332,hispanic,36.0,1,0,0,metastatic,0.599999905,0.4,dnr after sadm,1.0,67.0,4.29980469,112.0,10.0,36.19531,330.0,2.5996094,2.79980469,1.59985352,148.0,7.339844,100.0,22.0,1155.0,2.0,<2 mo. follow-up
80.41095,1,female,0,9,182,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,10985.0,5983.1719,8.0,white,34.0,1,0,0,no,0.699999809,0.7,dnr after sadm,1.0,121.0,11.1992188,81.0,22.0,36.5,244.0,3.2998047,0.29998779,3.5,135.0,7.449219,125.0,37.0,2775.0,3.7236328,<2 mo. follow-up
82.90198,1,female,1,3,3,Coma,Coma,3,12.0,under $11k,12558.0,7413.4844,30.0,white,56.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,123.0,10.5996094,104.0,24.0,38.59375,357.125,3.5,1.01,1.09985352,134.0,7.459961,79.0,16.0,1121.0,2.8261719,<2 mo. follow-up
78.80096,1,female,0,15,180,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,23985.0,15362.7188,16.333328,white,30.0,1,1,1,yes,0.949999809,0.9,dnr before sadm,-1.0,60.0,23.8984375,100.0,16.0,37.89844,160.0,4.0996094,2.5,4.59960938,137.0,7.389648,227.0,62.0,202.0,7.0,adl>=4 (>=5 if sur)
94.60095,1,female,0,6,13,CHF,COPD/CHF/Cirrhosis,4,17.0,>$50k,8027.0,4217.5195,13.0,white,42.0,1,0,1,no,0.899999619,0.6,dnr after sadm,1.0,66.0,8.69921875,116.0,16.0,37.89844,333.3,4.0996094,1.0,2.79980469,133.0,7.419922,291.0,39.0,4525.0,6.5625,<2 mo. follow-up
47.56998,1,female,1,28,28,MOSF w/Malig,ARF/MOSF,4,17.0,$25-$50k,141244.0,14452.7344,34.0,white,55.0,9,1,0,yes,0.5,0.3,no dnr,28.0,60.0,21.6992188,130.0,14.0,38.69531,97.0,1.5,1.19995117,0.59997559,137.0,7.379883,313.0,10.0,1764.0,7.0,<2 mo. follow-up
55.68799,0,female,0,19,415,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,73326.0,44157.9062,35.666657,white,20.0,1,1,0,no,0.899999619,0.9,no dnr,19.0,70.0,6.29980469,73.0,30.0,35.89844,228.0,3.5,0.59997559,2.29980469,136.0,7.299805,265.0,116.0,2502.0,0.0,no(M2 and SIP pres)
76.66296,0,female,0,18,413,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,90617.0,51941.1562,42.0,white,33.0,6,0,0,yes,0.5,0.4,no dnr,18.0,117.0,8.3984375,90.0,20.0,36.09375,333.3,3.7998047,11.0,0.79992676,136.0,7.419922,89.0,8.0,2502.0,0.0,no(M2 and SIP pres)
77.87799,1,male,0,13,44,MOSF w/Malig,ARF/MOSF,1,20.0,under $11k,20672.0,13498.3672,20.5,white,51.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,2.0,57.0,7.89941406,100.0,30.0,39.29688,121.65625,1.8999023,1.01,1.79980469,140.0,7.449219,295.0,43.0,5690.0,0.0,<2 mo. follow-up
68.98297,0,female,0,33,410,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,73746.0,46496.7812,25.5,white,74.0,1,0,0,no,0.5,0.5,no dnr,33.0,123.0,10.5996094,102.0,28.0,36.19531,333.3,3.0996094,1.01,5.19921875,148.0,7.419922,155.0,40.0,1255.0,0.0,no(M2 and SIP pres)
59.66098,0,male,0,4,410,CHF,COPD/CHF/Cirrhosis,4,22.0,>$50k,4702.0,2460.8809,14.0,white,21.0,1,1,0,yes,0.949999809,0.9,no dnr,4.0,123.0,9.8984375,70.0,20.0,36.09375,368.3125,3.5,1.01,0.79992676,135.0,7.209961,181.0,30.0,1550.0,0.0,no(M2 and SIP pres)
93.09796,1,female,0,9,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,23038.0,13553.7969,19.0,white,44.0,1,1,0,no,0.5,0.4,no dnr,9.0,48.0,10.0996094,105.0,24.0,37.79688,80.0,3.0996094,0.79992676,1.19995117,132.0,7.469727,153.0,20.0,1850.0,7.0,<2 mo. follow-up
84.79395,0,female,0,5,408,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5262.0,14452.7344,8.0,white,21.0,1,0,0,no,1.0,0.9,no dnr,5.0,75.0,5.69921875,96.0,24.0,36.29688,244.0,3.5996094,0.69995117,0.79992676,129.0,7.389648,139.0,31.0,3125.0,2.4179688,<2 mo. follow-up
49.10599,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,58753.0,14452.7344,32.0,white,52.0,13,0,0,yes,0.649999619,0.3,dnr after sadm,7.0,97.0,7.0,78.0,24.0,36.09375,333.3,2.2998047,2.39990234,0.69995117,135.0,7.419922,82.0,15.0,960.0,2.7182617,<2 mo. follow-up
50.92099,0,female,0,6,405,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,under $11k,20417.0,14452.7344,16.0,white,37.0,4,0,0,no,0.699999809,0.5,no dnr,6.0,73.0,12.2988281,143.0,30.0,38.29688,528.25,2.5996094,1.19995117,0.79992676,132.0,7.349609,211.0,24.0,627.0,2.0,SIP>=30
88.82996,1,female,0,9,60,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,14288.0,8781.875,15.0,white,36.0,1,0,0,no,0.649999619,0.5,dnr after sadm,1.0,107.0,8.29882812,124.0,24.0,36.29688,330.0,1.5,0.89990234,0.79992676,147.0,7.429688,104.0,12.0,4650.0,4.0,<2 mo. follow-up
63.37598,0,female,0,17,400,COPD,COPD/CHF/Cirrhosis,5,10.0,under $11k,27526.0,14452.7344,14.0,other,31.0,1,1,0,no,0.899999619,0.7,no dnr,17.0,55.0,19.1992188,70.0,28.0,35.59375,370.3125,3.0996094,1.19995117,2.5,146.0,7.519531,251.0,67.0,1560.0,1.0,no(M2 and SIP pres)
47.20099,0,male,0,8,399,MOSF w/Malig,ARF/MOSF,2,18.0,>$50k,19269.0,14394.6953,17.5,white,41.0,1,0,0,yes,0.989999771,0.99,no dnr,8.0,57.0,6.09960938,70.0,25.0,36.09375,533.25,3.5,1.01,0.69995117,141.0,7.40918,108.0,5.0,2780.0,0.0,no(M2 and SIP pres)
31.72899,0,female,0,17,397,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,46277.0,14452.7344,20.666656,black,26.0,1,0,0,no,0.949999809,0.85,no dnr,17.0,130.0,6.89941406,80.0,20.0,37.0,333.3,3.5,1.01,2.69970703,144.0,7.419922,79.0,36.0,1400.0,1.7744141,no(M2 and SIP pres)
51.31299,0,female,0,11,397,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,18757.0,14452.7344,13.5,white,21.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,77.0,11.7988281,80.0,20.0,35.89844,333.3,3.5,1.01,1.69995117,145.0,7.419922,94.0,16.0,800.0,2.9536133,<2 mo. follow-up
77.69995,0,male,0,10,396,CHF,COPD/CHF/Cirrhosis,5,13.0,$11-$25k,13155.0,7146.6094,9.5,white,38.0,1,0,0,yes,0.699999809,0.5,no dnr,10.0,53.0,4.79980469,77.0,40.0,35.79688,120.0,1.7998047,0.5,1.0,135.0,7.279297,115.0,24.0,2502.0,0.0,no(M2 and SIP pres)
86.07794,0,female,0,8,395,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,19059.0,14452.7344,15.0,white,32.0,1,0,0,no,0.75,0.7,no dnr,8.0,79.0,13.0,58.0,44.0,38.09375,285.6875,2.2998047,0.5,1.19995117,145.0,7.399414,176.0,48.0,1540.0,0.0,no(M2 and SIP pres)
82.96198,0,female,0,5,393,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,5468.0,3089.1016,11.0,white,25.0,1,0,0,no,0.949999809,0.9,no dnr,5.0,74.0,8.29882812,72.0,40.0,34.79688,333.3,1.8999023,3.5,0.89990234,138.0,7.419922,299.0,35.0,1505.0,0.494751,no(M2 and SIP pres)
85.90295,0,female,0,6,392,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,8641.0,5966.6211,18.0,white,35.0,1,1,0,no,0.799999714,0.6,no dnr,6.0,103.0,15.6992188,58.0,16.0,38.19531,436.0,2.699707,0.5,0.89990234,144.0,7.459961,185.0,20.0,1510.0,7.0,no(M2 and SIP pres)
60.85999,0,male,0,7,393,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,8193.0,4558.7617,5.5,white,15.0,1,0,0,yes,0.799999714,0.4,no dnr,7.0,120.0,5.19921875,90.0,25.0,36.09375,208.0,3.5,1.01,1.09985352,132.0,7.339844,537.0,31.0,2502.0,1.1667481,no(M2 and SIP pres)
46.71899,0,male,0,12,391,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,31701.0,21135.6094,29.0,white,31.0,1,0,0,yes,0.899999619,0.85,no dnr,12.0,67.0,15.1992188,61.0,12.0,38.0,543.25,3.0996094,0.69995117,1.09985352,138.0,7.259766,111.0,13.0,750.0,0.0,no(M2 and SIP pres)
68.01398,1,male,0,5,68,Lung Cancer,Cancer,2,9.0,under $11k,5924.0,3249.1504,10.0,black,9.0,1,0,0,metastatic,0.75,0.2,dnr after sadm,4.0,49.0,12.5,110.0,14.0,39.29688,85.0,3.5,4.29980469,0.79992676,142.0,7.349609,86.0,12.0,4865.0,1.8388672,<2 mo. follow-up
80.05499,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$25-$50k,75188.0,36809.5312,48.0,white,54.0,2,0,0,no,0.5,0.3,no dnr,10.0,101.0,14.5996094,110.0,23.0,38.89844,230.0,2.5,1.89990234,1.09985352,131.0,7.519531,123.0,29.0,1450.0,0.0,<2 mo. follow-up
75.33496,1,male,0,4,101,Colon Cancer,Cancer,1,20.0,$25-$50k,5624.0,3108.2344,6.0,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,63.0,7.89941406,100.0,25.0,38.69531,143.3125,3.5,0.79992676,1.39990234,143.0,7.419922,161.0,33.0,920.0,0.494751,no(M2 and SIP pres)
74.15698,1,male,0,8,101,Lung Cancer,Cancer,4,12.0,$25-$50k,11663.0,6169.6328,9.5,white,25.0,1,0,0,metastatic,0.989999771,0.9,no dnr,8.0,100.0,13.2988281,120.0,25.0,36.5,400.0,3.7998047,1.01,1.29980469,142.0,7.419922,184.0,20.0,800.0,0.0,adl>=4 (>=5 if sur)
65.52795,0,male,0,14,388,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,30687.0,20530.9375,11.0,white,24.0,1,0,0,no,0.5,0.4,dnr after sadm,1.0,83.0,10.5996094,80.0,20.0,37.09375,253.3125,3.5,1.01,1.0,147.0,7.379883,99.0,25.0,2502.0,1.0,no(M2 and SIP pres)
76.67096,0,male,0,13,386,CHF,COPD/CHF/Cirrhosis,3,16.0,>$50k,30798.0,17669.5,29.0,white,27.0,1,0,0,no,0.199999928,0.1,no dnr,13.0,62.0,11.0996094,110.0,42.0,39.29688,187.5,3.0,0.39996338,2.89990234,130.0,7.379883,234.0,64.0,1190.0,0.0,no(M2 and SIP pres)
77.31396,1,male,0,16,119,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,58339.0,35670.3438,33.0,white,84.0,6,0,0,metastatic,0.299999952,0.1,no dnr,16.0,131.0,11.8984375,160.0,27.0,39.0,222.0,3.5,0.5,1.19995117,147.0,7.469727,127.0,26.0,1239.0,6.0,no(M2 and SIP pres)
47.41098,1,male,0,4,183,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,19594.0,14452.7344,41.0,white,67.0,1,0,0,yes,0.299999952,0.15,no dnr,4.0,55.0,3.5,150.0,22.0,39.39844,135.6875,2.3999023,2.79980469,1.19995117,139.0,7.389648,106.0,17.0,4420.0,1.923584,<2 mo. follow-up
44.25998,0,male,0,44,387,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,183799.0,14452.7344,26.5,white,18.0,8,0,0,no,0.949999809,0.95,no dnr,44.0,73.0,14.3984375,70.0,6.0,38.59375,334.0,3.5,1.01,1.0,144.0,7.459961,126.0,16.0,1715.0,2.3081055,no(M2 and SIP pres)
29.517,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,3,19.0,under $11k,72789.0,14452.7344,47.0,white,50.0,4,0,0,no,0.299999952,0.2,dnr after sadm,5.0,97.0,5.69921875,100.0,20.0,38.89844,195.21875,3.5,1.01,1.59985352,138.0,7.5,137.0,22.0,2502.0,0.0,<2 mo. follow-up
41.90799,1,male,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,23213.0,14452.7344,51.0,white,52.0,1,0,0,no,0.799999714,0.6,no dnr,5.0,80.0,10.2988281,70.0,25.0,36.69531,96.65625,4.6992188,0.39996338,1.79980469,139.0,7.399414,145.0,31.0,2620.0,0.0,<2 mo. follow-up
72.56897,0,female,0,10,384,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,12717.0,6984.9648,17.0,white,25.0,1,0,1,no,0.5,0.3,dnr after sadm,1.0,72.0,7.29980469,50.0,28.0,35.29688,508.0,3.3999023,1.59985352,0.89990234,141.0,7.459961,160.0,28.0,1420.0,4.9863281,adl>=4 (>=5 if sur)
48.01898,1,male,0,5,116,Lung Cancer,Cancer,3,12.0,$25-$50k,23905.0,12403.8438,14.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,69.0,12.7988281,80.0,24.0,39.09375,506.625,3.199707,0.79992676,2.0,144.0,7.509766,245.0,47.0,3110.0,0.0,no(M2 and SIP pres)
55.633,0,male,0,4,384,Lung Cancer,Cancer,2,12.0,$25-$50k,19481.0,14452.7344,13.0,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,116.0,6.19921875,69.0,22.0,38.19531,376.625,5.5,1.01,1.09985352,141.0,6.90918,106.0,6.0,8175.0,0.494751,no(M2 and SIP pres)
43.20297,0,male,0,4,383,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$11-$25k,12806.0,8430.7344,28.0,white,16.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,73.0,5.0,80.0,16.0,36.79688,333.3,4.5996094,0.89990234,0.89990234,140.0,7.419922,111.0,14.0,1100.0,0.494751,<2 mo. follow-up
78.00098,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,56931.0,14452.7344,27.0,white,30.0,5,0,0,no,0.5,0.25,dnr after sadm,7.0,103.0,7.0,80.0,30.0,38.89844,128.3125,3.699707,1.01,0.79992676,137.0,7.319336,98.0,9.0,2400.0,0.0,<2 mo. follow-up
77.61298,0,male,0,11,379,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,26894.0,17784.5312,18.0,black,10.0,1,0,0,yes,0.899999619,0.8,no dnr,11.0,51.0,39.3984375,80.0,20.0,37.0,121.65625,3.5,1.01,1.69995117,144.0,7.479492,96.0,50.0,700.0,0.0,no(M2 and SIP pres)
69.24799,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,19191.0,13670.2812,24.0,white,23.0,1,0,0,no,0.009999998,0.01,dnr after sadm,5.0,70.0,12.8984375,114.0,28.0,38.09375,304.75,3.0996094,0.89990234,0.69995117,131.0,7.349609,189.0,13.0,2502.0,2.1279297,<2 mo. follow-up
59.44699,1,male,0,5,334,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,4928.0,14452.7344,6.0,white,18.0,1,1,0,no,0.899999619,0.75,no dnr,5.0,100.0,9.0,70.0,20.0,36.69531,333.3,3.5,1.01,0.69995117,139.0,7.419922,144.0,7.0,2502.0,0.0,no(M2 and SIP pres)
86.13599,1,male,0,26,40,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59443.0,42862.625,23.75,white,54.0,1,0,0,no,0.399999857,0.3,no dnr,26.0,60.0,7.89941406,130.0,26.0,38.0,353.3125,3.5,1.01,6.19921875,134.0,7.389648,80.0,43.0,0.0,0.0,<2 mo. follow-up
71.56195,1,female,1,11,11,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,31438.0,23215.6094,32.5,white,49.0,1,0,0,no,0.5,0.7,dnr after sadm,5.0,107.0,9.69921875,70.0,20.0,36.09375,238.09375,3.5,1.01,6.09960938,142.0,7.349609,124.0,68.0,2502.0,6.0,<2 mo. follow-up
81.91895,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,12394.0,8817.6406,27.0,white,68.0,1,1,0,yes,0.099999964,0.01,dnr before sadm,-1.0,70.0,10.8984375,92.0,50.0,37.09375,333.3,3.5,1.01,0.59997559,136.0,7.419922,81.0,6.0,700.0,3.2094727,<2 mo. follow-up
86.80896,1,female,1,50,50,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,222569.0,14452.7344,35.5,white,52.0,1,0,0,no,0.799999714,0.6,dnr after sadm,39.0,80.0,4.59960938,80.0,20.0,36.09375,333.3,3.7998047,0.59997559,1.5,138.0,7.419922,83.0,20.0,1.0,0.0,<2 mo. follow-up
52.76398,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,38836.0,28903.2031,45.0,white,54.0,1,0,0,yes,0.049999982,0.01,dnr after sadm,4.0,106.0,10.0996094,62.0,54.0,38.19531,217.5,1.0,1.01,1.69995117,139.0,7.389648,95.0,38.0,500.0,0.0,<2 mo. follow-up
77.42896,1,male,0,8,179,CHF,COPD/CHF/Cirrhosis,5,9.0,under $11k,9491.0,5027.0,7.5,white,29.0,1,1,0,no,0.899999619,0.8,no dnr,8.0,67.0,21.3984375,60.0,20.0,36.09375,319.0,3.5,0.19998169,0.69995117,142.0,7.479492,498.0,32.0,2100.0,0.0,no(M2 and SIP pres)
74.72998,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,24127.0,21646.7188,32.0,white,76.0,1,1,0,no,0.0,0.0,dnr after sadm,2.0,53.0,5.69921875,60.0,20.0,35.59375,266.625,3.699707,1.69995117,1.79980469,144.0,7.449219,166.0,92.0,2502.0,3.7675781,<2 mo. follow-up
84.745,1,male,0,18,107,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,32357.0,19647.4688,18.666656,white,29.0,1,0,0,no,0.599999905,0.5,no dnr,18.0,122.0,13.2988281,157.0,38.0,36.09375,285.0,3.5,0.69995117,0.79992676,137.0,7.299805,209.0,23.0,750.0,1.0,no(M2 and SIP pres)
88.19397,0,female,0,13,356,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,19104.0,13220.2812,11.0,white,45.0,1,0,1,no,0.799999714,0.7,dnr after sadm,3.0,107.0,8.5,68.0,24.0,38.5,275.0,3.5996094,0.69995117,1.0,137.0,7.359375,284.0,16.0,1285.0,3.0,no(M2 and SIP pres)
67.02295,1,female,0,53,104,MOSF w/Malig,ARF/MOSF,0,13.0,under $11k,159022.0,14452.7344,19.75,white,42.0,45,0,0,yes,0.699999809,0.3,dnr after sadm,20.0,60.0,14.5996094,61.0,8.0,38.29688,80.0,3.5,1.01,1.79980469,146.0,7.349609,121.0,26.0,3765.0,1.0,SIP>=30
47.45798,1,male,0,7,238,CHF,COPD/CHF/Cirrhosis,6,10.0,under $11k,17973.0,10558.2734,7.5,white,38.0,1,0,0,no,1.0,1.0,no dnr,7.0,79.0,24.5976562,71.0,18.0,35.59375,362.0,2.0996094,6.59960938,1.5,152.0,7.419922,561.0,45.0,3585.0,0.0,no(M2 and SIP pres)
76.87097,0,male,0,6,352,CHF,COPD/CHF/Cirrhosis,3,18.0,$11-$25k,5444.0,3222.0918,7.0,white,26.0,1,1,0,no,0.899999619,0.8,no dnr,6.0,113.0,30.6992188,80.0,16.0,36.19531,170.0,3.5,29.0976562,7.19921875,136.0,7.339844,85.0,118.0,185.0,1.1667481,no(M2 and SIP pres)
73.92694,0,female,0,8,351,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,21820.0,13192.5547,16.5,hispanic,18.0,1,0,0,no,0.989999771,0.99,no dnr,8.0,103.0,9.29882812,60.0,20.0,37.79688,333.3,3.5,1.01,1.69995117,141.0,7.419922,104.0,23.0,5200.0,3.0,no(M2 and SIP pres)
62.89099,0,female,0,4,348,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,4700.0,2471.3027,6.0,white,13.0,1,1,0,yes,0.899999619,0.5,dnr before sadm,-1.0,43.0,4.89941406,64.0,26.0,37.69531,176.65625,3.5,1.01,1.79980469,135.0,7.439453,76.0,33.0,525.0,4.5273438,SIP>=30
83.72296,0,male,0,8,347,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,11448.0,5841.5977,8.5,white,26.0,1,0,0,yes,0.949999809,0.5,no dnr,8.0,80.0,9.3984375,50.0,20.0,36.09375,333.3,3.5,1.01,1.5,142.0,7.419922,76.0,31.0,1450.0,0.0,<2 mo. follow-up
73.15796,1,male,1,17,17,Lung Cancer,Cancer,1,8.0,$11-$25k,30549.0,15945.3047,13.333328,white,9.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,14.0,100.0,17.1992188,130.0,40.0,35.89844,131.65625,2.0996094,1.01,0.79992676,137.0,7.5,178.0,22.0,700.0,1.0,<2 mo. follow-up
97.59595,1,male,0,5,247,CHF,COPD/CHF/Cirrhosis,2,20.0,>$50k,6900.0,3685.7031,11.0,white,26.0,1,0,0,yes,0.5,0.3,dnr after sadm,1.0,130.0,4.39941406,80.0,20.0,37.79688,333.3,3.5,1.01,5.19921875,143.0,7.419922,118.0,50.0,950.0,4.0439453,adl>=4 (>=5 if sur)
84.67596,0,female,0,29,344,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,123202.0,14452.7344,26.0,white,36.0,2,0,0,no,0.699999809,0.7,no dnr,29.0,113.0,14.8984375,80.0,25.0,36.09375,138.3125,3.5,1.01,3.79980469,145.0,7.439453,117.0,72.0,950.0,0.0,no(M2 and SIP pres)
81.06995,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,29290.906,16614.9375,40.0,white,61.0,13,0,0,yes,0.049999982,0.000125,dnr before sadm,0.0,115.0,24.0,142.0,36.0,37.69531,143.3125,2.5,0.79992676,1.5,155.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
78.10797,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,59070.875,33565.2812,34.0,black,57.0,4,0,0,yes,0.5,0.25,dnr after sadm,14.0,107.0,6.39941406,118.0,26.0,38.5,260.0,1.8999023,4.69921875,2.0,139.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.16595,1,female,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,2,20.0,$11-$25k,204219.875,112552.25,49.5,black,35.0,13,1,0,no,0.5,0.5,dnr after sadm,34.0,117.0,10.0,110.0,8.0,39.0,290.0,3.5,1.01,3.5,134.0,7.429688,135.0,23.0,2502.0,2.0,<2 mo. follow-up
27.76199,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,70693.625,40952.1562,52.0,black,88.0,1,0,0,no,0.299999952,0.2,dnr after sadm,16.0,60.0,13.6992188,152.0,12.0,35.69531,76.65625,1.5998535,13.0996094,3.59960938,132.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.29095,1,male,0,12,744,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,15564.695,9390.3203,18.0,white,25.0,2,0,0,no,0.899999619,0.5,no dnr,12.0,80.0,8.19921875,80.0,22.0,36.5,226.65625,3.5,1.01,1.59985352,137.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.67099,1,male,0,6,70,Lung Cancer,Cancer,1,9.0,under $11k,5074.648,3149.7344,11.0,white,35.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,87.0,26.0,108.0,36.0,37.69531,314.25,2.3999023,0.39996338,0.79992676,139.0,7.479492,135.0,23.0,2502.0,4.0,<2 mo. follow-up
42.09698,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,65025.031,35397.4062,62.5,white,92.0,11,0,0,metastatic,0.099999964,0.001,no dnr,9.0,63.0,0.19998169,145.0,28.0,37.89844,242.84375,2.0,5.19921875,4.09960938,161.0,7.519531,135.0,23.0,2502.0,2.9853516,<2 mo. follow-up
66.30499,1,female,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,182129.875,103131.188,45.0,white,37.0,1,0,0,no,0.699999809,0.75,dnr after sadm,31.0,93.0,18.796875,100.0,10.0,38.5,203.3125,2.0,1.0,3.09960938,138.0,7.369141,135.0,23.0,2502.0,1.0,<2 mo. follow-up
29.33299,0,female,0,20,2026,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,48388.219,28524.0625,35.333313,white,48.0,1,0,0,no,0.5,0.5,no dnr,20.0,62.0,27.796875,62.0,16.0,38.79688,118.45312,1.8999023,3.0,0.89990234,140.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
48.87097,1,male,0,14,207,Colon Cancer,Cancer,1,17.0,>$50k,13197.648,7754.8945,13.666664,white,15.0,1,0,0,metastatic,0.799999714,0.2,no dnr,14.0,101.0,5.19921875,95.0,18.0,38.5,333.3,2.3999023,0.19998169,0.89990234,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.81696,1,female,0,21,24,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,11220.297,8075.2109,11.0,black,36.0,1,0,0,no,1.0,0.8,dnr after sadm,2.0,130.0,5.79980469,60.0,26.0,35.5,509.5,2.7998047,0.5,1.5,139.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
63.48297,1,male,0,6,1162,Colon Cancer,Cancer,0,18.0,>$50k,3371.1,2288.6973,6.0,white,9.0,1,0,0,metastatic,0.899999619,0.7,no dnr,6.0,83.0,4.69921875,72.0,24.0,36.69531,333.3,3.0,0.5,0.89990234,139.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
60.939,1,male,0,4,455,CHF,COPD/CHF/Cirrhosis,0,7.0,$11-$25k,4007.6,2527.5527,7.0,black,6.0,1,0,0,no,0.799999714,0.5,no dnr,4.0,97.0,5.59960938,80.0,20.0,36.59375,333.3,3.5,1.01,1.0,139.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
74.52399,1,female,0,12,891,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5275.547,3996.9512,7.0,white,18.0,1,1,0,no,0.899999619,0.8,no dnr,12.0,87.0,3.89990234,65.0,20.0,35.89844,333.3,4.0996094,0.89990234,1.19995117,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.42599,1,male,0,5,1753,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,2317.148,1679.041,1.0,white,19.0,1,0,0,no,0.979999542,0.8,no dnr,5.0,96.0,5.29980469,82.0,20.0,37.09375,333.3,2.5996094,5.39941406,0.89990234,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.91098,1,female,0,7,85,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,3229.148,2311.6875,5.5,white,30.0,1,0,0,yes,0.979999542,0.9,no dnr,7.0,69.0,4.09960938,60.0,16.0,37.39844,333.3,2.2998047,2.09960938,1.39990234,135.0,7.419922,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
33.73297,0,female,0,32,2021,CHF,COPD/CHF/Cirrhosis,0,10.0,under $11k,65649.062,43195.5,20.75,white,15.0,1,0,0,no,0.899999619,0.8,no dnr,32.0,77.0,20.3984375,110.0,16.0,37.09375,328.0,3.5,0.39996338,0.69995117,138.0,7.429688,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
46.77899,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,18037.5,9498.8984,28.0,white,13.0,2,0,0,no,0.699999809,0.5,dnr after sadm,3.0,85.0,22.3984375,130.0,14.0,39.09375,432.5,3.7998047,0.69995117,0.89990234,137.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
49.85098,1,male,1,23,23,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,70955.75,41781.0625,33.333313,white,39.0,14,0,0,yes,0.099999964,0.001,dnr after sadm,8.0,67.0,1.39990234,112.0,25.0,37.39844,300.0,2.0996094,1.39990234,0.69995117,142.0,7.469727,135.0,23.0,2502.0,6.0,<2 mo. follow-up
50.82797,0,female,0,6,2020,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,12101.797,7537.4258,14.0,white,32.0,6,0,0,no,0.699999809,0.5,no dnr,6.0,91.0,10.0996094,125.0,22.0,36.89844,333.3,3.5,2.89990234,1.89990234,136.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
68.01398,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,1.0,under $11k,68718.562,37504.25,45.666657,other,39.0,4,1,0,no,0.5,0.4,no dnr,17.0,90.0,18.296875,100.0,10.0,37.29688,147.5,2.699707,0.5,3.19970703,137.0,7.429688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
62.67999,1,male,0,10,248,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5012.098,3631.3223,5.5,white,29.0,1,0,0,no,0.75,0.5,no dnr,10.0,63.0,7.0,100.0,24.0,36.19531,319.0,3.7998047,0.69995117,1.59985352,137.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.543,1,male,0,35,472,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,119274.125,68801.75,31.0,white,45.0,1,0,0,no,0.199999928,0.1,no dnr,35.0,109.0,16.5,118.0,40.0,38.79688,176.34375,1.3999023,0.19998169,0.79992676,136.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
82.62,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,123505.188,67257.9375,35.5,white,55.0,27,0,0,no,0.699999809,0.5,dnr after sadm,6.0,73.0,30.0,110.0,11.0,35.89844,116.65625,2.7998047,0.79992676,3.39990234,151.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
54.55399,0,male,0,10,2015,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,14758.742,8782.7109,19.0,black,23.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,90.0,7.79980469,104.0,32.0,36.59375,333.3,3.5,1.01,1.09985352,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.827,0,female,0,14,2015,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,24232.469,14970.9062,28.0,white,40.0,1,0,0,no,0.599999905,0.6,no dnr,14.0,60.0,16.3984375,108.0,24.0,37.5,368.0,1.6999512,1.79980469,2.79980469,140.0,7.389648,135.0,23.0,2502.0,1.0,SIP>=30
42.41498,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26228.594,14142.5312,54.0,white,96.0,6,0,0,no,0.699999809,0.5,dnr after sadm,4.0,47.0,16.5,200.0,34.0,39.0,74.0,2.5996094,30.5,6.19921875,141.0,7.229492,135.0,23.0,2502.0,2.8813477,<2 mo. follow-up
70.01196,1,male,0,5,1781,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,2736.148,1958.3613,11.0,black,15.0,1,0,0,no,1.0,0.8,no dnr,5.0,113.0,13.0996094,70.0,20.0,36.19531,252.375,3.5,1.01,1.09985352,138.0,7.479492,135.0,23.0,2502.0,3.1855469,<2 mo. follow-up
60.34497,1,female,0,7,1761,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,5197.066,3336.3731,8.0,white,29.0,1,0,0,no,0.949999809,0.8,no dnr,7.0,99.0,7.39941406,90.0,28.0,37.09375,194.375,4.0996094,0.5,0.79992676,144.0,7.369141,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
55.98898,0,female,0,6,2015,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,6171.199,3968.0488,10.0,white,19.0,1,1,0,no,1.0,0.99,no dnr,6.0,108.0,10.6992188,126.0,18.0,37.29688,333.3,3.5,1.01,1.0,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
42.89099,1,male,0,4,1380,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,4847.797,2779.7148,12.0,white,19.0,1,0,0,no,0.799999714,0.6,no dnr,4.0,77.0,8.59960938,94.0,16.0,36.5,333.3,3.5,1.01,1.69995117,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
26.407,1,female,1,15,15,Cirrhosis,COPD/CHF/Cirrhosis,4,10.0,under $11k,59995.78781114967,14452.7344,33.333313,black,84.0,30,0,0,no,0.099999964,0.001,dnr after sadm,15.0,52.0,52.0,82.0,25.0,36.89844,285.6875,2.2998047,44.09375,5.0,139.0,7.389648,135.0,23.0,2502.0,4.5273972,<2 mo. follow-up
55.13797,1,male,0,5,65,Lung Cancer,Cancer,1,14.0,$25-$50k,4260.598,2585.875,10.0,white,18.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,73.0,9.79882812,84.0,12.0,38.5,333.3,2.699707,0.19998169,0.59997559,139.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
37.65399,1,female,0,7,21,Colon Cancer,Cancer,1,17.0,$25-$50k,25829.297,14263.2422,14.0,other,5.0,1,0,0,metastatic,1.0,1.0,no dnr,7.0,91.0,4.39941406,86.0,20.0,37.59375,333.3,3.5,0.29998779,0.69995117,144.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.323,0,female,0,8,2013,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3637.6,2708.7031,10.0,black,34.0,1,1,0,no,0.75,0.6,no dnr,8.0,110.0,23.1992188,100.0,16.0,36.59375,270.0,3.5,0.19998169,5.19921875,144.0,7.339844,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
58.21198,1,female,1,3,3,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,14696.945,8260.25,32.0,white,104.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,37.0,34.296875,35.0,12.0,35.79688,261.0,2.3999023,8.79882812,3.0,122.0,7.269531,135.0,23.0,2502.0,3.3979492,<2 mo. follow-up
71.31799,1,male,1,14,14,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,25847.641,15369.0859,24.0,black,25.0,1,0,0,no,1.0,0.8,no dnr,14.0,102.0,11.2988281,88.0,28.0,36.5,229.15625,3.5,1.01,0.79992676,146.0,7.339844,135.0,23.0,2502.0,3.1699219,<2 mo. follow-up
69.79095,1,male,0,35,296,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,50310.688,30847.0469,16.0,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,35.0,63.0,9.0,70.0,20.0,35.09375,566.625,3.5,1.01,1.29980469,137.0,7.399414,135.0,23.0,2502.0,3.3188477,<2 mo. follow-up
69.92694,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,82018.938,47612.4375,46.0,white,57.0,1,1,0,no,0.099999964,0.001,no dnr,21.0,113.0,19.5976562,65.0,27.0,35.0,147.5,1.6999512,0.19998169,2.89990234,135.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
44.35599,0,female,0,136,2009,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,336191.75,191845.5,32.75,white,47.0,28,0,0,no,0.699999809,0.7,no dnr,136.0,130.0,20.3984375,100.0,10.0,36.89844,170.0,3.8999023,12.5996094,1.29980469,138.0,7.479492,135.0,23.0,2502.0,0.0,SIP>=30
46.83899,0,male,0,6,2009,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,4346.148,3380.3809,3.0,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,71.0,6.0,68.0,24.0,36.59375,357.125,3.5,1.09985352,1.79980469,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.28998,0,female,0,29,2008,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,115224.25,67811.125,18.0,black,20.0,26,0,0,no,0.699999809,0.5,no dnr,29.0,83.0,22.6992188,110.0,26.0,38.0,463.3125,3.3999023,1.01,0.59997559,152.0,7.479492,135.0,23.0,2502.0,3.0893555,<2 mo. follow-up
69.05396,1,male,0,5,132,CHF,COPD/CHF/Cirrhosis,1,11.0,$11-$25k,59995.78781114967,14452.7344,7.0,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,73.0,7.0,68.0,20.0,35.39844,333.3,3.5,1.01,1.5,143.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
18.946,1,male,1,12,12,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,61863.156,34996.3438,43.0,black,63.0,7,0,0,yes,0.399999857,0.4,dnr after sadm,9.0,110.0,0.09999084,110.0,29.0,37.79688,137.125,1.5998535,1.39990234,0.5,146.0,7.40918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
23.573,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,63657.625,36136.1562,45.0,white,56.0,23,0,0,no,0.0,0.0,no dnr,7.0,110.0,0.19998169,184.0,26.0,39.29688,128.875,3.5,0.19998169,0.79992676,134.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.07996,1,male,0,14,487,CHF,COPD/CHF/Cirrhosis,6,16.0,under $11k,10907.797,8287.3438,13.666664,hispanic,35.0,1,1,0,no,0.5,0.25,dnr after sadm,3.0,63.0,5.09960938,89.0,16.0,37.29688,223.78125,3.5,1.19995117,1.09985352,128.0,7.509766,135.0,23.0,2502.0,4.0,SIP>=30
73.40198,1,male,1,11,11,MOSF w/Malig,ARF/MOSF,2,11.0,$11-$25k,80833.062,46143.8125,43.0,white,86.0,30,0,0,yes,0.049999982,0.000125,dnr after sadm,10.0,137.0,1.79980469,140.0,30.0,39.19531,146.65625,1.2998047,13.1992188,2.29980469,139.0,7.399414,135.0,23.0,2502.0,1.0,<2 mo. follow-up
61.599,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,20699.797,13587.9766,43.0,white,59.0,1,0,0,no,0.299999952,0.3,dnr after sadm,3.0,48.0,11.0996094,118.0,12.0,36.69531,227.5,2.2998047,5.79980469,4.09960938,138.0,7.359375,135.0,23.0,2502.0,3.0581055,<2 mo. follow-up
39.31,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,32710.188,20681.2969,17.5,black,44.0,8,0,0,no,0.199999928,0.1,dnr after sadm,1.0,94.0,21.6992188,120.0,24.0,37.29688,363.3125,3.5,8.79882812,1.89990234,132.0,7.359375,135.0,23.0,2502.0,3.0,<2 mo. follow-up
62.26398,1,male,0,5,63,Lung Cancer,Cancer,2,13.0,$25-$50k,4991.348,3246.8242,15.0,white,17.0,1,0,0,metastatic,1.0,0.6,no dnr,5.0,127.0,5.39941406,115.0,20.0,36.0,333.3,3.5,1.01,0.79992676,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.93799,1,female,0,12,435,Lung Cancer,Cancer,2,12.0,under $11k,11457.445,8526.6406,10.5,white,24.0,1,0,0,metastatic,0.75,0.5,no dnr,12.0,87.0,7.19921875,68.0,32.0,39.0,333.3,3.5,1.01,1.09985352,133.0,7.419922,135.0,23.0,2502.0,3.3818359,<2 mo. follow-up
67.745,1,female,0,7,23,Colon Cancer,Cancer,3,12.0,under $11k,7447.699,5835.6016,12.0,white,35.0,1,0,0,metastatic,0.799999714,0.1,no dnr,7.0,110.0,6.5,72.0,16.0,36.79688,333.3,1.8999023,1.01,1.69995117,137.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
59.45499,1,male,0,11,25,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,14134.297,10915.0625,12.5,white,56.0,7,1,0,no,0.799999714,0.6,no dnr,11.0,58.0,12.6992188,120.0,28.0,37.29688,333.3,3.5,1.01,2.19970703,124.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
72.91998,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59995.78781114967,14452.7344,43.5,white,51.0,1,0,0,no,0.199999928,0.2,dnr after sadm,3.0,132.0,16.5976562,116.0,25.0,38.5,98.875,3.5,0.5,1.79980469,150.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.35699,1,male,1,4,4,Coma,Coma,0,12.0,under $11k,29703.188,19801.1094,49.0,white,73.0,1,0,0,no,0.099999964,0.001,no dnr,4.0,63.0,32.59375,110.0,14.0,39.09375,110.0,2.0,10.0,5.19921875,127.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.13797,1,female,1,5,5,Coma,Coma,1,11.0,under $11k,10753.492,7511.3359,17.0,black,33.0,2,0,0,no,0.009999998,1e-06,dnr after sadm,2.0,110.0,18.6992188,72.0,32.0,38.19531,225.0,3.5,1.01,1.5,163.0,7.469727,135.0,23.0,2502.0,2.0,<2 mo. follow-up
64.98596,1,male,0,11,1118,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,32710.891,19770.6406,23.5,white,27.0,1,0,0,no,0.899999619,0.7,no dnr,11.0,53.0,6.59960938,50.0,22.0,36.39844,333.3,3.5,1.01,1.39990234,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
90.75397,1,female,0,5,211,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,2153.648,1880.4893,12.0,black,34.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,115.0,1.69995117,76.0,18.0,34.89844,333.3,2.699707,0.29998779,0.79992676,146.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
69.48895,0,female,0,70,1999,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,$11-$25k,114818.812,70177.6875,21.25,white,43.0,17,0,0,no,0.899999619,0.8,no dnr,70.0,117.0,10.2988281,135.0,40.0,38.59375,118.32812,3.5,1.01,0.59997559,132.0,7.459961,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
71.29095,1,female,0,90,105,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,117566.938,84900.625,24.5,black,69.0,1,1,0,yes,0.5,0.5,no dnr,90.0,55.0,42.8984375,59.0,8.0,36.0,276.625,2.2998047,6.5,5.69921875,134.0,7.379883,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
69.30597,1,female,0,10,58,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,12514.547,9179.7188,12.0,white,24.0,1,0,0,no,0.899999619,0.6,no dnr,10.0,84.0,7.19921875,96.0,30.0,37.0,385.6875,3.5,1.01,1.5,139.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
44.31998,0,female,0,14,1997,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,34999.438,24712.7969,25.666656,black,36.0,1,1,0,no,0.799999714,0.8,no dnr,14.0,87.0,12.1992188,120.0,25.0,38.59375,125.45312,2.3999023,1.69995117,0.79992676,140.0,7.489258,135.0,23.0,2502.0,2.1767578,no(M2 and SIP pres)
33.85098,1,male,0,22,152,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,36510.125,26459.3594,17.0,white,11.0,4,0,0,yes,0.899999619,0.7,no dnr,22.0,79.0,7.69921875,60.0,10.0,36.29688,284.4375,3.5,0.59997559,1.0,151.0,7.459961,135.0,23.0,2502.0,1.6982422,<2 mo. follow-up
51.67697,0,male,0,4,1995,Colon Cancer,Cancer,1,16.0,>$50k,5212.348,3679.1934,9.0,white,12.0,1,0,0,metastatic,0.75,0.25,no dnr,4.0,63.0,4.0,68.0,18.0,37.39844,333.3,3.0,0.89990234,0.59997559,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.086,1,female,1,21,21,Coma,Coma,1,10.0,under $11k,13969.148,11240.9141,6.0,black,22.0,1,1,0,no,0.0,0.0,dnr after sadm,1.0,103.0,7.09960938,80.0,16.0,36.79688,263.25,3.5,1.01,1.29980469,144.0,7.379883,135.0,23.0,2502.0,5.0,<2 mo. follow-up
40.05197,1,female,0,4,116,CHF,COPD/CHF/Cirrhosis,4,17.0,under $11k,10388.547,7787.3867,10.0,other,21.0,7,1,0,no,0.899999619,0.7,no dnr,4.0,80.0,11.5996094,88.0,16.0,37.0,333.3,3.5,1.01,1.79980469,130.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
43.129,0,female,0,15,1994,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,32229.891,23546.1875,25.666656,white,13.0,1,0,0,no,0.949999809,0.95,no dnr,15.0,80.0,12.8984375,110.0,8.0,36.89844,340.0,3.5,0.69995117,1.19995117,142.0,7.479492,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
69.35498,0,female,0,12,1994,CHF,COPD/CHF/Cirrhosis,3,9.0,$11-$25k,34208.688,20752.0156,19.0,white,25.0,1,1,0,no,0.979999542,0.9,no dnr,12.0,97.0,6.5,60.0,28.0,36.79688,333.3,3.7998047,0.59997559,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.53796,1,male,0,33,43,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,15308.594,13682.9844,8.25,white,46.0,1,0,0,no,0.949999809,0.5,no dnr,33.0,59.0,8.5,54.0,20.0,35.29688,333.3,3.5,1.01,2.89990234,131.0,7.419922,135.0,23.0,2502.0,3.0239258,<2 mo. follow-up
52.392,1,male,0,4,1638,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,2009.25,1732.7705,5.0,black,30.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,110.0,6.29980469,70.0,18.0,36.0,404.75,2.8999023,1.09985352,4.69921875,140.0,7.479492,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
70.14899,1,male,0,77,88,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,85999.312,64279.6875,22.5,white,20.0,20,0,0,metastatic,0.5,0.3,dnr after sadm,1.0,94.0,6.29980469,112.0,16.0,37.09375,226.90625,2.5,1.5,0.89990234,139.0,7.40918,135.0,23.0,2502.0,4.0,SIP>=30
61.64297,1,male,0,28,78,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,69951.25,47864.1562,26.0,white,19.0,5,0,0,no,0.199999928,0.1,dnr after sadm,11.0,111.0,1.19995117,82.0,11.0,37.69531,226.65625,3.5,1.29980469,0.79992676,131.0,7.429688,135.0,23.0,2502.0,2.2856445,<2 mo. follow-up
65.396,1,male,1,15,15,Coma,Coma,1,12.0,under $11k,26288.375,18995.1875,19.333328,black,46.0,1,0,0,no,0.0,0.0,dnr after sadm,4.0,80.0,30.296875,130.0,32.0,37.89844,240.0,2.7998047,1.01,2.19970703,133.0,7.419922,135.0,23.0,2502.0,2.6391602,<2 mo. follow-up
64.17499,1,female,0,3,71,Lung Cancer,Cancer,1,8.0,under $11k,2555.35,1988.8213,5.0,black,16.0,1,0,0,metastatic,0.5,0.2,no dnr,3.0,79.0,10.1992188,100.0,20.0,36.79688,333.3,3.5,0.19998169,0.79992676,137.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
77.77399,0,male,0,25,1988,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,14452.7344,20.0,white,12.0,19,0,0,no,0.699999809,0.5,no dnr,25.0,106.0,11.2988281,68.0,11.0,38.59375,350.0,3.5,1.39990234,1.0,138.0,7.5,135.0,23.0,2502.0,1.8273926,<2 mo. follow-up
64.70398,1,female,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,146233.75,97332.125,44.25,white,12.0,11,0,0,no,0.199999928,0.2,dnr after sadm,34.0,87.0,15.8984375,94.0,14.0,37.5,165.0,3.5,1.01,0.59997559,129.0,7.459961,135.0,23.0,2502.0,5.0,<2 mo. follow-up
51.362,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,18635.0,13307.5312,55.0,black,15.0,1,0,0,no,0.099999964,0.001,no dnr,5.0,117.0,8.59960938,110.0,11.0,38.69531,400.0,3.5,1.01,0.69995117,140.0,7.509766,135.0,23.0,2502.0,2.0844727,<2 mo. follow-up
78.66699,1,female,0,12,334,Lung Cancer,Cancer,4,8.0,under $11k,10843.562,7996.9375,9.0,white,28.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,93.0,4.69921875,112.0,20.0,37.0,233.3125,3.5,1.01,0.59997559,141.0,7.429688,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
65.53595,1,male,0,7,88,Lung Cancer,Cancer,1,12.0,under $11k,5538.25,4378.1055,3.0,white,11.0,1,0,0,metastatic,0.5,0.2,no dnr,7.0,93.0,9.79882812,86.0,20.0,38.69531,342.8125,2.7998047,0.29998779,0.79992676,138.0,7.489258,135.0,23.0,2502.0,2.8876953,<2 mo. follow-up
62.37399,1,female,0,17,211,Colon Cancer,Cancer,1,12.0,under $11k,23129.641,15278.625,9.0,white,11.0,1,0,0,metastatic,0.899999619,0.5,no dnr,17.0,70.0,8.0,68.0,20.0,37.19531,333.3,3.199707,1.0,0.79992676,140.0,7.419922,135.0,23.0,2502.0,2.2993164,<2 mo. follow-up
54.168,1,male,0,5,174,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,9294.195,6839.5078,22.0,white,39.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,87.0,15.5996094,90.0,26.0,35.0,336.625,3.5,1.01,9.09960938,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.84198,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,72912.25,47838.625,42.333313,white,52.0,1,0,0,no,0.699999809,0.5,dnr after sadm,11.0,85.0,14.1992188,60.0,26.0,36.59375,157.5,1.6999512,0.89990234,2.89990234,138.0,7.439453,135.0,23.0,2502.0,7.0,<2 mo. follow-up
52.047,1,male,1,6,6,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4845.676,3496.2949,11.0,white,22.0,1,0,0,no,0.25,0.0,no dnr,6.0,88.0,9.0,100.0,32.0,35.29688,197.5,3.699707,1.69995117,1.0,133.0,7.449219,135.0,23.0,2502.0,2.2431641,<2 mo. follow-up
57.34198,1,male,0,6,1116,Colon Cancer,Cancer,2,12.0,$25-$50k,5654.199,3763.8496,15.0,white,22.0,1,1,0,metastatic,0.899999619,0.8,no dnr,6.0,129.0,2.89990234,95.0,20.0,36.5,333.3,3.699707,0.39996338,1.09985352,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.92096,1,male,0,20,113,CHF,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,23931.641,17996.2188,11.0,white,19.0,9,1,0,no,0.75,0.5,no dnr,20.0,83.0,9.0,72.0,22.0,37.0,333.3,3.5,1.01,1.29980469,139.0,7.419922,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
60.17499,0,female,0,10,1985,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,26265.516,18830.0469,23.5,white,18.0,10,0,0,no,0.699999809,0.5,no dnr,10.0,100.0,7.29980469,82.0,24.0,37.09375,190.0,3.5,1.01,1.09985352,133.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.06097,1,male,0,15,651,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,36334.688,23794.0312,24.0,black,28.0,2,0,0,no,0.799999714,0.75,no dnr,15.0,84.0,8.69921875,100.0,32.0,36.5,264.0,3.5,1.01,1.19995117,140.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.04797,1,male,0,37,63,Lung Cancer,Cancer,1,6.0,under $11k,31104.797,24269.2812,6.25,black,33.0,1,0,0,metastatic,0.5,0.1,no dnr,37.0,107.0,7.0,100.0,0.0,37.0,276.1875,3.5,1.01,0.89990234,138.0,7.569336,135.0,23.0,2502.0,2.0,<2 mo. follow-up
29.37399,0,male,0,38,1984,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$11-$25k,83731.188,58268.3125,31.75,white,64.0,1,0,0,no,0.399999857,0.4,no dnr,38.0,127.0,26.6992188,115.0,30.0,37.5,122.0,1.7998047,0.5,7.39941406,139.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.31195,1,male,1,51,51,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,167402.25,115299.625,40.25,white,51.0,1,1,0,no,0.699999809,0.6,dnr after sadm,48.0,65.0,23.0,80.0,8.0,35.69531,192.5,3.5,0.19998169,11.0,135.0,7.339844,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.92798,1,female,0,27,46,COPD,COPD/CHF/Cirrhosis,2,13.0,under $11k,28759.891,20046.1562,11.75,white,26.0,1,0,0,no,0.5,0.4,dnr after sadm,5.0,85.0,7.69921875,192.0,20.0,36.69531,247.8125,3.5,1.01,0.5,137.0,7.329102,135.0,23.0,2502.0,1.0,<2 mo. follow-up
40.24597,0,male,0,14,1982,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,46602.594,32411.6406,17.666656,white,13.0,6,0,0,no,0.799999714,0.8,no dnr,14.0,117.0,11.6992188,92.0,26.0,37.79688,352.0,3.5,0.89990234,0.59997559,135.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
37.21597,1,female,0,6,10,CHF,COPD/CHF/Cirrhosis,1,10.0,under $11k,3067.549,2543.8203,6.0,black,26.0,1,0,0,no,0.899999619,0.75,no dnr,6.0,79.0,9.3984375,68.0,28.0,36.29688,552.375,3.199707,1.09985352,1.79980469,137.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
36.91199,0,male,0,4,1980,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,7022.199,4800.3203,12.0,black,4.0,1,0,0,no,0.799999714,0.6,no dnr,4.0,84.0,5.29980469,54.0,22.0,35.79688,333.3,3.5,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.87598,1,female,0,10,993,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,38151.344,24751.4375,22.0,white,26.0,7,0,0,metastatic,0.699999809,0.5,no dnr,10.0,131.0,16.0,68.0,26.0,35.0,155.0,3.5,1.01,1.19995117,136.0,7.229492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.68698,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,68088.938,45102.3438,35.0,black,79.0,11,1,0,no,0.699999809,0.7,dnr after sadm,2.0,67.0,11.2988281,110.0,40.0,36.69531,160.0,2.8999023,19.0976562,1.5,148.0,7.509766,135.0,23.0,2502.0,7.0,<2 mo. follow-up
60.91397,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,20829.844,13774.2266,28.0,white,30.0,3,0,0,metastatic,0.099999964,0.001,dnr after sadm,2.0,73.0,21.6992188,98.0,18.0,38.89844,383.0,3.5,0.69995117,2.19970703,136.0,7.269531,135.0,23.0,2502.0,2.9545898,<2 mo. follow-up
72.09296,1,male,0,3,53,Lung Cancer,Cancer,1,12.0,under $11k,2642.119,2043.2197,3.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,93.0,11.2988281,96.0,20.0,37.09375,333.3,2.8999023,0.29998779,1.0,136.0,7.419922,135.0,23.0,2502.0,2.2226562,<2 mo. follow-up
51.28,1,male,0,7,8,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,5919.547,4320.3984,9.5,white,49.0,1,0,0,no,0.399999857,0.1,dnr after sadm,2.0,67.0,6.79980469,118.0,36.0,36.59375,309.5,2.5,1.01,5.59960938,127.0,7.449219,135.0,23.0,2502.0,3.2866211,<2 mo. follow-up
49.87799,0,female,0,6,1977,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,9162.547,6519.2109,13.0,black,23.0,1,0,0,no,0.799999714,0.75,no dnr,6.0,90.0,6.69921875,68.0,10.0,36.19531,271.375,3.5,1.09985352,1.0,142.0,7.269531,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
76.71198,1,male,0,46,1895,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,>$50k,41699.688,33209.4062,13.75,white,34.0,1,0,0,no,0.699999809,0.6,no dnr,46.0,109.0,5.0,115.0,29.0,35.59375,228.0,2.699707,0.79992676,1.0,142.0,7.479492,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
63.392,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,$25-$50k,39656.938,27532.3125,37.0,white,50.0,1,0,0,no,0.399999857,0.3,dnr after sadm,9.0,67.0,14.1992188,130.0,20.0,37.09375,180.0,2.2998047,0.29998779,5.29980469,130.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.99396,1,female,1,5,5,Coma,Coma,4,12.0,under $11k,17598.688,11907.1094,30.0,white,47.0,1,1,0,no,0.049999982,0.000125,dnr after sadm,2.0,53.0,12.7988281,114.0,10.0,39.29688,323.3125,3.5,0.09999084,4.09960938,151.0,7.55957,135.0,23.0,2502.0,3.3818359,<2 mo. follow-up
61.84497,1,female,0,13,50,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,11096.047,8529.4297,18.0,white,8.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,83.0,9.5,88.0,20.0,36.0,333.3,3.5,0.5,1.0,126.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
76.90094,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,59995.78781114967,14452.7344,38.0,white,43.0,1,0,0,no,0.399999857,0.25,dnr after sadm,5.0,130.0,11.0996094,85.0,26.0,37.89844,130.0,1.6999512,2.19970703,0.79992676,129.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
51.63898,0,male,0,25,1975,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,77591.312,52269.4375,24.75,white,34.0,8,0,0,no,0.5,0.3,no dnr,25.0,132.0,10.8984375,138.0,11.0,37.79688,202.5,3.5,1.01,2.19970703,151.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.85898,0,male,0,9,1973,CHF,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,7230.598,5601.1641,8.5,white,11.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,90.0,12.0996094,76.0,20.0,36.0,333.3,3.5,0.79992676,1.29980469,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.08798,0,female,0,19,1973,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,97578.812,64881.625,32.333313,white,14.0,13,0,0,no,0.699999809,0.5,no dnr,19.0,83.0,11.1992188,110.0,26.0,39.09375,328.5625,3.5,1.01,0.79992676,145.0,7.389648,135.0,23.0,2502.0,2.7900391,<2 mo. follow-up
63.07498,1,male,0,9,148,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,15978.344,12662.4219,17.0,white,27.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,73.0,8.0,112.0,20.0,36.79688,333.3,3.5,1.01,1.59985352,135.0,7.419922,135.0,23.0,2502.0,2.3588867,<2 mo. follow-up
31.16499,1,female,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,94713.188,61565.8125,36.5,white,24.0,7,0,0,yes,0.149999976,0.15,dnr after sadm,9.0,95.0,4.89941406,84.0,14.0,36.69531,164.0,3.5,1.01,1.59985352,141.0,7.529297,135.0,23.0,2502.0,7.0,<2 mo. follow-up
46.22598,0,male,0,223,1971,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,379459.75,259995.125,31.0,black,18.0,10,0,0,no,0.099999964,0.001,no dnr,223.0,73.0,22.796875,70.0,18.0,38.89844,134.0,3.5,1.01,0.79992676,147.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
50.754,1,male,0,38,63,Cirrhosis,COPD/CHF/Cirrhosis,1,15.0,$25-$50k,59995.78781114967,14452.7344,34.25,white,28.0,1,0,0,no,0.5,0.3,no dnr,38.0,107.0,9.69921875,95.0,12.0,38.89844,200.0,1.1999512,4.19921875,1.09985352,140.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.0,1,female,0,16,1382,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,28079.641,17201.5625,22.0,white,28.0,13,0,0,no,0.699999809,0.4,no dnr,16.0,93.0,3.69970703,105.0,24.0,37.19531,280.0,3.5,0.59997559,4.69921875,130.0,7.439453,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
75.40594,0,male,0,39,1971,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,113901.062,67952.9375,22.75,black,56.0,49,0,0,yes,0.5,0.5,no dnr,39.0,110.0,25.0,114.0,35.0,37.29688,202.5,2.0,5.39941406,1.59985352,150.0,7.429688,135.0,23.0,2502.0,3.0527344,<2 mo. follow-up
54.15997,1,female,0,4,524,Lung Cancer,Cancer,1,12.0,>$50k,3714.449,2417.3125,11.0,white,9.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,87.0,4.59960938,64.0,24.0,37.0,333.3,3.5,0.19998169,0.69995117,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.36499,1,male,0,4,831,Lung Cancer,Cancer,1,12.0,$11-$25k,3038.5,2171.8731,11.0,white,12.0,1,0,0,metastatic,0.699999809,0.6,no dnr,4.0,73.0,7.89941406,86.0,20.0,37.09375,476.1875,3.5,1.01,1.19995117,141.0,7.459961,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
43.20599,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,4,6.0,under $11k,49218.781,33914.5938,33.0,black,67.0,1,0,0,no,0.149999976,0.5,dnr after sadm,8.0,60.0,9.5,130.0,34.0,37.29688,120.0,2.0,16.796875,1.79980469,143.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
31.088,0,male,0,42,1969,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$25-$50k,68183.562,50421.75,18.0,black,5.0,2,0,0,no,0.699999809,0.5,no dnr,42.0,89.0,12.6992188,84.0,15.0,35.19531,383.3125,3.5,1.01,0.79992676,139.0,7.369141,135.0,23.0,2502.0,2.6416016,adl>=4 (>=5 if sur)
59.28,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,17659.438,12042.7422,18.0,black,50.0,7,0,0,no,0.099999964,0.001,dnr after sadm,1.0,79.0,21.5,130.0,22.0,37.19531,100.0,3.5,0.59997559,1.5,130.0,7.389648,135.0,23.0,2502.0,6.0,<2 mo. follow-up
60.67398,1,male,1,15,15,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,47.0,white,31.0,1,0,0,yes,0.199999928,0.3,dnr after sadm,15.0,96.0,5.59960938,125.0,24.0,35.09375,89.40625,3.5,0.29998779,1.0,138.0,7.509766,135.0,23.0,2502.0,2.5361328,<2 mo. follow-up
39.633,0,female,0,37,1967,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,140303.625,92924.625,35.75,white,44.0,8,0,0,no,0.75,0.75,no dnr,37.0,105.0,27.6992188,114.0,37.0,38.5,296.625,1.7998047,2.59960938,0.59997559,132.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.87399,1,female,0,60,298,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,149420.5,101527.875,44.75,white,41.0,1,0,0,no,0.699999809,0.5,no dnr,60.0,67.0,9.69921875,118.0,36.0,39.5,106.65625,2.5,0.89990234,0.59997559,135.0,7.479492,135.0,23.0,2502.0,0.0,SIP>=30
47.97498,1,male,0,15,423,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,34673.594,20768.1875,14.333328,black,20.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,89.0,6.39941406,62.0,16.0,36.39844,333.3,3.5,0.29998779,1.5,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.03598,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,47314.344,30738.2656,49.0,white,35.0,3,0,0,no,0.199999928,0.1,dnr after sadm,5.0,67.0,3.09960938,75.0,26.0,38.0,353.3125,3.5,1.19995117,2.0,136.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
73.57697,1,female,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,89045.438,61724.125,31.75,black,37.0,2,1,0,no,0.099999964,0.001,dnr after sadm,12.0,111.0,15.8984375,116.0,41.0,38.5,350.0,2.7998047,1.09985352,1.59985352,141.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
86.41199,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,18622.797,12580.5469,47.0,white,61.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,43.0,12.5,40.0,40.0,37.09375,104.07812,3.5,1.01,3.29980469,143.0,7.40918,135.0,23.0,2502.0,3.7089844,<2 mo. follow-up
32.97498,1,male,1,20,20,Coma,Coma,0,14.0,$11-$25k,74168.5,50308.7188,36.666657,white,28.0,4,0,0,no,0.299999952,0.3,no dnr,20.0,120.0,25.0,95.0,37.0,38.69531,192.5,3.5,1.01,1.0,141.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.50696,1,female,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,195778.25,126928.938,41.0,white,28.0,6,0,0,no,0.699999809,0.5,dnr after sadm,31.0,107.0,28.296875,100.0,36.0,36.09375,250.0,3.199707,1.29980469,0.69995117,131.0,7.439453,135.0,23.0,2502.0,2.2753906,<2 mo. follow-up
36.16199,0,female,0,47,1963,Coma,Coma,0,12.0,under $11k,120483.062,79610.0,35.75,white,25.0,1,0,0,no,0.5,0.5,no dnr,47.0,77.0,18.796875,110.0,25.0,36.19531,277.125,3.5996094,1.29980469,0.89990234,137.0,7.489258,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
49.12299,1,male,0,23,141,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,32006.594,22374.8281,26.666656,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,23.0,63.0,6.69921875,74.0,24.0,36.79688,333.3,3.5,2.5,1.29980469,118.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
24.049,1,male,0,22,29,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,59995.78781114967,14452.7344,18.666656,black,40.0,3,0,0,no,0.699999809,0.5,no dnr,22.0,88.0,30.0,112.0,36.0,38.0,322.8125,3.5,9.79882812,1.19995117,136.0,7.449219,135.0,23.0,2502.0,6.0,<2 mo. follow-up
30.76799,1,male,0,17,71,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20983.391,15626.0,11.0,black,37.0,2,0,0,no,0.799999714,0.75,no dnr,17.0,67.0,12.1992188,80.0,30.0,39.29688,276.1875,2.3999023,7.09960938,0.59997559,131.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.40497,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,130559.938,87684.9375,46.333313,white,37.0,29,0,0,yes,0.699999809,0.5,dnr after sadm,12.0,58.0,13.2988281,68.0,25.0,39.29688,316.625,2.0996094,1.01,0.89990234,135.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
46.53,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,21262.891,15565.0938,41.0,white,63.0,1,0,0,no,0.699999809,0.5,dnr after sadm,6.0,61.0,15.0,122.0,8.0,37.29688,196.0,3.0,3.89990234,2.39990234,135.0,7.269531,135.0,23.0,2502.0,1.0,<2 mo. follow-up
44.60498,0,male,0,31,1957,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,148688.0,103548.562,21.25,black,51.0,31,0,0,no,0.899999619,0.8,no dnr,31.0,133.0,9.59960938,90.0,22.0,37.5,440.0,2.5996094,23.6992188,2.79980469,136.0,7.329102,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
71.69098,1,male,1,4,4,Coma,Coma,2,12.0,under $11k,12116.844,8462.4375,36.0,white,73.0,1,0,0,no,0.0,0.0,dnr after sadm,2.0,55.0,10.5,152.0,50.0,38.0,282.8125,3.5,0.5,7.5,138.0,7.219727,135.0,23.0,2502.0,2.9052734,<2 mo. follow-up
64.94995,1,female,0,36,48,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,62986.688,43444.7188,26.5,black,59.0,3,0,0,metastatic,0.699999809,0.5,no dnr,36.0,52.0,24.6992188,180.0,7.0,38.0,260.0,2.5,2.39990234,1.69995117,141.0,7.529297,135.0,23.0,2502.0,3.8496094,<2 mo. follow-up
46.85797,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,under $11k,73627.125,50169.4062,40.5,white,78.0,6,0,0,no,0.299999952,0.2,dnr after sadm,9.0,68.0,28.6992188,100.0,29.0,38.09375,186.0,2.8999023,24.5,6.29980469,144.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.70197,1,male,0,8,39,Lung Cancer,Cancer,1,12.0,under $11k,7427.547,5059.1406,13.5,white,28.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,2.0,83.0,12.5996094,100.0,36.0,36.19531,308.0,3.5,0.29998779,1.09985352,143.0,7.459961,135.0,23.0,2502.0,2.8491211,<2 mo. follow-up
38.883,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,25195.344,16901.6562,30.0,black,34.0,1,0,0,no,0.849999905,0.75,dnr after sadm,10.0,70.0,11.0,98.0,9.0,34.59375,384.0,3.5,3.59960938,0.39996338,142.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
76.06799,1,male,0,5,70,Lung Cancer,Cancer,1,12.0,under $11k,3971.6,3286.3984,5.0,white,23.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,74.0,7.59960938,88.0,24.0,36.59375,480.9375,3.5,1.01,1.09985352,142.0,7.5,135.0,23.0,2502.0,2.0610352,<2 mo. follow-up
65.52197,1,male,0,7,80,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,5249.898,3816.7031,9.5,black,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,87.0,3.09960938,84.0,20.0,36.5,333.3,2.3999023,2.59960938,0.79992676,137.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
62.366,1,female,0,4,14,Colon Cancer,Cancer,1,16.0,$25-$50k,2857.299,2059.7793,10.0,white,50.0,1,0,0,metastatic,0.099999964,0.001,no dnr,4.0,78.0,13.0,110.0,36.0,36.0,333.3,2.2998047,4.0,1.0,131.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.64798,1,female,0,21,322,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,45167.531,31629.2344,27.0,white,38.0,3,1,0,yes,0.699999809,0.5,no dnr,21.0,78.0,11.0,112.0,40.0,38.5,290.0,3.5,1.01,1.09985352,138.0,7.519531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.60498,0,female,0,3,1952,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4187.199,2915.0039,4.0,white,14.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,67.0,6.89941406,68.0,20.0,36.0,333.3,3.5,0.59997559,1.19995117,139.0,7.419922,135.0,23.0,2502.0,1.9326172,<2 mo. follow-up
63.04199,1,male,0,236,1441,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,504659.5,338955.0,46.0,white,34.0,3,0,0,no,0.75,0.7,dnr after sadm,148.0,72.0,18.1992188,120.0,10.0,37.79688,267.5,1.7998047,0.39996338,1.39990234,137.0,7.389648,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
21.13599,1,male,0,32,275,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,163675.25,110659.25,29.25,white,41.0,20,0,0,no,0.699999809,0.5,no dnr,32.0,143.0,16.296875,68.0,8.0,35.09375,260.0,2.5,9.79882812,0.89990234,147.0,7.509766,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
58.32199,1,female,0,7,877,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,15772.445,11455.75,19.5,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,90.0,13.5996094,110.0,20.0,37.19531,148.0,3.5,1.01,0.59997559,138.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.97998,1,female,0,15,674,Colon Cancer,Cancer,1,12.0,under $11k,14023.094,10758.6016,12.333328,white,17.0,1,0,0,metastatic,0.899999619,0.75,no dnr,15.0,97.0,7.19921875,72.0,16.0,36.79688,333.3,4.0996094,5.29980469,0.69995117,139.0,7.419922,135.0,23.0,2502.0,2.0927734,<2 mo. follow-up
53.43997,0,male,0,53,1950,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,88128.812,63449.3438,32.5,white,60.0,1,0,0,no,0.699999809,0.5,no dnr,53.0,65.0,16.6992188,125.0,31.0,38.19531,152.0,3.3999023,2.69970703,7.39941406,133.0,7.369141,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
65.17999,1,male,0,52,103,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,under $11k,96142.25,65433.5938,25.75,white,22.0,1,0,0,no,0.949999809,0.94,no dnr,52.0,112.0,15.3984375,85.0,15.0,37.19531,266.625,1.6999512,0.59997559,0.89990234,131.0,7.469727,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
70.69397,1,male,0,18,865,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,22192.984,16123.9609,18.0,white,31.0,2,0,0,no,0.699999809,0.5,no dnr,18.0,74.0,12.0,90.0,19.0,35.5,316.0,2.5996094,5.79980469,0.89990234,133.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.806,1,male,0,5,362,Lung Cancer,Cancer,2,10.0,$25-$50k,6054.199,3734.2539,10.0,white,25.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,135.0,15.0996094,92.0,20.0,36.79688,333.3,4.0996094,0.5,1.5,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.38498,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,49908.031,33091.8125,50.0,black,16.0,12,0,0,metastatic,0.099999964,0.001,dnr after sadm,8.0,80.0,5.89941406,115.0,26.0,36.09375,282.8125,3.5,1.01,0.69995117,130.0,7.339844,135.0,23.0,2502.0,2.7504883,<2 mo. follow-up
44.13998,0,male,0,84,1947,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,148803.75,101513.938,26.25,black,26.0,2,0,0,no,0.949999809,0.95,no dnr,84.0,123.0,11.2988281,115.0,38.0,37.59375,175.5,2.7998047,0.89990234,1.0,142.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.33099,1,female,1,24,24,Coma,Coma,0,12.0,under $11k,59995.78781114967,14452.7344,21.333328,black,19.0,1,0,0,no,0.009999998,1e-06,dnr after sadm,5.0,125.0,15.0,85.0,22.0,37.29688,243.3125,3.5,1.01,1.09985352,141.0,7.439453,135.0,23.0,2502.0,2.0,<2 mo. follow-up
77.11694,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,59995.78781114967,14452.7344,38.0,white,50.0,8,0,0,yes,0.399999857,0.1,no dnr,21.0,55.0,17.8984375,110.0,14.0,36.0,140.0,1.5998535,0.39996338,1.09985352,151.0,7.389648,135.0,23.0,2502.0,7.0,<2 mo. follow-up
53.11697,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,36496.094,25353.0469,28.666656,black,51.0,1,0,0,no,0.699999809,0.5,dnr after sadm,13.0,72.0,24.296875,98.0,24.0,35.39844,344.4375,2.5,50.1953125,2.09960938,134.0,7.40918,135.0,23.0,2502.0,4.0,<2 mo. follow-up
50.64999,0,male,0,38,1945,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,59995.78781114967,14452.7344,13.75,white,7.0,2,0,0,no,0.899999619,0.85,no dnr,38.0,82.0,8.3984375,70.0,16.0,37.29688,466.625,3.5,0.39996338,1.09985352,141.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.47894,1,male,1,4,4,Lung Cancer,Cancer,1,12.0,under $11k,59995.78781114967,14452.7344,21.0,white,58.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,43.0,12.2988281,0.0,0.0,36.59375,108.32812,3.5,0.79992676,0.89990234,133.0,7.179688,135.0,23.0,2502.0,3.7460938,<2 mo. follow-up
66.90997,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,59995.78781114967,14452.7344,44.0,other,37.0,5,1,0,no,0.799999714,0.512,dnr after sadm,17.0,72.0,11.5,120.0,40.0,38.09375,271.375,3.5,1.01,1.09985352,138.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.42798,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,81086.875,55463.9688,44.0,white,35.0,35,0,0,metastatic,0.75,0.3,dnr before sadm,-8.0,67.0,18.0,135.0,10.0,38.0,276.625,2.699707,1.0,2.89990234,145.0,7.40918,135.0,23.0,2502.0,2.3833008,<2 mo. follow-up
53.09497,0,male,0,32,1946,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,57829.438,41323.5312,24.5,white,20.0,2,0,0,no,0.699999809,0.5,no dnr,32.0,100.0,15.1992188,70.0,28.0,37.59375,212.0,3.5,0.69995117,0.69995117,136.0,7.40918,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
42.95697,0,male,0,22,1945,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,45774.219,32444.4531,36.0,white,65.0,1,0,0,no,0.799999714,0.9,no dnr,22.0,67.0,28.5,125.0,24.0,38.69531,59.0,1.2998047,1.59985352,4.5,149.0,7.429688,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
61.38797,1,female,0,7,81,Lung Cancer,Cancer,1,16.0,>$50k,7101.348,5534.457,4.0,white,9.0,1,0,0,metastatic,0.299999952,0.05,no dnr,7.0,94.0,7.0,86.0,18.0,36.19531,333.3,3.5,1.01,0.89990234,135.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
30.63699,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,24373.297,17057.125,58.0,black,70.0,2,0,0,no,0.699999809,0.5,no dnr,5.0,131.0,16.0976562,220.0,36.0,35.5,465.0,3.5,32.59375,1.69995117,151.0,7.509766,135.0,23.0,2502.0,1.9372559,<2 mo. follow-up
51.77298,1,male,0,23,236,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,71611.188,49917.3438,31.333328,white,69.0,23,0,0,yes,0.5,0.5,no dnr,23.0,54.0,0.09999084,90.0,36.0,39.09375,115.0,3.5,1.09985352,2.5,136.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.41595,0,female,0,14,1940,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,19865.688,14454.7734,20.333328,white,55.0,4,0,0,yes,0.599999905,0.5,no dnr,14.0,112.0,18.296875,140.0,37.0,35.19531,142.84375,2.199707,0.39996338,1.29980469,136.0,7.489258,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
67.01398,0,female,0,32,1940,Lung Cancer,Cancer,1,10.0,under $11k,59995.78781114967,14452.7344,6.25,white,9.0,1,0,0,metastatic,0.899999619,0.7,no dnr,32.0,96.0,9.29882812,52.0,20.0,37.0,333.3,3.5,0.39996338,0.79992676,138.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
80.44098,1,male,1,70,70,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,221947.625,148211.0,47.0,white,57.0,7,0,0,no,0.699999809,0.65,dnr after sadm,69.0,58.0,14.5996094,154.0,10.0,38.59375,135.0,2.0,3.29980469,1.0,132.0,7.399414,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
46.45898,0,male,0,33,1939,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,87008.125,59460.2812,23.0,white,65.0,2,0,0,no,0.699999809,0.5,no dnr,33.0,45.0,25.1992188,124.0,28.0,39.0,206.65625,3.7998047,2.19970703,1.39990234,140.0,7.5,135.0,23.0,2502.0,0.0,SIP>=30
64.04095,1,female,0,13,75,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,12177.0,14452.7344,13.5,white,43.0,1,0,0,metastatic,0.299999952,0.3,no dnr,13.0,107.0,0.69995117,100.0,29.0,37.09375,371.375,3.5,0.5,0.59997559,132.0,7.469727,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
63.211,1,male,0,10,1132,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8286.344,6482.3594,11.5,white,15.0,1,0,0,no,0.799999714,0.6,no dnr,10.0,70.0,8.0,80.0,20.0,36.39844,428.5625,3.5,1.5,1.09985352,142.0,7.459961,135.0,23.0,2502.0,2.3369141,<2 mo. follow-up
44.909,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,45405.188,28532.3281,50.0,black,57.0,3,1,0,no,0.25,0.25,no dnr,5.0,112.0,21.796875,146.0,55.0,39.0,94.0,2.0996094,0.19998169,0.79992676,142.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
38.784,1,male,0,6,38,Lung Cancer,Cancer,1,12.0,under $11k,8524.148,5521.2148,12.0,white,10.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,103.0,23.0976562,90.0,20.0,36.5,333.3,3.0,0.29998779,0.89990234,139.0,7.419922,135.0,23.0,2502.0,2.1420898,<2 mo. follow-up
45.00497,1,male,0,97,142,Coma,Coma,0,12.0,$25-$50k,177418.375,120515.938,32.75,white,32.0,6,0,0,no,0.099999964,0.001,dnr after sadm,4.0,130.0,19.5976562,130.0,10.0,38.69531,246.65625,3.5,1.01,1.0,140.0,7.539062,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.91595,1,male,0,8,41,Lung Cancer,Cancer,1,1.0,under $11k,59995.78781114967,14452.7344,6.5,black,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,73.0,6.19921875,90.0,18.0,36.5,333.3,3.5,1.01,0.79992676,135.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
49.89697,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,36192.281,24370.8906,44.5,white,46.0,5,0,0,no,0.399999857,0.4,no dnr,7.0,73.0,0.29998779,116.0,33.0,37.79688,225.0,3.5,0.39996338,1.19995117,135.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.28799,1,female,1,25,25,Cirrhosis,COPD/CHF/Cirrhosis,2,7.0,$11-$25k,59995.78781114967,14452.7344,21.25,white,31.0,1,0,0,no,0.5,0.5,no dnr,25.0,84.0,6.09960938,110.0,24.0,36.89844,333.3,3.199707,6.69921875,1.39990234,140.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
33.254,1,male,1,61,61,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,123138.188,84588.25,21.25,black,96.0,31,0,0,yes,0.199999928,0.2,dnr after sadm,61.0,69.0,0.39996338,145.0,52.0,39.39844,373.3125,2.0,16.296875,1.69995117,148.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
45.97098,0,male,0,16,1934,CHF,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,34001.469,24492.7812,27.0,white,21.0,1,1,0,no,0.5,0.3,no dnr,16.0,80.0,14.3984375,114.0,26.0,36.79688,283.3125,2.7998047,1.39990234,1.0,125.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.81897,1,male,1,17,17,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,89738.938,61880.625,41.0,white,73.0,24,0,0,yes,0.199999928,0.1,dnr after sadm,7.0,63.0,0.39996338,112.0,10.0,37.19531,131.65625,3.5,0.59997559,9.19921875,134.0,7.469727,135.0,23.0,2502.0,3.0644531,<2 mo. follow-up
75.30194,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,23312.641,15998.5312,39.0,white,81.0,7,0,0,yes,0.399999857,0.4,dnr after sadm,3.0,0.0,58.59375,0.0,0.0,39.59375,137.75,2.5,0.89990234,1.69995117,149.0,7.439453,135.0,23.0,2502.0,1.5441894,<2 mo. follow-up
60.30399,1,male,0,9,40,Colon Cancer,Cancer,1,12.0,$11-$25k,59995.78781114967,14452.7344,18.0,black,18.0,1,0,0,metastatic,0.099999964,0.001,no dnr,9.0,93.0,4.89941406,112.0,28.0,39.79688,333.3,3.5,0.69995117,0.69995117,133.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.62198,0,male,0,5,1933,CHF,COPD/CHF/Cirrhosis,0,12.0,under $11k,14459.148,9915.3906,21.0,white,19.0,1,0,0,no,0.949999809,0.85,no dnr,5.0,97.0,10.2988281,110.0,24.0,36.39844,210.0,3.5,1.01,1.0,137.0,7.449219,135.0,23.0,2502.0,2.1704102,<2 mo. follow-up
43.159,1,male,0,4,701,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,13811.0,14452.7344,6.0,black,11.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,77.0,4.29980469,90.0,18.0,36.89844,333.3,3.5,0.79992676,0.79992676,138.0,7.419922,135.0,23.0,2502.0,2.215332,no(M2 and SIP pres)
68.19196,1,male,1,20,20,COPD,COPD/CHF/Cirrhosis,1,9.0,under $11k,69824.688,46296.5,28.333328,white,29.0,11,1,0,no,0.399999857,0.4,dnr after sadm,7.0,83.0,13.3984375,98.0,8.0,35.89844,156.0,3.5,1.01,1.29980469,152.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
77.98798,1,female,0,23,180,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,59995.78781114967,14452.7344,26.0,white,18.0,1,0,0,no,0.799999714,0.7,no dnr,23.0,113.0,15.1992188,82.0,25.0,37.59375,303.3125,3.5996094,0.29998779,0.39996338,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.99396,1,female,0,23,1659,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,53060.125,36860.4375,26.333328,black,32.0,2,0,0,no,0.899999619,0.9,no dnr,23.0,118.0,7.19921875,150.0,20.0,38.59375,206.65625,2.8999023,1.01,0.79992676,138.0,7.519531,135.0,23.0,2502.0,1.861084,<2 mo. follow-up
50.40097,0,male,0,7,1931,Lung Cancer,Cancer,1,14.0,$11-$25k,4376.5,3473.1387,5.5,other,23.0,1,0,0,metastatic,0.799999714,0.2,no dnr,7.0,83.0,2.69970703,52.0,24.0,37.5,333.3,3.5,0.69995117,1.5,133.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
77.10596,1,male,1,11,11,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,28218.141,19108.8438,28.5,white,27.0,5,0,0,yes,0.75,0.5,dnr after sadm,5.0,103.0,10.7988281,112.0,9.0,37.59375,213.3125,2.3999023,0.39996338,0.79992676,143.0,7.449219,135.0,23.0,2502.0,1.9489746,<2 mo. follow-up
80.13397,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,$25-$50k,67287.125,45010.0625,42.666657,white,59.0,1,1,0,no,0.199999928,0.2,dnr after sadm,2.0,59.0,10.5,94.0,12.0,38.0,85.0,3.5,1.0,2.39990234,130.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.05298,1,female,0,71,183,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,73721.125,52616.9062,15.25,white,17.0,1,0,0,no,0.989999771,0.9,no dnr,71.0,103.0,26.0,98.0,18.0,36.09375,385.6875,4.0,0.59997559,0.89990234,142.0,7.489258,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.073,1,male,0,10,1910,COPD,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,8162.348,6030.125,11.5,white,34.0,1,0,0,yes,0.899999619,0.75,no dnr,10.0,90.0,20.1992188,75.0,26.0,35.79688,214.28125,3.5,0.69995117,1.0,137.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
39.43597,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,111050.375,72371.5625,41.25,white,55.0,4,0,0,no,0.699999809,0.5,dnr after sadm,21.0,59.0,16.8984375,115.0,60.0,38.29688,226.65625,3.5,0.59997559,1.09985352,133.0,7.379883,135.0,23.0,2502.0,1.862793,<2 mo. follow-up
77.02698,1,male,1,85,85,CHF,COPD/CHF/Cirrhosis,1,15.0,$25-$50k,86263.0,63587.5625,16.5,white,41.0,9,0,0,yes,0.599999905,0.6,dnr after sadm,6.0,67.0,20.6992188,135.0,31.0,38.39844,211.40625,3.5,0.29998779,1.5,140.0,7.40918,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
37.41498,0,female,0,14,1927,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,140070.375,98097.8125,15.0,black,36.0,46,1,0,no,0.979999542,0.98,no dnr,14.0,111.0,19.0976562,98.0,16.0,35.5,268.0,2.7998047,0.29998779,5.0,138.0,7.40918,135.0,23.0,2502.0,2.78125,<2 mo. follow-up
48.84299,0,female,0,21,1927,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$25-$50k,55942.812,36934.5,26.666656,black,30.0,3,0,0,no,0.919999599,0.9,no dnr,21.0,77.0,20.296875,142.0,10.0,39.09375,168.0,2.699707,1.01,0.79992676,135.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.04596,1,female,1,30,30,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,87928.938,61871.6562,28.5,black,8.0,12,0,0,yes,0.099999964,0.001,dnr after sadm,19.0,93.0,11.3984375,106.0,11.0,38.5,406.625,2.5996094,0.5,1.0,133.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
72.29297,1,male,1,4,4,Lung Cancer,Cancer,5,12.0,under $11k,1849.149,1677.3008,9.0,white,37.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,70.0,5.5,64.0,36.0,36.39844,335.0,3.5,1.01,3.09960938,142.0,7.369141,135.0,23.0,2502.0,3.9194336,<2 mo. follow-up
50.30298,1,female,0,7,373,COPD,COPD/CHF/Cirrhosis,2,9.0,$25-$50k,59995.78781114967,14452.7344,9.0,white,21.0,1,0,0,no,0.899999619,0.9,dnr after sadm,1.0,108.0,9.5,115.0,24.0,35.39844,285.6875,3.5,0.29998779,0.79992676,142.0,7.339844,135.0,23.0,2502.0,5.0,SIP>=30
27.55899,0,male,0,24,1922,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,54286.625,39041.0,32.666657,white,55.0,1,0,0,no,0.699999809,0.7,no dnr,24.0,70.0,9.5,110.0,23.0,36.5,280.0,2.0996094,0.59997559,7.69921875,146.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.31598,1,male,0,18,397,CHF,COPD/CHF/Cirrhosis,4,7.0,$11-$25k,27578.297,19002.8281,14.0,white,24.0,1,1,0,no,0.949999809,0.93,no dnr,18.0,80.0,12.1992188,100.0,24.0,37.29688,333.3,3.3999023,1.01,1.59985352,136.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
38.74298,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,121979.062,81317.4375,51.5,white,69.0,6,0,0,no,0.0,0.0,no dnr,7.0,93.0,12.2988281,112.0,12.0,35.59375,144.875,4.0996094,29.1992188,3.69970703,142.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
82.89697,1,male,1,13,13,COPD,COPD/CHF/Cirrhosis,1,3.0,under $11k,37978.875,25475.9688,53.0,black,53.0,1,0,0,no,0.099999964,0.001,dnr after sadm,4.0,63.0,18.0,150.0,26.0,37.5,135.0,1.5998535,0.19998169,1.09985352,136.0,7.319336,135.0,23.0,2502.0,7.0,<2 mo. follow-up
60.84299,0,male,0,15,1920,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$11-$25k,31849.109,23183.5156,21.333328,white,31.0,1,0,0,no,0.799999714,0.8,no dnr,15.0,108.0,20.0976562,110.0,34.0,38.39844,168.5625,3.5,0.59997559,1.0,146.0,7.429688,135.0,23.0,2502.0,1.9399414,no(M2 and SIP pres)
59.48297,1,male,0,14,137,Lung Cancer,Cancer,2,12.0,$25-$50k,10657.312,8153.3203,12.666664,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,14.0,80.0,11.8984375,100.0,20.0,38.59375,304.75,3.5,1.01,0.69995117,135.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.00397,1,male,0,6,57,Colon Cancer,Cancer,1,21.0,>$50k,59995.78781114967,14452.7344,19.0,white,20.0,1,0,0,metastatic,0.699999809,0.4,no dnr,6.0,93.0,6.89941406,70.0,16.0,36.19531,333.3,2.7998047,0.39996338,1.5,135.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
55.90698,1,male,0,3,134,Lung Cancer,Cancer,2,12.0,under $11k,2410.699,1712.7959,3.0,white,25.0,1,1,0,metastatic,0.949999809,0.6,no dnr,3.0,113.0,7.19921875,80.0,22.0,35.89844,333.3,3.5,1.01,1.59985352,137.0,7.419922,135.0,23.0,2502.0,2.2163086,no(M2 and SIP pres)
83.92596,1,male,0,6,1868,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,22317.844,12897.8828,25.0,white,31.0,1,1,0,yes,0.699999809,0.5,no dnr,6.0,99.0,11.0,68.0,20.0,36.79688,342.8125,3.5,1.01,2.29980469,139.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.11395,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,$11-$25k,67608.5,43753.75,44.0,white,57.0,7,0,0,yes,0.0,0.0,dnr after sadm,5.0,43.0,8.8984375,124.0,25.0,39.0,122.84375,2.0,1.01,1.09985352,147.0,7.489258,135.0,23.0,2502.0,1.0,<2 mo. follow-up
58.09698,1,male,1,10,10,Lung Cancer,Cancer,1,12.0,under $11k,9295.594,6644.8711,9.5,white,13.0,1,0,0,metastatic,0.899999619,0.7,dnr after sadm,10.0,90.0,7.89941406,120.0,24.0,36.79688,333.3,2.5996094,1.29980469,0.79992676,139.0,7.419922,135.0,23.0,2502.0,3.2607422,<2 mo. follow-up
73.04596,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$11-$25k,99060.062,63955.4375,53.333313,black,43.0,9,1,1,no,0.5,0.5,no dnr,18.0,67.0,6.39941406,68.0,10.0,38.29688,533.25,1.1999512,0.29998779,2.09960938,141.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
69.15295,1,female,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,272269.5,173140.875,52.75,white,61.0,32,0,0,no,0.699999809,0.5,no dnr,28.0,87.0,9.29882812,100.0,50.0,38.5,165.0,4.6992188,3.09960938,2.0,140.0,7.5,135.0,23.0,2502.0,4.0703125,<2 mo. follow-up
65.52496,1,female,1,18,18,Coma,Coma,0,16.0,$25-$50k,16579.594,12479.7266,14.0,black,34.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,62.0,14.5996094,64.0,28.0,35.29688,476.625,3.5,1.0,1.5,136.0,7.429688,135.0,23.0,2502.0,2.3056641,<2 mo. follow-up
76.77997,1,male,1,110,110,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,under $11k,419652.25,280731.0,46.75,white,54.0,15,0,0,no,0.699999809,0.5,no dnr,110.0,59.0,7.0,142.0,8.0,35.69531,226.65625,2.7998047,1.01,1.89990234,134.0,7.379883,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
37.74698,1,female,1,56,56,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,75506.125,54050.4688,22.5,black,22.0,2,0,0,no,0.699999809,0.5,dnr after sadm,55.0,63.0,4.29980469,130.0,10.0,39.29688,544.0,2.699707,0.09999084,0.69995117,135.0,7.389648,135.0,23.0,2502.0,2.4042969,<2 mo. follow-up
57.57397,1,male,1,5,5,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,13889.844,10675.0,30.0,white,30.0,1,0,0,no,0.099999964,0.001,no dnr,5.0,74.0,6.19921875,108.0,14.0,35.0,264.0,2.8999023,0.69995117,1.59985352,135.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.07898,0,female,0,38,1915,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,$11-$25k,59744.844,40375.875,19.25,white,19.0,3,0,0,metastatic,0.899999619,0.85,no dnr,38.0,83.0,9.19921875,135.0,8.0,37.29688,323.3125,2.3999023,1.01,1.0,132.0,7.40918,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
62.03998,1,male,0,15,17,Lung Cancer,Cancer,2,9.0,$25-$50k,28018.188,18572.7344,21.0,white,43.0,1,0,0,metastatic,0.5,0.0,no dnr,15.0,112.0,29.5976562,130.0,36.0,35.79688,152.5,2.3999023,0.29998779,0.59997559,140.0,7.389648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.46698,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,35396.781,21861.125,45.0,black,59.0,4,1,0,no,0.699999809,0.5,dnr after sadm,2.0,45.0,10.5996094,140.0,36.0,38.59375,172.5,3.5,1.01,1.5,143.0,7.319336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.85498,1,male,1,24,24,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,19714.938,15110.1172,10.0,white,45.0,1,0,0,no,0.5,0.3,dnr after sadm,14.0,90.0,11.1992188,94.0,18.0,34.39844,333.3,2.7998047,33.0,1.39990234,126.0,7.419922,135.0,23.0,2502.0,3.3227539,<2 mo. follow-up
65.81195,1,male,0,26,51,CHF,COPD/CHF/Cirrhosis,5,9.0,under $11k,47714.625,33123.1562,25.25,white,40.0,1,1,0,no,0.199999928,0.008,no dnr,26.0,75.0,8.5,110.0,26.0,37.19531,312.0,3.5,0.79992676,1.69995117,135.0,7.429688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
26.834,0,female,0,11,1911,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,16465.844,11702.9375,14.0,black,66.0,2,0,0,no,0.799999714,0.8,no dnr,11.0,136.0,16.8984375,0.0,0.0,35.89844,336.0,3.5,1.29980469,5.89941406,139.0,7.329102,135.0,23.0,2502.0,2.0,<2 mo. follow-up
69.11395,1,male,1,15,15,Coma,Coma,2,12.0,under $11k,45662.281,31362.1875,27.0,black,33.0,5,1,0,no,0.699999809,0.5,dnr after sadm,12.0,123.0,12.0996094,94.0,35.0,38.09375,456.625,3.5,1.01,1.69995117,139.0,7.649414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
49.71698,1,male,1,103,103,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,345511.75,221787.375,50.0,white,47.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,18.0,83.0,11.5996094,140.0,36.0,39.0,73.32812,2.0,0.19998169,0.59997559,147.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
43.03897,1,male,0,18,128,Lung Cancer,Cancer,1,14.0,$25-$50k,25087.047,17921.0,12.333328,white,22.0,1,0,0,metastatic,0.899999619,0.6,no dnr,18.0,100.0,9.59960938,140.0,18.0,37.29688,333.3,3.5996094,0.29998779,1.09985352,142.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
67.85498,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,29172.891,18237.5938,45.0,white,57.0,3,0,0,no,0.699999809,0.5,dnr after sadm,4.0,46.0,14.0996094,62.0,24.0,36.69531,160.0,3.5,1.01,4.0,124.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.59698,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,68324.75,45443.0938,30.5,white,28.0,10,1,0,no,0.299999952,0.2,no dnr,9.0,65.0,8.0,58.0,9.0,37.29688,242.84375,3.5,1.01,2.0,142.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.409,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,28525.047,19878.1094,31.0,white,56.0,4,0,0,no,0.699999809,0.5,dnr after sadm,3.0,103.0,29.0976562,140.0,24.0,37.59375,160.0,3.5,1.39990234,2.79980469,133.0,7.489258,135.0,23.0,2502.0,2.597168,<2 mo. follow-up
71.82996,1,male,0,44,1106,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,110116.562,70567.125,20.5,black,22.0,2,0,0,no,0.699999809,0.5,no dnr,44.0,86.0,15.2988281,72.0,18.0,37.0,333.3,3.5,1.01,1.79980469,132.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
71.91797,1,male,0,41,1127,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,84830.938,58373.6875,26.5,white,25.0,5,0,0,no,0.699999809,0.5,dnr after sadm,16.0,57.0,5.69921875,110.0,8.0,38.59375,500.0,3.5,1.01,0.89990234,134.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
85.57996,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,59995.78781114967,14452.7344,37.0,white,42.0,2,0,0,no,0.099999964,0.001,dnr after sadm,3.0,60.0,23.5,62.0,18.0,37.09375,149.0,2.2998047,0.69995117,1.19995117,135.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.92697,1,male,0,9,432,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,17596.484,12805.6875,22.0,black,30.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,83.0,2.0,80.0,33.0,36.69531,216.65625,3.5,0.5,1.69995117,141.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
21.405,0,female,0,12,1906,CHF,COPD/CHF/Cirrhosis,0,12.0,$11-$25k,59995.78781114967,14452.7344,5.0,white,14.0,1,0,0,no,0.899999619,0.7,no dnr,12.0,65.0,10.8984375,118.0,20.0,36.5,333.3,3.5,1.01,1.09985352,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.83899,1,female,0,9,167,COPD,COPD/CHF/Cirrhosis,5,3.0,under $11k,15547.047,11720.3203,13.0,black,36.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,100.0,10.5996094,92.0,16.0,36.59375,252.0,3.2998047,0.09999084,7.09960938,136.0,7.219727,135.0,23.0,2502.0,0.0,SIP>=30
62.004,1,female,0,14,1123,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,18162.547,13435.8047,10.0,black,15.0,1,0,0,no,0.899999619,0.9,no dnr,14.0,77.0,14.8984375,90.0,24.0,36.29688,321.6875,3.5,0.29998779,0.89990234,140.0,7.359375,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
59.29599,1,female,0,5,65,Colon Cancer,Cancer,1,12.0,under $11k,59995.78781114967,14452.7344,11.0,white,13.0,1,0,0,metastatic,0.899999619,0.7,no dnr,5.0,100.0,7.59960938,96.0,20.0,36.79688,333.3,3.5996094,0.69995117,0.59997559,137.0,7.419922,135.0,23.0,2502.0,1.7023926,<2 mo. follow-up
78.84698,1,male,1,5,5,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4319.68,3077.4668,12.0,black,26.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,62.0,4.5,78.0,20.0,35.59375,338.0625,3.5,1.01,1.79980469,141.0,7.479492,135.0,23.0,2502.0,2.1801758,<2 mo. follow-up
65.83997,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,96527.75,61453.4062,51.333313,white,68.0,2,0,0,yes,0.199999928,0.18,dnr after sadm,16.0,48.0,6.79980469,110.0,29.0,38.5,138.0,2.5996094,5.09960938,2.69970703,137.0,7.359375,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.38995,1,female,0,8,1091,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,14528.797,10640.1562,9.5,black,12.0,2,0,0,no,0.799999714,0.7,no dnr,8.0,99.0,8.79882812,62.0,15.0,36.89844,319.0,3.5,1.01,0.59997559,140.0,7.419922,135.0,23.0,2502.0,2.3774414,<2 mo. follow-up
79.34296,0,male,0,14,1895,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,33593.688,23662.5469,25.0,white,35.0,2,0,0,no,0.699999809,0.5,no dnr,14.0,66.0,6.39941406,120.0,8.0,35.79688,392.5,3.5,1.01,2.09960938,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.95898,1,male,0,5,1186,CHF,COPD/CHF/Cirrhosis,3,4.0,under $11k,2900.449,2445.7988,11.0,black,18.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,82.0,7.59960938,80.0,16.0,36.29688,290.4375,3.5,1.01,1.19995117,139.0,7.5,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
66.20697,1,female,1,4,4,Colon Cancer,Cancer,1,4.0,under $11k,4139.977,3156.7598,21.0,black,51.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,4.0,93.0,35.0,96.0,28.0,35.79688,333.3,3.5,6.59960938,2.19970703,128.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
63.168,0,male,0,19,1895,COPD,COPD/CHF/Cirrhosis,4,11.0,under $11k,24771.141,17050.9844,16.0,hispanic,21.0,1,0,0,yes,0.699999809,0.5,no dnr,19.0,97.0,11.5996094,106.0,26.0,37.69531,240.0,3.199707,0.79992676,0.89990234,133.0,7.399414,135.0,23.0,2502.0,5.0,SIP>=30
71.48798,1,female,0,8,1202,CHF,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,5364.898,4105.3789,10.0,white,14.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,83.0,7.09960938,54.0,16.0,36.59375,333.3,4.0,0.69995117,1.0,139.0,7.419922,135.0,23.0,2502.0,5.0,SIP>=30
59.58398,1,female,0,7,493,Colon Cancer,Cancer,1,12.0,under $11k,6601.348,4765.2305,8.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,87.0,8.59960938,80.0,20.0,37.69531,333.3,3.5,1.01,0.69995117,142.0,7.419922,135.0,23.0,2502.0,1.6523438,<2 mo. follow-up
68.39197,0,male,0,12,1892,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,38632.281,26844.7188,23.0,white,15.0,30,0,0,no,0.699999809,0.5,no dnr,12.0,112.0,12.3984375,98.0,16.0,37.39844,334.75,3.5,1.29980469,1.09985352,138.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
31.83299,0,male,0,11,1892,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,24312.484,18691.125,18.5,black,32.0,2,0,0,no,0.699999809,0.6,no dnr,11.0,75.0,10.5,78.0,25.0,38.59375,272.0,2.5,5.69921875,0.89990234,140.0,7.389648,135.0,23.0,2502.0,0.0,SIP>=30
50.23398,0,female,0,12,1891,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,58971.531,38017.8438,48.5,white,30.0,3,0,0,no,0.099999964,0.001,no dnr,12.0,68.0,9.79882812,120.0,12.0,39.09375,254.28125,3.5,1.01,1.79980469,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.29199,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,73765.25,50947.5625,43.0,black,48.0,5,0,0,no,0.199999928,0.15,dnr after sadm,22.0,69.0,5.59960938,114.0,16.0,38.5,148.0,3.5,1.01,13.7988281,139.0,7.389648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
55.62799,1,male,0,23,60,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,71645.5,47409.7812,38.666657,white,30.0,2,0,0,no,0.0,0.0,no dnr,23.0,63.0,11.5996094,110.0,12.0,38.5,145.0,2.699707,1.01,1.19995117,128.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.293,0,male,0,8,1887,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,8464.25,6247.8789,5.0,black,8.0,1,0,0,no,0.799999714,0.6,no dnr,8.0,90.0,6.59960938,88.0,20.0,35.79688,333.3,3.5996094,1.29980469,1.0,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.78998,0,female,0,3,1887,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5985.949,4069.2969,5.0,black,3.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,90.0,3.79980469,94.0,20.0,36.29688,320.0,3.5,0.79992676,1.0,136.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.69498,1,female,0,13,470,ARF/MOSF w/Sepsis,ARF/MOSF,5,5.0,under $11k,32884.094,22593.8594,37.5,black,34.0,8,0,0,metastatic,0.699999809,0.5,no dnr,13.0,91.0,15.1992188,114.0,8.0,36.39844,305.6875,3.5,1.69995117,2.09960938,136.0,7.529297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.52594,0,female,0,4,1887,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,6475.199,4829.2969,14.0,black,36.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,79.0,7.89941406,76.0,25.0,36.29688,85.0,3.5,0.5,1.89990234,135.0,7.319336,135.0,23.0,2502.0,2.5893555,<2 mo. follow-up
71.15094,1,male,1,49,49,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,137788.75,93939.75,39.25,black,39.0,1,1,0,no,0.899999619,0.9,dnr after sadm,42.0,93.0,7.19921875,78.0,8.0,35.69531,265.6875,2.7998047,0.29998779,9.69921875,146.0,7.419922,135.0,23.0,2502.0,2.1655273,<2 mo. follow-up
39.84097,1,male,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,5,10.0,$11-$25k,31942.234,21611.3281,46.5,black,42.0,1,0,0,no,0.099999964,0.001,dnr after sadm,8.0,92.0,4.29980469,110.0,14.0,36.69531,207.5,1.7998047,4.79980469,1.79980469,134.0,7.399414,135.0,23.0,2502.0,1.0,<2 mo. follow-up
51.61099,1,female,1,44,44,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,136609.375,93343.875,42.5,white,48.0,1,0,0,no,0.399999857,0.2,dnr after sadm,30.0,86.0,22.8984375,112.0,30.0,36.59375,160.0,3.5,1.29980469,6.09960938,141.0,7.299805,135.0,23.0,2502.0,5.0,<2 mo. follow-up
63.431,0,female,0,60,1883,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,150283.625,100000.75,36.75,white,54.0,1,0,0,no,0.949999809,0.92,no dnr,60.0,67.0,13.5,188.0,25.0,39.09375,76.0,3.5,0.79992676,1.29980469,143.0,7.449219,135.0,23.0,2502.0,2.3330078,<2 mo. follow-up
68.64899,1,female,0,13,82,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,21254.391,15073.5391,28.0,white,39.0,4,1,0,no,0.599999905,0.45,no dnr,13.0,70.0,8.69921875,110.0,10.0,35.5,430.0,3.5,1.01,1.29980469,131.0,7.5,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
38.18198,1,female,0,5,100,Colon Cancer,Cancer,1,12.0,>$50k,3886.5,2888.7129,12.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,91.0,9.59960938,126.0,16.0,38.59375,333.3,3.5,0.69995117,0.5,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.41296,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,57947.938,39225.5938,50.0,black,73.0,4,0,0,no,0.099999964,0.001,dnr after sadm,8.0,111.0,9.5,102.0,13.0,35.79688,153.3125,2.699707,12.5996094,4.19921875,126.0,7.40918,135.0,23.0,2502.0,2.4824219,<2 mo. follow-up
56.45999,0,male,0,117,1882,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,253438.625,175935.75,34.0,white,59.0,8,0,0,no,0.75,0.6,no dnr,117.0,67.0,16.0976562,110.0,36.0,38.59375,230.0,2.5996094,2.59960938,8.5,134.0,7.319336,135.0,23.0,2502.0,2.5493164,<2 mo. follow-up
62.75998,1,female,0,8,127,Colon Cancer,Cancer,1,16.0,under $11k,6991.598,4942.6133,8.0,white,11.0,1,0,0,metastatic,1.0,0.5,no dnr,8.0,90.0,11.5996094,78.0,18.0,35.59375,333.3,3.5,0.89990234,0.79992676,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.62195,1,male,0,24,78,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,10631.492,9751.5312,2.333332,black,33.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,110.0,3.79980469,76.0,20.0,35.5,333.3,3.5,0.79992676,3.39990234,139.0,7.419922,135.0,23.0,2502.0,2.9091797,<2 mo. follow-up
83.61096,1,male,0,8,1230,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,4798.297,4055.584,8.0,black,42.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,67.0,7.5,64.0,28.0,37.29688,333.3,3.5,1.09985352,2.89990234,132.0,7.419922,135.0,23.0,2502.0,3.8242188,<2 mo. follow-up
83.32397,1,male,0,10,480,ARF/MOSF w/Sepsis,ARF/MOSF,4,23.0,$11-$25k,22936.141,16438.5312,21.0,white,31.0,4,0,1,yes,0.699999809,0.5,dnr after sadm,3.0,90.0,15.5,118.0,24.0,35.59375,282.5625,2.5,3.59960938,0.69995117,131.0,7.449219,135.0,23.0,2502.0,1.0,SIP>=30
57.65399,1,male,0,3,1142,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,2742.049,2030.5508,6.0,black,19.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,63.0,6.69921875,60.0,22.0,37.19531,333.3,3.5,1.0,1.39990234,140.0,7.419922,135.0,23.0,2502.0,1.9379883,<2 mo. follow-up
45.18799,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,121575.062,80014.1875,53.666657,white,63.0,13,0,0,no,0.099999964,0.001,dnr after sadm,13.0,74.0,14.0,142.0,36.0,39.59375,87.14062,3.5,2.0,2.0,134.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
53.25098,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,83062.625,51944.4688,38.5,white,26.0,10,1,0,no,0.849999905,0.7,dnr after sadm,10.0,87.0,10.8984375,92.0,8.0,37.19531,116.35938,3.5,1.01,1.5,145.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
47.86298,1,female,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,23279.203,16235.8438,47.0,black,59.0,1,0,0,no,0.099999964,0.001,no dnr,8.0,89.0,11.5996094,110.0,11.0,35.89844,157.5,3.5,39.0,3.0,152.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
64.61896,0,male,0,10,1876,Colon Cancer,Cancer,1,26.0,$11-$25k,21980.688,14755.4375,25.5,white,21.0,1,0,0,metastatic,1.0,1.0,no dnr,10.0,102.0,7.69921875,78.0,32.0,38.59375,390.0,3.5,0.5,0.79992676,134.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
25.47299,1,male,0,18,28,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,51170.219,36150.0625,27.0,white,60.0,11,0,0,no,0.699999809,0.5,dnr after sadm,4.0,113.0,22.796875,134.0,52.0,39.0,423.3125,3.5,1.01,3.59960938,137.0,7.329102,135.0,23.0,2502.0,3.0,<2 mo. follow-up
68.84595,1,male,0,13,764,COPD,COPD/CHF/Cirrhosis,1,13.0,>$50k,11347.469,8073.2383,12.0,white,20.0,1,0,0,no,0.989999771,0.95,no dnr,13.0,117.0,9.59960938,112.0,18.0,36.0,266.625,3.5,0.39996338,1.0,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.86694,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,148144.625,92974.3125,52.0,black,80.0,9,0,0,no,0.699999809,0.5,no dnr,18.0,58.0,24.296875,114.0,27.0,37.0,166.0,3.5,30.0,5.69921875,155.0,7.40918,135.0,23.0,2502.0,3.3989258,<2 mo. follow-up
39.93198,1,male,1,33,33,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,202703.625,137771.25,36.5,white,35.0,40,0,0,metastatic,0.099999964,0.001,dnr after sadm,31.0,90.0,1.0,114.0,16.0,38.0,148.875,2.5,3.79980469,1.5,142.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.97894,0,male,0,92,1873,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,306380.25,212576.375,36.25,white,28.0,14,0,0,no,0.699999809,0.5,no dnr,92.0,117.0,17.8984375,80.0,28.0,38.0,233.3125,3.5,1.01,1.59985352,133.0,7.449219,135.0,23.0,2502.0,2.2045898,<2 mo. follow-up
75.59497,1,female,1,16,16,Lung Cancer,Cancer,1,10.0,under $11k,13365.695,10269.4922,7.0,white,20.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,3.0,91.0,7.5,96.0,20.0,35.0,371.375,2.3999023,0.39996338,0.79992676,140.0,7.339844,135.0,23.0,2502.0,3.0,<2 mo. follow-up
61.00497,1,male,0,5,550,COPD,COPD/CHF/Cirrhosis,3,6.0,under $11k,3199.719,2482.4902,7.0,white,20.0,1,0,0,no,0.989999771,0.85,no dnr,5.0,128.0,6.69921875,100.0,20.0,36.5,257.125,3.5,0.19998169,1.09985352,132.0,7.40918,135.0,23.0,2502.0,2.3891602,no(M2 and SIP pres)
75.65796,1,male,0,57,226,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,88611.688,59934.1875,22.25,white,17.0,6,0,0,no,0.699999809,0.5,dnr after sadm,1.0,107.0,5.5,48.0,10.0,37.39844,323.3125,2.5996094,1.01,0.89990234,136.0,7.5,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
61.86697,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,74204.75,51113.4062,49.5,white,73.0,38,0,0,yes,0.0,0.0,dnr after sadm,8.0,63.0,0.29998779,146.0,17.0,36.69531,89.32812,3.5,1.01,2.79980469,127.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.80194,1,male,1,44,44,ARF/MOSF w/Sepsis,ARF/MOSF,1,20.0,$25-$50k,133353.125,88074.3125,42.0,white,45.0,7,1,0,no,0.099999964,0.001,dnr after sadm,3.0,99.0,21.3984375,110.0,10.0,36.59375,122.4375,2.3999023,1.29980469,5.89941406,151.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.65198,1,male,1,3,3,Coma,Coma,1,12.0,under $11k,20842.734,14142.6172,17.0,white,78.0,4,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,0.0,6.19921875,0.0,0.0,38.0,312.5,3.5,1.01,2.59960938,142.0,7.469727,135.0,23.0,2502.0,1.8364258,<2 mo. follow-up
47.39999,1,female,0,7,461,Colon Cancer,Cancer,1,15.0,>$50k,9032.297,6259.3008,6.5,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,93.0,5.19921875,68.0,24.0,37.39844,333.3,3.5,0.39996338,0.5,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.11499,1,female,0,6,804,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,6222.898,4641.1328,10.0,black,32.0,1,1,0,no,0.899999619,0.85,no dnr,6.0,102.0,6.69921875,68.0,20.0,36.59375,508.0,3.5,1.01,3.19970703,137.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
43.67999,1,male,0,5,849,Colon Cancer,Cancer,1,12.0,under $11k,3973.898,3191.6055,11.0,white,6.0,1,0,0,metastatic,0.989999771,0.5,no dnr,5.0,95.0,7.09960938,74.0,19.0,37.19531,333.3,3.5,1.01,1.0,138.0,7.419922,135.0,23.0,2502.0,1.6225586,<2 mo. follow-up
50.15997,1,female,1,89,89,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,144129.25,96060.75,26.75,black,40.0,1,0,0,no,0.799999714,0.6,dnr after sadm,88.0,79.0,10.0996094,118.0,36.0,37.5,428.5625,3.199707,3.19970703,1.19995117,138.0,7.5,135.0,23.0,2502.0,0.4947999,adl>=4 (>=5 if sur)
63.80798,1,male,0,6,384,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3234.049,2703.2148,11.0,white,9.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,84.0,6.19921875,90.0,20.0,36.79688,333.3,3.5,1.01,0.89990234,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
41.79599,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,41557.875,23583.0469,68.0,black,90.0,1,0,0,no,0.299999952,0.25,no dnr,3.0,0.0,20.6992188,0.0,0.0,39.69531,531.0,3.5,0.39996338,7.09960938,168.0,7.469727,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
49.94098,1,female,0,12,797,Colon Cancer,Cancer,1,14.0,>$50k,27833.797,18704.7812,21.5,white,13.0,1,0,0,metastatic,1.0,1.0,no dnr,12.0,103.0,7.39941406,118.0,8.0,36.5,370.0,3.5996094,0.19998169,0.89990234,142.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.05096,1,female,0,5,284,Lung Cancer,Cancer,1,12.0,$25-$50k,4287.848,2880.5723,14.0,hispanic,9.0,1,0,0,metastatic,1.0,0.8,no dnr,5.0,87.0,7.89941406,60.0,20.0,36.39844,333.3,3.5,0.19998169,0.79992676,143.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.82199,1,male,1,15,15,MOSF w/Malig,ARF/MOSF,3,11.0,$11-$25k,30126.047,22027.9531,25.0,white,33.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,13.0,109.0,44.09375,110.0,34.0,35.89844,255.8125,3.199707,0.19998169,0.79992676,143.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.01599,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,29811.031,19366.2188,53.0,white,98.0,8,1,0,yes,0.009999998,1e-06,dnr after sadm,4.0,44.0,0.09999084,180.0,12.0,37.29688,252.5,1.8999023,4.69921875,3.79980469,153.0,7.289062,135.0,23.0,2502.0,2.4750977,<2 mo. follow-up
71.75598,1,male,0,16,270,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,59008.219,39635.0312,23.333328,black,38.0,11,0,0,no,0.849999905,0.82,no dnr,16.0,63.0,24.796875,110.0,18.0,36.39844,170.0,2.5996094,0.89990234,2.09960938,140.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
39.34598,0,female,0,13,1856,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,23.0,black,36.0,2,0,0,no,0.75,0.7,no dnr,13.0,114.0,20.0,118.0,40.0,37.0,442.8125,3.5,2.29980469,1.19995117,146.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.22595,1,male,0,17,708,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,under $11k,34187.938,24100.2969,9.333328,white,18.0,14,0,0,no,0.5,0.4,no dnr,17.0,108.0,8.79882812,70.0,26.0,35.59375,142.84375,3.5,1.01,0.5,138.0,7.30957,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
29.55499,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,51709.438,33807.0938,59.0,black,74.0,10,0,0,no,0.049999982,0.000125,dnr after sadm,5.0,47.0,18.3984375,112.0,30.0,35.89844,90.0,3.5,3.59960938,5.79980469,142.0,7.529297,135.0,23.0,2502.0,2.0,<2 mo. follow-up
69.90594,1,male,0,5,929,Cirrhosis,COPD/CHF/Cirrhosis,2,9.0,$25-$50k,4728.047,3503.3516,14.0,white,20.0,1,0,0,no,0.849999905,0.5,no dnr,5.0,81.0,9.19921875,80.0,18.0,37.29688,333.3,3.199707,6.09960938,1.0,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.97998,1,male,0,18,127,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,29052.234,19552.2812,15.666664,white,38.0,2,0,0,yes,0.799999714,0.5,no dnr,18.0,89.0,100.0,90.0,36.0,38.79688,133.3125,3.5,1.01,1.59985352,137.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
57.81497,1,male,1,22,22,Lung Cancer,Cancer,1,10.0,$25-$50k,23437.938,16626.1875,11.666664,white,10.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,11.0,88.0,19.0976562,100.0,18.0,36.0,333.3,2.8999023,0.19998169,0.89990234,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.32498,1,male,0,10,25,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,33008.531,24771.1094,29.0,white,22.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,131.0,15.5996094,48.0,8.0,37.29688,302.8125,2.699707,0.29998779,1.29980469,146.0,7.5,135.0,23.0,2502.0,2.8583984,<2 mo. follow-up
76.11798,1,male,0,11,510,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,5847.648,4985.293,9.0,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,97.0,4.19921875,74.0,20.0,35.79688,333.3,4.0,2.09960938,1.79980469,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.94995,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,4,3.0,under $11k,73442.438,46502.6562,36.0,black,31.0,2,1,0,no,0.699999809,0.5,dnr after sadm,10.0,65.0,7.89941406,110.0,8.0,37.89844,356.625,2.5,0.39996338,1.79980469,132.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
26.92699,1,male,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,141803.25,94806.0,34.0,other,70.0,7,0,0,no,0.099999964,0.001,dnr after sadm,34.0,67.0,16.796875,140.0,36.0,37.5,130.0,2.7998047,5.5,5.39941406,134.0,7.289062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.05396,1,female,1,5,5,Coma,Coma,2,12.0,under $11k,9438.594,7084.5703,25.0,black,32.0,1,1,1,no,0.699999809,0.5,dnr after sadm,4.0,131.0,12.7988281,112.0,10.0,39.09375,366.625,3.5,0.29998779,0.79992676,142.0,7.459961,135.0,23.0,2502.0,4.4248047,<2 mo. follow-up
71.52594,1,male,1,53,53,ARF/MOSF w/Sepsis,ARF/MOSF,4,7.0,$11-$25k,238583.125,160377.875,32.5,white,38.0,43,1,0,no,1.0,1.0,dnr after sadm,48.0,80.0,6.29980469,110.0,39.0,36.09375,287.5,2.5,0.39996338,2.0,152.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.31799,1,male,0,6,19,Cirrhosis,COPD/CHF/Cirrhosis,0,16.0,$25-$50k,3554.6,2829.8418,9.0,white,32.0,1,0,0,no,0.949999809,0.6,no dnr,6.0,103.0,8.5,76.0,20.0,36.69531,438.0625,3.0,6.09960938,1.69995117,126.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
63.12399,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,80263.875,54229.2812,37.333313,white,47.0,5,0,0,no,0.699999809,0.5,dnr after sadm,14.0,87.0,0.79992676,76.0,10.0,36.59375,293.3125,2.5,1.01,7.39941406,136.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.03595,1,female,0,23,923,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,59995.78781114967,14452.7344,10.0,white,44.0,2,1,0,no,0.75,0.7,no dnr,23.0,123.0,11.6992188,78.0,25.0,35.89844,310.0,3.5,1.01,2.09960938,136.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.79199,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,48463.688,32859.2812,38.5,white,67.0,9,0,0,metastatic,0.699999809,0.5,dnr after sadm,6.0,63.0,7.09960938,110.0,25.0,36.0,220.0,2.7998047,15.2988281,3.59960938,130.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.97894,1,male,0,12,421,Lung Cancer,Cancer,2,7.0,under $11k,13066.297,9421.9062,10.0,white,13.0,1,0,0,metastatic,0.899999619,0.5,no dnr,12.0,105.0,7.79980469,74.0,18.0,36.59375,333.3,3.5,0.29998779,0.69995117,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.15698,1,male,0,3,78,Lung Cancer,Cancer,1,12.0,under $11k,3142.35,2077.5918,8.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,99.0,3.89990234,88.0,20.0,36.0,333.3,3.5,0.19998169,0.79992676,135.0,7.419922,135.0,23.0,2502.0,1.9938965,<2 mo. follow-up
67.74298,1,male,0,8,1530,CHF,COPD/CHF/Cirrhosis,2,18.0,$11-$25k,3384.398,3038.7207,7.0,white,13.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,93.0,6.39941406,54.0,20.0,36.09375,333.3,3.5,0.79992676,1.29980469,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.48599,1,female,0,5,60,Lung Cancer,Cancer,1,12.0,under $11k,3006.998,2284.6152,12.0,white,15.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,2.0,81.0,7.79980469,100.0,16.0,38.09375,238.09375,3.5,0.5,0.59997559,135.0,7.299805,135.0,23.0,2502.0,2.7084961,<2 mo. follow-up
59.75098,0,male,0,245,1846,ARF/MOSF w/Sepsis,ARF/MOSF,0,2.0,under $11k,405592.0,275511.75,49.5,white,27.0,5,0,0,no,0.699999809,0.5,no dnr,245.0,98.0,9.29882812,104.0,8.0,40.0,292.5,3.2998047,1.01,1.39990234,142.0,7.5,135.0,23.0,2502.0,2.0610352,<2 mo. follow-up
87.52899,1,male,1,3,3,Coma,Coma,0,12.0,under $11k,9511.203,6827.6094,27.0,black,74.0,1,0,0,no,0.049999982,0.000125,no dnr,3.0,0.0,9.29882812,0.0,0.0,36.59375,260.0,4.1992188,0.39996338,2.29980469,141.0,7.379883,135.0,23.0,2502.0,2.1782227,<2 mo. follow-up
43.09097,1,male,0,11,1358,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,9515.945,7197.6836,13.0,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,101.0,9.19921875,86.0,20.0,35.79688,819.0,3.5,1.39990234,1.09985352,135.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.06598,1,male,0,4,486,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,2045.55,1734.7861,7.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,79.0,8.8984375,64.0,16.0,35.59375,285.6875,3.5,1.01,2.59960938,138.0,7.419922,135.0,23.0,2502.0,2.8129883,<2 mo. follow-up
67.64398,1,male,0,6,172,Lung Cancer,Cancer,1,16.0,$25-$50k,6064.5,3969.1719,14.0,white,11.0,1,0,0,metastatic,1.0,0.9,no dnr,6.0,93.0,9.69921875,68.0,18.0,36.79688,333.3,3.5,0.29998779,1.0,139.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
56.06299,1,female,1,25,25,Cirrhosis,COPD/CHF/Cirrhosis,1,18.0,>$50k,141836.875,94576.6875,36.75,asian,33.0,1,0,0,no,0.599999905,0.4,dnr after sadm,19.0,81.0,7.0,84.0,20.0,36.5,333.3,2.5996094,21.5,1.29980469,135.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
77.01599,0,female,0,9,1844,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,59995.78781114967,14452.7344,21.0,white,40.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,113.0,34.796875,110.0,10.0,36.79688,400.0,1.3999023,1.01,1.0,131.0,7.429688,135.0,23.0,2502.0,3.4233398,<2 mo. follow-up
45.67297,1,male,0,14,346,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,10358.094,8390.8359,8.0,white,8.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,85.0,4.39941406,86.0,24.0,36.69531,374.9375,2.7998047,0.79992676,0.69995117,141.0,7.389648,135.0,23.0,2502.0,2.809082,<2 mo. follow-up
74.29395,1,female,0,9,453,ARF/MOSF w/Sepsis,ARF/MOSF,4,7.0,under $11k,19400.234,13264.3281,25.0,white,38.0,3,1,0,no,0.949999809,0.9,no dnr,9.0,67.0,25.0976562,66.0,16.0,36.69531,194.28125,3.5,0.59997559,1.59985352,141.0,7.449219,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
59.91498,1,male,0,28,301,MOSF w/Malig,ARF/MOSF,1,9.0,under $11k,51688.625,36456.1875,28.75,black,102.0,2,0,0,metastatic,0.25,0.15,dnr after sadm,4.0,60.0,0.89990234,200.0,35.0,39.0,277.0,2.2998047,1.79980469,3.69970703,140.0,7.179688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.57697,0,male,0,9,1840,Colon Cancer,Cancer,1,24.0,>$50k,13001.945,8862.6719,15.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,97.0,13.1992188,66.0,12.0,36.69531,436.0,3.5,0.69995117,0.79992676,133.0,7.399414,135.0,23.0,2502.0,2.4335938,<2 mo. follow-up
56.09598,0,female,0,66,1826,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,182209.5,122078.812,32.0,other,22.0,1,0,0,no,0.699999809,0.5,no dnr,66.0,67.0,8.0,120.0,16.0,37.09375,356.625,3.5,1.5,0.89990234,127.0,7.5,135.0,23.0,2502.0,5.0,SIP>=30
49.43997,1,female,0,6,128,Colon Cancer,Cancer,1,16.0,>$50k,5030.449,3832.707,13.0,hispanic,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,83.0,8.29882812,72.0,18.0,36.39844,333.3,3.5,1.0,0.89990234,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
40.81598,0,male,0,207,1825,CHF,COPD/CHF/Cirrhosis,3,16.0,$25-$50k,548741.5,357946.75,23.0,white,17.0,1,0,0,no,0.149999976,0.1,no dnr,207.0,63.0,7.89941406,114.0,16.0,36.79688,333.3,3.5,1.19995117,1.0,135.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
38.19299,1,male,0,24,290,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,16639.641,13194.3906,7.0,white,40.0,1,0,0,no,0.5,0.3,no dnr,24.0,89.0,4.89941406,80.0,12.0,36.5,240.0,2.7998047,5.59960938,1.89990234,123.0,7.5,135.0,23.0,2502.0,0.0,SIP>=30
62.46997,1,male,1,13,13,CHF,COPD/CHF/Cirrhosis,2,10.0,$25-$50k,26328.797,18009.0938,31.0,white,16.0,1,0,0,no,0.699999809,0.5,dnr after sadm,10.0,69.0,11.6992188,80.0,20.0,36.79688,180.0,3.5,1.89990234,1.09985352,133.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
41.09799,1,male,0,8,91,Lung Cancer,Cancer,1,12.0,under $11k,5966.547,4505.6875,6.5,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,8.0,86.0,8.19921875,116.0,24.0,38.09375,366.625,2.7998047,0.59997559,0.69995117,138.0,7.459961,135.0,23.0,2502.0,3.0063477,<2 mo. follow-up
73.81,0,male,0,14,1824,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,17738.891,13056.7734,14.333328,black,20.0,1,0,1,no,0.5,0.3,no dnr,14.0,113.0,6.69921875,114.0,12.0,36.29688,228.5625,2.8999023,1.01,0.89990234,139.0,7.349609,135.0,23.0,2502.0,5.5947266,<2 mo. follow-up
38.36298,0,male,0,9,1823,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,15814.742,12230.4922,16.0,white,53.0,1,1,0,no,0.899999619,0.85,no dnr,9.0,116.0,15.7988281,82.0,26.0,36.5,176.65625,1.7998047,0.29998779,2.69970703,137.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.20099,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,121286.188,78953.375,23.0,white,50.0,39,0,0,no,0.049999982,0.000125,dnr after sadm,1.0,63.0,12.0996094,122.0,36.0,35.79688,195.90625,3.5,1.01,2.5,124.0,7.489258,135.0,23.0,2502.0,2.0175781,<2 mo. follow-up
62.64999,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,59995.78781114967,14452.7344,46.333313,white,31.0,1,0,0,no,0.599999905,0.5,dnr after sadm,16.0,121.0,13.0996094,110.0,20.0,38.59375,215.53125,3.5,0.39996338,1.5,141.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.46997,1,female,0,7,439,COPD,COPD/CHF/Cirrhosis,3,6.0,under $11k,5841.199,4553.0547,8.0,black,14.0,1,0,0,no,0.899999619,0.7,no dnr,7.0,83.0,11.3984375,80.0,18.0,37.0,273.3125,3.5,1.01,1.0,141.0,7.139648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.01099,0,female,0,4,1821,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,2651.699,1935.8984,11.0,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,63.0,4.5,80.0,22.0,36.19531,328.5625,3.3999023,0.79992676,0.89990234,145.0,7.359375,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
23.07999,0,male,0,6,1820,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,12763.844,9594.2344,24.0,black,17.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,106.0,7.0,72.0,32.0,39.0,205.6875,3.5,0.29998779,1.0,134.0,7.399414,135.0,23.0,2502.0,2.5126953,no(M2 and SIP pres)
75.58398,1,male,1,19,19,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,91257.875,62239.5938,42.0,white,80.0,11,0,0,yes,0.699999809,0.5,dnr after sadm,17.0,123.0,0.09999084,124.0,37.0,38.5,410.0,3.5,5.0,4.79980469,145.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.28,1,male,0,4,194,Lung Cancer,Cancer,1,12.0,$11-$25k,3109.75,2196.4746,3.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,103.0,4.79980469,100.0,20.0,36.29688,333.3,3.5,0.29998779,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.47198,0,female,0,31,1818,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59530.938,40604.875,16.25,white,28.0,2,0,0,no,0.799999714,0.8,no dnr,31.0,120.0,14.7988281,124.0,32.0,39.09375,226.65625,3.5,1.01,0.69995117,142.0,7.479492,135.0,23.0,2502.0,2.425293,<2 mo. follow-up
26.53499,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,1,17.0,under $11k,43313.031,27733.25,33.0,white,62.0,15,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,0.0,50.09375,0.0,0.0,38.89844,252.5,2.0996094,1.79980469,0.89990234,146.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.88794,1,male,0,12,28,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,34118.438,23141.9219,33.0,white,42.0,1,0,0,yes,0.199999928,0.2,no dnr,12.0,121.0,14.7988281,146.0,9.0,39.39844,150.0,2.5996094,0.39996338,0.59997559,134.0,7.299805,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.24896,1,male,1,29,29,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,99316.812,67983.5,40.25,black,42.0,1,1,0,no,0.799999714,0.8,no dnr,29.0,143.0,6.19921875,180.0,12.0,36.59375,285.6875,2.2998047,0.19998169,1.0,138.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
60.28699,1,male,0,7,99,Lung Cancer,Cancer,3,6.0,>$50k,6261.598,4410.7773,7.0,white,22.0,1,0,0,metastatic,0.799999714,0.5,no dnr,7.0,104.0,9.8984375,72.0,26.0,38.29688,333.3,3.0,0.29998779,1.39990234,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
49.26199,1,female,1,26,26,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,178246.625,116131.625,43.0,white,40.0,16,0,0,yes,0.699999809,0.5,dnr after sadm,23.0,131.0,1.09985352,138.0,29.0,39.89844,230.0,2.5996094,6.79980469,0.69995117,134.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.26999,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$11-$25k,89426.625,60591.3438,31.5,black,69.0,1,0,0,no,0.199999928,0.15,no dnr,30.0,59.0,11.2988281,124.0,45.0,39.09375,128.3125,2.699707,1.01,2.09960938,158.0,7.459961,135.0,23.0,2502.0,5.0,<2 mo. follow-up
62.004,0,female,0,10,1814,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,14802.898,10652.4844,25.0,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,47.0,12.7988281,64.0,16.0,34.69531,110.20312,2.0996094,0.39996338,0.69995117,141.0,7.439453,135.0,23.0,2502.0,3.0693359,<2 mo. follow-up
48.32898,1,male,0,3,638,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,3862.049,2818.4746,7.0,black,31.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,81.0,4.69921875,80.0,28.0,36.79688,190.46875,3.199707,0.5,0.89990234,142.0,7.279297,135.0,23.0,2502.0,2.4345703,<2 mo. follow-up
70.23096,1,female,0,27,51,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,61871.781,42937.25,31.0,white,27.0,2,0,0,no,0.849999905,0.85,no dnr,27.0,63.0,14.1992188,72.0,24.0,36.69531,211.40625,3.5,1.01,1.5,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.297,1,female,0,6,317,Colon Cancer,Cancer,1,12.0,$11-$25k,5967.0,4048.7168,12.0,white,6.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,97.0,7.29980469,100.0,16.0,37.59375,333.3,4.0,0.29998779,0.69995117,141.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
69.62396,1,male,0,15,143,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,38503.188,27377.5,25.0,white,41.0,3,0,0,no,0.5,0.25,no dnr,15.0,67.0,12.5,110.0,14.0,38.59375,120.40625,3.5,1.01,2.19970703,144.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.409,0,male,0,3,1812,CHF,COPD/CHF/Cirrhosis,3,14.0,>$50k,4717.898,3261.6523,11.0,white,18.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,78.0,6.5,84.0,18.0,36.79688,333.3,4.2998047,4.0,0.69995117,146.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.03598,1,female,0,5,387,Colon Cancer,Cancer,1,21.0,under $11k,4229.547,2943.043,13.0,white,16.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,105.0,5.09960938,120.0,20.0,39.0,333.3,3.5,0.5,0.59997559,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.33499,1,male,0,6,396,Colon Cancer,Cancer,1,8.0,$25-$50k,5371.25,3912.6953,9.0,white,30.0,1,0,0,metastatic,0.899999619,0.6,no dnr,6.0,47.0,5.09960938,60.0,12.0,35.09375,333.3,3.5,0.5,0.89990234,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
20.605,1,female,0,90,92,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,152497.25,102769.375,29.25,black,39.0,2,0,0,no,0.949999809,0.95,no dnr,90.0,77.0,6.19921875,40.0,8.0,36.19531,187.5,3.5,3.09960938,2.09960938,147.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.52698,1,male,0,7,1302,CHF,COPD/CHF/Cirrhosis,3,22.0,$25-$50k,2618.5,2440.3203,4.5,white,22.0,1,0,0,no,0.899999619,0.8,no dnr,7.0,79.0,4.69921875,70.0,18.0,36.0,333.3,3.5,0.89990234,1.29980469,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.81,1,male,0,6,589,CHF,COPD/CHF/Cirrhosis,4,7.0,under $11k,4520.699,3556.5644,10.0,black,11.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,85.0,6.0,78.0,22.0,36.09375,368.0,3.5,1.5,1.0,133.0,7.459961,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
42.24799,1,male,0,11,201,CHF,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,18666.984,13877.7188,22.5,black,38.0,1,0,0,no,0.799999714,0.6,no dnr,11.0,47.0,4.59960938,112.0,28.0,35.39844,224.0,3.5,1.5,1.0,134.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.13998,0,female,0,19,1811,ARF/MOSF w/Sepsis,ARF/MOSF,6,14.0,under $11k,59995.78781114967,14452.7344,16.666656,white,51.0,3,0,0,yes,0.899999619,0.85,no dnr,19.0,163.0,5.5,118.0,38.0,37.79688,245.6875,3.5,0.19998169,5.29980469,140.0,7.479492,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
69.08398,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,95429.812,60088.8125,42.0,black,46.0,13,0,0,no,0.5,0.5,no dnr,7.0,76.0,27.1992188,118.0,10.0,36.09375,363.3125,3.5,2.19970703,2.39990234,152.0,7.419922,135.0,23.0,2502.0,2.5175781,<2 mo. follow-up
63.35699,1,male,0,8,89,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15985.195,11313.6406,23.5,black,55.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,57.0,4.0,148.0,24.0,35.89844,352.375,3.5,1.89990234,2.69970703,132.0,7.439453,135.0,23.0,2502.0,2.8442383,<2 mo. follow-up
83.24194,1,female,0,15,85,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,16066.695,12339.7422,15.666664,black,24.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,83.0,5.79980469,60.0,16.0,36.0,163.25,3.5,2.69970703,1.5,140.0,7.359375,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
57.28699,1,female,0,22,322,Lung Cancer,Cancer,1,10.0,$11-$25k,23456.391,16489.7344,11.0,white,21.0,1,0,0,metastatic,0.799999714,0.5,no dnr,22.0,76.0,9.19921875,108.0,28.0,36.29688,319.0,3.5,0.69995117,0.69995117,143.0,7.399414,135.0,23.0,2502.0,4.5273972,<2 mo. follow-up
46.65799,0,female,0,19,1806,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,39171.875,28236.4219,23.0,black,50.0,4,0,0,no,0.899999619,0.9,no dnr,19.0,145.0,17.6992188,110.0,32.0,38.59375,376.1875,3.5,1.09985352,8.19921875,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
42.935,1,male,1,7,7,Coma,Coma,0,12.0,under $11k,21663.938,14849.8281,30.5,black,12.0,3,0,0,no,0.699999809,0.5,no dnr,7.0,78.0,17.0,54.0,12.0,38.0,323.3125,3.5,1.01,0.79992676,142.0,7.5,135.0,23.0,2502.0,2.0869141,<2 mo. follow-up
65.24597,1,male,0,9,15,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,18175.234,14276.125,13.0,white,25.0,1,0,0,metastatic,0.25,0.1,no dnr,9.0,103.0,14.8984375,64.0,12.0,36.5,116.0,3.5,0.59997559,0.69995117,136.0,7.489258,135.0,23.0,2502.0,3.3769531,<2 mo. follow-up
79.07495,1,female,0,9,989,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,10.5,black,43.0,2,0,0,no,0.699999809,0.5,no dnr,9.0,97.0,21.6992188,75.0,28.0,37.19531,240.8125,3.2998047,0.59997559,9.0,140.0,7.399414,135.0,23.0,2502.0,2.7412109,<2 mo. follow-up
72.70398,1,male,0,77,833,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,108508.375,77681.375,27.0,white,69.0,4,1,0,no,0.699999809,0.5,no dnr,77.0,81.0,14.7988281,110.0,32.0,38.0,140.0,1.8999023,0.29998779,2.89990234,128.0,7.25,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
44.90598,1,male,0,17,338,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,38080.625,25337.0625,27.0,black,49.0,1,0,0,no,0.899999619,0.78,no dnr,17.0,121.0,14.7988281,116.0,35.0,36.79688,155.0,3.5,1.0,2.79980469,139.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.75198,1,male,0,40,86,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,61610.688,42038.8438,28.5,black,51.0,1,0,0,no,0.699999809,0.5,no dnr,40.0,55.0,8.3984375,138.0,40.0,39.0,330.0,2.7998047,1.5,1.5,129.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.33997,1,male,0,3,1443,CHF,COPD/CHF/Cirrhosis,4,16.0,under $11k,1314.449,1066.7598,16.0,black,17.0,1,0,0,yes,0.949999809,0.75,no dnr,3.0,93.0,5.79980469,80.0,20.0,36.39844,333.3,3.5,0.89990234,1.19995117,141.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
56.27399,1,female,1,21,21,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,72193.188,48118.1875,43.333313,black,40.0,1,0,0,no,0.199999928,0.15,dnr after sadm,19.0,110.0,10.0,148.0,8.0,36.29688,300.0,3.5,3.79980469,1.79980469,130.0,7.379883,135.0,23.0,2502.0,6.0,<2 mo. follow-up
72.56097,0,male,0,11,1804,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,8884.898,6848.4844,15.5,black,31.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,103.0,4.69921875,82.0,24.0,37.0,223.3125,3.199707,1.01,2.0,136.0,7.389648,135.0,23.0,2502.0,0.0,SIP>=30
45.14398,0,male,0,113,1803,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,116927.5,88552.1875,27.25,black,29.0,6,0,0,no,0.849999905,0.8,no dnr,113.0,135.0,24.6992188,114.0,30.0,38.09375,188.5625,3.5,1.01,0.89990234,147.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.65399,1,female,0,5,225,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,59995.78781114967,14452.7344,12.0,white,21.0,1,0,0,no,0.75,0.422,no dnr,5.0,69.0,5.29980469,72.0,20.0,36.29688,328.5625,3.5996094,0.59997559,1.09985352,141.0,7.369141,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
28.66299,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,44095.188,29580.2344,49.0,black,77.0,2,0,0,yes,0.0,0.0,dnr after sadm,7.0,67.0,0.39996338,144.0,32.0,38.89844,226.0,2.199707,2.39990234,1.69995117,143.0,7.399414,135.0,23.0,2502.0,2.28125,<2 mo. follow-up
69.85596,0,female,0,62,1801,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,111948.75,76592.375,24.5,black,57.0,1,0,0,no,0.25,0.15,no dnr,62.0,61.0,1.39990234,130.0,26.0,37.79688,144.28125,3.5,0.39996338,1.59985352,129.0,7.449219,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.56897,1,female,1,12,12,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,65322.344,43567.9688,33.0,white,42.0,10,0,0,yes,0.149999976,0.1,dnr after sadm,6.0,129.0,11.2988281,118.0,37.0,37.79688,380.0,3.5,0.79992676,3.79980469,153.0,7.329102,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.39398,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,59995.78781114967,14452.7344,40.0,white,43.0,7,0,0,no,0.699999809,0.5,dnr after sadm,3.0,125.0,17.1992188,180.0,36.0,38.89844,420.0,3.5,1.01,0.5,133.0,7.519531,135.0,23.0,2502.0,2.0,<2 mo. follow-up
51.61398,0,female,0,8,1799,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,6321.5,4776.6172,8.0,white,26.0,1,0,0,no,0.899999619,0.5,no dnr,8.0,80.0,5.09960938,100.0,24.0,36.79688,523.75,3.5,20.0976562,0.79992676,133.0,7.619141,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
69.02899,1,male,0,18,210,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,50995.469,35083.5312,21.0,white,68.0,13,0,0,yes,0.699999809,0.4,no dnr,18.0,70.0,0.19998169,104.0,42.0,36.09375,142.5,1.8999023,1.01,1.19995117,132.0,7.55957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.99298,1,female,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,97410.875,63252.7812,39.0,white,57.0,10,0,0,no,0.699999809,0.5,dnr after sadm,16.0,59.0,24.0976562,130.0,12.0,38.09375,70.0,2.5,0.89990234,3.29980469,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
28.465,0,female,0,59,1800,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,175319.625,116491.938,45.75,white,64.0,1,1,0,no,0.199999928,0.2,no dnr,59.0,111.0,30.1992188,150.0,24.0,37.79688,112.71875,2.8999023,0.29998779,5.89941406,142.0,7.40918,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
54.409,1,female,0,6,1017,Lung Cancer,Cancer,1,12.0,under $11k,5722.949,4023.6309,16.0,black,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,117.0,8.09960938,62.0,18.0,36.89844,333.3,3.5,0.5,1.5,136.0,7.419922,135.0,23.0,2502.0,2.0019531,<2 mo. follow-up
72.85095,0,female,0,10,1798,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,8237.742,5929.5586,13.0,white,15.0,1,0,0,no,0.989999771,0.95,no dnr,10.0,100.0,6.69921875,100.0,22.0,36.59375,285.6875,3.3999023,0.39996338,0.69995117,144.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.439,1,female,0,7,411,Lung Cancer,Cancer,1,12.0,under $11k,8158.945,5384.2227,6.0,black,20.0,1,0,0,metastatic,0.799999714,0.2,no dnr,7.0,76.0,8.0,100.0,24.0,36.29688,271.375,3.5,0.79992676,1.09985352,140.0,7.459961,135.0,23.0,2502.0,2.6962891,<2 mo. follow-up
50.41498,1,male,1,11,11,Lung Cancer,Cancer,1,13.0,$25-$50k,7345.949,5915.4453,8.5,white,18.0,1,0,0,metastatic,0.199999928,0.01,dnr after sadm,7.0,77.0,6.5,120.0,24.0,36.0,333.3,3.0996094,0.59997559,1.0,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.56497,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,2,10.0,under $11k,20683.688,13962.1172,37.0,white,50.0,1,0,0,metastatic,0.149999976,0.15,dnr after sadm,2.0,120.0,29.0976562,160.0,31.0,38.69531,113.32812,3.699707,1.01,1.09985352,137.0,7.399414,135.0,23.0,2502.0,5.0,<2 mo. follow-up
69.93799,1,male,1,10,10,Coma,Coma,1,8.0,under $11k,26657.688,18507.6094,33.0,black,44.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,69.0,19.5976562,130.0,22.0,40.0,147.5,3.5,0.5,3.69970703,146.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.452,1,male,0,9,402,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5301.496,4523.5391,12.5,black,42.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,75.0,9.3984375,72.0,20.0,36.29688,271.375,3.7998047,0.59997559,5.39941406,133.0,7.379883,135.0,23.0,2502.0,2.793457,<2 mo. follow-up
65.08997,1,male,0,134,585,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,361896.0,240649.75,48.5,white,76.0,29,0,0,no,0.75,0.422,dnr after sadm,3.0,120.0,29.1992188,118.0,36.0,35.79688,156.65625,2.8999023,4.5,5.39941406,134.0,7.359375,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
42.02899,1,male,0,6,186,Lung Cancer,Cancer,3,14.0,$11-$25k,5846.648,3857.8223,16.0,white,5.0,1,0,0,metastatic,0.849999905,0.5,no dnr,6.0,80.0,6.69921875,78.0,16.0,36.0,333.3,3.5,0.19998169,0.79992676,139.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
21.13599,0,male,0,14,1796,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,31238.188,21454.6875,17.333328,white,28.0,1,0,0,yes,0.199999928,0.2,no dnr,14.0,135.0,2.89990234,62.0,32.0,37.79688,384.0,3.5,2.59960938,0.59997559,136.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.88599,0,male,0,35,1796,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,68258.0,48212.6875,26.5,white,47.0,1,0,0,no,0.699999809,0.7,no dnr,35.0,55.0,11.3984375,56.0,10.0,35.5,134.0,1.1999512,0.5,1.29980469,142.0,7.449219,135.0,23.0,2502.0,5.0,SIP>=30
63.28799,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,88884.0,58544.5312,42.0,white,67.0,1,0,0,no,0.099999964,0.001,dnr after sadm,17.0,57.0,19.0,134.0,30.0,38.19531,88.0,3.5,0.89990234,4.5,133.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.81494,1,female,1,17,17,Coma,Coma,1,2.0,under $11k,42977.75,30679.125,32.0,black,36.0,1,0,0,no,0.199999928,0.1,dnr after sadm,15.0,55.0,19.0976562,64.0,8.0,36.59375,383.3125,3.5,1.01,2.39990234,150.0,7.429688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
67.66895,1,male,1,10,10,Coma,Coma,0,4.0,under $11k,39055.375,26184.4531,50.0,white,100.0,1,0,0,no,0.099999964,0.001,dnr after sadm,3.0,40.0,27.5976562,150.0,30.0,40.19531,228.0,3.5,3.09960938,9.79882812,131.0,7.30957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
47.03897,0,male,0,5,1794,Cirrhosis,COPD/CHF/Cirrhosis,2,7.0,under $11k,3280.449,2724.5938,15.0,white,28.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,92.0,8.0,100.0,24.0,36.5,333.3,1.7998047,2.59960938,0.69995117,130.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
77.18799,0,male,0,15,1794,COPD,COPD/CHF/Cirrhosis,3,2.0,under $11k,25724.891,17758.4375,24.333328,other,35.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,70.0,7.69921875,142.0,8.0,38.09375,194.28125,3.2998047,1.09985352,1.19995117,144.0,7.399414,135.0,23.0,2502.0,2.9472656,<2 mo. follow-up
49.23798,0,female,0,5,1785,Cirrhosis,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,5958.297,4430.75,11.0,white,34.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,60.0,4.0,72.0,20.0,35.5,500.0,2.7998047,8.0,0.89990234,133.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.68597,1,male,0,6,1178,Colon Cancer,Cancer,1,16.0,$25-$50k,5468.949,3953.1797,9.0,white,20.0,1,0,0,metastatic,0.899999619,0.5,no dnr,6.0,107.0,5.59960938,120.0,24.0,35.59375,333.3,3.5,0.59997559,1.09985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.03296,0,male,0,7,1785,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,11001.445,7942.6523,11.5,black,27.0,1,0,0,no,0.799999714,0.8,no dnr,7.0,127.0,16.8984375,68.0,26.0,35.79688,284.0,3.5,0.39996338,1.19995117,141.0,7.419922,135.0,23.0,2502.0,2.2504883,<2 mo. follow-up
89.76294,1,male,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,0,0.0,under $11k,63745.625,44125.3438,41.0,black,62.0,1,0,0,no,0.399999857,0.4,dnr after sadm,19.0,62.0,7.69921875,58.0,4.0,35.29688,438.0625,2.3999023,1.01,4.09960938,136.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.30798,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,22134.484,15105.8516,39.0,white,45.0,4,1,0,no,0.049999982,0.000125,dnr after sadm,3.0,68.0,18.5,122.0,8.0,38.09375,188.0,2.0996094,2.19970703,0.79992676,160.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
48.586,0,male,0,45,1784,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$11-$25k,132172.5,88508.3125,37.75,white,30.0,1,0,0,no,0.399999857,0.3,no dnr,45.0,103.0,23.0976562,132.0,28.0,39.39844,192.5,3.5,2.69970703,1.19995117,149.0,7.439453,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.28198,1,male,0,11,809,CHF,COPD/CHF/Cirrhosis,5,8.0,$25-$50k,6832.246,5436.1875,3.5,white,27.0,1,1,0,no,0.899999619,0.8,no dnr,11.0,97.0,6.0,76.0,28.0,36.29688,495.1875,4.3994141,0.69995117,2.0,139.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.40997,1,male,0,5,67,Lung Cancer,Cancer,1,6.0,under $11k,5862.547,4109.2969,11.0,white,9.0,1,0,0,metastatic,0.899999619,0.8,no dnr,5.0,119.0,5.09960938,72.0,20.0,36.89844,333.3,3.3999023,0.59997559,0.89990234,141.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
68.159,1,male,1,8,8,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4788.25,3870.5644,8.5,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,72.0,7.09960938,84.0,24.0,35.89844,333.3,3.5,1.01,1.79980469,133.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.28198,1,male,0,8,24,Lung Cancer,Cancer,1,12.0,under $11k,3523.699,3085.0391,3.5,black,22.0,1,0,0,metastatic,0.5,0.1,no dnr,8.0,107.0,7.59960938,68.0,16.0,35.19531,333.3,3.5,1.01,1.0,137.0,7.419922,135.0,23.0,2502.0,3.0517578,<2 mo. follow-up
24.54999,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,39816.438,25422.2656,43.0,white,71.0,7,0,0,yes,0.0,0.0,no dnr,6.0,130.0,0.09999084,150.0,55.0,37.89844,381.0,2.699707,0.5,1.09985352,137.0,7.369141,135.0,23.0,2502.0,2.190918,<2 mo. follow-up
68.40198,0,female,0,36,1778,CHF,COPD/CHF/Cirrhosis,0,12.0,under $11k,85186.938,52831.0312,15.25,white,13.0,1,0,0,no,0.699999809,0.5,no dnr,36.0,93.0,6.59960938,80.0,20.0,36.39844,333.3,3.5,0.59997559,1.09985352,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
65.45898,1,male,0,8,33,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,8641.648,6417.7227,9.5,white,59.0,1,0,0,no,0.199999928,0.1,no dnr,8.0,73.0,8.09960938,100.0,24.0,38.5,333.3,2.199707,10.2988281,3.19970703,126.0,7.419922,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
67.10699,1,female,0,16,87,Lung Cancer,Cancer,1,9.0,under $11k,16886.344,12085.1406,13.0,white,26.0,1,0,0,metastatic,0.699999809,0.2,dnr after sadm,5.0,103.0,6.5,92.0,24.0,38.09375,137.5,3.5,1.01,0.59997559,129.0,7.539062,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
56.08798,0,male,0,7,1777,Cirrhosis,COPD/CHF/Cirrhosis,1,9.0,$25-$50k,3525.949,3032.9102,4.5,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,83.0,3.19970703,80.0,20.0,36.5,333.3,3.0,3.5,0.89990234,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
32.73898,0,male,0,45,1777,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,164466.375,108297.125,45.75,white,50.0,3,0,0,no,0.25,0.25,no dnr,45.0,49.0,15.7988281,148.0,15.0,39.29688,113.32812,3.5,3.79980469,1.19995117,132.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
69.09796,1,male,1,16,16,COPD,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,109626.688,73472.5,52.333313,white,63.0,46,0,0,no,0.099999964,0.001,no dnr,16.0,43.0,25.5,175.0,23.0,38.39844,160.84375,2.8999023,1.01,1.19995117,141.0,7.399414,135.0,23.0,2502.0,6.0,<2 mo. follow-up
65.27594,1,female,0,7,852,Colon Cancer,Cancer,1,14.0,$25-$50k,6469.598,4429.7188,8.5,white,13.0,1,0,0,metastatic,1.0,1.0,no dnr,7.0,100.0,6.09960938,76.0,16.0,36.0,333.3,3.2998047,0.39996338,0.69995117,142.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
67.77295,1,male,0,5,541,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,3056.35,2487.2656,7.0,white,16.0,1,0,0,no,0.799999714,0.8,no dnr,5.0,73.0,18.5,100.0,16.0,35.69531,340.0,3.5,1.01,1.09985352,139.0,7.329102,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.80194,1,male,0,5,16,Lung Cancer,Cancer,1,9.0,under $11k,2793.549,2199.8731,4.0,white,28.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,1.0,110.0,9.0,84.0,20.0,36.09375,333.3,1.0,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
35.84399,0,female,0,48,1775,Coma,Coma,0,17.0,>$50k,82952.688,57020.7188,23.75,white,16.0,1,0,0,no,0.599999905,0.6,no dnr,48.0,75.0,18.3984375,130.0,7.0,38.0,396.0,3.5,0.5,0.89990234,137.0,7.479492,135.0,23.0,2502.0,0.0,SIP>=30
77.93799,1,male,1,9,9,CHF,COPD/CHF/Cirrhosis,5,11.0,$25-$50k,6770.699,5212.8438,11.5,white,51.0,1,0,0,no,0.199999928,0.2,dnr after sadm,6.0,73.0,4.79980469,156.0,28.0,35.89844,333.3,3.2998047,1.59985352,1.79980469,145.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
56.51199,1,male,0,13,19,Colon Cancer,Cancer,1,12.0,$25-$50k,11222.547,8539.25,10.5,white,29.0,1,0,0,metastatic,0.899999619,0.5,no dnr,13.0,89.0,8.79882812,98.0,20.0,35.19531,333.3,3.199707,0.59997559,3.19970703,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.91595,1,male,0,5,388,Lung Cancer,Cancer,1,16.0,$25-$50k,5290.047,3335.4199,15.0,white,11.0,1,0,0,metastatic,0.899999619,0.7,no dnr,5.0,80.0,7.79980469,76.0,20.0,36.69531,333.3,3.7998047,0.29998779,1.19995117,143.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.94299,1,female,0,6,215,CHF,COPD/CHF/Cirrhosis,0,10.0,under $11k,6483.449,5730.9727,16.0,white,14.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,65.0,9.8984375,80.0,20.0,36.29688,323.75,3.5,1.01,1.19995117,140.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.16394,1,male,1,3,3,Lung Cancer,Cancer,1,12.0,under $11k,6288.598,4459.4961,20.0,black,36.0,1,0,0,metastatic,0.299999952,0.1,no dnr,3.0,157.0,4.29980469,20.0,48.0,35.79688,308.5625,2.8999023,0.29998779,0.79992676,137.0,7.469727,135.0,23.0,2502.0,2.4746094,<2 mo. follow-up
63.41998,1,female,0,11,266,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,17999.094,12834.7578,19.5,black,33.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,70.0,4.09960938,44.0,22.0,36.09375,264.0,3.5,0.5,1.89990234,137.0,7.549805,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
81.31696,1,male,0,8,49,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,4875.238,3819.4688,7.0,black,34.0,1,0,0,no,0.75,0.5,no dnr,8.0,63.0,3.39990234,66.0,16.0,36.09375,333.3,3.2998047,0.19998169,4.79980469,147.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.17694,1,male,1,129,129,COPD,COPD/CHF/Cirrhosis,1,15.0,>$50k,398248.0,272052.25,46.0,white,46.0,21,0,0,no,0.799999714,0.75,dnr after sadm,126.0,63.0,13.6992188,110.0,32.0,36.59375,97.0,3.5,0.69995117,1.29980469,129.0,7.25,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.99695,0,male,0,7,1770,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,7358.797,5338.8594,3.5,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,100.0,6.09960938,78.0,20.0,36.39844,333.3,3.5,1.01,1.5,144.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
25.62099,1,female,0,30,45,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,434315.75,289424.0,34.25,black,42.0,73,0,0,no,0.099999964,0.001,no dnr,30.0,139.0,16.0,138.0,28.0,36.29688,91.65625,2.699707,7.79980469,1.0,150.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.20398,0,male,0,10,1768,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,>$50k,8795.25,6635.2422,11.0,white,31.0,1,0,0,no,0.799999714,0.6,no dnr,10.0,97.0,5.39941406,72.0,28.0,38.59375,333.3,2.2998047,5.89941406,0.79992676,120.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.375,1,female,0,15,185,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,20454.188,15171.6953,9.333328,black,28.0,2,0,0,no,0.799999714,0.8,no dnr,15.0,101.0,16.796875,80.0,24.0,38.09375,270.0,1.8999023,2.69970703,0.69995117,138.0,7.40918,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
57.86398,0,male,0,38,1767,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,96380.75,65349.2812,32.25,white,44.0,1,0,0,no,0.5,0.4,no dnr,38.0,75.0,14.1992188,62.0,42.0,36.39844,96.65625,1.1999512,0.19998169,0.79992676,146.0,7.459961,135.0,23.0,2502.0,1.0,SIP>=30
55.086,1,male,0,8,231,Lung Cancer,Cancer,1,16.0,>$50k,5840.5,4412.2109,9.5,white,10.0,1,0,0,metastatic,0.899999619,0.6,no dnr,8.0,80.0,2.29980469,78.0,20.0,37.69531,333.3,3.199707,1.0,0.89990234,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.22699,1,female,0,32,661,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,112743.062,74369.5625,32.0,white,41.0,7,0,0,no,0.799999714,0.8,no dnr,32.0,134.0,10.1992188,110.0,40.0,38.09375,183.3125,4.0996094,0.79992676,0.69995117,145.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
71.61694,1,male,0,52,440,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,under $11k,153677.0,106389.438,22.5,white,28.0,11,0,0,no,0.899999619,0.6,no dnr,52.0,110.0,35.3984375,130.0,7.0,36.39844,306.625,3.5,1.01,1.89990234,139.0,7.349609,135.0,23.0,2502.0,2.6728516,adl>=4 (>=5 if sur)
54.44199,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19789.594,13315.1406,13.0,white,65.0,8,0,0,metastatic,0.5,0.15,dnr after sadm,4.0,126.0,26.6992188,176.0,44.0,38.09375,124.0,3.5,5.39941406,0.69995117,126.0,7.519531,135.0,23.0,2502.0,2.6069336,<2 mo. follow-up
68.59399,1,female,1,18,18,CHF,COPD/CHF/Cirrhosis,5,6.0,under $11k,58190.719,38401.9062,35.666657,black,38.0,1,1,0,no,0.5,0.25,dnr after sadm,17.0,61.0,19.796875,108.0,27.0,35.59375,404.0,3.5,1.01,1.89990234,124.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.72998,1,female,0,5,1034,CHF,COPD/CHF/Cirrhosis,3,6.0,under $11k,3366.648,2877.0449,9.0,white,24.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,69.0,5.69921875,66.0,16.0,36.89844,333.3,2.699707,3.39990234,0.79992676,127.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
41.40698,1,male,0,44,209,Coma,Coma,0,16.0,$25-$50k,154288.875,104675.625,33.25,black,67.0,1,0,0,no,0.5,0.5,no dnr,44.0,65.0,15.8984375,180.0,20.0,38.29688,133.3125,2.5996094,5.59960938,4.5,151.0,7.439453,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
63.87097,1,female,0,23,229,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,48938.531,34675.1875,31.333328,white,78.0,1,0,0,no,0.699999809,0.5,no dnr,23.0,107.0,9.09960938,162.0,28.0,35.0,309.5,3.5,13.1992188,5.19921875,138.0,7.40918,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
46.72998,1,male,0,6,134,Colon Cancer,Cancer,1,12.0,$25-$50k,6932.848,4561.1914,10.0,white,11.0,1,0,0,metastatic,0.899999619,0.3,no dnr,6.0,107.0,7.5,96.0,20.0,37.29688,333.3,3.5,0.89990234,1.09985352,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.36899,1,female,0,9,60,Lung Cancer,Cancer,1,12.0,$25-$50k,6296.898,4840.4023,7.5,white,22.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,70.0,10.5996094,110.0,24.0,38.09375,333.3,2.199707,0.39996338,1.0,136.0,7.419922,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
61.42398,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,85084.125,55237.1562,39.666657,white,43.0,3,0,0,no,0.199999928,0.1,dnr after sadm,6.0,61.0,10.0,126.0,32.0,38.79688,127.14062,3.5,1.59985352,1.19995117,131.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
51.56699,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,22312.328,15496.0078,32.0,white,21.0,9,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,119.0,18.1992188,132.0,12.0,39.29688,228.0,3.0,0.5,0.89990234,138.0,7.40918,135.0,23.0,2502.0,2.3178711,<2 mo. follow-up
43.625,0,female,0,134,1759,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,401867.0,269131.25,42.5,white,46.0,4,0,0,no,0.899999619,0.9,no dnr,134.0,135.0,21.3984375,130.0,26.0,37.59375,250.0,3.5,0.79992676,9.0,143.0,7.449219,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
38.67999,1,male,1,8,8,Coma,Coma,2,12.0,under $11k,71634.188,46963.0625,43.0,white,50.0,8,1,0,no,0.099999964,0.001,dnr after sadm,8.0,136.0,25.0,108.0,8.0,36.0,330.0,1.8999023,1.01,8.0,145.0,7.449219,135.0,23.0,2502.0,2.7885742,<2 mo. follow-up
66.84497,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,77906.438,52351.8438,41.0,white,62.0,25,1,0,yes,0.099999964,0.001,dnr after sadm,5.0,105.0,24.6992188,118.0,25.0,36.5,370.0,3.0,8.19921875,2.79980469,129.0,7.479492,135.0,23.0,2502.0,3.1875,<2 mo. follow-up
58.56497,1,male,0,14,437,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,18640.047,13730.0547,15.666664,black,38.0,1,1,0,no,0.799999714,0.6,no dnr,14.0,78.0,24.8984375,62.0,10.0,35.09375,217.125,3.5,1.39990234,2.29980469,134.0,7.389648,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
59.42798,0,female,0,88,1757,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,284272.0,195666.125,32.0,white,46.0,12,0,0,no,0.599999905,0.5,no dnr,88.0,59.0,24.1992188,122.0,40.0,38.59375,263.3125,3.5,1.39990234,1.19995117,145.0,7.349609,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
35.62198,0,female,0,67,1757,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,200353.75,132550.25,46.25,white,36.0,2,0,0,no,0.099999964,0.001,no dnr,67.0,131.0,14.5996094,108.0,12.0,39.19531,240.0,3.5,12.0996094,0.89990234,156.0,7.5,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
66.94299,1,male,0,24,59,Lung Cancer,Cancer,1,12.0,under $11k,25465.234,18399.7969,15.0,white,20.0,1,0,0,metastatic,0.799999714,0.5,no dnr,24.0,85.0,6.19921875,116.0,24.0,35.69531,333.3,3.5,0.59997559,1.19995117,141.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.995,1,male,0,19,29,CHF,COPD/CHF/Cirrhosis,3,13.0,$25-$50k,22609.641,16044.7812,16.666656,white,36.0,1,0,0,no,0.699999809,0.2,no dnr,19.0,57.0,8.3984375,65.0,16.0,35.29688,333.3,3.5,1.01,2.0,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.51199,1,female,0,5,369,Lung Cancer,Cancer,1,12.0,$11-$25k,5159.949,3466.8379,11.0,white,16.0,1,0,0,metastatic,1.0,0.8,no dnr,5.0,73.0,6.69921875,110.0,16.0,36.89844,333.3,3.5,0.39996338,0.59997559,137.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
57.84299,1,female,0,23,69,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,23635.938,17293.25,14.666664,white,42.0,1,0,0,no,0.699999809,0.5,no dnr,23.0,77.0,12.5,80.0,18.0,36.19531,442.8125,2.5996094,4.79980469,4.09960938,138.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
41.42899,0,male,0,6,1754,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,12460.844,8586.1641,8.0,black,31.0,3,0,0,no,0.899999619,0.9,no dnr,6.0,107.0,5.69921875,108.0,22.0,37.69531,390.4375,3.3999023,0.89990234,12.3984375,144.0,7.319336,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.06,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$25-$50k,29518.891,20163.7969,44.0,white,74.0,8,0,0,no,0.049999982,0.000125,dnr after sadm,4.0,61.0,31.5,126.0,30.0,38.0,137.75,3.5,19.5,4.59960938,145.0,7.539062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.19397,0,male,0,25,1754,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,60910.531,42843.3125,18.75,white,19.0,15,0,0,no,0.399999857,0.6,no dnr,25.0,80.0,13.6992188,114.0,24.0,36.0,200.0,3.5,1.01,1.29980469,136.0,7.459961,135.0,23.0,2502.0,0.0,SIP>=30
53.63998,1,male,1,8,8,Lung Cancer,Cancer,1,14.0,$25-$50k,6536.648,4897.7344,11.5,black,25.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,8.0,83.0,10.7988281,120.0,28.0,36.29688,280.9375,2.7998047,0.69995117,1.0,132.0,7.389648,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
74.68298,1,female,1,4,4,Coma,Coma,1,6.0,under $11k,11897.195,8313.8281,24.0,black,73.0,4,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,131.0,18.1992188,116.0,36.0,36.0,304.0,3.5,23.5976562,2.09960938,125.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
73.862,0,female,0,14,1750,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,37997.719,25638.7812,13.333328,white,19.0,6,0,0,no,0.799999714,0.6,no dnr,14.0,123.0,9.79882812,82.0,20.0,36.09375,176.65625,3.5,1.01,1.0,136.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.12299,1,male,1,19,19,Coma,Coma,2,12.0,under $11k,70576.5,47851.1562,34.333313,black,47.0,6,1,0,no,0.099999964,0.001,dnr after sadm,11.0,109.0,15.3984375,82.0,75.0,39.09375,185.0,2.199707,0.69995117,1.79980469,145.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.52197,1,male,0,12,570,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,21888.344,14721.5156,19.5,white,30.0,1,1,0,no,0.699999809,0.5,no dnr,12.0,67.0,8.29882812,118.0,26.0,36.19531,333.3,3.5,0.69995117,1.39990234,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.84598,1,male,0,18,644,Cirrhosis,COPD/CHF/Cirrhosis,4,16.0,>$50k,14564.594,11304.0547,7.333332,white,32.0,1,1,0,no,0.989999771,0.97,no dnr,18.0,80.0,6.89941406,106.0,24.0,39.09375,347.5625,1.8999023,3.89990234,0.79992676,127.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.85498,0,male,0,36,1747,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,53360.844,37548.1562,17.5,black,31.0,4,0,0,no,1.0,0.95,no dnr,36.0,101.0,20.296875,110.0,12.0,36.19531,322.1875,2.5,1.01,1.69995117,146.0,7.429688,135.0,23.0,2502.0,3.0253906,no(M2 and SIP pres)
67.047,0,female,0,17,1746,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,21429.297,15346.4453,12.333328,white,9.0,3,0,0,no,0.799999714,0.7,no dnr,17.0,118.0,11.6992188,84.0,24.0,36.19531,215.0,3.5,1.01,0.5,127.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.21799,0,male,0,35,1747,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,97645.375,61893.25,16.5,white,10.0,1,0,0,no,0.75,0.6,no dnr,35.0,65.0,12.7988281,108.0,10.0,39.19531,333.3,3.5,1.01,0.89990234,133.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.75494,1,male,1,9,9,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,28524.625,18503.4219,27.5,white,45.0,1,0,0,no,0.699999809,0.5,dnr after sadm,9.0,103.0,20.6992188,156.0,26.0,35.0,128.5625,3.5,1.01,1.29980469,137.0,7.539062,135.0,23.0,2502.0,3.0,<2 mo. follow-up
58.08398,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26848.094,18352.8438,38.0,white,63.0,5,0,0,no,0.699999809,0.5,no dnr,5.0,99.0,8.19921875,130.0,40.0,37.59375,142.84375,3.5,26.8984375,1.59985352,134.0,7.299805,135.0,23.0,2502.0,2.3183594,<2 mo. follow-up
68.30896,1,male,0,15,266,Lung Cancer,Cancer,1,11.0,$11-$25k,19022.094,13289.7422,11.333328,black,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,15.0,81.0,4.39941406,80.0,24.0,36.5,333.3,3.2998047,0.5,1.09985352,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
49.56299,1,male,0,26,91,Lung Cancer,Cancer,1,12.0,$11-$25k,20963.141,16049.4844,5.5,white,17.0,1,0,0,metastatic,0.599999905,0.5,no dnr,26.0,75.0,10.1992188,100.0,24.0,35.29688,333.3,3.5,0.89990234,0.89990234,129.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
45.89499,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,105779.312,68334.9375,32.0,white,18.0,16,0,0,no,0.699999809,0.5,no dnr,14.0,153.0,6.59960938,102.0,14.0,40.0,297.125,3.5,1.01,0.69995117,142.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.51099,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,74188.188,50404.625,38.666657,black,59.0,3,0,0,no,0.049999982,0.000125,dnr after sadm,15.0,63.0,21.1992188,80.0,11.0,36.69531,216.0,3.5,15.8984375,2.19970703,122.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.03595,1,male,0,68,1485,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,194034.0,119902.875,23.5,white,56.0,40,0,0,yes,0.899999619,0.9,no dnr,68.0,55.0,10.3984375,126.0,28.0,38.5,272.0,3.0,1.19995117,3.0,149.0,7.469727,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
72.86798,1,female,0,31,1007,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,70304.062,49123.8125,29.0,white,36.0,4,0,0,yes,0.899999619,0.9,no dnr,31.0,131.0,14.7988281,144.0,28.0,38.5,270.0,2.5,1.01,0.69995117,132.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.15198,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,>$50k,68531.375,49419.8125,20.0,white,30.0,26,1,0,no,0.199999928,0.05,dnr after sadm,21.0,117.0,15.5996094,74.0,22.0,36.09375,386.625,3.5,1.01,7.89941406,132.0,7.369141,135.0,23.0,2502.0,6.0,<2 mo. follow-up
72.94196,1,male,1,77,77,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,224667.25,154288.0,32.0,white,36.0,1,0,0,yes,0.599999905,0.6,dnr after sadm,60.0,127.0,19.5976562,130.0,34.0,37.69531,260.0,2.5,1.01,0.79992676,148.0,7.429688,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
56.01398,1,male,0,4,906,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,4446.297,3174.543,3.0,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,60.0,5.69921875,124.0,24.0,36.09375,333.3,3.5,0.5,1.19995117,142.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
47.36798,1,male,1,12,12,Cirrhosis,COPD/CHF/Cirrhosis,1,10.0,under $11k,32115.641,23570.2656,40.0,white,54.0,1,0,0,no,0.199999928,0.1,dnr after sadm,12.0,109.0,10.7988281,114.0,12.0,37.79688,433.3125,2.0,31.0976562,1.59985352,131.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.39697,1,male,0,22,31,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,27399.438,19980.3125,19.666656,black,45.0,1,0,0,no,0.599999905,0.4,dnr after sadm,17.0,61.0,5.0,118.0,25.0,35.59375,333.3,3.5,1.01,4.09960938,130.0,7.419922,135.0,23.0,2502.0,2.0913086,<2 mo. follow-up
66.35199,1,female,0,16,310,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,26706.297,18707.6562,18.0,white,29.0,1,0,0,no,0.899999619,0.7,no dnr,16.0,115.0,27.3984375,114.0,26.0,38.0,210.0,3.5,0.39996338,0.79992676,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.133,0,male,0,65,1740,CHF,COPD/CHF/Cirrhosis,0,12.0,$11-$25k,135704.5,95831.5,16.25,white,18.0,1,0,0,no,0.899999619,0.6,no dnr,65.0,63.0,10.2988281,106.0,24.0,36.59375,252.0,3.5,0.69995117,1.29980469,149.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.33298,0,male,0,15,1740,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,22090.984,16710.5625,17.666656,white,56.0,1,0,0,yes,0.5,0.3,no dnr,15.0,53.0,6.59960938,112.0,36.0,35.29688,210.0,3.5,1.01,2.09960938,125.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.50195,1,male,1,95,95,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,14452.7344,47.0,white,70.0,2,0,0,no,0.5,0.4,no dnr,95.0,44.0,14.2988281,168.0,27.0,39.0,116.25,3.5,1.01,2.09960938,142.0,7.319336,135.0,23.0,2502.0,1.9936523,<2 mo. follow-up
60.03799,1,male,0,21,1214,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$11-$25k,62400.594,41833.6875,46.0,white,55.0,2,0,0,no,0.899999619,0.85,no dnr,21.0,50.0,5.89941406,140.0,31.0,40.29688,116.3125,3.5,1.01,1.39990234,128.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
30.92999,0,female,0,9,1735,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,$11-$25k,17066.641,12493.8516,13.5,black,31.0,2,0,0,no,0.799999714,0.7,no dnr,9.0,117.0,17.5,100.0,20.0,37.39844,495.1875,3.5,1.01,7.19921875,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.53699,1,male,0,9,31,CHF,COPD/CHF/Cirrhosis,4,6.0,under $11k,11333.148,9014.3438,11.5,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,65.0,10.2988281,70.0,28.0,38.39844,333.3,3.5,1.01,1.19995117,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.853,1,male,0,50,211,Coma,Coma,0,16.0,>$50k,67972.5,48889.6562,30.0,white,35.0,1,0,0,no,0.099999964,0.001,dnr after sadm,16.0,130.0,14.5,116.0,8.0,37.79688,356.625,2.5,0.5,4.29980469,137.0,7.369141,135.0,23.0,2502.0,2.3671875,adl>=4 (>=5 if sur)
84.79895,1,male,1,6,6,Coma,Coma,2,16.0,under $11k,14790.844,11221.7109,35.0,black,32.0,1,0,1,no,0.199999928,0.1,no dnr,6.0,140.0,13.2988281,124.0,9.0,36.0,280.9375,2.699707,1.0,1.19995117,141.0,7.359375,135.0,23.0,2502.0,7.0,<2 mo. follow-up
75.71295,1,male,0,14,477,Colon Cancer,Cancer,2,12.0,>$50k,21044.891,14540.7812,16.0,black,60.0,1,1,0,metastatic,0.799999714,0.8,no dnr,14.0,127.0,7.59960938,116.0,8.0,34.0,393.3125,2.2998047,3.39990234,2.59960938,136.0,7.319336,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
60.55298,1,male,0,38,1529,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,$11-$25k,139645.375,93788.5625,31.25,white,79.0,1,1,0,no,0.699999809,0.5,no dnr,38.0,56.0,21.8984375,150.0,38.0,40.19531,240.0,2.0,1.01,2.69970703,151.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.87198,1,female,0,5,60,Colon Cancer,Cancer,1,13.0,$11-$25k,5380.949,3435.7266,11.0,white,13.0,1,0,0,metastatic,0.799999714,0.1,no dnr,5.0,100.0,13.0996094,84.0,20.0,36.89844,333.3,2.7998047,0.39996338,0.89990234,135.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
43.73199,1,female,0,10,811,Cirrhosis,COPD/CHF/Cirrhosis,2,13.0,under $11k,23367.25,16260.5391,21.0,white,27.0,1,0,0,no,0.599999905,0.5,no dnr,10.0,121.0,5.69921875,76.0,26.0,36.39844,376.625,2.0,2.39990234,0.79992676,140.0,7.439453,135.0,23.0,2502.0,1.0,SIP>=30
72.64899,1,female,1,6,6,Coma,Coma,1,7.0,under $11k,18816.297,13245.6719,41.0,black,36.0,2,0,0,no,0.009999998,1e-06,dnr after sadm,4.0,80.0,22.1992188,126.0,32.0,38.09375,285.0,2.3999023,0.39996338,1.59985352,134.0,7.40918,135.0,23.0,2502.0,6.0,<2 mo. follow-up
44.50897,1,male,0,7,563,Colon Cancer,Cancer,1,13.0,$11-$25k,7222.297,5163.0391,7.0,black,9.0,1,0,0,metastatic,0.899999619,0.7,no dnr,7.0,103.0,6.29980469,64.0,16.0,37.29688,333.3,3.5,0.39996338,1.09985352,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
49.11398,1,female,1,4,4,Coma,Coma,0,16.0,under $11k,13132.547,10200.2109,33.0,white,31.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,193.0,16.6992188,68.0,16.0,38.5,296.625,3.5,0.39996338,3.39990234,148.0,7.639648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.33099,1,male,0,18,213,Lung Cancer,Cancer,2,10.0,$11-$25k,14604.5,11523.4062,10.666664,white,18.0,1,0,0,metastatic,0.799999714,0.6,no dnr,18.0,93.0,9.5,124.0,28.0,36.79688,333.3,3.3999023,0.29998779,0.69995117,140.0,7.419922,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
75.33698,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,$11-$25k,59995.78781114967,14452.7344,48.0,white,52.0,7,0,0,yes,0.299999952,0.2,dnr after sadm,8.0,57.0,10.0,118.0,14.0,35.79688,140.0,3.5,0.19998169,2.29980469,139.0,7.469727,135.0,23.0,2502.0,7.0,<2 mo. follow-up
63.87097,1,male,0,6,61,Colon Cancer,Cancer,1,12.0,under $11k,5620.898,3797.3769,18.0,black,13.0,1,0,0,metastatic,0.099999964,0.001,no dnr,6.0,82.0,15.6992188,60.0,20.0,35.79688,333.3,3.5,0.39996338,1.0,143.0,7.419922,135.0,23.0,2502.0,1.7595215,<2 mo. follow-up
46.146,0,female,0,93,1728,Coma,Coma,0,12.0,under $11k,110333.188,79961.75,16.5,other,35.0,1,0,0,no,0.5,0.4,dnr after sadm,12.0,114.0,22.6992188,130.0,33.0,37.79688,226.65625,2.699707,1.59985352,1.29980469,143.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
62.642,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,134189.125,86933.5625,32.666657,white,45.0,29,0,0,no,0.5,0.5,dnr after sadm,16.0,73.0,7.0,72.0,32.0,35.69531,266.625,3.5,1.01,2.19970703,126.0,7.539062,135.0,23.0,2502.0,3.3432617,<2 mo. follow-up
60.71198,1,male,0,13,610,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,18054.734,12643.5312,28.0,white,40.0,1,0,0,no,0.5,0.4,dnr after sadm,2.0,59.0,17.0976562,128.0,29.0,35.59375,186.65625,3.5,1.01,0.79992676,136.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.41599,1,male,0,5,256,Lung Cancer,Cancer,1,12.0,$11-$25k,6101.648,3718.8301,7.0,white,11.0,1,0,0,metastatic,0.799999714,0.2,no dnr,5.0,113.0,14.2988281,116.0,24.0,36.59375,333.3,3.8999023,0.29998779,0.89990234,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
79.33997,1,female,1,8,8,Coma,Coma,0,14.0,$11-$25k,16749.594,11828.3281,20.5,white,21.0,1,0,0,no,0.199999928,0.15,dnr after sadm,5.0,110.0,15.6992188,122.0,8.0,38.09375,340.0,3.5,0.89990234,1.19995117,140.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.10095,1,male,1,11,11,Coma,Coma,2,7.0,under $11k,29686.375,21820.5625,39.5,white,38.0,1,1,0,no,0.099999964,0.001,dnr after sadm,2.0,103.0,16.796875,60.0,32.0,36.39844,283.3125,3.5,1.01,2.19970703,138.0,7.429688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
83.02496,1,female,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,22340.797,17646.4531,13.5,black,25.0,1,1,0,no,0.25,0.2,dnr after sadm,14.0,83.0,13.6992188,76.0,22.0,36.29688,300.0,3.5,1.09985352,1.69995117,148.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
51.89899,0,male,0,10,1718,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,20532.094,15660.5156,20.5,white,27.0,1,0,0,no,0.989999771,0.98,no dnr,10.0,99.0,15.6992188,112.0,28.0,38.19531,180.0,3.5,1.01,1.39990234,130.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
33.54999,1,female,0,6,191,Colon Cancer,Cancer,1,14.0,$25-$50k,7093.848,5116.8594,18.0,white,24.0,1,0,0,metastatic,0.899999619,0.7,no dnr,6.0,73.0,15.1992188,140.0,22.0,39.59375,333.3,3.5,1.01,0.59997559,135.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
21.043,1,female,1,4,4,Coma,Coma,0,15.0,$25-$50k,15271.648,12390.4844,42.0,white,67.0,1,0,0,no,0.849999905,0.84,no dnr,4.0,46.0,12.2988281,134.0,10.0,32.5,112.5,3.5996094,0.79992676,0.79992676,175.0,7.599609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
46.09998,0,male,0,4,1714,CHF,COPD/CHF/Cirrhosis,1,11.0,under $11k,2824.148,2343.2715,6.0,black,6.0,1,0,0,no,0.949999809,0.6,no dnr,4.0,97.0,6.39941406,72.0,24.0,36.5,333.3,3.5,1.39990234,1.09985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.09998,0,male,0,3,1714,Cirrhosis,COPD/CHF/Cirrhosis,2,4.0,$25-$50k,2701.25,1954.959,3.0,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,81.0,5.0,86.0,18.0,36.59375,333.3,3.5996094,3.19970703,1.29980469,130.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.87695,1,male,0,16,189,CHF,COPD/CHF/Cirrhosis,0,5.0,$11-$25k,24346.391,18417.8594,11.666664,black,30.0,1,0,0,no,0.849999905,0.8,no dnr,16.0,70.0,13.0996094,120.0,22.0,36.5,333.3,3.5,1.01,1.59985352,135.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
58.55399,1,male,1,4,4,Lung Cancer,Cancer,1,11.0,$25-$50k,4597.379,3382.6074,17.0,white,66.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,2.0,73.0,0.39996338,114.0,40.0,38.39844,252.375,2.199707,2.19970703,0.89990234,160.0,7.489258,135.0,23.0,2502.0,7.0,<2 mo. follow-up
32.77499,1,female,0,41,989,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,72100.438,52992.1875,19.0,black,31.0,30,0,0,no,0.25,0.15,no dnr,41.0,147.0,22.3984375,108.0,8.0,38.5,388.0,3.5,2.09960938,1.69995117,148.0,7.369141,135.0,23.0,2502.0,5.0,SIP>=30
79.82196,1,male,0,16,1255,CHF,COPD/CHF/Cirrhosis,2,5.0,under $11k,26503.984,17639.2812,16.666656,black,31.0,1,0,0,no,0.699999809,0.4,dnr after sadm,10.0,71.0,18.0,108.0,24.0,36.39844,280.9375,3.5,1.09985352,1.39990234,129.0,7.529297,135.0,23.0,2502.0,2.5110989,no(M2 and SIP pres)
66.97595,0,male,0,7,1708,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,17114.547,12349.8984,9.5,white,36.0,7,0,0,no,0.699999809,0.5,no dnr,7.0,129.0,11.0996094,100.0,20.0,37.69531,120.40625,3.5,1.01,5.19921875,128.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.69397,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17514.391,10762.4609,49.0,black,100.0,1,0,0,yes,0.0,0.0,no dnr,3.0,27.0,9.69921875,26.0,24.0,35.5,41.0,1.5998535,1.09985352,4.79980469,164.0,7.149414,135.0,23.0,2502.0,2.6669922,<2 mo. follow-up
61.58499,0,female,0,12,1708,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,21559.438,15395.9688,28.5,white,33.0,1,0,0,no,0.5,0.5,no dnr,12.0,109.0,9.3984375,68.0,25.0,38.29688,336.625,3.3999023,13.7988281,0.79992676,142.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
41.336,0,female,0,11,1707,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,14625.898,10672.5547,16.5,white,36.0,1,0,0,no,0.899999619,0.9,no dnr,11.0,77.0,11.5,110.0,31.0,36.19531,216.65625,2.0,0.5,0.69995117,139.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.69299,1,female,1,23,23,Coma,Coma,0,8.0,under $11k,19765.344,16017.7656,11.666664,black,34.0,2,0,0,no,0.099999964,0.001,dnr after sadm,2.0,117.0,16.0,120.0,30.0,38.79688,342.8125,3.5,1.01,0.59997559,131.0,7.509766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
55.66299,0,male,0,4,1706,CHF,COPD/CHF/Cirrhosis,3,0.0,under $11k,4980.25,3698.125,7.0,black,17.0,1,0,0,no,0.899999619,0.75,no dnr,4.0,90.0,9.0,68.0,22.0,36.89844,333.3,3.3999023,0.79992676,1.5,139.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
34.53,0,female,0,4,1705,CHF,COPD/CHF/Cirrhosis,5,14.0,under $11k,6055.898,4246.4609,6.0,black,14.0,1,1,0,yes,1.0,0.5,no dnr,4.0,71.0,12.5,96.0,20.0,36.29688,333.3,3.5,1.39990234,0.79992676,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.30499,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,49924.438,33067.125,44.0,white,33.0,6,0,0,yes,0.5,0.4,dnr after sadm,11.0,113.0,12.2988281,106.0,28.0,38.5,117.5,3.5,1.39990234,0.89990234,130.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.58496,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,14208.648,10709.4922,37.0,white,123.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,0.0,80.09375,0.0,0.0,38.19531,53.32812,1.6999512,2.5,7.39941406,142.0,7.15918,135.0,23.0,2502.0,1.5786133,<2 mo. follow-up
73.56299,1,male,0,28,139,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,54476.031,36734.5625,26.75,white,86.0,1,0,0,yes,0.199999928,0.05,dnr after sadm,16.0,47.0,0.09999084,190.0,32.0,36.09375,304.0,2.2998047,0.29998779,3.09960938,143.0,7.40918,135.0,23.0,2502.0,2.237793,<2 mo. follow-up
57.793,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,59995.78781114967,14452.7344,47.0,white,105.0,2,0,0,no,0.099999964,0.001,no dnr,3.0,23.0,6.69921875,0.0,24.0,36.0,65.0,2.7998047,5.5,6.0,164.0,7.129883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
41.16098,1,female,0,5,253,Colon Cancer,Cancer,1,12.0,under $11k,4960.0,3366.8867,22.0,white,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,85.0,7.5,78.0,16.0,36.39844,333.3,3.5,0.29998779,0.79992676,140.0,7.419922,135.0,23.0,2502.0,1.6408691,<2 mo. follow-up
62.81198,1,female,0,11,1013,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,84675.625,56459.8438,17.0,white,25.0,19,0,0,no,0.989999771,0.99,no dnr,11.0,61.0,14.7988281,118.0,30.0,36.29688,190.0,2.5,1.01,0.5,134.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.70798,1,male,1,7,7,Lung Cancer,Cancer,1,14.0,$25-$50k,3095.148,2995.7598,6.5,white,5.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,80.0,9.8984375,70.0,22.0,36.0,333.3,3.5,1.01,1.0,135.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
50.29199,0,male,0,8,1699,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,31121.438,22044.7344,22.0,white,64.0,17,0,0,metastatic,1.0,0.5,no dnr,8.0,59.0,31.0,102.0,22.0,36.79688,396.0,1.5998535,0.89990234,7.19921875,131.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.81696,0,male,0,10,1697,COPD,COPD/CHF/Cirrhosis,1,20.0,$25-$50k,8032.547,6131.3477,10.0,white,19.0,1,0,0,no,0.899999619,0.6,no dnr,10.0,97.0,11.5996094,102.0,24.0,37.29688,247.59375,3.5,1.01,1.39990234,138.0,7.329102,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.64398,1,male,0,7,19,Colon Cancer,Cancer,1,16.0,$11-$25k,7005.727,4714.8516,10.0,white,31.0,1,0,0,metastatic,0.099999964,0.001,no dnr,7.0,113.0,11.0996094,94.0,16.0,36.29688,333.3,2.5996094,2.0,1.59985352,131.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
57.67297,0,male,0,9,1697,COPD,COPD/CHF/Cirrhosis,4,16.0,$25-$50k,12842.945,9616.5078,16.0,white,41.0,1,0,0,yes,0.599999905,0.5,no dnr,9.0,111.0,7.39941406,110.0,21.0,36.69531,268.0,2.5996094,1.01,2.79980469,155.0,7.30957,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
58.97598,1,male,0,26,329,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,209815.5,142808.875,35.75,white,36.0,52,0,0,no,0.5,0.45,no dnr,26.0,73.0,18.296875,74.0,8.0,35.5,250.0,2.7998047,1.01,8.09960938,128.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
63.89899,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,4.0,under $11k,68388.125,44266.1875,40.0,black,61.0,2,1,0,no,0.599999905,0.5,no dnr,17.0,71.0,18.3984375,110.0,40.0,35.79688,109.07812,3.5,1.01,2.29980469,129.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
49.37198,1,male,0,7,324,Colon Cancer,Cancer,1,12.0,>$50k,7472.5,5169.1484,11.0,white,6.0,1,0,0,metastatic,0.799999714,0.5,no dnr,7.0,87.0,12.1992188,56.0,16.0,36.59375,333.3,3.5,0.89990234,0.79992676,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.20496,1,female,0,5,653,CHF,COPD/CHF/Cirrhosis,5,20.0,$25-$50k,6022.0,4329.4102,6.0,other,41.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,77.0,9.8984375,102.0,20.0,36.19531,328.5625,3.5996094,0.39996338,2.39990234,137.0,7.439453,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
57.91397,1,female,0,24,837,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,38281.625,27834.9375,17.666656,hispanic,35.0,12,1,0,no,0.799999714,0.8,no dnr,24.0,119.0,14.1992188,116.0,40.0,38.29688,213.3125,3.5,0.29998779,0.79992676,134.0,7.40918,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.37195,1,female,1,9,9,Coma,Coma,0,12.0,under $11k,27641.391,20191.5,25.5,white,19.0,3,0,0,no,0.699999809,0.5,dnr after sadm,4.0,110.0,9.69921875,42.0,11.0,36.89844,250.0,3.5,1.01,0.59997559,148.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.19897,0,male,0,37,1682,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,91875.625,64329.7188,18.75,white,34.0,12,0,0,no,0.599999905,0.6,no dnr,37.0,101.0,14.1992188,108.0,22.0,36.79688,285.6875,2.3999023,4.39941406,1.0,148.0,7.55957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
33.07898,1,male,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,164121.625,108221.125,36.75,black,34.0,1,0,0,no,0.699999809,0.7,dnr after sadm,27.0,73.0,16.0976562,72.0,10.0,36.0,228.5625,3.5,1.0,11.3984375,133.0,7.319336,135.0,23.0,2502.0,2.0,<2 mo. follow-up
72.64899,1,male,1,4,4,Coma,Coma,0,12.0,under $11k,12858.797,9592.6719,37.0,white,22.0,1,0,0,no,0.019999996,8e-06,dnr after sadm,4.0,120.0,13.1992188,58.0,8.0,38.19531,197.125,3.5,1.01,1.29980469,139.0,7.40918,135.0,23.0,2502.0,2.059082,<2 mo. follow-up
69.01794,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,57983.438,39160.5,18.0,white,19.0,5,0,0,no,0.799999714,0.65,no dnr,18.0,80.0,10.0,90.0,12.0,38.5,242.84375,3.5,1.01,2.09960938,131.0,7.479492,135.0,23.0,2502.0,1.0,<2 mo. follow-up
46.13797,0,male,0,81,1681,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,165522.0,113269.062,41.0,white,38.0,3,0,0,no,0.599999905,0.6,no dnr,81.0,151.0,22.5976562,136.0,25.0,38.89844,116.0,3.2998047,1.79980469,0.89990234,132.0,7.449219,135.0,23.0,2502.0,2.2304688,<2 mo. follow-up
63.422,1,male,0,34,72,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,56185.094,41615.7812,25.75,white,53.0,4,0,0,no,0.099999964,0.001,no dnr,34.0,126.0,8.79882812,104.0,8.0,35.29688,142.84375,2.699707,4.39941406,7.0,128.0,7.459961,135.0,23.0,2502.0,2.65625,<2 mo. follow-up
65.89496,0,female,0,29,1679,Coma,Coma,0,9.0,$11-$25k,97451.25,65060.1875,30.0,white,12.0,12,0,0,no,0.699999809,0.5,no dnr,29.0,125.0,10.5996094,70.0,9.0,37.69531,331.375,3.5,1.01,0.69995117,134.0,7.469727,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.10394,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,65610.625,42855.7812,47.0,white,23.0,2,0,0,no,0.599999905,0.5,dnr after sadm,13.0,65.0,15.2988281,118.0,10.0,36.59375,167.5,3.199707,1.0,1.0,136.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.20496,1,female,0,15,1495,COPD,COPD/CHF/Cirrhosis,1,16.0,under $11k,89705.938,60473.875,25.666656,white,33.0,42,0,0,no,0.799999714,0.6,no dnr,15.0,136.0,10.0996094,54.0,26.0,36.19531,145.6875,3.199707,1.01,1.39990234,133.0,7.359375,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
42.88797,1,male,0,49,1364,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,107267.375,73935.5,26.5,black,48.0,18,0,0,no,0.699999809,0.5,no dnr,49.0,127.0,28.0976562,154.0,36.0,36.09375,226.65625,4.2998047,4.69921875,0.69995117,138.0,7.439453,135.0,23.0,2502.0,2.8745117,no(M2 and SIP pres)
70.51599,1,female,0,8,60,Lung Cancer,Cancer,1,8.0,$11-$25k,7154.898,5441.2773,12.5,white,11.0,1,0,0,metastatic,0.899999619,0.5,no dnr,8.0,97.0,8.29882812,68.0,16.0,35.29688,333.3,3.5,0.29998779,0.5,136.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
74.09998,1,female,0,16,78,Lung Cancer,Cancer,1,12.0,under $11k,11191.844,8596.3125,8.333328,black,22.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,2.0,137.0,13.6992188,112.0,24.0,36.39844,333.3,3.5,0.29998779,1.0,137.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
69.10895,1,male,0,34,37,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,53654.719,39518.2812,20.0,white,34.0,15,0,0,yes,0.199999928,0.05,dnr after sadm,9.0,119.0,6.59960938,110.0,50.0,38.0,296.0,3.5,1.01,0.59997559,134.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.73895,0,male,0,7,1673,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$25-$50k,30448.625,20684.0625,21.0,white,36.0,7,0,0,no,0.699999809,0.5,no dnr,7.0,72.0,12.0996094,64.0,30.0,36.79688,196.65625,3.0,1.01,1.39990234,136.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.62994,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,128551.688,84274.5625,46.0,white,68.0,1,0,0,no,0.299999952,0.3,dnr after sadm,27.0,68.0,29.5976562,144.0,40.0,40.59375,71.0,3.5,0.39996338,1.59985352,136.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.30899,1,female,0,12,86,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,16926.094,12640.9609,16.0,white,23.0,1,0,0,metastatic,0.0,0.0,no dnr,12.0,81.0,11.2988281,118.0,32.0,37.09375,144.875,3.5,0.69995117,1.09985352,136.0,7.449219,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
75.12695,0,male,0,6,1673,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,6113.828,4340.6133,20.0,black,36.0,1,1,0,yes,0.699999809,0.5,no dnr,6.0,100.0,15.0,76.0,40.0,36.0,252.375,3.5,0.19998169,0.79992676,138.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
65.80194,1,male,1,5,5,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,5412.527,3704.7129,16.0,white,18.0,1,0,0,yes,0.199999928,0.05,dnr after sadm,1.0,120.0,11.7988281,124.0,24.0,35.09375,364.0,3.5,1.01,0.89990234,135.0,7.25,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.67798,1,male,0,6,869,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,3498.949,2964.6816,9.0,black,32.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,97.0,7.59960938,70.0,21.0,36.39844,357.125,3.5,1.19995117,3.09960938,134.0,7.389648,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
47.51797,1,female,0,8,226,Lung Cancer,Cancer,2,12.0,$25-$50k,10569.695,7576.1016,15.5,white,26.0,1,0,0,metastatic,0.899999619,0.9,no dnr,8.0,99.0,20.1992188,74.0,10.0,36.69531,366.625,3.199707,0.5,0.69995117,143.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
28.211,1,male,1,14,14,Coma,Coma,1,12.0,under $11k,75495.125,52903.625,28.0,black,52.0,11,0,0,no,0.699999809,0.5,dnr after sadm,14.0,133.0,30.0976562,126.0,12.0,38.69531,172.5,3.5,0.79992676,1.89990234,143.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.89496,1,male,0,40,1394,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,33176.25,26470.5781,15.5,black,51.0,1,0,0,no,0.599999905,0.6,no dnr,40.0,60.0,27.5976562,104.0,10.0,36.39844,263.3125,3.5,0.29998779,5.79980469,131.0,7.379883,135.0,23.0,2502.0,3.1694336,no(M2 and SIP pres)
56.12299,1,female,0,23,1213,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,59076.75,39979.8125,31.0,white,47.0,7,1,0,no,0.5,0.4,no dnr,23.0,61.0,10.1992188,74.0,12.0,35.09375,83.0625,3.5,0.09999084,4.89941406,138.0,7.519531,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.81897,1,male,0,20,194,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,51952.594,36315.0625,29.666656,white,51.0,10,0,0,no,0.5,0.4,no dnr,20.0,59.0,15.7988281,48.0,22.0,37.5,176.65625,3.5,1.01,2.89990234,128.0,7.5,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.80396,0,male,0,12,1666,ARF/MOSF w/Sepsis,ARF/MOSF,1,4.0,$11-$25k,24017.844,16611.9844,18.5,white,33.0,2,0,0,no,0.75,0.422,no dnr,12.0,64.0,7.59960938,104.0,26.0,38.29688,220.0,3.5,0.5,1.39990234,135.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.39099,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,65632.688,41967.875,47.0,white,101.0,1,0,0,yes,0.5,0.3,dnr after sadm,6.0,45.0,0.09999084,140.0,30.0,38.69531,230.0,1.1999512,4.89941406,2.59960938,149.0,7.449219,135.0,23.0,2502.0,6.0,<2 mo. follow-up
65.01794,1,male,1,3,3,Coma,Coma,1,14.0,>$50k,10533.594,9178.8906,28.0,white,57.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,2.0,73.0,14.3984375,0.0,0.0,35.89844,270.0,3.699707,2.19970703,1.59985352,149.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
37.70798,1,male,0,17,95,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,28257.281,19791.9219,13.0,black,44.0,1,0,0,no,0.5,0.5,dnr after sadm,7.0,123.0,2.39990234,120.0,22.0,39.19531,485.6875,1.3999023,3.79980469,0.89990234,145.0,7.489258,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
51.80798,1,male,0,36,224,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,85036.875,57495.9688,29.25,white,54.0,1,0,0,no,0.699999809,0.5,dnr after sadm,23.0,69.0,18.8984375,110.0,10.0,36.29688,90.0,2.2998047,7.29980469,1.29980469,150.0,7.5,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
34.905,1,female,0,32,426,Lung Cancer,Cancer,1,15.0,$11-$25k,30184.844,22470.3438,10.5,black,10.0,1,0,0,metastatic,0.699999809,0.2,no dnr,32.0,83.0,1.09985352,80.0,16.0,36.79688,333.3,3.5,0.39996338,1.09985352,142.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
67.16797,1,male,0,5,239,Colon Cancer,Cancer,1,19.0,$25-$50k,2869.35,2204.5879,12.0,white,15.0,1,0,0,metastatic,0.899999619,0.8,no dnr,5.0,105.0,5.39941406,72.0,20.0,36.59375,333.3,3.5,0.29998779,1.0,142.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.53198,1,female,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,65764.688,46593.75,30.0,black,75.0,5,1,0,no,0.199999928,0.2,dnr after sadm,13.0,43.0,9.59960938,0.0,25.0,35.59375,294.0,3.5,1.29980469,3.39990234,149.0,7.359375,135.0,23.0,2502.0,7.0,<2 mo. follow-up
59.53699,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,36440.969,26306.7969,48.0,white,97.0,3,1,0,no,0.699999809,0.5,dnr after sadm,3.0,0.0,26.296875,0.0,25.0,36.79688,151.0,3.199707,0.39996338,10.0996094,131.0,7.239258,135.0,23.0,2502.0,2.0654297,<2 mo. follow-up
52.49799,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,64625.125,37736.7812,60.0,white,101.0,18,1,0,no,0.0,0.0,no dnr,3.0,32.0,60.09375,0.0,12.0,38.09375,58.0,3.5,17.1992188,4.69921875,128.0,7.179688,135.0,23.0,2502.0,1.0,<2 mo. follow-up
33.49799,0,male,0,17,1650,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,38352.75,26380.8906,28.0,black,38.0,1,0,0,no,0.899999619,0.9,no dnr,17.0,46.0,10.1992188,114.0,34.0,34.89844,138.3125,3.2998047,0.79992676,0.5,138.0,7.339844,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
63.31299,1,male,0,7,1023,Colon Cancer,Cancer,1,12.0,under $11k,6546.547,4539.9961,10.5,white,13.0,1,0,0,metastatic,1.0,0.9,no dnr,7.0,125.0,7.69921875,100.0,20.0,36.19531,333.3,3.5,0.29998779,0.79992676,139.0,7.419922,135.0,23.0,2502.0,2.2763672,<2 mo. follow-up
71.09698,1,male,0,8,67,Colon Cancer,Cancer,1,5.0,$11-$25k,6796.148,4837.2031,15.5,white,29.0,1,0,0,metastatic,0.799999714,0.5,no dnr,8.0,90.0,13.2988281,100.0,20.0,38.0,333.3,1.7998047,2.39990234,1.0,135.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
33.336,0,female,0,16,1648,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,38332.438,27009.375,21.0,white,48.0,2,0,0,no,0.699999809,0.5,no dnr,16.0,145.0,21.1992188,124.0,25.0,35.89844,300.0,1.0,0.19998169,0.89990234,135.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.323,1,male,1,9,9,Coma,Coma,1,11.0,$25-$50k,40760.781,27743.625,30.5,white,38.0,3,0,0,yes,0.699999809,0.5,dnr after sadm,6.0,115.0,3.89990234,110.0,40.0,38.29688,276.625,2.5,2.0,1.39990234,139.0,7.519531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.06195,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,60256.219,41535.4375,42.5,black,32.0,6,1,0,no,0.0,0.0,no dnr,10.0,105.0,7.29980469,126.0,32.0,36.09375,223.3125,3.5,1.09985352,1.19995117,142.0,7.399414,135.0,23.0,2502.0,2.1630859,<2 mo. follow-up
30.56499,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,111994.75,75745.25,48.0,black,53.0,9,0,0,no,0.299999952,0.3,dnr after sadm,14.0,101.0,17.1992188,114.0,9.0,35.29688,253.3125,1.0998535,5.29980469,4.19921875,137.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.047,0,male,0,17,1648,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$25-$50k,57010.281,37786.875,36.0,white,41.0,1,1,0,no,0.5,0.4,no dnr,17.0,62.0,10.5,136.0,22.0,37.89844,140.8125,3.5,1.01,2.0,142.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.51495,0,male,0,43,1647,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,134926.125,87521.75,12.5,white,29.0,4,0,0,no,0.799999714,0.7,no dnr,43.0,62.0,11.1992188,108.0,30.0,38.89844,196.65625,3.5,1.01,1.0,137.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.55896,1,male,1,26,26,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,117551.375,78834.0,50.5,white,62.0,2,0,0,metastatic,0.299999952,0.1,dnr after sadm,5.0,43.0,1.39990234,46.0,30.0,38.5,132.625,2.7998047,1.59985352,3.39990234,145.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.771,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,144017.875,95878.5,43.75,black,47.0,4,0,0,no,0.199999928,0.1,dnr after sadm,28.0,65.0,21.5976562,136.0,40.0,39.69531,127.5,1.0998535,1.01,0.5,135.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
36.78,0,male,0,34,1645,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,69588.438,47347.7812,20.75,white,42.0,2,1,0,no,0.899999619,0.9,no dnr,34.0,110.0,27.0976562,64.0,29.0,36.79688,196.65625,2.5,2.19970703,1.59985352,143.0,7.449219,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
57.37198,0,female,0,5,1644,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6919.348,4499.9922,27.0,black,40.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,57.0,11.2988281,74.0,12.0,36.0,333.3,3.5,1.01,1.79980469,131.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
66.06696,1,male,0,11,108,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,8746.344,6254.4844,8.5,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,101.0,12.5,120.0,24.0,36.19531,314.8125,3.5,1.01,1.39990234,138.0,7.379883,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
44.71198,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,2,10.0,under $11k,34335.719,23017.6406,40.5,black,48.0,6,1,0,metastatic,0.049999982,0.000125,dnr after sadm,8.0,82.0,30.3984375,136.0,37.0,38.09375,193.3125,1.7998047,0.39996338,0.89990234,148.0,7.509766,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
66.53296,1,male,0,53,941,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,84241.938,57762.9375,20.75,black,11.0,3,0,0,no,0.699999809,0.6,no dnr,53.0,113.0,7.39941406,64.0,22.0,35.29688,390.4375,3.5,1.01,1.0,139.0,7.389648,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.47095,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,239038.625,153327.625,46.25,white,82.0,38,0,0,no,0.699999809,0.5,dnr after sadm,19.0,79.0,25.6992188,150.0,14.0,38.5,274.25,3.699707,46.0,2.29980469,156.0,7.509766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
86.771,1,male,0,12,92,COPD,COPD/CHF/Cirrhosis,1,6.0,$25-$50k,9572.992,6706.3945,12.0,white,24.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,77.0,5.39941406,96.0,24.0,36.29688,254.15625,3.5,0.69995117,0.89990234,144.0,7.319336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.84497,1,male,0,11,21,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,36142.5,23028.0938,36.0,white,45.0,1,1,0,no,0.099999964,0.001,no dnr,11.0,56.0,7.5,96.0,26.0,34.89844,173.3125,3.5,1.01,0.69995117,130.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
36.46298,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,43674.094,27369.0312,40.5,black,49.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,49.0,6.69921875,130.0,10.0,36.89844,380.0,3.5,3.79980469,3.29980469,143.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.01196,1,female,0,6,809,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,4544.449,3349.0293,13.0,white,29.0,1,0,0,no,1.0,1.0,no dnr,6.0,73.0,7.59960938,80.0,20.0,36.0,232.0,3.5,1.01,1.59985352,142.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.34399,1,male,0,14,120,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,16616.234,11228.8359,13.0,white,26.0,1,0,0,no,0.799999714,0.6,no dnr,14.0,73.0,8.0,114.0,16.0,35.29688,361.875,4.0,0.5,1.29980469,142.0,7.469727,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.30096,1,male,0,4,107,Colon Cancer,Cancer,1,8.0,$25-$50k,2797.75,1885.8486,14.0,white,14.0,1,0,0,metastatic,0.75,0.25,no dnr,4.0,103.0,10.0,100.0,20.0,36.59375,333.3,2.8999023,1.09985352,0.59997559,135.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
74.836,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,100695.688,62287.8438,50.333313,white,69.0,3,1,0,no,0.699999809,0.5,no dnr,20.0,114.0,11.5996094,154.0,51.0,38.0,176.65625,3.0,0.09999084,5.09960938,148.0,7.429688,135.0,23.0,2502.0,3.0,<2 mo. follow-up
44.45697,1,female,0,23,1124,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,64678.375,43669.75,35.333313,white,34.0,1,0,0,no,0.799999714,0.8,no dnr,23.0,71.0,13.1992188,120.0,40.0,39.0,169.375,3.5,0.5,1.19995117,152.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.17694,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,75953.688,54295.0625,45.0,white,68.0,57,1,0,yes,0.199999928,0.1,dnr after sadm,2.0,52.0,0.09999084,146.0,23.0,39.0,126.65625,2.3999023,1.09985352,0.79992676,139.0,7.389648,135.0,23.0,2502.0,2.1538086,<2 mo. follow-up
40.961,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,26437.453,17019.7812,36.0,white,49.0,6,0,0,no,0.0,0.0,dnr after sadm,4.0,60.0,6.5,134.0,42.0,38.5,200.0,3.5,0.29998779,1.79980469,143.0,7.389648,135.0,23.0,2502.0,7.0,<2 mo. follow-up
46.20099,1,male,0,16,494,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,48938.625,31128.8594,32.0,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,16.0,47.0,7.69921875,114.0,8.0,38.09375,205.0,2.699707,1.59985352,0.79992676,142.0,7.339844,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
46.80099,1,female,0,24,81,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,100731.312,67725.0,19.666656,white,39.0,45,0,0,yes,0.199999928,0.1,no dnr,24.0,70.0,0.29998779,80.0,24.0,36.09375,215.0,2.2998047,1.39990234,0.79992676,138.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.78894,1,male,0,13,540,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,14408.992,9772.8594,13.5,white,29.0,1,1,0,no,0.799999714,0.75,no dnr,13.0,82.0,5.79980469,76.0,20.0,35.79688,304.75,3.5,0.39996338,1.79980469,144.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
33.98798,0,male,0,11,1627,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,32652.094,21513.1094,12.0,white,12.0,4,0,0,no,0.979999542,0.97,no dnr,11.0,107.0,8.79882812,78.0,24.0,36.69531,348.9375,3.5,1.01,1.19995117,137.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
34.44498,0,male,0,55,1627,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,90605.125,61912.2812,25.0,black,80.0,1,0,0,no,0.099999964,0.001,no dnr,55.0,59.0,28.5,70.0,19.0,35.29688,323.75,1.7998047,8.59960938,2.39990234,153.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.37598,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26869.891,15855.4297,49.5,black,55.0,1,0,0,no,0.049999982,0.000125,no dnr,7.0,42.0,13.5,116.0,14.0,35.5,173.46875,2.2998047,1.01,2.59960938,129.0,7.329102,135.0,23.0,2502.0,2.3037109,<2 mo. follow-up
72.73895,1,male,0,14,103,COPD,COPD/CHF/Cirrhosis,3,6.0,$11-$25k,237319.75,164784.5,9.333328,white,32.0,105,0,0,no,0.799999714,0.8,no dnr,14.0,57.0,7.39941406,116.0,24.0,36.19531,259.25,3.5,1.01,0.89990234,135.0,7.349609,135.0,23.0,2502.0,0.0,SIP>=30
62.60397,1,male,0,8,785,Colon Cancer,Cancer,1,16.0,$11-$25k,6939.148,4463.418,8.5,white,11.0,1,0,0,metastatic,0.899999619,0.8,no dnr,8.0,113.0,4.29980469,66.0,16.0,37.69531,333.3,3.5996094,0.59997559,1.09985352,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.05695,1,male,0,13,127,MOSF w/Malig,ARF/MOSF,1,8.0,$11-$25k,26677.734,17147.4219,24.5,white,42.0,1,0,0,metastatic,0.699999809,0.5,no dnr,13.0,69.0,20.296875,134.0,36.0,38.0,128.5625,3.5,1.01,1.29980469,142.0,7.5,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
33.30899,0,male,0,3,1625,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,1949.499,1513.6387,6.0,white,34.0,1,1,0,no,0.949999809,0.95,no dnr,3.0,93.0,14.2988281,102.0,18.0,36.5,319.0,3.5,1.01,5.5,135.0,7.359375,135.0,23.0,2502.0,2.1293945,no(M2 and SIP pres)
39.392,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,25431.641,16257.5078,24.5,black,45.0,1,0,0,no,0.25,0.2,dnr after sadm,12.0,59.0,35.296875,100.0,32.0,36.39844,428.0,2.0,2.0,1.09985352,133.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
50.297,1,male,0,24,55,CHF,COPD/CHF/Cirrhosis,3,17.0,$25-$50k,37236.906,23530.2969,20.333328,white,25.0,1,1,0,no,0.75,0.6,dnr after sadm,16.0,79.0,6.0,76.0,28.0,36.29688,342.8125,3.5,1.19995117,1.09985352,138.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
62.64798,1,female,1,19,19,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,114017.812,77522.1875,42.666657,white,39.0,23,0,0,yes,0.099999964,0.001,dnr after sadm,15.0,113.0,13.7988281,136.0,33.0,36.19531,55.0,3.5,1.01,0.69995117,130.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
46.431,0,male,0,6,1625,Cirrhosis,COPD/CHF/Cirrhosis,3,18.0,>$50k,13625.547,10169.0,11.0,white,32.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,109.0,7.59960938,92.0,20.0,38.19531,154.0,2.199707,5.19921875,0.79992676,141.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
44.48199,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,15.0,$25-$50k,14491.094,9780.6641,20.0,white,65.0,1,1,0,yes,0.0,0.0,dnr after sadm,3.0,46.0,1.09985352,130.0,12.0,36.29688,165.28125,1.6999512,1.01,1.5,125.0,7.369141,135.0,23.0,2502.0,4.0,<2 mo. follow-up
38.22598,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,113644.312,77640.1875,34.666657,black,37.0,37,0,0,no,0.0,0.0,dnr after sadm,6.0,53.0,9.5,166.0,20.0,38.59375,222.84375,3.5,0.79992676,1.19995117,147.0,7.399414,135.0,23.0,2502.0,2.0595703,<2 mo. follow-up
43.46899,0,male,0,6,1623,CHF,COPD/CHF/Cirrhosis,2,16.0,>$50k,9109.25,5954.8867,6.0,white,20.0,1,1,0,no,0.899999619,0.5,no dnr,6.0,79.0,7.0,60.0,16.0,36.0,333.3,3.5,1.59985352,1.19995117,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.448,0,male,0,5,1623,CHF,COPD/CHF/Cirrhosis,1,10.0,$25-$50k,8706.695,5779.0469,12.0,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,81.0,10.5,76.0,20.0,36.19531,333.3,3.5,0.59997559,1.79980469,140.0,7.419922,135.0,23.0,2502.0,1.7338867,<2 mo. follow-up
53.86697,1,male,0,6,71,Lung Cancer,Cancer,1,3.0,under $11k,4178.297,2940.7246,6.0,black,24.0,1,0,0,metastatic,0.75,0.4,no dnr,6.0,70.0,42.3984375,106.0,20.0,36.29688,333.3,3.7998047,0.69995117,1.39990234,141.0,7.419922,135.0,23.0,2502.0,7.0,SIP>=30
63.51797,0,female,0,7,1621,CHF,COPD/CHF/Cirrhosis,2,7.0,$25-$50k,12290.547,9199.0156,20.5,black,46.0,1,1,0,no,0.899999619,0.85,no dnr,7.0,122.0,11.2988281,70.0,15.0,36.59375,156.65625,3.5,1.01,3.09960938,136.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
43.50699,1,male,0,23,530,COPD,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,35417.5,23980.9844,18.0,white,26.0,1,0,0,no,0.849999905,0.8,no dnr,23.0,71.0,13.2988281,66.0,14.0,35.39844,160.0,3.5,1.01,0.89990234,134.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
49.79898,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,44865.125,29697.0312,33.0,hispanic,56.0,18,0,0,yes,0.5,0.2,dnr after sadm,6.0,66.0,0.09999084,120.0,12.0,36.0,177.5,1.3999023,1.19995117,0.79992676,136.0,7.319336,135.0,23.0,2502.0,6.0,<2 mo. follow-up
64.12897,1,female,0,6,344,Colon Cancer,Cancer,1,13.0,under $11k,4552.0,3259.5019,9.0,white,11.0,1,0,0,metastatic,1.0,1.0,no dnr,6.0,80.0,8.59960938,60.0,16.0,37.5,333.3,3.5,1.01,1.09985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
40.88397,0,female,0,35,1619,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,>$50k,164417.875,116632.562,32.25,white,71.0,1,0,0,no,0.699999809,0.5,no dnr,35.0,59.0,12.0,118.0,41.0,38.69531,165.0,0.3999634,14.3984375,1.0,147.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.92999,1,female,0,14,867,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,31304.594,21216.1562,19.666656,white,19.0,1,0,0,no,0.799999714,0.7,no dnr,14.0,105.0,9.09960938,60.0,8.0,37.59375,216.65625,3.5,2.69970703,0.69995117,141.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.88498,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,70330.438,44525.8125,56.0,white,101.0,19,0,0,yes,0.5,0.4,dnr after sadm,3.0,42.0,0.29998779,210.0,40.0,40.09375,57.0,3.199707,3.59960938,1.69995117,154.0,7.389648,135.0,23.0,2502.0,3.0,<2 mo. follow-up
70.51599,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,72465.938,44700.5,55.0,white,54.0,24,0,0,metastatic,0.699999809,0.5,no dnr,8.0,61.0,18.3984375,166.0,16.0,39.0,70.0,2.8999023,5.69921875,1.39990234,136.0,7.339844,135.0,23.0,2502.0,2.5200195,<2 mo. follow-up
59.69299,1,male,0,8,55,CHF,COPD/CHF/Cirrhosis,4,7.0,under $11k,6527.398,4549.4727,13.0,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,65.0,12.5996094,94.0,20.0,35.09375,348.0,3.5,1.69995117,1.69995117,141.0,7.449219,135.0,23.0,2502.0,3.0,<2 mo. follow-up
51.01398,1,female,0,18,1124,MOSF w/Malig,ARF/MOSF,3,14.0,under $11k,26606.234,19481.5,18.666656,white,27.0,2,0,0,yes,0.699999809,0.5,no dnr,18.0,64.0,9.8984375,110.0,16.0,35.89844,236.0,3.5,1.01,1.0,126.0,7.55957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
39.98898,0,male,0,47,1616,Coma,Coma,0,11.0,$11-$25k,96140.5,65851.3125,27.0,black,28.0,1,0,0,no,0.699999809,0.5,no dnr,47.0,150.0,21.5,54.0,16.0,36.5,314.25,3.5,0.79992676,2.0,142.0,7.549805,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.36896,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,3,16.0,$11-$25k,82882.0,50108.625,50.0,white,64.0,13,1,0,metastatic,0.0,0.0,no dnr,6.0,56.0,27.796875,144.0,15.0,36.39844,95.0,3.0,0.59997559,1.89990234,137.0,7.329102,135.0,23.0,2502.0,0.0,<2 mo. follow-up
49.28699,1,female,0,3,93,Lung Cancer,Cancer,1,18.0,>$50k,6130.148,3425.2812,9.0,white,14.0,1,0,0,metastatic,0.799999714,0.6,no dnr,3.0,93.0,50.0,92.0,18.0,36.89844,333.3,2.5996094,0.29998779,0.89990234,137.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
42.38199,1,male,0,13,161,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,17956.734,11401.1875,17.0,white,9.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,100.0,10.3984375,104.0,22.0,39.09375,165.28125,3.5,1.01,0.59997559,145.0,7.40918,135.0,23.0,2502.0,7.0,<2 mo. follow-up
72.82996,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,1,26.0,$25-$50k,64584.969,42675.625,16.5,white,24.0,9,0,0,yes,0.699999809,0.5,no dnr,28.0,123.0,25.5976562,100.0,26.0,38.09375,220.0,3.5,1.01,0.79992676,136.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
38.63397,1,male,0,40,280,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,64797.125,45844.5625,13.75,white,52.0,1,0,0,no,0.699999809,0.6,no dnr,40.0,148.0,10.2988281,64.0,35.0,36.0,280.9375,2.699707,0.19998169,8.19921875,129.0,7.379883,135.0,23.0,2502.0,6.0,SIP>=30
57.33099,1,female,0,9,24,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,7634.297,5276.5508,14.0,white,25.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,77.0,5.5,80.0,22.0,36.5,333.3,3.2998047,4.0,1.19995117,128.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.51495,1,male,1,7,7,Coma,Coma,1,12.0,under $11k,79534.062,50686.5625,28.5,black,42.0,8,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,60.0,12.6992188,114.0,12.0,39.5,208.5625,3.5,1.01,9.79882812,140.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.30798,1,male,1,16,16,MOSF w/Malig,ARF/MOSF,1,17.0,>$50k,65747.0,42281.875,39.666657,white,54.0,2,0,0,yes,0.699999809,0.5,no dnr,16.0,56.0,9.69921875,130.0,29.0,37.89844,226.65625,2.5996094,1.29980469,3.69970703,137.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
51.258,1,female,0,6,659,Colon Cancer,Cancer,1,11.0,>$50k,6629.898,3985.4883,18.0,white,15.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,150.0,6.39941406,68.0,20.0,36.5,333.3,3.5,0.59997559,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
40.75,0,male,0,29,1610,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,56770.312,38207.1875,28.25,white,35.0,1,0,0,no,0.949999809,0.94,no dnr,29.0,77.0,13.7988281,124.0,38.0,38.19531,233.3125,2.0996094,0.5,0.59997559,137.0,7.479492,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.03595,1,female,1,50,50,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,101556.688,70590.1875,7.75,white,21.0,14,0,0,no,0.75,0.6,dnr after sadm,46.0,73.0,9.09960938,70.0,28.0,36.19531,736.625,3.5,1.01,0.69995117,137.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.01898,1,male,0,5,165,Colon Cancer,Cancer,1,7.0,under $11k,3755.648,2598.2031,17.0,white,21.0,1,0,0,metastatic,1.0,0.8,no dnr,5.0,107.0,7.0,76.0,24.0,36.19531,333.3,3.5,0.39996338,1.69995117,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.11298,1,male,0,33,1564,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,73551.25,47569.375,30.25,black,39.0,1,1,0,no,0.5,0.4,no dnr,33.0,67.0,19.6992188,114.0,8.0,39.09375,195.0,3.5,1.5,2.09960938,132.0,7.509766,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
53.04898,1,female,1,6,6,Coma,Coma,0,12.0,under $11k,33600.531,21992.5469,43.0,other,38.0,7,0,0,yes,0.099999964,0.001,dnr after sadm,5.0,62.0,2.29980469,136.0,27.0,37.89844,273.3125,3.5,1.01,1.39990234,150.0,7.5,135.0,23.0,2502.0,7.0,<2 mo. follow-up
61.06198,0,male,0,14,1600,Coma,Coma,1,12.0,>$50k,25385.047,16424.75,19.0,white,7.0,1,0,0,no,0.199999928,0.1,no dnr,14.0,105.0,18.8984375,74.0,8.0,36.5,310.0,3.5,1.01,1.09985352,135.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
24.01399,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,98734.0,63452.4688,38.333313,white,41.0,1,0,0,no,0.5,0.3,dnr after sadm,17.0,112.0,16.8984375,144.0,30.0,40.0,110.0,3.5,0.89990234,0.69995117,147.0,7.489258,135.0,23.0,2502.0,5.0,<2 mo. follow-up
54.02899,0,male,0,5,1599,CHF,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,9305.555,6273.5117,25.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,53.0,6.89941406,54.0,11.0,36.09375,316.0,3.5,1.01,1.19995117,138.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
45.81497,1,male,1,3,3,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,20466.234,13310.0,42.0,white,87.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,0.0,7.19921875,0.0,22.0,36.39844,155.6875,1.8999023,1.01,4.19921875,152.0,7.25,135.0,23.0,2502.0,2.1298828,<2 mo. follow-up
62.65298,1,female,0,10,604,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,9345.742,6544.2227,14.5,white,12.0,1,0,0,no,0.599999905,0.5,no dnr,10.0,87.0,10.7988281,74.0,26.0,36.19531,436.0,3.5,1.01,1.09985352,147.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
48.95599,1,male,1,69,69,MOSF w/Malig,ARF/MOSF,1,18.0,$25-$50k,158581.125,105985.688,33.75,white,37.0,12,0,0,yes,0.199999928,0.1,dnr after sadm,62.0,111.0,6.69921875,114.0,11.0,36.29688,202.84375,3.5,1.01,6.89941406,141.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.60199,1,female,0,26,244,MOSF w/Malig,ARF/MOSF,1,13.0,$11-$25k,32563.297,22906.7031,14.75,white,57.0,1,0,0,yes,0.5,0.3,no dnr,26.0,63.0,25.1992188,126.0,42.0,38.29688,194.28125,2.5996094,0.89990234,1.09985352,145.0,7.549805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.93097,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,21.0,$11-$25k,57927.031,39838.1875,30.0,white,62.0,1,0,0,yes,0.5,0.4,dnr after sadm,16.0,134.0,1.0,126.0,36.0,36.0,160.0,2.3999023,1.89990234,3.5,142.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
50.95999,0,female,0,11,1595,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,20149.438,13549.0859,22.0,white,27.0,1,0,0,no,0.699999809,0.7,no dnr,11.0,59.0,10.1992188,120.0,6.0,38.09375,347.5625,2.5996094,0.19998169,0.69995117,143.0,7.449219,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
50.64999,1,male,0,5,388,Colon Cancer,Cancer,1,12.0,$25-$50k,7671.547,4854.7148,12.0,white,9.0,1,0,0,metastatic,0.899999619,0.6,no dnr,5.0,117.0,12.6992188,50.0,20.0,36.39844,333.3,4.1992188,0.59997559,1.09985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
37.396,0,male,0,9,1593,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,27632.438,17343.8125,28.0,black,27.0,1,1,0,no,0.299999952,0.28,no dnr,9.0,61.0,6.89941406,126.0,10.0,38.39844,223.3125,2.7998047,0.59997559,1.09985352,153.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.02496,1,male,0,16,619,ARF/MOSF w/Sepsis,ARF/MOSF,3,15.0,>$50k,27549.688,18694.5938,19.666656,white,42.0,1,0,0,no,0.699999809,0.6,no dnr,16.0,110.0,18.8984375,104.0,40.0,36.59375,146.40625,3.5,1.01,0.89990234,139.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.86899,0,male,0,73,1593,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,>$50k,212689.5,137019.0,34.5,white,42.0,1,0,0,no,0.799999714,0.8,no dnr,73.0,117.0,14.8984375,116.0,27.0,39.09375,216.65625,2.7998047,6.39941406,1.29980469,131.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
74.59796,0,male,0,6,1593,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3740.498,3070.2441,14.0,black,31.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,101.0,8.0,100.0,24.0,35.5,356.0,3.5,6.79980469,1.69995117,146.0,7.459961,135.0,23.0,2502.0,3.637207,<2 mo. follow-up
69.00494,1,female,0,9,1133,CHF,COPD/CHF/Cirrhosis,4,5.0,$11-$25k,20171.688,12962.7656,22.5,white,47.0,1,1,0,no,0.949999809,0.9,no dnr,9.0,124.0,6.69921875,176.0,8.0,36.19531,233.3125,3.5,1.01,1.39990234,137.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.89398,1,female,1,6,6,Coma,Coma,3,11.0,$25-$50k,20252.891,14738.0078,32.0,white,36.0,1,1,0,no,0.699999809,0.5,dnr after sadm,5.0,119.0,11.8984375,100.0,8.0,36.79688,386.625,3.5,1.01,9.8984375,133.0,7.399414,135.0,23.0,2502.0,5.0,<2 mo. follow-up
64.91998,1,male,0,32,156,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,107884.5,66731.6875,34.5,white,75.0,14,0,0,yes,0.699999809,0.5,no dnr,32.0,55.0,49.3984375,210.0,5.0,39.29688,253.3125,3.0,1.01,2.0,131.0,7.319336,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.88495,1,female,0,9,16,Colon Cancer,Cancer,2,14.0,$25-$50k,7538.297,5511.1602,12.0,white,34.0,1,0,0,metastatic,0.299999952,0.0,dnr after sadm,1.0,77.0,4.29980469,98.0,20.0,37.19531,333.3,3.5,19.0976562,1.09985352,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.99899,1,male,1,17,17,Colon Cancer,Cancer,1,10.0,>$50k,24066.344,15673.8203,12.333328,black,36.0,1,0,0,metastatic,0.699999809,0.5,no dnr,17.0,126.0,4.59960938,64.0,28.0,38.09375,333.3,3.5,13.0,1.09985352,139.0,7.419922,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
64.909,1,male,0,7,22,Colon Cancer,Cancer,2,12.0,$25-$50k,3950.5,2913.9922,6.5,white,26.0,1,1,0,metastatic,0.5,0.2,no dnr,7.0,67.0,5.39941406,52.0,16.0,37.69531,333.3,3.5,0.19998169,1.39990234,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
30.795,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59516.188,36226.1875,42.0,white,33.0,2,1,0,no,0.5,0.5,dnr after sadm,13.0,55.0,13.3984375,116.0,11.0,38.69531,148.0,2.5,0.5,0.89990234,140.0,7.419922,135.0,23.0,2502.0,2.7836914,<2 mo. follow-up
38.133,0,female,0,91,1587,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,202750.625,130006.375,24.5,white,50.0,22,0,0,no,0.149999976,0.1,no dnr,91.0,113.0,27.796875,140.0,33.0,38.59375,368.0,2.5,4.89941406,1.69995117,148.0,7.469727,135.0,23.0,2502.0,2.0,SIP>=30
69.00195,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,160610.125,98081.5625,41.666657,white,37.0,11,0,0,no,0.5,0.2,dnr after sadm,19.0,96.0,19.6992188,110.0,10.0,36.59375,290.0,2.699707,7.69921875,2.0,151.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
74.31299,1,female,0,15,40,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,27789.391,19155.1562,19.0,white,56.0,11,0,0,no,0.699999809,0.5,no dnr,15.0,72.0,5.79980469,124.0,31.0,35.5,176.0,2.8999023,1.01,0.39996338,138.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
66.18994,1,male,0,7,89,Colon Cancer,Cancer,2,10.0,under $11k,6248.0,4065.4219,6.0,black,16.0,1,1,0,metastatic,0.5,0.1,no dnr,7.0,101.0,11.7988281,64.0,16.0,37.39844,333.3,2.5,1.01,0.89990234,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
58.89697,0,female,0,25,1583,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,91730.875,65269.1562,23.5,white,14.0,12,0,0,no,0.5,0.25,no dnr,25.0,72.0,11.1992188,74.0,8.0,39.0,266.625,3.5,1.01,0.5,135.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.83398,1,male,1,7,7,Coma,Coma,1,11.0,$11-$25k,24014.984,16735.875,32.0,black,28.0,1,0,0,no,0.25,0.2,dnr after sadm,5.0,75.0,6.79980469,11.0,10.0,39.29688,386.625,3.0996094,0.59997559,1.5,142.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.487,1,male,1,37,37,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,122004.25,77422.375,38.25,white,15.0,2,0,0,yes,0.799999714,0.5,dnr after sadm,24.0,70.0,10.0,100.0,9.0,36.19531,226.65625,3.5,1.01,0.89990234,139.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
70.65295,0,male,0,18,1574,COPD,COPD/CHF/Cirrhosis,3,5.0,under $11k,19755.547,13855.2266,10.0,black,32.0,1,0,0,no,0.199999928,0.1,no dnr,18.0,77.0,9.79882812,72.0,26.0,36.79688,225.0,2.3999023,0.89990234,1.0,134.0,7.429688,135.0,23.0,2502.0,3.6118164,no(M2 and SIP pres)
53.185,1,male,0,8,17,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,33711.281,21372.6719,39.5,black,62.0,2,1,0,yes,0.699999809,0.5,no dnr,8.0,48.0,13.0,52.0,30.0,35.19531,104.0,2.0996094,0.69995117,2.39990234,136.0,7.339844,135.0,23.0,2502.0,2.6381836,<2 mo. follow-up
77.63696,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9904.242,6551.9062,11.5,white,67.0,1,1,1,no,0.149999976,0.1,dnr after sadm,1.0,37.0,26.0,96.0,38.0,35.79688,108.32812,3.5,1.01,1.69995117,141.0,7.129883,135.0,23.0,2502.0,4.7861328,<2 mo. follow-up
31.59799,1,male,0,11,747,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,156964.25,115626.062,15.5,white,51.0,38,1,0,no,0.949999809,0.95,no dnr,11.0,145.0,4.69921875,64.0,28.0,36.39844,132.5,2.0996094,0.39996338,5.19921875,142.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.13998,1,male,0,6,164,Lung Cancer,Cancer,1,17.0,>$50k,6011.648,3880.0293,18.0,white,12.0,1,0,0,metastatic,0.399999857,0.0,dnr after sadm,1.0,87.0,11.0,120.0,24.0,36.29688,333.3,3.5,0.19998169,0.59997559,135.0,7.419922,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
47.99698,0,male,0,117,1572,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,337299.25,222272.5,33.5,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,117.0,62.0,14.1992188,126.0,27.0,38.29688,384.0,3.0,1.09985352,0.79992676,128.0,7.449219,135.0,23.0,2502.0,2.0444336,<2 mo. follow-up
61.15298,1,male,0,6,1321,CHF,COPD/CHF/Cirrhosis,2,4.0,under $11k,6116.449,4469.4336,13.0,white,32.0,1,1,0,no,0.5,0.3,no dnr,6.0,60.0,7.19921875,62.0,36.0,35.89844,333.3,3.5,1.01,1.09985352,139.0,7.399414,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
64.07397,1,male,1,14,14,Lung Cancer,Cancer,1,8.0,under $11k,55642.438,37272.6562,30.666656,black,58.0,4,0,0,metastatic,0.199999928,0.1,dnr after sadm,12.0,73.0,28.6992188,114.0,27.0,36.0,123.32812,3.0996094,2.5,6.19921875,135.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
60.73398,0,male,0,24,1572,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$11-$25k,98783.438,61616.1562,31.333328,white,27.0,9,0,0,no,0.699999809,0.5,no dnr,24.0,71.0,19.1992188,114.0,8.0,38.09375,155.0,2.8999023,3.0,1.09985352,132.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
38.27499,0,female,0,145,1572,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,218732.875,141284.625,35.5,black,36.0,1,0,0,no,1.0,1.0,no dnr,145.0,147.0,17.5976562,134.0,12.0,38.5,160.0,2.2998047,1.29980469,0.59997559,130.0,7.359375,135.0,23.0,2502.0,2.2563477,adl>=4 (>=5 if sur)
43.53998,1,male,0,21,38,Lung Cancer,Cancer,2,12.0,under $11k,25725.641,16881.0312,14.666664,black,32.0,1,0,0,metastatic,0.799999714,0.5,no dnr,21.0,77.0,6.39941406,124.0,38.0,39.89844,376.1875,3.5,2.39990234,0.5,141.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
35.66898,0,female,0,39,1568,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,158145.75,99069.125,46.5,white,56.0,3,0,0,no,0.75,0.75,no dnr,39.0,49.0,19.6992188,144.0,48.0,39.59375,55.0,2.7998047,0.5,0.79992676,135.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.81598,1,female,1,5,5,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,12576.898,8586.6719,25.0,white,26.0,5,1,0,no,0.899999619,0.75,no dnr,5.0,115.0,7.79980469,72.0,24.0,36.19531,300.0,3.5,1.01,1.59985352,133.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.14099,0,male,0,27,1567,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,88426.188,64598.4375,27.0,white,22.0,1,0,0,no,0.799999714,0.7,no dnr,27.0,59.0,7.39941406,74.0,24.0,37.79688,376.625,3.5,1.0,1.09985352,132.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.62198,1,male,0,5,288,Colon Cancer,Cancer,1,16.0,>$50k,3364.6,2296.4531,13.0,white,12.0,1,0,0,metastatic,0.899999619,0.7,no dnr,5.0,78.0,3.59960938,64.0,16.0,36.19531,333.3,3.699707,1.69995117,0.79992676,136.0,7.419922,135.0,23.0,2502.0,1.6801758,no(M2 and SIP pres)
65.20697,0,female,0,7,1566,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,4139.348,3229.4004,7.0,black,48.0,1,1,0,no,0.5,0.3,no dnr,7.0,100.0,5.19921875,80.0,32.0,36.39844,161.875,3.3999023,2.19970703,1.09985352,136.0,7.399414,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
75.07495,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$25-$50k,75079.25,47504.6562,34.666657,white,54.0,5,0,0,no,0.099999964,0.001,no dnr,18.0,71.0,15.5996094,74.0,11.0,37.79688,146.65625,2.3999023,3.19970703,4.09960938,138.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
58.29199,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,20454.547,13545.375,41.0,white,77.0,6,0,0,no,0.0,0.0,dnr before sadm,-5.0,70.0,15.5996094,0.0,0.0,35.5,228.0,3.5,0.39996338,3.5,124.0,7.15918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
65.86395,1,male,0,17,99,Lung Cancer,Cancer,1,12.0,under $11k,15353.195,10907.9844,6.666664,black,40.0,1,0,0,metastatic,0.599999905,0.1,dnr after sadm,2.0,75.0,11.0,88.0,28.0,37.19531,228.5625,4.0,0.5,0.79992676,130.0,7.489258,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
59.064,1,male,0,5,418,Colon Cancer,Cancer,1,9.0,$25-$50k,6036.098,3612.1367,14.0,white,9.0,1,0,0,metastatic,0.899999619,0.7,no dnr,5.0,109.0,5.89941406,80.0,24.0,38.19531,333.3,3.199707,0.89990234,0.89990234,139.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
35.57797,0,male,0,13,1557,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,16707.297,10840.7656,12.5,black,27.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,70.0,9.79882812,120.0,30.0,36.0,295.625,2.699707,1.01,0.89990234,133.0,7.349609,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
25.56899,0,male,0,22,1558,ARF/MOSF w/Sepsis,ARF/MOSF,4,15.0,under $11k,36389.594,25027.0312,18.333328,white,57.0,9,1,0,no,0.699999809,0.5,no dnr,22.0,119.0,1.29980469,114.0,12.0,35.79688,456.625,2.199707,0.89990234,5.29980469,144.0,7.439453,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
60.05197,1,male,0,4,287,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,under $11k,4399.648,2730.6269,7.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,71.0,6.29980469,72.0,16.0,36.69531,333.3,3.5,7.29980469,1.0,136.0,7.419922,135.0,23.0,2502.0,1.8688965,no(M2 and SIP pres)
88.19196,1,male,0,17,711,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,29291.234,19606.7969,21.666656,black,65.0,1,0,1,no,0.799999714,0.6,dnr after sadm,2.0,52.0,7.29980469,144.0,11.0,36.69531,240.0,2.0996094,0.39996338,2.29980469,139.0,7.269531,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
48.42999,1,male,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,1,10.0,$11-$25k,22941.047,15236.8125,40.0,white,55.0,1,0,0,no,0.099999964,0.001,dnr after sadm,3.0,75.0,12.8984375,138.0,10.0,34.79688,98.32812,2.199707,2.39990234,1.89990234,138.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.78894,1,male,0,4,179,Lung Cancer,Cancer,2,14.0,>$50k,3910.1,2377.082,6.0,white,36.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,120.0,11.3984375,120.0,28.0,36.09375,333.3,3.5,0.59997559,1.79980469,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
25.618,1,female,1,12,12,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,47193.688,30280.5,46.0,black,83.0,1,0,0,no,0.5,0.5,dnr after sadm,10.0,59.0,15.6992188,100.0,33.0,35.59375,213.3125,2.2998047,20.296875,3.29980469,130.0,7.439453,135.0,23.0,2502.0,3.0,<2 mo. follow-up
50.11398,0,male,0,6,1551,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8178.348,5508.793,21.0,black,16.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,115.0,5.79980469,100.0,28.0,36.69531,304.75,3.5,1.01,0.89990234,141.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
59.28497,1,male,1,17,17,Lung Cancer,Cancer,1,12.0,$25-$50k,42512.125,27666.9688,32.666657,white,23.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,8.0,103.0,20.1992188,100.0,20.0,37.0,290.4375,2.0996094,0.19998169,0.5,138.0,7.5,135.0,23.0,2502.0,6.0,<2 mo. follow-up
50.396,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,1,10.0,$11-$25k,134989.125,83926.1875,33.333313,white,28.0,42,0,0,yes,0.699999809,0.4,dnr after sadm,14.0,109.0,39.1953125,106.0,28.0,36.59375,160.0,2.699707,1.01,1.09985352,137.0,7.479492,135.0,23.0,2502.0,5.0,<2 mo. follow-up
69.72498,1,female,1,56,56,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,303683.5,192640.75,43.25,white,36.0,14,0,0,no,0.0,0.0,dnr after sadm,46.0,113.0,12.5996094,120.0,36.0,38.0,193.3125,2.5996094,1.5,0.79992676,148.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
47.10999,1,female,0,7,532,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,6076.496,4425.5273,6.0,black,29.0,1,0,1,no,0.699999809,0.5,no dnr,7.0,80.0,10.3984375,100.0,20.0,38.0,333.3,1.5998535,5.79980469,0.89990234,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
77.96899,1,female,1,19,19,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,63867.688,43432.9062,36.0,white,40.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,16.0,103.0,12.1992188,96.0,36.0,36.09375,260.0,2.5,5.29980469,0.69995117,129.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.99698,1,male,1,19,19,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,under $11k,42310.281,27209.7812,18.666656,hispanic,20.0,1,0,0,no,0.699999809,0.5,no dnr,19.0,97.0,8.19921875,130.0,12.0,38.79688,496.625,3.5,1.79980469,0.79992676,142.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
19.85199,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,95530.875,59617.7812,49.5,white,65.0,8,0,0,no,0.009999998,1e-06,no dnr,8.0,63.0,20.0976562,124.0,20.0,38.39844,98.32812,3.199707,21.1992188,3.69970703,137.0,7.429688,135.0,23.0,2502.0,1.8825684,<2 mo. follow-up
79.69098,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,172505.125,110413.75,39.666657,white,56.0,17,0,0,no,0.699999809,0.5,dnr after sadm,17.0,56.0,9.59960938,114.0,34.0,38.5,293.3125,4.0996094,9.5,0.79992676,136.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
40.34998,0,female,0,19,1546,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,34898.594,22762.2812,10.0,black,42.0,4,0,0,no,0.699999809,0.5,no dnr,19.0,87.0,13.6992188,80.0,20.0,35.59375,125.0,2.7998047,0.29998779,8.3984375,127.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
36.90298,1,male,0,16,53,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,25755.594,17364.1406,24.333328,hispanic,73.0,2,0,0,no,0.699999809,0.5,no dnr,16.0,73.0,12.2988281,130.0,9.0,34.89844,347.5625,2.3999023,5.5,2.59960938,131.0,7.40918,135.0,23.0,2502.0,6.0,<2 mo. follow-up
76.51196,1,female,0,9,331,Lung Cancer,Cancer,1,8.0,under $11k,6821.75,4828.9609,8.0,white,25.0,1,0,0,metastatic,0.799999714,0.5,no dnr,9.0,109.0,1.29980469,92.0,20.0,36.79688,333.3,3.5,1.01,1.09985352,139.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
41.629,1,male,0,38,1238,Coma,Coma,0,8.0,$11-$25k,64012.688,42502.8438,22.25,white,46.0,1,0,0,no,0.799999714,0.75,no dnr,38.0,114.0,13.7988281,114.0,60.0,40.0,227.5,3.5,1.19995117,1.39990234,144.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
40.452,0,male,0,12,1545,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,31204.594,20957.7812,20.0,black,14.0,4,0,0,no,0.799999714,0.7,no dnr,12.0,117.0,16.0976562,98.0,26.0,36.09375,260.0,3.5,1.01,0.79992676,135.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.96698,1,female,1,19,19,Coma,Coma,0,12.0,$25-$50k,50624.125,33906.875,34.666657,white,51.0,1,0,0,no,0.199999928,0.1,dnr after sadm,10.0,137.0,15.5,116.0,35.0,38.5,372.0,2.7998047,1.01,2.09960938,134.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.37299,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,15.0,$25-$50k,21115.188,12553.6641,44.0,black,84.0,5,0,0,metastatic,0.099999964,0.001,dnr after sadm,3.0,0.0,16.8984375,0.0,14.0,35.79688,273.3125,2.5996094,12.5996094,4.29980469,149.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
56.556,1,female,0,6,283,Colon Cancer,Cancer,1,12.0,$25-$50k,6480.297,4016.7168,10.0,white,16.0,1,0,0,metastatic,0.899999619,0.6,no dnr,6.0,103.0,6.0,100.0,28.0,38.5,333.3,2.8999023,1.19995117,0.59997559,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
82.58197,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,63105.875,39187.0312,31.5,white,62.0,6,0,0,no,0.0,0.0,dnr after sadm,7.0,47.0,17.0,106.0,10.0,36.09375,260.0,3.5,10.0,6.09960938,123.0,7.319336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
36.74197,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,36980.094,24034.9375,37.0,black,42.0,8,0,0,yes,0.5,0.1,dnr after sadm,8.0,63.0,14.5,140.0,32.0,35.69531,146.65625,3.5,1.01,1.09985352,143.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
48.30698,0,male,0,17,1540,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,33070.469,20807.9219,12.333328,white,32.0,2,0,0,no,1.0,1.0,no dnr,17.0,110.0,28.1992188,50.0,16.0,37.0,443.4375,2.7998047,1.01,5.0,131.0,7.40918,135.0,23.0,2502.0,2.6401367,<2 mo. follow-up
65.13599,1,male,0,15,1178,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$25-$50k,57069.969,36112.25,31.333328,white,67.0,1,0,0,yes,0.899999619,0.9,no dnr,15.0,53.0,20.0,116.0,28.0,39.0,194.0,3.2998047,4.79980469,2.19970703,130.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.931,0,male,0,37,1538,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,>$50k,79986.812,54028.7812,27.0,black,10.0,9,0,0,no,0.699999809,0.6,no dnr,37.0,111.0,13.7988281,74.0,8.0,38.89844,304.0,3.199707,0.29998779,1.0,138.0,7.369141,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
73.54999,1,male,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,154653.25,101745.938,38.5,white,85.0,1,0,0,no,0.049999982,0.000125,no dnr,40.0,136.0,14.5996094,158.0,29.0,35.59375,200.0,1.5998535,3.29980469,5.5,138.0,7.519531,135.0,23.0,2502.0,7.0,<2 mo. follow-up
77.86694,0,male,0,192,1537,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,492828.0,334111.75,38.75,white,47.0,14,1,0,no,0.599999905,0.6,dnr after sadm,82.0,75.0,21.5976562,140.0,9.0,38.29688,187.5,3.5,1.01,2.19970703,151.0,7.389648,135.0,23.0,2502.0,2.6162109,adl>=4 (>=5 if sur)
67.54297,1,female,1,11,11,COPD,COPD/CHF/Cirrhosis,3,13.0,under $11k,7606.227,5431.7109,11.0,white,25.0,1,0,0,no,0.299999952,0.15,dnr after sadm,1.0,80.0,3.69970703,106.0,24.0,37.39844,164.0,3.5,0.29998779,0.39996338,136.0,7.25,135.0,23.0,2502.0,5.0,<2 mo. follow-up
76.61597,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,54942.594,35570.4375,30.5,white,21.0,4,0,0,no,0.699999809,0.5,dnr after sadm,1.0,81.0,13.8984375,64.0,40.0,39.79688,410.0,3.0996094,0.89990234,0.79992676,146.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
56.91998,1,male,1,8,8,Coma,Coma,1,16.0,>$50k,39522.688,27228.875,29.5,white,23.0,16,0,0,metastatic,0.599999905,0.3,dnr after sadm,2.0,111.0,12.1992188,116.0,22.0,36.59375,316.625,1.7998047,0.69995117,0.5,135.0,7.429688,135.0,23.0,2502.0,5.0,<2 mo. follow-up
42.46997,0,male,0,11,1534,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,22030.047,15530.1797,14.0,white,12.0,2,0,0,no,0.899999619,0.9,no dnr,11.0,101.0,5.79980469,70.0,12.0,38.09375,304.75,3.5,0.19998169,0.69995117,136.0,7.439453,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
34.56299,1,male,0,5,427,Lung Cancer,Cancer,1,12.0,under $11k,6135.598,3612.6094,12.0,white,7.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,87.0,11.8984375,84.0,20.0,36.09375,266.625,3.699707,0.5,0.69995117,140.0,7.469727,135.0,23.0,2502.0,1.9155273,<2 mo. follow-up
79.19196,1,male,0,44,390,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,>$50k,99666.938,66717.125,24.25,white,48.0,3,0,0,no,0.75,0.75,no dnr,44.0,52.0,16.296875,74.0,26.0,37.59375,179.5625,2.5,1.01,4.29980469,130.0,7.359375,135.0,23.0,2502.0,0.0,SIP>=30
80.60498,1,male,0,36,193,COPD,COPD/CHF/Cirrhosis,3,24.0,$25-$50k,36915.625,25450.3594,10.5,white,29.0,2,0,0,yes,0.699999809,0.5,no dnr,36.0,87.0,15.5996094,64.0,28.0,36.59375,145.6875,3.5,0.29998779,1.0,134.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.39398,1,male,1,3,3,Coma,Coma,0,12.0,under $11k,11347.344,7430.0469,25.0,black,73.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,0.0,20.796875,0.0,0.0,35.0,544.0,3.5,1.01,2.5,154.0,7.479492,135.0,23.0,2502.0,1.3742676,<2 mo. follow-up
51.504,1,male,0,171,259,Coma,Coma,0,12.0,under $11k,156180.375,108716.25,27.25,black,11.0,1,0,0,no,0.399999857,0.1,dnr after sadm,36.0,81.0,7.5,66.0,26.0,38.29688,303.3125,2.8999023,1.01,1.19995117,145.0,7.439453,135.0,23.0,2502.0,2.0087891,<2 mo. follow-up
75.35699,1,male,1,62,62,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,169118.25,111419.812,31.5,black,59.0,21,1,0,no,0.699999809,0.5,dnr after sadm,59.0,65.0,0.19998169,110.0,8.0,36.79688,233.3125,2.3999023,1.01,0.59997559,134.0,7.5,135.0,23.0,2502.0,7.0,<2 mo. follow-up
67.52399,0,male,0,44,1529,Coma,Coma,1,8.0,under $11k,141597.75,92144.4375,34.5,black,52.0,8,0,0,no,0.949999809,0.9,no dnr,44.0,75.0,8.3984375,156.0,37.0,38.5,305.6875,2.3999023,0.39996338,1.5,138.0,7.40918,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
48.728,1,male,0,10,849,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,10446.398,7117.5312,8.5,black,33.0,1,1,0,no,0.799999714,0.6,no dnr,10.0,106.0,5.69921875,84.0,20.0,35.79688,333.3,3.0996094,2.19970703,1.69995117,134.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
66.80597,1,male,0,8,320,Lung Cancer,Cancer,1,12.0,$11-$25k,7554.199,5042.9414,8.0,white,17.0,1,0,0,metastatic,0.599999905,0.4,no dnr,8.0,100.0,14.7988281,100.0,24.0,36.59375,420.0,2.2998047,1.29980469,1.0,144.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.70898,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,94199.812,59171.6875,38.0,white,36.0,1,0,0,no,0.599999905,0.5,dnr after sadm,19.0,115.0,12.7988281,124.0,33.0,37.19531,108.32812,3.5,0.79992676,0.89990234,140.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
40.99899,1,male,0,14,444,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,13750.117,9702.7188,9.0,black,36.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,120.0,5.29980469,85.0,22.0,36.0,300.0,2.0996094,0.39996338,3.29980469,142.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.97198,1,male,1,8,8,Coma,Coma,0,11.0,under $11k,18601.594,12105.8828,20.5,black,6.0,1,0,0,no,0.019999996,8e-06,no dnr,8.0,96.0,17.1992188,52.0,12.0,36.69531,290.0,3.5,0.29998779,1.09985352,136.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.64496,0,female,0,78,1527,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,269475.5,176331.75,42.75,black,76.0,13,0,0,no,0.799999714,0.8,no dnr,78.0,51.0,20.0,104.0,38.0,38.79688,208.0,3.7998047,12.0996094,2.09960938,131.0,7.399414,135.0,23.0,2502.0,2.4394531,<2 mo. follow-up
62.69998,0,male,0,14,1526,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,55241.594,36863.125,14.0,white,19.0,7,0,0,no,0.799999714,0.8,no dnr,14.0,100.0,16.296875,124.0,14.0,36.0,255.53125,3.5,1.01,0.69995117,147.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
49.45099,1,female,0,23,297,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,92412.438,56558.4062,36.0,white,28.0,6,0,0,no,0.799999714,0.7,no dnr,23.0,133.0,8.0,64.0,12.0,37.39844,292.0,3.5,1.01,0.39996338,132.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.99298,1,female,1,13,13,MOSF w/Malig,ARF/MOSF,2,7.0,under $11k,58915.594,38120.125,49.5,white,50.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,13.0,50.0,25.296875,110.0,20.0,36.59375,54.0,2.3999023,0.09999084,1.09985352,139.0,7.349609,135.0,23.0,2502.0,5.0,<2 mo. follow-up
39.82999,0,female,0,9,1525,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,28210.188,19233.4688,22.0,black,43.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,142.0,6.39941406,114.0,28.0,38.29688,160.0,2.5996094,0.5,1.19995117,137.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
41.91898,0,male,0,5,1524,Colon Cancer,Cancer,1,12.0,under $11k,4684.547,2984.4473,14.0,black,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,73.0,5.69921875,104.0,24.0,38.29688,333.3,2.8999023,0.19998169,1.19995117,139.0,7.419922,135.0,23.0,2502.0,1.8041992,<2 mo. follow-up
70.52197,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,93077.688,60741.5312,32.333313,white,30.0,4,0,0,no,0.299999952,0.15,dnr after sadm,19.0,65.0,14.5996094,118.0,23.0,36.79688,157.5,3.5,2.59960938,1.09985352,152.0,7.509766,135.0,23.0,2502.0,3.0449219,<2 mo. follow-up
59.95099,1,male,0,9,493,ARF/MOSF w/Sepsis,ARF/MOSF,3,6.0,under $11k,37907.438,24762.9375,27.5,white,40.0,2,0,0,no,0.599999905,0.5,no dnr,9.0,109.0,9.29882812,126.0,32.0,35.39844,168.5625,3.5,1.01,1.59985352,138.0,7.469727,135.0,23.0,2502.0,7.0,SIP>=30
63.064,0,female,0,23,1522,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,70353.0,45316.9688,31.333328,white,35.0,3,1,0,no,0.799999714,0.75,no dnr,23.0,67.0,11.3984375,120.0,17.0,37.79688,141.65625,2.5,0.59997559,1.19995117,156.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
52.70898,1,female,0,9,29,Lung Cancer,Cancer,1,10.0,under $11k,13646.242,9036.8516,20.5,white,24.0,1,0,0,metastatic,0.799999714,0.6,no dnr,9.0,77.0,7.19921875,124.0,24.0,38.59375,292.0,2.3999023,0.39996338,0.69995117,140.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
31.28299,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,52990.125,34947.8438,40.0,white,63.0,1,0,0,no,0.599999905,0.5,dnr after sadm,6.0,105.0,19.3984375,124.0,30.0,38.19531,303.3125,2.5996094,20.0,2.5,145.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
57.21597,0,female,0,53,1521,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,173402.5,116365.75,37.0,white,44.0,1,0,0,no,0.899999619,0.8,no dnr,53.0,129.0,8.19921875,124.0,10.0,38.39844,146.0,2.5996094,0.79992676,5.0,131.0,7.359375,135.0,23.0,2502.0,1.0,<2 mo. follow-up
53.33298,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,57244.219,36879.25,33.0,white,26.0,4,0,0,no,0.299999952,0.2,no dnr,10.0,70.0,6.0,130.0,18.0,38.29688,93.32812,3.5,1.01,0.79992676,135.0,7.389648,135.0,23.0,2502.0,7.0,<2 mo. follow-up
56.04898,1,male,0,38,742,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,67626.438,44162.25,26.0,white,52.0,2,0,0,yes,0.699999809,0.5,no dnr,38.0,95.0,0.79992676,136.0,9.0,38.29688,185.0,3.5,1.01,2.59960938,144.0,7.299805,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
54.92099,0,male,0,148,1518,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,244624.625,159445.375,26.5,white,87.0,1,0,0,no,0.699999809,0.5,no dnr,148.0,77.0,11.0,70.0,38.0,36.09375,312.0,1.7998047,9.59960938,9.19921875,132.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.29898,1,male,0,14,67,Lung Cancer,Cancer,1,14.0,$25-$50k,16175.344,10839.3125,13.5,white,9.0,1,0,0,metastatic,1.0,0.8,no dnr,14.0,95.0,10.7988281,76.0,16.0,36.89844,333.3,3.5,0.5,0.79992676,138.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
53.03198,0,male,0,261,1517,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,59995.78781114967,14452.7344,20.5,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,261.0,67.0,7.89941406,112.0,15.0,35.59375,428.5625,3.5,0.79992676,1.09985352,134.0,7.509766,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
61.55499,1,male,0,15,770,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,$25-$50k,35619.375,21743.2031,23.666656,white,53.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,172.0,6.5,136.0,47.0,35.59375,233.3125,1.8999023,0.39996338,1.39990234,141.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
77.659,1,male,1,12,12,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,37074.156,21822.0469,31.0,white,42.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,63.0,7.19921875,106.0,15.0,35.69531,167.5,3.5,1.01,2.69970703,128.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.18597,1,male,0,29,99,Lung Cancer,Cancer,2,13.0,$25-$50k,32881.094,22047.1562,10.5,white,11.0,1,0,0,metastatic,0.5,0.3,no dnr,29.0,83.0,13.0996094,80.0,20.0,37.5,333.3,3.5,0.19998169,0.69995117,134.0,7.419922,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
63.83298,1,male,0,6,930,Colon Cancer,Cancer,1,16.0,>$50k,5728.848,3659.584,8.0,white,9.0,1,0,0,metastatic,0.899999619,0.7,no dnr,6.0,99.0,4.5,76.0,22.0,36.69531,333.3,3.0996094,1.01,1.0,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
43.58698,1,female,0,35,362,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,116817.688,74611.0,28.25,white,39.0,19,0,0,metastatic,0.849999905,0.8,no dnr,35.0,114.0,15.8984375,134.0,10.0,38.5,140.0,2.7998047,5.5,0.79992676,142.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
89.23199,1,male,0,18,201,COPD,COPD/CHF/Cirrhosis,3,4.0,under $11k,33702.719,21365.2656,25.0,black,49.0,1,0,0,no,0.049999982,0.000125,no dnr,18.0,63.0,5.69921875,130.0,6.0,37.0,117.76562,3.5,1.01,1.79980469,146.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.98499,1,female,0,8,87,Colon Cancer,Cancer,1,16.0,>$50k,7079.297,5065.1289,6.0,white,27.0,1,0,0,metastatic,0.399999857,0.2,no dnr,8.0,122.0,31.0976562,76.0,28.0,35.79688,333.3,2.699707,0.09999084,0.59997559,137.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.62396,1,male,0,13,64,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,under $11k,43053.844,26501.4375,20.5,black,18.0,13,0,0,metastatic,0.799999714,0.8,dnr after sadm,8.0,75.0,10.0,130.0,24.0,36.5,333.3,3.5,1.01,0.79992676,139.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
23.19199,1,male,0,11,82,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,24461.188,16495.3906,27.5,black,34.0,1,0,0,no,0.989999771,0.98,no dnr,11.0,122.0,15.1992188,114.0,41.0,37.69531,220.0,3.5,1.01,0.19998169,136.0,7.589844,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
60.646,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,79154.938,46919.625,53.0,white,48.0,13,0,0,no,0.699999809,0.5,dnr after sadm,4.0,61.0,16.5976562,124.0,8.0,36.0,160.0,2.5,3.09960938,5.39941406,131.0,7.369141,135.0,23.0,2502.0,3.0366211,<2 mo. follow-up
44.05197,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,121420.875,92187.5,51.0,white,68.0,6,0,0,no,0.699999809,0.5,no dnr,5.0,51.0,9.8984375,60.0,31.0,40.09375,283.3125,3.2998047,12.0,3.0,133.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.14899,1,female,1,4,4,Coma,Coma,1,7.0,under $11k,83997.625,51037.4375,14.0,white,43.0,20,1,0,no,0.699999809,0.5,dnr after sadm,2.0,70.0,16.5976562,64.0,28.0,38.5,220.0,2.5,1.09985352,2.69970703,135.0,7.579102,135.0,23.0,2502.0,2.46875,<2 mo. follow-up
69.66498,0,female,0,9,1510,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,4562.496,3465.2734,10.0,white,34.0,1,0,0,no,0.75,0.65,no dnr,9.0,107.0,9.59960938,84.0,22.0,36.39844,214.28125,3.3999023,0.29998779,1.59985352,136.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
65.47296,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,87248.375,54247.8438,23.0,white,86.0,21,0,0,no,0.699999809,0.5,dnr after sadm,2.0,0.0,11.8984375,0.0,0.0,38.09375,248.0,4.0996094,4.5,2.59960938,135.0,7.459961,135.0,23.0,2502.0,1.7382812,<2 mo. follow-up
68.18097,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,40095.0,26610.0,37.5,white,55.0,1,0,0,yes,0.25,0.15,dnr after sadm,7.0,69.0,29.5976562,122.0,34.0,36.79688,72.0,1.3999023,1.01,0.69995117,139.0,7.539062,135.0,23.0,2502.0,2.1450195,<2 mo. follow-up
75.15399,1,male,0,9,1421,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,6329.598,4483.8203,13.0,white,13.0,1,0,0,no,0.899999619,0.6,no dnr,9.0,107.0,5.5,108.0,24.0,36.0,364.0,4.2998047,0.39996338,0.89990234,144.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.42395,0,female,0,13,1500,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,9626.047,7334.457,7.5,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,77.0,3.59960938,80.0,20.0,37.0,333.3,2.8999023,3.5,0.69995117,124.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.79095,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,26893.812,17477.2656,46.0,white,49.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,68.0,22.296875,112.0,8.0,38.79688,151.65625,3.5,0.09999084,7.29980469,128.0,7.40918,135.0,23.0,2502.0,2.4125977,<2 mo. follow-up
66.146,1,male,1,12,12,MOSF w/Malig,ARF/MOSF,2,7.0,under $11k,71331.938,46761.8438,55.5,black,79.0,6,1,0,yes,0.699999809,0.5,dnr after sadm,5.0,53.0,1.0,160.0,40.0,36.5,313.3125,3.0,1.09985352,5.29980469,134.0,7.349609,135.0,23.0,2502.0,2.0,<2 mo. follow-up
74.89697,0,male,0,10,1499,CHF,COPD/CHF/Cirrhosis,1,18.0,$11-$25k,23341.547,16540.5312,20.0,white,36.0,8,0,0,no,0.979999542,0.95,no dnr,10.0,75.0,14.3984375,96.0,12.0,36.59375,288.0,2.8999023,1.19995117,1.59985352,131.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.241,0,female,0,9,1497,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59781.688,37313.0,16.5,white,25.0,15,0,0,yes,0.799999714,0.7,no dnr,9.0,108.0,7.0,46.0,16.0,36.19531,396.0,1.2998047,0.29998779,0.59997559,129.0,7.449219,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
51.85498,0,female,0,14,1497,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,24805.141,16157.6328,14.0,white,14.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,76.0,8.5,114.0,24.0,36.19531,328.0,3.5,1.01,0.5,137.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
43.63898,0,male,0,18,1496,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,45775.469,28687.6094,18.666656,white,16.0,1,0,0,no,0.699999809,0.5,no dnr,18.0,78.0,7.0,56.0,24.0,36.0,352.375,2.8999023,2.09960938,0.79992676,139.0,7.419922,135.0,23.0,2502.0,2.1977539,<2 mo. follow-up
40.41898,1,female,1,99,99,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,363470.25,238485.375,34.75,white,53.0,1,0,0,no,0.199999928,0.2,no dnr,99.0,69.0,14.0,114.0,26.0,37.79688,126.65625,3.5,1.19995117,3.39990234,149.0,7.469727,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
33.66998,1,male,0,10,22,Colon Cancer,Cancer,1,14.0,under $11k,9953.547,6871.8125,9.5,black,9.0,1,0,0,metastatic,0.199999928,0.1,no dnr,10.0,107.0,17.1992188,84.0,24.0,36.29688,333.3,2.699707,0.79992676,0.79992676,137.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
75.66595,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$25-$50k,60396.969,37721.1875,48.0,white,33.0,1,0,0,no,0.699999809,0.5,dnr after sadm,13.0,71.0,8.5,64.0,40.0,38.59375,194.28125,2.199707,1.01,0.59997559,138.0,7.369141,135.0,23.0,2502.0,4.0,<2 mo. follow-up
44.85999,1,male,0,9,26,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,27579.141,17868.6094,39.0,black,43.0,2,0,0,no,0.699999809,0.5,no dnr,9.0,141.0,11.5996094,116.0,60.0,35.39844,447.5625,3.5,1.01,0.39996338,130.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
51.90097,1,male,0,6,517,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,12283.992,7625.2305,27.0,black,23.0,1,0,0,no,0.699999809,0.6,no dnr,6.0,65.0,7.19921875,64.0,26.0,36.29688,385.6875,3.199707,1.69995117,1.0,126.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.06799,1,male,1,36,36,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,238776.0,149039.25,39.0,white,51.0,9,0,0,no,0.25,0.2,no dnr,36.0,120.0,19.296875,110.0,25.0,38.29688,303.3125,2.7998047,5.59960938,7.0,138.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
30.70499,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,71635.188,48012.9375,50.333313,other,60.0,1,0,0,no,0.099999964,0.001,dnr after sadm,15.0,70.0,13.6992188,156.0,36.0,41.0,125.0,2.8999023,1.29980469,1.59985352,145.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.57498,1,male,0,4,78,Lung Cancer,Cancer,1,12.0,under $11k,3042.049,2174.0625,7.0,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,115.0,12.1992188,84.0,20.0,36.89844,333.3,3.5,0.79992676,1.09985352,139.0,7.419922,135.0,23.0,2502.0,1.9589844,adl>=4 (>=5 if sur)
59.69598,0,male,0,4,1488,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,2390.049,1955.835,3.0,black,32.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,87.0,5.5,110.0,20.0,35.69531,433.3125,3.5,4.19921875,1.39990234,129.0,7.519531,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
65.62598,1,male,0,18,626,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,53957.688,33482.8438,32.0,black,22.0,1,0,0,no,0.699999809,0.5,no dnr,18.0,109.0,11.7988281,60.0,10.0,36.79688,142.0,3.5,1.01,1.29980469,128.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
62.30298,1,male,0,11,758,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,24865.984,15584.4922,22.0,white,31.0,1,0,0,no,0.599999905,0.5,no dnr,11.0,67.0,9.0,108.0,16.0,37.0,312.0,3.5,0.5,2.19970703,136.0,7.40918,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
48.72299,0,female,0,32,1488,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,115659.5,75410.1875,35.25,black,53.0,1,1,0,no,0.25,0.2,no dnr,32.0,55.0,4.09960938,130.0,14.0,39.79688,288.0,2.7998047,0.19998169,10.0,145.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
79.80798,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,>$50k,30417.844,21071.0312,42.0,white,40.0,1,1,0,yes,0.5,0.25,dnr after sadm,3.0,64.0,13.3984375,50.0,6.0,37.5,310.0,2.5,1.01,5.09960938,133.0,7.359375,135.0,23.0,2502.0,7.0,<2 mo. follow-up
55.64999,1,female,0,37,777,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,92960.125,59123.4375,31.5,white,43.0,1,1,0,no,0.799999714,0.78,no dnr,37.0,63.0,17.296875,110.0,24.0,38.0,253.3125,3.5,0.39996338,4.59960938,143.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.57397,0,female,0,15,1487,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,34929.969,22198.3594,12.333328,black,17.0,3,0,0,no,0.989999771,0.99,no dnr,15.0,80.0,12.6992188,104.0,40.0,38.59375,316.625,3.5,1.01,0.59997559,128.0,7.429688,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
52.16199,1,male,0,5,284,Lung Cancer,Cancer,1,12.0,$25-$50k,4945.75,3090.332,17.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,107.0,10.0,75.0,16.0,35.79688,333.3,3.5,0.39996338,0.89990234,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.52795,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,44709.406,26464.9844,37.0,white,44.0,6,1,0,no,0.199999928,0.1,dnr after sadm,3.0,51.0,9.5,114.0,30.0,39.09375,162.5,3.5,1.01,1.19995117,154.0,7.339844,135.0,23.0,2502.0,2.0,<2 mo. follow-up
61.37399,1,male,0,4,40,Colon Cancer,Cancer,1,12.0,$25-$50k,3351.299,2423.291,4.0,white,13.0,1,0,0,metastatic,0.399999857,0.3,no dnr,4.0,83.0,14.0996094,75.0,16.0,35.69531,342.8125,3.5,1.69995117,0.59997559,140.0,7.489258,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.52698,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,82417.812,52280.0625,50.666657,white,42.0,1,0,0,yes,0.5,0.3,dnr after sadm,8.0,50.0,8.69921875,110.0,25.0,35.69531,111.65625,2.699707,0.29998779,1.09985352,141.0,7.339844,135.0,23.0,2502.0,1.0,<2 mo. follow-up
59.60599,0,male,0,75,1483,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,142387.875,93420.625,27.0,white,18.0,3,1,0,no,0.899999619,0.9,no dnr,75.0,110.0,13.7988281,96.0,8.0,38.19531,316.625,2.7998047,4.29980469,1.29980469,142.0,7.439453,135.0,23.0,2502.0,7.0,SIP>=30
54.92999,1,female,0,6,472,Lung Cancer,Cancer,1,12.0,$11-$25k,7007.297,4616.1367,7.0,white,9.0,1,0,0,metastatic,0.899999619,0.8,no dnr,6.0,87.0,5.79980469,80.0,20.0,36.5,333.3,3.2998047,0.09999084,0.5,143.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
30.07799,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,209604.625,147492.5,57.0,white,74.0,11,0,0,no,0.0,0.0,no dnr,6.0,129.0,6.89941406,70.0,45.0,35.39844,283.3125,4.8994141,44.09375,4.79980469,151.0,7.469727,135.0,23.0,2502.0,2.2128906,<2 mo. follow-up
71.83795,1,male,0,6,264,Lung Cancer,Cancer,4,11.0,$11-$25k,4572.348,3001.1348,9.0,white,26.0,1,1,0,metastatic,0.899999619,0.5,no dnr,6.0,99.0,5.59960938,96.0,24.0,36.79688,333.3,3.3999023,8.79882812,0.79992676,139.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
83.21997,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,118611.438,71038.4375,33.0,white,75.0,16,0,0,no,0.699999809,0.5,dnr after sadm,2.0,28.0,11.3984375,70.0,24.0,38.5,184.0,3.5,27.0,5.39941406,152.0,7.379883,135.0,23.0,2502.0,2.2944336,<2 mo. follow-up
69.60999,1,male,0,10,174,CHF,COPD/CHF/Cirrhosis,2,3.0,under $11k,10542.648,7303.0156,25.5,other,23.0,1,1,0,no,0.699999809,0.5,no dnr,10.0,80.0,6.89941406,60.0,24.0,36.59375,333.3,3.5,1.01,2.0,143.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
65.65399,0,female,0,17,1478,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,76424.625,45303.5,25.666656,white,39.0,5,0,0,no,0.5,0.45,no dnr,17.0,133.0,10.1992188,11.398438,36.0,38.79688,137.5,3.5,1.01,0.79992676,136.0,7.509766,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
72.797,0,female,0,76,1478,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,168419.875,104400.125,39.5,white,64.0,1,0,0,no,0.5,0.5,dnr after sadm,7.0,66.0,4.69921875,130.0,10.0,35.89844,260.0,1.8999023,12.8984375,1.39990234,149.0,7.449219,135.0,23.0,2502.0,2.0439453,adl>=4 (>=5 if sur)
77.46198,1,male,0,77,107,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,237865.75,151713.375,41.25,white,51.0,32,0,0,no,0.299999952,0.2,dnr after sadm,38.0,117.0,22.1992188,118.0,10.0,35.39844,230.0,1.5998535,0.5,3.59960938,149.0,7.489258,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
71.06097,0,female,0,10,1460,COPD,COPD/CHF/Cirrhosis,1,15.0,under $11k,10342.977,7143.0,13.5,white,25.0,1,0,0,no,0.699999809,0.6,no dnr,10.0,90.0,10.6992188,126.0,28.0,38.0,200.0,3.5,1.01,0.89990234,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.73395,0,female,0,8,1458,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,16283.492,10915.9531,16.0,white,25.0,2,0,0,no,0.699999809,0.5,no dnr,8.0,97.0,3.79980469,110.0,25.0,38.29688,126.51562,3.5,1.01,0.89990234,139.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
40.92499,1,female,0,19,113,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,53731.688,33714.9375,29.333328,white,31.0,5,0,0,yes,0.699999809,0.5,no dnr,19.0,63.0,11.6992188,120.0,14.0,36.09375,74.28125,3.5,0.69995117,0.59997559,143.0,7.509766,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
61.74399,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,26100.234,16942.4375,27.5,white,28.0,1,0,0,no,0.699999809,0.5,dnr after sadm,6.0,137.0,12.5996094,60.0,10.0,35.0,230.0,2.0996094,0.09999084,0.79992676,147.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.405,1,female,0,5,784,Lung Cancer,Cancer,1,16.0,$25-$50k,5310.949,3328.5,9.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,120.0,20.5976562,86.0,20.0,36.19531,333.3,3.5,0.29998779,1.09985352,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
25.00999,0,male,0,116,1455,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,14452.7344,19.25,black,23.0,2,0,0,no,0.699999809,0.5,no dnr,116.0,69.0,12.2988281,104.0,11.0,36.19531,352.0,2.3999023,4.0,1.19995117,137.0,7.359375,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
46.702,0,female,0,16,1454,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,>$50k,61325.469,36784.6875,25.0,white,19.0,3,0,0,no,0.799999714,0.75,no dnr,16.0,73.0,11.1992188,74.0,24.0,38.29688,177.5,2.3999023,1.01,1.29980469,136.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.98999,1,female,0,24,224,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,40662.344,26147.1562,20.0,white,26.0,1,0,0,yes,0.799999714,0.3,no dnr,24.0,65.0,9.0,96.0,8.0,36.29688,326.625,3.5,1.01,1.59985352,139.0,7.369141,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
80.45197,1,female,1,19,19,Colon Cancer,Cancer,1,16.0,under $11k,9865.195,7908.918,8.333328,white,33.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,6.0,89.0,13.8984375,86.0,20.0,36.39844,333.3,2.5,11.1992188,1.19995117,140.0,7.419922,135.0,23.0,2502.0,3.1020508,<2 mo. follow-up
50.88599,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,45795.031,27621.7188,49.5,white,40.0,1,0,0,yes,0.199999928,0.2,no dnr,10.0,67.0,6.5,134.0,30.0,38.5,98.65625,2.199707,0.39996338,0.79992676,141.0,7.389648,135.0,23.0,2502.0,2.1328125,<2 mo. follow-up
68.39996,1,male,0,28,1346,MOSF w/Malig,ARF/MOSF,1,7.0,under $11k,76318.688,50595.25,31.5,black,56.0,7,0,0,yes,0.5,0.5,no dnr,28.0,121.0,3.39990234,140.0,8.0,39.79688,167.5,1.5,0.5,2.19970703,148.0,7.529297,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
59.35898,1,male,0,11,499,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,19767.641,13664.2031,20.5,white,18.0,1,0,0,no,0.699999809,0.7,no dnr,11.0,113.0,13.5,110.0,24.0,36.5,220.0,3.199707,0.09999084,0.69995117,147.0,7.399414,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
30.33299,1,female,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,191009.625,119011.625,37.5,white,35.0,1,0,0,no,0.299999952,0.3,dnr after sadm,42.0,113.0,11.5996094,130.0,28.0,39.0,132.71875,2.0,0.19998169,0.59997559,143.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.82996,1,male,0,62,724,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,213969.625,141854.0,39.0,white,45.0,1,0,0,no,0.699999809,0.5,no dnr,62.0,145.0,5.59960938,186.0,8.0,38.0,91.0,3.5,0.89990234,0.69995117,142.0,7.369141,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
68.75,1,female,1,10,10,Coma,Coma,2,8.0,>$50k,36883.469,23581.6719,36.5,black,44.0,1,1,0,no,0.099999964,0.001,dnr after sadm,9.0,70.0,14.5,108.0,8.0,36.19531,423.3125,1.1999512,0.29998779,3.0,134.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
83.79999,1,male,0,12,598,Lung Cancer,Cancer,2,16.0,under $11k,6363.598,5015.9961,4.0,white,17.0,1,0,0,metastatic,0.75,0.5,no dnr,12.0,99.0,5.89941406,80.0,16.0,36.19531,333.3,3.199707,0.5,1.19995117,145.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.698,1,male,0,7,247,Colon Cancer,Cancer,1,12.0,$11-$25k,8570.148,5568.0586,9.0,white,6.0,1,0,0,metastatic,0.799999714,0.5,no dnr,7.0,119.0,8.8984375,60.0,24.0,36.29688,333.3,3.8999023,0.59997559,0.89990234,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
29.30299,1,female,0,48,336,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,78111.062,49858.8438,20.0,white,53.0,1,0,0,yes,0.199999928,0.2,no dnr,48.0,56.0,1.09985352,134.0,38.0,39.29688,414.25,2.2998047,5.89941406,0.89990234,135.0,7.419922,135.0,23.0,2502.0,3.0,SIP>=30
74.89697,1,male,1,100,100,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,202651.25,132608.375,26.0,white,47.0,3,1,0,no,0.849999905,0.82,no dnr,100.0,103.0,14.5,55.0,32.0,38.5,108.15625,3.5,1.01,2.89990234,134.0,7.459961,135.0,23.0,2502.0,3.3496094,<2 mo. follow-up
60.44098,1,male,0,18,95,Cirrhosis,COPD/CHF/Cirrhosis,1,18.0,>$50k,16636.344,11546.3203,11.666664,white,43.0,1,0,0,no,0.5,0.3,dnr after sadm,14.0,63.0,7.0,74.0,22.0,36.19531,542.75,2.8999023,1.29980469,3.79980469,132.0,7.269531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
37.06198,1,female,0,48,436,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,217273.625,136385.0,49.5,white,65.0,3,0,0,yes,0.399999857,0.4,dnr after sadm,14.0,73.0,0.29998779,144.0,32.0,39.29688,206.65625,1.6999512,0.39996338,1.0,154.0,7.379883,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
85.40997,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19168.188,12807.8047,19.0,black,64.0,8,0,0,no,0.199999928,0.2,dnr after sadm,4.0,70.0,42.6953125,120.0,48.0,33.89844,112.23438,3.5,1.69995117,0.79992676,139.0,7.529297,135.0,23.0,2502.0,1.0,<2 mo. follow-up
35.71799,1,female,1,22,22,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,239604.75,152206.5,22.333328,white,60.0,45,0,0,metastatic,0.599999905,0.5,dnr after sadm,5.0,59.0,14.2988281,144.0,9.0,36.79688,286.625,2.2998047,1.01,5.5,134.0,7.289062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.65097,1,male,0,5,274,Lung Cancer,Cancer,1,8.0,under $11k,6005.699,3721.2285,22.0,white,10.0,1,0,0,metastatic,0.799999714,0.2,no dnr,5.0,83.0,15.5996094,108.0,16.0,36.19531,333.3,3.0,0.29998779,0.89990234,135.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
57.34399,0,female,0,5,1441,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,4947.398,3368.4941,6.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,70.0,3.89990234,74.0,20.0,36.79688,333.3,2.5,2.5,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.05499,0,female,0,47,1441,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,under $11k,60292.469,38939.5625,20.0,black,42.0,3,0,0,no,0.799999714,0.6,no dnr,47.0,87.0,9.5,114.0,28.0,37.79688,452.375,2.199707,1.09985352,2.0,141.0,7.439453,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
52.38599,1,male,0,12,59,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,64889.688,38822.0312,30.5,black,43.0,6,1,0,no,0.699999809,0.5,no dnr,12.0,65.0,11.7988281,106.0,8.0,37.39844,110.0,3.5,1.01,2.89990234,136.0,7.389648,135.0,23.0,2502.0,2.3422852,<2 mo. follow-up
19.92599,0,male,0,13,1438,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,17898.344,11910.3516,19.0,white,32.0,1,0,0,no,0.5,0.5,dnr after sadm,2.0,125.0,9.19921875,136.0,44.0,38.69531,376.1875,3.5,1.01,0.69995117,144.0,7.469727,135.0,23.0,2502.0,7.0,<2 mo. follow-up
57.72998,1,male,1,13,13,Coma,Coma,2,3.0,under $11k,125777.25,86312.9375,50.0,black,50.0,18,1,0,no,0.699999809,0.5,dnr after sadm,12.0,107.0,7.09960938,136.0,8.0,35.89844,266.625,3.0996094,7.0,4.69921875,135.0,7.469727,135.0,23.0,2502.0,2.9760742,<2 mo. follow-up
73.13898,0,female,0,52,1439,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,140687.375,90904.1875,30.0,white,32.0,14,1,0,no,0.799999714,0.8,no dnr,52.0,107.0,12.5996094,116.0,10.0,38.69531,260.0,2.3999023,0.69995117,1.79980469,146.0,7.40918,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
43.90399,0,male,0,14,1437,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,>$50k,63622.125,38628.3125,40.333313,white,20.0,3,0,0,no,0.699999809,0.5,no dnr,14.0,111.0,13.1992188,68.0,10.0,38.29688,172.5,3.5,4.39941406,1.0,134.0,7.399414,135.0,23.0,2502.0,1.9741211,no(M2 and SIP pres)
25.67,1,male,0,5,229,Colon Cancer,Cancer,1,16.0,under $11k,3895.0,2701.5801,8.0,white,19.0,1,0,0,metastatic,0.5,0.3,no dnr,5.0,81.0,3.69970703,20.0,20.0,36.5,333.3,2.2998047,0.29998779,0.89990234,139.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
80.13696,1,female,0,30,621,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$25-$50k,54550.188,36936.5938,16.5,white,31.0,5,0,0,no,0.699999809,0.5,no dnr,30.0,111.0,6.19921875,56.0,26.0,36.0,157.5,3.5,1.01,0.79992676,140.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
70.57898,1,male,0,81,617,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,176328.0,110634.125,19.5,white,30.0,11,0,0,no,0.799999714,0.7,no dnr,81.0,129.0,4.79980469,68.0,9.0,36.69531,142.0,2.0,1.59985352,0.89990234,132.0,7.519531,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
86.35999,1,female,0,9,741,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,7843.297,5713.1523,11.0,white,34.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,61.0,6.39941406,56.0,16.0,35.69531,442.8125,3.5,1.01,1.09985352,134.0,7.469727,135.0,23.0,2502.0,3.5561523,<2 mo. follow-up
40.74698,1,male,0,9,46,Cirrhosis,COPD/CHF/Cirrhosis,3,7.0,$11-$25k,10535.398,6943.8008,9.0,white,26.0,1,1,0,no,0.75,0.75,no dnr,9.0,103.0,4.39941406,100.0,20.0,36.79688,333.3,2.5,1.5,1.5,127.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
54.86398,0,male,0,14,1434,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,16353.844,10914.2969,11.666664,white,37.0,1,0,0,no,0.699999809,0.5,dnr after sadm,9.0,83.0,8.19921875,106.0,24.0,36.19531,347.5625,2.0,11.1992188,0.89990234,130.0,7.529297,135.0,23.0,2502.0,2.0,<2 mo. follow-up
60.46799,1,male,1,5,5,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,15643.797,10127.2734,35.0,white,40.0,1,0,0,no,0.0,0.0,dnr after sadm,4.0,115.0,13.0,139.0,32.0,37.69531,256.625,1.2998047,0.29998779,1.39990234,138.0,7.349609,135.0,23.0,2502.0,3.4399414,<2 mo. follow-up
57.49799,1,female,0,9,74,Colon Cancer,Cancer,1,9.0,under $11k,7245.699,5296.6523,9.5,white,14.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,4.0,83.0,5.29980469,94.0,20.0,36.19531,333.3,2.0996094,0.19998169,0.39996338,136.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
68.45197,1,female,0,11,356,Colon Cancer,Cancer,1,12.0,under $11k,18796.734,12338.3828,9.5,white,27.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,75.0,2.79980469,60.0,10.0,38.29688,358.3125,3.3999023,1.01,0.69995117,134.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
39.67697,1,male,0,14,69,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,14717.844,10088.6016,7.0,black,45.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,88.0,6.19921875,106.0,28.0,37.69531,285.6875,1.5998535,5.39941406,1.0,133.0,7.449219,135.0,23.0,2502.0,7.0,SIP>=30
60.81897,1,male,0,12,194,CHF,COPD/CHF/Cirrhosis,2,5.0,under $11k,25250.438,15713.0938,22.0,other,31.0,2,0,0,no,0.5,0.2,no dnr,12.0,113.0,9.3984375,64.0,22.0,36.79688,300.0,1.7998047,0.69995117,1.69995117,130.0,7.439453,135.0,23.0,2502.0,6.0,SIP>=30
66.70795,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,125133.938,77324.25,50.0,white,76.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,22.0,56.0,15.1992188,124.0,46.0,38.29688,116.0,2.699707,0.29998779,9.59960938,138.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.43298,1,female,0,28,197,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,38696.375,27296.1406,17.75,white,29.0,3,0,0,no,0.699999809,0.5,no dnr,28.0,115.0,10.2988281,66.0,6.0,38.39844,428.5625,3.5,1.01,6.89941406,136.0,7.379883,135.0,23.0,2502.0,1.0,<2 mo. follow-up
47.21997,1,male,1,12,12,Coma,Coma,1,12.0,under $11k,30785.938,21102.9844,31.0,black,47.0,2,0,0,no,0.009999998,1e-06,dnr after sadm,7.0,150.0,7.09960938,70.0,10.0,38.69531,388.0,1.7998047,0.79992676,5.29980469,145.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
43.05798,0,female,0,15,1430,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$25-$50k,56844.312,36040.0625,21.333328,hispanic,44.0,11,0,0,no,0.75,0.75,no dnr,15.0,118.0,20.796875,104.0,52.0,37.79688,200.0,2.2998047,7.45996094,1.19995117,137.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
88.94495,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,54263.375,32871.2812,36.666657,white,31.0,1,0,0,no,0.799999714,0.6,dnr after sadm,12.0,107.0,6.79980469,124.0,28.0,38.5,290.0,2.7998047,1.01,0.89990234,142.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.31598,1,female,0,12,147,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,18113.938,13517.5469,10.5,black,38.0,1,0,0,no,0.599999905,0.8,no dnr,12.0,117.0,24.0,104.0,32.0,36.39844,300.0,2.2998047,0.39996338,1.39990234,141.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
90.95996,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,18570.594,12917.6016,31.0,white,65.0,8,0,0,no,0.299999952,0.3,dnr after sadm,1.0,107.0,8.3984375,154.0,54.0,36.19531,105.70312,3.5,1.01,0.69995117,151.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
84.17798,1,male,0,4,225,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3358.498,2412.7949,9.0,white,53.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,93.0,29.0,120.0,28.0,36.19531,204.75,3.5,0.39996338,1.79980469,143.0,7.339844,135.0,23.0,2502.0,4.3662109,no(M2 and SIP pres)
66.00696,1,male,0,4,349,Cirrhosis,COPD/CHF/Cirrhosis,1,5.0,under $11k,3166.85,2237.1016,1.0,black,35.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,100.0,7.59960938,60.0,28.0,35.69531,333.3,2.199707,3.39990234,0.79992676,136.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
78.05896,1,female,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,171969.5,105160.625,34.25,black,68.0,11,1,0,yes,0.25,0.15,dnr after sadm,20.0,50.0,23.0,100.0,32.0,38.0,131.09375,3.2998047,2.89990234,6.19921875,136.0,7.5,135.0,23.0,2502.0,3.1533203,<2 mo. follow-up
85.06195,1,female,0,6,42,CHF,COPD/CHF/Cirrhosis,0,12.0,under $11k,4003.299,2980.1953,4.0,white,31.0,1,0,0,no,0.5,0.45,dnr after sadm,3.0,107.0,8.0,52.0,36.0,35.39844,333.3,3.0996094,0.79992676,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
45.89499,1,male,0,8,377,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,18237.391,13212.0156,9.5,white,17.0,2,0,0,no,0.699999809,0.5,no dnr,8.0,75.0,7.89941406,76.0,16.0,35.79688,272.0,3.5,1.01,0.69995117,134.0,7.479492,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
36.64899,1,female,0,5,244,Lung Cancer,Cancer,1,14.0,$11-$25k,5317.398,3209.3789,11.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,70.0,8.0,104.0,20.0,36.79688,333.3,3.5,0.09999084,0.69995117,136.0,7.419922,135.0,23.0,2502.0,1.9953613,no(M2 and SIP pres)
57.81799,1,male,0,5,113,Lung Cancer,Cancer,1,14.0,$25-$50k,5601.098,3373.2715,18.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,104.0,11.2988281,120.0,20.0,36.09375,333.3,3.5,0.19998169,0.79992676,141.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
53.66998,0,male,0,13,1422,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,18630.891,12266.3672,16.0,white,20.0,1,0,0,no,0.989999771,0.95,no dnr,13.0,77.0,16.3984375,72.0,24.0,35.5,240.0,3.5,1.01,1.19995117,141.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.76196,1,female,0,26,137,Colon Cancer,Cancer,2,6.0,under $11k,20179.938,14588.6016,12.5,white,38.0,1,0,0,metastatic,0.5,0.4,no dnr,26.0,130.0,10.2988281,120.0,32.0,40.09375,423.75,3.2998047,0.29998779,0.79992676,143.0,7.489258,135.0,23.0,2502.0,1.0,SIP>=30
60.38898,0,male,0,25,1422,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,61711.688,42741.7188,15.0,white,20.0,4,0,0,no,0.899999619,0.9,no dnr,25.0,125.0,18.5976562,124.0,9.0,39.0,348.0,2.699707,1.01,0.89990234,141.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.01599,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,101109.75,64730.2812,47.0,white,69.0,2,1,0,no,0.049999982,0.000125,dnr after sadm,18.0,54.0,12.0,116.0,10.0,38.5,182.84375,2.199707,7.5,4.19921875,133.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.573,1,male,0,17,807,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,33095.094,20809.25,22.0,black,38.0,1,0,0,no,0.799999714,0.7,no dnr,17.0,80.0,7.29980469,164.0,25.0,36.19531,352.8125,3.5,0.59997559,1.0,137.0,7.599609,135.0,23.0,2502.0,3.4301758,<2 mo. follow-up
61.81799,1,male,0,7,762,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,16462.984,11815.6094,14.0,white,35.0,1,0,0,no,0.75,0.75,no dnr,7.0,123.0,16.796875,134.0,28.0,36.29688,195.90625,3.5,0.09999084,1.09985352,134.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.63898,0,female,0,20,1422,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,46942.281,31829.9219,27.666656,white,33.0,1,0,0,no,0.699999809,0.5,no dnr,20.0,61.0,8.19921875,104.0,12.0,36.19531,236.65625,3.5,0.59997559,2.29980469,142.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.78296,1,female,1,8,8,Coma,Coma,0,12.0,under $11k,16429.391,10578.7656,22.5,black,31.0,1,0,0,no,0.099999964,0.001,no dnr,8.0,119.0,21.5976562,104.0,30.0,37.89844,316.625,4.2998047,1.01,0.69995117,142.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.92499,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,14077.844,9115.2031,37.0,black,57.0,1,0,0,no,0.099999964,0.001,no dnr,4.0,60.0,16.0976562,114.0,27.0,38.5,292.0,3.5,2.89990234,8.59960938,128.0,7.399414,135.0,23.0,2502.0,2.2626953,<2 mo. follow-up
65.19897,1,female,0,26,244,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,78598.625,50603.0312,23.25,white,47.0,13,0,0,no,0.699999809,0.5,no dnr,26.0,55.0,27.6992188,124.0,24.0,37.89844,140.0,1.8999023,1.09985352,0.69995117,146.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.99896,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,110167.938,70867.0,41.0,white,52.0,14,0,0,no,0.5,0.5,dnr after sadm,22.0,65.0,10.7988281,136.0,28.0,39.09375,60.0,1.5,1.0,0.5,133.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.849,1,male,0,27,105,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,73245.688,49878.3125,23.5,black,50.0,1,0,1,metastatic,0.399999857,0.4,no dnr,27.0,79.0,9.5,156.0,40.0,37.59375,217.84375,2.5,0.29998779,1.0,139.0,7.439453,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
60.41898,1,male,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,>$50k,316291.0,198929.125,35.0,white,17.0,80,0,0,no,0.699999809,0.5,dnr after sadm,37.0,89.0,18.0,100.0,7.0,38.59375,276.625,3.5,0.09999084,1.59985352,129.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.93198,1,male,0,9,258,Lung Cancer,Cancer,1,10.0,under $11k,59995.78781114967,14452.7344,10.5,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,110.0,2.5,104.0,32.0,37.5,333.3,3.8999023,0.09999084,0.69995117,142.0,7.419922,135.0,23.0,2502.0,5.0,SIP>=30
81.81799,1,female,0,7,17,Colon Cancer,Cancer,1,18.0,under $11k,5206.25,3978.8965,8.0,white,22.0,1,0,0,metastatic,0.5,0.1,no dnr,7.0,115.0,9.59960938,74.0,22.0,35.79688,333.3,2.5996094,0.69995117,0.89990234,144.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
61.133,1,male,0,12,213,Lung Cancer,Cancer,1,16.0,$25-$50k,14348.945,9699.9844,14.5,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,107.0,9.19921875,64.0,10.0,36.5,371.375,2.7998047,1.39990234,1.0,136.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.58197,1,female,0,22,84,Lung Cancer,Cancer,1,9.0,under $11k,19568.297,14059.5469,7.666664,white,19.0,1,0,0,metastatic,0.599999905,0.2,no dnr,22.0,78.0,8.29882812,116.0,20.0,36.59375,333.3,3.5,0.39996338,0.59997559,133.0,7.419922,135.0,23.0,2502.0,4.5273972,no(M2 and SIP pres)
76.98798,1,male,0,37,92,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,103783.375,69377.75,28.25,white,52.0,4,0,0,yes,0.5,0.5,no dnr,37.0,110.0,18.6992188,140.0,40.0,38.39844,144.875,2.5,1.0,1.89990234,150.0,7.429688,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
74.89697,1,female,0,9,167,COPD,COPD/CHF/Cirrhosis,4,9.0,$11-$25k,12089.344,7884.4219,10.5,white,32.0,1,0,0,no,0.799999714,0.75,no dnr,9.0,105.0,13.7988281,120.0,28.0,36.29688,311.0625,3.5,1.01,1.09985352,138.0,7.40918,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
73.20197,0,female,0,19,1415,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,38421.125,26814.0312,18.333328,white,51.0,1,1,0,no,0.099999964,0.001,no dnr,19.0,141.0,7.69921875,50.0,8.0,36.5,248.0,1.3999023,1.09985352,2.79980469,158.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
28.09299,1,male,0,5,180,Colon Cancer,Cancer,1,8.0,under $11k,7952.297,4544.7227,11.0,white,8.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,77.0,9.29882812,80.0,20.0,36.59375,333.3,3.199707,1.01,0.89990234,139.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
60.15298,1,male,0,14,205,Lung Cancer,Cancer,1,14.0,$11-$25k,17149.938,11558.3047,8.333328,white,9.0,1,0,0,metastatic,0.5,0.4,no dnr,14.0,83.0,6.59960938,86.0,20.0,38.39844,224.96875,3.699707,0.39996338,0.69995117,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
41.13898,1,male,0,5,89,Lung Cancer,Cancer,1,8.0,under $11k,4330.859,2927.4707,4.0,white,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,87.0,9.0,80.0,24.0,36.69531,333.3,3.7998047,0.19998169,0.59997559,141.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
64.71497,1,male,0,6,1029,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,4430.047,3109.2207,7.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,70.0,10.3984375,70.0,20.0,36.39844,333.3,2.5996094,2.19970703,0.89990234,135.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
30.33499,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,59995.78781114967,14452.7344,41.5,white,58.0,4,0,0,no,0.699999809,0.5,dnr after sadm,9.0,140.0,6.5,156.0,26.0,38.59375,82.21875,3.5,2.69970703,0.79992676,145.0,7.269531,135.0,23.0,2502.0,2.7250977,<2 mo. follow-up
53.22098,1,female,1,109,109,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,530330.0,338627.25,47.0,white,44.0,14,1,0,no,0.75,0.75,dnr after sadm,104.0,75.0,27.6992188,96.0,12.0,37.89844,272.0,3.5,2.5,2.19970703,134.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.10498,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,1,2.0,under $11k,73564.562,49620.125,15.25,white,45.0,11,0,0,no,0.699999809,0.5,no dnr,30.0,63.0,18.5,120.0,28.0,37.39844,293.3125,3.5,1.01,2.5,135.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
69.04297,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,86513.75,56714.1562,48.666657,white,63.0,1,0,0,no,0.099999964,0.001,dnr after sadm,5.0,62.0,13.7988281,66.0,39.0,36.59375,147.5,2.5,2.5,2.09960938,145.0,7.169922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
26.519,0,female,0,17,1410,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,32705.891,21617.4688,16.333328,black,84.0,2,1,0,no,0.699999809,0.5,no dnr,17.0,145.0,49.6953125,166.0,56.0,38.89844,132.625,1.5,2.79980469,1.09985352,132.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
64.52295,1,female,0,15,1409,COPD,COPD/CHF/Cirrhosis,2,18.0,>$50k,14548.125,9736.9297,13.333328,white,17.0,1,0,0,no,0.989999771,0.95,no dnr,15.0,73.0,3.89990234,105.0,20.0,36.89844,260.8125,4.3994141,0.29998779,0.69995117,141.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.79999,0,male,0,8,1409,COPD,COPD/CHF/Cirrhosis,1,6.0,under $11k,6795.148,4689.0,8.5,white,32.0,1,0,0,no,0.75,0.6,no dnr,8.0,100.0,9.3984375,110.0,22.0,36.29688,156.0,3.199707,0.09999084,0.69995117,141.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.10095,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,45839.344,27262.6094,39.5,white,40.0,5,1,0,no,0.099999964,0.001,dnr after sadm,8.0,65.0,11.0996094,64.0,24.0,35.29688,352.0,3.5,1.01,5.29980469,128.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
74.36798,0,female,0,12,1409,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,15472.344,10627.0859,19.5,black,39.0,1,0,0,yes,0.949999809,0.9,no dnr,12.0,57.0,11.0996094,70.0,28.0,36.69531,412.0,2.7998047,0.89990234,1.69995117,143.0,7.339844,135.0,23.0,2502.0,2.5039062,no(M2 and SIP pres)
81.10297,1,male,0,21,615,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,20806.703,16225.6094,13.333328,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,21.0,100.0,3.79980469,72.0,18.0,36.59375,228.5625,2.8999023,2.09960938,1.39990234,148.0,7.449219,135.0,23.0,2502.0,2.7905273,<2 mo. follow-up
56.64099,1,male,0,18,60,Lung Cancer,Cancer,1,12.0,under $11k,21573.094,14371.5078,10.0,white,17.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,14.0,84.0,18.0,126.0,22.0,37.0,319.0,2.8999023,1.01,0.69995117,141.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
47.21997,1,male,0,7,400,Colon Cancer,Cancer,1,16.0,>$50k,7890.449,5285.582,11.0,white,7.0,1,0,0,metastatic,0.899999619,0.6,no dnr,7.0,80.0,4.29980469,100.0,22.0,38.59375,333.3,4.0,0.29998779,0.89990234,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.42297,1,female,0,11,109,Colon Cancer,Cancer,1,12.0,$11-$25k,6924.148,5220.8633,8.5,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,87.0,6.29980469,100.0,28.0,37.79688,447.5625,3.5,1.01,0.59997559,139.0,7.569336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
61.07599,1,female,0,5,134,Colon Cancer,Cancer,1,12.0,under $11k,5752.047,3460.1836,10.0,white,11.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,113.0,5.5,70.0,24.0,35.69531,333.3,3.8999023,0.19998169,0.69995117,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.35898,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,31451.266,18780.1094,49.0,black,51.0,1,0,0,no,0.5,0.5,no dnr,5.0,55.0,13.0996094,124.0,30.0,40.69531,300.0,1.2998047,0.09999084,0.79992676,136.0,7.439453,135.0,23.0,2502.0,1.8881836,<2 mo. follow-up
61.65598,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,1,13.0,>$50k,68828.75,42445.4375,47.5,white,87.0,8,0,0,yes,0.699999809,0.5,dnr after sadm,9.0,110.0,0.19998169,120.0,42.0,38.5,248.0,3.5,8.79882812,2.89990234,140.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.60797,1,female,0,5,93,Colon Cancer,Cancer,1,8.0,under $11k,5229.797,3796.2519,7.0,black,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,81.0,10.5996094,64.0,28.0,36.39844,352.375,3.5,1.39990234,1.39990234,139.0,7.5,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
80.37,1,male,1,87,87,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,14452.7344,39.25,white,96.0,1,0,0,no,0.099999964,0.001,dnr after sadm,15.0,49.0,29.6992188,80.0,36.0,34.0,146.65625,1.2998047,2.69970703,2.29980469,153.0,7.469727,135.0,23.0,2502.0,2.9868164,<2 mo. follow-up
70.74298,0,female,0,21,1397,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,93786.312,58329.4062,27.0,hispanic,45.0,8,0,0,no,0.949999809,0.95,no dnr,21.0,62.0,12.7988281,110.0,8.0,36.19531,383.3125,2.8999023,5.29980469,2.29980469,147.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
45.84497,0,male,0,10,1396,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,17144.141,12614.4609,18.0,black,22.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,101.0,18.6992188,104.0,31.0,37.89844,246.65625,2.699707,0.19998169,1.0,139.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.22998,1,female,1,4,4,Lung Cancer,Cancer,1,12.0,under $11k,6356.336,4161.4805,28.0,black,72.0,1,0,0,metastatic,0.099999964,0.001,no dnr,4.0,0.0,18.5,0.0,0.0,38.69531,223.78125,3.5,1.01,0.69995117,126.0,7.439453,135.0,23.0,2502.0,2.3569336,<2 mo. follow-up
47.16998,0,male,0,90,1396,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,163735.875,111310.188,20.5,black,18.0,1,0,0,no,0.649999619,0.65,no dnr,90.0,137.0,9.69921875,136.0,12.0,37.59375,360.0,3.5,0.89990234,1.19995117,134.0,7.439453,135.0,23.0,2502.0,1.7980957,<2 mo. follow-up
53.18799,0,male,0,7,1396,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,15708.242,11773.0078,7.5,white,17.0,1,0,0,no,0.949999809,0.9,no dnr,7.0,82.0,5.79980469,80.0,20.0,36.19531,432.0,3.5,0.59997559,1.5,141.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
78.09198,1,female,0,6,303,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,11205.695,7529.1602,29.0,black,42.0,1,1,0,no,0.699999809,0.7,no dnr,6.0,73.0,11.2988281,130.0,25.0,36.89844,372.0,3.5,1.01,1.89990234,141.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
70.47797,1,male,0,6,51,Colon Cancer,Cancer,1,12.0,under $11k,6633.75,4108.207,9.0,black,29.0,1,1,0,metastatic,0.699999809,0.1,no dnr,6.0,113.0,10.6992188,80.0,28.0,36.39844,333.3,2.8999023,2.39990234,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.89999,1,male,1,106,106,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,23.0,white,52.0,41,0,0,no,0.5,0.5,dnr after sadm,9.0,81.0,14.1992188,124.0,33.0,35.09375,193.3125,3.3999023,1.5,4.39941406,130.0,7.479492,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
57.47299,1,female,0,18,222,Colon Cancer,Cancer,1,12.0,under $11k,17594.547,11910.8281,7.666664,white,15.0,1,0,0,metastatic,1.0,1.0,no dnr,18.0,74.0,10.5,84.0,20.0,37.59375,333.3,3.5,0.29998779,0.89990234,140.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
39.93198,0,male,0,45,1393,Coma,Coma,1,8.0,under $11k,93780.188,60261.5938,35.25,white,17.0,1,0,0,no,0.299999952,0.2,dnr after sadm,10.0,72.0,16.296875,70.0,30.0,36.5,242.84375,3.5,0.19998169,0.79992676,144.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
48.077,0,female,0,10,1392,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,9770.945,6952.6992,8.5,white,27.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,77.0,6.0,74.0,20.0,37.79688,333.3,2.2998047,4.5,0.79992676,136.0,7.419922,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
60.59399,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,0,3.0,under $11k,60863.469,40220.8438,22.5,white,68.0,26,0,0,yes,0.0,0.0,dnr after sadm,2.0,43.0,0.89990234,114.0,12.0,40.0,298.0,3.5,5.0,1.69995117,129.0,7.40918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
56.35898,0,female,0,16,1391,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,28776.484,19103.0938,16.666656,white,73.0,2,0,0,metastatic,0.599999905,0.5,no dnr,16.0,60.0,6.69921875,122.0,40.0,38.5,248.0,2.3999023,2.59960938,2.19970703,127.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.69299,1,male,1,44,44,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,94629.0,66053.125,20.0,black,56.0,23,1,0,no,0.5,0.125,dnr after sadm,2.0,111.0,12.3984375,60.0,3.0,36.5,217.125,2.8999023,0.79992676,3.09960938,142.0,7.40918,135.0,23.0,2502.0,5.0,<2 mo. follow-up
67.07196,1,male,0,4,94,Lung Cancer,Cancer,1,16.0,$25-$50k,1635.75,1285.1836,7.0,white,8.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,90.0,6.89941406,72.0,22.0,36.69531,333.3,3.5,1.29980469,1.0,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.75897,0,female,0,12,1390,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,54305.781,32730.2031,27.5,white,21.0,2,0,0,no,0.989999771,0.99,no dnr,12.0,63.0,11.5996094,114.0,6.0,38.09375,226.65625,3.5,1.69995117,0.69995117,144.0,7.359375,135.0,23.0,2502.0,0.0,SIP>=30
67.77295,1,female,1,37,37,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,60532.938,38475.0,21.0,white,36.0,1,1,0,no,0.699999809,0.5,no dnr,37.0,94.0,22.0,130.0,28.0,38.5,186.65625,3.5,0.79992676,1.59985352,135.0,7.329102,135.0,23.0,2502.0,6.0,<2 mo. follow-up
69.95996,1,female,0,3,77,CHF,COPD/CHF/Cirrhosis,4,3.0,under $11k,1672.449,1343.5801,7.0,black,25.0,1,1,0,no,0.899999619,0.5,no dnr,3.0,80.0,4.29980469,64.0,28.0,36.5,366.625,3.5,1.01,1.29980469,140.0,7.40918,135.0,23.0,2502.0,2.9931641,no(M2 and SIP pres)
65.39398,1,male,1,3,3,Coma,Coma,1,7.0,under $11k,14855.242,9849.8047,41.0,black,80.0,1,0,0,no,0.049999982,0.000125,no dnr,3.0,0.0,9.3984375,0.0,14.0,35.09375,187.5,1.7998047,1.01,4.39941406,143.0,7.329102,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.92694,0,male,0,35,1387,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59747.969,40751.8125,22.25,black,62.0,3,0,0,no,0.699999809,0.5,dnr after sadm,6.0,65.0,15.0,64.0,26.0,36.69531,137.5,2.199707,0.29998779,10.8984375,129.0,7.399414,135.0,23.0,2502.0,3.6303711,<2 mo. follow-up
76.65399,1,female,0,7,33,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4969.898,3531.9766,10.5,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,71.0,11.6992188,56.0,16.0,35.09375,400.0,3.5,1.01,1.19995117,137.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.05698,1,male,1,6,6,Lung Cancer,Cancer,1,12.0,under $11k,8189.148,5071.8945,18.0,white,20.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,83.0,6.09960938,114.0,28.0,36.39844,356.625,2.7998047,0.29998779,0.79992676,139.0,7.299805,135.0,23.0,2502.0,2.4106445,<2 mo. follow-up
48.51999,0,male,0,81,1385,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,322828.75,205589.25,48.0,white,57.0,13,0,0,no,0.699999809,0.5,no dnr,81.0,54.0,15.0,124.0,28.0,39.39844,190.0,2.2998047,1.0,2.39990234,150.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
61.71899,1,female,0,11,577,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,31584.484,20443.0781,19.5,white,14.0,11,0,0,no,0.699999809,0.5,no dnr,11.0,101.0,11.0,124.0,23.0,36.29688,316.3125,2.8999023,0.5,0.5,141.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.36798,1,female,0,28,108,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,75277.938,46333.0625,29.5,white,19.0,3,1,0,no,0.849999905,0.8,no dnr,28.0,82.0,5.89941406,110.0,26.0,39.0,333.3,3.5,1.01,0.69995117,137.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
50.17697,0,female,0,30,1382,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,94015.438,60084.4062,26.0,black,20.0,5,0,0,no,0.599999905,0.5,no dnr,30.0,130.0,20.1992188,114.0,24.0,38.39844,250.0,3.8999023,1.01,0.79992676,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
34.15698,0,female,0,13,1382,CHF,COPD/CHF/Cirrhosis,0,18.0,>$50k,31092.484,21191.4688,31.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,112.0,8.29882812,110.0,26.0,36.79688,266.625,2.8999023,0.89990234,1.0,136.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
50.62299,0,female,0,23,1382,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,52901.719,36472.8125,27.0,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,23.0,114.0,7.19921875,104.0,30.0,38.5,256.625,2.0,1.19995117,0.59997559,140.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.81195,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,0.0,under $11k,58640.125,36645.7812,41.5,white,64.0,15,0,0,yes,0.699999809,0.5,dnr after sadm,6.0,109.0,0.5,174.0,29.0,40.19531,166.0,3.5,0.59997559,0.79992676,138.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
85.53894,0,male,0,21,1379,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,28541.031,19546.8594,12.333328,black,24.0,7,0,0,yes,0.699999809,0.5,no dnr,21.0,93.0,11.0,80.0,26.0,36.0,146.9375,3.5,0.19998169,1.29980469,146.0,7.399414,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
53.18799,1,male,0,101,285,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,284256.75,193046.75,39.0,white,43.0,1,0,0,no,0.699999809,0.5,no dnr,101.0,39.0,16.0,124.0,10.0,36.5,165.6875,2.699707,1.01,1.39990234,148.0,7.449219,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
43.39499,0,female,0,17,1379,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,68084.312,44917.2812,23.666656,white,43.0,1,0,0,yes,0.699999809,0.5,no dnr,17.0,107.0,3.0,130.0,46.0,36.0,304.75,2.0996094,1.01,1.0,140.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.90594,1,male,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,3840.35,2740.5918,13.0,white,70.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,73.0,8.09960938,76.0,22.0,35.29688,457.125,1.7998047,26.296875,3.5,130.0,7.419922,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
54.42798,0,male,0,46,1378,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,149515.0,97945.25,24.5,black,44.0,18,1,0,no,0.899999619,0.8,no dnr,46.0,102.0,16.296875,104.0,28.0,38.09375,150.0,1.6999512,1.01,1.69995117,146.0,7.389648,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
54.754,0,female,0,19,1378,CHF,COPD/CHF/Cirrhosis,3,10.0,$25-$50k,45468.906,28772.2188,25.0,black,18.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,83.0,4.59960938,74.0,36.0,36.09375,290.0,3.5,1.01,0.79992676,134.0,7.479492,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
79.55396,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,57881.625,38559.0312,28.5,white,50.0,7,0,0,no,0.099999964,0.001,dnr after sadm,6.0,115.0,10.8984375,180.0,36.0,36.79688,126.65625,3.5,1.01,1.69995117,138.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.586,1,male,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,156079.125,99411.4375,17.75,white,56.0,10,0,0,no,0.949999809,0.95,no dnr,39.0,60.0,28.5,156.0,32.0,36.0,476.1875,2.5,1.79980469,2.19970703,146.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
89.35199,0,female,0,18,1377,COPD,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,26882.234,17633.8281,20.666656,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,18.0,103.0,11.3984375,124.0,28.0,36.19531,157.125,3.5,0.79992676,1.29980469,140.0,7.439453,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
62.37598,1,male,1,28,28,MOSF w/Malig,ARF/MOSF,1,19.0,>$50k,88716.75,55218.75,23.5,white,49.0,10,0,0,yes,0.699999809,0.5,dnr after sadm,22.0,61.0,0.09999084,126.0,30.0,38.79688,256.0,3.5,0.79992676,0.89990234,138.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.45197,1,male,0,7,52,Lung Cancer,Cancer,1,12.0,$11-$25k,14996.648,8643.25,14.5,white,40.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,57.0,17.1992188,146.0,24.0,35.69531,333.3,2.0996094,0.19998169,0.89990234,137.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
44.70599,0,male,0,14,1375,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,>$50k,54420.094,32991.3438,32.0,white,34.0,2,0,0,no,0.989999771,0.99,no dnr,14.0,67.0,12.5,74.0,5.0,36.59375,146.65625,3.5,1.01,1.39990234,136.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.95294,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,2,16.0,$11-$25k,43507.656,27881.4688,31.0,white,96.0,17,0,0,yes,0.699999809,0.5,dnr after sadm,4.0,51.0,0.19998169,140.0,27.0,39.09375,128.3125,2.5996094,3.29980469,3.29980469,141.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
40.82999,1,male,0,12,73,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,10073.695,7346.5,9.0,black,40.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,83.0,13.0,108.0,20.0,36.29688,323.75,1.0998535,13.5,1.19995117,146.0,7.469727,135.0,23.0,2502.0,3.6713867,<2 mo. follow-up
72.97998,0,male,0,19,1365,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,37242.969,24578.5469,22.0,black,37.0,1,0,0,no,0.899999619,0.88,no dnr,19.0,87.0,10.6992188,146.0,33.0,37.0,205.6875,3.0996094,0.5,1.69995117,121.0,7.389648,135.0,23.0,2502.0,2.9077148,<2 mo. follow-up
63.74799,1,female,1,32,32,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,21.25,white,63.0,8,0,0,metastatic,0.949999809,0.85,dnr after sadm,30.0,130.0,10.8984375,136.0,32.0,39.19531,193.3125,2.199707,8.59960938,1.89990234,137.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.35498,0,male,0,39,1364,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,104662.625,67909.6875,30.5,black,64.0,1,0,0,no,0.699999809,0.5,no dnr,39.0,63.0,10.7988281,126.0,24.0,38.89844,224.0,1.6999512,16.0976562,1.89990234,149.0,7.389648,135.0,23.0,2502.0,2.34375,SIP>=30
56.40198,1,male,1,15,15,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,>$50k,37778.875,24318.8906,27.0,white,46.0,1,0,0,no,0.5,0.7,dnr after sadm,15.0,63.0,6.29980469,68.0,26.0,36.39844,210.0,2.199707,5.09960938,1.0,142.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
81.07599,1,male,0,27,30,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,40158.719,27819.7812,14.5,white,41.0,6,0,0,no,0.699999809,0.5,dnr after sadm,9.0,47.0,12.5,42.0,25.0,36.29688,190.0,2.8999023,1.01,1.19995117,139.0,7.469727,135.0,23.0,2502.0,4.0,<2 mo. follow-up
83.90997,1,female,0,9,307,COPD,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,7561.797,5520.7109,14.0,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,108.0,7.69921875,120.0,20.0,36.89844,390.0,3.5,0.39996338,0.69995117,143.0,7.219727,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
88.58899,0,female,0,17,1359,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,59995.78781114967,14452.7344,14.666664,white,45.0,10,0,0,no,0.5,0.5,dnr after sadm,3.0,69.0,13.0,64.0,35.0,34.79688,110.20312,3.5,1.01,1.19995117,139.0,7.469727,135.0,23.0,2502.0,0.0,SIP>=30
68.73395,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,$11-$25k,34104.062,21455.3281,47.0,white,72.0,1,1,0,no,0.049999982,0.000125,no dnr,6.0,46.0,10.0996094,160.0,40.0,39.09375,112.0,2.699707,0.09999084,1.79980469,143.0,7.589844,135.0,23.0,2502.0,2.3891602,<2 mo. follow-up
39.01398,1,female,0,10,552,Colon Cancer,Cancer,1,16.0,$25-$50k,15749.195,9910.6797,13.5,hispanic,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,10.0,85.0,9.3984375,76.0,20.0,36.29688,333.3,3.7998047,0.59997559,0.59997559,142.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
72.62695,0,male,0,48,1358,Coma,Coma,0,6.0,under $11k,114186.188,77824.25,24.0,white,17.0,7,0,0,no,0.599999905,0.55,no dnr,48.0,109.0,17.1992188,56.0,28.0,37.5,316.625,3.5,1.01,0.79992676,131.0,7.429688,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
65.32794,1,male,0,5,307,Lung Cancer,Cancer,1,17.0,>$50k,6116.098,3664.3906,10.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,100.0,10.0,64.0,20.0,36.69531,333.3,3.5,0.5,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
33.16898,0,male,0,24,1355,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,49249.938,31747.3594,18.333328,white,50.0,2,0,0,no,0.799999714,0.8,no dnr,24.0,44.0,5.39941406,120.0,27.0,36.5,480.9375,2.5,1.19995117,2.19970703,141.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
72.70398,1,male,0,21,207,ARF/MOSF w/Sepsis,ARF/MOSF,2,4.0,under $11k,49507.219,33661.8125,26.333328,white,37.0,1,0,0,yes,0.299999952,0.15,dnr after sadm,10.0,132.0,21.796875,126.0,23.0,38.69531,110.0,2.2998047,0.29998779,0.69995117,133.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.27399,1,female,0,5,201,Lung Cancer,Cancer,1,10.0,$25-$50k,5416.098,3314.0606,8.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,96.0,11.8984375,76.0,28.0,37.39844,333.3,3.5,0.29998779,0.69995117,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
23.85199,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,67589.312,43827.4062,39.0,black,68.0,4,0,0,no,0.199999928,0.1,no dnr,7.0,127.0,8.8984375,160.0,36.0,35.39844,404.0,3.5,13.5996094,1.39990234,161.0,7.509766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.79297,1,male,0,4,31,Lung Cancer,Cancer,1,12.0,$11-$25k,5295.699,3165.8652,16.0,white,22.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,77.0,21.1992188,84.0,24.0,37.59375,333.3,3.5,0.69995117,1.19995117,132.0,7.419922,135.0,23.0,2502.0,2.015625,<2 mo. follow-up
76.18097,0,female,0,6,1350,Colon Cancer,Cancer,1,13.0,under $11k,5235.797,3665.3242,10.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,100.0,3.09960938,68.0,20.0,36.79688,333.3,3.2998047,0.29998779,0.79992676,143.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.13898,1,male,0,6,376,Lung Cancer,Cancer,1,12.0,under $11k,3427.949,2561.9609,9.0,white,13.0,1,0,0,metastatic,1.0,1.0,no dnr,6.0,110.0,9.8984375,100.0,20.0,36.79688,333.3,3.5,1.01,0.39996338,136.0,7.419922,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
65.16095,1,male,0,21,214,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,27118.438,18046.5625,20.333328,white,44.0,1,1,0,no,0.799999714,0.7,dnr after sadm,4.0,63.0,7.29980469,100.0,11.0,36.39844,300.0,3.0,1.01,2.79980469,130.0,7.439453,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
37.50598,1,male,1,9,9,Coma,Coma,1,12.0,$11-$25k,69511.312,44734.5625,29.5,white,17.0,23,0,0,no,0.699999809,0.5,dnr after sadm,2.0,113.0,4.5,44.0,6.0,36.89844,547.5,3.5,1.01,0.89990234,154.0,7.429688,135.0,23.0,2502.0,2.0087891,<2 mo. follow-up
71.56195,1,female,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,171998.75,108769.625,38.75,white,42.0,23,1,0,no,0.5,0.4,dnr after sadm,27.0,123.0,6.79980469,120.0,7.0,38.69531,450.0,1.7998047,6.19921875,0.69995117,150.0,7.5,135.0,23.0,2502.0,2.3378906,<2 mo. follow-up
71.95599,0,female,0,10,1348,CHF,COPD/CHF/Cirrhosis,0,12.0,under $11k,15265.047,10070.7109,20.0,black,29.0,1,0,0,no,0.899999619,0.75,no dnr,10.0,75.0,10.3984375,106.0,26.0,36.79688,234.78125,2.3999023,0.79992676,0.69995117,141.0,7.389648,135.0,23.0,2502.0,2.3769531,<2 mo. follow-up
63.52399,0,male,0,7,1348,ARF/MOSF w/Sepsis,ARF/MOSF,3,5.0,under $11k,8887.242,6031.0938,11.5,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,67.0,17.5976562,126.0,20.0,35.79688,312.0,3.5,0.69995117,1.0,139.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.24597,1,male,1,3,3,Coma,Coma,0,12.0,$11-$25k,29102.234,18106.1875,48.0,white,80.0,3,0,0,no,0.699999809,0.5,dnr after sadm,2.0,0.0,15.0996094,0.0,0.0,39.19531,195.0,3.5,1.01,2.0,181.0,7.40918,135.0,23.0,2502.0,1.3105469,<2 mo. follow-up
78.86896,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,60337.531,35466.3125,22.0,white,41.0,8,0,0,no,0.699999809,0.5,dnr after sadm,4.0,105.0,16.0,110.0,32.0,38.5,197.125,3.5,1.01,2.69970703,136.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.215,0,female,0,110,1345,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,166448.625,111714.688,19.75,black,49.0,7,0,0,no,0.699999809,0.5,no dnr,110.0,160.0,29.8984375,130.0,42.0,38.29688,170.0,2.5,4.39941406,0.69995117,133.0,7.399414,135.0,23.0,2502.0,2.5649414,adl>=4 (>=5 if sur)
33.66699,0,male,0,11,1345,Cirrhosis,COPD/CHF/Cirrhosis,3,9.0,under $11k,29377.688,20656.7031,25.0,white,32.0,1,0,0,no,0.599999905,0.5,no dnr,11.0,108.0,5.29980469,74.0,26.0,38.5,300.0,2.2998047,7.39941406,0.69995117,136.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
81.53296,1,female,0,11,26,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$11-$25k,25805.188,17326.8438,24.0,white,33.0,1,0,1,no,0.5,0.3,dnr after sadm,3.0,107.0,10.2988281,126.0,30.0,38.59375,240.0,2.7998047,0.19998169,0.79992676,143.0,7.389648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
43.88998,0,male,0,14,1345,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,$11-$25k,48116.688,31653.0781,21.666656,white,37.0,4,0,0,no,1.0,1.0,no dnr,14.0,100.0,16.6992188,114.0,25.0,36.59375,147.5,3.0,0.5,1.69995117,153.0,7.509766,135.0,23.0,2502.0,1.0,SIP>=30
69.07599,1,female,0,11,269,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,12173.898,8183.8711,17.5,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,49.0,8.8984375,66.0,24.0,35.59375,385.6875,3.5,0.5,0.69995117,138.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.56799,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,89779.188,57363.9688,45.666657,black,60.0,1,0,0,no,0.5,0.4,dnr after sadm,17.0,56.0,4.09960938,136.0,14.0,38.09375,128.0,2.5996094,4.29980469,4.5,141.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
31.034,1,female,0,14,47,MOSF w/Malig,ARF/MOSF,1,8.0,$11-$25k,62115.281,39471.7188,29.666656,white,44.0,17,0,0,yes,0.5,0.1,dnr after sadm,4.0,110.0,11.5996094,124.0,32.0,39.0,300.0,1.8999023,0.39996338,1.5,146.0,7.399414,135.0,23.0,2502.0,5.0,<2 mo. follow-up
78.78998,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,53350.75,35540.5,31.0,white,80.0,11,0,0,no,0.399999857,0.5,no dnr,10.0,115.0,0.79992676,136.0,32.0,34.79688,480.0,2.0996094,0.69995117,3.59960938,138.0,7.479492,135.0,23.0,2502.0,5.0,<2 mo. follow-up
68.20294,1,male,0,35,37,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,141644.125,89196.3125,31.0,white,53.0,10,0,0,no,0.699999809,0.5,no dnr,35.0,53.0,41.5,90.0,15.0,37.59375,260.0,2.7998047,1.09985352,3.29980469,127.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
21.506,0,female,0,25,1341,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,78420.438,50620.8125,36.5,black,33.0,2,0,0,no,0.899999619,0.9,no dnr,25.0,63.0,25.6992188,120.0,28.0,38.59375,147.5,2.7998047,0.79992676,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.05197,0,male,0,26,1339,COPD,COPD/CHF/Cirrhosis,2,15.0,$25-$50k,59995.78781114967,14452.7344,29.25,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,26.0,150.0,9.29882812,136.0,24.0,36.09375,188.0,3.0,0.19998169,0.79992676,143.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
36.00497,1,female,0,15,109,Cirrhosis,COPD/CHF/Cirrhosis,2,17.0,under $11k,34299.781,22116.7969,22.0,white,34.0,1,1,0,no,0.699999809,0.5,no dnr,15.0,63.0,9.3984375,72.0,10.0,36.39844,213.3125,2.3999023,5.09960938,0.79992676,133.0,7.439453,135.0,23.0,2502.0,6.0,<2 mo. follow-up
71.10199,1,male,0,12,259,Lung Cancer,Cancer,1,8.0,$25-$50k,16560.844,10550.1875,10.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,78.0,9.5,98.0,20.0,36.89844,347.5625,2.7998047,0.5,0.59997559,141.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.03198,1,female,1,4,4,Coma,Coma,0,11.0,under $11k,22531.438,13481.4766,33.0,white,23.0,1,0,0,no,0.099999964,0.001,dnr after sadm,3.0,108.0,11.5,106.0,32.0,36.09375,414.25,3.5,1.01,0.89990234,134.0,7.609375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.42499,1,male,0,25,39,Cirrhosis,COPD/CHF/Cirrhosis,1,19.0,under $11k,74816.188,47502.25,24.75,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,25.0,61.0,10.6992188,120.0,8.0,35.69531,162.5,1.5,1.79980469,1.29980469,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.84299,1,male,0,28,244,CHF,COPD/CHF/Cirrhosis,1,7.0,under $11k,68604.688,43377.3125,27.5,white,22.0,1,1,0,no,0.5,0.45,no dnr,28.0,60.0,9.8984375,126.0,24.0,38.5,273.3125,3.0996094,0.39996338,0.89990234,133.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.89499,0,male,0,9,1335,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,35564.938,22103.875,24.5,black,48.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,72.0,11.2988281,58.0,28.0,38.69531,102.5,3.0,0.19998169,3.0,141.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.34198,1,male,0,4,125,Lung Cancer,Cancer,2,8.0,under $11k,4382.75,2688.4356,9.0,white,18.0,1,1,0,metastatic,0.899999619,0.7,no dnr,4.0,109.0,11.8984375,76.0,16.0,36.79688,333.3,3.0996094,0.29998779,0.89990234,140.0,7.419922,135.0,23.0,2502.0,2.3007812,no(M2 and SIP pres)
58.491,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,19705.547,12076.5703,51.0,black,63.0,1,1,0,no,0.699999809,0.5,dnr after sadm,5.0,61.0,14.1992188,134.0,44.0,37.69531,122.0,3.0,0.89990234,2.69970703,135.0,7.279297,135.0,23.0,2502.0,2.4057617,<2 mo. follow-up
61.91898,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,under $11k,53453.531,32532.9219,42.5,white,48.0,4,0,0,no,0.5,0.4,dnr after sadm,6.0,59.0,3.5,106.0,10.0,36.29688,197.5,3.3999023,1.89990234,7.0,133.0,7.25,135.0,23.0,2502.0,0.0,<2 mo. follow-up
91.20898,1,male,0,28,63,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,175216.125,115518.0,24.75,white,49.0,24,0,0,no,0.799999714,0.7,no dnr,28.0,74.0,11.8984375,70.0,32.0,37.69531,222.84375,3.2998047,11.0,1.5,154.0,7.429688,135.0,23.0,2502.0,3.2890625,<2 mo. follow-up
64.97998,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,80000.812,53980.0,38.666657,white,60.0,1,1,0,no,0.299999952,0.2,dnr after sadm,23.0,115.0,19.6992188,134.0,26.0,37.89844,115.54688,1.3999023,1.69995117,2.89990234,129.0,7.399414,135.0,23.0,2502.0,2.5664062,<2 mo. follow-up
72.24097,1,male,0,24,60,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,143222.5,87619.625,46.333313,white,46.0,26,0,0,no,0.599999905,0.5,no dnr,24.0,121.0,4.39941406,134.0,29.0,36.5,193.3125,3.5,1.01,2.69970703,137.0,7.399414,135.0,23.0,2502.0,2.1987305,<2 mo. follow-up
75.67395,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,171279.125,106489.75,49.0,white,61.0,14,1,0,no,0.699999809,0.5,dnr after sadm,23.0,60.0,22.5,136.0,9.0,35.89844,202.5,2.3999023,3.09960938,2.0,152.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
25.56899,0,female,0,38,1331,Coma,Coma,0,17.0,$11-$25k,85945.312,57810.7188,22.25,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,38.0,73.0,6.89941406,40.0,8.0,35.0,519.0,3.7998047,1.5,0.59997559,142.0,7.519531,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
58.81198,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,54651.594,33309.8125,42.5,black,53.0,10,1,0,no,0.399999857,0.1,dnr after sadm,11.0,76.0,12.5996094,130.0,30.0,36.19531,187.5,2.2998047,1.01,3.19970703,134.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.92395,1,male,0,7,183,Colon Cancer,Cancer,1,15.0,$11-$25k,7351.648,4601.1953,10.5,white,15.0,1,0,0,metastatic,0.799999714,0.5,no dnr,7.0,107.0,5.39941406,64.0,20.0,37.09375,333.3,3.5,0.79992676,1.0,141.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.78699,1,male,1,74,74,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,14452.7344,37.5,white,59.0,12,0,0,no,0.5,0.4,no dnr,74.0,83.0,25.0976562,120.0,4.0,38.39844,157.5,2.3999023,1.19995117,1.69995117,137.0,7.30957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
27.661,0,male,0,7,1327,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,22497.688,14607.8906,12.0,black,14.0,3,0,0,no,1.0,1.0,no dnr,7.0,110.0,14.3984375,100.0,22.0,36.29688,260.0,2.5,1.01,0.89990234,138.0,7.449219,135.0,23.0,2502.0,2.190918,<2 mo. follow-up
58.823,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,109539.875,70529.375,44.0,white,40.0,13,1,0,no,0.599999905,0.5,dnr after sadm,16.0,117.0,12.7988281,110.0,13.0,36.39844,180.0,1.1999512,0.79992676,0.89990234,133.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
73.37994,1,female,0,45,676,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,14452.7344,16.5,black,33.0,17,0,0,no,0.799999714,0.85,no dnr,45.0,124.0,6.29980469,116.0,28.0,37.79688,204.0,3.5,1.01,0.89990234,144.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.431,1,female,0,4,261,Colon Cancer,Cancer,1,12.0,under $11k,2386.049,1735.0772,13.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,76.0,5.0,104.0,20.0,39.0,333.3,2.7998047,1.01,0.89990234,137.0,7.419922,135.0,23.0,2502.0,1.8874512,<2 mo. follow-up
70.12195,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,92355.25,54605.0,53.0,black,32.0,3,0,0,no,0.5,0.5,dnr after sadm,22.0,56.0,14.1992188,124.0,10.0,35.69531,237.125,3.5,0.09999084,1.19995117,154.0,7.529297,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.20496,1,male,1,11,11,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,38628.625,24617.3281,40.5,white,90.0,2,0,0,metastatic,0.099999964,0.001,dnr before sadm,0.0,59.0,0.09999084,136.0,28.0,36.39844,250.0,1.8999023,2.19970703,2.09960938,143.0,7.429688,135.0,23.0,2502.0,3.0,<2 mo. follow-up
80.71198,0,female,0,34,1324,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,61520.188,41577.7188,24.25,white,13.0,4,0,0,no,0.25,0.1,no dnr,34.0,75.0,9.59960938,66.0,9.0,37.5,225.6875,2.5996094,1.01,0.69995117,141.0,7.479492,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
47.918,1,male,0,5,37,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,3757.0,2664.832,4.0,black,48.0,1,0,0,no,0.799999714,0.8,no dnr,5.0,118.0,15.5996094,91.0,44.0,37.89844,333.3,2.3999023,22.0,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.32599,1,male,0,7,57,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,20914.094,14036.7734,17.5,white,41.0,6,1,0,no,0.699999809,0.3,no dnr,7.0,46.0,12.1992188,60.0,32.0,36.39844,338.0625,3.5,1.01,1.0,128.0,7.519531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.03699,1,male,1,16,16,Coma,Coma,1,12.0,under $11k,59995.78781114967,14452.7344,24.0,white,43.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,109.0,14.2988281,130.0,28.0,39.0,270.0,1.7998047,0.79992676,1.69995117,141.0,7.349609,135.0,23.0,2502.0,2.5361328,<2 mo. follow-up
54.63098,0,female,0,113,1321,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,59995.78781114967,14452.7344,38.75,white,27.0,16,0,0,no,0.399999857,0.4,no dnr,113.0,99.0,23.5,184.0,14.0,38.5,236.65625,3.5,0.79992676,0.39996338,135.0,7.449219,135.0,23.0,2502.0,7.0,<2 mo. follow-up
54.40399,0,female,0,31,1320,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,77659.062,52406.4375,29.5,white,50.0,1,1,0,no,0.699999809,0.5,no dnr,31.0,69.0,5.79980469,106.0,23.0,38.59375,113.84375,1.5998535,0.89990234,1.69995117,142.0,7.55957,135.0,23.0,2502.0,2.9580078,<2 mo. follow-up
70.43695,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,196870.625,117628.062,52.0,white,71.0,11,0,0,no,0.699999809,0.5,dnr after sadm,19.0,59.0,46.5,138.0,30.0,35.89844,272.5,3.5,5.19921875,4.39941406,127.0,7.359375,135.0,23.0,2502.0,2.1875,<2 mo. follow-up
68.85095,1,male,0,16,220,Colon Cancer,Cancer,1,12.0,under $11k,18922.438,12394.3828,16.666656,white,50.0,1,0,0,metastatic,0.699999809,0.5,no dnr,16.0,133.0,13.6992188,128.0,36.0,39.29688,276.0,3.5,6.09960938,0.89990234,134.0,7.489258,135.0,23.0,2502.0,2.6162109,<2 mo. follow-up
54.08899,0,female,0,57,1319,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,121103.375,80398.8125,25.5,black,41.0,1,0,0,no,0.699999809,0.5,no dnr,57.0,113.0,7.5,110.0,30.0,38.19531,368.0,2.7998047,0.5,2.29980469,144.0,7.469727,135.0,23.0,2502.0,6.0,<2 mo. follow-up
66.349,0,male,0,9,1320,COPD,COPD/CHF/Cirrhosis,3,14.0,under $11k,13372.742,9138.5938,21.5,black,36.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,127.0,14.6992188,126.0,6.0,36.29688,182.84375,2.3999023,0.5,1.39990234,139.0,7.379883,135.0,23.0,2502.0,1.1668997,SIP>=30
60.89297,1,female,0,9,11,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,15443.594,11158.2109,14.0,white,16.0,1,0,0,no,0.799999714,0.6,no dnr,9.0,103.0,13.8984375,64.0,24.0,35.59375,252.0,3.5,1.01,1.19995117,137.0,7.449219,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
44.89798,1,male,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,26682.391,18153.2812,42.0,white,85.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,45.0,5.59960938,174.0,36.0,38.19531,206.0,2.199707,11.6992188,1.19995117,132.0,7.55957,135.0,23.0,2502.0,3.0,<2 mo. follow-up
69.20197,1,female,0,10,41,Lung Cancer,Cancer,1,12.0,under $11k,6285.047,4821.9883,7.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,10.0,93.0,9.29882812,100.0,16.0,35.39844,333.3,3.5,0.5,0.89990234,138.0,7.419922,135.0,23.0,2502.0,2.8095703,<2 mo. follow-up
56.06299,0,female,0,5,1317,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,8491.492,5716.0938,9.0,black,25.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,73.0,9.69921875,52.0,24.0,36.79688,376.1875,3.5,1.01,1.69995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.14294,1,male,0,54,595,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,218304.75,141797.875,37.25,white,57.0,17,0,0,yes,0.699999809,0.5,no dnr,54.0,133.0,0.29998779,134.0,24.0,39.0,231.40625,2.3999023,4.39941406,1.0,152.0,7.429688,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
77.42596,1,male,0,21,697,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,42596.344,28186.9375,26.333328,white,66.0,1,1,0,no,0.75,0.6,no dnr,21.0,63.0,15.7988281,60.0,0.0,34.89844,343.3125,2.5,1.01,5.5,131.0,7.5,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
64.51196,1,female,0,6,1292,Colon Cancer,Cancer,1,15.0,$11-$25k,8172.75,4955.9102,16.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,104.0,4.5,76.0,20.0,36.19531,333.3,3.3999023,0.39996338,0.79992676,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.57199,1,male,0,6,284,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,3218.248,2497.7969,12.0,hispanic,28.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,110.0,8.09960938,96.0,24.0,36.79688,333.3,3.5,1.01,3.0,144.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
82.52698,1,male,1,7,7,CHF,COPD/CHF/Cirrhosis,1,5.0,under $11k,27246.438,16079.7734,37.5,black,68.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,39.0,15.8984375,134.0,20.0,36.69531,108.75,2.7998047,0.39996338,3.79980469,132.0,7.319336,135.0,23.0,2502.0,6.0,<2 mo. follow-up
64.961,1,female,0,42,564,MOSF w/Malig,ARF/MOSF,0,11.0,under $11k,59995.78781114967,14452.7344,14.5,black,43.0,3,0,0,yes,0.75,0.5,no dnr,42.0,137.0,9.0,106.0,30.0,38.5,350.0,2.0,1.01,2.0,132.0,7.469727,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
90.71594,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,under $11k,21404.297,13206.875,26.0,black,54.0,3,0,0,no,0.25,0.2,dnr after sadm,5.0,108.0,12.0,100.0,36.0,35.19531,91.82812,3.5,1.01,1.89990234,135.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.21594,1,female,0,34,55,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,86351.562,55435.9688,40.0,white,70.0,2,1,0,yes,0.699999809,0.5,no dnr,34.0,67.0,1.09985352,170.0,32.0,35.79688,336.625,1.7998047,0.59997559,1.29980469,147.0,7.299805,135.0,23.0,2502.0,1.0,<2 mo. follow-up
56.37198,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,under $11k,42452.438,27247.7812,41.5,white,59.0,2,0,0,yes,0.699999809,0.5,dnr after sadm,6.0,56.0,16.6992188,140.0,12.0,39.89844,240.0,1.7998047,3.19970703,1.89990234,143.0,7.359375,135.0,23.0,2502.0,2.1220703,<2 mo. follow-up
44.67398,1,female,0,5,134,Colon Cancer,Cancer,3,12.0,$11-$25k,2538.799,1843.1514,9.0,white,14.0,1,1,0,metastatic,0.699999809,0.5,no dnr,5.0,73.0,4.79980469,80.0,20.0,36.59375,333.3,3.5,0.5,0.59997559,136.0,7.419922,135.0,23.0,2502.0,1.9455566,no(M2 and SIP pres)
26.752,0,male,0,14,1310,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,35316.125,23421.3906,23.0,black,46.0,1,0,0,no,0.899999619,0.9,no dnr,14.0,51.0,21.6992188,130.0,12.0,39.39844,108.0,2.199707,1.69995117,1.0,137.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
23.26399,0,male,0,22,1309,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,93008.875,58490.0625,36.666657,black,34.0,4,0,0,no,0.699999809,0.5,no dnr,22.0,110.0,20.1992188,110.0,38.0,38.69531,150.0,2.0996094,0.89990234,0.89990234,143.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
88.172,1,male,1,7,7,Coma,Coma,1,12.0,under $11k,17919.734,12661.3359,15.0,white,17.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,89.0,14.6992188,54.0,14.0,37.09375,433.3125,3.5,1.01,1.09985352,135.0,7.55957,135.0,23.0,2502.0,4.0,<2 mo. follow-up
49.711,0,female,0,14,1309,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,49613.438,31112.6875,23.0,white,29.0,15,0,0,no,0.899999619,0.88,no dnr,14.0,82.0,8.8984375,112.0,42.0,37.59375,180.0,3.5,1.01,0.5,131.0,7.5,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
66.02295,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,68266.188,41666.3125,50.0,white,39.0,3,0,0,no,0.399999857,0.35,dnr after sadm,10.0,61.0,8.0,120.0,40.0,39.19531,147.25,3.5,1.01,0.79992676,135.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.86694,1,female,0,38,145,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,139384.25,91699.9375,24.5,white,16.0,13,0,0,no,0.699999809,0.5,dnr after sadm,21.0,63.0,9.09960938,100.0,11.0,37.39844,336.0,3.0,1.01,0.5,140.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
76.97998,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,58267.438,38300.0938,36.333313,white,69.0,1,0,0,yes,0.599999905,0.55,dnr after sadm,11.0,45.0,4.29980469,74.0,14.0,37.89844,92.0,1.5,0.39996338,2.59960938,148.0,7.199219,135.0,23.0,2502.0,3.0024414,<2 mo. follow-up
58.92999,0,female,0,79,1307,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,128515.375,85647.1875,16.5,white,51.0,5,0,0,no,0.5,0.5,no dnr,79.0,137.0,16.8984375,160.0,29.0,39.0,360.0,1.5998535,0.69995117,0.39996338,136.0,7.459961,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
38.74597,0,female,0,20,1307,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,132709.625,93150.0625,15.0,white,37.0,39,1,0,no,0.5,0.5,no dnr,20.0,109.0,1.69995117,66.0,22.0,36.29688,290.0,1.5998535,0.69995117,1.89990234,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
29.62099,1,female,0,15,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,53349.375,34999.0,34.666657,white,35.0,1,0,0,yes,0.5,0.4,no dnr,15.0,75.0,2.69970703,50.0,29.0,35.29688,256.0,2.699707,0.59997559,0.5,118.0,7.449219,135.0,23.0,2502.0,7.0,<2 mo. follow-up
64.54199,1,female,0,31,100,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,213444.5,144919.0,17.5,white,28.0,59,0,0,no,0.699999809,0.5,no dnr,31.0,112.0,7.59960938,124.0,40.0,38.0,233.3125,3.5,1.01,0.5,139.0,7.40918,135.0,23.0,2502.0,2.5263672,<2 mo. follow-up
77.40698,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,37871.438,24670.9062,23.0,white,102.0,14,1,0,metastatic,0.699999809,0.5,dnr after sadm,6.0,51.0,4.59960938,104.0,26.0,34.29688,176.0,1.3999023,5.79980469,4.5,137.0,7.329102,135.0,23.0,2502.0,6.0,<2 mo. follow-up
55.491,0,female,0,33,1301,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,98300.812,64919.1562,26.0,white,30.0,3,0,0,no,0.699999809,0.5,no dnr,33.0,111.0,6.89941406,110.0,40.0,38.29688,373.3125,2.3999023,1.01,0.5,141.0,7.349609,135.0,23.0,2502.0,0.0,SIP>=30
74.96497,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,35012.969,22773.625,38.5,white,56.0,6,0,0,no,0.299999952,0.3,no dnr,12.0,67.0,16.3984375,150.0,48.0,36.29688,223.3125,2.2998047,1.09985352,1.59985352,135.0,7.40918,135.0,23.0,2502.0,5.0,<2 mo. follow-up
65.41498,1,female,0,14,803,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,14174.0,14452.7344,9.333328,white,29.0,1,0,0,yes,0.799999714,0.8,dnr before sadm,0.0,80.0,8.69921875,80.0,25.0,37.79688,201.65625,3.8999023,0.79992676,2.29980469,139.0,7.319336,337.0,41.0,3800.0,0.0,no(M2 and SIP pres)
44.909,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,55018.0,14452.7344,17.333328,white,59.0,3,0,0,no,0.75,0.7,dnr after sadm,24.0,46.0,10.8984375,122.0,33.0,36.09375,333.3,2.5996094,1.0,1.29980469,144.0,7.419922,94.0,20.0,4950.0,0.0,<2 mo. follow-up
65.31396,1,female,0,40,129,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,57653.0,14452.7344,23.25,white,46.0,1,0,0,no,0.75,0.6,no dnr,40.0,73.0,7.39941406,138.0,32.0,38.89844,400.0,3.5,0.69995117,0.69995117,138.0,7.419922,88.0,4.0,1600.0,1.0,<2 mo. follow-up
50.396,0,female,0,35,1086,Coma,Coma,1,12.0,$25-$50k,90395.0,14452.7344,24.75,white,38.0,2,1,0,no,0.049999982,0.05,dnr after sadm,3.0,73.0,6.79980469,54.0,22.0,36.69531,333.3,2.5,2.39990234,0.59997559,137.0,7.419922,66.0,9.0,1100.0,0.0,no(M2 and SIP pres)
39.26898,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,75303.0,47321.2812,29.0,white,83.0,20,0,0,metastatic,0.5,0.0,dnr after sadm,2.0,73.0,5.59960938,80.0,25.0,37.79688,247.59375,3.5996094,0.69995117,2.5,138.0,7.489258,104.0,53.0,2502.0,1.0,<2 mo. follow-up
69.13599,1,female,1,3,3,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,18689.0,14452.7344,46.0,white,87.0,1,1,0,no,0.099999964,0.5,no dnr,3.0,73.0,23.5976562,108.0,26.0,36.19531,410.6875,3.0996094,1.01,1.19995117,141.0,7.359375,291.0,38.0,1605.0,2.0,<2 mo. follow-up
40.34998,1,female,0,4,70,CHF,COPD/CHF/Cirrhosis,1,13.0,under $11k,2466.0,14452.7344,8.0,black,36.0,1,0,0,no,0.399999857,0.05,dnr after sadm,1.0,110.0,5.5,60.0,20.0,36.09375,276.1875,3.5,1.01,1.09985352,137.0,7.349609,152.0,23.0,550.0,4.5273438,adl>=4 (>=5 if sur)
67.87695,1,male,0,17,767,Colon Cancer,Cancer,1,12.0,under $11k,32329.0,14452.7344,19.333328,white,33.0,1,0,0,metastatic,0.929999828,0.8,no dnr,17.0,67.0,9.0,60.0,25.0,38.29688,370.3125,2.5996094,1.01,1.59985352,142.0,7.419922,278.0,24.0,1300.0,1.0,<2 mo. follow-up
76.71997,1,female,0,8,736,Lung Cancer,Cancer,2,18.0,$11-$25k,11391.0,14452.7344,15.5,white,14.0,1,1,0,metastatic,0.799999714,0.6,no dnr,8.0,77.0,21.296875,80.0,20.0,36.09375,300.0,3.5,1.29980469,0.89990234,140.0,7.429688,136.0,11.0,2502.0,1.0,<2 mo. follow-up
47.52399,0,male,0,93,1082,Coma,Coma,0,14.0,under $11k,154483.0,100133.438,26.75,white,16.0,3,0,0,no,0.799999714,0.75,dnr after sadm,42.0,56.0,5.09960938,102.0,40.0,38.29688,330.0,2.8999023,1.01,1.09985352,136.0,7.479492,108.0,16.0,5380.0,0.0,adl>=4 (>=5 if sur)
80.68994,1,female,1,4,4,Coma,Coma,2,6.0,$11-$25k,67555.0,14452.7344,40.0,white,37.0,15,1,0,no,0.049999982,0.05,dnr after sadm,3.0,107.0,7.39941406,68.0,20.0,36.39844,333.3,3.5,1.01,0.79992676,135.0,7.419922,93.0,12.0,2502.0,3.0395508,<2 mo. follow-up
46.39297,1,male,0,29,60,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,46628.0,14452.7344,20.75,white,17.0,1,0,0,yes,0.799999714,0.5,no dnr,29.0,52.0,12.2988281,107.0,8.0,35.59375,135.0,3.5,0.5,2.89990234,142.0,7.319336,99.0,65.0,2095.0,1.9868164,<2 mo. follow-up
68.96899,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,46514.0,14452.7344,50.0,white,98.0,31,0,0,no,0.099999964,0.1,no dnr,4.0,107.0,9.59960938,76.0,16.0,37.09375,333.3,3.5,0.5,1.09985352,144.0,7.419922,63.0,17.0,2502.0,2.0,<2 mo. follow-up
67.67395,1,male,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,162435.0,14452.7344,37.75,hispanic,72.0,15,0,0,no,0.199999928,0.2,dnr after sadm,35.0,70.0,5.89941406,80.0,20.0,35.59375,400.0,3.5,1.01,2.09960938,143.0,7.5,139.0,24.0,2502.0,0.0,<2 mo. follow-up
58.22897,1,male,0,6,195,Colon Cancer,Cancer,1,16.0,>$50k,10123.0,14452.7344,9.0,white,6.0,1,0,0,metastatic,0.899999619,0.6,no dnr,6.0,119.0,16.3984375,102.0,28.0,35.59375,113.32812,2.5,0.29998779,0.69995117,137.0,7.509766,72.0,13.0,3265.0,1.0,no(M2 and SIP pres)
55.99698,1,male,0,78,183,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,325893.0,14452.7344,39.0,white,54.0,15,0,0,no,0.949999809,0.95,no dnr,78.0,77.0,6.79980469,70.0,20.0,36.09375,333.3,3.699707,2.09960938,2.29980469,138.0,7.419922,120.0,35.0,2502.0,2.1894531,Coma or Intub
59.38397,0,male,0,41,1078,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,92841.0,64880.2812,22.75,white,47.0,5,0,0,no,0.5,0.5,no dnr,41.0,37.0,0.39996338,188.0,10.0,36.09375,140.0,2.2998047,1.29980469,1.0,143.0,7.459961,150.0,31.0,2235.0,1.0,adl>=4 (>=5 if sur)
34.853,0,female,0,29,1077,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,67010.0,14452.7344,21.0,white,24.0,2,0,0,no,0.699999809,0.7,no dnr,29.0,69.0,0.69995117,77.0,32.0,39.39844,170.0,2.7998047,2.09960938,2.79980469,134.0,7.469727,118.0,46.0,3410.0,7.0,no(M2 and SIP pres)
68.39996,0,male,0,17,1076,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,45859.0,14452.7344,13.666664,white,7.0,7,0,0,no,0.75,0.5,dnr after sadm,2.0,63.0,6.29980469,110.0,6.0,39.89844,312.5,3.5,1.01,1.39990234,132.0,7.329102,165.0,10.0,6990.0,0.0,adl>=4 (>=5 if sur)
54.84198,0,male,0,10,1076,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,30104.0,19874.3594,15.5,black,38.0,4,1,0,no,0.799999714,0.8,no dnr,10.0,110.0,6.39941406,116.0,46.0,39.19531,130.0,3.5,8.79882812,1.0,129.0,7.439453,124.0,18.0,1515.0,0.0,no(M2 and SIP pres)
51.19498,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,under $11k,110430.0,14452.7344,36.0,white,63.0,7,0,0,no,0.5,0.5,dnr after sadm,17.0,41.0,17.5,44.0,12.0,39.0,130.0,2.0996094,2.59960938,1.59985352,145.0,7.429688,184.0,15.0,2240.0,2.1733398,<2 mo. follow-up
75.37897,1,female,0,12,667,COPD,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,14949.0,14452.7344,21.5,white,20.0,1,0,0,no,0.599999905,0.3,dnr after sadm,3.0,107.0,15.1992188,110.0,20.0,37.79688,323.3125,3.5,1.01,0.79992676,150.0,7.389648,105.0,26.0,1350.0,1.0,no(M2 and SIP pres)
48.47598,1,male,0,15,211,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,17299.0,14452.7344,16.666656,white,24.0,1,0,0,metastatic,0.899999619,0.7,no dnr,15.0,67.0,6.0,80.0,16.0,35.59375,333.3,3.3999023,0.79992676,1.0,136.0,7.419922,119.0,12.0,2502.0,7.0,SIP>=30
69.33295,1,female,0,12,436,Colon Cancer,Cancer,2,9.0,under $11k,21897.0,14452.7344,19.5,hispanic,23.0,1,0,0,metastatic,1.0,0.5,no dnr,12.0,69.0,9.0,68.0,22.0,36.0,333.3,3.5,1.01,1.0,139.0,7.419922,172.0,12.0,5450.0,0.0,no(M2 and SIP pres)
38.508,0,female,0,12,1074,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,33349.0,14452.7344,24.5,white,46.0,1,0,0,no,0.949999809,0.95,no dnr,12.0,105.0,11.2988281,77.0,26.0,38.09375,200.0,4.1992188,0.29998779,0.59997559,140.0,7.379883,118.0,6.0,1180.0,0.0,no(M2 and SIP pres)
69.75494,0,male,0,15,1074,COPD,COPD/CHF/Cirrhosis,1,3.0,under $11k,31384.0,14452.7344,22.333328,black,43.0,1,0,0,no,0.599999905,0.5,no dnr,15.0,69.0,14.8984375,63.0,6.0,38.19531,148.96875,3.5,1.01,4.29980469,135.0,7.30957,87.0,57.0,2143.0,1.0,no(M2 and SIP pres)
74.25598,0,female,0,23,1074,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,39642.0,14452.7344,26.0,white,25.0,1,1,0,no,0.75,0.65,no dnr,23.0,147.0,13.1992188,69.0,8.0,36.89844,330.0,3.5,1.01,0.89990234,141.0,7.449219,185.0,11.0,2830.0,5.0,no(M2 and SIP pres)
64.12897,0,male,0,16,1074,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,38587.0,14452.7344,17.666656,white,41.0,1,0,0,no,0.899999619,0.8,no dnr,16.0,71.0,13.6992188,111.0,10.0,39.19531,305.0,4.1992188,0.19998169,0.39996338,140.0,7.399414,154.0,13.0,1193.0,0.0,no(M2 and SIP pres)
57.43997,1,male,1,20,20,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,128232.0,14452.7344,43.333313,white,92.0,8,1,0,yes,0.799999714,0.7,dnr after sadm,19.0,97.0,3.89990234,110.0,20.0,36.89844,333.3,2.5996094,6.39941406,1.0,140.0,7.419922,157.0,16.0,2502.0,1.0,<2 mo. follow-up
44.36099,1,female,1,10,10,Lung Cancer,Cancer,1,16.0,under $11k,33195.0,14452.7344,29.0,white,23.0,1,0,0,metastatic,0.799999714,0.5,no dnr,10.0,49.0,10.1992188,68.0,30.0,35.69531,110.0,3.5,1.01,4.0,147.0,7.359375,90.0,89.0,1945.0,0.0,<2 mo. follow-up
56.00299,1,male,0,14,36,COPD,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,15116.0,14452.7344,8.0,white,18.0,1,0,0,no,0.75,0.7,dnr after sadm,12.0,57.0,9.5,106.0,4.0,38.09375,240.0,3.0,1.01,1.29980469,143.0,7.449219,148.0,36.0,1400.0,0.0,<2 mo. follow-up
72.60797,0,male,0,43,1073,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,60769.0,14452.7344,15.75,white,40.0,1,1,0,no,0.599999905,0.6,no dnr,43.0,49.0,17.5,120.0,12.0,35.69531,121.65625,3.5996094,0.39996338,2.79980469,144.0,7.279297,121.0,57.0,560.0,1.0,no(M2 and SIP pres)
83.95294,1,female,0,22,63,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,68803.0,14452.7344,35.333313,white,43.0,4,1,0,no,0.699999809,0.5,no dnr,22.0,128.0,13.5,134.0,28.0,38.09375,206.0,3.699707,0.5,1.89990234,142.0,7.319336,104.0,96.0,1240.0,4.0,<2 mo. follow-up
61.71899,1,male,0,8,231,Colon Cancer,Cancer,1,3.0,$11-$25k,10202.0,14452.7344,10.0,white,19.0,1,0,0,metastatic,0.799999714,0.5,no dnr,8.0,106.0,5.89941406,134.0,10.0,37.0,236.65625,2.2998047,19.0976562,1.39990234,141.0,7.469727,224.0,56.0,3990.0,0.0,no(M2 and SIP pres)
59.86298,1,male,0,10,15,Lung Cancer,Cancer,3,4.0,under $11k,7594.0,14452.7344,7.5,black,28.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,1.0,67.0,7.69921875,70.0,20.0,36.09375,333.3,3.5,1.01,1.5,141.0,7.419922,56.0,27.0,2050.0,6.0,<2 mo. follow-up
70.75696,1,female,0,7,41,Colon Cancer,Cancer,1,8.0,under $11k,3803.0,14452.7344,7.5,black,32.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,55.0,18.0976562,118.0,30.0,38.29688,333.3,1.7998047,0.5,3.39990234,131.0,7.419922,299.0,27.0,0.0,6.0,<2 mo. follow-up
30.834,0,female,0,37,1070,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,65783.0,42571.5312,17.0,black,19.0,1,0,0,no,0.699999809,0.5,no dnr,37.0,67.0,10.3984375,60.0,20.0,38.29688,98.32812,3.5,1.01,1.69995117,141.0,7.509766,134.0,27.0,2075.0,5.0,SIP>=30
67.24695,1,male,0,10,699,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,$11-$25k,29237.0,14452.7344,28.5,black,18.0,2,0,0,no,0.799999714,0.8,no dnr,10.0,59.0,24.6992188,60.0,24.0,35.79688,333.3,3.5996094,1.09985352,2.29980469,141.0,7.419922,102.0,58.0,1650.0,1.0,adl>=4 (>=5 if sur)
25.114,0,female,0,12,1069,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$11-$25k,40468.0,14452.7344,17.0,black,36.0,5,0,0,no,0.75,0.7,no dnr,12.0,104.0,0.19998169,125.0,22.0,36.89844,333.3,2.2998047,0.69995117,0.5,136.0,7.419922,113.0,6.0,5000.0,0.0,no(M2 and SIP pres)
71.96997,1,female,1,5,5,Coma,Coma,2,12.0,under $11k,18530.0,14452.7344,17.0,white,43.0,4,1,0,no,0.699999809,0.5,dnr after sadm,1.0,38.0,8.0,70.0,16.0,35.79688,333.3,4.6992188,0.69995117,1.19995117,135.0,7.419922,94.0,21.0,3050.0,2.8364258,<2 mo. follow-up
52.26599,0,male,0,19,1069,Colon Cancer,Cancer,1,20.0,>$50k,18529.0,14452.7344,14.666664,asian,22.0,1,0,0,metastatic,0.699999809,0.5,no dnr,19.0,77.0,10.3984375,60.0,20.0,35.59375,333.3,3.5,1.01,1.69995117,135.0,7.419922,125.0,33.0,1150.0,0.0,no(M2 and SIP pres)
25.96599,1,female,0,8,203,Colon Cancer,Cancer,1,14.0,$11-$25k,14354.0,14452.7344,10.0,black,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,114.0,9.09960938,53.0,28.0,38.19531,225.6875,3.8999023,0.39996338,1.09985352,139.0,7.399414,108.0,18.0,2700.0,0.0,no(M2 and SIP pres)
37.25098,1,male,0,12,540,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,24578.0,14452.7344,25.0,white,27.0,1,0,0,yes,0.799999714,0.7,no dnr,12.0,80.0,6.59960938,70.0,20.0,36.79688,315.375,3.5,1.01,1.19995117,139.0,7.319336,95.0,23.0,1150.0,1.0,no(M2 and SIP pres)
67.14899,1,female,0,5,291,Lung Cancer,Cancer,1,14.0,under $11k,7070.0,14452.7344,12.0,white,16.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,100.0,6.5,80.0,25.0,36.0,333.3,3.2998047,1.01,1.29980469,146.0,7.419922,88.0,24.0,1500.0,1.0,no(M2 and SIP pres)
57.19098,0,male,0,11,1069,COPD,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,18074.0,14452.7344,14.5,black,36.0,1,0,0,no,0.949999809,0.95,no dnr,11.0,100.0,7.79980469,70.0,20.0,36.09375,333.3,3.0996094,0.5,1.29980469,144.0,7.419922,103.0,16.0,2502.0,0.0,no(M2 and SIP pres)
67.56494,0,male,0,11,1069,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,11944.0,14452.7344,13.0,white,10.0,1,1,0,no,0.599999905,0.6,no dnr,11.0,63.0,7.29980469,80.0,20.0,37.09375,458.3125,3.5,1.01,1.59985352,142.0,7.359375,111.0,21.0,1300.0,0.0,no(M2 and SIP pres)
51.88498,1,female,1,9,9,Lung Cancer,Cancer,1,12.0,$11-$25k,35326.0,14452.7344,33.0,white,23.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,9.0,63.0,29.0976562,80.0,7.0,38.0,214.0,3.5,1.01,3.19970703,142.0,7.399414,111.0,35.0,3336.0,1.0,<2 mo. follow-up
82.53497,1,female,0,17,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,75513.0,14452.7344,22.666656,white,37.0,13,0,0,yes,0.25,0.15,dnr after sadm,1.0,65.0,14.2988281,106.0,24.0,36.39844,248.0,3.5,1.01,0.79992676,136.0,7.359375,105.0,21.0,1100.0,6.0,<2 mo. follow-up
84.23499,1,male,0,13,99,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,18640.0,14452.7344,13.5,black,52.0,1,0,0,no,0.25,0.2,dnr after sadm,2.0,119.0,5.69921875,114.0,27.0,36.59375,140.8125,3.5,15.0,5.0,154.0,7.479492,104.0,78.0,3560.0,0.0,no(M2 and SIP pres)
61.22699,1,female,0,17,40,Lung Cancer,Cancer,1,18.0,>$50k,25452.0,14452.7344,8.666664,white,19.0,1,0,0,metastatic,0.799999714,0.5,no dnr,17.0,75.0,26.1992188,120.0,48.0,38.29688,185.0,3.5,1.01,1.59985352,138.0,7.449219,123.0,20.0,2190.0,0.0,<2 mo. follow-up
56.797,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,71320.0,14452.7344,36.0,black,89.0,28,0,0,metastatic,0.099999964,0.05,dnr after sadm,2.0,73.0,13.5,124.0,36.0,39.0,211.40625,2.2998047,0.59997559,0.39996338,134.0,7.459961,123.0,5.0,3425.0,2.6601562,<2 mo. follow-up
63.655,1,male,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,168511.0,112099.5,31.5,white,44.0,12,0,0,metastatic,0.199999928,0.2,dnr after sadm,33.0,65.0,4.39941406,106.0,28.0,36.69531,340.0,2.5996094,18.8984375,2.5,134.0,7.149414,114.0,67.0,75.0,1.0,<2 mo. follow-up
63.01199,1,female,1,47,47,ARF/MOSF w/Sepsis,ARF/MOSF,2,4.0,under $11k,266672.0,14452.7344,44.75,white,45.0,10,0,0,yes,0.899999619,0.9,dnr after sadm,38.0,0.0,11.5,0.0,0.0,38.89844,151.65625,3.5,1.01,2.0,137.0,7.239258,203.0,35.0,4135.0,4.0,<2 mo. follow-up
62.20099,1,male,0,3,958,Colon Cancer,Cancer,1,12.0,under $11k,59995.78781114967,14452.7344,4.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,72.0,6.5,54.0,22.0,35.79688,333.3,3.5,1.01,2.09960938,135.0,7.419922,100.0,79.0,1000.0,1.6896973,no(M2 and SIP pres)
47.95297,1,male,1,26,26,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,124393.0,14452.7344,37.25,white,72.0,1,0,0,no,0.5,0.5,dnr after sadm,22.0,113.0,23.0,106.0,10.0,36.0,333.3,2.0996094,4.0,1.09985352,137.0,7.419922,94.0,13.0,990.0,0.0,<2 mo. follow-up
82.06995,1,female,0,12,14,Lung Cancer,Cancer,3,12.0,$11-$25k,9039.0,14452.7344,7.5,white,27.0,1,0,1,metastatic,0.699999809,0.1,dnr before sadm,0.0,119.0,14.5,100.0,24.0,35.59375,333.3,3.5,0.39996338,0.59997559,133.0,7.419922,160.0,9.0,3700.0,3.0,<2 mo. follow-up
62.28299,0,female,0,9,1060,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,6597.0,14452.7344,8.0,white,12.0,1,0,0,no,0.989999771,0.95,no dnr,9.0,100.0,17.296875,60.0,29.0,38.79688,217.125,3.5,1.01,0.79992676,137.0,7.459961,105.0,10.0,5710.0,2.0,SIP>=30
65.70294,1,male,0,87,773,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,272666.0,192386.125,35.25,white,29.0,1,0,0,no,0.799999714,0.7,no dnr,87.0,97.0,17.5,65.0,8.0,38.0,362.8125,3.5,1.01,5.5,141.0,7.439453,274.0,110.0,625.0,2.8095703,Coma or Intub
62.43399,1,male,0,6,233,Colon Cancer,Cancer,1,12.0,$11-$25k,9179.0,14452.7344,8.0,white,2.0,1,0,0,metastatic,0.899999619,0.5,no dnr,6.0,119.0,12.1992188,66.0,24.0,38.59375,368.0,2.5996094,0.79992676,1.29980469,133.0,7.449219,87.0,25.0,6110.0,0.0,no(M2 and SIP pres)
79.98096,1,female,1,3,3,Coma,Coma,2,12.0,under $11k,21247.0,14452.7344,16.0,other,73.0,4,0,0,no,0.699999809,0.5,dnr after sadm,2.0,36.0,57.796875,224.0,32.0,36.09375,41.0,2.0996094,0.69995117,1.79980469,135.0,7.30957,123.0,50.0,580.0,1.8786621,<2 mo. follow-up
52.51498,1,female,0,25,226,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,67737.0,14452.7344,24.25,white,54.0,2,0,0,no,0.849999905,0.8,no dnr,25.0,55.0,65.6875,140.0,21.0,38.09375,133.3125,1.5998535,0.79992676,1.5,142.0,7.429688,136.0,22.0,1400.0,3.0,adl>=4 (>=5 if sur)
84.07697,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,35499.0,14452.7344,32.0,black,47.0,1,0,0,no,0.75,0.75,no dnr,10.0,87.0,5.89941406,74.0,16.0,36.59375,333.3,3.5,1.0,1.09985352,140.0,7.419922,126.0,9.0,4500.0,5.0,<2 mo. follow-up
80.16394,1,male,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,under $11k,177245.0,14452.7344,27.25,other,54.0,32,0,0,yes,0.699999809,0.5,dnr after sadm,22.0,51.0,16.8984375,116.0,34.0,39.59375,124.4375,3.5,3.39990234,1.59985352,136.0,7.399414,249.0,33.0,2655.0,7.0,<2 mo. follow-up
50.03699,1,male,1,21,21,Coma,Coma,1,14.0,$11-$25k,17795.0,14452.7344,12.666664,white,27.0,1,0,0,no,0.5,0.25,dnr after sadm,2.0,73.0,11.3984375,110.0,46.0,38.69531,182.84375,3.5,0.39996338,0.39996338,131.0,7.519531,148.0,15.0,2180.0,5.0,<2 mo. follow-up
72.51196,0,male,0,24,1056,COPD,COPD/CHF/Cirrhosis,1,16.0,$11-$25k,6038.0,14452.7344,27.0,black,37.0,1,0,0,no,0.399999857,0.35,no dnr,24.0,109.0,10.0996094,124.0,33.0,38.0,164.4375,3.0996094,1.19995117,0.5,137.0,7.459961,130.0,14.0,3555.0,0.0,no(M2 and SIP pres)
67.45496,1,male,0,13,24,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,37913.0,14452.7344,9.5,white,21.0,1,0,0,no,0.849999905,0.75,no dnr,13.0,112.0,10.5996094,54.0,8.0,38.29688,333.3,2.699707,1.01,0.79992676,138.0,7.429688,146.0,4.0,3200.0,1.0,<2 mo. follow-up
44.63498,1,male,0,7,258,Lung Cancer,Cancer,1,16.0,>$50k,14703.0,14452.7344,8.5,white,5.0,1,0,0,metastatic,0.899999619,0.7,no dnr,7.0,116.0,14.2988281,112.0,26.0,36.39844,186.65625,2.3999023,0.69995117,1.39990234,140.0,7.489258,279.0,31.0,3025.0,4.0,no(M2 and SIP pres)
76.16394,0,male,0,9,1055,ARF/MOSF w/Sepsis,ARF/MOSF,0,3.0,under $11k,23055.0,14452.7344,17.0,black,23.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,62.0,5.0,104.0,23.0,37.89844,91.25,2.0996094,9.3984375,1.0,147.0,7.539062,424.0,30.0,1790.0,0.0,no(M2 and SIP pres)
46.26099,0,male,0,7,1056,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,18417.0,14452.7344,5.0,white,18.0,1,0,0,no,0.849999905,0.8,no dnr,7.0,103.0,12.3984375,112.0,24.0,36.0,414.25,3.199707,0.39996338,1.19995117,141.0,7.429688,137.0,24.0,2300.0,3.0,no(M2 and SIP pres)
62.543,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,under $11k,75022.0,14452.7344,42.0,white,56.0,14,0,0,no,0.599999905,0.5,dnr after sadm,5.0,120.0,7.69921875,80.0,24.0,35.5,200.0,3.5,0.69995117,1.29980469,140.0,7.429688,118.0,26.0,2500.0,6.0,<2 mo. follow-up
37.314,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,51971.0,14452.7344,55.0,white,46.0,1,0,0,no,0.399999857,0.3,no dnr,6.0,124.0,16.0976562,106.0,11.0,37.59375,356.625,3.5,0.5,1.19995117,141.0,7.389648,116.0,12.0,1555.0,0.0,<2 mo. follow-up
66.53796,1,male,1,23,23,MOSF w/Malig,ARF/MOSF,2,15.0,$11-$25k,188481.0,14452.7344,47.333313,white,61.0,15,0,0,yes,0.5,0.3,dnr after sadm,21.0,65.0,17.8984375,20.0,50.0,38.79688,226.65625,2.7998047,0.39996338,0.79992676,145.0,7.439453,176.0,8.0,2150.0,0.0,<2 mo. follow-up
63.784,0,male,0,6,1054,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,21519.0,14452.7344,22.0,white,22.0,2,0,0,no,0.899999619,0.8,no dnr,6.0,125.0,68.5,134.0,28.0,35.5,190.0,2.8999023,0.59997559,0.89990234,144.0,7.379883,184.0,20.0,2880.0,6.0,no(M2 and SIP pres)
69.16394,1,male,1,87,87,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,217056.0,145305.0,39.75,white,37.0,6,1,0,yes,0.199999928,0.2,dnr after sadm,85.0,91.0,24.0,76.0,24.0,36.29688,171.40625,3.5,1.09985352,3.29980469,131.0,7.449219,168.0,55.0,4435.0,0.0,adl>=4 (>=5 if sur)
67.49298,1,male,0,6,298,Colon Cancer,Cancer,1,15.0,$25-$50k,7680.0,14452.7344,12.0,white,10.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,105.0,12.6992188,160.0,26.0,38.59375,125.0,2.699707,0.69995117,0.59997559,141.0,7.459961,222.0,14.0,1785.0,4.0,no(M2 and SIP pres)
58.50198,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,42141.0,14452.7344,44.0,white,115.0,11,0,0,yes,0.049999982,0.0,dnr after sadm,4.0,61.0,0.19998169,186.0,36.0,38.59375,275.5,1.8999023,1.0,1.69995117,140.0,7.419922,200.0,34.0,650.0,1.9799805,<2 mo. follow-up
73.26794,1,male,1,59,59,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,225766.0,150638.875,35.75,white,32.0,16,0,0,no,0.049999982,0.02,dnr after sadm,49.0,87.0,1.79980469,120.0,22.0,37.79688,314.25,3.5,0.79992676,0.79992676,136.0,7.509766,101.0,8.0,3050.0,1.0,<2 mo. follow-up
69.28998,1,male,1,6,6,Coma,Coma,2,12.0,$25-$50k,23434.0,14452.7344,26.0,white,7.0,3,1,0,no,0.0,0.0,dnr after sadm,2.0,107.0,13.8984375,104.0,20.0,36.19531,284.0,3.7998047,0.59997559,1.19995117,139.0,7.359375,150.0,28.0,2502.0,0.0,<2 mo. follow-up
72.36395,1,male,1,63,63,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,>$50k,149405.0,94173.8125,26.25,white,41.0,13,0,0,yes,0.5,0.3,dnr after sadm,63.0,112.0,13.3984375,114.0,12.0,36.79688,182.0,3.5,1.01,1.59985352,144.0,7.329102,69.0,30.0,4415.0,4.0,<2 mo. follow-up
42.21198,1,male,0,8,636,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,14313.0,14452.7344,10.0,white,8.0,1,0,0,no,0.799999714,0.8,no dnr,8.0,111.0,13.8984375,116.0,25.0,38.09375,151.0,3.0,0.39996338,3.59960938,137.0,7.379883,244.0,54.0,3265.0,0.0,no(M2 and SIP pres)
56.48199,1,male,0,5,18,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,50879.0,14452.7344,29.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,75.0,3.79980469,74.0,18.0,36.69531,333.3,3.699707,0.59997559,2.09960938,140.0,7.419922,88.0,13.0,4350.0,1.8664551,<2 mo. follow-up
25.64499,0,male,0,20,1047,COPD,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,49765.0,14452.7344,22.0,white,50.0,3,0,0,no,0.399999857,0.4,no dnr,20.0,70.0,13.0,70.0,16.0,35.0,333.3,2.8999023,1.19995117,1.09985352,133.0,7.419922,120.0,61.0,1400.0,0.0,no(M2 and SIP pres)
67.89294,0,male,0,22,1046,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,65432.0,14452.7344,34.333313,white,53.0,1,0,0,no,0.779999733,0.7,no dnr,22.0,71.0,25.5,100.0,20.0,37.69531,333.3,3.5,1.01,1.79980469,135.0,7.419922,58.0,17.0,2502.0,0.0,no(M2 and SIP pres)
70.57397,0,male,0,11,1046,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,22068.0,14452.7344,10.5,white,20.0,1,0,0,no,0.949999809,0.75,no dnr,11.0,81.0,9.8984375,130.0,24.0,37.89844,253.3125,2.2998047,0.5,0.89990234,139.0,7.40918,143.0,8.0,4870.0,2.0,no(M2 and SIP pres)
60.22998,0,male,0,7,1046,CHF,COPD/CHF/Cirrhosis,3,14.0,>$50k,12106.0,14452.7344,6.0,white,22.0,1,1,0,no,0.949999809,0.9,no dnr,7.0,131.0,6.89941406,54.0,14.0,37.59375,157.5,3.5,1.01,0.89990234,138.0,7.389648,121.0,7.0,6915.0,0.0,no(M2 and SIP pres)
50.37399,0,female,0,38,1045,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,220001.0,143696.125,20.25,black,30.0,36,1,0,no,0.899999619,0.75,no dnr,38.0,107.0,15.0,120.0,44.0,38.29688,63.32812,3.5,1.01,0.69995117,138.0,7.379883,69.0,7.0,1270.0,2.0,no(M2 and SIP pres)
28.709,1,female,0,4,170,Colon Cancer,Cancer,1,15.0,$25-$50k,2712.0,14452.7344,10.0,white,17.0,1,0,0,metastatic,0.5,0.15,no dnr,4.0,109.0,6.69921875,96.0,22.0,35.79688,352.0,3.5,1.01,11.5996094,138.0,7.429688,152.0,89.0,0.0,0.0,<2 mo. follow-up
69.91095,1,male,0,7,56,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3738.0,14452.7344,5.5,white,41.0,1,1,0,no,0.949999809,0.75,no dnr,7.0,121.0,14.6992188,100.0,8.0,36.09375,380.0,2.0,0.59997559,0.69995117,135.0,7.379883,274.0,8.0,1270.0,2.9311523,<2 mo. follow-up
23.10699,0,female,0,8,1045,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,24572.0,14452.7344,17.5,black,26.0,1,1,0,no,0.949999809,0.95,no dnr,8.0,73.0,7.59960938,60.0,16.0,39.19531,333.3,3.5,1.01,1.01,138.0,7.419922,143.0,6.0,1390.0,0.0,no(M2 and SIP pres)
69.54095,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,58201.0,14452.7344,53.0,white,95.0,2,0,0,no,0.0,0.0,dnr after sadm,5.0,71.0,12.7988281,106.0,24.0,36.89844,409.5,3.5,1.01,1.5,129.0,7.5,181.0,37.0,4600.0,2.7041016,<2 mo. follow-up
81.68396,1,male,0,26,363,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,53116.0,14452.7344,16.0,white,50.0,7,0,0,no,0.799999714,0.75,no dnr,26.0,130.0,10.1992188,108.0,20.0,36.69531,333.3,3.5,0.5,0.89990234,141.0,7.419922,122.0,16.0,5900.0,0.0,no(M2 and SIP pres)
65.53894,1,male,0,6,191,Colon Cancer,Cancer,2,8.0,under $11k,5489.0,14452.7344,7.0,black,17.0,1,0,0,metastatic,0.5,0.2,no dnr,6.0,139.0,43.09375,120.0,35.0,36.19531,264.0,3.5,1.01,0.89990234,141.0,7.329102,170.0,14.0,2325.0,5.0,<2 mo. follow-up
83.99695,1,male,0,5,349,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,9379.0,14452.7344,15.0,white,31.0,1,0,0,no,0.799999714,0.6,no dnr,5.0,70.0,7.5,100.0,16.0,36.0,423.75,3.5,1.01,1.29980469,139.0,7.449219,228.0,14.0,2380.0,3.0,no(M2 and SIP pres)
66.24194,1,female,0,14,27,Lung Cancer,Cancer,2,15.0,under $11k,21273.0,14452.7344,12.666664,white,39.0,1,0,0,metastatic,0.849999905,0.78,no dnr,14.0,109.0,8.09960938,126.0,24.0,38.29688,368.0,3.5,1.01,0.69995117,133.0,7.379883,131.0,6.0,865.0,3.2792969,<2 mo. follow-up
51.46597,0,female,0,45,1040,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,$25-$50k,98005.0,14452.7344,14.25,white,23.0,19,0,0,yes,1.0,1.0,no dnr,45.0,125.0,9.3984375,120.0,24.0,38.59375,333.3,1.7998047,0.79992676,0.59997559,135.0,7.419922,148.0,31.0,2502.0,1.0,no(M2 and SIP pres)
63.47998,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,64614.0,14452.7344,33.0,white,47.0,16,0,0,no,0.099999964,0.05,dnr after sadm,5.0,122.0,11.2988281,70.0,10.0,35.29688,428.5625,3.5,2.0,2.89990234,141.0,7.289062,126.0,66.0,2875.0,0.0,<2 mo. follow-up
72.10699,1,male,1,126,126,COPD,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,412406.0,299965.75,31.75,white,58.0,1,0,0,no,0.699999809,0.6,dnr after sadm,93.0,80.0,20.5,118.0,16.0,36.0,333.3,3.5996094,0.39996338,0.89990234,136.0,7.419922,110.0,22.0,5650.0,0.0,adl>=4 (>=5 if sur)
24.05699,0,female,0,23,1037,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,87463.0,14452.7344,30.0,white,14.0,4,0,0,no,0.699999809,0.7,no dnr,23.0,58.0,31.5,140.0,35.0,38.0,146.9375,2.0,1.29980469,4.0,146.0,7.349609,108.0,67.0,5.0,0.0,no(M2 and SIP pres)
77.30896,1,male,1,9,9,Coma,Coma,1,9.0,under $11k,31303.0,14452.7344,32.0,white,43.0,1,1,0,no,0.049999982,0.02,dnr after sadm,6.0,149.0,1.59985352,124.0,25.0,37.79688,177.5,3.5,0.79992676,1.29980469,142.0,7.429688,159.0,53.0,3615.0,2.2851562,<2 mo. follow-up
22.116,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,195681.0,59831.8125,52.5,black,105.0,1,0,0,no,0.149999976,0.15,dnr after sadm,30.0,64.0,16.1992188,126.0,40.0,36.39844,147.5,3.5,1.01,0.79992676,149.0,7.399414,168.0,20.0,1245.0,0.0,<2 mo. follow-up
61.487,1,male,0,39,431,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,$11-$25k,99152.0,14452.7344,24.0,black,47.0,22,1,0,no,0.199999928,0.15,no dnr,39.0,80.0,5.29980469,76.0,12.0,35.59375,333.3,3.5,0.39996338,1.0,142.0,7.419922,126.0,17.0,2502.0,0.0,adl>=4 (>=5 if sur)
43.65799,0,female,0,24,1036,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,42531.0,14452.7344,13.666664,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,24.0,53.0,12.7988281,140.0,10.0,38.29688,280.0,3.0996094,11.5,1.09985352,139.0,7.509766,156.0,39.0,1505.0,0.0,<2 mo. follow-up
61.465,1,male,1,53,53,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,261018.0,170933.125,38.0,white,34.0,5,0,0,yes,1.0,1.0,no dnr,53.0,81.0,13.3984375,76.0,20.0,36.59375,333.3,3.5,1.01,2.5,152.0,7.419922,178.0,55.0,1850.0,0.0,<2 mo. follow-up
56.23798,1,female,1,33,33,MOSF w/Malig,ARF/MOSF,1,17.0,$25-$50k,52458.0,14452.7344,19.0,white,39.0,1,0,0,metastatic,0.149999976,0.05,dnr after sadm,27.0,80.0,8.09960938,76.0,20.0,35.5,333.3,4.0996094,0.39996338,0.29998779,138.0,7.419922,91.0,14.0,1400.0,6.0,<2 mo. follow-up
77.22095,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,59938.0,14452.7344,40.0,white,81.0,15,0,0,metastatic,0.019999996,0.02,dnr after sadm,4.0,116.0,18.6992188,146.0,11.0,38.0,270.0,3.199707,0.39996338,1.29980469,136.0,7.459961,165.0,23.0,2580.0,1.0,<2 mo. follow-up
78.04797,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,112976.0,14452.7344,56.0,black,86.0,12,0,1,no,0.0,0.0,no dnr,4.0,95.0,6.39941406,94.0,20.0,37.0,333.3,3.5,0.59997559,1.0,140.0,7.419922,115.0,4.0,3250.0,0.0,<2 mo. follow-up
55.57797,0,male,0,23,1034,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,103968.0,14452.7344,40.333313,white,45.0,1,0,0,no,0.699999809,0.5,no dnr,23.0,0.0,15.6992188,0.0,0.0,37.09375,159.15625,3.5,0.89990234,1.19995117,127.0,7.379883,249.0,20.0,420.0,6.0,no(M2 and SIP pres)
46.73499,1,male,0,4,100,Colon Cancer,Cancer,1,13.0,$11-$25k,3267.0,14452.7344,11.0,white,9.0,1,0,0,metastatic,0.649999619,0.35,no dnr,4.0,69.0,9.19921875,80.0,26.0,36.5,260.0,3.5,1.01,6.79980469,130.0,7.339844,100.0,82.0,0.0,0.0,no(M2 and SIP pres)
64.047,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,28500.0,14452.7344,12.0,white,32.0,4,0,0,no,0.849999905,0.75,no dnr,11.0,103.0,14.7988281,64.0,27.0,36.19531,227.5,4.5996094,4.19921875,3.79980469,147.0,7.359375,196.0,104.0,1120.0,4.0,<2 mo. follow-up
57.82599,1,female,1,13,13,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,26240.0,14452.7344,30.0,white,51.0,1,0,0,yes,0.399999857,0.25,dnr after sadm,9.0,127.0,12.0,116.0,30.0,38.0,283.3125,2.5996094,6.5,2.5,141.0,7.509766,142.0,68.0,1585.0,6.0,<2 mo. follow-up
59.39798,1,male,0,17,86,CHF,COPD/CHF/Cirrhosis,4,13.0,$11-$25k,59896.0,14452.7344,24.333328,white,55.0,1,1,0,no,0.899999619,0.6,no dnr,17.0,124.0,17.8984375,104.0,22.0,36.39844,267.5,2.3999023,0.69995117,0.39996338,130.0,7.449219,111.0,15.0,1175.0,0.0,adl>=4 (>=5 if sur)
68.40198,1,male,0,13,43,Colon Cancer,Cancer,4,16.0,>$50k,24885.0,14452.7344,16.5,white,40.0,1,1,0,metastatic,0.699999809,0.2,no dnr,13.0,123.0,10.0996094,124.0,30.0,38.0,188.5625,3.5,1.01,1.19995117,142.0,7.269531,124.0,29.0,2745.0,1.0,<2 mo. follow-up
58.08398,1,female,1,11,11,Coma,Coma,1,12.0,under $11k,59286.0,14452.7344,26.0,black,42.0,22,1,0,no,0.699999809,0.1,dnr after sadm,3.0,69.0,5.09960938,60.0,16.0,36.59375,333.3,3.5,1.09985352,1.39990234,133.0,7.419922,102.0,23.0,2175.0,0.0,<2 mo. follow-up
77.24298,1,male,0,16,88,COPD,COPD/CHF/Cirrhosis,2,19.0,under $11k,32418.0,14452.7344,19.666656,white,35.0,4,0,0,no,0.75,0.7,no dnr,16.0,81.0,8.59960938,76.0,16.0,36.0,333.3,4.0,0.39996338,0.89990234,143.0,7.419922,99.0,9.0,2502.0,2.0,<2 mo. follow-up
71.66296,1,male,0,14,218,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,33404.0,14452.7344,14.0,white,8.0,8,1,0,no,0.5,0.5,dnr before sadm,0.0,50.0,15.3984375,64.0,16.0,37.89844,314.25,3.199707,1.01,1.09985352,137.0,7.429688,118.0,13.0,3060.0,7.0,adl>=4 (>=5 if sur)
67.57599,1,male,0,10,1029,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,9614.0,14452.7344,5.5,white,16.0,1,0,0,yes,0.699999809,0.5,no dnr,10.0,71.0,7.89941406,66.0,18.0,36.5,328.5625,3.5,0.69995117,1.39990234,140.0,7.40918,88.0,22.0,2502.0,2.7451172,<2 mo. follow-up
47.51797,0,male,0,13,1029,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,30760.0,14452.7344,16.5,black,50.0,2,0,0,no,0.899999619,0.85,no dnr,13.0,121.0,6.59960938,124.0,10.0,34.59375,186.0,1.8999023,5.5,1.0,132.0,7.429688,268.0,15.0,2350.0,0.0,adl>=4 (>=5 if sur)
26.045,0,male,0,31,1029,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,59995.78781114967,14452.7344,40.75,black,80.0,1,0,0,yes,0.099999964,0.1,no dnr,14.58258953168044,51.0,12.0,114.0,24.0,38.19531,276.625,3.5,1.01,3.39990234,133.0,7.399414,296.0,57.0,3085.0,5.0,no(M2 and SIP pres)
68.10394,0,female,0,19,1029,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,24701.0,14452.7344,7.0,black,30.0,1,1,0,no,0.799999714,0.7,no dnr,19.0,66.0,95.296875,120.0,32.0,37.5,118.35938,2.7998047,2.5,3.59960938,142.0,7.329102,90.0,59.0,1285.0,2.0,SIP>=30
88.20795,1,female,0,12,23,Coma,Coma,1,12.0,under $11k,6887.0,14452.7344,7.5,black,28.0,1,0,0,no,0.049999982,0.02,dnr after sadm,1.0,147.0,8.8984375,70.0,24.0,36.09375,404.0,3.5,0.89990234,0.89990234,142.0,7.40918,179.0,23.0,5150.0,2.0,<2 mo. follow-up
65.84497,1,male,0,4,61,Lung Cancer,Cancer,1,5.0,$11-$25k,4475.0,14452.7344,22.610928270087555,black,11.0,2,0,0,metastatic,0.799999714,0.7,no dnr,4.0,55.0,7.89941406,104.0,22.0,37.79688,122.0,3.5,0.5,1.29980469,147.0,7.429688,191.0,15.0,1975.0,0.0,<2 mo. follow-up
71.66095,1,male,0,11,313,Colon Cancer,Cancer,2,18.0,under $11k,20083.0,11667.2031,7.5,hispanic,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,103.0,12.0,84.0,16.0,36.59375,333.3,3.8999023,0.59997559,0.89990234,139.0,7.419922,140.0,8.0,4150.0,1.0,no(M2 and SIP pres)
70.59497,1,male,0,17,26,MOSF w/Malig,ARF/MOSF,1,17.0,under $11k,44516.0,14452.7344,21.666656,white,42.0,3,0,0,yes,0.799999714,0.7,no dnr,17.0,57.0,0.09999084,146.0,27.0,35.89844,177.5,2.199707,0.79992676,4.5,142.0,7.349609,209.0,97.0,185.0,1.0,<2 mo. follow-up
47.75598,1,male,1,7,7,Coma,Coma,1,12.0,under $11k,20038.0,14452.7344,24.0,black,35.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,117.0,11.5996094,134.0,21.0,37.09375,274.25,3.5,0.5,2.09960938,135.0,7.369141,97.0,67.0,2030.0,1.8833008,<2 mo. follow-up
49.52197,0,female,0,9,1026,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,53838.0,14452.7344,16.5,white,43.0,9,0,0,metastatic,0.699999809,0.5,no dnr,9.0,117.0,10.5,64.0,10.0,38.39844,312.0,3.5,1.01,0.59997559,141.0,7.399414,111.0,7.0,4050.0,1.0,no(M2 and SIP pres)
67.50397,1,female,0,8,64,Lung Cancer,Cancer,1,14.0,>$50k,12570.0,14452.7344,18.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,130.0,7.5,116.0,26.0,36.0,323.3125,3.5,0.59997559,1.5,138.0,7.399414,253.0,44.0,2350.0,7.0,<2 mo. follow-up
45.89999,1,male,0,12,212,Lung Cancer,Cancer,0,10.0,$11-$25k,10337.0,14452.7344,7.0,hispanic,12.0,1,0,0,metastatic,0.799999714,0.6,no dnr,12.0,71.0,6.69921875,54.0,20.0,36.5,333.3,3.5,1.01,1.19995117,138.0,7.419922,72.0,12.0,2160.0,0.0,no(M2 and SIP pres)
35.099,0,male,0,15,1025,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,50602.0,14452.7344,18.0,white,52.0,1,0,0,no,0.599999905,0.5,no dnr,15.0,69.0,10.5996094,70.0,12.0,36.5,253.3125,3.5,1.01,0.89990234,134.0,7.469727,130.0,23.0,1170.0,5.0,SIP>=30
50.43399,1,female,0,25,61,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,155353.0,14452.7344,33.25,black,54.0,20,0,0,no,0.599999905,0.5,no dnr,25.0,76.0,16.8984375,126.0,32.0,37.69531,105.0,3.5,1.01,1.0,137.0,7.479492,134.0,22.0,3320.0,0.0,<2 mo. follow-up
65.23999,1,male,1,58,58,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,205279.0,14452.7344,33.5,white,57.0,14,0,0,yes,0.699999809,0.5,dnr after sadm,49.0,58.0,11.0,96.0,36.0,36.59375,304.0,3.5,1.01,2.09960938,133.0,7.509766,165.0,60.0,4485.0,0.0,<2 mo. follow-up
74.57397,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,93795.0,14452.7344,41.0,white,76.0,20,0,0,yes,0.199999928,0.05,no dnr,5.0,73.0,5.79980469,70.0,16.0,36.5,333.3,3.8999023,1.89990234,1.29980469,136.0,7.419922,155.0,25.0,1400.0,1.0,<2 mo. follow-up
67.81696,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,>$50k,53038.0,14452.7344,47.0,white,82.0,2,0,0,no,0.599999905,0.4,dnr after sadm,6.0,79.0,10.0,70.0,20.0,36.79688,333.3,3.5,0.89990234,1.5,142.0,7.419922,153.0,22.0,2502.0,0.0,<2 mo. follow-up
79.21698,0,female,0,71,1023,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,175574.0,120693.125,40.25,white,37.0,1,0,0,no,0.5,0.45,no dnr,71.0,103.0,9.3984375,114.0,35.0,36.39844,433.3125,3.5,1.01,0.89990234,131.0,7.429688,343.0,13.0,1555.0,0.0,SIP>=30
70.75696,1,male,1,8,8,COPD,COPD/CHF/Cirrhosis,0,3.0,$11-$25k,39964.0,14452.7344,35.5,white,43.0,6,0,0,no,0.25,0.05,dnr after sadm,4.0,63.0,6.29980469,116.0,20.0,38.19531,333.3,3.5,0.59997559,0.59997559,139.0,7.419922,96.0,8.0,2502.0,0.0,<2 mo. follow-up
65.74097,0,male,0,40,1021,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,144457.0,96665.3125,24.5,white,27.0,8,0,0,no,0.5,0.45,no dnr,40.0,73.0,8.3984375,66.0,28.0,36.0,333.3,3.5,0.79992676,3.59960938,136.0,7.419922,196.0,92.0,1030.0,0.0,no(M2 and SIP pres)
63.33197,1,male,0,8,143,Colon Cancer,Cancer,1,9.0,$25-$50k,10891.0,14452.7344,10.0,white,5.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,145.0,7.0,146.0,24.0,38.09375,596.0,3.0,0.5,0.89990234,137.0,7.449219,98.0,4.0,3300.0,0.0,no(M2 and SIP pres)
64.63196,1,female,0,14,29,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,50961.0,14452.7344,20.666656,white,35.0,10,0,0,metastatic,0.099999964,0.0,dnr after sadm,3.0,41.0,2.39990234,126.0,18.0,35.79688,115.0,2.0,6.59960938,2.0,133.0,7.329102,42.0,31.0,360.0,0.0,<2 mo. follow-up
58.59799,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,0.0,under $11k,47649.0,14452.7344,48.0,white,44.0,9,1,0,metastatic,0.399999857,0.1,dnr after sadm,3.0,134.0,14.5,120.0,34.0,36.39844,226.65625,3.5,0.39996338,2.89990234,138.0,7.239258,155.0,61.0,2070.0,7.0,<2 mo. follow-up
56.63199,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,77474.0,14452.7344,41.5,white,29.0,7,0,0,no,0.699999809,0.5,dnr after sadm,6.0,112.0,22.5976562,67.0,20.0,36.79688,333.3,3.2998047,1.0,1.29980469,136.0,7.419922,93.0,16.0,700.0,0.0,<2 mo. follow-up
84.50696,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,57715.0,14452.7344,34.5,white,45.0,8,0,0,no,0.699999809,0.5,dnr after sadm,2.0,78.0,7.19921875,75.0,22.0,34.69531,450.0,3.5,1.01,1.39990234,138.0,7.459961,101.0,23.0,1450.0,3.1162109,<2 mo. follow-up
71.02496,1,female,1,7,7,Coma,Coma,0,13.0,under $11k,21937.0,14452.7344,26.5,black,38.0,1,0,0,no,0.049999982,0.05,dnr after sadm,4.0,116.0,11.0,160.0,10.0,38.19531,266.625,3.5,1.01,0.89990234,128.0,7.489258,144.0,16.0,2700.0,0.0,<2 mo. follow-up
55.22498,0,male,0,7,1017,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,7268.0,14452.7344,7.0,black,27.0,1,0,0,no,0.799999714,0.6,no dnr,7.0,73.0,8.09960938,130.0,22.0,37.69531,212.5,2.5996094,1.59985352,0.89990234,137.0,7.389648,107.0,18.0,1000.0,1.0,no(M2 and SIP pres)
76.81897,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,53023.0,14452.7344,39.5,white,56.0,5,0,0,yes,0.5,0.4,dnr after sadm,6.0,136.0,14.1992188,126.0,30.0,37.89844,127.5,2.3999023,0.39996338,1.19995117,143.0,7.399414,181.0,56.0,2390.0,1.0,<2 mo. follow-up
69.17499,0,male,0,69,1016,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,176045.0,118669.938,25.0,white,41.0,4,0,0,no,0.899999619,0.8,no dnr,69.0,49.0,10.5,134.0,35.0,36.09375,39.0,3.5,0.39996338,0.39996338,128.0,7.419922,169.0,12.0,1835.0,6.0,adl>=4 (>=5 if sur)
29.59299,1,female,0,20,507,MOSF w/Malig,ARF/MOSF,3,12.0,$11-$25k,62432.0,14452.7344,20.0,white,51.0,10,0,0,yes,0.799999714,0.75,no dnr,20.0,109.0,21.5,60.0,8.0,38.19531,214.28125,2.7998047,1.01,0.59997559,134.0,7.439453,94.0,16.0,1390.0,0.0,no(M2 and SIP pres)
66.18195,1,female,0,12,58,Colon Cancer,Cancer,1,12.0,$11-$25k,15025.0,14452.7344,16.0,white,19.0,1,0,0,metastatic,0.75,0.5,no dnr,12.0,79.0,14.1992188,66.0,22.0,36.69531,245.6875,3.5,1.01,5.59960938,141.0,7.429688,207.0,50.0,483.0,0.0,<2 mo. follow-up
67.93994,1,male,0,9,227,Lung Cancer,Cancer,2,10.0,under $11k,11082.0,14452.7344,9.5,black,39.0,1,0,0,metastatic,0.699999809,0.4,no dnr,9.0,131.0,16.5,154.0,25.0,34.5,90.0,1.5,0.29998779,3.19970703,135.0,7.439453,271.0,41.0,165.0,4.0,no(M2 and SIP pres)
29.09499,0,male,0,6,1014,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,2940.0,14452.7344,7.0,black,23.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,111.0,18.3984375,134.0,36.0,36.5,115.0,3.5,1.89990234,1.0,142.0,7.40918,288.0,21.0,1270.0,0.0,SIP>=30
63.573,0,male,0,12,1013,Colon Cancer,Cancer,1,3.0,under $11k,32942.0,18734.1562,22.5,other,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,74.0,11.0,80.0,30.0,36.89844,246.0,2.699707,1.01,0.5,117.0,7.5,106.0,9.0,2840.0,0.0,no(M2 and SIP pres)
72.71497,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,67741.0,14452.7344,23.0,white,56.0,21,0,0,no,0.299999952,0.15,dnr after sadm,5.0,103.0,4.09960938,110.0,9.0,37.89844,225.6875,3.5,0.69995117,3.59960938,143.0,7.329102,91.0,81.0,2357.0,5.0,<2 mo. follow-up
60.01398,0,male,0,20,1012,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,94502.0,63838.9688,24.0,white,44.0,5,0,0,no,0.599999905,0.6,no dnr,20.0,69.0,19.6992188,76.0,31.0,36.59375,433.3125,3.5,0.89990234,3.29980469,138.0,7.449219,103.0,98.0,1835.0,2.3203125,no(M2 and SIP pres)
71.66895,0,male,0,9,1012,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,10752.0,14452.7344,9.0,white,23.0,1,0,0,no,0.799999714,0.8,no dnr,9.0,73.0,1.79980469,116.0,32.0,35.39844,92.29688,3.5,19.5976562,3.79980469,128.0,7.449219,177.0,106.0,4090.0,2.6357422,<2 mo. follow-up
30.853,0,male,0,9,1012,ARF/MOSF w/Sepsis,ARF/MOSF,0,1.0,$25-$50k,14503.0,14452.7344,15.5,white,16.0,1,0,0,no,1.0,1.0,no dnr,9.0,87.0,27.3984375,206.0,34.0,38.5,130.0,3.2998047,6.89941406,4.0,126.0,7.329102,668.0,86.0,107.0,0.0,no(M2 and SIP pres)
47.09399,0,female,0,29,1012,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,under $11k,48037.0,14452.7344,21.5,white,42.0,1,0,0,no,0.799999714,0.8,no dnr,29.0,53.0,16.0976562,76.0,29.0,38.0,146.9375,1.7998047,4.59960938,1.19995117,148.0,7.449219,81.0,19.0,3770.0,0.0,SIP>=30
49.35199,0,male,0,4,1012,CHF,COPD/CHF/Cirrhosis,3,14.0,>$50k,5036.0,14452.7344,6.0,hispanic,15.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,108.0,6.89941406,96.0,22.0,38.69531,333.3,3.5996094,0.59997559,0.89990234,136.0,7.419922,69.0,14.0,3700.0,0.494751,no(M2 and SIP pres)
59.35397,0,male,0,29,1009,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,96798.0,58078.9375,27.5,white,32.0,2,1,0,no,0.299999952,0.2,no dnr,29.0,77.0,7.39941406,54.0,22.0,36.19531,270.0,2.7299805,1.01,4.19921875,131.0,7.529297,82.0,64.0,2190.0,0.0,no(M2 and SIP pres)
81.78796,0,female,0,8,1009,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,30732.0,14452.7344,10.5,white,36.0,3,0,0,no,0.949999809,0.9,no dnr,8.0,56.0,15.5,106.0,10.0,36.59375,324.0,2.5,4.59960938,3.79980469,145.0,7.30957,95.0,62.0,2367.0,1.0,no(M2 and SIP pres)
74.56494,0,male,0,18,1009,ARF/MOSF w/Sepsis,ARF/MOSF,0,3.0,$11-$25k,65352.0,14452.7344,30.666656,black,33.0,1,0,0,no,0.5,0.4,no dnr,18.0,103.0,8.19921875,116.0,26.0,36.79688,211.40625,3.2998047,1.01,8.19921875,133.0,7.329102,184.0,103.0,1260.0,0.0,no(M2 and SIP pres)
19.866,0,female,0,26,1009,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,44245.0,27406.2344,15.5,white,30.0,1,0,0,no,0.899999619,0.9,no dnr,26.0,73.0,3.0,114.0,24.0,36.79688,333.3,2.0,13.7988281,0.69995117,129.0,7.419922,160.0,9.0,3050.0,4.0,no(M2 and SIP pres)
54.17398,1,male,0,6,459,Colon Cancer,Cancer,1,12.0,>$50k,9281.0,14452.7344,10.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,129.0,13.1992188,96.0,55.0,36.09375,292.0,3.5,1.01,0.69995117,135.0,7.389648,184.0,21.0,1480.0,1.0,no(M2 and SIP pres)
72.38098,1,male,1,63,63,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,215817.0,140466.0,30.0,white,24.0,4,1,0,no,0.599999905,0.55,dnr after sadm,61.0,117.0,25.6992188,106.0,30.0,35.69531,172.5,3.5,1.01,1.19995117,143.0,7.479492,124.0,31.0,2830.0,0.0,<2 mo. follow-up
39.11298,1,female,1,65,65,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,211744.0,147594.125,33.5,black,76.0,5,0,0,no,0.399999857,0.4,dnr after sadm,54.0,89.0,8.59960938,94.0,24.0,36.89844,309.5,2.7998047,0.59997559,0.59997559,140.0,7.40918,158.0,8.0,2025.0,6.0,<2 mo. follow-up
45.50598,1,male,1,13,13,Cirrhosis,COPD/CHF/Cirrhosis,3,15.0,$25-$50k,136951.0,14452.7344,51.5,white,46.0,4,0,0,no,0.199999928,0.2,no dnr,13.0,114.0,9.29882812,70.0,24.0,36.69531,333.3,3.5,1.01,1.29980469,141.0,7.419922,97.0,24.0,2502.0,0.0,<2 mo. follow-up
38.00098,0,male,0,10,1007,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,20619.0,14452.7344,15.0,white,29.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,97.0,18.5,170.0,60.0,36.19531,216.65625,3.5,0.5,0.79992676,132.0,7.469727,144.0,12.0,3716.0,0.0,no(M2 and SIP pres)
82.57098,1,female,1,8,8,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,18749.0,14452.7344,24.5,white,40.0,1,0,0,no,0.5,0.5,dnr after sadm,4.0,48.0,0.09999084,124.0,11.0,35.29688,444.0,1.1999512,0.59997559,1.59985352,133.0,7.369141,76.0,23.0,1430.0,1.0,<2 mo. follow-up
60.84299,0,female,0,11,1006,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,54325.0,14452.7344,35.5,white,10.0,2,0,0,no,0.899999619,0.8,no dnr,11.0,106.0,60.0,74.0,22.0,36.39844,417.375,3.5,1.01,6.39941406,142.0,7.319336,70.0,59.0,2502.0,0.0,no(M2 and SIP pres)
47.39499,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,27011.0,18225.9375,31.0,black,84.0,1,0,0,no,0.199999928,0.1,dnr after sadm,4.0,112.0,18.0,60.0,40.0,38.09375,333.3,3.5,1.01,0.79992676,139.0,7.419922,179.0,11.0,575.0,3.375,<2 mo. follow-up
57.728,1,male,0,6,86,Lung Cancer,Cancer,2,18.0,>$50k,13046.0,14452.7344,17.0,white,18.0,1,1,0,metastatic,0.799999714,0.6,no dnr,6.0,105.0,5.89941406,86.0,24.0,37.69531,333.3,3.5,0.39996338,0.59997559,131.0,7.419922,151.0,6.0,2502.0,0.0,<2 mo. follow-up
62.49698,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,73631.0,14452.7344,45.0,other,104.0,1,1,0,metastatic,0.0,0.0,dnr after sadm,3.0,110.0,6.59960938,96.0,16.0,35.69531,333.3,3.5,0.29998779,0.79992676,138.0,7.419922,185.0,17.0,2225.0,1.4541016,<2 mo. follow-up
61.09,1,female,1,5,5,Coma,Coma,1,10.0,under $11k,16863.0,14452.7344,20.0,black,25.0,1,0,0,no,0.099999964,0.1,dnr after sadm,5.0,73.0,51.3984375,106.0,36.0,36.5,126.51562,2.5,1.59985352,1.19995117,150.0,7.479492,100.0,34.0,1810.0,0.0,<2 mo. follow-up
55.017,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,3.0,under $11k,27510.0,14452.7344,47.0,white,93.0,6,0,0,yes,0.0,0.0,dnr after sadm,1.0,111.0,16.0976562,126.0,18.0,37.79688,340.0,2.199707,1.19995117,0.69995117,141.0,7.529297,156.0,24.0,975.0,1.0,<2 mo. follow-up
73.86694,1,male,0,13,174,CHF,COPD/CHF/Cirrhosis,2,19.0,>$50k,60145.0,34741.5312,34.0,white,27.0,3,0,0,no,0.799999714,0.7,no dnr,13.0,57.0,12.7988281,116.0,28.0,38.0,276.0,3.5,1.01,1.09985352,130.0,7.389648,176.0,20.0,2065.0,0.0,no(M2 and SIP pres)
46.349,0,female,0,41,1004,COPD,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,104262.0,69474.75,26.25,white,35.0,1,0,0,no,0.5,0.5,no dnr,41.0,73.0,10.0996094,60.0,16.0,35.69531,333.3,2.699707,0.5,0.59997559,139.0,7.419922,133.0,10.0,3350.0,0.0,no(M2 and SIP pres)
33.56598,0,female,0,18,1002,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,67523.0,14452.7344,23.333328,white,44.0,4,0,0,no,0.799999714,0.8,no dnr,18.0,82.0,19.796875,120.0,24.0,36.0,333.3,3.0,0.5,0.69995117,137.0,7.419922,145.0,12.0,2502.0,0.0,no(M2 and SIP pres)
52.44897,1,male,0,5,328,Lung Cancer,Cancer,1,11.0,under $11k,6349.0,14452.7344,23.0,white,13.0,1,0,0,metastatic,1.0,0.8,no dnr,5.0,133.0,2.19970703,136.0,26.0,36.29688,308.0,2.2998047,1.0,1.19995117,155.0,7.509766,95.0,35.0,3765.0,0.494751,no(M2 and SIP pres)
45.25098,0,male,0,32,1001,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,144548.0,14452.7344,36.25,black,49.0,3,0,0,no,0.5,0.5,no dnr,32.0,162.0,5.79980469,126.0,8.0,38.69531,303.3125,2.5996094,4.5,3.0,136.0,7.429688,59.0,121.0,2195.0,1.9951172,no(M2 and SIP pres)
51.58698,1,female,0,12,199,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,23850.0,15265.5391,23.0,other,35.0,2,0,0,metastatic,0.599999905,0.3,no dnr,12.0,59.0,2.29980469,124.0,40.0,38.19531,172.5,3.5,1.0,0.89990234,151.0,7.479492,171.0,31.0,1790.0,0.0,<2 mo. follow-up
27.644,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,55573.0,14452.7344,37.0,black,64.0,5,0,0,no,0.899999619,0.9,no dnr,5.0,51.0,0.29998779,124.0,30.0,35.19531,168.5625,3.5,1.01,1.39990234,132.0,7.349609,164.0,50.0,1091.0,1.954834,<2 mo. follow-up
44.08197,0,male,0,24,998,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,45380.0,28963.5625,20.0,white,56.0,1,0,0,no,0.599999905,0.4,no dnr,24.0,39.0,16.296875,124.0,32.0,38.29688,113.75,3.5,0.79992676,2.09960938,128.0,7.339844,215.0,47.0,2920.0,0.0,no(M2 and SIP pres)
79.67096,1,male,0,28,515,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,57108.0,34602.7188,25.25,white,24.0,1,0,0,no,0.299999952,0.15,dnr after sadm,2.0,46.0,4.39941406,74.0,10.0,38.89844,197.5,1.6999512,1.01,0.89990234,135.0,7.419922,115.0,17.0,1830.0,6.0,adl>=4 (>=5 if sur)
67.09094,1,male,0,10,568,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,59995.78781114967,14452.7344,26.5,white,33.0,1,1,0,no,0.849999905,0.75,no dnr,14.58258953168044,52.0,11.0996094,110.0,42.0,38.69531,253.3125,3.5,1.01,1.29980469,148.0,7.429688,135.0,31.0,3065.0,4.0,no(M2 and SIP pres)
100.67896,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,3920.0,14452.7344,8.0,black,41.0,1,1,0,no,0.5,0.5,dnr after sadm,1.0,70.0,5.39941406,64.0,8.0,35.79688,177.5,3.5,1.01,1.29980469,138.0,7.5,128.0,38.0,1545.0,7.0,<2 mo. follow-up
84.13995,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,105122.0,61753.4375,35.0,white,77.0,9,0,0,no,0.399999857,0.3,dnr after sadm,3.0,83.0,7.09960938,73.0,20.0,37.59375,333.3,3.2998047,0.29998779,1.0,143.0,7.419922,100.0,10.0,2502.0,1.0,<2 mo. follow-up
56.71198,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,88913.0,55612.4375,44.666657,white,56.0,11,1,0,no,0.5,0.4,dnr after sadm,12.0,134.0,17.6992188,224.0,8.0,37.89844,330.0,2.199707,0.5,0.89990234,135.0,7.489258,85.0,16.0,2750.0,1.0,<2 mo. follow-up
53.00497,1,male,0,4,107,Lung Cancer,Cancer,1,12.0,>$50k,3597.0,2311.5449,10.0,white,19.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,49.0,17.0,134.0,12.0,38.59375,140.0,3.5,1.01,0.5,133.0,7.359375,150.0,16.0,665.0,0.0,<2 mo. follow-up
72.31494,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,under $11k,75777.0,48117.125,47.0,black,45.0,4,1,0,no,0.299999952,0.2,dnr after sadm,12.0,139.0,16.0,114.0,32.0,38.59375,324.0,3.5,0.59997559,0.5,136.0,7.449219,278.0,19.0,5190.0,6.0,<2 mo. follow-up
70.31097,0,male,0,30,992,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,70800.0,52140.75,21.75,white,32.0,1,0,0,no,0.599999905,0.5,no dnr,30.0,61.0,11.0996094,76.0,31.0,38.19531,191.40625,2.8999023,2.59960938,4.69921875,142.0,7.379883,80.0,90.0,2215.0,2.0336914,no(M2 and SIP pres)
61.72498,1,female,1,6,6,Coma,Coma,0,9.0,under $11k,38154.0,26825.9531,44.0,white,31.0,5,0,0,no,0.0,0.0,dnr after sadm,2.0,107.0,18.0,146.0,7.0,38.29688,292.0,3.3999023,0.5,1.29980469,147.0,7.459961,376.0,23.0,1660.0,2.0869141,<2 mo. follow-up
68.13696,1,female,0,4,163,Colon Cancer,Cancer,3,12.0,>$50k,7693.0,4762.9375,7.0,white,12.0,1,1,0,metastatic,0.699999809,0.5,no dnr,4.0,108.0,16.5,76.0,24.0,36.5,164.0,4.3994141,0.69995117,1.0,137.0,7.30957,126.0,22.0,2050.0,1.9821777,no(M2 and SIP pres)
81.94897,0,female,0,14,991,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,51340.0,32087.4375,21.0,white,30.0,14,0,0,no,0.0,0.0,no dnr,14.0,62.0,5.69921875,110.0,46.0,36.09375,165.6875,3.5,1.01,4.89941406,128.0,7.399414,148.0,76.0,1495.0,0.0,no(M2 and SIP pres)
79.034,0,male,0,10,991,COPD,COPD/CHF/Cirrhosis,1,5.0,$11-$25k,14735.0,9159.4531,10.5,white,22.0,1,0,0,no,0.879999638,0.8,no dnr,10.0,117.0,2.89990234,116.0,25.0,36.19531,190.0,3.0996094,0.19998169,0.19998169,132.0,7.509766,213.0,18.0,3375.0,2.0,no(M2 and SIP pres)
69.60699,1,female,0,3,324,Lung Cancer,Cancer,1,13.0,under $11k,5958.0,2977.6484,3.0,white,11.0,1,0,0,metastatic,0.899999619,0.7,no dnr,3.0,128.0,32.5,134.0,8.0,35.79688,266.625,1.8999023,0.79992676,0.69995117,141.0,7.459961,159.0,25.0,800.0,1.8388672,SIP>=30
72.00494,1,female,0,6,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,68144.0,47068.375,32.0,white,59.0,24,0,0,no,0.199999928,0.5,dnr after sadm,3.0,73.0,11.2988281,50.0,14.0,36.79688,333.3,3.0996094,0.59997559,0.5,136.0,7.419922,92.0,11.0,450.0,3.0,<2 mo. follow-up
54.65799,1,male,0,6,330,Colon Cancer,Cancer,1,12.0,under $11k,8430.0,4578.5547,11.0,white,10.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,103.0,10.1992188,140.0,24.0,36.5,225.90625,3.5,1.01,0.79992676,136.0,7.459961,108.0,11.0,0.0,1.6433106,<2 mo. follow-up
36.38098,0,male,0,18,989,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,41443.0,27296.5,22.0,white,36.0,3,0,0,no,0.649999619,0.6,no dnr,18.0,70.0,4.0,80.0,28.0,36.09375,333.3,3.5,3.69970703,1.19995117,139.0,7.419922,88.0,13.0,3670.0,4.0,SIP>=30
72.56097,1,female,1,32,32,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,263761.0,154728.25,35.25,white,66.0,40,1,0,no,0.5,0.4,dnr after sadm,28.0,111.0,23.296875,110.0,10.0,35.89844,306.625,2.0996094,1.39990234,1.19995117,135.0,7.419922,253.0,8.0,2502.0,0.0,<2 mo. follow-up
69.224,0,female,0,74,988,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,112202.0,73917.9375,14.0,white,42.0,4,0,0,no,0.75,0.7,no dnr,74.0,69.0,20.796875,116.0,45.0,36.89844,210.0,6.0,1.01,1.69995117,134.0,7.5,101.0,59.0,2885.0,0.494751,no(M2 and SIP pres)
69.41296,1,male,1,3,3,Coma,Coma,2,14.0,under $11k,22805.0,13870.9531,30.0,white,78.0,2,1,0,no,0.0,0.0,dnr after sadm,3.0,124.0,10.5,50.0,52.0,38.69531,121.42188,3.5,1.69995117,0.89990234,132.0,7.379883,223.0,10.0,3115.0,1.6760254,<2 mo. follow-up
92.07898,1,male,1,17,17,Coma,Coma,1,4.0,under $11k,21422.0,15316.3672,15.333328,black,49.0,1,0,0,no,0.099999964,0.05,dnr after sadm,2.0,139.0,13.5,52.0,20.0,36.0,333.3,3.5,0.39996338,1.69995117,141.0,7.419922,156.0,26.0,4530.0,3.0,<2 mo. follow-up
79.60596,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,124058.0,84398.0625,34.0,white,43.0,17,1,0,no,0.25,0.2,no dnr,15.0,109.0,5.19921875,106.0,28.0,38.09375,240.0,3.0996094,0.79992676,0.79992676,136.0,7.5,105.0,7.0,2175.0,1.0,<2 mo. follow-up
60.08197,1,female,1,6,6,Coma,Coma,2,12.0,under $11k,20261.0,12103.0781,35.0,white,46.0,1,0,0,no,0.25,0.1,dnr after sadm,3.0,109.0,11.3984375,130.0,42.0,38.19531,328.5625,2.3999023,0.5,1.19995117,146.0,7.40918,101.0,11.0,5445.0,2.2875977,<2 mo. follow-up
43.60599,0,male,0,15,985,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,>$50k,47040.0,14452.7344,29.0,black,39.0,1,0,0,no,0.5,0.5,no dnr,15.0,130.0,12.6992188,105.0,22.0,36.0,333.3,3.5,1.01,1.19995117,138.0,7.419922,102.0,10.0,2502.0,0.0,no(M2 and SIP pres)
52.90598,1,female,0,185,441,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,387733.0,289438.25,38.25,white,36.0,6,1,0,no,0.5,0.25,no dnr,185.0,66.0,14.8984375,120.0,30.0,38.0,260.0,3.5,1.01,1.29980469,135.0,7.459961,362.0,17.0,2130.0,5.0,<2 mo. follow-up
56.36099,1,male,0,4,292,Lung Cancer,Cancer,0,14.0,$25-$50k,3364.0,2276.2129,4.0,white,5.0,1,0,0,metastatic,0.75,0.6,no dnr,4.0,75.0,13.0,72.0,6.0,36.19531,180.0,2.2998047,1.01,1.19995117,141.0,7.449219,168.0,21.0,1925.0,1.5546875,no(M2 and SIP pres)
46.17398,1,female,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,191962.0,110909.062,35.0,other,38.0,2,0,0,no,0.299999952,0.25,no dnr,39.0,51.0,12.7988281,114.0,8.0,36.79688,286.625,3.5,1.01,1.29980469,133.0,7.429688,138.0,11.0,3760.0,0.0,<2 mo. follow-up
75.55597,1,male,0,10,339,Colon Cancer,Cancer,2,11.0,$11-$25k,24408.0,13726.4297,23.0,other,34.0,1,1,0,metastatic,0.699999809,0.5,no dnr,10.0,122.0,17.3984375,56.0,26.0,36.09375,177.125,2.0,0.69995117,0.69995117,141.0,7.419922,205.0,14.0,2180.0,0.0,no(M2 and SIP pres)
74.06696,0,female,0,63,984,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,351646.0,235729.75,32.0,white,48.0,39,0,0,no,0.0,0.0,dnr after sadm,1.0,117.0,11.0996094,104.0,22.0,38.09375,333.3,3.5,0.89990234,0.79992676,136.0,7.419922,126.0,6.0,1200.0,2.4677734,adl>=4 (>=5 if sur)
77.97095,1,male,0,4,757,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,12064.0,6601.418,21.0,white,47.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,110.0,13.0996094,114.0,10.0,36.19531,280.0,3.5,1.01,1.39990234,147.0,7.419922,149.0,32.0,1190.0,0.0,<2 mo. follow-up
64.79395,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,48334.0,14452.7344,52.0,white,95.0,15,0,0,metastatic,0.149999976,0.05,dnr after sadm,3.0,55.0,10.1992188,120.0,34.0,35.89844,154.28125,3.5,1.01,3.79980469,138.0,7.229492,83.0,58.0,65.0,0.0,<2 mo. follow-up
69.62396,1,male,0,5,78,Colon Cancer,Cancer,1,14.0,>$50k,8843.0,4625.3203,16.0,white,24.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,121.0,10.0996094,124.0,16.0,38.89844,184.0,3.5,3.79980469,1.79980469,149.0,7.479492,151.0,55.0,5600.0,1.0,no(M2 and SIP pres)
66.41498,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,63235.0,43191.6875,49.0,white,67.0,3,0,0,no,0.299999952,0.25,dnr after sadm,10.0,69.0,9.29882812,114.0,33.0,38.0,233.3125,2.699707,0.89990234,0.89990234,134.0,7.489258,135.0,17.0,2980.0,6.0,<2 mo. follow-up
43.88797,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,33859.0,20129.8125,40.0,white,101.0,6,0,0,no,0.699999809,0.5,dnr after sadm,2.0,73.0,11.5996094,66.0,43.0,36.89844,171.40625,3.5,1.01,0.59997559,143.0,7.459961,144.0,19.0,5270.0,1.300293,<2 mo. follow-up
64.60498,1,female,0,11,685,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,20922.0,14122.8906,19.5,white,67.0,6,0,0,yes,0.799999714,0.75,no dnr,11.0,77.0,11.8984375,84.0,10.0,38.39844,205.0,3.5,1.01,0.59997559,135.0,7.359375,131.0,7.0,4025.0,1.0,no(M2 and SIP pres)
25.83699,0,male,0,13,979,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,37859.0,26204.4531,36.0,white,36.0,1,0,0,no,0.699999809,0.7,no dnr,13.0,55.0,17.5976562,100.0,9.0,35.69531,120.0,3.5,2.5,6.39941406,132.0,7.439453,163.0,52.0,0.0,0.0,no(M2 and SIP pres)
53.27597,1,male,0,5,112,Colon Cancer,Cancer,1,12.0,under $11k,4133.0,2510.0586,11.0,white,11.0,1,0,0,metastatic,0.699999809,0.3,no dnr,5.0,117.0,11.1992188,64.0,28.0,36.89844,333.3,3.8999023,0.89990234,0.69995117,138.0,7.419922,269.0,14.0,2575.0,1.6984863,<2 mo. follow-up
76.84094,1,female,1,29,29,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,197568.0,125466.125,50.25,white,60.0,8,0,0,no,0.5,0.125,dnr after sadm,29.0,0.0,15.6992188,0.0,8.0,35.39844,172.5,1.0,1.09985352,2.69970703,129.0,7.299805,393.0,40.0,0.0,0.0,<2 mo. follow-up
73.45099,1,male,0,17,28,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,49163.0,31625.6719,13.333328,white,28.0,4,0,0,no,0.049999982,0.0,dnr after sadm,4.0,137.0,12.8984375,66.0,12.0,38.19531,222.84375,3.5,1.01,0.89990234,150.0,7.5,113.0,20.0,4445.0,6.0,<2 mo. follow-up
54.74298,1,male,0,11,92,Lung Cancer,Cancer,1,12.0,$25-$50k,12573.0,7762.1016,9.0,white,31.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,36.0,1.19995117,30.0,33.0,37.59375,93.875,3.5,1.01,1.89990234,143.0,7.40918,98.0,32.0,110.0,0.0,adl>=4 (>=5 if sur)
68.35297,1,male,0,9,36,Lung Cancer,Cancer,1,12.0,under $11k,10104.0,6418.5742,11.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,76.0,9.8984375,56.0,8.0,36.0,332.0,3.5,1.01,1.29980469,131.0,7.379883,116.0,17.0,1165.0,0.0,<2 mo. follow-up
66.00995,1,male,0,11,430,CHF,COPD/CHF/Cirrhosis,4,14.0,$11-$25k,16025.0,12553.1641,11.0,white,25.0,1,1,0,yes,0.75,0.5,no dnr,11.0,153.0,15.8984375,140.0,14.0,36.89844,280.0,4.0,0.39996338,0.59997559,143.0,7.479492,186.0,23.0,2510.0,0.494751,no(M2 and SIP pres)
62.15698,0,female,0,18,977,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,43691.0,27075.0625,22.0,black,53.0,1,0,0,no,0.699999809,0.6,no dnr,18.0,109.0,6.39941406,170.0,10.0,38.69531,210.0,1.5,1.89990234,0.5,137.0,7.40918,94.0,12.0,1963.0,3.6245117,no(M2 and SIP pres)
68.27399,0,male,0,15,977,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,$11-$25k,51694.0,31447.4531,26.666656,white,35.0,1,0,0,no,0.799999714,0.7,no dnr,15.0,75.0,9.0,100.0,21.0,36.19531,333.3,3.5,0.5,1.29980469,141.0,7.419922,91.0,9.0,4575.0,0.0,no(M2 and SIP pres)
68.89294,1,male,1,22,22,COPD,COPD/CHF/Cirrhosis,3,4.0,under $11k,43100.0,27005.6719,17.666656,black,22.0,1,0,0,no,0.599999905,0.5,dnr after sadm,18.0,57.0,11.3984375,150.0,10.0,39.89844,102.0,3.5,2.09960938,0.79992676,136.0,7.349609,101.0,18.0,2080.0,1.0,<2 mo. follow-up
66.92694,1,female,0,6,104,Lung Cancer,Cancer,2,14.0,under $11k,8787.0,4992.8555,11.0,white,12.0,1,0,0,metastatic,0.599999905,0.2,no dnr,6.0,69.0,1.09985352,106.0,26.0,35.89844,472.0,2.5,1.5,1.19995117,127.0,7.399414,196.0,10.0,1680.0,2.0,<2 mo. follow-up
79.23297,1,female,0,14,865,COPD,COPD/CHF/Cirrhosis,2,7.0,under $11k,150446.0,95675.0625,18.0,white,22.0,35,0,0,no,0.5,0.4,no dnr,14.0,103.0,14.6992188,128.0,42.0,36.69531,364.0,1.8999023,6.39941406,2.19970703,147.0,7.389648,113.0,43.0,1670.0,0.0,SIP>=30
44.82999,1,female,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,4454.0,14452.7344,12.0,white,96.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,103.0,15.0,114.0,24.0,33.79688,256.5,2.0996094,9.79882812,1.0,141.0,7.40918,113.0,14.0,1575.0,3.8598633,<2 mo. follow-up
66.71295,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,130396.0,84253.5625,45.0,white,69.0,23,0,0,no,0.199999928,0.1,dnr after sadm,2.0,100.0,14.6992188,118.0,24.0,36.69531,276.625,3.5,1.01,1.09985352,135.0,7.469727,107.0,18.0,1445.0,0.0,<2 mo. follow-up
70.92694,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,113333.0,69972.8125,54.0,white,86.0,32,0,0,yes,0.299999952,0.3,no dnr,9.0,74.0,4.09960938,74.0,10.0,36.59375,290.4375,3.5,1.01,0.89990234,135.0,7.40918,210.0,22.0,2090.0,0.0,<2 mo. follow-up
64.07397,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,78530.0,48207.4375,37.333313,black,58.0,3,1,0,no,0.699999809,0.5,dnr after sadm,15.0,77.0,16.0976562,100.0,30.0,35.09375,90.0,3.5,1.01,1.5,146.0,7.229492,430.0,27.0,2502.0,2.2875977,<2 mo. follow-up
63.948,0,male,0,12,973,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,22745.0,13961.0625,28.5,black,36.0,1,0,0,no,0.599999905,0.6,no dnr,12.0,66.0,32.6953125,64.0,29.0,35.79688,134.0,2.0,1.01,1.59985352,132.0,7.399414,110.0,21.0,380.0,0.0,no(M2 and SIP pres)
66.47498,0,female,0,7,972,CHF,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,5886.0,4096.3672,10.5,black,27.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,65.0,16.6992188,104.0,40.0,36.5,200.0,2.3999023,22.5,1.19995117,139.0,7.459961,199.0,38.0,4450.0,1.1667481,no(M2 and SIP pres)
54.92398,1,male,1,6,6,Coma,Coma,2,12.0,under $11k,25869.0,19248.6094,16.0,white,38.0,6,0,0,no,0.699999809,0.5,dnr after sadm,1.0,67.0,4.5,100.0,22.0,36.0,333.3,3.5,0.39996338,1.0,139.0,7.419922,98.0,19.0,1500.0,2.609375,<2 mo. follow-up
57.91397,1,female,0,5,17,Lung Cancer,Cancer,1,12.0,>$50k,7104.0,14452.7344,8.0,white,25.0,1,0,0,metastatic,0.5,0.2,no dnr,5.0,71.0,13.5,73.0,25.0,36.69531,155.0,3.5,0.69995117,7.09960938,148.0,7.40918,200.0,57.0,1960.0,4.0,<2 mo. follow-up
30.84698,1,female,0,66,896,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,95845.0,64135.25,16.75,black,20.0,1,0,0,no,0.899999619,0.95,no dnr,66.0,65.0,14.7988281,50.0,12.0,36.89844,152.5,2.0996094,0.79992676,0.79992676,136.0,7.459961,108.0,18.0,780.0,3.2353516,<2 mo. follow-up
36.92499,1,female,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,151066.0,95726.5,33.25,white,45.0,1,0,0,no,0.599999905,0.6,dnr after sadm,14.0,129.0,11.3984375,56.0,45.0,39.39844,284.0,3.5,1.01,0.89990234,144.0,7.459961,243.0,12.0,2110.0,0.0,<2 mo. follow-up
44.32898,1,male,0,5,864,CHF,COPD/CHF/Cirrhosis,3,8.0,$25-$50k,59995.78781114967,14452.7344,11.0,white,22.0,1,1,0,no,0.799999714,0.7,no dnr,14.58258953168044,83.0,9.0,70.0,12.0,36.29688,333.3,3.5,1.01,1.01,140.0,7.419922,282.0,23.0,3800.0,0.494751,no(M2 and SIP pres)
47.37299,1,female,1,24,24,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,under $11k,101234.0,67325.0625,40.333313,black,82.0,1,0,0,no,0.5,0.5,dnr after sadm,20.0,97.0,28.796875,106.0,46.0,38.0,151.0,2.3999023,1.5,1.29980469,136.0,7.449219,87.0,17.0,2950.0,1.0,<2 mo. follow-up
67.53699,1,male,0,8,54,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,16884.0,10548.1094,17.0,black,20.0,2,0,0,no,0.5,0.5,no dnr,8.0,100.0,6.0,84.0,24.0,36.29688,176.1875,3.5,0.69995117,0.69995117,140.0,7.339844,115.0,18.0,3025.0,4.0,<2 mo. follow-up
59.76199,1,male,0,6,136,Lung Cancer,Cancer,1,6.0,$11-$25k,13286.0,6966.7109,15.0,black,22.0,1,0,0,metastatic,0.5,0.25,no dnr,6.0,77.0,7.09960938,80.0,20.0,36.09375,333.3,3.699707,0.5,0.79992676,139.0,7.419922,157.0,12.0,2650.0,2.0,SIP>=30
67.55096,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,49159.0,30353.2031,31.0,white,98.0,12,0,0,yes,0.699999809,0.5,no dnr,3.0,53.0,8.8984375,110.0,23.0,36.0,197.9375,3.5,1.01,3.09960938,129.0,7.339844,108.0,103.0,380.0,1.9743652,<2 mo. follow-up
77.659,1,male,0,61,162,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,219246.0,146584.75,40.75,white,44.0,3,0,0,no,0.699999809,0.5,no dnr,61.0,115.0,9.5,70.0,23.0,36.09375,333.3,3.699707,0.79992676,1.19995117,142.0,7.419922,112.0,7.0,4600.0,0.0,adl>=4 (>=5 if sur)
72.42395,1,male,0,21,656,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,30845.0,20463.3125,19.666656,white,42.0,1,0,0,no,0.849999905,0.75,no dnr,21.0,65.0,20.3984375,136.0,12.0,39.59375,208.0,1.8999023,0.39996338,0.89990234,135.0,7.40918,72.0,7.0,2010.0,2.8266602,<2 mo. follow-up
37.71698,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,123504.0,83198.125,42.25,white,64.0,1,0,0,no,0.25,0.25,dnr after sadm,10.0,55.0,12.1992188,74.0,38.0,35.5,290.0,3.5,1.01,5.79980469,139.0,7.40918,218.0,120.0,110.0,6.0,<2 mo. follow-up
73.22699,1,female,0,113,173,Coma,Coma,0,2.0,under $11k,173742.0,123581.25,28.0,white,18.0,1,0,0,no,0.699999809,0.5,dnr after sadm,38.0,121.0,8.29882812,124.0,32.0,36.09375,162.5,3.5,1.5,0.69995117,145.0,7.519531,179.0,35.0,1755.0,1.0,adl>=4 (>=5 if sur)
56.05698,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,15.0,$11-$25k,44639.0,29698.5469,12.0,black,94.0,22,1,0,no,0.099999964,0.1,dnr after sadm,2.0,0.0,15.7988281,0.0,0.0,35.5,232.5,3.5,1.01,2.0,153.0,7.449219,378.0,26.0,5635.0,3.0,<2 mo. follow-up
63.84698,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,20.0,>$50k,39993.0,25133.3281,3.0,white,48.0,5,1,0,no,0.699999809,0.5,dnr after sadm,2.0,73.0,14.6992188,130.0,32.0,36.19531,300.0,2.5996094,1.09985352,2.0,141.0,7.439453,150.0,28.0,443.0,3.5327148,<2 mo. follow-up
68.73895,0,male,0,12,965,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,11075.0,7144.2578,11.0,other,15.0,1,0,0,no,0.899999619,0.8,dnr after sadm,10.0,156.0,14.5996094,124.0,32.0,38.19531,208.5625,3.5,1.01,0.89990234,146.0,7.439453,297.0,47.0,2010.0,2.753418,<2 mo. follow-up
67.35095,1,female,0,7,69,Lung Cancer,Cancer,1,11.0,$25-$50k,12901.0,7968.5469,3.5,white,19.0,1,0,0,metastatic,0.899999619,0.75,no dnr,7.0,69.0,14.3984375,114.0,36.0,36.29688,87.75,3.5,1.01,1.0,138.0,7.429688,160.0,23.0,3050.0,3.0,<2 mo. follow-up
43.047,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,20626.0,15471.5938,48.0,white,28.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,3.0,59.0,17.0,116.0,16.0,38.79688,145.4375,2.8999023,0.69995117,1.09985352,137.0,7.479492,128.0,19.0,1250.0,2.3613281,<2 mo. follow-up
50.71597,1,male,0,5,297,Colon Cancer,Cancer,1,14.0,under $11k,5168.0,3181.8672,13.0,black,29.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,69.0,16.0976562,70.0,14.0,38.19531,212.5,1.6999512,1.69995117,1.69995117,142.0,7.419922,199.0,53.0,3865.0,1.0,no(M2 and SIP pres)
58.448,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,53336.0,33709.875,43.5,white,47.0,2,0,0,yes,0.299999952,0.2,dnr after sadm,9.0,82.0,10.0,72.0,20.0,37.0,333.3,4.1992188,0.39996338,0.89990234,141.0,7.419922,96.0,12.0,2502.0,5.0,<2 mo. follow-up
36.62097,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,40649.0,26247.6094,42.0,white,81.0,1,0,0,no,0.5,0.5,dnr after sadm,7.0,69.0,19.8984375,66.0,20.0,37.39844,148.96875,2.699707,1.01,3.89990234,130.0,7.5,237.0,62.0,2970.0,0.0,<2 mo. follow-up
41.92697,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,206256.0,138603.875,47.5,white,41.0,22,0,0,no,0.75,0.7,dnr after sadm,7.0,113.0,7.69921875,74.0,22.0,33.79688,230.59375,1.8999023,0.69995117,1.09985352,135.0,7.329102,290.0,15.0,2240.0,0.0,<2 mo. follow-up
24.101,0,female,0,10,958,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,10079.0,6416.2148,12.5,white,36.0,1,0,0,no,1.0,0.75,no dnr,10.0,49.0,13.0,60.0,6.0,36.79688,265.0,2.3999023,1.59985352,2.0,150.0,7.369141,100.0,66.0,1490.0,3.0,adl>=4 (>=5 if sur)
76.97198,1,male,0,8,608,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,17070.0,10639.7812,11.5,white,34.0,1,1,0,no,0.799999714,0.75,no dnr,8.0,73.0,8.5,46.0,16.0,35.79688,152.375,3.5,1.09985352,1.79980469,144.0,7.429688,88.0,29.0,1000.0,0.0,no(M2 and SIP pres)
68.62994,0,male,0,69,960,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,134910.0,14452.7344,22.75,black,24.0,8,0,0,no,0.5,0.3,no dnr,69.0,39.0,1.0,144.0,28.0,38.89844,160.0,2.2998047,2.19970703,5.0,143.0,7.219727,70.0,68.0,975.0,0.0,adl>=4 (>=5 if sur)
50.23099,1,male,0,44,312,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,151085.0,98833.75,27.25,white,74.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,10.0,52.0,9.3984375,64.0,16.0,36.5,333.3,3.0996094,0.59997559,0.79992676,138.0,7.419922,294.0,9.0,5525.0,4.0,adl>=4 (>=5 if sur)
52.91199,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,101406.0,63986.6562,34.0,white,34.0,30,0,0,yes,0.5,0.2,dnr after sadm,3.0,151.0,9.79882812,134.0,30.0,35.29688,174.0,3.5,0.39996338,4.0,132.0,7.369141,129.0,50.0,670.0,3.0,<2 mo. follow-up
62.86398,0,male,0,5,957,CHF,COPD/CHF/Cirrhosis,4,16.0,$25-$50k,59995.78781114967,14452.7344,7.0,white,13.0,1,1,0,no,0.899999619,0.8,no dnr,14.58258953168044,0.0,7.19921875,0.0,10.0,36.09375,115.0,2.3999023,17.6992188,1.09985352,139.0,7.399414,51.0,23.0,195.0,0.0,no(M2 and SIP pres)
38.78198,1,male,0,8,63,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,8195.0,5477.7969,8.5,white,17.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,153.0,18.8984375,160.0,40.0,36.19531,156.0,3.5,0.69995117,0.5,131.0,7.429688,78.0,6.0,1945.0,0.494751,<2 mo. follow-up
42.83398,0,female,0,68,956,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,293248.0,206553.625,42.0,black,44.0,28,0,0,no,0.75,0.65,no dnr,68.0,53.0,17.5,120.0,14.0,38.39844,147.125,2.5996094,1.0,1.0,135.0,7.489258,124.0,16.0,2320.0,0.0,adl>=4 (>=5 if sur)
63.44397,1,female,1,4,4,Coma,Coma,1,12.0,under $11k,20151.0,13220.0391,38.0,white,72.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,70.0,5.59960938,62.0,20.0,36.39844,333.3,3.5,0.89990234,0.89990234,138.0,7.419922,79.0,11.0,2502.0,2.6313477,<2 mo. follow-up
71.10699,1,female,0,14,79,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,11445.0,7709.0078,7.333332,white,26.0,1,0,0,yes,0.599999905,0.5,dnr after sadm,2.0,55.0,39.59375,104.0,10.0,36.59375,164.0,3.5,1.59985352,1.89990234,133.0,7.339844,253.0,122.0,618.0,0.0,no(M2 and SIP pres)
53.73898,1,female,1,86,86,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,264539.0,180809.375,36.75,white,64.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,4.0,119.0,9.3984375,44.0,42.0,39.79688,363.3125,3.5,1.01,1.09985352,143.0,7.519531,133.0,17.0,2230.0,0.0,adl>=4 (>=5 if sur)
19.14899,0,male,0,16,953,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,43894.0,29063.0938,13.333328,black,32.0,5,0,0,no,0.899999619,0.9,no dnr,16.0,79.0,7.59960938,92.0,26.0,39.0,333.3,3.0,0.59997559,2.09960938,139.0,7.419922,99.0,21.0,2425.0,5.0,no(M2 and SIP pres)
68.31995,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,56203.0,35560.4375,34.0,white,102.0,6,0,0,no,0.699999809,0.5,dnr after sadm,3.0,99.0,2.5,100.0,24.0,36.69531,333.3,3.7998047,0.59997559,1.29980469,138.0,7.419922,339.0,23.0,2502.0,6.0,<2 mo. follow-up
72.99097,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,62598.0,41066.875,19.0,black,49.0,1,0,0,yes,0.699999809,0.6,dnr after sadm,12.0,75.0,5.79980469,56.0,16.0,36.59375,333.3,4.0996094,0.39996338,1.29980469,138.0,7.419922,249.0,48.0,2225.0,1.0,<2 mo. follow-up
72.90295,1,male,0,8,36,Lung Cancer,Cancer,2,12.0,under $11k,5657.0,3751.4981,6.5,white,52.0,1,1,0,metastatic,1.0,0.95,no dnr,8.0,107.0,14.2988281,124.0,10.0,35.69531,127.5,3.2998047,0.5,2.5,131.0,7.519531,103.0,128.0,3145.0,6.0,<2 mo. follow-up
19.96199,0,female,0,28,951,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,105433.0,71099.1875,36.25,black,53.0,1,0,0,no,0.75,0.7,no dnr,28.0,75.0,10.8984375,72.0,36.0,37.89844,228.0,3.8999023,1.01,1.39990234,134.0,7.289062,105.0,21.0,6710.0,0.0,no(M2 and SIP pres)
63.74298,0,female,0,15,950,CHF,COPD/CHF/Cirrhosis,1,15.0,$25-$50k,50256.0,30249.4531,18.333328,white,27.0,1,0,0,no,0.899999619,0.75,no dnr,15.0,119.0,16.5976562,66.0,34.0,35.29688,376.0,3.199707,1.0,0.79992676,139.0,7.449219,199.0,27.0,3485.0,2.0,no(M2 and SIP pres)
59.48798,1,male,0,9,149,Colon Cancer,Cancer,1,12.0,$11-$25k,11417.0,7147.6914,8.0,white,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,70.0,7.69921875,64.0,18.0,36.39844,333.3,3.199707,0.5,1.0,139.0,7.419922,113.0,9.0,4000.0,0.0,SIP>=30
31.797,0,male,0,51,950,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,113949.0,73953.375,31.75,white,53.0,1,1,0,no,0.599999905,0.6,dnr after sadm,10.0,109.0,3.39990234,116.0,28.0,36.5,320.0,3.0,0.39996338,0.89990234,129.0,7.479492,76.0,13.0,3820.0,1.0,no(M2 and SIP pres)
65.45898,1,female,0,9,41,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,12912.0,9768.9141,15.0,white,31.0,1,0,0,no,0.989999771,0.95,no dnr,9.0,60.0,15.5996094,140.0,36.0,35.0,333.3,2.199707,18.0976562,6.29980469,126.0,7.419922,111.0,51.0,80.0,2.0,<2 mo. follow-up
74.672,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,48434.0,28172.8281,44.0,white,96.0,16,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,61.0,21.296875,104.0,35.0,38.5,225.0,2.2998047,28.5,6.89941406,131.0,7.349609,142.0,110.0,1320.0,1.112793,<2 mo. follow-up
58.40698,1,male,0,5,11,Lung Cancer,Cancer,1,12.0,$25-$50k,7980.0,4603.7109,6.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,68.0,2.0,106.0,31.0,36.0,172.5,2.0996094,22.0976562,3.5,136.0,7.349609,76.0,117.0,130.0,2.2324219,<2 mo. follow-up
39.34598,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,37006.0,24103.6406,32.0,black,33.0,3,0,0,no,0.019999996,0.0,dnr after sadm,4.0,59.0,9.59960938,60.0,32.0,36.19531,301.625,3.5,1.01,2.5,143.0,7.40918,235.0,99.0,1180.0,0.0,<2 mo. follow-up
41.90799,1,female,1,23,23,MOSF w/Malig,ARF/MOSF,1,13.0,$11-$25k,113704.0,73262.5625,28.333328,white,37.0,4,0,0,metastatic,0.199999928,0.1,dnr after sadm,23.0,127.0,8.8984375,150.0,10.0,39.59375,218.0,2.8999023,1.79980469,0.79992676,132.0,7.399414,107.0,8.0,630.0,4.0,<2 mo. follow-up
77.26495,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,53824.0,32864.5625,24.333328,white,65.0,1,1,0,no,0.799999714,0.8,dnr after sadm,16.0,111.0,6.79980469,66.0,24.0,36.89844,333.3,3.5,1.01,3.69970703,141.0,7.419922,169.0,26.0,1500.0,3.0,<2 mo. follow-up
65.67798,1,male,0,16,230,ARF/MOSF w/Sepsis,ARF/MOSF,4,2.0,under $11k,30435.0,20161.2969,16.333328,black,59.0,1,0,0,yes,0.5,0.5,no dnr,16.0,171.0,11.0,116.0,26.0,37.69531,393.3125,3.5,1.01,1.19995117,145.0,7.599609,144.0,25.0,1565.0,0.0,no(M2 and SIP pres)
49.29199,1,female,0,14,221,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$25-$50k,23026.0,14854.1719,16.333328,white,28.0,1,0,0,metastatic,0.299999952,0.2,no dnr,14.0,75.0,10.7988281,110.0,24.0,36.5,309.5,3.3999023,0.5,0.69995117,134.0,7.459961,101.0,9.0,1700.0,1.0,<2 mo. follow-up
77.17999,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,32283.0,20509.1406,15.333328,black,53.0,4,1,0,no,0.099999964,0.1,dnr after sadm,6.0,67.0,19.8984375,124.0,14.0,38.89844,250.0,3.5,0.5,0.69995117,147.0,7.40918,186.0,3.0,4880.0,4.0,<2 mo. follow-up
74.52399,0,male,0,17,944,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,74630.0,46074.6562,19.666656,white,55.0,14,1,0,no,0.699999809,0.5,no dnr,17.0,129.0,19.1992188,136.0,12.0,39.09375,124.0,1.7998047,0.89990234,0.39996338,140.0,7.389648,118.0,11.0,1485.0,0.0,no(M2 and SIP pres)
76.70898,1,male,1,46,46,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,167401.0,99435.5,33.75,white,40.0,1,0,0,no,0.699999809,0.5,dnr after sadm,41.0,69.0,8.19921875,100.0,12.0,36.19531,271.375,3.5,1.01,0.59997559,134.0,7.449219,146.0,12.0,2600.0,4.0,<2 mo. follow-up
66.59497,1,female,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,under $11k,5718.0,3435.2969,16.0,hispanic,66.0,1,0,0,no,0.0,0.0,dnr after sadm,2.0,41.0,21.1992188,134.0,48.0,35.59375,72.0,2.2998047,10.5996094,0.69995117,141.0,7.479492,85.0,16.0,1430.0,7.0,<2 mo. follow-up
67.02795,1,male,0,6,101,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,13864.0,8040.1992,22.0,white,35.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,68.0,10.0,66.0,22.0,36.59375,364.0,3.5,1.01,0.79992676,132.0,7.5,87.0,7.0,1190.0,1.0,no(M2 and SIP pres)
47.26099,1,male,0,7,266,CHF,COPD/CHF/Cirrhosis,2,6.0,$11-$25k,5337.0,3614.2812,10.0,black,26.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,63.0,7.59960938,100.0,20.0,37.09375,333.3,3.5,0.39996338,1.19995117,142.0,7.419922,51.0,6.0,3200.0,2.0,no(M2 and SIP pres)
49.69199,1,male,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,30257.0,22688.4844,32.0,white,68.0,2,0,0,no,0.299999952,0.3,dnr after sadm,4.0,30.0,1.19995117,0.0,10.0,37.19531,246.0,3.5,2.09960938,4.0,137.0,7.289062,154.0,99.0,120.0,0.0,<2 mo. follow-up
49.5,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,92135.0,57447.5938,53.333313,white,69.0,6,1,0,no,0.599999905,0.6,dnr after sadm,15.0,67.0,4.5,130.0,28.0,36.79688,185.6875,3.2998047,1.01,0.69995117,143.0,7.459961,285.0,25.0,4300.0,3.0,<2 mo. follow-up
72.87598,1,male,0,7,193,Lung Cancer,Cancer,3,16.0,under $11k,6623.0,4288.4531,8.5,white,9.0,1,0,0,metastatic,0.899999619,0.6,no dnr,7.0,135.0,16.3984375,116.0,28.0,35.89844,370.3125,3.5,0.59997559,1.29980469,137.0,7.459961,262.0,29.0,1458.0,0.0,no(M2 and SIP pres)
21.59299,1,male,0,20,342,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,35222.0,22459.4531,21.333328,white,4.0,1,0,0,no,0.799999714,0.7,no dnr,20.0,63.0,30.5976562,144.0,25.0,38.89844,74.0,2.3999023,0.89990234,0.79992676,130.0,7.319336,111.0,20.0,2390.0,1.9145508,Coma or Intub
65.27295,1,male,0,11,843,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,31903.0,19699.6562,22.0,white,45.0,7,0,0,no,0.5,0.4,no dnr,11.0,118.0,17.1992188,114.0,34.0,38.69531,413.3125,3.2998047,1.0,0.59997559,136.0,7.479492,124.0,6.0,3670.0,0.0,no(M2 and SIP pres)
40.30099,1,female,0,7,291,Lung Cancer,Cancer,1,16.0,$25-$50k,5085.0,3449.3496,9.5,white,40.0,1,0,0,metastatic,0.799999714,0.5,no dnr,7.0,0.0,23.0976562,0.0,0.0,39.79688,368.0,3.5,3.19970703,6.09960938,135.0,7.419922,187.0,67.0,0.0,0.0,no(M2 and SIP pres)
51.09097,0,male,0,60,940,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,167620.0,98773.0625,28.25,white,71.0,12,0,0,no,0.699999809,0.5,no dnr,60.0,58.0,22.0976562,95.0,9.0,35.89844,163.25,2.199707,1.79980469,1.39990234,128.0,7.399414,332.0,33.0,8340.0,2.0,SIP>=30
31.59499,0,male,0,10,940,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,27143.0,16342.8125,16.5,black,53.0,2,0,0,no,0.699999809,0.5,no dnr,10.0,106.0,12.5,94.0,21.0,36.0,388.875,3.5,0.59997559,0.89990234,137.0,7.30957,126.0,22.0,2502.0,0.0,no(M2 and SIP pres)
39.797,0,male,0,5,940,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,5901.0,3753.3652,12.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,109.0,28.296875,64.0,20.0,37.79688,508.6875,3.5,1.01,0.69995117,130.0,7.479492,245.0,18.0,2502.0,1.0,no(M2 and SIP pres)
58.33499,0,male,0,105,939,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,298711.0,201417.625,43.5,white,40.0,1,0,0,no,0.399999857,0.4,no dnr,105.0,55.0,10.3984375,110.0,14.0,36.09375,170.0,3.5,1.01,0.5,141.0,7.389648,196.0,3.0,2480.0,5.0,SIP>=30
59.34598,1,male,1,6,6,Coma,Coma,1,0.0,$11-$25k,26989.0,19152.7812,33.0,black,16.0,3,0,0,no,0.009999998,0.0,dnr after sadm,5.0,138.0,7.59960938,84.0,22.0,36.29688,333.3,4.0996094,1.0,1.0,140.0,7.419922,83.0,10.0,210.0,0.0,<2 mo. follow-up
52.94199,0,female,0,14,937,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,40230.0,24462.9844,20.666656,white,15.0,5,0,0,no,0.699999809,0.7,no dnr,14.0,81.0,100.0,104.0,11.0,36.39844,159.15625,3.5,1.01,3.89990234,135.0,7.319336,240.0,98.0,1356.0,0.0,no(M2 and SIP pres)
44.00497,1,male,0,19,441,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$11-$25k,42924.0,30731.9688,28.666656,white,11.0,2,0,0,no,0.799999714,0.8,dnr after sadm,12.0,62.0,15.6992188,134.0,30.0,35.89844,122.5,2.5996094,18.6992188,1.79980469,144.0,7.5,168.0,56.0,790.0,7.0,Coma or Intub
75.02295,1,male,0,8,168,Lung Cancer,Cancer,1,8.0,under $11k,9280.0,5833.0,10.0,white,23.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,65.0,7.5,114.0,28.0,38.09375,208.5625,2.5996094,1.59985352,1.79980469,146.0,7.359375,241.0,78.0,2020.0,0.0,no(M2 and SIP pres)
60.52798,1,female,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,334835.0,253204.0,21.25,white,49.0,73,1,0,yes,0.199999928,0.1,dnr after sadm,6.0,75.0,12.0,120.0,24.0,37.09375,333.3,1.5,0.89990234,0.79992676,136.0,7.419922,75.0,21.0,2502.0,0.0,<2 mo. follow-up
66.93799,0,male,0,38,934,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,135947.0,75008.0,33.0,white,70.0,4,0,0,yes,0.399999857,0.3,no dnr,38.0,63.0,10.3984375,104.0,20.0,37.59375,336.625,3.5,0.79992676,1.69995117,132.0,7.449219,245.0,33.0,880.0,2.0,adl>=4 (>=5 if sur)
69.70599,0,male,0,11,933,CHF,COPD/CHF/Cirrhosis,3,6.0,$25-$50k,23536.0,15357.625,24.0,white,52.0,2,0,0,no,0.699999809,0.5,no dnr,11.0,119.0,15.1992188,66.0,36.0,38.19531,303.3125,3.5,1.01,0.89990234,133.0,7.509766,200.0,7.0,2280.0,7.0,no(M2 and SIP pres)
70.43896,1,male,0,15,613,ARF/MOSF w/Sepsis,ARF/MOSF,3,4.0,under $11k,38926.0,25641.9844,24.333328,white,73.0,1,0,0,no,0.599999905,0.5,no dnr,15.0,79.0,0.69995117,114.0,45.0,36.19531,316.625,3.5,3.5,8.09960938,153.0,7.459961,186.0,144.0,3480.0,2.5576172,no(M2 and SIP pres)
92.15594,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,under $11k,11834.0,6943.1367,31.0,white,95.0,2,1,0,no,0.699999809,0.5,dnr after sadm,1.0,63.0,12.0,120.0,12.0,36.09375,263.3125,2.0,2.79980469,0.69995117,141.0,7.459961,140.0,19.0,2365.0,0.0,<2 mo. follow-up
45.59598,0,female,0,14,933,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,31083.0,20342.7344,8.666664,black,32.0,3,0,0,no,0.849999905,0.8,no dnr,14.0,96.0,7.29980469,70.0,20.0,36.29688,333.3,4.0996094,1.0,1.5,136.0,7.419922,139.0,31.0,2502.0,0.0,<2 mo. follow-up
21.85899,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,159990.0,98132.5,69.0,white,72.0,48,0,0,no,0.699999809,0.5,dnr after sadm,4.0,65.0,14.0996094,106.0,20.0,35.69531,333.3,3.8999023,1.01,0.89990234,128.0,7.419922,97.0,14.0,2502.0,2.0195312,<2 mo. follow-up
49.69199,1,female,1,110,110,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,536290.0,14452.7344,34.25,black,66.0,5,1,0,no,0.299999952,0.2,dnr after sadm,69.0,78.0,19.0976562,64.0,9.0,36.59375,380.0,2.2998047,1.59985352,5.0,129.0,7.379883,230.0,99.0,1290.0,1.0,adl>=4 (>=5 if sur)
70.83099,1,male,0,25,270,ARF/MOSF w/Sepsis,ARF/MOSF,3,4.0,under $11k,39684.0,25477.6406,12.5,other,33.0,1,1,0,no,0.799999714,0.75,no dnr,25.0,61.0,17.6992188,106.0,40.0,38.59375,177.5,2.0996094,0.89990234,3.29980469,151.0,7.469727,190.0,149.0,173.0,6.0,adl>=4 (>=5 if sur)
62.54599,1,male,0,13,189,MOSF w/Malig,ARF/MOSF,4,14.0,$25-$50k,40684.0,25259.9219,32.5,white,47.0,1,0,0,yes,0.699999809,0.5,no dnr,13.0,73.0,8.3984375,70.0,28.0,36.19531,191.40625,3.5,1.01,0.5,139.0,7.389648,80.0,16.0,1100.0,6.0,adl>=4 (>=5 if sur)
79.95294,1,male,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,101923.0,70486.75,34.5,black,36.0,1,0,0,no,0.599999905,0.5,dnr after sadm,23.0,119.0,37.296875,176.0,28.0,36.0,223.3125,2.2998047,0.29998779,0.69995117,142.0,7.5,148.0,47.0,1910.0,2.7651367,<2 mo. follow-up
60.20499,1,male,0,12,193,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,36077.0,22552.1875,34.0,white,55.0,1,1,0,no,0.399999857,0.25,no dnr,12.0,113.0,28.0976562,106.0,44.0,39.0,240.0,3.5,4.5,0.69995117,137.0,7.419922,117.0,8.0,4900.0,1.0,no(M2 and SIP pres)
58.09998,1,male,0,13,108,Lung Cancer,Cancer,2,12.0,under $11k,12119.0,7854.8711,7.5,white,13.0,1,0,0,metastatic,0.799999714,0.4,no dnr,13.0,27.0,15.5996094,135.0,12.0,37.89844,218.0,1.7998047,1.01,2.39990234,135.0,7.289062,43.0,48.0,140.0,2.8222656,<2 mo. follow-up
82.37396,1,female,0,20,826,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,$11-$25k,52865.0,36617.4062,25.666656,black,44.0,3,1,0,no,0.5,0.4,no dnr,20.0,53.0,17.0,70.0,34.0,38.79688,122.0,3.5,0.69995117,1.59985352,151.0,7.479492,185.0,28.0,2080.0,0.0,no(M2 and SIP pres)
70.18799,0,female,0,15,926,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,46529.0,31239.9219,27.0,black,23.0,1,0,0,no,0.25,0.2,no dnr,15.0,76.0,4.0,120.0,28.0,38.09375,333.3,2.199707,0.59997559,1.89990234,131.0,7.419922,103.0,48.0,1150.0,0.0,no(M2 and SIP pres)
66.44995,1,female,0,19,69,Coma,Coma,3,12.0,under $11k,28300.0,19586.7188,13.666664,black,52.0,1,1,0,no,0.799999714,0.7,dnr after sadm,1.0,145.0,26.0,144.0,35.0,39.0,84.60938,3.5,0.39996338,0.89990234,139.0,7.439453,94.0,19.0,2595.0,7.0,<2 mo. follow-up
72.43298,0,female,0,42,926,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,48857.0,32073.5781,14.25,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,42.0,71.0,7.0,64.0,22.0,36.59375,291.25,3.5,1.01,1.19995117,141.0,7.399414,197.0,20.0,1220.0,0.494751,no(M2 and SIP pres)
40.70398,1,male,0,71,99,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,207743.0,131070.938,25.75,black,32.0,1,0,0,no,0.699999809,0.5,dnr after sadm,39.0,79.0,7.59960938,116.0,24.0,37.79688,333.3,3.5,0.39996338,1.0,141.0,7.419922,103.0,14.0,1925.0,6.0,adl>=4 (>=5 if sur)
83.76495,1,male,0,4,99,CHF,COPD/CHF/Cirrhosis,3,9.0,$11-$25k,5175.0,3558.0781,17.0,white,29.0,1,1,0,no,0.5,0.25,no dnr,4.0,124.0,12.2988281,136.0,26.0,38.39844,142.0,4.5996094,0.19998169,1.29980469,144.0,7.419922,474.0,20.0,2155.0,3.0,adl>=4 (>=5 if sur)
37.80399,1,male,0,5,182,Lung Cancer,Cancer,1,12.0,under $11k,5296.0,3480.457,2.0,white,14.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,122.0,9.59960938,140.0,28.0,36.89844,333.3,3.5,1.01,1.0,140.0,7.419922,148.0,5.0,2502.0,1.7819824,<2 mo. follow-up
73.57996,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,2,14.0,$11-$25k,51620.0,33419.8125,29.5,white,60.0,12,1,0,yes,0.899999619,0.8,dnr after sadm,7.0,0.0,1.19995117,0.0,0.0,38.89844,93.32812,3.5,1.79980469,3.79980469,136.0,7.259766,91.0,88.0,1510.0,2.9594727,<2 mo. follow-up
27.13799,0,male,0,11,923,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,30684.0,20034.7188,29.5,white,29.0,1,0,0,no,0.699999809,0.7,no dnr,11.0,114.0,9.69921875,103.0,20.0,36.79688,361.875,3.5,0.5,0.79992676,123.0,7.469727,144.0,17.0,800.0,0.0,<2 mo. follow-up
33.53,0,female,0,4,922,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,5940.0,3547.0684,5.0,black,6.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,146.0,20.8984375,60.0,28.0,38.5,350.0,3.5,1.01,1.5,147.0,7.459961,102.0,31.0,2195.0,0.494751,no(M2 and SIP pres)
70.04199,1,male,1,14,14,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,58371.0,38666.5,36.0,white,47.0,2,0,0,no,0.649999619,0.5,dnr after sadm,14.0,123.0,20.0,135.0,33.0,38.79688,212.5,2.2998047,1.0,0.69995117,143.0,7.529297,98.0,14.0,1615.0,0.0,<2 mo. follow-up
48.83798,0,male,0,101,921,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,>$50k,562579.0,343860.25,44.5,white,49.0,67,0,0,no,0.899999619,0.9,no dnr,101.0,58.0,18.0,120.0,10.0,36.69531,151.0,1.5998535,0.39996338,2.5,141.0,7.359375,70.0,37.0,1935.0,1.0,adl>=4 (>=5 if sur)
23.99199,0,male,0,35,921,Coma,Coma,2,13.0,under $11k,204389.0,143170.875,27.0,white,53.0,8,0,0,no,0.699999809,0.5,no dnr,35.0,128.0,22.0976562,150.0,40.0,36.5,288.0,3.5,1.29980469,2.59960938,135.0,7.30957,214.0,45.0,2110.0,1.0,no(M2 and SIP pres)
49.383,1,female,0,5,231,Lung Cancer,Cancer,1,12.0,under $11k,7343.0,3871.666,11.0,white,14.0,1,0,0,metastatic,1.0,0.9,no dnr,5.0,108.0,12.0996094,135.0,35.0,36.09375,256.625,2.7998047,0.29998779,0.5,143.0,7.5,155.0,12.0,3155.0,2.0932617,<2 mo. follow-up
61.67599,1,male,1,5,5,Colon Cancer,Cancer,1,8.0,$11-$25k,2958.0,1935.3555,15.0,black,44.0,1,0,0,metastatic,0.0,0.0,no dnr,5.0,105.0,9.29882812,135.0,6.0,35.79688,395.1875,3.5,5.19921875,5.09960938,137.0,7.469727,383.0,101.0,1040.0,7.0,<2 mo. follow-up
74.97095,0,male,0,26,920,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,96936.0,58131.75,22.25,white,41.0,6,0,0,no,0.649999619,0.6,no dnr,26.0,70.0,14.1992188,120.0,29.0,38.79688,106.0,3.5,1.01,1.09985352,133.0,7.5,211.0,44.0,1175.0,0.0,<2 mo. follow-up
76.53699,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,17981.0,10559.3828,50.0,black,76.0,2,1,0,yes,0.699999809,0.5,no dnr,3.0,58.0,18.1992188,70.0,14.0,39.09375,96.65625,3.5,1.01,1.19995117,141.0,7.459961,104.0,36.0,1550.0,0.0,<2 mo. follow-up
63.96997,1,male,0,16,113,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,33433.0,19486.6562,22.666656,black,86.0,1,0,0,no,0.299999952,0.15,dnr after sadm,3.0,66.0,16.5976562,64.0,28.0,32.19531,333.3,2.2998047,2.09960938,1.39990234,151.0,7.419922,189.0,18.0,125.0,6.0,no(M2 and SIP pres)
80.58295,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,48776.0,28987.375,50.0,white,62.0,12,1,0,no,0.099999964,0.0,dnr after sadm,2.0,117.0,7.39941406,100.0,24.0,36.39844,240.0,3.5,1.01,1.29980469,141.0,7.449219,87.0,22.0,100.0,2.9082031,<2 mo. follow-up
75.56195,0,male,0,34,917,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,75121.0,48257.625,12.75,white,30.0,18,0,0,no,0.699999809,0.5,no dnr,34.0,80.0,5.69921875,125.0,22.0,35.69531,333.3,3.5,1.0,1.29980469,142.0,7.419922,78.0,21.0,1000.0,6.0,no(M2 and SIP pres)
83.46594,1,female,0,17,23,Coma,Coma,1,8.0,under $11k,41887.0,14452.7344,24.0,black,48.0,4,0,0,no,0.099999964,0.1,dnr after sadm,2.0,128.0,7.69921875,110.0,12.0,35.39844,264.0,3.5,24.0,10.8984375,131.0,7.509766,100.0,68.0,2980.0,0.0,<2 mo. follow-up
78.12195,1,male,0,13,341,COPD,COPD/CHF/Cirrhosis,4,6.0,under $11k,23784.0,14434.2188,20.0,white,40.0,1,1,0,yes,0.75,0.6,no dnr,13.0,57.0,3.29980469,115.0,12.0,36.0,117.76562,2.2998047,0.5,7.89941406,126.0,7.369141,374.0,73.0,900.0,5.0,SIP>=30
59.66599,1,male,0,5,233,Lung Cancer,Cancer,1,12.0,$11-$25k,7854.0,4179.0,14.0,white,16.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,102.0,12.8984375,114.0,24.0,36.39844,365.1875,3.7998047,0.39996338,1.29980469,144.0,7.429688,199.0,15.0,2502.0,2.0,<2 mo. follow-up
37.86697,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,35427.0,24140.5781,40.5,black,87.0,1,1,0,no,0.099999964,0.05,dnr after sadm,8.0,80.0,9.3984375,75.0,8.0,37.79688,368.0,3.5,1.01,0.5,142.0,7.419922,117.0,4.0,4520.0,2.9277344,<2 mo. follow-up
73.59296,0,male,0,30,916,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,100898.0,59514.1562,33.0,white,42.0,2,0,0,no,0.5,0.3,no dnr,30.0,115.0,16.796875,115.0,12.0,36.19531,128.5625,3.5,0.69995117,4.89941406,133.0,7.40918,108.0,72.0,4185.0,0.0,no(M2 and SIP pres)
68.33698,0,male,0,94,916,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,324557.0,193135.0,34.75,white,36.0,4,0,0,no,0.75,0.6,no dnr,94.0,73.0,5.09960938,128.0,20.0,36.39844,333.3,2.5,0.39996338,0.69995117,132.0,7.419922,520.0,6.0,200.0,0.0,adl>=4 (>=5 if sur)
37.55499,0,male,0,18,916,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,58201.0,41127.0938,27.0,white,60.0,2,0,0,no,0.799999714,0.7,no dnr,18.0,108.0,5.39941406,135.0,35.0,38.39844,142.5,1.5,8.5,1.09985352,145.0,7.399414,52.0,20.0,2180.0,0.0,no(M2 and SIP pres)
68.58295,1,male,1,6,6,Lung Cancer,Cancer,1,21.0,under $11k,9984.0,5991.3438,7.0,white,43.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,5.0,115.0,14.5,145.0,36.0,36.5,253.3125,2.8999023,0.19998169,2.0,134.0,7.469727,122.0,20.0,5510.0,2.2724609,<2 mo. follow-up
54.021,0,male,0,23,914,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,89819.0,52582.5938,28.666656,white,19.0,2,0,0,no,0.899999619,0.85,no dnr,23.0,92.0,5.09960938,70.0,20.0,37.0,333.3,1.0,3.79980469,0.79992676,136.0,7.419922,69.0,10.0,4900.0,0.0,SIP>=30
18.84999,0,male,0,27,914,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$25-$50k,112985.0,72790.5,18.0,white,48.0,4,0,0,no,0.75,0.75,no dnr,27.0,93.0,22.3984375,100.0,10.0,37.59375,182.5,2.3999023,6.19921875,5.89941406,137.0,7.319336,99.0,97.0,3040.0,0.0,no(M2 and SIP pres)
55.96698,0,female,0,22,913,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,81191.0,48240.375,25.666656,white,30.0,5,0,0,no,0.899999619,0.8,no dnr,22.0,163.0,14.3984375,55.0,14.0,38.29688,245.0,3.7998047,1.01,1.39990234,148.0,7.519531,192.0,16.0,3005.0,0.0,no(M2 and SIP pres)
67.81696,0,male,0,16,913,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,36085.0,22808.9688,18.666656,white,35.0,3,0,0,no,0.979999542,0.9,no dnr,16.0,88.0,6.59960938,60.0,42.0,38.39844,255.0,2.7998047,0.39996338,0.79992676,143.0,7.439453,96.0,16.0,5430.0,2.1010742,no(M2 and SIP pres)
43.87997,0,female,0,23,912,COPD,COPD/CHF/Cirrhosis,2,9.0,$25-$50k,35225.0,24241.7344,15.0,white,51.0,1,0,0,no,0.849999905,0.75,no dnr,23.0,75.0,6.0,60.0,8.0,38.09375,360.0,2.699707,1.01,0.59997559,137.0,7.479492,90.0,6.0,3140.0,6.0,no(M2 and SIP pres)
73.35199,1,male,0,6,259,Colon Cancer,Cancer,1,18.0,under $11k,8575.0,4780.0039,11.0,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,78.0,6.19921875,62.0,20.0,36.5,333.3,3.5996094,0.69995117,1.39990234,135.0,7.419922,78.0,44.0,1750.0,0.0,no(M2 and SIP pres)
66.95099,1,male,0,6,652,Colon Cancer,Cancer,1,12.0,$25-$50k,9823.0,5222.8516,12.0,white,16.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,144.0,12.2988281,70.0,37.0,35.59375,333.3,3.5,1.01,2.09960938,137.0,7.419922,190.0,126.0,1700.0,0.0,no(M2 and SIP pres)
27.28499,0,male,0,17,911,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,54747.0,33137.2188,28.0,white,24.0,1,0,0,no,0.699999809,0.7,no dnr,17.0,65.0,10.6992188,95.0,25.0,36.29688,120.0,1.8999023,1.01,3.0,127.0,7.379883,132.0,37.0,170.0,0.0,no(M2 and SIP pres)
65.23199,0,male,0,38,909,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,90020.0,53483.9688,22.5,white,37.0,4,0,0,no,0.75,0.65,no dnr,38.0,57.0,7.19921875,145.0,24.0,36.39844,333.3,3.5,2.79980469,1.39990234,130.0,7.419922,92.0,46.0,1700.0,0.0,no(M2 and SIP pres)
62.27197,1,male,0,12,44,Lung Cancer,Cancer,1,10.0,$11-$25k,12126.0,8072.0898,6.0,white,11.0,1,0,0,metastatic,0.599999905,0.2,dnr after sadm,5.0,58.0,7.79980469,65.0,44.0,35.0,188.5625,3.5,0.39996338,1.79980469,136.0,7.429688,191.0,25.0,330.0,6.0,<2 mo. follow-up
64.69495,1,male,1,18,18,CHF,COPD/CHF/Cirrhosis,4,7.0,$11-$25k,75950.0,43130.25,35.666657,white,40.0,2,0,0,no,0.899999619,0.8,dnr after sadm,17.0,30.0,13.5996094,0.0,0.0,37.19531,152.5,3.5,1.01,1.5,131.0,7.419922,169.0,25.0,72.0,4.0,<2 mo. follow-up
54.89697,1,female,0,8,127,Lung Cancer,Cancer,1,16.0,>$50k,6629.0,4383.3828,4.5,white,3.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,2.0,139.0,16.8984375,70.0,22.0,37.69531,280.9375,3.5,0.39996338,1.79980469,144.0,7.349609,99.0,66.0,2300.0,5.0,adl>=4 (>=5 if sur)
47.96198,1,male,0,11,814,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,37890.0,14452.7344,28.0,black,47.0,3,1,0,no,1.0,1.0,no dnr,11.0,55.0,33.1953125,50.0,12.0,39.09375,120.0,3.5,2.29980469,4.79980469,131.0,7.349609,69.0,75.0,144.0,4.0,SIP>=30
57.84,0,female,0,140,906,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,59995.78781114967,581140.0,37.75,white,45.0,66,0,0,yes,0.699999809,0.5,no dnr,140.0,148.0,20.1992188,115.0,28.0,36.29688,126.65625,2.5,1.01,3.79980469,147.0,7.439453,69.0,64.0,46.0,0.0,adl>=4 (>=5 if sur)
63.73199,0,female,0,47,903,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,143396.0,83986.8125,38.75,white,57.0,1,0,0,yes,0.599999905,0.5,no dnr,47.0,68.0,12.0,100.0,36.0,35.0,256.625,3.5,1.01,0.89990234,137.0,7.469727,173.0,30.0,2435.0,0.0,no(M2 and SIP pres)
72.32898,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,122706.0,70672.0625,38.666657,white,48.0,7,0,0,no,0.599999905,0.6,dnr after sadm,8.0,115.0,0.69995117,30.0,11.0,36.39844,188.5625,3.0996094,0.89990234,1.0,136.0,7.469727,96.0,18.0,4470.0,0.0,<2 mo. follow-up
62.89899,0,male,0,156,903,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,59995.78781114967,483192.5,48.5,white,44.0,28,0,0,no,0.399999857,0.064,no dnr,156.0,63.0,15.1992188,65.0,24.0,37.79688,257.125,2.2998047,0.69995117,1.69995117,143.0,7.369141,93.0,47.0,3015.0,1.0,adl>=4 (>=5 if sur)
44.16699,1,female,1,53,53,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,141044.0,88699.5,24.25,hispanic,74.0,1,0,0,no,0.699999809,0.65,no dnr,53.0,58.0,27.6992188,130.0,28.0,36.5,185.6875,3.5,0.59997559,1.39990234,138.0,7.479492,337.0,68.0,3440.0,0.0,<2 mo. follow-up
85.89996,1,male,1,57,57,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,253935.0,147299.375,41.25,white,37.0,2,0,0,yes,0.699999809,0.5,dnr after sadm,55.0,100.0,9.3984375,85.0,22.0,36.59375,333.3,3.5,0.59997559,0.89990234,137.0,7.419922,129.0,16.0,1900.0,0.0,<2 mo. follow-up
58.13797,1,male,0,32,681,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$25-$50k,117341.0,67746.375,28.5,white,54.0,10,0,0,no,0.699999809,0.5,no dnr,32.0,72.0,18.3984375,100.0,14.0,37.79688,155.0,3.0,1.01,3.09960938,131.0,7.449219,102.0,53.0,1990.0,2.0,adl>=4 (>=5 if sur)
66.97296,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,1,19.0,$11-$25k,27791.0,17151.7656,13.5,white,31.0,9,0,0,yes,0.699999809,0.4,dnr after sadm,1.0,72.0,8.79882812,105.0,40.0,38.0,230.0,3.7998047,0.5,1.19995117,139.0,7.459961,94.0,13.0,2830.0,0.0,<2 mo. follow-up
81.26996,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,69968.0,39407.5625,45.5,white,80.0,5,0,0,no,0.25,0.25,no dnr,11.0,135.0,17.296875,105.0,12.0,36.69531,514.25,2.699707,0.5,2.29980469,140.0,7.259766,353.0,38.0,870.0,0.0,<2 mo. follow-up
61.771,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,51834.0,30533.4219,31.0,white,44.0,1,0,0,yes,0.399999857,0.2,dnr after sadm,4.0,78.0,6.89941406,115.0,24.0,38.5,186.65625,2.7998047,0.59997559,1.19995117,130.0,7.429688,95.0,32.0,3335.0,0.0,<2 mo. follow-up
44.73398,1,female,0,6,554,Lung Cancer,Cancer,1,18.0,>$50k,8851.0,4862.5469,11.0,white,5.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,72.0,5.39941406,105.0,24.0,35.19531,333.3,3.2998047,2.79980469,1.5,123.0,7.419922,108.0,34.0,2950.0,0.0,no(M2 and SIP pres)
63.69299,0,female,0,5,902,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,4883.0,3504.1641,12.0,black,19.0,1,0,0,no,0.75,0.5,no dnr,5.0,93.0,7.59960938,70.0,20.0,36.29688,228.5625,3.7998047,0.5,2.79980469,135.0,7.40918,220.0,61.0,1900.0,0.0,no(M2 and SIP pres)
57.61298,1,male,0,9,604,Colon Cancer,Cancer,1,12.0,$25-$50k,13696.0,8415.9453,9.0,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,107.0,5.19921875,70.0,18.0,36.39844,333.3,3.7998047,0.39996338,1.0,138.0,7.419922,103.0,11.0,1000.0,2.3105469,no(M2 and SIP pres)
74.79797,0,female,0,14,901,Colon Cancer,Cancer,1,12.0,$11-$25k,22498.0,13941.4922,9.666664,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,14.0,103.0,11.5,110.0,26.0,36.09375,246.65625,1.6999512,5.09960938,3.89990234,136.0,7.429688,319.0,73.0,2705.0,0.0,no(M2 and SIP pres)
24.709,0,male,0,27,900,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,135950.0,75986.9375,37.5,black,75.0,1,0,0,no,0.5,0.5,no dnr,27.0,72.0,16.5976562,55.0,26.0,36.19531,177.125,2.3999023,0.39996338,1.19995117,141.0,7.419922,92.0,19.0,5445.0,0.0,<2 mo. follow-up
92.31995,1,female,0,13,32,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,23363.0,14359.7891,22.5,white,75.0,1,0,0,yes,0.5,0.25,dnr after sadm,2.0,117.0,6.19921875,75.0,22.0,36.39844,333.3,4.1992188,0.5,0.79992676,140.0,7.419922,84.0,9.0,2960.0,3.0,<2 mo. follow-up
47.31299,1,male,0,40,76,Colon Cancer,Cancer,1,12.0,under $11k,55251.0,33087.5312,10.75,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,40.0,55.0,14.8984375,130.0,30.0,35.69531,296.0,3.5,1.01,1.29980469,136.0,7.339844,151.0,44.0,1940.0,2.2666016,<2 mo. follow-up
56.41098,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,106196.0,54926.6562,52.0,white,94.0,3,0,0,no,0.75,0.75,dnr after sadm,14.0,72.0,32.0,115.0,28.0,38.0,185.0,2.0996094,5.0,1.19995117,148.0,7.439453,134.0,26.0,6115.0,0.0,<2 mo. follow-up
51.51797,1,female,0,18,160,Lung Cancer,Cancer,1,11.0,$11-$25k,25189.0,16071.8516,6.666664,white,11.0,1,0,0,metastatic,1.0,0.9,no dnr,18.0,135.0,12.1992188,115.0,10.0,38.29688,392.0,2.0996094,14.0996094,1.19995117,127.0,7.549805,229.0,17.0,1545.0,1.0,no(M2 and SIP pres)
76.42395,1,male,0,8,149,Colon Cancer,Cancer,1,11.0,under $11k,9101.0,5863.6836,5.5,black,31.0,1,0,0,metastatic,0.349999905,0.1,dnr after sadm,2.0,102.0,6.39941406,115.0,20.0,36.5,333.3,3.5,0.29998779,0.79992676,135.0,7.419922,95.0,3.0,2305.0,0.0,no(M2 and SIP pres)
47.72897,1,male,0,23,61,Lung Cancer,Cancer,1,16.0,$25-$50k,37925.0,22524.75,11.666664,white,23.0,1,0,0,metastatic,0.699999809,0.5,no dnr,23.0,98.0,7.69921875,111.0,20.0,36.5,333.3,2.2998047,4.09960938,1.0,140.0,7.419922,141.0,26.0,200.0,3.0,<2 mo. follow-up
62.08099,1,male,0,16,67,Lung Cancer,Cancer,1,14.0,$11-$25k,34952.0,20978.7188,16.333328,black,18.0,1,0,0,metastatic,0.989999771,0.9,no dnr,16.0,62.0,12.8984375,145.0,44.0,39.59375,192.5,3.5,1.01,1.09985352,137.0,7.469727,138.0,19.0,5125.0,0.0,<2 mo. follow-up
77.60699,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,48632.0,28300.7969,42.0,white,44.0,2,0,0,no,0.399999857,0.25,dnr after sadm,4.0,0.0,24.5976562,0.0,10.0,38.5,157.5,1.7998047,0.59997559,2.59960938,148.0,7.339844,172.0,59.0,832.0,2.0,<2 mo. follow-up
77.17694,1,male,0,46,57,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,97799.0,60579.9688,28.5,black,21.0,14,1,1,no,0.799999714,0.8,no dnr,46.0,45.0,13.1992188,110.0,0.0,39.0,126.51562,3.5,1.01,2.89990234,123.0,7.519531,83.0,58.0,230.0,5.6279297,<2 mo. follow-up
72.83795,1,male,0,4,152,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6601.0,4359.1523,16.0,white,48.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,42.0,21.296875,60.0,10.0,36.69531,370.0,3.5,1.01,5.59960938,128.0,7.30957,377.0,106.0,500.0,2.1274414,no(M2 and SIP pres)
77.87,1,female,1,7,7,Coma,Coma,2,16.0,under $11k,46219.0,26834.6406,13.5,black,54.0,15,0,0,yes,0.149999976,0.05,dnr after sadm,6.0,103.0,18.0976562,95.0,10.0,36.59375,288.0,2.3999023,1.29980469,1.29980469,129.0,7.5,104.0,19.0,2745.0,2.644043,<2 mo. follow-up
53.599,0,female,0,10,895,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,7853.0,5763.418,9.0,black,8.0,1,0,0,no,0.899999619,0.7,no dnr,10.0,135.0,8.09960938,120.0,4.0,38.0,283.3125,3.2998047,1.01,1.0,139.0,7.439453,971.0,22.0,2295.0,0.0,no(M2 and SIP pres)
71.362,0,female,0,20,892,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,31418.0,20014.6719,19.0,black,37.0,1,0,0,no,0.899999619,0.9,no dnr,20.0,107.0,5.5,55.0,26.0,36.19531,186.0,3.5,0.79992676,2.09960938,141.0,7.419922,325.0,53.0,5200.0,0.0,no(M2 and SIP pres)
68.78894,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,177484.0,102778.688,49.0,white,70.0,12,0,0,no,0.799999714,0.7,dnr after sadm,18.0,80.0,14.3984375,60.0,22.0,36.19531,333.3,3.5996094,0.59997559,0.89990234,134.0,7.419922,336.0,17.0,1600.0,1.0,<2 mo. follow-up
73.99298,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,112800.0,66367.5,31.333328,white,56.0,24,1,0,metastatic,0.599999905,0.35,no dnr,20.0,63.0,24.0976562,115.0,30.0,35.19531,150.0,2.5,17.5976562,4.79980469,140.0,7.379883,328.0,80.0,8.0,0.0,<2 mo. follow-up
60.70099,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,$25-$50k,100215.0,56954.2812,54.5,white,71.0,2,0,0,no,0.5,0.5,no dnr,10.0,70.0,19.5976562,80.0,12.0,35.89844,167.5,3.5,1.01,5.5,134.0,7.379883,84.0,100.0,2100.0,0.0,<2 mo. follow-up
44.63797,1,female,0,10,39,Lung Cancer,Cancer,2,12.0,under $11k,15027.0,8958.0078,13.5,white,44.0,1,0,0,metastatic,0.799999714,0.2,dnr after sadm,3.0,63.0,6.19921875,105.0,30.0,36.89844,123.625,3.5,1.01,1.09985352,132.0,7.459961,118.0,23.0,4505.0,5.0,<2 mo. follow-up
60.69498,0,male,0,27,889,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,96528.0,56634.75,29.5,white,37.0,4,0,0,no,0.299999952,0.2,dnr after sadm,8.0,52.0,32.5,135.0,48.0,38.39844,94.0,3.5,1.0,0.59997559,140.0,7.419922,117.0,7.0,3060.0,0.0,adl>=4 (>=5 if sur)
59.44699,1,female,1,5,5,Coma,Coma,1,8.0,under $11k,24836.0,15311.375,42.0,black,31.0,8,0,0,metastatic,0.049999982,0.0,dnr after sadm,3.0,64.0,67.09375,80.0,28.0,39.0,333.3,3.5,1.01,1.39990234,140.0,7.419922,11.0,26.0,1000.0,2.8945312,<2 mo. follow-up
75.95898,1,male,1,16,16,COPD,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,83494.0,49170.5312,33.666657,white,48.0,6,0,0,yes,0.5,0.5,dnr after sadm,15.0,70.0,11.8984375,105.0,10.0,38.69531,154.28125,3.5,1.01,1.29980469,132.0,7.40918,151.0,19.0,2450.0,1.0,<2 mo. follow-up
58.37598,1,female,0,9,287,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,29065.0,19337.3438,19.0,white,41.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,132.0,28.3984375,135.0,8.0,38.79688,270.0,3.5,2.59960938,1.39990234,137.0,7.30957,92.0,48.0,3180.0,0.0,no(M2 and SIP pres)
73.22095,0,female,0,5,887,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5317.0,3414.8769,13.0,white,14.0,1,0,0,no,0.75,0.75,no dnr,5.0,135.0,10.6992188,65.0,30.0,38.0,233.0,3.5,1.01,0.59997559,137.0,7.429688,99.0,10.0,5195.0,2.0,no(M2 and SIP pres)
91.48798,1,female,1,6,6,Coma,Coma,2,12.0,under $11k,46934.0,14452.7344,37.0,black,55.0,20,0,0,yes,0.0,0.0,dnr after sadm,1.0,115.0,9.69921875,75.0,31.0,38.79688,232.0,2.5996094,0.39996338,12.8984375,144.0,7.389648,107.0,83.0,5112.0,3.0,<2 mo. follow-up
60.28497,1,female,0,4,593,Colon Cancer,Cancer,1,9.0,under $11k,2439.0,2092.8027,8.0,white,5.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,115.0,27.3984375,125.0,10.0,36.29688,182.5,2.3999023,0.69995117,0.39996338,137.0,7.439453,81.0,20.0,900.0,0.494751,SIP>=30
77.44299,1,male,1,31,31,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,143014.0,81730.0,43.0,white,45.0,1,0,0,no,0.5,0.5,dnr after sadm,27.0,83.0,10.5996094,65.0,20.0,36.09375,333.3,2.8999023,0.39996338,1.0,141.0,7.419922,139.0,11.0,4900.0,0.0,<2 mo. follow-up
67.39496,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,39396.0,24119.1719,48.5,white,70.0,1,0,0,no,0.019999996,0.02,dnr after sadm,7.0,75.0,5.29980469,60.0,20.0,36.5,333.3,4.5,0.5,1.09985352,142.0,7.419922,98.0,12.0,5925.0,0.0,<2 mo. follow-up
55.01398,1,male,0,7,24,Lung Cancer,Cancer,2,4.0,$11-$25k,6700.0,4328.8984,6.5,white,26.0,1,0,0,metastatic,0.5,0.1,dnr before sadm,0.0,115.0,12.0996094,80.0,16.0,38.29688,91.25,2.3999023,0.5,0.89990234,142.0,7.40918,149.0,10.0,3910.0,3.0,<2 mo. follow-up
47.53699,0,male,0,14,883,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,73925.0,41813.8438,20.666656,white,24.0,6,0,0,no,0.849999905,0.8,no dnr,14.0,72.0,11.5996094,105.0,16.0,37.79688,180.0,3.5,1.01,1.89990234,146.0,7.40918,255.0,58.0,1675.0,0.0,<2 mo. follow-up
72.00299,1,female,1,11,11,Coma,Coma,1,14.0,under $11k,29982.0,18713.8125,23.0,white,12.0,2,0,0,no,0.099999964,0.05,dnr after sadm,6.0,70.0,9.0,76.0,16.0,36.29688,333.3,3.5,1.01,0.5,138.0,7.419922,90.0,4.0,2502.0,1.0,<2 mo. follow-up
74.91895,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,$11-$25k,63505.0,35324.125,48.0,white,113.0,13,0,0,no,0.019999996,0.02,dnr after sadm,3.0,138.0,10.6992188,125.0,10.0,38.69531,197.5,3.5,1.01,2.59960938,133.0,7.519531,133.0,35.0,3395.0,0.0,<2 mo. follow-up
30.86699,1,male,1,44,44,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,93251.0,57726.3438,18.5,white,63.0,5,0,0,no,0.699999809,0.5,dnr after sadm,43.0,99.0,10.1992188,106.0,20.0,37.0,333.3,3.5,1.01,0.59997559,136.0,7.419922,106.0,11.0,2502.0,6.0,<2 mo. follow-up
76.646,1,male,0,10,558,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,9616.0,6967.2773,11.5,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,68.0,19.0,105.0,8.0,39.29688,312.0,2.2998047,1.09985352,11.1992188,132.0,7.359375,188.0,92.0,850.0,2.0,no(M2 and SIP pres)
61.89697,1,male,1,5,5,Coma,Coma,4,12.0,under $11k,25350.0,14670.7344,35.0,white,75.0,5,0,0,no,0.009999998,0.01,dnr after sadm,4.0,112.0,21.0,105.0,28.0,36.39844,283.3125,1.7998047,2.79980469,0.69995117,136.0,7.509766,124.0,48.0,3280.0,3.4121094,<2 mo. follow-up
38.83398,1,male,0,7,78,Lung Cancer,Cancer,1,16.0,$25-$50k,12767.0,7167.6797,5.0,white,12.0,1,0,0,metastatic,0.699999809,0.4,no dnr,7.0,57.0,26.0,125.0,20.0,38.69531,78.75,2.5996094,1.01,0.59997559,133.0,7.299805,173.0,20.0,900.0,1.8913574,SIP>=30
56.93399,0,male,0,23,880,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,178049.0,106424.438,27.333328,white,31.0,36,0,0,yes,0.699999809,0.5,no dnr,23.0,117.0,6.89941406,130.0,10.0,38.69531,140.0,1.1999512,1.01,0.59997559,133.0,7.40918,238.0,25.0,1485.0,2.515625,<2 mo. follow-up
63.26099,1,male,1,5,5,Coma,Coma,3,12.0,under $11k,18203.0,10571.1016,43.0,black,22.0,1,0,0,no,0.0,0.0,dnr after sadm,4.0,112.0,7.59960938,120.0,10.0,36.29688,136.0,2.699707,0.19998169,4.89941406,148.0,7.379883,80.0,135.0,1740.0,2.7045898,<2 mo. follow-up
59.573,0,female,0,21,880,COPD,COPD/CHF/Cirrhosis,1,10.0,$25-$50k,28897.0,18869.1875,9.0,white,15.0,3,0,0,no,0.699999809,0.5,no dnr,21.0,138.0,12.0,115.0,38.0,37.79688,220.0,1.8999023,0.39996338,5.39941406,131.0,7.429688,114.0,72.0,780.0,2.8676758,<2 mo. follow-up
64.39398,1,male,0,11,576,MOSF w/Malig,ARF/MOSF,2,14.0,$25-$50k,51695.0,30432.25,29.5,white,45.0,12,1,0,metastatic,0.699999809,0.5,no dnr,11.0,63.0,12.5,80.0,12.0,37.79688,180.0,2.0,0.79992676,2.09960938,137.0,7.379883,114.0,36.0,1365.0,0.0,no(M2 and SIP pres)
64.02997,1,female,0,7,192,Colon Cancer,Cancer,1,20.0,under $11k,13248.0,7570.4336,6.5,white,9.0,1,0,0,metastatic,0.899999619,0.8,no dnr,7.0,78.0,23.0976562,120.0,44.0,38.29688,210.0,1.5998535,3.89990234,0.79992676,129.0,7.489258,189.0,12.0,2745.0,0.0,no(M2 and SIP pres)
39.53497,0,female,0,15,879,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$25-$50k,47511.0,29027.0781,26.333328,black,19.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,77.0,20.3984375,120.0,24.0,38.0,118.0,3.5,0.69995117,1.29980469,135.0,7.439453,206.0,44.0,2502.0,6.0,no(M2 and SIP pres)
53.76297,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,$11-$25k,57148.0,14452.7344,39.5,white,29.0,1,0,0,no,0.699999809,0.65,dnr after sadm,12.0,40.0,20.1992188,155.0,8.0,38.09375,54.0,2.0996094,1.59985352,2.0,131.0,7.389648,71.0,40.0,1570.0,0.0,<2 mo. follow-up
59.73999,1,male,0,14,805,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,39612.0,23242.3281,17.666656,white,41.0,4,0,0,no,0.799999714,0.65,dnr after sadm,10.0,47.0,22.0,130.0,35.0,39.19531,220.0,2.5,0.39996338,0.5,140.0,7.40918,89.0,11.0,2860.0,6.0,no(M2 and SIP pres)
63.685,1,female,0,5,94,Lung Cancer,Cancer,1,12.0,under $11k,7560.0,4113.7734,14.0,white,11.0,1,0,0,metastatic,1.0,1.0,no dnr,5.0,82.0,8.3984375,75.0,20.0,37.19531,333.3,4.0996094,0.39996338,0.79992676,141.0,7.419922,122.0,6.0,2502.0,2.6206055,<2 mo. follow-up
54.94299,1,male,0,6,36,Lung Cancer,Cancer,1,12.0,under $11k,9718.0,5279.8398,14.0,white,13.0,1,0,0,metastatic,0.5,0.1,no dnr,6.0,83.0,5.79980469,65.0,20.0,36.5,204.75,3.5,1.29980469,0.89990234,143.0,7.299805,197.0,18.0,2502.0,2.1577148,<2 mo. follow-up
62.146,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,216076.0,122452.875,49.25,white,59.0,12,1,0,no,0.699999809,0.5,no dnr,27.0,80.0,7.19921875,65.0,14.0,35.29688,333.3,3.5,0.89990234,0.89990234,139.0,7.419922,93.0,19.0,2502.0,5.0,<2 mo. follow-up
30.672,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,3,10.0,under $11k,35140.0,20746.8125,35.0,black,51.0,6,0,0,yes,0.199999928,0.1,dnr after sadm,4.0,77.0,21.5976562,70.0,20.0,38.09375,333.3,3.5,0.39996338,0.79992676,139.0,7.419922,173.0,9.0,2625.0,0.0,<2 mo. follow-up
52.59998,0,male,0,7,875,CHF,COPD/CHF/Cirrhosis,2,15.0,$25-$50k,8361.0,5628.3125,7.5,white,41.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,52.0,10.5996094,125.0,26.0,39.19531,191.40625,3.5,6.0,5.5,145.0,7.399414,111.0,56.0,1755.0,0.0,SIP>=30
67.685,1,female,0,39,49,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,41386.75,21.0,black,49.0,4,0,0,no,0.599999905,0.5,dnr after sadm,9.0,0.0,24.1992188,0.0,0.0,36.5,413.3125,3.5,1.01,2.09960938,143.0,7.40918,167.0,46.0,1180.0,0.0,<2 mo. follow-up
75.85797,1,female,1,19,19,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,128017.0,71371.9375,52.0,white,61.0,6,0,0,yes,0.099999964,0.05,dnr after sadm,3.0,69.0,9.0,68.0,12.0,36.19531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.40796,1,female,0,102,465,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,59995.78781114967,206201.625,45.75,white,45.0,3,1,0,no,0.199999928,0.15,no dnr,102.0,0.0,18.6992188,0.0,32.0,38.59375,69.0,1.1999512,1.01,6.39941406,141.0,7.289062,154.0,82.0,1560.0,0.0,adl>=4 (>=5 if sur)
51.23297,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,18435.0,11561.6641,24.5,black,41.0,1,0,0,no,0.599999905,0.55,dnr after sadm,3.0,78.0,5.69921875,50.0,24.0,36.69531,333.3,3.5,0.59997559,0.79992676,139.0,7.419922,93.0,8.0,2502.0,7.0,<2 mo. follow-up
63.655,1,male,0,5,271,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,3472.0,2695.6484,6.0,black,20.0,1,1,0,no,0.799999714,0.5,no dnr,5.0,78.0,6.19921875,65.0,20.0,37.29688,333.3,3.5,25.5,1.0,136.0,7.419922,115.0,8.0,1500.0,0.494751,no(M2 and SIP pres)
45.52197,0,male,0,7,872,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,$11-$25k,40904.0,23198.3906,14.5,white,12.0,3,0,0,no,0.799999714,0.75,no dnr,7.0,101.0,7.09960938,104.0,28.0,36.69531,333.3,2.5,0.69995117,0.69995117,138.0,7.419922,125.0,21.0,2502.0,0.0,no(M2 and SIP pres)
67.69897,1,male,0,6,537,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,13530.0,8061.7969,27.0,white,31.0,1,1,0,no,0.699999809,0.6,no dnr,6.0,103.0,2.79980469,65.0,24.0,38.19531,310.0,2.199707,1.01,0.79992676,137.0,7.439453,126.0,8.0,2895.0,2.0,no(M2 and SIP pres)
72.93597,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,91573.0,50005.9688,73.0,white,95.0,6,0,0,no,0.699999809,0.5,no dnr,4.0,58.0,10.8984375,60.0,10.0,38.09375,136.65625,3.5,1.01,0.59997559,129.0,7.389648,112.0,26.0,670.0,1.0,<2 mo. follow-up
67.01398,1,female,0,17,414,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,49608.0,30856.4219,15.666664,white,24.0,13,0,0,metastatic,0.199999928,0.2,dnr after sadm,2.0,118.0,13.0,65.0,42.0,37.89844,253.3125,2.5996094,1.69995117,0.5,142.0,7.439453,91.0,13.0,6340.0,0.0,adl>=4 (>=5 if sur)
44.64297,1,female,0,44,842,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,127319.0,14452.7344,32.25,other,32.0,2,0,0,no,0.699999809,0.5,no dnr,44.0,53.0,5.29980469,70.0,24.0,35.09375,357.125,3.5,2.29980469,1.79980469,131.0,7.489258,82.0,54.0,940.0,1.8671875,no(M2 and SIP pres)
80.46295,0,female,0,96,868,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,under $11k,59995.78781114967,143812.875,36.25,white,36.0,5,0,0,no,0.299999952,0.1,no dnr,96.0,155.0,9.59960938,125.0,36.0,36.39844,142.84375,3.5,1.01,1.39990234,128.0,7.509766,1.399902,26.0,3270.0,0.0,SIP>=30
72.16998,1,female,0,10,42,COPD,COPD/CHF/Cirrhosis,2,16.0,under $11k,10077.0,6900.418,10.0,white,18.0,1,0,0,yes,0.5,0.5,dnr before sadm,-1.0,85.0,5.79980469,105.0,24.0,35.39844,333.3,3.5,0.79992676,1.0,143.0,7.419922,77.0,13.0,3425.0,1.0,<2 mo. follow-up
60.668,1,male,0,6,40,Lung Cancer,Cancer,1,12.0,$11-$25k,15007.0,7510.8633,15.0,white,7.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,133.0,10.3984375,135.0,26.0,35.59375,270.0,3.5,0.5,1.09985352,139.0,7.439453,247.0,21.0,3745.0,0.494751,<2 mo. follow-up
76.41595,1,female,0,7,141,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,13907.0,8406.4141,14.0,black,48.0,1,1,0,no,0.599999905,0.55,no dnr,7.0,115.0,0.79992676,70.0,32.0,38.19531,288.0,1.7998047,0.69995117,2.09960938,132.0,7.359375,106.0,77.0,1445.0,3.3657227,<2 mo. follow-up
56.57199,0,female,0,11,867,Lung Cancer,Cancer,1,13.0,under $11k,11383.0,7596.5508,11.0,white,17.0,1,0,0,metastatic,0.699999809,0.4,no dnr,11.0,120.0,6.09960938,125.0,30.0,35.79688,263.3125,1.1999512,3.79980469,1.09985352,137.0,7.389648,69.0,26.0,3500.0,1.0,no(M2 and SIP pres)
28.786,0,female,0,10,867,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,31965.0,20141.1094,14.0,black,46.0,1,0,0,no,0.699999809,0.7,no dnr,10.0,65.0,1.29980469,140.0,13.0,38.5,167.5,2.5,4.59960938,1.89990234,143.0,7.349609,53.0,39.0,1475.0,1.0,no(M2 and SIP pres)
75.39197,1,female,0,8,11,Lung Cancer,Cancer,1,12.0,$25-$50k,7706.0,5489.1211,6.5,white,13.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,2.0,60.0,20.296875,115.0,28.0,36.29688,156.65625,2.5,0.39996338,0.5,137.0,7.489258,99.0,14.0,1275.0,0.0,<2 mo. follow-up
54.18799,0,male,0,20,866,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,51179.0,32586.8594,21.0,white,43.0,1,1,0,no,0.599999905,0.55,no dnr,20.0,153.0,13.0996094,145.0,12.0,37.69531,187.5,3.5,1.01,1.19995117,138.0,7.479492,141.0,23.0,3055.0,0.0,no(M2 and SIP pres)
72.68195,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,96468.0,54964.375,37.0,white,29.0,2,0,0,no,0.199999928,0.15,dnr after sadm,5.0,67.0,16.296875,115.0,37.0,36.29688,300.0,2.8999023,1.59985352,0.89990234,136.0,7.319336,95.0,18.0,1110.0,0.0,<2 mo. follow-up
69.14398,1,female,1,48,48,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,81683.0,50131.6562,26.25,white,56.0,4,0,0,no,0.599999905,0.4,dnr after sadm,31.0,159.0,12.0,125.0,8.0,38.0,152.5,3.3999023,0.39996338,5.0,145.0,7.639648,198.0,102.0,5040.0,4.0,<2 mo. follow-up
25.51399,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,>$50k,214081.0,14452.7344,43.666657,white,34.0,31,0,0,no,0.699999809,0.5,dnr after sadm,22.0,120.0,3.19970703,125.0,10.0,36.0,236.0,2.5,3.29980469,0.79992676,140.0,7.329102,121.0,13.0,1165.0,1.0,<2 mo. follow-up
63.16199,1,female,0,31,49,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,46093.0,30062.0469,23.75,white,44.0,1,0,0,yes,0.699999809,0.5,no dnr,31.0,93.0,15.5,100.0,22.0,36.59375,292.0,3.5,0.39996338,0.79992676,140.0,7.399414,130.0,21.0,2200.0,2.7456055,<2 mo. follow-up
76.474,0,male,0,10,865,Colon Cancer,Cancer,1,16.0,>$50k,30924.0,17635.5938,14.0,white,17.0,1,0,0,metastatic,1.0,1.0,no dnr,10.0,113.0,12.8984375,75.0,29.0,34.5,270.0,2.199707,1.01,2.59960938,137.0,7.349609,49.0,30.0,1145.0,5.0,no(M2 and SIP pres)
55.35898,1,female,1,18,18,Lung Cancer,Cancer,2,11.0,$11-$25k,20520.0,13153.9531,15.666664,black,28.0,1,1,0,metastatic,0.699999809,0.5,no dnr,18.0,85.0,6.09960938,68.0,14.0,37.69531,333.3,3.699707,0.39996338,1.39990234,144.0,7.419922,128.0,16.0,2502.0,3.7563477,<2 mo. follow-up
65.23499,0,female,0,7,864,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,under $11k,5937.0,4279.6328,5.5,white,22.0,1,0,0,no,0.799999714,0.6,no dnr,7.0,108.0,12.0,130.0,8.0,35.59375,312.0,3.8999023,0.79992676,2.89990234,136.0,7.40918,687.0,43.0,1680.0,0.0,<2 mo. follow-up
45.142,0,female,0,12,864,Cirrhosis,COPD/CHF/Cirrhosis,2,7.0,under $11k,12627.0,8946.6797,10.5,other,31.0,1,0,0,no,0.899999619,0.6,no dnr,12.0,165.0,22.5976562,120.0,27.0,38.59375,56.0,2.0996094,2.19970703,1.79980469,142.0,7.349609,183.0,28.0,855.0,3.0,no(M2 and SIP pres)
63.56497,1,male,0,6,55,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,3223.0,2557.2129,8.0,white,50.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,63.0,10.0996094,131.0,20.0,38.19531,308.0,3.199707,1.01,0.69995117,138.0,7.459961,169.0,8.0,1100.0,0.0,<2 mo. follow-up
21.489,0,female,0,6,863,ARF/MOSF w/Sepsis,ARF/MOSF,1,2.0,under $11k,9570.0,6218.1367,15.0,black,23.0,1,1,0,no,1.0,1.0,no dnr,6.0,105.0,11.3984375,115.0,24.0,38.09375,134.6875,3.5,1.01,1.0,136.0,7.439453,131.0,23.0,2720.0,0.494751,no(M2 and SIP pres)
68.0,1,female,0,5,29,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,12333.0,14452.7344,22.0,white,24.0,1,0,0,yes,0.699999809,0.5,no dnr,5.0,108.0,11.5,105.0,22.0,36.69531,260.0,3.5,1.01,0.59997559,137.0,7.459961,136.0,11.0,2705.0,1.8388672,<2 mo. follow-up
65.23798,1,male,0,12,574,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,29142.0,18768.1875,26.5,white,58.0,1,0,0,yes,0.599999905,0.4,no dnr,12.0,33.0,11.1992188,150.0,36.0,39.59375,157.5,2.3999023,2.59960938,3.89990234,135.0,7.369141,38.0,55.0,80.0,0.0,no(M2 and SIP pres)
81.05695,0,male,0,72,861,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,59995.78781114967,14452.7344,28.25,white,68.0,5,1,0,no,0.699999809,0.5,no dnr,72.0,65.0,34.796875,65.0,22.0,36.09375,217.5,1.7998047,37.59375,4.19921875,128.0,7.359375,97.0,49.0,5465.0,3.1557617,<2 mo. follow-up
49.18298,1,male,0,18,41,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,$11-$25k,28282.0,18109.2656,18.666656,white,52.0,1,1,0,no,0.849999905,0.75,dnr after sadm,4.0,73.0,6.89941406,95.0,26.0,35.69531,528.0,3.5,0.79992676,1.89990234,140.0,7.459961,109.0,62.0,1405.0,0.0,<2 mo. follow-up
83.77496,0,male,0,7,860,COPD,COPD/CHF/Cirrhosis,1,7.0,under $11k,12501.0,8251.3281,11.5,black,41.0,1,0,0,no,0.699999809,0.6,no dnr,7.0,45.0,14.7988281,105.0,27.0,38.89844,182.5,3.5,1.5,5.89941406,129.0,7.339844,95.0,82.0,115.0,0.0,no(M2 and SIP pres)
63.95297,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,96337.0,52540.7188,36.5,white,42.0,11,0,0,no,0.5,0.25,dnr after sadm,3.0,97.0,8.69921875,76.0,10.0,35.59375,333.3,3.8999023,1.19995117,1.19995117,139.0,7.419922,82.0,4.0,2502.0,2.4970703,<2 mo. follow-up
69.86395,1,male,0,3,15,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,2876.0,1988.1016,1.0,black,16.0,1,0,0,no,0.899999619,0.65,no dnr,3.0,140.0,7.09960938,125.0,10.0,37.79688,313.3125,2.2998047,1.01,0.59997559,129.0,7.469727,128.0,5.0,6280.0,0.0,<2 mo. follow-up
52.24899,1,female,0,8,110,Lung Cancer,Cancer,2,15.0,>$50k,6711.0,4352.8633,5.0,white,13.0,1,0,0,metastatic,0.599999905,0.5,no dnr,8.0,161.0,9.79882812,50.0,14.0,38.69531,366.625,3.5,1.01,1.5,152.0,7.419922,144.0,12.0,2780.0,1.0,no(M2 and SIP pres)
52.59399,1,male,0,21,276,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,56633.0,34006.4062,26.333328,white,25.0,1,0,0,no,0.599999905,0.4,no dnr,21.0,73.0,15.5996094,105.0,24.0,37.89844,226.90625,3.5,1.09985352,0.59997559,133.0,7.40918,122.0,7.0,2502.0,6.0,adl>=4 (>=5 if sur)
76.72296,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,116654.0,67757.1875,36.0,white,80.0,24,0,0,no,0.199999928,0.1,dnr after sadm,5.0,62.0,6.09960938,105.0,24.0,37.0,140.0,3.5,1.09985352,1.19995117,142.0,7.519531,367.0,41.0,6315.0,3.0,<2 mo. follow-up
78.09698,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,63577.0,14452.7344,53.0,white,77.0,1,1,0,no,0.699999809,0.5,dnr after sadm,8.0,100.0,7.59960938,64.0,24.0,39.29688,333.3,3.8999023,1.39990234,0.89990234,141.0,7.419922,92.0,6.0,2502.0,6.0,<2 mo. follow-up
76.698,1,male,1,5,5,Coma,Coma,1,16.0,$25-$50k,3462.0,2690.6816,8.0,white,20.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,113.0,9.3984375,125.0,10.0,37.79688,346.625,3.3999023,2.09960938,1.0,142.0,7.449219,190.0,13.0,2990.0,2.0375977,<2 mo. follow-up
64.96399,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,42713.0,24700.4375,45.0,white,112.0,12,1,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,113.0,13.8984375,115.0,26.0,39.19531,96.65625,3.5,1.59985352,1.0,142.0,7.399414,114.0,18.0,3270.0,2.5395508,<2 mo. follow-up
53.63397,1,female,0,50,156,MOSF w/Malig,ARF/MOSF,1,14.0,$11-$25k,204110.0,114735.125,33.25,white,54.0,13,0,0,metastatic,0.699999809,0.5,dnr after sadm,24.0,58.0,3.39990234,105.0,10.0,35.5,380.0,3.5,3.79980469,0.89990234,130.0,7.489258,97.0,15.0,1050.0,0.0,adl>=4 (>=5 if sur)
72.33099,0,female,0,19,854,ARF/MOSF w/Sepsis,ARF/MOSF,2,5.0,under $11k,34368.0,20941.1094,16.666656,black,31.0,1,1,0,no,0.699999809,0.9,no dnr,19.0,77.0,5.69921875,65.0,20.0,36.29688,333.3,3.5,0.59997559,1.09985352,142.0,7.419922,114.0,12.0,3900.0,0.0,no(M2 and SIP pres)
45.38498,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,43002.0,25865.5781,21.0,black,75.0,9,0,0,metastatic,0.199999928,0.1,dnr after sadm,7.0,65.0,12.5996094,85.0,16.0,36.39844,333.3,3.0996094,0.69995117,1.39990234,137.0,7.419922,97.0,14.0,4025.0,3.2001953,<2 mo. follow-up
50.82797,1,male,0,6,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,13347.0,8863.7734,17.0,black,53.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,112.0,18.6992188,135.0,28.0,36.5,175.0,2.2998047,1.69995117,2.5,133.0,7.299805,220.0,56.0,955.0,0.494751,<2 mo. follow-up
75.02795,0,male,0,11,853,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,24806.0,15019.7969,18.5,white,34.0,1,1,0,no,0.699999809,0.5,no dnr,11.0,112.0,3.09960938,145.0,67.0,38.29688,106.10938,3.0,6.19921875,1.0,138.0,7.419922,135.0,9.0,3420.0,0.0,no(M2 and SIP pres)
63.56998,0,female,0,14,853,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,46649.0,28247.2812,20.0,white,50.0,1,0,0,no,0.699999809,0.6,no dnr,14.0,77.0,9.19921875,120.0,26.0,38.0,323.75,3.5,1.89990234,1.69995117,136.0,7.509766,114.0,24.0,3850.0,0.0,no(M2 and SIP pres)
76.61597,0,female,0,4,853,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,6633.0,4034.3262,7.0,white,19.0,1,1,0,no,0.799999714,0.6,no dnr,4.0,112.0,15.8984375,165.0,46.0,37.69531,333.3,3.699707,1.01,0.89990234,138.0,7.419922,129.0,23.0,1110.0,0.494751,no(M2 and SIP pres)
63.87399,1,female,1,8,8,Coma,Coma,0,12.0,under $11k,179570.0,96443.0,50.5,white,78.0,21,0,0,no,0.699999809,0.5,dnr after sadm,8.0,63.0,5.89941406,135.0,10.0,35.5,220.0,2.0996094,2.89990234,2.79980469,142.0,7.509766,374.0,62.0,3760.0,2.0654297,<2 mo. follow-up
65.42896,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,43352.0,25331.6875,35.0,white,30.0,2,0,0,yes,0.5,0.3,dnr after sadm,9.0,58.0,12.0996094,110.0,8.0,38.29688,340.0,3.5,0.5,2.69970703,145.0,7.369141,299.0,50.0,5645.0,0.0,<2 mo. follow-up
69.008,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$25-$50k,20466.0,11629.3125,32.0,white,102.0,2,0,0,no,0.699999809,0.5,dnr after sadm,2.0,62.0,18.0976562,135.0,41.0,38.89844,226.65625,3.5,0.5,1.0,132.0,7.569336,184.0,17.0,6840.0,0.0,<2 mo. follow-up
77.19397,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,216528.0,124308.75,36.333313,white,42.0,33,0,0,no,0.699999809,0.5,dnr after sadm,23.0,100.0,11.5,74.0,20.0,37.59375,123.32812,3.5,1.01,1.89990234,139.0,7.289062,66.0,27.0,2502.0,1.0,<2 mo. follow-up
62.88797,0,male,0,22,847,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,140338.0,81788.9375,31.0,black,48.0,10,0,0,no,0.949999809,0.95,no dnr,22.0,95.0,12.5,110.0,24.0,37.79688,169.375,3.5,1.01,1.19995117,136.0,7.429688,98.0,21.0,2870.0,0.0,SIP>=30
61.12299,1,female,1,15,15,Coma,Coma,1,14.0,$25-$50k,38083.0,22628.7812,16.0,white,27.0,3,0,0,no,0.099999964,0.1,dnr after sadm,6.0,125.0,19.296875,105.0,26.0,37.19531,343.4375,3.7998047,0.69995117,1.39990234,137.0,7.419922,285.0,36.0,1093.0,1.0,<2 mo. follow-up
43.38098,0,female,0,40,847,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$25-$50k,95022.0,60139.0938,25.25,black,64.0,1,0,0,no,0.649999619,0.6,no dnr,40.0,50.0,5.0,145.0,40.0,33.89844,55.0,4.6992188,4.09960938,2.29980469,152.0,7.439453,393.0,25.0,2750.0,0.0,no(M2 and SIP pres)
61.78497,0,male,0,51,847,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,113757.0,66821.8125,30.0,white,49.0,2,0,0,no,0.199999928,0.1,dnr after sadm,12.0,108.0,6.5,105.0,26.0,35.69531,150.0,3.5,1.01,0.5,134.0,7.319336,80.0,11.0,1390.0,0.0,adl>=4 (>=5 if sur)
70.02295,1,male,1,12,12,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,146048.0,87808.8125,43.0,black,104.0,34,0,0,yes,0.199999928,0.1,dnr after sadm,5.0,67.0,11.6992188,105.0,12.0,38.69531,326.625,2.0996094,2.29980469,0.59997559,130.0,7.469727,157.0,17.0,1890.0,0.0,<2 mo. follow-up
66.41199,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,2,7.0,under $11k,29635.0,18554.125,20.333328,white,46.0,8,0,0,metastatic,0.399999857,0.2,no dnr,14.0,73.0,11.6992188,130.0,10.0,37.69531,104.0,1.5,1.59985352,0.69995117,136.0,7.429688,125.0,11.0,2225.0,0.0,<2 mo. follow-up
67.737,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,77412.0,43302.9688,45.0,white,93.0,3,1,0,no,0.299999952,0.2,dnr after sadm,3.0,118.0,10.3984375,105.0,24.0,37.0,266.625,3.5,0.59997559,0.79992676,134.0,7.399414,128.0,9.0,1150.0,0.0,<2 mo. follow-up
46.65598,1,male,0,15,425,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,45527.0,25871.6406,21.666656,black,59.0,1,0,0,no,0.649999619,0.55,no dnr,15.0,95.0,13.6992188,85.0,20.0,36.0,333.3,3.5,0.69995117,1.09985352,138.0,7.419922,104.0,18.0,3950.0,0.0,no(M2 and SIP pres)
70.073,1,female,0,5,72,CHF,COPD/CHF/Cirrhosis,4,10.0,$11-$25k,4990.0,3376.4356,11.0,black,31.0,1,1,0,yes,0.699999809,0.2,no dnr,5.0,75.0,12.2988281,60.0,14.0,36.0,493.3125,3.5,1.01,6.29980469,137.0,7.539062,108.0,53.0,0.0,5.0,<2 mo. follow-up
56.75598,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,31855.0,18527.2031,35.0,white,84.0,1,0,0,yes,0.399999857,0.2,dnr after sadm,6.0,80.0,8.0,126.0,22.0,36.0,247.59375,3.3999023,0.59997559,0.59997559,132.0,7.439453,105.0,6.0,2502.0,0.0,<2 mo. follow-up
77.17694,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,12136.0,7305.8594,25.0,white,45.0,1,0,0,no,0.549999714,0.5,dnr after sadm,4.0,135.0,9.8984375,125.0,38.0,36.69531,398.0,2.8999023,1.59985352,2.29980469,136.0,7.589844,77.0,28.0,4425.0,2.3920898,<2 mo. follow-up
64.047,1,female,0,22,716,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,44905.0,26915.875,21.666656,black,52.0,1,0,0,no,0.599999905,0.5,no dnr,22.0,110.0,14.1992188,95.0,24.0,35.79688,333.3,3.5,1.01,0.69995117,130.0,7.419922,85.0,11.0,2502.0,0.0,<2 mo. follow-up
56.18298,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,$25-$50k,59066.0,33900.4375,40.0,white,90.0,11,0,0,no,0.0,0.0,dnr after sadm,3.0,65.0,16.8984375,125.0,24.0,36.5,376.0,3.5,1.01,1.89990234,132.0,7.439453,257.0,31.0,1425.0,1.0,<2 mo. follow-up
65.31696,0,female,0,67,839,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,59995.78781114967,105694.75,25.5,white,37.0,6,0,0,no,0.399999857,0.3,no dnr,67.0,60.0,20.5976562,125.0,10.0,38.39844,276.625,2.3999023,1.01,0.89990234,135.0,7.429688,179.0,9.0,990.0,0.0,no(M2 and SIP pres)
58.198,1,male,1,14,14,Coma,Coma,2,8.0,$11-$25k,35896.0,14452.7344,17.0,white,24.0,1,1,0,no,0.049999982,0.02,dnr after sadm,2.0,47.0,12.8984375,65.0,10.0,38.0,370.0,2.699707,5.09960938,3.5,128.0,7.399414,155.0,63.0,1300.0,0.0,<2 mo. follow-up
56.646,1,male,0,15,74,CHF,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,31154.0,18346.0625,16.666656,black,50.0,1,1,0,no,0.899999619,0.8,no dnr,15.0,62.0,23.6992188,130.0,8.0,36.79688,252.5,3.5,2.5,1.29980469,149.0,7.399414,212.0,51.0,3885.0,5.0,adl>=4 (>=5 if sur)
75.94299,1,female,0,22,152,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,16361.0,12048.6797,8.666664,black,42.0,1,1,0,no,0.799999714,0.6,no dnr,22.0,65.0,17.0,115.0,32.0,36.89844,372.0,29.0,1.0,5.59960938,145.0,7.329102,92.0,127.0,3205.0,1.0,no(M2 and SIP pres)
57.84799,1,male,0,8,638,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,32299.0,20089.7656,19.5,white,25.0,4,0,0,no,0.699999809,0.7,no dnr,8.0,117.0,21.8984375,70.0,24.0,38.09375,333.3,3.2998047,1.09985352,1.19995117,135.0,7.419922,149.0,17.0,1070.0,0.0,no(M2 and SIP pres)
64.61896,1,male,0,15,25,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,39790.0,26220.0,8.333328,white,18.0,16,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,69.0,17.8984375,138.0,22.0,36.5,333.3,2.199707,0.69995117,0.59997559,144.0,7.419922,203.0,6.0,2502.0,2.9291992,<2 mo. follow-up
64.04895,0,male,0,7,837,CHF,COPD/CHF/Cirrhosis,2,18.0,>$50k,6522.0,4604.7148,7.5,white,24.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,71.0,12.0996094,80.0,24.0,36.59375,333.3,2.3999023,0.79992676,0.79992676,135.0,7.419922,76.0,9.0,1350.0,0.0,no(M2 and SIP pres)
53.172,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,120668.0,67220.1875,58.0,asian,45.0,23,1,0,no,0.699999809,0.5,dnr after sadm,6.0,66.0,9.29882812,84.0,24.0,37.59375,333.3,1.0,3.0,0.79992676,134.0,7.419922,105.0,2.0,2300.0,1.0,<2 mo. follow-up
61.54398,1,male,0,11,48,COPD,COPD/CHF/Cirrhosis,2,3.0,under $11k,12650.0,7735.4883,15.0,white,22.0,1,0,0,metastatic,0.599999905,0.5,no dnr,11.0,58.0,10.3984375,70.0,24.0,34.89844,633.25,3.5,1.01,1.5,131.0,7.509766,238.0,32.0,1400.0,0.0,<2 mo. follow-up
49.67297,1,female,0,5,11,Colon Cancer,Cancer,1,10.0,under $11k,5648.0,14452.7344,14.0,black,65.0,1,0,0,metastatic,0.019999996,0.02,dnr after sadm,1.0,73.0,10.1992188,100.0,20.0,36.69531,401.625,3.699707,1.09985352,0.79992676,146.0,6.919922,195.0,5.0,5230.0,0.0,<2 mo. follow-up
42.01498,0,male,0,5,835,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$11-$25k,12763.0,9769.4062,16.0,white,32.0,1,0,0,no,0.799999714,0.8,no dnr,5.0,72.0,12.0,115.0,24.0,36.59375,262.9375,3.5,1.01,0.89990234,140.0,7.389648,157.0,21.0,2085.0,2.0244141,<2 mo. follow-up
67.73999,1,male,0,6,285,Colon Cancer,Cancer,1,12.0,$11-$25k,5624.0,3785.209,7.0,white,12.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,62.0,9.3984375,135.0,31.0,35.69531,223.3125,3.5,2.29980469,1.89990234,138.0,7.429688,69.0,30.0,785.0,0.0,no(M2 and SIP pres)
69.83398,1,female,0,19,581,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,65899.0,38949.6562,32.0,white,32.0,1,1,0,no,0.5,0.5,no dnr,19.0,118.0,10.6992188,115.0,32.0,38.39844,97.95312,2.3999023,1.09985352,1.79980469,134.0,7.449219,221.0,47.0,1880.0,1.0,adl>=4 (>=5 if sur)
49.02399,1,male,0,6,9,Cirrhosis,COPD/CHF/Cirrhosis,4,13.0,under $11k,5844.0,3874.1211,8.0,black,18.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,68.0,18.8984375,80.0,23.0,35.39844,244.0,3.5,1.01,2.29980469,126.0,7.519531,326.0,75.0,3145.0,0.0,<2 mo. follow-up
45.24298,0,female,0,18,832,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,67484.0,39542.9375,18.666656,white,40.0,6,0,0,no,0.899999619,0.7,no dnr,18.0,87.0,12.0,75.0,30.0,35.69531,181.8125,3.5,1.01,1.39990234,139.0,7.359375,206.0,31.0,700.0,2.7587891,<2 mo. follow-up
58.01498,1,female,1,32,32,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,265216.0,147972.25,47.0,other,61.0,4,0,0,no,0.099999964,0.8,dnr after sadm,31.0,117.0,21.6992188,120.0,40.0,38.0,165.0,3.5,1.01,1.39990234,143.0,7.40918,181.0,64.0,2085.0,6.0,<2 mo. follow-up
58.20898,0,male,0,44,831,CHF,COPD/CHF/Cirrhosis,1,13.0,under $11k,122895.0,79846.6875,19.0,white,8.0,1,0,0,no,0.699999809,0.5,no dnr,44.0,89.0,7.59960938,70.0,16.0,36.0,228.5625,4.1992188,0.69995117,0.79992676,143.0,7.369141,74.0,10.0,2502.0,0.0,no(M2 and SIP pres)
78.461,0,male,0,9,829,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,25238.0,14528.2891,22.0,white,48.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,83.0,12.5996094,100.0,22.0,36.79688,333.3,3.699707,1.01,0.89990234,136.0,7.419922,108.0,34.0,2502.0,1.0,no(M2 and SIP pres)
82.98395,1,male,0,9,283,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,21437.0,12664.7109,16.5,white,52.0,4,0,0,no,0.699999809,0.5,dnr after sadm,6.0,112.0,11.3984375,65.0,35.0,37.69531,170.0,3.5,1.01,0.59997559,137.0,7.40918,71.0,8.0,1770.0,0.0,no(M2 and SIP pres)
85.72998,1,male,0,5,372,COPD,COPD/CHF/Cirrhosis,5,13.0,$25-$50k,4450.0,14452.7344,12.0,white,39.0,1,1,0,no,0.5,0.3,dnr after sadm,2.0,43.0,16.6992188,145.0,27.0,36.39844,175.0,2.199707,1.39990234,4.0,139.0,7.369141,57.0,105.0,720.0,2.0,no(M2 and SIP pres)
78.44495,1,female,1,6,6,Coma,Coma,0,12.0,under $11k,24018.0,13985.0547,37.0,black,52.0,2,0,0,no,0.699999809,0.5,dnr after sadm,1.0,45.0,15.0,80.0,12.0,36.79688,146.0,2.3999023,6.29980469,2.89990234,131.0,7.459961,240.0,83.0,727.0,6.0,<2 mo. follow-up
74.56799,1,male,0,107,349,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59995.78781114967,174840.875,32.75,white,84.0,1,1,0,no,0.699999809,0.5,dnr after sadm,65.0,107.0,9.09960938,84.0,30.0,37.69531,518.25,3.5,0.69995117,1.19995117,131.0,7.30957,223.0,14.0,1170.0,2.8466797,<2 mo. follow-up
74.09198,0,female,0,11,824,Coma,Coma,0,6.0,under $11k,30836.0,19206.1094,34.0,white,25.0,1,0,0,no,0.5,0.5,no dnr,11.0,58.0,0.39996338,135.0,31.0,37.89844,185.0,2.0,8.5,4.5,129.0,7.289062,63.0,100.0,440.0,4.0,adl>=4 (>=5 if sur)
43.13498,0,female,0,55,824,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59995.78781114967,123479.062,30.0,white,71.0,29,1,0,no,0.699999809,0.5,no dnr,55.0,137.0,29.5976562,145.0,14.0,36.79688,140.0,3.5,1.01,2.29980469,150.0,7.449219,96.0,46.0,4115.0,3.0,SIP>=30
52.99899,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,43817.0,25759.375,28.0,white,55.0,8,0,0,metastatic,0.099999964,0.0,dnr after sadm,5.0,122.0,17.1992188,115.0,22.0,38.89844,292.5625,3.5,1.01,1.79980469,139.0,7.40918,251.0,25.0,3165.0,0.0,<2 mo. follow-up
44.383,1,male,0,11,162,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,24372.0,14127.7031,19.5,black,18.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,98.0,1.0,115.0,36.0,35.09375,293.3125,1.2998047,11.8984375,2.69970703,145.0,7.349609,181.0,87.0,915.0,2.0,no(M2 and SIP pres)
62.771,1,male,0,5,24,Colon Cancer,Cancer,2,18.0,under $11k,5826.0,3842.9121,7.0,white,59.0,1,1,0,metastatic,0.649999619,0.3,no dnr,5.0,102.0,13.2988281,95.0,28.0,37.29688,128.3125,3.5,0.79992676,7.39941406,137.0,7.439453,100.0,78.0,15.0,1.0,<2 mo. follow-up
57.30298,0,female,0,6,821,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,6106.0,3974.8887,8.0,white,23.0,1,0,0,no,0.799999714,0.75,no dnr,6.0,118.0,18.0,102.0,40.0,35.09375,142.5,3.5,1.01,1.29980469,135.0,7.399414,180.0,29.0,3060.0,2.3447266,no(M2 and SIP pres)
69.62396,1,female,1,69,69,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,59995.78781114967,225678.375,47.0,white,57.0,10,0,0,no,0.099999964,0.1,dnr after sadm,67.0,62.0,11.7988281,150.0,30.0,36.5,157.5,1.7998047,1.01,0.69995117,136.0,7.359375,95.0,12.0,950.0,5.0,<2 mo. follow-up
33.94897,0,female,0,38,820,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,70401.0,43772.875,21.25,white,26.0,2,0,0,no,0.5,0.5,no dnr,38.0,133.0,11.5,85.0,28.0,37.59375,333.3,3.5,0.59997559,1.39990234,140.0,7.419922,109.0,18.0,2502.0,0.0,<2 mo. follow-up
80.51495,1,female,1,6,6,Coma,Coma,1,14.0,under $11k,22544.0,12786.2422,32.0,white,34.0,1,0,1,no,0.199999928,0.15,dnr after sadm,2.0,57.0,34.3984375,95.0,31.0,37.79688,152.5,3.5,1.01,2.69970703,130.0,7.419922,56.0,75.0,344.0,2.0,<2 mo. follow-up
64.61298,0,male,0,73,819,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,127890.562,25.5,white,18.0,4,0,0,no,0.799999714,0.75,no dnr,73.0,85.0,15.3984375,55.0,40.0,35.0,182.5,3.5,1.01,0.89990234,136.0,7.459961,106.0,20.0,2680.0,0.0,adl>=4 (>=5 if sur)
61.83197,0,male,0,12,819,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,62594.0,34359.5938,30.5,white,39.0,2,0,0,no,0.879999638,0.85,no dnr,12.0,32.0,14.5996094,35.0,0.0,36.79688,140.0,3.5,1.01,3.5,142.0,7.519531,226.0,73.0,0.0,2.1088867,<2 mo. follow-up
70.70795,0,male,0,12,818,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,32075.0,20653.9531,26.0,white,42.0,1,1,0,no,0.599999905,0.5,no dnr,12.0,72.0,20.3984375,105.0,22.0,37.79688,134.6875,1.8999023,1.39990234,1.89990234,144.0,7.449219,137.0,41.0,2850.0,0.0,no(M2 and SIP pres)
69.03998,0,male,0,3,817,CHF,COPD/CHF/Cirrhosis,4,11.0,$25-$50k,2368.0,1803.2598,7.0,white,6.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,110.0,16.5976562,110.0,36.0,39.19531,263.3125,2.2998047,3.29980469,1.19995117,141.0,7.489258,129.0,20.0,1650.0,0.494751,no(M2 and SIP pres)
66.086,1,male,0,11,548,Lung Cancer,Cancer,1,3.0,$11-$25k,22257.0,13260.1797,12.5,white,24.0,1,0,0,metastatic,1.0,1.0,no dnr,11.0,117.0,6.29980469,145.0,8.0,39.5,338.0625,3.0,1.01,0.5,129.0,7.509766,199.0,12.0,2750.0,0.0,no(M2 and SIP pres)
36.181,0,female,0,12,816,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,25602.0,16377.4219,22.0,white,17.0,1,0,0,no,0.899999619,0.9,no dnr,12.0,117.0,20.0,155.0,44.0,39.69531,117.0,2.3999023,4.19921875,0.5,144.0,7.329102,82.0,5.0,4045.0,0.0,no(M2 and SIP pres)
48.99698,1,male,0,3,97,Colon Cancer,Cancer,3,9.0,under $11k,5688.0,3466.8477,1.0,white,27.0,1,0,0,metastatic,0.899999619,0.7,no dnr,3.0,65.0,8.19921875,170.0,40.0,38.09375,136.0,3.5,1.01,0.69995117,132.0,7.329102,150.0,7.0,2570.0,1.9433594,adl>=4 (>=5 if sur)
67.25299,1,male,1,9,9,COPD,COPD/CHF/Cirrhosis,1,17.0,$25-$50k,37006.0,21821.0156,29.0,white,46.0,6,0,0,no,0.5,0.2,dnr before sadm,-5.0,42.0,0.29998779,165.0,26.0,35.89844,284.0,3.5,25.0976562,4.59960938,141.0,7.369141,81.0,132.0,2420.0,6.0,<2 mo. follow-up
51.978,1,female,0,6,347,Lung Cancer,Cancer,1,11.0,$11-$25k,12753.0,6469.1133,11.0,white,13.0,1,0,0,metastatic,1.0,0.8,no dnr,6.0,123.0,22.8984375,117.0,28.0,36.39844,164.28125,3.5,0.79992676,0.69995117,138.0,7.399414,211.0,12.0,1400.0,0.494751,no(M2 and SIP pres)
54.59497,1,male,0,5,420,Colon Cancer,Cancer,1,16.0,>$50k,13289.0,6735.8594,11.0,white,13.0,1,0,0,metastatic,0.799999714,0.65,no dnr,5.0,56.0,6.09960938,145.0,55.0,38.69531,140.0,1.7998047,0.79992676,1.5,143.0,7.449219,289.0,39.0,1340.0,0.0,no(M2 and SIP pres)
45.85397,1,male,0,5,224,Lung Cancer,Cancer,1,12.0,under $11k,4246.0,3055.1699,10.0,white,22.0,1,0,0,metastatic,0.0,0.0,no dnr,5.0,45.0,7.69921875,140.0,5.0,39.29688,128.0,3.5,1.01,1.09985352,129.0,7.479492,112.0,11.0,4760.0,0.0,<2 mo. follow-up
70.06995,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,31884.0,17663.625,23.0,white,29.0,4,0,0,no,0.699999809,0.5,dnr after sadm,2.0,93.0,7.0,72.0,24.0,36.19531,333.3,3.3999023,0.69995117,4.69921875,143.0,7.419922,281.0,54.0,1250.0,2.3881836,<2 mo. follow-up
78.52997,1,male,1,16,16,Coma,Coma,2,16.0,$11-$25k,295624.0,174851.0,43.666657,white,58.0,67,0,0,no,0.299999952,0.027,dnr after sadm,12.0,133.0,0.09999084,110.0,43.0,36.0,116.3125,3.5,20.5,1.29980469,152.0,7.459961,231.0,51.0,3460.0,0.0,<2 mo. follow-up
43.95599,0,male,0,7,814,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,22270.0,14354.4141,21.0,black,27.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,150.0,7.89941406,105.0,34.0,36.29688,260.0,2.8999023,1.09985352,2.29980469,142.0,7.369141,98.0,58.0,1490.0,0.0,<2 mo. follow-up
47.85797,0,male,0,19,815,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,29024.0,17875.7656,11.0,white,14.0,1,1,0,no,0.949999809,0.75,no dnr,19.0,62.0,9.29882812,140.0,20.0,35.0,237.125,2.5,4.0,3.0,142.0,7.509766,104.0,67.0,3400.0,1.0,no(M2 and SIP pres)
46.155,0,male,0,20,815,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,115662.0,66758.75,30.666656,white,37.0,11,0,0,no,0.949999809,0.94,no dnr,20.0,58.0,11.2988281,115.0,41.0,36.69531,63.0,3.5,14.3984375,2.39990234,150.0,7.339844,90.0,10.0,355.0,3.0,no(M2 and SIP pres)
45.60999,0,female,0,13,814,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,20191.0,12313.1172,15.0,hispanic,27.0,1,0,0,no,0.989999771,0.99,no dnr,13.0,48.0,14.3984375,105.0,11.0,38.39844,184.4375,3.5,1.01,2.09960938,137.0,7.439453,150.0,51.0,2640.0,1.0,<2 mo. follow-up
66.95099,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,107918.0,56022.4062,52.0,white,80.0,16,1,0,no,0.0,0.0,dnr after sadm,2.0,100.0,14.8984375,125.0,14.0,38.79688,376.625,3.5,1.01,1.0,137.0,7.419922,244.0,19.0,2235.0,2.9541016,<2 mo. follow-up
68.26599,1,female,0,10,117,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,8255.0,6076.8086,7.5,white,28.0,1,0,0,no,0.799999714,0.5,no dnr,10.0,78.0,4.19921875,120.0,10.0,35.59375,333.3,3.5,0.89990234,3.69970703,126.0,7.419922,180.0,83.0,4035.0,1.1667481,no(M2 and SIP pres)
50.46698,0,male,0,19,812,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,$11-$25k,55520.0,34977.0,13.333328,black,26.0,6,0,0,no,0.5,0.4,no dnr,19.0,108.0,5.69921875,80.0,20.0,36.09375,185.6875,3.3999023,0.5,3.0,136.0,7.399414,130.0,47.0,4500.0,0.0,no(M2 and SIP pres)
65.79596,1,female,1,11,11,Lung Cancer,Cancer,1,12.0,$11-$25k,10715.0,7155.7812,9.5,white,31.0,1,1,0,metastatic,0.399999857,0.2,dnr after sadm,10.0,112.0,1.69995117,65.0,26.0,36.59375,283.3125,3.5,1.39990234,0.59997559,146.0,7.449219,93.0,21.0,3720.0,0.0,<2 mo. follow-up
70.25098,1,female,0,16,262,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,68825.0,38212.2188,16.0,black,22.0,1,1,0,no,0.699999809,0.65,no dnr,16.0,103.0,16.0,102.0,24.0,36.79688,159.15625,3.5,1.0,0.69995117,145.0,7.329102,237.0,6.0,950.0,0.0,no(M2 and SIP pres)
56.76398,0,male,0,17,810,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,68058.0,39405.25,16.666656,white,25.0,7,0,0,yes,0.989999771,0.97,no dnr,17.0,65.0,7.69921875,55.0,20.0,36.39844,333.3,3.5,0.5,1.19995117,136.0,7.419922,80.0,26.0,950.0,0.0,no(M2 and SIP pres)
59.35397,1,male,0,3,315,COPD,COPD/CHF/Cirrhosis,3,11.0,$25-$50k,2370.0,1662.3418,8.0,white,18.0,1,0,0,no,0.5,0.3,no dnr,3.0,112.0,15.7988281,130.0,24.0,36.29688,87.6875,2.8999023,3.39990234,1.19995117,140.0,7.40918,202.0,72.0,3320.0,0.0,no(M2 and SIP pres)
52.465,0,male,0,22,809,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,109993.0,64156.375,39.666657,white,54.0,6,1,0,no,0.699999809,0.5,no dnr,22.0,115.0,13.0996094,120.0,24.0,36.5,300.0,3.699707,0.79992676,1.0,138.0,7.30957,132.0,14.0,900.0,1.0,no(M2 and SIP pres)
61.41498,1,male,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,316205.0,172765.625,45.0,white,54.0,9,0,0,yes,0.5,0.5,dnr after sadm,40.0,64.0,15.5,98.0,20.0,35.19531,480.9375,2.2998047,7.39941406,2.29980469,135.0,7.509766,114.0,74.0,305.0,0.0,<2 mo. follow-up
62.35999,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,64166.0,38736.25,29.333328,white,38.0,1,0,0,yes,0.5,0.25,dnr after sadm,10.0,101.0,16.8984375,65.0,14.0,36.5,304.75,3.5,0.59997559,2.0,130.0,7.469727,177.0,58.0,3135.0,1.8505859,<2 mo. follow-up
84.07898,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,76664.0,14452.7344,33.0,white,35.0,11,0,0,no,0.5,0.45,dnr after sadm,2.0,98.0,7.29980469,72.0,16.0,36.39844,333.3,4.5,0.69995117,1.5,142.0,7.419922,105.0,19.0,2502.0,2.1982422,<2 mo. follow-up
36.82397,0,male,0,12,808,Cirrhosis,COPD/CHF/Cirrhosis,4,7.0,under $11k,25253.0,15538.0781,17.5,white,47.0,1,0,0,no,0.599999905,0.45,no dnr,12.0,65.0,22.5976562,60.0,10.0,38.29688,137.5,3.0,0.59997559,1.5,136.0,7.489258,261.0,30.0,2695.0,0.0,no(M2 and SIP pres)
51.16998,0,female,0,13,807,MOSF w/Malig,ARF/MOSF,1,14.0,$11-$25k,26200.0,16062.0,22.5,white,51.0,2,0,0,yes,0.5,0.5,no dnr,13.0,69.0,3.39990234,64.0,16.0,36.29688,333.3,2.699707,1.01,0.89990234,124.0,7.419922,78.0,11.0,1750.0,1.0,SIP>=30
64.20496,0,female,0,8,807,MOSF w/Malig,ARF/MOSF,1,0.0,under $11k,32290.0,14452.7344,22.5,black,25.0,3,0,0,yes,0.899999619,0.85,no dnr,8.0,108.0,19.5976562,65.0,8.0,36.19531,388.0,3.5,0.39996338,8.29882812,136.0,7.329102,146.0,54.0,835.0,1.0,<2 mo. follow-up
50.76199,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,8819.0,5596.2266,20.0,black,53.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,58.0,16.1992188,125.0,12.0,39.5,286.625,3.5,1.01,5.39941406,133.0,7.40918,156.0,88.0,70.0,3.6152344,<2 mo. follow-up
63.67398,0,female,0,10,806,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,27389.0,15589.3984,15.0,white,24.0,3,0,0,no,0.899999619,0.85,no dnr,10.0,83.0,7.59960938,75.0,20.0,35.5,333.3,3.5,1.01,1.59985352,141.0,7.419922,97.0,13.0,2502.0,0.494751,no(M2 and SIP pres)
68.58295,0,female,0,4,806,Lung Cancer,Cancer,1,11.0,under $11k,10106.0,5244.6758,15.0,white,5.0,1,0,0,metastatic,0.899999619,0.6,no dnr,4.0,72.0,9.19921875,145.0,24.0,35.59375,309.5,3.5,1.0,1.59985352,137.0,7.529297,157.0,41.0,1730.0,0.0,adl>=4 (>=5 if sur)
79.58099,1,male,1,4,4,Coma,Coma,2,12.0,under $11k,36162.0,21214.6406,35.0,white,84.0,13,1,1,no,0.049999982,0.05,dnr after sadm,2.0,50.0,11.0,80.0,22.0,35.79688,264.0,3.5,1.01,3.09960938,132.0,7.449219,104.0,52.0,770.0,4.3925781,<2 mo. follow-up
83.58398,0,female,0,17,806,Coma,Coma,0,17.0,>$50k,73879.0,43665.25,13.666664,white,34.0,14,0,0,no,0.599999905,0.5,dnr after sadm,3.0,73.0,5.59960938,80.0,22.0,35.39844,239.125,3.3999023,1.01,1.59985352,137.0,7.389648,90.0,41.0,850.0,1.0,adl>=4 (>=5 if sur)
34.439,0,male,0,25,805,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,59995.78781114967,14452.7344,29.25,white,28.0,3,0,0,no,0.799999714,0.75,no dnr,25.0,75.0,10.8984375,125.0,25.0,38.59375,438.0625,3.5,0.59997559,3.5,137.0,7.329102,108.0,29.0,790.0,0.0,<2 mo. follow-up
53.40198,1,male,0,4,102,Lung Cancer,Cancer,1,14.0,>$50k,9731.0,5429.5742,14.0,white,5.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,60.0,10.3984375,60.0,25.0,35.89844,362.8125,1.5,2.59960938,5.29980469,125.0,7.339844,206.0,72.0,94.0,0.0,no(M2 and SIP pres)
44.81897,0,female,0,16,803,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,54182.0,31910.4219,31.666656,black,51.0,2,0,0,no,0.399999857,0.4,no dnr,16.0,153.0,16.5,115.0,29.0,39.09375,283.3125,3.5,0.89990234,0.79992676,138.0,7.419922,173.0,8.0,4400.0,1.0,no(M2 and SIP pres)
74.78699,1,male,1,8,8,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,35324.0,14452.7344,33.5,white,51.0,1,1,0,no,0.199999928,0.1,dnr after sadm,7.0,72.0,18.796875,125.0,32.0,36.59375,266.625,1.8999023,1.29980469,3.29980469,136.0,7.469727,99.0,74.0,120.0,1.1667481,<2 mo. follow-up
69.97894,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,27063.0,16028.375,28.0,white,40.0,3,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,70.0,21.5976562,105.0,24.0,35.89844,333.3,3.5,20.296875,2.59960938,138.0,7.419922,92.0,98.0,1090.0,2.0,<2 mo. follow-up
25.254,0,female,0,73,803,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,59995.78781114967,14452.7344,45.5,black,71.0,3,0,0,no,0.199999928,0.2,dnr after sadm,24.0,122.0,6.79980469,125.0,24.0,36.19531,280.0,3.5,1.01,1.39990234,141.0,7.459961,95.0,18.0,3430.0,0.0,no(M2 and SIP pres)
56.24597,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,107025.0,59218.7812,43.0,white,80.0,13,0,0,no,0.699999809,0.5,dnr after sadm,9.0,75.0,13.3984375,65.0,20.0,36.0,333.3,2.5,18.5976562,2.09960938,131.0,7.419922,36.0,55.0,1600.0,5.0,<2 mo. follow-up
61.15298,1,male,0,5,240,Colon Cancer,Cancer,1,12.0,>$50k,8201.0,4998.1562,6.0,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,100.0,9.0,75.0,26.0,36.59375,254.15625,3.5,1.01,0.79992676,136.0,7.389648,148.0,21.0,2502.0,0.0,no(M2 and SIP pres)
69.42596,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,1,3.0,$11-$25k,37687.0,24268.3906,30.0,white,29.0,3,0,0,yes,0.049999982,0.0,no dnr,6.0,135.0,22.8984375,65.0,35.0,36.5,200.0,2.7998047,1.59985352,6.29980469,127.0,7.319336,91.0,68.0,36.0,0.0,<2 mo. follow-up
49.30298,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,18720.0,10866.8438,28.0,white,56.0,5,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,60.0,15.2988281,125.0,10.0,38.19531,167.5,3.5,1.01,0.59997559,135.0,7.429688,94.0,5.0,1730.0,2.4360352,<2 mo. follow-up
42.70499,0,female,0,19,801,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,95884.0,14452.7344,20.333328,black,18.0,10,0,0,no,0.899999619,0.9,no dnr,19.0,125.0,9.5,115.0,9.0,38.5,164.0,3.5,1.01,1.09985352,136.0,7.459961,174.0,26.0,3335.0,2.5112305,adl>=4 (>=5 if sur)
60.36697,1,female,0,6,109,Lung Cancer,Cancer,1,15.0,>$50k,10652.0,14452.7344,9.0,white,10.0,1,0,0,metastatic,1.0,0.95,no dnr,6.0,113.0,4.89941406,115.0,34.0,37.89844,215.0,3.5,1.01,0.89990234,142.0,7.459961,118.0,13.0,3480.0,0.0,no(M2 and SIP pres)
59.51297,0,male,0,11,801,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,8861.0,6182.6094,14.5,white,22.0,1,1,0,no,0.699999809,0.5,no dnr,11.0,72.0,12.0,75.0,4.0,38.39844,215.0,2.0,1.01,1.39990234,140.0,7.40918,128.0,26.0,2605.0,0.0,no(M2 and SIP pres)
81.52197,1,female,0,6,118,Colon Cancer,Cancer,1,15.0,under $11k,9687.0,5528.4688,11.0,black,12.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,108.0,12.1992188,115.0,9.0,38.59375,157.5,3.5,1.01,4.29980469,149.0,7.509766,233.0,81.0,3095.0,3.0,no(M2 and SIP pres)
60.65698,0,male,0,27,801,Cirrhosis,COPD/CHF/Cirrhosis,3,4.0,under $11k,116117.0,66416.0,25.5,white,32.0,3,0,0,no,0.599999905,0.6,no dnr,27.0,85.0,4.69921875,65.0,22.0,36.5,333.3,3.699707,0.69995117,1.5,140.0,7.419922,85.0,8.0,2502.0,0.0,no(M2 and SIP pres)
57.53897,1,male,0,4,29,Lung Cancer,Cancer,1,12.0,under $11k,4855.0,3390.8594,14.0,white,26.0,1,0,0,metastatic,0.75,0.6,no dnr,4.0,58.0,14.5996094,65.0,26.0,38.39844,400.0,3.5,1.01,0.69995117,142.0,7.389648,141.0,9.0,3220.0,4.0,<2 mo. follow-up
36.84097,0,female,0,12,798,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59995.78781114967,28480.3594,44.0,black,59.0,1,0,0,no,0.299999952,0.3,no dnr,12.0,118.0,14.1992188,105.0,26.0,38.59375,284.0,3.5,0.89990234,0.59997559,141.0,7.439453,101.0,3.0,4340.0,2.7104492,no(M2 and SIP pres)
67.49896,1,male,0,6,250,Colon Cancer,Cancer,1,12.0,$25-$50k,7342.0,4205.8242,13.0,white,11.0,1,0,0,metastatic,0.799999714,0.7,no dnr,6.0,113.0,5.29980469,68.0,20.0,36.5,333.3,3.699707,0.5,10.3984375,138.0,7.419922,72.0,45.0,2502.0,0.0,<2 mo. follow-up
61.06497,0,male,0,10,798,Lung Cancer,Cancer,1,20.0,under $11k,19506.0,11892.625,17.0,white,26.0,1,0,0,metastatic,1.0,1.0,no dnr,10.0,112.0,6.5,125.0,28.0,35.89844,110.20312,3.5,1.01,0.5,138.0,7.509766,145.0,21.0,3535.0,0.0,no(M2 and SIP pres)
61.65097,1,male,1,16,16,Coma,Coma,4,12.0,under $11k,44669.0,26613.8281,29.333328,black,32.0,1,1,0,no,0.099999964,0.1,dnr after sadm,1.0,71.0,7.09960938,74.0,16.0,35.79688,333.3,3.5,0.39996338,0.79992676,139.0,7.419922,114.0,12.0,2050.0,3.0,<2 mo. follow-up
49.125,1,female,1,60,60,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,59995.78781114967,197475.75,52.0,white,52.0,2,0,0,metastatic,0.699999809,0.5,dnr after sadm,45.0,72.0,4.79980469,45.0,20.0,36.29688,333.3,3.8999023,0.5,1.09985352,139.0,7.419922,104.0,7.0,2502.0,1.0,<2 mo. follow-up
48.67899,0,female,0,8,797,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,8753.0,5985.1289,13.0,white,24.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,119.0,7.0,128.0,32.0,36.39844,333.3,3.5,1.01,0.89990234,139.0,7.419922,118.0,8.0,2502.0,0.0,SIP>=30
71.90997,1,male,0,22,318,MOSF w/Malig,ARF/MOSF,2,3.0,under $11k,58249.0,14452.7344,22.0,other,38.0,7,0,0,metastatic,0.5,0.2,no dnr,22.0,77.0,16.1992188,115.0,6.0,39.39844,252.5,3.5,1.01,0.89990234,143.0,7.569336,176.0,14.0,1980.0,7.0,no(M2 and SIP pres)
49.21799,1,male,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,37986.0,23976.9844,26.0,white,82.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,150.0,19.0976562,140.0,40.0,38.79688,187.5,3.5,1.01,2.0,142.0,7.5,158.0,113.0,2950.0,0.0,<2 mo. follow-up
56.36697,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,15479.0,8717.2109,36.0,white,48.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,103.0,9.5,65.0,28.0,38.19531,148.96875,3.5,1.01,1.19995117,141.0,7.429688,118.0,23.0,925.0,0.0,<2 mo. follow-up
73.85394,1,female,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,156015.0,88125.1875,43.25,black,37.0,2,1,0,no,0.5,0.5,dnr after sadm,16.0,103.0,7.5,80.0,20.0,36.29688,333.3,3.0,3.5,1.0,133.0,7.419922,105.0,10.0,2075.0,2.5649414,<2 mo. follow-up
66.63098,0,male,0,17,796,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,50995.0,14452.7344,25.0,white,22.0,1,0,0,no,0.299999952,0.2,no dnr,17.0,60.0,20.5,100.0,9.0,37.0,180.0,2.5996094,1.01,1.09985352,145.0,7.459961,206.0,42.0,1545.0,0.0,no(M2 and SIP pres)
67.46295,1,female,0,19,70,CHF,COPD/CHF/Cirrhosis,4,7.0,under $11k,62389.0,14452.7344,17.666656,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,19.0,73.0,15.7988281,75.0,28.0,36.0,200.0,4.0996094,0.69995117,0.69995117,140.0,7.389648,281.0,5.0,1800.0,3.8549805,<2 mo. follow-up
22.63699,0,male,0,42,795,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,172064.0,103872.812,26.0,black,36.0,4,0,0,no,0.699999809,0.5,no dnr,42.0,38.0,14.0996094,95.0,12.0,35.09375,197.5,1.8999023,1.0,3.19970703,129.0,7.449219,244.0,31.0,0.0,0.0,<2 mo. follow-up
58.52197,1,male,0,10,65,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,59995.78781114967,8245.4297,15.0,white,20.0,1,1,0,no,0.899999619,0.8,no dnr,10.0,82.0,9.29882812,112.0,20.0,36.39844,333.3,2.699707,2.89990234,1.0,127.0,7.419922,114.0,31.0,1900.0,0.0,adl>=4 (>=5 if sur)
69.45099,1,female,0,20,81,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,45707.0,26465.7188,22.666656,black,16.0,3,0,0,no,0.199999928,0.1,dnr after sadm,5.0,147.0,10.6992188,115.0,25.0,38.5,393.3125,3.5,1.01,0.79992676,133.0,7.439453,161.0,16.0,2305.0,6.0,adl>=4 (>=5 if sur)
71.18695,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,69569.0,40665.0312,25.0,black,96.0,18,0,0,no,0.029999986,0.01,dnr after sadm,2.0,67.0,10.0,119.0,26.0,37.69531,333.3,2.0996094,0.89990234,0.39996338,134.0,7.419922,174.0,3.0,2502.0,2.8095703,<2 mo. follow-up
44.44098,1,female,0,5,96,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,5385.0,3102.6836,10.0,black,44.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,102.0,14.0,45.0,12.0,38.29688,344.0,3.5,1.01,0.89990234,132.0,7.439453,189.0,13.0,2135.0,1.1667481,no(M2 and SIP pres)
61.36099,1,male,0,5,465,Colon Cancer,Cancer,1,15.0,>$50k,9995.0,5151.3203,13.0,white,3.0,1,0,0,metastatic,0.75,0.5,no dnr,5.0,125.0,3.79980469,60.0,28.0,35.29688,266.625,2.699707,1.01,0.79992676,137.0,7.449219,285.0,13.0,1955.0,0.0,no(M2 and SIP pres)
71.99695,1,male,0,89,222,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,207723.0,127257.875,32.75,black,36.0,1,0,0,no,0.699999809,0.7,no dnr,89.0,100.0,8.5,75.0,18.0,36.5,256.5,4.0996094,0.39996338,1.0,139.0,7.40918,79.0,13.0,900.0,6.0,<2 mo. follow-up
57.70599,1,male,0,50,130,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,191559.0,118099.75,14.75,white,54.0,14,0,0,no,0.699999809,0.5,no dnr,50.0,53.0,16.296875,105.0,10.0,37.79688,165.0,1.7998047,1.01,0.5,129.0,7.479492,213.0,18.0,3900.0,2.0,no(M2 and SIP pres)
57.34198,0,male,0,18,790,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,42913.0,25772.3906,19.333328,black,33.0,1,0,0,no,0.699999809,0.7,no dnr,18.0,68.0,11.0996094,145.0,9.0,35.0,220.0,3.5,0.79992676,2.39990234,129.0,7.349609,192.0,55.0,2230.0,0.0,no(M2 and SIP pres)
50.89398,1,female,0,9,74,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,59995.78781114967,18112.0,21.5,white,36.0,2,0,0,metastatic,0.899999619,0.8,no dnr,9.0,75.0,7.79980469,75.0,32.0,35.89844,226.65625,2.699707,1.89990234,1.29980469,141.0,7.339844,126.0,48.0,1550.0,1.0,no(M2 and SIP pres)
64.70398,0,male,0,4,789,Colon Cancer,Cancer,2,16.0,under $11k,20581.0,14452.7344,7.0,white,5.0,1,1,0,metastatic,0.699999809,0.5,no dnr,4.0,62.0,7.79980469,65.0,28.0,36.0,333.3,3.5,1.01,1.79980469,132.0,7.419922,155.0,45.0,2390.0,0.0,no(M2 and SIP pres)
84.862,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,34260.0,14452.7344,19.5,white,58.0,13,0,0,no,0.699999809,0.5,dnr after sadm,2.0,100.0,17.6992188,120.0,30.0,38.29688,310.0,2.0,2.69970703,1.39990234,139.0,7.419922,121.0,48.0,2330.0,6.0,<2 mo. follow-up
70.77594,1,female,1,12,12,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,94253.0,56570.1562,59.5,white,87.0,16,1,0,yes,0.5,0.3,dnr after sadm,9.0,62.0,2.5,125.0,33.0,37.79688,404.0,2.5996094,1.69995117,2.19970703,149.0,7.40918,74.0,25.0,1550.0,5.0,<2 mo. follow-up
55.30698,0,female,0,16,788,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,45838.0,14452.7344,23.0,black,17.0,2,0,0,no,0.899999619,0.9,no dnr,16.0,122.0,6.0,125.0,26.0,36.19531,185.6875,3.5,1.01,0.69995117,130.0,7.439453,126.0,7.0,2035.0,0.0,no(M2 and SIP pres)
70.74896,0,male,0,42,788,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,153838.0,86810.3125,40.25,white,56.0,1,0,0,no,0.699999809,0.5,no dnr,42.0,48.0,1.79980469,0.0,24.0,36.09375,142.5,3.5,1.01,0.59997559,128.0,7.429688,36.0,18.0,3180.0,2.5224609,<2 mo. follow-up
84.474,1,female,0,3,4,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,2348.0,1736.6465,9.0,white,34.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,73.0,4.39941406,64.0,32.0,38.39844,138.3125,3.5,1.01,0.89990234,134.0,7.449219,210.0,15.0,1940.0,2.6855469,<2 mo. follow-up
53.29999,1,female,0,14,19,Cirrhosis,COPD/CHF/Cirrhosis,0,10.0,under $11k,16419.0,14452.7344,7.333332,hispanic,44.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,97.0,5.19921875,70.0,20.0,37.0,333.3,3.699707,0.59997559,0.89990234,140.0,7.419922,98.0,6.0,3400.0,6.0,<2 mo. follow-up
45.26797,1,male,1,31,31,MOSF w/Malig,ARF/MOSF,1,18.0,under $11k,88046.0,56097.2188,26.75,black,84.0,5,0,0,yes,0.199999928,0.1,dnr after sadm,3.0,20.0,12.2988281,0.0,0.0,37.79688,154.0,3.3999023,0.79992676,1.5,135.0,7.40918,255.0,31.0,1310.0,0.0,<2 mo. follow-up
70.88599,1,female,0,31,46,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,91599.0,53839.2812,25.25,white,34.0,3,1,0,metastatic,0.949999809,0.9,no dnr,31.0,78.0,14.0,65.0,26.0,37.59375,333.3,3.5,1.01,0.69995117,137.0,7.419922,365.0,30.0,1280.0,0.0,<2 mo. follow-up
75.90094,1,male,0,4,645,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,3281.0,2380.8574,9.0,white,31.0,1,1,0,no,0.849999905,0.8,no dnr,4.0,112.0,11.7988281,45.0,35.0,39.0,188.5625,3.5,1.01,0.79992676,133.0,7.399414,148.0,14.0,3950.0,2.2456055,SIP>=30
58.58197,0,male,0,18,786,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,62225.0,34993.1562,31.666656,black,78.0,2,1,0,no,0.5,0.45,no dnr,18.0,80.0,13.0,72.0,20.0,36.89844,333.3,3.2998047,0.59997559,0.79992676,138.0,7.419922,171.0,3.0,2500.0,0.0,no(M2 and SIP pres)
76.12299,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,81539.0,46428.0,42.5,white,52.0,16,0,0,yes,0.199999928,0.1,dnr after sadm,2.0,45.0,11.3984375,145.0,41.0,38.19531,151.40625,2.699707,1.39990234,0.69995117,139.0,7.05957,68.0,7.0,2005.0,2.2407227,<2 mo. follow-up
56.89798,0,female,0,39,786,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,167108.0,14452.7344,33.75,white,46.0,6,0,0,no,0.5,0.4,no dnr,39.0,65.0,6.89941406,70.0,26.0,37.79688,352.0,3.5,1.01,4.29980469,131.0,7.519531,237.0,94.0,585.0,0.0,<2 mo. follow-up
79.31799,1,male,0,75,104,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,59995.78781114967,205665.625,38.25,white,68.0,1,0,0,yes,0.5,0.4,dnr after sadm,57.0,128.0,19.296875,160.0,14.0,35.09375,330.0,3.5,1.01,1.0,136.0,7.40918,138.0,26.0,1700.0,0.0,adl>=4 (>=5 if sur)
49.10599,0,female,0,34,783,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,147854.0,81525.25,31.75,black,44.0,2,0,0,no,0.699999809,0.65,no dnr,34.0,48.0,15.2988281,145.0,15.0,39.0,140.0,2.5,4.0,3.59960938,131.0,7.399414,103.0,23.0,1600.0,0.0,no(M2 and SIP pres)
49.28098,1,male,0,11,14,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,17741.0,14452.7344,15.5,white,53.0,1,0,0,no,0.299999952,0.1,dnr after sadm,1.0,58.0,19.0976562,190.0,47.0,37.69531,176.0,2.199707,11.2988281,0.79992676,143.0,7.449219,234.0,7.0,7790.0,0.0,<2 mo. follow-up
77.17999,1,female,0,88,264,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,59995.78781114967,412953.0,34.25,white,79.0,86,1,0,no,0.199999928,0.5,no dnr,88.0,112.0,9.5,65.0,20.0,37.79688,333.3,3.5,0.59997559,1.0,137.0,7.419922,117.0,12.0,1880.0,0.0,adl>=4 (>=5 if sur)
51.504,0,female,0,22,782,Coma,Coma,1,11.0,$25-$50k,52590.0,14452.7344,30.666656,white,8.0,2,0,0,no,0.799999714,0.6,no dnr,22.0,108.0,78.1875,105.0,10.0,37.79688,167.34375,3.5,1.19995117,0.89990234,149.0,7.349609,99.0,22.0,2170.0,0.0,no(M2 and SIP pres)
65.56598,1,female,0,18,452,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,57122.0,33227.5938,29.0,white,60.0,1,0,0,yes,0.699999809,0.5,no dnr,18.0,72.0,22.8984375,125.0,13.0,37.89844,164.0,3.5,1.01,2.89990234,130.0,7.349609,124.0,58.0,1066.0,7.0,SIP>=30
64.66498,0,female,0,15,781,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,$11-$25k,59995.78781114967,21407.9375,17.0,white,36.0,1,1,0,no,0.799999714,0.75,no dnr,15.0,93.0,14.8984375,75.0,30.0,36.39844,305.0,3.0996094,1.89990234,0.89990234,132.0,7.429688,150.0,30.0,3685.0,0.0,no(M2 and SIP pres)
75.77295,0,male,0,23,781,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,226055.0,124220.188,28.333328,white,47.0,32,0,0,no,0.649999619,0.6,no dnr,23.0,117.0,6.5,100.0,20.0,36.29688,333.3,3.5,0.59997559,1.0,138.0,7.419922,103.0,15.0,2502.0,5.0,SIP>=30
71.19495,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,38463.0,23534.8594,32.0,white,74.0,1,0,0,no,0.399999857,0.4,dnr after sadm,3.0,80.0,8.29882812,109.0,22.0,36.19531,333.3,3.5,2.19970703,1.5,138.0,7.419922,82.0,27.0,2800.0,0.0,<2 mo. follow-up
37.83698,0,male,0,10,780,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,46743.0,14452.7344,20.0,asian,26.0,5,0,0,metastatic,0.699999809,0.5,no dnr,10.0,79.0,7.19921875,72.0,20.0,38.69531,333.3,2.8999023,0.59997559,0.89990234,141.0,7.419922,97.0,5.0,4700.0,0.0,no(M2 and SIP pres)
47.13498,0,male,0,26,780,Coma,Coma,0,17.0,$11-$25k,72007.0,45311.5312,23.0,white,22.0,6,0,0,no,0.699999809,0.5,no dnr,26.0,112.0,18.1992188,135.0,33.0,38.39844,243.3125,2.0,1.29980469,0.59997559,145.0,7.419922,118.0,15.0,1705.0,0.0,no(M2 and SIP pres)
70.49097,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,59995.78781114967,13936.1016,39.0,white,82.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,71.0,3.09960938,113.0,28.0,35.09375,333.3,3.5,1.01,1.29980469,135.0,7.419922,107.0,18.0,2502.0,1.9504394,<2 mo. follow-up
69.42896,1,female,0,122,253,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,367125.0,220730.75,39.5,black,79.0,1,0,0,no,0.5,0.5,no dnr,122.0,147.0,7.79980469,120.0,6.0,36.09375,253.3125,2.3999023,3.89990234,4.09960938,147.0,7.399414,177.0,54.0,820.0,1.0,adl>=4 (>=5 if sur)
65.54999,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,219969.0,114773.188,44.666657,white,60.0,20,0,0,yes,0.699999809,0.5,dnr after sadm,18.0,106.0,10.3984375,55.0,16.0,35.59375,333.3,3.3999023,0.5,1.09985352,140.0,7.419922,191.0,14.0,3650.0,2.347168,<2 mo. follow-up
58.66098,0,male,0,4,778,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,3723.0,14452.7344,8.0,black,43.0,1,0,0,no,0.599999905,0.5,no dnr,4.0,65.0,11.5996094,105.0,14.0,38.19531,312.0,3.5,1.01,1.0,135.0,7.359375,144.0,21.0,1260.0,0.494751,no(M2 and SIP pres)
61.82898,1,female,1,30,30,COPD,COPD/CHF/Cirrhosis,4,21.0,>$50k,43942.0,27844.7969,17.25,white,64.0,1,0,0,yes,0.5,0.4,dnr after sadm,9.0,118.0,14.6992188,75.0,10.0,35.89844,253.3125,3.5,3.0,1.19995117,147.0,7.489258,239.0,18.0,930.0,2.0,<2 mo. follow-up
77.01294,0,female,0,57,776,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,177611.0,102840.75,44.25,white,52.0,1,0,0,no,0.5,0.125,no dnr,57.0,65.0,10.5,120.0,12.0,37.79688,178.0,2.7998047,3.59960938,2.59960938,149.0,7.389648,74.0,26.0,710.0,0.0,SIP>=30
64.586,1,male,0,16,197,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,53737.0,30612.4062,26.333328,white,27.0,2,0,0,no,0.399999857,0.35,no dnr,16.0,98.0,15.3984375,75.0,24.0,36.69531,271.375,3.5,0.69995117,2.89990234,138.0,7.289062,182.0,59.0,2502.0,0.0,no(M2 and SIP pres)
69.20197,0,male,0,22,775,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,66688.0,43376.4688,13.0,white,27.0,35,0,0,no,0.899999619,0.88,no dnr,22.0,108.0,1.0,110.0,33.0,38.09375,230.0,2.5996094,0.69995117,0.89990234,145.0,7.539062,99.0,27.0,2375.0,7.0,adl>=4 (>=5 if sur)
63.28299,1,male,0,17,82,Colon Cancer,Cancer,1,18.0,>$50k,23392.0,14452.7344,18.666656,white,12.0,1,0,0,metastatic,0.799999714,0.6,no dnr,17.0,55.0,28.0,70.0,30.0,36.09375,214.28125,1.0,18.1992188,8.0,136.0,7.389648,84.0,101.0,940.0,0.0,<2 mo. follow-up
70.04797,1,male,0,13,122,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,56994.0,33252.2812,43.5,white,18.0,1,0,0,no,0.75,0.7,no dnr,13.0,42.0,4.89941406,75.0,11.0,37.59375,324.0,3.5,1.01,1.59985352,127.0,7.479492,210.0,49.0,3955.0,1.0,no(M2 and SIP pres)
59.32599,1,male,0,6,196,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,11088.0,14452.7344,16.0,white,22.0,1,0,0,no,0.799999714,0.8,no dnr,6.0,48.0,22.0976562,115.0,8.0,38.69531,220.0,2.2998047,0.69995117,1.39990234,144.0,7.429688,227.0,18.0,3620.0,0.494751,no(M2 and SIP pres)
74.836,1,female,0,55,205,Coma,Coma,2,12.0,$11-$25k,121446.0,73198.25,22.75,white,42.0,3,0,0,no,0.5,0.4,no dnr,55.0,78.0,13.7988281,105.0,16.0,36.0,145.0,3.5,1.01,0.89990234,135.0,7.449219,96.0,31.0,3745.0,0.0,adl>=4 (>=5 if sur)
67.29895,1,male,0,16,145,Lung Cancer,Cancer,1,12.0,under $11k,16352.0,11122.2734,9.0,white,14.0,1,0,0,metastatic,0.599999905,0.2,dnr after sadm,13.0,67.0,9.8984375,105.0,16.0,36.09375,333.3,3.5,0.89990234,0.89990234,135.0,7.419922,87.0,12.0,1650.0,0.0,no(M2 and SIP pres)
65.03796,0,female,0,40,772,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,>$50k,102799.0,63792.2188,26.25,white,44.0,1,0,0,no,0.5,0.5,no dnr,40.0,105.0,2.59960938,130.0,8.0,38.19531,260.0,1.1999512,1.01,1.19995117,136.0,7.399414,104.0,15.0,1373.0,6.0,no(M2 and SIP pres)
55.05499,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,24.0,>$50k,44118.0,26434.5938,31.0,white,73.0,18,0,0,metastatic,0.099999964,0.0,dnr after sadm,2.0,72.0,10.3984375,101.0,16.0,36.5,333.3,3.7998047,0.89990234,1.19995117,133.0,7.419922,265.0,18.0,1775.0,2.4492188,<2 mo. follow-up
28.19399,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,96558.0,57177.4688,38.0,white,74.0,13,0,0,no,0.099999964,0.05,dnr after sadm,2.0,62.0,6.39941406,60.0,10.0,36.09375,170.0,3.5,1.01,0.59997559,139.0,7.419922,115.0,10.0,3025.0,1.0,<2 mo. follow-up
60.66299,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,188767.0,103457.812,35.75,white,58.0,3,0,0,no,0.799999714,0.7,dnr after sadm,33.0,52.0,21.0,145.0,10.0,39.29688,182.21875,1.8999023,2.89990234,1.5,139.0,7.5,196.0,55.0,330.0,1.9780273,<2 mo. follow-up
55.56198,0,female,0,16,770,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,35993.0,20256.8438,22.666656,white,31.0,1,0,0,no,0.799999714,0.7,no dnr,16.0,73.0,8.8984375,115.0,24.0,35.59375,623.75,2.0,6.19921875,1.0,128.0,7.469727,91.0,6.0,750.0,2.0,SIP>=30
75.28796,1,female,1,5,5,Coma,Coma,2,14.0,under $11k,59995.78781114967,11422.7578,34.0,white,72.0,1,0,0,no,0.149999976,0.1,dnr after sadm,2.0,98.0,5.0,70.0,20.0,36.29688,333.3,2.8999023,0.39996338,1.09985352,141.0,7.419922,158.0,5.0,9000.0,1.0,<2 mo. follow-up
75.27698,0,female,0,53,769,COPD,COPD/CHF/Cirrhosis,3,12.0,>$50k,129050.0,77979.6875,26.25,white,29.0,1,0,0,no,0.5,0.5,no dnr,53.0,75.0,23.3984375,115.0,35.0,38.5,211.40625,2.199707,0.79992676,1.09985352,138.0,7.429688,174.0,13.0,1860.0,0.0,no(M2 and SIP pres)
53.02698,1,male,0,5,385,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,3519.0,2716.1777,2.0,black,24.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,83.0,7.79980469,55.0,12.0,35.39844,512.0,2.0,3.79980469,3.29980469,134.0,7.40918,141.0,97.0,1900.0,0.494751,no(M2 and SIP pres)
65.44299,1,male,0,14,105,Lung Cancer,Cancer,2,19.0,under $11k,15948.0,10670.1875,7.333332,white,21.0,1,0,0,metastatic,0.699999809,0.3,no dnr,14.0,108.0,15.2988281,125.0,38.0,37.59375,252.0,3.5,0.79992676,0.69995117,136.0,7.349609,136.0,9.0,665.0,5.0,<2 mo. follow-up
54.543,1,male,0,10,192,Lung Cancer,Cancer,1,5.0,$25-$50k,17099.0,10467.5703,11.0,white,2.0,1,0,0,metastatic,1.0,0.5,no dnr,10.0,112.0,25.796875,100.0,12.0,36.39844,348.0,1.5998535,0.39996338,0.5,138.0,7.429688,144.0,10.0,990.0,0.0,no(M2 and SIP pres)
80.28198,1,male,1,5,5,Lung Cancer,Cancer,2,12.0,under $11k,9725.0,14452.7344,20.0,black,43.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,93.0,8.0,65.0,20.0,36.19531,333.3,3.5,0.5,0.89990234,138.0,7.419922,199.0,15.0,2400.0,6.0,<2 mo. follow-up
52.88199,1,female,0,11,504,Cirrhosis,COPD/CHF/Cirrhosis,1,17.0,under $11k,30125.0,19121.0,12.5,white,34.0,8,0,0,no,0.699999809,0.5,no dnr,11.0,48.0,15.2988281,105.0,60.0,37.89844,295.0,3.5,0.69995117,1.5,134.0,7.379883,203.0,27.0,2200.0,1.0,<2 mo. follow-up
60.65399,1,male,0,21,67,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,71922.0,39465.0,29.0,white,44.0,2,0,0,no,0.549999714,0.5,no dnr,21.0,42.0,1.29980469,75.0,12.0,35.69531,230.0,2.5,22.296875,2.19970703,146.0,7.339844,157.0,84.0,340.0,0.0,no(M2 and SIP pres)
55.181,1,male,0,7,288,Lung Cancer,Cancer,1,12.0,$25-$50k,4957.0,3451.5,3.5,white,9.0,1,0,0,metastatic,0.599999905,0.25,no dnr,7.0,118.0,14.0,125.0,10.0,36.69531,260.6875,4.0996094,1.01,0.69995117,140.0,7.369141,119.0,11.0,2670.0,0.0,SIP>=30
50.01199,0,male,0,3,764,Lung Cancer,Cancer,1,20.0,>$50k,6388.0,3168.7422,11.0,white,6.0,1,0,0,metastatic,1.0,0.8,no dnr,3.0,65.0,9.29882812,120.0,10.0,36.29688,177.75,1.5,4.19921875,3.19970703,146.0,7.389648,214.0,85.0,2815.0,1.8657227,no(M2 and SIP pres)
22.62799,0,male,0,37,763,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,323059.0,189009.25,40.0,black,51.0,10,0,0,no,0.699999809,0.5,no dnr,37.0,72.0,6.09960938,60.0,20.0,36.5,333.3,3.5,1.01,2.09960938,139.0,7.419922,83.0,53.0,1300.0,4.0,no(M2 and SIP pres)
47.62799,1,male,0,76,521,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,376664.0,207720.0,45.25,white,56.0,7,0,0,metastatic,0.699999809,0.5,no dnr,76.0,70.0,23.296875,64.0,28.0,37.79688,333.3,2.5,11.8984375,0.59997559,131.0,7.419922,33.0,4.0,2502.0,0.0,adl>=4 (>=5 if sur)
73.59094,0,female,0,25,762,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,73327.0,43064.3438,27.25,white,28.0,1,1,0,no,0.599999905,0.4,no dnr,25.0,127.0,0.39996338,115.0,33.0,36.69531,428.5625,2.8999023,22.3984375,8.59960938,154.0,7.30957,195.0,142.0,2130.0,0.0,no(M2 and SIP pres)
36.76099,0,female,0,14,761,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,41480.0,24610.7969,29.333328,black,33.0,1,0,0,no,0.699999809,0.7,no dnr,14.0,72.0,14.5996094,110.0,32.0,38.09375,200.0,2.0996094,0.69995117,0.69995117,143.0,7.449219,206.0,10.0,3200.0,0.0,no(M2 and SIP pres)
82.75696,1,male,0,29,279,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,$11-$25k,73813.0,44928.0625,20.5,white,17.0,8,0,1,no,0.799999714,0.8,no dnr,29.0,72.0,6.5,45.0,16.0,36.0,333.3,3.5,1.01,1.79980469,138.0,7.419922,188.0,57.0,2550.0,4.9345703,no(M2 and SIP pres)
70.21997,0,female,0,10,761,Colon Cancer,Cancer,1,12.0,under $11k,16592.0,9469.4141,9.5,white,5.0,1,0,0,metastatic,0.799999714,0.6,no dnr,10.0,55.0,15.1992188,145.0,0.0,36.69531,190.0,3.5,1.01,2.29980469,136.0,7.489258,361.0,48.0,2670.0,0.0,no(M2 and SIP pres)
77.35498,1,male,0,28,66,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,63807.0,38045.8125,24.25,white,49.0,1,0,0,no,0.699999809,0.5,dnr after sadm,11.0,128.0,14.8984375,110.0,35.0,36.0,98.75,3.5,1.59985352,0.69995117,136.0,7.519531,267.0,26.0,1535.0,2.0,<2 mo. follow-up
48.40198,1,male,0,5,21,Lung Cancer,Cancer,1,16.0,$25-$50k,4142.0,2687.8477,7.0,white,26.0,1,0,0,metastatic,0.099999964,0.0,no dnr,5.0,135.0,30.8984375,125.0,18.0,38.0,208.5625,3.5,7.29980469,1.19995117,141.0,7.439453,109.0,35.0,1350.0,1.0,<2 mo. follow-up
38.875,0,female,0,19,760,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,113529.0,65544.0625,16.0,white,16.0,42,0,0,no,0.799999714,0.8,no dnr,19.0,53.0,13.0,55.0,22.0,38.79688,191.40625,2.0996094,1.59985352,7.5,121.0,7.379883,150.0,113.0,88.0,7.0,adl>=4 (>=5 if sur)
65.93597,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,62017.0,36789.2188,36.0,black,80.0,1,1,0,no,0.75,0.65,dnr after sadm,9.0,60.0,16.3984375,125.0,10.0,38.19531,133.3125,2.3999023,2.39990234,1.09985352,130.0,7.489258,97.0,9.0,1970.0,0.0,<2 mo. follow-up
60.44397,0,female,0,16,759,Coma,Coma,0,12.0,under $11k,44441.0,27747.375,25.0,white,22.0,3,0,0,no,0.599999905,0.6,dnr after sadm,1.0,67.0,19.5,108.0,20.0,34.29688,338.0625,3.5,3.69970703,3.29980469,147.0,7.539062,111.0,78.0,1300.0,0.0,adl>=4 (>=5 if sur)
57.51099,0,male,0,18,759,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,76162.0,43470.0625,27.666656,white,36.0,3,1,0,no,0.849999905,0.8,no dnr,18.0,58.0,11.7988281,155.0,40.0,37.89844,130.0,2.5,6.89941406,1.19995117,134.0,7.609375,167.0,48.0,2002.0,0.0,no(M2 and SIP pres)
58.28098,0,female,0,9,759,COPD,COPD/CHF/Cirrhosis,3,13.0,under $11k,10409.0,6518.168,10.0,white,14.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,118.0,11.0,55.0,22.0,37.79688,272.5,3.5,1.01,0.69995117,136.0,7.429688,153.0,5.0,5295.0,2.0,no(M2 and SIP pres)
62.80899,1,female,1,15,15,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,78898.0,44584.9688,51.666657,white,43.0,1,0,0,yes,0.5,0.2,dnr after sadm,9.0,112.0,17.5976562,135.0,44.0,38.59375,146.65625,2.5996094,0.5,1.69995117,149.0,7.429688,148.0,23.0,1530.0,6.0,<2 mo. follow-up
51.16498,1,male,0,5,76,Lung Cancer,Cancer,1,15.0,>$50k,6343.0,3586.1406,10.0,white,9.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,130.0,14.5,75.0,25.0,38.09375,300.0,3.5,0.5,1.5,146.0,7.449219,384.0,39.0,3890.0,0.0,no(M2 and SIP pres)
60.52798,0,female,0,11,757,COPD,COPD/CHF/Cirrhosis,1,9.0,$11-$25k,10831.0,7174.082,10.5,white,20.0,1,0,0,no,0.899999619,0.9,no dnr,11.0,68.0,14.5,125.0,12.0,35.59375,220.0,3.5,1.79980469,1.5,140.0,7.429688,177.0,41.0,4000.0,0.0,no(M2 and SIP pres)
45.56299,0,male,0,13,756,MOSF w/Malig,ARF/MOSF,1,18.0,under $11k,92440.0,48631.625,40.0,white,88.0,8,0,0,metastatic,0.5,0.5,no dnr,13.0,50.0,18.296875,115.0,20.0,36.5,72.0,2.0996094,6.29980469,5.69921875,139.0,7.339844,100.0,63.0,580.0,2.3662109,no(M2 and SIP pres)
71.16998,0,female,0,53,756,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,248546.0,142914.625,43.75,black,32.0,12,1,0,no,0.699999809,0.5,no dnr,53.0,123.0,16.796875,75.0,16.0,36.89844,130.0,2.3999023,1.01,1.29980469,137.0,7.349609,128.0,26.0,2240.0,1.0,SIP>=30
76.85999,0,female,0,18,756,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,35513.0,22049.8125,15.333328,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,18.0,125.0,14.2988281,135.0,12.0,39.0,263.3125,3.3999023,1.89990234,0.69995117,138.0,7.529297,120.0,11.0,2985.0,3.0,no(M2 and SIP pres)
66.612,1,male,0,9,333,MOSF w/Malig,ARF/MOSF,2,17.0,$25-$50k,15178.0,9082.9531,15.0,other,71.0,1,1,0,metastatic,0.699999809,0.5,no dnr,9.0,38.0,15.5996094,75.0,20.0,36.79688,131.40625,2.0996094,3.89990234,4.69921875,144.0,7.419922,89.0,49.0,120.0,2.0,adl>=4 (>=5 if sur)
80.23798,0,female,0,27,754,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,42852.0,26986.3438,10.75,black,24.0,5,0,0,no,0.699999809,0.5,no dnr,27.0,50.0,5.39941406,195.0,30.0,39.19531,270.0,3.199707,0.89990234,4.89941406,136.0,7.459961,149.0,47.0,460.0,5.0,adl>=4 (>=5 if sur)
30.245,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,11320.0,6489.4727,30.0,black,83.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,47.0,17.296875,125.0,38.0,36.69531,116.65625,3.5,1.01,1.09985352,142.0,7.299805,273.0,58.0,5450.0,1.5695801,<2 mo. follow-up
50.36798,1,female,1,24,24,Coma,Coma,1,18.0,$11-$25k,56208.0,34438.6875,23.0,black,83.0,1,0,0,metastatic,0.149999976,0.05,no dnr,24.0,67.0,19.0,95.0,28.0,36.69531,228.5625,3.5,1.01,1.59985352,142.0,7.399414,83.0,30.0,2502.0,7.0,<2 mo. follow-up
55.16199,1,female,0,10,66,Lung Cancer,Cancer,1,12.0,under $11k,8135.0,5829.5977,1.5,white,11.0,1,0,0,metastatic,0.699999809,0.4,no dnr,10.0,57.0,15.3984375,145.0,38.0,35.79688,230.0,3.5,0.59997559,1.39990234,142.0,7.389648,92.0,44.0,985.0,2.2358398,<2 mo. follow-up
40.271,1,male,0,21,109,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,58691.0,31759.5156,29.333328,white,13.0,1,0,0,no,0.699999809,0.5,dnr after sadm,8.0,47.0,17.5,75.0,32.0,38.69531,134.0,1.8999023,0.69995117,1.09985352,132.0,7.439453,107.0,18.0,1659.0,1.0,no(M2 and SIP pres)
68.25494,0,male,0,12,752,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,92206.0,50704.9062,36.0,white,45.0,10,1,0,no,0.799999714,0.7,no dnr,12.0,62.0,9.69921875,105.0,10.0,38.0,245.6875,3.5,1.01,1.5,134.0,7.489258,114.0,38.0,5780.0,0.0,no(M2 and SIP pres)
84.29797,1,female,1,17,17,MOSF w/Malig,ARF/MOSF,0,16.0,$25-$50k,109768.0,63122.5938,46.0,white,68.0,2,0,0,yes,0.699999809,0.5,dnr after sadm,17.0,132.0,8.59960938,120.0,30.0,38.5,135.0,2.5996094,1.01,0.89990234,150.0,7.429688,153.0,17.0,3570.0,3.0,<2 mo. follow-up
80.474,0,female,0,47,751,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,>$50k,204836.0,121360.25,33.25,white,49.0,27,0,0,no,0.699999809,0.5,no dnr,47.0,128.0,5.0,52.0,20.0,36.69531,333.3,3.8999023,0.69995117,1.29980469,137.0,7.419922,81.0,9.0,3200.0,0.0,adl>=4 (>=5 if sur)
46.89099,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,5.0,under $11k,50893.0,30054.4062,38.0,white,88.0,3,0,0,no,0.099999964,0.1,dnr before sadm,-1.0,108.0,11.6992188,115.0,24.0,38.0,297.3125,3.0996094,0.59997559,0.89990234,133.0,7.469727,133.0,19.0,2045.0,0.0,<2 mo. follow-up
67.90997,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,49488.0,29109.1094,31.0,white,111.0,12,0,0,no,0.699999809,0.5,dnr after sadm,1.0,66.0,10.5,70.0,12.0,36.29688,200.0,3.199707,0.59997559,0.5,131.0,7.389648,98.0,15.0,3680.0,1.5153809,<2 mo. follow-up
89.07599,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,63254.0,37061.9688,35.0,white,55.0,14,0,0,no,0.5,0.3,dnr after sadm,1.0,77.0,23.3984375,70.0,27.0,35.19531,266.625,3.5,0.29998779,3.59960938,146.0,7.399414,163.0,60.0,4500.0,1.0,<2 mo. follow-up
40.20798,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,14.0,under $11k,84543.0,52347.1875,49.0,black,118.0,22,0,0,yes,0.149999976,0.1,no dnr,4.0,73.0,4.0,65.0,20.0,38.09375,328.5625,2.7998047,0.79992676,1.39990234,139.0,7.449219,107.0,13.0,2502.0,2.652832,<2 mo. follow-up
47.64697,1,female,0,9,400,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,42225.0,23947.1406,21.5,black,51.0,7,1,0,no,0.699999809,0.6,no dnr,9.0,67.0,19.5976562,140.0,34.0,38.09375,160.0,2.5996094,0.39996338,0.69995117,143.0,7.449219,83.0,35.0,1390.0,0.0,no(M2 and SIP pres)
59.461,0,female,0,13,747,Colon Cancer,Cancer,1,10.0,$25-$50k,19294.0,11926.1016,13.0,white,16.0,1,0,0,metastatic,0.799999714,0.75,no dnr,13.0,52.0,11.2988281,175.0,26.0,38.89844,53.0,3.5,1.0,1.0,131.0,7.279297,170.0,19.0,460.0,1.0,no(M2 and SIP pres)
64.44598,1,female,0,10,71,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,59995.78781114967,14452.7344,19.0,black,51.0,1,1,0,no,0.699999809,0.5,dnr after sadm,5.0,118.0,52.09375,115.0,14.0,36.09375,104.20312,3.0996094,24.5976562,3.79980469,138.0,7.479492,186.0,57.0,840.0,6.0,adl>=4 (>=5 if sur)
77.21295,0,male,0,38,748,MOSF w/Malig,ARF/MOSF,2,17.0,$25-$50k,59995.78781114967,103211.875,31.0,white,56.0,25,0,0,yes,0.799999714,0.8,no dnr,38.0,40.0,6.59960938,0.0,8.0,37.89844,102.0,3.5,1.01,2.69970703,144.0,7.389648,153.0,46.0,2010.0,0.0,no(M2 and SIP pres)
47.79999,0,male,0,16,747,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,$11-$25k,51266.0,30347.0781,29.666656,white,61.0,2,1,0,no,0.699999809,0.5,no dnr,16.0,67.0,22.5,115.0,7.0,35.39844,165.0,3.199707,0.5,1.09985352,139.0,7.399414,158.0,26.0,2220.0,2.2680664,no(M2 and SIP pres)
80.51996,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,92304.0,53414.0,35.666657,white,31.0,14,0,0,metastatic,0.599999905,0.2,dnr after sadm,15.0,42.0,19.0976562,75.0,38.0,39.0,126.65625,3.5,1.79980469,3.19970703,139.0,7.459961,155.0,71.0,375.0,0.0,<2 mo. follow-up
57.125,1,male,0,8,63,Lung Cancer,Cancer,2,14.0,$25-$50k,19218.0,10343.4609,11.0,white,16.0,1,0,0,metastatic,0.799999714,0.5,no dnr,8.0,120.0,7.69921875,115.0,32.0,38.29688,216.65625,3.5,1.09985352,0.59997559,142.0,7.399414,144.0,16.0,1360.0,2.0,adl>=4 (>=5 if sur)
41.39398,1,male,0,7,33,Colon Cancer,Cancer,1,13.0,$11-$25k,16309.0,9141.0547,11.5,white,12.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,125.0,8.09960938,75.0,20.0,36.79688,333.3,3.5,1.01,1.29980469,137.0,7.419922,182.0,20.0,1400.0,0.0,<2 mo. follow-up
60.95798,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,46783.0,26275.0781,31.0,black,39.0,3,0,0,yes,0.0,0.0,dnr after sadm,7.0,103.0,7.69921875,106.0,20.0,36.39844,333.3,3.5,0.5,1.5,136.0,7.419922,141.0,20.0,2502.0,2.0,<2 mo. follow-up
71.27197,1,male,0,3,357,Colon Cancer,Cancer,2,12.0,under $11k,7277.0,4163.2031,8.0,white,13.0,1,1,0,metastatic,0.699999809,0.5,no dnr,3.0,97.0,8.5,86.0,20.0,36.89844,333.3,4.2998047,0.59997559,0.89990234,142.0,7.419922,133.0,14.0,2502.0,0.494751,<2 mo. follow-up
42.27499,0,female,0,16,745,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,81268.0,48695.8438,22.666656,black,77.0,10,0,0,no,0.949999809,0.95,no dnr,16.0,101.0,11.1992188,110.0,42.0,35.5,214.8125,3.0,0.5,1.0,144.0,7.299805,87.0,31.0,1700.0,0.0,SIP>=30
49.37698,0,female,0,37,745,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,$25-$50k,59995.78781114967,57057.7812,35.5,white,37.0,1,0,0,no,0.149999976,0.1,dnr after sadm,15.0,115.0,20.3984375,71.0,16.0,36.29688,333.3,2.199707,4.39941406,0.69995117,134.0,7.419922,97.0,18.0,530.0,0.0,<2 mo. follow-up
63.85199,1,female,0,6,25,Lung Cancer,Cancer,2,7.0,under $11k,7383.0,4555.8555,9.0,white,23.0,1,0,0,metastatic,0.049999982,0.0,dnr after sadm,2.0,68.0,12.6992188,135.0,6.0,38.19531,188.3125,3.5,1.01,1.79980469,131.0,7.459961,154.0,41.0,3860.0,6.0,<2 mo. follow-up
73.71399,1,male,0,36,72,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$11-$25k,59995.78781114967,46177.1562,30.5,white,63.0,1,0,0,no,0.099999964,0.1,no dnr,36.0,110.0,4.59960938,66.0,24.0,38.59375,333.3,3.5,1.09985352,1.29980469,141.0,7.419922,265.0,9.0,2502.0,0.0,<2 mo. follow-up
62.379,1,female,1,111,111,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,>$50k,363297.0,14452.7344,40.25,white,71.0,1,1,0,no,0.799999714,0.7,no dnr,111.0,95.0,5.09960938,78.0,20.0,36.59375,333.3,3.5996094,0.59997559,1.09985352,140.0,7.419922,104.0,8.0,5625.0,0.0,adl>=4 (>=5 if sur)
65.01294,1,female,1,11,11,Coma,Coma,1,12.0,under $11k,69652.0,39999.1562,36.5,black,60.0,9,0,0,no,0.5,0.25,dnr after sadm,11.0,142.0,6.0,105.0,10.0,35.39844,186.65625,1.8999023,3.79980469,1.79980469,137.0,7.479492,165.0,40.0,4653.0,0.0,<2 mo. follow-up
71.49097,1,female,0,46,52,ARF/MOSF w/Sepsis,ARF/MOSF,3,5.0,under $11k,71954.0,46952.9062,27.25,white,47.0,1,1,0,no,0.5,0.3,dnr after sadm,22.0,125.0,18.5,105.0,13.0,37.89844,165.0,1.7998047,1.69995117,4.79980469,146.0,7.339844,75.0,59.0,1660.0,2.0,<2 mo. follow-up
55.61398,1,male,0,6,49,Colon Cancer,Cancer,2,12.0,$25-$50k,7829.0,14452.7344,13.0,white,19.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,73.0,10.5996094,65.0,24.0,39.19531,144.0,3.5,1.19995117,1.29980469,135.0,7.489258,216.0,28.0,3130.0,2.5107422,<2 mo. follow-up
77.04297,0,male,0,14,742,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,38469.0,22497.7969,19.666656,white,48.0,1,0,0,no,0.5,0.47,no dnr,14.0,65.0,11.0,135.0,45.0,38.0,182.84375,3.5,1.5,1.19995117,143.0,7.40918,97.0,16.0,3390.0,0.0,no(M2 and SIP pres)
85.03998,1,female,1,14,14,Coma,Coma,1,12.0,under $11k,9931.0,14452.7344,7.333332,black,28.0,1,0,0,yes,0.099999964,0.01,dnr after sadm,2.0,113.0,7.79980469,65.0,10.0,38.0,276.625,3.5,1.01,0.69995117,129.0,7.509766,96.0,15.0,1180.0,7.0,<2 mo. follow-up
60.54498,1,female,1,8,8,COPD,COPD/CHF/Cirrhosis,1,5.0,under $11k,40885.0,22991.3438,35.5,white,25.0,4,0,0,no,0.799999714,0.7,dnr after sadm,8.0,89.0,5.69921875,60.0,20.0,36.5,333.3,3.5,0.5,1.0,140.0,7.419922,142.0,16.0,2975.0,0.0,<2 mo. follow-up
65.03796,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,67810.0,38456.7188,46.0,black,70.0,2,0,1,no,0.149999976,0.1,dnr after sadm,9.0,68.0,14.6992188,80.0,10.0,35.59375,342.5,3.5,0.59997559,5.59960938,130.0,7.40918,129.0,129.0,560.0,1.0,<2 mo. follow-up
63.83298,1,female,1,8,8,Coma,Coma,0,12.0,under $11k,27301.0,15918.8828,33.5,white,18.0,1,0,0,no,0.099999964,0.1,dnr after sadm,4.0,68.0,29.5976562,75.0,20.0,36.39844,333.3,2.8999023,0.5,1.39990234,134.0,7.419922,115.0,30.0,2502.0,1.7094727,<2 mo. follow-up
51.87399,0,male,0,11,728,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,18135.0,11270.7422,9.0,white,18.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,62.0,2.09960938,72.0,16.0,38.0,536.0,2.699707,0.5,0.5,138.0,7.439453,89.0,8.0,4440.0,2.5927734,<2 mo. follow-up
18.88799,0,male,0,23,728,Coma,Coma,0,11.0,$25-$50k,61596.0,37417.375,21.333328,white,28.0,1,0,0,no,0.5,0.6,no dnr,23.0,112.0,18.296875,125.0,44.0,38.89844,120.0,2.699707,0.39996338,2.09960938,145.0,7.189453,417.0,45.0,1445.0,0.0,no(M2 and SIP pres)
65.5,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,59995.78781114967,46616.8125,47.0,white,75.0,18,1,0,yes,0.099999964,0.05,dnr after sadm,6.0,63.0,13.5,55.0,10.0,36.09375,310.0,3.5,2.39990234,1.0,135.0,7.439453,93.0,20.0,2135.0,1.0,<2 mo. follow-up
74.08099,1,female,0,10,589,COPD,COPD/CHF/Cirrhosis,2,7.0,under $11k,10223.0,6574.7031,9.5,white,18.0,1,0,0,no,0.699999809,0.6,no dnr,10.0,62.0,6.89941406,115.0,36.0,39.59375,157.5,3.5,1.01,0.89990234,134.0,7.489258,424.0,16.0,2145.0,2.0,no(M2 and SIP pres)
62.14398,1,male,0,10,77,Lung Cancer,Cancer,1,8.0,$11-$25k,12666.0,7809.8164,16.5,white,12.0,1,0,0,metastatic,0.799999714,0.4,no dnr,10.0,104.0,10.8984375,70.0,20.0,36.39844,316.0,4.0,0.59997559,0.69995117,137.0,7.399414,147.0,22.0,2200.0,0.0,adl>=4 (>=5 if sur)
73.56897,1,male,1,15,15,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,69294.0,36262.0,50.333313,white,45.0,1,1,0,no,0.599999905,0.5,dnr after sadm,13.0,65.0,2.89990234,135.0,30.0,39.19531,228.5625,3.5,0.69995117,1.19995117,147.0,7.369141,231.0,31.0,3775.0,2.0,<2 mo. follow-up
65.08398,1,female,0,49,64,Coma,Coma,1,11.0,under $11k,244277.0,142366.5,44.5,black,49.0,26,0,0,yes,0.299999952,0.3,dnr after sadm,43.0,77.0,12.2988281,100.0,20.0,36.69531,333.3,3.0996094,0.39996338,1.0,142.0,7.419922,92.0,16.0,2502.0,1.0,adl>=4 (>=5 if sur)
81.96594,0,female,0,22,725,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,55711.0,34053.3125,29.0,white,35.0,2,0,0,no,0.75,0.6,no dnr,22.0,86.0,10.7988281,75.0,24.0,36.09375,195.21875,3.5,1.01,0.59997559,139.0,7.289062,126.0,8.0,2502.0,1.0,<2 mo. follow-up
55.55899,0,female,0,6,726,CHF,COPD/CHF/Cirrhosis,5,16.0,>$50k,4390.0,3090.0312,9.0,white,40.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,43.0,11.5996094,140.0,25.0,38.19531,119.98438,1.6999512,6.39941406,2.79980469,145.0,7.389648,117.0,60.0,1460.0,1.1667481,no(M2 and SIP pres)
72.43799,0,male,0,10,726,Colon Cancer,Cancer,1,16.0,under $11k,29470.0,16680.2812,31.5,white,39.0,1,0,0,metastatic,0.849999905,0.75,no dnr,10.0,78.0,36.09375,75.0,8.0,36.19531,286.625,2.5,0.59997559,1.89990234,149.0,7.439453,293.0,54.0,2265.0,0.494751,no(M2 and SIP pres)
71.62195,1,female,0,31,74,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,59995.78781114967,14452.7344,13.0,white,31.0,1,0,0,no,0.899999619,0.9,dnr after sadm,5.0,125.0,18.0,45.0,12.0,36.0,356.0,3.5,0.5,2.69970703,138.0,7.369141,80.0,36.0,2965.0,2.0,adl>=4 (>=5 if sur)
62.25299,0,male,0,9,725,COPD,COPD/CHF/Cirrhosis,3,5.0,$11-$25k,8922.0,5818.3086,10.5,white,13.0,1,0,0,no,0.599999905,0.5,no dnr,9.0,57.0,0.29998779,115.0,24.0,35.0,226.65625,3.5,1.01,0.89990234,133.0,7.5,385.0,23.0,1000.0,0.494751,no(M2 and SIP pres)
73.47595,1,female,0,23,173,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,173420.0,106988.0,42.0,white,60.0,22,1,0,yes,0.099999964,0.1,no dnr,23.0,97.0,23.3984375,125.0,26.0,38.29688,120.40625,3.5,1.01,1.29980469,134.0,7.319336,181.0,5.0,2065.0,0.0,no(M2 and SIP pres)
21.092,0,male,0,17,724,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,85249.0,14452.7344,33.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,17.0,0.0,12.2988281,0.0,40.0,34.89844,45.0,2.5,0.69995117,1.19995117,136.0,7.319336,134.0,67.0,1130.0,1.7385254,no(M2 and SIP pres)
73.96295,1,female,0,20,360,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,52654.0,32165.2656,24.333328,black,42.0,5,0,0,metastatic,0.099999964,0.5,dnr after sadm,2.0,138.0,24.1992188,155.0,36.0,36.5,152.5,1.0998535,1.5,2.29980469,131.0,7.489258,123.0,30.0,638.0,3.0,SIP>=30
85.04297,1,male,0,22,517,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,45706.0,27916.375,19.333328,white,37.0,4,0,0,no,0.399999857,0.4,no dnr,22.0,75.0,10.5,54.0,16.0,36.59375,333.3,3.2998047,0.39996338,0.89990234,139.0,7.419922,74.0,15.0,2502.0,4.0,SIP>=30
35.32397,0,female,0,25,723,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,109937.0,64685.5938,29.0,white,55.0,11,0,0,no,0.599999905,0.6,no dnr,25.0,102.0,9.19921875,125.0,22.0,36.39844,236.65625,3.5,1.01,1.09985352,135.0,7.449219,89.0,13.0,3725.0,2.5751953,<2 mo. follow-up
67.75397,1,female,0,6,42,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5817.0,4031.8711,17.0,black,27.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,53.0,12.5,105.0,36.0,38.5,223.3125,3.5,1.01,1.39990234,138.0,7.459961,269.0,28.0,2275.0,3.0,<2 mo. follow-up
61.728,1,male,1,11,11,Coma,Coma,0,12.0,under $11k,40375.0,22013.4062,31.5,white,36.0,2,0,0,no,0.0,0.0,dnr after sadm,8.0,58.0,3.0,35.0,30.0,34.89844,395.1875,2.5996094,1.29980469,2.09960938,126.0,7.539062,705.0,46.0,3820.0,2.5805664,<2 mo. follow-up
60.435,0,male,0,18,721,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,31813.0,19738.3906,19.333328,white,16.0,3,0,0,no,0.799999714,0.75,no dnr,18.0,110.0,10.2988281,120.0,40.0,38.69531,152.5,3.5,1.01,0.5,139.0,7.489258,189.0,25.0,2805.0,1.0,adl>=4 (>=5 if sur)
63.72098,1,male,0,19,193,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,56207.0,33346.6562,17.666656,white,44.0,6,0,0,no,0.399999857,0.3,no dnr,19.0,60.0,11.7988281,120.0,30.0,35.59375,172.5,3.5,21.796875,8.8984375,139.0,7.369141,168.0,83.0,9.0,5.0,no(M2 and SIP pres)
72.79095,0,female,0,13,721,CHF,COPD/CHF/Cirrhosis,3,7.0,$11-$25k,59995.78781114967,19391.375,18.0,white,26.0,1,1,0,no,0.699999809,0.5,no dnr,13.0,22.0,29.6992188,0.0,0.0,37.59375,478.0,3.5,1.01,3.59960938,126.0,7.229492,536.0,39.0,64.0,0.0,no(M2 and SIP pres)
25.95499,0,female,0,13,720,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,59995.78781114967,14452.7344,15.0,white,24.0,5,0,0,no,0.899999619,0.9,no dnr,13.0,58.0,9.29882812,80.0,35.0,38.09375,243.3125,3.5,1.01,2.69970703,143.0,7.5,108.0,111.0,1785.0,0.0,no(M2 and SIP pres)
46.146,0,female,0,31,720,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,116527.0,66050.1875,39.5,white,38.0,3,0,0,no,0.5,0.4,no dnr,31.0,52.0,1.09985352,135.0,38.0,38.59375,44.0,3.5,22.0,4.5,150.0,7.129883,87.0,143.0,15.0,0.0,no(M2 and SIP pres)
65.37396,1,male,0,13,57,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,59995.78781114967,15356.0469,23.5,white,28.0,1,1,0,no,0.699999809,0.5,no dnr,13.0,158.0,12.5,105.0,12.0,38.29688,356.0,2.8999023,1.01,7.59960938,138.0,7.349609,312.0,61.0,450.0,3.1254883,<2 mo. follow-up
54.08899,0,male,0,7,718,Lung Cancer,Cancer,1,12.0,under $11k,59995.78781114967,7479.207,12.5,black,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,72.0,5.89941406,75.0,16.0,36.5,333.3,3.5,0.39996338,0.69995117,143.0,7.419922,77.0,13.0,1475.0,0.0,no(M2 and SIP pres)
20.31799,0,female,0,16,719,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$11-$25k,70709.0,39993.9062,32.333313,white,32.0,1,0,0,yes,0.5,0.5,no dnr,16.0,115.0,11.2988281,75.0,27.0,33.89844,263.3125,3.5,0.69995117,1.59985352,148.0,7.399414,327.0,42.0,1255.0,0.0,no(M2 and SIP pres)
60.82098,0,male,0,10,718,Coma,Coma,3,7.0,under $11k,59995.78781114967,25320.9062,31.5,black,22.0,2,0,0,yes,0.799999714,0.75,no dnr,10.0,62.0,7.59960938,145.0,10.0,39.09375,175.0,2.5,4.0,2.0,147.0,7.509766,149.0,77.0,1520.0,0.0,no(M2 and SIP pres)
43.23599,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,59995.78781114967,36952.3438,46.0,black,53.0,1,0,0,no,0.699999809,0.7,no dnr,11.0,110.0,30.3984375,80.0,27.0,38.69531,56.66406,2.8999023,0.89990234,2.29980469,126.0,7.5,340.0,39.0,740.0,0.0,<2 mo. follow-up
67.93195,1,female,0,7,565,CHF,COPD/CHF/Cirrhosis,2,14.0,under $11k,59995.78781114967,4060.2891,4.0,white,28.0,1,0,0,no,0.899999619,0.85,no dnr,7.0,75.0,15.7988281,110.0,30.0,36.19531,264.0,2.5,0.39996338,0.89990234,135.0,7.419922,198.0,14.0,1300.0,3.0,no(M2 and SIP pres)
65.008,1,male,0,7,315,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,59995.78781114967,4747.207,6.5,white,14.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,100.0,14.6992188,100.0,22.0,36.39844,333.3,3.5,0.69995117,1.5,125.0,7.419922,158.0,16.0,3205.0,2.5322266,<2 mo. follow-up
73.62097,0,male,0,13,716,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,25411.0,15708.2734,15.5,black,45.0,1,0,0,no,0.75,0.7,no dnr,13.0,80.0,4.79980469,75.0,20.0,39.19531,333.3,2.7998047,0.59997559,1.09985352,134.0,7.419922,111.0,9.0,1300.0,0.0,no(M2 and SIP pres)
67.49097,0,male,0,28,716,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,98625.0,55380.875,21.25,white,40.0,1,0,0,no,0.299999952,0.25,no dnr,28.0,62.0,7.69921875,110.0,31.0,36.89844,276.625,3.5,1.09985352,3.09960938,143.0,7.369141,99.0,59.0,2050.0,0.0,adl>=4 (>=5 if sur)
70.21198,0,male,0,48,716,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,102847.0,14452.7344,27.25,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,48.0,75.0,9.3984375,64.0,20.0,37.5,333.3,3.5,0.39996338,1.09985352,132.0,7.419922,163.0,9.0,2502.0,0.0,adl>=4 (>=5 if sur)
74.40094,1,female,0,79,80,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,299345.0,172386.5,41.25,white,39.0,13,1,0,no,0.75,0.95,dnr after sadm,17.0,142.0,28.3984375,115.0,28.0,36.69531,122.4375,2.0,0.39996338,9.79882812,135.0,7.399414,133.0,87.0,97.0,3.0,SIP>=30
65.42896,0,female,0,41,713,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,103987.0,62892.3125,28.75,black,47.0,5,0,0,no,0.699999809,0.5,no dnr,41.0,58.0,12.0996094,95.0,14.0,37.69531,410.0,3.5,1.01,1.09985352,132.0,7.469727,137.0,24.0,1270.0,0.0,no(M2 and SIP pres)
38.13599,1,female,0,12,46,MOSF w/Malig,ARF/MOSF,3,12.0,$25-$50k,35399.0,21580.125,27.5,white,52.0,5,0,0,metastatic,0.699999809,0.3,dnr after sadm,6.0,67.0,12.1992188,76.0,24.0,38.19531,600.0,2.7998047,1.01,0.79992676,131.0,7.469727,51.0,3.0,2525.0,0.0,<2 mo. follow-up
73.32196,1,male,0,4,380,Lung Cancer,Cancer,1,16.0,under $11k,59995.78781114967,2548.1387,15.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,52.0,10.7988281,45.0,24.0,36.5,222.84375,2.3999023,2.79980469,5.0,130.0,7.269531,268.0,89.0,3200.0,0.494751,no(M2 and SIP pres)
64.45197,1,male,0,8,165,Colon Cancer,Cancer,1,12.0,under $11k,14340.0,8680.0156,10.5,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,50.0,13.5,125.0,35.0,36.59375,120.0,3.5,1.01,2.59960938,127.0,7.349609,280.0,48.0,1023.0,2.215332,<2 mo. follow-up
67.49896,0,female,0,24,711,COPD,COPD/CHF/Cirrhosis,1,11.0,$11-$25k,37117.0,23135.1562,18.0,white,24.0,3,0,0,no,0.699999809,0.5,no dnr,24.0,125.0,16.8984375,115.0,40.0,38.09375,226.0,3.5,1.01,2.79980469,145.0,7.469727,133.0,79.0,1540.0,0.0,no(M2 and SIP pres)
62.20898,1,male,0,9,601,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,37356.0,23096.7031,18.0,white,20.0,4,0,0,no,0.979999542,0.95,no dnr,9.0,68.0,10.5996094,115.0,35.0,37.89844,157.125,2.7998047,1.19995117,2.29980469,134.0,7.239258,306.0,35.0,2394.0,0.0,no(M2 and SIP pres)
63.95297,0,male,0,15,710,CHF,COPD/CHF/Cirrhosis,4,15.0,>$50k,46614.0,14452.7344,21.333328,white,43.0,1,1,0,no,0.799999714,0.75,no dnr,15.0,71.0,19.5976562,60.0,16.0,35.5,333.3,2.2998047,0.39996338,0.69995117,137.0,7.419922,78.0,6.0,2800.0,1.0,no(M2 and SIP pres)
53.81799,1,male,0,44,431,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,87681.0,51575.9688,19.25,white,18.0,1,0,0,yes,0.899999619,0.8,no dnr,44.0,72.0,11.2988281,50.0,10.0,35.89844,144.0,3.5,0.59997559,2.39990234,133.0,7.529297,158.0,88.0,1620.0,0.0,no(M2 and SIP pres)
72.72797,1,male,0,20,259,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,35733.0,21160.5781,27.0,white,63.0,1,0,0,no,0.899999619,0.7,no dnr,20.0,70.0,4.69921875,75.0,16.0,35.59375,333.3,3.5,1.19995117,1.29980469,142.0,7.419922,140.0,41.0,1880.0,1.0,<2 mo. follow-up
76.36694,1,male,0,21,38,Colon Cancer,Cancer,1,14.0,under $11k,23314.0,15320.5312,10.333328,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,21.0,112.0,7.19921875,130.0,16.0,36.0,213.3125,2.8999023,0.5,0.79992676,139.0,7.40918,165.0,12.0,980.0,1.0,<2 mo. follow-up
66.27795,1,male,0,13,128,ARF/MOSF w/Sepsis,ARF/MOSF,2,0.0,under $11k,87124.0,49238.125,16.5,other,45.0,13,1,0,no,0.699999809,0.5,no dnr,13.0,48.0,9.09960938,115.0,24.0,35.79688,363.3125,2.199707,3.0,5.69921875,143.0,7.429688,137.0,51.0,23.0,2.0,adl>=4 (>=5 if sur)
82.70996,1,female,0,20,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,>$50k,81507.0,50401.25,34.333313,white,40.0,1,0,0,metastatic,0.199999928,0.1,no dnr,20.0,160.0,19.0,55.0,16.0,38.19531,210.0,3.5,1.01,1.09985352,142.0,7.489258,185.0,14.0,3480.0,7.0,<2 mo. follow-up
63.76999,1,male,0,7,150,Lung Cancer,Cancer,1,12.0,under $11k,10343.0,6567.582,9.5,white,14.0,1,0,0,metastatic,0.5,0.1,no dnr,7.0,85.0,6.29980469,75.0,20.0,36.19531,333.3,2.3999023,0.79992676,1.29980469,140.0,7.419922,72.0,29.0,2502.0,3.0053711,<2 mo. follow-up
51.58698,0,male,0,41,707,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,80835.0,52924.9062,19.75,black,75.0,2,1,0,no,0.699999809,0.7,no dnr,41.0,118.0,4.79980469,125.0,10.0,36.19531,260.0,4.0,0.69995117,0.79992676,137.0,7.40918,121.0,11.0,3730.0,1.0,SIP>=30
75.82495,1,female,0,10,14,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,33451.0,20574.2031,23.5,black,26.0,11,1,0,metastatic,0.099999964,0.1,dnr after sadm,6.0,118.0,0.09999084,135.0,25.0,38.19531,200.0,2.0996094,0.69995117,3.0,133.0,7.359375,248.0,124.0,1805.0,6.0,<2 mo. follow-up
69.66498,1,male,1,19,19,Coma,Coma,0,0.0,under $11k,70791.0,42966.5312,25.666656,black,62.0,1,0,0,no,0.599999905,0.6,dnr after sadm,18.0,108.0,14.7988281,70.0,18.0,36.79688,308.0,3.5,0.59997559,0.89990234,137.0,7.469727,280.0,27.0,2502.0,0.0,<2 mo. follow-up
82.69995,1,male,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,44008.0,28144.6562,13.5,white,40.0,5,0,0,no,0.699999809,0.5,dnr after sadm,3.0,110.0,8.09960938,100.0,22.0,36.29688,347.5625,3.5,0.39996338,0.89990234,135.0,7.469727,92.0,6.0,2502.0,6.0,<2 mo. follow-up
58.19299,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,25996.0,15017.2188,14.0,white,30.0,6,0,0,metastatic,0.399999857,0.1,dnr after sadm,5.0,73.0,6.89941406,120.0,27.0,38.59375,161.65625,3.5,0.69995117,1.69995117,136.0,7.5,172.0,30.0,3165.0,2.7827148,<2 mo. follow-up
33.78,0,female,0,15,705,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,41677.0,25193.125,28.0,white,42.0,1,0,0,no,0.799999714,0.8,no dnr,15.0,58.0,3.39990234,110.0,10.0,36.09375,126.0,3.5,2.5,0.79992676,146.0,7.469727,217.0,25.0,3120.0,2.0717773,no(M2 and SIP pres)
47.93198,0,female,0,22,705,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,58215.0,14452.7344,23.0,black,39.0,5,1,0,no,0.899999619,0.9,no dnr,22.0,75.0,17.8984375,115.0,10.0,36.09375,148.875,2.199707,1.01,0.69995117,136.0,7.509766,157.0,36.0,3065.0,0.494751,<2 mo. follow-up
48.375,1,male,0,8,50,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,19396.0,11940.75,21.0,white,22.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,5.0,78.0,5.0,65.0,16.0,36.39844,214.28125,3.5,0.5,1.79980469,136.0,7.439453,178.0,48.0,2050.0,0.0,<2 mo. follow-up
65.37396,1,female,1,61,61,COPD,COPD/CHF/Cirrhosis,1,12.0,>$50k,413887.0,246825.125,29.0,white,43.0,105,0,0,no,0.399999857,0.4,dnr after sadm,59.0,132.0,11.8984375,55.0,10.0,34.19531,270.0,1.5998535,1.19995117,1.29980469,136.0,7.289062,240.0,17.0,2502.0,2.0,<2 mo. follow-up
64.53699,0,male,0,9,703,COPD,COPD/CHF/Cirrhosis,1,7.0,$25-$50k,11580.0,7392.9297,12.5,white,39.0,1,0,0,no,1.0,1.0,no dnr,9.0,97.0,7.89941406,80.0,28.0,36.79688,247.59375,3.5,1.01,0.5,139.0,7.479492,185.0,11.0,900.0,0.0,no(M2 and SIP pres)
57.46198,0,male,0,27,703,COPD,COPD/CHF/Cirrhosis,3,18.0,$25-$50k,21367.0,15081.9297,7.25,white,13.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,86.0,11.5996094,88.0,22.0,37.0,256.0,3.3999023,0.5,1.29980469,143.0,7.369141,147.0,22.0,2000.0,4.5273438,no(M2 and SIP pres)
47.69598,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,32557.0,18351.9062,52.0,black,75.0,1,0,0,yes,0.399999857,0.35,dnr after sadm,5.0,142.0,0.19998169,115.0,25.0,39.39844,120.0,2.2998047,1.39990234,0.59997559,129.0,7.439453,201.0,13.0,5630.0,2.0,<2 mo. follow-up
56.60199,1,female,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,18544.0,11228.7109,9.5,black,38.0,2,0,0,no,0.5,0.4,dnr after sadm,7.0,122.0,9.69921875,115.0,12.0,38.19531,187.5,2.8999023,2.79980469,1.19995117,137.0,7.459961,83.0,16.0,4150.0,0.0,<2 mo. follow-up
66.41998,0,male,0,68,702,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,236103.0,136933.75,40.25,white,53.0,5,1,0,no,0.799999714,0.8,no dnr,68.0,65.0,7.79980469,65.0,33.0,37.69531,232.5,3.5,1.01,0.89990234,138.0,7.509766,110.0,20.0,850.0,0.0,no(M2 and SIP pres)
23.55099,0,female,0,104,702,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,433851.0,245377.875,39.25,white,43.0,6,1,0,no,0.599999905,0.6,no dnr,104.0,122.0,17.8984375,115.0,31.0,36.5,208.5625,3.2998047,1.01,1.09985352,133.0,7.489258,248.0,23.0,2230.0,5.0,adl>=4 (>=5 if sur)
57.74698,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,$11-$25k,89650.0,50894.0938,43.5,white,36.0,18,0,0,no,0.5,0.5,dnr after sadm,7.0,107.0,13.8984375,135.0,39.0,37.69531,246.65625,3.5,8.0,2.09960938,150.0,7.439453,115.0,31.0,3610.0,0.0,<2 mo. follow-up
62.508,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,under $11k,58969.0,34627.7812,42.5,white,53.0,2,0,0,no,0.599999905,0.4,dnr after sadm,10.0,72.0,3.59960938,79.0,32.0,36.79688,265.0,2.199707,1.01,0.89990234,140.0,7.279297,69.0,14.0,2950.0,0.0,<2 mo. follow-up
76.97998,1,male,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,1,21.0,>$50k,236578.0,131075.25,46.75,white,65.0,14,0,0,yes,0.699999809,0.5,dnr after sadm,16.0,127.0,7.0,105.0,0.0,38.39844,188.875,3.5,1.01,1.69995117,142.0,7.449219,183.0,38.0,2550.0,5.0,<2 mo. follow-up
79.59796,0,male,0,12,700,ARF/MOSF w/Sepsis,ARF/MOSF,2,5.0,under $11k,25694.0,18034.7812,17.0,black,49.0,1,1,0,no,0.699999809,0.6,no dnr,12.0,115.0,7.0,130.0,16.0,37.89844,316.0,3.5,1.01,0.79992676,139.0,7.459961,136.0,10.0,2350.0,0.0,no(M2 and SIP pres)
75.63599,0,female,0,61,699,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,140074.0,87156.75,34.0,white,49.0,1,0,0,no,0.599999905,0.55,dnr after sadm,31.0,53.0,10.8984375,105.0,12.0,37.0,162.5,3.5,1.01,1.29980469,125.0,7.459961,96.0,25.0,1650.0,0.0,SIP>=30
62.84998,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,6,16.0,$25-$50k,9831.0,6922.8008,35.0,black,108.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,105.0,22.0976562,65.0,20.0,36.0,376.0,3.5996094,0.69995117,2.09960938,136.0,7.439453,161.0,57.0,2050.0,0.0,<2 mo. follow-up
75.65198,1,female,1,7,7,Colon Cancer,Cancer,1,12.0,under $11k,7277.0,4784.5391,8.5,white,41.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,1.0,72.0,15.8984375,55.0,14.0,36.19531,219.03125,3.5,0.69995117,0.69995117,138.0,7.399414,126.0,14.0,2580.0,4.0,<2 mo. follow-up
44.97498,1,female,0,4,245,Colon Cancer,Cancer,1,12.0,$25-$50k,6834.0,4132.0703,1.0,white,9.0,1,0,0,metastatic,0.849999905,0.6,no dnr,4.0,146.0,17.8984375,120.0,10.0,38.5,98.5625,3.5,1.01,0.79992676,153.0,7.449219,105.0,26.0,3635.0,2.1835938,no(M2 and SIP pres)
70.71899,1,male,0,4,301,Lung Cancer,Cancer,1,13.0,under $11k,3052.0,14452.7344,7.0,white,2.0,1,0,0,metastatic,0.649999619,0.25,no dnr,4.0,80.0,9.19921875,75.0,20.0,35.19531,330.0,3.5,1.01,1.79980469,140.0,7.589844,75.0,41.0,925.0,0.0,no(M2 and SIP pres)
64.55896,0,male,0,13,696,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,53126.0,30766.7812,41.5,other,21.0,3,1,0,no,0.699999809,0.6,no dnr,13.0,67.0,12.3984375,120.0,22.0,38.0,333.3,3.5,1.01,0.69995117,131.0,7.419922,149.0,5.0,1750.0,3.0,no(M2 and SIP pres)
69.36597,1,male,0,19,469,ARF/MOSF w/Sepsis,ARF/MOSF,2,0.0,under $11k,41611.0,23837.875,19.666656,white,40.0,3,0,0,no,0.399999857,0.3,dnr before sadm,-2.0,112.0,15.5996094,125.0,14.0,38.79688,137.5,2.3999023,0.79992676,0.59997559,136.0,7.449219,113.0,20.0,2555.0,2.8608398,SIP>=30
75.23895,1,male,0,6,58,CHF,COPD/CHF/Cirrhosis,2,13.0,$25-$50k,5511.0,4134.3594,12.0,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,105.0,14.5,95.0,12.0,38.5,246.65625,3.3999023,7.0,0.89990234,135.0,7.439453,107.0,11.0,3170.0,0.494751,<2 mo. follow-up
68.62695,1,male,0,54,117,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,135769.0,14452.7344,32.5,black,13.0,5,1,0,no,0.75,0.5,dnr after sadm,1.0,70.0,13.2988281,120.0,32.0,39.29688,151.65625,3.5,1.01,2.89990234,142.0,7.419922,115.0,42.0,1960.0,2.0234375,adl>=4 (>=5 if sur)
44.172,1,male,0,21,24,Lung Cancer,Cancer,4,12.0,under $11k,19222.0,12926.8438,7.333332,black,34.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,2.0,67.0,5.39941406,82.0,16.0,36.0,357.125,4.1992188,2.19970703,0.89990234,133.0,7.479492,105.0,23.0,2400.0,0.494751,<2 mo. follow-up
39.81699,1,male,0,20,64,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,55934.0,34209.9375,28.666656,black,64.0,1,0,0,no,0.299999952,0.15,no dnr,20.0,110.0,8.19921875,80.0,20.0,37.0,404.75,3.2998047,1.19995117,1.09985352,139.0,7.469727,81.0,21.0,2300.0,2.7719727,<2 mo. follow-up
80.35895,1,male,0,19,28,Lung Cancer,Cancer,1,6.0,under $11k,16602.0,11312.6719,9.333328,black,29.0,1,0,0,metastatic,0.299999952,0.5,dnr after sadm,3.0,130.0,35.3984375,125.0,28.0,36.29688,356.0,4.0,1.01,0.89990234,139.0,7.369141,110.0,22.0,620.0,2.0,<2 mo. follow-up
61.92999,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,139557.0,79442.0,37.333313,white,61.0,12,1,0,no,0.399999857,0.15,dnr after sadm,7.0,78.0,15.7988281,105.0,11.0,36.79688,170.0,3.5,2.09960938,3.09960938,137.0,7.40918,100.0,58.0,3470.0,0.0,<2 mo. follow-up
71.35895,0,male,0,10,691,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,55359.0,32655.5,21.0,white,26.0,12,0,0,no,0.949999809,0.93,no dnr,10.0,60.0,14.3984375,135.0,24.0,38.09375,112.23438,3.5,0.5,0.79992676,125.0,7.549805,193.0,28.0,1050.0,2.5205078,<2 mo. follow-up
74.37396,1,female,1,18,18,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,24211.0,14452.7344,13.0,white,31.0,1,1,0,no,0.599999905,0.4,dnr after sadm,8.0,138.0,17.3984375,0.0,38.0,38.0,260.8125,3.0,1.19995117,0.5,143.0,7.239258,268.0,14.0,2797.0,2.0,<2 mo. follow-up
50.14398,0,male,0,13,691,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,37721.0,22164.2344,26.5,white,30.0,2,1,0,no,0.5,0.45,no dnr,13.0,60.0,6.09960938,125.0,13.0,38.79688,158.0,3.5,5.29980469,1.39990234,149.0,7.379883,283.0,16.0,3430.0,0.0,SIP>=30
69.67798,1,male,0,28,77,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,42808.0,26644.5,13.0,white,47.0,1,0,0,yes,0.699999809,0.6,dnr after sadm,7.0,113.0,3.5,125.0,35.0,36.19531,185.6875,3.5,1.79980469,2.19970703,140.0,7.389648,149.0,33.0,1225.0,7.0,adl>=4 (>=5 if sur)
76.62695,0,male,0,7,691,Colon Cancer,Cancer,1,19.0,under $11k,13251.0,7951.0664,7.5,white,16.0,1,0,0,metastatic,0.849999905,0.6,no dnr,7.0,63.0,4.69921875,79.0,28.0,38.0,333.3,3.2998047,1.01,1.0,135.0,7.419922,88.0,9.0,2502.0,1.9753418,no(M2 and SIP pres)
24.02199,1,female,1,18,18,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,101207.0,14452.7344,42.666657,black,61.0,2,0,0,no,0.149999976,0.05,dnr after sadm,16.0,100.0,9.0,65.0,20.0,36.09375,333.3,3.5,0.69995117,1.0,139.0,7.419922,88.0,6.0,1590.0,0.0,<2 mo. follow-up
37.34198,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,34273.0,19557.6719,41.5,black,100.0,1,0,0,no,0.25,0.1,dnr after sadm,8.0,115.0,14.8984375,105.0,24.0,35.59375,284.0,3.199707,0.5,0.69995117,149.0,7.449219,125.0,21.0,655.0,0.0,<2 mo. follow-up
76.23798,1,male,1,27,27,COPD,COPD/CHF/Cirrhosis,6,3.0,under $11k,69596.0,42462.75,21.0,white,38.0,13,1,0,no,0.5,0.5,dnr after sadm,11.0,98.0,10.3984375,95.0,24.0,36.89844,223.3125,3.0996094,1.29980469,1.5,139.0,7.359375,94.0,31.0,2760.0,6.0,<2 mo. follow-up
73.36597,0,male,0,8,690,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,7477.0,5118.168,12.5,black,24.0,1,0,0,no,0.899999619,0.9,no dnr,8.0,118.0,10.7988281,145.0,10.0,38.09375,205.6875,3.5,0.59997559,2.19970703,126.0,7.389648,199.0,62.0,3510.0,1.0,no(M2 and SIP pres)
66.75696,1,male,0,4,52,Lung Cancer,Cancer,2,14.0,$25-$50k,4269.0,2855.1348,9.0,black,14.0,1,1,0,metastatic,0.599999905,0.2,no dnr,4.0,107.0,79.390625,88.0,20.0,37.69531,205.6875,3.2998047,0.79992676,1.69995117,140.0,7.429688,97.0,13.0,3370.0,2.8466797,<2 mo. follow-up
62.15698,0,female,0,28,690,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,77908.0,45678.2188,25.5,white,32.0,3,0,0,yes,0.699999809,0.65,no dnr,28.0,43.0,27.1992188,0.0,12.0,38.0,164.0,3.699707,1.0,1.89990234,126.0,7.319336,297.0,30.0,1650.0,0.0,no(M2 and SIP pres)
81.57697,1,male,1,20,20,Lung Cancer,Cancer,1,16.0,$25-$50k,25226.0,15696.3906,9.666664,white,26.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,11.0,117.0,12.2988281,97.0,20.0,35.29688,333.3,2.7998047,1.5,1.0,136.0,7.419922,98.0,18.0,1600.0,0.0,<2 mo. follow-up
76.271,0,male,0,14,688,COPD,COPD/CHF/Cirrhosis,1,13.0,under $11k,37912.0,21666.0156,20.333328,white,24.0,1,0,0,no,0.599999905,0.6,no dnr,14.0,65.0,10.0996094,65.0,24.0,34.69531,388.0,3.5,1.01,1.89990234,127.0,7.459961,211.0,50.0,930.0,3.0,no(M2 and SIP pres)
45.17697,0,male,0,16,686,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,61094.0,14452.7344,16.666656,black,42.0,6,0,0,no,0.899999619,0.9,no dnr,16.0,59.0,10.3984375,130.0,12.0,36.59375,160.0,2.0996094,1.01,0.39996338,137.0,7.40918,134.0,13.0,1585.0,0.0,no(M2 and SIP pres)
81.74695,1,female,0,18,311,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,20315.0,13006.9844,12.666664,white,22.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,113.0,10.7988281,117.0,24.0,36.29688,333.3,3.0996094,0.39996338,1.09985352,136.0,7.419922,113.0,15.0,2502.0,1.0,adl>=4 (>=5 if sur)
68.70099,1,male,0,5,161,Lung Cancer,Cancer,1,11.0,$25-$50k,8034.0,4381.0547,10.0,white,22.0,1,0,0,metastatic,0.799999714,0.3,no dnr,5.0,127.0,21.1992188,65.0,27.0,34.5,155.0,2.7998047,1.01,12.2988281,132.0,7.289062,318.0,97.0,0.0,0.0,no(M2 and SIP pres)
40.323,0,male,0,6,685,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,6150.0,14452.7344,9.0,white,23.0,1,0,0,no,0.989999771,0.95,no dnr,6.0,115.0,18.5,110.0,27.0,36.19531,192.5,2.199707,0.5,1.29980469,142.0,7.399414,89.0,15.0,3545.0,1.0,no(M2 and SIP pres)
54.87997,1,male,1,8,8,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,9508.0,6299.5547,13.0,black,42.0,1,1,0,no,0.399999857,0.25,dnr after sadm,2.0,120.0,19.5,155.0,40.0,35.39844,300.0,2.5,1.59985352,1.59985352,135.0,7.439453,244.0,43.0,1875.0,5.0,<2 mo. follow-up
67.85999,1,male,0,35,54,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,41179.0,26610.875,13.25,white,41.0,1,0,0,no,0.599999905,0.5,dnr after sadm,23.0,73.0,9.8984375,70.0,28.0,36.0,260.0,3.5,1.01,1.5,137.0,7.389648,88.0,53.0,1100.0,6.0,<2 mo. follow-up
62.73499,0,male,0,10,684,Colon Cancer,Cancer,1,12.0,$11-$25k,24370.0,14301.3906,23.5,white,36.0,1,0,0,metastatic,0.849999905,0.6,no dnr,10.0,113.0,30.8984375,110.0,22.0,35.5,175.0,3.0996094,0.79992676,0.5,130.0,7.429688,223.0,14.0,1510.0,0.0,no(M2 and SIP pres)
33.59299,0,female,0,35,683,Coma,Coma,0,14.0,$11-$25k,141781.0,79643.0,43.5,black,29.0,4,0,0,no,0.799999714,0.75,no dnr,35.0,105.0,3.39990234,110.0,33.0,35.19531,192.5,2.199707,1.09985352,0.89990234,144.0,7.419922,535.0,12.0,1840.0,0.0,adl>=4 (>=5 if sur)
67.849,0,male,0,18,683,Colon Cancer,Cancer,3,13.0,$11-$25k,42241.0,25081.6094,20.333328,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,18.0,75.0,19.5976562,125.0,28.0,37.69531,360.0,1.5998535,1.0,1.69995117,143.0,7.399414,62.0,18.0,2940.0,0.0,no(M2 and SIP pres)
75.98395,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,124688.0,69735.1875,36.0,white,57.0,11,0,0,no,0.5,0.5,dnr after sadm,14.0,128.0,7.0,115.0,10.0,38.0,266.625,2.5,0.5,0.59997559,130.0,7.379883,125.0,8.0,1570.0,0.0,<2 mo. follow-up
59.98898,1,male,1,4,4,Coma,Coma,0,12.0,under $11k,19554.0,11011.9375,32.0,white,79.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,148.0,13.0996094,125.0,40.0,36.29688,240.0,3.5,0.5,0.5,140.0,7.399414,166.0,36.0,1920.0,2.3847656,<2 mo. follow-up
66.16296,1,female,0,5,23,Lung Cancer,Cancer,1,12.0,$25-$50k,3425.0,2377.1035,8.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,100.0,8.19921875,112.0,24.0,36.29688,191.28125,3.5,1.01,1.29980469,136.0,7.349609,78.0,24.0,1850.0,1.1667481,<2 mo. follow-up
54.34598,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,39155.0,22249.7188,41.0,white,85.0,8,0,0,yes,0.009999998,0.01,dnr after sadm,1.0,120.0,5.39941406,84.0,24.0,36.59375,216.0,3.5,1.01,1.0,139.0,7.429688,95.0,10.0,2502.0,1.9470215,<2 mo. follow-up
51.129,0,male,0,29,680,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,131464.0,74448.0,37.0,hispanic,72.0,4,0,0,no,0.5,0.5,no dnr,29.0,50.0,7.5,140.0,20.0,41.19531,62.0,2.7998047,1.09985352,4.59960938,149.0,7.419922,269.0,73.0,1320.0,2.0161133,<2 mo. follow-up
71.69897,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,3,6.0,under $11k,107816.0,61209.9062,35.0,white,50.0,11,0,0,yes,0.699999809,0.5,dnr after sadm,11.0,72.0,22.1992188,105.0,24.0,35.0,300.0,3.5,21.8984375,1.69995117,142.0,7.399414,109.0,15.0,2502.0,3.0,<2 mo. follow-up
38.905,0,female,0,15,679,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$25-$50k,98683.0,53027.2812,13.666664,white,55.0,8,0,0,no,0.699999809,0.5,no dnr,15.0,103.0,12.0,145.0,42.0,39.0,236.65625,3.5,1.01,1.39990234,160.0,7.459961,378.0,36.0,1955.0,0.0,no(M2 and SIP pres)
71.43896,1,female,0,12,47,Lung Cancer,Cancer,1,4.0,$11-$25k,12884.0,8372.8438,6.5,white,16.0,1,0,0,metastatic,0.299999952,0.1,no dnr,12.0,68.0,16.3984375,135.0,36.0,39.59375,122.21875,3.0996094,1.0,0.59997559,134.0,7.509766,78.0,21.0,2210.0,5.0,<2 mo. follow-up
71.625,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,126801.0,70188.5625,42.0,white,72.0,7,0,0,no,0.299999952,0.15,dnr after sadm,16.0,63.0,45.5,115.0,22.0,37.79688,100.0,2.5,4.39941406,0.79992676,151.0,7.339844,62.0,9.0,4270.0,6.0,<2 mo. follow-up
55.79999,1,female,0,12,63,Lung Cancer,Cancer,1,15.0,under $11k,11030.0,7579.8672,8.0,white,13.0,1,0,0,metastatic,0.699999809,0.3,no dnr,12.0,103.0,1.09985352,75.0,29.0,36.5,196.65625,2.5,5.19921875,1.79980469,142.0,7.489258,174.0,41.0,1070.0,2.0,<2 mo. follow-up
33.405,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,198996.0,130510.75,55.0,white,114.0,10,0,0,no,0.699999809,0.5,dnr after sadm,4.0,53.0,23.0976562,120.0,12.0,39.29688,138.4375,3.3999023,5.0,3.89990234,146.0,7.479492,88.0,79.0,1545.0,1.8044434,<2 mo. follow-up
43.25,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,133810.0,72628.0625,53.333313,white,66.0,2,0,0,no,0.5,0.5,dnr after sadm,12.0,133.0,8.5,115.0,33.0,39.39844,259.25,3.199707,1.59985352,2.89990234,145.0,7.479492,212.0,81.0,2215.0,5.0,<2 mo. follow-up
38.68298,0,female,0,6,676,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17416.0,11765.0156,20.0,black,16.0,1,1,0,no,0.799999714,0.8,no dnr,6.0,132.0,13.1992188,140.0,26.0,38.29688,131.09375,3.5,0.69995117,0.89990234,143.0,7.459961,331.0,28.0,4210.0,1.0,no(M2 and SIP pres)
48.04099,1,male,0,7,253,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,21921.0,12741.7891,21.5,white,23.0,2,0,0,no,0.799999714,0.75,no dnr,7.0,0.0,11.7988281,0.0,0.0,36.39844,31.0,1.0,0.79992676,2.0,136.0,7.239258,267.0,48.0,1415.0,0.0,no(M2 and SIP pres)
69.64294,0,female,0,15,674,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,58826.0,32107.7812,20.0,white,39.0,3,1,1,no,0.949999809,0.93,no dnr,15.0,53.0,9.59960938,96.0,20.0,34.29688,340.0,3.5,1.01,0.89990234,140.0,7.429688,65.0,10.0,220.0,3.0,adl>=4 (>=5 if sur)
77.57397,0,female,0,13,674,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,53539.0,30638.8281,24.5,white,37.0,2,1,0,no,0.949999809,0.94,no dnr,13.0,105.0,7.89941406,80.0,20.0,36.79688,333.3,3.5,0.19998169,0.59997559,142.0,7.419922,101.0,11.0,2502.0,0.0,adl>=4 (>=5 if sur)
70.34399,1,male,0,5,128,ARF/MOSF w/Sepsis,ARF/MOSF,3,5.0,under $11k,10496.0,6644.6328,18.0,black,36.0,1,1,1,no,0.699999809,0.5,no dnr,5.0,96.0,10.8984375,76.0,18.0,36.79688,428.5625,3.699707,0.79992676,0.89990234,140.0,7.459961,91.0,8.0,2502.0,5.2832031,adl>=4 (>=5 if sur)
59.37,1,female,1,17,17,Coma,Coma,0,12.0,under $11k,58477.0,35668.375,35.666657,black,25.0,1,0,0,no,0.199999928,0.2,dnr after sadm,17.0,105.0,9.3984375,105.0,33.0,36.29688,175.0,3.5,1.01,1.19995117,132.0,7.439453,251.0,13.0,3130.0,2.1723633,<2 mo. follow-up
54.94897,0,female,0,46,672,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,174126.0,14452.7344,25.75,black,10.0,26,0,1,no,0.899999619,0.5,no dnr,46.0,68.0,20.8984375,125.0,12.0,37.39844,184.0,2.0996094,0.19998169,0.69995117,142.0,7.389648,89.0,17.0,795.0,1.0,adl>=4 (>=5 if sur)
68.99896,1,male,0,7,134,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,19868.0,11311.4609,20.0,white,18.0,1,0,0,no,0.949999809,0.92,no dnr,7.0,70.0,11.5,85.0,20.0,36.0,247.59375,4.0996094,1.69995117,1.69995117,138.0,7.509766,97.0,25.0,1810.0,0.0,no(M2 and SIP pres)
71.96399,1,female,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,256844.0,137596.625,44.25,white,53.0,16,0,0,no,0.699999809,0.5,dnr after sadm,28.0,113.0,11.7988281,55.0,30.0,38.5,353.3125,3.5,1.01,0.59997559,136.0,7.449219,158.0,11.0,2670.0,2.034668,<2 mo. follow-up
47.35098,1,male,0,5,339,Lung Cancer,Cancer,1,12.0,under $11k,3470.0,2491.9434,4.0,white,13.0,1,0,0,metastatic,0.299999952,0.1,no dnr,5.0,74.0,11.3984375,126.0,24.0,38.39844,304.0,3.5,0.79992676,0.89990234,128.0,7.429688,80.0,26.0,825.0,2.0,no(M2 and SIP pres)
69.92499,0,female,0,8,671,COPD,COPD/CHF/Cirrhosis,1,18.0,>$50k,8151.0,5344.1797,5.5,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,57.0,4.09960938,115.0,40.0,35.59375,192.71875,2.0996094,0.79992676,1.29980469,148.0,7.479492,82.0,21.0,4140.0,0.0,no(M2 and SIP pres)
33.577,0,female,0,10,671,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,50575.0,29621.375,33.5,black,60.0,8,0,0,yes,0.75,0.5,no dnr,10.0,130.0,8.8984375,64.0,22.0,35.59375,333.3,3.0996094,0.79992676,1.59985352,134.0,7.419922,129.0,34.0,2502.0,0.0,no(M2 and SIP pres)
27.392,0,female,0,24,671,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,54847.0,34702.4688,28.0,white,39.0,1,0,0,no,0.799999714,0.8,no dnr,24.0,70.0,7.69921875,80.0,28.0,36.69531,154.0,1.7998047,1.09985352,2.0,138.0,7.399414,303.0,51.0,2825.0,0.0,no(M2 and SIP pres)
55.715,1,female,0,12,211,Lung Cancer,Cancer,1,12.0,under $11k,13445.0,9268.0547,12.0,white,32.0,1,0,0,metastatic,0.799999714,0.6,no dnr,12.0,72.0,17.1992188,115.0,28.0,36.59375,217.125,3.5,0.69995117,0.89990234,129.0,7.489258,102.0,8.0,2750.0,1.0,no(M2 and SIP pres)
78.89697,0,female,0,9,670,CHF,COPD/CHF/Cirrhosis,2,11.0,under $11k,21818.0,12756.3516,13.0,white,16.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,66.0,7.0,110.0,32.0,36.69531,226.0625,3.199707,1.01,0.5,138.0,7.379883,260.0,8.0,4525.0,0.0,no(M2 and SIP pres)
40.80798,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,60445.0,34727.7812,53.0,white,44.0,2,0,0,no,0.699999809,0.5,no dnr,7.0,122.0,9.79882812,55.0,14.0,39.5,151.40625,3.0,1.19995117,0.79992676,140.0,7.5,291.0,13.0,2505.0,0.0,<2 mo. follow-up
72.02997,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,0,3.0,under $11k,109406.0,66974.1875,40.75,black,86.0,1,0,0,no,0.5,0.4,dnr after sadm,28.0,63.0,11.0,74.0,42.0,38.59375,374.9375,2.5,0.29998779,4.69921875,145.0,7.40918,87.0,113.0,847.0,0.0,<2 mo. follow-up
60.90298,1,male,0,76,253,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,275754.0,160613.25,42.0,white,48.0,4,0,0,yes,0.699999809,0.5,no dnr,76.0,103.0,10.0996094,55.0,10.0,35.39844,333.3,3.5,0.89990234,0.79992676,136.0,7.419922,152.0,14.0,2502.0,0.0,<2 mo. follow-up
46.38998,0,female,0,19,667,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,60434.0,35845.125,31.0,black,46.0,1,1,0,no,0.799999714,0.7,no dnr,19.0,108.0,8.69921875,110.0,36.0,36.19531,55.0,3.5,11.0,1.19995117,148.0,7.479492,93.0,31.0,6590.0,6.0,SIP>=30
75.034,0,female,0,16,668,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,33122.0,21182.2344,15.666664,white,39.0,1,0,0,no,0.849999905,0.75,no dnr,16.0,62.0,5.19921875,130.0,52.0,32.09375,144.0,2.699707,5.89941406,1.69995117,137.0,7.369141,42.0,74.0,1145.0,1.0,no(M2 and SIP pres)
63.17297,1,female,0,6,375,Colon Cancer,Cancer,1,16.0,>$50k,10983.0,6165.0703,16.0,white,9.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,105.0,19.3984375,75.0,28.0,36.0,170.0,3.5,0.79992676,1.39990234,148.0,7.40918,283.0,64.0,1470.0,0.494751,no(M2 and SIP pres)
65.89697,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,58303.0,34019.0,33.0,white,68.0,10,1,0,no,0.199999928,0.2,dnr after sadm,5.0,107.0,5.19921875,108.0,20.0,36.5,257.125,3.7998047,0.5,1.19995117,128.0,7.469727,105.0,33.0,1025.0,6.0,<2 mo. follow-up
74.81494,1,male,0,6,347,Colon Cancer,Cancer,1,8.0,under $11k,8861.0,4987.0117,12.0,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,73.0,4.79980469,75.0,20.0,36.29688,257.125,3.3999023,0.39996338,1.09985352,138.0,7.429688,99.0,13.0,2225.0,0.0,no(M2 and SIP pres)
60.41599,0,female,0,37,665,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,105918.0,66441.9375,29.0,white,32.0,1,0,0,no,0.599999905,0.6,no dnr,37.0,127.0,15.0996094,125.0,32.0,38.39844,204.0625,3.5,1.01,1.29980469,145.0,7.459961,191.0,19.0,900.0,7.0,no(M2 and SIP pres)
55.84399,0,male,0,27,665,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,under $11k,40892.0,27040.8281,12.5,black,46.0,2,0,0,no,0.799999714,0.7,no dnr,27.0,100.0,8.3984375,72.0,32.0,38.39844,292.0,3.2998047,0.39996338,0.89990234,133.0,7.469727,93.0,23.0,2502.0,0.494751,<2 mo. follow-up
43.05798,1,male,0,4,250,Lung Cancer,Cancer,1,12.0,$25-$50k,9909.0,5033.582,12.0,white,14.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,105.0,11.8984375,55.0,12.0,36.79688,118.45312,3.199707,0.59997559,0.89990234,142.0,7.449219,133.0,30.0,3840.0,0.0,no(M2 and SIP pres)
55.26099,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,24646.0,14752.6719,21.5,white,38.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,6.0,58.0,18.796875,55.0,24.0,38.29688,169.375,1.5998535,0.39996338,1.0,131.0,7.369141,177.0,21.0,1520.0,6.0,<2 mo. follow-up
57.06998,1,male,1,35,35,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,157909.0,92457.75,43.75,white,56.0,14,0,0,metastatic,0.399999857,0.2,dnr after sadm,16.0,70.0,14.5996094,96.0,22.0,35.59375,252.15625,3.5,1.01,0.79992676,125.0,7.419922,209.0,11.0,2100.0,0.0,<2 mo. follow-up
60.32898,0,male,0,15,663,ARF/MOSF w/Sepsis,ARF/MOSF,1,24.0,under $11k,49023.0,29819.8281,29.666656,white,41.0,1,0,0,no,0.699999809,0.5,no dnr,15.0,113.0,3.69970703,100.0,12.0,36.59375,333.3,2.8999023,1.01,0.89990234,134.0,7.419922,209.0,9.0,2970.0,0.0,no(M2 and SIP pres)
75.32098,1,female,1,19,19,Coma,Coma,2,12.0,under $11k,71949.0,14452.7344,33.666657,black,30.0,1,0,0,no,0.799999714,0.75,dnr after sadm,12.0,113.0,7.0,80.0,20.0,38.19531,333.3,2.7998047,1.19995117,1.19995117,134.0,7.419922,117.0,28.0,900.0,2.0,<2 mo. follow-up
66.935,1,male,0,38,200,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,70401.0,42746.9688,17.25,white,54.0,10,0,0,metastatic,0.5,0.3,dnr after sadm,12.0,77.0,3.59960938,75.0,24.0,35.59375,360.0,3.199707,2.19970703,3.79980469,135.0,7.369141,161.0,101.0,780.0,3.121582,<2 mo. follow-up
53.577,0,female,0,58,661,Coma,Coma,4,12.0,under $11k,123391.0,72837.125,26.0,black,26.0,14,1,0,no,0.599999905,0.5,no dnr,58.0,118.0,12.6992188,125.0,24.0,36.89844,203.3125,3.5,0.5,0.59997559,138.0,7.459961,203.0,37.0,2535.0,4.0,adl>=4 (>=5 if sur)
64.86798,1,male,0,4,140,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,8329.0,5168.0312,7.0,white,17.0,1,1,0,yes,0.699999809,0.5,no dnr,4.0,75.0,24.5,80.0,24.0,38.0,293.3125,2.5,0.79992676,1.69995117,133.0,7.379883,10.0,192.0,2502.0,0.0,no(M2 and SIP pres)
78.54596,1,female,1,7,7,Coma,Coma,2,8.0,under $11k,32912.0,14452.7344,26.5,black,63.0,12,1,0,yes,0.009999998,0.0,dnr after sadm,5.0,118.0,19.0,125.0,46.0,38.79688,240.0,3.5,1.19995117,0.5,143.0,7.429688,212.0,3.0,4445.0,6.0,<2 mo. follow-up
66.57098,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,61060.0,35093.3125,41.0,white,61.0,6,1,0,no,0.0,0.0,dnr after sadm,4.0,103.0,7.39941406,85.0,22.0,36.89844,333.3,3.5,0.39996338,1.29980469,140.0,7.419922,95.0,24.0,2502.0,3.190918,<2 mo. follow-up
49.52798,0,female,0,11,659,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,66030.0,37520.5625,32.0,white,27.0,5,0,0,no,0.899999619,0.6,no dnr,11.0,78.0,12.6992188,115.0,42.0,38.69531,236.65625,3.0,3.89990234,3.29980469,148.0,7.419922,174.0,96.0,1000.0,0.0,no(M2 and SIP pres)
70.32196,1,male,0,15,467,ARF/MOSF w/Sepsis,ARF/MOSF,3,4.0,under $11k,53749.0,29518.1562,29.666656,white,78.0,6,1,0,yes,0.5,0.2,no dnr,15.0,30.0,7.79980469,135.0,33.0,40.59375,305.0,3.5,1.01,5.79980469,144.0,7.319336,90.0,54.0,140.0,0.0,no(M2 and SIP pres)
34.168,1,female,1,41,41,Coma,Coma,1,11.0,under $11k,63687.0,39086.125,23.5,black,16.0,3,0,0,no,0.699999809,0.5,dnr after sadm,34.0,100.0,11.5996094,120.0,28.0,36.59375,333.3,2.699707,0.5,0.59997559,141.0,7.419922,61.0,17.0,2502.0,0.0,<2 mo. follow-up
63.66599,1,male,0,32,415,Coma,Coma,1,14.0,under $11k,56792.0,36616.5,20.25,black,38.0,1,1,0,no,0.299999952,0.3,no dnr,32.0,38.0,71.890625,145.0,12.0,38.69531,104.28125,1.5998535,0.29998779,2.5,145.0,7.379883,85.0,28.0,1110.0,0.0,adl>=4 (>=5 if sur)
59.29099,0,male,0,6,659,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,4828.0,3260.1367,8.0,black,24.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,132.0,11.2988281,155.0,10.0,36.29688,147.5,1.5,3.79980469,2.39990234,133.0,7.359375,60.0,31.0,1120.0,0.494751,no(M2 and SIP pres)
62.29199,0,female,0,9,658,CHF,COPD/CHF/Cirrhosis,3,5.0,under $11k,8323.0,6026.5977,15.5,black,40.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,112.0,18.6992188,95.0,26.0,38.39844,106.65625,3.5,1.01,3.09960938,152.0,7.349609,362.0,86.0,1790.0,4.0,no(M2 and SIP pres)
68.08197,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,57265.0,32837.0625,35.5,black,58.0,12,0,0,yes,0.299999952,0.25,dnr before sadm,-2.0,55.0,11.1992188,75.0,40.0,36.0,189.78125,2.2998047,1.01,1.5,135.0,7.489258,88.0,22.0,695.0,0.0,<2 mo. follow-up
73.71399,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,80540.0,43399.2812,46.0,white,60.0,3,0,0,yes,0.099999964,0.0,no dnr,7.0,69.0,5.59960938,76.0,14.0,35.59375,333.3,2.8999023,0.5,0.59997559,133.0,7.419922,90.0,4.0,2502.0,5.0,<2 mo. follow-up
48.25497,1,male,0,13,395,Colon Cancer,Cancer,1,16.0,under $11k,23651.0,13812.6797,11.5,white,19.0,1,0,0,metastatic,0.699999809,0.3,no dnr,13.0,48.0,8.29882812,65.0,8.0,37.89844,247.5,2.3999023,1.01,1.59985352,138.0,7.459961,165.0,70.0,97.5,6.0,no(M2 and SIP pres)
37.20697,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,111985.0,14452.7344,43.0,black,31.0,2,0,0,no,0.5,0.3,dnr after sadm,15.0,74.0,7.89941406,74.0,20.0,37.69531,333.3,3.5,1.01,0.59997559,134.0,7.419922,80.0,4.0,2502.0,1.0,<2 mo. follow-up
83.29895,1,female,0,24,146,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,15835.0,12287.8438,5.666664,black,23.0,1,0,1,no,0.799999714,0.6,no dnr,24.0,45.0,2.89990234,125.0,26.0,38.09375,80.0,4.0996094,25.296875,5.69921875,146.0,7.239258,55.0,60.0,5.0,1.0,no(M2 and SIP pres)
70.95099,1,male,1,37,37,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,76564.0,45860.5312,29.25,white,52.0,1,0,0,no,0.199999928,0.5,dnr after sadm,13.0,62.0,10.0996094,195.0,12.0,38.39844,131.09375,1.5,1.89990234,2.0,138.0,7.379883,112.0,54.0,1217.0,0.0,<2 mo. follow-up
79.78595,1,female,1,8,8,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,6594.0,4640.9648,24.5,white,37.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,115.0,13.0996094,105.0,32.0,38.29688,284.0,3.5,1.01,0.69995117,138.0,7.449219,94.0,6.0,3020.0,0.0,<2 mo. follow-up
55.59998,0,male,0,11,655,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,36284.0,14452.7344,26.0,white,12.0,1,0,0,no,0.75,0.6,no dnr,11.0,128.0,14.0996094,75.0,12.0,37.69531,188.5625,3.0,0.59997559,0.59997559,143.0,7.419922,181.0,22.0,2640.0,0.0,adl>=4 (>=5 if sur)
39.23099,0,female,0,37,655,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,159687.0,95423.4375,43.0,white,88.0,1,0,0,no,0.699999809,0.5,no dnr,37.0,130.0,15.6992188,55.0,40.0,37.5,371.375,3.5,1.01,1.5,137.0,7.429688,156.0,36.0,1225.0,0.0,no(M2 and SIP pres)
35.32098,1,male,1,25,25,Coma,Coma,0,14.0,under $11k,192755.0,14452.7344,34.0,black,30.0,34,0,0,no,0.099999964,0.0,no dnr,25.0,153.0,13.0,110.0,24.0,35.09375,140.8125,3.8999023,1.01,1.29980469,136.0,7.40918,205.0,49.0,4230.0,0.0,<2 mo. follow-up
66.81494,1,female,1,20,20,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,65242.0,38550.9375,24.0,white,58.0,9,0,0,yes,0.5,0.5,dnr after sadm,16.0,105.0,8.19921875,65.0,14.0,35.09375,385.6875,3.5,0.39996338,1.89990234,139.0,7.489258,231.0,52.0,1950.0,3.0,<2 mo. follow-up
58.85797,1,male,0,21,90,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,47752.0,30081.6094,14.333328,black,36.0,8,1,0,no,0.699999809,0.7,no dnr,21.0,142.0,14.5996094,135.0,10.0,38.69531,388.0,3.5,0.59997559,0.69995117,146.0,7.429688,108.0,5.0,3100.0,7.0,adl>=4 (>=5 if sur)
47.65799,0,male,0,12,652,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,26875.0,15939.4609,16.0,black,59.0,2,0,0,no,0.949999809,0.95,no dnr,12.0,118.0,5.19921875,65.0,6.0,36.5,396.0,3.199707,0.5,0.69995117,139.0,7.509766,132.0,23.0,2675.0,0.0,no(M2 and SIP pres)
68.87897,0,male,0,21,652,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,15410.0,11309.7656,6.0,white,12.0,1,1,0,no,0.699999809,0.5,no dnr,21.0,72.0,6.09960938,105.0,14.0,36.19531,290.0,3.5,1.09985352,1.19995117,135.0,7.449219,117.0,20.0,5460.0,0.0,adl>=4 (>=5 if sur)
71.92096,0,female,0,26,652,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,99233.0,57108.9688,34.5,white,45.0,2,0,0,no,0.5,0.4,no dnr,26.0,52.0,24.0,115.0,18.0,37.89844,98.32812,2.0,1.01,0.79992676,133.0,7.399414,129.0,34.0,1290.0,0.0,no(M2 and SIP pres)
77.18799,1,male,0,32,90,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,50610.0,31015.6094,19.75,black,15.0,2,0,0,no,0.699999809,0.5,no dnr,32.0,70.0,12.1992188,116.0,20.0,36.69531,333.3,3.5,1.01,0.89990234,139.0,7.419922,71.0,15.0,2502.0,0.0,adl>=4 (>=5 if sur)
52.22998,0,male,0,23,650,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,48448.0,27241.3438,20.333328,white,34.0,2,0,0,no,0.5,0.5,no dnr,23.0,143.0,7.19921875,55.0,22.0,36.29688,226.0625,3.7998047,0.5,0.79992676,144.0,7.399414,122.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
72.909,1,male,1,7,7,Coma,Coma,2,3.0,under $11k,53008.0,30680.5156,34.5,white,63.0,11,1,0,no,0.049999982,0.05,dnr after sadm,4.0,117.0,2.39990234,165.0,53.0,39.69531,132.5,3.0996094,0.5,1.19995117,133.0,7.359375,157.0,10.0,4550.0,1.0,<2 mo. follow-up
72.96899,0,male,0,15,650,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,28292.0,17936.1094,9.0,white,33.0,3,1,0,no,0.599999905,0.6,no dnr,15.0,105.0,17.0976562,120.0,30.0,39.19531,192.5,2.3999023,2.39990234,0.5,137.0,7.399414,97.0,7.0,6869.0,1.0,no(M2 and SIP pres)
65.03796,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$11-$25k,68227.0,38085.5312,35.0,white,54.0,1,0,0,no,0.899999619,0.85,dnr after sadm,15.0,69.0,0.69995117,108.0,24.0,38.39844,333.3,3.5,1.01,0.5,142.0,7.419922,70.0,4.0,2502.0,1.0,<2 mo. follow-up
53.36899,0,female,0,26,649,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,74535.0,42580.4375,25.25,black,43.0,1,1,0,no,0.899999619,0.9,no dnr,26.0,68.0,7.0,65.0,24.0,36.39844,333.3,3.5,0.5,0.79992676,136.0,7.419922,124.0,13.0,1550.0,2.1347656,no(M2 and SIP pres)
70.935,0,female,0,9,649,COPD,COPD/CHF/Cirrhosis,1,15.0,>$50k,9011.0,5791.9414,7.5,white,30.0,1,0,0,no,0.699999809,0.5,dnr after sadm,4.0,112.0,23.796875,120.0,12.0,38.5,283.3125,2.5996094,1.59985352,3.0,145.0,7.259766,82.0,58.0,1490.0,5.0,no(M2 and SIP pres)
74.86395,1,female,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,293806.0,168017.0,36.25,white,44.0,42,0,0,yes,0.0,0.0,dnr after sadm,41.0,42.0,16.8984375,145.0,45.0,38.59375,210.0,3.5,0.39996338,7.5,139.0,7.419922,507.0,101.0,15.0,6.0,<2 mo. follow-up
71.64099,1,male,0,6,52,Coma,Coma,1,12.0,under $11k,6228.0,4059.707,9.0,white,28.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,57.0,14.0996094,115.0,10.0,39.5,118.32812,2.2998047,0.69995117,0.69995117,141.0,7.439453,281.0,20.0,3545.0,7.0,<2 mo. follow-up
29.65599,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$11-$25k,281407.0,160268.5,37.666657,black,64.0,40,0,0,no,0.199999928,0.2,dnr after sadm,16.0,68.0,16.3984375,105.0,36.0,38.69531,110.0,3.5,0.5,0.79992676,146.0,7.5,243.0,18.0,3480.0,0.0,<2 mo. follow-up
51.73398,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,24569.0,14623.6016,52.0,white,105.0,1,0,0,no,0.5,0.4,dnr after sadm,2.0,58.0,9.5,115.0,30.0,38.29688,202.84375,2.5,0.5,0.89990234,149.0,7.399414,137.0,25.0,2370.0,0.0,<2 mo. follow-up
56.29797,0,male,0,64,646,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,227291.0,151162.875,46.0,white,47.0,1,1,0,no,0.699999809,0.65,no dnr,64.0,101.0,6.79980469,80.0,16.0,37.79688,333.3,3.8999023,0.19998169,1.09985352,142.0,7.419922,175.0,11.0,2502.0,1.0,SIP>=30
49.26199,1,male,0,13,175,Cirrhosis,COPD/CHF/Cirrhosis,4,10.0,under $11k,15670.0,10045.3906,5.0,white,48.0,1,1,0,no,0.949999809,0.9,no dnr,13.0,62.0,15.5996094,35.0,33.0,35.0,190.0,2.5996094,1.01,2.69970703,138.0,7.369141,224.0,134.0,240.0,3.0,SIP>=30
61.46698,1,male,1,9,9,Lung Cancer,Cancer,2,12.0,under $11k,13209.0,7907.5664,7.0,white,12.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,9.0,75.0,6.79980469,67.0,20.0,36.19531,333.3,3.5996094,0.39996338,1.0,140.0,7.419922,98.0,13.0,5700.0,0.0,<2 mo. follow-up
92.73096,1,female,0,32,461,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,91653.0,56649.7812,20.0,black,23.0,19,0,0,yes,0.699999809,0.5,dnr after sadm,19.0,65.0,10.2988281,115.0,27.0,39.09375,146.0,2.7998047,0.19998169,0.39996338,137.0,7.439453,139.0,11.0,2174.0,0.0,adl>=4 (>=5 if sur)
60.63797,1,female,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,145919.0,14452.7344,32.25,white,23.0,1,0,0,no,0.899999619,0.85,dnr after sadm,20.0,142.0,10.6992188,72.0,26.0,38.0,246.65625,3.5,1.01,10.5996094,136.0,7.429688,84.0,52.0,615.0,1.0,<2 mo. follow-up
56.59399,1,female,0,9,128,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,21295.0,12869.1562,16.0,black,47.0,2,0,0,metastatic,0.699999809,0.5,no dnr,9.0,68.0,9.3984375,102.0,16.0,36.39844,333.3,3.3999023,0.39996338,0.5,141.0,7.419922,88.0,5.0,7455.0,0.0,adl>=4 (>=5 if sur)
63.02298,0,female,0,16,643,CHF,COPD/CHF/Cirrhosis,3,13.0,$25-$50k,21498.0,13531.0625,20.333328,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,16.0,68.0,10.0,110.0,29.0,37.79688,270.0,2.2998047,0.39996338,1.59985352,154.0,7.339844,119.0,38.0,2795.0,0.0,no(M2 and SIP pres)
60.90097,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,99519.0,14452.7344,39.0,white,82.0,2,0,0,yes,0.5,0.25,dnr after sadm,12.0,62.0,2.79980469,175.0,20.0,37.89844,133.3125,2.5996094,1.19995117,2.19970703,140.0,7.40918,185.0,54.0,4155.0,6.0,<2 mo. follow-up
63.92099,1,female,0,3,353,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,3315.0,2266.6445,12.0,white,37.0,1,0,0,yes,0.5,0.25,no dnr,3.0,65.0,3.39990234,105.0,36.0,37.89844,126.51562,3.5,1.0,2.29980469,132.0,7.369141,107.0,37.0,2325.0,2.5341797,no(M2 and SIP pres)
55.85999,0,female,0,25,642,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,79183.0,14452.7344,30.25,white,53.0,1,0,0,no,0.799999714,0.75,no dnr,25.0,70.0,6.59960938,65.0,30.0,35.0,223.3125,2.8999023,1.01,1.39990234,136.0,7.40918,92.0,34.0,2530.0,0.0,no(M2 and SIP pres)
54.021,1,male,0,3,536,Lung Cancer,Cancer,2,11.0,$11-$25k,59995.78781114967,1357.7764,5.0,white,17.0,1,0,0,metastatic,0.799999714,0.5,no dnr,3.0,78.0,2.5,105.0,20.0,36.0,214.28125,1.5998535,1.89990234,1.39990234,142.0,7.40918,132.0,40.0,200.0,2.0,no(M2 and SIP pres)
64.49799,0,male,0,49,641,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,148554.0,83934.25,30.25,white,43.0,4,0,0,no,0.799999714,0.75,no dnr,49.0,72.0,18.3984375,85.0,19.0,36.39844,180.0,2.5996094,1.01,1.5,134.0,7.429688,166.0,39.0,5778.0,0.0,no(M2 and SIP pres)
60.86798,0,male,0,6,641,CHF,COPD/CHF/Cirrhosis,2,4.0,under $11k,9822.0,6247.3242,23.0,white,18.0,1,0,0,no,0.899999619,0.6,no dnr,6.0,100.0,20.296875,84.0,20.0,37.0,498.0,3.5,1.01,0.89990234,143.0,7.279297,102.0,26.0,2660.0,1.8388672,adl>=4 (>=5 if sur)
55.17899,0,male,0,106,640,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,573218.0,320278.0,37.75,black,34.0,57,0,0,no,0.699999809,0.5,no dnr,106.0,35.0,13.3984375,145.0,34.0,39.0,237.125,3.5,1.01,1.69995117,146.0,7.389648,114.0,39.0,845.0,0.0,<2 mo. follow-up
47.84399,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,34109.0,14452.7344,33.0,other,22.0,3,1,0,no,0.0,0.0,dnr after sadm,2.0,117.0,10.0,75.0,40.0,38.39844,260.0,3.5,11.5996094,2.59960938,141.0,7.479492,250.0,63.0,1950.0,0.0,<2 mo. follow-up
53.51099,1,female,0,18,88,Lung Cancer,Cancer,1,20.0,>$50k,36304.0,21369.9688,11.666664,white,13.0,1,0,0,metastatic,0.799999714,0.6,no dnr,18.0,115.0,15.8984375,125.0,45.0,38.5,233.3125,2.5996094,1.01,0.69995117,137.0,7.439453,132.0,6.0,3555.0,1.8388672,adl>=4 (>=5 if sur)
78.64795,0,female,0,6,637,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,43537.0,25966.8438,11.0,white,16.0,6,1,0,no,0.949999809,0.9,no dnr,6.0,38.0,3.59960938,130.0,8.0,34.79688,152.0,2.0,0.69995117,2.09960938,130.0,7.429688,33.0,24.0,3280.0,0.0,no(M2 and SIP pres)
41.11697,0,female,0,27,637,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,113278.0,66799.8125,27.0,black,24.0,16,0,0,no,0.5,0.5,no dnr,27.0,126.0,4.19921875,70.0,26.0,38.09375,371.375,3.5,1.01,1.29980469,137.0,7.369141,87.0,7.0,2800.0,1.0,adl>=4 (>=5 if sur)
79.37897,0,male,0,17,637,Coma,Coma,0,12.0,under $11k,169122.0,99286.75,33.666657,white,28.0,41,0,0,no,0.699999809,0.5,no dnr,17.0,136.0,7.09960938,45.0,12.0,38.0,286.625,2.7998047,1.01,2.0,137.0,7.389648,288.0,31.0,1715.0,1.8620606,<2 mo. follow-up
55.61899,0,male,0,17,637,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,32806.0,14452.7344,12.666664,white,14.0,3,1,0,yes,0.75,0.6,no dnr,17.0,120.0,5.29980469,60.0,26.0,36.19531,276.0,3.5,0.39996338,1.0,144.0,7.379883,194.0,18.0,2250.0,1.0,no(M2 and SIP pres)
30.40099,0,female,0,113,635,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,461600.0,14452.7344,43.25,black,40.0,1,0,0,no,0.599999905,0.6,no dnr,113.0,132.0,4.5,68.0,24.0,38.09375,219.03125,3.5,0.59997559,1.79980469,139.0,7.369141,229.0,33.0,4150.0,1.0,adl>=4 (>=5 if sur)
64.797,0,male,0,63,635,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,286996.0,162759.125,43.5,white,44.0,16,0,0,no,0.799999714,0.8,no dnr,63.0,72.0,17.1992188,125.0,25.0,36.5,330.0,1.8999023,2.89990234,1.79980469,149.0,7.419922,108.0,30.0,1550.0,0.0,SIP>=30
86.91595,1,female,0,16,53,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,96288.0,59030.1875,18.333328,white,30.0,36,0,0,no,0.699999809,0.5,dnr after sadm,3.0,68.0,22.5976562,95.0,14.0,36.09375,116.65625,3.5,1.5,5.39941406,130.0,7.429688,156.0,75.0,43.0,0.0,<2 mo. follow-up
80.323,0,male,0,9,634,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,24828.0,14452.7344,22.0,white,36.0,3,0,0,yes,1.0,0.6,no dnr,9.0,103.0,3.59960938,75.0,20.0,36.79688,333.3,2.2998047,1.39990234,1.59985352,137.0,7.419922,109.0,4.0,2502.0,0.0,<2 mo. follow-up
27.26099,0,male,0,9,633,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,22451.0,14452.7344,19.0,black,59.0,1,0,0,no,0.899999619,0.85,no dnr,9.0,118.0,15.2988281,55.0,34.0,38.79688,220.0,2.3999023,4.09960938,0.79992676,152.0,7.389648,102.0,13.0,4770.0,0.0,no(M2 and SIP pres)
46.47998,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,4,9.0,under $11k,36739.0,14452.7344,38.0,black,52.0,1,0,0,no,0.5,0.3,dnr after sadm,5.0,77.0,8.29882812,60.0,26.0,37.59375,257.125,3.5,1.09985352,1.19995117,141.0,7.519531,111.0,10.0,2025.0,0.0,<2 mo. follow-up
65.94397,1,female,1,18,18,Cirrhosis,COPD/CHF/Cirrhosis,4,4.0,under $11k,26626.0,14452.7344,16.0,black,49.0,1,1,0,no,0.199999928,0.05,dnr after sadm,18.0,67.0,10.2988281,55.0,35.0,38.59375,212.5,3.5,5.0,3.69970703,136.0,7.469727,286.0,82.0,4600.0,4.0,<2 mo. follow-up
70.75397,0,female,0,13,631,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,27012.0,16491.5312,22.5,white,31.0,2,1,0,no,0.599999905,0.4,no dnr,13.0,60.0,9.79882812,55.0,24.0,35.79688,309.5,4.0,1.09985352,1.89990234,150.0,7.449219,70.0,53.0,1475.0,0.0,no(M2 and SIP pres)
73.10596,0,female,0,22,632,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,$25-$50k,174244.0,14452.7344,36.0,white,63.0,22,0,0,no,0.5,0.3,no dnr,22.0,103.0,14.0,75.0,24.0,38.79688,281.0,3.5,0.69995117,1.19995117,137.0,7.439453,88.0,13.0,1240.0,6.0,Coma or Intub
56.89499,0,male,0,8,632,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,18632.0,14452.7344,20.0,black,45.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,62.0,26.8984375,75.0,36.0,35.79688,115.70312,2.2998047,0.89990234,5.0,137.0,7.329102,148.0,69.0,66.0,2.8930664,<2 mo. follow-up
52.79099,0,male,0,8,632,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,12395.0,4226.0586,7.5,white,9.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,120.0,14.5,105.0,11.0,38.5,316.625,3.5,2.5,2.09960938,148.0,7.419922,60.0,34.0,2510.0,0.0,no(M2 and SIP pres)
75.87994,1,female,0,9,225,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,17026.0,14452.7344,18.0,white,40.0,1,0,0,no,0.399999857,0.3,dnr after sadm,2.0,125.0,25.6992188,125.0,32.0,37.69531,246.65625,3.5,1.01,2.59960938,141.0,7.399414,249.0,70.0,1155.0,0.0,no(M2 and SIP pres)
60.66498,0,male,0,7,631,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,14779.0,14452.7344,19.5,white,43.0,1,1,0,no,0.799999714,0.7,no dnr,7.0,117.0,12.3984375,112.0,24.0,38.19531,210.1875,1.3999023,4.89941406,1.09985352,132.0,7.299805,174.0,19.0,3575.0,1.0,no(M2 and SIP pres)
69.64496,1,female,0,14,49,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,>$50k,79048.0,46799.625,23.0,white,42.0,22,0,0,no,0.099999964,0.5,dnr after sadm,3.0,160.0,43.1953125,125.0,28.0,37.69531,280.0,2.199707,1.09985352,2.5,151.0,7.369141,202.0,59.0,2110.0,0.0,<2 mo. follow-up
53.06998,1,male,0,4,202,Lung Cancer,Cancer,1,12.0,$11-$25k,6650.0,14452.7344,9.0,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,103.0,5.5,80.0,20.0,36.19531,333.3,3.5,1.01,1.5,138.0,7.419922,148.0,17.0,2502.0,0.0,no(M2 and SIP pres)
82.54297,1,male,0,14,15,COPD,COPD/CHF/Cirrhosis,2,13.0,$11-$25k,14698.0,14452.7344,9.333328,white,8.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,5.0,58.0,16.796875,65.0,8.0,38.29688,172.0,3.5,1.01,1.5,144.0,7.349609,292.0,32.0,7315.0,1.0,<2 mo. follow-up
68.383,0,male,0,10,628,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,35772.0,14452.7344,25.5,white,38.0,2,1,0,no,0.799999714,0.7,no dnr,10.0,93.0,8.8984375,65.0,28.0,39.5,185.0,3.5,1.01,0.69995117,137.0,7.369141,149.0,14.0,1595.0,0.0,no(M2 and SIP pres)
85.74396,1,female,0,7,263,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5616.0,3942.7949,4.0,white,22.0,1,1,0,no,0.799999714,0.7,no dnr,7.0,122.0,13.8984375,120.0,29.0,36.59375,250.0,2.0996094,0.19998169,0.89990234,133.0,7.359375,81.0,8.0,3965.0,2.5107422,<2 mo. follow-up
68.02496,1,male,0,5,154,CHF,COPD/CHF/Cirrhosis,2,5.0,under $11k,3742.0,2707.2363,8.0,black,45.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,52.0,13.8984375,60.0,11.0,39.5,205.6875,2.7998047,0.29998779,2.59960938,142.0,7.239258,527.0,44.0,360.0,2.0,adl>=4 (>=5 if sur)
49.93298,1,male,0,18,50,Colon Cancer,Cancer,1,12.0,>$50k,27935.0,14452.7344,17.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,18.0,70.0,5.29980469,105.0,33.0,38.19531,205.0,3.5,1.01,1.19995117,127.0,7.379883,234.0,21.0,960.0,0.0,<2 mo. follow-up
20.48199,0,male,0,35,627,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,200937.0,114746.375,36.75,white,64.0,6,0,0,no,0.599999905,0.6,no dnr,35.0,58.0,13.6992188,115.0,38.0,38.19531,213.3125,3.5,0.79992676,1.39990234,148.0,7.339844,100.0,55.0,1375.0,0.494751,no(M2 and SIP pres)
87.92596,1,female,0,49,465,COPD,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,50071.0,33320.0312,16.75,white,24.0,1,0,1,no,0.699999809,0.5,dnr after sadm,3.0,120.0,16.1992188,125.0,42.0,37.69531,170.0,2.3999023,0.5,0.5,132.0,7.449219,113.0,13.0,5325.0,1.0,adl>=4 (>=5 if sur)
34.995,0,male,0,10,626,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,19106.0,11641.5312,11.0,white,42.0,2,0,0,metastatic,0.949999809,0.85,no dnr,10.0,101.0,26.796875,136.0,24.0,36.69531,348.0,3.7998047,0.29998779,0.89990234,140.0,7.389648,220.0,22.0,2502.0,0.0,no(M2 and SIP pres)
76.047,0,male,0,6,626,COPD,COPD/CHF/Cirrhosis,4,16.0,>$50k,5420.0,14452.7344,9.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,52.0,21.5976562,70.0,12.0,38.09375,134.0,2.5996094,0.79992676,1.29980469,149.0,7.379883,147.0,46.0,910.0,0.494751,no(M2 and SIP pres)
46.99197,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,109299.0,55014.5938,38.666657,other,19.0,12,0,0,no,0.699999809,0.5,dnr before sadm,-2.0,145.0,20.296875,56.0,22.0,36.0,333.3,3.5,1.0,1.29980469,143.0,7.419922,121.0,32.0,1425.0,7.0,<2 mo. follow-up
40.47897,0,female,0,7,624,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$11-$25k,9844.0,6419.6797,6.0,black,18.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,115.0,27.796875,115.0,20.0,35.69531,176.65625,3.5,3.09960938,3.0,129.0,7.449219,380.0,70.0,975.0,0.0,no(M2 and SIP pres)
62.07797,0,male,0,4,624,COPD,COPD/CHF/Cirrhosis,1,6.0,under $11k,6699.0,4312.0977,15.0,black,31.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,58.0,31.3984375,145.0,34.0,35.29688,91.42188,3.5,1.01,2.79980469,150.0,7.429688,53.0,41.0,350.0,1.1667481,no(M2 and SIP pres)
41.26199,0,male,0,25,624,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,71995.0,42603.4375,21.75,black,28.0,6,0,0,no,0.699999809,0.5,no dnr,25.0,45.0,19.0,125.0,14.0,39.09375,77.0,3.5,0.79992676,0.89990234,131.0,7.319336,346.0,18.0,2912.0,0.0,no(M2 and SIP pres)
69.25397,1,male,0,23,105,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,85837.0,48802.375,19.0,white,47.0,13,1,0,yes,0.599999905,0.3,no dnr,23.0,71.0,6.29980469,104.0,22.0,36.39844,333.3,1.0998535,2.09960938,1.89990234,137.0,7.419922,167.0,117.0,1725.0,0.0,no(M2 and SIP pres)
20.767,1,female,1,121,121,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,314505.0,14452.7344,16.25,white,26.0,46,0,0,metastatic,0.699999809,0.5,dnr after sadm,121.0,83.0,12.5,76.0,16.0,36.29688,333.3,3.8999023,0.69995117,1.39990234,135.0,7.419922,68.0,23.0,2502.0,4.0,no(M2 and SIP pres)
55.29398,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,25610.0,14894.8516,32.0,white,52.0,4,0,0,no,0.5,0.25,dnr after sadm,3.0,80.0,7.69921875,110.0,12.0,36.79688,177.5,2.3999023,1.01,0.79992676,136.0,7.399414,141.0,11.0,2430.0,2.4755859,<2 mo. follow-up
32.62399,0,male,0,5,622,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,9490.0,5901.4141,17.0,black,28.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,70.0,5.39941406,72.0,24.0,36.69531,459.25,3.5,0.5,1.29980469,135.0,7.429688,62.0,24.0,850.0,0.0,<2 mo. follow-up
62.5,1,male,1,5,5,Coma,Coma,0,3.0,under $11k,28348.0,14452.7344,37.0,black,71.0,1,0,0,no,0.099999964,0.5,dnr after sadm,4.0,113.0,6.29980469,193.0,32.0,36.29688,118.35938,3.5,1.01,0.69995117,135.0,7.399414,195.0,21.0,3700.0,7.0,<2 mo. follow-up
44.52597,1,male,0,50,165,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,122325.0,73861.4375,24.75,black,27.0,16,0,0,metastatic,0.299999952,0.2,no dnr,50.0,55.0,6.39941406,67.0,20.0,36.5,333.3,3.5,0.79992676,1.0,140.0,7.419922,87.0,29.0,2475.0,0.0,no(M2 and SIP pres)
52.82098,1,female,0,5,153,Colon Cancer,Cancer,2,12.0,$11-$25k,5884.0,3786.0137,13.0,white,15.0,1,1,0,metastatic,0.899999619,0.95,no dnr,5.0,147.0,0.19998169,135.0,30.0,35.79688,412.0,2.5996094,11.8984375,2.59960938,142.0,7.399414,164.0,105.0,2060.0,2.0,no(M2 and SIP pres)
42.41998,0,female,0,16,621,COPD,COPD/CHF/Cirrhosis,1,18.0,$25-$50k,21687.0,14074.9141,9.666664,black,26.0,1,0,0,no,0.899999619,0.8,no dnr,16.0,113.0,18.5976562,92.0,20.0,36.59375,242.84375,3.5,1.01,7.0,138.0,7.149414,200.0,67.0,2502.0,0.494751,no(M2 and SIP pres)
65.36096,1,male,0,6,265,CHF,COPD/CHF/Cirrhosis,4,12.0,>$50k,10511.0,6464.8906,12.0,white,30.0,1,1,0,no,0.899999619,0.85,no dnr,6.0,77.0,8.59960938,60.0,36.0,38.19531,185.6875,2.8999023,1.29980469,2.19970703,134.0,7.399414,356.0,70.0,1200.0,3.0,no(M2 and SIP pres)
41.58197,0,male,0,9,620,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,36979.0,14452.7344,20.0,white,44.0,4,0,0,no,0.949999809,0.95,no dnr,9.0,109.0,6.79980469,95.0,16.0,36.39844,333.3,2.0996094,0.29998779,1.09985352,137.0,7.419922,97.0,17.0,2502.0,2.4272461,<2 mo. follow-up
85.185,1,female,1,3,3,Coma,Coma,0,16.0,under $11k,59995.78781114967,14452.7344,33.0,white,58.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,53.0,14.2988281,125.0,30.0,38.79688,130.0,3.5,1.01,1.39990234,138.0,7.40918,106.0,27.0,2730.0,2.1591797,<2 mo. follow-up
72.20795,1,male,1,9,9,Coma,Coma,0,12.0,under $11k,57252.0,14452.7344,34.0,white,31.0,5,0,0,no,0.699999809,0.5,dnr after sadm,3.0,68.0,9.0,65.0,16.0,35.79688,333.3,3.5,0.69995117,1.39990234,140.0,7.419922,122.0,20.0,3350.0,2.2416992,<2 mo. follow-up
41.06998,1,female,1,4,4,Coma,Coma,2,12.0,under $11k,45291.0,14452.7344,22.0,white,74.0,23,1,0,no,0.699999809,0.5,dnr after sadm,1.0,89.5,17.0976562,115.0,24.0,36.5,228.96875,3.5,1.01,2.09960938,148.0,7.399414,103.0,86.0,4665.0,2.8759766,<2 mo. follow-up
64.83197,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,49863.0,14452.7344,46.5,white,57.0,3,0,0,metastatic,0.299999952,0.1,dnr after sadm,8.0,68.0,6.5,65.0,12.0,35.5,215.0,3.5,0.39996338,0.69995117,152.0,7.489258,222.0,10.0,1190.0,6.0,<2 mo. follow-up
47.44397,0,female,0,20,619,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,24405.0,15665.9922,15.0,white,6.0,1,0,0,no,0.699999809,0.5,no dnr,20.0,79.0,13.0996094,104.0,20.0,38.5,333.3,3.7998047,0.59997559,0.59997559,138.0,7.419922,106.0,4.0,4700.0,4.0,no(M2 and SIP pres)
79.69598,1,female,0,57,185,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,59995.78781114967,103971.5,36.25,white,44.0,9,0,0,no,0.75,0.7,no dnr,57.0,75.0,5.19921875,75.0,18.0,38.29688,333.3,3.5,0.59997559,1.29980469,140.0,7.419922,153.0,11.0,1160.0,5.0,adl>=4 (>=5 if sur)
45.16397,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,83679.0,48635.375,33.333313,black,37.0,13,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,68.0,11.8984375,65.0,10.0,39.0,300.0,3.5,1.01,1.09985352,135.0,7.489258,205.0,21.0,2765.0,2.4082031,<2 mo. follow-up
56.03,1,male,0,19,505,MOSF w/Malig,ARF/MOSF,2,16.0,>$50k,34500.0,20821.2969,13.0,white,17.0,2,0,0,yes,0.599999905,0.4,no dnr,19.0,128.0,13.0996094,65.0,11.0,38.09375,285.6875,2.7998047,1.01,1.59985352,136.0,7.439453,148.0,30.0,663.0,1.1667481,no(M2 and SIP pres)
61.56598,1,female,1,339,339,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,1016214.0,14452.7344,42.0,white,63.0,13,0,0,no,0.699999809,0.5,dnr after sadm,186.0,131.0,6.0,62.0,24.0,37.69531,366.625,3.7998047,0.79992676,0.59997559,140.0,7.439453,137.0,7.0,2000.0,2.8676758,adl>=4 (>=5 if sur)
75.85498,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$11-$25k,63978.0,14452.7344,43.0,white,66.0,1,0,0,no,0.299999952,0.2,dnr after sadm,6.0,73.0,11.8984375,150.0,16.0,38.59375,61.66406,2.0996094,1.01,0.89990234,140.0,7.349609,113.0,18.0,3500.0,1.0,<2 mo. follow-up
57.17999,0,female,0,5,617,CHF,COPD/CHF/Cirrhosis,3,17.0,under $11k,4719.0,3361.4668,6.0,white,11.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,98.0,23.0,115.0,12.0,36.69531,187.5,1.0998535,3.29980469,1.39990234,144.0,7.40918,78.0,43.0,1480.0,0.0,no(M2 and SIP pres)
68.68195,0,male,0,20,616,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,68006.0,41975.4062,28.666656,white,41.0,4,0,0,no,0.799999714,0.8,no dnr,20.0,57.0,10.2988281,75.0,16.0,35.0,368.0,3.5,0.29998779,0.5,135.0,7.459961,104.0,13.0,490.0,0.0,no(M2 and SIP pres)
38.56299,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,34125.0,18525.8594,47.0,white,129.0,3,0,0,no,0.099999964,0.05,dnr after sadm,3.0,65.0,6.5,55.0,16.0,36.5,177.5,3.5,1.01,1.19995117,137.0,7.459961,152.0,33.0,1400.0,1.0517578,<2 mo. follow-up
69.71899,1,male,0,5,68,Lung Cancer,Cancer,4,3.0,under $11k,4335.0,14452.7344,8.0,white,19.0,1,1,0,metastatic,0.699999809,0.5,no dnr,5.0,108.0,25.296875,70.0,12.0,36.29688,287.5,3.5,14.8984375,7.39941406,140.0,7.359375,77.0,83.0,1975.0,0.0,<2 mo. follow-up
58.793,0,male,0,11,616,CHF,COPD/CHF/Cirrhosis,5,10.0,$25-$50k,26940.0,14998.5781,30.5,white,47.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,55.0,16.296875,135.0,24.0,38.0,72.5,3.5,2.29980469,1.5,137.0,7.319336,74.0,20.0,2220.0,0.0,no(M2 and SIP pres)
75.93695,1,male,0,13,143,COPD,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,13997.0,9179.1484,8.0,white,37.0,1,0,0,metastatic,0.799999714,0.6,no dnr,13.0,100.0,4.69921875,104.0,26.0,36.0,454.125,1.5,0.59997559,5.69921875,136.0,7.569336,165.0,35.0,675.0,4.0,adl>=4 (>=5 if sur)
64.85699,1,male,0,4,536,Colon Cancer,Cancer,2,12.0,under $11k,10381.0,6016.0352,7.0,white,5.0,1,1,0,metastatic,0.799999714,0.5,no dnr,4.0,73.0,10.5,65.0,32.0,38.59375,208.5625,2.8999023,0.5,1.69995117,135.0,7.389648,242.0,34.0,3062.0,1.7866211,<2 mo. follow-up
62.41199,1,male,0,4,183,CHF,COPD/CHF/Cirrhosis,6,12.0,$11-$25k,3217.0,2380.4453,13.0,black,11.0,1,1,0,no,0.599999905,0.5,no dnr,4.0,47.0,29.6992188,125.0,42.0,38.79688,161.65625,3.5,0.39996338,1.29980469,146.0,7.389648,376.0,81.0,1277.0,2.0,adl>=4 (>=5 if sur)
65.64294,1,male,1,36,36,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,205473.0,118190.562,48.25,white,80.0,1,0,0,no,0.599999905,0.5,dnr after sadm,35.0,72.0,8.59960938,60.0,12.0,35.69531,223.78125,3.5,1.5,1.89990234,143.0,7.419922,121.0,38.0,2365.0,0.0,<2 mo. follow-up
74.42297,1,female,0,112,174,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,235109.0,14452.7344,27.5,white,34.0,2,0,0,no,0.799999714,0.7,no dnr,112.0,103.0,5.79980469,84.0,20.0,36.09375,333.3,3.5996094,1.29980469,0.79992676,146.0,7.419922,88.0,14.0,2710.0,0.0,adl>=4 (>=5 if sur)
50.63397,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,50165.0,31491.5781,55.5,black,93.0,1,0,0,no,0.099999964,0.1,dnr after sadm,9.0,47.0,8.3984375,60.0,32.0,36.59375,162.5,3.5,0.29998779,0.79992676,136.0,7.369141,128.0,28.0,1690.0,0.0,<2 mo. follow-up
50.37399,1,female,0,9,182,Colon Cancer,Cancer,2,12.0,>$50k,9406.0,6254.0508,8.0,white,19.0,1,1,0,metastatic,0.799999714,0.6,no dnr,9.0,123.0,14.5,115.0,28.0,37.79688,366.625,3.5,1.01,1.09985352,136.0,7.459961,259.0,25.0,3820.0,0.0,no(M2 and SIP pres)
41.125,0,male,0,12,612,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59788.0,34637.9688,29.0,white,28.0,2,0,0,no,0.849999905,0.8,no dnr,12.0,75.0,15.2988281,115.0,28.0,38.19531,250.0,2.2998047,4.39941406,0.79992676,146.0,7.449219,109.0,29.0,3250.0,0.0,<2 mo. follow-up
50.237,1,male,0,4,199,Lung Cancer,Cancer,1,16.0,>$50k,10702.0,5278.9219,14.0,white,13.0,1,0,0,metastatic,0.899999619,0.6,no dnr,4.0,103.0,4.39941406,80.0,20.0,36.29688,333.3,3.5,0.5,1.0,135.0,7.419922,89.0,16.0,2502.0,0.494751,<2 mo. follow-up
65.67798,1,female,0,4,432,Lung Cancer,Cancer,1,12.0,under $11k,10072.0,5396.9336,12.0,white,17.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,95.0,10.8984375,136.0,20.0,36.69531,348.0,3.5,0.69995117,0.69995117,138.0,7.439453,109.0,12.0,2502.0,2.6655273,<2 mo. follow-up
78.64996,1,female,1,5,5,Coma,Coma,0,4.0,$11-$25k,15947.0,9404.7422,35.0,white,58.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,105.0,7.79980469,55.0,12.0,38.79688,202.5,3.5,0.59997559,2.59960938,133.0,7.459961,258.0,66.0,5620.0,2.0,<2 mo. follow-up
54.33798,1,male,0,11,141,Cirrhosis,COPD/CHF/Cirrhosis,2,6.0,under $11k,14277.0,9446.7812,16.0,black,31.0,1,0,0,no,0.75,0.5,no dnr,11.0,79.0,12.0996094,49.0,24.0,36.5,597.125,3.5,0.29998779,1.0,139.0,7.319336,189.0,31.0,2502.0,3.0,no(M2 and SIP pres)
45.37997,1,female,0,21,97,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,35444.0,22814.7031,26.666656,other,45.0,1,1,0,no,0.849999905,0.7,no dnr,21.0,49.0,7.5,62.0,28.0,35.29688,333.3,3.5996094,1.29980469,1.69995117,130.0,7.419922,76.0,43.0,2900.0,4.0,<2 mo. follow-up
58.34598,1,male,1,17,17,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,33035.0,20674.2188,27.666656,white,96.0,1,0,0,yes,0.25,0.15,dnr after sadm,1.0,107.0,8.59960938,74.0,16.0,35.39844,333.3,3.5,0.5,1.89990234,145.0,7.419922,212.0,29.0,2350.0,1.0,<2 mo. follow-up
52.86499,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,32148.0,19020.4219,19.0,black,38.0,6,0,0,metastatic,0.099999964,0.0,dnr before sadm,-3.0,138.0,28.5,145.0,10.0,38.79688,236.0,2.0996094,15.1992188,1.0,140.0,7.439453,136.0,30.0,3540.0,4.4863281,<2 mo. follow-up
70.85596,0,male,0,14,610,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,29607.0,19447.8281,10.333328,white,38.0,1,0,0,yes,0.899999619,0.8,no dnr,14.0,60.0,11.8984375,65.0,30.0,38.0,272.0,4.0,0.39996338,0.59997559,124.0,7.40918,108.0,10.0,3800.0,3.0,SIP>=30
72.422,1,male,0,6,540,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,26938.0,15409.5234,16.0,white,38.0,4,0,0,no,0.899999619,0.85,no dnr,6.0,65.0,11.5,140.0,16.0,39.09375,292.0,1.7998047,1.09985352,1.79980469,137.0,7.259766,121.0,14.0,2850.0,0.0,no(M2 and SIP pres)
70.36298,1,male,1,14,14,COPD,COPD/CHF/Cirrhosis,2,16.0,under $11k,50172.0,29052.5781,31.333328,white,36.0,1,0,0,yes,0.5,0.4,dnr after sadm,12.0,65.0,6.5,55.0,20.0,36.09375,276.1875,3.8999023,0.79992676,1.19995117,138.0,7.439453,83.0,21.0,2075.0,0.0,<2 mo. follow-up
65.43195,1,male,0,5,181,Lung Cancer,Cancer,2,15.0,>$50k,11205.0,5668.1016,13.0,white,21.0,1,1,0,metastatic,0.699999809,0.5,no dnr,5.0,65.0,14.0,135.0,6.0,38.5,185.0,3.5,0.29998779,0.89990234,142.0,7.449219,92.0,7.0,3515.0,0.0,no(M2 and SIP pres)
78.47998,1,female,1,13,13,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,36049.0,21361.4844,32.0,white,36.0,1,0,0,no,0.699999809,0.6,dnr after sadm,10.0,99.0,10.6992188,75.0,22.0,38.09375,228.5625,3.0,0.39996338,0.79992676,142.0,7.479492,117.0,5.0,2502.0,6.0,<2 mo. follow-up
77.12,1,male,0,18,83,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,49281.0,29451.9375,23.333328,white,52.0,4,0,0,no,0.5,0.35,no dnr,18.0,107.0,10.0,109.0,28.0,36.59375,176.1875,4.0,0.29998779,0.89990234,139.0,7.379883,132.0,15.0,1600.0,1.0,no(M2 and SIP pres)
57.92999,1,female,0,14,572,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,43351.0,25587.25,21.666656,white,40.0,1,1,0,yes,0.799999714,0.75,no dnr,14.0,73.0,8.19921875,75.0,0.0,38.09375,200.0,3.5,1.01,0.89990234,141.0,7.449219,109.0,16.0,3225.0,1.0,SIP>=30
44.76898,0,female,0,12,608,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,41805.0,23602.1875,37.0,white,39.0,1,0,0,no,0.799999714,0.8,no dnr,12.0,74.0,0.69995117,100.0,32.0,36.59375,204.0625,3.5,1.01,0.79992676,136.0,7.359375,205.0,21.0,4485.0,0.0,no(M2 and SIP pres)
58.793,0,male,0,81,608,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,under $11k,264071.0,151383.5,21.75,other,32.0,33,0,0,no,0.699999809,0.5,no dnr,81.0,98.0,0.09999084,105.0,20.0,38.5,333.3,3.199707,0.69995117,0.69995117,140.0,7.419922,99.0,6.0,4625.0,1.0,adl>=4 (>=5 if sur)
52.42999,0,male,0,28,608,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,>$50k,102454.0,14452.7344,29.5,white,55.0,1,1,0,no,0.5,0.4,no dnr,28.0,58.0,19.3984375,115.0,8.0,40.0,142.0,2.0,0.29998779,0.79992676,143.0,7.399414,119.0,39.0,1340.0,0.0,no(M2 and SIP pres)
70.612,0,male,0,22,608,Coma,Coma,0,10.0,under $11k,48467.0,28802.6406,24.0,black,34.0,1,0,0,no,0.099999964,0.05,no dnr,22.0,79.0,11.1992188,130.0,25.0,36.19531,333.3,4.1992188,1.19995117,1.39990234,141.0,7.419922,96.0,21.0,2275.0,0.0,adl>=4 (>=5 if sur)
69.771,1,female,0,9,37,Colon Cancer,Cancer,1,13.0,$25-$50k,13072.0,7609.6094,14.0,white,12.0,1,0,0,metastatic,0.5,0.2,no dnr,9.0,105.0,6.19921875,130.0,30.0,36.39844,53.0,2.0,3.89990234,0.59997559,138.0,7.339844,305.0,25.0,239.0,0.0,<2 mo. follow-up
69.08698,1,female,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,180614.0,102454.125,31.0,white,26.0,6,0,0,no,0.799999714,0.75,dnr after sadm,17.0,112.0,13.0,135.0,24.0,37.0,93.75,3.5,1.59985352,0.69995117,140.0,7.389648,185.0,16.0,4860.0,6.0,<2 mo. follow-up
76.54797,1,male,1,26,26,MOSF w/Malig,ARF/MOSF,0,4.0,under $11k,99145.0,57523.125,24.5,white,25.0,14,0,0,yes,0.799999714,0.7,dnr after sadm,6.0,102.0,6.09960938,55.0,24.0,36.09375,333.3,3.5,3.19970703,0.79992676,135.0,7.419922,331.0,11.0,2502.0,7.0,<2 mo. follow-up
61.45697,1,female,0,13,524,Colon Cancer,Cancer,1,12.0,under $11k,31807.0,19082.6562,24.5,white,10.0,1,0,0,metastatic,0.849999905,0.65,no dnr,13.0,105.0,6.5,110.0,22.0,36.59375,200.0,3.5,0.29998779,0.59997559,141.0,7.289062,122.0,5.0,2502.0,0.0,no(M2 and SIP pres)
43.159,0,male,0,68,607,CHF,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,181664.0,113593.125,13.75,black,25.0,1,0,0,no,0.699999809,0.5,no dnr,68.0,110.0,16.5,112.0,32.0,36.39844,333.3,3.2998047,0.19998169,0.69995117,141.0,7.419922,285.0,32.0,2800.0,0.0,no(M2 and SIP pres)
74.83899,0,female,0,7,606,COPD,COPD/CHF/Cirrhosis,1,14.0,under $11k,13540.0,8456.5469,9.0,white,21.0,1,0,0,no,0.799999714,0.5,no dnr,7.0,68.0,14.2988281,125.0,42.0,39.0,124.48438,2.7998047,0.69995117,0.89990234,138.0,7.429688,106.0,29.0,1525.0,1.0,SIP>=30
59.504,1,male,1,15,15,MOSF w/Malig,ARF/MOSF,3,12.0,$11-$25k,72035.0,43440.6875,29.666656,white,88.0,16,1,0,metastatic,0.5,0.5,dnr after sadm,2.0,0.0,10.5,0.0,0.0,36.0,234.28125,3.5,0.39996338,0.79992676,143.0,7.399414,133.0,17.0,1070.0,3.0,<2 mo. follow-up
81.31995,1,male,0,4,289,Lung Cancer,Cancer,2,12.0,$25-$50k,6434.0,3885.0566,20.0,white,10.0,1,0,0,metastatic,0.799999714,0.4,no dnr,4.0,72.0,10.7988281,85.0,7.0,38.59375,146.65625,3.5,1.01,1.09985352,136.0,7.479492,141.0,48.0,1590.0,0.0,<2 mo. follow-up
40.68698,0,male,0,6,605,CHF,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,8484.0,5322.5312,19.0,black,11.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,105.0,30.5,115.0,32.0,35.59375,66.0,2.0,1.01,5.59960938,137.0,7.239258,259.0,72.0,485.0,0.494751,no(M2 and SIP pres)
58.23999,0,female,0,26,605,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,99840.0,56244.9062,33.75,white,40.0,1,0,0,no,0.799999714,0.512,no dnr,26.0,58.0,2.5,125.0,36.0,40.0,208.5625,3.5,1.09985352,1.29980469,150.0,7.399414,141.0,27.0,2890.0,0.0,no(M2 and SIP pres)
70.97894,0,male,0,6,605,CHF,COPD/CHF/Cirrhosis,3,0.0,under $11k,4417.0,3228.3809,12.0,black,24.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,96.0,10.0,72.0,16.0,36.79688,225.90625,3.5,0.69995117,0.69995117,139.0,7.389648,100.0,5.0,2502.0,0.0,no(M2 and SIP pres)
82.54895,1,female,1,9,9,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,12084.0,7861.2812,12.0,white,40.0,1,0,0,yes,0.049999982,0.05,dnr after sadm,2.0,102.0,7.69921875,125.0,40.0,37.79688,328.5625,3.5,1.01,0.69995117,137.0,7.369141,228.0,26.0,1770.0,0.0,<2 mo. follow-up
64.80194,1,female,0,24,560,MOSF w/Malig,ARF/MOSF,2,15.0,under $11k,106845.0,64932.3125,13.333328,white,63.0,34,0,0,yes,0.699999809,0.6,no dnr,24.0,65.0,15.1992188,125.0,14.0,39.5,132.5,2.0,2.09960938,1.29980469,136.0,7.389648,81.0,12.0,1750.0,3.0,adl>=4 (>=5 if sur)
70.07794,1,male,0,4,83,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,59995.78781114967,2366.9219,9.0,white,32.0,1,0,0,no,0.699999809,0.7,no dnr,4.0,100.0,1.29980469,104.0,22.0,38.39844,364.0,3.5,0.5,0.89990234,137.0,7.399414,101.0,10.0,1775.0,7.0,<2 mo. follow-up
72.12,1,male,1,31,31,MOSF w/Malig,ARF/MOSF,1,7.0,$25-$50k,172847.0,98894.1875,42.0,black,69.0,4,0,0,metastatic,0.299999952,0.3,dnr after sadm,23.0,113.0,26.5,115.0,9.0,36.5,275.0,3.5,2.69970703,6.5,125.0,7.399414,354.0,108.0,533.0,0.0,<2 mo. follow-up
59.00598,1,male,0,11,413,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,>$50k,51587.0,31702.0469,42.5,other,69.0,2,1,0,no,0.799999714,0.75,no dnr,11.0,58.0,10.3984375,75.0,16.0,35.09375,123.32812,2.0996094,0.59997559,5.0,133.0,7.419922,216.0,98.0,625.0,6.0,<2 mo. follow-up
72.65997,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,2.0,under $11k,24193.0,16319.5625,46.0,white,70.0,2,0,0,no,0.049999982,0.0,dnr after sadm,2.0,96.0,6.39941406,97.0,20.0,36.59375,476.1875,3.2998047,0.89990234,0.89990234,137.0,7.5,93.0,10.0,900.0,1.8234863,<2 mo. follow-up
63.48798,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,55969.0,32768.0938,36.0,black,104.0,8,0,0,no,0.099999964,0.5,dnr after sadm,5.0,130.0,7.29980469,130.0,30.0,39.79688,296.625,3.5,1.01,1.89990234,130.0,7.399414,206.0,26.0,2555.0,5.0,<2 mo. follow-up
55.50699,0,male,0,3,599,CHF,COPD/CHF/Cirrhosis,3,18.0,under $11k,3751.0,2599.6055,6.0,white,20.0,1,0,0,no,0.849999905,0.8,no dnr,3.0,0.0,21.0976562,0.0,0.0,36.29688,53.32812,1.2998047,17.5976562,3.69970703,147.0,7.289062,7.0,11.0,0.0,0.494751,no(M2 and SIP pres)
60.82999,0,male,0,38,599,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,$25-$50k,59995.78781114967,55461.4062,24.5,white,41.0,4,0,0,no,0.899999619,0.9,no dnr,38.0,76.0,5.09960938,88.0,28.0,36.79688,333.3,3.5,1.5,0.59997559,127.0,7.419922,184.0,9.0,2502.0,0.0,adl>=4 (>=5 if sur)
79.65796,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,115444.0,62643.2812,46.0,white,84.0,10,0,0,no,0.299999952,0.2,dnr after sadm,4.0,108.0,7.39941406,125.0,0.0,38.5,183.65625,3.8999023,2.69970703,1.79980469,140.0,7.5,199.0,22.0,3850.0,0.0,<2 mo. follow-up
33.75198,1,female,0,21,47,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$25-$50k,176006.0,96187.125,34.333313,white,85.0,49,1,0,no,0.899999619,0.85,no dnr,21.0,72.0,7.69921875,115.0,20.0,37.79688,233.3125,3.5,1.01,0.89990234,144.0,7.339844,133.0,24.0,2502.0,6.0,<2 mo. follow-up
68.07397,1,male,0,27,36,Cirrhosis,COPD/CHF/Cirrhosis,3,20.0,>$50k,83878.0,52124.8438,21.5,white,56.0,15,0,0,metastatic,0.5,0.15,dnr after sadm,6.0,82.0,4.5,60.0,24.0,36.59375,333.3,3.5,0.39996338,1.0,140.0,7.419922,98.0,12.0,2502.0,3.1816406,<2 mo. follow-up
48.33698,0,male,0,4,597,Lung Cancer,Cancer,2,13.0,under $11k,7371.0,4496.9922,17.0,black,12.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,73.0,11.7988281,75.0,22.0,36.19531,390.4375,3.5,0.39996338,1.29980469,136.0,7.479492,66.0,19.0,2000.0,1.8444824,SIP>=30
66.784,1,male,0,4,155,Lung Cancer,Cancer,3,13.0,>$50k,6887.0,3874.1602,13.0,white,14.0,1,1,0,metastatic,0.699999809,0.5,no dnr,4.0,65.0,10.7988281,125.0,29.0,36.29688,114.28125,1.6999512,0.29998779,9.09960938,133.0,7.389648,108.0,66.0,220.0,2.1689453,SIP>=30
47.702,1,male,0,7,543,Cirrhosis,COPD/CHF/Cirrhosis,3,4.0,under $11k,5262.0,3858.5606,2.5,white,24.0,1,1,0,no,0.899999619,0.85,no dnr,7.0,125.0,22.5,115.0,36.0,38.0,190.0,3.5,2.5,0.69995117,142.0,7.389648,107.0,19.0,3215.0,1.8388672,adl>=4 (>=5 if sur)
68.80499,0,male,0,5,595,Lung Cancer,Cancer,3,12.0,$11-$25k,7790.0,4193.7852,14.0,white,9.0,1,1,0,metastatic,1.0,0.9,no dnr,5.0,65.0,22.8984375,115.0,35.0,35.79688,47.0,2.199707,2.09960938,4.89941406,146.0,7.179688,224.0,114.0,224.0,2.1796875,no(M2 and SIP pres)
75.31799,1,male,0,18,19,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,13355.0,9905.4141,8.666664,white,30.0,1,1,0,no,0.699999809,0.5,dnr after sadm,10.0,75.0,10.5,100.0,22.0,36.0,333.3,3.5,0.89990234,0.79992676,134.0,7.419922,330.0,17.0,3300.0,3.402832,<2 mo. follow-up
72.96594,1,male,0,17,236,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,117270.0,66003.5625,19.333328,hispanic,43.0,27,0,0,no,0.699999809,0.5,no dnr,17.0,127.0,11.5,125.0,10.0,38.69531,118.32812,3.5,1.01,1.09985352,134.0,7.429688,168.0,16.0,2495.0,0.0,no(M2 and SIP pres)
73.37396,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,11001.0,7667.4492,14.0,white,30.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,77.0,5.09960938,80.0,20.0,35.89844,333.3,3.5,1.01,0.69995117,137.0,7.419922,93.0,6.0,3200.0,1.1667481,<2 mo. follow-up
71.58698,1,male,0,12,78,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,36480.0,22031.25,20.5,black,44.0,3,0,0,no,0.699999809,0.5,no dnr,12.0,69.0,5.39941406,50.0,16.0,37.69531,333.3,3.5,0.5,0.79992676,138.0,7.419922,75.0,6.0,1400.0,6.0,<2 mo. follow-up
58.06198,0,male,0,3,592,CHF,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,59995.78781114967,14452.7344,9.0,black,17.0,1,0,0,no,0.849999905,0.8,no dnr,3.0,138.0,11.6992188,145.0,0.0,38.19531,190.0,3.5,0.59997559,0.69995117,143.0,7.459961,101.0,14.0,1680.0,0.0,<2 mo. follow-up
61.32199,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,81430.0,45189.9688,47.0,black,55.0,8,1,0,no,0.399999857,0.3,dnr after sadm,5.0,67.0,6.29980469,119.0,28.0,38.89844,333.3,2.5,5.59960938,0.79992676,137.0,7.419922,80.0,5.0,2502.0,2.1245117,<2 mo. follow-up
26.355,0,male,0,27,591,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,59995.78781114967,41310.8438,9.25,white,28.0,8,0,0,no,1.0,1.0,no dnr,27.0,75.0,11.5,78.0,14.0,36.5,328.0,3.0996094,0.5,5.5,130.0,7.349609,404.0,31.0,20.0,0.0,no(M2 and SIP pres)
63.30499,0,female,0,12,590,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,50617.0,27886.4531,35.5,white,28.0,3,0,0,no,0.799999714,0.75,no dnr,12.0,50.0,5.79980469,165.0,28.0,36.39844,116.65625,2.0,1.01,3.5,133.0,7.299805,322.0,74.0,45.0,5.0,no(M2 and SIP pres)
58.056,1,female,1,7,7,Lung Cancer,Cancer,1,12.0,$25-$50k,6012.0,3815.5801,8.0,white,23.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,2.0,157.0,12.8984375,135.0,32.0,38.09375,333.3,3.5,1.01,0.69995117,141.0,7.419922,498.0,4.0,1405.0,3.0,<2 mo. follow-up
34.54898,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,21703.0,13767.3281,36.0,other,58.0,1,0,0,no,0.399999857,0.35,dnr after sadm,4.0,117.0,10.3984375,105.0,28.0,36.39844,138.75,3.5,0.5,1.39990234,136.0,7.459961,142.0,36.0,3280.0,0.0,<2 mo. follow-up
69.74097,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,24106.0,14195.3359,24.0,black,65.0,1,0,0,no,0.299999952,0.2,dnr after sadm,8.0,112.0,25.796875,80.0,14.0,36.5,200.0,3.5,1.01,1.89990234,141.0,7.30957,196.0,32.0,2210.0,7.0,<2 mo. follow-up
68.10394,1,male,0,5,273,Lung Cancer,Cancer,1,12.0,under $11k,10815.0,5907.2461,13.0,white,5.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,122.0,8.5,105.0,25.0,37.59375,220.0,2.7998047,0.39996338,1.29980469,136.0,7.299805,187.0,27.0,1330.0,0.494751,no(M2 and SIP pres)
62.51099,0,female,0,5,590,Lung Cancer,Cancer,2,12.0,$25-$50k,12801.0,6578.5117,11.0,white,12.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,72.0,3.89990234,68.0,20.0,35.79688,333.3,4.0,0.59997559,0.79992676,138.0,7.419922,191.0,23.0,4475.0,0.0,no(M2 and SIP pres)
45.32498,1,female,0,25,512,Coma,Coma,1,12.0,under $11k,55698.0,14452.7344,22.5,black,20.0,1,0,0,no,0.799999714,0.78,no dnr,25.0,65.0,7.09960938,128.0,32.0,36.79688,238.09375,2.7998047,0.29998779,0.69995117,139.0,7.449219,223.0,16.0,1520.0,0.0,<2 mo. follow-up
62.38199,1,male,0,13,44,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,26571.0,18846.5781,19.5,white,31.0,1,0,0,no,0.599999905,0.4,no dnr,13.0,38.0,15.2988281,150.0,24.0,35.69531,333.3,3.5,1.01,0.79992676,135.0,7.419922,111.0,28.0,915.0,0.494751,<2 mo. follow-up
41.93799,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,25122.0,15689.3438,25.0,white,68.0,2,0,0,no,0.699999809,0.5,dnr after sadm,2.0,62.0,17.296875,125.0,26.0,38.0,362.0,3.5,0.29998779,2.0,136.0,7.439453,286.0,35.0,3140.0,2.2495117,<2 mo. follow-up
38.91599,1,female,0,10,395,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,15182.0,10071.1641,14.5,black,28.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,115.0,31.296875,145.0,31.0,36.59375,246.65625,2.5,0.89990234,0.39996338,131.0,7.40918,89.0,5.0,6820.0,5.0,adl>=4 (>=5 if sur)
26.883,0,male,0,16,588,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,51208.0,29285.9688,16.666656,black,24.0,2,0,0,no,0.989999771,0.99,no dnr,16.0,95.0,30.1992188,145.0,24.0,38.5,236.0,2.3999023,0.69995117,1.29980469,137.0,7.399414,94.0,8.0,2250.0,0.0,no(M2 and SIP pres)
64.59698,0,female,0,47,588,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,$11-$25k,150749.0,84257.9375,33.25,white,34.0,5,0,0,no,0.5,0.35,dnr after sadm,13.0,119.0,13.1992188,130.0,6.0,35.59375,340.0,2.2998047,5.5,0.89990234,137.0,7.469727,324.0,38.0,1335.0,1.0,<2 mo. follow-up
57.547,0,male,0,11,588,Colon Cancer,Cancer,1,16.0,>$50k,24415.0,13932.5469,7.5,white,14.0,1,0,0,metastatic,1.0,0.8,no dnr,11.0,108.0,11.5,125.0,30.0,38.0,250.0,3.5,1.01,0.89990234,142.0,7.449219,148.0,28.0,1175.0,0.0,no(M2 and SIP pres)
57.74899,1,male,1,9,9,Lung Cancer,Cancer,1,14.0,>$50k,9471.0,5769.2539,12.0,white,22.0,1,0,0,metastatic,0.399999857,0.1,dnr after sadm,4.0,109.0,8.5,84.0,16.0,36.79688,333.3,3.5,0.39996338,0.79992676,134.0,7.419922,69.0,6.0,4300.0,1.0,<2 mo. follow-up
72.59698,1,male,0,46,136,MOSF w/Malig,ARF/MOSF,2,8.0,$25-$50k,114631.0,14452.7344,21.5,white,103.0,18,1,0,yes,0.799999714,0.5,no dnr,46.0,128.0,10.7988281,115.0,12.0,36.89844,292.5,3.199707,1.69995117,0.59997559,146.0,7.40918,279.0,24.0,4000.0,1.0,adl>=4 (>=5 if sur)
70.125,1,female,0,22,366,MOSF w/Malig,ARF/MOSF,2,13.0,under $11k,89992.0,14452.7344,40.666657,black,63.0,2,1,0,metastatic,0.699999809,0.4,no dnr,22.0,62.0,13.8984375,70.0,32.0,36.39844,155.0,3.5,1.01,0.69995117,132.0,7.449219,85.0,19.0,2980.0,0.0,no(M2 and SIP pres)
46.612,1,female,0,38,140,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,139684.0,14452.7344,31.0,white,62.0,7,0,0,metastatic,0.799999714,0.6,no dnr,38.0,105.0,3.59960938,100.0,24.0,37.5,333.3,3.5,0.29998779,1.0,143.0,7.419922,93.0,11.0,2400.0,0.0,<2 mo. follow-up
42.56799,1,female,0,47,53,MOSF w/Malig,ARF/MOSF,2,15.0,$11-$25k,90541.0,54508.6875,16.25,black,40.0,1,0,0,yes,1.0,1.0,no dnr,47.0,63.0,4.89941406,105.0,24.0,35.89844,333.3,3.5,3.69970703,1.19995117,137.0,7.419922,113.0,34.0,2502.0,0.0,<2 mo. follow-up
41.60699,0,male,0,32,587,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59995.78781114967,14452.7344,20.5,white,88.0,16,0,0,yes,0.75,0.75,no dnr,32.0,73.0,8.09960938,114.0,28.0,36.5,291.375,3.8999023,0.59997559,0.5,139.0,7.319336,80.0,9.0,2050.0,2.0,no(M2 and SIP pres)
48.71698,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,64982.0,36829.125,46.0,black,54.0,3,0,0,no,0.399999857,0.2,dnr after sadm,8.0,68.0,11.1992188,65.0,10.0,35.29688,395.1875,2.0996094,13.6992188,6.89941406,142.0,7.339844,231.0,120.0,160.0,1.0,<2 mo. follow-up
43.00598,1,male,0,12,147,MOSF w/Malig,ARF/MOSF,1,9.0,$25-$50k,35825.0,22253.6562,17.5,white,64.0,6,0,0,yes,0.699999809,0.5,no dnr,12.0,99.0,10.7988281,72.0,20.0,37.39844,333.3,2.699707,0.39996338,1.19995117,128.0,7.419922,102.0,17.0,6150.0,0.0,no(M2 and SIP pres)
82.52399,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,$25-$50k,35284.0,21131.6719,31.5,black,38.0,1,0,1,no,0.399999857,0.3,no dnr,12.0,73.0,6.69921875,76.0,20.0,36.09375,333.3,3.7998047,1.29980469,1.29980469,136.0,7.419922,86.0,16.0,2300.0,4.921875,<2 mo. follow-up
44.57199,0,female,0,14,584,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,53322.0,33376.5625,27.333328,white,36.0,1,0,0,no,0.699999809,0.6,no dnr,14.0,63.0,16.6992188,115.0,22.0,37.69531,157.125,1.8999023,4.69921875,0.39996338,135.0,7.439453,100.0,13.0,2675.0,1.0,SIP>=30
69.72998,0,male,0,14,584,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,51703.0,29591.9531,14.666664,white,33.0,1,0,0,yes,0.949999809,0.93,no dnr,14.0,52.0,8.0,65.0,24.0,36.19531,333.3,3.699707,1.0,1.0,135.0,7.419922,114.0,11.0,1950.0,2.7675781,<2 mo. follow-up
53.72998,1,female,0,4,492,Lung Cancer,Cancer,1,12.0,under $11k,59995.78781114967,2964.75,13.0,black,15.0,1,0,0,metastatic,0.799999714,0.6,no dnr,4.0,97.0,13.0996094,106.0,32.0,36.59375,133.3125,3.5,1.01,1.0,135.0,7.289062,159.0,40.0,1200.0,1.9628906,no(M2 and SIP pres)
68.91699,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,87973.0,46006.25,33.0,white,59.0,14,0,0,no,0.25,0.5,dnr after sadm,7.0,123.0,1.5,185.0,26.0,38.0,280.0,3.5,2.5,1.0,141.0,7.459961,136.0,40.0,1220.0,3.0893555,<2 mo. follow-up
68.211,1,male,0,56,72,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,120387.0,74504.75,18.5,white,30.0,1,1,0,no,0.799999714,0.8,dnr after sadm,41.0,70.0,13.6992188,70.0,22.0,36.19531,153.3125,3.5,1.01,0.89990234,140.0,7.439453,102.0,21.0,2502.0,2.6601562,<2 mo. follow-up
78.79297,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,77543.0,46027.3438,14.5,black,72.0,15,1,0,yes,0.199999928,0.1,dnr after sadm,2.0,70.0,3.09960938,115.0,42.0,38.19531,157.5,3.5,1.01,3.0,133.0,7.5,115.0,66.0,680.0,3.0620117,<2 mo. follow-up
58.86099,1,male,0,4,223,Lung Cancer,Cancer,2,10.0,$25-$50k,6491.0,3419.3613,9.0,white,19.0,1,0,0,metastatic,0.899999619,0.7,no dnr,4.0,105.0,2.19970703,135.0,32.0,38.29688,280.0,3.5,1.5,4.79980469,127.0,7.30957,446.0,102.0,282.0,0.0,no(M2 and SIP pres)
61.19598,0,female,0,29,582,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$25-$50k,59995.78781114967,39673.9688,15.5,black,47.0,1,1,0,no,0.699999809,0.7,no dnr,29.0,0.0,19.796875,0.0,0.0,38.39844,148.0,2.0996094,1.01,0.5,128.0,7.399414,132.0,10.0,1710.0,0.0,no(M2 and SIP pres)
66.22296,1,male,0,41,204,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,85318.0,52149.25,30.0,black,43.0,1,0,0,no,0.25,0.2,no dnr,41.0,58.0,16.296875,105.0,28.0,36.0,158.0,1.5998535,5.69921875,3.69970703,130.0,7.349609,30.0,35.0,70.0,2.4462891,no(M2 and SIP pres)
49.54999,0,female,0,15,582,Lung Cancer,Cancer,1,12.0,under $11k,11291.0,8300.6562,6.666664,white,8.0,1,0,0,metastatic,0.899999619,0.7,no dnr,15.0,52.0,7.29980469,81.0,24.0,36.59375,333.3,3.5,0.69995117,0.89990234,139.0,7.419922,88.0,12.0,2502.0,0.0,no(M2 and SIP pres)
26.10799,1,female,1,19,19,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,59995.78781114967,32633.625,16.0,black,50.0,10,0,0,metastatic,0.399999857,0.1,dnr after sadm,5.0,155.0,9.29882812,50.0,26.0,35.5,409.5,3.0996094,1.01,1.79980469,147.0,7.459961,139.0,43.0,2195.0,2.7392578,<2 mo. follow-up
61.73898,1,male,1,8,8,Coma,Coma,0,16.0,$25-$50k,28443.0,17677.4062,26.0,white,27.0,1,0,0,no,0.0,0.0,dnr after sadm,5.0,49.0,41.296875,50.0,7.0,38.09375,106.0,3.5,24.796875,3.69970703,135.0,7.399414,299.0,41.0,20.0,0.0,<2 mo. follow-up
69.01599,1,female,1,21,21,Coma,Coma,2,4.0,under $11k,59995.78781114967,23308.2031,19.666656,black,52.0,1,1,0,no,0.0,0.0,dnr after sadm,7.0,78.0,25.0976562,155.0,32.0,38.5,203.3125,2.2998047,0.5,5.59960938,138.0,7.459961,310.0,91.0,0.0,1.0,<2 mo. follow-up
72.66797,1,male,0,4,177,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,59995.78781114967,4063.8418,12.0,white,31.0,1,1,0,no,0.5,0.4,dnr after sadm,2.0,127.0,18.0976562,125.0,29.0,36.0,260.0,2.0,1.09985352,0.79992676,123.0,7.529297,364.0,36.0,1462.0,7.0,adl>=4 (>=5 if sur)
67.461,0,female,0,22,579,Colon Cancer,Cancer,1,12.0,under $11k,59995.78781114967,32987.5625,24.333328,white,26.0,1,0,0,metastatic,0.699999809,0.5,no dnr,22.0,79.0,10.0,74.0,20.0,36.5,333.3,4.0996094,0.59997559,1.0,143.0,7.419922,112.0,9.0,4550.0,0.0,no(M2 and SIP pres)
76.96399,0,male,0,20,577,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,$11-$25k,59995.78781114967,25542.1406,14.0,black,44.0,1,1,0,yes,0.699999809,0.5,no dnr,20.0,73.0,4.5,80.0,24.0,36.19531,333.3,3.699707,0.59997559,1.0,138.0,7.419922,233.0,9.0,3875.0,0.0,<2 mo. follow-up
52.20499,0,female,0,36,577,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,86035.0,53994.6562,25.75,black,49.0,1,0,0,no,0.5,0.5,no dnr,36.0,62.0,7.79980469,70.0,16.0,36.79688,333.3,2.2998047,1.39990234,1.39990234,135.0,7.419922,90.0,17.0,1800.0,0.0,<2 mo. follow-up
67.94495,1,male,0,27,223,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,97439.0,54870.0625,32.25,white,25.0,5,0,0,no,0.5,0.3,dnr after sadm,5.0,107.0,8.69921875,80.0,20.0,37.5,333.3,3.5,0.39996338,1.0,140.0,7.419922,83.0,6.0,2840.0,0.0,adl>=4 (>=5 if sur)
68.99695,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,94104.0,52377.1875,48.0,white,79.0,22,0,0,no,0.799999714,0.8,no dnr,4.0,98.0,6.39941406,65.0,20.0,35.89844,304.75,3.5,0.69995117,3.79980469,139.0,7.419922,88.0,115.0,2575.0,2.2871094,<2 mo. follow-up
89.82098,0,female,0,19,577,Coma,Coma,1,12.0,under $11k,59995.78781114967,14452.7344,11.333328,black,12.0,1,0,0,no,0.599999905,0.6,dnr after sadm,1.0,115.0,1.79980469,75.0,29.0,35.39844,160.0,2.8999023,0.89990234,1.5,134.0,7.439453,110.0,43.0,5860.0,1.0,adl>=4 (>=5 if sur)
63.159,1,male,1,17,17,Coma,Coma,0,7.0,under $11k,59995.78781114967,57245.75,42.666657,black,41.0,3,0,0,no,0.199999928,0.2,dnr after sadm,17.0,112.0,19.0,0.0,28.0,36.5,352.375,4.0996094,0.39996338,1.09985352,138.0,7.429688,171.0,22.0,2790.0,6.0,<2 mo. follow-up
72.81897,1,male,0,7,73,Lung Cancer,Cancer,1,20.0,>$50k,6116.0,4265.1016,5.5,white,18.0,1,0,0,metastatic,0.799999714,0.6,dnr after sadm,2.0,120.0,40.0,115.0,26.0,35.19531,360.0,1.8999023,1.0,1.19995117,137.0,7.389648,111.0,13.0,2405.0,2.0,adl>=4 (>=5 if sur)
43.34598,1,female,0,5,403,Lung Cancer,Cancer,1,14.0,>$50k,12808.0,6627.9453,12.0,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,5.0,90.0,6.19921875,64.0,20.0,36.59375,130.0,3.5,1.01,1.79980469,138.0,7.389648,109.0,28.0,4315.0,0.494751,no(M2 and SIP pres)
80.58295,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,59995.78781114967,21836.2969,21.0,white,27.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,125.0,13.5996094,145.0,20.0,39.5,86.14062,3.0996094,0.59997559,1.79980469,155.0,7.319336,210.0,46.0,2920.0,2.7485352,<2 mo. follow-up
42.24197,1,male,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,59995.78781114967,14452.7344,40.666657,black,83.0,2,0,0,no,0.299999952,0.25,dnr after sadm,16.0,63.0,9.0,70.0,32.0,37.89844,196.65625,2.0,1.01,0.79992676,135.0,7.399414,103.0,8.0,4150.0,0.0,<2 mo. follow-up
66.82794,1,female,0,115,244,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,445984.0,14452.7344,41.0,white,79.0,20,0,0,no,0.5,0.4,no dnr,115.0,58.0,5.89941406,60.0,22.0,36.09375,136.71875,3.5,1.01,1.0,138.0,7.349609,100.0,13.0,1760.0,2.1435547,Coma or Intub
70.69397,1,female,1,19,19,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,45.666657,white,45.0,2,0,0,yes,0.899999619,0.8,dnr after sadm,10.0,78.0,12.1992188,78.0,24.0,36.5,333.3,3.5,0.29998779,1.0,141.0,7.419922,112.0,24.0,1150.0,0.0,<2 mo. follow-up
65.71698,0,male,0,6,575,Cirrhosis,COPD/CHF/Cirrhosis,1,11.0,under $11k,6897.0,4673.8594,9.0,black,41.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,30.0,10.3984375,180.0,33.0,36.09375,350.0,2.5996094,0.19998169,0.59997559,120.0,7.55957,224.0,4.0,7360.0,0.0,no(M2 and SIP pres)
64.07397,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,280170.0,158999.875,40.5,white,60.0,53,0,0,no,0.099999964,0.1,dnr after sadm,7.0,50.0,24.8984375,115.0,27.0,35.79688,438.0625,3.5,0.5,5.19921875,147.0,7.429688,272.0,41.0,705.0,2.1625977,<2 mo. follow-up
74.20898,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,$11-$25k,59995.78781114967,14452.7344,54.0,white,70.0,19,0,0,no,0.199999928,0.2,no dnr,12.0,99.0,7.5,70.0,16.0,36.19531,333.3,3.5996094,0.69995117,1.19995117,139.0,7.419922,91.0,8.0,2525.0,2.2539062,<2 mo. follow-up
67.896,1,male,0,9,92,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,59995.78781114967,13553.0,24.5,white,45.0,1,1,0,no,0.5,0.5,no dnr,9.0,113.0,9.69921875,95.0,16.0,35.79688,333.3,4.0,0.59997559,0.79992676,138.0,7.419922,92.0,7.0,6600.0,0.0,adl>=4 (>=5 if sur)
61.77698,0,female,0,16,573,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,86438.0,48095.8125,28.333328,white,27.0,2,0,0,no,0.699999809,0.5,no dnr,16.0,110.0,22.6992188,110.0,8.0,38.39844,185.6875,3.5,0.59997559,1.09985352,131.0,7.449219,164.0,14.0,2700.0,0.0,no(M2 and SIP pres)
68.99896,1,male,0,4,474,COPD,COPD/CHF/Cirrhosis,5,3.0,under $11k,7860.0,5247.0859,14.0,black,29.0,1,1,0,no,0.599999905,0.4,no dnr,4.0,65.0,8.19921875,65.0,23.0,37.0,138.75,3.5,5.59960938,0.89990234,139.0,7.489258,121.0,23.0,4140.0,3.0,adl>=4 (>=5 if sur)
28.75299,0,female,0,9,572,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,59995.78781114967,14452.7344,14.0,white,17.0,1,0,0,no,1.0,1.0,no dnr,9.0,25.0,14.5996094,0.0,12.0,37.39844,368.0,2.5,19.5,1.5,150.0,7.419922,85.0,25.0,2305.0,3.2045898,<2 mo. follow-up
75.99695,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,1,8.0,$11-$25k,59995.78781114967,38309.9688,46.0,white,60.0,14,0,0,metastatic,0.049999982,0.0,dnr after sadm,1.0,82.0,24.6992188,105.0,12.0,36.0,333.3,3.5,0.09999084,1.29980469,134.0,7.419922,84.0,28.0,1460.0,7.0,<2 mo. follow-up
47.80298,1,male,0,4,114,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,59995.78781114967,2903.2246,9.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,110.0,12.0,115.0,38.0,38.5,148.96875,3.5,1.01,1.0,136.0,7.389648,103.0,6.0,4450.0,1.1667481,adl>=4 (>=5 if sur)
53.47299,0,female,0,7,570,Lung Cancer,Cancer,2,16.0,>$50k,59995.78781114967,7263.5156,7.5,white,2.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,75.0,9.69921875,70.0,24.0,37.79688,256.625,3.5,1.01,1.59985352,147.0,7.459961,136.0,38.0,3400.0,1.0,no(M2 and SIP pres)
46.90198,1,male,1,21,21,MOSF w/Malig,ARF/MOSF,3,11.0,under $11k,36932.0,24180.2188,19.333328,black,63.0,1,0,0,yes,0.699999809,0.5,no dnr,21.0,72.0,9.79882812,75.0,24.0,38.39844,385.6875,3.5,0.59997559,1.29980469,137.0,7.389648,111.0,12.0,1120.0,7.0,<2 mo. follow-up
84.60199,1,female,0,14,199,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,59995.78781114967,17063.7344,19.0,white,53.0,1,0,0,no,0.5,0.45,no dnr,14.0,118.0,46.8984375,96.0,26.0,36.5,333.3,3.199707,0.5,1.19995117,129.0,7.419922,80.0,16.0,2870.0,0.0,<2 mo. follow-up
64.48999,0,female,0,16,569,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,59995.78781114967,22021.2812,22.666656,white,47.0,1,0,0,yes,0.5,0.5,no dnr,16.0,142.0,0.09999084,160.0,28.0,34.59375,436.0,1.5,2.0,1.5,140.0,7.489258,333.0,34.0,1345.0,0.0,no(M2 and SIP pres)
54.81497,1,male,0,5,307,Lung Cancer,Cancer,1,16.0,>$50k,59995.78781114967,6166.4492,12.0,white,11.0,1,0,0,metastatic,1.0,0.8,no dnr,5.0,62.0,5.19921875,135.0,40.0,38.5,103.32812,1.5,1.01,1.69995117,143.0,7.329102,160.0,26.0,1955.0,1.8615723,<2 mo. follow-up
47.35397,1,female,0,21,271,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,54872.0,32157.9219,29.0,white,50.0,4,1,0,no,0.5,0.5,no dnr,21.0,60.0,12.1992188,120.0,31.0,39.5,115.0,1.6999512,1.09985352,0.79992676,145.0,7.519531,295.0,21.0,2570.0,1.0,SIP>=30
38.70798,1,male,0,65,170,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,262777.0,14452.7344,26.75,white,73.0,10,1,0,no,0.949999809,0.95,no dnr,65.0,97.0,52.296875,104.0,24.0,38.5,223.78125,3.199707,4.69921875,0.5,134.0,7.469727,212.0,13.0,3050.0,2.0,SIP>=30
55.25299,0,male,0,4,568,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,59995.78781114967,2724.9902,10.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,107.0,22.6992188,175.0,11.0,37.89844,226.65625,2.2998047,19.3984375,6.69921875,132.0,7.399414,167.0,99.0,105.0,2.0629883,<2 mo. follow-up
76.18896,0,male,0,4,568,COPD,COPD/CHF/Cirrhosis,4,6.0,under $11k,59995.78781114967,3370.7441,7.0,black,21.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,40.0,15.7988281,135.0,18.0,38.39844,88.5625,2.199707,5.59960938,1.89990234,137.0,7.389648,175.0,15.0,3735.0,0.494751,no(M2 and SIP pres)
58.97897,1,male,0,18,492,Colon Cancer,Cancer,1,16.0,>$50k,30679.0,18150.0938,8.666664,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,18.0,55.0,1.29980469,125.0,36.0,36.29688,200.0,3.5,1.29980469,0.69995117,145.0,7.359375,204.0,30.0,3415.0,0.0,no(M2 and SIP pres)
71.16998,1,female,0,18,440,MOSF w/Malig,ARF/MOSF,1,15.0,$25-$50k,32147.0,14452.7344,19.666656,white,33.0,3,0,0,metastatic,0.799999714,0.6,dnr after sadm,3.0,138.0,22.5,110.0,40.0,36.39844,242.84375,2.5,0.39996338,0.39996338,123.0,7.429688,147.0,13.0,1980.0,0.0,no(M2 and SIP pres)
76.02698,0,male,0,20,567,MOSF w/Malig,ARF/MOSF,1,20.0,under $11k,28544.0,18567.6094,13.666664,black,41.0,1,0,0,metastatic,0.5,0.4,dnr before sadm,-1.0,123.0,12.1992188,55.0,26.0,35.89844,212.5,3.8999023,0.59997559,3.5,143.0,7.369141,186.0,65.0,3010.0,3.0,adl>=4 (>=5 if sur)
59.29099,1,female,1,46,46,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,under $11k,191462.0,14452.7344,39.0,white,69.0,1,1,0,no,0.699999809,0.7,dnr after sadm,43.0,73.0,6.69921875,115.0,26.0,35.5,307.375,3.2998047,0.59997559,0.79992676,134.0,7.459961,294.0,16.0,1700.0,1.0,<2 mo. follow-up
71.47998,0,male,0,10,565,Colon Cancer,Cancer,1,12.0,under $11k,59995.78781114967,12923.5781,23.0,white,27.0,1,0,0,metastatic,0.699999809,0.5,no dnr,10.0,105.0,2.39990234,97.0,18.0,38.09375,400.0,3.5,1.01,0.89990234,135.0,7.5,103.0,9.0,2502.0,2.0,no(M2 and SIP pres)
69.59094,0,male,0,49,565,Coma,Coma,0,12.0,under $11k,97424.0,14452.7344,27.0,black,19.0,2,0,0,no,0.699999809,0.6,no dnr,49.0,50.0,16.5,105.0,22.0,38.59375,224.0,3.5,1.01,4.0,129.0,7.429688,116.0,76.0,370.0,0.0,SIP>=30
64.93396,0,female,0,9,565,Colon Cancer,Cancer,1,28.0,>$50k,59995.78781114967,11891.6328,21.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,120.0,8.0,115.0,7.0,36.5,213.3125,2.3999023,0.29998779,0.59997559,135.0,7.439453,252.0,15.0,3820.0,0.0,no(M2 and SIP pres)
39.52597,1,female,0,39,119,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,128410.0,76735.625,34.75,white,86.0,1,0,0,yes,0.699999809,0.5,no dnr,39.0,62.0,7.0,84.0,2.0,36.59375,240.0,3.5,3.69970703,2.89990234,131.0,7.329102,86.0,48.0,234.0,0.0,SIP>=30
72.64099,1,male,0,10,389,Colon Cancer,Cancer,1,14.0,$25-$50k,59995.78781114967,13854.9609,21.5,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,10.0,63.0,5.59960938,64.0,20.0,36.5,333.3,3.7998047,0.29998779,11.0,140.0,7.419922,112.0,11.0,3285.0,0.0,no(M2 and SIP pres)
80.008,1,male,0,16,477,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,18096.0,11917.1875,17.0,white,32.0,1,0,0,no,0.5,0.3,dnr after sadm,4.0,68.0,20.0976562,70.0,29.0,35.59375,394.25,2.699707,1.59985352,2.39990234,137.0,7.349609,212.0,49.0,790.0,6.0,SIP>=30
77.76294,0,female,0,9,564,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,59995.78781114967,5457.9023,11.0,white,45.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,65.0,46.296875,80.0,32.0,38.29688,265.0,3.199707,0.69995117,1.5,133.0,7.429688,95.0,24.0,1680.0,0.494751,<2 mo. follow-up
84.435,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,59995.78781114967,14452.7344,31.0,white,80.0,60,0,1,no,0.699999809,0.5,dnr after sadm,4.0,73.0,7.39941406,80.0,20.0,36.59375,333.3,3.5,0.59997559,0.89990234,140.0,7.419922,92.0,14.0,2080.0,0.0,<2 mo. follow-up
79.71497,1,male,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,under $11k,153976.0,88431.3125,45.25,white,32.0,5,1,0,no,0.799999714,0.6,dnr after sadm,35.0,98.0,16.1992188,119.0,36.0,37.89844,280.9375,1.3999023,1.01,1.29980469,146.0,7.389648,84.0,30.0,1042.0,2.2841797,<2 mo. follow-up
28.142,0,male,0,152,562,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,660091.0,14452.7344,55.75,other,81.0,1,0,0,no,0.049999982,0.05,no dnr,152.0,133.0,19.296875,115.0,22.0,39.0,362.8125,3.5,1.01,1.19995117,151.0,7.529297,134.0,24.0,2232.0,0.0,adl>=4 (>=5 if sur)
66.70496,1,female,1,4,4,Coma,Coma,1,12.0,under $11k,59995.78781114967,8884.0078,25.0,black,53.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,132.0,11.6992188,65.0,0.0,36.09375,400.0,3.5,1.01,6.09960938,140.0,7.399414,90.0,75.0,1000.0,0.0,<2 mo. follow-up
44.85699,0,male,0,31,561,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,121495.0,75694.625,21.5,white,28.0,5,0,0,no,0.5,0.45,no dnr,31.0,52.0,17.296875,55.0,18.0,35.79688,91.65625,3.5,1.29980469,1.19995117,134.0,7.279297,73.0,14.0,4400.0,0.0,no(M2 and SIP pres)
81.24298,1,male,0,53,72,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,144170.0,86758.1875,30.0,white,35.0,5,0,0,yes,0.099999964,0.05,no dnr,53.0,105.0,3.5,65.0,10.0,34.79688,253.3125,2.199707,0.59997559,1.09985352,140.0,7.40918,207.0,15.0,2502.0,0.0,<2 mo. follow-up
39.034,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59995.78781114967,15246.4141,29.5,black,54.0,1,1,0,no,0.199999928,0.2,dnr after sadm,6.0,82.0,13.7988281,75.0,20.0,36.0,167.34375,3.5,1.01,3.69970703,142.0,7.429688,185.0,69.0,200.0,3.5083008,<2 mo. follow-up
69.08997,1,male,1,15,15,COPD,COPD/CHF/Cirrhosis,2,3.0,under $11k,62341.0,36025.25,32.666657,black,25.0,1,1,0,no,0.699999809,0.7,dnr after sadm,14.0,55.0,12.5,125.0,0.0,38.09375,340.0,2.0996094,0.69995117,0.89990234,137.0,7.379883,154.0,11.0,3330.0,0.0,<2 mo. follow-up
74.53296,1,female,1,3,3,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,16283.0,9550.2188,43.0,white,73.0,1,0,0,yes,0.049999982,0.02,dnr after sadm,2.0,105.0,9.0,70.0,8.0,36.09375,193.3125,3.5,1.01,1.19995117,132.0,7.40918,228.0,31.0,2390.0,0.0,<2 mo. follow-up
67.64398,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,59995.78781114967,61174.4688,51.0,white,102.0,18,0,0,no,0.099999964,0.05,dnr after sadm,5.0,43.0,29.1992188,120.0,8.0,38.39844,202.0,2.3999023,5.59960938,6.79980469,131.0,7.40918,166.0,96.0,890.0,0.0,<2 mo. follow-up
63.46899,1,male,1,7,7,Lung Cancer,Cancer,3,6.0,under $11k,59995.78781114967,8803.6562,12.0,white,23.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,4.0,123.0,7.39941406,74.0,24.0,36.0,300.0,3.8999023,0.59997559,1.0,145.0,7.40918,96.0,12.0,1100.0,2.7407227,<2 mo. follow-up
33.77399,0,male,0,23,560,Coma,Coma,1,14.0,$25-$50k,83227.0,47545.5938,36.0,white,16.0,2,0,0,no,0.699999809,0.8,no dnr,23.0,82.0,16.5,115.0,34.0,35.69531,195.0,3.5,1.79980469,2.19970703,145.0,7.40918,119.0,29.0,1535.0,4.0,<2 mo. follow-up
71.258,1,male,1,5,5,Coma,Coma,2,11.0,$11-$25k,59995.78781114967,10750.5703,37.0,black,11.0,1,1,0,no,0.099999964,0.05,dnr after sadm,2.0,80.0,10.8984375,112.0,20.0,34.5,333.3,3.2998047,0.5,1.0,138.0,7.419922,108.0,16.0,2502.0,2.3549805,<2 mo. follow-up
59.16998,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59995.78781114967,17679.9531,52.0,black,101.0,7,0,0,yes,0.5,0.2,dnr after sadm,3.0,77.0,7.69921875,68.0,18.0,37.89844,333.3,3.5,1.01,0.69995117,141.0,7.419922,86.0,7.0,4175.0,2.0605469,<2 mo. follow-up
67.70197,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,78431.0,46890.5938,28.0,black,41.0,10,1,0,no,0.699999809,0.6,dnr after sadm,19.0,112.0,9.09960938,105.0,30.0,35.89844,207.5,2.5996094,0.5,1.19995117,142.0,7.399414,145.0,45.0,2755.0,2.3598633,<2 mo. follow-up
22.40099,1,male,1,7,7,Coma,Coma,0,11.0,$11-$25k,28376.0,14452.7344,21.5,black,20.0,1,0,0,no,0.099999964,0.05,dnr after sadm,6.0,40.0,26.296875,65.0,20.0,34.0,118.5625,3.5,0.89990234,3.0,134.0,7.419922,363.0,27.0,12.0,0.0,<2 mo. follow-up
69.65094,1,female,0,28,265,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,43552.0,26990.4688,15.75,white,67.0,1,0,1,yes,0.75,0.65,no dnr,28.0,55.0,10.2988281,160.0,10.0,38.0,217.125,2.5996094,3.69970703,6.79980469,135.0,7.349609,66.0,60.0,25.0,7.0,adl>=4 (>=5 if sur)
54.853,1,female,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$11-$25k,390011.0,229951.75,53.5,white,69.0,7,1,0,no,0.75,0.7,dnr after sadm,33.0,57.0,11.5,125.0,6.0,35.69531,310.0,0.5999756,1.01,0.79992676,132.0,7.389648,78.0,13.0,1005.0,2.0,<2 mo. follow-up
64.33398,0,male,0,15,555,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,28800.0,18037.4062,14.666664,white,35.0,1,0,0,no,0.599999905,0.3,no dnr,15.0,116.0,7.69921875,110.0,28.0,36.79688,333.3,0.8999023,7.59960938,0.89990234,145.0,7.419922,118.0,17.0,2502.0,0.0,no(M2 and SIP pres)
73.40198,1,female,1,10,10,Coma,Coma,0,12.0,under $11k,37878.0,22510.1094,37.5,black,23.0,1,0,0,no,0.199999928,0.1,dnr after sadm,8.0,58.0,7.69921875,105.0,45.0,35.69531,87.14062,2.0,0.39996338,0.39996338,144.0,7.40918,142.0,18.0,1320.0,0.0,<2 mo. follow-up
47.543,1,male,0,4,236,Lung Cancer,Cancer,1,16.0,under $11k,9912.0,4916.1719,15.0,white,12.0,1,0,0,metastatic,0.899999619,0.8,no dnr,4.0,52.0,21.5,100.0,12.0,39.0,78.5625,3.5,4.19921875,3.79980469,136.0,7.369141,261.0,60.0,135.0,0.0,no(M2 and SIP pres)
66.17896,0,male,0,5,553,CHF,COPD/CHF/Cirrhosis,2,3.0,under $11k,3540.0,2554.6914,15.0,black,14.0,1,0,0,no,1.0,1.0,no dnr,5.0,72.0,14.2988281,95.0,29.0,36.79688,98.32812,3.5,1.01,0.79992676,142.0,7.459961,156.0,31.0,765.0,0.494751,no(M2 and SIP pres)
66.90497,1,male,0,14,19,Lung Cancer,Cancer,1,15.0,$25-$50k,20427.0,13461.5547,11.0,white,16.0,1,0,0,metastatic,0.399999857,0.2,no dnr,14.0,75.0,10.3984375,115.0,24.0,37.79688,106.65625,3.5,1.01,0.79992676,134.0,7.419922,114.0,17.0,2410.0,0.494751,<2 mo. follow-up
41.35199,0,male,0,33,551,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,157301.0,87189.4375,32.25,white,44.0,4,0,0,no,0.099999964,0.1,no dnr,33.0,112.0,8.79882812,106.0,20.0,36.79688,103.32812,3.5,1.01,2.39990234,147.0,7.279297,158.0,31.0,2115.0,1.9960938,adl>=4 (>=5 if sur)
61.52798,1,female,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,227499.0,130203.062,47.0,white,39.0,4,0,0,no,0.699999809,0.7,dnr after sadm,35.0,96.0,5.29980469,104.0,30.0,39.29688,172.5,3.5,1.29980469,0.59997559,134.0,7.399414,82.0,11.0,3910.0,1.0,<2 mo. follow-up
59.38898,1,female,0,6,60,Colon Cancer,Cancer,1,12.0,>$50k,5506.0,3822.9062,8.0,hispanic,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,127.0,10.7988281,140.0,35.0,38.59375,172.5,2.5,0.39996338,2.09960938,147.0,7.40918,90.0,57.0,3005.0,0.0,<2 mo. follow-up
56.31198,1,male,0,15,25,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,>$50k,46602.0,30916.0,18.0,white,28.0,1,0,0,no,0.849999905,0.75,no dnr,15.0,76.0,16.296875,100.0,24.0,37.5,333.3,1.8999023,4.59960938,1.29980469,139.0,7.419922,75.0,12.0,980.0,0.0,<2 mo. follow-up
51.63599,1,female,0,77,230,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,456885.0,282560.0,32.75,black,48.0,84,0,0,no,0.649999619,0.5,no dnr,77.0,80.0,5.09960938,72.0,24.0,36.59375,333.3,3.3999023,0.5,0.5,139.0,7.419922,132.0,1.899902,2650.0,0.0,no(M2 and SIP pres)
80.86499,1,female,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,174811.0,98899.875,48.666657,black,51.0,10,0,0,no,0.199999928,0.2,dnr after sadm,17.0,50.0,23.8984375,78.0,12.0,34.79688,383.3125,3.199707,0.39996338,5.59960938,140.0,7.469727,129.0,101.0,0.0,0.0,<2 mo. follow-up
62.52197,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,59995.78781114967,14452.7344,22.610928270087555,white,37.59797891036907,1,1,0,no,0.699999809,0.5,no dnr,14.58258953168044,55.0,13.0996094,110.0,25.0,35.89844,333.3,3.5,1.01,1.79980469,133.0,7.419922,259.0,60.0,3170.0,0.0,<2 mo. follow-up
52.68399,1,male,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,>$50k,367304.0,14452.7344,63.0,white,77.0,1,0,0,no,0.399999857,0.4,no dnr,31.0,72.0,32.09375,115.0,25.0,35.89844,166.65625,2.8999023,1.09985352,0.79992676,143.0,7.429688,221.0,38.0,2530.0,0.0,<2 mo. follow-up
65.01599,0,female,0,13,546,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,33672.0,19349.9219,27.0,black,37.0,1,1,0,no,0.899999619,0.85,no dnr,13.0,79.0,11.0996094,86.0,20.0,37.39844,333.3,3.7998047,0.79992676,0.79992676,137.0,7.419922,109.0,9.0,2502.0,0.0,no(M2 and SIP pres)
40.00299,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,81236.0,14452.7344,30.666656,black,76.0,6,0,0,no,0.5,0.4,no dnr,14.0,55.0,13.2988281,75.0,26.0,36.39844,110.20312,1.6999512,1.01,1.39990234,140.0,7.319336,266.0,26.0,3030.0,6.0,<2 mo. follow-up
43.168,0,male,0,54,547,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,104206.0,63689.6875,18.0,white,32.0,1,0,0,no,0.849999905,0.85,no dnr,54.0,138.0,20.296875,155.0,36.0,38.69531,226.65625,2.699707,8.69921875,1.19995117,145.0,7.519531,226.0,25.0,3645.0,0.0,no(M2 and SIP pres)
70.28094,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,under $11k,68397.0,37768.3125,38.0,white,60.0,15,0,0,no,0.199999928,0.1,dnr after sadm,3.0,83.0,12.3984375,72.0,20.0,36.0,254.53125,3.5,0.89990234,1.5,137.0,7.379883,251.0,37.0,2502.0,7.0,<2 mo. follow-up
63.14899,1,female,0,7,54,Lung Cancer,Cancer,1,12.0,$11-$25k,9809.0,5832.0078,13.0,black,21.0,1,0,0,metastatic,0.599999905,0.3,no dnr,7.0,86.0,13.5996094,80.0,18.0,36.29688,171.40625,3.5,0.69995117,1.0,135.0,7.439453,144.0,19.0,2502.0,3.0,<2 mo. follow-up
66.26099,1,female,0,9,252,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26964.0,16679.6406,16.5,black,51.0,4,1,0,no,0.799999714,0.75,no dnr,9.0,102.0,6.79980469,60.0,16.0,38.0,333.3,3.5,0.59997559,1.29980469,140.0,7.419922,91.0,15.0,2502.0,6.0,<2 mo. follow-up
68.88196,1,male,0,10,334,COPD,COPD/CHF/Cirrhosis,6,7.0,under $11k,21663.0,13114.1641,18.5,white,37.0,1,0,0,no,0.5,0.5,no dnr,10.0,112.0,5.59960938,80.0,10.0,36.89844,292.0,1.3999023,1.19995117,0.59997559,138.0,7.429688,104.0,13.0,1450.0,0.0,no(M2 and SIP pres)
73.79297,1,female,0,10,16,Lung Cancer,Cancer,1,12.0,under $11k,10375.0,6902.6602,11.5,white,23.0,1,0,0,metastatic,0.399999857,0.1,dnr after sadm,4.0,77.0,7.89941406,95.0,26.0,38.39844,78.0,3.3999023,0.69995117,1.09985352,138.0,7.069336,130.0,28.0,1175.0,3.0,<2 mo. follow-up
52.76898,1,male,0,55,193,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,121661.0,14452.7344,23.0,black,77.0,41,1,0,no,0.5,0.4,no dnr,55.0,154.0,27.3984375,150.0,36.0,35.79688,168.3125,2.5996094,6.79980469,1.79980469,146.0,7.319336,210.0,60.0,4670.0,0.494751,adl>=4 (>=5 if sur)
91.16797,0,female,0,6,543,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,7025.0,4443.6758,8.0,white,44.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,133.0,6.89941406,135.0,6.0,35.89844,300.0,3.5,0.39996338,1.19995117,142.0,7.329102,133.0,10.0,1120.0,5.0654297,adl>=4 (>=5 if sur)
53.26199,1,male,0,4,16,Lung Cancer,Cancer,1,12.0,$25-$50k,4797.0,2928.8633,6.0,white,13.0,1,0,0,metastatic,0.599999905,0.3,no dnr,4.0,135.0,10.0,55.0,24.0,35.69531,203.3125,3.5,0.69995117,1.19995117,150.0,7.469727,145.0,11.0,2749.0,1.9692383,<2 mo. follow-up
59.73999,1,female,1,30,30,CHF,COPD/CHF/Cirrhosis,1,16.0,under $11k,90045.0,14452.7344,28.5,white,60.0,1,0,0,no,0.699999809,0.5,dnr after sadm,30.0,60.0,9.79882812,100.0,8.0,36.19531,348.5625,3.5,1.01,0.69995117,141.0,7.369141,162.0,7.0,1900.0,0.0,<2 mo. follow-up
82.56,0,male,0,12,541,CHF,COPD/CHF/Cirrhosis,3,2.0,under $11k,31745.0,18582.2031,11.5,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,53.0,128.78125,150.0,24.0,38.69531,242.5,2.5,2.29980469,2.39990234,142.0,7.30957,109.0,44.0,260.0,0.0,no(M2 and SIP pres)
54.237,1,male,1,5,5,Coma,Coma,0,7.0,under $11k,36353.0,14452.7344,45.0,other,78.0,1,0,0,no,0.5,0.35,dnr after sadm,5.0,103.0,7.29980469,60.0,24.0,36.09375,185.0,2.5,1.59985352,0.79992676,134.0,7.359375,240.0,8.0,2080.0,1.0,<2 mo. follow-up
65.60699,1,male,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,14532.0,14452.7344,31.0,hispanic,100.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,63.0,6.59960938,70.0,16.0,36.69531,333.3,3.5996094,0.5,1.79980469,135.0,7.419922,73.0,40.0,1200.0,1.7995606,<2 mo. follow-up
69.224,1,male,0,9,104,Lung Cancer,Cancer,1,16.0,under $11k,10246.0,6972.5977,10.0,white,5.0,1,0,0,metastatic,0.599999905,0.3,no dnr,9.0,53.0,7.5,68.0,48.0,36.59375,168.0,3.5,0.5,0.69995117,137.0,7.369141,85.0,13.0,2650.0,0.0,Coma or Intub
65.28998,0,female,0,46,538,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,198680.0,116222.125,34.75,white,35.0,8,0,0,no,0.699999809,0.8,no dnr,46.0,27.0,18.1992188,180.0,22.0,38.19531,243.3125,3.5,1.01,1.59985352,142.0,7.30957,211.0,26.0,0.0,0.0,adl>=4 (>=5 if sur)
73.32196,1,male,0,10,42,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,24700.0,14452.7344,18.0,white,18.0,1,0,0,no,0.75,0.7,dnr after sadm,9.0,113.0,6.29980469,60.0,9.0,38.39844,259.0,3.5,1.01,1.39990234,133.0,7.489258,102.0,20.0,2030.0,2.8100586,<2 mo. follow-up
80.39996,1,male,0,10,28,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,27456.0,14452.7344,26.5,white,32.0,1,0,0,no,0.849999905,0.65,no dnr,10.0,43.0,45.8984375,135.0,22.0,38.69531,125.45312,3.5,5.19921875,11.2988281,136.0,7.339844,142.0,111.0,15.0,0.0,<2 mo. follow-up
47.97498,0,male,0,43,536,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,89130.0,57088.8438,21.25,white,12.0,4,0,0,no,0.849999905,0.85,no dnr,43.0,105.0,15.0,105.0,30.0,34.19531,297.125,3.3999023,1.0,5.79980469,140.0,7.279297,145.0,53.0,810.0,0.0,no(M2 and SIP pres)
57.02899,1,male,0,17,48,Lung Cancer,Cancer,1,0.0,under $11k,16234.0,10966.8984,5.666664,white,22.0,1,0,0,metastatic,0.5,0.15,no dnr,17.0,120.0,3.0,115.0,10.0,38.5,167.5,3.2998047,2.59960938,0.89990234,146.0,7.30957,89.0,19.0,2110.0,1.0,<2 mo. follow-up
71.59998,1,female,0,7,130,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,8299.0,6645.6406,10.5,black,10.0,1,1,0,no,0.899999619,0.8,no dnr,7.0,62.0,8.79882812,75.0,28.0,35.29688,172.5,3.5,1.01,1.19995117,140.0,7.449219,123.0,35.0,1165.0,1.0,<2 mo. follow-up
59.39798,0,male,0,20,536,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,38214.0,23649.0312,24.333328,white,25.0,1,0,0,yes,0.75,0.65,no dnr,20.0,62.0,13.0,125.0,36.0,39.09375,343.3125,3.5,0.5,4.69921875,138.0,7.419922,546.0,43.0,1012.0,6.0,adl>=4 (>=5 if sur)
85.25397,0,female,0,4,535,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,5269.0,3610.668,7.0,white,16.0,1,0,0,no,0.75,0.5,no dnr,4.0,145.0,6.59960938,60.0,8.0,37.89844,283.3125,3.0996094,0.39996338,1.09985352,141.0,7.299805,258.0,27.0,2147.0,0.0,no(M2 and SIP pres)
66.89398,0,male,0,35,534,CHF,COPD/CHF/Cirrhosis,2,15.0,$11-$25k,42993.0,29988.3438,17.25,white,49.0,1,0,0,no,0.799999714,0.5,dnr after sadm,5.0,18.0,9.8984375,35.0,36.0,38.19531,195.0,3.5,1.01,2.09960938,137.0,7.449219,413.0,52.0,1065.0,0.0,no(M2 and SIP pres)
72.74194,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,79139.0,45057.0312,39.333313,white,77.0,1,0,0,no,0.349999905,0.3,dnr after sadm,11.0,52.0,0.09999084,135.0,26.0,36.09375,316.625,2.5996094,10.5,2.89990234,143.0,7.299805,86.0,90.0,435.0,0.0,<2 mo. follow-up
63.92599,1,male,1,16,16,Coma,Coma,1,10.0,under $11k,45913.0,27442.4531,22.666656,white,31.0,1,0,0,yes,0.099999964,0.02,dnr after sadm,4.0,108.0,18.5976562,120.0,20.0,35.79688,660.0,3.5,1.01,0.69995117,136.0,7.449219,156.0,15.0,700.0,0.0,<2 mo. follow-up
44.85699,1,male,0,14,135,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,51906.0,29462.7344,16.0,black,37.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,68.0,8.3984375,105.0,8.0,35.29688,250.0,2.699707,0.39996338,0.59997559,142.0,7.429688,106.0,8.0,5065.0,0.0,adl>=4 (>=5 if sur)
66.54596,1,female,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,147889.0,14452.7344,44.25,white,77.0,1,0,0,yes,0.5,0.4,dnr after sadm,24.0,115.0,9.0,75.0,12.0,36.19531,433.3125,3.5,1.01,1.19995117,145.0,7.40918,178.0,16.0,1725.0,0.0,<2 mo. follow-up
30.10799,0,female,0,9,532,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,59995.78781114967,14452.7344,14.0,white,31.0,3,0,0,no,0.799999714,0.6,no dnr,14.58258953168044,30.0,1.0,175.0,35.0,39.09375,131.65625,3.0996094,0.29998779,1.89990234,153.0,7.149414,9.0,52.0,843.0,0.0,no(M2 and SIP pres)
64.12,0,female,0,14,531,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,39588.0,23305.7969,23.333328,black,50.0,3,1,0,no,0.699999809,0.5,no dnr,14.0,108.0,12.1992188,65.0,24.0,38.09375,268.5625,3.5,0.79992676,8.19921875,129.0,7.439453,225.0,39.0,0.0,0.0,SIP>=30
65.81799,1,female,0,7,397,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,7743.0,5370.8398,6.5,white,1.0,1,0,0,no,0.899999619,0.75,no dnr,7.0,128.0,10.7988281,55.0,8.0,39.09375,270.0,3.5,0.69995117,1.29980469,160.0,7.449219,153.0,17.0,1975.0,0.494751,SIP>=30
69.10297,0,female,0,6,533,CHF,COPD/CHF/Cirrhosis,4,16.0,under $11k,13926.0,8603.0234,17.0,white,23.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,48.0,12.1992188,125.0,26.0,36.19531,869.375,3.5,1.01,2.89990234,158.0,7.30957,272.0,79.0,925.0,2.1191406,no(M2 and SIP pres)
74.58997,1,male,1,8,8,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,8683.0,5717.5,12.5,white,19.0,1,0,0,no,0.5,0.4,dnr after sadm,5.0,112.0,33.0,115.0,38.0,38.09375,251.40625,2.3999023,24.3984375,2.0,145.0,7.459961,379.0,121.0,2330.0,2.0,<2 mo. follow-up
56.939,0,female,0,12,532,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,54366.0,35763.0938,19.0,black,43.0,26,0,0,no,1.0,1.0,no dnr,12.0,75.0,6.39941406,95.0,30.0,38.0,348.0,2.0,1.5,0.89990234,147.0,7.489258,138.0,22.0,1010.0,3.0,no(M2 and SIP pres)
66.02594,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,under $11k,44230.0,22836.0156,57.0,white,64.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,148.0,12.7988281,105.0,26.0,36.59375,232.5,3.5,1.01,0.69995117,148.0,7.429688,298.0,14.0,2875.0,1.9631348,<2 mo. follow-up
41.09,1,male,0,5,23,Lung Cancer,Cancer,1,14.0,$11-$25k,6703.0,4328.6406,4.0,black,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,75.0,6.09960938,70.0,16.0,36.29688,333.3,4.0996094,0.39996338,0.79992676,144.0,7.419922,112.0,6.0,7250.0,0.494751,<2 mo. follow-up
75.95898,1,female,0,14,241,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,43724.0,26366.875,24.333328,white,38.0,5,0,0,yes,0.899999619,0.8,no dnr,14.0,95.0,6.19921875,70.0,18.0,36.09375,323.75,3.5,2.79980469,1.19995117,135.0,7.439453,68.0,15.0,1925.0,7.0,adl>=4 (>=5 if sur)
52.45999,1,female,1,9,9,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,under $11k,119149.0,67033.5,43.0,white,73.0,21,0,0,no,0.399999857,0.2,dnr after sadm,8.0,68.0,13.0996094,105.0,32.0,36.69531,357.125,3.0,0.39996338,0.89990234,137.0,7.379883,105.0,15.0,2502.0,2.0,<2 mo. follow-up
49.71698,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,70066.0,14452.7344,53.5,white,59.0,3,0,0,no,0.049999982,0.0,dnr after sadm,4.0,138.0,15.2988281,125.0,20.0,38.0,242.0,2.0996094,1.19995117,0.59997559,132.0,7.279297,153.0,12.0,1915.0,2.6157227,<2 mo. follow-up
39.32098,0,male,0,15,529,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,36544.0,23668.5156,19.0,black,24.0,2,0,0,no,1.0,0.9,no dnr,15.0,53.0,22.8984375,130.0,24.0,39.19531,132.0,3.5,1.01,1.0,135.0,7.419922,99.0,14.0,1665.0,5.0,<2 mo. follow-up
67.51495,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,98266.0,14452.7344,52.0,white,127.0,20,0,0,yes,0.0,0.0,no dnr,5.0,97.0,17.0,68.0,20.0,36.0,333.3,4.0,0.79992676,0.69995117,142.0,7.419922,125.0,13.0,2502.0,1.925293,<2 mo. follow-up
61.80698,1,male,1,14,14,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,44938.0,24608.9219,28.0,white,48.0,1,0,0,no,0.049999982,0.0,dnr after sadm,9.0,115.0,3.09960938,105.0,12.0,38.39844,385.6875,2.699707,4.39941406,1.0,131.0,7.449219,97.0,10.0,1235.0,1.0,<2 mo. follow-up
56.13397,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,87450.0,49439.0625,38.333313,black,95.0,7,0,0,yes,0.699999809,0.6,dnr after sadm,14.0,102.0,23.0976562,105.0,33.0,36.29688,233.3125,3.5,0.79992676,6.19921875,133.0,7.379883,284.0,105.0,811.0,3.0,<2 mo. follow-up
34.34399,0,female,0,17,528,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,46653.0,14452.7344,23.333328,black,57.0,1,0,0,no,0.949999809,0.9,no dnr,17.0,53.0,3.09960938,115.0,10.0,36.39844,302.8125,1.3999023,2.19970703,0.69995117,134.0,7.299805,81.0,27.0,3160.0,0.0,no(M2 and SIP pres)
55.52597,1,female,0,47,56,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,92466.0,14452.7344,26.25,white,60.0,1,1,0,no,0.799999714,0.8,no dnr,47.0,84.54640817223199,9.0,97.15671114268454,23.33029437609842,37.103341063268886,333.3,3.5,1.01,1.01,137.56854130052724,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
52.57999,0,male,0,6,525,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,13753.0,8494.375,12.0,black,11.0,3,1,0,no,0.899999619,0.8,no dnr,6.0,58.0,17.3984375,115.0,16.0,35.79688,133.3125,0.8999023,1.69995117,4.89941406,137.0,7.319336,72.0,60.0,88.0,1.0,no(M2 and SIP pres)
69.14996,0,male,0,6,525,CHF,COPD/CHF/Cirrhosis,3,3.0,under $11k,12983.0,8177.3086,19.0,black,28.0,1,0,0,no,0.899999619,0.75,no dnr,6.0,125.0,17.8984375,75.0,26.0,36.39844,196.65625,3.5,1.01,1.0,144.0,7.299805,512.0,18.0,3945.0,0.0,no(M2 and SIP pres)
51.59497,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,43406.0,14452.7344,40.0,black,91.0,1,1,0,no,0.899999619,0.85,no dnr,9.0,112.0,25.0,95.0,13.0,35.29688,356.0,3.5,14.3984375,7.69921875,134.0,7.419922,89.0,88.0,200.0,3.0,<2 mo. follow-up
65.33099,1,male,1,3,3,Coma,Coma,0,18.0,>$50k,30271.0,17778.3438,19.0,white,55.0,8,0,0,no,0.199999928,0.1,dnr after sadm,2.0,123.0,14.7988281,135.0,40.0,39.09375,266.625,2.8999023,1.09985352,0.69995117,140.0,7.429688,179.0,13.0,4125.0,0.0,<2 mo. follow-up
49.81198,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,17471.0,14452.7344,50.0,black,104.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,68.0,12.3984375,115.0,9.0,38.89844,331.375,3.5,1.09985352,5.0,144.0,7.489258,210.0,123.0,60.0,3.3730469,<2 mo. follow-up
58.439,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,53976.0,30542.7031,32.0,white,55.0,12,0,0,yes,0.299999952,0.1,dnr after sadm,1.0,107.0,10.0,80.0,28.0,36.29688,333.3,3.0996094,0.5,0.59997559,130.0,7.419922,248.0,9.0,4800.0,2.5424805,<2 mo. follow-up
46.93799,1,male,1,6,6,Coma,Coma,0,12.0,under $11k,80331.0,45993.3438,45.0,white,32.0,9,0,0,no,0.699999809,0.6,dnr after sadm,5.0,124.0,15.0,125.0,30.0,36.19531,286.9375,3.5,1.01,1.69995117,146.0,7.399414,114.0,52.0,875.0,1.7890625,<2 mo. follow-up
29.782,0,male,0,35,522,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,165685.0,14452.7344,33.0,black,38.0,3,0,0,no,0.799999714,0.8,no dnr,35.0,100.0,7.29980469,64.0,32.0,36.59375,204.75,3.5,1.01,0.69995117,139.0,7.299805,159.0,29.0,3050.0,1.8352051,<2 mo. follow-up
71.42499,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,186564.0,103832.562,43.333313,white,26.0,12,0,0,no,0.699999809,0.5,dnr after sadm,22.0,75.0,16.3984375,112.0,16.0,36.29688,333.3,3.5,0.59997559,0.69995117,135.0,7.419922,111.0,33.0,2502.0,7.0,<2 mo. follow-up
55.87097,1,female,1,4,4,Lung Cancer,Cancer,1,12.0,under $11k,3932.0,2679.8769,7.0,white,22.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,55.0,19.5,160.0,30.0,38.0,320.0,2.7998047,0.79992676,10.0,133.0,7.399414,78.0,89.0,200.0,2.4589844,<2 mo. follow-up
32.43799,0,female,0,129,519,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$11-$25k,440306.0,14452.7344,40.25,hispanic,64.0,1,0,0,no,0.699999809,0.7,no dnr,129.0,80.0,13.0996094,128.0,24.0,36.09375,200.0,3.5,1.01,1.09985352,135.0,7.129883,227.0,34.0,500.0,0.0,adl>=4 (>=5 if sur)
70.64496,0,female,0,108,519,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,171148.0,14452.7344,26.5,white,66.0,2,0,0,no,0.699999809,0.6,dnr after sadm,6.0,73.0,10.2988281,75.0,20.0,38.29688,452.375,3.5,1.01,0.69995117,134.0,7.469727,136.0,10.0,2502.0,6.0,adl>=4 (>=5 if sur)
50.95398,1,male,1,41,41,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,180519.0,14452.7344,40.0,white,33.0,2,0,0,yes,0.5,0.3,dnr after sadm,21.0,40.0,27.5,40.0,15.0,35.19531,268.0,3.5,2.0,1.29980469,129.0,7.509766,106.0,20.0,455.0,0.0,<2 mo. follow-up
26.09698,0,female,0,10,517,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,25295.0,16307.4609,16.0,white,69.0,1,1,0,no,1.0,1.0,dnr after sadm,4.0,105.0,9.69921875,65.0,24.0,37.0,390.4375,3.5,1.01,1.29980469,143.0,7.519531,107.0,22.0,2150.0,1.8388672,SIP>=30
67.26099,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,59995.78781114967,14452.7344,44.0,white,141.0,8,0,0,no,0.599999905,0.4,dnr after sadm,3.0,68.0,5.5,115.0,36.0,39.19531,82.84375,2.3999023,11.0996094,1.19995117,155.0,7.449219,400.0,48.0,2460.0,0.0,<2 mo. follow-up
64.66498,0,male,0,28,516,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,$11-$25k,85357.0,51161.6875,22.5,other,47.0,5,1,0,no,0.5,0.5,no dnr,28.0,42.0,19.296875,65.0,33.0,33.69531,34.0,3.2998047,32.3984375,7.39941406,147.0,7.279297,102.0,88.0,570.0,2.625,<2 mo. follow-up
31.22499,1,male,0,4,330,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$25-$50k,27355.0,16787.5156,17.0,white,27.0,10,0,0,no,0.5,0.4,no dnr,4.0,83.0,8.59960938,105.0,20.0,36.29688,333.3,3.5996094,0.5,0.89990234,134.0,7.419922,121.0,14.0,2502.0,7.0,adl>=4 (>=5 if sur)
50.97897,1,male,0,14,35,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,20779.0,12855.9375,14.333328,white,37.0,1,0,0,no,0.599999905,0.4,no dnr,14.0,137.0,13.1992188,115.0,35.0,39.09375,319.0,3.5,1.01,0.59997559,133.0,7.449219,160.0,17.0,2065.0,2.0,<2 mo. follow-up
60.57797,0,male,0,8,516,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,8274.0,5460.8398,13.0,white,25.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,102.0,7.79980469,70.0,24.0,35.89844,333.3,3.2998047,2.29980469,1.19995117,135.0,7.419922,88.0,18.0,2600.0,3.0,no(M2 and SIP pres)
87.29596,0,female,0,15,515,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,29832.0,14452.7344,21.666656,white,53.0,1,0,0,no,0.599999905,0.6,dnr after sadm,5.0,68.0,17.796875,55.0,6.0,36.09375,193.3125,3.0996094,0.59997559,1.0,136.0,7.299805,246.0,26.0,1390.0,0.0,no(M2 and SIP pres)
78.70795,1,male,1,49,49,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,231581.0,14452.7344,34.5,black,67.0,20,0,0,no,0.699999809,0.5,dnr after sadm,46.0,78.0,8.09960938,75.0,6.0,36.29688,200.0,3.5,0.69995117,0.69995117,135.0,7.429688,81.0,15.0,2930.0,3.0581055,<2 mo. follow-up
41.94897,1,female,0,12,30,Lung Cancer,Cancer,1,12.0,under $11k,14354.0,9377.4453,11.5,hispanic,25.0,1,0,0,metastatic,0.5,0.1,no dnr,12.0,105.0,7.19921875,150.0,22.0,36.59375,333.3,2.8999023,0.89990234,0.79992676,139.0,7.419922,99.0,7.0,2725.0,1.0,<2 mo. follow-up
64.94995,1,male,0,35,337,COPD,COPD/CHF/Cirrhosis,3,12.0,>$50k,100447.0,59049.2188,35.0,white,33.0,1,1,0,no,0.5,0.4,dnr after sadm,19.0,63.0,6.79980469,75.0,20.0,36.09375,644.0,3.5,1.01,1.29980469,136.0,7.449219,63.0,19.0,4700.0,7.0,adl>=4 (>=5 if sur)
85.20197,1,female,0,10,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,70407.0,40572.1562,42.5,other,93.0,9,0,0,yes,0.099999964,0.05,dnr after sadm,3.0,73.0,4.19921875,55.0,8.0,36.0,226.65625,2.2998047,0.5,0.69995117,141.0,7.379883,77.0,16.0,1175.0,7.0,<2 mo. follow-up
33.13599,1,female,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,187105.0,109487.562,40.25,black,64.0,1,1,0,no,0.699999809,0.6,dnr after sadm,1.0,111.0,7.59960938,50.0,16.0,35.79688,210.1875,3.5,1.01,1.0,138.0,7.439453,78.0,14.0,700.0,2.0,<2 mo. follow-up
45.55798,1,male,1,6,6,Coma,Coma,2,12.0,under $11k,24542.0,14387.2812,27.0,black,66.0,1,1,0,no,0.099999964,0.05,dnr after sadm,5.0,52.0,10.7988281,105.0,26.0,40.0,210.0,3.3999023,0.79992676,1.69995117,141.0,7.439453,100.0,66.0,1210.0,1.0,<2 mo. follow-up
61.32199,0,male,0,4,514,Lung Cancer,Cancer,1,16.0,$25-$50k,12236.0,5965.6328,11.0,white,5.0,1,0,0,metastatic,0.899999619,0.6,no dnr,4.0,58.0,23.5976562,135.0,20.0,38.59375,98.0,2.0996094,1.0,2.0,139.0,7.40918,206.0,73.0,1030.0,0.0,no(M2 and SIP pres)
57.50598,0,female,0,17,512,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,99616.0,56783.5312,28.666656,white,65.0,7,0,0,no,0.699999809,0.5,no dnr,17.0,118.0,7.09960938,125.0,9.0,38.29688,240.0,3.5,1.01,0.89990234,140.0,7.589844,96.0,28.0,1220.0,0.0,no(M2 and SIP pres)
72.68994,0,female,0,17,512,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,84148.0,14452.7344,25.666656,white,44.0,14,1,0,no,0.699999809,0.5,no dnr,17.0,63.0,14.0996094,55.0,6.0,35.5,214.28125,2.5,2.59960938,0.89990234,143.0,7.369141,314.0,28.0,620.0,0.0,no(M2 and SIP pres)
69.44299,0,female,0,97,511,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,$25-$50k,207500.0,14452.7344,28.25,white,49.0,1,1,1,no,0.5,0.5,no dnr,97.0,108.0,30.6992188,135.0,16.0,37.09375,106.65625,2.3999023,13.1992188,5.39941406,139.0,7.349609,99.0,142.0,431.0,6.0,adl>=4 (>=5 if sur)
27.29399,0,female,0,12,510,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,43502.0,27744.9219,20.0,black,17.0,5,0,0,no,0.699999809,0.5,no dnr,12.0,122.0,15.6992188,120.0,24.0,37.59375,193.3125,3.5,0.5,1.29980469,136.0,7.489258,94.0,23.0,2940.0,0.0,no(M2 and SIP pres)
54.75198,0,male,0,18,510,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,49333.0,29308.0625,26.333328,black,12.0,2,0,0,no,0.699999809,0.5,no dnr,18.0,108.0,12.5,75.0,30.0,35.5,146.65625,3.5,1.01,5.0,125.0,7.389648,351.0,74.0,1350.0,0.0,adl>=4 (>=5 if sur)
67.27997,0,male,0,11,509,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,25244.0,14452.7344,29.0,white,38.0,1,0,1,no,0.599999905,0.6,no dnr,11.0,80.0,10.5996094,80.0,20.0,36.59375,420.0,3.5,0.39996338,0.5,137.0,7.389648,184.0,7.0,2600.0,5.2197266,<2 mo. follow-up
75.90698,0,male,0,17,509,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,457800.0,14452.7344,25.666656,white,15.0,2,1,0,yes,1.0,0.95,no dnr,17.0,62.0,12.5,65.0,24.0,36.79688,260.0,3.5,1.01,1.19995117,136.0,7.529297,211.0,23.0,2470.0,1.0,no(M2 and SIP pres)
72.93097,1,male,0,11,223,CHF,COPD/CHF/Cirrhosis,1,11.0,$11-$25k,20894.0,12428.8359,21.0,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,112.0,4.09960938,105.0,32.0,36.29688,330.375,3.5,1.01,0.69995117,136.0,7.359375,109.0,16.0,1460.0,0.0,no(M2 and SIP pres)
65.40997,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,>$50k,158768.0,86304.1875,47.666657,white,54.0,14,0,0,no,0.199999928,0.1,dnr after sadm,16.0,118.0,6.79980469,65.0,26.0,36.89844,112.23438,3.5,0.69995117,10.7988281,134.0,7.389648,81.0,45.0,1400.0,4.0,<2 mo. follow-up
88.487,1,female,1,9,9,Coma,Coma,1,15.0,under $11k,6748.0,5192.2344,8.0,white,24.0,1,0,0,no,0.049999982,0.0,dnr after sadm,1.0,48.0,4.29980469,65.0,24.0,38.09375,57.0,3.5,0.5,2.89990234,140.0,7.30957,149.0,30.0,140.0,5.0,<2 mo. follow-up
59.75598,0,male,0,59,509,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,287011.0,14452.7344,48.75,white,52.0,3,0,0,no,0.5,0.5,no dnr,59.0,100.0,10.8984375,104.0,20.0,37.0,333.3,3.0996094,1.0,0.89990234,133.0,7.419922,102.0,8.0,2502.0,0.0,adl>=4 (>=5 if sur)
86.50494,1,female,0,35,150,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,113600.0,65823.9375,34.75,white,37.0,1,0,0,no,0.399999857,0.3,no dnr,35.0,46.0,10.0996094,135.0,38.0,37.79688,231.40625,3.5,1.01,0.5,136.0,7.519531,103.0,4.0,5095.0,2.5615234,adl>=4 (>=5 if sur)
67.87396,1,male,0,11,172,Lung Cancer,Cancer,1,16.0,$25-$50k,17619.0,10628.3594,13.0,white,30.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,62.0,19.5,135.0,40.0,35.59375,145.0,2.699707,7.59960938,1.79980469,135.0,7.479492,238.0,43.0,711.0,5.0,SIP>=30
47.10999,0,male,0,27,507,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,95153.0,55380.75,20.5,white,41.0,4,0,0,no,0.5,0.3,no dnr,27.0,58.0,16.6992188,125.0,47.0,36.19531,82.84375,3.5,1.01,0.89990234,137.0,7.389648,150.0,13.0,694.0,0.0,no(M2 and SIP pres)
49.79099,0,female,0,6,508,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,5730.0,4198.6523,12.0,white,34.0,1,1,0,no,0.5,0.35,no dnr,6.0,112.0,8.3984375,100.0,27.0,38.19531,226.65625,3.5,1.01,0.69995117,148.0,7.429688,118.0,5.0,1290.0,7.0,no(M2 and SIP pres)
79.00299,1,female,0,10,374,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,22539.0,14452.7344,24.0,black,30.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,52.0,0.09999084,155.0,31.0,38.19531,233.3125,3.5,14.8984375,5.29980469,141.0,7.339844,271.0,98.0,22.0,0.0,no(M2 and SIP pres)
68.42999,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$25-$50k,664520.0,39274.75,46.0,white,59.0,1,0,0,yes,0.599999905,0.6,dnr after sadm,3.0,52.0,10.0996094,130.0,32.0,39.79688,127.5,3.5,0.89990234,1.09985352,131.0,7.5,135.0,23.0,3115.0,1.0,<2 mo. follow-up
84.69299,1,female,1,9,9,Coma,Coma,0,8.0,under $11k,15003.0,9909.3594,17.5,white,13.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,67.0,0.59997559,125.0,32.0,39.0,420.0,2.0996094,4.89941406,3.39990234,138.0,7.329102,193.0,23.0,290.0,0.0,<2 mo. follow-up
65.61798,1,male,0,9,433,Colon Cancer,Cancer,1,12.0,under $11k,9071.0,6422.4492,11.5,white,18.0,1,0,0,metastatic,0.899999619,0.7,no dnr,9.0,133.0,23.0,115.0,13.0,36.89844,304.0,2.0996094,0.89990234,6.69921875,131.0,7.369141,102.0,67.0,1595.0,2.0,no(M2 and SIP pres)
25.45099,0,female,0,31,504,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,under $11k,118800.0,75492.0,34.0,white,71.0,1,0,0,no,0.699999809,0.7,no dnr,31.0,55.0,10.5996094,125.0,9.0,36.69531,297.125,3.5,0.89990234,5.5,133.0,7.30957,75.0,72.0,0.0,2.3271484,no(M2 and SIP pres)
70.81195,1,male,0,8,35,Colon Cancer,Cancer,1,12.0,$25-$50k,13868.0,8521.0938,6.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,103.0,12.0,60.0,16.0,37.5,255.0,2.8999023,0.59997559,1.0,140.0,7.40918,204.0,2.0,4960.0,0.0,<2 mo. follow-up
51.02298,0,male,0,6,501,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,22219.0,14452.7344,25.0,black,28.0,4,1,0,no,0.5,0.5,no dnr,6.0,97.0,11.5996094,60.0,20.0,36.69531,101.65625,4.0996094,0.69995117,6.69921875,134.0,7.329102,92.0,46.0,3205.0,0.494751,no(M2 and SIP pres)
62.702,0,male,0,26,501,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,96689.0,58644.0,33.25,white,36.0,1,0,0,no,0.25,0.25,no dnr,26.0,0.0,9.19921875,0.0,0.0,36.0,76.0,2.0996094,0.69995117,1.5,138.0,7.279297,292.0,11.0,1640.0,0.0,no(M2 and SIP pres)
71.49597,1,male,1,23,23,MOSF w/Malig,ARF/MOSF,2,4.0,under $11k,87170.0,47979.6875,32.666657,white,76.0,4,1,0,metastatic,0.699999809,0.5,dnr after sadm,22.0,0.0,9.3984375,0.0,0.0,38.19531,236.65625,3.5,1.01,0.79992676,140.0,7.459961,142.0,14.0,2300.0,4.0,<2 mo. follow-up
66.98199,0,male,0,95,498,COPD,COPD/CHF/Cirrhosis,4,14.0,under $11k,373539.0,14452.7344,36.5,white,32.0,5,1,0,no,0.899999619,0.9,dnr after sadm,45.0,41.0,13.5,0.0,26.0,38.19531,137.0,3.5,2.59960938,2.59960938,137.0,6.929688,543.0,40.0,140.0,6.0,Coma or Intub
64.80499,1,male,0,10,399,Coma,Coma,1,12.0,under $11k,25298.0,15532.8359,25.5,white,33.0,1,0,0,no,0.899999619,0.75,no dnr,10.0,65.0,0.09999084,75.0,25.0,35.59375,271.375,2.2998047,1.29980469,1.0,139.0,7.429688,178.0,28.0,2040.0,3.0,adl>=4 (>=5 if sur)
47.27399,1,female,0,11,177,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,42132.0,25258.0781,22.0,white,28.0,4,0,0,no,0.699999809,0.5,no dnr,11.0,167.0,11.6992188,170.0,24.0,39.59375,254.28125,3.5,1.01,0.5,135.0,7.459961,136.0,16.0,3940.0,0.0,no(M2 and SIP pres)
58.87698,1,male,1,26,26,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,60235.0,14452.7344,21.5,white,23.0,1,0,0,no,0.849999905,0.75,no dnr,26.0,115.0,8.09960938,140.0,10.0,39.09375,168.5625,3.199707,3.09960938,1.5,135.0,7.369141,110.0,18.0,2750.0,5.0,<2 mo. follow-up
62.40097,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,21075.0,12266.7188,33.0,white,48.0,1,0,0,metastatic,0.299999952,0.3,dnr after sadm,4.0,72.0,20.796875,75.0,9.0,36.79688,277.125,3.5,1.01,1.39990234,139.0,7.419922,199.0,71.0,1190.0,2.6025391,<2 mo. follow-up
60.84097,0,female,0,28,494,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,80127.0,14452.7344,27.0,white,55.0,3,0,0,no,0.699999809,0.5,no dnr,28.0,107.0,12.7988281,88.0,28.0,36.0,135.0,3.5,1.01,0.79992676,125.0,7.379883,149.0,19.0,1700.0,6.0,<2 mo. follow-up
58.97598,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,30892.0,18894.8906,35.0,white,44.0,2,1,0,no,0.799999714,0.8,dnr after sadm,7.0,112.0,55.8984375,135.0,37.0,38.79688,77.0,1.5,3.09960938,0.59997559,136.0,7.379883,104.0,9.0,1420.0,3.1943359,<2 mo. follow-up
81.08698,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,20828.0,14452.7344,27.0,white,42.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,125.0,12.5996094,155.0,40.0,39.79688,316.0,2.2998047,0.89990234,0.59997559,145.0,7.399414,229.0,31.0,1300.0,2.2841797,<2 mo. follow-up
66.05096,0,female,0,42,493,Coma,Coma,1,9.0,under $11k,146193.0,14452.7344,33.0,white,45.0,7,0,0,no,0.699999809,0.5,dnr after sadm,1.0,120.0,48.5,125.0,18.0,36.09375,160.0,3.5,0.89990234,1.79980469,137.0,7.40918,85.0,19.0,2560.0,0.0,adl>=4 (>=5 if sur)
52.98297,0,male,0,4,493,Lung Cancer,Cancer,0,18.0,>$50k,11170.0,5573.0039,12.0,white,11.0,1,0,0,metastatic,0.899999619,0.8,no dnr,4.0,132.0,6.29980469,110.0,11.0,36.39844,147.59375,3.0996094,1.29980469,4.0,128.0,7.319336,661.0,28.0,780.0,0.0,no(M2 and SIP pres)
52.01898,1,male,0,7,228,Lung Cancer,Cancer,1,15.0,$25-$50k,13461.0,7303.3203,10.0,white,6.0,1,0,0,metastatic,0.899999619,0.8,no dnr,7.0,0.0,64.890625,0.0,0.0,32.89844,33.0,3.5,1.01,3.09960938,132.0,7.149414,180.0,80.0,280.0,0.0,<2 mo. follow-up
44.54999,0,male,0,8,493,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,11776.0,14452.7344,10.0,black,11.0,1,0,0,no,0.849999905,0.75,no dnr,8.0,75.0,9.19921875,60.0,12.0,36.79688,188.5625,3.5,1.01,3.79980469,130.0,7.479492,220.0,72.0,1240.0,0.0,no(M2 and SIP pres)
63.88797,1,female,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,94398.0,14452.7344,36.0,white,65.0,14,0,0,no,0.0,0.0,dnr after sadm,6.0,72.0,7.5,110.0,26.0,36.5,361.875,3.2998047,0.59997559,0.39996338,140.0,7.479492,126.0,1.0,2675.0,2.902832,<2 mo. follow-up
66.56799,1,female,0,19,45,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,95765.0,56222.1875,22.666656,white,63.0,23,0,0,yes,0.599999905,0.3,no dnr,19.0,57.0,5.19921875,65.0,20.0,35.89844,333.3,3.5,2.59960938,1.19995117,122.0,7.419922,64.0,22.0,4290.0,1.0,<2 mo. follow-up
59.047,0,female,0,17,490,COPD,COPD/CHF/Cirrhosis,2,8.0,$25-$50k,35298.0,23559.5312,19.0,white,27.0,1,0,0,no,0.599999905,0.5,no dnr,17.0,114.0,5.39941406,69.0,24.0,36.5,324.0,3.2998047,1.89990234,1.5,141.0,7.529297,93.0,27.0,1975.0,2.0,adl>=4 (>=5 if sur)
39.90399,0,female,0,55,490,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,210813.0,14452.7344,36.5,white,74.0,2,0,0,metastatic,0.099999964,0.02,dnr after sadm,2.0,105.0,25.1992188,115.0,32.0,37.89844,97.95312,2.5996094,0.5,1.5,147.0,7.419922,153.0,33.0,1930.0,2.9741211,<2 mo. follow-up
63.82999,0,male,0,7,490,CHF,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,15924.0,14452.7344,10.5,white,13.0,1,0,0,no,0.899999619,0.75,no dnr,7.0,70.0,36.1953125,125.0,36.0,38.39844,137.75,2.5996094,2.19970703,2.0,158.0,7.459961,203.0,77.0,2790.0,1.0,no(M2 and SIP pres)
67.25,0,male,0,8,488,COPD,COPD/CHF/Cirrhosis,1,16.0,$11-$25k,12425.0,7684.7969,13.0,white,38.0,1,0,0,no,0.799999714,0.8,no dnr,8.0,106.0,10.5,119.0,28.0,37.89844,333.3,3.5,1.01,0.5,145.0,7.419922,117.0,4.0,1200.0,0.0,no(M2 and SIP pres)
66.12195,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,177754.0,14452.7344,34.5,white,60.0,16,0,0,no,0.699999809,0.5,dnr after sadm,24.0,105.0,5.89941406,110.0,32.0,36.69531,182.5,3.5,1.89990234,0.69995117,144.0,7.40918,373.0,20.0,3795.0,0.0,<2 mo. follow-up
59.96698,1,male,1,7,7,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,8896.0,6078.3438,17.5,white,24.0,1,1,0,no,0.699999809,0.5,dnr after sadm,3.0,48.0,20.296875,225.0,26.0,36.69531,262.8125,2.0996094,47.0,2.29980469,128.0,7.429688,46.0,47.0,2305.0,0.0,<2 mo. follow-up
64.28497,0,male,0,11,487,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,49466.0,27233.4844,25.0,black,21.0,3,0,0,no,0.75,0.7,no dnr,11.0,52.0,13.6992188,135.0,12.0,38.39844,142.0,3.5,7.79980469,0.89990234,150.0,7.549805,226.0,22.0,1535.0,1.0,no(M2 and SIP pres)
61.50299,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,11292.0,14452.7344,15.0,white,95.0,1,0,0,metastatic,0.099999964,0.3,dnr after sadm,1.0,62.0,10.1992188,125.0,26.0,40.29688,228.5625,3.5,1.01,9.69921875,139.0,7.319336,327.0,64.0,225.0,5.0,<2 mo. follow-up
71.737,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,33091.0,14452.7344,47.0,black,81.0,3,1,0,no,0.649999619,0.6,dnr after sadm,3.0,95.0,4.59960938,72.0,20.0,37.59375,333.3,3.2998047,0.69995117,0.89990234,139.0,7.419922,93.0,6.0,2502.0,7.0,<2 mo. follow-up
71.19196,0,female,0,30,486,COPD,COPD/CHF/Cirrhosis,1,12.0,>$50k,61413.0,14452.7344,13.25,white,38.0,1,0,0,no,0.699999809,0.7,dnr after sadm,5.0,58.0,15.5,105.0,8.0,39.09375,227.5,3.5,4.69921875,1.5,156.0,7.519531,49.0,50.0,2365.0,0.494751,<2 mo. follow-up
69.87799,1,male,0,11,166,ARF/MOSF w/Sepsis,ARF/MOSF,3,3.0,under $11k,27756.0,14452.7344,18.0,white,36.0,1,0,0,no,0.5,0.5,no dnr,11.0,78.0,10.2988281,75.0,6.0,36.39844,250.0,1.5998535,1.01,3.0,148.0,7.40918,105.0,52.0,1680.0,0.0,no(M2 and SIP pres)
78.85596,1,female,0,77,89,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,478649.0,14452.7344,32.75,white,43.0,46,0,0,no,0.299999952,0.3,dnr after sadm,68.0,128.0,12.5,75.0,44.0,38.5,371.625,3.5,1.01,1.09985352,145.0,7.329102,387.0,34.0,1840.0,0.0,Coma or Intub
45.60397,0,female,0,10,484,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,22584.0,14452.7344,22.5,white,16.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,111.0,10.0,105.0,36.0,38.29688,384.0,3.5,1.5,0.69995117,135.0,7.359375,185.0,8.0,2950.0,0.0,<2 mo. follow-up
48.91998,1,male,1,58,58,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,482255.0,14452.7344,47.25,white,59.0,5,0,0,yes,0.799999714,0.8,no dnr,58.0,135.0,6.5,65.0,12.0,36.29688,326.625,3.5,1.01,0.79992676,144.0,7.379883,93.0,5.0,2425.0,1.1667481,<2 mo. follow-up
66.086,1,female,0,16,25,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,112648.0,14452.7344,36.0,white,75.0,8,0,0,no,0.299999952,0.1,dnr after sadm,14.0,50.0,21.5976562,135.0,31.0,39.0,147.5,3.5,0.69995117,0.59997559,142.0,7.429688,109.0,9.0,5130.0,0.0,<2 mo. follow-up
70.09698,0,male,0,13,483,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,22644.0,14452.7344,16.0,white,17.0,2,0,0,no,0.899999619,0.9,no dnr,13.0,73.0,10.5996094,65.0,7.0,36.5,182.5,3.5,1.01,1.39990234,138.0,7.489258,94.0,19.0,2010.0,0.0,adl>=4 (>=5 if sur)
68.67596,0,male,0,63,483,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,131874.0,14452.7344,40.25,white,81.0,1,0,0,yes,0.599999905,0.6,no dnr,63.0,78.0,5.59960938,70.0,22.0,36.19531,333.3,3.5,1.01,2.39990234,134.0,7.419922,79.0,42.0,1910.0,5.0,adl>=4 (>=5 if sur)
36.78598,0,male,0,33,482,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,97532.0,14452.7344,28.0,black,52.0,6,0,0,no,0.5,0.5,no dnr,33.0,117.0,22.5,125.0,40.0,35.59375,165.0,3.5,1.01,3.0,131.0,7.389648,128.0,125.0,2160.0,6.0,no(M2 and SIP pres)
85.41296,1,female,0,9,126,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,12424.0,8568.8906,18.0,white,23.0,1,0,1,no,0.599999905,0.6,dnr after sadm,1.0,143.0,13.2988281,104.0,32.0,38.19531,490.4375,3.5,1.01,0.89990234,133.0,7.379883,193.0,8.0,1300.0,7.0,adl>=4 (>=5 if sur)
72.04395,0,male,0,25,482,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,100393.0,14452.7344,23.25,white,46.0,12,0,0,no,0.949999809,0.8,no dnr,25.0,140.0,26.5976562,135.0,22.0,39.29688,75.0,3.5,1.01,1.59985352,142.0,7.399414,97.0,25.0,1005.0,0.0,no(M2 and SIP pres)
52.47598,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,94485.0,14452.7344,58.0,white,100.0,18,0,0,yes,0.399999857,0.35,dnr after sadm,4.0,125.0,12.8984375,125.0,8.0,36.29688,172.5,3.5,1.01,1.89990234,145.0,7.439453,286.0,19.0,4385.0,2.2856445,<2 mo. follow-up
59.34299,1,female,0,29,38,MOSF w/Malig,ARF/MOSF,2,18.0,under $11k,59995.78781114967,14452.7344,36.75,white,37.0,5,0,0,metastatic,0.799999714,0.3,no dnr,14.58258953168044,77.0,0.39996338,72.0,24.0,38.79688,333.3,3.5,0.89990234,0.89990234,138.0,7.419922,107.0,4.0,2502.0,2.0,<2 mo. follow-up
44.38898,0,female,0,114,479,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,256454.0,14452.7344,42.75,white,21.0,1,0,0,no,0.199999928,0.18,no dnr,114.0,58.0,8.8984375,105.0,48.0,38.69531,231.40625,2.8999023,0.89990234,0.89990234,131.0,7.479492,117.0,24.0,2410.0,2.0,SIP>=30
65.82098,0,female,0,36,479,ARF/MOSF w/Sepsis,ARF/MOSF,0,17.0,$11-$25k,97652.0,14452.7344,21.5,white,39.0,15,0,0,no,0.5,0.3,no dnr,36.0,75.0,1.5,104.0,20.0,36.5,466.625,2.0996094,2.39990234,0.79992676,136.0,7.509766,143.0,8.0,1050.0,7.0,no(M2 and SIP pres)
63.439,1,male,1,20,20,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,101509.0,14452.7344,35.666657,white,36.0,1,0,0,yes,0.299999952,0.1,dnr after sadm,20.0,72.0,9.8984375,75.0,28.0,36.19531,273.3125,4.0,1.19995117,1.5,138.0,7.469727,90.0,40.0,2790.0,0.0,<2 mo. follow-up
36.33398,0,female,0,5,478,Lung Cancer,Cancer,1,14.0,$25-$50k,11640.0,5957.5625,11.0,hispanic,13.0,1,0,0,metastatic,0.989999771,0.5,no dnr,5.0,135.0,14.2988281,150.0,18.0,35.5,124.0,3.5,1.29980469,1.59985352,139.0,7.379883,344.0,64.0,960.0,0.0,no(M2 and SIP pres)
80.53894,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,42736.0,14452.7344,29.666656,white,50.0,1,0,0,no,0.069999993,0.05,dnr after sadm,7.0,112.0,10.8984375,75.0,28.0,38.69531,400.0,3.5,1.09985352,0.79992676,139.0,7.419922,138.0,12.0,2095.0,4.9121094,<2 mo. follow-up
40.84097,0,male,0,26,476,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,82428.0,14452.7344,21.25,white,30.0,1,0,0,no,0.799999714,0.75,no dnr,26.0,83.0,11.7988281,58.0,20.0,36.59375,333.3,3.5,6.09960938,0.89990234,138.0,7.419922,93.0,11.0,1000.0,1.0,SIP>=30
48.59097,0,male,0,15,477,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,55846.0,14452.7344,36.0,hispanic,66.0,4,0,0,no,0.799999714,0.8,no dnr,15.0,118.0,10.3984375,130.0,27.0,38.79688,185.0,3.5,24.8984375,6.59960938,138.0,7.429688,93.0,44.0,30.0,0.0,no(M2 and SIP pres)
71.00598,1,female,0,9,114,Lung Cancer,Cancer,3,12.0,under $11k,16093.0,9058.0,14.5,white,7.0,1,1,0,metastatic,0.899999619,0.6,no dnr,9.0,99.0,9.8984375,75.0,18.0,39.0,333.3,3.5,1.0,1.29980469,140.0,7.419922,119.0,26.0,1200.0,6.0,adl>=4 (>=5 if sur)
62.92999,1,male,0,6,152,Lung Cancer,Cancer,1,17.0,>$50k,12412.0,14452.7344,11.0,black,10.0,1,0,0,metastatic,0.899999619,0.3,no dnr,6.0,118.0,17.5976562,65.0,22.0,36.39844,333.3,3.199707,1.0,3.69970703,135.0,7.419922,60.0,87.0,2525.0,0.0,no(M2 and SIP pres)
44.61298,1,male,0,6,200,Lung Cancer,Cancer,1,19.0,>$50k,12011.0,14452.7344,7.0,white,16.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,77.0,10.5996094,95.0,28.0,38.29688,283.3125,2.0996094,0.5,1.39990234,137.0,7.419922,189.0,40.0,1750.0,0.494751,no(M2 and SIP pres)
64.98596,0,female,0,13,475,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,29487.0,14452.7344,21.0,black,35.0,1,0,0,no,0.699999809,0.7,no dnr,13.0,33.0,19.1992188,125.0,20.0,36.19531,230.0,1.5998535,0.59997559,4.0,136.0,7.439453,354.0,34.0,435.0,1.0,no(M2 and SIP pres)
68.92297,1,female,0,8,95,Lung Cancer,Cancer,2,12.0,under $11k,9227.0,14452.7344,8.5,white,33.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,102.0,7.09960938,120.0,38.0,35.39844,180.0,3.5,0.29998779,0.5,142.0,7.489258,282.0,16.0,2675.0,5.0,<2 mo. follow-up
67.98596,1,male,0,9,10,Lung Cancer,Cancer,2,12.0,$11-$25k,8297.0,14452.7344,10.0,white,14.0,1,0,0,metastatic,0.5,0.2,no dnr,9.0,122.0,11.0,115.0,8.0,38.09375,190.0,2.3999023,1.29980469,0.29998779,138.0,7.619141,110.0,10.0,1950.0,1.0,<2 mo. follow-up
37.97098,0,male,0,45,474,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,221820.0,14452.7344,36.5,black,23.0,5,0,0,no,0.599999905,0.6,dnr after sadm,18.0,133.0,4.5,110.0,28.0,38.5,323.75,3.5,1.5,0.69995117,137.0,7.439453,66.0,10.0,2835.0,4.0,no(M2 and SIP pres)
63.61099,0,female,0,12,474,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,33089.0,14452.7344,27.5,white,10.0,1,0,0,no,0.75,0.7,no dnr,12.0,62.0,4.89941406,105.0,20.0,35.39844,333.3,3.5,2.29980469,1.0,137.0,7.419922,89.0,18.0,4600.0,0.0,no(M2 and SIP pres)
68.14496,1,male,0,5,110,Lung Cancer,Cancer,2,10.0,under $11k,4951.0,3143.1602,12.0,white,23.0,1,0,0,metastatic,0.5,0.4,no dnr,5.0,58.0,7.09960938,105.0,32.0,36.39844,96.65625,3.5,3.79980469,1.09985352,141.0,7.349609,106.0,34.0,1555.0,0.0,no(M2 and SIP pres)
53.54099,1,female,0,9,52,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,18073.0,14452.7344,20.0,white,27.0,1,0,0,no,0.5,0.5,no dnr,9.0,144.0,11.0996094,155.0,9.0,35.79688,344.0,3.5,1.01,0.5,135.0,7.439453,115.0,25.0,815.0,3.8549805,<2 mo. follow-up
51.38699,1,male,0,44,120,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,223362.0,14452.7344,31.0,white,30.0,17,0,0,yes,0.699999809,0.5,no dnr,44.0,138.0,16.3984375,105.0,25.0,38.19531,147.5,3.5,1.29980469,1.19995117,144.0,7.429688,364.0,40.0,1933.0,2.8178711,<2 mo. follow-up
41.41299,0,male,0,9,473,Colon Cancer,Cancer,1,13.0,$11-$25k,12398.0,14452.7344,11.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,72.0,10.1992188,75.0,26.0,36.19531,197.9375,3.5,1.09985352,4.0,135.0,7.389648,153.0,36.0,480.0,1.0,no(M2 and SIP pres)
40.54498,0,male,0,10,472,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,25414.0,14452.7344,21.5,black,22.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,161.0,26.6992188,55.0,45.0,40.29688,260.0,3.5,1.01,0.69995117,136.0,7.519531,159.0,20.0,3180.0,0.494751,SIP>=30
74.81195,1,male,1,24,24,Coma,Coma,0,12.0,under $11k,31364.0,14452.7344,12.333328,white,26.0,1,0,0,no,0.25,0.15,dnr after sadm,4.0,76.0,3.39990234,68.0,16.0,36.5,333.3,3.2998047,1.0,0.79992676,138.0,7.419922,101.0,4.0,3850.0,0.0,<2 mo. follow-up
40.63199,0,male,0,54,472,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,278369.0,14452.7344,27.75,white,50.0,2,1,0,no,0.949999809,0.95,no dnr,54.0,99.0,8.19921875,72.0,20.0,36.89844,333.3,4.3994141,0.59997559,1.0,143.0,7.419922,90.0,7.0,5000.0,0.0,adl>=4 (>=5 if sur)
59.90399,1,male,0,19,224,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,59995.78781114967,14452.7344,16.333328,white,25.0,11,0,0,yes,0.75,0.5,no dnr,14.58258953168044,78.0,5.39941406,72.0,20.0,36.0,333.3,3.5,0.89990234,1.0,140.0,7.419922,79.0,14.0,2000.0,1.0,no(M2 and SIP pres)
62.59,0,male,0,7,471,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,12107.0,14452.7344,11.5,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,46.0,11.0,75.0,38.0,39.09375,120.0,2.699707,4.89941406,1.5,150.0,7.469727,169.0,29.0,1920.0,0.494751,no(M2 and SIP pres)
47.89297,1,male,1,18,18,Coma,Coma,4,10.0,under $11k,71025.0,14452.7344,43.0,black,52.0,1,1,0,no,0.599999905,0.6,no dnr,18.0,48.0,0.09999084,65.0,28.0,35.59375,376.1875,2.0,0.5,0.59997559,136.0,7.509766,173.0,22.0,3050.0,0.0,<2 mo. follow-up
19.21399,0,female,0,17,469,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,38076.0,14452.7344,13.666664,white,42.0,1,0,0,no,0.899999619,0.9,no dnr,17.0,108.0,6.59960938,115.0,6.0,36.29688,171.40625,3.5,0.69995117,0.69995117,134.0,7.30957,125.0,22.0,2270.0,1.0,no(M2 and SIP pres)
71.79498,1,male,1,7,7,Lung Cancer,Cancer,1,12.0,under $11k,8297.0,14452.7344,10.0,white,48.0,1,0,0,metastatic,0.099999964,0.05,dnr after sadm,1.0,65.0,0.09999084,135.0,40.0,38.59375,81.32812,3.5,1.01,0.39996338,146.0,7.5,200.0,23.0,2615.0,2.9853516,<2 mo. follow-up
78.33295,0,female,0,6,468,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,7350.0,14452.7344,17.0,white,26.0,1,0,0,no,0.899999619,0.75,no dnr,6.0,97.0,11.6992188,74.0,24.0,35.89844,333.3,4.5,0.79992676,1.09985352,135.0,7.419922,65.0,12.0,1400.0,1.986084,no(M2 and SIP pres)
38.75198,0,female,0,7,468,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,15121.0,14452.7344,6.0,other,12.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,62.0,6.0,124.0,26.0,36.09375,288.0,3.5,0.79992676,1.19995117,137.0,7.389648,137.0,30.0,1010.0,4.5273438,SIP>=30
44.43799,0,female,0,9,468,Cirrhosis,COPD/CHF/Cirrhosis,2,9.0,under $11k,9608.0,14452.7344,7.5,black,44.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,58.0,12.5,65.0,10.0,36.0,364.0,3.3999023,2.69970703,2.09960938,128.0,7.329102,147.0,59.0,419.0,0.0,no(M2 and SIP pres)
69.08698,1,female,0,15,70,COPD,COPD/CHF/Cirrhosis,2,9.0,$25-$50k,14097.0,14452.7344,10.333328,white,15.0,1,0,0,yes,0.699999809,0.5,no dnr,15.0,67.0,10.2988281,69.0,24.0,36.29688,268.0,3.5,1.39990234,1.19995117,132.0,7.479492,64.0,23.0,2850.0,2.9399414,adl>=4 (>=5 if sur)
67.737,0,female,0,22,467,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,40796.0,14452.7344,19.333328,black,49.0,1,1,0,no,0.5,0.4,no dnr,22.0,68.0,16.1992188,75.0,40.0,38.79688,288.5625,3.5,1.01,1.39990234,136.0,7.369141,125.0,12.0,3475.0,7.0,adl>=4 (>=5 if sur)
53.771,0,female,0,29,467,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,110603.0,14452.7344,22.75,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,29.0,0.0,13.0,0.0,0.0,38.0,333.3,3.5,1.01,1.89990234,133.0,7.419922,295.0,133.0,350.0,1.0,no(M2 and SIP pres)
62.80899,1,male,0,18,125,Cirrhosis,COPD/CHF/Cirrhosis,3,18.0,under $11k,17174.0,14452.7344,10.333328,white,13.0,1,0,0,no,0.699999809,0.5,no dnr,18.0,45.0,15.8984375,115.0,38.0,36.0,293.3125,3.5,1.59985352,3.29980469,145.0,7.319336,297.0,96.0,288.0,1.1667481,no(M2 and SIP pres)
58.15997,1,male,1,8,8,Lung Cancer,Cancer,1,12.0,under $11k,59995.78781114967,14452.7344,13.0,black,38.0,1,0,0,metastatic,0.099999964,0.05,no dnr,14.58258953168044,95.0,9.09960938,160.0,26.0,36.09375,359.25,3.5,0.69995117,0.69995117,135.0,7.509766,137.0,17.0,7160.0,2.3520508,<2 mo. follow-up
54.34097,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,22928.0,14452.7344,37.0,white,91.0,4,0,0,no,0.699999809,0.5,dnr after sadm,3.0,108.0,18.8984375,140.0,12.0,36.19531,322.1875,2.5996094,0.59997559,0.79992676,141.0,7.439453,90.0,22.0,1790.0,6.0,<2 mo. follow-up
78.44495,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,137050.0,14452.7344,19.75,white,37.0,47,1,0,yes,0.5,0.5,dnr after sadm,27.0,65.0,6.59960938,65.0,42.0,38.69531,280.0,3.5,0.89990234,3.39990234,136.0,7.40918,206.0,134.0,2020.0,1.0,<2 mo. follow-up
64.78296,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,3,6.0,under $11k,156244.0,14452.7344,51.0,black,50.0,6,1,0,no,0.699999809,0.5,dnr after sadm,17.0,107.0,10.0,65.0,28.0,36.09375,280.0,2.5996094,0.29998779,0.59997559,135.0,7.40918,97.0,8.0,7175.0,3.0,<2 mo. follow-up
68.99097,0,male,0,11,466,CHF,COPD/CHF/Cirrhosis,3,2.0,under $11k,15076.0,14452.7344,17.0,black,35.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,159.0,11.6992188,50.0,10.0,36.79688,197.125,3.5,10.7988281,1.39990234,153.0,7.469727,155.0,42.0,1595.0,0.0,no(M2 and SIP pres)
59.69098,1,male,0,9,175,Lung Cancer,Cancer,1,12.0,$25-$50k,12240.0,14452.7344,12.5,white,16.0,1,0,0,metastatic,0.899999619,0.8,no dnr,9.0,125.0,15.5996094,125.0,40.0,38.39844,154.28125,1.7998047,21.0,1.09985352,142.0,7.389648,204.0,21.0,1470.0,0.0,<2 mo. follow-up
58.94897,1,male,0,5,231,Lung Cancer,Cancer,1,22.0,>$50k,11230.0,14452.7344,13.0,white,13.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,78.0,10.0996094,75.0,25.0,36.09375,356.625,2.7998047,0.69995117,0.79992676,141.0,7.40918,91.0,18.0,2040.0,0.0,<2 mo. follow-up
71.69897,1,female,1,21,21,CHF,COPD/CHF/Cirrhosis,5,11.0,under $11k,19356.0,14452.7344,11.0,white,25.0,1,1,0,no,0.699999809,0.6,dnr after sadm,6.0,45.0,14.0996094,110.0,10.0,35.59375,87.14062,1.2998047,1.69995117,4.09960938,143.0,7.449219,267.0,114.0,655.0,3.8549805,<2 mo. follow-up
51.47198,1,male,1,12,12,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,>$50k,90014.0,14452.7344,42.0,white,31.0,1,0,0,no,0.699999809,0.5,dnr after sadm,12.0,68.0,15.1992188,105.0,27.0,36.69531,225.6875,3.5,1.69995117,7.39941406,135.0,7.40918,139.0,79.0,169.0,1.0,<2 mo. follow-up
83.70197,1,female,1,3,3,Coma,Coma,0,12.0,under $11k,44537.0,14452.7344,36.0,white,103.0,11,0,0,no,0.699999809,0.5,dnr after sadm,3.0,122.0,15.2988281,88.0,28.0,36.09375,148.3125,2.5996094,0.5,0.59997559,141.0,7.429688,134.0,18.0,975.0,2.3256836,<2 mo. follow-up
56.70099,1,male,0,6,9,Lung Cancer,Cancer,2,11.0,under $11k,8106.0,14452.7344,8.0,white,26.0,1,0,0,metastatic,0.299999952,0.1,dnr before sadm,0.0,58.0,15.3984375,60.0,12.0,36.0,292.0,3.5,1.59985352,1.09985352,133.0,7.479492,99.0,42.0,1640.0,3.0,<2 mo. follow-up
49.39899,0,male,0,18,462,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,62140.0,14452.7344,28.666656,white,34.0,1,0,0,no,0.979999542,0.9,no dnr,18.0,43.0,25.296875,165.0,14.0,37.89844,150.0,1.5,1.39990234,3.5,145.0,7.379883,227.0,40.0,145.0,0.0,no(M2 and SIP pres)
77.32794,0,female,0,15,462,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,under $11k,48687.0,14452.7344,19.0,black,58.0,3,0,0,no,0.299999952,0.2,no dnr,15.0,112.0,2.5,135.0,10.0,36.39844,133.3125,2.5996094,1.01,1.29980469,129.0,7.349609,154.0,41.0,2235.0,1.0,no(M2 and SIP pres)
70.65796,1,male,0,39,268,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,91132.0,14452.7344,23.0,black,30.0,1,1,0,no,0.799999714,0.7,no dnr,39.0,63.0,13.6992188,65.0,8.0,36.09375,373.3125,3.5,1.0,0.59997559,138.0,7.449219,192.0,65.0,2480.0,2.0,no(M2 and SIP pres)
51.01199,1,female,0,54,430,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,83982.0,14452.7344,32.5,asian,21.0,3,0,0,no,0.5,0.4,no dnr,54.0,122.0,18.0,105.0,24.0,36.5,213.3125,2.0996094,1.29980469,1.5,140.0,7.469727,145.0,45.0,2900.0,0.0,<2 mo. follow-up
39.67099,0,male,0,19,461,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,88980.0,14452.7344,30.0,white,57.0,8,1,0,no,0.5,0.5,no dnr,19.0,112.0,63.5,65.0,24.0,38.59375,185.0,3.2998047,0.89990234,1.0,148.0,7.469727,343.0,30.0,2910.0,4.0,no(M2 and SIP pres)
77.07599,0,male,0,4,461,CHF,COPD/CHF/Cirrhosis,3,3.0,under $11k,5846.0,14452.7344,6.0,black,28.0,1,1,0,no,0.699999809,0.5,no dnr,4.0,60.0,3.89990234,68.0,20.0,37.09375,333.3,3.5,1.01,0.69995117,139.0,7.419922,88.0,4.0,4400.0,0.0,no(M2 and SIP pres)
57.06998,1,female,0,26,29,Lung Cancer,Cancer,1,12.0,$25-$50k,40442.0,14452.7344,11.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,26.0,135.0,12.8984375,115.0,36.0,38.19531,305.0,3.5,0.5,6.19921875,139.0,7.369141,158.0,101.0,960.0,0.0,<2 mo. follow-up
54.20398,0,male,0,19,460,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,$25-$50k,88300.0,14452.7344,18.666656,white,21.0,7,0,0,no,0.979999542,0.96,no dnr,19.0,102.0,33.09375,105.0,24.0,36.39844,196.65625,3.5,1.01,3.5,146.0,7.419922,122.0,35.0,4140.0,0.0,no(M2 and SIP pres)
73.07599,1,male,0,7,220,Colon Cancer,Cancer,2,16.0,$11-$25k,13001.0,14452.7344,10.5,white,15.0,1,1,0,metastatic,0.899999619,0.8,no dnr,7.0,125.0,11.8984375,120.0,10.0,35.39844,145.0,3.5,0.5,9.0,131.0,7.399414,223.0,99.0,170.0,0.0,no(M2 and SIP pres)
66.86694,0,male,0,15,459,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,$25-$50k,57345.0,14452.7344,32.666657,white,19.0,4,0,0,no,0.699999809,0.5,no dnr,15.0,81.0,10.0,62.0,22.0,36.39844,333.3,2.8999023,0.59997559,0.69995117,134.0,7.419922,168.0,4.0,2800.0,0.0,adl>=4 (>=5 if sur)
25.95999,0,male,0,24,459,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,161427.0,14452.7344,35.0,black,51.0,14,0,0,no,0.699999809,0.5,no dnr,24.0,103.0,9.0,80.0,20.0,36.29688,333.3,3.0996094,0.29998779,0.89990234,139.0,7.419922,129.0,9.0,4150.0,2.4677734,<2 mo. follow-up
59.53699,0,male,0,12,459,Colon Cancer,Cancer,1,18.0,under $11k,32064.0,14452.7344,15.5,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,71.0,9.5,112.0,24.0,37.59375,333.3,3.699707,0.5,0.79992676,142.0,7.419922,80.0,6.0,2502.0,0.0,no(M2 and SIP pres)
56.00299,1,female,0,25,266,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,170509.0,14452.7344,19.75,white,66.0,43,0,0,no,0.5,0.2,dnr after sadm,1.0,110.0,6.59960938,115.0,30.0,36.79688,330.0,3.7998047,1.39990234,0.89990234,141.0,7.40918,403.0,20.0,2300.0,3.0,no(M2 and SIP pres)
75.14899,1,male,0,5,9,Coma,Coma,2,12.0,under $11k,28049.0,14452.7344,22.0,white,18.0,6,1,0,yes,0.5,0.1,dnr after sadm,3.0,94.0,1.5,118.0,32.0,35.5,333.3,2.5996094,2.29980469,0.39996338,143.0,7.419922,87.0,19.0,2700.0,2.0766602,<2 mo. follow-up
68.54797,0,female,0,20,457,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,91794.0,14452.7344,29.666656,white,43.0,3,1,0,no,0.949999809,0.9,dnr after sadm,6.0,67.0,6.39941406,82.0,20.0,36.69531,333.3,3.5,0.59997559,1.39990234,136.0,7.419922,66.0,18.0,2502.0,0.0,no(M2 and SIP pres)
37.12,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,201047.0,14452.7344,48.0,white,93.0,30,0,0,no,0.699999809,0.5,dnr after sadm,5.0,125.0,5.0,105.0,12.0,38.79688,125.0,3.5,1.01,1.29980469,150.0,7.429688,80.0,33.0,2635.0,0.0,<2 mo. follow-up
62.66098,1,male,0,4,192,Lung Cancer,Cancer,2,15.0,>$50k,11150.0,14452.7344,14.0,white,12.0,1,0,0,metastatic,0.599999905,0.4,no dnr,4.0,95.0,14.6992188,60.0,10.0,37.0,174.28125,3.5,0.69995117,0.69995117,130.0,7.589844,118.0,12.0,3702.0,0.0,no(M2 and SIP pres)
60.54797,1,male,0,12,14,Coma,Coma,0,12.0,$11-$25k,49329.0,14452.7344,38.5,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,102.0,12.3984375,100.0,16.0,35.69531,376.1875,2.8999023,0.39996338,1.59985352,142.0,7.419922,117.0,31.0,2502.0,1.0,<2 mo. follow-up
38.66898,0,female,0,18,456,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,48615.0,14452.7344,23.0,black,33.0,1,0,0,no,0.899999619,0.9,no dnr,18.0,80.0,10.6992188,120.0,24.0,38.19531,300.0,2.0996094,1.01,0.69995117,143.0,7.439453,123.0,18.0,860.0,1.0,no(M2 and SIP pres)
91.27698,1,female,0,6,95,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,6053.0,14452.7344,12.0,white,22.0,1,0,0,no,0.899999619,0.9,no dnr,6.0,107.0,7.29980469,105.0,32.0,38.5,263.3125,2.0,1.01,0.69995117,133.0,7.449219,343.0,17.0,4880.0,1.0,adl>=4 (>=5 if sur)
60.93597,0,female,0,40,454,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,106360.0,14452.7344,27.25,black,37.0,1,1,0,no,0.699999809,0.5,no dnr,40.0,100.0,5.59960938,75.0,20.0,38.0,333.3,3.5,1.01,0.89990234,140.0,7.419922,97.0,6.0,2450.0,1.0,no(M2 and SIP pres)
46.52399,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,91630.0,14452.7344,41.0,white,54.0,11,0,0,yes,0.599999905,0.2,dnr after sadm,9.0,133.0,5.89941406,115.0,10.0,38.59375,145.0,3.5,1.0,1.19995117,141.0,7.439453,94.0,15.0,2290.0,2.1176758,<2 mo. follow-up
77.80396,1,male,0,9,51,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,9589.0,14452.7344,10.5,white,33.0,1,0,0,no,0.5,0.3,no dnr,9.0,115.0,13.5996094,75.0,14.0,36.69531,511.0,3.5,1.01,0.89990234,135.0,7.379883,131.0,20.0,1100.0,0.0,<2 mo. follow-up
64.08197,1,female,1,148,148,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,526585.0,14452.7344,36.75,white,39.0,15,0,0,yes,0.75,0.7,dnr after sadm,35.0,128.0,13.0,115.0,8.0,36.39844,376.625,3.5,1.01,7.29980469,136.0,7.299805,100.0,86.0,1138.0,0.0,adl>=4 (>=5 if sur)
61.25897,1,male,0,7,70,Lung Cancer,Cancer,1,14.0,>$50k,6386.0,14452.7344,5.0,white,5.0,1,0,0,metastatic,0.599999905,0.1,no dnr,7.0,137.0,2.29980469,120.0,24.0,38.09375,270.0,3.5,0.69995117,0.59997559,137.0,7.469727,121.0,13.0,5250.0,0.0,<2 mo. follow-up
72.25696,0,male,0,9,451,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,57475.0,14452.7344,27.5,white,48.0,4,0,0,no,0.879999638,0.85,no dnr,9.0,133.0,7.39941406,75.0,28.0,37.5,333.3,3.5,1.01,1.89990234,139.0,7.419922,95.0,24.0,5200.0,0.0,no(M2 and SIP pres)
74.23096,1,male,1,19,19,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,175130.0,14452.7344,45.0,white,97.0,42,0,0,yes,0.199999928,0.15,dnr after sadm,3.0,75.0,13.8984375,65.0,13.0,36.5,344.0,3.3999023,1.39990234,8.19921875,138.0,7.379883,193.0,66.0,0.0,0.0,<2 mo. follow-up
62.26398,0,male,0,8,450,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,26205.0,14452.7344,29.0,black,65.0,1,1,0,no,0.799999714,0.6,no dnr,8.0,74.0,2.09960938,132.0,36.0,38.79688,419.0,3.5,5.69921875,0.69995117,135.0,7.379883,77.0,14.0,1750.0,0.0,no(M2 and SIP pres)
76.82996,0,male,0,25,449,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,$25-$50k,120051.0,14452.7344,24.5,white,34.0,33,0,0,yes,0.75,0.5,no dnr,25.0,130.0,15.0996094,115.0,40.0,35.0,185.6875,2.8999023,0.69995117,1.09985352,139.0,7.5,116.0,14.0,2502.0,0.0,adl>=4 (>=5 if sur)
45.27899,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,21231.0,14452.7344,20.5,black,55.0,2,0,0,no,0.399999857,0.88,dnr after sadm,6.0,72.0,9.8984375,83.0,20.0,36.39844,319.0,3.5,1.01,0.79992676,135.0,7.479492,102.0,18.0,500.0,6.0,<2 mo. follow-up
54.793,0,female,0,8,449,COPD,COPD/CHF/Cirrhosis,3,10.0,$25-$50k,11367.0,14452.7344,9.0,white,35.0,1,0,0,no,0.899999619,0.9,no dnr,8.0,71.0,6.89941406,100.0,18.0,36.5,361.875,3.5,0.69995117,0.79992676,138.0,7.439453,86.0,8.0,2400.0,3.3666992,SIP>=30
58.61697,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,2,0.0,under $11k,39128.0,14452.7344,22.0,white,34.0,9,0,0,no,0.799999714,0.3,dnr after sadm,4.0,53.0,6.79980469,108.0,20.0,38.0,333.3,3.5,8.19921875,0.69995117,130.0,7.419922,80.0,9.0,1185.0,0.0,<2 mo. follow-up
46.26398,1,male,1,15,15,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,80718.0,14452.7344,36.666657,other,63.0,3,0,0,metastatic,0.599999905,0.6,dnr after sadm,11.0,73.0,7.79980469,76.0,24.0,36.89844,242.84375,3.0,0.59997559,0.69995117,139.0,7.369141,227.0,14.0,2502.0,0.0,<2 mo. follow-up
72.88696,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,122871.0,14452.7344,50.0,white,78.0,11,0,0,no,0.199999928,0.1,dnr after sadm,10.0,138.0,14.0,105.0,29.0,38.69531,380.0,2.0996094,0.19998169,1.89990234,155.0,7.469727,621.0,43.0,3135.0,1.925293,<2 mo. follow-up
57.659,1,female,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,191281.0,14452.7344,48.25,white,26.0,6,1,0,no,0.959999561,0.94,dnr after sadm,12.0,65.0,6.89941406,115.0,30.0,35.0,231.65625,3.3999023,1.01,0.79992676,131.0,7.439453,142.0,30.0,2375.0,0.0,<2 mo. follow-up
66.72095,1,female,1,38,38,ARF/MOSF w/Sepsis,ARF/MOSF,1,4.0,$11-$25k,59995.78781114967,14452.7344,35.25,black,73.0,6,0,0,no,0.049999982,0.01,no dnr,14.58258953168044,81.0,6.19921875,72.0,20.0,37.79688,333.3,2.699707,3.39990234,1.19995117,130.0,7.419922,104.0,15.0,2502.0,0.0,<2 mo. follow-up
77.65094,0,male,0,25,447,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,90077.0,14452.7344,28.0,white,70.0,1,0,0,no,0.299999952,0.2,dnr after sadm,2.0,63.0,11.6992188,110.0,44.0,37.69531,114.28125,3.7998047,0.89990234,0.69995117,138.0,7.469727,129.0,32.0,2125.0,0.0,no(M2 and SIP pres)
70.15997,0,male,0,23,446,Coma,Coma,0,12.0,under $11k,62877.0,14452.7344,29.333328,black,31.0,1,0,0,no,0.5,0.45,no dnr,23.0,52.0,20.796875,135.0,22.0,37.69531,110.90625,3.5,6.39941406,2.79980469,132.0,7.379883,50.0,96.0,126.0,0.0,adl>=4 (>=5 if sur)
37.51099,0,male,0,18,446,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,71649.0,14452.7344,33.666657,white,45.0,3,0,0,no,0.699999809,0.5,no dnr,18.0,105.0,8.79882812,160.0,14.0,36.5,271.375,2.8999023,0.5,0.59997559,138.0,7.519531,171.0,14.0,930.0,2.7729492,<2 mo. follow-up
44.60199,1,male,0,6,15,Cirrhosis,COPD/CHF/Cirrhosis,4,10.0,under $11k,17393.0,14452.7344,14.0,white,35.0,1,0,0,no,0.75,0.65,no dnr,6.0,123.0,11.3984375,125.0,20.0,36.89844,144.4375,2.3999023,1.69995117,2.39990234,146.0,7.469727,240.0,28.0,3670.0,5.0,<2 mo. follow-up
61.73297,0,female,0,11,446,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,39205.0,14452.7344,34.5,other,48.0,1,1,0,no,0.349999905,0.3,dnr after sadm,1.0,68.0,5.69921875,74.0,28.0,36.29688,333.3,3.5,1.01,1.89990234,138.0,7.419922,79.0,41.0,1000.0,0.0,no(M2 and SIP pres)
39.67697,0,male,0,11,446,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,35968.0,14452.7344,29.0,black,41.0,1,0,0,no,0.849999905,0.84,no dnr,11.0,79.0,5.5,80.0,20.0,36.59375,333.3,3.699707,1.01,0.79992676,145.0,7.419922,98.0,11.0,975.0,0.0,no(M2 and SIP pres)
75.30499,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,139100.0,14452.7344,37.0,black,63.0,17,0,0,yes,0.599999905,0.5,dnr after sadm,8.0,73.0,10.1992188,76.0,24.0,38.69531,333.3,3.5996094,0.29998779,0.59997559,134.0,7.419922,85.0,8.0,3100.0,5.0,<2 mo. follow-up
54.20898,0,male,0,9,445,CHF,COPD/CHF/Cirrhosis,3,16.0,$11-$25k,7800.0,14452.7344,13.0,white,41.0,1,1,0,no,0.799999714,0.7,no dnr,9.0,84.0,10.0996094,76.0,22.0,35.29688,404.75,3.199707,1.0,1.5,134.0,7.489258,107.0,88.0,950.0,5.0,no(M2 and SIP pres)
41.87799,1,male,0,4,389,Lung Cancer,Cancer,1,14.0,$25-$50k,10471.0,14452.7344,12.0,white,12.0,1,0,0,metastatic,0.899999619,0.7,no dnr,4.0,108.0,5.79980469,125.0,6.0,36.39844,197.5,2.3999023,7.29980469,1.09985352,145.0,7.359375,103.0,14.0,2070.0,0.0,no(M2 and SIP pres)
44.10098,1,male,0,5,196,Lung Cancer,Cancer,1,12.0,under $11k,14569.0,14452.7344,15.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,28.0,41.09375,0.0,0.0,36.59375,88.5625,3.5,1.01,1.59985352,149.0,7.379883,163.0,53.0,110.0,0.0,no(M2 and SIP pres)
56.50897,1,male,1,14,14,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,34959.0,14452.7344,19.333328,other,26.0,1,0,0,no,0.799999714,0.7,dnr after sadm,6.0,105.0,17.1992188,125.0,24.0,39.5,266.625,3.5,0.59997559,0.69995117,131.0,7.489258,87.0,6.0,1375.0,3.0,<2 mo. follow-up
81.85596,0,male,0,8,444,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,5708.0,14452.7344,8.0,white,34.0,1,0,0,no,0.799999714,0.65,no dnr,8.0,165.0,10.1992188,105.0,12.0,38.09375,147.5,2.2998047,0.59997559,0.89990234,145.0,7.359375,160.0,21.0,4500.0,0.0,no(M2 and SIP pres)
59.67999,1,male,0,18,146,Colon Cancer,Cancer,1,12.0,>$50k,23874.0,14452.7344,9.666664,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,18.0,62.0,9.69921875,75.0,32.0,36.19531,179.5625,3.199707,4.0,2.0,139.0,7.419922,137.0,47.0,88.1875,0.0,no(M2 and SIP pres)
51.504,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$25-$50k,96981.0,14452.7344,25.0,black,33.0,13,1,0,no,0.5,0.5,dnr after sadm,17.0,78.0,22.5,70.0,32.0,35.09375,190.0,2.8999023,0.39996338,0.79992676,138.0,7.359375,208.0,12.0,1920.0,0.0,<2 mo. follow-up
19.81899,0,male,0,18,442,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,37577.0,14452.7344,23.666656,white,35.0,1,0,0,no,0.899999619,0.9,no dnr,18.0,125.0,9.8984375,125.0,11.0,39.19531,330.0,3.5,1.01,0.5,135.0,7.40918,184.0,7.0,1865.0,0.0,no(M2 and SIP pres)
38.35699,0,male,0,14,442,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,28330.0,14452.7344,14.333328,black,46.0,2,0,0,no,0.799999714,0.8,no dnr,14.0,108.0,24.296875,75.0,12.0,38.0,230.0,1.7998047,1.01,7.5,130.0,7.439453,330.0,73.0,90.0,0.0,<2 mo. follow-up
81.24799,1,male,0,16,91,ARF/MOSF w/Sepsis,ARF/MOSF,2,5.0,$11-$25k,35584.0,14452.7344,20.0,white,51.0,3,0,0,yes,0.25,0.05,dnr after sadm,12.0,73.0,8.29882812,100.0,22.0,36.5,333.3,3.5,1.01,2.0,133.0,7.419922,88.0,34.0,2502.0,6.0,adl>=4 (>=5 if sur)
81.45898,1,male,0,19,349,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,148940.0,14452.7344,24.666656,white,23.0,27,0,0,no,0.25,0.15,dnr after sadm,2.0,68.0,12.6992188,82.0,20.0,36.29688,333.3,3.5996094,0.59997559,0.69995117,151.0,7.419922,89.0,12.0,1000.0,7.0,adl>=4 (>=5 if sur)
49.52197,1,male,0,6,53,Lung Cancer,Cancer,1,12.0,>$50k,10604.0,14452.7344,20.0,white,22.0,1,0,0,metastatic,0.899999619,0.6,dnr after sadm,4.0,112.0,9.19921875,105.0,41.0,37.79688,161.21875,3.5,1.01,0.89990234,140.0,7.449219,135.0,13.0,2850.0,0.0,<2 mo. follow-up
19.127,0,female,0,4,439,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,17649.0,14452.7344,18.0,white,19.0,1,0,0,no,0.949999809,0.95,no dnr,4.0,104.0,8.69921875,112.0,20.0,37.5,333.3,3.0996094,0.59997559,0.89990234,135.0,7.419922,314.0,11.0,5700.0,0.0,no(M2 and SIP pres)
79.41998,1,male,1,52,52,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,134458.0,14452.7344,31.75,white,38.0,1,0,0,no,0.699999809,0.65,dnr after sadm,48.0,107.0,11.5996094,50.0,22.0,36.69531,155.0,3.5,1.01,0.89990234,135.0,7.469727,103.0,23.0,2625.0,6.0,<2 mo. follow-up
36.06799,1,male,0,32,142,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,73203.0,14452.7344,19.0,black,35.0,7,1,0,no,0.699999809,0.5,no dnr,32.0,52.0,36.8984375,145.0,10.0,39.09375,167.5,3.5,1.01,1.5,139.0,7.399414,145.0,17.0,1650.0,1.0,SIP>=30
69.66699,1,female,0,15,326,Colon Cancer,Cancer,1,11.0,$25-$50k,25405.0,14452.7344,14.333328,white,19.0,1,0,0,metastatic,0.899999619,0.75,no dnr,15.0,78.0,10.1992188,65.0,16.0,36.19531,642.75,3.5,1.69995117,1.09985352,140.0,7.349609,158.0,10.0,2950.0,1.0,<2 mo. follow-up
34.42297,0,male,0,4,439,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,3491.0,14452.7344,8.0,black,35.0,1,0,0,no,0.5,0.3,no dnr,4.0,58.0,21.6992188,115.0,10.0,38.59375,150.0,3.5,1.01,2.19970703,139.0,7.489258,156.0,54.0,1315.0,2.3891602,no(M2 and SIP pres)
46.58698,1,female,0,45,365,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,>$50k,125548.0,14452.7344,32.75,black,40.0,3,1,0,no,0.75,0.75,no dnr,45.0,113.0,9.0,55.0,30.0,36.5,333.3,3.5,1.01,1.01,140.0,7.419922,420.0,23.0,4005.0,0.0,adl>=4 (>=5 if sur)
50.57098,1,female,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,42242.0,14452.7344,18.0,black,25.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,155.0,6.79980469,105.0,30.0,36.39844,144.4375,3.5,1.01,1.29980469,137.0,7.509766,267.0,26.0,1460.0,4.0,<2 mo. follow-up
74.85797,1,female,0,41,52,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,51726.0,14452.7344,20.0,white,40.0,1,0,0,no,0.5,0.3,dnr after sadm,7.0,58.0,19.6992188,115.0,56.0,38.59375,200.0,3.0996094,36.1953125,4.19921875,137.0,7.40918,122.0,136.0,665.0,0.0,<2 mo. follow-up
68.71698,1,male,1,21,21,MOSF w/Malig,ARF/MOSF,1,7.0,under $11k,84442.0,14452.7344,29.333328,white,35.0,1,0,0,yes,0.099999964,0.05,dnr after sadm,14.0,79.0,10.0996094,68.0,20.0,37.69531,333.3,4.0,0.59997559,0.89990234,138.0,7.419922,86.0,7.0,4970.0,1.0,<2 mo. follow-up
66.54596,1,male,0,40,165,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,162193.0,14452.7344,34.75,white,26.0,7,0,0,no,0.699999809,0.5,no dnr,40.0,115.0,13.6992188,135.0,32.0,38.59375,185.6875,3.5,1.01,0.59997559,136.0,7.479492,185.0,9.0,950.0,0.0,no(M2 and SIP pres)
63.75098,0,female,0,33,437,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,106855.0,14452.7344,28.75,white,44.0,11,0,0,metastatic,0.699999809,0.5,no dnr,33.0,72.0,33.5,65.0,32.0,37.69531,116.3125,3.0,2.09960938,0.89990234,131.0,7.399414,98.0,15.0,3475.0,1.0,adl>=4 (>=5 if sur)
57.487,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,78351.0,14452.7344,32.0,white,57.0,3,0,0,no,0.699999809,0.5,dnr after sadm,3.0,103.0,5.69921875,64.0,28.0,36.5,340.0,3.5,0.5,0.69995117,137.0,7.40918,133.0,14.0,550.0,0.0,<2 mo. follow-up
72.73596,0,female,0,40,436,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,145725.0,14452.7344,31.25,black,65.0,3,0,0,no,0.699999809,0.5,no dnr,40.0,60.0,15.5,105.0,24.0,38.89844,170.0,2.5996094,0.5,4.89941406,141.0,7.389648,232.0,61.0,3765.0,2.0,no(M2 and SIP pres)
57.29199,0,male,0,31,435,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,121247.0,14452.7344,22.5,white,41.0,6,0,0,no,0.799999714,0.8,no dnr,31.0,122.0,0.09999084,115.0,42.0,38.79688,135.0,3.5,1.69995117,0.5,136.0,7.439453,232.0,12.0,5620.0,0.0,adl>=4 (>=5 if sur)
70.73499,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20379.0,14452.7344,34.0,white,71.0,1,0,0,no,0.099999964,0.05,dnr after sadm,3.0,75.0,5.29980469,72.0,24.0,36.39844,333.3,2.5,5.79980469,1.0,134.0,7.419922,112.0,31.0,925.0,3.3344727,<2 mo. follow-up
64.43799,0,male,0,52,434,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,165091.0,14452.7344,13.75,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,52.0,107.0,10.7988281,45.0,34.0,35.19531,115.29688,3.5,1.01,0.5,133.0,7.339844,131.0,20.0,1730.0,2.2319336,<2 mo. follow-up
72.85699,1,male,0,14,225,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,35895.0,14452.7344,22.0,black,37.0,1,1,0,yes,0.699999809,0.5,no dnr,14.0,81.0,8.59960938,68.0,20.0,37.79688,333.3,3.5,0.59997559,0.69995117,138.0,7.419922,116.0,4.0,2502.0,1.1667481,<2 mo. follow-up
77.35797,0,female,0,10,433,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,87387.0,14452.7344,27.5,white,19.0,21,1,0,no,0.699999809,0.5,no dnr,10.0,122.0,9.0,140.0,12.0,36.0,205.0,3.5,1.01,1.19995117,141.0,7.519531,103.0,32.0,165.5,2.6953125,<2 mo. follow-up
69.76599,1,female,0,3,101,Colon Cancer,Cancer,2,12.0,under $11k,11018.0,14452.7344,9.0,white,23.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,42.0,30.0976562,155.0,8.0,35.89844,256.625,1.1999512,2.5,4.0,133.0,7.279297,109.0,136.0,712.0,1.8696289,SIP>=30
69.40497,1,male,0,13,388,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,28535.0,14452.7344,23.0,white,24.0,1,0,0,no,0.949999809,0.95,no dnr,13.0,75.0,11.3984375,155.0,34.0,38.29688,240.0,1.1999512,1.01,1.79980469,142.0,7.459961,229.0,48.0,3990.0,0.0,no(M2 and SIP pres)
49.45697,1,male,0,15,83,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59995.78781114967,14452.7344,24.0,white,41.0,17,0,0,no,0.599999905,0.5,no dnr,14.58258953168044,72.0,19.0,45.0,34.0,38.09375,233.3125,2.7998047,0.69995117,0.69995117,136.0,7.449219,94.0,39.0,1375.0,0.0,adl>=4 (>=5 if sur)
51.82199,0,male,0,16,432,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,75528.0,14452.7344,17.0,white,36.0,4,0,0,no,0.599999905,0.5,no dnr,16.0,132.0,12.1992188,125.0,32.0,36.19531,215.0,2.699707,4.39941406,2.79980469,145.0,7.479492,79.0,100.0,2325.0,0.0,SIP>=30
82.65594,1,female,0,8,53,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,17117.0,14452.7344,15.5,white,30.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,73.0,7.79980469,105.0,22.0,35.79688,200.0,3.5,1.01,1.09985352,141.0,7.369141,96.0,20.0,2300.0,0.0,<2 mo. follow-up
50.06198,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,50018.0,14452.7344,48.0,white,106.0,1,0,0,no,0.299999952,0.15,dnr after sadm,3.0,72.0,6.19921875,119.0,32.0,35.5,293.3125,3.5,1.01,1.09985352,138.0,7.389648,69.0,29.0,2525.0,0.0,<2 mo. follow-up
61.26199,0,male,0,18,431,Colon Cancer,Cancer,2,8.0,$25-$50k,37422.0,14452.7344,18.666656,white,27.0,1,1,0,metastatic,0.699999809,0.5,no dnr,18.0,48.0,13.6992188,135.0,47.0,39.09375,148.0,3.5,0.59997559,1.69995117,147.0,7.389648,211.0,21.0,1945.0,0.0,no(M2 and SIP pres)
50.20898,0,male,0,10,430,Colon Cancer,Cancer,1,14.0,$25-$50k,14872.0,14452.7344,11.5,white,6.0,1,0,0,metastatic,0.899999619,0.7,no dnr,10.0,38.0,18.0976562,115.0,27.0,39.0,100.0,2.0,4.09960938,2.5,148.0,7.349609,162.0,71.0,2040.0,1.0,no(M2 and SIP pres)
45.76599,1,male,0,4,38,Lung Cancer,Cancer,2,12.0,under $11k,5333.0,14452.7344,13.0,white,54.0,1,1,0,metastatic,0.399999857,0.1,dnr after sadm,2.0,72.0,10.3984375,75.0,8.0,39.0,120.0,2.0,0.69995117,1.09985352,140.0,7.399414,68.0,17.0,1770.0,4.0,<2 mo. follow-up
70.34595,0,male,0,14,428,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,22967.0,14452.7344,14.333328,white,45.0,1,0,0,no,0.75,0.75,no dnr,14.0,68.0,15.2988281,115.0,30.0,38.39844,226.65625,1.7998047,1.09985352,6.79980469,141.0,7.349609,77.0,71.0,5.0,0.0,no(M2 and SIP pres)
60.47897,0,female,0,9,428,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,11988.0,14452.7344,13.0,white,34.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,55.0,5.79980469,70.0,36.0,35.79688,203.3125,1.5,0.5,2.5,133.0,7.359375,139.0,50.0,2760.0,0.0,SIP>=30
75.29395,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,23497.0,14452.7344,37.0,white,43.0,4,0,0,metastatic,0.099999964,0.0,dnr after sadm,2.0,152.0,5.5,60.0,30.0,38.69531,228.5625,3.5,1.01,0.89990234,134.0,7.439453,103.0,13.0,1320.0,0.0,<2 mo. follow-up
65.396,1,male,0,25,38,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,78471.0,14452.7344,26.25,white,34.0,1,1,0,no,0.699999809,0.6,dnr after sadm,16.0,108.0,9.69921875,160.0,35.0,37.79688,165.0,3.5,1.01,0.69995117,137.0,7.479492,130.0,17.0,3775.0,3.5927734,<2 mo. follow-up
69.08698,1,male,0,8,225,Lung Cancer,Cancer,1,14.0,under $11k,13090.0,14452.7344,13.0,white,6.0,1,0,0,metastatic,0.699999809,0.3,no dnr,8.0,61.0,5.0,76.0,24.0,36.79688,333.3,2.5,1.69995117,3.0,136.0,7.419922,120.0,56.0,1275.0,0.494751,<2 mo. follow-up
59.61398,1,female,0,8,173,Colon Cancer,Cancer,1,15.0,>$50k,17474.0,14452.7344,10.0,white,16.0,1,0,0,metastatic,0.899999619,0.8,no dnr,8.0,67.0,15.3984375,105.0,28.0,35.89844,170.0,3.2998047,1.01,4.59960938,127.0,7.349609,200.0,101.0,3355.0,0.494751,<2 mo. follow-up
51.06897,0,male,0,50,424,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,153904.0,14452.7344,33.25,hispanic,19.0,1,0,0,no,0.799999714,0.7,no dnr,50.0,112.0,15.5,115.0,50.0,39.09375,191.40625,3.5,0.89990234,0.79992676,141.0,7.449219,103.0,11.0,4955.0,2.137207,no(M2 and SIP pres)
55.36798,1,male,0,12,226,Cirrhosis,COPD/CHF/Cirrhosis,1,1.0,under $11k,41291.0,14452.7344,37.0,white,29.0,1,0,0,no,0.599999905,0.6,no dnr,12.0,138.0,10.0,135.0,25.0,37.79688,167.5,3.5,1.01,6.0,136.0,7.399414,101.0,58.0,0.0,1.0,no(M2 and SIP pres)
68.646,0,female,0,8,423,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,14600.0,14452.7344,6.0,white,25.0,2,0,0,no,0.799999714,0.8,no dnr,8.0,67.0,9.29882812,70.0,20.0,36.5,333.3,2.0996094,1.39990234,1.29980469,132.0,7.419922,59.0,40.0,4450.0,1.1667481,no(M2 and SIP pres)
72.71198,0,male,0,7,424,CHF,COPD/CHF/Cirrhosis,3,12.0,>$50k,10007.0,14452.7344,9.5,white,36.0,1,0,0,no,0.949999809,0.75,no dnr,7.0,73.0,5.69921875,96.0,20.0,36.29688,333.3,3.8999023,0.5,0.79992676,137.0,7.419922,90.0,5.0,5175.0,0.0,no(M2 and SIP pres)
67.50397,0,male,0,49,422,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,162444.0,14452.7344,26.0,white,61.0,16,0,0,no,0.5,0.45,no dnr,49.0,79.0,5.79980469,64.0,16.0,37.0,333.3,3.5996094,0.79992676,0.89990234,137.0,7.419922,90.0,11.0,4725.0,0.0,SIP>=30
74.81696,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,22608.0,14452.7344,31.0,white,32.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,73.0,12.0996094,119.0,22.0,35.79688,476.0,3.5,1.01,0.79992676,132.0,7.479492,208.0,11.0,3520.0,2.480957,<2 mo. follow-up
74.93195,1,male,1,42,42,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$11-$25k,59995.78781114967,14452.7344,24.0,white,46.0,1,0,0,no,0.399999857,0.2,no dnr,14.58258953168044,77.0,5.79980469,66.0,24.0,36.39844,333.3,3.5,2.0,1.69995117,132.0,7.419922,88.0,34.0,1200.0,7.0,<2 mo. follow-up
40.24899,0,female,0,49,422,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,211918.0,14452.7344,42.5,white,69.0,1,0,0,no,0.399999857,0.3,no dnr,49.0,113.0,3.19970703,72.0,22.0,37.69531,333.3,3.8999023,1.29980469,1.19995117,136.0,7.419922,112.0,13.0,3600.0,0.0,no(M2 and SIP pres)
70.89697,1,male,1,20,20,Lung Cancer,Cancer,4,13.0,under $11k,28242.0,14452.7344,14.666664,white,30.0,1,1,0,metastatic,0.399999857,0.4,dnr after sadm,12.0,108.0,14.5,104.0,32.0,35.79688,242.84375,3.5,1.29980469,1.0,139.0,7.479492,112.0,37.0,3900.0,0.0,<2 mo. follow-up
34.60098,0,female,0,56,421,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,227914.0,14452.7344,41.0,black,38.0,1,0,0,no,0.799999714,0.8,no dnr,56.0,62.0,8.29882812,125.0,44.0,36.69531,280.0,2.5996094,1.5,1.29980469,138.0,7.419922,108.0,28.0,2315.0,0.0,no(M2 and SIP pres)
81.71899,1,female,1,7,7,Coma,Coma,2,12.0,under $11k,26992.0,14452.7344,30.0,black,30.0,1,1,0,yes,0.5,0.5,dnr after sadm,4.0,113.0,43.3984375,125.0,29.0,38.0,187.5,2.5,1.39990234,6.69921875,139.0,7.329102,112.0,87.0,2055.0,3.0,<2 mo. follow-up
66.43695,1,male,0,6,180,Lung Cancer,Cancer,2,12.0,under $11k,12589.0,14452.7344,15.0,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,65.0,16.5976562,105.0,36.0,38.89844,306.625,2.0,1.01,1.89990234,160.0,7.459961,129.0,35.0,1365.0,2.0859375,<2 mo. follow-up
55.754,0,male,0,24,420,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,>$50k,75213.0,14452.7344,28.333328,white,95.0,3,0,0,no,0.899999619,0.9,no dnr,24.0,57.0,6.09960938,110.0,9.0,37.59375,175.5,3.5,1.01,0.89990234,135.0,7.449219,142.0,16.0,2645.0,0.0,no(M2 and SIP pres)
65.55194,1,male,0,32,63,Coma,Coma,1,12.0,under $11k,65156.0,14452.7344,25.0,white,25.0,1,0,0,no,0.5,0.5,dnr after sadm,4.0,78.0,8.8984375,118.0,34.0,36.89844,333.3,2.7998047,0.79992676,0.79992676,139.0,7.419922,91.0,4.0,2700.0,0.0,<2 mo. follow-up
68.84094,1,female,0,12,32,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,13711.0,14452.7344,6.5,white,26.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,72.0,5.5,115.0,14.0,37.09375,210.0,3.2998047,0.69995117,0.59997559,136.0,7.379883,96.0,3.0,3905.0,3.0214844,<2 mo. follow-up
86.17395,1,male,1,4,4,Coma,Coma,0,12.0,under $11k,7012.0,14452.7344,8.0,white,31.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,118.0,20.5,53.0,36.0,38.19531,236.65625,2.0996094,0.39996338,1.0,134.0,7.449219,92.0,31.0,1540.0,2.8237305,<2 mo. follow-up
50.61697,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,82086.0,14452.7344,40.0,black,80.0,22,0,0,no,0.699999809,0.5,dnr after sadm,4.0,115.0,17.1992188,115.0,7.0,37.79688,213.3125,2.0,0.29998779,1.0,133.0,7.439453,243.0,22.0,3590.0,2.5800781,<2 mo. follow-up
48.73099,0,female,0,11,418,Lung Cancer,Cancer,1,12.0,under $11k,15076.0,14452.7344,10.5,white,12.0,1,0,0,metastatic,0.75,0.5,no dnr,11.0,79.0,4.09960938,75.0,20.0,36.69531,333.3,3.5,0.59997559,0.79992676,139.0,7.419922,212.0,8.0,1100.0,0.0,no(M2 and SIP pres)
60.92499,0,female,0,44,418,Coma,Coma,0,12.0,under $11k,115272.0,14452.7344,31.5,black,28.0,3,0,0,no,0.049999982,0.05,no dnr,44.0,65.0,9.59960938,72.0,12.0,36.19531,333.3,2.699707,17.5976562,0.69995117,136.0,7.419922,95.0,11.0,2502.0,0.0,adl>=4 (>=5 if sur)
80.51495,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,57044.0,14452.7344,41.0,white,45.0,8,1,0,no,0.299999952,0.2,dnr after sadm,2.0,125.0,6.89941406,170.0,8.0,40.29688,438.0625,3.5,1.01,0.59997559,134.0,7.479492,377.0,8.0,2820.0,0.0,<2 mo. follow-up
49.54398,0,female,0,6,417,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,19758.0,14452.7344,23.0,black,14.0,2,0,0,no,0.799999714,0.75,no dnr,6.0,75.0,8.29882812,68.0,20.0,37.0,333.3,2.0,4.89941406,0.89990234,129.0,7.419922,112.0,12.0,2502.0,0.0,SIP>=30
68.44098,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,17.0,>$50k,22156.0,14452.7344,46.0,white,40.0,4,0,0,yes,0.049999982,0.05,dnr after sadm,2.0,73.0,18.8984375,78.0,12.0,36.59375,276.625,3.5,1.0,6.79980469,131.0,7.459961,139.0,107.0,1005.0,7.0,<2 mo. follow-up
65.47797,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,4656.0,14452.7344,9.0,white,32.0,1,0,0,yes,0.599999905,0.4,no dnr,4.0,70.0,8.79882812,110.0,16.0,36.39844,217.5,2.8999023,1.01,4.5,130.0,7.419922,74.0,113.0,2510.0,4.0,<2 mo. follow-up
73.04297,1,female,0,12,263,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,29016.0,14452.7344,25.5,black,59.0,1,1,0,no,0.199999928,0.2,no dnr,12.0,142.0,5.79980469,115.0,28.0,38.59375,227.5,2.699707,1.01,0.69995117,138.0,7.429688,121.0,18.0,2360.0,0.0,adl>=4 (>=5 if sur)
77.08698,1,male,0,19,65,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,39533.0,14452.7344,26.333328,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,19.0,60.0,10.6992188,115.0,5.0,36.79688,251.40625,1.0,1.01,1.09985352,136.0,7.369141,141.0,7.0,3352.0,2.9536133,<2 mo. follow-up
45.64499,0,male,0,7,415,Lung Cancer,Cancer,1,23.0,$25-$50k,7302.0,14452.7344,6.5,white,10.0,1,0,0,metastatic,0.599999905,0.3,no dnr,7.0,48.0,22.3984375,175.0,28.0,39.89844,130.0,3.5,1.01,0.89990234,142.0,7.359375,178.0,18.0,1710.0,0.494751,no(M2 and SIP pres)
50.02597,0,male,0,20,415,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,66125.0,14452.7344,22.0,white,70.0,1,0,0,metastatic,0.699999809,0.5,no dnr,20.0,108.0,15.0,70.0,4.0,36.09375,320.0,3.5,1.01,7.5,137.0,7.399414,121.0,47.0,0.0,0.0,no(M2 and SIP pres)
78.72095,1,male,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,$11-$25k,112577.0,14452.7344,32.75,black,56.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,4.0,105.0,13.2988281,120.0,13.0,39.29688,193.3125,2.3999023,1.79980469,0.79992676,133.0,7.449219,105.0,20.0,3700.0,0.0,<2 mo. follow-up
55.38898,1,male,1,79,79,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,$11-$25k,292373.0,14452.7344,41.75,white,57.0,5,0,0,no,0.699999809,0.5,dnr after sadm,17.0,49.0,5.5,0.0,0.0,39.29688,177.0,2.8999023,0.5,1.19995117,147.0,7.549805,312.0,28.0,4065.0,0.0,adl>=4 (>=5 if sur)
63.24399,1,female,0,11,66,Coma,Coma,2,10.0,under $11k,13705.0,14452.7344,13.0,white,27.0,1,0,0,yes,0.199999928,0.05,dnr before sadm,-1.0,77.0,15.0996094,84.0,20.0,36.09375,333.3,4.2998047,0.69995117,1.29980469,142.0,7.419922,92.0,26.0,1125.0,1.0,adl>=4 (>=5 if sur)
95.53699,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,11729.0,14452.7344,26.0,white,66.0,1,0,0,no,0.5,0.5,no dnr,4.0,107.0,71.6875,45.0,13.0,36.59375,251.84375,3.3999023,0.59997559,1.19995117,138.0,7.40918,79.0,23.0,2470.0,0.0,<2 mo. follow-up
27.25299,0,female,0,38,412,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,161518.0,14452.7344,37.0,white,47.0,7,0,0,no,0.599999905,0.2,no dnr,38.0,115.0,14.0,105.0,24.0,37.79688,340.0,2.699707,1.01,0.79992676,136.0,7.469727,189.0,25.0,1935.0,0.0,no(M2 and SIP pres)
53.728,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,33447.0,14452.7344,36.0,black,62.0,4,0,0,metastatic,0.299999952,0.15,dnr after sadm,2.0,103.0,8.69921875,55.0,12.0,36.59375,333.3,3.5,0.29998779,0.89990234,141.0,7.419922,128.0,14.0,850.0,1.0,<2 mo. follow-up
50.73199,1,male,0,4,185,Lung Cancer,Cancer,1,14.0,$25-$50k,5207.0,14452.7344,11.0,white,20.0,1,0,0,metastatic,0.75,0.6,no dnr,4.0,115.0,8.19921875,115.0,12.0,36.79688,142.5,3.2998047,1.01,1.09985352,135.0,7.359375,111.0,18.0,2080.0,0.0,no(M2 and SIP pres)
44.89798,0,male,0,12,411,Colon Cancer,Cancer,1,12.0,under $11k,33648.0,14452.7344,24.0,black,36.0,1,0,0,metastatic,0.699999809,0.5,no dnr,12.0,108.0,17.5,60.0,32.0,36.29688,286.625,1.8999023,0.59997559,1.0,140.0,7.459961,120.0,21.0,1180.0,0.0,no(M2 and SIP pres)
39.90997,0,male,0,6,411,Colon Cancer,Cancer,1,12.0,$11-$25k,8356.0,14452.7344,12.0,black,10.0,1,0,0,metastatic,0.799999714,0.6,no dnr,6.0,127.0,5.89941406,120.0,10.0,38.5,157.5,1.8999023,1.5,0.69995117,127.0,7.459961,99.0,10.0,5565.0,0.494751,no(M2 and SIP pres)
66.80896,1,male,1,11,11,Lung Cancer,Cancer,2,12.0,under $11k,9857.0,14452.7344,11.5,white,47.0,1,1,0,metastatic,0.199999928,0.05,dnr after sadm,3.0,72.0,6.79980469,75.0,32.0,35.29688,287.75,2.699707,0.39996338,1.29980469,126.0,7.419922,96.0,49.0,2555.0,0.0,<2 mo. follow-up
40.129,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,98253.0,14452.7344,45.0,black,71.0,2,0,0,no,0.5,0.5,dnr after sadm,14.0,42.0,22.0,155.0,37.0,34.69531,234.28125,1.3999023,1.69995117,1.39990234,144.0,7.199219,57.0,27.0,1260.0,0.0,<2 mo. follow-up
40.24899,0,male,0,6,410,Colon Cancer,Cancer,1,16.0,>$50k,11127.0,14452.7344,14.0,white,6.0,1,0,0,metastatic,0.899999619,0.8,no dnr,6.0,130.0,6.39941406,75.0,8.0,35.0,428.5625,2.0996094,0.79992676,0.69995117,134.0,7.469727,244.0,7.0,2502.0,0.494751,<2 mo. follow-up
66.50195,1,male,0,3,380,Lung Cancer,Cancer,1,12.0,under $11k,9212.0,14452.7344,11.0,white,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,88.0,9.59960938,68.0,24.0,37.69531,333.3,3.5,1.01,1.5,142.0,7.419922,97.0,15.0,2502.0,2.0893555,<2 mo. follow-up
58.55399,0,male,0,40,408,CHF,COPD/CHF/Cirrhosis,2,8.0,$25-$50k,59511.0,14452.7344,20.5,white,43.0,1,0,0,no,0.849999905,0.75,no dnr,40.0,132.0,11.7988281,125.0,28.0,35.29688,333.3,2.199707,0.19998169,3.39990234,129.0,7.419922,237.0,38.0,2502.0,0.0,<2 mo. follow-up
56.879,1,female,0,19,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,28747.0,14452.7344,14.333328,black,59.0,3,1,0,no,0.699999809,0.5,no dnr,19.0,65.0,13.1992188,40.0,28.0,36.0,230.0,2.0996094,0.89990234,0.79992676,147.0,7.509766,292.0,25.0,3685.0,1.0,<2 mo. follow-up
68.70398,0,female,0,20,407,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,67965.0,14452.7344,27.0,white,32.0,5,0,0,yes,0.699999809,0.5,no dnr,20.0,135.0,13.7988281,115.0,40.0,36.79688,225.0,3.5,1.01,1.0,143.0,7.399414,154.0,17.0,4350.0,0.0,no(M2 and SIP pres)
62.52698,1,male,0,11,36,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,47565.0,14452.7344,15.5,black,27.0,13,0,0,no,0.399999857,0.4,no dnr,11.0,128.0,23.296875,125.0,12.0,36.5,100.0,4.0,1.01,1.29980469,132.0,7.419922,201.0,49.0,2865.0,0.0,<2 mo. follow-up
38.116,0,male,0,33,407,Coma,Coma,0,12.0,$11-$25k,75735.0,14452.7344,31.25,hispanic,29.0,1,0,0,no,0.699999809,0.5,no dnr,33.0,82.0,5.5,115.0,3.0,38.79688,255.0,2.699707,3.89990234,0.79992676,150.0,7.459961,98.0,10.0,4680.0,0.0,adl>=4 (>=5 if sur)
55.60599,0,female,0,6,406,Colon Cancer,Cancer,1,12.0,under $11k,19455.0,14452.7344,16.0,white,34.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,80.0,20.5976562,88.0,24.0,36.39844,333.3,3.699707,0.59997559,0.69995117,135.0,7.419922,86.0,5.0,2502.0,1.1667481,<2 mo. follow-up
32.75598,0,female,0,10,406,Colon Cancer,Cancer,1,12.0,under $11k,21960.0,14452.7344,19.5,hispanic,28.0,1,0,0,metastatic,0.849999905,0.65,no dnr,10.0,77.0,10.7988281,80.0,16.0,38.09375,333.3,4.5,0.69995117,0.79992676,145.0,7.419922,88.0,12.0,7275.0,6.0,no(M2 and SIP pres)
58.51599,1,male,0,8,12,Lung Cancer,Cancer,2,16.0,>$50k,11001.0,14452.7344,12.5,white,46.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,3.0,118.0,5.59960938,115.0,24.0,35.59375,120.40625,3.0,0.5,0.79992676,135.0,7.419922,91.0,10.0,2020.0,6.0,<2 mo. follow-up
61.89999,0,male,0,46,405,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,>$50k,154913.0,14452.7344,31.25,white,34.0,5,0,0,no,0.979999542,0.97,no dnr,46.0,102.0,7.09960938,55.0,8.0,36.59375,205.0,2.199707,4.29980469,0.59997559,138.0,7.339844,246.0,19.0,1090.0,0.0,adl>=4 (>=5 if sur)
30.467,0,male,0,123,405,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,320730.0,14452.7344,14.25,white,19.0,1,0,0,no,0.699999809,0.5,no dnr,123.0,108.0,15.8984375,110.0,22.0,36.79688,324.0,2.2998047,1.29980469,1.19995117,140.0,7.40918,98.0,33.0,2060.0,0.0,no(M2 and SIP pres)
55.806,0,male,0,12,404,ARF/MOSF w/Sepsis,ARF/MOSF,1,2.0,under $11k,15359.0,14452.7344,14.0,black,30.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,73.0,5.19921875,170.0,26.0,36.29688,333.3,3.5,2.59960938,1.09985352,140.0,7.419922,95.0,15.0,2160.0,2.0,no(M2 and SIP pres)
39.28799,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,67588.0,14452.7344,23.0,black,67.0,8,0,0,no,0.699999809,0.5,dnr after sadm,2.0,108.0,14.0996094,115.0,8.0,38.09375,160.0,2.3999023,1.39990234,8.69921875,139.0,7.40918,216.0,96.0,215.0,2.9194336,<2 mo. follow-up
76.82397,0,female,0,29,404,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,130680.0,14452.7344,23.0,white,39.0,21,0,0,no,0.849999905,0.75,no dnr,29.0,72.0,16.6992188,65.0,10.0,37.5,120.0,3.5,0.89990234,1.29980469,139.0,7.479492,151.0,27.0,940.0,1.0,adl>=4 (>=5 if sur)
68.75598,0,female,0,7,404,Colon Cancer,Cancer,1,14.0,$25-$50k,9662.0,14452.7344,8.0,white,10.0,1,0,0,metastatic,0.899999619,0.8,no dnr,7.0,95.0,11.5996094,55.0,29.0,35.69531,108.32812,2.5,2.29980469,2.89990234,123.0,7.349609,109.0,72.0,1290.0,0.0,no(M2 and SIP pres)
70.66095,0,male,0,37,404,MOSF w/Malig,ARF/MOSF,1,16.0,under $11k,70272.0,14452.7344,18.75,white,38.0,1,0,0,yes,0.099999964,0.1,dnr after sadm,2.0,122.0,19.0976562,135.0,10.0,35.89844,247.5,5.0996094,5.09960938,5.89941406,148.0,7.389648,243.0,51.0,140.0,0.0,no(M2 and SIP pres)
37.76898,0,female,0,9,403,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,19026.0,14452.7344,17.0,white,57.0,1,1,0,no,0.799999714,0.7,no dnr,9.0,107.0,9.8984375,80.0,20.0,36.0,333.3,2.8999023,0.59997559,3.89990234,132.0,7.419922,73.0,56.0,4025.0,4.5273438,no(M2 and SIP pres)
22.905,0,male,0,20,403,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,79249.0,14452.7344,26.333328,white,69.0,7,0,0,no,0.899999619,0.9,no dnr,20.0,135.0,37.6953125,135.0,10.0,38.89844,135.53125,2.0,1.29980469,1.19995117,134.0,7.429688,164.0,9.0,4413.0,0.0,no(M2 and SIP pres)
72.73395,1,female,0,70,140,COPD,COPD/CHF/Cirrhosis,1,14.0,under $11k,186634.0,14452.7344,31.5,black,40.0,1,0,0,no,0.799999714,0.7,no dnr,70.0,122.0,24.5976562,100.0,30.0,35.19531,436.625,3.5,0.59997559,1.19995117,144.0,7.369141,261.0,22.0,3005.0,0.0,SIP>=30
72.80194,0,male,0,38,400,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,193359.0,14452.7344,34.75,white,58.0,7,0,0,no,0.299999952,0.25,no dnr,38.0,111.0,8.0,69.0,24.0,36.59375,333.3,3.5,1.01,1.0,139.0,7.419922,92.0,8.0,4450.0,0.0,adl>=4 (>=5 if sur)
70.68896,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,95812.0,14452.7344,40.5,white,50.0,4,0,0,no,0.299999952,0.25,no dnr,13.0,48.0,10.2988281,175.0,38.0,38.29688,260.0,1.8999023,1.01,10.8984375,131.0,7.279297,89.0,68.0,0.0,0.0,<2 mo. follow-up
73.771,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,162977.0,14452.7344,58.0,white,107.0,27,0,0,no,0.399999857,0.3,dnr after sadm,5.0,108.0,11.0996094,75.0,34.0,39.59375,142.5,3.199707,1.01,0.89990234,139.0,7.439453,146.0,24.0,3140.0,2.1186523,<2 mo. follow-up
67.77295,0,male,0,19,400,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$25-$50k,103944.0,14452.7344,30.333328,white,18.0,11,0,0,yes,0.799999714,0.75,no dnr,19.0,71.0,19.3984375,72.0,36.0,35.79688,296.625,2.699707,0.69995117,0.79992676,137.0,7.439453,86.0,11.0,900.0,0.0,no(M2 and SIP pres)
72.97498,0,female,0,20,399,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,59837.0,14452.7344,23.666656,white,50.0,1,1,0,no,0.199999928,0.25,dnr after sadm,3.0,124.0,17.796875,69.0,28.0,36.0,447.0,3.5,1.01,1.19995117,136.0,7.509766,203.0,19.0,750.0,3.0,no(M2 and SIP pres)
53.01599,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,39559.0,14452.7344,25.0,black,48.0,4,0,0,no,0.099999964,0.05,dnr after sadm,3.0,65.0,17.296875,52.0,29.0,35.5,396.0,3.5,41.59375,5.69921875,143.0,7.189453,60.0,80.0,180.0,0.0,<2 mo. follow-up
66.92694,1,female,0,12,50,Colon Cancer,Cancer,1,11.0,under $11k,12287.0,14452.7344,8.0,white,30.0,1,0,0,metastatic,0.799999714,0.1,no dnr,12.0,80.0,4.0,80.0,12.0,37.89844,333.3,4.2998047,0.59997559,0.79992676,137.0,7.419922,93.0,12.0,2502.0,1.0,<2 mo. follow-up
64.05695,1,female,1,3,3,Coma,Coma,2,12.0,under $11k,12862.0,14452.7344,22.0,black,89.0,1,1,0,no,0.0,0.0,no dnr,3.0,187.0,8.3984375,55.0,40.0,38.69531,254.28125,3.5,1.01,0.79992676,145.0,7.449219,123.0,13.0,1930.0,2.6577148,<2 mo. follow-up
66.30499,1,female,0,10,66,Colon Cancer,Cancer,2,2.0,under $11k,8695.0,14452.7344,6.0,black,19.0,1,0,0,metastatic,0.899999619,0.5,no dnr,10.0,58.0,12.2988281,80.0,30.0,39.29688,147.5,3.5,1.01,1.29980469,144.0,7.269531,293.0,34.0,1800.0,4.0,no(M2 and SIP pres)
77.06,1,male,0,12,49,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,61323.0,14452.7344,28.5,white,38.0,16,1,0,no,0.599999905,0.5,dnr after sadm,2.0,112.0,9.59960938,105.0,30.0,37.59375,380.9375,3.2998047,1.29980469,0.5,137.0,7.439453,78.0,3.0,2560.0,0.0,<2 mo. follow-up
73.93799,1,female,0,14,66,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,32261.0,14452.7344,22.333328,white,52.0,1,0,0,no,0.599999905,0.5,no dnr,14.0,58.0,10.3984375,135.0,22.0,38.29688,111.42188,3.5,0.59997559,0.79992676,136.0,7.379883,170.0,14.0,1520.0,1.0,<2 mo. follow-up
57.60999,1,female,1,42,42,MOSF w/Malig,ARF/MOSF,1,7.0,under $11k,160066.0,14452.7344,28.5,black,43.0,3,1,0,yes,0.949999809,0.9,dnr after sadm,40.0,73.0,4.79980469,100.0,36.0,36.0,214.8125,3.0996094,0.39996338,0.69995117,125.0,7.419922,78.0,7.0,1310.0,1.0,<2 mo. follow-up
63.74298,1,male,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,9053.0,14452.7344,11.5,white,49.0,1,0,0,no,0.25,0.1,dnr after sadm,3.0,143.0,13.0,75.0,28.0,35.89844,280.0,2.5,0.59997559,9.59960938,131.0,7.379883,338.0,58.0,0.0,6.0,<2 mo. follow-up
68.94196,1,female,1,5,5,Coma,Coma,0,8.0,under $11k,19644.0,14452.7344,36.0,white,28.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,70.0,9.3984375,80.0,30.0,35.0,333.3,2.8999023,1.5,1.0,131.0,7.419922,99.0,26.0,1560.0,1.8562012,<2 mo. follow-up
22.196,1,female,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,323158.0,14452.7344,49.5,white,63.0,10,0,0,no,0.399999857,0.4,dnr after sadm,33.0,83.0,7.59960938,112.0,20.0,36.39844,333.3,3.5,1.01,0.5,138.0,7.419922,105.0,5.0,2502.0,0.0,<2 mo. follow-up
71.98395,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,94706.0,14452.7344,39.5,white,89.0,8,0,0,no,0.5,0.5,dnr after sadm,7.0,115.0,10.7988281,125.0,38.0,38.39844,160.0,1.6999512,4.19921875,6.79980469,136.0,7.429688,181.0,68.0,3890.0,0.0,<2 mo. follow-up
65.58795,1,male,0,17,62,MOSF w/Malig,ARF/MOSF,2,11.0,$11-$25k,47590.0,14452.7344,23.666656,white,25.0,1,1,0,yes,0.899999619,0.5,no dnr,17.0,58.0,10.5,125.0,36.0,36.79688,92.5,2.8999023,1.0,1.59985352,143.0,7.349609,95.0,36.0,2365.0,0.0,<2 mo. follow-up
46.18799,1,female,0,9,153,Coma,Coma,2,12.0,under $11k,9301.0,14452.7344,9.5,black,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,9.0,127.0,13.8984375,160.0,8.0,36.79688,165.0,2.0,1.0,4.69921875,142.0,7.429688,164.0,76.0,4200.0,2.6689453,<2 mo. follow-up
75.27997,1,female,0,6,158,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,6089.0,14452.7344,14.0,white,13.0,1,0,0,no,0.799999714,0.3,dnr before sadm,0.0,77.0,12.7988281,130.0,24.0,37.09375,323.75,3.5,0.39996338,0.5,134.0,6.989258,97.0,15.0,2502.0,1.0,no(M2 and SIP pres)
59.06897,0,female,0,7,391,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,7544.0,14452.7344,8.5,black,16.0,1,0,0,no,0.899999619,0.9,no dnr,7.0,68.0,15.6992188,115.0,10.0,35.69531,174.0625,3.5,2.69970703,2.89990234,145.0,7.469727,128.0,117.0,2360.0,0.494751,<2 mo. follow-up
40.91397,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,23896.0,14452.7344,38.0,white,66.0,2,0,0,no,0.699999809,0.7,dnr after sadm,3.0,52.0,23.8984375,145.0,8.0,38.69531,200.0,1.5,0.59997559,0.5,130.0,7.429688,109.0,6.0,2645.0,6.0,<2 mo. follow-up
49.41498,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,2,13.0,$25-$50k,32612.0,14452.7344,44.0,white,59.0,2,0,0,metastatic,0.099999964,0.05,dnr after sadm,6.0,55.0,16.8984375,145.0,31.0,38.19531,162.5,2.7998047,0.39996338,1.09985352,142.0,7.369141,117.0,32.0,527.0,0.0,<2 mo. follow-up
33.76297,0,male,0,14,389,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,61906.0,14452.7344,22.333328,white,49.0,4,0,0,no,0.699999809,0.5,no dnr,14.0,74.0,1.89990234,108.0,24.0,37.5,227.5,3.5,1.01,1.0,132.0,7.549805,93.0,10.0,2502.0,2.2768555,<2 mo. follow-up
65.54999,1,male,1,47,47,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,319757.0,14452.7344,34.0,white,52.0,32,0,0,yes,0.099999964,0.0,dnr after sadm,37.0,128.0,13.5996094,125.0,10.0,36.09375,556.0,1.1999512,1.69995117,0.79992676,134.0,7.259766,214.0,5.0,2175.0,2.1630859,<2 mo. follow-up
53.15799,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,108762.0,14452.7344,42.666657,white,33.0,3,0,0,no,0.399999857,0.35,no dnr,20.0,80.0,2.09960938,60.0,20.0,36.5,333.3,4.2998047,0.59997559,1.09985352,139.0,7.419922,82.0,6.0,3650.0,1.0,<2 mo. follow-up
73.39899,0,male,0,8,389,CHF,COPD/CHF/Cirrhosis,2,18.0,$11-$25k,12499.0,14452.7344,17.0,white,24.0,1,0,0,no,0.899999619,0.8,no dnr,8.0,123.0,7.5,128.0,12.0,35.59375,333.3,3.699707,1.0,1.79980469,145.0,7.419922,199.0,36.0,450.0,1.0,no(M2 and SIP pres)
55.13797,1,female,1,5,5,Coma,Coma,2,14.0,$11-$25k,42498.0,14452.7344,31.0,white,23.0,5,0,0,no,0.099999964,0.1,dnr after sadm,5.0,40.0,12.8984375,55.0,37.0,39.69531,303.3125,3.5,3.0,5.79980469,136.0,7.379883,70.0,67.0,7.0,0.0,<2 mo. follow-up
74.935,0,male,0,14,388,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,37297.0,14452.7344,18.333328,white,33.0,2,0,0,no,0.699999809,0.5,no dnr,14.0,109.0,4.09960938,72.0,18.0,37.69531,333.3,3.699707,0.5,0.79992676,136.0,7.419922,92.0,4.0,2550.0,0.0,no(M2 and SIP pres)
65.68097,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,63760.0,14452.7344,36.5,white,45.0,2,1,0,no,0.5,0.45,dnr after sadm,13.0,100.0,62.0,100.0,24.0,37.59375,333.3,3.5,0.39996338,0.79992676,142.0,7.419922,94.0,10.0,1100.0,6.0,<2 mo. follow-up
66.185,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,under $11k,94784.0,14452.7344,56.0,hispanic,71.0,14,1,0,no,0.699999809,0.5,no dnr,3.0,75.0,16.796875,115.0,30.0,38.29688,140.0,3.5,1.59985352,1.29980469,137.0,7.519531,181.0,27.0,5480.0,3.2675781,<2 mo. follow-up
51.14297,0,male,0,6,386,Colon Cancer,Cancer,1,16.0,>$50k,11328.0,14452.7344,11.0,white,3.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,140.0,10.2988281,105.0,26.0,36.29688,492.0,3.3999023,1.01,8.3984375,135.0,7.419922,282.0,48.0,390.0,0.0,no(M2 and SIP pres)
61.28998,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,40815.0,14452.7344,23.5,white,54.0,1,0,0,no,0.5,0.1,dnr after sadm,10.0,142.0,14.6992188,115.0,33.0,35.69531,210.0,3.5,1.01,0.59997559,123.0,7.439453,181.0,18.0,1400.0,0.0,<2 mo. follow-up
33.32199,0,male,0,61,385,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,59995.78781114967,14452.7344,37.0,black,45.0,1,1,0,no,0.299999952,0.2,no dnr,14.58258953168044,107.0,14.7988281,60.0,14.0,36.79688,306.625,2.3999023,0.69995117,1.39990234,142.0,7.40918,184.0,36.0,600.0,0.0,adl>=4 (>=5 if sur)
84.66498,0,male,0,11,384,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,28875.0,14452.7344,24.5,white,43.0,1,0,0,yes,0.25,0.0156,no dnr,11.0,142.0,16.0,65.0,30.0,39.0,191.40625,3.5,1.01,1.0,140.0,7.469727,115.0,9.0,3525.0,0.0,no(M2 and SIP pres)
62.06198,1,male,1,37,37,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,251172.0,14452.7344,35.0,white,40.0,24,0,0,yes,0.599999905,0.5,dnr after sadm,30.0,57.0,6.29980469,60.0,16.0,38.0,333.3,3.5,0.59997559,0.69995117,133.0,7.419922,120.0,120.0,2050.0,0.0,<2 mo. follow-up
47.48297,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,28102.0,14452.7344,47.0,other,38.0,1,0,0,no,0.199999928,0.1,dnr after sadm,4.0,73.0,20.796875,125.0,16.0,38.59375,570.0,3.5,1.5,0.79992676,137.0,7.289062,288.0,14.0,1460.0,0.0,<2 mo. follow-up
44.79398,0,male,0,5,384,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,>$50k,19115.0,14452.7344,20.0,white,10.0,2,0,0,no,0.949999809,0.9,no dnr,5.0,108.0,10.3984375,140.0,36.0,36.19531,333.3,2.699707,1.09985352,1.5,143.0,7.419922,134.0,53.0,2502.0,0.0,no(M2 and SIP pres)
60.698,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,52512.0,14452.7344,53.5,white,70.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,102.0,7.0,120.0,24.0,38.69531,168.5625,2.199707,1.01,1.09985352,150.0,7.469727,98.0,20.0,2425.0,5.0,<2 mo. follow-up
75.49597,1,female,0,7,14,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,9065.0,14452.7344,7.0,white,29.0,1,1,1,no,0.699999809,0.5,no dnr,7.0,78.0,8.3984375,80.0,20.0,36.5,471.375,3.5,0.89990234,1.29980469,134.0,7.459961,77.0,23.0,1850.0,5.0,<2 mo. follow-up
72.422,0,male,0,9,382,ARF/MOSF w/Sepsis,ARF/MOSF,1,4.0,$11-$25k,18527.0,14452.7344,11.5,black,27.0,1,0,0,no,0.25,0.25,dnr after sadm,1.0,117.0,17.0976562,80.0,20.0,36.69531,376.0,3.5,0.5,6.0,139.0,7.369141,64.0,53.0,2450.0,1.0,no(M2 and SIP pres)
85.01599,0,female,0,4,382,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,3918.0,14452.7344,4.0,white,10.0,1,0,0,yes,0.75,0.65,no dnr,4.0,75.0,21.5976562,125.0,44.0,34.79688,212.5,3.5,22.3984375,0.89990234,139.0,7.429688,76.0,9.0,395.0,2.3554688,no(M2 and SIP pres)
76.00299,1,male,0,42,51,MOSF w/Malig,ARF/MOSF,1,15.0,>$50k,88879.0,14452.7344,20.75,white,48.0,2,0,0,metastatic,0.899999619,0.75,no dnr,42.0,75.0,13.7988281,115.0,38.0,35.39844,338.0625,3.5,0.69995117,0.69995117,134.0,7.5,185.0,22.0,2410.0,0.0,<2 mo. follow-up
58.24197,0,male,0,9,382,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,31389.0,14452.7344,29.0,white,33.0,1,0,0,no,0.699999809,0.7,no dnr,9.0,117.0,7.5,72.0,20.0,36.79688,333.3,3.8999023,0.5,0.69995117,136.0,7.419922,168.0,9.0,6100.0,2.6660156,no(M2 and SIP pres)
64.84094,1,male,0,4,28,Lung Cancer,Cancer,0,16.0,$11-$25k,4582.0,14452.7344,6.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,65.0,10.3984375,115.0,29.0,38.59375,243.3125,3.5,1.0,1.79980469,138.0,7.509766,117.0,24.0,4410.0,2.0,<2 mo. follow-up
45.23199,1,male,0,55,369,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,268271.0,14452.7344,39.0,white,51.0,3,1,0,no,0.899999619,0.9,no dnr,55.0,128.0,12.7988281,115.0,12.0,36.09375,360.0,2.0996094,0.19998169,11.8984375,138.0,7.399414,240.0,111.0,600.0,0.0,SIP>=30
78.836,1,female,0,6,370,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,13603.0,14452.7344,20.0,black,42.0,1,0,0,no,0.799999714,0.8,no dnr,6.0,112.0,21.296875,125.0,40.0,38.39844,256.0,2.199707,10.5996094,2.19970703,132.0,7.459961,183.0,28.0,3040.0,0.494751,no(M2 and SIP pres)
67.53497,0,female,0,21,381,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,70783.0,14452.7344,27.333328,black,44.0,3,0,0,no,0.5,0.4,no dnr,21.0,95.0,27.796875,125.0,38.0,37.59375,263.3125,4.1992188,1.01,1.0,140.0,7.459961,192.0,28.0,1065.0,0.0,no(M2 and SIP pres)
34.75699,0,male,0,17,380,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,51410.0,14452.7344,23.333328,black,26.0,2,0,0,no,0.849999905,0.75,no dnr,17.0,58.0,13.1992188,118.0,50.0,38.39844,206.65625,3.5,1.59985352,1.19995117,135.0,7.449219,351.0,37.0,3605.0,0.0,no(M2 and SIP pres)
71.20599,0,male,0,6,379,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5433.0,14452.7344,10.0,white,18.0,1,0,0,yes,0.799999714,0.8,no dnr,6.0,58.0,10.1992188,65.0,10.0,36.89844,190.0,3.5,1.01,2.59960938,132.0,7.399414,160.0,81.0,4690.0,5.0,no(M2 and SIP pres)
69.78796,0,female,0,7,379,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,35607.0,14452.7344,10.0,black,10.0,7,0,0,no,0.899999619,0.9,no dnr,7.0,49.0,20.5976562,200.0,12.0,37.69531,140.0,3.0,13.5,4.09960938,151.0,7.279297,41.0,68.0,0.0,0.0,no(M2 and SIP pres)
51.33499,0,male,0,17,365,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,65095.0,14452.7344,26.333328,white,37.0,1,0,0,yes,0.899999619,0.85,no dnr,17.0,68.0,11.7988281,55.0,11.0,38.89844,165.0,3.5,1.01,0.69995117,135.0,7.439453,149.0,17.0,3270.0,0.0,no(M2 and SIP pres)
72.08197,0,female,0,4,363,COPD,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,2941.0,14452.7344,8.0,white,7.0,1,0,0,no,0.799999714,0.8,no dnr,4.0,68.0,12.2988281,125.0,36.0,36.39844,186.65625,3.3999023,0.59997559,1.09985352,138.0,7.419922,331.0,24.0,565.0,0.0,no(M2 and SIP pres)
79.38397,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,3,2.0,under $11k,17612.0,14452.7344,48.0,black,71.0,1,0,0,yes,0.099999964,0.1,dnr after sadm,2.0,138.0,16.5976562,195.0,35.0,41.09375,296.375,3.5,1.01,0.89990234,131.0,7.449219,181.0,11.0,1587.0,5.0,<2 mo. follow-up
73.71698,1,male,1,12,12,Lung Cancer,Cancer,2,11.0,$11-$25k,41184.0,14452.7344,11.5,white,2.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,4.0,107.0,5.29980469,80.0,20.0,36.69531,333.3,2.699707,1.5,2.29980469,144.0,7.419922,89.0,32.0,675.0,0.0,<2 mo. follow-up
73.81494,0,male,0,3,362,Lung Cancer,Cancer,1,12.0,$11-$25k,10558.0,14452.7344,12.0,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,3.0,28.0,12.0,0.0,0.0,38.39844,306.625,3.8999023,1.01,11.7988281,153.0,7.40918,192.0,87.0,0.0,0.494751,no(M2 and SIP pres)
48.39999,0,female,0,43,361,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,91974.0,14452.7344,19.0,white,73.0,3,0,0,no,0.899999619,0.9,no dnr,43.0,111.0,19.5,124.0,22.0,36.29688,333.3,3.5,1.01,0.59997559,143.0,7.419922,236.0,15.0,2502.0,0.0,no(M2 and SIP pres)
80.29297,1,male,1,34,34,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,147291.0,14452.7344,28.25,white,75.0,1,0,0,no,0.699999809,0.5,no dnr,34.0,65.0,7.59960938,75.0,23.0,37.79688,203.3125,3.5,1.01,3.0,135.0,7.509766,131.0,112.0,4060.0,0.0,<2 mo. follow-up
86.55194,0,female,0,6,360,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,8949.0,14452.7344,11.0,black,33.0,1,0,0,no,0.899999619,0.85,no dnr,6.0,62.0,8.19921875,120.0,42.0,36.79688,157.5,2.2998047,1.39990234,0.69995117,150.0,7.469727,112.0,33.0,1730.0,0.494751,no(M2 and SIP pres)
37.57999,0,female,0,15,360,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,52072.0,14452.7344,24.0,white,34.0,1,1,0,no,0.699999809,0.5,no dnr,15.0,65.0,28.8984375,125.0,9.0,36.79688,205.0,2.0,1.01,1.29980469,144.0,7.229492,104.0,31.0,1165.0,0.0,<2 mo. follow-up
56.38098,0,female,0,37,359,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,123004.0,14452.7344,32.25,white,50.0,2,1,0,no,0.649999619,0.6,no dnr,37.0,73.0,12.5,148.0,24.0,36.19531,333.3,2.5996094,6.09960938,0.89990234,129.0,7.419922,172.0,31.0,465.0,6.0,no(M2 and SIP pres)
69.47595,0,female,0,17,358,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,74091.0,14452.7344,29.333328,black,43.0,5,1,0,no,0.799999714,0.75,no dnr,17.0,132.0,8.69921875,105.0,13.0,38.59375,230.0,3.5,1.01,0.5,137.0,7.539062,180.0,7.0,2945.0,1.0,adl>=4 (>=5 if sur)
61.79599,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,66966.0,14452.7344,36.0,white,55.0,1,0,0,yes,0.399999857,0.4,no dnr,15.0,108.0,46.59375,140.0,12.0,38.0,356.0,1.1999512,3.0,1.59985352,130.0,7.299805,140.0,39.0,1385.0,5.0,<2 mo. follow-up
75.92297,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$11-$25k,89086.0,14452.7344,34.666657,white,40.0,2,0,0,no,0.699999809,0.6,dnr after sadm,20.0,48.0,17.796875,170.0,33.0,38.59375,128.0,3.5,1.01,5.0,131.0,7.369141,110.0,111.0,235.0,0.0,<2 mo. follow-up
83.23297,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,16502.0,14452.7344,29.0,white,64.0,5,0,1,yes,0.0,0.0,dnr after sadm,2.0,80.0,32.8984375,70.0,6.0,39.39844,150.0,2.5996094,0.89990234,1.09985352,131.0,7.479492,104.0,30.0,5145.0,4.0,<2 mo. follow-up
71.31598,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,28355.0,14452.7344,21.5,white,64.0,7,0,0,metastatic,0.099999964,0.0,dnr after sadm,2.0,107.0,9.5,72.0,24.0,36.39844,333.3,3.7998047,0.39996338,0.5,141.0,7.419922,210.0,3.0,1975.0,1.0,<2 mo. follow-up
59.59198,0,male,0,20,355,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,83944.0,14452.7344,19.666656,white,10.0,8,0,0,yes,0.699999809,0.5,no dnr,20.0,77.0,16.3984375,66.0,22.0,36.19531,150.0,3.5,1.01,0.79992676,133.0,7.449219,82.0,17.0,2650.0,2.4614258,<2 mo. follow-up
42.49698,0,female,0,23,355,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,76321.0,14452.7344,28.0,white,30.0,1,0,0,no,0.799999714,0.7,no dnr,23.0,80.0,18.3984375,80.0,20.0,36.59375,314.25,3.5,1.01,1.19995117,141.0,7.379883,109.0,33.0,1925.0,0.0,no(M2 and SIP pres)
49.78,0,female,0,9,355,Colon Cancer,Cancer,1,14.0,under $11k,22099.0,14452.7344,21.5,white,27.0,1,0,0,metastatic,0.899999619,0.75,no dnr,9.0,58.0,11.0996094,115.0,26.0,35.29688,224.0,3.5,1.01,1.5,130.0,7.129883,290.0,110.0,990.0,0.494751,no(M2 and SIP pres)
66.11395,0,female,0,10,353,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,38449.0,14452.7344,22.0,white,26.0,2,0,0,no,0.899999619,0.88,no dnr,10.0,65.0,21.796875,125.0,22.0,36.0,148.875,2.3999023,0.29998779,2.39990234,138.0,7.299805,195.0,89.0,950.0,0.0,no(M2 and SIP pres)
75.21997,1,male,1,8,8,Lung Cancer,Cancer,1,3.0,under $11k,17272.0,14452.7344,33.5,black,18.0,1,0,0,metastatic,0.5,0.2,no dnr,8.0,108.0,6.89941406,115.0,32.0,38.5,304.0,1.7998047,1.01,6.79980469,142.0,7.379883,96.0,72.0,2225.0,0.494751,<2 mo. follow-up
75.61395,0,female,0,7,354,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,14778.0,14452.7344,12.0,black,38.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,85.0,19.8984375,135.0,31.0,36.19531,132.0,3.5,4.89941406,1.59985352,130.0,7.359375,149.0,51.0,1210.0,2.2709961,<2 mo. follow-up
87.71497,1,female,0,10,340,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8642.0,14452.7344,14.0,black,28.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,45.0,13.1992188,135.0,28.0,38.09375,220.0,3.5,1.01,0.89990234,133.0,7.40918,144.0,11.0,3160.0,3.4067383,<2 mo. follow-up
65.008,0,male,0,18,352,Lung Cancer,Cancer,1,12.0,$11-$25k,15592.0,14452.7344,6.333332,white,17.0,1,0,0,metastatic,0.599999905,0.4,no dnr,18.0,68.0,9.0,78.0,26.0,36.59375,333.3,3.5,1.01,1.39990234,134.0,7.419922,97.0,30.0,2590.0,0.0,no(M2 and SIP pres)
70.44495,1,male,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,0,3.0,under $11k,171822.0,14452.7344,33.75,white,10.0,4,0,0,no,0.049999982,0.5,dnr after sadm,38.0,107.0,13.3984375,65.0,25.0,35.0,276.625,3.5,1.01,0.59997559,132.0,7.459961,170.0,13.0,1550.0,0.0,<2 mo. follow-up
76.23499,0,male,0,13,351,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,30143.0,14452.7344,21.0,white,17.0,2,0,0,no,0.75,0.75,no dnr,13.0,118.0,10.8984375,55.0,12.0,35.89844,190.0,3.5,1.59985352,1.59985352,136.0,7.399414,154.0,29.0,7560.0,1.0,no(M2 and SIP pres)
37.689,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,61762.0,14452.7344,38.0,white,70.0,13,0,0,yes,0.5,0.2,no dnr,8.0,68.0,12.8984375,110.0,9.0,38.5,217.125,3.5,1.01,1.19995117,142.0,7.329102,325.0,48.0,1460.0,0.494751,<2 mo. follow-up
71.22198,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,109881.0,14452.7344,40.0,white,49.0,10,1,0,no,0.5,0.4,dnr after sadm,13.0,42.0,18.6992188,125.0,8.0,39.89844,166.0,3.5,1.01,3.69970703,143.0,7.259766,122.0,77.0,15.0,0.0,<2 mo. follow-up
58.66699,1,male,0,59,196,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,130457.0,14452.7344,23.75,white,11.0,1,0,0,yes,0.699999809,0.6,dnr after sadm,13.0,95.0,6.79980469,68.0,20.0,37.0,333.3,3.8999023,1.0,0.89990234,138.0,7.419922,98.0,6.0,5060.0,7.0,adl>=4 (>=5 if sur)
56.91199,1,male,0,12,82,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,13279.0,14452.7344,10.5,white,36.0,1,0,0,no,0.899999619,0.9,no dnr,12.0,72.0,29.0976562,125.0,28.0,36.29688,192.5,2.5,3.5,1.69995117,138.0,7.449219,123.0,74.0,1645.0,4.5273438,no(M2 and SIP pres)
33.59598,0,female,0,18,348,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,82387.0,14452.7344,25.333328,white,49.0,6,0,0,metastatic,0.699999809,0.5,no dnr,18.0,60.0,14.7988281,60.0,10.0,38.19531,283.3125,2.5996094,1.29980469,9.09960938,134.0,7.379883,249.0,39.0,0.0,0.0,no(M2 and SIP pres)
66.82495,0,male,0,3,348,Lung Cancer,Cancer,1,14.0,>$50k,8769.0,14452.7344,6.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,70.0,3.0,125.0,28.0,36.29688,125.0,2.699707,1.01,1.09985352,132.0,7.539062,140.0,42.0,3500.0,0.0,no(M2 and SIP pres)
71.69299,0,male,0,13,348,Colon Cancer,Cancer,1,18.0,>$50k,30518.0,14452.7344,26.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,13.0,112.0,11.3984375,135.0,31.0,38.29688,145.0,3.0996094,1.29980469,0.79992676,135.0,7.399414,133.0,12.0,1220.0,0.0,no(M2 and SIP pres)
73.28699,0,male,0,6,348,Colon Cancer,Cancer,1,14.0,under $11k,10775.0,14452.7344,12.0,white,4.0,1,0,0,metastatic,0.599999905,0.4,no dnr,6.0,118.0,8.29882812,135.0,38.0,35.5,226.65625,2.3999023,0.5,0.69995117,128.0,7.319336,103.0,10.0,3730.0,0.494751,no(M2 and SIP pres)
70.461,0,male,0,15,347,Lung Cancer,Cancer,2,12.0,under $11k,15315.0,14452.7344,9.333328,white,39.0,1,0,0,metastatic,0.299999952,0.2,dnr after sadm,2.0,108.0,10.5996094,65.0,16.0,38.09375,333.3,3.5,1.01,0.69995117,138.0,7.429688,99.0,5.0,4280.0,0.0,adl>=4 (>=5 if sur)
69.74896,1,female,1,29,29,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,213137.0,14452.7344,45.5,white,46.0,10,0,0,yes,0.5,0.5,dnr after sadm,28.0,50.0,3.19970703,145.0,36.0,38.5,56.46875,2.0,0.89990234,1.19995117,142.0,7.25,94.0,11.0,1696.0,2.0776367,<2 mo. follow-up
51.13199,0,male,0,7,347,MOSF w/Malig,ARF/MOSF,2,0.0,under $11k,24871.0,14452.7344,16.5,white,34.0,4,0,0,yes,0.699999809,0.5,no dnr,7.0,103.0,7.79980469,66.0,26.0,36.69531,333.3,3.5,1.01,0.69995117,139.0,7.419922,237.0,24.0,1800.0,6.0,adl>=4 (>=5 if sur)
56.70898,1,male,1,43,43,CHF,COPD/CHF/Cirrhosis,2,9.0,$11-$25k,204861.0,14452.7344,30.0,white,26.0,1,0,0,no,0.899999619,0.7,dnr after sadm,43.0,115.0,6.5,101.0,28.0,36.79688,177.5,2.5996094,0.89990234,0.89990234,145.0,7.449219,87.0,21.0,1700.0,0.0,<2 mo. follow-up
58.03998,1,male,0,8,141,Colon Cancer,Cancer,1,12.0,under $11k,15249.0,14452.7344,11.5,black,21.0,1,0,0,metastatic,0.599999905,0.3,no dnr,8.0,83.0,7.79980469,75.0,18.0,36.79688,304.0,3.5,1.01,0.89990234,143.0,7.40918,125.0,23.0,2502.0,1.0,no(M2 and SIP pres)
26.44199,0,male,0,19,346,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,59332.0,14452.7344,15.0,black,35.0,10,0,0,no,0.799999714,0.75,no dnr,19.0,118.0,11.3984375,75.0,8.0,36.0,316.625,1.8999023,5.19921875,1.29980469,134.0,7.359375,176.0,25.0,1325.0,2.4907227,no(M2 and SIP pres)
45.71399,0,female,0,6,345,Colon Cancer,Cancer,2,12.0,under $11k,10864.0,14452.7344,11.0,black,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,118.0,11.0,145.0,24.0,35.89844,162.5,3.5,0.5,0.69995117,135.0,7.439453,264.0,19.0,1775.0,0.0,no(M2 and SIP pres)
65.89697,1,male,0,18,295,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,67982.0,14452.7344,32.666657,white,51.0,3,0,0,no,0.399999857,0.2,no dnr,18.0,111.0,8.5,66.0,20.0,38.09375,333.3,4.1992188,0.69995117,0.79992676,139.0,7.419922,95.0,18.0,2502.0,1.8525391,no(M2 and SIP pres)
42.28598,1,male,0,32,39,MOSF w/Malig,ARF/MOSF,2,10.0,under $11k,48077.0,14452.7344,7.75,black,37.0,2,0,0,metastatic,0.049999982,0.0,dnr after sadm,6.0,65.0,20.0,65.0,10.0,38.69531,191.40625,1.7998047,3.79980469,1.89990234,144.0,7.419922,247.0,68.0,3920.0,1.0,<2 mo. follow-up
47.33197,1,male,0,8,26,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$25-$50k,24074.0,14452.7344,19.0,white,15.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,90.0,10.5996094,105.0,12.0,36.39844,195.21875,3.2998047,0.29998779,0.89990234,142.0,7.269531,110.0,20.0,860.0,0.0,<2 mo. follow-up
67.56995,1,male,0,20,55,Colon Cancer,Cancer,1,12.0,>$50k,21601.0,14452.7344,8.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,20.0,45.0,11.5,115.0,13.0,39.19531,124.4375,2.7998047,1.01,0.89990234,134.0,7.469727,141.0,18.0,3810.0,0.0,<2 mo. follow-up
46.92697,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,61115.0,14452.7344,33.5,white,44.0,13,0,0,metastatic,0.699999809,0.5,no dnr,8.0,72.0,6.79980469,125.0,8.0,38.79688,230.0,2.5,1.01,1.0,137.0,7.359375,89.0,6.0,1910.0,2.7519531,<2 mo. follow-up
83.10699,1,female,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,1,4.0,under $11k,141681.0,14452.7344,36.0,black,51.0,12,0,0,yes,0.599999905,0.6,dnr after sadm,10.0,99.0,9.8984375,76.0,20.0,36.39844,332.0,3.5,1.01,0.89990234,136.0,7.399414,131.0,21.0,650.0,2.0,<2 mo. follow-up
61.26999,1,male,0,6,377,Lung Cancer,Cancer,2,10.0,$25-$50k,3754.0,2838.4238,18.0,white,26.0,1,0,0,metastatic,0.899999619,0.8,no dnr,6.0,73.0,5.79980469,100.0,28.0,35.39844,333.3,3.5,1.01,0.79992676,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
51.836,0,female,0,8,2029,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,5572.0,4188.9023,7.5,white,15.0,1,0,0,no,0.75,0.5,no dnr,8.0,93.0,3.5,80.0,26.0,36.39844,369.0,3.0,0.29998779,0.69995117,138.0,7.339844,135.0,23.0,2502.0,0.0,SIP>=30
30.04799,1,female,0,36,540,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,40193.0,30074.125,30.25,white,20.0,2,0,0,no,0.75,0.5,no dnr,36.0,68.0,8.8984375,116.0,7.0,36.0,246.46875,2.699707,0.5,0.5,135.0,7.449219,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
56.88397,0,female,0,18,2026,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,38938.0,30539.2812,36.333313,white,49.0,2,0,0,yes,0.5,0.5,no dnr,18.0,137.0,10.2988281,157.0,13.0,38.09375,88.0,2.5996094,1.29980469,0.59997559,134.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
49.20499,1,female,0,7,24,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,5771.0,4279.543,7.5,other,29.0,1,1,0,no,0.099999964,0.001,no dnr,7.0,67.0,11.1992188,104.0,26.0,35.79688,391.375,3.0996094,1.5,0.89990234,133.0,7.489258,135.0,23.0,2502.0,5.0,<2 mo. follow-up
34.98398,1,male,0,5,31,CHF,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,6339.0,4722.0547,15.0,black,31.0,1,1,0,no,0.949999809,0.95,no dnr,5.0,73.0,10.1992188,105.0,32.0,36.59375,409.5,3.5996094,0.39996338,1.29980469,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.64899,1,male,1,4,4,Coma,Coma,4,12.0,under $11k,11802.0,8355.5938,41.0,white,38.0,3,0,0,yes,0.0,0.0,dnr after sadm,4.0,57.0,33.59375,103.0,12.0,39.59375,135.0,3.5,1.01,2.19970703,138.0,7.449219,135.0,23.0,2502.0,3.9301758,<2 mo. follow-up
40.44397,1,male,0,16,325,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,11137.0,8525.7734,8.0,white,36.0,1,0,0,no,0.899999619,0.7,no dnr,16.0,96.0,8.09960938,84.0,20.0,39.0,333.3,1.8999023,8.79882812,0.59997559,135.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
40.55899,1,female,0,15,586,Cirrhosis,COPD/CHF/Cirrhosis,6,12.0,under $11k,15201.0,12027.7031,15.0,black,47.0,2,0,0,no,0.799999714,0.5,no dnr,15.0,145.0,5.59960938,82.0,30.0,36.0,336.0625,2.8999023,3.09960938,8.3984375,135.0,7.399414,135.0,23.0,2502.0,0.0,SIP>=30
42.71597,1,male,0,6,791,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,4538.0,3398.3379,14.0,white,15.0,1,0,0,no,0.5,0.5,no dnr,6.0,97.0,11.3984375,115.0,22.0,36.0,457.125,3.5996094,0.79992676,1.19995117,131.0,7.40918,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
30.407,1,male,0,27,230,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,138207.0,98951.75,41.75,black,83.0,43,0,0,yes,0.299999952,0.1,no dnr,27.0,107.0,0.31994629,176.0,32.0,39.59375,147.125,3.7998047,2.09960938,3.09960938,135.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.409,1,male,0,8,15,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,5608.0,4262.5117,7.5,black,51.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,2.0,97.0,17.8984375,114.0,36.0,36.29688,430.4375,2.699707,1.79980469,2.29980469,130.0,7.209961,135.0,23.0,2502.0,3.7788086,<2 mo. follow-up
62.49698,1,female,1,79,79,ARF/MOSF w/Sepsis,ARF/MOSF,5,8.0,under $11k,151172.0,113714.812,31.0,white,47.0,23,1,0,yes,0.25,0.2,dnr after sadm,22.0,114.0,17.5976562,68.0,32.0,36.5,85.625,3.5,1.01,2.19970703,133.0,7.429688,135.0,23.0,2502.0,3.0,SIP>=30
44.32898,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,21020.0,16124.1562,50.0,white,48.0,1,0,0,no,0.5,0.5,dnr after sadm,7.0,70.0,25.296875,111.0,22.0,38.5,109.5625,2.5996094,0.39996338,1.69995117,133.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
37.84,0,male,0,15,2019,ARF/MOSF w/Sepsis,ARF/MOSF,4,17.0,under $11k,26070.0,19550.6719,31.666656,white,45.0,1,1,0,no,0.75,0.75,no dnr,15.0,113.0,9.19921875,118.0,20.0,35.39844,254.53125,2.0,6.39941406,0.89990234,128.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
40.29797,1,female,0,16,94,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,14205.0,10412.1328,12.666664,white,35.0,1,0,0,no,0.799999714,0.5,no dnr,16.0,61.0,5.0,102.0,20.0,36.69531,375.6875,4.5996094,1.89990234,1.5,129.0,7.449219,135.0,23.0,2502.0,4.0,SIP>=30
79.69299,1,male,0,40,174,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,109357.0,78708.625,30.0,white,57.0,26,0,0,no,0.299999952,0.25,no dnr,40.0,110.0,11.0,127.0,11.0,39.19531,305.0,1.8999023,5.19921875,2.29980469,133.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
35.49899,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,1,18.0,$25-$50k,32652.0,24079.4688,52.0,white,77.0,4,0,0,metastatic,0.049999982,0.000125,no dnr,9.0,54.0,3.19970703,176.0,60.0,40.0,98.59375,2.5996094,1.09985352,0.89990234,145.0,7.289062,135.0,23.0,2502.0,2.0,<2 mo. follow-up
77.30896,1,male,0,18,237,Colon Cancer,Cancer,1,12.0,>$50k,12567.0,9706.6719,9.333328,white,22.0,1,0,0,metastatic,1.0,0.5,no dnr,18.0,103.0,7.09960938,60.0,20.0,36.59375,333.3,3.0996094,0.79992676,1.39990234,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.64099,1,male,0,5,35,Lung Cancer,Cancer,1,12.0,$11-$25k,3671.0,2911.4199,1.0,white,16.0,1,0,0,metastatic,0.25,0.01,dnr after sadm,1.0,95.0,3.89990234,92.0,28.0,35.79688,333.3,3.5,1.01,1.0,141.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
62.56497,0,male,0,4,2016,COPD,COPD/CHF/Cirrhosis,2,3.0,under $11k,2928.0,2173.5625,11.0,white,28.0,1,0,0,yes,0.949999809,0.9,no dnr,4.0,98.0,7.59960938,100.0,28.0,36.19531,273.75,4.0996094,0.29998779,1.09985352,138.0,7.229492,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
55.66898,1,male,0,4,400,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3072.0,2277.4668,13.0,white,19.0,1,1,0,no,0.899999619,0.75,no dnr,4.0,75.0,8.0,76.0,22.0,36.29688,284.75,3.5,0.5,1.19995117,142.0,7.429688,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
64.70099,1,female,0,18,70,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,30035.0,23424.5625,25.333328,white,57.0,1,0,0,metastatic,0.399999857,0.2,no dnr,18.0,72.0,2.69970703,128.0,28.0,36.0,199.625,3.0,1.0,3.19970703,131.0,7.429688,135.0,23.0,2502.0,3.9174805,<2 mo. follow-up
69.37195,1,female,1,17,17,Lung Cancer,Cancer,3,12.0,under $11k,13583.0,10518.6953,7.333332,black,29.0,2,1,0,metastatic,0.5,0.1,dnr after sadm,4.0,83.0,10.6992188,110.0,28.0,36.19531,466.625,2.5996094,0.59997559,1.09985352,138.0,7.389648,135.0,23.0,2502.0,4.4345703,<2 mo. follow-up
78.35498,1,male,0,5,291,CHF,COPD/CHF/Cirrhosis,5,6.0,under $11k,4032.0,2952.9238,7.0,white,35.0,1,1,0,yes,0.5,0.2,dnr after sadm,1.0,73.0,15.8984375,120.0,24.0,36.0,333.3,3.199707,1.0,1.59985352,132.0,7.419922,135.0,23.0,2502.0,3.0,SIP>=30
24.931,0,male,0,22,2014,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,41978.0,14452.7344,34.0,white,39.0,1,0,0,no,0.989999771,0.99,no dnr,22.0,51.0,21.0,46.0,10.0,35.69531,87.5625,3.5,1.01,0.5,135.0,7.459961,135.0,23.0,2502.0,6.0,SIP>=30
67.32898,1,female,0,17,145,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,10263.0,8112.8359,7.0,white,37.0,1,1,0,no,0.599999905,0.6,no dnr,17.0,60.0,4.59960938,58.0,20.0,36.19531,333.3,3.5,0.5,2.19970703,135.0,7.419922,135.0,23.0,2502.0,3.3242188,<2 mo. follow-up
56.35599,0,male,0,4,2012,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6956.0,5181.9805,7.0,white,13.0,3,0,0,no,0.699999809,0.5,no dnr,4.0,79.0,5.0,68.0,16.0,36.39844,333.3,3.5,1.01,1.0,134.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
28.435,0,male,0,19,2011,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,28546.0,21811.0938,26.0,white,23.0,3,1,0,no,0.799999714,0.8,no dnr,19.0,135.0,8.29882812,126.0,10.0,36.69531,200.0,3.2998047,0.5,0.69995117,137.0,7.429688,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
44.74698,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,62724.0,44182.9062,54.5,white,56.0,5,0,0,no,0.099999964,0.001,dnr after sadm,13.0,70.0,19.0,149.0,27.0,39.69531,75.70312,2.2998047,1.59985352,1.59985352,147.0,7.449219,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.90094,1,male,0,14,21,Colon Cancer,Cancer,1,10.0,under $11k,51678.0,39554.6562,21.666656,white,23.0,42,0,0,metastatic,0.75,0.5,no dnr,14.0,73.0,4.89941406,94.0,20.0,36.59375,333.3,2.0,1.09985352,0.59997559,129.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
68.48199,0,male,0,22,2010,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,48631.0,36397.8125,32.0,white,40.0,10,0,0,yes,0.899999619,0.9,no dnr,22.0,53.0,13.3984375,71.0,10.0,36.5,262.9375,1.8999023,0.19998169,1.69995117,135.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.52298,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,25975.0,20341.9688,37.5,white,30.0,1,0,0,no,0.5,0.5,no dnr,11.0,124.0,7.0,115.0,25.0,38.19531,304.0,2.7998047,0.5,0.89990234,135.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
28.55899,1,female,1,138,138,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,94804.0,197694.0,44.25,black,30.0,52,0,0,no,1.0,0.5,dnr after sadm,62.0,78.0,33.09375,127.0,36.0,38.39844,212.5,2.7998047,0.29998779,0.69995117,142.0,7.469727,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
71.93195,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,20133.0,13816.5078,59.0,white,68.0,1,0,0,no,0.699999809,0.5,dnr after sadm,6.0,36.0,17.0,187.0,14.0,37.59375,103.1875,3.2998047,1.09985352,1.69995117,142.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.78497,0,female,0,37,2007,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,42011.0,36107.4062,36.0,white,37.0,1,0,0,no,0.099999964,0.001,no dnr,37.0,44.0,10.8984375,116.0,40.0,37.79688,210.4375,3.0,0.89990234,0.5,135.0,7.519531,135.0,23.0,2502.0,6.0,<2 mo. follow-up
19.82999,0,male,0,47,2005,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,88468.0,66124.5,28.0,white,58.0,8,0,0,no,0.899999619,0.9,no dnr,47.0,73.0,31.5,111.0,43.0,38.59375,240.0,1.7998047,4.69921875,1.59985352,135.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
41.78,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,23366.0,16430.8281,54.0,white,67.0,10,0,0,no,0.099999964,0.001,dnr after sadm,5.0,61.0,29.1992188,115.0,12.0,40.5,182.59375,0.7999268,2.39990234,2.69970703,133.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
32.81,1,male,1,8,8,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,22651.0,14452.7344,55.5,other,32.0,1,0,0,no,0.599999905,0.4,no dnr,8.0,123.0,9.8984375,136.0,30.0,35.89844,333.3,2.5,2.69970703,0.59997559,137.0,7.419922,135.0,23.0,2502.0,3.1582031,<2 mo. follow-up
71.67999,1,female,0,6,295,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,4250.0,3164.7832,7.0,white,33.0,1,0,0,yes,0.799999714,0.6,no dnr,6.0,77.0,7.5,136.0,30.0,38.39844,333.3,3.3999023,0.89990234,1.0,134.0,7.419922,135.0,23.0,2502.0,2.0,SIP>=30
69.06494,1,female,0,35,316,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,51892.0,38072.0,23.5,white,43.0,1,0,0,no,0.699999809,0.5,no dnr,35.0,63.0,7.69921875,52.0,18.0,35.29688,257.75,2.699707,5.0,1.79980469,121.0,7.449219,135.0,23.0,2502.0,3.9838867,<2 mo. follow-up
47.31,1,male,0,4,75,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,2390.0,1865.4102,10.0,white,31.0,1,0,0,no,0.25,0.1,no dnr,4.0,63.0,10.8984375,70.0,20.0,36.0,351.375,2.699707,1.5,2.29980469,123.0,7.359375,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
44.34497,0,male,0,4,2002,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,3131.0,2288.5469,3.0,white,33.0,1,0,0,no,0.899999619,0.5,no dnr,4.0,65.0,9.59960938,110.0,22.0,36.79688,333.3,2.199707,5.09960938,1.0,129.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
61.28998,1,male,0,14,92,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,11336.0,8405.0625,13.0,black,74.0,1,0,0,no,0.799999714,0.4,no dnr,14.0,79.0,7.59960938,110.0,36.0,35.79688,59.58594,3.699707,3.5,1.79980469,144.0,7.199219,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
71.52899,1,female,0,6,62,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,7352.0,5145.6758,36.0,black,59.0,1,0,0,no,0.5,0.4,no dnr,6.0,157.0,14.0996094,155.0,34.0,36.79688,302.625,3.2998047,1.0,4.29980469,141.0,7.379883,135.0,23.0,2502.0,2.5991211,adl>=4 (>=5 if sur)
55.159,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,2,8.0,$11-$25k,8871.0,6550.4883,17.0,black,66.0,8,0,0,metastatic,0.0,0.0,dnr after sadm,2.0,0.0,21.5,0.0,0.0,38.19531,311.875,3.5,1.01,0.59997559,145.0,7.40918,135.0,23.0,2502.0,3.3364258,<2 mo. follow-up
58.431,1,female,0,6,218,CHF,COPD/CHF/Cirrhosis,7,12.0,under $11k,8990.0,6529.2305,23.0,white,43.0,1,0,0,no,1.0,1.0,no dnr,6.0,60.0,16.296875,75.0,24.0,37.69531,203.65625,3.8999023,0.89990234,7.19921875,121.0,7.5,135.0,23.0,2502.0,2.0,SIP>=30
68.20496,1,male,0,9,399,Colon Cancer,Cancer,3,15.0,$25-$50k,6141.0,4727.3555,7.5,white,32.0,1,1,0,metastatic,0.899999619,0.7,no dnr,9.0,75.0,10.5,56.0,16.0,36.39844,333.3,3.5,1.01,2.09960938,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
31.95299,1,female,1,91,91,Coma,Coma,1,10.0,under $11k,119299.0,89641.0625,29.5,hispanic,30.0,1,0,0,no,0.649999619,0.6,dnr after sadm,46.0,69.0,15.1992188,126.0,24.0,38.09375,132.0,2.5996094,3.29980469,1.09985352,143.0,7.349609,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
36.62698,1,male,0,7,1338,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,8429.0,6005.6445,10.0,white,22.0,1,1,1,no,0.949999809,0.95,no dnr,7.0,68.0,6.5,68.0,20.0,35.79688,514.25,2.7998047,0.39996338,0.59997559,130.0,7.429688,135.0,23.0,2502.0,5.5439453,<2 mo. follow-up
46.05298,1,female,1,4,4,Lung Cancer,Cancer,1,12.0,under $11k,3829.0,2781.1406,21.0,black,24.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,108.0,10.3984375,122.0,28.0,37.5,333.3,3.0996094,0.5,1.0,141.0,7.419922,135.0,23.0,2502.0,2.7573242,<2 mo. follow-up
49.26797,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,10142.0,7426.9219,19.5,white,73.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,47.0,10.8984375,51.0,44.0,34.09375,251.65625,2.5996094,1.89990234,2.39990234,133.0,7.229492,135.0,23.0,2502.0,4.1054688,<2 mo. follow-up
64.88196,1,male,1,16,16,Colon Cancer,Cancer,1,10.0,$11-$25k,14860.0,11180.2422,20.333328,white,32.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,13.0,73.0,13.0996094,75.0,26.0,35.0,333.3,1.5998535,1.09985352,0.5,133.0,7.419922,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
87.64697,1,female,0,12,28,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,8111.0,6287.2188,15.5,white,40.0,1,0,0,metastatic,0.199999928,0.0,dnr before sadm,0.0,104.0,10.5996094,109.0,28.0,36.5,159.15625,2.699707,0.39996338,2.0,133.0,7.379883,135.0,23.0,2502.0,6.0,<2 mo. follow-up
50.46997,1,female,0,6,1254,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,5985.0,4367.8477,14.0,white,38.0,1,0,0,metastatic,0.899999619,0.9,no dnr,6.0,63.0,2.19970703,90.0,20.0,38.39844,333.3,4.0996094,4.0,1.79980469,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.19495,1,male,0,22,661,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,161730.0,125781.938,24.666656,black,33.0,53,0,0,no,0.399999857,0.3,no dnr,22.0,76.0,20.296875,150.0,9.0,35.79688,300.0,2.7998047,0.5,0.79992676,129.0,7.439453,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
78.724,0,female,0,61,1994,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,83082.0,64754.0625,33.0,white,42.0,1,0,0,no,0.699999809,0.6,no dnr,61.0,72.0,7.19921875,63.0,29.0,36.39844,168.15625,3.0996094,0.39996338,0.69995117,136.0,7.419922,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
48.45999,1,female,0,17,167,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,18182.0,13137.2734,11.333328,white,18.0,1,0,0,no,0.799999714,0.5,no dnr,17.0,91.0,6.5,105.0,20.0,36.5,338.0625,2.7998047,4.59960938,1.0,134.0,7.429688,135.0,23.0,2502.0,1.1668997,SIP>=30
55.66599,0,female,0,6,1993,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,4172.0,3183.1231,10.0,black,18.0,1,1,0,no,1.0,1.0,no dnr,6.0,113.0,6.59960938,70.0,23.0,35.79688,333.3,3.0996094,0.29998779,1.19995117,134.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
57.35797,1,female,0,9,1814,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,6204.0,4697.7812,15.0,white,19.0,1,0,0,no,0.75,0.75,no dnr,9.0,124.0,13.0,96.0,24.0,36.59375,232.25,3.5,1.01,1.39990234,134.0,7.379883,135.0,23.0,2502.0,2.0,SIP>=30
78.54297,1,male,0,6,39,COPD,COPD/CHF/Cirrhosis,3,14.0,under $11k,4418.0,3298.2129,6.0,white,43.0,1,0,0,no,0.699999809,0.4,dnr after sadm,1.0,54.0,11.0,55.0,26.0,35.09375,101.65625,3.699707,0.69995117,1.09985352,147.0,7.399414,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
61.142,1,male,0,17,149,COPD,COPD/CHF/Cirrhosis,3,7.0,under $11k,26263.0,19732.5938,13.666664,black,33.0,8,0,0,no,0.799999714,0.9,no dnr,17.0,108.0,18.3984375,116.0,34.0,36.39844,163.6875,3.3999023,0.5,1.19995117,132.0,7.399414,135.0,23.0,2502.0,0.0,SIP>=30
54.43698,1,male,0,5,75,Lung Cancer,Cancer,1,12.0,$11-$25k,3960.0,3163.5859,15.0,black,26.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,68.0,9.59960938,108.0,28.0,37.79688,361.875,3.699707,1.0,1.39990234,138.0,7.459961,135.0,23.0,2502.0,2.4023438,<2 mo. follow-up
56.23798,0,male,0,7,1991,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,10796.0,8250.9375,13.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,72.0,15.5,52.0,25.0,36.29688,333.3,2.0996094,1.39990234,0.89990234,140.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
76.64899,1,male,0,7,94,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,5597.0,4162.5547,7.0,white,33.0,1,0,0,yes,0.699999809,0.5,no dnr,7.0,103.0,7.19921875,76.0,25.0,35.69531,283.875,3.3999023,0.39996338,1.09985352,128.0,7.509766,135.0,23.0,2502.0,2.8061523,<2 mo. follow-up
60.00497,1,female,0,9,1552,CHF,COPD/CHF/Cirrhosis,5,9.0,under $11k,6427.0,4872.8867,7.5,black,27.0,1,1,0,yes,0.899999619,0.6,no dnr,9.0,105.0,7.79980469,65.0,15.0,36.5,247.59375,3.5,1.01,1.69995117,141.0,7.40918,135.0,23.0,2502.0,0.0,SIP>=30
37.89499,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,35796.0,26760.6719,50.0,white,54.0,1,0,0,no,0.099999964,0.001,dnr after sadm,10.0,55.0,13.6992188,113.0,32.0,38.09375,88.10938,2.5996094,3.39990234,0.59997559,131.0,7.549805,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.92999,0,male,0,11,1987,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,11858.0,8400.3438,15.0,white,35.0,1,0,0,no,0.899999619,0.9,no dnr,11.0,71.0,11.5996094,114.0,34.0,37.69531,167.5,2.3999023,1.09985352,0.69995117,137.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
66.51099,1,female,0,7,802,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5125.0,3824.4434,6.5,black,34.0,1,0,0,no,0.989999771,0.99,no dnr,7.0,75.0,5.39941406,73.0,25.0,35.09375,203.96875,3.699707,0.39996338,1.19995117,138.0,7.319336,135.0,23.0,2502.0,1.0,SIP>=30
61.28998,0,female,0,4,1985,CHF,COPD/CHF/Cirrhosis,2,11.0,under $11k,2292.0,1767.9736,10.0,white,13.0,1,0,0,no,1.0,0.9,no dnr,4.0,73.0,5.39941406,96.0,24.0,36.0,401.875,3.0996094,0.59997559,0.89990234,138.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
61.952,1,female,0,29,72,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,under $11k,37986.0,28746.4062,31.5,black,37.0,1,1,0,no,0.699999809,0.65,no dnr,29.0,127.0,9.19921875,107.0,30.0,37.89844,168.75,3.0996094,1.0,1.0,136.0,7.469727,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
69.15295,0,female,0,4,1984,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,3073.0,2255.6621,11.0,white,34.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,61.0,3.5,64.0,32.0,36.29688,204.75,4.0,0.59997559,0.69995117,137.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
73.53296,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,251017.0,187147.5,42.333313,white,28.0,94,0,0,no,0.699999809,0.5,dnr after sadm,19.0,125.0,18.8984375,118.0,9.0,36.69531,239.3125,1.8999023,0.79992676,0.79992676,131.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.73395,1,male,0,12,35,Colon Cancer,Cancer,1,11.0,$11-$25k,9608.0,7434.043,12.0,white,31.0,1,0,0,metastatic,0.5,0.5,no dnr,12.0,110.0,7.19921875,60.0,20.0,36.0,333.3,3.5,0.39996338,6.69921875,141.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.14496,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,4432.0,3190.625,24.0,white,24.0,1,0,0,metastatic,0.099999964,0.001,dnr before sadm,-1.0,115.0,9.3984375,106.0,30.0,36.0,418.5625,2.5996094,0.19998169,0.69995117,126.0,7.209961,135.0,23.0,2502.0,6.0,<2 mo. follow-up
67.59998,0,female,0,45,1979,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,61206.0,45495.75,26.25,black,86.0,15,0,0,no,0.099999964,0.001,dnr after sadm,23.0,63.0,15.0996094,140.0,40.0,35.39844,126.6875,1.8999023,0.5,2.29980469,129.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
51.33698,1,female,0,42,181,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,66895.0,50142.4688,17.5,black,25.0,10,0,0,no,0.899999619,0.8,no dnr,42.0,68.0,8.09960938,76.0,22.0,35.5,333.3,3.0996094,0.39996338,1.5,135.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
56.14798,1,male,0,31,374,MOSF w/Malig,ARF/MOSF,3,12.0,$25-$50k,54778.0,39451.75,26.25,white,43.0,25,1,0,yes,0.699999809,0.3,no dnr,31.0,63.0,0.09999084,120.0,24.0,38.5,333.3,3.0996094,0.59997559,0.89990234,126.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.82196,0,male,0,9,1977,CHF,COPD/CHF/Cirrhosis,3,0.0,under $11k,7363.0,5533.4102,6.0,black,23.0,1,0,0,yes,0.949999809,0.9,no dnr,9.0,60.0,5.69921875,64.0,24.0,35.5,309.5,3.8999023,0.69995117,1.0,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
38.45599,0,male,0,43,1977,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,62292.0,48560.375,16.25,white,21.0,22,1,0,no,0.899999619,0.6,no dnr,43.0,82.0,13.0,122.0,22.0,38.0,403.3125,3.2998047,4.09960938,0.5,131.0,7.449219,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
69.51099,0,male,0,4,1976,CHF,COPD/CHF/Cirrhosis,7,9.0,$11-$25k,2553.0,1985.8906,6.0,white,25.0,1,1,0,metastatic,0.989999771,0.95,no dnr,4.0,73.0,6.39941406,58.0,20.0,36.0,333.3,3.3999023,0.39996338,1.19995117,135.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
74.21198,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,4,8.0,under $11k,8157.0,6242.8867,34.0,white,75.0,3,1,0,metastatic,0.049999982,0.000125,no dnr,3.0,0.0,2.79980469,0.0,0.0,39.0,99.15625,2.5996094,1.19995117,1.0,137.0,7.289062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.81299,1,female,0,12,488,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,9217.0,7024.7773,10.5,hispanic,30.0,1,1,0,no,0.799999714,0.7,no dnr,12.0,58.0,8.69921875,44.0,16.0,36.09375,333.3,3.5996094,1.09985352,1.0,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.21997,0,male,0,6,1976,Lung Cancer,Cancer,2,14.0,under $11k,4723.0,3596.1172,10.0,white,9.0,1,0,0,metastatic,1.0,1.0,no dnr,6.0,87.0,11.1992188,72.0,16.0,36.59375,238.09375,4.2998047,1.01,1.0,140.0,7.40918,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
46.98398,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,2358.0,1865.3467,24.0,white,41.0,1,0,0,yes,0.0,0.0,dnr before sadm,-1.0,79.0,2.19970703,124.0,36.0,38.79688,333.3,2.699707,0.79992676,1.09985352,130.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
58.267,1,male,0,9,379,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$25-$50k,9897.0,7161.2695,14.5,white,24.0,1,0,0,no,0.799999714,0.8,no dnr,9.0,75.0,8.0,74.0,24.0,35.59375,139.0,2.8999023,1.89990234,1.0,124.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
67.89294,1,male,0,13,1157,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,9953.0,7496.0234,10.0,black,37.0,1,1,0,no,0.989999771,0.9,no dnr,13.0,115.0,9.0,104.0,24.0,37.0,333.3,2.0,2.79980469,1.29980469,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
33.65399,1,male,0,16,897,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,12790.0,9496.6484,15.666664,black,16.0,1,0,0,no,0.699999809,0.6,no dnr,16.0,89.0,14.0996094,100.0,28.0,35.5,210.96875,3.0,0.79992676,1.0,133.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.62799,1,female,0,5,37,Lung Cancer,Cancer,3,9.0,under $11k,3439.0,2551.7461,16.0,black,25.0,1,0,0,metastatic,0.5,0.3,no dnr,5.0,69.0,5.69921875,118.0,26.0,36.29688,333.3,3.2998047,0.59997559,0.69995117,132.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
62.65799,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,76847.0,56111.875,47.666657,white,59.0,18,0,0,no,0.699999809,0.7,no dnr,20.0,113.0,5.0,133.0,12.0,36.19531,120.0,2.199707,4.19921875,1.39990234,135.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.83197,1,female,0,50,434,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,60071.0,45310.125,23.25,white,25.0,1,0,0,no,0.699999809,0.5,no dnr,50.0,105.0,5.09960938,94.0,24.0,37.0,226.65625,3.5,1.01,1.69995117,138.0,7.479492,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
31.30199,0,male,0,13,1971,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,11601.0,8575.0,22.5,white,9.0,2,0,0,no,1.0,0.9,no dnr,13.0,77.0,5.0,82.0,15.0,36.19531,167.34375,3.0996094,0.5,0.79992676,137.0,7.379883,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
41.18799,0,male,0,16,1970,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,35748.0,27310.6094,34.666657,white,41.0,3,0,0,no,0.5,0.5,no dnr,16.0,117.0,21.0976562,157.0,20.0,39.29688,79.23438,2.5,0.89990234,0.29998779,129.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.10199,1,male,0,4,1776,CHF,COPD/CHF/Cirrhosis,6,10.0,under $11k,3856.0,2844.5586,5.0,black,34.0,2,1,0,yes,0.699999809,0.5,no dnr,4.0,77.0,6.5,50.0,20.0,35.79688,275.1875,3.5,1.01,1.69995117,144.0,7.419922,135.0,23.0,2502.0,3.1699219,<2 mo. follow-up
75.10498,1,male,0,9,1172,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5940.0,4563.8242,8.0,black,33.0,1,0,0,no,0.949999809,0.9,no dnr,9.0,122.0,3.79980469,42.0,26.0,36.0,331.375,3.3999023,1.0,1.29980469,139.0,7.449219,135.0,23.0,2502.0,1.0,SIP>=30
63.98898,1,male,0,9,1304,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,8977.0,6760.8672,21.0,white,34.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,61.0,11.5,126.0,38.0,36.5,240.78125,3.5,0.59997559,0.59997559,137.0,7.349609,135.0,23.0,2502.0,1.8389997,SIP>=30
64.36694,1,female,0,17,151,Colon Cancer,Cancer,2,11.0,under $11k,12585.0,9749.75,13.333328,white,17.0,1,1,0,metastatic,0.899999619,0.5,no dnr,17.0,71.0,10.5996094,80.0,24.0,36.39844,333.3,3.5,0.69995117,0.89990234,131.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
32.85098,1,female,0,43,1659,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,100792.0,74970.9375,31.5,black,42.0,13,0,0,no,0.799999714,0.8,no dnr,43.0,160.0,12.5,126.0,20.0,36.0,300.0,2.199707,0.79992676,2.0,134.0,7.389648,135.0,23.0,2502.0,6.0,<2 mo. follow-up
72.15094,1,male,0,9,169,Lung Cancer,Cancer,3,8.0,under $11k,6397.0,14452.7344,9.0,black,18.0,1,0,0,metastatic,0.199999928,0.0,no dnr,9.0,109.0,19.0976562,112.0,24.0,36.0,349.0,3.3999023,0.39996338,0.89990234,136.0,7.459961,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
60.89499,1,female,1,8,8,Lung Cancer,Cancer,2,12.0,under $11k,6031.0,4530.5781,17.0,white,32.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,119.0,26.6992188,112.0,32.0,36.19531,164.84375,3.0996094,0.59997559,0.89990234,132.0,7.469727,135.0,23.0,2502.0,6.0,<2 mo. follow-up
77.95795,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,2,13.0,under $11k,11693.0,9303.3516,25.0,white,37.0,11,1,0,metastatic,0.699999809,0.5,dnr before sadm,-10.0,87.0,9.09960938,112.0,16.0,35.59375,333.3,3.5,1.01,3.69970703,139.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
69.35797,1,male,0,16,124,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,11617.0,8792.6953,17.333328,white,28.0,1,0,0,no,0.5,0.3,dnr after sadm,1.0,71.0,5.69921875,80.0,24.0,36.5,333.3,3.0996094,1.09985352,1.79980469,131.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.98999,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,3,13.0,under $11k,8416.0,6332.2227,22.0,black,73.0,8,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,0.0,10.8984375,0.0,0.0,37.69531,114.28125,2.8999023,2.59960938,1.09985352,129.0,7.429688,135.0,23.0,2502.0,5.0,<2 mo. follow-up
55.12698,0,male,0,10,1959,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,21427.0,15261.8984,17.0,white,9.0,3,0,0,no,0.799999714,0.7,no dnr,10.0,109.0,8.09960938,60.0,20.0,36.69531,310.0,3.2998047,0.79992676,0.79992676,132.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.73395,0,female,0,15,1954,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,23022.0,17563.1094,20.333328,white,45.0,3,1,1,no,0.949999809,0.95,no dnr,15.0,143.0,14.6992188,138.0,40.0,39.19531,202.5,2.3999023,0.39996338,0.69995117,147.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.97498,1,female,1,21,21,MOSF w/Malig,ARF/MOSF,2,4.0,under $11k,68081.0,49404.1562,56.0,white,44.0,6,0,0,metastatic,0.699999809,0.5,dnr after sadm,17.0,55.0,61.1953125,119.0,14.0,36.29688,266.625,1.7998047,0.69995117,0.39996338,143.0,7.25,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.784,1,female,0,5,257,Lung Cancer,Cancer,3,8.0,$11-$25k,3535.0,2658.6289,10.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,97.0,10.6992188,105.0,24.0,36.5,323.75,3.5,0.29998779,0.79992676,130.0,7.459961,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
59.35098,1,male,0,27,161,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,72570.0,56103.75,38.0,white,58.0,15,1,0,no,0.899999619,0.8,no dnr,27.0,57.0,9.0,67.0,28.0,38.5,208.15625,1.2998047,1.0,1.59985352,156.0,7.449219,135.0,23.0,2502.0,6.0,SIP>=30
73.51099,0,female,0,27,1952,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,100583.0,74381.9375,22.5,white,55.0,26,0,0,no,0.099999964,0.001,no dnr,27.0,47.0,9.5,122.0,36.0,36.09375,227.5,2.5,0.39996338,1.09985352,134.0,7.529297,135.0,23.0,2502.0,0.0,SIP>=30
44.61099,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,104117.0,76492.125,31.75,black,57.0,49,0,0,no,0.5,0.2,dnr after sadm,24.0,149.0,5.69921875,156.0,40.0,39.09375,234.28125,2.2998047,5.69921875,0.79992676,133.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.94199,1,male,1,18,18,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,50110.0,38838.6562,48.0,white,51.0,1,0,0,no,0.5,0.25,dnr after sadm,17.0,112.0,20.6992188,130.0,31.0,35.89844,128.78125,1.5998535,3.59960938,0.69995117,131.0,7.399414,135.0,23.0,2502.0,3.0,<2 mo. follow-up
57.46997,1,female,0,9,183,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,7984.0,6035.125,10.5,white,22.0,1,1,0,no,0.099999964,0.001,dnr after sadm,3.0,66.0,11.0996094,70.0,24.0,35.0,191.8125,3.0996094,1.89990234,0.89990234,130.0,7.459961,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
71.13495,1,female,1,47,47,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,148311.0,115883.312,31.0,black,55.0,87,1,0,no,0.5,0.1,dnr after sadm,45.0,118.0,21.0,80.0,32.0,38.39844,317.0625,2.0996094,2.39990234,2.39990234,144.0,7.419922,135.0,23.0,2502.0,4.3076172,<2 mo. follow-up
68.75299,1,male,1,45,45,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,123218.0,96347.0625,49.5,white,72.0,1,0,0,no,0.099999964,0.001,dnr after sadm,42.0,52.0,2.59960938,122.0,28.0,36.79688,132.71875,1.5998535,1.59985352,1.29980469,142.0,7.329102,135.0,23.0,2502.0,2.8217773,<2 mo. follow-up
66.08398,1,male,1,98,98,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,125092.0,127136.0,49.5,white,60.0,9,1,0,no,0.899999619,0.7,dnr after sadm,67.0,148.0,20.3984375,132.0,52.0,37.39844,93.32812,2.199707,0.29998779,1.09985352,139.0,7.439453,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
58.086,0,male,0,11,1948,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,7472.0,5659.6719,14.5,white,19.0,1,1,0,no,0.75,0.5,no dnr,11.0,76.0,11.8984375,104.0,24.0,36.0,333.3,3.3999023,0.89990234,1.09985352,134.0,7.419922,135.0,23.0,2502.0,3.340332,<2 mo. follow-up
19.674,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,137877.0,99592.1875,57.5,white,66.0,4,0,0,no,0.099999964,0.001,no dnr,33.0,105.0,22.0,146.0,14.0,39.19531,252.5,1.8999023,9.69921875,7.89941406,148.0,7.419922,135.0,23.0,2502.0,3.4604492,<2 mo. follow-up
69.09497,1,male,0,23,187,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,22671.0,16697.625,15.666664,white,24.0,2,1,0,no,0.75,0.5,dnr after sadm,4.0,79.0,9.79882812,107.0,24.0,36.0,128.75,3.5,1.01,1.09985352,126.0,7.329102,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
70.11096,1,male,0,92,165,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,135625.0,99232.4375,35.25,white,38.0,11,1,0,yes,0.099999964,0.001,no dnr,92.0,66.0,26.3984375,110.0,24.0,38.89844,207.5,2.0,0.39996338,1.09985352,127.0,7.439453,135.0,23.0,2502.0,0.0,SIP>=30
61.17499,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,60984.0,46833.125,49.333313,white,64.0,1,0,0,no,0.799999714,1.0,dnr after sadm,18.0,54.0,23.5976562,73.0,12.0,36.5,173.3125,1.1999512,0.39996338,4.09960938,131.0,7.399414,135.0,23.0,2502.0,3.0,<2 mo. follow-up
52.33899,0,female,0,7,1944,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,4351.0,14452.7344,8.0,black,12.0,1,0,0,no,0.799999714,0.5,no dnr,7.0,99.0,5.19921875,102.0,20.0,37.0,333.3,3.5996094,1.39990234,0.89990234,132.0,7.419922,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
69.63196,1,male,0,18,385,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,11426.0,8963.9688,9.666664,white,42.0,1,1,0,yes,0.899999619,0.8,no dnr,18.0,149.0,12.0,74.0,34.0,36.0,333.3,3.699707,1.09985352,2.39990234,140.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
59.08798,1,male,0,5,310,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,3004.0,2276.9844,8.0,white,32.0,1,0,0,no,1.0,1.0,no dnr,5.0,107.0,6.19921875,120.0,25.0,36.5,238.09375,3.7998047,0.5,1.0,141.0,7.359375,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.35999,0,male,0,102,1940,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,156300.0,118342.5,44.25,white,54.0,7,0,0,no,0.5,0.5,no dnr,102.0,63.0,20.6992188,118.0,36.0,38.59375,152.0,2.0,2.59960938,1.0,139.0,7.439453,135.0,23.0,2502.0,2.6904297,<2 mo. follow-up
78.45599,1,female,0,61,1445,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,49368.0,38919.6562,15.0,white,25.0,1,1,0,no,0.899999619,0.8,no dnr,61.0,66.0,9.5,76.0,20.0,35.59375,333.3,3.5,1.01,0.89990234,133.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
81.02399,1,male,1,11,11,Coma,Coma,2,12.0,under $11k,13649.0,9688.2344,21.0,hispanic,45.0,1,0,1,no,0.199999928,0.1,dnr after sadm,4.0,67.0,9.3984375,102.0,26.0,38.19531,137.125,3.699707,0.69995117,0.89990234,128.0,7.399414,135.0,23.0,2502.0,7.0,<2 mo. follow-up
58.18997,1,female,0,14,231,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$25-$50k,21747.0,16633.875,27.333328,white,55.0,1,0,0,yes,0.799999714,0.65,no dnr,14.0,121.0,15.0,158.0,27.0,38.39844,182.0,3.5,0.29998779,1.89990234,156.0,7.369141,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
59.96198,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,15954.0,11898.375,21.333328,white,19.0,1,0,1,no,0.899999619,0.6,dnr after sadm,10.0,71.0,7.69921875,55.0,28.0,36.5,190.0,2.5996094,0.29998779,0.59997559,131.0,7.359375,135.0,23.0,2502.0,4.6025391,<2 mo. follow-up
53.47299,1,male,0,16,322,ARF/MOSF w/Sepsis,ARF/MOSF,5,9.0,$11-$25k,21176.0,16458.8906,22.333328,white,42.0,1,1,0,no,0.899999619,0.8,no dnr,16.0,106.0,9.69921875,118.0,36.0,36.79688,191.40625,2.699707,0.29998779,1.5,134.0,7.399414,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
42.46997,1,male,0,14,536,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,10818.0,8129.3477,5.666664,white,42.0,1,0,0,no,0.699999809,0.4,no dnr,14.0,77.0,14.0,74.0,20.0,36.79688,333.3,2.2998047,14.5,0.39996338,123.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
97.51099,1,female,1,6,6,Coma,Coma,2,12.0,under $11k,6582.0,4682.0391,13.0,black,44.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,72.0,11.3984375,60.0,38.0,35.29688,204.75,4.0,0.89990234,1.09985352,137.0,7.439453,135.0,23.0,2502.0,4.0,<2 mo. follow-up
53.81497,1,female,0,31,82,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,21837.0,16782.0469,8.25,white,28.0,1,0,0,no,0.5,0.25,dnr before sadm,0.0,66.0,13.2988281,132.0,30.0,35.79688,274.0625,3.0996094,0.29998779,0.5,138.0,7.449219,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
67.10199,1,male,0,23,969,ARF/MOSF w/Sepsis,ARF/MOSF,6,8.0,$11-$25k,23710.0,18728.4375,9.666664,black,53.0,1,1,1,no,0.399999857,0.25,dnr after sadm,5.0,105.0,18.8984375,115.0,20.0,37.39844,351.5625,1.2998047,0.29998779,2.69970703,144.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
55.09698,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,9866.0,7651.3242,33.0,white,24.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,118.0,16.796875,129.0,32.0,38.79688,295.1875,2.7998047,1.79980469,1.0,137.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
54.81497,1,female,0,17,236,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,23764.0,17309.9844,24.666656,black,56.0,4,0,0,yes,0.599999905,0.6,no dnr,17.0,122.0,14.3984375,69.0,34.0,38.5,121.82812,2.199707,0.39996338,4.69921875,131.0,7.279297,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
44.24597,1,male,0,10,473,COPD,COPD/CHF/Cirrhosis,5,11.0,under $11k,9844.0,7045.5039,11.0,white,34.0,1,0,0,no,0.5,0.3,no dnr,10.0,74.0,11.1992188,114.0,25.0,35.0,163.96875,3.3999023,1.29980469,0.79992676,133.0,7.339844,135.0,23.0,2502.0,6.0,SIP>=30
65.77399,1,male,0,3,24,Lung Cancer,Cancer,1,15.0,$25-$50k,2269.0,1606.2598,24.0,white,30.0,1,0,0,metastatic,0.149999976,0.0,dnr after sadm,2.0,75.0,7.19921875,138.0,32.0,36.0,214.96875,3.3999023,0.29998779,0.79992676,135.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
81.22095,1,male,1,23,23,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,24940.0,18283.5781,22.0,white,29.0,1,0,0,no,0.799999714,0.2,dnr after sadm,12.0,106.0,15.1992188,99.0,30.0,36.0,183.84375,2.7998047,0.59997559,1.19995117,137.0,7.299805,135.0,23.0,2502.0,2.0,<2 mo. follow-up
60.68698,1,female,1,17,17,MOSF w/Malig,ARF/MOSF,1,15.0,$25-$50k,67389.0,50678.5938,50.0,white,53.0,10,0,0,yes,0.799999714,0.7,dnr after sadm,16.0,114.0,0.0,136.0,32.0,39.59375,293.3125,2.2998047,2.39990234,0.5,137.0,7.539062,135.0,23.0,2502.0,1.0,<2 mo. follow-up
58.26099,1,male,0,13,310,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,9280.0,7060.2305,14.5,black,35.0,1,1,0,metastatic,0.5,0.1,no dnr,13.0,77.0,13.5996094,100.0,24.0,36.19531,423.75,2.5,1.59985352,1.89990234,133.0,7.40918,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
81.17999,0,female,0,9,1928,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,13445.0,10031.125,17.0,white,31.0,2,1,0,no,0.75,0.5,no dnr,9.0,81.0,7.59960938,113.0,16.0,36.5,302.375,3.199707,0.59997559,1.59985352,138.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.63498,0,female,0,9,1928,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,6719.0,5142.0195,6.5,white,34.0,1,0,0,no,0.649999619,0.5,no dnr,9.0,65.0,6.0,94.0,20.0,36.5,333.3,1.5998535,2.79980469,1.19995117,133.0,7.419922,135.0,23.0,2502.0,3.3818359,no(M2 and SIP pres)
43.28497,1,male,0,7,431,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,under $11k,3861.0,3065.5371,6.0,white,20.0,1,0,0,no,0.799999714,0.7,no dnr,7.0,100.0,7.0,76.0,15.0,36.69531,333.3,1.7998047,1.29980469,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
54.48898,0,female,0,4,1926,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,4416.0,3126.1562,12.0,white,14.0,1,1,0,no,0.299999952,0.15,no dnr,4.0,95.0,7.0,110.0,20.0,36.09375,337.0,3.8999023,1.0,1.0,130.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.29297,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,4563.0,3250.4434,23.0,white,62.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,59.0,7.69921875,118.0,24.0,35.69531,375.875,2.0,4.69921875,3.89990234,133.0,7.389648,135.0,23.0,2502.0,4.5888672,<2 mo. follow-up
61.25098,1,male,0,81,497,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,58240.0,44682.1875,16.0,white,54.0,1,1,0,no,0.699999809,0.7,dnr after sadm,18.0,74.0,15.2988281,111.0,35.0,36.0,205.65625,2.5996094,2.39990234,1.09985352,129.0,7.469727,135.0,23.0,2502.0,5.1994972,<2 mo. follow-up
63.02499,1,male,0,39,521,Coma,Coma,2,12.0,under $11k,55836.0,43521.7812,16.25,white,36.0,1,0,0,no,0.5,0.25,no dnr,39.0,124.0,13.0,126.0,32.0,38.19531,333.3,3.5,1.01,1.89990234,140.0,7.419922,135.0,23.0,2502.0,3.4887695,<2 mo. follow-up
68.05695,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,3,11.0,under $11k,22884.0,17847.6875,38.0,hispanic,60.0,20,0,0,metastatic,0.0,0.0,dnr after sadm,2.0,45.0,18.0,131.0,40.0,36.19531,111.65625,3.5,1.01,1.59985352,135.0,7.129883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.25598,1,male,0,9,10,COPD,COPD/CHF/Cirrhosis,2,7.0,under $11k,7871.0,5668.7891,10.0,white,40.0,1,0,0,metastatic,0.799999714,0.65,dnr after sadm,1.0,99.0,3.29980469,136.0,30.0,35.5,281.875,2.8999023,1.5,1.69995117,133.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
69.10596,1,male,0,9,217,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,6378.0,4818.0977,10.0,white,18.0,1,0,0,no,0.899999619,0.75,no dnr,9.0,87.0,10.6992188,60.0,26.0,36.5,328.5625,3.699707,0.69995117,0.89990234,135.0,7.419922,135.0,23.0,2502.0,3.5063477,<2 mo. follow-up
80.08496,1,male,0,20,83,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,13990.0,10778.9375,12.0,white,29.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,120.0,9.29882812,50.0,24.0,36.5,333.3,2.5996094,4.29980469,1.0,141.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
35.09399,0,male,0,20,1918,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,56032.0,42128.8125,35.0,white,31.0,4,0,0,no,1.0,1.0,no dnr,20.0,107.0,9.5,108.0,12.0,38.5,305.0,1.7998047,1.59985352,0.69995117,134.0,7.519531,135.0,23.0,2502.0,2.0273438,no(M2 and SIP pres)
62.67798,1,female,1,3,3,Lung Cancer,Cancer,1,10.0,under $11k,2421.0,1791.9062,20.0,white,14.0,1,0,0,metastatic,0.599999905,0.5,dnr after sadm,2.0,108.0,13.1992188,96.0,20.0,36.5,233.3125,3.2998047,0.79992676,0.79992676,132.0,7.359375,135.0,23.0,2502.0,2.6816406,<2 mo. follow-up
66.23096,1,male,0,17,862,COPD,COPD/CHF/Cirrhosis,5,10.0,under $11k,15916.0,12191.6875,16.333328,white,39.0,3,0,0,no,0.899999619,0.5,no dnr,17.0,62.0,8.0,141.0,28.0,35.59375,147.5,3.0,0.89990234,1.0,136.0,7.319336,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
60.71698,1,male,0,11,211,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,22029.0,17131.5312,44.0,white,17.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,61.0,10.3984375,118.0,10.0,37.0,164.4375,3.0,1.39990234,1.0,137.0,7.399414,135.0,23.0,2502.0,3.2792969,SIP>=30
56.63199,0,female,0,73,1918,Coma,Coma,2,9.0,under $11k,107288.0,78264.3125,46.25,white,25.0,3,1,0,no,0.0,0.0,no dnr,73.0,124.0,16.8984375,72.0,12.0,39.09375,185.375,3.3999023,0.79992676,0.69995117,135.0,7.449219,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
70.16296,1,female,0,6,1192,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4602.0,3407.0176,12.0,white,35.0,1,0,0,no,0.899999619,0.6,no dnr,6.0,58.0,8.0,72.0,24.0,36.19531,232.0,3.5996094,0.89990234,1.79980469,138.0,7.439453,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
79.98395,1,female,0,5,778,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,3243.0,2459.5098,13.0,white,29.0,1,0,0,yes,0.5,0.5,no dnr,5.0,70.0,6.59960938,110.0,24.0,35.09375,333.3,3.5996094,0.59997559,1.39990234,133.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
57.36099,1,male,0,6,83,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,4543.0,3403.832,10.0,hispanic,23.0,1,0,0,no,0.799999714,0.85,no dnr,6.0,77.0,10.3984375,81.0,24.0,35.09375,366.625,3.5996094,0.69995117,1.39990234,134.0,7.459961,135.0,23.0,2502.0,1.1668997,SIP>=30
82.63696,0,male,0,36,1915,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,36403.0,28387.4844,16.5,white,46.0,1,0,0,no,0.799999714,0.7,no dnr,36.0,71.0,20.0,62.0,24.0,35.69531,287.5,2.2998047,0.89990234,7.19921875,146.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.42499,1,male,0,3,965,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,2265.0,1679.8623,17.0,white,38.0,1,0,0,yes,0.699999809,0.5,no dnr,3.0,88.0,10.0,98.0,24.0,36.39844,189.5,3.2998047,2.89990234,1.5,134.0,7.369141,135.0,23.0,2502.0,2.6040039,no(M2 and SIP pres)
81.03198,1,female,1,19,19,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,76676.0,53833.0625,47.0,black,44.0,10,0,0,yes,0.149999976,0.05,dnr after sadm,6.0,42.0,20.3984375,102.0,10.0,36.0,266.625,3.699707,1.59985352,2.09960938,137.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
71.10498,1,male,0,37,179,Lung Cancer,Cancer,1,12.0,under $11k,26591.0,20801.1719,11.75,white,16.0,1,0,0,metastatic,1.0,0.8,no dnr,37.0,80.0,6.09960938,116.0,20.0,36.79688,416.1875,2.5996094,0.19998169,1.09985352,131.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
42.116,0,male,0,7,1914,Cirrhosis,COPD/CHF/Cirrhosis,2,13.0,$25-$50k,5568.0,4211.7305,15.0,other,30.0,1,0,0,no,0.949999809,0.8,no dnr,7.0,119.0,4.5,113.0,20.0,36.59375,333.3,2.2998047,6.39941406,0.59997559,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
35.45499,1,male,0,30,491,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,40848.0,31828.0,17.5,white,32.0,1,0,0,no,0.899999619,0.85,no dnr,30.0,73.0,6.29980469,109.0,35.0,38.69531,300.0,2.199707,2.59960938,0.79992676,133.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.11694,1,female,0,11,534,CHF,COPD/CHF/Cirrhosis,5,11.0,under $11k,13868.0,10194.6094,12.0,black,40.0,2,1,0,yes,0.949999809,0.9,no dnr,11.0,108.0,5.79980469,62.0,28.0,36.09375,333.3,3.2998047,0.59997559,2.79980469,135.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
64.50098,1,male,1,16,16,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,73720.0,52804.9375,62.666657,white,34.0,19,0,0,no,0.899999619,0.9,no dnr,16.0,0.0,14.5996094,103.0,6.0,36.69531,220.0,2.5,1.01,0.59997559,135.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
81.37396,1,male,0,10,664,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,9924.0,7466.3359,8.5,black,25.0,1,0,0,yes,0.5,0.5,no dnr,10.0,119.0,18.1992188,107.0,24.0,36.0,165.6875,3.3999023,0.69995117,0.89990234,138.0,7.389648,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
49.659,1,female,1,5,5,Lung Cancer,Cancer,1,9.0,under $11k,4489.0,3237.5391,17.0,black,38.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,5.0,79.0,41.8984375,110.0,28.0,36.59375,304.75,2.7998047,0.59997559,0.79992676,119.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
54.57397,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,41318.0,30086.0,38.0,white,41.0,22,0,0,yes,0.0,0.0,dnr after sadm,2.0,83.0,2.39990234,128.0,24.0,35.29688,91.01562,3.0996094,2.19970703,0.79992676,130.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
36.392,1,male,0,17,1185,Cirrhosis,COPD/CHF/Cirrhosis,4,14.0,$11-$25k,10893.0,8705.5938,8.333328,hispanic,36.0,1,0,0,no,1.0,1.0,no dnr,17.0,96.0,4.79980469,104.0,32.0,37.59375,333.3,2.5996094,1.79980469,2.69970703,133.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
75.48297,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,263763.0,192710.0,46.5,white,63.0,128,0,0,no,0.099999964,0.001,dnr after sadm,3.0,66.0,19.296875,114.0,12.0,39.0,160.0,1.7998047,5.29980469,3.69970703,136.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.53497,0,male,0,13,1908,ARF/MOSF w/Sepsis,ARF/MOSF,3,4.0,under $11k,23338.0,18856.4688,35.5,black,35.0,1,0,0,no,0.599999905,0.6,no dnr,13.0,108.0,12.0996094,68.0,26.0,38.09375,242.84375,2.5996094,2.0,1.5,134.0,7.399414,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
77.95996,1,male,0,3,26,Lung Cancer,Cancer,2,10.0,under $11k,3146.0,2199.2891,15.0,white,19.0,1,0,0,metastatic,0.5,0.3,no dnr,3.0,117.0,5.29980469,60.0,22.0,35.5,333.3,3.0,0.19998169,0.69995117,128.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
38.86398,0,female,0,16,1907,COPD,COPD/CHF/Cirrhosis,4,11.0,under $11k,30316.0,23582.0,26.333328,black,30.0,1,0,0,no,0.649999619,0.65,no dnr,16.0,117.0,6.09960938,122.0,12.0,38.89844,167.5,3.2998047,0.5,1.59985352,134.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
37.29999,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,39395.0,14452.7344,24.0,black,78.0,30,0,0,metastatic,0.0,0.0,dnr before sadm,-17.0,63.0,0.59997559,108.0,22.0,36.29688,333.3,2.2998047,13.0996094,2.5,128.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
83.96997,1,female,0,5,199,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,2727.0,2107.1406,11.0,white,28.0,1,0,0,no,0.799999714,0.5,no dnr,5.0,60.0,6.19921875,80.0,20.0,36.0,318.0625,3.7998047,1.19995117,0.79992676,138.0,7.459961,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
46.48898,0,male,0,5,1905,Cirrhosis,COPD/CHF/Cirrhosis,5,8.0,under $11k,3504.0,2670.8945,6.0,white,34.0,1,0,0,yes,0.849999905,0.75,no dnr,5.0,67.0,6.0,62.0,20.0,36.79688,438.0625,2.199707,4.89941406,0.69995117,134.0,7.269531,135.0,23.0,2502.0,1.8389997,adl>=4 (>=5 if sur)
75.23096,0,female,0,39,1904,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,48176.0,38014.4688,22.25,white,20.0,1,0,0,no,0.699999809,0.6,dnr after sadm,25.0,180.0,18.5976562,116.0,10.0,38.09375,262.5,4.0996094,0.69995117,0.89990234,135.0,7.399414,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
40.76898,1,female,0,15,368,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,11920.0,8964.0859,11.666664,white,19.0,1,0,0,no,0.899999619,0.9,no dnr,15.0,64.0,6.0,114.0,20.0,38.19531,333.3,2.699707,1.89990234,0.59997559,124.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
72.55597,1,male,1,14,14,Lung Cancer,Cancer,2,12.0,under $11k,11540.0,8652.2188,16.333328,white,26.0,1,0,0,metastatic,0.599999905,0.25,dnr after sadm,5.0,115.0,11.8984375,68.0,32.0,36.59375,333.3,2.5996094,0.5,0.89990234,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.02197,1,female,1,17,17,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,53379.0,41452.4688,41.666657,black,34.0,6,0,0,metastatic,0.299999952,0.2,dnr after sadm,7.0,102.0,1.59985352,116.0,12.0,38.89844,344.3125,1.6999512,0.69995117,1.09985352,162.0,7.349609,135.0,23.0,2502.0,7.0,<2 mo. follow-up
45.98798,1,female,0,14,74,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,26266.0,20121.9375,21.333328,white,56.0,2,0,0,metastatic,0.799999714,0.7,no dnr,14.0,114.0,5.39941406,136.0,28.0,36.0,304.4375,3.0996094,3.79980469,7.5,134.0,7.379883,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
81.62097,1,male,0,9,60,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,7208.0,5522.5273,6.0,hispanic,36.0,1,0,0,yes,0.799999714,0.4,no dnr,9.0,71.0,6.59960938,65.0,20.0,36.5,333.3,3.199707,0.5,5.59960938,133.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
63.00897,1,male,0,18,150,Colon Cancer,Cancer,1,22.0,$25-$50k,12734.0,9802.4297,13.666664,white,18.0,1,0,0,metastatic,0.5,0.25,no dnr,18.0,103.0,14.8984375,102.0,20.0,38.79688,333.3,3.0,0.39996338,1.09985352,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.35498,1,female,0,12,523,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,9907.0,7324.4648,13.0,white,23.0,1,0,0,no,0.75,0.75,no dnr,12.0,71.0,13.7988281,130.0,24.0,36.5,231.28125,3.199707,0.39996338,0.79992676,136.0,7.369141,135.0,23.0,2502.0,0.4947999,adl>=4 (>=5 if sur)
57.435,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,9983.0,7126.0078,46.0,black,46.0,2,0,0,no,0.5,0.4,dnr before sadm,0.0,67.0,4.39941406,109.0,24.0,35.0,468.0,1.6999512,11.0,0.89990234,132.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.63898,1,male,1,14,14,Lung Cancer,Cancer,5,8.0,under $11k,13241.0,9668.6797,14.666664,white,37.0,1,0,0,metastatic,0.799999714,0.7,dnr after sadm,7.0,77.0,24.0976562,124.0,30.0,37.39844,414.25,3.7998047,0.59997559,1.09985352,134.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
36.22198,0,female,0,14,1892,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,12878.0,14452.7344,10.666664,black,27.0,1,0,0,no,0.989999771,0.9,no dnr,14.0,147.0,13.1992188,114.0,13.0,37.79688,294.625,3.2998047,2.79980469,0.5,141.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
57.91599,1,male,0,5,769,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,4528.0,3296.6719,14.0,white,30.0,1,0,0,no,1.0,1.0,no dnr,5.0,63.0,10.3984375,68.0,24.0,35.89844,143.3125,3.8999023,0.89990234,0.89990234,132.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.32397,1,male,0,24,1289,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,23591.0,17805.0156,14.666664,white,27.0,1,0,0,no,0.949999809,0.95,no dnr,24.0,119.0,17.296875,111.0,28.0,36.5,232.0,2.8999023,0.5,0.79992676,119.0,7.359375,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.07196,1,male,1,5,5,Coma,Coma,1,12.0,under $11k,14385.0,10782.2812,46.0,white,54.0,1,0,0,no,0.0,0.0,dnr after sadm,5.0,63.0,8.3984375,113.0,20.0,39.69531,140.59375,2.3999023,2.0,6.39941406,126.0,7.30957,135.0,23.0,2502.0,3.21875,<2 mo. follow-up
55.17297,1,male,0,27,29,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,15683.0,37632.875,30.75,white,55.0,15,0,0,yes,0.699999809,0.2,dnr after sadm,15.0,60.0,0.10998535,103.0,24.0,36.0,198.75,2.5996094,2.79980469,1.59985352,135.0,7.5,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
58.836,1,female,1,53,53,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,$11-$25k,66621.0,48740.4375,25.0,white,37.0,5,0,0,no,0.5,0.1,dnr after sadm,19.0,109.0,11.7988281,120.0,24.0,38.39844,113.23438,2.0,0.39996338,1.0,138.0,7.429688,135.0,23.0,2502.0,5.0,<2 mo. follow-up
67.74298,1,male,0,28,221,ARF/MOSF w/Sepsis,ARF/MOSF,6,9.0,under $11k,25813.0,20529.9531,11.25,black,28.0,2,1,0,no,0.699999809,0.5,dnr after sadm,7.0,79.0,11.8984375,100.0,12.0,38.29688,250.0,3.199707,1.29980469,1.09985352,134.0,7.429688,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
44.47098,0,male,0,26,1886,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,>$50k,29825.0,23189.625,12.0,white,33.0,7,0,0,no,0.599999905,0.5,no dnr,26.0,108.0,13.0,129.0,36.0,38.59375,157.9375,2.2998047,0.29998779,0.79992676,130.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
19.44099,1,female,0,27,73,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,>$50k,26602.0,19745.0312,23.0,white,48.0,2,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,120.0,10.1992188,153.0,60.0,39.29688,217.65625,3.0,0.39996338,0.59997559,131.0,7.469727,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
28.85699,0,male,0,23,1886,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,48348.0,33997.0312,52.0,white,45.0,1,0,0,no,0.5,0.5,no dnr,23.0,75.0,10.3984375,115.0,16.0,39.19531,93.28125,2.7998047,4.79980469,1.5,141.0,7.279297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.57098,0,male,0,14,1884,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,10517.0,8146.3789,4.666664,white,32.0,1,0,0,no,0.5,0.3,no dnr,14.0,72.0,9.09960938,88.0,22.0,37.79688,331.875,2.199707,3.89990234,0.69995117,134.0,7.459961,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
66.49396,1,female,0,4,21,Lung Cancer,Cancer,3,8.0,under $11k,2963.0,2225.7715,6.0,white,26.0,1,0,0,metastatic,0.699999809,0.5,dnr before sadm,0.0,103.0,8.0,77.0,24.0,36.5,333.3,3.5,0.19998169,1.89990234,126.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
68.69299,1,female,0,8,344,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,10490.0,7969.9062,16.5,white,32.0,1,0,1,no,1.0,0.8,dnr before sadm,-1.0,108.0,14.2988281,136.0,36.0,38.5,177.125,4.2998047,0.79992676,0.69995117,130.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
56.85397,1,female,0,15,236,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,12699.0,9728.1484,15.666664,white,49.0,1,1,0,no,1.0,0.95,no dnr,15.0,131.0,12.6992188,83.0,31.0,35.69531,314.8125,2.199707,0.19998169,2.5,133.0,7.389648,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
65.26495,1,male,1,5,5,CHF,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,16432.0,13072.0391,39.0,white,71.0,5,0,0,no,0.099999964,0.001,dnr after sadm,3.0,46.0,18.5,160.0,38.0,39.0,111.625,2.7998047,1.19995117,1.5,131.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
38.43698,1,male,0,16,69,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,44481.0,31427.0938,40.0,white,45.0,12,0,0,metastatic,0.75,0.422,no dnr,16.0,57.0,28.3984375,109.0,28.0,38.69531,124.4375,2.0,0.79992676,0.89990234,130.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
89.36096,1,female,0,4,607,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,2386.0,1827.4287,4.0,black,16.0,1,0,0,no,0.899999619,0.7,no dnr,4.0,99.0,6.69921875,66.0,20.0,36.0,442.8125,3.5996094,0.39996338,1.5,136.0,7.459961,135.0,23.0,2502.0,0.0,SIP>=30
62.93997,1,female,0,10,32,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,11791.0,9143.8281,11.5,white,20.0,1,0,0,no,0.799999714,0.5,dnr after sadm,1.0,110.0,6.19921875,62.0,34.0,36.29688,396.25,3.199707,0.5,1.39990234,136.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
65.55499,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,49916.0,35438.4375,69.0,black,91.0,18,0,0,yes,0.0,0.0,no dnr,3.0,31.0,58.59375,0.0,36.0,38.29688,52.0,2.699707,5.69921875,0.59997559,132.0,7.119141,135.0,23.0,2502.0,2.9624023,<2 mo. follow-up
57.62399,0,female,0,35,1879,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,71696.0,56249.2812,27.75,white,20.0,6,0,0,no,0.75,0.5,dnr after sadm,1.0,115.0,19.0,136.0,12.0,38.79688,233.96875,2.8999023,0.5,0.39996338,131.0,7.339844,135.0,23.0,2502.0,4.0,SIP>=30
77.77698,1,male,0,6,18,Lung Cancer,Cancer,3,12.0,under $11k,4039.0,3098.3418,10.0,black,17.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,96.0,11.5996094,102.0,20.0,35.0,333.3,2.699707,0.19998169,0.79992676,127.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
57.16898,1,male,0,36,1548,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,43385.0,33680.7812,23.25,white,57.0,1,0,0,no,0.799999714,0.75,dnr after sadm,4.0,55.0,20.1992188,68.0,24.0,36.89844,342.8125,2.3999023,0.39996338,3.29980469,133.0,7.289062,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
70.64795,1,female,0,9,504,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,11537.0,8542.9219,13.0,white,20.0,1,0,0,no,0.899999619,0.7,no dnr,9.0,69.0,11.0,55.0,24.0,36.89844,185.0,3.699707,0.39996338,0.89990234,134.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.12897,1,male,1,24,24,Coma,Coma,3,12.0,under $11k,33190.0,24041.8281,25.333328,white,32.0,1,0,0,no,0.399999857,0.3,dnr after sadm,6.0,63.0,9.8984375,77.0,12.0,36.39844,143.3125,4.0,1.5,1.89990234,133.0,7.379883,135.0,23.0,2502.0,3.5893555,<2 mo. follow-up
19.17599,0,male,0,18,1876,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,23266.0,17812.2812,14.666664,black,26.0,5,0,0,no,0.989999771,0.99,no dnr,18.0,74.0,22.3984375,111.0,48.0,36.59375,320.0,3.0996094,1.69995117,0.59997559,137.0,7.419922,135.0,23.0,2502.0,2.9887695,<2 mo. follow-up
44.698,1,male,1,12,12,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,59995.78781114967,14452.7344,26.0,white,47.0,1,0,0,yes,0.75,0.5,no dnr,14.58258953168044,105.0,0.30999756,58.0,28.0,36.29688,333.3,3.0996094,1.19995117,1.89990234,130.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.13098,1,female,0,6,79,MOSF w/Malig,ARF/MOSF,2,13.0,under $11k,23735.0,16893.375,34.0,black,38.0,8,0,0,metastatic,0.25,0.1,no dnr,6.0,65.0,16.8984375,106.0,22.0,36.0,141.71875,2.0996094,0.69995117,0.79992676,139.0,7.189453,135.0,23.0,2502.0,0.0,SIP>=30
75.64996,1,female,0,17,323,COPD,COPD/CHF/Cirrhosis,3,13.0,under $11k,16397.0,12036.5859,20.666656,white,48.0,1,1,0,no,0.899999619,0.9,dnr before sadm,-1.0,121.0,43.09375,114.0,36.0,36.39844,319.1875,2.3999023,0.79992676,0.89990234,140.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
50.90198,1,male,0,6,59,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,4139.0,3192.3516,11.0,black,32.0,1,0,0,no,0.699999809,0.7,no dnr,6.0,106.0,6.09960938,66.0,25.0,36.0,347.5625,3.7998047,1.69995117,1.89990234,130.0,7.439453,135.0,23.0,2502.0,2.0,<2 mo. follow-up
61.46997,1,male,0,24,1423,CHF,COPD/CHF/Cirrhosis,6,5.0,under $11k,17282.0,13229.7422,11.0,black,38.0,1,0,0,no,0.799999714,0.6,no dnr,24.0,81.0,4.29980469,65.0,24.0,35.19531,333.3,4.0996094,9.69921875,1.59985352,133.0,7.419922,135.0,23.0,2502.0,2.5110989,SIP>=30
31.778,0,female,0,5,1871,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,8632.0,6479.1289,16.0,hispanic,15.0,3,0,0,no,1.0,1.0,no dnr,5.0,85.0,13.5996094,107.0,16.0,35.5,360.0,2.699707,0.09999084,0.79992676,143.0,7.279297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.90997,1,male,0,12,469,CHF,COPD/CHF/Cirrhosis,5,8.0,$11-$25k,6866.0,5545.7188,9.0,white,32.0,1,1,0,no,0.899999619,0.9,no dnr,12.0,107.0,7.89941406,72.0,20.0,36.19531,333.3,2.5996094,0.39996338,2.09960938,134.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
59.94299,1,male,0,7,389,CHF,COPD/CHF/Cirrhosis,6,8.0,under $11k,5369.0,4071.6289,17.0,white,36.0,1,1,0,no,0.299999952,0.25,dnr after sadm,2.0,67.0,8.5,58.0,22.0,35.5,276.1875,3.699707,1.0,1.59985352,137.0,7.459961,135.0,23.0,2502.0,3.0,<2 mo. follow-up
44.36697,1,female,1,7,7,Coma,Coma,1,9.0,under $11k,34994.0,27346.5156,46.0,white,31.0,24,1,0,no,0.0,0.0,dnr after sadm,1.0,119.0,9.19921875,122.0,44.0,38.29688,310.0,3.2998047,0.29998779,0.59997559,136.0,7.519531,135.0,23.0,2502.0,6.0,<2 mo. follow-up
56.82397,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,11003.0,8158.1055,47.0,white,80.0,1,0,0,no,0.75,0.75,dnr after sadm,4.0,40.0,18.5976562,104.0,42.0,36.69531,128.3125,1.8999023,1.5,4.79980469,128.0,7.279297,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.81799,1,male,0,28,782,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,67894.0,51587.5938,27.25,white,17.0,5,0,0,no,0.979999542,0.98,no dnr,28.0,76.0,8.0,64.0,6.0,36.59375,190.0,2.0,0.79992676,1.09985352,127.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
40.82098,0,female,0,12,1870,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,22096.0,16272.7656,30.0,black,56.0,8,0,0,no,0.599999905,0.4,no dnr,12.0,62.0,27.1992188,157.0,12.0,37.59375,330.0,1.7998047,0.39996338,0.29998779,155.0,7.269531,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
61.862,0,female,0,10,1867,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,7547.0,5688.0742,10.5,white,34.0,1,0,0,no,0.949999809,1.0,no dnr,10.0,65.0,18.0976562,78.0,24.0,36.59375,333.3,2.8999023,8.09960938,0.69995117,134.0,7.419922,135.0,23.0,2502.0,3.4897461,no(M2 and SIP pres)
58.21799,1,male,0,3,392,Lung Cancer,Cancer,1,10.0,under $11k,2678.0,1860.1299,15.0,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,3.0,93.0,6.09960938,82.0,20.0,36.59375,333.3,4.3994141,0.5,0.59997559,137.0,7.419922,135.0,23.0,2502.0,1.9018555,no(M2 and SIP pres)
62.85797,0,female,0,54,1867,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,101794.0,73628.625,44.5,white,42.0,3,0,0,no,0.649999619,0.65,no dnr,54.0,60.0,5.39941406,135.0,25.0,38.29688,92.84375,2.0,0.5,1.09985352,137.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.09198,0,male,0,20,1865,Cirrhosis,COPD/CHF/Cirrhosis,5,11.0,under $11k,22227.0,16526.3438,13.333328,white,43.0,1,1,0,no,0.799999714,0.6,dnr after sadm,9.0,75.0,6.89941406,124.0,24.0,36.0,476.1875,2.5996094,3.89990234,1.69995117,142.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.72797,1,female,0,5,33,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,3533.0,2659.3281,10.0,black,33.0,1,0,0,no,0.599999905,0.5,no dnr,5.0,104.0,7.29980469,60.0,32.0,36.19531,242.84375,3.5,0.89990234,1.89990234,142.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
76.38898,0,female,0,18,1866,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,36207.0,26361.5625,13.333328,white,42.0,8,0,0,no,0.849999905,0.75,no dnr,18.0,103.0,15.8984375,101.0,20.0,36.29688,310.0,1.8999023,1.59985352,2.5,135.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.13498,1,female,0,5,1401,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,3112.0,2397.3359,10.0,white,35.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,62.0,6.79980469,120.0,23.0,36.59375,333.3,2.5996094,2.09960938,1.29980469,135.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
55.474,1,female,0,94,257,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,212445.0,164982.375,44.5,white,72.0,1,1,0,no,0.5,0.5,no dnr,94.0,61.0,11.1992188,133.0,36.0,38.5,426.0,2.0,2.29980469,2.09960938,136.0,7.469727,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
54.146,1,female,0,8,524,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,27282.0,19477.1719,21.5,white,45.0,19,0,0,yes,0.949999809,0.95,no dnr,8.0,91.0,0.0,140.0,28.0,39.0,333.3,2.5,1.39990234,0.79992676,125.0,7.419922,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
54.883,1,female,0,6,261,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,5706.0,4203.7383,10.0,black,34.0,1,1,0,no,0.979999542,0.95,no dnr,6.0,113.0,8.29882812,104.0,24.0,36.29688,252.375,2.5996094,0.39996338,2.5,137.0,7.359375,135.0,23.0,2502.0,3.855299,<2 mo. follow-up
65.659,1,male,0,51,251,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,71701.0,55313.6562,21.75,white,58.0,12,1,1,no,0.5,0.5,no dnr,51.0,53.0,6.39941406,118.0,28.0,35.59375,133.25,2.0996094,0.39996338,1.69995117,130.0,7.489258,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.13098,0,female,0,10,1859,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,7997.0,5999.3281,12.5,white,23.0,1,0,0,yes,0.5,0.4,dnr after sadm,1.0,76.0,6.09960938,114.0,24.0,36.59375,202.0,3.3999023,0.89990234,1.0,136.0,7.349609,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
61.75998,1,male,0,7,15,COPD,COPD/CHF/Cirrhosis,3,0.0,under $11k,5883.0,4348.332,8.0,white,38.0,1,0,0,no,0.299999952,0.1,dnr after sadm,2.0,71.0,6.19921875,104.0,22.0,36.29688,189.1875,3.5,1.01,1.39990234,137.0,7.239258,135.0,23.0,2502.0,6.0,<2 mo. follow-up
59.61099,1,female,0,9,81,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,8314.0,6497.7617,10.5,white,17.0,1,1,0,no,0.949999809,0.9,no dnr,9.0,106.0,9.5,110.0,22.0,36.0,372.0,3.699707,1.19995117,0.79992676,134.0,7.379883,135.0,23.0,2502.0,4.0,SIP>=30
61.76898,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,105139.0,75388.625,53.75,white,58.0,7,1,0,no,0.5,0.5,dnr after sadm,27.0,71.0,16.0976562,128.0,30.0,38.0,92.29688,2.3999023,3.89990234,1.0,143.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
70.24194,0,female,0,6,1857,CHF,COPD/CHF/Cirrhosis,4,3.0,under $11k,4524.0,3394.2441,12.0,black,19.0,1,0,0,no,0.899999619,0.9,no dnr,6.0,106.0,9.79882812,98.0,22.0,36.0,369.5,4.5996094,0.69995117,1.09985352,142.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.51297,0,male,0,12,1855,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,16698.0,12657.3438,22.0,black,40.0,7,0,0,no,0.799999714,0.5,no dnr,12.0,121.0,10.5,101.0,14.0,35.59375,480.4375,2.7998047,1.39990234,6.69921875,126.0,7.489258,135.0,23.0,2502.0,4.0,SIP>=30
80.76898,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,43134.0,33944.875,29.0,white,50.0,1,0,0,no,0.5,0.25,dnr after sadm,2.0,48.0,16.6992188,101.0,20.0,36.19531,108.32812,1.6999512,2.0,0.5,126.0,7.389648,135.0,23.0,2502.0,2.75,<2 mo. follow-up
59.995,0,female,0,11,1854,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,16998.0,13500.625,21.5,white,37.0,2,0,0,no,0.979999542,0.9,no dnr,11.0,104.0,8.69921875,110.0,30.0,36.79688,288.875,2.699707,6.29980469,1.0,133.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.487,1,female,0,14,875,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,46234.0,38764.875,17.333328,white,38.0,7,1,1,yes,1.0,0.8,no dnr,14.0,127.0,11.7988281,50.0,10.0,36.59375,146.25,3.5,1.01,3.0,134.0,7.40918,135.0,23.0,2502.0,5.2802734,no(M2 and SIP pres)
75.58099,1,female,0,8,496,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,8458.0,6429.4102,15.5,white,35.0,1,1,0,no,0.699999809,0.5,no dnr,8.0,82.0,7.09960938,72.0,20.0,35.69531,394.75,3.3999023,4.0,2.0,134.0,7.40918,135.0,23.0,2502.0,1.0,SIP>=30
77.44598,1,female,0,24,144,Colon Cancer,Cancer,2,10.0,under $11k,17083.0,13181.4922,12.333328,white,16.0,1,0,0,metastatic,0.5,0.3,no dnr,24.0,96.0,7.09960938,96.0,20.0,37.0,333.3,3.2998047,0.69995117,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
66.34399,1,female,1,14,14,Lung Cancer,Cancer,1,12.0,under $11k,10776.0,8134.1602,20.666656,white,53.0,1,0,0,metastatic,0.049999982,0.000125,dnr after sadm,3.0,59.0,15.5996094,106.0,40.0,35.29688,170.0,1.6999512,0.29998779,0.79992676,138.0,7.25,135.0,23.0,2502.0,0.0,<2 mo. follow-up
48.76398,1,male,0,5,369,COPD,COPD/CHF/Cirrhosis,5,8.0,under $11k,4564.0,3269.1152,17.0,white,24.0,1,0,0,no,1.0,0.75,no dnr,5.0,78.0,20.5976562,75.0,24.0,35.59375,208.0,4.5996094,0.69995117,1.0,136.0,7.229492,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
47.64999,0,male,0,11,1847,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,18079.0,13855.7578,20.0,white,32.0,3,0,0,no,0.899999619,0.9,no dnr,11.0,107.0,15.6992188,110.0,28.0,36.29688,147.5,3.5,1.5,1.0,132.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
68.93896,1,male,0,14,326,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,under $11k,26031.0,20241.2969,34.333313,white,30.0,1,0,0,no,0.899999619,0.5,dnr after sadm,10.0,106.0,9.0,106.0,38.0,36.09375,187.5,3.0,0.69995117,1.09985352,142.0,7.349609,135.0,23.0,2502.0,2.5727539,no(M2 and SIP pres)
67.55896,1,male,0,12,44,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,30357.0,22907.75,17.5,white,44.0,7,0,0,no,0.899999619,0.6,no dnr,12.0,139.0,17.5,100.0,24.0,35.09375,115.0,2.5996094,0.89990234,8.0,134.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
55.82999,1,female,0,12,124,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,8649.0,6666.0781,2.5,white,31.0,1,0,0,no,0.799999714,0.7,no dnr,12.0,76.0,5.89941406,94.0,22.0,37.59375,333.3,2.0,6.0,0.79992676,129.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
81.25098,1,female,0,10,285,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,7897.0,5884.1719,16.5,white,55.0,1,0,0,no,0.949999809,0.85,no dnr,10.0,67.0,14.0996094,68.0,32.0,36.69531,230.46875,3.8999023,1.19995117,2.89990234,130.0,7.369141,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
48.92798,0,male,0,9,1839,CHF,COPD/CHF/Cirrhosis,5,16.0,under $11k,9129.0,6780.3516,19.5,black,37.0,1,0,0,no,0.899999619,0.8,no dnr,9.0,129.0,3.79980469,80.0,16.0,36.29688,382.8125,3.0996094,0.5,3.0,135.0,7.349609,135.0,23.0,2502.0,3.0,SIP>=30
77.73895,1,male,1,32,32,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,74682.0,53243.0,32.75,white,41.0,14,1,0,no,0.799999714,0.5,no dnr,32.0,102.0,14.1992188,117.0,36.0,39.89844,433.3125,2.3999023,0.29998779,0.59997559,130.0,7.479492,135.0,23.0,2502.0,1.0,<2 mo. follow-up
61.19897,1,male,1,60,60,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,67041.0,51980.4375,21.5,white,39.0,1,0,0,no,0.799999714,0.5,dnr after sadm,43.0,103.0,15.1992188,111.0,12.0,37.79688,126.0,2.699707,0.69995117,6.69921875,143.0,7.449219,135.0,23.0,2502.0,2.0,<2 mo. follow-up
64.34497,1,female,1,138,138,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,400010.0,313637.5,49.0,white,41.0,8,0,0,metastatic,0.799999714,0.4,dnr after sadm,112.0,65.0,10.1992188,114.0,12.0,36.5,146.15625,2.3999023,0.5,1.59985352,138.0,7.539062,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
29.62399,1,female,0,6,25,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,6229.0,4874.7773,15.0,black,30.0,1,1,0,no,0.989999771,1.0,no dnr,6.0,62.0,9.29882812,48.0,24.0,37.0,528.5,3.0,0.19998169,0.79992676,137.0,7.199219,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
22.20399,0,female,0,202,1837,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,290573.0,223134.375,35.0,white,44.0,35,0,0,no,0.299999952,0.3,no dnr,202.0,144.0,17.8984375,189.0,28.0,37.79688,157.5,3.0,0.59997559,0.59997559,133.0,7.65918,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
43.064,0,female,0,23,1826,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,50118.0,38679.25,31.333328,white,45.0,4,1,0,no,0.599999905,0.6,no dnr,23.0,68.0,15.2988281,129.0,30.0,37.79688,118.71875,2.199707,0.79992676,1.09985352,134.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.23297,0,male,0,25,1826,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,$11-$25k,41357.0,32244.8281,17.0,black,44.0,1,0,0,no,0.899999619,0.8,no dnr,25.0,68.0,9.8984375,80.0,16.0,35.89844,366.625,4.0,2.0,10.2988281,131.0,7.389648,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
72.91998,1,female,0,10,17,MOSF w/Malig,ARF/MOSF,3,8.0,under $11k,8968.0,6329.0781,12.0,white,26.0,1,0,0,metastatic,0.25,0.1,dnr after sadm,2.0,101.0,19.6992188,108.0,20.0,36.29688,266.625,2.0,1.0,0.5,137.0,7.279297,135.0,23.0,2502.0,7.0,<2 mo. follow-up
64.52594,1,female,0,12,1041,MOSF w/Malig,ARF/MOSF,1,10.0,$11-$25k,17900.0,14150.2969,35.0,white,59.0,1,0,0,yes,0.5,0.5,no dnr,12.0,67.0,13.0996094,107.0,14.0,36.69531,356.625,1.7998047,3.0,2.89990234,139.0,7.329102,135.0,23.0,2502.0,2.3022461,no(M2 and SIP pres)
66.11896,1,female,0,5,236,Lung Cancer,Cancer,2,12.0,under $11k,4149.0,2941.3828,9.0,black,15.0,1,1,0,metastatic,0.799999714,0.3,dnr after sadm,1.0,95.0,10.5,66.0,24.0,37.79688,257.125,3.199707,0.39996338,0.69995117,139.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.71698,1,female,0,6,26,Lung Cancer,Cancer,1,12.0,under $11k,3515.0,2652.0137,7.0,white,35.0,1,0,0,metastatic,0.5,0.4,dnr after sadm,1.0,76.0,7.09960938,114.0,24.0,36.39844,227.125,3.0,0.39996338,0.5,132.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
64.849,1,female,0,20,54,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,37256.0,28256.3594,29.0,black,55.0,4,0,0,no,0.299999952,0.2,no dnr,20.0,54.0,12.3984375,111.0,30.0,35.0,300.0,2.699707,1.59985352,2.79980469,142.0,7.40918,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
68.85095,0,male,0,16,1821,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,15825.0,11496.8828,16.0,white,34.0,5,0,0,yes,0.899999619,0.8,no dnr,16.0,85.0,11.1992188,56.0,20.0,36.09375,275.0,2.2998047,6.39941406,1.19995117,138.0,7.519531,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.487,1,female,0,4,28,Lung Cancer,Cancer,3,11.0,under $11k,7190.0,2025.7129,15.0,black,17.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,1.0,103.0,3.59960938,108.0,20.0,36.5,267.5625,4.0996094,0.69995117,0.89990234,139.0,7.389648,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
73.32495,1,female,0,5,1070,CHF,COPD/CHF/Cirrhosis,5,14.0,under $11k,3602.0,2656.4199,9.0,black,32.0,1,1,0,yes,1.0,0.7,no dnr,5.0,119.0,7.59960938,78.0,24.0,36.0,386.1875,3.3999023,0.29998779,3.69970703,139.0,7.369141,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
51.26099,1,male,0,6,1409,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5223.0,3622.3848,16.0,black,15.0,1,0,0,no,1.0,0.85,no dnr,6.0,75.0,8.79882812,96.0,24.0,36.0,314.75,4.1992188,1.19995117,1.0,137.0,7.399414,135.0,23.0,2502.0,5.0,<2 mo. follow-up
50.69098,1,female,0,10,79,Lung Cancer,Cancer,4,11.0,$11-$25k,9506.0,6553.1758,13.0,black,44.0,1,0,0,metastatic,0.599999905,0.3,no dnr,10.0,60.0,0.89990234,112.0,30.0,39.19531,352.375,3.699707,0.59997559,0.89990234,138.0,7.389648,135.0,23.0,2502.0,0.0,SIP>=30
66.67999,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,57846.0,41928.1875,46.666657,white,71.0,19,0,0,no,0.199999928,0.2,dnr after sadm,19.0,125.0,23.0,120.0,28.0,35.5,230.65625,2.7998047,11.2988281,2.09960938,128.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.27399,1,female,1,18,18,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,55395.0,39613.875,53.666657,white,66.0,12,1,0,metastatic,0.5,0.0,dnr after sadm,16.0,54.0,12.3984375,130.0,24.0,38.29688,98.79688,1.6999512,2.59960938,1.5,132.0,7.449219,135.0,23.0,2502.0,4.1484375,<2 mo. follow-up
56.80197,1,male,0,8,1657,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,5660.0,4237.1289,5.5,white,36.0,1,1,0,no,0.949999809,0.9,no dnr,8.0,73.0,13.3984375,72.0,16.0,38.19531,333.3,3.0996094,8.59960938,0.59997559,130.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
62.672,0,female,0,17,1819,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,14477.0,10420.1484,8.333328,white,34.0,1,0,0,no,0.899999619,0.8,no dnr,17.0,75.0,13.1992188,62.0,28.0,36.59375,342.8125,2.8999023,4.29980469,0.69995117,131.0,7.469727,135.0,23.0,2502.0,3.4008789,no(M2 and SIP pres)
63.81897,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,34153.0,25040.625,78.0,black,87.0,20,1,0,no,0.699999809,0.5,no dnr,4.0,141.0,17.5,144.0,50.0,38.69531,70.1875,2.5,0.89990234,4.69921875,131.0,7.239258,135.0,23.0,2502.0,3.8041992,<2 mo. follow-up
54.13599,1,male,0,13,1363,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,18031.0,15195.3438,26.5,black,20.0,1,0,0,no,0.799999714,0.7,no dnr,13.0,119.0,17.0,131.0,30.0,38.59375,217.9375,2.5,0.39996338,0.59997559,139.0,7.389648,135.0,23.0,2502.0,6.0,<2 mo. follow-up
70.52997,0,female,0,16,1816,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,27348.0,19935.2812,16.666656,white,40.0,9,1,0,yes,0.949999809,0.85,no dnr,16.0,131.0,16.0,114.0,30.0,36.0,114.28125,2.5,0.59997559,1.09985352,133.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
65.94397,1,female,1,43,43,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,43172.0,32274.2969,8.0,black,28.0,1,0,0,no,0.5,0.25,no dnr,43.0,119.0,5.29980469,104.0,20.0,36.39844,333.3,2.199707,6.89941406,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.69998,1,female,1,9,9,Coma,Coma,2,12.0,under $11k,39025.0,31000.5625,44.0,white,43.0,12,0,0,no,0.199999928,0.1,dnr after sadm,4.0,145.0,20.5976562,153.0,32.0,40.29688,242.71875,2.2998047,0.39996338,0.59997559,147.0,7.399414,135.0,23.0,2502.0,3.3535156,<2 mo. follow-up
75.83295,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,2,6.0,under $11k,14140.0,10036.8438,18.5,black,75.0,5,0,0,metastatic,0.099999964,0.001,dnr after sadm,3.0,70.0,11.7988281,72.0,32.0,32.39844,293.3125,2.199707,2.89990234,1.29980469,139.0,7.179688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
81.44598,0,female,0,10,1811,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,13105.0,10368.3516,11.5,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,63.0,9.5,69.0,24.0,36.0,318.3125,4.0,0.69995117,1.29980469,135.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.008,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,5,9.0,under $11k,20080.0,15475.9531,19.0,white,22.0,5,1,1,no,0.849999905,0.85,no dnr,11.0,126.0,6.59960938,67.0,24.0,36.0,328.5625,2.699707,0.79992676,0.89990234,132.0,7.449219,135.0,23.0,2502.0,7.0,<2 mo. follow-up
46.20099,1,female,0,19,1527,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,16140.0,12431.75,10.333328,white,37.0,1,1,0,no,0.899999619,0.85,no dnr,19.0,114.0,5.0,118.0,28.0,36.0,300.0,2.5996094,3.0,0.5,135.0,7.419922,135.0,23.0,2502.0,4.1152344,<2 mo. follow-up
66.16595,1,female,0,10,890,Colon Cancer,Cancer,1,12.0,under $11k,13752.0,10945.625,20.0,white,16.0,1,0,0,metastatic,1.0,0.8,no dnr,10.0,106.0,12.2988281,106.0,20.0,36.19531,333.3,2.199707,0.5,0.69995117,135.0,7.419922,135.0,23.0,2502.0,2.6787109,<2 mo. follow-up
74.02295,1,female,1,5,5,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,20338.0,17173.6562,11.0,white,22.0,9,0,0,no,0.699999809,0.5,dnr after sadm,2.0,61.0,16.0976562,54.0,22.0,34.89844,333.3,3.5,1.01,0.79992676,131.0,7.419922,135.0,23.0,2502.0,2.8188477,<2 mo. follow-up
77.62897,1,female,0,4,403,Lung Cancer,Cancer,3,12.0,under $11k,2329.0,1721.9814,10.0,white,24.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,63.0,3.89990234,86.0,28.0,36.19531,296.0,3.8999023,0.29998779,0.69995117,136.0,7.389648,135.0,23.0,2502.0,2.8779297,<2 mo. follow-up
63.159,1,male,0,10,114,Lung Cancer,Cancer,3,2.0,under $11k,6314.0,4904.9883,5.5,white,14.0,1,0,0,metastatic,0.899999619,0.5,dnr after sadm,8.0,65.0,7.0,94.0,21.0,36.09375,333.3,3.199707,0.5,0.79992676,130.0,7.419922,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
61.95999,0,female,0,8,1810,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,14632.0,12260.9844,16.5,white,28.0,1,0,0,no,0.899999619,0.85,dnr after sadm,4.0,72.0,3.39990234,118.0,32.0,36.79688,520.875,2.5996094,0.29998779,0.09999084,135.0,7.389648,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
74.38696,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,11969.0,8219.4922,32.0,white,54.0,1,0,0,metastatic,0.5,0.5,no dnr,11.0,110.0,0.0,108.0,30.0,36.0,333.3,2.0,1.09985352,1.79980469,127.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
53.46997,1,male,1,31,31,Lung Cancer,Cancer,1,13.0,$25-$50k,64508.0,45421.3438,40.0,other,16.0,3,0,0,metastatic,0.199999928,0.1,dnr after sadm,15.0,142.0,11.0,68.0,10.0,38.19531,300.0,3.0996094,0.79992676,0.89990234,138.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.31995,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,49996.0,34270.7188,58.5,black,51.0,11,0,0,no,0.25,0.25,dnr after sadm,10.0,47.0,28.0,79.0,8.0,35.39844,166.0,2.3999023,0.79992676,1.29980469,134.0,7.319336,135.0,23.0,2502.0,6.0,<2 mo. follow-up
25.56899,0,female,0,8,1808,CHF,COPD/CHF/Cirrhosis,2,11.0,under $11k,10774.0,8177.8164,14.5,white,27.0,3,0,0,no,0.899999619,0.9,no dnr,8.0,106.0,11.0996094,113.0,26.0,37.5,333.3,3.5,2.19970703,1.29980469,136.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
90.79297,0,female,0,5,1806,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,3583.0,2672.3301,15.0,black,31.0,1,0,0,yes,0.899999619,0.8,dnr after sadm,4.0,114.0,5.59960938,104.0,24.0,36.39844,285.6875,3.5,0.39996338,1.39990234,136.0,7.289062,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
49.34198,0,female,0,14,1807,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,>$50k,21761.0,16395.3594,25.666656,white,68.0,1,0,0,no,0.599999905,0.6,no dnr,14.0,115.0,19.0,75.0,32.0,35.79688,208.0,2.699707,19.5976562,7.39941406,138.0,7.269531,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
28.674,1,male,0,42,122,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,41966.0,31984.6875,30.0,black,25.0,1,0,0,no,0.199999928,0.05,no dnr,42.0,71.0,15.3984375,113.0,28.0,39.09375,223.96875,2.5996094,2.89990234,0.79992676,136.0,7.399414,135.0,23.0,2502.0,2.7998047,adl>=4 (>=5 if sur)
40.67398,0,male,0,18,1805,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,32228.0,26405.9688,25.0,white,44.0,1,0,0,no,0.5,0.45,no dnr,18.0,81.0,18.5,104.0,32.0,38.19531,118.32812,2.7998047,1.0,8.8984375,137.0,7.289062,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.20499,0,male,0,21,1805,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,24785.0,19240.0938,22.666656,white,53.0,1,0,0,no,0.75,0.6,dnr after sadm,14.0,75.0,17.0976562,120.0,24.0,36.39844,149.96875,2.7998047,17.296875,0.69995117,136.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.25897,1,female,1,9,9,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,24767.0,20170.4375,43.0,white,73.0,1,0,0,no,0.5,0.4,dnr after sadm,9.0,67.0,27.5,172.0,40.0,37.89844,145.0,2.8999023,0.69995117,1.09985352,135.0,7.199219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.10098,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,15277.0,10335.9844,22.0,white,20.0,5,0,0,metastatic,0.5,0.5,dnr after sadm,1.0,68.0,12.6992188,68.0,22.0,36.19531,169.5625,3.0996094,0.79992676,0.39996338,127.0,7.459961,135.0,23.0,2502.0,6.0,<2 mo. follow-up
70.67798,1,male,0,15,82,COPD,COPD/CHF/Cirrhosis,5,10.0,under $11k,27689.0,22611.8906,28.333328,white,30.0,1,0,0,yes,0.399999857,0.35,no dnr,15.0,128.0,11.0996094,136.0,36.0,38.29688,323.3125,2.7998047,0.59997559,0.59997559,130.0,7.40918,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
76.13397,0,male,0,21,1803,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,25041.0,19356.9375,17.0,white,37.0,1,0,0,no,0.699999809,0.5,no dnr,21.0,106.0,23.3984375,109.0,8.0,37.89844,61.09375,4.2998047,1.0,1.29980469,136.0,7.219727,135.0,23.0,2502.0,3.2832031,adl>=4 (>=5 if sur)
42.034,1,male,0,21,451,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,21258.0,16261.6641,17.0,black,42.0,1,0,0,no,0.699999809,0.7,no dnr,21.0,82.0,30.0,122.0,26.0,37.79688,476.0,2.699707,7.59960938,0.5,143.0,7.329102,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
61.69998,1,male,0,6,12,Lung Cancer,Cancer,3,4.0,under $11k,5497.0,3823.4199,14.0,black,29.0,1,0,0,metastatic,0.5,0.4,dnr after sadm,2.0,93.0,15.2988281,112.0,24.0,37.5,233.3125,3.5996094,0.59997559,0.5,127.0,7.40918,135.0,23.0,2502.0,5.0,<2 mo. follow-up
34.21997,0,female,0,20,1801,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26755.0,21557.2812,28.0,black,54.0,1,1,0,no,0.699999809,0.65,no dnr,20.0,107.0,14.0,154.0,20.0,38.5,321.625,2.8999023,0.89990234,5.0,143.0,7.289062,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.71198,1,male,0,52,942,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,80965.0,60449.4688,39.25,black,60.0,4,0,0,metastatic,0.349999905,0.3,no dnr,52.0,63.0,16.8984375,141.0,48.0,39.69531,308.5625,2.3999023,0.39996338,2.09960938,135.0,7.25,135.0,23.0,2502.0,3.1201172,Coma or Intub
37.66699,0,male,0,10,1798,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,8869.0,6339.2773,14.0,white,21.0,1,0,0,no,0.979999542,0.95,no dnr,10.0,103.0,10.0996094,106.0,26.0,37.39844,240.0,2.5,0.5,0.5,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.40198,1,female,0,14,1598,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,19842.0,15220.7266,31.333328,white,32.0,1,1,0,no,0.5,0.3,no dnr,14.0,101.0,9.69921875,69.0,30.0,36.0,367.125,4.0,0.59997559,1.39990234,132.0,7.339844,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
54.58197,1,male,0,28,788,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,35406.0,16886.2656,16.25,white,34.0,1,1,0,no,0.899999619,0.9,no dnr,28.0,69.0,14.0996094,115.0,24.0,35.0,289.0,2.5,1.29980469,1.39990234,134.0,7.40918,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
60.28198,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,8966.0,6013.7773,25.0,white,29.0,2,0,0,no,0.029999986,2.7e-05,dnr after sadm,2.0,114.0,17.3984375,57.0,8.0,38.0,102.84375,3.5,1.01,1.5,137.0,7.55957,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.23096,0,female,0,14,1796,Lung Cancer,Cancer,4,8.0,under $11k,13297.0,9301.0312,14.333328,white,34.0,1,1,0,metastatic,0.799999714,0.7,no dnr,14.0,117.0,11.5,74.0,30.0,39.09375,274.25,2.699707,0.97998047,0.69995117,134.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
63.461,1,female,0,7,39,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,13104.0,11109.5781,23.0,black,60.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,61.0,25.796875,107.0,36.0,36.19531,355.5,2.199707,1.59985352,11.2988281,125.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
46.03699,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,93619.0,64251.2812,51.75,white,47.0,5,0,0,no,0.799999714,0.7,no dnr,27.0,111.0,4.39941406,108.0,14.0,37.59375,191.0,1.8999023,0.69995117,2.09960938,134.0,7.449219,135.0,23.0,2502.0,2.671875,<2 mo. follow-up
70.44995,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,13830.0,10619.9219,23.5,white,55.0,1,1,1,no,0.799999714,0.6,dnr after sadm,4.0,126.0,22.0,130.0,24.0,37.59375,480.9375,2.199707,2.59960938,3.69970703,141.0,7.399414,135.0,23.0,2502.0,7.0,<2 mo. follow-up
60.93399,0,female,0,5,1792,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,4762.0,3383.1133,13.0,hispanic,26.0,1,0,0,no,0.949999809,0.9,no dnr,5.0,74.0,10.1992188,100.0,16.0,36.09375,409.5,3.699707,0.79992676,1.29980469,137.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
38.32397,1,female,0,12,683,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,27923.0,21899.0938,48.0,white,43.0,1,0,0,no,0.5,0.3,no dnr,12.0,120.0,9.0,114.0,40.0,38.09375,111.65625,2.699707,4.09960938,0.89990234,137.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
51.72098,1,male,0,37,274,MOSF w/Malig,ARF/MOSF,2,11.0,$11-$25k,71184.0,55309.4375,36.75,black,107.0,1,0,0,yes,0.0,0.0,dnr after sadm,8.0,55.0,0.11999512,164.0,58.0,38.5,205.0,2.7998047,0.59997559,5.09960938,133.0,7.299805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.60098,1,male,0,9,745,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,6502.0,4792.9609,7.5,white,43.0,1,0,0,no,0.75,0.6,no dnr,9.0,83.0,8.69921875,120.0,24.0,39.79688,314.25,2.3999023,23.1992188,1.0,129.0,7.489258,135.0,23.0,2502.0,2.0,SIP>=30
71.39795,1,female,1,3,3,Coma,Coma,1,8.0,under $11k,9371.0,7837.5391,37.0,white,72.0,2,0,0,no,0.0,0.0,dnr after sadm,2.0,141.0,30.5,167.0,0.0,35.79688,375.5,3.5,1.0,0.79992676,140.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
50.98999,1,male,0,18,695,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,35167.0,26106.5469,15.0,black,26.0,15,0,0,no,0.899999619,0.9,no dnr,18.0,120.0,5.89941406,81.0,24.0,36.79688,380.9375,2.3999023,2.5,0.59997559,141.0,7.489258,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
64.97998,1,female,0,51,82,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,79752.0,61106.6562,33.5,black,67.0,22,1,0,no,0.5,0.4,no dnr,51.0,151.0,8.69921875,122.0,48.0,35.79688,333.3,2.7998047,3.59960938,2.59960938,142.0,7.379883,135.0,23.0,2502.0,6.0,<2 mo. follow-up
60.44098,1,male,0,142,435,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,215368.0,147888.75,47.25,white,40.0,1,1,0,no,0.009999998,1e-06,no dnr,142.0,61.0,17.8984375,66.0,10.0,38.09375,150.0,1.5998535,0.5,1.79980469,142.0,7.30957,135.0,23.0,2502.0,4.3125,adl>=4 (>=5 if sur)
29.37199,0,female,0,4,1788,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,8842.0,7442.1211,36.0,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,76.0,8.5,64.0,44.0,36.19531,206.65625,2.3999023,3.29980469,0.5,124.0,7.439453,135.0,23.0,2502.0,3.855299,SIP>=30
56.77499,1,female,0,7,478,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,11870.0,9637.2969,25.0,hispanic,49.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,63.0,10.8984375,120.0,12.0,35.5,576.0,3.3999023,1.69995117,2.5,139.0,7.40918,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
38.51297,1,male,0,5,1265,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,3277.0,2470.75,6.0,black,18.0,1,0,0,no,1.0,0.95,no dnr,5.0,83.0,11.1992188,78.0,28.0,35.39844,333.3,3.0996094,0.79992676,1.09985352,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.504,0,female,0,6,1786,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,4814.0,3455.4551,4.0,black,16.0,1,0,0,no,1.0,1.0,no dnr,6.0,63.0,5.0,76.0,22.0,37.0,317.5625,4.0,0.5,0.79992676,141.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.89697,0,female,0,11,1783,ARF/MOSF w/Sepsis,ARF/MOSF,2,1.0,under $11k,9648.0,7119.8281,8.5,white,23.0,1,1,0,no,0.849999905,0.7,no dnr,11.0,107.0,9.3984375,55.0,22.0,35.59375,390.75,3.2998047,2.0,0.5,123.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.20496,1,male,0,15,139,MOSF w/Malig,ARF/MOSF,4,9.0,under $11k,17320.0,13018.6016,10.666664,white,33.0,2,0,1,metastatic,0.699999809,0.5,no dnr,15.0,101.0,5.0,60.0,22.0,36.0,333.3,3.5,1.01,2.09960938,131.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
65.19397,1,male,1,52,52,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,95928.0,149235.375,49.75,white,76.0,4,0,0,no,0.5,0.5,dnr after sadm,31.0,140.0,7.79980469,160.0,50.0,38.39844,66.65625,2.5996094,2.09960938,1.39990234,138.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.71597,1,male,0,7,409,CHF,COPD/CHF/Cirrhosis,7,9.0,under $11k,5241.0,3779.2324,6.0,white,13.0,1,0,0,no,0.799999714,0.7,no dnr,7.0,117.0,11.3984375,76.0,24.0,35.79688,345.6875,4.2998047,0.5,1.19995117,137.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
39.53998,1,male,0,15,137,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,14958.0,10852.5078,12.666664,black,44.0,4,0,0,yes,1.0,0.95,no dnr,15.0,68.0,0.79992676,110.0,28.0,38.59375,333.3,3.199707,0.69995117,1.09985352,136.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
77.09198,1,male,0,12,228,Colon Cancer,Cancer,1,12.0,under $11k,8254.0,6119.1133,17.5,white,27.0,1,0,0,metastatic,0.849999905,0.7,no dnr,12.0,76.0,1.5,72.0,20.0,36.5,333.3,3.5996094,1.29980469,1.39990234,137.0,7.419922,135.0,23.0,2502.0,2.8115234,no(M2 and SIP pres)
63.35397,1,female,0,6,570,Lung Cancer,Cancer,2,12.0,under $11k,5825.0,4132.4453,12.0,white,16.0,1,0,0,metastatic,0.949999809,0.75,no dnr,6.0,95.0,18.5976562,100.0,28.0,36.69531,333.3,4.3994141,0.59997559,0.79992676,141.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
69.07898,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$11-$25k,58852.0,42840.1562,25.5,white,43.0,1,0,0,no,0.5,0.2,dnr after sadm,8.0,64.0,7.29980469,116.0,24.0,35.19531,220.0,4.6992188,0.79992676,6.09960938,135.0,7.319336,135.0,23.0,2502.0,3.9785156,<2 mo. follow-up
64.79095,0,female,0,25,1778,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,25943.0,19867.2188,17.5,white,28.0,1,0,0,no,0.799999714,0.6,no dnr,25.0,114.0,10.0,100.0,28.0,38.09375,188.0,3.5,0.5,1.29980469,139.0,7.389648,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
40.54999,0,male,0,11,1777,Coma,Coma,1,12.0,$11-$25k,31993.0,23123.7188,25.0,white,7.0,6,0,0,no,0.949999809,0.92,no dnr,11.0,107.0,13.0,57.0,12.0,36.79688,416.625,4.1992188,0.79992676,0.69995117,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.03296,1,female,1,62,62,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,152535.0,108015.625,51.25,white,36.0,10,1,0,no,0.299999952,0.2,dnr after sadm,59.0,67.0,24.5976562,130.0,36.0,36.5,161.40625,3.5,1.01,0.59997559,136.0,7.489258,135.0,23.0,2502.0,5.1994972,<2 mo. follow-up
65.23999,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,73712.0,49551.5,46.666657,white,52.0,17,0,0,metastatic,0.5,0.5,dnr after sadm,11.0,71.0,30.296875,116.0,28.0,36.89844,218.3125,1.8999023,3.89990234,0.89990234,135.0,7.389648,135.0,23.0,2502.0,7.0,<2 mo. follow-up
80.383,1,male,1,14,14,MOSF w/Malig,ARF/MOSF,2,8.0,under $11k,66713.0,51143.25,58.0,white,70.0,23,0,0,yes,0.799999714,0.6,dnr after sadm,11.0,64.0,2.39990234,114.0,32.0,38.59375,114.0,2.2998047,4.79980469,2.79980469,138.0,7.329102,135.0,23.0,2502.0,0.0,<2 mo. follow-up
79.79199,1,female,0,7,658,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,10283.0,7498.4453,23.0,black,20.0,3,0,0,no,0.599999905,0.4,no dnr,7.0,101.0,11.7988281,116.0,24.0,36.79688,321.1875,2.7998047,0.5,0.59997559,131.0,7.319336,135.0,23.0,2502.0,6.0,<2 mo. follow-up
40.93399,0,female,0,5,1776,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,8101.0,6421.1484,16.0,other,17.0,1,0,0,no,0.949999809,0.95,no dnr,5.0,74.0,4.0,113.0,14.0,36.69531,595.125,3.3999023,1.5,0.79992676,135.0,7.509766,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
32.50699,1,male,0,15,136,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,13892.0,10281.625,11.0,white,14.0,1,0,0,no,0.799999714,0.7,no dnr,15.0,93.0,4.89941406,80.0,14.0,36.0,333.3,3.699707,2.39990234,0.69995117,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.40097,1,female,0,7,346,Cirrhosis,COPD/CHF/Cirrhosis,4,14.0,under $11k,5292.0,3863.125,9.0,white,30.0,1,1,0,no,0.5,0.5,no dnr,7.0,99.0,3.29980469,80.0,20.0,36.19531,333.3,2.699707,0.69995117,3.69970703,135.0,7.419922,135.0,23.0,2502.0,1.1668997,SIP>=30
47.76498,0,female,0,7,1774,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,7541.0,5135.9883,17.0,white,35.0,1,0,0,yes,0.699999809,0.5,no dnr,7.0,77.0,14.6992188,126.0,32.0,35.59375,168.5625,3.5,0.89990234,0.79992676,138.0,7.279297,135.0,23.0,2502.0,3.2368164,<2 mo. follow-up
61.72498,1,male,0,6,1177,CHF,COPD/CHF/Cirrhosis,4,11.0,$25-$50k,3477.0,2635.6445,12.0,white,13.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,99.0,6.0,68.0,24.0,35.59375,309.5,3.2998047,1.29980469,1.09985352,141.0,7.389648,135.0,23.0,2502.0,2.5844727,adl>=4 (>=5 if sur)
36.99899,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,40579.0,34104.3125,30.5,white,65.0,17,0,0,no,0.0,0.0,dnr after sadm,4.0,69.0,14.0996094,111.0,23.0,38.39844,127.26562,3.699707,63.0,5.59960938,139.0,7.439453,135.0,23.0,2502.0,2.9394531,<2 mo. follow-up
58.28897,1,female,0,8,25,Lung Cancer,Cancer,1,16.0,under $11k,6811.0,5021.3906,4.5,white,18.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,4.0,67.0,5.19921875,106.0,16.0,38.19531,333.3,3.8999023,1.0,0.39996338,130.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
86.72998,0,female,0,18,1772,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,19233.0,15117.0859,26.0,white,44.0,1,0,0,yes,0.799999714,0.8,no dnr,18.0,71.0,5.0,141.0,28.0,38.69531,220.0,2.8999023,0.39996338,0.39996338,125.0,7.429688,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
62.09399,0,female,0,17,1771,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,14936.0,10613.7734,13.333328,white,37.0,1,0,0,yes,0.799999714,0.6,no dnr,17.0,122.0,13.3984375,124.0,28.0,37.39844,203.3125,4.5996094,1.29980469,0.39996338,131.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
49.10098,0,male,0,42,1769,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,91684.0,60923.8125,43.5,white,37.0,2,0,0,no,0.849999905,0.85,no dnr,42.0,67.0,21.1992188,126.0,9.0,39.59375,177.5,2.0996094,3.5,1.39990234,145.0,7.509766,135.0,23.0,2502.0,0.0,SIP>=30
68.14795,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,32717.0,24427.875,39.666657,white,36.0,3,0,0,no,0.5,0.4,dnr after sadm,11.0,113.0,17.6992188,76.0,24.0,38.29688,182.0,2.7998047,1.09985352,2.59960938,145.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.87897,1,male,1,6,6,Coma,Coma,1,12.0,$25-$50k,18925.0,13683.5859,62.0,white,78.0,2,0,0,no,0.049999982,0.000125,dnr after sadm,6.0,65.0,14.2988281,180.0,40.0,39.19531,146.25,2.2998047,4.39941406,3.39990234,130.0,7.40918,135.0,23.0,2502.0,3.1762695,<2 mo. follow-up
53.55197,0,male,0,8,1765,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,19763.0,15451.3359,26.0,white,40.0,1,0,0,no,0.799999714,0.8,no dnr,8.0,70.0,10.0996094,111.0,28.0,38.69531,122.84375,2.7998047,2.89990234,0.59997559,147.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.74298,0,female,0,101,1764,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,156394.0,114891.938,40.25,white,37.0,1,0,0,no,0.849999905,0.85,dnr after sadm,44.0,71.0,10.8984375,74.0,24.0,36.0,144.875,2.3999023,2.69970703,1.59985352,139.0,7.389648,135.0,23.0,2502.0,5.0,SIP>=30
19.351,0,male,0,11,1763,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,139899.0,98136.8125,18.5,white,38.0,47,0,0,no,0.699999809,0.7,no dnr,11.0,71.0,15.8984375,152.0,30.0,39.59375,210.0,3.0,0.5,0.29998779,128.0,7.449219,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.85095,1,male,1,58,58,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,214606.0,147583.875,54.0,white,62.0,15,0,0,no,0.5,0.5,dnr after sadm,45.0,67.0,18.296875,48.0,28.0,38.19531,132.375,2.3999023,2.39990234,2.59960938,143.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.91394,1,male,0,3,42,Lung Cancer,Cancer,6,12.0,under $11k,4052.0,2795.0059,9.0,white,13.0,2,0,0,metastatic,0.699999809,0.5,no dnr,3.0,76.0,8.0,104.0,22.0,36.19531,333.3,3.5,1.01,0.79992676,141.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
34.905,1,female,0,4,217,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,3180.0,2314.9434,8.0,white,22.0,1,0,0,no,0.5,0.5,no dnr,4.0,95.0,12.5,116.0,24.0,37.0,333.3,2.5,3.59960938,0.5,134.0,7.419922,135.0,23.0,2502.0,2.2905273,no(M2 and SIP pres)
56.46799,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,53228.0,41687.2188,44.666657,white,82.0,1,0,0,no,0.149999976,0.15,dnr after sadm,17.0,69.0,9.79882812,138.0,32.0,38.19531,186.375,1.5998535,14.5996094,2.59960938,133.0,7.419922,135.0,23.0,2502.0,3.1894531,<2 mo. follow-up
78.90997,1,female,1,7,7,Coma,Coma,0,5.0,under $11k,13488.0,10996.8281,31.0,white,34.0,1,0,0,no,0.0,0.0,dnr before sadm,-1.0,122.0,17.6992188,116.0,20.0,39.09375,318.0,2.699707,0.39996338,1.29980469,151.0,7.399414,135.0,23.0,2502.0,1.0,<2 mo. follow-up
48.715,0,female,0,28,1759,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,38119.0,30093.0312,33.75,white,34.0,1,0,0,no,0.899999619,0.9,no dnr,28.0,61.0,14.0,68.0,26.0,35.29688,175.0,2.3999023,0.59997559,1.09985352,151.0,7.229492,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
53.16098,1,female,1,56,56,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,203235.0,161786.875,52.5,white,65.0,22,1,0,yes,0.25,0.25,dnr after sadm,56.0,63.0,19.296875,136.0,8.0,36.79688,234.0,1.5998535,7.69921875,2.79980469,136.0,7.379883,135.0,23.0,2502.0,3.2768555,<2 mo. follow-up
41.418,1,female,1,7,7,Coma,Coma,1,14.0,under $11k,25814.0,20979.4375,48.0,black,60.0,6,0,0,no,0.0,0.0,dnr after sadm,5.0,59.0,16.796875,78.0,12.0,35.19531,271.375,1.5,0.59997559,2.69970703,133.0,7.279297,135.0,23.0,2502.0,3.0,<2 mo. follow-up
42.67499,1,female,1,4,4,Coma,Coma,2,12.0,under $11k,7940.0,6883.0859,14.0,black,73.0,1,0,0,no,0.0,0.0,dnr after sadm,2.0,38.0,6.19921875,153.0,10.0,36.59375,387.125,3.3999023,0.79992676,9.0,144.0,7.189453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
82.88599,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,35067.0,27143.7344,27.25,white,43.0,1,0,0,no,0.25,0.25,dnr after sadm,1.0,66.0,8.8984375,71.0,12.0,38.0,246.0,2.699707,1.29980469,2.29980469,157.0,7.439453,135.0,23.0,2502.0,4.8681641,<2 mo. follow-up
63.49298,0,male,0,14,1752,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,28506.0,22617.5,24.0,white,36.0,1,0,0,no,0.799999714,0.8,no dnr,14.0,73.0,20.796875,114.0,12.0,38.19531,208.5625,2.199707,1.39990234,1.79980469,140.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.41895,1,female,0,22,64,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,38784.0,31622.9375,36.333313,white,49.0,1,0,0,no,0.5,0.5,dnr after sadm,14.0,133.0,8.69921875,113.0,48.0,36.59375,122.5,2.699707,0.59997559,0.89990234,132.0,7.209961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
38.98398,1,male,0,16,425,MOSF w/Malig,ARF/MOSF,2,14.0,under $11k,22489.0,16593.1719,15.0,black,27.0,7,1,0,metastatic,0.75,0.5,no dnr,16.0,109.0,25.6992188,108.0,16.0,37.89844,434.25,1.7998047,0.59997559,0.79992676,139.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.41199,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,3,11.0,$11-$25k,13175.0,10220.5547,24.5,white,37.0,1,1,0,metastatic,0.049999982,0.000125,dnr after sadm,5.0,61.0,20.6992188,110.0,34.0,39.19531,388.0,2.8999023,1.39990234,1.29980469,136.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.22699,1,female,0,5,37,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,15031.0,10768.1172,23.0,black,9.0,9,0,0,metastatic,0.5,0.25,dnr after sadm,2.0,81.0,12.5996094,106.0,24.0,36.5,304.75,2.7998047,0.69995117,1.0,136.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
60.82098,1,male,1,4,4,Coma,Coma,0,16.0,$25-$50k,3746.0,2563.1621,16.0,white,52.0,1,0,0,no,0.069999993,0.000343,dnr before sadm,-1.0,127.0,16.796875,144.0,10.0,40.39844,288.0,3.2998047,0.39996338,1.19995117,130.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.96997,1,male,0,7,55,Colon Cancer,Cancer,1,7.0,under $11k,6863.0,4849.3125,13.0,white,20.0,1,0,0,metastatic,0.299999952,0.15,no dnr,7.0,77.0,10.7988281,84.0,22.0,36.79688,407.125,2.5,1.69995117,0.69995117,132.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.63898,1,male,0,12,18,Lung Cancer,Cancer,3,7.0,under $11k,7860.0,5982.418,8.0,black,22.0,1,0,0,metastatic,0.199999928,0.05,dnr before sadm,-1.0,101.0,12.7988281,56.0,16.0,36.19531,890.375,2.7998047,0.29998779,1.29980469,158.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
27.44099,0,male,0,30,1747,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,62613.0,45073.9062,29.5,white,32.0,2,0,0,no,0.799999714,0.8,no dnr,30.0,75.0,7.09960938,126.0,16.0,38.69531,157.5,1.6999512,1.79980469,0.69995117,135.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.73895,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,18471.0,15439.2266,27.0,white,74.0,2,0,0,no,0.009999998,1e-06,dnr after sadm,3.0,72.0,22.1992188,108.0,44.0,38.19531,112.32812,1.7998047,2.59960938,5.39941406,146.0,7.449219,135.0,23.0,2502.0,3.1245117,<2 mo. follow-up
66.26099,0,female,0,19,1747,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,20285.0,15411.9375,17.666656,black,28.0,1,1,0,no,0.899999619,0.7,no dnr,19.0,112.0,16.1992188,69.0,16.0,35.0,495.1875,2.5996094,0.29998779,1.39990234,151.0,7.349609,135.0,23.0,2502.0,2.0,<2 mo. follow-up
47.14899,1,male,0,7,209,Cirrhosis,COPD/CHF/Cirrhosis,5,9.0,under $11k,7390.0,5705.2969,8.5,hispanic,17.0,1,0,0,no,0.75,0.7,no dnr,7.0,69.0,8.5,75.0,20.0,36.0,437.5625,3.199707,0.79992676,1.09985352,134.0,7.489258,135.0,23.0,2502.0,3.8134766,SIP>=30
51.04199,1,male,0,30,944,MOSF w/Malig,ARF/MOSF,1,14.0,>$50k,52045.0,35465.7812,28.5,white,39.0,11,0,0,yes,0.699999809,0.3,no dnr,30.0,94.0,0.0,104.0,24.0,36.69531,333.3,2.5,3.19970703,1.09985352,127.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
43.49298,1,female,0,7,40,CHF,COPD/CHF/Cirrhosis,6,12.0,$11-$25k,4658.0,3478.6856,9.0,white,16.0,1,1,0,no,0.399999857,0.3,dnr before sadm,-1.0,60.0,8.8984375,70.0,24.0,36.19531,333.3,3.5,1.01,1.19995117,134.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
54.63898,0,male,0,55,1745,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,19172.0,40448.4062,19.75,white,22.0,1,1,0,no,0.699999809,0.7,dnr after sadm,14.0,121.0,16.6992188,130.0,24.0,36.29688,350.0,2.8999023,0.69995117,0.69995117,133.0,7.429688,135.0,23.0,2502.0,6.0,<2 mo. follow-up
56.48999,1,male,0,3,1383,Colon Cancer,Cancer,1,11.0,$11-$25k,1837.0,1393.9902,13.0,black,19.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,60.0,2.69970703,70.0,22.0,36.5,333.3,3.699707,1.09985352,0.89990234,133.0,7.419922,135.0,23.0,2502.0,1.9187012,no(M2 and SIP pres)
77.63397,1,male,0,72,78,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,144351.0,102315.188,38.75,white,49.0,26,0,0,no,0.5,0.5,no dnr,72.0,65.0,3.5,73.0,34.0,38.59375,183.21875,1.6999512,2.89990234,1.69995117,145.0,7.429688,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
76.03796,1,male,0,4,236,Lung Cancer,Cancer,2,12.0,$25-$50k,2028.0,1553.627,4.0,white,14.0,1,0,0,metastatic,0.199999928,0.0,dnr before sadm,-1.0,99.0,3.29980469,64.0,16.0,36.19531,333.3,3.5996094,0.39996338,1.19995117,136.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
68.48199,1,male,0,7,910,COPD,COPD/CHF/Cirrhosis,6,10.0,under $11k,11045.0,8732.6016,31.0,white,37.0,1,0,0,yes,0.75,0.7,no dnr,7.0,138.0,11.5,57.0,12.0,36.79688,224.46875,3.2998047,1.09985352,3.0,140.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
20.58899,0,female,0,13,1739,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,16083.0,11785.3828,12.0,black,48.0,1,0,0,no,0.949999809,0.9,no dnr,13.0,83.0,12.2988281,155.0,36.0,39.0,336.0,4.0996094,0.59997559,11.1992188,135.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.13696,1,male,0,18,253,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,25015.0,17548.375,27.333328,white,91.0,1,0,0,yes,0.299999952,0.05,dnr after sadm,5.0,62.0,0.25,108.0,23.0,38.09375,361.875,1.7998047,10.8984375,2.29980469,140.0,7.329102,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
66.77899,1,male,0,27,35,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,41097.0,32138.6406,21.75,white,38.0,4,0,0,no,0.799999714,0.75,no dnr,27.0,114.0,4.0,120.0,34.0,37.79688,213.3125,2.199707,1.29980469,0.79992676,139.0,7.449219,135.0,23.0,2502.0,3.9804688,<2 mo. follow-up
61.37997,1,female,0,13,748,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,17195.0,13187.8906,26.5,white,38.0,1,0,0,no,0.979999542,0.9,no dnr,13.0,154.0,8.59960938,141.0,30.0,37.69531,150.0,3.0996094,0.59997559,0.59997559,141.0,7.319336,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.392,0,female,0,4,1736,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,3863.0,2772.7852,13.0,black,21.0,1,0,0,no,0.899999619,0.9,no dnr,4.0,97.0,6.59960938,114.0,24.0,35.39844,261.875,3.5,0.5,1.19995117,136.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
81.44598,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,63753.0,44092.0625,44.0,white,65.0,13,0,0,no,0.199999928,0.1,dnr after sadm,1.0,73.0,29.8984375,136.0,54.0,38.59375,186.25,2.2998047,2.79980469,0.69995117,127.0,7.40918,135.0,23.0,2502.0,6.0,<2 mo. follow-up
70.10498,1,female,0,16,418,MOSF w/Malig,ARF/MOSF,3,10.0,$11-$25k,15832.0,11012.5156,20.333328,white,50.0,1,0,0,metastatic,0.599999905,0.3,no dnr,16.0,65.0,0.0,74.0,22.0,35.79688,341.375,2.5996094,3.0,1.09985352,138.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
58.29398,0,female,0,11,1733,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,10777.0,8412.125,14.0,black,19.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,103.0,9.69921875,108.0,24.0,36.19531,376.1875,2.5,0.59997559,0.59997559,139.0,7.319336,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
51.29398,1,female,0,24,64,Colon Cancer,Cancer,1,12.0,$11-$25k,17845.0,13605.9219,16.666656,hispanic,38.0,1,0,0,metastatic,0.199999928,0.1,no dnr,24.0,69.0,11.8984375,108.0,20.0,36.19531,333.3,1.7998047,6.79980469,0.69995117,123.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.48895,1,male,0,8,351,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,12177.0,9755.1797,13.0,white,23.0,1,0,0,no,0.949999809,0.9,no dnr,8.0,82.0,23.296875,111.0,24.0,36.19531,289.9375,3.8999023,0.5,1.09985352,132.0,7.25,135.0,23.0,2502.0,1.0,<2 mo. follow-up
52.28497,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,36974.0,28766.9219,58.5,white,80.0,9,0,0,no,0.099999964,0.001,dnr after sadm,6.0,57.0,19.0976562,103.0,43.0,35.69531,108.32812,1.7998047,4.5,1.09985352,131.0,7.319336,135.0,23.0,2502.0,6.0,<2 mo. follow-up
93.008,0,female,0,5,1731,CHF,COPD/CHF/Cirrhosis,2,0.0,under $11k,3541.0,2628.5019,16.0,white,39.0,1,0,0,no,0.899999619,0.8,dnr before sadm,-1.0,98.0,4.79980469,110.0,28.0,36.29688,329.5,4.3994141,1.09985352,1.89990234,138.0,7.379883,135.0,23.0,2502.0,3.3041992,no(M2 and SIP pres)
69.24597,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,$11-$25k,47436.0,33556.7812,52.0,white,48.0,1,0,0,yes,0.5,0.5,dnr after sadm,10.0,119.0,2.19970703,73.0,10.0,36.5,214.0,1.8999023,0.79992676,4.59960938,136.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.92999,1,female,0,29,430,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,42297.0,33734.9062,32.75,white,64.0,1,1,0,no,0.799999714,0.8,no dnr,29.0,103.0,12.8984375,104.0,40.0,39.29688,127.26562,2.0996094,0.19998169,6.0,135.0,7.349609,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
73.55499,1,male,0,35,421,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,38373.0,29278.0,18.75,white,34.0,1,0,1,yes,0.699999809,0.6,no dnr,35.0,68.0,22.3984375,77.0,29.0,37.79688,210.46875,2.2998047,0.29998779,1.79980469,145.0,7.419922,135.0,23.0,2502.0,5.7412109,<2 mo. follow-up
73.72198,1,female,0,10,168,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,6401.0,4831.8086,12.0,black,32.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,71.0,9.0,66.0,26.0,36.5,333.3,3.5,0.89990234,1.59985352,139.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
84.08496,1,male,0,3,728,CHF,COPD/CHF/Cirrhosis,2,4.0,under $11k,1705.0,1299.8232,10.0,white,26.0,1,0,0,no,0.949999809,0.7,no dnr,3.0,82.0,8.19921875,76.0,32.0,36.5,323.75,3.3999023,0.59997559,1.19995117,139.0,7.429688,135.0,23.0,2502.0,2.6245117,no(M2 and SIP pres)
89.52496,0,female,0,15,1725,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,20729.0,16369.9453,15.0,white,43.0,1,0,0,yes,0.5,0.3,no dnr,15.0,62.0,8.59960938,66.0,26.0,36.0,327.625,2.699707,1.19995117,2.19970703,140.0,7.359375,135.0,23.0,2502.0,4.1464844,<2 mo. follow-up
34.53299,1,male,0,10,708,Cirrhosis,COPD/CHF/Cirrhosis,4,13.0,under $11k,16270.0,12321.6016,25.5,white,25.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,71.0,11.5,51.0,24.0,36.19531,102.84375,3.0996094,2.69970703,0.5,136.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.103,1,male,1,3,3,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,13521.0,9469.1875,65.0,white,102.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,33.0,15.0996094,0.0,30.0,37.79688,88.09375,2.199707,6.5,3.69970703,154.0,7.069336,135.0,23.0,2502.0,3.7548828,<2 mo. follow-up
26.75699,0,female,0,18,1722,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,34571.0,24394.75,32.0,white,23.0,1,0,0,no,0.799999714,0.8,no dnr,18.0,80.0,19.8984375,139.0,24.0,38.0,255.96875,1.7998047,1.39990234,0.79992676,138.0,7.399414,135.0,23.0,2502.0,0.0,SIP>=30
83.31299,1,male,0,4,560,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,2717.0,1988.3877,14.0,white,28.0,1,0,0,yes,0.799999714,0.5,no dnr,4.0,115.0,5.89941406,66.0,28.0,35.0,368.5625,3.8999023,0.69995117,1.09985352,139.0,7.429688,135.0,23.0,2502.0,3.3417969,no(M2 and SIP pres)
64.45398,1,female,0,7,972,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,5484.0,4037.291,17.0,white,21.0,1,1,0,yes,0.949999809,0.9,no dnr,7.0,96.0,6.0,65.0,22.0,36.19531,390.4375,3.5,0.59997559,1.69995117,137.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
58.87997,1,female,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,$11-$25k,98466.0,74373.6875,43.5,white,56.0,7,1,0,no,0.049999982,0.000125,no dnr,41.0,60.0,26.8984375,125.0,24.0,38.19531,445.9375,2.3999023,1.59985352,7.29980469,130.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
65.172,0,female,0,14,1719,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,19606.0,15423.0078,24.666656,white,25.0,2,1,0,no,0.799999714,0.7,no dnr,14.0,70.0,12.1992188,74.0,32.0,36.39844,385.6875,2.5996094,0.79992676,1.39990234,145.0,7.379883,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
64.69299,1,female,0,14,1099,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,64100.0,49874.6562,19.333328,white,47.0,17,0,0,no,0.979999542,0.97,no dnr,14.0,79.0,16.8984375,54.0,36.0,36.19531,296.0,3.5,1.01,5.5,129.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
35.461,1,male,0,42,61,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,55640.0,37463.4375,30.5,black,41.0,1,0,0,yes,0.099999964,0.001,dnr after sadm,32.0,80.0,23.0976562,128.0,40.0,40.09375,319.0,2.2998047,1.09985352,1.09985352,131.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.88696,1,male,1,9,9,Coma,Coma,1,8.0,$11-$25k,14939.0,12200.5156,33.5,white,50.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,1.0,131.0,19.5,126.0,10.0,38.09375,58.0,3.5,6.0,1.09985352,147.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.47699,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,50465.0,33040.4062,49.333313,white,52.0,4,1,0,yes,0.099999964,0.001,dnr after sadm,17.0,54.0,9.8984375,103.0,24.0,36.39844,129.0,2.7998047,4.59960938,1.59985352,133.0,7.439453,135.0,23.0,2502.0,7.0,<2 mo. follow-up
26.752,1,female,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,46415.0,36414.0938,26.333328,white,30.0,1,0,0,yes,0.949999809,0.9,no dnr,22.0,62.0,6.09960938,131.0,22.0,38.79688,376.1875,2.0,0.29998779,0.39996338,134.0,7.389648,135.0,23.0,2502.0,3.1831989,<2 mo. follow-up
64.34796,1,female,1,27,27,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,59995.78781114967,14452.7344,31.5,white,32.0,5,0,0,metastatic,0.899999619,0.9,no dnr,14.58258953168044,63.0,13.0,122.0,28.0,38.09375,176.0,2.699707,0.29998779,0.79992676,138.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.62598,1,male,0,9,334,MOSF w/Malig,ARF/MOSF,1,17.0,$25-$50k,7240.0,5208.207,15.0,white,38.0,1,0,0,yes,0.799999714,0.7,no dnr,9.0,70.0,0.2199707,80.0,22.0,37.79688,333.3,2.199707,1.09985352,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.771,0,male,0,285,1717,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,344593.0,228765.125,33.5,white,28.0,1,0,0,no,0.799999714,0.8,no dnr,285.0,114.0,9.3984375,124.0,27.0,37.69531,206.4375,3.0996094,1.39990234,1.09985352,137.0,7.40918,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
68.06598,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,38804.0,26502.6562,60.0,white,90.0,8,0,0,no,0.699999809,0.5,dnr after sadm,5.0,59.0,39.0,103.0,38.0,39.19531,166.0,2.0,10.0,6.0,141.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
48.35898,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,4,7.0,under $11k,50534.0,40139.25,47.333313,white,67.0,5,1,0,no,0.099999964,0.001,no dnr,14.0,43.0,11.1992188,164.0,36.0,39.79688,89.0,2.3999023,1.89990234,0.69995117,137.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.284,1,male,0,10,129,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,7160.0,5280.0586,10.5,white,19.0,1,0,0,no,0.599999905,0.4,dnr after sadm,1.0,81.0,14.0996094,70.0,25.0,36.39844,333.3,3.5996094,0.89990234,1.0,131.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
54.86899,1,male,0,32,1050,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,43079.0,31790.9688,29.5,white,36.0,1,0,0,no,0.899999619,0.9,no dnr,32.0,48.0,27.0,118.0,10.0,36.39844,260.0,2.7998047,4.29980469,1.19995117,140.0,7.359375,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
55.86298,1,male,0,6,136,Colon Cancer,Cancer,1,12.0,$11-$25k,5997.0,4148.6406,8.0,white,13.0,1,0,0,metastatic,0.799999714,0.7,no dnr,6.0,103.0,8.59960938,60.0,20.0,36.5,333.3,3.699707,0.29998779,0.69995117,139.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
29.05699,1,female,0,7,61,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,under $11k,8497.0,6915.5156,41.0,black,59.0,1,0,0,yes,0.5,0.5,dnr after sadm,1.0,57.0,22.5976562,164.0,72.0,38.39844,288.3125,3.699707,0.59997559,0.39996338,125.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
55.27399,1,male,1,3,3,Coma,Coma,2,12.0,under $11k,7765.0,5475.0547,33.0,white,73.0,2,1,0,no,0.0,0.0,dnr after sadm,2.0,58.0,12.7988281,30.0,22.0,41.69531,127.14062,3.5,2.89990234,3.39990234,134.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
33.57999,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,31600.0,24093.25,34.0,white,63.0,18,0,0,yes,0.099999964,0.001,dnr after sadm,2.0,58.0,20.0976562,157.0,43.0,36.39844,46.0,2.5996094,1.09985352,0.59997559,144.0,7.25,135.0,23.0,2502.0,2.9355469,<2 mo. follow-up
45.89697,1,male,0,13,54,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,10048.0,7389.8828,8.0,white,38.0,1,1,0,no,0.5,0.3,no dnr,13.0,73.0,10.8984375,104.0,22.0,36.79688,333.3,2.7998047,29.296875,1.0,130.0,7.419922,135.0,23.0,2502.0,3.9741211,<2 mo. follow-up
38.83398,1,female,0,6,55,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,4638.0,3372.1992,10.0,black,48.0,1,0,0,no,0.5,0.4,no dnr,6.0,63.0,8.8984375,60.0,15.0,35.59375,421.375,2.0996094,17.296875,0.39996338,128.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
55.37,0,male,0,11,1710,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,8763.0,6394.5742,13.5,white,60.0,1,0,0,no,0.899999619,0.75,no dnr,11.0,54.0,13.5996094,74.0,28.0,38.19531,297.5625,2.3999023,17.296875,0.69995117,133.0,7.5,135.0,23.0,2502.0,3.6704102,no(M2 and SIP pres)
55.34299,1,male,0,4,131,Colon Cancer,Cancer,2,12.0,$11-$25k,2774.0,2039.4951,8.0,white,24.0,1,1,0,metastatic,0.399999857,0.3,no dnr,4.0,120.0,5.59960938,134.0,20.0,38.19531,333.3,2.7998047,0.79992676,1.0,132.0,7.419922,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
58.81998,1,male,0,3,68,Lung Cancer,Cancer,2,10.0,under $11k,2551.0,1671.3389,11.0,black,14.0,1,1,0,metastatic,0.699999809,0.5,no dnr,3.0,95.0,12.3984375,86.0,21.0,35.19531,333.3,3.5996094,0.5,0.69995117,141.0,7.419922,135.0,23.0,2502.0,2.6762695,no(M2 and SIP pres)
51.50198,1,female,0,42,446,Coma,Coma,0,11.0,under $11k,52344.0,39543.2812,29.25,black,60.0,2,0,0,no,0.199999928,0.1,no dnr,42.0,109.0,22.0976562,66.0,30.0,36.09375,319.625,1.5998535,4.5,3.5,133.0,7.359375,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
55.51797,1,male,0,22,156,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,24343.0,16756.9375,12.333328,white,48.0,4,0,0,no,0.899999619,0.7,no dnr,22.0,121.0,26.6992188,150.0,56.0,36.09375,259.25,3.5,1.01,0.89990234,136.0,7.419922,135.0,23.0,2502.0,4.5195312,no(M2 and SIP pres)
70.41998,1,male,0,10,280,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,8446.0,5952.4453,13.0,white,28.0,1,0,0,no,0.979999542,0.95,dnr after sadm,1.0,131.0,11.3984375,84.0,28.0,37.19531,277.8125,3.699707,0.29998779,0.69995117,136.0,7.289062,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
65.08997,1,female,0,15,71,MOSF w/Malig,ARF/MOSF,1,10.0,$11-$25k,19519.0,15068.7812,21.666656,white,19.0,1,0,0,metastatic,0.099999964,0.001,no dnr,15.0,115.0,7.19921875,113.0,14.0,36.09375,286.625,2.699707,1.0,1.19995117,133.0,7.509766,135.0,23.0,2502.0,2.0,SIP>=30
25.69699,1,male,0,8,891,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,12994.0,10274.8672,22.5,white,53.0,3,1,0,no,0.949999809,0.95,no dnr,8.0,100.0,15.0,78.0,24.0,36.39844,404.0,3.199707,3.39990234,7.89941406,129.0,7.349609,135.0,23.0,2502.0,0.0,SIP>=30
70.14099,1,male,0,3,76,Lung Cancer,Cancer,2,14.0,$11-$25k,2942.0,1867.9678,13.0,white,9.0,1,0,0,metastatic,0.599999905,0.15,no dnr,3.0,94.0,14.5,86.0,20.0,36.59375,333.3,3.2998047,0.5,0.89990234,139.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
56.34198,1,male,0,25,226,MOSF w/Malig,ARF/MOSF,2,16.0,$25-$50k,49663.0,33070.1875,29.0,white,40.0,5,1,0,yes,0.75,0.4,no dnr,25.0,105.0,0.29998779,122.0,22.0,36.0,333.3,3.0996094,1.59985352,0.89990234,124.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.33496,0,male,0,5,1703,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5459.0,4383.8945,13.0,white,16.0,1,0,0,no,0.899999619,0.5,no dnr,5.0,117.0,15.0,70.0,24.0,36.0,261.1875,4.0,0.59997559,0.79992676,141.0,7.389648,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
69.37994,1,female,0,20,1171,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,18470.0,13978.9375,12.333328,white,38.0,1,1,0,yes,0.899999619,0.5,no dnr,20.0,71.0,9.5,107.0,20.0,36.79688,333.3,1.8999023,3.5,0.69995117,129.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
65.36298,1,female,0,8,365,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5975.0,4376.9805,7.0,white,22.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,71.0,8.5,82.0,20.0,36.5,266.625,3.5,0.89990234,1.0,135.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.97299,1,male,0,13,1258,CHF,COPD/CHF/Cirrhosis,4,0.0,under $11k,9679.0,7019.1406,13.5,black,28.0,1,0,0,no,0.899999619,0.75,no dnr,13.0,76.0,7.39941406,68.0,20.0,36.79688,228.09375,2.7998047,0.09999084,1.0,134.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.18698,1,male,1,6,6,Lung Cancer,Cancer,2,11.0,under $11k,4981.0,3580.6914,13.0,white,19.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,1.0,76.0,7.69921875,112.0,24.0,36.0,371.375,3.3999023,0.69995117,1.0,140.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
79.88794,1,male,1,70,70,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,235460.0,167200.875,46.0,white,38.0,73,0,0,yes,0.5,0.3,dnr after sadm,65.0,73.0,5.59960938,121.0,29.0,36.79688,200.0,2.5996094,1.09985352,1.79980469,134.0,7.369141,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
40.62698,0,male,0,21,1697,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,62342.0,45183.9688,44.666657,white,27.0,7,0,0,no,0.699999809,0.5,no dnr,21.0,105.0,15.2988281,100.0,12.0,36.5,165.6875,2.3999023,3.89990234,1.09985352,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.05298,0,female,0,26,1697,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,40883.0,29752.3906,22.5,white,30.0,14,0,0,no,0.799999714,0.8,no dnr,26.0,72.0,16.1992188,73.0,24.0,35.79688,212.5,1.5998535,1.29980469,0.79992676,136.0,7.299805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.0,0,female,0,34,1697,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,71478.0,49773.9375,28.25,white,20.0,9,0,0,no,0.949999809,0.95,no dnr,34.0,71.0,22.6992188,73.0,28.0,38.09375,278.8125,3.5,1.01,0.89990234,139.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
51.23099,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,2,10.0,under $11k,7038.0,5127.2344,48.0,black,67.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,35.0,22.0976562,55.0,4.0,36.0,75.32812,3.0,0.39996338,0.5,138.0,7.189453,135.0,23.0,2502.0,3.0908203,<2 mo. follow-up
41.435,1,female,0,7,41,MOSF w/Malig,ARF/MOSF,3,11.0,under $11k,7838.0,5635.4297,12.0,black,62.0,3,1,0,yes,0.599999905,0.3,no dnr,7.0,109.0,44.8984375,116.0,28.0,36.39844,309.9375,2.2998047,0.5,1.69995117,130.0,7.519531,135.0,23.0,2502.0,3.0,<2 mo. follow-up
80.18298,1,male,1,13,13,Coma,Coma,2,12.0,under $11k,36723.0,29460.5938,41.0,white,74.0,6,0,0,no,0.099999964,0.001,dnr after sadm,1.0,47.0,32.0,120.0,40.0,38.89844,163.3125,1.7998047,0.5,0.69995117,138.0,7.40918,135.0,23.0,2502.0,3.9951172,<2 mo. follow-up
69.57697,1,female,0,9,320,Cirrhosis,COPD/CHF/Cirrhosis,5,11.0,$11-$25k,8347.0,5874.9531,10.5,white,42.0,1,1,0,no,0.5,0.4,no dnr,9.0,73.0,11.3984375,82.0,21.0,36.5,404.75,2.5,2.89990234,2.39990234,130.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.95398,1,male,0,4,24,CHF,COPD/CHF/Cirrhosis,2,16.0,$11-$25k,2309.0,1776.9834,20.0,white,27.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,97.0,9.09960938,68.0,20.0,36.0,333.3,3.5996094,0.69995117,2.09960938,137.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
51.81897,0,female,0,19,1690,CHF,COPD/CHF/Cirrhosis,5,11.0,$11-$25k,28809.0,22083.4062,17.0,white,36.0,1,1,0,no,0.949999809,0.95,no dnr,19.0,77.0,8.09960938,71.0,24.0,36.79688,258.9375,3.3999023,0.29998779,3.79980469,136.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
41.24298,0,female,0,6,1690,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,10551.0,8130.5781,20.0,black,17.0,1,1,0,no,0.849999905,0.8,no dnr,6.0,128.0,19.5,131.0,20.0,38.59375,404.0,4.0996094,0.89990234,1.0,137.0,7.339844,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
68.04095,1,female,1,3,3,Coma,Coma,2,12.0,under $11k,8269.0,6074.5156,62.0,white,91.0,2,0,1,no,0.699999809,0.5,no dnr,3.0,33.0,14.1992188,34.0,32.0,36.29688,98.32812,2.3999023,2.0,2.19970703,135.0,6.969727,135.0,23.0,2502.0,4.0390625,<2 mo. follow-up
60.95297,0,male,0,26,1689,COPD,COPD/CHF/Cirrhosis,1,9.0,under $11k,53324.0,40835.4688,32.5,white,26.0,1,0,0,no,0.799999714,0.8,no dnr,26.0,110.0,10.3984375,133.0,12.0,38.69531,120.0,2.7998047,0.5,1.29980469,138.0,7.449219,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
42.75198,1,male,0,22,1090,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,27695.0,22400.5781,19.666656,white,44.0,1,1,0,no,0.899999619,0.75,no dnr,22.0,137.0,12.6992188,68.0,24.0,36.0,296.25,1.5998535,0.39996338,6.19921875,139.0,7.339844,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
56.01898,0,female,0,6,1689,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,under $11k,8783.0,6218.5195,30.0,black,16.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,104.0,23.3984375,108.0,30.0,37.79688,240.0,2.7998047,0.59997559,0.79992676,139.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.53699,1,male,0,12,68,CHF,COPD/CHF/Cirrhosis,1,9.0,$11-$25k,23592.0,18083.8438,22.0,white,38.0,10,0,0,no,0.699999809,0.5,dnr after sadm,3.0,67.0,11.0,111.0,22.0,35.0,235.53125,3.0,2.69970703,0.89990234,121.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.73895,1,male,0,10,17,Lung Cancer,Cancer,2,9.0,under $11k,7838.0,5817.9648,7.5,other,31.0,1,0,0,metastatic,0.299999952,0.15,no dnr,10.0,67.0,32.8984375,94.0,28.0,35.79688,333.3,3.2998047,0.29998779,0.69995117,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.02499,1,male,0,4,1312,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3383.0,2272.8789,9.0,white,23.0,1,0,0,no,0.899999619,0.85,no dnr,4.0,82.0,6.69921875,83.0,22.0,36.39844,204.15625,3.5,0.69995117,0.59997559,136.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
81.87,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,9502.0,6618.2266,20.0,white,44.0,7,0,0,metastatic,0.699999809,0.5,dnr after sadm,3.0,103.0,15.8984375,116.0,32.0,36.19531,175.90625,3.2998047,1.0,1.19995117,146.0,7.389648,135.0,23.0,2502.0,4.2587891,<2 mo. follow-up
20.99399,0,male,0,9,1682,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$25-$50k,12648.0,9978.9609,27.5,white,24.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,109.0,6.19921875,113.0,48.0,38.89844,251.96875,2.5996094,0.19998169,0.69995117,145.0,7.319336,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
58.409,1,male,0,31,33,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,46172.0,32606.9531,33.0,white,50.0,10,0,0,metastatic,0.75,0.422,dnr after sadm,14.0,54.0,19.5,120.0,8.0,36.19531,173.3125,3.5,1.01,3.0,134.0,7.389648,135.0,23.0,2502.0,4.3798828,<2 mo. follow-up
39.48798,1,female,1,112,112,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,321392.0,262124.25,52.0,black,57.0,1,1,0,no,0.5,0.5,no dnr,112.0,67.0,8.09960938,122.0,31.0,36.5,118.32812,2.0,0.39996338,1.59985352,150.0,7.449219,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
62.66898,0,female,0,4,1677,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4871.0,4022.8203,17.0,hispanic,19.0,1,0,0,yes,0.989999771,0.98,no dnr,4.0,79.0,7.19921875,101.0,18.0,36.0,309.5,4.3994141,0.79992676,0.79992676,135.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.36597,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,33368.0,24966.2656,31.666656,white,41.0,5,1,0,yes,0.699999809,0.6,dnr after sadm,14.0,66.0,11.0996094,109.0,24.0,36.09375,210.0,2.5,1.5,5.69921875,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.71295,1,female,0,5,1029,COPD,COPD/CHF/Cirrhosis,1,7.0,under $11k,3584.0,2589.7754,9.0,white,16.0,1,0,0,no,0.899999619,0.75,dnr after sadm,2.0,92.0,6.69921875,64.0,24.0,36.29688,250.0,3.699707,0.29998779,0.69995117,140.0,7.339844,135.0,23.0,2502.0,2.5722656,SIP>=30
63.54797,1,male,0,7,647,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,7074.0,5695.9258,9.5,white,22.0,1,1,0,no,0.5,0.5,no dnr,7.0,72.0,7.39941406,76.0,24.0,38.19531,252.0,3.5996094,1.59985352,1.09985352,133.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.59998,1,female,1,14,14,Coma,Coma,0,14.0,under $11k,37827.0,25447.2344,35.666657,white,25.0,7,0,0,no,1.0,1.0,dnr after sadm,11.0,124.0,21.1992188,118.0,24.0,38.5,290.0,4.6992188,0.5,0.59997559,127.0,7.579102,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.98499,1,male,0,18,31,Lung Cancer,Cancer,1,12.0,under $11k,17861.0,12884.8359,9.666664,white,13.0,1,0,0,metastatic,0.899999619,0.6,no dnr,18.0,101.0,6.5,98.0,24.0,36.89844,333.3,2.7998047,0.69995117,0.69995117,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
42.25299,1,male,0,8,122,Cirrhosis,COPD/CHF/Cirrhosis,1,0.0,under $11k,6724.0,4834.4141,5.0,white,10.0,1,0,0,no,0.799999714,0.5,no dnr,8.0,112.0,3.69970703,104.0,20.0,37.59375,333.3,2.5,0.79992676,0.69995117,138.0,7.419922,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
68.04395,0,male,0,20,1670,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,22680.0,16296.9141,14.333328,white,38.0,1,0,0,metastatic,0.699999809,0.5,no dnr,20.0,64.0,4.69921875,144.0,24.0,35.59375,333.3,2.2998047,0.29998779,0.39996338,131.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
60.56699,0,female,0,3,1670,Cirrhosis,COPD/CHF/Cirrhosis,6,10.0,under $11k,2917.0,2180.8457,9.0,white,20.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,87.0,6.59960938,87.0,20.0,36.69531,333.3,2.3999023,1.29980469,1.19995117,137.0,7.419922,135.0,23.0,2502.0,3.0483398,no(M2 and SIP pres)
49.13098,1,female,0,12,945,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,36857.0,27530.7656,21.5,white,23.0,21,0,0,metastatic,0.649999619,0.5,no dnr,12.0,102.0,1.29980469,126.0,22.0,38.5,333.3,3.5,1.01,0.5,131.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
50.32397,1,female,1,27,27,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,70501.0,59879.0938,38.25,white,21.0,1,0,0,no,0.599999905,0.5,dnr after sadm,21.0,69.0,10.2988281,131.0,10.0,38.39844,197.125,3.0996094,0.39996338,1.09985352,132.0,7.349609,135.0,23.0,2502.0,3.0703125,<2 mo. follow-up
45.69699,1,female,0,5,355,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4335.0,3087.1445,13.0,black,24.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,69.0,5.5,78.0,18.0,36.59375,400.0,3.699707,0.19998169,1.89990234,142.0,7.419922,135.0,23.0,2502.0,2.2543945,no(M2 and SIP pres)
62.689,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$25-$50k,87477.0,59774.2812,37.666657,white,45.0,36,0,0,metastatic,0.0,0.0,no dnr,16.0,112.0,17.1992188,117.0,27.0,38.69531,89.85938,2.0996094,5.59960938,0.59997559,128.0,7.449219,135.0,23.0,2502.0,4.0,<2 mo. follow-up
72.98297,1,female,0,4,880,CHF,COPD/CHF/Cirrhosis,5,7.0,under $11k,3225.0,2338.6484,4.0,black,40.0,1,1,0,yes,0.949999809,0.75,no dnr,4.0,103.0,5.79980469,65.0,20.0,36.19531,366.1875,3.8999023,0.39996338,6.59960938,135.0,7.389648,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
87.55597,1,female,0,9,509,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,5840.0,4547.3086,7.5,white,18.0,1,0,0,yes,0.949999809,0.7,dnr after sadm,3.0,110.0,6.79980469,96.0,24.0,36.09375,333.3,3.699707,0.89990234,1.09985352,142.0,7.419922,135.0,23.0,2502.0,6.0,SIP>=30
48.30399,1,female,0,7,116,Colon Cancer,Cancer,1,14.0,$11-$25k,6058.0,4324.293,9.0,black,35.0,1,0,0,metastatic,0.199999928,0.05,no dnr,7.0,96.0,16.296875,122.0,24.0,39.19531,442.8125,2.699707,9.8984375,0.39996338,132.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
68.39197,1,male,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,16055.0,12093.0312,46.0,white,55.0,1,1,0,no,0.099999964,0.001,no dnr,5.0,108.0,9.79882812,71.0,12.0,36.29688,380.375,1.7998047,2.39990234,1.89990234,131.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
49.93597,1,male,0,7,97,Lung Cancer,Cancer,1,18.0,>$50k,11273.0,8660.2344,18.0,white,12.0,1,0,0,metastatic,0.399999857,0.2,no dnr,7.0,73.0,3.5,104.0,22.0,36.19531,333.3,3.0996094,0.29998779,0.5,136.0,7.419922,135.0,23.0,2502.0,5.0,SIP>=30
71.461,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,42908.0,31028.6406,54.0,white,45.0,8,0,0,yes,0.75,0.5,no dnr,6.0,67.0,17.0976562,117.0,12.0,36.19531,132.28125,3.5,1.01,3.39990234,138.0,7.5,135.0,23.0,2502.0,2.4379883,<2 mo. follow-up
63.46298,1,male,1,20,20,Lung Cancer,Cancer,2,11.0,$11-$25k,18784.0,15695.4219,16.666656,white,35.0,1,0,0,metastatic,0.799999714,0.4,dnr after sadm,7.0,68.0,10.7988281,120.0,32.0,36.29688,276.1875,3.5,0.69995117,0.79992676,132.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.91998,0,female,0,30,1657,Coma,Coma,1,12.0,under $11k,57527.0,43478.3125,24.75,white,43.0,8,0,0,no,0.699999809,0.6,no dnr,30.0,106.0,16.3984375,75.0,60.0,36.0,127.98438,3.5,1.59985352,0.79992676,131.0,7.439453,135.0,23.0,2502.0,2.3061523,<2 mo. follow-up
71.84094,0,male,0,6,1655,COPD,COPD/CHF/Cirrhosis,1,6.0,$11-$25k,9770.0,7548.2852,17.0,white,33.0,1,0,0,no,0.799999714,0.8,no dnr,6.0,109.0,22.1992188,106.0,32.0,36.09375,196.28125,3.3999023,0.59997559,1.09985352,137.0,7.479492,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
73.14197,1,male,0,4,104,Lung Cancer,Cancer,3,12.0,under $11k,8258.0,5899.8984,2.0,white,15.0,6,0,0,metastatic,0.5,0.4,dnr before sadm,-5.0,69.0,9.0,98.0,23.0,38.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,2.7695312,SIP>=30
50.431,0,female,0,9,1654,CHF,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,9614.0,7212.3164,16.0,white,27.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,74.0,17.296875,113.0,24.0,36.29688,144.875,3.7998047,0.89990234,1.89990234,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.01797,0,male,0,6,1654,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,4175.0,3112.6426,4.0,white,24.0,1,0,0,no,1.0,1.0,no dnr,6.0,111.0,8.5,106.0,22.0,36.09375,423.75,2.0,2.09960938,1.19995117,130.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
81.86694,1,female,0,5,623,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,3919.0,2813.0059,15.0,white,23.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,83.0,13.1992188,94.0,16.0,35.5,257.125,3.5996094,0.5,1.29980469,136.0,7.369141,135.0,23.0,2502.0,1.1668997,SIP>=30
68.25494,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,15990.0,12494.8281,34.5,white,63.0,1,0,0,no,0.899999619,0.8,no dnr,9.0,71.0,26.0976562,176.0,8.0,36.5,198.0,2.7998047,0.59997559,7.0,131.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.98199,0,female,0,10,1651,COPD,COPD/CHF/Cirrhosis,1,13.0,$11-$25k,14576.0,10641.5156,6.5,white,27.0,5,0,0,no,0.899999619,0.7,no dnr,10.0,105.0,9.0,70.0,30.0,37.79688,207.125,3.5,1.01,1.0,142.0,7.369141,135.0,23.0,2502.0,0.0,SIP>=30
37.35498,1,male,0,275,386,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,515884.0,393331.25,40.5,white,50.0,2,1,0,yes,0.699999809,0.6,dnr after sadm,83.0,62.0,21.5,129.0,30.0,37.5,124.48438,2.0,0.29998779,1.89990234,139.0,7.349609,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
89.61499,1,female,0,3,393,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3340.0,2736.7285,17.0,white,15.0,1,0,0,yes,0.25,0.25,no dnr,3.0,90.0,6.0,70.0,20.0,36.5,395.0,3.5996094,1.0,1.29980469,141.0,7.349609,135.0,23.0,2502.0,3.1831989,SIP>=30
91.18994,1,female,0,10,634,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,6592.0,5046.0312,7.0,white,27.0,1,0,0,no,0.699999809,0.343,no dnr,10.0,70.0,6.79980469,62.0,24.0,35.0,476.625,4.0,0.79992676,1.29980469,136.0,7.479492,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
66.86896,1,male,0,15,448,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,24721.0,20425.1406,20.333328,white,62.0,1,1,0,no,0.5,0.35,no dnr,15.0,59.0,16.5976562,122.0,40.0,35.39844,326.625,2.7998047,1.29980469,2.0,116.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.17499,0,male,0,8,1647,Cirrhosis,COPD/CHF/Cirrhosis,3,6.0,under $11k,6206.0,4584.9414,14.0,white,5.0,1,0,0,no,0.849999905,0.75,no dnr,8.0,81.0,6.39941406,98.0,20.0,37.0,428.5625,3.0,0.59997559,0.79992676,132.0,7.459961,135.0,23.0,2502.0,0.0,SIP>=30
79.01697,1,female,0,4,30,Lung Cancer,Cancer,2,7.0,under $11k,2480.0,1898.6211,10.0,black,26.0,1,0,0,metastatic,0.149999976,0.2,dnr after sadm,2.0,105.0,6.39941406,60.0,22.0,36.39844,333.3,4.0,0.39996338,1.59985352,132.0,7.439453,135.0,23.0,2502.0,2.7490234,<2 mo. follow-up
83.15399,1,male,0,8,127,MOSF w/Malig,ARF/MOSF,1,7.0,under $11k,6988.0,4875.9414,14.5,white,32.0,1,0,0,yes,0.5,0.3,dnr after sadm,4.0,66.0,1.09985352,58.0,22.0,35.5,333.3,2.699707,0.89990234,0.89990234,134.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
93.22699,1,female,0,22,101,Coma,Coma,3,8.0,under $11k,16027.0,12126.0312,19.0,white,28.0,1,0,1,yes,0.5,0.4,dnr after sadm,1.0,79.0,9.19921875,76.0,24.0,36.5,556.625,2.8999023,0.5,0.59997559,133.0,7.469727,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
64.909,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,2,13.0,under $11k,15017.0,10283.2812,19.0,white,75.0,10,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,41.0,0.09999084,180.0,24.0,36.29688,333.3,2.3999023,1.39990234,1.79980469,133.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
35.06097,1,female,0,18,118,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,19369.0,13598.0312,20.666656,white,30.0,3,0,0,yes,0.699999809,0.6,no dnr,18.0,72.0,0.1499939,96.0,22.0,38.29688,333.3,3.5,1.01,0.59997559,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.452,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,32150.0,23731.8125,29.0,white,76.0,17,0,0,yes,0.699999809,0.5,dnr before sadm,0.0,53.0,27.796875,100.0,12.0,36.89844,125.0,1.2998047,5.59960938,1.5,137.0,7.349609,135.0,23.0,2502.0,3.8549805,<2 mo. follow-up
69.93799,0,male,0,29,1639,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,28396.0,22406.625,13.5,white,59.0,1,0,0,no,0.949999809,0.95,no dnr,29.0,68.0,9.69921875,73.0,32.0,37.59375,300.375,2.199707,2.09960938,2.0,138.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
52.73398,1,female,0,20,74,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,35241.0,50658.9688,41.333313,white,31.0,14,0,0,metastatic,0.5,0.3,no dnr,20.0,61.0,37.796875,47.0,14.0,37.59375,122.21875,2.8999023,0.79992676,0.59997559,139.0,7.229492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.90198,1,male,0,4,1598,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,2795.0,2089.5195,3.0,white,18.0,1,0,0,no,1.0,0.9,no dnr,4.0,127.0,4.89941406,60.0,22.0,35.89844,333.3,8.5996094,0.69995117,0.79992676,142.0,7.419922,135.0,23.0,2502.0,2.3120117,no(M2 and SIP pres)
45.57999,1,female,0,8,27,Lung Cancer,Cancer,2,12.0,under $11k,7759.0,6144.3945,7.5,white,11.0,1,0,0,metastatic,0.5,0.4,dnr after sadm,1.0,63.0,16.5976562,72.0,24.0,35.79688,333.3,3.5996094,0.29998779,0.89990234,136.0,7.419922,135.0,23.0,2502.0,3.4472656,<2 mo. follow-up
74.63098,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,$11-$25k,17657.0,13710.0078,15.0,white,46.0,6,1,0,no,0.099999964,0.001,dnr after sadm,2.0,67.0,18.0976562,138.0,16.0,36.39844,333.3,3.5,1.01,2.09960938,121.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
76.58899,0,female,0,8,1635,MOSF w/Malig,ARF/MOSF,1,6.0,under $11k,8191.0,6202.5859,17.0,white,19.0,3,0,0,yes,0.699999809,0.7,no dnr,8.0,126.0,1.79980469,64.0,20.0,36.39844,333.3,3.5,1.01,0.59997559,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
60.98599,0,male,0,29,1636,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,89069.0,63768.75,23.75,white,47.0,12,0,0,no,0.5,0.5,no dnr,29.0,108.0,9.8984375,107.0,30.0,38.39844,337.5,1.8999023,23.5976562,0.89990234,138.0,7.439453,135.0,23.0,2502.0,0.0,SIP>=30
72.31799,1,male,0,5,158,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,under $11k,3561.0,2611.6152,17.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,63.0,5.79980469,60.0,16.0,36.5,333.3,1.8999023,1.29980469,1.39990234,137.0,7.419922,135.0,23.0,2502.0,2.315918,adl>=4 (>=5 if sur)
44.02499,1,female,0,21,278,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26237.0,20897.1562,22.666656,black,50.0,1,1,0,no,0.299999952,0.3,no dnr,21.0,110.0,16.0976562,131.0,29.0,35.39844,136.71875,3.0996094,1.09985352,3.69970703,134.0,7.349609,135.0,23.0,2502.0,3.769043,<2 mo. follow-up
57.49799,0,female,0,15,1634,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,23609.0,17487.375,20.333328,white,29.0,3,0,0,yes,0.25,0.25,no dnr,15.0,65.0,2.19970703,108.0,14.0,36.59375,316.0,2.199707,0.59997559,0.69995117,132.0,7.519531,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.47198,0,male,0,8,1636,Lung Cancer,Cancer,1,15.0,$25-$50k,14028.0,11103.7266,19.0,white,9.0,1,0,0,metastatic,1.0,1.0,no dnr,8.0,108.0,5.79980469,76.0,14.0,36.39844,336.0,3.5,1.01,0.79992676,135.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
47.89297,1,male,0,13,1567,CHF,COPD/CHF/Cirrhosis,3,16.0,under $11k,12490.0,9780.9297,16.5,black,36.0,1,1,0,no,0.979999542,0.98,no dnr,13.0,123.0,3.29980469,94.0,24.0,36.09375,327.125,3.2998047,0.39996338,7.29980469,140.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
47.47699,0,male,0,87,1635,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,144883.0,105295.938,45.5,black,44.0,5,1,0,no,0.599999905,0.6,no dnr,87.0,53.0,12.7988281,112.0,14.0,36.79688,290.0,1.2998047,0.89990234,0.69995117,148.0,7.489258,135.0,23.0,2502.0,2.4526367,SIP>=30
66.07495,1,female,0,23,274,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,24990.0,19123.7969,24.0,white,51.0,1,0,0,no,0.25,0.2,no dnr,23.0,57.0,14.0,105.0,36.0,38.09375,180.0,1.5998535,0.29998779,1.19995117,141.0,7.40918,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
71.95599,1,female,0,7,22,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,7521.0,5667.1562,17.0,black,32.0,5,0,0,metastatic,0.0,0.0,no dnr,7.0,72.0,0.79992676,79.0,22.0,35.39844,333.3,3.5,1.01,0.5,143.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
27.85799,0,female,0,11,1634,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,8972.0,6571.5312,9.5,white,30.0,1,0,0,no,0.979999542,0.98,no dnr,11.0,67.0,15.0,102.0,20.0,37.19531,350.0,2.0996094,4.29980469,0.29998779,127.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
73.81,1,male,0,5,218,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,6665.0,5066.7617,22.0,white,39.0,1,0,0,yes,0.899999619,0.6,dnr after sadm,1.0,103.0,7.59960938,189.0,30.0,36.19531,222.21875,3.0996094,0.29998779,0.79992676,137.0,7.479492,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
40.77798,0,male,0,4,1633,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,2707.0,2048.6641,8.0,black,39.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,118.0,8.0,110.0,40.0,35.09375,269.5,4.0,2.09960938,1.39990234,140.0,7.40918,135.0,23.0,2502.0,2.5097656,SIP>=30
62.80399,1,male,0,8,1503,Cirrhosis,COPD/CHF/Cirrhosis,4,9.0,under $11k,6059.0,4487.9258,8.0,white,51.0,1,0,0,no,0.75,0.5,dnr after sadm,3.0,104.0,5.59960938,136.0,25.0,36.29688,447.5625,2.0,12.8984375,0.5,136.0,7.459961,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
83.76996,0,female,0,19,1630,Coma,Coma,1,5.0,under $11k,16348.0,13164.0156,11.666664,black,35.0,2,0,1,no,0.5,0.2,dnr after sadm,1.0,125.0,12.8984375,83.0,34.0,36.39844,226.65625,2.699707,0.79992676,1.0,138.0,7.529297,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
39.56998,1,female,1,6,6,Lung Cancer,Cancer,2,12.0,under $11k,4717.0,3545.166,10.0,white,28.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,66.0,13.2988281,70.0,24.0,35.09375,333.3,1.3999023,0.59997559,0.39996338,147.0,7.419922,135.0,23.0,2502.0,3.1762695,<2 mo. follow-up
81.90594,1,female,0,33,1489,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,57319.0,41473.8438,29.0,white,29.0,1,0,0,yes,0.899999619,0.9,no dnr,33.0,103.0,10.1992188,64.0,16.0,36.09375,281.875,4.5,1.29980469,1.19995117,134.0,7.489258,135.0,23.0,2502.0,5.0,SIP>=30
55.01199,0,female,0,12,1629,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,12360.0,9786.9609,14.0,white,32.0,1,0,0,yes,1.0,0.8,no dnr,12.0,65.0,9.09960938,104.0,30.0,36.0,115.0,3.5996094,0.29998779,0.59997559,139.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
36.97699,0,male,0,8,1627,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,6816.0,4874.2539,12.5,white,10.0,1,1,0,no,1.0,1.0,no dnr,8.0,103.0,9.0,75.0,14.0,37.0,433.3125,2.5996094,0.69995117,0.59997559,139.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.32196,1,female,0,41,568,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,43100.0,33070.25,21.75,white,20.0,1,0,0,no,0.5,0.1,no dnr,41.0,145.0,15.0996094,60.0,14.0,36.69531,229.15625,2.699707,0.39996338,0.59997559,137.0,7.399414,135.0,23.0,2502.0,2.809082,<2 mo. follow-up
40.59698,0,male,0,7,1627,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,8025.0,6036.043,2.5,white,17.0,1,1,0,no,0.899999619,0.8,no dnr,7.0,138.0,18.0,93.0,20.0,35.69531,485.6875,3.3999023,0.79992676,0.69995117,137.0,7.709961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
43.95599,1,male,1,28,28,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,under $11k,38219.0,28785.4219,24.5,white,83.0,1,0,0,no,0.199999928,0.2,dnr after sadm,25.0,70.0,29.296875,100.0,20.0,36.5,152.375,2.7998047,21.5976562,3.0,126.0,7.479492,135.0,23.0,2502.0,6.0,<2 mo. follow-up
66.80396,1,male,0,115,116,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,244096.0,167700.625,54.5,white,54.0,27,0,0,yes,0.699999809,0.5,no dnr,115.0,65.0,21.296875,128.0,29.0,38.79688,215.0,1.3999023,4.0,1.5,131.0,7.379883,135.0,23.0,2502.0,2.7006836,Coma or Intub
89.38495,1,female,1,20,20,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,15973.0,11722.5391,14.333328,black,44.0,1,0,1,metastatic,0.5,0.25,dnr before sadm,-1.0,55.0,9.3984375,112.0,24.0,38.19531,580.0,3.0,2.79980469,1.79980469,143.0,7.40918,135.0,23.0,2502.0,7.0,<2 mo. follow-up
57.60699,1,female,0,15,163,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,31984.0,24273.5625,33.333313,white,60.0,7,0,0,no,0.599999905,0.6,no dnr,15.0,115.0,16.296875,124.0,32.0,38.69531,311.1875,2.0996094,2.09960938,2.29980469,138.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
31.20099,1,female,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,38936.0,31662.0625,48.5,white,45.0,1,1,0,no,0.5,0.5,dnr after sadm,9.0,70.0,9.5,122.0,34.0,39.29688,59.19531,2.3999023,0.69995117,0.79992676,135.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
37.91397,1,male,0,14,58,MOSF w/Malig,ARF/MOSF,1,15.0,under $11k,14411.0,10678.875,13.333328,white,34.0,4,0,0,metastatic,0.699999809,0.4,no dnr,14.0,103.0,6.79980469,128.0,24.0,38.69531,333.3,3.5,1.01,3.5,137.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
73.02899,0,female,0,12,1617,Coma,Coma,2,12.0,>$50k,15104.0,11376.9453,26.0,white,38.0,1,1,0,yes,0.75,0.75,no dnr,12.0,104.0,10.0996094,160.0,28.0,37.79688,297.5625,2.7998047,0.39996338,0.5,143.0,7.429688,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
61.34698,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,55068.0,40111.0938,53.333313,white,68.0,8,0,0,no,0.0,0.0,dnr after sadm,4.0,67.0,37.3984375,118.0,38.0,40.19531,131.40625,2.5,4.19921875,2.59960938,143.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.98199,1,female,0,8,148,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,9911.0,8030.6055,6.0,black,27.0,1,1,0,no,0.899999619,0.5,dnr after sadm,2.0,110.0,16.5976562,97.0,24.0,36.39844,460.0,3.5,0.79992676,1.59985352,134.0,7.509766,135.0,23.0,2502.0,0.4947999,SIP>=30
78.40698,1,female,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$11-$25k,42104.0,32445.1406,23.666656,black,15.0,6,1,0,no,0.799999714,0.5,dnr after sadm,19.0,68.0,9.79882812,61.0,10.0,38.79688,240.0,2.5996094,0.59997559,1.0,145.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
88.59998,0,female,0,3,1614,COPD,COPD/CHF/Cirrhosis,2,5.0,under $11k,2138.0,1544.082,9.0,white,29.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,100.0,13.6992188,126.0,20.0,36.5,231.1875,4.1992188,0.39996338,0.69995117,143.0,7.379883,135.0,23.0,2502.0,1.8389997,SIP>=30
74.396,1,female,0,12,260,Cirrhosis,COPD/CHF/Cirrhosis,6,11.0,under $11k,22765.0,17024.2969,25.0,white,46.0,3,1,0,no,0.699999809,0.5,no dnr,12.0,59.0,6.0,110.0,20.0,37.69531,470.0,2.2998047,3.79980469,1.0,132.0,7.429688,135.0,23.0,2502.0,1.0,SIP>=30
61.711,1,female,0,3,113,Lung Cancer,Cancer,3,9.0,under $11k,2241.0,1491.46,18.0,white,15.0,1,1,0,metastatic,0.699999809,0.5,no dnr,3.0,121.0,8.0,98.0,20.0,37.5,333.3,3.5,1.01,0.69995117,140.0,7.419922,135.0,23.0,2502.0,2.7915039,SIP>=30
46.97598,1,female,0,3,128,Lung Cancer,Cancer,1,14.0,under $11k,4465.0,2777.5527,10.0,white,5.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,97.0,6.5,66.0,22.0,37.09375,333.3,3.699707,0.5,0.59997559,139.0,7.419922,135.0,23.0,2502.0,2.2387695,SIP>=30
49.48099,0,female,0,5,1613,Cirrhosis,COPD/CHF/Cirrhosis,1,9.0,under $11k,3999.0,2799.4941,9.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,57.0,4.69921875,100.0,22.0,37.39844,333.3,2.699707,5.39941406,0.59997559,130.0,7.419922,135.0,23.0,2502.0,2.3730469,adl>=4 (>=5 if sur)
82.20898,0,male,0,12,1613,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$11-$25k,16802.0,13449.875,13.5,white,35.0,1,0,0,yes,1.0,0.8,no dnr,12.0,117.0,6.89941406,69.0,26.0,36.09375,339.5625,3.0,0.29998779,2.5,140.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.46997,0,female,0,8,1613,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,$11-$25k,8682.0,6913.1758,14.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,135.0,7.89941406,63.0,16.0,36.69531,71.42188,3.5,1.01,0.89990234,141.0,7.359375,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
42.09399,0,female,0,4,1612,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,2058.0,1570.3447,6.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,69.0,13.1992188,98.0,24.0,36.19531,333.3,2.0996094,3.79980469,0.59997559,125.0,7.419922,135.0,23.0,2502.0,3.0673828,<2 mo. follow-up
37.51099,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,31305.0,20700.5625,62.5,black,44.0,2,1,0,no,0.5,0.125,dnr after sadm,7.0,66.0,3.0,140.0,14.0,38.79688,150.0,1.0,0.89990234,1.09985352,154.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
91.60297,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,92223.0,67052.5,45.666657,black,56.0,20,1,0,no,0.699999809,0.5,no dnr,14.0,38.0,18.0,82.0,10.0,35.39844,189.3125,2.2998047,0.69995117,1.69995117,132.0,7.459961,135.0,23.0,2502.0,5.0,<2 mo. follow-up
64.06299,1,female,0,21,23,Colon Cancer,Cancer,3,2.0,under $11k,17616.0,13505.1328,13.666664,white,28.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,4.0,79.0,20.3984375,102.0,24.0,36.5,333.3,2.2998047,1.19995117,0.5,133.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
62.34097,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,36127.0,28923.5781,28.333328,white,71.0,4,0,0,no,0.649999619,0.5,no dnr,14.0,38.0,4.79980469,120.0,24.0,37.59375,333.3,2.5996094,17.8984375,10.3984375,134.0,7.419922,135.0,23.0,2502.0,3.2797852,<2 mo. follow-up
80.66498,1,female,1,5,5,Coma,Coma,2,12.0,under $11k,28454.0,23329.7031,47.0,white,53.0,8,0,0,yes,0.099999964,0.001,dnr after sadm,1.0,68.0,12.3984375,70.0,26.0,38.79688,180.0,2.0996094,0.5,4.19921875,126.0,7.469727,135.0,23.0,2502.0,3.0,<2 mo. follow-up
65.48395,1,female,0,55,104,Coma,Coma,2,16.0,under $11k,117667.0,97933.875,46.75,black,43.0,1,0,0,yes,0.299999952,0.2,no dnr,55.0,61.0,22.8984375,70.0,12.0,34.79688,160.0,2.199707,0.89990234,1.09985352,134.0,7.279297,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
57.69199,1,female,0,11,927,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,11586.0,7908.2656,22.0,white,61.0,1,0,0,yes,0.799999714,0.8,no dnr,11.0,72.0,0.59997559,97.0,36.0,38.09375,252.375,2.5996094,3.19970703,1.09985352,132.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.06598,0,female,0,12,1605,COPD,COPD/CHF/Cirrhosis,2,2.0,under $11k,10151.0,7150.9766,7.0,white,29.0,1,0,0,no,0.949999809,0.95,no dnr,12.0,130.0,15.0996094,114.0,28.0,35.69531,233.3125,4.3994141,0.39996338,0.69995117,133.0,7.449219,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
37.40698,0,male,0,10,1602,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,15144.0,11418.4609,24.0,white,31.0,1,1,0,no,0.899999619,0.7,no dnr,10.0,82.0,11.0996094,100.0,24.0,36.19531,384.25,2.0996094,3.0,0.39996338,138.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
77.84497,1,male,0,33,44,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,29913.0,21028.9688,17.75,white,54.0,1,0,0,yes,0.5,0.2,dnr before sadm,0.0,70.0,0.69995117,112.0,42.0,39.79688,523.75,2.7998047,1.69995117,0.79992676,138.0,7.539062,135.0,23.0,2502.0,6.0,<2 mo. follow-up
25.40999,0,female,0,9,1602,ARF/MOSF w/Sepsis,ARF/MOSF,0,0.0,$11-$25k,8032.0,5697.8945,13.5,white,32.0,1,0,0,no,0.799999714,0.7,dnr after sadm,2.0,69.0,17.0976562,106.0,26.0,39.39844,271.375,2.2998047,1.0,1.39990234,134.0,7.30957,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
65.06494,1,male,0,18,1590,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,23400.0,17767.0781,26.666656,white,22.0,1,0,0,no,0.75,0.65,no dnr,18.0,102.0,13.0,122.0,10.0,36.5,188.0,2.7998047,0.79992676,0.79992676,138.0,7.389648,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
27.61699,0,female,0,21,1600,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,34378.0,27041.7188,24.666656,white,57.0,3,0,0,no,0.799999714,0.8,no dnr,21.0,128.0,12.5,122.0,54.0,38.09375,192.5,2.3999023,4.89941406,0.39996338,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
86.45294,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,6261.0,4557.543,3.0,white,45.0,6,0,0,yes,0.0,0.0,dnr before sadm,-4.0,75.0,14.6992188,80.0,12.0,35.09375,333.3,3.5,1.01,4.09960938,133.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
64.59094,0,female,0,26,1598,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,63159.0,46434.3125,22.5,white,15.0,5,0,0,no,0.949999809,0.8,no dnr,26.0,108.0,20.1992188,59.0,24.0,36.69531,278.5625,3.5,1.01,0.89990234,128.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
65.547,0,male,0,7,1598,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,17531.0,13567.3438,20.5,white,23.0,3,0,0,no,0.899999619,0.8,no dnr,7.0,123.0,10.7988281,53.0,16.0,36.89844,205.6875,3.199707,0.5,1.5,140.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.474,1,male,0,3,591,CHF,COPD/CHF/Cirrhosis,4,4.0,under $11k,1703.0,1318.2285,8.0,black,44.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,93.0,6.39941406,84.0,32.0,35.5,274.25,3.5996094,1.5,3.29980469,136.0,7.429688,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
88.28699,1,male,1,13,13,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,36616.0,25085.9375,48.0,white,59.0,2,0,0,metastatic,0.949999809,0.5,dnr after sadm,9.0,111.0,20.1992188,142.0,28.0,37.89844,169.09375,2.199707,1.89990234,0.79992676,145.0,7.479492,135.0,23.0,2502.0,2.0,<2 mo. follow-up
79.23297,1,male,1,68,68,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,198616.0,157963.75,46.5,white,57.0,37,0,0,no,0.199999928,0.1,no dnr,68.0,62.0,66.796875,129.0,9.0,35.5,187.5,1.5998535,0.59997559,2.89990234,129.0,7.359375,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
59.56998,0,female,0,15,1591,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,20819.0,16970.4844,23.0,black,30.0,2,0,0,no,0.399999857,0.3,dnr after sadm,2.0,126.0,10.0,114.0,14.0,35.29688,350.375,2.0996094,0.39996338,1.39990234,146.0,7.379883,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
79.13995,1,male,0,7,136,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,8804.0,5774.4102,27.0,white,32.0,1,1,0,no,0.5,0.3,no dnr,7.0,106.0,11.0996094,111.0,28.0,36.0,224.46875,3.0996094,0.59997559,1.09985352,140.0,7.389648,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
57.05698,1,female,0,3,112,Lung Cancer,Cancer,2,10.0,under $11k,1661.0,1254.2422,8.0,white,15.0,1,0,0,metastatic,0.5,0.2,no dnr,3.0,60.0,7.09960938,80.0,20.0,36.59375,333.3,3.5996094,0.29998779,0.39996338,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.47198,1,male,0,4,28,Lung Cancer,Cancer,1,8.0,under $11k,2276.0,1799.4326,16.0,hispanic,10.0,1,0,0,metastatic,0.25,0.1,dnr after sadm,1.0,83.0,9.09960938,110.0,24.0,36.29688,333.3,3.199707,0.39996338,0.59997559,135.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
51.68198,1,male,0,10,662,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,12063.0,7601.918,30.0,white,50.0,2,0,0,yes,0.099999964,0.001,no dnr,10.0,93.0,0.0,136.0,24.0,39.79688,333.3,2.0,0.59997559,1.59985352,130.0,7.419922,135.0,23.0,2502.0,3.0395508,no(M2 and SIP pres)
77.65594,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,54414.0,42434.5625,44.0,other,81.0,3,0,0,no,0.5,0.5,no dnr,16.0,64.0,4.09960938,129.0,36.0,38.39844,107.09375,2.199707,3.0,3.79980469,120.0,7.419922,135.0,23.0,2502.0,2.8203125,<2 mo. follow-up
41.45099,0,male,0,29,1585,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,64709.0,50988.2812,27.0,white,19.0,6,0,0,no,0.699999809,0.7,no dnr,29.0,111.0,14.2988281,100.0,32.0,38.79688,248.375,2.699707,0.59997559,0.79992676,127.0,7.369141,135.0,23.0,2502.0,3.6274414,no(M2 and SIP pres)
53.465,1,male,0,7,37,Colon Cancer,Cancer,2,9.0,under $11k,5161.0,3808.4844,9.0,black,23.0,1,0,0,metastatic,0.5,0.2,no dnr,7.0,121.0,10.2988281,126.0,22.0,36.59375,333.3,3.2998047,1.09985352,1.19995117,130.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
83.39996,1,female,1,4,4,Coma,Coma,1,12.0,under $11k,3172.0,2325.7422,6.0,white,31.0,1,0,0,yes,0.0,0.0,dnr after sadm,2.0,97.0,11.2988281,104.0,42.0,36.39844,162.3125,3.8999023,1.09985352,1.59985352,143.0,7.25,135.0,23.0,2502.0,1.0,<2 mo. follow-up
56.83499,1,male,1,30,30,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,94095.0,62270.2188,55.0,white,77.0,1,0,0,no,0.099999964,0.001,dnr after sadm,29.0,64.0,7.5,144.0,40.0,34.89844,203.0,1.3999023,4.89941406,0.79992676,135.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
48.65399,1,male,1,20,20,Lung Cancer,Cancer,2,14.0,under $11k,18367.0,13296.7344,16.0,white,31.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,8.0,80.0,8.5,110.0,26.0,35.69531,352.375,2.199707,0.39996338,0.59997559,130.0,7.459961,135.0,23.0,2502.0,5.0,<2 mo. follow-up
58.50198,1,female,1,4,4,Coma,Coma,1,12.0,under $11k,27599.0,19816.7969,39.0,white,38.0,15,0,0,no,0.699999809,0.5,dnr after sadm,2.0,42.0,27.0976562,105.0,8.0,36.0,87.14062,3.5,1.01,0.79992676,136.0,7.5,135.0,23.0,2502.0,3.1772461,<2 mo. follow-up
52.25699,1,female,1,4,4,Coma,Coma,0,15.0,$11-$25k,12858.0,8761.1094,61.0,white,49.0,2,0,0,no,0.699999809,0.5,no dnr,4.0,105.0,26.3984375,141.0,28.0,39.5,220.0,3.3999023,0.79992676,0.79992676,133.0,7.469727,135.0,23.0,2502.0,2.6489258,<2 mo. follow-up
72.08197,1,female,0,5,122,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,4243.0,2803.6289,12.0,white,20.0,1,0,0,yes,0.599999905,0.6,dnr after sadm,2.0,67.0,10.5,108.0,24.0,35.69531,302.0,4.3994141,0.59997559,0.59997559,133.0,7.369141,135.0,23.0,2502.0,5.0,SIP>=30
36.85098,0,male,0,10,1579,Cirrhosis,COPD/CHF/Cirrhosis,2,9.0,under $11k,7314.0,5446.1992,2.5,white,22.0,1,0,0,no,0.799999714,0.5,no dnr,10.0,79.0,7.19921875,80.0,16.0,37.09375,333.3,2.699707,4.59960938,0.39996338,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
30.66899,0,male,0,36,1577,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,67223.0,53348.6875,33.0,black,53.0,5,0,0,no,0.899999619,0.9,no dnr,36.0,70.0,19.0,129.0,34.0,39.19531,98.59375,2.199707,1.5,1.69995117,143.0,7.369141,135.0,23.0,2502.0,0.0,SIP>=30
73.43195,1,female,0,8,18,Lung Cancer,Cancer,2,8.0,under $11k,7356.0,5247.4062,15.0,white,34.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,2.0,108.0,13.8984375,118.0,28.0,36.39844,314.25,3.3999023,1.29980469,1.0,143.0,7.429688,135.0,23.0,2502.0,6.0,<2 mo. follow-up
62.215,1,male,0,71,74,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,118709.0,92193.25,34.25,white,33.0,1,0,0,no,0.25,0.15,no dnr,71.0,73.0,17.0,131.0,26.0,38.09375,87.14062,2.5,1.79980469,0.79992676,147.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
55.431,1,male,0,9,100,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,59995.78781114967,14452.7344,30.0,white,50.0,2,0,0,yes,0.75,0.8,no dnr,9.0,60.0,7.29980469,45.0,24.0,36.09375,156.0,2.5996094,6.69921875,2.69970703,132.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.34998,1,male,0,3,974,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,2921.0,2004.8916,7.0,white,11.0,1,0,0,yes,0.699999809,0.5,no dnr,3.0,80.0,18.6992188,102.0,22.0,36.29688,295.1875,4.2998047,0.59997559,0.69995117,142.0,7.379883,135.0,23.0,2502.0,1.1668997,SIP>=30
24.63499,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,70090.0,47834.6875,58.0,white,59.0,10,0,0,no,0.299999952,0.3,no dnr,9.0,62.0,42.3984375,122.0,32.0,40.09375,115.0,1.5,2.69970703,1.19995117,142.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.93198,1,female,0,65,546,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,121038.0,94205.5625,42.0,black,49.0,8,0,0,no,0.099999964,0.001,no dnr,65.0,58.0,17.5,129.0,30.0,36.39844,150.0,2.199707,0.39996338,0.79992676,141.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.75897,0,male,0,6,1572,CHF,COPD/CHF/Cirrhosis,4,11.0,$11-$25k,7224.0,5954.7852,21.0,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,61.0,6.89941406,103.0,20.0,35.79688,333.3,4.2998047,1.19995117,1.0,138.0,7.419922,135.0,23.0,2502.0,2.4023438,adl>=4 (>=5 if sur)
69.23999,1,male,1,19,19,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,28541.0,20001.3281,19.0,white,34.0,10,0,0,metastatic,0.899999619,0.2,dnr after sadm,1.0,93.0,9.09960938,122.0,32.0,36.69531,247.40625,2.5,0.89990234,0.89990234,124.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.58197,1,male,0,14,40,Colon Cancer,Cancer,2,16.0,$25-$50k,12342.0,9445.5,13.333328,white,17.0,1,0,0,metastatic,0.799999714,0.55,no dnr,14.0,101.0,15.0996094,76.0,20.0,37.89844,333.3,3.3999023,0.69995117,1.09985352,133.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
60.90298,1,male,0,7,250,Colon Cancer,Cancer,1,18.0,>$50k,5255.0,3663.7324,10.0,white,5.0,1,0,0,metastatic,0.799999714,0.4,no dnr,7.0,98.0,6.09960938,76.0,20.0,38.0,333.3,3.199707,0.69995117,0.69995117,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
82.92395,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,63732.0,42654.625,48.0,white,67.0,13,1,0,no,0.699999809,0.4,dnr after sadm,10.0,70.0,16.0,125.0,10.0,38.0,164.0,1.6999512,5.29980469,3.09960938,145.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.31598,0,male,0,10,1565,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,12129.0,9292.9609,19.0,white,26.0,1,1,0,no,0.899999619,0.8,no dnr,10.0,127.0,11.8984375,72.0,24.0,35.0,364.0,2.5,1.0,1.79980469,144.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.54095,1,male,0,5,110,Cirrhosis,COPD/CHF/Cirrhosis,6,10.0,under $11k,3099.0,2337.0879,8.0,white,32.0,1,1,0,no,0.899999619,0.6,no dnr,5.0,98.0,8.69921875,77.0,20.0,36.0,333.3,2.5996094,4.29980469,1.79980469,133.0,7.419922,135.0,23.0,2502.0,6.0,SIP>=30
59.37299,1,male,0,9,60,MOSF w/Malig,ARF/MOSF,3,13.0,$25-$50k,24994.0,17398.7031,31.5,white,53.0,11,0,0,metastatic,0.699999809,0.5,no dnr,9.0,95.0,0.18997192,110.0,28.0,38.19531,333.3,3.5,1.01,2.59960938,142.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
59.20898,1,male,0,12,101,MOSF w/Malig,ARF/MOSF,3,14.0,$25-$50k,13388.0,8849.3984,13.5,white,20.0,1,1,0,metastatic,0.399999857,0.2,no dnr,12.0,77.0,4.29980469,93.0,24.0,38.0,280.9375,3.2998047,0.5,0.79992676,140.0,7.529297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.202,1,male,0,14,1112,MOSF w/Malig,ARF/MOSF,4,11.0,under $11k,21705.0,15965.4844,22.666656,black,33.0,1,0,0,metastatic,0.799999714,0.7,dnr after sadm,2.0,118.0,15.0,77.0,10.0,36.39844,241.3125,2.0996094,0.5,8.19921875,136.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.04895,0,female,0,57,1560,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,150284.0,104787.0,50.0,white,55.0,9,0,0,no,0.099999964,0.001,no dnr,57.0,49.0,24.1992188,76.0,13.0,36.89844,124.65625,2.2998047,2.0,1.39990234,127.0,7.449219,135.0,23.0,2502.0,0.0,SIP>=30
75.78094,1,female,0,6,33,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,18125.0,15311.4688,20.0,white,26.0,1,1,0,no,0.989999771,0.85,no dnr,6.0,76.0,9.8984375,78.0,24.0,36.0,536.0,3.5996094,1.19995117,1.29980469,137.0,7.589844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.24799,1,female,0,18,1086,CHF,COPD/CHF/Cirrhosis,2,11.0,under $11k,12521.0,9499.0625,9.666664,black,31.0,1,1,0,no,0.949999809,0.95,no dnr,18.0,125.0,10.0996094,80.0,24.0,36.59375,272.9375,3.3999023,0.5,5.29980469,139.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.61499,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,36215.0,27182.9688,32.5,white,35.0,15,0,0,no,0.399999857,0.3,dnr after sadm,7.0,113.0,6.89941406,133.0,42.0,38.39844,360.0,2.7998047,0.5,1.09985352,144.0,7.5,135.0,23.0,2502.0,7.0,<2 mo. follow-up
63.73398,1,female,0,6,94,CHF,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,4131.0,3065.4316,9.0,black,43.0,1,1,0,no,0.799999714,0.7,no dnr,6.0,75.0,4.29980469,118.0,28.0,35.79688,288.0,3.3999023,1.0,1.5,134.0,7.5,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
71.73999,1,male,1,50,50,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,145564.0,95848.6875,47.25,white,41.0,11,0,0,no,0.899999619,0.5,dnr after sadm,50.0,61.0,12.2988281,130.0,32.0,37.89844,135.53125,2.0996094,0.59997559,0.79992676,137.0,7.429688,135.0,23.0,2502.0,2.8168945,<2 mo. follow-up
54.12698,1,male,0,17,22,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,35355.0,28343.1719,33.333313,white,20.0,1,0,0,no,0.899999619,0.85,no dnr,17.0,111.0,19.8984375,129.0,12.0,36.5,246.65625,3.0,1.0,0.59997559,128.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.78699,1,male,0,23,52,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,39033.0,28216.25,18.666656,white,69.0,7,0,0,no,0.5,0.3,dnr after sadm,3.0,69.0,4.5,107.0,9.0,36.09375,345.6875,1.8999023,18.1992188,1.5,146.0,7.469727,135.0,23.0,2502.0,2.0,<2 mo. follow-up
73.48096,1,female,0,31,1373,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,40095.0,31011.5938,23.75,black,44.0,1,1,0,yes,0.949999809,0.9,no dnr,31.0,104.0,25.8984375,107.0,22.0,38.59375,136.0,2.3999023,0.59997559,1.5,145.0,7.379883,135.0,23.0,2502.0,5.0,SIP>=30
56.13699,0,female,0,12,1550,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,18628.0,14305.6953,34.0,white,61.0,1,1,0,no,0.699999809,0.65,no dnr,12.0,68.0,12.5996094,111.0,24.0,36.0,256.625,2.199707,0.59997559,2.79980469,157.0,7.209961,135.0,23.0,2502.0,2.0,SIP>=30
68.698,0,male,0,9,1548,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,9996.0,7947.2148,18.5,white,20.0,1,0,1,no,0.799999714,0.7,no dnr,9.0,104.0,11.2988281,109.0,28.0,36.0,437.0,3.0,0.59997559,0.89990234,141.0,7.439453,135.0,23.0,2502.0,5.1994972,adl>=4 (>=5 if sur)
44.73599,0,male,0,38,1547,MOSF w/Malig,ARF/MOSF,2,8.0,$11-$25k,49828.0,37918.0,26.75,white,62.0,1,0,0,yes,0.399999857,0.4,no dnr,38.0,123.0,29.5976562,136.0,28.0,39.19531,108.75,2.7998047,2.39990234,6.39941406,137.0,7.359375,135.0,23.0,2502.0,0.0,SIP>=30
66.40698,1,male,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,5,6.0,$11-$25k,13879.0,10523.6406,56.0,white,104.0,3,0,0,no,0.199999928,0.15,dnr after sadm,4.0,50.0,14.7988281,200.0,40.0,34.79688,223.3125,2.8999023,16.6992188,2.29980469,128.0,7.349609,135.0,23.0,2502.0,1.0,<2 mo. follow-up
69.31396,1,female,1,46,46,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,222812.0,154127.75,49.25,white,45.0,28,0,0,no,0.199999928,0.2,dnr after sadm,36.0,125.0,11.6992188,120.0,46.0,38.59375,208.5625,1.5998535,0.69995117,0.79992676,131.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
51.54797,0,male,0,7,1544,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,6082.0,4347.3516,12.0,white,28.0,1,0,0,no,0.899999619,0.7,no dnr,7.0,80.0,6.09960938,110.0,22.0,36.39844,285.6875,2.2998047,2.09960938,0.79992676,136.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
31.099,0,female,0,12,1544,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,17925.0,13259.8516,22.0,hispanic,28.0,4,1,0,no,0.949999809,0.8,no dnr,12.0,118.0,7.19921875,111.0,24.0,36.29688,497.75,2.3999023,2.39990234,0.79992676,143.0,7.459961,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
92.73895,1,female,0,13,719,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17435.0,12993.5234,17.0,white,33.0,2,1,0,no,0.599999905,0.6,no dnr,13.0,69.0,9.09960938,60.0,24.0,36.0,164.0,3.5,1.01,1.89990234,139.0,7.40918,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
66.17395,1,male,1,27,27,Coma,Coma,1,11.0,$11-$25k,39355.0,28586.9688,28.75,black,21.0,2,0,0,no,0.0,0.0,dnr after sadm,8.0,108.0,12.5996094,100.0,10.0,38.39844,237.5,2.2998047,0.39996338,1.39990234,138.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.57999,1,female,0,6,170,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,4130.0,3030.0137,14.0,black,23.0,1,0,0,no,0.899999619,0.7,no dnr,6.0,111.0,9.5,77.0,28.0,35.89844,228.0,3.7998047,0.19998169,1.0,141.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.396,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,15109.0,9874.5781,51.0,black,99.0,3,0,0,yes,0.099999964,0.001,no dnr,5.0,39.0,15.6992188,158.0,26.0,37.89844,81.29688,2.3999023,5.89941406,2.59960938,136.0,7.30957,135.0,23.0,2502.0,1.0,<2 mo. follow-up
63.159,1,female,1,4,4,Coma,Coma,1,14.0,under $11k,8552.0,7287.543,38.0,white,21.0,1,0,0,no,0.019999996,8e-06,dnr after sadm,2.0,139.0,16.0976562,132.0,10.0,38.89844,247.46875,3.5,1.29980469,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.46198,1,female,0,5,546,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3210.0,2347.4258,7.0,black,21.0,1,0,0,no,0.899999619,0.5,no dnr,5.0,113.0,7.79980469,55.0,20.0,36.19531,457.125,3.0,0.5,2.19970703,138.0,7.489258,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
77.659,1,male,1,56,56,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,167906.0,113322.375,57.25,white,63.0,6,0,0,yes,0.5,0.3,dnr after sadm,56.0,100.0,18.296875,64.0,25.0,36.39844,252.5,1.7998047,21.0976562,3.89990234,146.0,7.389648,135.0,23.0,2502.0,2.0,<2 mo. follow-up
49.86697,1,female,1,5,5,Coma,Coma,1,12.0,under $11k,7362.0,4973.8711,14.0,white,46.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,45.0,27.5976562,46.0,12.0,33.0,473.3125,2.699707,0.39996338,0.79992676,127.0,7.40918,135.0,23.0,2502.0,3.1674805,<2 mo. follow-up
73.08099,1,male,0,13,216,CHF,COPD/CHF/Cirrhosis,5,8.0,$11-$25k,18012.0,15090.1484,18.0,white,41.0,1,1,0,no,0.899999619,0.75,no dnr,13.0,73.0,8.3984375,113.0,28.0,36.29688,338.0625,3.5,2.59960938,1.19995117,134.0,7.429688,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
71.04199,1,female,1,37,37,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,119144.0,81028.625,48.75,white,74.0,13,0,0,no,0.799999714,0.8,dnr after sadm,37.0,59.0,13.8984375,164.0,12.0,38.19531,162.0,2.0996094,5.69921875,2.79980469,139.0,7.359375,135.0,23.0,2502.0,2.8344727,<2 mo. follow-up
43.82199,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,9219.0,7003.7266,66.0,white,121.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,14.0,36.296875,32.0,30.0,35.0,166.0,1.8999023,23.0,9.0,118.0,7.109375,135.0,23.0,2502.0,1.9084473,<2 mo. follow-up
92.34198,1,male,0,5,64,Lung Cancer,Cancer,2,6.0,under $11k,3485.0,2561.5019,11.0,white,24.0,1,1,0,metastatic,0.599999905,0.4,dnr after sadm,1.0,97.0,8.0,72.0,20.0,35.39844,316.0,3.0,0.29998779,1.09985352,132.0,7.439453,135.0,23.0,2502.0,1.8389997,adl>=4 (>=5 if sur)
39.31,0,male,0,41,1533,Coma,Coma,0,14.0,under $11k,70883.0,50410.5,36.25,white,33.0,1,0,0,no,0.949999809,0.95,no dnr,41.0,144.0,15.8984375,59.0,10.0,34.59375,130.0,3.5996094,0.5,0.69995117,136.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.73596,1,male,0,17,1007,Coma,Coma,1,8.0,$11-$25k,21383.0,15185.8672,17.0,white,22.0,3,0,0,no,0.849999905,0.8,no dnr,17.0,130.0,11.2988281,70.0,10.0,38.0,316.625,3.5,1.01,1.09985352,136.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
51.099,1,male,1,3,3,Coma,Coma,0,12.0,under $11k,11302.0,9611.4922,40.0,white,78.0,3,0,0,no,0.0,0.0,dnr after sadm,1.0,0.0,15.0,0.0,0.0,40.29688,58.0,3.7998047,0.89990234,0.69995117,128.0,7.259766,135.0,23.0,2502.0,1.3986816,<2 mo. follow-up
62.12198,1,male,0,6,170,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,5372.0,3855.9375,7.0,white,22.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,121.0,5.29980469,98.0,24.0,36.79688,333.3,2.5,3.39990234,0.69995117,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
76.10394,1,male,0,5,207,CHF,COPD/CHF/Cirrhosis,3,5.0,under $11k,3831.0,2746.9727,11.0,black,35.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,73.0,5.69921875,111.0,22.0,36.5,333.3,4.6992188,1.39990234,1.89990234,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
76.48199,1,female,0,3,1424,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,1485.0,1123.4209,5.0,white,23.0,1,1,0,no,0.799999714,0.6,dnr before sadm,-1.0,102.0,6.29980469,83.0,24.0,36.19531,333.3,3.5996094,1.69995117,1.09985352,139.0,7.419922,135.0,23.0,2502.0,2.6508789,no(M2 and SIP pres)
81.18298,0,male,0,5,1529,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3143.0,2237.2871,14.0,black,34.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,104.0,5.89941406,65.0,28.0,36.19531,271.375,3.199707,0.69995117,1.5,140.0,7.399414,135.0,23.0,2502.0,2.8657227,no(M2 and SIP pres)
83.17596,1,male,0,10,614,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,7450.0,5479.3633,6.0,black,23.0,1,0,0,no,0.799999714,0.8,no dnr,10.0,96.0,4.69921875,73.0,24.0,35.0,395.1875,3.0996094,1.39990234,1.59985352,134.0,7.40918,135.0,23.0,2502.0,0.0,SIP>=30
72.28699,1,male,0,16,156,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,58761.0,43151.4375,24.333328,white,26.0,27,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,129.0,10.0,60.0,28.0,36.19531,178.96875,2.5,1.69995117,1.0,137.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.01099,0,male,0,45,1524,ARF/MOSF w/Sepsis,ARF/MOSF,2,5.0,under $11k,98491.0,64779.0312,49.25,black,49.0,1,1,0,no,0.039999992,6.4e-05,no dnr,45.0,59.0,11.5996094,107.0,12.0,36.59375,126.82812,1.1999512,1.5,1.39990234,147.0,7.319336,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.07599,1,male,0,11,1416,CHF,COPD/CHF/Cirrhosis,6,16.0,$11-$25k,9630.0,7190.9336,15.5,white,29.0,1,0,0,yes,0.649999619,0.5,no dnr,11.0,103.0,11.0996094,80.0,24.0,35.79688,314.25,3.7998047,2.69970703,1.39990234,144.0,7.459961,135.0,23.0,2502.0,4.0,SIP>=30
72.04895,0,male,0,4,1523,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,5151.0,4191.4531,18.0,white,20.0,1,0,0,no,0.979999542,0.85,no dnr,4.0,143.0,11.0,64.0,16.0,36.19531,220.0,4.0,1.39990234,1.29980469,137.0,7.619141,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
40.63498,0,male,0,15,1522,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,15813.0,10832.8281,7.666664,white,40.0,1,0,0,no,0.399999857,0.25,no dnr,15.0,102.0,4.0,130.0,24.0,38.39844,333.3,2.0996094,8.8984375,0.59997559,133.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
51.57599,1,male,1,62,62,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,109958.0,84129.75,10.0,white,45.0,1,0,0,no,0.75,0.5,dnr after sadm,48.0,82.0,14.1992188,118.0,22.0,36.79688,233.3125,2.3999023,5.79980469,1.0,126.0,7.479492,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
78.21198,1,male,1,5,5,Coma,Coma,1,16.0,$11-$25k,7074.0,5531.0703,30.0,white,39.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,1.0,63.0,9.29882812,138.0,40.0,39.59375,187.5,2.7998047,0.69995117,1.0,137.0,7.469727,135.0,23.0,2502.0,3.0,<2 mo. follow-up
50.90198,1,female,0,20,438,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,35852.0,26896.2969,19.0,white,54.0,7,1,0,no,0.899999619,0.9,no dnr,20.0,62.0,12.2988281,131.0,28.0,36.0,131.09375,2.5,0.59997559,5.39941406,135.0,7.369141,135.0,23.0,2502.0,1.1668997,SIP>=30
37.86398,1,female,1,13,13,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,30459.0,24991.5,30.0,black,45.0,1,0,0,metastatic,0.75,0.5,no dnr,13.0,108.0,1.19995117,146.0,56.0,36.19531,143.3125,2.699707,0.5,0.79992676,137.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.97095,0,female,0,13,1519,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,23557.0,19011.375,32.0,white,53.0,1,1,0,no,0.899999619,0.85,no dnr,13.0,67.0,21.8984375,78.0,32.0,38.19531,118.35938,3.0996094,0.39996338,4.89941406,144.0,7.299805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.33899,0,male,0,7,1518,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,under $11k,6231.0,4453.2852,12.0,white,22.0,1,0,0,no,1.0,0.95,no dnr,7.0,86.0,9.0,122.0,20.0,36.5,333.3,2.8999023,3.69970703,0.69995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.69299,1,male,1,13,13,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,59995.78781114967,14452.7344,44.5,white,51.0,1,0,0,yes,1.0,0.5,no dnr,14.58258953168044,57.0,23.796875,114.0,30.0,35.39844,278.3125,2.8999023,2.5,1.89990234,135.0,7.519531,135.0,23.0,2502.0,6.0,<2 mo. follow-up
65.75995,1,male,0,15,180,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,15250.0,11646.2812,14.333328,white,36.0,1,0,0,no,0.099999964,0.001,dnr after sadm,1.0,114.0,19.296875,129.0,34.0,35.79688,173.6875,4.3994141,0.19998169,1.39990234,142.0,7.259766,135.0,23.0,2502.0,3.5917969,<2 mo. follow-up
52.44397,1,male,0,7,16,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,7134.0,5004.3164,7.5,white,40.0,1,0,0,no,0.75,0.5,no dnr,7.0,79.0,5.0,122.0,20.0,38.09375,333.3,1.7998047,2.79980469,0.79992676,129.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
52.82098,0,female,0,46,1516,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,69674.0,51659.4688,24.75,white,34.0,28,0,0,no,0.799999714,0.8,no dnr,46.0,113.0,14.5996094,131.0,32.0,38.69531,162.84375,2.5,0.39996338,1.29980469,134.0,7.40918,135.0,23.0,2502.0,2.0,SIP>=30
64.08197,1,female,0,14,714,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8881.0,6775.668,9.0,white,22.0,1,0,0,no,0.5,0.4,no dnr,14.0,60.0,8.69921875,77.0,20.0,35.79688,333.3,2.8999023,1.89990234,1.39990234,138.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
32.28497,1,male,0,8,70,Cirrhosis,COPD/CHF/Cirrhosis,4,16.0,$25-$50k,43378.0,33269.3438,9.0,asian,14.0,25,0,0,no,0.599999905,0.6,no dnr,8.0,101.0,6.79980469,65.0,20.0,35.79688,566.625,3.0,1.69995117,0.5,128.0,7.529297,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
35.96698,0,female,0,10,1511,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,14767.0,11501.6328,14.5,white,51.0,1,1,0,no,1.0,1.0,no dnr,10.0,137.0,24.8984375,108.0,20.0,36.69531,342.8125,2.3999023,0.39996338,5.29980469,130.0,7.459961,135.0,23.0,2502.0,7.0,SIP>=30
46.61499,1,female,1,41,41,Cirrhosis,COPD/CHF/Cirrhosis,1,4.0,under $11k,146540.0,14452.7344,57.0,white,74.0,6,0,0,no,1.0,1.0,dnr after sadm,25.0,152.0,14.0996094,120.0,26.0,33.89844,186.0,1.6999512,2.79980469,0.39996338,119.0,7.299805,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.40796,1,female,0,8,84,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,10279.0,8144.3477,19.0,white,32.0,1,1,0,no,0.5,0.5,no dnr,8.0,108.0,13.3984375,80.0,23.0,36.29688,560.0,2.8999023,4.89941406,1.69995117,138.0,7.40918,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
70.67999,1,male,0,37,1126,Coma,Coma,2,13.0,$11-$25k,72793.0,52152.0938,28.0,white,48.0,8,0,0,yes,0.799999714,0.8,no dnr,37.0,128.0,7.29980469,130.0,34.0,39.19531,118.75,2.5,1.59985352,0.89990234,138.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.45996,1,female,0,3,1266,COPD,COPD/CHF/Cirrhosis,2,17.0,$11-$25k,2464.0,1709.9492,8.0,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,91.0,12.5,106.0,22.0,36.89844,219.03125,3.5,0.39996338,0.69995117,130.0,7.439453,135.0,23.0,2502.0,2.7983398,no(M2 and SIP pres)
62.45297,1,male,0,4,1458,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,3041.0,2167.2227,8.0,black,19.0,1,0,0,no,0.989999771,0.9,no dnr,4.0,106.0,6.69921875,126.0,24.0,36.39844,261.875,3.8999023,0.5,1.09985352,139.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.62799,0,female,0,24,1508,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,36492.0,27719.8906,24.666656,white,40.0,2,0,0,no,0.699999809,0.7,no dnr,24.0,66.0,8.09960938,0.0,28.0,36.79688,272.0,3.0,0.69995117,1.19995117,130.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.81396,0,female,0,15,1507,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,29975.0,23039.9531,27.0,white,25.0,10,0,0,yes,0.599999905,0.55,no dnr,15.0,111.0,5.5,109.0,28.0,36.5,206.09375,2.5996094,0.79992676,1.39990234,137.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.15198,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,8957.0,6620.2188,49.0,black,77.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,3.0,9.0,3.5,0.0,32.0,35.0,55.0,2.8999023,0.79992676,1.5,145.0,7.229492,135.0,23.0,2502.0,2.3945312,<2 mo. follow-up
61.87299,1,male,0,12,167,Lung Cancer,Cancer,2,15.0,$11-$25k,20528.0,16074.0312,35.0,white,55.0,1,0,0,metastatic,0.399999857,0.4,no dnr,12.0,128.0,12.5,212.0,10.0,37.0,170.0,3.3999023,0.69995117,1.5,135.0,7.529297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.42499,0,female,0,8,1503,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,19233.0,15846.8672,23.5,white,45.0,2,0,0,no,1.0,1.0,no dnr,8.0,125.0,27.796875,109.0,28.0,35.69531,464.0,2.5,7.89941406,1.59985352,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.88599,1,female,0,44,70,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,47430.0,36199.0625,25.5,white,37.0,1,1,0,no,0.599999905,0.25,dnr after sadm,6.0,115.0,13.1992188,153.0,24.0,38.29688,192.5,3.0996094,1.89990234,1.29980469,132.0,7.5,135.0,23.0,2502.0,3.4614258,<2 mo. follow-up
57.27597,0,male,0,8,1499,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,14786.0,11121.4375,22.5,white,26.0,1,0,0,no,1.0,0.9,no dnr,8.0,110.0,17.0976562,130.0,32.0,36.79688,130.0,3.0,0.29998779,0.59997559,146.0,7.349609,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
50.37598,1,male,0,7,151,Colon Cancer,Cancer,1,12.0,under $11k,5884.0,4288.4805,16.5,white,11.0,1,0,0,metastatic,0.899999619,0.6,no dnr,7.0,76.0,7.59960938,63.0,24.0,36.89844,333.3,3.199707,0.39996338,0.79992676,143.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
62.41998,1,male,0,4,1088,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,3349.0,2351.6484,18.0,black,36.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,104.0,10.3984375,98.0,24.0,36.29688,328.5625,4.0996094,0.29998779,2.69970703,130.0,7.359375,135.0,23.0,2502.0,2.3027344,no(M2 and SIP pres)
35.13797,0,female,0,15,1498,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,38924.0,27626.375,36.333313,white,33.0,7,0,0,no,1.0,1.0,no dnr,15.0,67.0,17.5976562,118.0,24.0,38.09375,112.71875,2.0,1.79980469,0.79992676,137.0,7.549805,135.0,23.0,2502.0,1.0,SIP>=30
64.08496,1,female,0,12,92,Lung Cancer,Cancer,2,11.0,under $11k,9142.0,6777.0859,11.0,black,14.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,7.0,116.0,5.89941406,126.0,20.0,37.0,428.5625,3.199707,0.39996338,0.59997559,140.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
60.44397,1,male,0,29,360,Colon Cancer,Cancer,2,14.0,$25-$50k,24969.0,18502.9844,16.5,white,19.0,1,1,0,metastatic,1.0,0.8,no dnr,29.0,144.0,10.3984375,78.0,20.0,37.59375,333.3,4.0996094,0.29998779,1.19995117,134.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
35.07498,0,female,0,29,1495,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,72746.0,59193.9375,26.25,white,73.0,7,0,0,no,0.039999992,6.4e-05,no dnr,29.0,151.0,31.296875,133.0,41.0,34.29688,403.3125,2.699707,1.69995117,5.79980469,133.0,7.489258,135.0,23.0,2502.0,5.0,SIP>=30
59.21997,1,female,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,4,15.0,under $11k,130534.0,99470.6875,59.5,white,40.0,1,0,0,no,0.299999952,0.15,dnr after sadm,13.0,118.0,7.0,61.0,28.0,36.79688,62.0,4.0,4.09960938,0.69995117,121.0,7.489258,135.0,23.0,2502.0,1.0,<2 mo. follow-up
65.63196,0,female,0,17,1494,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,13453.0,9745.1641,10.666664,black,26.0,1,0,0,yes,0.5,0.25,no dnr,17.0,119.0,8.8984375,81.0,28.0,36.39844,458.75,4.3994141,1.39990234,1.79980469,130.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
86.93195,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,27213.0,20818.8125,57.0,white,67.0,4,0,0,no,0.199999928,0.05,no dnr,7.0,45.0,22.0976562,120.0,36.0,38.69531,94.4375,1.7998047,0.89990234,1.19995117,143.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.07697,0,female,0,35,1493,COPD,COPD/CHF/Cirrhosis,3,13.0,under $11k,41387.0,31464.9062,20.25,white,48.0,1,0,0,yes,0.899999619,0.8,no dnr,35.0,101.0,23.796875,120.0,28.0,35.39844,195.21875,4.3994141,0.39996338,0.79992676,132.0,7.25,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
26.05299,0,male,0,22,1492,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,47825.0,37815.5625,27.333328,white,56.0,4,0,0,no,0.799999714,0.75,no dnr,22.0,102.0,13.6992188,124.0,44.0,36.69531,122.5,2.0996094,1.69995117,1.39990234,132.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
21.30899,1,female,0,11,219,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,34141.0,22367.0156,25.0,white,28.0,3,0,0,no,0.699999809,0.5,no dnr,11.0,133.0,27.5976562,52.0,10.0,39.59375,120.0,3.5,1.01,0.79992676,144.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.284,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,80523.0,53196.0625,62.666657,white,49.0,1,1,0,no,0.099999964,0.001,dnr after sadm,15.0,51.0,20.0,108.0,10.0,35.5,172.0,1.1999512,0.69995117,0.39996338,137.0,7.509766,135.0,23.0,2502.0,5.0,<2 mo. follow-up
42.478,1,male,1,5,5,Cirrhosis,COPD/CHF/Cirrhosis,4,9.0,$25-$50k,16578.0,11960.375,61.0,white,80.0,1,0,0,no,0.5,0.2,dnr after sadm,5.0,120.0,14.6992188,124.0,42.0,39.79688,156.0,2.5996094,36.8984375,2.5,134.0,7.459961,135.0,23.0,2502.0,4.0,<2 mo. follow-up
51.59198,0,female,0,26,1487,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,under $11k,10544.0,17940.6875,11.0,white,60.0,3,0,0,no,0.799999714,0.7,no dnr,26.0,57.0,26.296875,76.0,20.0,36.5,333.3,2.3999023,17.296875,1.39990234,131.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.78,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$25-$50k,23740.0,17844.5625,27.5,white,30.0,10,0,0,metastatic,0.599999905,0.3,dnr after sadm,11.0,62.0,4.09960938,55.0,25.0,35.19531,752.375,2.3999023,0.29998779,0.19998169,136.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
51.67398,1,male,0,3,67,Lung Cancer,Cancer,1,12.0,under $11k,2580.0,1669.4326,16.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,92.0,10.7988281,90.0,20.0,36.19531,333.3,3.2998047,0.59997559,1.09985352,136.0,7.419922,135.0,23.0,2502.0,2.6455078,adl>=4 (>=5 if sur)
71.54596,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,24382.0,17394.1875,19.0,white,56.0,12,0,0,metastatic,0.5,0.25,dnr after sadm,5.0,74.0,11.5996094,104.0,32.0,36.5,180.0,2.2998047,1.0,2.5,133.0,7.429688,135.0,23.0,2502.0,4.0771484,<2 mo. follow-up
44.56097,1,male,0,4,352,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,3092.0,2274.1348,16.0,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,78.0,11.7988281,77.0,24.0,35.09375,314.25,3.3999023,1.39990234,0.79992676,129.0,7.509766,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
83.02295,1,female,0,5,214,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,4563.0,3114.4473,24.0,black,41.0,1,1,0,no,0.899999619,0.6,no dnr,5.0,95.0,10.0,100.0,28.0,36.09375,233.3125,3.5,0.39996338,1.09985352,136.0,7.359375,135.0,23.0,2502.0,4.0,SIP>=30
47.29398,0,female,0,10,1485,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,7790.0,5803.7695,7.0,hispanic,8.0,1,0,0,no,0.799999714,0.75,no dnr,10.0,80.0,6.39941406,100.0,24.0,36.29688,376.1875,3.5,1.09985352,1.0,136.0,7.489258,135.0,23.0,2502.0,0.0,SIP>=30
51.15698,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,8.0,$11-$25k,3387.0,2218.2695,20.0,white,59.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,75.0,0.0,130.0,36.0,37.19531,120.0,2.8999023,0.5,1.5,142.0,7.209961,135.0,23.0,2502.0,2.9169922,<2 mo. follow-up
53.47299,1,female,0,5,395,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,3567.0,2547.8691,18.0,white,39.0,1,1,0,no,1.0,1.0,no dnr,5.0,113.0,8.3984375,79.0,28.0,36.19531,319.0,3.3999023,0.39996338,2.89990234,141.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.98599,1,female,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,4,16.0,$11-$25k,23264.0,16929.9375,53.0,white,76.0,1,0,0,no,0.299999952,0.2,dnr after sadm,4.0,60.0,17.0,136.0,42.0,36.09375,67.0,4.1992188,11.6992188,2.39990234,149.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
65.14398,1,male,1,3,3,Colon Cancer,Cancer,2,16.0,$11-$25k,2223.0,1524.2764,4.0,white,55.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,2.0,83.0,19.796875,110.0,12.0,35.0,333.3,2.7998047,11.0,2.59960938,142.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
41.26498,1,male,1,27,27,MOSF w/Malig,ARF/MOSF,6,12.0,under $11k,88324.0,57915.2188,59.25,white,77.0,1,0,0,yes,0.5,0.5,dnr after sadm,27.0,160.0,0.0,116.0,8.0,34.19531,210.0,2.699707,9.19921875,1.5,143.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.245,1,female,1,13,13,Coma,Coma,1,11.0,$11-$25k,98007.0,80836.6875,49.5,black,49.0,22,0,0,no,0.049999982,0.000125,no dnr,13.0,125.0,15.3984375,107.0,29.0,35.5,57.0,2.7998047,2.29980469,1.29980469,130.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
74.75696,1,male,0,8,36,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$11-$25k,10009.0,7786.9141,9.5,white,38.0,1,0,1,no,0.699999809,0.5,no dnr,8.0,109.0,13.5996094,80.0,22.0,35.89844,140.8125,3.5996094,1.09985352,2.89990234,133.0,7.30957,135.0,23.0,2502.0,6.0,<2 mo. follow-up
68.64099,1,male,0,14,471,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,10229.0,7585.3086,22.0,black,52.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,1.0,68.0,0.89990234,85.0,28.0,38.89844,333.3,1.8999023,1.29980469,0.69995117,138.0,7.419922,135.0,23.0,2502.0,6.0,SIP>=30
75.01398,1,male,0,7,137,MOSF w/Malig,ARF/MOSF,3,9.0,$11-$25k,4869.0,3544.7383,15.0,white,53.0,1,0,0,yes,0.199999928,0.05,dnr before sadm,-1.0,59.0,21.5976562,96.0,38.0,35.69531,290.4375,3.2998047,1.0,1.29980469,126.0,7.469727,135.0,23.0,2502.0,4.0,SIP>=30
69.77698,0,female,0,7,1475,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,9604.0,7108.6914,13.0,white,31.0,2,0,0,no,0.599999905,0.6,no dnr,7.0,99.0,6.39941406,101.0,26.0,36.5,130.0,3.5,0.5,0.79992676,142.0,7.379883,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
28.02499,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,16090.0,12267.7734,65.0,white,46.0,1,0,0,no,0.099999964,0.001,dnr after sadm,3.0,59.0,21.5976562,150.0,14.0,39.89844,98.875,2.5,1.5,0.69995117,135.0,7.429688,135.0,23.0,2502.0,6.0,<2 mo. follow-up
67.461,1,female,0,4,536,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,3236.0,2334.3535,13.0,black,51.0,1,1,0,no,0.899999619,0.9,no dnr,4.0,125.0,7.79980469,70.0,20.0,36.0,100.0,3.2998047,0.5,3.89990234,135.0,7.349609,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
41.61298,1,male,0,4,716,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,3803.0,2692.3594,13.0,white,40.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,57.0,7.19921875,145.0,20.0,36.5,357.125,3.0,2.59960938,0.59997559,134.0,7.479492,135.0,23.0,2502.0,2.7602539,<2 mo. follow-up
41.50897,1,female,0,23,180,Coma,Coma,0,12.0,$11-$25k,53733.0,35883.5,38.666657,black,52.0,9,0,0,no,0.399999857,0.4,no dnr,23.0,65.0,28.5,140.0,43.0,39.19531,448.875,2.2998047,1.79980469,1.19995117,145.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.41498,1,male,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,39900.0,29680.0,34.5,white,47.0,1,0,0,metastatic,0.699999809,0.1,dnr after sadm,9.0,110.0,9.19921875,171.0,32.0,36.29688,193.59375,2.3999023,0.5,0.59997559,134.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
78.28595,0,female,0,5,1474,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6560.0,5348.8711,22.0,white,35.0,1,0,0,no,0.5,0.5,no dnr,5.0,57.0,9.19921875,61.0,16.0,36.0,333.3,4.3994141,0.79992676,1.5,135.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
69.56897,1,male,0,4,174,Lung Cancer,Cancer,3,16.0,under $11k,5789.0,3082.3457,17.0,white,23.0,3,0,0,metastatic,0.599999905,0.3,no dnr,4.0,113.0,13.0,121.0,24.0,36.59375,333.3,3.5,1.01,1.19995117,138.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
65.01599,1,male,0,8,11,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,13441.0,7388.4766,20.0,white,51.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,63.0,24.5976562,126.0,28.0,35.79688,200.0,3.3999023,0.69995117,2.19970703,139.0,7.369141,135.0,23.0,2502.0,6.0,<2 mo. follow-up
74.29999,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,40752.0,27083.0156,42.5,white,62.0,8,0,0,metastatic,0.049999982,0.000125,dnr after sadm,1.0,109.0,13.7988281,117.0,8.0,38.0,280.0,1.2998047,12.6992188,3.89990234,136.0,7.379883,135.0,23.0,2502.0,1.0,<2 mo. follow-up
39.73199,0,male,0,3,1458,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,4754.0,3010.7754,46.0,white,3.0,1,0,0,no,1.0,1.0,no dnr,3.0,95.0,8.79882812,66.0,24.0,36.0,183.65625,4.2998047,1.19995117,0.89990234,138.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
30.88599,1,male,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,169997.0,111276.875,58.25,white,70.0,1,0,0,no,0.799999714,0.8,dnr after sadm,39.0,65.0,6.19921875,120.0,30.0,38.79688,116.65625,2.2998047,2.5,10.5996094,148.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.86597,1,female,1,69,69,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,196778.0,140242.625,51.25,black,31.0,17,0,0,no,0.399999857,0.4,dnr after sadm,55.0,61.0,19.8984375,131.0,10.0,36.09375,400.0,3.5,1.01,1.89990234,132.0,7.30957,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.33099,1,female,0,10,23,Lung Cancer,Cancer,1,12.0,$25-$50k,7942.0,5353.5312,14.5,white,18.0,1,0,0,metastatic,0.5,0.1,no dnr,10.0,79.0,8.19921875,110.0,24.0,38.0,333.3,2.699707,0.29998779,0.69995117,128.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
66.64197,0,male,0,21,1454,COPD,COPD/CHF/Cirrhosis,2,3.0,under $11k,21567.0,14687.9609,14.333328,white,24.0,1,0,0,no,0.899999619,0.8,no dnr,21.0,109.0,16.3984375,81.0,32.0,35.29688,208.0,3.0,0.79992676,0.79992676,138.0,7.389648,135.0,23.0,2502.0,3.0,SIP>=30
64.62695,0,female,0,18,1452,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,37273.0,24393.25,31.333328,black,64.0,1,1,0,no,0.799999714,0.8,no dnr,18.0,53.0,20.3984375,58.0,48.0,36.09375,207.75,2.8999023,0.59997559,4.29980469,146.0,7.229492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.02698,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,15597.0,10053.7109,41.0,white,63.0,6,0,0,no,0.5,0.5,dnr before sadm,-4.0,29.0,9.09960938,232.0,46.0,36.0,159.15625,2.699707,0.39996338,1.19995117,137.0,7.40918,135.0,23.0,2502.0,2.8198242,<2 mo. follow-up
60.87097,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,12379.0,6517.9336,54.0,white,104.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,34.0,15.5996094,136.0,30.0,35.29688,42.0,2.199707,3.19970703,5.59960938,132.0,7.119141,135.0,23.0,2502.0,3.5751953,<2 mo. follow-up
61.81799,0,male,0,7,1450,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,19615.0,9873.7734,24.0,white,28.0,3,1,0,no,0.899999619,0.9,no dnr,7.0,102.0,10.7988281,71.0,36.0,36.19531,320.0,2.5996094,0.59997559,1.19995117,141.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.98395,1,male,0,7,99,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,5761.0,3532.8262,10.5,white,22.0,1,0,0,yes,0.899999619,0.8,no dnr,7.0,87.0,13.0996094,114.0,24.0,36.0,213.5625,3.5,0.39996338,1.29980469,139.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.88995,1,female,0,5,783,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,5999.0,3557.8906,20.0,white,27.0,1,0,0,no,0.799999714,0.65,no dnr,5.0,75.0,4.39941406,68.0,26.0,36.59375,291.25,3.5996094,0.69995117,0.79992676,138.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
63.34,0,male,0,10,1448,ARF/MOSF w/Sepsis,ARF/MOSF,5,7.0,under $11k,13169.0,7743.918,16.5,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,62.0,7.39941406,81.0,28.0,36.39844,318.5,2.7998047,1.0,1.19995117,136.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.99896,1,female,1,4,4,CHF,COPD/CHF/Cirrhosis,4,6.0,under $11k,2775.0,1863.1728,25.0,black,67.0,1,1,1,no,0.799999714,0.6,no dnr,4.0,121.0,5.39941406,120.0,32.0,36.29688,100.0,3.0996094,0.5,2.5,145.0,7.149414,135.0,23.0,2502.0,5.0,<2 mo. follow-up
43.29099,1,male,0,16,238,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,32387.0,21183.4062,29.333328,white,35.0,1,0,0,no,0.799999714,0.8,no dnr,16.0,108.0,11.3984375,56.0,10.0,35.69531,280.0,2.8999023,3.0,0.39996338,128.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.81696,1,male,0,38,48,Coma,Coma,0,12.0,under $11k,71849.0,48105.375,40.0,white,34.0,1,0,0,no,0.199999928,0.1,no dnr,38.0,110.0,7.69921875,57.0,10.0,36.79688,190.0,2.2998047,5.5,1.29980469,153.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.66699,0,female,0,6,1444,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,5740.0,3372.3379,12.0,white,21.0,1,0,0,yes,0.799999714,0.7,no dnr,6.0,100.0,8.8984375,118.0,22.0,36.29688,264.0,3.5,1.01,0.69995117,133.0,7.389648,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
48.25198,0,female,0,3,1442,CHF,COPD/CHF/Cirrhosis,4,7.0,under $11k,2119.0,1352.2275,2.0,black,23.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,127.0,8.19921875,84.0,20.0,36.39844,361.875,2.7998047,0.69995117,1.69995117,137.0,7.449219,135.0,23.0,2502.0,2.6889648,no(M2 and SIP pres)
87.836,1,female,0,31,209,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,63726.0,41403.5,31.5,white,26.0,2,0,0,no,0.599999905,0.6,no dnr,31.0,123.0,12.3984375,113.0,8.0,38.69531,290.0,3.0,1.0,1.89990234,143.0,7.40918,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
84.55298,1,female,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,69005.0,41842.9062,22.5,white,44.0,7,0,0,no,0.5,0.2,dnr after sadm,5.0,112.0,15.0,114.0,24.0,36.19531,333.3,2.0996094,1.01,2.39990234,128.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.91998,1,male,0,3,47,Lung Cancer,Cancer,1,8.0,under $11k,3005.0,1091.9355,20.0,white,16.0,1,0,0,metastatic,0.5,0.2,no dnr,3.0,107.0,12.7988281,118.0,20.0,36.69531,333.3,3.5996094,0.89990234,1.0,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
79.77295,1,female,1,7,7,Lung Cancer,Cancer,2,10.0,under $11k,9584.0,6354.2695,6.0,white,25.0,6,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,76.0,15.3984375,107.0,24.0,36.09375,333.3,2.8999023,1.01,0.89990234,134.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.125,0,female,0,22,1440,ARF/MOSF w/Sepsis,ARF/MOSF,4,15.0,under $11k,36693.0,14452.7344,28.666656,white,33.0,5,1,0,no,0.5,0.4,no dnr,22.0,64.0,4.39941406,72.0,12.0,36.19531,280.625,2.2998047,0.5,1.5,143.0,7.5,135.0,23.0,2502.0,2.9243164,no(M2 and SIP pres)
54.62799,1,male,0,35,226,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,68558.0,45297.6562,30.0,black,60.0,17,0,0,yes,0.299999952,0.3,dnr after sadm,16.0,56.0,1.19995117,138.0,12.0,39.0,220.0,2.2998047,3.39990234,1.89990234,138.0,7.40918,135.0,23.0,2502.0,5.0,SIP>=30
61.76599,1,female,1,4,4,Coma,Coma,3,12.0,$25-$50k,10765.0,5051.3945,47.0,white,35.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,135.0,26.6992188,144.0,12.0,39.5,130.0,3.0996094,0.39996338,0.89990234,149.0,7.399414,135.0,23.0,2502.0,3.5952148,<2 mo. follow-up
28.50699,0,male,0,12,1435,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,36646.0,21162.4375,43.5,black,45.0,3,0,0,no,0.399999857,0.3,no dnr,12.0,121.0,21.1992188,69.0,22.0,36.29688,173.3125,2.699707,0.5,5.29980469,134.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.73798,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19132.0,12136.4609,52.0,black,57.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,45.0,12.0,157.0,24.0,38.19531,64.0,2.3999023,0.59997559,0.5,133.0,7.369141,135.0,23.0,2502.0,2.0,<2 mo. follow-up
24.47899,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,82030.0,53853.9375,48.333313,white,38.0,2,0,0,no,0.799999714,0.8,no dnr,18.0,113.0,15.2988281,138.0,24.0,39.69531,297.125,1.8999023,1.19995117,1.5,134.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.05899,1,male,0,15,213,Lung Cancer,Cancer,4,3.0,under $11k,12205.0,8258.0469,8.0,white,13.0,1,0,0,metastatic,0.199999928,0.04,dnr before sadm,-1.0,97.0,9.0,74.0,24.0,35.59375,333.3,4.0996094,0.29998779,0.89990234,132.0,7.419922,135.0,23.0,2502.0,1.0,SIP>=30
66.43396,1,male,0,11,128,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,18040.0,11452.9219,28.0,white,43.0,1,1,0,no,0.5,0.5,no dnr,11.0,105.0,24.3984375,124.0,25.0,37.79688,124.0,4.6992188,0.69995117,1.39990234,139.0,7.389648,135.0,23.0,2502.0,3.2075195,SIP>=30
58.37097,1,female,0,7,230,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,7453.0,4463.0195,13.0,white,21.0,1,1,0,no,0.799999714,0.6,no dnr,7.0,96.0,15.0,107.0,28.0,36.19531,380.0,4.7998047,0.79992676,1.0,150.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
65.52997,1,male,0,6,421,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,4795.0,2914.5606,4.0,white,31.0,1,1,0,no,0.5,0.5,no dnr,6.0,96.0,2.0,112.0,20.0,36.0,333.3,3.0996094,6.0,0.89990234,135.0,7.419922,135.0,23.0,2502.0,3.2480469,<2 mo. follow-up
66.90997,1,female,0,12,673,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,27529.0,17784.2812,20.5,white,31.0,5,0,0,metastatic,0.5,0.3,no dnr,12.0,103.0,7.69921875,103.0,30.0,36.79688,247.5,2.699707,0.89990234,1.79980469,133.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.11499,0,male,0,6,1428,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,9411.0,6061.9492,25.0,white,28.0,1,0,0,no,0.899999619,0.75,no dnr,6.0,79.0,18.5,77.0,26.0,35.39844,188.5625,3.7998047,0.69995117,0.79992676,139.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
81.91095,1,male,0,13,907,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,34636.0,20214.7344,45.5,white,56.0,4,0,0,no,0.5,0.5,no dnr,13.0,110.0,9.29882812,124.0,25.0,37.59375,79.0,1.5,1.39990234,1.09985352,148.0,7.139648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
32.81299,1,male,1,154,154,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,479465.0,316924.5,51.0,white,93.0,10,0,0,no,0.699999809,0.5,dnr after sadm,154.0,58.0,24.6992188,156.0,14.0,38.09375,204.0,4.1992188,11.1992188,8.3984375,130.0,7.289062,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
31.20299,0,male,0,5,1427,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,under $11k,7541.0,4971.6055,23.0,white,21.0,1,0,0,no,0.949999809,0.9,no dnr,5.0,77.0,18.0,114.0,34.0,36.79688,574.0,2.8999023,0.59997559,0.79992676,137.0,7.349609,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
82.58698,1,female,1,164,164,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,289468.0,231848.75,52.0,white,40.0,36,0,0,yes,0.5,0.5,dnr after sadm,157.0,162.0,12.3984375,130.0,12.0,36.69531,325.6875,3.5,1.59985352,2.0,131.0,7.349609,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
48.04398,1,male,0,10,16,Cirrhosis,COPD/CHF/Cirrhosis,2,7.0,under $11k,9761.0,6477.8945,13.5,white,40.0,1,0,0,no,0.949999809,0.85,no dnr,10.0,85.0,11.7988281,72.0,28.0,36.69531,333.3,2.3999023,24.1992188,0.5,131.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.63696,1,male,0,5,6,MOSF w/Malig,ARF/MOSF,2,15.0,$11-$25k,11128.0,7264.6836,30.0,white,57.0,1,0,0,metastatic,0.799999714,0.7,no dnr,5.0,64.0,12.3984375,131.0,39.0,36.19531,133.3125,2.0996094,1.0,0.89990234,135.0,7.539062,135.0,23.0,2502.0,4.5273972,<2 mo. follow-up
34.116,1,female,0,5,98,Cirrhosis,COPD/CHF/Cirrhosis,4,7.0,under $11k,9156.0,6053.8008,27.0,hispanic,27.0,2,0,0,no,0.399999857,0.3,no dnr,5.0,104.0,6.39941406,107.0,28.0,38.19531,257.125,2.699707,2.59960938,0.89990234,139.0,7.509766,135.0,23.0,2502.0,0.4947999,Coma or Intub
73.39398,1,female,1,8,8,Coma,Coma,0,12.0,under $11k,34045.0,22063.0,27.0,white,28.0,7,0,0,no,0.75,0.6,dnr after sadm,5.0,126.0,17.3984375,70.0,34.0,37.79688,256.625,2.5,0.59997559,0.69995117,136.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
65.073,1,male,0,28,53,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,44964.0,29248.8594,24.25,white,35.0,1,1,0,no,1.0,0.8,no dnr,28.0,103.0,11.5996094,70.0,34.0,37.79688,124.48438,2.199707,0.39996338,0.69995117,133.0,7.449219,135.0,23.0,2502.0,4.0,<2 mo. follow-up
42.905,1,male,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,124495.0,80604.5625,54.0,black,49.0,2,0,0,no,0.5,0.5,dnr after sadm,41.0,51.0,13.5,111.0,10.0,36.59375,215.0,2.699707,2.0,3.0,136.0,7.269531,135.0,23.0,2502.0,3.6347656,<2 mo. follow-up
79.09698,1,female,0,13,23,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,14050.0,9417.7109,18.0,white,37.0,1,0,0,no,0.899999619,0.7,dnr after sadm,3.0,132.0,14.2988281,10.0,22.0,35.39844,132.625,3.3999023,0.69995117,1.19995117,140.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
30.19299,1,male,0,36,74,Coma,Coma,0,12.0,$11-$25k,46838.0,31740.5469,26.25,hispanic,20.0,1,0,0,no,0.899999619,0.9,no dnr,36.0,132.0,24.0976562,131.0,24.0,37.79688,413.3125,3.3999023,0.39996338,1.09985352,146.0,7.399414,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
41.66998,0,male,0,22,1416,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,37499.0,25443.2031,19.666656,white,46.0,7,0,0,no,1.0,0.95,no dnr,22.0,129.0,9.09960938,131.0,26.0,38.79688,352.0,2.5,0.29998779,3.39990234,155.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
55.06897,0,male,0,10,1414,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,$25-$50k,16669.0,11251.7812,28.0,white,41.0,1,0,0,no,0.5,0.3,no dnr,10.0,119.0,7.39941406,150.0,28.0,39.09375,471.375,2.8999023,6.5,0.79992676,129.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
31.24699,1,female,0,6,1083,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,4111.0,2825.4961,3.0,black,47.0,1,0,0,no,1.0,0.9,no dnr,6.0,57.0,6.19921875,79.0,16.0,35.79688,333.3,2.5996094,5.89941406,1.5,133.0,7.419922,135.0,23.0,2502.0,7.0,SIP>=30
27.10699,0,female,0,22,1416,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,35273.0,23438.5156,37.333313,white,47.0,1,0,0,no,0.799999714,0.8,no dnr,22.0,115.0,18.5,191.0,27.0,38.19531,285.6875,1.7998047,3.59960938,0.5,135.0,7.439453,135.0,23.0,2502.0,7.0,no(M2 and SIP pres)
66.20398,1,male,1,22,22,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,62927.0,39654.5312,41.666657,white,54.0,1,0,0,no,0.799999714,0.6,dnr after sadm,12.0,64.0,14.3984375,141.0,48.0,38.39844,80.0,2.2998047,1.5,0.69995117,146.0,7.449219,135.0,23.0,2502.0,3.8251953,<2 mo. follow-up
58.034,0,female,0,25,1410,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,53220.0,34428.3438,33.75,white,30.0,3,0,0,no,0.25,0.3,no dnr,25.0,103.0,13.6992188,114.0,10.0,39.0,202.0,2.0996094,2.79980469,0.69995117,144.0,7.399414,135.0,23.0,2502.0,6.0,SIP>=30
35.44998,1,male,0,21,775,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,37261.0,23804.8125,31.666656,white,20.0,1,0,0,no,0.799999714,0.6,no dnr,21.0,119.0,12.8984375,60.0,12.0,36.39844,372.0,2.2998047,0.89990234,0.89990234,143.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.909,1,female,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,92986.0,61717.8125,44.25,white,62.0,7,0,0,no,0.649999619,0.65,dnr after sadm,27.0,63.0,12.0,78.0,8.0,36.0,185.0,1.5,21.5976562,4.0,135.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
28.23,0,female,0,38,1409,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,46400.0,30953.7969,16.25,hispanic,16.0,4,0,0,no,1.0,1.0,no dnr,38.0,81.0,4.19921875,124.0,32.0,38.79688,480.9375,2.7998047,1.09985352,0.69995117,135.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.22595,1,male,0,43,206,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,70934.0,44802.0312,30.25,white,28.0,3,0,0,yes,0.349999905,0.3,dnr after sadm,1.0,63.0,4.0,101.0,9.0,39.19531,128.0,2.5996094,2.39990234,0.79992676,142.0,7.449219,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
71.82495,0,female,0,12,1406,ARF/MOSF w/Sepsis,ARF/MOSF,6,11.0,$11-$25k,14032.0,9681.8359,21.5,black,45.0,1,1,1,no,0.25,0.2,no dnr,12.0,103.0,55.3984375,111.0,22.0,37.0,571.375,3.3999023,0.69995117,5.69921875,135.0,7.449219,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
85.16394,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,75455.0,49430.6562,52.5,white,66.0,11,0,0,no,0.099999964,0.001,dnr after sadm,9.0,52.0,8.19921875,122.0,20.0,38.0,198.0,1.7998047,25.296875,0.69995117,140.0,7.399414,135.0,23.0,2502.0,4.0,<2 mo. follow-up
48.42398,0,female,0,20,1403,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,36511.0,23229.4531,31.666656,white,50.0,3,0,0,yes,0.5,0.45,no dnr,20.0,56.0,21.796875,116.0,30.0,38.80469,73.32812,1.7998047,0.89990234,0.59997559,143.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.44098,1,male,0,5,620,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,4164.0,2751.9941,12.0,white,20.0,1,0,0,no,0.699999809,0.6,no dnr,5.0,90.0,10.0,53.0,24.0,36.0,207.40625,3.699707,0.5,1.09985352,139.0,7.399414,135.0,23.0,2502.0,0.0,SIP>=30
62.20898,1,female,1,3,3,Coma,Coma,0,12.0,under $11k,6400.0,3844.5488,28.0,white,28.0,1,0,0,no,0.0,0.0,no dnr,3.0,60.0,27.3984375,136.0,8.0,36.29688,239.21875,3.2998047,0.5,1.19995117,145.0,7.069336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
35.93997,1,male,0,5,242,CHF,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,3809.0,2524.8672,16.0,black,14.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,83.0,3.59960938,79.0,20.0,35.0,333.3,3.199707,3.19970703,0.89990234,139.0,7.419922,135.0,23.0,2502.0,2.6850586,no(M2 and SIP pres)
61.25897,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,5,4.0,under $11k,90017.0,60139.4688,60.0,white,68.0,19,1,0,no,0.0,0.0,dnr after sadm,5.0,59.0,18.796875,117.0,12.0,35.69531,133.3125,2.0996094,11.3984375,1.19995117,146.0,7.219727,135.0,23.0,2502.0,5.1230469,<2 mo. follow-up
70.84698,1,male,0,5,296,Lung Cancer,Cancer,3,9.0,under $11k,2911.0,2018.918,11.0,white,22.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,99.0,44.8984375,110.0,20.0,36.5,333.3,4.0996094,0.5,1.29980469,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
55.56998,1,male,0,16,477,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,21393.0,14453.625,23.666656,white,63.0,1,0,0,no,0.699999809,0.65,no dnr,16.0,140.0,1.09985352,200.0,32.0,36.0,290.4375,2.5,2.29980469,1.29980469,133.0,7.539062,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
36.67899,0,female,0,9,1397,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,20380.0,13409.4688,41.5,white,60.0,1,0,0,no,0.5,0.45,no dnr,9.0,139.0,18.8984375,114.0,10.0,39.5,117.5,2.2998047,0.89990234,10.3984375,135.0,7.439453,135.0,23.0,2502.0,0.0,SIP>=30
65.66199,1,male,0,17,75,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,33079.0,21716.5156,26.666656,black,81.0,1,0,0,metastatic,0.5,0.3,no dnr,17.0,56.0,0.59997559,122.0,28.0,38.19531,296.0,1.8999023,2.19970703,1.19995117,131.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.45898,1,female,0,7,449,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,5609.0,3537.2305,7.0,white,23.0,1,0,0,no,0.799999714,0.8,no dnr,7.0,79.0,8.19921875,107.0,28.0,36.5,292.0,3.699707,0.29998779,0.5,140.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.78894,1,male,0,4,450,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,$11-$25k,3005.0,2012.7266,7.0,white,38.0,1,1,0,no,0.899999619,0.9,no dnr,4.0,65.0,5.59960938,61.0,20.0,36.69531,380.9375,3.0,2.39990234,1.69995117,134.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.26099,0,male,0,53,1395,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,88038.0,57035.4062,43.25,white,35.0,21,0,0,no,0.699999809,0.6,no dnr,53.0,61.0,20.0976562,118.0,40.0,38.0,440.0,2.0,1.0,0.59997559,138.0,7.449219,135.0,23.0,2502.0,3.3129883,<2 mo. follow-up
46.086,0,female,0,4,1392,Lung Cancer,Cancer,1,11.0,$11-$25k,4690.0,3126.9766,18.0,black,11.0,1,0,0,metastatic,0.099999964,0.001,no dnr,4.0,112.0,3.89990234,98.0,20.0,37.39844,333.3,3.7998047,0.19998169,1.29980469,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.21198,1,male,1,4,4,Lung Cancer,Cancer,3,12.0,$11-$25k,6481.0,4199.7734,23.0,white,31.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,1.0,69.0,12.5996094,96.0,28.0,35.0,90.0,2.8999023,1.09985352,0.59997559,130.0,7.209961,135.0,23.0,2502.0,6.0,<2 mo. follow-up
65.44598,1,male,0,20,461,ARF/MOSF w/Sepsis,ARF/MOSF,5,13.0,under $11k,46758.0,30252.8594,38.333313,white,85.0,1,1,0,yes,0.699999809,0.6,no dnr,20.0,33.0,40.3984375,167.0,38.0,36.0,360.0,2.7998047,1.59985352,5.89941406,126.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
54.98199,1,male,0,33,393,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59155.0,39054.875,36.0,white,75.0,11,0,0,no,0.5,0.5,no dnr,33.0,129.0,21.8984375,178.0,34.0,36.79688,172.0,1.8999023,0.59997559,3.29980469,134.0,7.509766,135.0,23.0,2502.0,6.0,<2 mo. follow-up
80.02197,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,27433.0,18217.9375,48.0,white,38.0,6,0,0,yes,0.299999952,0.25,dnr before sadm,0.0,72.0,1.19995117,116.0,10.0,36.89844,215.0,1.2998047,1.19995117,1.29980469,138.0,7.369141,135.0,23.0,2502.0,5.0,<2 mo. follow-up
61.54099,0,male,0,12,1392,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,15302.0,9206.6484,16.0,white,48.0,1,0,0,no,0.899999619,0.85,no dnr,12.0,77.0,8.59960938,126.0,38.0,36.19531,233.3125,3.5,1.19995117,0.89990234,135.0,7.429688,135.0,23.0,2502.0,0.0,SIP>=30
64.15295,1,female,1,60,60,MOSF w/Malig,ARF/MOSF,3,10.0,under $11k,93140.0,64560.9062,25.5,black,34.0,14,1,0,metastatic,0.599999905,0.5,dnr after sadm,32.0,115.0,10.3984375,67.0,24.0,38.19531,347.5625,2.2998047,0.59997559,1.09985352,132.0,7.469727,135.0,23.0,2502.0,4.2880859,<2 mo. follow-up
62.04498,1,male,0,10,667,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,7436.0,5171.5898,9.5,white,37.0,1,0,0,no,0.899999619,0.7,no dnr,10.0,101.0,4.69921875,91.0,26.0,36.59375,377.75,3.3999023,0.59997559,2.39990234,143.0,7.25,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
32.534,0,male,0,49,1390,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,89321.0,56365.625,40.0,white,64.0,2,0,0,no,0.599999905,0.5,no dnr,49.0,117.0,3.09960938,147.0,50.0,40.5,126.25,2.8999023,0.59997559,0.79992676,133.0,7.269531,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
70.836,0,female,0,7,1391,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,6396.0,4260.0547,9.5,white,29.0,1,1,0,yes,0.949999809,0.9,no dnr,7.0,72.0,6.29980469,63.0,20.0,36.5,333.3,4.5,0.5,1.29980469,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.35599,0,male,0,14,1389,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,14332.0,9368.1875,11.666664,white,18.0,1,0,0,no,0.899999619,0.9,no dnr,14.0,116.0,4.89941406,86.0,28.0,36.29688,157.125,3.0996094,0.5,1.09985352,140.0,7.369141,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
63.80298,1,male,0,27,201,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,42604.0,29358.1094,17.25,black,49.0,2,0,0,yes,0.5,0.125,no dnr,27.0,132.0,5.09960938,103.0,24.0,36.59375,182.5,1.2998047,0.69995117,9.3984375,138.0,7.349609,135.0,23.0,2502.0,1.0,SIP>=30
45.90799,1,male,1,56,56,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,133090.0,87987.375,43.0,white,60.0,1,0,0,no,0.5,0.5,no dnr,56.0,107.0,24.5976562,129.0,22.0,38.59375,245.0,2.0996094,9.29882812,2.69970703,144.0,7.40918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
63.52597,0,female,0,83,1386,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,160341.0,98017.375,44.0,white,54.0,2,0,0,no,0.399999857,0.3,no dnr,83.0,50.0,22.0976562,114.0,22.0,38.79688,101.42188,2.0996094,1.29980469,1.59985352,130.0,7.429688,135.0,23.0,2502.0,2.5898438,<2 mo. follow-up
42.17697,1,male,1,14,14,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,55616.0,36861.0,49.333313,white,34.0,2,0,0,no,0.5,0.5,dnr after sadm,14.0,73.0,16.796875,104.0,12.0,36.19531,236.34375,1.6999512,2.5,0.69995117,136.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.50696,0,male,0,16,1386,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,19955.0,13055.0156,15.0,white,54.0,1,0,0,no,0.799999714,0.8,no dnr,16.0,74.0,1.59985352,58.0,24.0,34.89844,53.05469,3.3999023,4.0,1.09985352,138.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
76.78296,1,female,1,58,58,Coma,Coma,0,8.0,$11-$25k,138632.0,85347.3125,37.5,white,49.0,1,0,0,no,0.75,0.25,dnr after sadm,26.0,54.0,29.5976562,99.0,34.0,38.19531,225.0,2.5996094,1.0,2.0,126.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
44.353,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$11-$25k,32768.0,21883.5156,77.0,white,93.0,8,0,0,no,0.699999809,0.5,no dnr,3.0,30.0,45.59375,117.0,34.0,36.59375,116.92188,3.0,3.09960938,6.5,136.0,7.229492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.15295,1,male,0,50,290,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$11-$25k,120896.0,80620.25,47.5,black,73.0,9,1,0,no,0.989999771,0.97,no dnr,50.0,142.0,24.0,134.0,10.0,38.29688,168.875,1.6999512,10.0996094,4.5,132.0,7.319336,135.0,23.0,2502.0,5.0,SIP>=30
73.15295,0,male,0,9,1385,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,21349.0,14302.0547,10.5,white,40.0,12,0,0,no,0.699999809,0.6,no dnr,9.0,70.0,14.2988281,63.0,28.0,36.89844,395.1875,2.8999023,0.69995117,6.69921875,148.0,7.509766,135.0,23.0,2502.0,3.2358398,SIP>=30
64.92297,1,female,1,8,8,Lung Cancer,Cancer,2,12.0,under $11k,17009.0,10775.4688,35.0,white,42.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,7.0,54.0,6.79980469,101.0,12.0,36.19531,194.28125,1.8999023,0.59997559,1.29980469,135.0,7.40918,135.0,23.0,2502.0,3.0,<2 mo. follow-up
64.56097,1,male,0,101,110,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,321836.0,210850.75,50.25,white,34.0,79,1,0,no,0.75,0.5,no dnr,101.0,68.0,23.5,128.0,12.0,38.39844,215.0,2.5,1.0,1.59985352,134.0,7.399414,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
60.19699,1,male,0,65,970,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,178996.0,112564.5,38.5,white,44.0,13,0,0,no,0.5,0.4,no dnr,65.0,142.0,39.296875,136.0,14.0,37.79688,174.0,2.8999023,0.79992676,0.89990234,142.0,7.459961,135.0,23.0,2502.0,1.0,SIP>=30
75.09698,0,male,0,3,1383,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,1680.0,1162.4287,7.0,white,25.0,1,1,0,no,0.799999714,0.7,no dnr,3.0,99.0,9.09960938,93.0,20.0,35.69531,338.0625,3.5,1.01,1.69995117,142.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.26794,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19288.0,8867.4922,64.0,white,109.0,3,0,0,no,0.099999964,0.001,dnr after sadm,3.0,0.0,19.3984375,0.0,0.0,36.69531,54.0,2.0,3.59960938,4.39941406,130.0,7.149414,135.0,23.0,2502.0,7.0,<2 mo. follow-up
35.98398,0,male,0,8,1383,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,11756.0,7610.8555,16.5,white,12.0,1,0,0,no,0.949999809,0.95,no dnr,8.0,104.0,13.3984375,52.0,20.0,38.19531,371.375,3.3999023,1.09985352,0.89990234,139.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.62799,0,female,0,7,1380,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,9395.0,6109.8984,18.0,black,29.0,1,1,0,no,0.75,0.6,no dnr,7.0,116.0,11.7988281,109.0,12.0,36.59375,360.0,3.2998047,0.5,1.5,140.0,7.449219,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
56.909,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,22436.0,11593.8047,51.0,white,46.0,2,0,0,no,0.049999982,0.000125,dnr after sadm,8.0,54.0,11.0,115.0,6.0,36.09375,106.65625,3.5,1.01,1.09985352,126.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.55197,1,male,1,7,7,Coma,Coma,2,12.0,under $11k,40084.0,25945.5625,32.0,white,61.0,14,0,0,yes,0.5,0.2,dnr after sadm,5.0,103.0,0.69995117,104.0,36.0,37.79688,151.0,2.5,0.89990234,1.79980469,148.0,7.519531,135.0,23.0,2502.0,2.2192383,<2 mo. follow-up
36.517,0,male,0,15,1377,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,27843.0,18594.5625,27.0,white,54.0,1,0,0,no,0.5,0.35,no dnr,15.0,75.0,20.3984375,129.0,22.0,36.0,200.0,2.7998047,7.19921875,5.5,128.0,7.429688,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
22.76199,0,male,0,6,1376,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$25-$50k,8681.0,5767.1133,16.0,white,18.0,1,0,0,no,0.949999809,0.95,no dnr,6.0,100.0,10.8984375,118.0,33.0,36.59375,385.6875,3.699707,0.59997559,0.69995117,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
47.71298,1,female,0,8,970,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,8219.0,5388.7266,13.0,black,35.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,85.0,4.79980469,116.0,24.0,36.5,314.25,1.0998535,1.19995117,1.79980469,136.0,7.379883,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
48.05499,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,97107.0,64679.1562,37.0,black,35.0,38,0,0,yes,0.849999905,0.3,dnr after sadm,14.0,98.0,23.1992188,148.0,48.0,38.0,184.4375,3.5,1.01,1.29980469,145.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.94098,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,48901.0,32393.4844,62.0,white,83.0,7,0,0,yes,0.299999952,0.3,dnr after sadm,3.0,61.0,11.2988281,156.0,26.0,35.69531,53.0,2.0,6.79980469,1.39990234,140.0,7.199219,135.0,23.0,2502.0,2.0,<2 mo. follow-up
90.22595,1,female,1,10,10,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,8830.0,5900.7969,15.5,white,44.0,1,0,1,no,0.0,0.0,dnr after sadm,1.0,62.0,11.3984375,118.0,24.0,35.59375,192.0,3.0,0.39996338,0.79992676,153.0,7.379883,135.0,23.0,2502.0,7.0,<2 mo. follow-up
66.03699,1,female,0,5,159,Colon Cancer,Cancer,1,12.0,under $11k,3097.0,2165.1621,17.0,white,38.0,1,0,0,metastatic,0.199999928,0.0,no dnr,5.0,67.0,5.19921875,114.0,20.0,34.89844,333.3,3.0996094,0.5,1.59985352,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.86298,1,female,1,15,15,Coma,Coma,2,8.0,under $11k,29361.0,19186.2812,38.666657,black,32.0,1,1,0,no,0.019999996,8e-06,dnr after sadm,8.0,70.0,17.8984375,144.0,12.0,39.09375,225.0,2.5,0.59997559,0.89990234,131.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
70.59796,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,49659.0,33306.9062,69.0,white,81.0,1,1,0,no,0.199999928,0.1,no dnr,8.0,44.0,16.5,116.0,12.0,35.09375,105.0,1.2998047,2.89990234,4.59960938,146.0,7.219727,135.0,23.0,2502.0,3.3916016,<2 mo. follow-up
52.38898,1,female,0,16,540,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,39953.0,27074.7031,19.666656,white,54.0,19,0,0,yes,0.949999809,0.9,no dnr,16.0,61.0,0.06999207,122.0,24.0,38.79688,333.3,3.0996094,1.09985352,2.09960938,132.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
63.64999,1,female,0,16,44,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,17688.0,12061.3438,27.333328,white,42.0,3,1,0,yes,0.899999619,0.8,dnr after sadm,10.0,105.0,2.29980469,104.0,24.0,36.19531,333.3,3.0,0.59997559,7.39941406,123.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
84.06598,1,female,0,5,1067,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,3843.0,2547.4453,14.0,white,30.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,94.0,9.29882812,74.0,28.0,36.0,385.6875,3.5,1.01,1.59985352,140.0,7.609375,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
46.40097,0,female,0,6,1369,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,5005.0,3216.9316,11.0,white,19.0,1,0,0,no,1.0,1.0,no dnr,6.0,119.0,27.796875,114.0,22.0,36.5,537.0,3.5,1.01,0.89990234,128.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.14899,1,male,0,16,331,ARF/MOSF w/Sepsis,ARF/MOSF,5,9.0,under $11k,21386.0,14476.8516,10.666664,black,28.0,4,1,0,no,0.899999619,0.9,no dnr,16.0,123.0,20.0,100.0,24.0,38.0,333.3,2.5996094,0.29998779,1.79980469,138.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
47.58899,0,male,0,9,1369,Cirrhosis,COPD/CHF/Cirrhosis,4,16.0,>$50k,7535.0,5107.9727,10.0,white,37.0,1,0,0,no,1.0,0.9,no dnr,9.0,110.0,10.6992188,110.0,22.0,35.0,333.3,2.8999023,3.69970703,1.5,135.0,7.419922,135.0,23.0,2502.0,3.0,SIP>=30
76.96399,1,female,1,32,32,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,122608.0,80382.25,38.5,white,27.0,18,1,0,no,0.699999809,0.5,dnr after sadm,32.0,65.0,21.8984375,62.0,12.0,36.19531,300.0,2.5996094,0.89990234,1.5,131.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.56396,1,female,0,8,56,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$11-$25k,10663.0,7142.5781,16.0,white,54.0,1,1,0,no,0.5,0.2,no dnr,8.0,101.0,11.3984375,70.0,24.0,36.0,231.40625,3.5996094,0.5,6.19921875,132.0,7.489258,135.0,23.0,2502.0,7.0,<2 mo. follow-up
73.01794,0,female,0,7,1365,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,11598.0,7485.3086,12.5,white,30.0,1,0,0,no,0.949999809,0.95,no dnr,7.0,106.0,27.796875,113.0,24.0,36.89844,292.0,3.5996094,0.39996338,1.09985352,138.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
41.25897,0,male,0,38,1366,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,66635.0,43963.4688,34.0,white,16.0,1,0,0,no,0.899999619,0.9,no dnr,38.0,68.0,13.2988281,103.0,22.0,38.09375,182.5,2.8999023,0.79992676,0.89990234,139.0,7.5,135.0,23.0,2502.0,0.0,SIP>=30
79.04999,0,female,0,17,1366,CHF,COPD/CHF/Cirrhosis,1,10.0,$11-$25k,35571.0,18596.2188,31.333328,white,59.0,1,1,0,no,0.5,0.4,no dnr,17.0,65.0,12.1992188,75.0,32.0,36.19531,295.0,2.0996094,0.5,3.5,136.0,7.419922,135.0,23.0,2502.0,3.0,SIP>=30
42.59799,1,male,1,11,11,Lung Cancer,Cancer,3,12.0,under $11k,51666.0,33604.75,58.5,white,63.0,1,0,0,metastatic,0.099999964,0.001,dnr after sadm,8.0,137.0,14.0,113.0,30.0,35.09375,55.0,1.0998535,5.5,0.39996338,134.0,7.399414,135.0,23.0,2502.0,6.0,<2 mo. follow-up
37.073,1,male,0,6,76,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,5109.0,3444.1562,18.0,white,34.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,86.0,10.7988281,118.0,22.0,36.69531,295.1875,2.5,0.5,2.0,131.0,7.479492,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
70.11395,0,female,0,5,1363,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,3525.0,2384.9785,8.0,black,30.0,1,1,0,no,0.799999714,0.8,no dnr,5.0,67.0,4.59960938,53.0,20.0,36.29688,373.75,4.0,0.39996338,1.5,137.0,7.439453,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
42.08899,0,male,0,21,1363,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,66406.0,44127.2188,25.0,white,37.0,24,0,0,yes,0.699999809,0.65,no dnr,21.0,75.0,0.07998657,77.0,20.0,36.79688,333.3,2.8999023,2.59960938,1.09985352,128.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
43.92599,1,male,0,22,52,Colon Cancer,Cancer,1,10.0,$25-$50k,22780.0,15617.7266,16.0,white,14.0,1,0,0,metastatic,0.599999905,0.3,dnr after sadm,10.0,117.0,10.5996094,114.0,20.0,36.59375,333.3,3.5996094,0.89990234,1.0,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.51996,1,female,0,17,21,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,10663.0,7593.9922,5.333332,black,47.0,1,0,0,yes,0.799999714,0.8,no dnr,17.0,69.0,6.39941406,120.0,24.0,35.0,276.1875,2.5,1.09985352,1.59985352,141.0,7.509766,135.0,23.0,2502.0,5.0,<2 mo. follow-up
32.487,0,male,0,11,1363,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,12045.0,8052.4062,18.5,white,23.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,103.0,12.0996094,129.0,24.0,35.09375,344.4375,3.199707,2.0,0.69995117,129.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.00497,0,male,0,5,1363,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,4122.0,2744.3144,6.0,black,25.0,1,0,0,no,0.949999809,0.95,no dnr,5.0,97.0,6.89941406,114.0,20.0,36.69531,295.1875,2.8999023,4.5,0.79992676,132.0,7.439453,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
52.09,1,male,0,98,841,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,146637.0,97826.875,37.0,black,48.0,16,0,0,no,0.599999905,0.4,no dnr,98.0,142.0,38.8984375,68.0,10.0,36.5,134.0,3.199707,1.39990234,2.59960938,155.0,7.399414,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
61.92999,1,male,0,12,56,COPD,COPD/CHF/Cirrhosis,3,6.0,under $11k,20880.0,12499.5859,21.0,white,42.0,1,0,0,no,0.899999619,0.8,no dnr,12.0,117.0,9.59960938,133.0,48.0,35.5,195.8125,3.2998047,1.39990234,0.79992676,137.0,7.359375,135.0,23.0,2502.0,1.0,<2 mo. follow-up
80.39398,1,male,0,19,40,Coma,Coma,2,8.0,under $11k,17833.0,12272.9688,17.666656,white,34.0,1,1,0,no,0.5,0.4,dnr after sadm,2.0,144.0,18.0976562,120.0,24.0,38.0,333.3,3.5,1.09985352,1.29980469,129.0,7.469727,135.0,23.0,2502.0,5.0,<2 mo. follow-up
32.51199,1,male,1,32,32,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,91929.0,60005.625,42.5,white,64.0,5,0,0,no,0.599999905,0.4,dnr after sadm,19.0,73.0,36.09375,104.0,22.0,36.29688,333.3,2.2998047,35.796875,3.09960938,129.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.83496,1,male,0,3,347,Lung Cancer,Cancer,2,16.0,>$50k,3619.0,2349.4531,11.0,white,26.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,77.0,11.6992188,85.0,20.0,36.79688,333.3,4.0,0.5,1.69995117,137.0,7.419922,135.0,23.0,2502.0,2.3652344,no(M2 and SIP pres)
36.94699,0,male,0,9,1356,ARF/MOSF w/Sepsis,ARF/MOSF,3,18.0,under $11k,18359.0,12018.5,29.5,black,69.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,153.0,11.0,44.0,40.0,35.89844,102.84375,2.2998047,4.89941406,1.5,135.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
71.55597,1,female,0,4,481,CHF,COPD/CHF/Cirrhosis,3,6.0,under $11k,3269.0,2109.3984,11.0,hispanic,36.0,1,1,0,no,0.899999619,0.6,no dnr,4.0,53.0,4.89941406,62.0,22.0,35.39844,285.6875,3.3999023,1.39990234,1.0,130.0,7.429688,135.0,23.0,2502.0,1.8389997,SIP>=30
81.45898,1,female,0,6,120,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,7343.0,4772.5156,18.0,white,21.0,2,0,0,metastatic,0.5,0.2,dnr before sadm,-1.0,83.0,22.8984375,112.0,24.0,35.69531,333.3,3.5,1.01,0.59997559,129.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
24.44399,0,female,0,8,1352,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,11039.0,7373.1641,17.5,black,37.0,1,0,0,no,0.949999809,0.95,no dnr,8.0,68.0,20.0976562,120.0,28.0,38.89844,376.1875,2.3999023,0.5,1.0,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
79.35699,0,female,0,4,1352,CHF,COPD/CHF/Cirrhosis,2,16.0,under $11k,2569.0,1768.1455,11.0,white,30.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,85.0,6.39941406,50.0,20.0,36.39844,333.3,3.5,0.39996338,2.39990234,129.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
76.93097,1,male,0,5,202,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,4166.0,2688.6777,17.0,white,28.0,1,0,1,no,0.699999809,0.8,dnr after sadm,1.0,105.0,12.0996094,112.0,22.0,36.29688,248.0,4.0,0.39996338,1.19995117,145.0,7.429688,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
56.0,0,male,0,14,1350,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,26670.0,14787.7266,22.333328,hispanic,51.0,1,0,0,no,0.25,0.2,no dnr,14.0,73.0,11.1992188,125.0,31.0,38.0,130.0,4.1992188,1.29980469,1.19995117,134.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
28.47099,1,male,0,25,235,Colon Cancer,Cancer,1,18.0,$25-$50k,24310.0,16874.4062,12.0,white,5.0,1,0,0,metastatic,1.0,0.75,no dnr,25.0,96.0,10.5996094,74.0,20.0,37.69531,333.3,3.5996094,0.39996338,0.69995117,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
37.254,0,male,0,9,1351,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,15118.0,10010.7344,18.5,white,33.0,1,0,0,no,0.989999771,0.9,no dnr,9.0,76.0,33.3984375,118.0,32.0,38.39844,286.625,2.7998047,3.29980469,0.69995117,130.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
55.16498,1,male,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,122472.0,80453.0,51.5,white,60.0,7,0,0,no,0.699999809,0.8,dnr after sadm,28.0,53.0,18.5976562,117.0,29.0,39.19531,145.0,1.7998047,5.29980469,1.29980469,148.0,7.389648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
55.81699,1,female,0,98,116,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,169530.0,109842.25,45.0,white,29.0,5,0,0,no,0.599999905,0.6,no dnr,98.0,71.0,15.8984375,114.0,12.0,36.0,111.65625,2.199707,0.5,0.59997559,142.0,7.469727,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
60.34799,1,male,0,3,205,Lung Cancer,Cancer,1,10.0,$11-$25k,3128.0,2014.3809,4.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,78.0,6.79980469,98.0,20.0,36.09375,333.3,3.5996094,0.19998169,1.0,135.0,7.419922,135.0,23.0,2502.0,2.347168,SIP>=30
76.89496,1,male,0,17,26,MOSF w/Malig,ARF/MOSF,2,19.0,under $11k,29263.0,19455.6406,23.333328,white,35.0,6,0,0,yes,0.5,0.3,dnr before sadm,-5.0,89.0,0.17999268,71.0,22.0,38.09375,333.3,3.5,1.01,1.39990234,135.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
57.55798,1,female,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,91058.0,59330.0938,53.0,white,53.0,20,0,0,metastatic,0.5,0.5,no dnr,25.0,61.0,15.1992188,132.0,28.0,37.59375,106.65625,1.2998047,5.5,0.69995117,130.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.87396,1,male,0,13,36,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,19872.0,13052.7031,20.0,hispanic,18.0,1,0,0,yes,0.699999809,0.6,no dnr,13.0,114.0,11.5996094,67.0,30.0,36.59375,380.0,2.8999023,0.5,0.89990234,139.0,7.529297,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.745,1,female,0,74,185,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,155280.0,99237.875,42.25,white,31.0,5,0,0,yes,0.899999619,0.5,no dnr,74.0,58.0,29.5976562,71.0,10.0,39.09375,166.65625,2.199707,0.69995117,0.79992676,141.0,7.439453,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
71.29895,1,male,0,4,134,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,13484.0,7040.2148,27.0,white,35.0,4,0,0,no,0.899999619,0.6,dnr after sadm,3.0,81.0,9.19921875,138.0,20.0,36.59375,283.3125,2.8999023,0.29998779,8.3984375,135.0,7.429688,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
57.71698,1,female,0,5,14,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,5169.0,3299.7637,17.0,white,37.0,1,0,0,metastatic,0.049999982,0.000125,dnr after sadm,2.0,116.0,2.39990234,118.0,20.0,36.39844,333.3,2.699707,0.79992676,5.69921875,138.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
41.306,0,male,0,8,1342,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,7684.0,5010.5156,11.0,white,48.0,1,0,0,no,0.799999714,0.8,no dnr,8.0,101.0,10.2988281,110.0,20.0,37.89844,338.0625,3.0,9.3984375,0.59997559,132.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
48.51999,0,female,0,7,1342,Coma,Coma,0,16.0,$25-$50k,9025.0,6035.9375,30.0,white,13.0,1,0,0,no,0.799999714,0.6,no dnr,7.0,109.0,18.0976562,62.0,27.0,36.29688,596.25,4.2998047,0.19998169,0.59997559,145.0,7.40918,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
30.70799,1,male,0,4,250,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4510.0,2412.8984,11.0,black,29.0,1,0,0,no,0.949999809,0.95,no dnr,4.0,79.0,3.59960938,110.0,22.0,35.79688,446.625,3.5996094,1.59985352,1.69995117,133.0,7.539062,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
68.29596,1,female,1,5,5,Coma,Coma,0,12.0,under $11k,133305.0,88152.25,55.0,white,21.0,68,0,0,no,0.699999809,0.5,no dnr,5.0,121.0,11.5996094,138.0,12.0,35.29688,212.5,2.5996094,0.5,1.19995117,150.0,7.489258,135.0,23.0,2502.0,2.8398438,<2 mo. follow-up
57.98999,1,male,0,18,46,Cirrhosis,COPD/CHF/Cirrhosis,4,8.0,under $11k,40193.0,26652.375,41.0,white,30.0,3,0,0,no,0.899999619,0.7,no dnr,18.0,81.0,22.796875,73.0,28.0,36.0,333.3,2.2998047,3.79980469,0.59997559,134.0,7.419922,135.0,23.0,2502.0,3.0,<2 mo. follow-up
86.22595,1,female,0,7,8,Coma,Coma,1,12.0,under $11k,17560.0,9003.4609,25.5,white,28.0,3,0,0,no,0.0,0.0,dnr after sadm,3.0,128.0,14.8984375,54.0,24.0,38.0,370.0,3.0996094,0.89990234,2.39990234,137.0,7.479492,135.0,23.0,2502.0,7.0,<2 mo. follow-up
85.35498,1,female,0,161,311,MOSF w/Malig,ARF/MOSF,3,10.0,under $11k,281985.0,181805.75,50.5,white,49.0,23,0,1,metastatic,0.699999809,0.6,no dnr,161.0,53.0,21.1992188,137.0,36.0,37.79688,142.21875,3.5,1.01,1.19995117,132.0,7.459961,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
44.25699,1,female,0,13,20,Lung Cancer,Cancer,1,12.0,$11-$25k,12040.0,8074.7148,15.5,white,24.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,1.0,85.0,1.89990234,76.0,12.0,35.89844,342.8125,3.0996094,0.69995117,0.59997559,131.0,7.519531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.14798,1,female,0,59,72,MOSF w/Malig,ARF/MOSF,3,16.0,under $11k,174127.0,113074.812,46.5,white,81.0,17,1,0,yes,0.799999714,0.8,no dnr,59.0,58.0,0.06999207,141.0,32.0,39.0,215.0,2.7998047,0.79992676,1.59985352,155.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
47.79498,0,male,0,10,1339,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,14875.0,9237.9219,19.5,white,37.0,1,0,0,no,0.989999771,0.8,no dnr,10.0,113.0,18.0976562,118.0,28.0,36.09375,323.75,3.8999023,0.5,1.5,125.0,7.399414,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
74.56494,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,66352.0,46258.3125,40.0,white,52.0,52,0,1,no,0.0,0.0,dnr before sadm,-1.0,57.0,9.5,130.0,32.0,35.39844,290.0,1.5,0.79992676,0.39996338,142.0,7.529297,135.0,23.0,2502.0,2.0,<2 mo. follow-up
39.45798,1,male,0,8,1172,Cirrhosis,COPD/CHF/Cirrhosis,4,11.0,under $11k,7043.0,4771.7617,5.0,hispanic,32.0,1,1,0,no,0.799999714,0.6,no dnr,8.0,111.0,11.3984375,96.0,20.0,36.59375,333.3,2.5,0.39996338,3.89990234,132.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
61.31097,1,male,0,3,218,Lung Cancer,Cancer,1,10.0,$11-$25k,4140.0,2697.5898,8.0,white,17.0,1,0,0,metastatic,0.699999809,0.2,no dnr,3.0,97.0,9.0,101.0,22.0,36.29688,333.3,4.2998047,0.5,1.39990234,135.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
81.224,1,female,0,5,30,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,4326.0,2747.2949,12.0,white,35.0,1,0,0,yes,0.75,0.5,dnr after sadm,1.0,75.0,3.59960938,70.0,20.0,35.79688,204.75,4.3994141,0.69995117,0.69995117,136.0,7.299805,135.0,23.0,2502.0,1.0,<2 mo. follow-up
68.78296,1,male,1,22,22,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,70108.0,46481.1875,35.666657,white,38.0,3,1,0,no,0.5,0.4,dnr after sadm,21.0,71.0,12.7988281,106.0,26.0,36.79688,259.25,2.8999023,7.39941406,1.0,131.0,7.449219,135.0,23.0,2502.0,2.0,<2 mo. follow-up
85.41498,1,male,1,4,4,Coma,Coma,3,8.0,under $11k,11734.0,7946.3281,32.0,white,68.0,4,0,1,no,0.0,0.0,dnr after sadm,1.0,36.0,13.0,46.0,32.0,39.5,98.32812,2.7998047,0.59997559,5.09960938,136.0,7.429688,135.0,23.0,2502.0,5.5830078,<2 mo. follow-up
77.125,1,female,0,6,193,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3972.0,2723.7598,9.0,white,27.0,1,1,0,no,0.899999619,0.8,no dnr,6.0,67.0,4.89941406,100.0,22.0,36.19531,333.3,3.7998047,1.69995117,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.22198,0,male,0,17,1330,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26270.0,17649.9688,16.0,white,26.0,4,0,0,no,0.949999809,0.85,no dnr,17.0,113.0,15.2988281,60.0,28.0,37.59375,144.875,3.5996094,1.0,0.89990234,141.0,7.439453,135.0,23.0,2502.0,3.855299,SIP>=30
50.702,1,male,0,19,968,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,27858.0,17403.3281,18.666656,white,26.0,1,0,0,no,0.75,0.6,no dnr,19.0,110.0,24.1992188,120.0,32.0,36.39844,145.6875,3.5996094,0.79992676,0.89990234,144.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.81696,0,female,0,10,1328,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,10632.0,6724.168,20.5,black,49.0,1,1,0,no,0.899999619,0.9,no dnr,10.0,107.0,15.5996094,111.0,38.0,36.19531,164.5,3.2998047,0.59997559,1.89990234,138.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.57397,0,female,0,18,1328,MOSF w/Malig,ARF/MOSF,1,15.0,under $11k,68899.0,45641.6875,23.666656,white,50.0,23,0,0,yes,0.25,0.1,dnr after sadm,3.0,131.0,0.08999634,76.0,24.0,39.39844,333.3,3.199707,1.69995117,1.69995117,132.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
66.77899,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,33506.0,21843.0625,50.0,white,53.0,4,0,0,no,0.049999982,0.000125,dnr after sadm,5.0,126.0,28.0,130.0,30.0,35.39844,138.0,2.0,3.09960938,0.5,127.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
65.13898,0,male,0,5,1326,COPD,COPD/CHF/Cirrhosis,3,4.0,under $11k,4045.0,2666.4102,11.0,white,20.0,1,0,0,no,0.899999619,0.7,no dnr,5.0,104.0,4.79980469,77.0,28.0,36.79688,328.0,4.3994141,1.09985352,0.79992676,140.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
61.435,0,female,0,11,1325,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,21128.0,13303.3438,32.5,white,24.0,1,0,0,no,0.799999714,0.8,no dnr,11.0,74.0,35.0,126.0,10.0,36.59375,240.0,2.7998047,0.5,0.59997559,144.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
45.89999,1,female,0,17,90,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,under $11k,15710.0,10601.0859,19.666656,white,44.0,1,0,0,no,0.699999809,0.343,no dnr,17.0,78.0,10.0996094,110.0,24.0,37.79688,338.0625,2.7998047,30.0,0.79992676,134.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
29.073,1,male,0,5,1237,CHF,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,4748.0,3073.3691,10.0,white,13.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,79.0,14.1992188,79.0,22.0,37.0,380.9375,3.8999023,2.19970703,0.89990234,134.0,7.429688,135.0,23.0,2502.0,1.8520508,no(M2 and SIP pres)
28.81299,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,54911.0,35893.0938,52.0,white,69.0,4,0,0,no,0.75,0.75,no dnr,10.0,125.0,13.5,134.0,14.0,39.89844,146.0,1.8999023,10.7988281,2.89990234,146.0,7.319336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.17599,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,30752.0,20501.6094,46.5,white,79.0,6,0,0,yes,0.25,0.15,dnr after sadm,6.0,69.0,37.59375,120.0,40.0,33.19531,134.6875,2.699707,1.39990234,3.0,130.0,7.449219,135.0,23.0,2502.0,1.0,<2 mo. follow-up
62.004,0,female,0,6,1324,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,6033.0,3833.4531,14.0,black,29.0,1,1,0,no,0.949999809,0.9,no dnr,6.0,141.0,8.5,65.0,20.0,36.79688,333.3,3.5,0.5,1.59985352,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.44098,1,male,1,4,4,Coma,Coma,1,10.0,under $11k,10197.0,6800.8477,38.0,white,48.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,36.0,11.5,72.0,22.0,34.0,188.5625,2.199707,0.39996338,0.79992676,135.0,7.509766,135.0,23.0,2502.0,3.190918,<2 mo. follow-up
69.50897,0,female,0,4,1322,CHF,COPD/CHF/Cirrhosis,4,5.0,under $11k,7024.0,3988.1426,10.0,white,29.0,2,1,0,no,0.699999809,0.5,no dnr,4.0,116.0,13.2988281,81.0,20.0,37.89844,333.3,3.5,1.01,1.89990234,134.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
33.72998,0,female,0,9,1321,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,35602.0,24688.875,13.0,black,12.0,22,0,0,no,1.0,1.0,no dnr,9.0,95.0,5.0,104.0,24.0,37.69531,253.03125,2.0,1.09985352,0.69995117,133.0,7.40918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
57.71399,1,female,0,21,31,MOSF w/Malig,ARF/MOSF,4,11.0,under $11k,22480.0,14848.2656,25.0,black,20.0,1,1,0,metastatic,0.099999964,0.001,dnr after sadm,8.0,89.0,40.09375,96.0,24.0,39.59375,261.875,2.5996094,0.5,1.09985352,141.0,7.489258,135.0,23.0,2502.0,5.0,<2 mo. follow-up
70.40094,1,male,0,6,307,CHF,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,4826.0,3220.4199,6.0,white,25.0,1,0,0,no,0.529999733,0.3,dnr after sadm,2.0,108.0,7.59960938,74.0,22.0,36.29688,380.9375,3.5996094,1.0,1.59985352,140.0,7.5,135.0,23.0,2502.0,2.5078125,<2 mo. follow-up
26.26099,1,male,1,4,4,Coma,Coma,4,12.0,under $11k,11013.0,7114.2812,70.0,black,68.0,1,1,0,no,0.199999928,0.2,dnr after sadm,4.0,41.0,11.6992188,0.0,46.0,39.09375,167.5,2.5,0.89990234,1.69995117,143.0,7.199219,135.0,23.0,2502.0,2.440918,<2 mo. follow-up
70.79297,1,male,0,5,668,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,3689.0,2464.5469,7.0,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,107.0,5.89941406,53.0,22.0,35.69531,333.3,4.3994141,0.69995117,1.39990234,141.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
63.56998,1,male,0,44,227,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,126224.0,82239.625,42.5,white,24.0,4,0,0,no,0.5,0.5,no dnr,44.0,118.0,17.796875,136.0,8.0,39.19531,190.0,2.0,1.39990234,1.19995117,150.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.29797,1,male,1,25,25,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,108667.0,69016.75,57.0,white,53.0,2,0,0,yes,0.699999809,0.5,no dnr,25.0,57.0,22.5976562,136.0,32.0,39.19531,131.09375,2.3999023,0.69995117,1.09985352,147.0,7.569336,135.0,23.0,2502.0,6.0,<2 mo. follow-up
50.10797,1,female,0,20,448,MOSF w/Malig,ARF/MOSF,1,13.0,$11-$25k,59953.0,32717.1094,30.333328,white,35.0,14,0,0,yes,0.5,0.5,no dnr,20.0,74.0,0.0,101.0,20.0,35.79688,333.3,2.5996094,0.5,0.89990234,133.0,7.419922,135.0,23.0,2502.0,0.0,SIP>=30
40.57999,0,male,0,61,1316,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,173158.0,116037.625,54.0,white,66.0,4,0,0,no,0.049999982,0.000125,no dnr,61.0,60.0,12.0,132.0,14.0,38.39844,108.0,1.6999512,2.89990234,4.79980469,142.0,7.279297,135.0,23.0,2502.0,1.0,SIP>=30
53.823,1,female,0,8,68,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,15461.0,9543.1797,13.0,white,25.0,7,0,0,metastatic,0.799999714,0.6,no dnr,8.0,89.0,0.69995117,101.0,20.0,36.69531,333.3,3.5,1.01,0.89990234,135.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
74.22894,1,male,0,13,118,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,15964.0,9384.25,20.0,white,31.0,1,0,0,no,0.899999619,0.8,no dnr,13.0,77.0,9.8984375,107.0,28.0,36.29688,276.625,2.5,1.69995117,1.39990234,131.0,7.479492,135.0,23.0,2502.0,6.0,<2 mo. follow-up
76.61096,1,male,0,3,160,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,2487.0,1572.0332,11.0,black,31.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,62.0,5.39941406,110.0,20.0,36.39844,376.1875,3.5,1.19995117,1.29980469,138.0,7.529297,135.0,23.0,2502.0,2.5449219,<2 mo. follow-up
49.28699,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,86797.0,55757.6562,45.25,white,50.0,14,0,0,no,0.5,0.5,no dnr,28.0,115.0,34.09375,140.0,28.0,38.0,347.5625,2.3999023,3.39990234,0.5,137.0,7.489258,135.0,23.0,2502.0,3.2250977,<2 mo. follow-up
69.37994,1,female,0,7,55,CHF,COPD/CHF/Cirrhosis,2,13.0,under $11k,10879.0,5274.4727,18.0,white,36.0,1,0,0,metastatic,0.799999714,0.8,no dnr,7.0,59.0,5.5,136.0,22.0,36.59375,333.3,2.5,1.5,1.19995117,130.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.88599,1,male,0,7,793,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,6045.0,3868.6758,9.5,white,17.0,1,0,0,no,0.949999809,0.9,no dnr,7.0,94.0,17.5976562,118.0,24.0,36.59375,280.0,4.0,1.0,1.0,136.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.59299,1,male,1,36,36,Cirrhosis,COPD/CHF/Cirrhosis,7,10.0,$11-$25k,119264.0,76845.0,48.25,white,50.0,5,1,0,no,0.699999809,0.6,dnr after sadm,32.0,120.0,20.5,61.0,33.0,36.0,257.125,2.199707,3.09960938,1.29980469,129.0,7.399414,135.0,23.0,2502.0,0.0,<2 mo. follow-up
36.98297,1,male,0,24,60,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,26586.0,17302.4688,17.0,black,35.0,6,0,0,no,0.5,0.3,no dnr,24.0,73.0,9.0,107.0,28.0,35.89844,280.0,2.3999023,2.39990234,1.29980469,127.0,7.449219,135.0,23.0,2502.0,0.0,SIP>=30
52.19199,1,female,0,6,179,Colon Cancer,Cancer,1,12.0,$25-$50k,5321.0,3410.6738,10.0,white,5.0,1,0,0,metastatic,0.5,0.3,no dnr,6.0,86.0,8.5,59.0,20.0,36.5,333.3,3.2998047,1.0,0.79992676,136.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
70.46997,1,female,0,38,100,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,94955.0,62118.1562,38.5,white,52.0,12,0,0,no,1.0,1.0,no dnr,38.0,50.0,29.296875,80.0,10.0,36.39844,115.54688,1.6999512,6.89941406,0.59997559,135.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.80597,1,male,1,15,15,MOSF w/Malig,ARF/MOSF,1,6.0,under $11k,15662.0,10750.6406,10.333328,black,39.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,1.0,66.0,17.5,71.0,20.0,35.89844,523.75,2.5,1.59985352,2.29980469,142.0,7.459961,135.0,23.0,2502.0,2.0,<2 mo. follow-up
71.78894,1,male,0,38,937,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,91348.0,59310.0625,50.25,white,38.0,1,0,0,no,0.399999857,0.4,no dnr,38.0,82.0,24.1992188,106.0,15.0,38.09375,91.25,2.5,1.5,2.5,144.0,7.369141,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
34.875,1,male,1,14,14,MOSF w/Malig,ARF/MOSF,2,0.0,under $11k,59218.0,37512.0,56.666657,white,67.0,3,0,0,yes,0.599999905,0.5,no dnr,14.0,51.0,2.19970703,160.0,28.0,35.89844,123.75,2.2998047,1.5,0.69995117,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.97095,1,female,0,4,30,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,5415.0,2838.0508,24.0,black,22.0,3,0,0,metastatic,0.299999952,0.2,no dnr,4.0,101.0,9.79882812,76.0,22.0,36.09375,333.3,3.5,1.01,1.19995117,129.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
62.74298,0,female,0,6,1302,ARF/MOSF w/Sepsis,ARF/MOSF,4,6.0,under $11k,7487.0,4930.6758,10.0,black,39.0,2,1,0,no,0.949999809,0.8,no dnr,6.0,132.0,11.7988281,96.0,24.0,36.69531,252.375,3.5,0.39996338,2.39990234,136.0,7.329102,135.0,23.0,2502.0,1.0,SIP>=30
84.112,1,male,0,30,274,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,under $11k,25533.0,16575.125,17.75,white,59.0,1,0,1,no,0.5,0.4,dnr after sadm,2.0,61.0,3.19970703,138.0,36.0,39.0,191.40625,2.0,1.09985352,2.5,150.0,7.329102,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
59.23898,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,15.0,$25-$50k,5891.0,3676.1289,13.0,white,32.0,3,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,63.0,19.296875,122.0,24.0,37.79688,333.3,3.5,1.01,1.69995117,122.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.465,1,male,0,4,225,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,5590.0,3078.4727,12.0,black,27.0,1,0,0,no,0.949999809,0.95,no dnr,4.0,71.0,9.3984375,71.0,22.0,35.89844,152.0,4.1992188,0.59997559,1.59985352,138.0,7.099609,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
47.439,1,female,0,11,323,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,14155.0,9264.0078,15.0,white,37.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,104.0,17.296875,113.0,20.0,36.19531,566.625,2.5996094,12.0,0.5,144.0,7.489258,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
41.91898,1,male,1,24,24,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,under $11k,49526.0,31816.1719,21.333328,black,43.0,1,0,0,no,0.799999714,0.75,dnr after sadm,19.0,76.0,3.79980469,69.0,20.0,36.0,333.3,1.6999512,25.296875,0.5,135.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
71.04395,1,female,1,8,8,Coma,Coma,3,12.0,$25-$50k,39241.0,25236.375,35.0,white,16.0,17,0,0,yes,0.099999964,0.001,dnr after sadm,3.0,62.0,10.5,65.0,10.0,38.59375,346.625,2.699707,0.29998779,1.09985352,166.0,7.399414,135.0,23.0,2502.0,7.0,<2 mo. follow-up
77.55194,1,male,1,163,163,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,265926.0,177235.25,41.5,white,51.0,1,1,0,no,0.799999714,0.8,dnr after sadm,146.0,155.0,17.8984375,125.0,28.0,38.89844,226.65625,2.199707,0.79992676,1.5,137.0,7.429688,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
57.25699,1,male,0,3,230,Colon Cancer,Cancer,2,7.0,under $11k,2124.0,1498.0596,22.610928270087555,black,5.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,2.0,95.0,10.5,58.0,24.0,37.5,333.3,3.5,0.79992676,0.79992676,138.0,7.419922,107.0,6.0,940.0,0.0,adl>=4 (>=5 if sur)
61.84,0,female,0,11,1090,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,12300.0,8202.9453,17.0,black,23.0,1,0,0,yes,0.899999619,0.89,no dnr,11.0,65.0,9.5,105.0,28.0,38.09375,137.5,3.5,1.01,2.0,137.0,7.419922,126.0,29.0,4955.0,0.0,no(M2 and SIP pres)
67.31,1,female,1,22,22,MOSF w/Malig,ARF/MOSF,1,16.0,$25-$50k,18881.0,13809.0859,21.0,white,37.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,17.0,83.0,5.5,100.0,18.0,36.69531,274.0625,3.5,0.39996338,0.69995117,137.0,7.389648,242.0,10.0,2502.0,2.0,<2 mo. follow-up
25.43199,0,female,0,98,1088,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,277810.0,175246.125,42.25,white,45.0,1,0,0,no,0.799999714,0.7,no dnr,98.0,48.0,3.89990234,115.0,12.0,35.59375,388.0,2.5996094,1.5,9.79882812,126.0,7.449219,205.0,56.0,0.0,0.0,adl>=4 (>=5 if sur)
50.19598,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,41359.0,25705.0625,35.5,white,83.0,1,0,0,no,0.399999857,0.35,dnr after sadm,4.0,83.0,7.79980469,74.0,24.0,36.79688,333.3,3.0,0.59997559,0.79992676,141.0,7.419922,106.0,11.0,2502.0,0.0,<2 mo. follow-up
77.21295,1,male,0,5,434,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4117.0,2907.9648,12.0,white,34.0,1,0,0,no,0.699999809,0.6,no dnr,5.0,121.0,14.5996094,74.0,20.0,36.09375,333.3,3.5996094,0.39996338,0.69995117,140.0,7.419922,73.0,7.0,2310.0,0.0,no(M2 and SIP pres)
72.20795,1,female,1,6,6,Coma,Coma,1,14.0,under $11k,5676.0,3781.8262,19.0,white,57.0,1,1,0,no,0.049999982,0.05,dnr after sadm,1.0,122.0,26.5,125.0,8.0,38.09375,304.0,3.5,15.1992188,8.59960938,139.0,7.359375,166.0,78.0,0.0,0.0,<2 mo. follow-up
79.10699,1,male,0,6,403,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,6479.0,4432.9688,12.0,white,31.0,1,0,0,no,0.899999619,0.7,no dnr,6.0,68.0,21.6992188,145.0,25.0,35.5,445.0,1.8999023,0.79992676,3.79980469,135.0,7.229492,151.0,54.0,1850.0,0.0,no(M2 and SIP pres)
61.78198,0,male,0,18,1085,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,30163.0,17284.2656,23.333328,white,53.0,4,1,0,no,0.049999982,0.01,dnr after sadm,1.0,63.0,10.5996094,71.0,28.0,36.0,195.0,3.5,1.19995117,1.89990234,147.0,7.379883,106.0,41.0,1020.0,1.1667481,<2 mo. follow-up
51.34299,1,male,0,9,493,COPD,COPD/CHF/Cirrhosis,1,0.0,under $11k,10785.0,6678.9844,12.5,white,22.0,1,0,0,no,0.75,0.5,no dnr,9.0,127.0,19.796875,120.0,10.0,37.79688,171.40625,3.5,0.59997559,1.19995117,144.0,7.319336,260.0,35.0,1720.0,0.494751,SIP>=30
79.93994,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,34382.0,21277.8281,48.5,white,69.0,1,0,1,yes,0.399999857,0.2,dnr after sadm,7.0,55.0,14.3984375,60.0,34.0,38.79688,237.125,2.0,1.01,1.09985352,130.0,7.379883,251.0,17.0,480.0,7.0,<2 mo. follow-up
54.853,1,female,1,14,14,MOSF w/Malig,ARF/MOSF,4,12.0,>$50k,53156.0,32901.25,49.0,white,46.0,1,0,0,metastatic,0.399999857,0.4,dnr after sadm,11.0,113.0,20.6992188,75.0,11.0,38.79688,290.0,3.5,1.01,6.5,132.0,7.389648,85.0,44.0,230.0,2.0,<2 mo. follow-up
58.349,0,female,0,9,1080,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,7481.0,5456.5703,11.5,white,21.0,1,1,0,no,0.899999619,0.7,no dnr,9.0,102.0,11.0996094,125.0,52.0,39.59375,152.0,3.5,0.69995117,0.69995117,131.0,7.419922,178.0,31.0,770.0,1.0,no(M2 and SIP pres)
34.44199,0,male,0,20,1079,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,38032.0,20595.1406,32.333313,white,26.0,1,0,0,no,1.0,1.0,no dnr,20.0,65.0,8.69921875,95.0,29.0,38.39844,159.15625,3.5,1.01,3.5,136.0,7.30957,151.0,77.0,1920.0,0.0,adl>=4 (>=5 if sur)
60.64899,1,female,0,7,92,COPD,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,6610.0,4424.2109,3.0,white,21.0,1,1,0,yes,0.899999619,0.8,no dnr,7.0,0.0,12.1992188,0.0,0.0,36.09375,157.0,3.5,1.01,0.89990234,143.0,7.239258,141.0,15.0,3040.0,3.1831055,no(M2 and SIP pres)
73.98199,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,9644.0,6020.7266,66.0,white,85.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,53.0,21.296875,110.0,36.0,36.19531,205.0,3.5,1.01,2.19970703,139.0,7.349609,144.0,35.0,425.0,3.5825195,<2 mo. follow-up
43.98898,0,male,0,14,1079,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,15008.0,10454.0859,10.0,white,32.0,1,0,0,no,0.799999714,0.75,no dnr,14.0,102.0,6.5,70.0,12.0,38.09375,266.625,3.5,1.01,0.59997559,135.0,7.459961,103.0,7.0,5570.0,2.5107422,no(M2 and SIP pres)
34.56799,0,female,0,19,1077,ARF/MOSF w/Sepsis,ARF/MOSF,0,0.0,under $11k,57730.0,36738.7188,33.666657,white,17.0,4,0,0,no,0.799999714,0.8,no dnr,19.0,113.0,18.3984375,105.0,35.0,38.59375,177.5,3.0996094,1.5,0.59997559,138.0,7.419922,86.0,48.0,3700.0,2.0,no(M2 and SIP pres)
73.08997,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,0,12.0,$11-$25k,26275.0,16161.6875,55.0,white,83.0,1,0,0,yes,0.5,0.5,dnr after sadm,5.0,62.0,6.79980469,65.0,10.0,35.0,596.0,2.8999023,1.29980469,0.59997559,135.0,7.389648,183.0,12.0,713.0,2.2304688,<2 mo. follow-up
63.51297,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,73398.0,39047.5625,38.75,white,36.0,1,0,0,no,0.5,0.2,dnr after sadm,25.0,115.0,11.0,65.0,48.0,38.5,170.0,3.5,0.5,0.79992676,131.0,7.40918,144.0,16.0,6820.0,0.0,<2 mo. follow-up
51.431,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$25-$50k,42284.0,26786.9375,58.0,white,52.0,1,0,0,no,0.199999928,0.1,dnr after sadm,11.0,113.0,7.59960938,95.0,16.0,36.29688,333.3,3.5,1.69995117,0.59997559,130.0,7.419922,193.0,25.0,2502.0,0.0,<2 mo. follow-up
59.34598,0,female,0,11,1076,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,12036.0,7768.1016,19.5,white,36.0,1,1,0,no,0.799999714,0.75,no dnr,11.0,131.0,8.69921875,55.0,20.0,36.19531,253.03125,3.5,1.01,2.79980469,144.0,7.389648,84.0,49.0,800.0,0.0,no(M2 and SIP pres)
78.448,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,4403.0,2999.4981,17.0,white,44.0,1,0,0,metastatic,0.0,0.0,dnr before sadm,-1.0,96.0,5.39941406,126.0,24.0,38.29688,266.625,3.199707,1.01,1.19995117,142.0,7.439453,90.0,44.0,1350.0,4.7529297,<2 mo. follow-up
52.189,1,male,0,3,284,Lung Cancer,Cancer,1,5.0,$25-$50k,3155.0,2068.5938,8.0,white,3.0,1,0,0,metastatic,1.0,0.6,no dnr,3.0,74.0,7.69921875,72.0,20.0,38.5,333.3,3.5,1.01,0.79992676,130.0,7.419922,103.0,12.0,1550.0,1.0,no(M2 and SIP pres)
66.62,1,female,0,3,217,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,2313.0,1624.4463,22.610928270087555,white,36.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,115.0,11.7988281,60.0,10.0,36.59375,215.0,3.0996094,1.01,0.69995117,132.0,7.449219,189.0,16.0,5230.0,1.0,no(M2 and SIP pres)
53.43698,1,male,0,4,295,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,4110.0,2725.1269,8.0,white,21.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,107.0,8.79882812,115.0,22.0,37.89844,218.5,3.5,1.01,0.59997559,128.0,7.399414,116.0,4.0,2275.0,0.494751,no(M2 and SIP pres)
75.01697,0,female,0,18,1074,ARF/MOSF w/Sepsis,ARF/MOSF,4,7.0,under $11k,27437.0,18642.6875,24.666656,white,42.0,1,0,0,no,0.799999714,0.6,no dnr,18.0,72.0,0.09999084,145.0,36.0,35.59375,250.0,3.5,0.39996338,1.19995117,136.0,7.439453,185.0,61.0,3070.0,3.0,no(M2 and SIP pres)
37.34998,0,male,0,68,1073,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,205034.0,133860.375,49.75,white,42.0,2,1,0,no,0.699999809,0.5,no dnr,68.0,62.0,14.1992188,120.0,34.0,38.29688,240.0,3.5,1.01,2.29980469,144.0,7.419922,308.0,83.0,4245.0,3.105957,<2 mo. follow-up
63.439,0,female,0,12,1073,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,23836.0,16231.2422,27.5,white,76.0,3,0,0,no,0.199999928,0.15,dnr after sadm,1.0,78.0,4.79980469,80.0,6.0,36.39844,306.625,3.5,1.19995117,0.59997559,141.0,7.439453,148.0,7.0,6310.0,1.0,SIP>=30
69.32794,1,female,0,3,411,Lung Cancer,Cancer,1,11.0,under $11k,4540.0,3229.625,22.610928270087555,white,14.0,1,0,0,metastatic,0.989999771,0.95,no dnr,3.0,63.0,7.09960938,75.0,28.0,36.09375,333.3,3.699707,1.0,3.19970703,143.0,7.419922,84.0,75.0,2400.0,2.0,no(M2 and SIP pres)
59.86298,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,2,10.0,$25-$50k,37759.0,23176.9375,51.0,white,93.0,1,0,0,metastatic,0.149999976,0.1,no dnr,11.0,105.0,4.89941406,140.0,40.0,38.19531,176.65625,3.5,7.5,0.59997559,135.0,7.489258,115.0,11.0,2860.0,4.0,<2 mo. follow-up
77.45697,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,91649.0,56680.8438,44.25,white,77.0,2,0,0,no,0.5,0.5,no dnr,27.0,77.0,5.39941406,59.0,20.0,35.89844,333.3,3.5,0.59997559,1.09985352,138.0,7.419922,80.0,15.0,2502.0,0.0,<2 mo. follow-up
66.73798,1,male,0,10,397,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,9034.0,6444.5742,19.0,white,47.0,1,0,0,no,0.5,0.2,no dnr,10.0,130.0,13.0996094,65.0,10.0,36.5,356.625,3.5,0.59997559,1.29980469,138.0,7.339844,256.0,11.0,2502.0,0.0,no(M2 and SIP pres)
35.35699,1,male,0,17,490,MOSF w/Malig,ARF/MOSF,2,12.0,>$50k,58401.0,38772.9062,24.0,white,35.0,16,0,0,yes,1.0,0.8,no dnr,17.0,97.0,4.79980469,52.0,16.0,37.79688,333.3,3.5,0.59997559,1.39990234,139.0,7.419922,103.0,19.0,3120.0,0.0,no(M2 and SIP pres)
40.94498,1,male,0,13,77,Lung Cancer,Cancer,2,12.0,$11-$25k,15632.0,10662.7188,14.0,black,20.0,1,0,0,metastatic,1.0,0.6,no dnr,13.0,79.0,14.2988281,140.0,24.0,36.19531,357.125,2.5996094,0.79992676,1.89990234,135.0,7.439453,182.0,24.0,1700.0,0.0,no(M2 and SIP pres)
81.38495,1,male,0,4,283,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,3165.0,2084.1113,9.0,white,25.0,1,1,0,no,0.75,0.7,no dnr,4.0,65.0,9.0,105.0,10.0,37.59375,145.0,1.5998535,1.01,3.19970703,138.0,7.439453,99.0,39.0,1105.0,0.494751,no(M2 and SIP pres)
80.21899,1,male,0,26,28,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,under $11k,85205.0,56216.3125,40.0,hispanic,57.0,10,1,0,no,0.699999809,0.5,dnr after sadm,13.0,62.0,5.79980469,115.0,31.0,37.69531,142.5,2.0996094,0.79992676,0.69995117,136.0,7.479492,115.0,11.0,3090.0,0.0,<2 mo. follow-up
64.13995,1,male,0,31,435,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$25-$50k,73708.0,50837.7188,20.0,white,48.0,11,1,0,no,0.75,0.5,no dnr,31.0,52.0,6.29980469,125.0,24.0,36.19531,333.3,3.5,1.59985352,1.39990234,133.0,7.419922,100.0,15.0,3540.0,0.0,SIP>=30
41.383,1,male,0,7,519,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,17069.0,10756.2969,15.5,white,22.0,2,0,0,no,1.0,1.0,no dnr,7.0,103.0,5.69921875,120.0,24.0,36.59375,333.3,3.7998047,0.39996338,0.79992676,135.0,7.419922,120.0,4.0,925.0,4.0,SIP>=30
66.28595,1,male,1,8,8,Coma,Coma,3,18.0,under $11k,25847.0,16392.5469,34.5,white,55.0,4,1,0,no,0.049999982,0.05,dnr after sadm,5.0,127.0,20.1992188,96.0,20.0,36.59375,428.0,3.5,1.01,3.59960938,132.0,7.239258,132.0,87.0,2502.0,0.0,<2 mo. follow-up
54.12198,1,male,0,11,278,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,11246.0,8049.043,5.0,white,36.0,1,1,0,no,0.899999619,0.8,no dnr,11.0,83.0,4.59960938,72.0,16.0,36.79688,333.3,3.8999023,0.79992676,1.0,137.0,7.419922,113.0,9.0,6000.0,0.494751,no(M2 and SIP pres)
60.69299,0,female,0,17,1062,MOSF w/Malig,ARF/MOSF,3,13.0,$11-$25k,35867.0,25898.4531,18.0,black,21.0,21,0,0,metastatic,0.199999928,0.1,dnr after sadm,5.0,0.0,10.1992188,70.0,22.0,36.59375,142.0,3.5,0.79992676,2.09960938,133.0,7.40918,98.0,38.0,2170.0,7.0,adl>=4 (>=5 if sur)
73.76599,1,male,1,17,17,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,132628.0,85909.3125,48.666657,white,49.0,24,0,0,yes,0.799999714,0.6,dnr after sadm,9.0,137.0,14.7988281,59.0,12.0,36.29688,145.0,3.5,1.01,0.79992676,123.0,7.479492,157.0,29.0,1845.0,0.0,<2 mo. follow-up
51.52399,0,female,0,13,1060,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,18329.0,12042.0703,14.0,white,20.0,1,0,0,yes,1.0,1.0,no dnr,13.0,68.0,6.09960938,115.0,20.0,37.79688,324.0,3.5,0.79992676,0.69995117,137.0,7.439453,132.0,6.0,2450.0,4.0,SIP>=30
74.51099,1,male,0,6,18,Colon Cancer,Cancer,3,6.0,under $11k,7807.0,5308.9805,17.0,white,34.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,1.0,110.0,6.89941406,100.0,24.0,37.5,333.3,3.5,0.69995117,0.69995117,138.0,7.419922,105.0,14.0,6500.0,4.0,<2 mo. follow-up
52.58899,0,male,0,11,1060,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,>$50k,50177.0,28641.6406,35.0,white,22.0,16,0,0,no,0.899999619,0.85,no dnr,11.0,62.0,21.1992188,70.0,27.0,36.39844,132.0,3.5,0.5,0.79992676,145.0,7.5,228.0,27.0,1180.0,0.0,no(M2 and SIP pres)
70.21997,0,male,0,5,1059,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,5102.0,3456.8359,17.0,black,16.0,1,0,0,no,0.979999542,0.98,no dnr,5.0,68.0,6.19921875,125.0,30.0,36.59375,122.21875,3.5,1.01,3.0,136.0,7.319336,118.0,57.0,1525.0,0.494751,<2 mo. follow-up
74.19598,0,male,0,21,1057,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,62839.0,35514.8438,18.666656,white,17.0,3,1,0,no,0.849999905,0.75,no dnr,21.0,82.0,8.79882812,96.0,24.0,37.19531,314.25,4.0,0.59997559,1.19995117,141.0,7.479492,95.0,9.0,2502.0,0.0,no(M2 and SIP pres)
45.60699,0,male,0,34,1057,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,41640.0,29972.3125,23.75,black,50.0,1,0,0,no,0.799999714,0.8,no dnr,34.0,80.0,9.0,104.0,20.0,36.5,260.0,3.5,0.79992676,1.09985352,143.0,7.469727,143.0,16.0,987.0,5.0,SIP>=30
82.85797,1,female,1,11,11,CHF,COPD/CHF/Cirrhosis,6,8.0,under $11k,10010.0,7016.332,11.0,white,38.0,1,0,0,yes,0.849999905,0.6,no dnr,11.0,99.0,8.19921875,114.0,20.0,35.79688,333.3,2.7998047,1.09985352,4.09960938,136.0,7.419922,83.0,62.0,850.0,2.0,<2 mo. follow-up
69.83398,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,4,14.0,$25-$50k,54848.0,35273.5625,49.666657,white,62.0,5,0,0,no,0.199999928,0.0,dnr after sadm,12.0,127.0,13.7988281,150.0,12.0,38.79688,133.3125,2.3999023,1.0,1.29980469,146.0,7.369141,148.0,20.0,2645.0,3.0,<2 mo. follow-up
60.98297,1,female,0,14,97,Colon Cancer,Cancer,1,10.0,under $11k,14493.0,10190.1797,16.666656,white,26.0,1,0,0,metastatic,0.599999905,0.4,no dnr,14.0,132.0,16.0976562,118.0,34.0,38.5,63.32812,2.5,6.19921875,3.5,136.0,7.549805,251.0,36.0,218.0,0.0,SIP>=30
48.08197,1,male,0,5,147,MOSF w/Malig,ARF/MOSF,1,18.0,>$50k,6724.0,4564.9688,24.0,white,30.0,1,0,0,yes,0.799999714,0.6,no dnr,5.0,108.0,9.0,70.0,20.0,35.59375,448.0,3.8999023,0.5,3.19970703,138.0,7.40918,99.0,64.0,850.0,0.0,no(M2 and SIP pres)
59.81097,1,male,1,9,9,Coma,Coma,3,4.0,under $11k,78194.0,48746.3438,57.0,hispanic,68.0,21,1,0,no,0.25,0.1,no dnr,9.0,105.0,20.0976562,114.0,12.0,40.59375,415.0,4.2998047,0.59997559,2.0,147.0,7.639648,402.0,56.0,1350.0,0.0,<2 mo. follow-up
28.112,0,male,0,14,1055,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,24992.0,16218.3984,15.666664,white,21.0,1,0,0,no,0.949999809,1.0,no dnr,14.0,72.0,4.79980469,79.0,20.0,35.59375,333.3,3.5,0.5,2.29980469,137.0,7.419922,99.0,45.0,3535.0,1.0,SIP>=30
64.85999,0,male,0,40,1055,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,110427.0,72151.0,51.5,white,37.0,4,0,0,no,0.799999714,0.8,no dnr,40.0,71.0,11.0996094,106.0,6.0,36.19531,140.0,3.5,1.01,2.29980469,121.0,7.419922,611.0,50.0,1175.0,1.0,no(M2 and SIP pres)
55.38098,1,female,0,6,106,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,6525.0,4105.5742,11.0,white,32.0,1,1,0,no,0.699999809,0.4,no dnr,6.0,92.0,10.6992188,114.0,22.0,37.09375,134.6875,3.3999023,0.19998169,0.89990234,137.0,7.299805,152.0,35.0,2502.0,0.0,adl>=4 (>=5 if sur)
62.327,1,male,0,7,75,COPD,COPD/CHF/Cirrhosis,6,8.0,under $11k,9241.0,5891.6875,14.0,white,47.0,1,0,0,yes,0.899999619,0.8,dnr after sadm,2.0,48.0,13.6992188,147.0,28.0,38.0,240.0,1.6999512,0.59997559,5.19921875,151.0,7.349609,104.0,102.0,2010.0,1.0,no(M2 and SIP pres)
59.03598,1,male,0,7,204,Lung Cancer,Cancer,2,9.0,under $11k,5416.0,4056.1523,7.5,black,36.0,1,0,0,metastatic,0.599999905,0.5,no dnr,7.0,69.0,24.0976562,129.0,22.0,38.09375,115.0,2.8999023,1.79980469,1.19995117,145.0,7.5,365.0,42.0,3327.0,4.0,SIP>=30
84.53699,1,female,0,14,79,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,under $11k,12444.0,8894.4688,9.333328,white,53.0,1,0,1,no,0.0,0.0,dnr after sadm,1.0,103.0,8.79882812,80.0,20.0,36.19531,333.3,3.5,0.39996338,1.29980469,131.0,7.419922,300.0,28.0,2502.0,7.0,adl>=4 (>=5 if sur)
44.931,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,37033.0,25186.625,46.0,hispanic,82.0,22,1,0,yes,0.699999809,0.5,no dnr,5.0,60.0,13.1992188,61.0,28.0,36.19531,195.0,2.5996094,1.09985352,0.5,134.0,7.359375,94.0,16.0,1490.0,2.0,<2 mo. follow-up
72.02496,1,female,0,49,735,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,112799.0,74849.375,34.25,white,22.0,5,0,0,yes,0.699999809,0.5,no dnr,49.0,105.0,24.5,114.0,24.0,36.39844,214.8125,4.2998047,0.69995117,0.79992676,138.0,7.429688,348.0,19.0,2300.0,2.3647461,adl>=4 (>=5 if sur)
50.461,1,female,0,10,730,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,26216.0,17106.7031,31.0,hispanic,39.0,6,1,0,no,0.699999809,0.5,no dnr,10.0,24.0,17.5,0.0,34.0,38.39844,77.0,3.0996094,0.79992676,2.0,132.0,7.359375,199.0,33.0,129.0,3.3359375,no(M2 and SIP pres)
62.724,1,female,0,14,117,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,19549.0,12885.7266,22.666656,black,54.0,1,0,0,yes,0.949999809,0.8,no dnr,14.0,71.0,13.1992188,79.0,20.0,36.79688,333.3,2.5,22.0,0.69995117,132.0,7.419922,339.0,5.0,2502.0,0.0,no(M2 and SIP pres)
30.24199,0,male,0,21,1043,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,41209.0,26259.5,39.666657,black,41.0,1,0,0,no,0.5,0.5,no dnr,21.0,70.0,7.19921875,67.0,10.0,38.89844,222.5,2.2998047,1.0,1.19995117,133.0,7.419922,115.0,10.0,3270.0,7.0,adl>=4 (>=5 if sur)
74.47797,1,female,0,24,271,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,31667.0,21269.9531,29.333328,white,54.0,1,0,0,no,0.25,0.2,dnr before sadm,0.0,147.0,63.796875,157.0,34.0,40.19531,94.0,2.3999023,1.29980469,0.59997559,134.0,7.369141,184.0,23.0,1870.0,7.0,adl>=4 (>=5 if sur)
63.56198,1,female,0,14,546,MOSF w/Malig,ARF/MOSF,1,16.0,$11-$25k,13988.0,10064.0312,12.0,white,10.0,1,0,0,metastatic,0.849999905,0.6,no dnr,14.0,61.0,19.5,118.0,29.0,38.0,206.65625,3.5996094,0.59997559,1.19995117,137.0,7.449219,89.0,18.0,560.0,6.0,SIP>=30
50.05099,1,male,1,56,56,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,120445.0,81407.6875,35.5,white,48.0,12,0,0,yes,0.75,0.6,dnr after sadm,25.0,105.0,8.09960938,122.0,30.0,36.89844,132.5,3.0,13.3984375,1.09985352,137.0,7.339844,109.0,42.0,2155.0,0.0,<2 mo. follow-up
70.60596,1,female,0,100,130,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,148396.0,98204.875,38.0,black,79.0,2,1,0,no,0.299999952,0.3,dnr after sadm,11.0,105.0,8.3984375,118.0,16.0,35.59375,273.3125,3.2998047,1.19995117,1.0,135.0,7.459961,214.0,32.0,2935.0,7.0,adl>=4 (>=5 if sur)
73.59296,1,male,1,25,25,ARF/MOSF w/Sepsis,ARF/MOSF,3,6.0,under $11k,72719.0,45524.3125,29.5,black,48.0,1,0,0,yes,0.25,0.4,no dnr,25.0,53.0,21.796875,67.0,28.0,35.5,333.3,2.199707,0.19998169,0.69995117,131.0,7.419922,80.0,12.0,750.0,0.0,<2 mo. follow-up
77.73596,1,female,1,18,18,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,29169.0,19525.7812,25.333328,black,24.0,7,0,0,yes,0.0,0.0,dnr before sadm,-1.0,83.0,9.0,76.0,18.0,36.5,333.3,3.5,1.01,1.19995117,135.0,7.419922,86.0,6.0,5050.0,5.0,<2 mo. follow-up
49.56897,1,male,1,27,27,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,50888.0,32832.5938,35.75,white,54.0,1,0,0,no,0.75,0.3,dnr after sadm,21.0,74.0,9.09960938,101.0,24.0,35.79688,333.3,4.5,1.79980469,2.0,137.0,7.419922,100.0,46.0,2502.0,1.0,<2 mo. follow-up
62.05298,0,male,0,41,1039,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,104496.0,66482.625,52.25,white,69.0,1,0,0,no,0.5,0.5,no dnr,41.0,103.0,10.6992188,68.0,14.0,36.0,247.59375,3.5996094,0.79992676,1.79980469,138.0,7.40918,122.0,35.0,4050.0,0.0,no(M2 and SIP pres)
63.51498,1,male,0,23,914,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,85938.0,57368.0938,13.666664,white,37.0,18,0,0,no,1.0,1.0,no dnr,23.0,70.0,3.33984375,150.0,22.0,36.5,303.3125,2.699707,0.69995117,2.5,133.0,7.419922,205.0,39.0,2520.0,0.0,no(M2 and SIP pres)
76.73096,1,male,0,11,157,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,11799.0,7380.9805,11.0,white,19.0,1,0,0,no,1.0,0.9,no dnr,11.0,114.0,5.5,119.0,41.0,40.29688,296.625,2.5996094,1.5,1.89990234,147.0,7.399414,216.0,27.0,4517.0,0.0,no(M2 and SIP pres)
76.62695,1,female,1,26,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,89138.0,56273.4062,33.25,white,42.0,5,0,0,no,0.599999905,0.6,dnr after sadm,23.0,55.0,36.59375,190.0,24.0,36.39844,455.5,1.3999023,0.89990234,6.29980469,125.0,7.40918,89.0,68.0,1100.0,5.0,<2 mo. follow-up
75.53699,0,male,0,43,1038,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,98295.0,64238.125,42.75,white,63.0,2,0,0,no,0.75,0.75,dnr after sadm,28.0,100.0,6.89941406,110.0,24.0,36.89844,333.3,3.7998047,0.29998779,1.0,139.0,7.419922,125.0,10.0,2520.0,0.0,adl>=4 (>=5 if sur)
36.73898,0,female,0,11,1036,CHF,COPD/CHF/Cirrhosis,1,14.0,under $11k,28019.0,17699.375,23.5,black,37.0,10,0,0,no,0.75,0.75,no dnr,11.0,47.0,0.79992676,124.0,36.0,35.79688,177.75,2.5,0.69995117,2.09960938,136.0,7.40918,99.0,54.0,1280.0,0.0,no(M2 and SIP pres)
66.71594,0,male,0,21,1037,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,52966.0,32957.3125,29.0,white,22.0,1,0,0,no,0.949999809,0.9,no dnr,21.0,130.0,20.1992188,156.0,40.0,36.09375,220.40625,2.0996094,5.09960938,1.29980469,127.0,7.389648,57.0,26.0,1525.0,1.0,no(M2 and SIP pres)
48.91699,0,female,0,6,1037,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,11941.0,7673.4336,36.0,white,23.0,1,0,0,no,0.899999619,0.95,no dnr,6.0,79.0,9.29882812,118.0,24.0,36.0,404.75,3.699707,0.59997559,2.19970703,132.0,7.489258,110.0,55.0,1645.0,1.1667481,no(M2 and SIP pres)
80.73895,0,female,0,18,1036,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,26876.0,16527.1719,20.666656,white,21.0,1,0,0,no,0.75,0.75,dnr after sadm,14.0,81.0,0.04999542,104.0,22.0,40.0,333.3,2.5,1.79980469,1.0,132.0,7.419922,254.0,13.0,4725.0,0.0,no(M2 and SIP pres)
71.01996,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,9989.0,6770.5664,22.610928270087555,white,70.0,7,0,0,metastatic,0.699999809,0.5,dnr before sadm,-1.0,70.0,13.1992188,126.0,24.0,39.39844,333.3,2.5,0.5,0.89990234,132.0,7.419922,90.0,8.0,2502.0,4.3330078,<2 mo. follow-up
30.765,1,male,0,6,832,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,19435.0,13216.4766,6.0,white,31.0,7,0,0,yes,0.979999542,0.9,no dnr,6.0,83.0,10.5996094,135.0,20.0,35.89844,476.0,3.8999023,0.39996338,1.29980469,139.0,7.399414,404.0,22.0,3800.0,2.5112305,<2 mo. follow-up
41.95999,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,27633.0,0.0,63.0,white,100.0,2,0,0,no,0.009999998,1e-06,dnr after sadm,5.0,76.0,7.89941406,124.0,24.0,36.39844,167.34375,2.3999023,6.0,3.0,133.0,7.359375,173.0,70.0,638.0,0.0,<2 mo. follow-up
79.258,1,male,0,10,37,Lung Cancer,Cancer,1,12.0,under $11k,8220.0,6202.9141,10.0,black,16.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,1.0,107.0,19.0976562,107.0,24.0,36.59375,165.28125,2.2998047,2.0,7.39941406,135.0,7.319336,242.0,80.0,790.0,5.0,<2 mo. follow-up
79.159,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,5,15.0,under $11k,16072.0,10463.8125,27.333328,black,69.0,1,1,1,no,0.5,0.1,dnr after sadm,3.0,75.0,5.29980469,104.0,40.0,38.29688,283.3125,2.5,1.0,0.79992676,143.0,7.399414,97.0,7.0,4550.0,7.0,<2 mo. follow-up
70.38495,1,male,1,4,4,Lung Cancer,Cancer,3,10.0,under $11k,4010.0,2658.7598,22.0,white,37.0,1,1,0,metastatic,0.099999964,0.0,dnr after sadm,2.0,74.0,41.3984375,107.0,8.0,37.79688,247.5,2.2998047,5.5,4.5,146.0,7.359375,233.0,147.0,1955.0,3.6289062,<2 mo. follow-up
91.86597,1,female,1,6,6,Coma,Coma,0,6.0,under $11k,9946.0,6350.8555,36.0,white,69.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,67.0,6.5,93.0,20.0,37.5,333.3,2.199707,1.19995117,3.59960938,140.0,7.419922,75.0,49.0,2502.0,1.0,<2 mo. follow-up
71.81396,1,female,0,20,845,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$11-$25k,34771.0,19316.3281,35.333313,white,55.0,1,1,0,no,0.799999714,0.6,no dnr,20.0,69.0,7.19921875,107.0,24.0,37.79688,333.3,3.5,0.39996338,0.79992676,140.0,7.419922,146.0,13.0,425.0,6.0,adl>=4 (>=5 if sur)
66.09998,1,female,1,34,34,Cirrhosis,COPD/CHF/Cirrhosis,4,10.0,under $11k,118170.0,75117.25,52.75,white,84.0,1,1,0,no,0.25,0.15,dnr after sadm,34.0,62.0,3.69970703,106.0,27.0,38.0,333.3,2.5996094,38.8984375,1.19995117,126.0,7.419922,86.0,29.0,1465.0,0.0,<2 mo. follow-up
42.31598,0,male,0,10,1030,ARF/MOSF w/Sepsis,ARF/MOSF,0,0.0,under $11k,16046.0,10801.6797,34.0,white,14.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,119.0,10.2988281,114.0,32.0,36.19531,232.625,4.0996094,0.19998169,1.09985352,138.0,7.419922,182.0,19.0,2020.0,0.0,adl>=4 (>=5 if sur)
45.05698,0,male,0,26,1027,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,48690.0,32809.0625,14.75,white,34.0,5,0,0,no,0.949999809,0.95,no dnr,26.0,99.0,25.6992188,107.0,24.0,36.39844,228.5625,2.5996094,1.19995117,0.69995117,135.0,7.399414,84.0,15.0,1200.0,0.0,no(M2 and SIP pres)
73.49194,0,male,0,6,1027,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,6658.0,3897.0918,7.0,white,35.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,71.0,18.8984375,126.0,24.0,39.0,268.0,2.7998047,1.0,1.09985352,131.0,7.579102,107.0,13.0,4010.0,4.0,no(M2 and SIP pres)
63.23599,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,101217.0,64560.5625,53.75,white,60.0,12,0,0,no,0.599999905,0.6,dnr after sadm,33.0,100.0,11.6992188,82.0,20.0,36.19531,224.0,3.699707,1.0,0.89990234,138.0,7.369141,175.0,17.0,1550.0,2.0,<2 mo. follow-up
38.59799,1,male,0,7,187,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,8412.0,5658.4922,6.5,white,26.0,1,0,0,no,0.649999619,0.5,no dnr,7.0,102.0,10.5996094,77.0,30.0,38.29688,333.3,3.0996094,1.59985352,1.09985352,139.0,7.419922,86.0,19.0,3100.0,3.1713867,no(M2 and SIP pres)
66.05597,1,male,0,12,32,MOSF w/Malig,ARF/MOSF,1,10.0,$11-$25k,11636.0,8340.9766,12.5,white,50.0,1,0,0,metastatic,0.699999809,0.6,dnr after sadm,1.0,83.0,7.59960938,123.0,28.0,38.39844,265.6875,1.6999512,1.09985352,2.5,135.0,7.429688,132.0,51.0,2523.0,6.0,<2 mo. follow-up
68.59399,1,male,0,20,758,Cirrhosis,COPD/CHF/Cirrhosis,4,7.0,under $11k,24108.0,16869.2656,13.333328,black,19.0,1,0,0,no,0.949999809,0.9,no dnr,20.0,123.0,9.69921875,70.0,20.0,35.79688,333.3,3.5,1.01,2.09960938,133.0,7.449219,116.0,41.0,1750.0,1.0,<2 mo. follow-up
78.05298,0,male,0,7,1025,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,6979.0,4518.457,7.0,white,45.0,1,0,0,no,1.0,0.9,no dnr,7.0,111.0,9.3984375,120.0,10.0,36.0,217.5,1.6999512,3.79980469,3.79980469,138.0,7.359375,80.0,55.0,435.0,5.0,adl>=4 (>=5 if sur)
67.86896,1,male,0,16,87,Lung Cancer,Cancer,4,10.0,under $11k,14776.0,10952.4766,13.0,black,23.0,1,1,0,metastatic,0.899999619,0.75,no dnr,16.0,77.0,7.89941406,110.0,24.0,36.19531,333.3,3.0,1.5,0.89990234,131.0,7.419922,220.0,11.0,1350.0,3.8549805,no(M2 and SIP pres)
65.24298,1,male,0,9,31,Lung Cancer,Cancer,6,12.0,$11-$25k,12269.0,8320.5469,7.5,white,28.0,1,0,0,metastatic,0.099999964,0.02,dnr after sadm,5.0,103.0,4.79980469,65.0,22.0,37.29688,333.3,2.8999023,0.5,3.69970703,132.0,7.419922,101.0,50.0,4700.0,1.0,<2 mo. follow-up
94.70996,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,0,4.0,under $11k,8346.0,4438.5547,29.0,black,41.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,61.0,17.296875,115.0,14.0,38.69531,180.0,2.0,11.8984375,2.29980469,157.0,7.459961,368.0,72.0,2645.0,5.0,<2 mo. follow-up
45.57999,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,>$50k,30749.0,19384.8438,70.0,white,40.0,1,0,0,no,0.949999809,0.95,dnr after sadm,9.0,121.0,22.6992188,136.0,27.0,39.0,232.5,3.199707,0.59997559,1.09985352,136.0,7.469727,128.0,10.0,2600.0,0.0,<2 mo. follow-up
63.16199,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,65833.0,42372.0938,50.0,white,65.0,8,0,0,no,0.799999714,0.7,dnr after sadm,10.0,118.0,8.09960938,64.0,12.0,38.69531,187.5,2.0,8.0,0.79992676,136.0,7.419922,79.0,12.0,4825.0,0.0,<2 mo. follow-up
66.08899,1,female,0,45,154,MOSF w/Malig,ARF/MOSF,1,11.0,$11-$25k,73540.0,50863.8125,35.0,white,37.0,5,0,0,metastatic,0.899999619,0.8,no dnr,45.0,79.0,8.29882812,110.0,24.0,35.79688,204.75,3.5996094,1.29980469,0.59997559,139.0,7.419922,262.0,8.0,2502.0,0.0,SIP>=30
65.86395,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,20931.0,10538.9219,38.0,white,51.0,4,0,0,no,0.5,0.25,no dnr,8.0,139.0,17.296875,124.0,38.0,36.0,182.84375,4.0996094,0.79992676,0.89990234,142.0,7.509766,151.0,19.0,2502.0,0.0,<2 mo. follow-up
51.96198,0,male,0,5,1019,Colon Cancer,Cancer,1,13.0,$25-$50k,13199.0,8313.1406,17.0,white,10.0,1,0,0,metastatic,0.849999905,0.85,no dnr,5.0,72.0,5.89941406,65.0,28.0,35.39844,333.3,3.3999023,1.0,1.39990234,137.0,7.5,95.0,29.0,600.0,0.0,no(M2 and SIP pres)
78.71295,1,female,0,14,61,Lung Cancer,Cancer,4,12.0,under $11k,10003.0,7692.2266,7.0,white,34.0,1,0,0,metastatic,0.5,0.1,dnr before sadm,-1.0,72.0,13.7988281,110.0,32.0,38.09375,304.0,3.5,0.19998169,7.0,173.0,7.339844,98.0,148.0,525.0,0.494751,<2 mo. follow-up
77.87,1,female,0,34,232,ARF/MOSF w/Sepsis,ARF/MOSF,1,0.0,under $11k,59632.0,37024.9688,33.25,black,52.0,3,0,0,no,0.049999982,0.000125,no dnr,34.0,72.0,22.5,167.0,12.0,37.09375,336.625,1.8999023,5.09960938,1.39990234,118.0,7.489258,219.0,57.0,842.0,0.0,adl>=4 (>=5 if sur)
56.86499,1,male,1,13,13,Coma,Coma,2,16.0,$25-$50k,30854.0,16650.0625,28.5,black,67.0,4,1,0,no,0.049999982,0.03,dnr after sadm,11.0,61.0,6.79980469,94.0,8.0,36.5,336.625,2.3999023,0.5,0.79992676,137.0,7.469727,160.0,15.0,1855.0,1.0,<2 mo. follow-up
23.68799,0,male,0,7,1018,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,32150.0,21773.7969,5.5,black,24.0,9,0,0,no,0.699999809,0.5,no dnr,7.0,68.0,11.0996094,103.0,36.0,36.19531,293.3125,2.2998047,3.69970703,1.29980469,136.0,7.429688,277.0,23.0,2470.0,2.9472656,<2 mo. follow-up
48.98798,1,female,0,21,501,MOSF w/Malig,ARF/MOSF,2,11.0,$25-$50k,41310.0,27047.2812,37.666657,white,48.0,2,0,0,metastatic,0.5,0.5,no dnr,21.0,123.0,23.0,136.0,26.0,36.39844,310.0,2.699707,1.0,3.29980469,142.0,7.459961,230.0,54.0,1546.0,2.0,no(M2 and SIP pres)
19.70999,1,male,0,26,303,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,62643.0,40415.6875,25.5,black,38.0,4,0,0,no,0.5,0.4,no dnr,26.0,57.0,5.0,129.0,12.0,39.39844,108.32812,2.5,2.29980469,0.79992676,131.0,7.459961,91.0,6.0,3275.0,7.0,<2 mo. follow-up
62.75198,0,female,0,38,1016,Coma,Coma,0,12.0,under $11k,75458.0,48957.2188,30.0,white,25.0,1,0,0,no,0.799999714,0.8,no dnr,38.0,50.0,7.09960938,50.0,10.0,34.09375,380.9375,2.5,0.5,1.5,150.0,7.399414,47.0,33.0,2535.0,0.0,no(M2 and SIP pres)
56.71698,1,male,0,52,437,Coma,Coma,1,12.0,under $11k,71283.0,46700.2812,30.5,white,38.0,1,0,0,no,0.199999928,0.1,dnr after sadm,28.0,96.0,1.19995117,69.0,20.0,36.29688,333.3,3.2998047,0.29998779,0.89990234,142.0,7.419922,170.0,10.0,2750.0,3.0610352,<2 mo. follow-up
59.79498,0,female,0,6,1012,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,5397.0,3738.9668,12.0,white,20.0,1,0,0,yes,0.949999809,0.95,no dnr,6.0,71.0,0.29998779,114.0,20.0,36.89844,333.3,3.7998047,1.0,1.69995117,133.0,7.419922,188.0,21.0,2575.0,4.0,no(M2 and SIP pres)
85.284,1,female,0,11,42,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,16843.0,10260.3906,21.0,white,47.0,1,0,0,yes,0.899999619,0.75,dnr after sadm,8.0,73.0,40.6953125,77.0,38.0,35.69531,104.0,2.0,0.59997559,2.69970703,141.0,7.5,152.0,59.0,319.0,1.0,<2 mo. follow-up
77.85596,1,female,1,7,7,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,6140.0,4446.1875,23.0,black,19.0,1,0,0,metastatic,0.699999809,0.6,dnr after sadm,7.0,64.0,12.2988281,120.0,37.0,39.09375,160.0,2.5,0.69995117,1.59985352,132.0,7.429688,114.0,22.0,1810.0,0.0,<2 mo. follow-up
67.08295,0,male,0,48,1009,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,88688.0,58003.0625,38.75,white,23.0,1,1,0,no,0.75,0.75,no dnr,48.0,117.0,9.3984375,77.0,36.0,36.39844,333.3,3.5,1.01,0.79992676,126.0,7.419922,112.0,16.0,1850.0,1.0,no(M2 and SIP pres)
67.836,0,male,0,16,1008,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,31353.0,21080.125,22.666656,white,38.0,4,0,0,no,0.949999809,0.9,no dnr,16.0,74.0,17.296875,65.0,36.0,37.69531,108.32812,2.3999023,9.69921875,1.29980469,129.0,7.469727,74.0,32.0,2419.0,0.0,SIP>=30
78.05597,1,female,0,45,195,ARF/MOSF w/Sepsis,ARF/MOSF,2,5.0,under $11k,100750.0,63637.6562,36.75,black,36.0,1,0,0,no,0.5,0.4,no dnr,45.0,69.0,9.5,189.0,10.0,38.5,146.0,1.3999023,2.0,1.79980469,147.0,7.599609,208.0,37.0,2517.0,4.0,adl>=4 (>=5 if sur)
71.95599,0,female,0,13,1008,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,9569.0,7085.5625,9.0,white,36.0,1,1,0,yes,0.899999619,0.8,no dnr,13.0,113.0,12.5996094,63.0,36.0,35.89844,286.625,2.3999023,2.59960938,1.29980469,136.0,7.40918,152.0,29.0,2150.0,0.0,no(M2 and SIP pres)
65.88599,1,female,1,18,18,MOSF w/Malig,ARF/MOSF,1,9.0,under $11k,59995.78781114967,14452.7344,35.333313,black,70.0,2,0,0,metastatic,0.299999952,0.1,no dnr,14.58258953168044,77.0,14.0,104.0,20.0,36.09375,203.3125,4.1992188,0.39996338,1.09985352,142.0,7.449219,145.0,21.0,3090.0,0.0,<2 mo. follow-up
57.13898,1,female,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,124947.0,80193.3125,49.25,white,73.0,6,1,0,no,0.5,0.5,no dnr,35.0,120.0,16.0,48.0,10.0,35.29688,188.0,1.8999023,0.69995117,0.69995117,134.0,7.509766,138.0,17.0,2713.0,6.0,<2 mo. follow-up
67.68195,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,54893.0,33656.0312,48.0,black,79.0,6,1,0,no,0.5,0.5,dnr after sadm,8.0,53.0,17.0,120.0,26.0,38.79688,230.0,2.5996094,5.39941406,1.59985352,155.0,7.449219,143.0,46.0,2690.0,0.0,<2 mo. follow-up
63.814,1,male,0,6,92,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,19911.0,12975.0781,34.0,white,39.0,4,1,0,no,0.949999809,0.9,no dnr,6.0,134.0,8.29882812,129.0,8.0,38.0,193.3125,2.7998047,1.69995117,0.89990234,147.0,7.5,62.0,11.0,7220.0,0.0,<2 mo. follow-up
87.29095,1,female,0,11,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19740.0,12731.9453,21.5,white,35.0,1,0,1,no,0.399999857,0.35,dnr after sadm,4.0,74.0,10.5996094,116.0,16.0,36.19531,428.0,3.7998047,1.0,1.39990234,141.0,7.479492,74.0,23.0,4760.0,4.0,<2 mo. follow-up
67.29895,1,male,0,54,706,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,173938.0,115405.938,46.0,white,48.0,29,0,0,no,0.849999905,0.75,no dnr,54.0,130.0,10.8984375,71.0,32.0,38.0,202.5,3.0,0.69995117,1.39990234,143.0,7.469727,162.0,10.0,1305.0,2.0,no(M2 and SIP pres)
53.88898,0,female,0,28,1002,Coma,Coma,2,12.0,under $11k,46212.0,31023.3125,26.75,white,53.0,1,1,0,metastatic,0.099999964,0.05,dnr after sadm,8.0,116.0,10.5,72.0,8.0,36.59375,195.0,2.699707,1.19995117,1.29980469,139.0,7.389648,137.0,22.0,1760.0,6.0,SIP>=30
51.43298,0,female,0,6,1002,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,8304.0,4943.8906,21.0,black,22.0,1,0,0,no,1.0,1.0,no dnr,6.0,31.0,18.5976562,63.0,36.0,36.29688,122.5,2.199707,2.0,0.89990234,138.0,7.459961,107.0,20.0,2030.0,0.0,no(M2 and SIP pres)
74.47498,1,male,0,3,265,Lung Cancer,Cancer,1,12.0,$11-$25k,2994.0,2017.0703,22.610928270087555,white,20.0,1,0,0,metastatic,0.799999714,0.6,no dnr,3.0,69.0,42.59375,101.0,24.0,37.89844,333.3,4.0996094,1.39990234,1.5,128.0,7.419922,99.0,30.0,2200.0,0.0,no(M2 and SIP pres)
51.41699,0,female,0,10,1000,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,15681.0,10553.5234,19.5,black,42.0,1,0,0,no,0.949999809,0.85,no dnr,10.0,56.0,17.0,129.0,24.0,38.19531,72.0,2.5,5.5,5.0,146.0,7.289062,37.0,40.0,207.0,0.0,no(M2 and SIP pres)
63.258,0,male,0,5,1000,COPD,COPD/CHF/Cirrhosis,5,11.0,under $11k,8534.0,4432.4023,19.0,white,32.0,1,1,0,no,0.75,0.75,no dnr,5.0,68.0,4.79980469,71.0,24.0,36.39844,240.0,3.2998047,0.5,0.89990234,137.0,7.349609,97.0,12.0,2502.0,0.0,no(M2 and SIP pres)
66.00098,0,male,0,4,1000,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,12022.0,6259.5586,8.0,black,4.0,4,0,0,no,0.989999771,0.95,no dnr,4.0,75.0,28.796875,96.0,24.0,35.39844,77.54688,1.7998047,0.69995117,4.79980469,145.0,7.449219,322.0,158.0,1430.0,0.0,no(M2 and SIP pres)
56.88397,1,male,0,7,24,Lung Cancer,Cancer,1,14.0,>$50k,4245.0,3281.3887,4.0,white,39.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,2.0,85.0,3.59960938,135.0,30.0,35.59375,112.23438,2.5,0.19998169,1.19995117,147.0,7.229492,180.0,27.0,1300.0,0.0,<2 mo. follow-up
51.55399,0,female,0,27,998,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,31701.0,21109.5625,12.5,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,27.0,147.0,16.1992188,153.0,28.0,38.0,93.32812,4.5996094,1.29980469,1.89990234,129.0,7.5,254.0,33.0,1495.0,0.494751,no(M2 and SIP pres)
77.96594,1,female,1,11,11,Coma,Coma,0,12.0,under $11k,53921.0,36673.3438,31.0,white,20.0,21,0,0,no,0.099999964,0.0,dnr after sadm,6.0,67.0,11.0996094,147.0,38.0,38.19531,180.0,2.0996094,0.59997559,1.39990234,134.0,7.40918,278.0,28.0,1310.0,1.0,<2 mo. follow-up
41.405,0,male,0,14,998,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,11648.0,8647.1719,5.666664,white,18.0,1,0,0,no,1.0,1.0,no dnr,14.0,47.0,18.3984375,150.0,34.0,39.5,306.0,1.3999023,2.19970703,1.5,146.0,7.379883,373.0,42.0,2545.0,2.0,no(M2 and SIP pres)
59.41699,0,male,0,6,997,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,3689.0,2812.7773,4.0,hispanic,13.0,1,1,0,no,0.949999809,0.85,no dnr,6.0,135.0,19.8984375,111.0,7.0,38.39844,340.0,3.2998047,0.89990234,0.79992676,136.0,7.449219,138.0,5.0,3625.0,3.1831055,SIP>=30
78.76196,1,female,0,13,164,Coma,Coma,4,8.0,under $11k,34205.0,18992.0469,21.0,white,41.0,8,1,0,no,0.599999905,0.5,no dnr,13.0,60.0,12.5,124.0,32.0,38.69531,245.6875,3.5,1.01,0.89990234,137.0,7.429688,164.0,20.0,1800.0,0.0,adl>=4 (>=5 if sur)
70.04199,1,female,0,17,92,MOSF w/Malig,ARF/MOSF,4,8.0,under $11k,30676.0,21929.1094,17.0,white,53.0,11,0,0,metastatic,0.099999964,0.0,dnr before sadm,-9.0,77.0,9.79882812,70.0,12.0,36.19531,404.75,4.0,0.5,1.79980469,140.0,7.549805,83.0,22.0,900.0,0.0,adl>=4 (>=5 if sur)
57.366,1,female,0,10,156,Lung Cancer,Cancer,1,11.0,$11-$25k,10310.0,7487.3047,11.0,black,5.0,1,0,0,metastatic,0.799999714,0.5,no dnr,10.0,143.0,26.3984375,118.0,30.0,37.0,278.0,2.3999023,1.19995117,1.89990234,154.0,7.429688,256.0,47.0,3655.0,0.494751,<2 mo. follow-up
70.69098,1,male,1,24,24,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,29236.0,20551.6562,26.0,white,35.0,4,0,0,metastatic,0.5,0.2,dnr after sadm,6.0,71.0,5.0,108.0,20.0,37.5,333.3,2.699707,2.39990234,1.29980469,132.0,7.419922,134.0,35.0,2502.0,0.0,<2 mo. follow-up
70.17395,0,female,0,4,996,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,3382.0,2383.6094,5.0,white,33.0,1,1,0,no,0.799999714,0.8,no dnr,4.0,67.0,2.69970703,100.0,28.0,36.59375,371.375,3.5,0.89990234,2.0,147.0,7.489258,254.0,78.0,2375.0,0.494751,no(M2 and SIP pres)
37.71899,0,male,0,4,994,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,4348.0,2924.3496,7.0,black,22.0,1,0,0,no,0.949999809,0.85,no dnr,4.0,114.0,5.59960938,79.0,20.0,36.5,333.3,2.5996094,5.09960938,1.0,133.0,7.419922,112.0,7.0,2502.0,1.0,no(M2 and SIP pres)
29.33099,1,female,1,36,36,MOSF w/Malig,ARF/MOSF,2,15.0,under $11k,94641.0,60107.875,49.75,white,50.0,3,0,0,yes,0.5,0.5,no dnr,36.0,64.0,11.0996094,110.0,28.0,36.69531,209.5,4.0996094,0.59997559,1.09985352,142.0,7.389648,176.0,22.0,1500.0,2.0,<2 mo. follow-up
63.10199,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,101785.0,14452.7344,54.666657,hispanic,56.0,4,0,0,no,0.5,0.5,dnr after sadm,18.0,107.0,11.0996094,107.0,28.0,35.39844,333.3,3.2998047,0.29998779,1.19995117,147.0,7.419922,161.0,7.0,1200.0,0.0,<2 mo. follow-up
47.97299,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,34317.0,21957.0469,50.0,white,95.0,6,0,0,no,0.0,0.0,dnr after sadm,3.0,68.0,11.0996094,77.0,22.0,36.0,333.3,4.0996094,1.0,1.19995117,122.0,7.419922,1051.0,22.0,1450.0,0.0,<2 mo. follow-up
63.10199,1,male,1,8,8,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,45091.0,24652.875,63.0,white,62.0,3,1,0,no,0.049999982,0.0,no dnr,8.0,97.0,4.29980469,50.0,16.0,35.79688,238.09375,3.0996094,0.29998779,2.5,146.0,7.289062,64.0,71.0,1535.0,0.0,<2 mo. follow-up
67.64697,1,female,0,22,234,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,39043.0,25974.0781,40.0,white,44.0,5,1,0,yes,0.799999714,0.7,no dnr,22.0,100.0,11.0996094,151.0,11.0,39.0,80.0,2.0,0.5,0.59997559,147.0,7.40918,77.0,7.0,2000.0,1.0,<2 mo. follow-up
91.69598,0,male,0,15,989,COPD,COPD/CHF/Cirrhosis,1,1.0,under $11k,29155.0,19497.1406,12.333328,black,19.0,15,0,0,no,0.699999809,0.5,dnr after sadm,1.0,61.0,24.3984375,99.0,10.0,38.29688,148.3125,2.0996094,40.09375,0.89990234,158.0,7.419922,135.0,54.0,433.0,2.0,adl>=4 (>=5 if sur)
68.24597,1,male,1,18,18,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,23307.0,16309.6172,16.333328,white,48.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,7.0,63.0,30.0976562,118.0,22.0,37.29688,310.0,1.1999512,0.5,0.5,127.0,7.429688,115.0,8.0,1980.0,3.0,<2 mo. follow-up
43.754,1,female,1,4,4,Lung Cancer,Cancer,1,2.0,under $11k,3065.0,2168.3652,14.0,black,67.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,47.0,15.0996094,150.0,30.0,36.59375,177.53125,2.8999023,2.79980469,1.29980469,154.0,7.369141,192.0,36.0,1670.0,5.0,<2 mo. follow-up
54.08398,1,female,1,23,23,Coma,Coma,0,18.0,$25-$50k,43798.0,28933.9219,29.666656,white,25.0,1,0,0,no,0.599999905,0.5,dnr after sadm,12.0,76.0,8.29882812,70.0,20.0,35.89844,333.3,3.699707,0.39996338,1.09985352,139.0,7.419922,98.0,11.0,3850.0,0.0,<2 mo. follow-up
74.02899,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,45086.0,28275.7812,42.0,white,62.0,1,1,0,no,0.799999714,0.5,no dnr,16.0,59.0,18.0976562,77.0,28.0,36.09375,333.3,3.8999023,0.59997559,0.69995117,141.0,7.419922,115.0,4.0,590.0,0.0,<2 mo. follow-up
52.93399,0,male,0,7,986,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,7492.0,5008.3906,8.5,white,36.0,1,1,0,no,0.799999714,0.75,no dnr,7.0,61.0,18.3984375,124.0,9.0,36.69531,133.3125,3.0,1.89990234,8.8984375,154.0,7.479492,165.0,111.0,744.0,3.0,no(M2 and SIP pres)
69.74896,0,female,0,13,988,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,17451.0,11142.8672,21.0,white,23.0,1,0,0,no,0.5,0.3,dnr after sadm,2.0,120.0,27.6992188,106.0,40.0,38.09375,333.3,3.2998047,1.19995117,10.2988281,135.0,7.389648,254.0,83.0,0.0,5.0,adl>=4 (>=5 if sur)
78.17896,1,female,1,46,46,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,118516.0,75014.6875,53.25,white,89.0,1,1,0,no,0.199999928,0.05,dnr after sadm,16.0,45.0,18.296875,100.0,20.0,37.59375,300.0,3.5,1.01,0.89990234,138.0,7.399414,100.0,15.0,1355.0,7.0,<2 mo. follow-up
45.862,0,male,0,25,985,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,64846.0,42125.4688,36.5,white,40.0,4,0,0,no,0.5,0.5,no dnr,25.0,60.0,4.39941406,113.0,14.0,36.69531,88.875,1.8999023,0.39996338,0.59997559,135.0,7.459961,388.0,10.0,5840.0,2.7524414,<2 mo. follow-up
68.77795,1,male,0,18,34,Cirrhosis,COPD/CHF/Cirrhosis,4,11.0,under $11k,16177.0,11637.75,12.666664,white,26.0,1,0,0,no,0.049999982,0.02,dnr after sadm,2.0,64.0,6.29980469,120.0,42.0,39.09375,257.125,2.699707,0.89990234,0.29998779,132.0,7.55957,135.0,2.0,2415.0,5.0,<2 mo. follow-up
49.41498,1,male,1,146,146,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,380612.0,250155.0,51.25,white,65.0,8,0,0,no,0.699999809,0.9,dnr after sadm,145.0,116.0,10.0996094,74.0,12.0,40.0,330.0,3.0,0.69995117,1.09985352,131.0,7.479492,117.0,13.0,2240.0,2.0,adl>=4 (>=5 if sur)
33.19897,0,male,0,8,984,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,$11-$25k,12548.0,8606.9453,16.5,hispanic,52.0,1,1,0,no,0.5,0.5,no dnr,8.0,128.0,19.0,116.0,40.0,37.69531,206.65625,2.5996094,0.69995117,0.59997559,142.0,7.439453,192.0,22.0,2370.0,4.0,SIP>=30
61.314,1,female,0,5,47,Lung Cancer,Cancer,3,9.0,under $11k,4206.0,3020.4023,8.0,white,18.0,1,0,0,metastatic,0.299999952,0.0,dnr after sadm,2.0,109.0,9.09960938,78.0,24.0,37.09375,216.0,3.699707,0.5,0.89990234,141.0,7.369141,146.0,30.0,2502.0,0.494751,<2 mo. follow-up
53.71399,1,female,0,7,80,Lung Cancer,Cancer,3,7.0,under $11k,6541.0,4582.8438,3.5,white,18.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,1.0,68.0,22.1992188,65.0,12.0,35.59375,158.0,3.5996094,0.5,3.89990234,136.0,7.329102,210.0,148.0,1325.0,5.0,SIP>=30
57.383,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,80893.0,51551.375,40.5,white,46.0,8,0,0,no,0.099999964,0.05,dnr after sadm,9.0,63.0,9.0,60.0,24.0,36.0,292.5625,3.7998047,0.79992676,1.29980469,142.0,7.429688,103.0,29.0,2502.0,4.0,<2 mo. follow-up
66.88599,0,female,0,7,982,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,11154.0,7366.8008,21.5,white,19.0,1,1,0,no,1.0,0.95,no dnr,7.0,64.0,6.09960938,75.0,9.0,37.79688,280.0,3.199707,1.09985352,1.39990234,137.0,7.489258,168.0,30.0,1698.0,0.0,<2 mo. follow-up
78.00098,1,male,0,10,248,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,15832.0,9529.125,13.5,white,32.0,1,0,0,no,0.899999619,0.95,no dnr,10.0,69.0,13.0,126.0,28.0,37.79688,151.0,2.199707,0.5,0.89990234,146.0,7.489258,95.0,13.0,1315.0,1.0,<2 mo. follow-up
79.02295,1,male,0,24,26,MOSF w/Malig,ARF/MOSF,4,12.0,$11-$25k,35428.0,24418.9062,32.333313,white,52.0,7,0,0,yes,0.149999976,0.0,dnr before sadm,-5.0,63.0,9.3984375,116.0,10.0,38.19531,125.0,3.699707,1.0,0.69995117,147.0,7.419922,147.0,20.0,760.0,5.0,<2 mo. follow-up
40.961,0,female,0,43,978,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,93065.0,60890.4062,41.5,white,56.0,1,0,0,no,0.599999905,0.6,no dnr,43.0,131.0,8.8984375,77.0,22.0,36.29688,163.25,2.8999023,0.39996338,5.39941406,135.0,7.359375,374.0,82.0,2250.0,0.0,no(M2 and SIP pres)
55.96198,1,female,0,5,386,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,3799.0,2804.1816,10.0,white,25.0,1,1,0,no,0.799999714,0.7,no dnr,5.0,120.0,0.79992676,119.0,40.0,35.39844,333.3,3.5,1.01,1.5,142.0,7.419922,314.0,23.0,605.0,3.0,no(M2 and SIP pres)
80.46295,0,female,0,18,978,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,30255.0,16452.5,24.666656,white,39.0,1,0,1,no,0.949999809,0.95,no dnr,18.0,58.0,23.296875,111.0,10.0,40.59375,337.125,3.0,0.79992676,9.09960938,134.0,7.259766,229.0,104.0,0.0,1.0,no(M2 and SIP pres)
26.14099,0,male,0,21,978,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,39642.0,25904.9375,33.666657,black,57.0,2,0,0,no,0.799999714,0.75,no dnr,21.0,64.0,12.7988281,147.0,22.0,39.09375,140.0,3.0996094,3.29980469,8.0,154.0,7.459961,287.0,70.0,374.0,0.0,no(M2 and SIP pres)
62.56799,1,male,0,3,364,Lung Cancer,Cancer,2,7.0,$11-$25k,4076.0,2655.3203,22.610928270087555,white,11.0,1,0,0,metastatic,0.899999619,0.8,no dnr,3.0,70.0,15.1992188,73.0,22.0,36.19531,183.3125,2.3999023,6.59960938,1.0,139.0,7.55957,287.0,14.0,1235.0,0.0,no(M2 and SIP pres)
61.50299,1,female,0,12,28,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,11624.0,7809.5,22.5,white,28.0,1,0,0,no,0.399999857,0.2,no dnr,12.0,64.0,12.0,118.0,36.0,39.59375,212.0,2.5,0.59997559,0.89990234,141.0,7.449219,121.0,13.0,1950.0,1.0,<2 mo. follow-up
55.55099,1,male,0,8,21,Lung Cancer,Cancer,2,12.0,under $11k,10439.0,7119.3398,14.5,white,18.0,2,0,0,metastatic,0.5,0.0,dnr after sadm,2.0,45.0,10.0,107.0,36.0,38.79688,250.0,1.8999023,1.09985352,0.79992676,141.0,7.399414,125.0,11.0,1975.0,1.0,<2 mo. follow-up
49.47598,0,female,0,4,972,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,3747.0,2515.7344,14.0,white,10.0,1,0,0,no,1.0,1.0,no dnr,4.0,124.0,14.5,113.0,38.0,38.39844,214.0,2.699707,0.5,2.0,141.0,7.449219,329.0,21.0,3580.0,0.494751,<2 mo. follow-up
60.28998,1,male,0,17,305,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,22398.0,15733.2578,25.333328,white,30.0,2,0,0,metastatic,0.75,0.6,no dnr,17.0,121.0,20.5,112.0,26.0,36.89844,409.5,3.5,1.01,0.89990234,138.0,7.459961,100.0,9.0,2502.0,2.0,<2 mo. follow-up
87.50995,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,34901.0,22252.25,22.333328,white,40.0,4,0,0,no,0.049999982,0.0,dnr after sadm,3.0,120.0,7.09960938,104.0,20.0,36.69531,333.3,3.5,0.59997559,1.79980469,136.0,7.419922,85.0,18.0,5050.0,0.0,<2 mo. follow-up
44.94199,1,male,0,35,259,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,57429.0,39990.0938,26.5,white,55.0,8,1,0,no,0.849999905,0.85,no dnr,35.0,137.0,8.69921875,57.0,11.0,36.09375,176.1875,3.5,0.59997559,1.29980469,138.0,7.399414,99.0,34.0,2400.0,1.0,SIP>=30
71.37897,1,male,0,11,220,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,61449.0,41978.9062,22.5,white,30.0,32,0,0,yes,0.75,0.6,no dnr,11.0,68.0,18.3984375,99.0,28.0,36.29688,216.0,3.7998047,0.39996338,0.79992676,136.0,7.419922,272.0,19.0,1400.0,0.0,no(M2 and SIP pres)
72.06,1,male,0,5,597,ARF/MOSF w/Sepsis,ARF/MOSF,5,14.0,$25-$50k,6993.0,3622.8027,10.0,white,44.0,1,1,0,no,1.0,1.0,no dnr,5.0,99.0,9.0,93.0,16.0,36.59375,333.3,3.2998047,0.89990234,1.39990234,139.0,7.419922,103.0,18.0,2502.0,0.0,no(M2 and SIP pres)
83.75098,0,female,0,70,969,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,181987.0,103046.062,43.75,white,32.0,4,0,0,no,0.399999857,0.3,no dnr,70.0,105.0,37.59375,112.0,28.0,34.69531,333.3,2.2998047,0.29998779,1.19995117,139.0,7.419922,78.0,12.0,3650.0,0.0,<2 mo. follow-up
70.883,1,female,1,65,65,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,118401.0,76483.0,39.0,white,36.0,1,0,0,no,0.699999809,0.6,dnr after sadm,64.0,107.0,11.8984375,110.0,26.0,36.39844,196.0,3.5,1.01,0.79992676,143.0,7.449219,124.0,15.0,1225.0,6.0,<2 mo. follow-up
29.599,0,female,0,8,969,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,11390.0,7259.5664,21.0,white,30.0,1,0,0,no,0.799999714,0.8,no dnr,8.0,63.0,6.29980469,104.0,10.0,36.39844,312.5,2.0996094,1.19995117,0.79992676,141.0,7.429688,206.0,6.0,3525.0,7.0,adl>=4 (>=5 if sur)
65.12299,1,female,0,13,70,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,14012.0,8812.9766,16.0,white,23.0,1,1,0,no,0.5,0.5,no dnr,13.0,97.0,45.6953125,96.0,22.0,36.29688,333.3,2.0996094,1.69995117,0.69995117,131.0,7.419922,76.0,7.0,2502.0,0.0,no(M2 and SIP pres)
57.681,1,male,0,8,34,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,5691.0,4221.4297,3.5,black,15.0,1,1,0,metastatic,0.599999905,0.4,no dnr,8.0,110.0,7.0,96.0,20.0,36.19531,333.3,4.0996094,1.09985352,1.5,137.0,7.419922,71.0,16.0,2300.0,0.494751,<2 mo. follow-up
44.94699,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,9729.0,6151.3398,60.0,white,36.0,1,0,0,no,0.0,0.0,no dnr,4.0,134.0,3.69970703,69.0,28.0,36.59375,130.0,2.7998047,0.79992676,0.69995117,133.0,7.419922,246.0,17.0,2475.0,2.6704102,<2 mo. follow-up
82.12695,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,49945.0,31731.4219,31.333328,white,51.0,5,0,0,yes,0.799999714,0.7,dnr after sadm,1.0,52.0,0.32995606,118.0,16.0,37.59375,333.3,3.5,1.01,0.79992676,130.0,7.419922,108.0,6.0,800.0,0.0,<2 mo. follow-up
53.63397,0,male,0,29,965,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,53136.0,35150.0625,24.0,black,37.0,1,0,0,no,0.5,0.5,no dnr,29.0,88.0,9.0,79.0,24.0,36.89844,333.3,3.3999023,0.29998779,0.89990234,136.0,7.419922,112.0,9.0,3000.0,0.0,no(M2 and SIP pres)
72.80499,1,female,0,15,66,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,13106.0,9451.4375,25.666656,white,46.0,1,0,0,metastatic,0.5,0.4,dnr before sadm,-1.0,77.0,19.796875,83.0,22.0,36.19531,153.03125,3.5,1.01,2.0,127.0,7.519531,119.0,39.0,1300.0,2.0,<2 mo. follow-up
67.08295,1,female,0,7,233,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,6727.0,4673.5195,8.5,black,9.0,1,1,1,no,0.799999714,0.8,no dnr,7.0,126.0,9.0,70.0,26.0,36.0,276.0,3.7998047,0.5,1.09985352,134.0,7.479492,338.0,15.0,1300.0,6.0,SIP>=30
53.48898,1,female,1,5,5,Coma,Coma,0,10.0,$11-$25k,20101.0,12916.0781,47.0,white,24.0,4,0,0,no,0.099999964,0.0,dnr after sadm,1.0,115.0,5.09960938,64.0,20.0,36.69531,333.3,2.8999023,3.0,0.89990234,136.0,7.419922,88.0,8.0,600.0,0.0,<2 mo. follow-up
67.25494,0,male,0,8,960,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,15122.0,9767.0078,18.5,white,24.0,4,0,0,no,0.899999619,0.8,no dnr,8.0,107.0,19.6992188,122.0,11.0,36.0,320.0,1.8999023,0.39996338,1.89990234,126.0,7.439453,84.0,52.0,518.0,0.0,no(M2 and SIP pres)
40.50897,1,male,0,41,69,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,$25-$50k,104936.0,69373.4375,29.75,white,70.0,2,0,0,no,0.5,0.5,no dnr,41.0,143.0,6.89941406,130.0,10.0,38.29688,95.70312,2.199707,3.39990234,1.5,134.0,7.419922,145.0,20.0,2350.0,0.0,<2 mo. follow-up
59.49298,0,male,0,5,960,COPD,COPD/CHF/Cirrhosis,4,7.0,under $11k,5043.0,2951.9746,14.0,hispanic,13.0,1,0,0,no,0.699999809,1.0,no dnr,5.0,30.0,43.3984375,40.0,12.0,37.89844,126.65625,2.199707,5.19921875,8.3984375,132.0,7.319336,112.0,92.0,0.0,0.0,no(M2 and SIP pres)
37.25897,0,male,0,5,958,CHF,COPD/CHF/Cirrhosis,1,9.0,under $11k,5429.0,3599.8047,19.0,white,18.0,1,0,0,no,0.849999905,0.7,no dnr,5.0,59.0,6.89941406,118.0,10.0,38.39844,110.0,3.0,1.5,2.09960938,134.0,7.479492,516.0,38.0,1989.0,1.0,<2 mo. follow-up
54.60098,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,4,9.0,under $11k,76945.0,47713.375,48.5,white,60.0,14,0,0,no,0.009999998,0.01,dnr after sadm,2.0,118.0,14.0,120.0,32.0,36.59375,330.0,2.8999023,0.69995117,4.5,132.0,7.449219,245.0,74.0,5045.0,6.0,<2 mo. follow-up
59.84698,0,female,0,3,956,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,3144.0,1688.7353,22.610928270087555,white,14.0,1,0,0,no,0.799999714,0.8,no dnr,3.0,110.0,9.0,100.0,28.0,35.5,207.40625,3.5,1.01,1.01,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.47595,1,female,1,34,34,Coma,Coma,1,12.0,$11-$25k,130061.0,82382.125,42.25,black,55.0,30,1,0,no,0.5,0.4,no dnr,34.0,65.0,2.19970703,114.0,20.0,38.29688,333.3,2.5996094,3.79980469,2.0,133.0,7.419922,114.0,63.0,2502.0,5.0,<2 mo. follow-up
27.51299,1,female,1,13,13,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,42951.0,26061.1094,43.5,white,72.0,2,0,0,yes,0.299999952,0.2,dnr after sadm,13.0,63.0,45.5,128.0,30.0,32.89844,333.3,2.7998047,0.89990234,0.5,128.0,7.419922,88.0,8.0,300.0,2.2954102,<2 mo. follow-up
66.12695,0,male,0,9,951,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$11-$25k,16249.0,9609.2031,22.5,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,140.0,21.6992188,70.0,28.0,37.59375,262.5,3.8999023,0.69995117,0.79992676,142.0,7.489258,152.0,12.0,2900.0,0.0,no(M2 and SIP pres)
51.07999,0,male,0,100,951,Coma,Coma,0,12.0,under $11k,199885.0,133230.0,45.25,white,28.0,3,0,0,no,0.989999771,0.99,dnr after sadm,82.0,51.0,27.5976562,150.0,7.0,39.19531,203.3125,2.199707,0.89990234,1.29980469,147.0,7.15918,92.0,76.0,2320.0,0.0,adl>=4 (>=5 if sur)
63.58398,0,male,0,4,952,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,3756.0,2421.0879,7.0,white,33.0,1,0,0,no,0.949999809,0.75,no dnr,4.0,113.0,17.5976562,72.0,24.0,36.19531,284.0,2.699707,0.59997559,2.59960938,127.0,7.449219,551.0,99.0,2502.0,1.0,no(M2 and SIP pres)
64.38898,1,female,1,6,6,Coma,Coma,0,16.0,>$50k,14148.0,9069.4766,44.0,white,15.0,1,0,0,no,0.949999809,0.7,dnr after sadm,6.0,100.0,7.0,130.0,24.0,37.39844,207.125,3.0,1.79980469,0.69995117,141.0,7.369141,227.0,9.0,2875.0,2.2138672,<2 mo. follow-up
74.086,0,male,0,13,948,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,12917.0,9056.0156,15.0,white,39.0,1,0,0,no,0.5,0.125,no dnr,13.0,39.0,36.796875,180.0,36.0,36.59375,148.0,2.5,0.29998779,0.59997559,133.0,7.399414,305.0,27.0,1006.0,4.0,no(M2 and SIP pres)
30.37599,0,male,0,4,946,Cirrhosis,COPD/CHF/Cirrhosis,2,9.0,under $11k,2946.0,2133.3555,10.0,white,18.0,1,0,0,no,1.0,0.95,no dnr,4.0,60.0,15.8984375,132.0,10.0,38.79688,116.0,2.0996094,3.19970703,0.79992676,134.0,7.369141,112.0,13.0,3050.0,1.1667481,no(M2 and SIP pres)
52.16998,0,male,0,5,946,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,6341.0,3915.8477,19.0,white,29.0,1,0,0,no,0.899999619,0.75,no dnr,5.0,70.0,6.5,98.0,22.0,37.79688,196.65625,2.199707,1.89990234,1.59985352,138.0,7.429688,100.0,25.0,2502.0,0.494751,no(M2 and SIP pres)
74.76495,0,male,0,18,946,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,39087.0,21207.2188,21.333328,white,29.0,1,1,0,no,1.0,1.0,no dnr,18.0,100.0,4.29980469,153.0,48.0,39.19531,274.0625,1.5998535,1.89990234,2.09960938,152.0,7.349609,238.0,41.0,3657.0,1.1667481,SIP>=30
74.11896,1,female,0,41,622,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,88703.0,60055.9062,33.25,black,79.0,14,1,1,no,0.799999714,0.6,no dnr,41.0,124.0,11.2988281,100.0,14.0,36.59375,360.0,3.0996094,0.89990234,9.19921875,128.0,7.40918,370.0,82.0,0.0,5.0,<2 mo. follow-up
76.79895,1,female,0,6,296,COPD,COPD/CHF/Cirrhosis,4,7.0,under $11k,7148.0,3759.2031,13.0,white,19.0,1,0,0,no,1.0,1.0,no dnr,6.0,65.0,7.89941406,79.0,20.0,36.0,333.3,2.5996094,0.29998779,0.79992676,133.0,7.419922,115.0,13.0,1800.0,0.0,no(M2 and SIP pres)
65.08099,1,male,0,16,363,CHF,COPD/CHF/Cirrhosis,1,11.0,$11-$25k,27319.0,18400.7969,21.333328,white,49.0,1,0,0,no,0.849999905,0.7,no dnr,16.0,67.0,16.296875,122.0,24.0,38.09375,333.3,3.0,0.59997559,0.5,132.0,7.419922,92.0,4.0,2502.0,1.0,no(M2 and SIP pres)
65.659,0,male,0,4,943,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,7408.0,4798.8672,22.610928270087555,black,45.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,109.0,23.6992188,70.0,16.0,36.39844,188.0,1.5998535,13.1992188,0.59997559,133.0,7.419922,103.0,17.0,2742.0,0.0,no(M2 and SIP pres)
74.86395,1,male,0,7,884,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6128.0,3951.1348,4.0,white,14.0,1,0,0,no,0.799999714,0.8,no dnr,7.0,125.0,10.6992188,90.0,20.0,38.09375,380.0,2.699707,0.39996338,0.79992676,139.0,7.479492,281.0,16.0,5410.0,3.0,adl>=4 (>=5 if sur)
63.46899,1,female,0,9,301,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,11195.0,7726.3906,17.0,white,35.0,1,0,0,metastatic,0.799999714,0.35,no dnr,9.0,110.0,12.0996094,122.0,20.0,36.29688,218.5,4.7998047,0.69995117,0.89990234,136.0,7.319336,90.0,23.0,1400.0,4.0,no(M2 and SIP pres)
68.12299,1,male,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,104141.0,65324.5625,37.75,white,36.0,1,0,0,no,0.599999905,0.5,dnr after sadm,5.0,44.0,13.2988281,71.0,14.0,35.89844,333.3,2.3999023,0.69995117,3.39990234,129.0,7.419922,82.0,65.0,1532.0,2.4077148,<2 mo. follow-up
76.28998,0,female,0,35,940,Coma,Coma,0,13.0,under $11k,65325.0,42988.6875,38.25,white,18.0,3,0,0,no,0.199999928,0.1,no dnr,35.0,128.0,18.0976562,129.0,10.0,40.09375,273.3125,2.199707,1.69995117,5.5,147.0,7.369141,227.0,113.0,3695.0,0.0,adl>=4 (>=5 if sur)
45.952,1,female,0,32,138,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,67736.0,45461.9375,19.0,white,81.0,1,0,0,no,0.849999905,0.8,no dnr,32.0,81.0,6.0,80.0,20.0,35.59375,333.3,3.699707,0.89990234,2.19970703,137.0,7.419922,73.0,60.0,2250.0,1.1667481,no(M2 and SIP pres)
41.83698,1,male,1,10,10,Coma,Coma,0,8.0,under $11k,30086.0,20112.0156,36.5,white,17.0,6,0,0,no,0.099999964,0.05,dnr after sadm,7.0,124.0,9.79882812,45.0,42.0,37.79688,105.0,2.7998047,0.59997559,1.0,137.0,7.459961,124.0,17.0,2945.0,1.0,<2 mo. follow-up
62.25098,0,female,0,4,937,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,4692.0,2274.0332,10.0,white,23.0,1,1,0,yes,0.849999905,0.75,no dnr,4.0,43.0,15.6992188,118.0,12.0,37.89844,185.0,2.199707,3.69970703,5.39941406,132.0,7.379883,93.0,92.0,4775.0,2.0,no(M2 and SIP pres)
54.93997,1,female,0,16,800,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,34150.0,21269.9844,24.0,white,40.0,1,0,0,no,0.899999619,0.8,no dnr,16.0,101.0,8.8984375,77.0,20.0,36.0,333.3,3.8999023,0.39996338,1.19995117,131.0,7.419922,99.0,10.0,2502.0,0.494751,no(M2 and SIP pres)
65.24298,1,male,0,6,84,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,5116.0,3360.7422,8.0,white,33.0,1,0,0,no,0.649999619,0.25,no dnr,6.0,71.0,19.1992188,104.0,24.0,36.09375,280.9375,3.3999023,0.29998779,1.29980469,139.0,7.30957,133.0,31.0,1440.0,0.0,<2 mo. follow-up
50.89398,0,female,0,57,936,Coma,Coma,0,12.0,>$50k,78506.0,53960.5938,26.75,hispanic,18.0,1,0,0,no,0.199999928,0.15,no dnr,57.0,105.0,7.5,96.0,24.0,35.89844,333.3,3.8999023,0.69995117,1.19995117,128.0,7.419922,103.0,15.0,900.0,0.0,adl>=4 (>=5 if sur)
57.94897,1,male,0,3,713,Lung Cancer,Cancer,4,8.0,under $11k,2711.0,1268.1865,4.0,white,11.0,1,0,0,metastatic,0.699999809,0.2,no dnr,3.0,101.0,13.7988281,71.0,16.0,36.0,276.1875,4.0,0.29998779,0.89990234,139.0,7.399414,160.0,13.0,2502.0,0.0,<2 mo. follow-up
62.71298,0,male,0,10,936,MOSF w/Malig,ARF/MOSF,1,5.0,under $11k,9280.0,6758.4492,14.5,white,26.0,1,0,0,yes,0.979999542,0.9,no dnr,10.0,100.0,0.69995117,62.0,24.0,36.79688,333.3,3.0,0.69995117,0.89990234,126.0,7.419922,143.0,9.0,2502.0,0.0,SIP>=30
44.07098,1,male,0,7,83,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,$25-$50k,8506.0,5785.7461,4.5,white,30.0,1,1,0,no,0.949999809,0.9,no dnr,7.0,111.0,17.5976562,167.0,10.0,38.79688,215.0,2.0996094,0.39996338,1.09985352,149.0,7.519531,152.0,19.0,1195.0,0.0,SIP>=30
58.349,1,male,0,39,71,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,71530.0,46069.75,28.5,white,46.0,1,0,0,no,0.899999619,0.8,no dnr,39.0,67.0,9.5,126.0,24.0,35.79688,217.125,1.7998047,0.39996338,1.59985352,129.0,7.459961,576.0,32.0,3715.0,3.434082,<2 mo. follow-up
60.62097,1,female,0,26,752,Coma,Coma,2,11.0,under $11k,35039.0,23389.2969,21.25,white,34.0,1,0,0,yes,0.5,0.4,dnr after sadm,6.0,99.0,0.59997559,77.0,20.0,36.69531,333.3,3.0,2.29980469,1.29980469,139.0,7.419922,133.0,14.0,4375.0,0.0,adl>=4 (>=5 if sur)
61.78799,0,female,0,8,932,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,6178.0,4197.6484,13.5,black,33.0,1,1,0,no,0.75,0.25,no dnr,8.0,77.0,10.5,44.0,16.0,36.29688,285.6875,2.8999023,0.5,3.09960938,136.0,7.479492,170.0,57.0,1000.0,6.0,no(M2 and SIP pres)
52.82999,0,female,0,27,930,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,62142.0,37195.8438,22.5,white,57.0,4,1,0,no,0.649999619,0.5,no dnr,27.0,114.0,12.1992188,123.0,8.0,38.5,215.53125,2.699707,3.69970703,1.09985352,137.0,7.419922,125.0,24.0,1480.0,0.0,no(M2 and SIP pres)
76.79395,1,male,1,18,18,Lung Cancer,Cancer,1,12.0,$25-$50k,69459.0,44001.6562,60.0,white,39.0,1,0,0,metastatic,0.699999809,0.6,dnr after sadm,18.0,107.0,14.5,113.0,14.0,37.0,94.28125,3.5,0.59997559,0.79992676,136.0,7.509766,317.0,20.0,2570.0,0.0,<2 mo. follow-up
68.646,0,male,0,3,930,Colon Cancer,Cancer,1,16.0,under $11k,4301.0,2853.2051,22.610928270087555,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,105.0,5.5,128.0,30.0,36.09375,390.4375,2.3999023,0.89990234,0.5,137.0,7.449219,71.0,16.0,1945.0,0.0,no(M2 and SIP pres)
35.74799,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,$11-$25k,102586.0,65330.875,52.0,white,50.0,8,0,0,no,0.5,0.5,dnr after sadm,16.0,63.0,5.79980469,120.0,22.0,36.5,296.0,2.7998047,0.59997559,1.09985352,142.0,7.439453,188.0,16.0,1700.0,1.0,<2 mo. follow-up
82.80896,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,under $11k,15861.0,10002.4297,50.0,white,60.0,3,0,0,no,0.5,0.45,no dnr,6.0,70.0,9.0,71.0,22.0,36.29688,371.375,3.5,1.01,1.01,140.0,7.469727,135.0,23.0,1025.0,3.0,<2 mo. follow-up
62.81198,0,male,0,59,929,Coma,Coma,0,6.0,$11-$25k,131979.0,88000.75,47.25,white,23.0,9,0,0,no,0.75,0.75,no dnr,59.0,141.0,23.796875,129.0,10.0,39.29688,473.0,3.2998047,0.5,0.69995117,143.0,7.449219,211.0,8.0,3545.0,0.0,adl>=4 (>=5 if sur)
75.36499,1,male,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,115841.0,62708.5938,50.25,white,68.0,3,1,0,no,0.399999857,0.4,dnr after sadm,39.0,63.0,10.0,69.0,38.0,37.59375,342.0,2.199707,2.39990234,0.79992676,136.0,7.319336,108.0,32.0,1797.0,4.0,<2 mo. follow-up
52.98599,0,male,0,6,928,Cirrhosis,COPD/CHF/Cirrhosis,5,10.0,under $11k,4615.0,3394.2012,9.0,white,22.0,1,1,0,no,0.699999809,0.7,no dnr,6.0,145.0,12.3984375,71.0,10.0,38.89844,257.125,4.0996094,1.09985352,2.89990234,136.0,7.239258,146.0,40.0,3450.0,1.1667481,SIP>=30
76.27698,0,male,0,7,927,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,10527.0,6250.2891,21.0,white,65.0,1,1,0,no,0.799999714,0.7,no dnr,7.0,75.0,9.59960938,118.0,24.0,35.29688,123.32812,2.7998047,2.59960938,1.29980469,139.0,7.139648,133.0,35.0,1725.0,0.0,no(M2 and SIP pres)
52.84299,1,male,0,28,95,Coma,Coma,2,12.0,under $11k,62645.0,39683.0,28.75,white,38.0,1,1,0,no,0.049999982,0.0,no dnr,28.0,105.0,8.79882812,98.0,22.0,36.89844,423.75,3.2998047,2.0,1.09985352,140.0,7.399414,95.0,14.0,2502.0,3.3974609,Coma or Intub
86.26099,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,60772.0,40073.0625,59.0,white,67.0,38,1,0,no,0.199999928,0.15,dnr after sadm,5.0,158.0,8.3984375,61.0,10.0,36.69531,405.6875,2.8999023,0.5,1.29980469,136.0,7.449219,188.0,23.0,1770.0,0.0,<2 mo. follow-up
67.34595,1,female,0,38,44,Coma,Coma,0,11.0,under $11k,67080.0,44024.9062,24.25,white,29.0,4,0,0,no,0.0,0.0,no dnr,38.0,127.0,12.0996094,76.0,24.0,35.69531,348.125,3.199707,0.69995117,1.29980469,143.0,7.459961,74.0,26.0,1100.0,1.0,<2 mo. follow-up
75.08795,1,female,0,83,84,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,167523.0,14452.7344,35.25,black,54.0,20,0,0,no,0.349999905,0.25,no dnr,83.0,72.0,49.296875,127.0,38.0,35.69531,158.0,2.0,3.5,2.09960938,147.0,7.429688,194.0,42.0,4266.0,6.0,adl>=4 (>=5 if sur)
78.35699,1,female,1,35,35,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,89714.0,58427.1562,47.5,white,64.0,1,0,0,yes,0.25,0.25,dnr after sadm,2.0,102.0,10.5996094,108.0,24.0,36.5,237.5,3.5,1.01,1.09985352,138.0,7.40918,167.0,19.0,3700.0,7.0,<2 mo. follow-up
80.435,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,59384.0,38416.875,36.0,black,17.0,1,0,1,no,0.349999905,0.25,dnr after sadm,16.0,110.0,12.7988281,80.0,24.0,35.59375,276.1875,3.8999023,1.0,1.29980469,144.0,7.429688,80.0,25.0,2900.0,6.0,<2 mo. follow-up
56.73599,1,female,0,5,811,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,3902.0,2822.6523,16.0,black,30.0,1,0,0,no,0.5,0.25,no dnr,5.0,110.0,36.59375,118.0,27.0,36.29688,57.0,1.8999023,0.5,0.59997559,136.0,7.369141,270.0,22.0,4155.0,0.0,no(M2 and SIP pres)
74.95697,1,male,0,4,266,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3199.0,2166.9727,13.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,80.0,6.89941406,76.0,18.0,35.59375,295.1875,4.2998047,0.39996338,0.89990234,141.0,7.419922,260.0,15.0,1550.0,0.0,no(M2 and SIP pres)
39.79199,0,male,0,42,918,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,94345.0,60466.8125,41.75,white,42.0,1,0,0,no,0.699999809,0.65,no dnr,42.0,53.0,17.1992188,130.0,8.0,38.69531,198.1875,1.6999512,1.19995117,0.79992676,133.0,7.449219,224.0,28.0,3180.0,0.0,no(M2 and SIP pres)
19.34299,0,female,0,11,918,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,12438.0,8445.2969,18.5,black,30.0,1,0,0,no,0.949999809,0.95,no dnr,11.0,68.0,19.796875,164.0,44.0,36.09375,104.4375,2.0996094,0.39996338,0.79992676,139.0,7.339844,103.0,22.0,842.0,0.0,no(M2 and SIP pres)
35.63599,0,male,0,28,919,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,97668.0,63861.1562,35.75,black,38.0,12,0,0,no,0.599999905,0.6,no dnr,28.0,143.0,16.1992188,67.0,26.0,36.59375,173.3125,2.7998047,0.79992676,2.0,144.0,7.479492,135.0,39.0,4320.0,0.0,no(M2 and SIP pres)
69.07898,1,female,0,6,26,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,6995.0,4697.9375,23.0,white,42.0,1,0,0,no,0.299999952,0.1,no dnr,6.0,105.0,5.19921875,78.0,12.0,37.79688,185.0,3.2998047,7.5,0.89990234,150.0,7.439453,226.0,26.0,5165.0,2.5107422,<2 mo. follow-up
94.48895,0,female,0,9,916,ARF/MOSF w/Sepsis,ARF/MOSF,2,3.0,under $11k,25024.0,13719.4766,22.0,black,61.0,1,0,0,no,0.75,0.6,no dnr,9.0,77.0,5.69921875,77.0,26.0,36.29688,214.28125,4.2998047,1.0,0.79992676,140.0,7.349609,122.0,12.0,1150.0,5.0,no(M2 and SIP pres)
41.65399,1,male,0,9,234,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,9005.0,6316.875,12.5,white,33.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,114.0,12.6992188,63.0,32.0,39.19531,383.3125,3.5,1.01,0.5,133.0,7.449219,158.0,7.0,2285.0,0.0,SIP>=30
40.84598,0,female,0,33,911,MOSF w/Malig,ARF/MOSF,1,18.0,$25-$50k,131327.0,85019.5,43.5,hispanic,80.0,18,0,0,yes,0.799999714,0.8,no dnr,33.0,83.0,6.69921875,76.0,20.0,35.09375,323.75,2.699707,4.89941406,2.59960938,150.0,7.459961,176.0,102.0,1530.0,0.0,no(M2 and SIP pres)
79.07495,1,female,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,63754.0,40198.2812,57.333313,white,56.0,3,0,0,no,0.899999619,0.9,dnr after sadm,14.0,98.0,8.19921875,118.0,22.0,37.69531,333.3,2.7998047,4.09960938,0.79992676,130.0,7.419922,89.0,3.0,2502.0,2.7797852,<2 mo. follow-up
44.03,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,12056.0,7435.4062,49.0,white,51.0,2,0,0,no,0.099999964,0.1,dnr after sadm,2.0,73.0,7.19921875,130.0,22.0,37.39844,233.3125,3.3999023,1.09985352,1.29980469,137.0,7.40918,85.0,15.0,3400.0,1.0,<2 mo. follow-up
40.92499,1,female,0,17,125,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,17371.0,12434.0391,21.666656,white,54.0,1,0,0,no,0.699999809,0.6,no dnr,17.0,112.0,9.8984375,48.0,24.0,36.0,272.0,3.5,1.01,1.69995117,138.0,7.439453,178.0,39.0,2400.0,3.0,SIP>=30
63.15698,1,female,1,30,30,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,98272.0,62250.9375,54.5,white,38.0,1,0,0,no,0.599999905,0.6,dnr after sadm,28.0,69.0,27.3984375,68.0,8.0,34.69531,244.0,1.8999023,4.79980469,3.69970703,132.0,7.40918,244.0,44.0,1544.0,0.0,<2 mo. follow-up
44.29599,0,male,0,3,906,CHF,COPD/CHF/Cirrhosis,1,14.0,$11-$25k,5119.0,2734.3769,22.610928270087555,black,10.0,1,0,0,no,0.949999809,0.9,no dnr,3.0,117.0,8.59960938,114.0,24.0,35.39844,295.625,3.7998047,0.69995117,0.89990234,142.0,7.449219,126.0,19.0,2502.0,0.494751,SIP>=30
43.88797,0,female,0,20,904,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,35501.0,23562.0781,24.333328,white,20.0,1,0,0,no,0.899999619,0.9,no dnr,20.0,61.0,6.89941406,126.0,40.0,38.69531,316.625,2.5996094,1.0,1.29980469,134.0,7.469727,174.0,21.0,2149.0,6.0,adl>=4 (>=5 if sur)
95.40295,0,female,0,4,903,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,4043.0,2071.1914,11.0,black,23.0,1,0,0,no,0.75,0.65,no dnr,4.0,116.0,6.69921875,109.0,22.0,37.09375,296.625,4.3994141,0.69995117,18.3984375,141.0,7.439453,155.0,85.0,0.0,0.0,no(M2 and SIP pres)
74.63397,0,male,0,8,901,CHF,COPD/CHF/Cirrhosis,4,9.0,$11-$25k,7199.0,5192.7656,11.0,white,46.0,1,1,0,no,0.5,0.4,dnr before sadm,0.0,85.0,6.19921875,96.0,24.0,36.09375,285.6875,3.699707,2.5,1.09985352,138.0,7.459961,110.0,19.0,2502.0,3.0,SIP>=30
26.95699,1,male,1,5,5,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,8751.0,4468.6953,23.0,white,19.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,106.0,0.19998169,122.0,24.0,39.19531,333.3,3.8999023,1.0,0.79992676,137.0,7.419922,119.0,6.0,2502.0,2.5673828,<2 mo. follow-up
71.52399,1,male,0,15,183,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,51340.0,30959.0312,15.0,white,26.0,1,1,0,no,0.949999809,0.95,no dnr,15.0,66.0,10.0,58.0,10.0,37.79688,152.0,2.2998047,1.09985352,0.89990234,134.0,7.489258,106.0,21.0,1999.0,1.0,no(M2 and SIP pres)
84.26599,0,female,0,12,901,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,26540.0,17341.2812,16.0,white,46.0,1,1,0,no,0.899999619,0.75,no dnr,12.0,128.0,15.2988281,98.0,8.0,38.79688,220.0,3.0,0.5,0.89990234,136.0,7.509766,207.0,17.0,3365.0,0.0,no(M2 and SIP pres)
68.56396,0,female,0,8,901,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5639.0,4186.4648,9.5,white,15.0,1,0,0,yes,0.799999714,0.6,no dnr,8.0,40.0,8.0,66.0,30.0,35.79688,138.09375,3.199707,2.09960938,7.5,130.0,7.389648,108.0,64.0,0.0,1.1667481,SIP>=30
64.03595,1,female,0,29,99,Coma,Coma,2,9.0,under $11k,100133.0,65855.9375,38.25,white,26.0,15,1,0,no,0.5,0.5,dnr after sadm,16.0,66.0,10.5996094,80.0,8.0,38.0,282.5,2.699707,1.5,0.59997559,135.0,7.399414,108.0,18.0,1430.0,0.0,Coma or Intub
28.50899,0,female,0,5,898,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,3978.0,2864.7871,4.0,white,35.0,1,0,0,no,0.5,0.4,no dnr,5.0,100.0,8.5,79.0,24.0,36.39844,376.1875,3.8999023,0.69995117,1.59985352,138.0,7.5,113.0,25.0,2900.0,0.0,<2 mo. follow-up
66.85797,0,male,0,25,897,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,244211.0,158419.625,21.75,white,31.0,93,0,0,no,0.75,0.75,no dnr,25.0,76.0,16.1992188,120.0,32.0,37.89844,167.84375,3.0996094,0.5,0.69995117,144.0,7.389648,172.0,11.0,1177.0,0.0,<2 mo. follow-up
70.59796,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,13129.0,8689.875,23.0,white,40.0,4,0,0,no,0.199999928,0.2,dnr before sadm,-1.0,95.0,12.0996094,65.0,16.0,35.79688,333.3,2.699707,2.89990234,1.39990234,136.0,7.429688,51.0,36.0,2502.0,3.3486328,<2 mo. follow-up
58.86697,1,male,0,7,54,Lung Cancer,Cancer,1,8.0,$11-$25k,9073.0,6029.3008,4.0,white,16.0,1,0,0,metastatic,0.599999905,0.3,no dnr,7.0,107.0,8.8984375,45.0,12.0,39.39844,265.6875,3.5,1.69995117,0.79992676,142.0,7.489258,163.0,10.0,1837.0,4.0,<2 mo. follow-up
58.92398,0,female,0,9,896,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,8432.0,5708.6289,7.5,white,16.0,1,0,0,no,0.799999714,0.6,no dnr,9.0,99.0,5.5,135.0,20.0,36.09375,333.3,4.3994141,0.69995117,1.09985352,132.0,7.419922,112.0,8.0,2250.0,1.0,no(M2 and SIP pres)
68.112,1,female,0,25,27,Lung Cancer,Cancer,5,12.0,under $11k,25699.0,18062.3438,11.25,white,28.0,1,0,0,metastatic,0.399999857,0.1,dnr after sadm,6.0,79.0,100.0,70.0,22.0,37.5,319.0,3.7998047,1.0,1.29980469,142.0,7.479492,84.0,21.0,2502.0,5.1835938,<2 mo. follow-up
68.67096,1,female,0,37,86,Coma,Coma,2,12.0,under $11k,100640.0,66801.3125,33.5,white,40.0,21,1,0,yes,0.599999905,0.4,no dnr,37.0,77.0,5.0,60.0,20.0,36.5,333.3,2.0,7.89941406,0.89990234,126.0,7.419922,289.0,11.0,2606.0,6.0,adl>=4 (>=5 if sur)
67.97797,1,female,1,5,5,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,68460.0,43711.4062,44.0,white,32.0,18,0,0,no,0.75,0.6,no dnr,5.0,122.0,6.79980469,195.0,38.0,38.39844,176.65625,2.7998047,0.59997559,0.79992676,135.0,7.359375,99.0,11.0,1565.0,2.5458984,<2 mo. follow-up
59.73999,1,male,0,10,12,Lung Cancer,Cancer,2,12.0,$25-$50k,8042.0,6030.7617,13.5,white,17.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,1.0,136.0,18.8984375,111.0,8.0,39.69531,148.0,3.0,0.69995117,1.09985352,146.0,7.489258,139.0,7.0,1366.0,6.0,<2 mo. follow-up
69.383,1,female,1,112,112,ARF/MOSF w/Sepsis,ARF/MOSF,0,4.0,under $11k,435766.0,293525.0,27.75,hispanic,35.0,140,0,0,no,0.899999619,0.9,dnr after sadm,109.0,73.0,6.09960938,76.0,24.0,35.0,333.3,3.2998047,1.59985352,1.5,143.0,7.419922,45.0,33.0,2502.0,0.0,adl>=4 (>=5 if sur)
78.51294,1,female,0,21,58,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,30168.0,20644.1094,31.0,white,48.0,1,0,0,no,0.5,0.2,dnr after sadm,3.0,64.0,12.5996094,120.0,32.0,36.5,240.0,2.3999023,0.5,5.29980469,130.0,7.339844,162.0,69.0,1079.0,3.9838867,<2 mo. follow-up
69.16595,1,female,0,15,376,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,31257.0,20410.9219,24.666656,white,49.0,7,0,0,no,0.799999714,0.8,no dnr,15.0,116.0,6.89941406,114.0,8.0,36.19531,136.0,3.0,1.09985352,2.0,144.0,7.40918,206.0,28.0,4115.0,2.0,SIP>=30
84.27899,1,female,0,54,65,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,68870.0,47045.5,26.0,white,71.0,2,0,0,no,0.5,0.1,dnr after sadm,47.0,101.0,6.0,66.0,22.0,36.39844,333.3,3.5996094,0.89990234,2.0,141.0,7.419922,123.0,18.0,2502.0,1.0,<2 mo. follow-up
76.36395,0,female,0,73,890,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,119087.0,79334.5625,43.25,white,21.0,2,0,0,no,0.799999714,0.8,no dnr,73.0,56.0,20.8984375,132.0,36.0,40.0,231.40625,1.2998047,0.89990234,0.79992676,143.0,7.349609,134.0,15.0,2505.0,2.0,adl>=4 (>=5 if sur)
72.57794,1,female,0,5,379,MOSF w/Malig,ARF/MOSF,3,10.0,under $11k,6049.0,4106.0,18.0,white,29.0,1,1,0,metastatic,0.5,0.3,dnr before sadm,-1.0,60.0,14.5996094,113.0,28.0,38.79688,324.0,2.0,3.09960938,0.89990234,137.0,7.419922,153.0,33.0,3.959961,2.0,adl>=4 (>=5 if sur)
75.30695,0,female,0,9,887,ARF/MOSF w/Sepsis,ARF/MOSF,3,13.0,under $11k,9566.0,6663.5625,11.5,white,32.0,1,1,0,no,0.899999619,0.7,no dnr,9.0,132.0,14.6992188,119.0,24.0,36.19531,233.3125,3.5,1.01,1.0,133.0,7.439453,159.0,19.0,2770.0,2.0,adl>=4 (>=5 if sur)
69.05695,0,male,0,13,886,Cirrhosis,COPD/CHF/Cirrhosis,2,5.0,under $11k,12084.0,8825.9062,8.5,white,31.0,1,0,0,no,0.799999714,0.8,no dnr,13.0,52.0,10.5996094,173.0,38.0,37.5,142.0,2.0,1.79980469,1.79980469,135.0,7.449219,181.0,29.0,2810.0,0.0,no(M2 and SIP pres)
41.89697,1,male,0,18,576,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,41054.0,28431.0625,18.333328,white,42.0,15,0,0,no,0.5,0.5,no dnr,18.0,85.0,3.19970703,77.0,20.0,36.39844,333.3,2.2998047,0.69995117,1.19995117,135.0,7.419922,153.0,38.0,1660.0,1.0,SIP>=30
74.69995,1,female,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,38627.0,27789.3906,14.5,white,36.0,1,0,0,no,0.099999964,0.1,dnr after sadm,1.0,126.0,11.6992188,111.0,29.0,36.19531,162.84375,3.5996094,0.5,2.09960938,136.0,7.449219,280.0,41.0,1.019775,4.0,<2 mo. follow-up
42.13599,0,male,0,13,885,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,28696.0,18141.125,37.0,white,48.0,1,0,0,no,0.399999857,0.4,no dnr,13.0,117.0,13.1992188,124.0,34.0,39.09375,150.0,2.3999023,0.69995117,1.29980469,133.0,7.399414,204.0,14.0,2510.0,0.0,no(M2 and SIP pres)
55.737,1,male,0,7,812,Colon Cancer,Cancer,1,24.0,>$50k,14069.0,9302.2656,15.0,white,27.0,1,0,0,metastatic,1.0,0.9,no dnr,7.0,61.0,18.0,116.0,25.0,36.59375,266.625,1.6999512,1.09985352,2.19970703,129.0,7.339844,71.0,120.0,1380.0,1.1667481,<2 mo. follow-up
68.50897,1,male,0,11,177,Lung Cancer,Cancer,1,5.0,under $11k,16483.0,11302.1797,14.0,black,21.0,2,0,0,metastatic,0.989999771,0.9,no dnr,11.0,111.0,16.5,69.0,39.0,38.39844,176.0,3.5,1.01,0.89990234,136.0,7.459961,182.0,17.0,1874.0,0.0,no(M2 and SIP pres)
55.82498,1,female,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,10498.0,6723.6055,20.0,black,56.0,1,1,0,no,0.799999714,0.6,no dnr,6.0,115.0,29.3984375,189.0,10.0,38.79688,333.3,3.5996094,0.89990234,1.69995117,141.0,7.419922,241.0,87.0,1929.0,0.0,<2 mo. follow-up
38.59799,1,female,0,25,44,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,53366.0,37353.7812,23.0,white,83.0,9,0,0,no,0.799999714,0.5,no dnr,25.0,61.0,13.5,129.0,34.0,38.09375,172.0,1.5,2.59960938,1.59985352,136.0,7.299805,144.0,37.0,1710.0,5.0,<2 mo. follow-up
68.36694,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,$11-$25k,35077.0,22686.0156,48.0,white,77.0,1,0,0,no,0.799999714,0.7,dnr after sadm,11.0,123.0,10.0996094,107.0,28.0,38.89844,262.5,2.5,0.59997559,0.59997559,145.0,7.429688,168.0,13.0,2575.0,0.0,<2 mo. follow-up
66.5,1,male,0,16,133,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,29556.0,19580.9375,23.0,black,40.0,1,0,0,no,0.699999809,0.7,no dnr,16.0,64.0,5.29980469,69.0,20.0,36.39844,333.3,4.2998047,0.79992676,3.0,142.0,7.419922,86.0,45.0,3900.0,0.0,no(M2 and SIP pres)
30.51599,1,female,1,6,6,Coma,Coma,0,12.0,under $11k,37150.0,23628.5781,72.0,white,48.0,4,0,0,no,0.699999809,0.8,no dnr,6.0,73.0,9.0,107.0,20.0,36.09375,197.125,4.1992188,0.89990234,1.39990234,141.0,7.449219,89.0,27.0,1475.0,0.0,<2 mo. follow-up
47.20297,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,17934.0,11697.0781,27.5,white,44.0,1,0,0,no,0.599999905,0.6,dnr after sadm,2.0,107.0,4.19921875,138.0,28.0,39.39844,204.0,2.5,0.79992676,1.19995117,155.0,7.379883,113.0,22.0,2130.0,7.0,<2 mo. follow-up
69.05396,1,female,1,15,15,CHF,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,12111.0,8669.0,12.333328,white,39.0,1,1,0,yes,0.099999964,0.08,dnr after sadm,2.0,67.0,9.59960938,91.0,34.0,38.39844,428.5625,2.0,0.59997559,1.09985352,133.0,7.399414,112.0,13.0,6370.0,3.0,<2 mo. follow-up
39.03897,1,male,1,24,24,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,98885.0,0.0,59.666657,black,50.0,5,0,0,no,0.199999928,0.2,dnr after sadm,23.0,67.0,14.0,118.0,10.0,40.29688,185.0,2.5996094,3.29980469,1.59985352,136.0,7.429688,78.0,36.0,2261.0,1.0,<2 mo. follow-up
65.91095,1,male,0,7,10,Lung Cancer,Cancer,3,12.0,under $11k,8834.0,5903.5859,6.5,white,36.0,1,0,0,metastatic,0.399999857,0.5,no dnr,7.0,67.0,5.19921875,98.0,20.0,35.5,333.3,2.699707,2.19970703,2.59960938,140.0,7.419922,165.0,62.0,1415.0,4.546875,<2 mo. follow-up
72.07098,1,male,1,44,44,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,116999.0,73644.9375,49.25,black,39.0,4,0,0,yes,0.799999714,0.6,dnr after sadm,32.0,54.0,8.29882812,29.0,16.0,36.09375,259.25,3.5,0.59997559,3.09960938,129.0,7.30957,158.0,69.0,1575.0,6.0,<2 mo. follow-up
74.81696,1,male,1,7,7,Coma,Coma,2,12.0,$11-$25k,51614.0,33735.75,30.0,white,86.0,12,0,0,no,0.0,0.0,dnr after sadm,4.0,61.0,4.69921875,100.0,20.0,38.0,333.3,2.5,5.09960938,1.0,135.0,7.419922,176.0,31.0,900.0,5.0,<2 mo. follow-up
77.89697,1,male,0,40,100,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,78090.0,51049.0312,39.0,white,77.0,1,1,0,yes,0.699999809,0.5,no dnr,40.0,143.0,0.06999207,150.0,32.0,39.19531,124.28125,2.7998047,3.39990234,1.89990234,139.0,7.349609,198.0,28.0,4610.0,1.0,no(M2 and SIP pres)
52.94498,0,female,0,4,873,COPD,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,3607.0,2301.6797,20.0,white,30.0,1,0,0,no,0.799999714,0.8,dnr after sadm,1.0,48.0,2.59960938,105.0,12.0,38.09375,68.0,1.8999023,1.79980469,0.59997559,136.0,7.419922,102.0,17.0,1158.0,4.5273438,SIP>=30
67.85797,0,male,0,24,872,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$25-$50k,39652.0,26462.3906,23.0,white,41.0,1,0,0,yes,0.799999714,0.8,no dnr,24.0,65.0,21.6992188,129.0,28.0,35.39844,154.0,2.199707,1.19995117,6.19921875,138.0,7.429688,82.0,119.0,2200.0,0.494751,no(M2 and SIP pres)
53.01797,0,female,0,7,871,MOSF w/Malig,ARF/MOSF,1,16.0,>$50k,7959.0,5581.6875,19.0,white,43.0,1,0,0,metastatic,0.799999714,0.6,no dnr,7.0,56.0,2.09960938,110.0,20.0,36.5,333.3,2.0,10.0,0.69995117,125.0,7.419922,93.0,5.0,2475.0,0.0,no(M2 and SIP pres)
61.43997,1,male,0,56,62,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,180143.0,115483.5,50.75,white,80.0,1,0,0,yes,0.699999809,0.5,no dnr,56.0,57.0,12.5,74.0,11.0,36.79688,184.0,2.3999023,2.39990234,0.69995117,137.0,7.479492,109.0,16.0,2160.0,4.0644531,<2 mo. follow-up
58.20398,0,male,0,86,871,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,216314.0,140226.625,59.0,white,68.0,1,0,0,yes,0.799999714,0.8,no dnr,86.0,114.0,6.19921875,97.0,20.0,36.29688,333.3,3.8999023,0.59997559,1.19995117,141.0,7.419922,145.0,10.0,1850.0,1.0,adl>=4 (>=5 if sur)
69.45697,1,female,0,8,706,COPD,COPD/CHF/Cirrhosis,0,8.0,under $11k,7372.0,5136.1484,10.5,white,29.0,1,0,0,no,0.899999619,0.7,no dnr,8.0,127.0,19.0,104.0,36.0,37.69531,297.125,2.7998047,1.0,0.59997559,136.0,7.399414,101.0,13.0,2881.0,1.1667481,no(M2 and SIP pres)
57.53299,1,female,0,7,223,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,9775.0,6172.2305,18.5,black,29.0,1,0,0,no,0.899999619,0.95,no dnr,7.0,76.0,4.79980469,73.0,16.0,36.09375,371.375,4.1992188,1.0,1.19995117,137.0,7.419922,106.0,23.0,1220.0,2.0,no(M2 and SIP pres)
50.76797,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,6.0,under $11k,16143.0,9824.7109,22.610928270087555,white,74.0,1,0,0,no,0.099999964,0.1,no dnr,3.0,65.0,7.09960938,107.0,24.0,36.0,100.0,3.2998047,0.69995117,2.5,137.0,7.369141,114.0,42.0,4150.0,2.1879883,<2 mo. follow-up
82.63898,1,female,1,4,4,Coma,Coma,1,7.0,under $11k,18882.0,11802.0625,64.0,black,87.0,1,0,0,no,0.009999998,0.0,dnr after sadm,2.0,66.0,7.5,96.0,28.0,38.09375,333.3,3.3999023,1.59985352,1.29980469,144.0,7.419922,81.0,12.0,5872.0,2.4731445,<2 mo. follow-up
39.04999,1,female,0,4,39,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,3991.0,2759.334,11.0,white,38.0,1,0,0,no,0.799999714,0.8,no dnr,4.0,67.0,5.59960938,58.0,16.0,36.29688,333.3,3.8999023,1.19995117,1.69995117,131.0,7.419922,179.0,38.0,1580.0,0.0,<2 mo. follow-up
67.25299,1,male,0,11,24,Lung Cancer,Cancer,2,12.0,under $11k,12915.0,8760.2344,18.0,white,52.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,5.0,129.0,10.1992188,146.0,38.0,36.79688,436.0,3.5,1.01,1.29980469,141.0,7.419922,119.0,27.0,820.0,4.0273438,<2 mo. follow-up
63.99698,0,male,0,11,867,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$25-$50k,22779.0,14968.2656,33.0,white,37.0,1,0,0,no,0.5,0.6,no dnr,11.0,76.0,9.0,70.0,22.0,36.59375,333.3,3.5,1.01,1.09985352,141.0,7.419922,95.0,20.0,2502.0,6.0,SIP>=30
53.21298,0,female,0,26,864,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,72955.0,48619.0938,28.0,white,14.0,6,0,0,no,0.799999714,0.8,no dnr,26.0,116.0,16.5,122.0,9.0,36.09375,172.5,3.0996094,0.89990234,0.69995117,145.0,7.489258,267.0,18.0,3717.0,0.0,<2 mo. follow-up
41.67599,1,male,0,3,208,Lung Cancer,Cancer,3,10.0,under $11k,2901.0,1967.1094,22.610928270087555,black,5.0,1,0,0,metastatic,0.799999714,0.6,no dnr,3.0,74.0,12.2988281,98.0,20.0,38.59375,333.3,2.0996094,27.796875,1.09985352,129.0,7.419922,80.0,6.0,2502.0,0.0,no(M2 and SIP pres)
62.15198,1,female,0,4,331,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,4001.0,2693.3906,14.0,white,23.0,1,1,0,yes,0.989999771,0.85,no dnr,4.0,69.0,5.79980469,111.0,8.0,37.69531,66.0,2.7998047,0.89990234,1.0,133.0,7.519531,132.0,18.0,2585.0,1.0,no(M2 and SIP pres)
61.37198,1,male,1,4,4,Coma,Coma,0,17.0,under $11k,10455.0,5621.2656,48.0,white,58.0,1,0,0,no,0.009999998,0.01,dnr after sadm,2.0,76.0,13.5,96.0,24.0,36.39844,333.3,1.6999512,0.69995117,2.29980469,139.0,7.419922,129.0,22.0,1750.0,0.0,<2 mo. follow-up
78.74298,1,female,1,30,30,MOSF w/Malig,ARF/MOSF,1,9.0,$11-$25k,80556.0,51749.7812,29.5,white,50.0,1,0,0,metastatic,0.099999964,0.01,no dnr,30.0,85.0,28.6992188,64.0,20.0,37.69531,333.3,3.7998047,0.69995117,1.0,130.0,7.419922,76.0,6.0,1875.0,1.1667481,<2 mo. follow-up
23.493,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,13030.0,8057.0117,53.0,white,87.0,1,0,0,no,0.009999998,0.01,dnr after sadm,2.0,69.0,16.1992188,64.0,24.0,36.59375,319.0,3.5,1.01,0.59997559,143.0,7.379883,90.0,11.0,2502.0,0.0,<2 mo. follow-up
69.91895,0,male,0,9,859,COPD,COPD/CHF/Cirrhosis,2,5.0,$11-$25k,12092.0,8069.5352,10.5,white,27.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,106.0,22.1992188,122.0,20.0,36.59375,507.375,2.0996094,1.19995117,0.89990234,137.0,7.479492,203.0,17.0,2800.0,0.0,no(M2 and SIP pres)
41.16599,1,male,0,15,66,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,34917.0,24943.7812,19.0,black,71.0,4,0,0,no,0.699999809,0.7,no dnr,15.0,174.0,7.59960938,116.0,40.0,38.69531,263.3125,2.5996094,0.5,0.59997559,136.0,7.479492,368.0,15.0,1807.0,0.0,<2 mo. follow-up
41.29199,1,male,0,16,75,Colon Cancer,Cancer,1,12.0,under $11k,19689.0,13671.9922,14.666664,white,15.0,1,0,0,metastatic,0.5,0.2,no dnr,16.0,64.0,12.5,67.0,35.0,36.89844,250.0,3.5,1.01,0.69995117,134.0,7.479492,191.0,22.0,2258.0,1.0,SIP>=30
86.36298,0,female,0,30,857,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,58245.0,31631.7969,20.75,white,20.0,2,0,0,no,0.799999714,0.7,dnr before sadm,-1.0,84.0,8.19921875,79.0,32.0,39.09375,333.3,2.5,0.89990234,0.89990234,127.0,7.419922,113.0,13.0,1550.0,4.0,no(M2 and SIP pres)
68.36694,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,3360.0,2318.0449,20.0,white,45.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,105.0,6.5,99.0,28.0,35.69531,210.0,3.5,1.01,1.89990234,126.0,7.239258,115.0,38.0,1893.0,5.375,<2 mo. follow-up
55.047,0,male,0,58,857,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,156289.0,106187.125,47.0,white,32.0,34,0,0,no,0.849999905,0.85,no dnr,58.0,111.0,16.1992188,136.0,12.0,35.89844,130.0,2.0,0.59997559,1.89990234,133.0,7.379883,73.0,61.0,2790.0,0.0,SIP>=30
77.91394,0,female,0,13,856,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,27049.0,18148.6719,30.0,black,37.0,2,0,0,metastatic,0.849999905,0.85,no dnr,13.0,133.0,22.0976562,141.0,42.0,36.69531,186.65625,3.2998047,0.59997559,0.69995117,125.0,7.399414,159.0,16.0,1316.0,1.0,no(M2 and SIP pres)
75.05499,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,82102.0,51896.9375,48.25,white,29.0,1,0,0,no,0.799999714,0.7,no dnr,33.0,125.0,25.796875,131.0,26.0,36.69531,400.0,2.199707,5.19921875,2.59960938,146.0,7.299805,191.0,87.0,4825.0,5.0,<2 mo. follow-up
58.82498,0,female,0,20,853,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,44069.0,28972.2031,35.333313,white,76.0,1,0,0,no,0.699999809,0.9,no dnr,20.0,61.0,18.1992188,108.0,10.0,39.0,234.0,3.5,1.01,0.59997559,137.0,7.519531,116.0,9.0,3299.0,5.0,<2 mo. follow-up
76.61298,1,male,0,6,57,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,5398.0,3957.8242,17.0,white,45.0,1,1,0,no,0.75,0.5,no dnr,6.0,109.0,1.69995117,63.0,20.0,35.5,333.3,2.5,0.5,1.59985352,130.0,7.419922,157.0,14.0,700.0,1.1667481,<2 mo. follow-up
44.05499,1,male,0,9,602,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,7828.0,5585.0234,8.5,white,0.0,1,0,0,no,1.0,0.95,no dnr,9.0,73.0,16.8984375,70.0,16.0,35.89844,112.23438,3.0996094,0.59997559,1.19995117,129.0,7.479492,415.0,28.0,2500.0,0.494751,no(M2 and SIP pres)
73.79895,0,female,0,9,849,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,12704.0,7072.0625,12.5,white,31.0,1,0,0,no,0.899999619,0.7,no dnr,9.0,73.0,8.79882812,76.0,20.0,36.19531,342.8125,2.0,1.69995117,0.79992676,133.0,7.429688,127.0,20.0,2730.0,0.0,no(M2 and SIP pres)
60.04898,1,female,0,7,14,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5874.0,4007.1875,8.0,white,22.0,1,0,0,no,0.799999714,0.6,no dnr,7.0,73.0,12.5996094,114.0,26.0,38.5,333.3,2.2998047,3.59960938,0.69995117,134.0,7.419922,96.0,17.0,1840.0,5.0,<2 mo. follow-up
34.59299,0,male,0,9,849,COPD,COPD/CHF/Cirrhosis,4,11.0,under $11k,10607.0,7043.9961,11.5,black,23.0,1,0,0,no,1.0,1.0,no dnr,9.0,61.0,6.59960938,63.0,10.0,36.29688,195.0,3.3999023,0.59997559,0.79992676,140.0,7.129883,124.0,9.0,2067.0,1.1667481,<2 mo. follow-up
60.81299,0,male,0,51,847,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$25-$50k,139666.0,90593.75,57.25,white,72.0,1,0,0,no,0.75,0.75,no dnr,51.0,64.0,13.7988281,100.0,26.0,39.0,136.0,2.3999023,0.79992676,1.29980469,134.0,7.529297,211.0,9.0,4660.0,7.0,adl>=4 (>=5 if sur)
38.78198,0,male,0,3,846,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,2783.0,1907.6865,22.610928270087555,white,13.0,1,0,0,no,1.0,0.95,no dnr,3.0,110.0,13.1992188,122.0,24.0,38.79688,333.3,4.5996094,1.0,1.19995117,132.0,7.419922,159.0,6.0,1250.0,0.494751,<2 mo. follow-up
63.228,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,13880.0,9691.0312,15.0,white,72.0,8,0,0,yes,0.199999928,0.1,dnr after sadm,2.0,95.0,7.79980469,110.0,22.0,38.69531,251.40625,3.5,1.01,1.5,132.0,7.399414,193.0,17.0,1210.0,1.0,<2 mo. follow-up
38.69397,0,male,0,56,845,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,105673.0,71900.75,36.75,white,42.0,6,0,0,no,0.699999809,0.7,no dnr,56.0,101.0,6.5,170.0,28.0,36.69531,333.3,2.8999023,20.8984375,0.39996338,132.0,7.419922,327.0,15.0,2502.0,2.0,no(M2 and SIP pres)
57.599,0,male,0,14,845,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,23119.0,15648.1562,19.333328,hispanic,39.0,1,0,0,no,0.949999809,0.95,no dnr,14.0,78.0,27.8984375,120.0,10.0,35.5,595.125,1.5998535,0.39996338,3.69970703,135.0,7.449219,89.0,40.0,0.0,0.0,no(M2 and SIP pres)
69.67798,1,male,0,3,750,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,1684.0,1282.1348,22.610928270087555,white,20.0,1,0,0,no,0.799999714,0.8,no dnr,3.0,60.0,15.5996094,122.0,52.0,38.09375,140.0,1.8999023,1.19995117,4.89941406,138.0,7.389648,160.0,37.0,526.0,6.0,no(M2 and SIP pres)
57.04898,1,male,1,19,19,Coma,Coma,0,8.0,under $11k,56392.0,36381.0312,57.333313,white,31.0,1,0,0,no,0.299999952,0.2,dnr after sadm,17.0,138.0,26.796875,72.0,24.0,35.0,390.4375,2.0,5.29980469,1.39990234,152.0,7.40918,173.0,20.0,2800.0,0.0,<2 mo. follow-up
76.66498,1,male,0,20,278,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,43677.0,29397.1719,30.333328,white,33.0,7,1,0,no,0.799999714,0.8,no dnr,20.0,128.0,28.0976562,147.0,0.0,38.5,163.25,3.5,1.01,0.59997559,134.0,7.379883,101.0,13.0,3000.0,3.0,no(M2 and SIP pres)
56.95798,1,male,0,38,674,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,43875.0,30696.6875,13.5,black,21.0,2,0,0,no,0.799999714,0.5,no dnr,38.0,106.0,15.1992188,121.0,32.0,37.79688,325.0,2.699707,1.29980469,1.79980469,161.0,7.329102,98.0,24.0,3150.0,1.0,no(M2 and SIP pres)
68.94696,1,male,0,17,58,MOSF w/Malig,ARF/MOSF,2,8.0,under $11k,22022.0,15748.1641,17.333328,black,29.0,4,0,0,metastatic,0.899999619,0.8,no dnr,17.0,109.0,11.0996094,100.0,32.0,35.19531,333.3,3.0,1.19995117,1.19995117,134.0,7.419922,197.0,21.0,300.0,2.0,<2 mo. follow-up
70.02899,0,female,0,6,839,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5310.0,3739.8125,8.0,white,19.0,1,1,0,no,0.949999809,0.9,no dnr,6.0,125.0,6.0,120.0,8.0,38.19531,205.6875,1.3999023,5.0,0.69995117,129.0,7.539062,163.0,21.0,2174.0,0.0,no(M2 and SIP pres)
39.29898,0,male,0,4,837,Cirrhosis,COPD/CHF/Cirrhosis,4,8.0,under $11k,8162.0,5345.1914,15.0,white,18.0,2,0,0,no,0.199999928,0.05,no dnr,4.0,66.0,13.0996094,48.0,20.0,34.79688,333.3,2.7998047,0.29998779,1.69995117,138.0,7.419922,83.0,32.0,2502.0,0.0,no(M2 and SIP pres)
63.13998,1,male,0,9,752,COPD,COPD/CHF/Cirrhosis,4,11.0,under $11k,8050.0,5557.668,9.0,white,36.0,1,1,0,no,1.0,1.0,no dnr,9.0,69.0,14.0,75.0,22.0,37.79688,142.5,2.0,1.19995117,1.29980469,132.0,7.509766,511.0,32.0,5660.0,2.5107422,SIP>=30
65.69196,1,male,0,25,253,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,under $11k,54606.0,36313.7812,24.25,white,30.0,4,0,0,yes,0.75,0.6,no dnr,25.0,53.0,13.5,114.0,12.0,35.39844,226.65625,1.7998047,4.09960938,2.5,134.0,7.419922,194.0,30.0,362.0,0.0,no(M2 and SIP pres)
58.23398,1,female,0,46,626,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,147887.0,91126.9375,33.75,white,48.0,6,1,0,yes,0.399999857,0.2,no dnr,46.0,53.0,16.296875,63.0,10.0,35.0,132.0,2.2998047,0.59997559,8.19921875,125.0,7.299805,152.0,124.0,290.0,0.0,no(M2 and SIP pres)
76.22998,1,female,1,5,5,Coma,Coma,1,11.0,$11-$25k,10842.0,6858.332,31.0,white,40.0,1,0,0,no,0.0,0.0,dnr after sadm,2.0,61.0,16.3984375,72.0,22.0,36.29688,107.5,2.699707,0.39996338,0.59997559,139.0,7.379883,155.0,12.0,1615.0,7.0,<2 mo. follow-up
34.49399,0,female,0,9,836,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,21510.0,13542.9688,22.5,black,31.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,72.0,11.0996094,96.0,24.0,38.89844,303.6875,2.199707,0.89990234,1.0,133.0,7.489258,114.0,21.0,3.519531,0.0,no(M2 and SIP pres)
72.62097,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,93984.0,60547.6562,64.0,white,71.0,16,0,0,no,0.299999952,0.3,no dnr,9.0,64.0,0.39996338,126.0,20.0,38.89844,333.3,3.5,1.01,1.59985352,135.0,7.419922,180.0,12.0,4400.0,1.0,<2 mo. follow-up
83.66595,1,male,1,23,23,Coma,Coma,3,12.0,under $11k,76277.0,44498.9062,27.666656,white,58.0,11,0,0,no,0.009999998,0.01,dnr after sadm,21.0,68.0,19.0,140.0,40.0,38.59375,150.0,3.0,8.0,2.09960938,136.0,7.399414,96.0,94.0,4435.0,0.0,<2 mo. follow-up
65.71698,1,female,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,152366.0,107529.938,58.5,white,49.0,7,0,0,no,0.599999905,0.6,dnr after sadm,41.0,55.0,14.3984375,107.0,13.0,37.69531,154.0,1.3999023,1.19995117,1.59985352,136.0,7.349609,402.0,46.0,1577.0,0.0,<2 mo. follow-up
57.88098,1,female,1,103,103,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,231688.0,148618.375,42.25,white,28.0,2,0,0,no,0.5,0.1,dnr after sadm,92.0,83.0,11.5,110.0,20.0,36.59375,268.0,3.3999023,0.59997559,0.89990234,149.0,7.419922,113.0,21.0,550.0,1.0,SIP>=30
55.784,1,male,0,9,130,Lung Cancer,Cancer,3,9.0,$11-$25k,9178.0,6278.0234,14.0,white,22.0,1,0,0,metastatic,0.599999905,0.4,no dnr,9.0,146.0,9.0,71.0,39.0,36.5,165.0,4.1992188,1.5,0.89990234,143.0,7.339844,135.0,14.0,4078.0,1.0,no(M2 and SIP pres)
23.452,0,male,0,6,832,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,8584.0,5815.5508,38.0,hispanic,43.0,1,1,0,no,0.949999809,0.9,no dnr,6.0,38.0,27.0976562,138.0,38.0,35.39844,39.0,2.8999023,1.09985352,1.19995117,134.0,7.319336,393.0,16.0,851.0,1.1667481,SIP>=30
62.77298,0,male,0,22,831,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,35988.0,22787.0312,21.333328,white,32.0,1,0,0,no,0.599999905,0.6,no dnr,22.0,58.0,39.09375,130.0,10.0,39.69531,180.0,2.5,4.19921875,4.0,147.0,7.399414,236.0,65.0,83.0,2.5986328,SIP>=30
60.94699,1,male,0,9,21,Lung Cancer,Cancer,2,3.0,under $11k,10915.0,7250.5625,15.0,white,18.0,1,0,0,metastatic,0.599999905,0.5,no dnr,9.0,70.0,2.39990234,104.0,20.0,37.59375,333.3,2.2998047,7.0,0.5,133.0,7.419922,78.0,2.0,950.0,4.0,<2 mo. follow-up
66.5,1,male,0,3,269,Lung Cancer,Cancer,1,14.0,$25-$50k,3819.0,2507.5723,13.0,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,56.0,4.69921875,101.0,20.0,34.5,333.3,2.3999023,5.39941406,0.79992676,131.0,7.419922,139.0,9.0,675.0,1.8388672,no(M2 and SIP pres)
59.57797,0,female,0,9,829,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,27295.0,17937.1875,25.0,white,25.0,5,0,0,metastatic,0.5,0.4,no dnr,9.0,133.0,11.7988281,100.0,10.0,35.0,257.125,2.3999023,0.39996338,1.5,142.0,7.439453,82.0,40.0,5210.0,6.0,no(M2 and SIP pres)
81.55194,0,female,0,3,828,COPD,COPD/CHF/Cirrhosis,3,7.0,under $11k,4090.0,2069.9492,22.610928270087555,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,126.0,10.7988281,67.0,22.0,38.09375,185.0,4.0,1.09985352,0.5,133.0,7.379883,105.0,7.0,3980.0,1.0,no(M2 and SIP pres)
44.35599,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,14176.0,8502.6875,63.0,white,129.0,1,0,0,no,0.0,0.0,dnr after sadm,4.0,89.0,3.59960938,60.0,20.0,37.0,333.3,4.0,0.39996338,1.19995117,136.0,7.419922,122.0,9.0,2502.0,5.0,<2 mo. follow-up
88.77997,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,22140.0,14377.9844,59.0,white,39.0,4,0,0,no,0.699999809,0.5,no dnr,5.0,70.0,7.19921875,114.0,16.0,36.39844,292.0,3.5,1.01,1.19995117,139.0,7.40918,198.0,18.0,1590.0,5.0,<2 mo. follow-up
73.37695,1,male,1,21,21,Coma,Coma,4,12.0,under $11k,38297.0,24944.0625,35.0,black,42.0,1,0,1,no,1.0,0.5,dnr after sadm,19.0,49.0,11.3984375,60.0,18.0,39.89844,156.0,2.7998047,1.79980469,1.29980469,137.0,7.129883,216.0,23.0,1554.0,5.6474609,<2 mo. follow-up
74.64996,1,male,0,14,36,MOSF w/Malig,ARF/MOSF,1,11.0,under $11k,15429.0,10809.7266,13.666664,white,42.0,2,0,0,yes,0.799999714,0.6,dnr after sadm,1.0,101.0,41.796875,74.0,28.0,35.89844,219.03125,3.699707,2.39990234,0.89990234,137.0,7.519531,97.0,33.0,2502.0,0.0,<2 mo. follow-up
82.41998,0,male,0,20,823,ARF/MOSF w/Sepsis,ARF/MOSF,2,20.0,$25-$50k,35216.0,24531.2031,22.0,white,36.0,9,0,0,yes,0.649999619,0.55,no dnr,20.0,0.0,14.6992188,0.0,16.0,37.69531,55.0,1.6999512,0.59997559,2.89990234,121.0,7.269531,257.0,38.0,2502.0,0.494751,adl>=4 (>=5 if sur)
71.48297,1,female,0,11,93,Colon Cancer,Cancer,1,12.0,under $11k,8207.0,6213.6523,8.0,hispanic,19.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,7.0,115.0,6.39941406,114.0,24.0,36.69531,216.0,3.699707,0.59997559,1.09985352,134.0,7.349609,103.0,17.0,1325.0,0.0,adl>=4 (>=5 if sur)
63.25299,0,male,0,30,823,Coma,Coma,1,12.0,under $11k,44181.0,25202.3906,23.5,white,14.0,1,0,0,no,0.049999982,0.0,no dnr,30.0,57.0,8.69921875,109.0,36.0,36.19531,173.46875,2.199707,0.59997559,12.1992188,136.0,7.379883,115.0,83.0,0.0,0.0,no(M2 and SIP pres)
69.82898,1,male,0,3,225,Lung Cancer,Cancer,2,12.0,$11-$25k,2899.0,1931.8603,8.0,white,9.0,1,0,0,metastatic,0.899999619,0.5,no dnr,3.0,105.0,4.09960938,71.0,28.0,37.0,333.3,3.5,1.01,0.79992676,136.0,7.419922,79.0,9.0,2502.0,2.4165039,no(M2 and SIP pres)
76.04895,0,female,0,8,822,CHF,COPD/CHF/Cirrhosis,5,13.0,under $11k,9818.0,5800.0547,10.5,white,44.0,1,1,0,no,0.899999619,0.85,dnr after sadm,2.0,114.0,15.0,69.0,26.0,38.69531,304.125,3.5,1.01,1.19995117,134.0,7.40918,109.0,18.0,2335.0,5.0,no(M2 and SIP pres)
68.28198,1,female,0,10,228,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,22189.0,14281.4219,35.0,white,51.0,1,1,0,no,0.349999905,0.25,no dnr,10.0,114.0,19.5976562,140.0,28.0,37.59375,240.0,2.7998047,1.69995117,1.5,144.0,7.119141,199.0,49.0,2502.0,2.0,no(M2 and SIP pres)
64.22198,1,female,0,28,173,CHF,COPD/CHF/Cirrhosis,7,12.0,under $11k,34293.0,22793.4844,22.5,white,43.0,1,1,0,no,0.899999619,0.8,dnr after sadm,8.0,109.0,43.59375,128.0,8.0,36.89844,290.0,1.3999023,1.89990234,0.79992676,135.0,7.449219,174.0,18.0,3067.0,1.0,no(M2 and SIP pres)
83.64398,0,male,0,12,819,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,14988.0,10007.9531,18.0,white,31.0,1,0,0,metastatic,0.699999809,0.6,no dnr,12.0,116.0,9.79882812,66.0,32.0,36.0,242.5,1.3999023,0.69995117,2.09960938,139.0,7.349609,170.0,18.0,1795.0,3.0,no(M2 and SIP pres)
76.56396,1,male,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,6,20.0,$11-$25k,3525.0,2471.7988,30.0,white,76.0,1,0,0,no,0.699999809,0.5,dnr before sadm,0.0,107.0,20.6992188,103.0,34.0,35.59375,167.5,2.199707,0.39996338,1.29980469,142.0,7.359375,157.0,12.0,5360.0,2.0,<2 mo. follow-up
70.94897,0,female,0,18,820,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,53884.0,34887.6562,42.333313,white,31.0,6,0,0,no,0.949999809,0.95,no dnr,18.0,58.0,22.0976562,122.0,38.0,38.29688,176.65625,2.0996094,0.69995117,5.29980469,145.0,7.439453,138.0,68.0,617.0,0.0,no(M2 and SIP pres)
44.112,1,male,0,6,369,Cirrhosis,COPD/CHF/Cirrhosis,2,9.0,under $11k,5430.0,3820.9727,3.0,white,26.0,1,0,0,no,0.949999809,0.8,no dnr,6.0,63.0,6.5,61.0,24.0,36.19531,309.5,1.8999023,0.69995117,1.19995117,142.0,7.539062,113.0,39.0,2502.0,0.0,no(M2 and SIP pres)
28.523,1,female,0,4,708,Lung Cancer,Cancer,1,12.0,under $11k,5666.0,3811.1543,15.0,white,12.0,1,0,0,metastatic,0.899999619,0.6,no dnr,4.0,95.0,9.69921875,69.0,20.0,36.29688,442.8125,4.0996094,1.0,1.09985352,136.0,7.449219,123.0,10.0,2900.0,0.0,<2 mo. follow-up
43.603,0,female,0,3,817,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5065.0,2676.707,22.610928270087555,white,14.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,70.0,8.29882812,176.0,20.0,37.89844,333.3,4.0,1.0,0.79992676,134.0,7.419922,94.0,14.0,1500.0,0.0,no(M2 and SIP pres)
79.55597,1,male,0,35,98,Coma,Coma,0,16.0,$11-$25k,68866.0,45992.9688,21.0,hispanic,43.0,6,0,0,no,0.669999599,0.7,no dnr,35.0,85.0,9.0,114.0,24.0,36.09375,136.0,3.5,1.01,0.89990234,136.0,7.299805,129.0,9.0,2175.0,1.0,adl>=4 (>=5 if sur)
62.29199,0,male,0,3,817,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,2223.0,1608.5732,22.610928270087555,white,18.0,1,0,0,yes,0.899999619,0.8,no dnr,3.0,122.0,10.1992188,109.0,24.0,35.69531,229.625,3.7998047,0.79992676,0.79992676,136.0,7.30957,120.0,14.0,1900.0,2.4311523,no(M2 and SIP pres)
90.52399,1,female,1,7,7,CHF,COPD/CHF/Cirrhosis,2,5.0,under $11k,6025.0,4134.9375,6.0,white,34.0,1,0,0,no,0.75,0.5,dnr after sadm,6.0,144.0,14.2988281,138.0,13.0,36.69531,134.65625,2.0996094,1.69995117,5.19921875,134.0,7.269531,178.0,63.0,1126.0,1.0,<2 mo. follow-up
64.16699,0,female,0,4,813,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,2727.0,0.0,10.0,black,41.0,1,1,0,no,0.699999809,0.6,no dnr,4.0,101.0,3.89990234,68.0,24.0,36.79688,466.625,2.8999023,4.29980469,0.69995117,138.0,7.389648,92.0,5.0,2502.0,5.0,no(M2 and SIP pres)
65.34998,1,male,0,5,44,Lung Cancer,Cancer,3,12.0,$11-$25k,3482.0,2540.1289,13.0,white,9.0,1,1,0,metastatic,0.5,0.1,no dnr,5.0,123.0,0.69995117,140.0,32.0,35.89844,333.3,3.5,1.01,4.19921875,130.0,7.419922,119.0,42.0,2502.0,4.0,<2 mo. follow-up
54.40399,1,female,0,7,28,Lung Cancer,Cancer,2,12.0,under $11k,6504.0,4654.293,6.0,white,19.0,1,0,0,metastatic,0.5,0.1,dnr before sadm,-1.0,112.0,26.1992188,140.0,12.0,38.5,222.5,1.3999023,3.89990234,0.69995117,139.0,7.40918,194.0,7.0,2250.0,0.0,<2 mo. follow-up
58.995,0,male,0,26,810,CHF,COPD/CHF/Cirrhosis,6,8.0,under $11k,45541.0,30684.9844,28.25,white,29.0,1,1,0,no,0.799999714,0.65,no dnr,26.0,118.0,9.0,53.0,28.0,38.29688,313.3125,1.5998535,1.09985352,2.0,145.0,7.459961,109.0,39.0,4210.0,0.0,SIP>=30
55.702,1,male,0,7,84,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,$11-$25k,10151.0,6042.293,14.5,white,20.0,1,0,0,no,0.899999619,0.85,no dnr,7.0,89.0,10.5,79.0,20.0,36.0,333.3,3.699707,1.0,2.0,138.0,7.419922,113.0,45.0,2502.0,0.0,no(M2 and SIP pres)
77.49799,1,female,1,6,6,Coma,Coma,0,10.0,under $11k,14161.0,9069.25,52.0,white,54.0,1,0,0,no,0.0,0.0,dnr after sadm,1.0,113.0,17.0976562,152.0,10.0,39.79688,190.0,3.5,1.01,0.89990234,143.0,7.429688,176.0,22.0,3695.0,0.0,<2 mo. follow-up
40.93399,0,male,0,8,804,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,6717.0,4903.5938,8.0,white,27.0,1,0,0,no,1.0,1.0,no dnr,8.0,107.0,10.5,121.0,9.0,36.5,184.0,2.3999023,1.0,1.29980469,132.0,7.429688,233.0,16.0,4575.0,0.0,no(M2 and SIP pres)
74.146,0,female,0,4,803,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,3434.0,1934.5312,12.0,white,19.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,116.0,6.5,116.0,24.0,36.39844,224.96875,3.199707,0.89990234,0.5,130.0,7.459961,102.0,4.0,3075.0,1.0,no(M2 and SIP pres)
34.64798,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,49625.0,30662.9688,22.610928270087555,white,98.0,14,0,0,no,0.199999928,0.2,no dnr,3.0,103.0,21.796875,85.0,20.0,36.19531,333.3,3.0996094,0.59997559,13.3984375,140.0,7.419922,151.0,83.0,2450.0,5.0,<2 mo. follow-up
74.19299,1,male,0,15,176,Colon Cancer,Cancer,1,20.0,under $11k,11182.0,8331.7891,10.666664,white,19.0,1,0,0,metastatic,0.799999714,0.4,dnr after sadm,13.0,65.0,7.29980469,64.0,20.0,36.09375,333.3,4.2998047,0.59997559,1.0,138.0,7.419922,261.0,22.0,2475.0,1.1667481,SIP>=30
84.10394,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,41670.0,25552.9531,62.0,white,74.0,1,0,0,no,0.399999857,0.35,dnr after sadm,8.0,96.0,4.89941406,65.0,20.0,36.5,333.3,2.5996094,4.29980469,0.59997559,140.0,7.419922,80.0,7.0,860.0,2.9750977,<2 mo. follow-up
69.71899,0,male,0,7,799,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,14225.0,7411.1992,10.5,white,57.0,1,0,0,no,0.899999619,0.85,no dnr,7.0,104.0,12.0,130.0,26.0,35.5,257.125,3.0996094,0.59997559,1.0,141.0,7.339844,202.0,7.0,1475.0,0.494751,no(M2 and SIP pres)
65.66998,1,male,1,13,13,Coma,Coma,0,11.0,under $11k,34190.0,21498.0781,43.0,white,34.0,2,0,0,no,0.399999857,0.35,dnr after sadm,11.0,153.0,11.2988281,63.0,24.0,36.79688,153.03125,2.2998047,0.79992676,1.29980469,142.0,7.329102,96.0,24.0,5565.0,0.0,<2 mo. follow-up
85.48895,1,female,0,13,147,CHF,COPD/CHF/Cirrhosis,5,5.0,under $11k,13746.0,9013.9375,9.5,white,36.0,1,1,1,no,0.799999714,0.6,no dnr,13.0,121.0,11.2988281,147.0,34.0,40.0,202.0,3.2998047,0.59997559,0.89990234,143.0,7.529297,398.0,14.0,2183.0,7.0,adl>=4 (>=5 if sur)
52.22198,0,female,0,9,799,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,9511.0,6064.7969,11.0,black,20.0,1,0,0,no,0.949999809,0.85,no dnr,9.0,123.0,11.3984375,124.0,36.0,38.79688,215.0,3.0996094,1.0,1.39990234,160.0,7.5,183.0,24.0,2885.0,1.0,no(M2 and SIP pres)
61.59097,0,female,0,174,798,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,528991.0,343305.25,53.5,white,56.0,3,0,0,no,0.5,0.75,no dnr,174.0,116.0,15.6992188,122.0,42.0,36.69531,126.65625,2.5,0.19998169,0.69995117,141.0,7.489258,78.0,8.0,9000.0,0.0,adl>=4 (>=5 if sur)
87.44696,1,female,0,4,248,CHF,COPD/CHF/Cirrhosis,4,10.0,under $11k,3190.0,2298.9609,7.0,white,31.0,1,1,1,no,0.699999809,0.5,no dnr,4.0,54.0,18.5976562,117.0,35.0,39.5,328.5625,2.0,3.19970703,3.5,130.0,7.359375,187.0,44.0,853.0,5.1425781,adl>=4 (>=5 if sur)
74.64496,1,male,0,6,70,Lung Cancer,Cancer,3,9.0,under $11k,5841.0,3918.9316,15.0,white,32.0,1,0,0,metastatic,0.599999905,0.2,dnr after sadm,2.0,57.0,22.8984375,63.0,8.0,35.69531,325.6875,2.8999023,0.89990234,12.0,137.0,7.399414,117.0,154.0,0.0,0.0,<2 mo. follow-up
70.85797,0,female,0,9,795,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,15318.0,9469.1094,29.0,white,50.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,71.0,14.0996094,119.0,8.0,38.5,115.0,1.6999512,2.5,0.5,126.0,7.529297,122.0,15.0,1478.0,3.0,SIP>=30
38.54898,0,female,0,6,795,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,19873.0,12585.9062,25.0,white,27.0,4,0,0,no,0.75,0.6,no dnr,6.0,69.0,9.3984375,130.0,28.0,36.59375,134.6875,2.8999023,1.5,0.69995117,137.0,7.40918,74.0,14.0,2368.0,0.0,no(M2 and SIP pres)
77.29498,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,99954.0,64701.1562,52.5,white,48.0,1,1,0,no,0.049999982,0.0,dnr after sadm,30.0,68.0,15.2988281,107.0,30.0,36.59375,333.3,2.699707,0.79992676,0.79992676,136.0,7.419922,286.0,6.0,2050.0,7.0,<2 mo. follow-up
44.34998,1,male,0,6,42,Lung Cancer,Cancer,2,12.0,under $11k,5294.0,0.0,13.0,black,21.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,2.0,118.0,6.89941406,61.0,22.0,36.59375,460.0,1.5,0.39996338,3.69970703,133.0,7.40918,383.0,50.0,2646.0,6.0,<2 mo. follow-up
64.91699,0,male,0,22,794,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,42535.0,27290.4375,37.0,white,47.0,3,0,0,no,0.5,0.45,no dnr,22.0,131.0,9.79882812,77.0,43.0,36.29688,202.5,2.699707,1.59985352,0.5,149.0,7.539062,119.0,12.0,3795.0,0.0,no(M2 and SIP pres)
71.81396,0,female,0,10,790,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,17482.0,11167.8828,38.0,white,45.0,1,1,0,no,0.949999809,0.9,no dnr,10.0,80.0,11.8984375,101.0,32.0,37.5,252.375,2.8999023,0.19998169,1.19995117,137.0,7.429688,87.0,18.0,2675.0,7.0,adl>=4 (>=5 if sur)
82.91296,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,17620.0,9559.0625,18.5,white,41.0,5,1,0,yes,0.0,0.0,dnr after sadm,4.0,82.0,5.5,85.0,24.0,36.39844,333.3,3.7998047,0.39996338,1.0,137.0,7.419922,141.0,13.0,6625.0,0.0,<2 mo. follow-up
76.646,0,female,0,4,790,Colon Cancer,Cancer,1,12.0,under $11k,3833.0,2677.7578,5.0,white,9.0,1,0,0,metastatic,1.0,0.8,no dnr,4.0,69.0,5.0,118.0,24.0,36.79688,161.65625,2.5996094,3.09960938,0.69995117,135.0,7.379883,96.0,6.0,1890.0,1.0,no(M2 and SIP pres)
60.70398,0,female,0,4,790,Cirrhosis,COPD/CHF/Cirrhosis,4,9.0,$11-$25k,7557.0,5053.4688,11.0,white,9.0,2,1,0,yes,0.799999714,0.6,no dnr,4.0,85.0,6.59960938,88.0,24.0,37.0,270.3125,3.5,1.01,1.19995117,137.0,7.399414,118.0,25.0,100.0,0.0,no(M2 and SIP pres)
62.71899,1,female,1,3,3,Coma,Coma,0,8.0,$25-$50k,6113.0,3972.3184,34.0,white,90.0,1,0,0,no,0.099999964,0.0,dnr after sadm,2.0,45.0,17.5976562,200.0,36.0,36.09375,114.0,1.8999023,21.8984375,2.59960938,124.0,7.30957,34.0,12.0,144.0,1.0,<2 mo. follow-up
58.30798,0,male,0,10,789,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,9487.0,6871.7852,10.5,white,27.0,1,0,0,no,0.799999714,0.8,no dnr,10.0,71.0,10.3984375,76.0,24.0,35.79688,195.0,2.8999023,2.29980469,1.59985352,134.0,7.429688,98.0,54.0,1990.0,0.0,SIP>=30
79.12396,1,male,0,16,42,MOSF w/Malig,ARF/MOSF,3,0.0,under $11k,17993.0,13135.5078,11.333328,white,39.0,6,1,0,metastatic,0.5,0.1,dnr before sadm,-1.0,84.0,6.19921875,72.0,20.0,34.89844,228.5625,3.199707,2.19970703,0.69995117,132.0,7.389648,89.0,10.0,545.0,1.0,<2 mo. follow-up
74.724,1,male,0,15,17,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,26976.0,17403.8281,31.333328,white,72.0,1,0,0,no,0.349999905,0.3,dnr after sadm,1.0,102.0,43.1953125,107.0,36.0,36.09375,333.3,3.5,1.01,3.0,138.0,7.419922,94.0,33.0,1950.0,5.0,<2 mo. follow-up
65.61499,1,male,0,7,25,CHF,COPD/CHF/Cirrhosis,1,12.0,>$50k,11004.0,5491.8789,11.0,white,27.0,1,0,0,no,0.949999809,0.9,no dnr,7.0,102.0,6.39941406,75.0,38.0,35.5,288.875,2.0996094,0.89990234,1.69995117,141.0,7.429688,78.0,18.0,1830.0,0.0,<2 mo. follow-up
75.24396,1,male,1,46,46,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,81024.0,53595.125,32.5,white,39.0,1,1,1,no,0.75,0.1,dnr after sadm,3.0,75.0,9.69921875,76.0,16.0,36.0,333.3,2.0996094,1.39990234,0.69995117,129.0,7.419922,135.0,16.0,2502.0,6.0,<2 mo. follow-up
67.28296,0,female,0,8,785,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,under $11k,10817.0,7378.5508,12.0,white,16.0,1,0,0,no,0.949999809,0.95,no dnr,8.0,75.0,20.296875,68.0,10.0,38.09375,231.40625,4.2998047,0.5,1.0,141.0,7.469727,107.0,16.0,704.0,0.494751,<2 mo. follow-up
64.55298,0,male,0,4,782,COPD,COPD/CHF/Cirrhosis,4,6.0,under $11k,3957.0,2566.5977,12.0,white,7.0,1,0,0,no,0.899999619,0.85,no dnr,4.0,111.0,8.29882812,81.0,20.0,37.69531,333.3,3.5,1.01,1.09985352,140.0,7.419922,112.0,13.0,2502.0,0.494751,no(M2 and SIP pres)
76.271,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,22169.0,14495.5469,37.5,white,53.0,2,1,0,no,0.25,0.1,dnr after sadm,8.0,107.0,6.79980469,74.0,20.0,35.29688,137.03125,4.1992188,1.29980469,1.89990234,136.0,7.339844,158.0,63.0,1485.0,3.1337891,<2 mo. follow-up
74.93195,1,female,0,8,21,Cirrhosis,COPD/CHF/Cirrhosis,5,9.0,$11-$25k,9535.0,6474.2812,23.0,white,37.0,1,1,0,yes,0.199999928,0.1,dnr after sadm,1.0,115.0,12.7988281,111.0,11.0,36.59375,160.0,2.7998047,3.0,4.09960938,137.0,7.549805,159.0,42.0,747.0,3.0,<2 mo. follow-up
82.85596,0,female,0,20,780,CHF,COPD/CHF/Cirrhosis,4,5.0,under $11k,16190.0,12133.25,6.666664,black,38.0,2,1,0,no,0.799999714,0.7,dnr before sadm,-1.0,68.0,10.8984375,104.0,24.0,36.0,157.5,3.8999023,0.89990234,2.0,139.0,7.209961,202.0,76.0,1675.0,6.0,adl>=4 (>=5 if sur)
63.63898,1,male,0,8,758,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,10863.0,6378.3438,18.0,white,29.0,1,0,0,no,0.949999809,0.9,no dnr,8.0,117.0,11.0996094,100.0,21.0,37.59375,203.6875,3.2998047,0.59997559,3.59960938,146.0,7.439453,103.0,63.0,2540.0,0.0,no(M2 and SIP pres)
71.474,0,male,0,9,777,CHF,COPD/CHF/Cirrhosis,5,5.0,under $11k,8004.0,5895.2852,11.0,black,31.0,1,1,0,no,0.799999714,0.7,no dnr,9.0,53.0,10.1992188,66.0,28.0,37.0,333.3,2.0996094,5.19921875,3.09960938,136.0,7.419922,98.0,45.0,190.0,4.0,adl>=4 (>=5 if sur)
73.45398,1,female,1,57,57,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,171216.0,108781.875,39.5,white,23.0,14,0,0,no,0.599999905,0.4,dnr after sadm,57.0,107.0,14.0996094,140.0,10.0,38.0,140.0,3.5,1.01,0.89990234,132.0,7.429688,86.0,13.0,2913.0,1.0,<2 mo. follow-up
57.08398,1,female,1,32,32,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,119689.0,78583.4375,53.25,white,53.0,9,0,0,yes,0.299999952,0.2,dnr after sadm,30.0,96.0,6.79980469,130.0,20.0,36.5,400.0,2.0996094,7.39941406,0.59997559,131.0,7.419922,148.0,6.0,2502.0,1.0,<2 mo. follow-up
27.91499,0,male,0,32,775,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,51737.0,34929.4375,29.75,white,40.0,2,0,0,no,0.799999714,0.95,no dnr,32.0,75.0,6.29980469,55.0,20.0,36.59375,333.3,3.5,1.01,0.89990234,138.0,7.419922,121.0,7.0,4200.0,0.0,no(M2 and SIP pres)
43.31799,0,female,0,4,775,CHF,COPD/CHF/Cirrhosis,3,11.0,>$50k,3774.0,2671.8027,13.0,white,30.0,1,1,0,no,0.5,0.25,dnr before sadm,-1.0,106.0,9.3984375,53.0,22.0,36.39844,333.3,4.0996094,1.09985352,1.0,138.0,7.419922,92.0,14.0,900.0,6.0,adl>=4 (>=5 if sur)
73.27594,1,female,1,4,4,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,4532.0,2593.2266,20.0,white,69.0,1,1,0,no,0.799999714,0.7,dnr after sadm,3.0,110.0,17.6992188,68.0,10.0,38.29688,218.0,3.5,1.01,1.09985352,132.0,7.439453,158.0,25.0,1.569824,7.0,<2 mo. follow-up
59.504,1,male,1,6,6,Coma,Coma,3,12.0,under $11k,28075.0,18682.875,61.0,white,80.0,9,0,0,yes,0.019999996,0.01,dnr after sadm,2.0,87.0,2.69970703,69.0,22.0,36.39844,333.3,2.199707,1.29980469,0.89990234,133.0,7.419922,91.0,5.0,2502.0,0.0,<2 mo. follow-up
57.94699,1,female,0,8,171,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,12181.0,7889.6992,30.0,white,30.0,1,1,0,metastatic,0.5,0.2,no dnr,8.0,64.0,5.5,69.0,24.0,35.89844,333.3,3.699707,0.29998779,1.69995117,138.0,7.419922,93.0,64.0,1275.0,6.0,SIP>=30
60.91699,1,female,0,8,466,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,6069.0,4591.3398,9.0,white,30.0,1,1,0,no,0.799999714,0.7,no dnr,8.0,97.0,10.1992188,59.0,20.0,36.09375,195.21875,3.0996094,0.69995117,4.89941406,140.0,7.329102,178.0,59.0,1300.0,5.0,no(M2 and SIP pres)
77.93799,0,female,0,8,773,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,8357.0,5456.5352,11.5,black,22.0,1,0,1,no,0.799999714,0.6,no dnr,8.0,113.0,9.0,76.0,20.0,36.5,333.3,3.5,1.01,1.09985352,146.0,7.419922,65.0,16.0,2502.0,0.0,no(M2 and SIP pres)
53.85898,1,female,1,5,5,Coma,Coma,0,12.0,under $11k,41029.0,26436.7656,61.0,black,25.0,8,0,0,no,0.799999714,0.9,no dnr,5.0,116.0,19.1992188,62.0,18.0,35.59375,390.4375,4.3994141,0.69995117,0.79992676,133.0,7.259766,330.0,18.0,3400.0,1.6091309,<2 mo. follow-up
74.46698,1,female,0,11,634,CHF,COPD/CHF/Cirrhosis,2,17.0,>$50k,16886.0,9589.0,30.0,white,68.0,1,1,0,no,0.899999619,0.75,no dnr,11.0,67.0,9.5,116.0,12.0,35.59375,344.0,3.5,1.01,1.39990234,112.0,7.459961,168.0,16.0,2128.0,0.0,<2 mo. follow-up
48.181,1,male,1,67,67,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,121285.0,82648.0,16.25,white,38.0,21,0,0,no,0.5,0.5,dnr after sadm,58.0,72.0,12.5,50.0,24.0,36.19531,282.0,4.1992188,0.69995117,1.59985352,141.0,7.299805,123.0,25.0,2260.0,1.8388672,<2 mo. follow-up
49.96298,0,male,0,12,770,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,26074.0,16713.625,16.5,white,43.0,4,0,0,no,0.949999809,0.8,no dnr,12.0,124.0,16.296875,180.0,37.0,38.0,367.5,2.2998047,0.79992676,0.89990234,135.0,7.459961,114.0,29.0,2024.0,3.0,no(M2 and SIP pres)
62.48297,0,male,0,18,769,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,50318.0,33684.7812,20.666656,white,35.0,6,1,0,no,0.899999619,0.7,no dnr,18.0,74.0,6.59960938,72.0,16.0,38.09375,333.3,2.0996094,4.89941406,0.89990234,138.0,7.419922,91.0,4.0,1750.0,0.0,no(M2 and SIP pres)
41.37399,0,female,0,87,769,Coma,Coma,0,14.0,under $11k,161771.0,111000.875,27.0,white,16.0,7,0,0,no,0.949999809,0.95,no dnr,87.0,72.0,11.5996094,58.0,22.0,36.5,333.3,3.7998047,0.89990234,0.69995117,140.0,7.419922,91.0,11.0,475.0,0.0,adl>=4 (>=5 if sur)
68.73895,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,51447.0,32388.7031,51.0,black,111.0,12,0,0,yes,0.049999982,0.05,dnr after sadm,3.0,45.0,26.6992188,122.0,44.0,40.79688,305.0,2.0,1.69995117,6.0,134.0,7.299805,73.0,76.0,0.0,0.0,<2 mo. follow-up
32.26599,0,female,0,11,766,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,29835.0,19437.3906,25.5,white,34.0,4,0,0,no,0.989999771,0.99,no dnr,11.0,114.0,5.5,60.0,20.0,36.19531,333.3,3.699707,1.0,1.39990234,145.0,7.419922,282.0,31.0,2502.0,0.0,<2 mo. follow-up
77.27594,1,female,0,10,148,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,13611.0,8746.2656,15.0,white,33.0,1,0,0,no,0.5,0.5,dnr after sadm,2.0,64.0,27.6992188,77.0,34.0,36.0,55.0,1.8999023,1.29980469,2.59960938,147.0,7.379883,90.0,62.0,1123.0,1.0,SIP>=30
67.87396,0,female,0,10,763,Lung Cancer,Cancer,1,12.0,under $11k,11873.0,8039.5586,14.5,black,17.0,1,0,0,metastatic,0.899999619,0.75,dnr after sadm,9.0,112.0,14.1992188,74.0,32.0,36.39844,157.125,4.5,2.19970703,2.0,140.0,7.459961,124.0,39.0,1625.0,0.0,no(M2 and SIP pres)
51.06598,1,female,0,13,58,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,10079.0,7440.2852,20.5,black,44.0,1,0,0,yes,0.0,0.0,dnr after sadm,2.0,143.0,16.5,72.0,10.0,38.5,221.65625,3.2998047,1.79980469,1.69995117,142.0,7.459961,155.0,46.0,3680.0,3.0,<2 mo. follow-up
52.99399,1,male,1,13,13,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,31891.0,20829.9844,47.0,white,45.0,1,0,0,no,0.699999809,0.5,dnr after sadm,10.0,118.0,6.89941406,76.0,20.0,35.59375,381.625,4.0996094,1.19995117,1.59985352,131.0,7.429688,120.0,55.0,1450.0,2.8759766,<2 mo. follow-up
50.26999,1,male,0,4,397,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,3801.0,2191.418,4.0,black,28.0,1,0,0,no,0.759999752,0.6,no dnr,4.0,97.0,12.5996094,65.0,24.0,36.5,309.5,4.5996094,2.5,1.0,136.0,7.40918,103.0,18.0,2000.0,3.0,no(M2 and SIP pres)
46.86398,1,male,0,3,513,Lung Cancer,Cancer,1,12.0,under $11k,3070.0,2063.2363,22.610928270087555,black,9.0,1,0,0,metastatic,0.899999619,0.6,no dnr,3.0,128.0,9.59960938,110.0,60.0,39.29688,98.5625,1.3999023,1.09985352,0.59997559,138.0,7.40918,121.0,4.0,4730.0,2.0,SIP>=30
74.75195,1,female,0,9,78,Cirrhosis,COPD/CHF/Cirrhosis,3,7.0,under $11k,7948.0,5618.1289,5.0,white,8.0,1,1,0,metastatic,0.399999857,0.3,dnr after sadm,2.0,142.0,5.19921875,70.0,24.0,35.89844,323.75,3.8999023,0.89990234,1.29980469,144.0,7.459961,172.0,30.0,1350.0,0.494751,<2 mo. follow-up
60.33099,1,male,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,103796.0,66242.3125,44.333313,white,53.0,1,1,0,no,0.599999905,0.6,dnr after sadm,20.0,67.0,9.5,110.0,32.0,35.79688,333.3,3.8999023,0.89990234,0.89990234,138.0,7.419922,149.0,9.0,850.0,5.0,<2 mo. follow-up
90.31598,0,female,0,23,759,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,27841.0,19648.4531,17.666656,white,33.0,1,0,0,no,1.0,0.8,no dnr,23.0,58.0,11.3984375,65.0,24.0,37.89844,152.0,2.199707,0.29998779,0.59997559,141.0,7.509766,121.0,20.0,2005.0,6.0,adl>=4 (>=5 if sur)
64.56897,1,male,0,4,387,Lung Cancer,Cancer,1,12.0,$11-$25k,5765.0,3704.4961,11.0,white,32.0,1,0,0,metastatic,0.099999964,0.0,no dnr,4.0,143.0,23.5,128.0,32.0,36.19531,379.5625,2.699707,0.29998779,0.79992676,137.0,7.449219,104.0,14.0,3655.0,1.1667481,<2 mo. follow-up
52.88199,0,male,0,4,759,CHF,COPD/CHF/Cirrhosis,3,7.0,under $11k,5504.0,2770.3203,14.0,white,31.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,119.0,21.5,115.0,8.0,38.19531,305.6875,2.0996094,5.5,1.89990234,149.0,7.459961,245.0,80.0,2510.0,0.494751,no(M2 and SIP pres)
57.69498,1,female,1,12,12,Lung Cancer,Cancer,1,12.0,under $11k,11371.0,7853.918,13.0,white,17.0,1,0,0,metastatic,0.099999964,0.0,dnr before sadm,0.0,74.0,8.3984375,110.0,28.0,36.0,376.1875,3.0,0.89990234,0.69995117,133.0,7.489258,107.0,7.0,2502.0,0.0,<2 mo. follow-up
75.14899,1,female,0,38,140,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,81821.0,56451.2188,42.0,white,73.0,9,1,0,no,0.599999905,0.6,no dnr,38.0,58.0,11.3984375,99.0,12.0,36.59375,126.25,2.7998047,0.59997559,1.5,139.0,7.389648,227.0,42.0,2110.0,0.0,SIP>=30
70.28296,0,female,0,4,757,COPD,COPD/CHF/Cirrhosis,2,7.0,under $11k,3537.0,2384.1836,14.0,white,13.0,1,0,0,no,0.899999619,0.75,no dnr,4.0,122.0,30.296875,300.0,12.0,36.29688,225.0,2.0,0.29998779,0.59997559,138.0,7.389648,171.0,28.0,2465.0,1.8388672,SIP>=30
83.24194,0,female,0,20,757,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,42356.0,24962.9844,15.666664,white,28.0,2,0,0,no,0.899999619,0.9,no dnr,20.0,59.0,6.79980469,58.0,24.0,35.19531,333.3,2.5996094,1.09985352,2.39990234,150.0,7.419922,181.0,32.0,1400.0,0.0,no(M2 and SIP pres)
54.09998,0,female,0,9,756,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,$11-$25k,20297.0,12216.4219,29.0,white,60.0,1,1,0,no,0.799999714,0.8,no dnr,9.0,115.0,4.39941406,69.0,24.0,36.39844,333.3,3.2998047,0.59997559,0.79992676,140.0,7.419922,85.0,15.0,2502.0,5.0,SIP>=30
75.92297,1,female,0,20,68,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,43953.0,28345.7969,35.333313,white,69.0,1,0,0,yes,0.0,0.0,no dnr,20.0,113.0,6.59960938,82.0,20.0,37.0,333.3,2.699707,0.79992676,1.0,146.0,7.419922,115.0,16.0,3117.0,2.0,<2 mo. follow-up
78.87994,0,male,0,57,754,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$25-$50k,99342.0,62509.9688,32.0,white,45.0,7,1,0,no,0.899999619,0.9,no dnr,57.0,42.0,20.6992188,66.0,3.0,34.39844,86.0,3.0,0.59997559,2.0,136.0,7.259766,111.0,29.0,10.0,0.0,no(M2 and SIP pres)
47.41699,1,female,0,39,74,MOSF w/Malig,ARF/MOSF,1,12.0,>$50k,147284.0,93937.5625,47.0,white,35.0,16,0,0,metastatic,0.25,0.1,dnr before sadm,-1.0,68.0,12.1992188,71.0,20.0,36.69531,352.0,2.5996094,5.39941406,1.09985352,128.0,7.489258,107.0,18.0,2750.0,0.0,SIP>=30
25.659,1,female,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,50963.0,31926.7188,54.0,white,24.0,1,0,0,no,0.5,0.8,dnr after sadm,15.0,47.0,16.1992188,66.0,24.0,36.0,333.3,3.5,1.01,1.59985352,132.0,7.419922,478.0,26.0,4150.0,7.0,<2 mo. follow-up
68.27899,1,male,0,35,271,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,56443.0,37968.6875,27.5,white,43.0,1,1,0,no,0.5,0.5,no dnr,35.0,58.0,15.1992188,80.0,13.0,36.0,174.28125,2.199707,1.59985352,3.19970703,131.0,7.449219,144.0,158.0,400.0,3.0,no(M2 and SIP pres)
58.04199,0,male,0,4,754,CHF,COPD/CHF/Cirrhosis,2,3.0,under $11k,4621.0,2825.0508,5.0,black,22.0,1,1,0,no,0.599999905,0.6,no dnr,4.0,70.0,6.29980469,101.0,24.0,35.39844,360.0,3.8999023,1.09985352,2.5,136.0,7.40918,101.0,30.0,1848.0,0.494751,no(M2 and SIP pres)
64.534,1,female,0,10,195,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,9137.0,6217.2305,9.0,white,19.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,126.0,21.1992188,124.0,34.0,39.89844,278.0,3.0,1.09985352,1.19995117,133.0,7.599609,329.0,16.0,3980.0,0.0,no(M2 and SIP pres)
55.04999,0,male,0,29,752,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,$11-$25k,60692.0,40551.0312,35.75,white,37.0,4,1,0,no,0.799999714,0.7,no dnr,29.0,102.0,12.3984375,77.0,14.0,37.89844,333.3,3.0,0.59997559,0.79992676,142.0,7.419922,96.0,31.0,2502.0,1.0,no(M2 and SIP pres)
59.39999,0,female,0,83,751,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,166403.0,0.0,40.5,white,50.0,1,0,0,no,1.0,1.0,no dnr,83.0,93.0,13.0996094,108.0,16.0,36.5,316.0,4.0,0.59997559,1.0,139.0,7.359375,108.0,12.0,2502.0,0.0,SIP>=30
83.92297,0,female,0,11,750,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,9448.0,6874.3594,18.0,black,45.0,1,1,1,no,1.0,1.0,no dnr,11.0,115.0,15.3984375,113.0,34.0,38.09375,333.3,1.8999023,0.79992676,1.89990234,147.0,7.359375,213.0,81.0,3130.0,7.0,adl>=4 (>=5 if sur)
67.71497,1,male,0,5,26,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,10883.0,6483.543,40.0,white,49.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,73.0,4.69921875,96.0,24.0,35.79688,588.0,3.0,6.19921875,3.69970703,140.0,7.319336,143.0,70.0,2825.0,2.0,<2 mo. follow-up
57.35199,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,44357.0,30127.9531,34.0,black,53.0,21,1,0,no,0.0,0.0,dnr after sadm,2.0,83.0,6.59960938,76.0,24.0,36.5,233.3125,3.3999023,0.79992676,1.09985352,137.0,7.459961,201.0,14.0,1.199951,3.2211914,<2 mo. follow-up
80.44397,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,under $11k,28011.0,18735.6094,52.0,black,112.0,14,0,0,no,0.699999809,0.5,dnr after sadm,3.0,77.0,12.5996094,129.0,30.0,36.0,296.0,2.7998047,0.5,1.0,131.0,7.539062,96.0,10.0,2800.0,2.2382812,<2 mo. follow-up
65.59595,1,male,0,23,499,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,83233.0,55499.1562,33.333313,white,38.0,16,0,0,yes,0.799999714,0.7,no dnr,23.0,83.0,6.09960938,93.0,20.0,37.59375,376.1875,3.5,1.29980469,2.19970703,137.0,7.519531,112.0,45.0,1325.0,6.0,<2 mo. follow-up
77.98798,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,38200.0,19655.75,54.5,white,50.0,1,0,0,no,0.199999928,0.15,dnr after sadm,12.0,63.0,12.5,69.0,12.0,38.19531,275.6875,2.8999023,0.69995117,0.69995117,127.0,7.469727,172.0,15.0,2166.0,2.8496094,<2 mo. follow-up
70.66095,0,male,0,19,748,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,20463.0,14014.3594,12.333328,white,26.0,1,0,0,no,0.949999809,0.94,no dnr,19.0,109.0,26.0,80.0,10.0,36.5,303.3125,1.8999023,9.0,1.19995117,133.0,7.479492,67.0,29.0,1219.0,1.1667481,<2 mo. follow-up
52.07098,1,male,0,7,89,Cirrhosis,COPD/CHF/Cirrhosis,1,10.0,under $11k,9472.0,6581.4414,8.0,black,39.0,3,0,0,no,0.599999905,0.45,no dnr,7.0,69.0,25.296875,112.0,11.0,39.59375,116.0,2.2998047,0.29998779,0.89990234,144.0,7.419922,121.0,16.0,1206.0,5.1992188,<2 mo. follow-up
67.07697,0,female,0,22,746,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,50276.0,32878.0312,45.333313,white,63.0,1,0,0,yes,0.849999905,0.8,no dnr,22.0,80.0,10.7988281,72.0,20.0,36.19531,333.3,3.5996094,1.19995117,1.69995117,122.0,7.419922,283.0,51.0,1460.0,1.0,no(M2 and SIP pres)
46.35498,1,male,0,5,260,Lung Cancer,Cancer,2,12.0,under $11k,5674.0,3828.9844,28.0,white,18.0,1,0,0,metastatic,0.899999619,0.9,no dnr,5.0,65.0,12.1992188,114.0,42.0,36.09375,314.25,4.2998047,0.89990234,2.19970703,132.0,7.419922,315.0,46.0,80.0,0.0,no(M2 and SIP pres)
70.97894,0,male,0,8,746,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8574.0,6221.0352,14.0,white,20.0,1,0,0,yes,0.899999619,0.8,no dnr,8.0,56.0,12.0996094,65.0,30.0,34.09375,48.0,1.3999023,1.0,1.5,148.0,7.329102,259.0,15.0,855.0,1.8388672,<2 mo. follow-up
68.91199,0,male,0,4,746,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,3216.0,2273.0098,9.0,white,15.0,1,0,0,no,0.5,0.5,no dnr,4.0,103.0,8.0,122.0,24.0,35.19531,333.3,2.0,0.5,0.5,132.0,7.419922,345.0,7.0,4215.0,0.0,SIP>=30
85.26495,1,female,0,8,517,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,9667.0,6643.6367,16.0,black,23.0,1,0,1,no,0.299999952,0.2,dnr after sadm,1.0,105.0,4.5,61.0,24.0,36.69531,252.375,2.8999023,0.79992676,2.29980469,140.0,7.389648,85.0,48.0,2200.0,6.0,adl>=4 (>=5 if sur)
45.02698,0,female,0,48,743,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,58833.0,40751.25,30.25,white,62.0,1,0,0,no,0.0,0.0,dnr after sadm,11.0,61.0,5.69921875,48.0,24.0,36.19531,319.0,4.0,0.69995117,1.39990234,142.0,7.379883,179.0,18.0,2502.0,3.0,adl>=4 (>=5 if sur)
48.33698,1,female,0,63,164,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,124981.0,83853.9375,43.75,white,39.0,2,1,0,no,1.0,1.0,no dnr,63.0,130.0,14.3984375,73.0,30.0,38.39844,372.0,3.5,1.01,0.89990234,140.0,7.419922,155.0,39.0,2475.0,6.0,adl>=4 (>=5 if sur)
38.58499,0,male,0,11,728,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,34372.0,22292.2031,26.5,white,37.0,9,0,0,no,0.799999714,0.7,no dnr,11.0,53.0,13.5996094,136.0,44.0,36.59375,127.5,3.5996094,1.0,2.29980469,135.0,7.439453,226.0,46.0,2537.0,0.0,no(M2 and SIP pres)
30.754,1,male,0,6,7,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,7459.0,4904.0312,9.0,white,50.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,4.0,107.0,13.5,64.0,20.0,36.19531,144.4375,2.0996094,2.19970703,0.5,131.0,7.529297,158.0,8.0,3600.0,5.0,<2 mo. follow-up
34.93997,1,male,1,3,3,Coma,Coma,0,12.0,under $11k,45217.0,29206.0625,38.0,black,41.0,10,0,0,no,0.699999809,0.5,no dnr,3.0,118.0,7.0,60.0,33.0,35.79688,134.6875,2.5996094,13.0,0.59997559,136.0,7.479492,180.0,15.0,1305.0,2.6269531,<2 mo. follow-up
70.62598,0,male,0,7,726,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,13183.0,8607.6953,16.5,black,30.0,3,0,1,no,0.799999714,0.75,no dnr,7.0,63.0,27.3984375,96.0,22.0,36.0,157.5,2.199707,0.59997559,1.79980469,123.0,7.489258,307.0,7.0,3480.0,1.0,no(M2 and SIP pres)
57.84299,1,female,1,5,5,Coma,Coma,1,12.0,>$50k,27572.0,17283.375,40.0,white,31.0,5,0,0,no,1.0,0.5,no dnr,5.0,68.0,13.5996094,69.0,28.0,39.89844,506.625,3.5,1.01,0.89990234,137.0,7.439453,161.0,12.0,2660.0,0.0,<2 mo. follow-up
78.60394,1,male,0,9,186,COPD,COPD/CHF/Cirrhosis,0,10.0,$11-$25k,20281.0,12641.4688,26.0,white,24.0,2,0,0,no,0.899999619,0.7,no dnr,9.0,37.0,28.296875,129.0,8.0,35.40625,188.5625,1.6999512,2.29980469,4.19921875,123.0,7.189453,111.0,48.0,115.0,2.0,no(M2 and SIP pres)
42.41498,0,male,0,4,726,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,3282.0,2309.2637,8.0,white,21.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,68.0,16.0,117.0,40.0,39.0,175.0,2.0,0.39996338,0.69995117,138.0,7.429688,104.0,7.0,2780.0,1.0,no(M2 and SIP pres)
30.30299,0,male,0,24,725,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,52302.0,32196.7656,35.666657,white,51.0,1,0,0,no,0.799999714,0.7,no dnr,24.0,105.0,6.39941406,112.0,32.0,35.19531,164.5,3.5,1.09985352,0.59997559,133.0,7.259766,150.0,16.0,680.0,7.0,adl>=4 (>=5 if sur)
62.66098,1,male,0,5,499,CHF,COPD/CHF/Cirrhosis,8,8.0,under $11k,4819.0,3246.1875,15.0,white,21.0,1,1,0,no,0.699999809,0.7,no dnr,5.0,86.0,12.3984375,74.0,24.0,37.0,319.0,3.8999023,1.0,1.0,133.0,7.459961,111.0,14.0,1325.0,0.494751,no(M2 and SIP pres)
22.03099,0,male,0,52,724,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,111446.0,72256.6875,25.75,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,52.0,103.0,5.29980469,110.0,20.0,36.19531,237.125,2.7998047,0.79992676,1.79980469,142.0,7.429688,74.0,34.0,1.899902,7.0,no(M2 and SIP pres)
62.98398,1,male,1,32,32,MOSF w/Malig,ARF/MOSF,1,18.0,$11-$25k,160668.0,102005.562,39.25,white,31.0,15,0,0,yes,0.699999809,0.7,dnr after sadm,27.0,69.0,4.89941406,106.0,32.0,37.69531,385.6875,1.8999023,36.6953125,1.39990234,149.0,7.379883,106.0,12.0,4580.0,0.0,<2 mo. follow-up
54.793,0,male,0,4,721,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,3509.0,2266.6348,8.0,white,14.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,85.0,10.2988281,104.0,28.0,37.5,109.51562,4.2998047,0.59997559,1.09985352,133.0,7.349609,76.0,11.0,2502.0,1.0,no(M2 and SIP pres)
70.97296,1,female,0,23,74,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,44927.0,26642.4688,32.333313,white,55.0,1,1,0,metastatic,0.199999928,0.1,no dnr,23.0,101.0,5.59960938,74.0,20.0,37.0,333.3,3.7998047,0.5,1.09985352,137.0,7.419922,105.0,15.0,2502.0,2.0,adl>=4 (>=5 if sur)
53.40698,0,male,0,10,720,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,16622.0,10085.3672,24.0,black,32.0,1,0,0,no,0.899999619,0.85,no dnr,10.0,83.0,6.69921875,104.0,20.0,36.29688,333.3,2.5996094,1.09985352,1.29980469,133.0,7.419922,129.0,13.0,2502.0,2.0,<2 mo. follow-up
57.57199,0,male,0,3,720,COPD,COPD/CHF/Cirrhosis,5,10.0,$25-$50k,3402.0,2083.3262,22.610928270087555,black,21.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,107.0,30.5976562,131.0,28.0,36.39844,371.375,1.7998047,3.19970703,1.09985352,130.0,7.449219,146.0,32.0,2284.0,3.1777344,<2 mo. follow-up
81.32495,1,female,1,45,45,ARF/MOSF w/Sepsis,ARF/MOSF,3,6.0,under $11k,98873.0,62997.375,31.0,black,56.0,1,1,0,no,0.649999619,0.5,dnr after sadm,40.0,76.0,10.0996094,70.0,24.0,36.59375,307.375,2.7998047,0.69995117,2.09960938,147.0,7.359375,99.0,54.0,1010.0,7.0,<2 mo. follow-up
50.58197,1,female,0,16,65,COPD,COPD/CHF/Cirrhosis,1,9.0,under $11k,43719.0,27188.3125,32.0,black,28.0,1,0,0,no,0.849999905,0.8,no dnr,16.0,63.0,11.1992188,114.0,24.0,36.59375,333.3,3.7998047,0.89990234,1.89990234,139.0,7.419922,119.0,20.0,1650.0,3.2021484,<2 mo. follow-up
62.51898,1,female,0,4,46,Colon Cancer,Cancer,2,9.0,under $11k,3170.0,2188.7773,16.0,hispanic,25.0,1,1,0,metastatic,0.599999905,0.2,dnr after sadm,2.0,69.0,7.39941406,71.0,32.0,35.59375,333.3,4.2998047,1.29980469,1.5,139.0,7.419922,88.0,23.0,2502.0,2.0,<2 mo. follow-up
80.08197,0,female,0,11,718,CHF,COPD/CHF/Cirrhosis,4,4.0,under $11k,16537.0,8672.2656,25.0,black,19.0,1,0,1,no,0.799999714,0.7,no dnr,11.0,69.0,5.39941406,114.0,24.0,36.09375,333.3,3.5,1.01,0.79992676,142.0,7.419922,113.0,12.0,2502.0,3.0,SIP>=30
45.42099,0,male,0,15,717,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,27278.0,13349.4062,18.0,white,20.0,1,0,0,no,0.799999714,0.6,no dnr,15.0,72.0,22.1992188,121.0,10.0,36.0,218.0,1.5998535,1.39990234,2.89990234,130.0,7.389648,393.0,49.0,473.0,0.0,no(M2 and SIP pres)
77.52997,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,89850.0,57595.7188,50.0,white,63.0,19,0,0,no,0.5,0.3,dnr after sadm,8.0,115.0,10.3984375,100.0,20.0,36.5,288.875,4.5996094,1.09985352,0.89990234,142.0,7.459961,103.0,12.0,2502.0,0.0,<2 mo. follow-up
36.99698,1,female,1,6,6,Coma,Coma,2,11.0,under $11k,33561.0,22041.4844,47.0,black,83.0,12,0,0,yes,0.049999982,0.05,dnr after sadm,2.0,71.0,9.0,70.0,22.0,36.29688,155.09375,3.5,1.01,1.69995117,136.0,7.429688,116.0,53.0,1390.0,0.0,<2 mo. follow-up
37.18799,1,male,1,55,55,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,158605.0,99295.6875,38.0,white,61.0,2,0,0,no,0.5,0.45,dnr after sadm,54.0,166.0,19.5,120.0,32.0,36.89844,264.0,3.0,0.5,2.29980469,142.0,7.539062,356.0,40.0,4598.0,2.0,<2 mo. follow-up
72.68994,1,male,0,25,111,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,24423.0,16853.5938,11.5,white,44.0,1,1,0,no,0.149999976,0.1,dnr after sadm,1.0,51.0,1.0,124.0,22.0,37.79688,125.0,2.5,2.69970703,2.19970703,133.0,7.379883,102.0,47.0,2105.0,6.0,adl>=4 (>=5 if sur)
81.24799,0,male,0,55,714,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,113127.0,72381.75,41.25,white,41.0,2,0,0,metastatic,0.799999714,0.8,no dnr,55.0,116.0,16.0976562,73.0,24.0,38.09375,233.3125,3.0,0.69995117,1.39990234,148.0,7.459961,186.0,31.0,1998.0,0.0,SIP>=30
52.33398,1,male,0,5,391,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,4861.0,2851.1953,8.0,black,12.0,1,1,0,no,0.899999619,0.75,no dnr,5.0,68.0,19.0,122.0,24.0,38.39844,225.0,1.7998047,0.89990234,1.19995117,135.0,7.419922,98.0,31.0,2630.0,0.0,no(M2 and SIP pres)
39.33499,0,male,0,85,713,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,227671.0,142435.625,36.25,white,45.0,3,0,0,no,0.599999905,0.55,no dnr,85.0,65.0,13.0,124.0,30.0,37.79688,344.0,2.8999023,0.89990234,0.5,148.0,7.369141,119.0,6.0,4310.0,1.0,adl>=4 (>=5 if sur)
61.99298,1,male,1,18,18,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,42526.0,25656.2812,35.333313,white,32.0,5,1,0,yes,0.149999976,0.1,dnr after sadm,8.0,66.0,8.5,101.0,40.0,38.69531,413.3125,2.2998047,1.69995117,0.89990234,142.0,7.479492,270.0,24.0,2620.0,0.0,<2 mo. follow-up
56.41898,1,male,1,50,50,MOSF w/Malig,ARF/MOSF,2,11.0,$25-$50k,98742.0,65428.8125,23.5,white,36.0,1,0,0,yes,0.5,0.2,dnr after sadm,10.0,107.0,8.8984375,80.0,16.0,36.29688,319.0,4.2998047,0.5,1.79980469,137.0,7.469727,198.0,23.0,2502.0,1.0,<2 mo. follow-up
33.63998,0,female,0,10,712,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,27331.0,17178.3125,26.0,white,57.0,3,0,0,no,0.799999714,0.75,no dnr,10.0,113.0,11.8984375,108.0,26.0,36.29688,276.1875,3.8999023,0.39996338,0.79992676,138.0,7.359375,153.0,18.0,2502.0,0.0,<2 mo. follow-up
44.08798,1,male,0,5,492,CHF,COPD/CHF/Cirrhosis,3,16.0,under $11k,3698.0,2560.4688,8.0,black,47.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,120.0,10.0996094,112.0,12.0,38.89844,154.53125,2.7998047,2.09960938,1.09985352,131.0,7.399414,108.0,19.0,1562.0,0.0,no(M2 and SIP pres)
50.95398,1,female,0,13,33,MOSF w/Malig,ARF/MOSF,3,10.0,$25-$50k,13636.0,9183.375,13.5,white,37.0,1,1,0,yes,1.0,0.5,dnr before sadm,-1.0,130.0,18.1992188,147.0,10.0,36.19531,182.125,3.0996094,0.5,0.79992676,133.0,7.219727,686.0,22.0,869.0,4.0,<2 mo. follow-up
75.78094,0,male,0,15,711,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,31215.0,20074.5469,26.0,black,70.0,4,0,0,no,0.75,0.7,no dnr,15.0,65.0,34.8984375,101.0,22.0,39.0,376.1875,2.8999023,1.59985352,2.0,133.0,7.519531,151.0,61.0,1875.0,0.0,no(M2 and SIP pres)
61.629,0,male,0,6,710,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,11989.0,7518.2695,18.0,hispanic,9.0,1,0,0,no,0.949999809,0.95,no dnr,6.0,105.0,4.39941406,114.0,22.0,37.69531,358.0,1.5998535,9.29882812,0.69995117,138.0,7.479492,75.0,9.0,1166.0,0.0,<2 mo. follow-up
53.37698,0,female,0,13,710,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,12878.0,7846.6602,11.5,white,30.0,1,0,0,no,0.899999619,0.9,no dnr,13.0,107.0,10.0996094,65.0,9.0,36.0,400.0,2.199707,1.29980469,10.2988281,142.0,7.5,156.0,101.0,0.0,4.5273438,adl>=4 (>=5 if sur)
64.23297,0,female,0,6,710,COPD,COPD/CHF/Cirrhosis,4,6.0,under $11k,5989.0,4009.6348,4.0,white,18.0,1,0,0,yes,0.799999714,0.8,no dnr,6.0,0.0,18.5,0.0,8.0,33.59375,260.0,2.199707,10.2988281,3.69970703,144.0,7.419922,74.0,60.0,3.0,1.1667481,no(M2 and SIP pres)
80.07098,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,46282.0,29802.5625,42.0,white,47.0,2,0,0,no,0.5,0.2,dnr after sadm,8.0,122.0,13.5996094,113.0,32.0,39.79688,165.6875,3.5,1.01,1.0,148.0,7.549805,114.0,22.0,3525.0,0.0,<2 mo. follow-up
44.76398,0,male,0,5,708,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,6375.0,3729.4258,19.0,white,27.0,1,0,0,no,0.949999809,0.95,no dnr,5.0,69.0,17.5976562,146.0,9.0,37.89844,153.03125,2.3999023,1.79980469,1.5,140.0,7.289062,143.0,7.0,2620.0,0.0,no(M2 and SIP pres)
57.90298,0,female,0,6,708,COPD,COPD/CHF/Cirrhosis,3,5.0,under $11k,6613.0,4251.0508,16.0,white,37.0,1,1,0,no,0.899999619,0.9,no dnr,6.0,50.0,13.0996094,101.0,10.0,36.39844,150.0,3.0,1.0,2.69970703,126.0,7.459961,177.0,60.0,3116.0,1.0,no(M2 and SIP pres)
53.96597,1,female,0,28,84,COPD,COPD/CHF/Cirrhosis,5,12.0,>$50k,53536.0,32119.7188,29.25,white,49.0,1,0,0,no,0.949999809,0.9,no dnr,28.0,106.0,25.0976562,76.0,20.0,35.89844,333.3,4.5996094,0.79992676,1.19995117,128.0,7.419922,124.0,22.0,2865.0,0.0,SIP>=30
89.58795,0,female,0,15,705,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,12953.0,9127.6875,7.333332,black,18.0,1,0,0,no,0.599999905,0.5,no dnr,15.0,65.0,5.09960938,62.0,20.0,36.19531,333.3,2.199707,6.39941406,1.19995117,126.0,7.419922,209.0,31.0,1300.0,4.0,no(M2 and SIP pres)
37.689,0,female,0,7,704,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,12902.0,8303.4297,17.0,white,37.0,1,0,0,no,0.599999905,0.5,no dnr,7.0,60.0,8.09960938,70.0,14.0,37.89844,333.3,1.3999023,3.09960938,0.89990234,132.0,7.419922,104.0,4.0,420.0,0.494751,SIP>=30
76.422,1,male,0,10,548,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,15849.0,9946.5312,19.5,black,24.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,57.0,16.0,127.0,10.0,36.19531,152.0,1.5998535,3.29980469,1.59985352,135.0,7.419922,287.0,19.0,1185.0,1.0,no(M2 and SIP pres)
34.69699,1,male,0,6,156,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,11810.0,8064.6641,12.0,white,34.0,5,0,0,no,0.799999714,0.7,no dnr,6.0,103.0,10.2988281,126.0,16.0,36.19531,333.3,3.699707,0.29998779,1.09985352,130.0,7.419922,90.0,12.0,2502.0,1.0,no(M2 and SIP pres)
49.99899,0,female,0,15,702,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,under $11k,18604.0,11809.9219,18.333328,black,42.0,1,1,0,no,0.699999809,0.5,no dnr,15.0,107.0,6.89941406,70.0,24.0,36.39844,333.3,4.2998047,1.19995117,1.79980469,138.0,7.419922,88.0,28.0,2502.0,5.0,no(M2 and SIP pres)
25.31999,0,female,0,7,699,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,21874.0,15546.0,10.0,white,29.0,10,0,0,no,0.949999809,0.95,no dnr,7.0,77.0,8.19921875,52.0,16.0,36.19531,333.3,3.7998047,0.59997559,1.29980469,126.0,7.419922,86.0,18.0,2885.0,3.0,no(M2 and SIP pres)
65.112,1,female,0,68,190,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,78561.0,50516.25,20.25,white,33.0,1,1,0,no,0.099999964,0.05,no dnr,68.0,80.0,17.5,80.0,28.0,37.09375,240.0,2.3999023,0.19998169,1.0,136.0,7.489258,240.0,16.0,2200.0,4.0,SIP>=30
55.797,0,female,0,7,699,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,5698.0,3965.9062,6.5,white,10.0,1,0,0,no,0.599999905,0.6,no dnr,7.0,65.0,13.6992188,144.0,36.0,36.29688,255.53125,1.7998047,0.5,0.79992676,133.0,7.489258,161.0,20.0,2875.0,0.494751,SIP>=30
58.97897,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,14134.0,8741.8984,47.0,white,49.0,1,0,0,metastatic,0.049999982,0.0,dnr after sadm,3.0,120.0,20.796875,133.0,10.0,39.29688,147.5,1.7998047,0.69995117,0.5,145.0,7.459961,335.0,14.0,2614.0,6.0,<2 mo. follow-up
80.48499,1,male,0,7,310,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,under $11k,8545.0,5517.5664,11.0,white,20.0,1,0,0,no,1.0,1.0,no dnr,7.0,106.0,0.09999084,128.0,30.0,38.89844,160.0,3.199707,6.59960938,4.79980469,136.0,7.369141,113.0,99.0,2075.0,1.1667481,SIP>=30
33.60999,1,male,1,25,25,Coma,Coma,4,10.0,under $11k,69568.0,35766.9688,27.0,black,60.0,2,1,0,no,0.049999982,0.02,dnr after sadm,25.0,117.0,12.5996094,61.0,32.0,38.39844,176.0,2.0,0.69995117,0.89990234,138.0,7.519531,133.0,25.0,4059.0,1.0,<2 mo. follow-up
60.375,0,male,0,16,696,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,under $11k,15397.0,10636.5703,9.333328,white,21.0,1,0,0,no,0.799999714,0.5,no dnr,16.0,62.0,18.0,101.0,26.0,35.89844,272.0,2.3999023,1.79980469,0.79992676,121.0,7.399414,111.0,57.0,725.0,4.4296875,<2 mo. follow-up
62.67999,1,male,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,2,16.0,under $11k,24246.0,15020.5391,51.0,white,35.0,1,0,0,no,0.599999905,0.55,no dnr,6.0,162.0,19.0,135.0,8.0,39.0,194.0,5.5996094,0.5,1.09985352,135.0,7.169922,146.0,17.0,3730.0,0.0,<2 mo. follow-up
26.18199,1,male,0,40,207,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,55309.0,38386.7188,19.0,hispanic,57.0,3,1,0,no,0.899999619,0.9,no dnr,40.0,116.0,13.6992188,65.0,38.0,36.0,340.0,3.5,1.01,2.0,138.0,7.369141,64.0,33.0,2300.0,7.0,SIP>=30
64.20294,0,male,0,4,695,COPD,COPD/CHF/Cirrhosis,2,18.0,under $11k,6455.0,3459.8203,8.0,white,22.0,1,0,0,no,0.599999905,0.5,no dnr,4.0,65.0,16.0976562,123.0,8.0,36.29688,188.0,3.5,1.01,0.59997559,128.0,7.489258,195.0,11.0,2930.0,1.1667481,no(M2 and SIP pres)
54.26099,1,male,1,4,4,Coma,Coma,3,9.0,under $11k,40589.0,25289.75,43.0,white,52.0,8,0,0,no,0.0,0.0,dnr after sadm,3.0,63.0,13.5996094,129.0,14.0,36.79688,177.125,2.8999023,0.39996338,1.19995117,138.0,7.299805,147.0,11.0,3565.0,3.3774414,<2 mo. follow-up
76.59094,0,male,0,5,694,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,3921.0,2711.7344,11.0,white,14.0,1,1,0,yes,0.5,0.3,no dnr,5.0,102.0,11.0996094,94.0,20.0,36.0,360.0,3.3999023,0.89990234,1.89990234,136.0,7.479492,100.0,34.0,1625.0,6.0,adl>=4 (>=5 if sur)
74.49396,1,female,0,13,163,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,18677.0,12616.0,16.0,white,37.0,4,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,57.0,7.39941406,133.0,8.0,35.59375,278.0,3.0,2.09960938,0.29998779,137.0,7.529297,86.0,18.0,700.0,3.8828125,<2 mo. follow-up
63.01398,1,male,1,41,41,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,176364.0,111877.75,46.75,white,56.0,15,0,0,no,0.599999905,0.5,dnr after sadm,36.0,75.0,10.0996094,118.0,16.0,35.69531,372.0,3.3999023,0.79992676,1.79980469,136.0,7.469727,92.0,19.0,2675.0,0.0,<2 mo. follow-up
58.87997,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,61942.0,31753.5,24.0,white,46.0,9,1,0,no,0.199999928,0.1,dnr after sadm,6.0,109.0,20.1992188,107.0,38.0,36.29688,208.5625,3.3999023,1.5,0.89990234,137.0,7.449219,133.0,26.0,2420.0,1.0,<2 mo. follow-up
49.98798,1,male,0,5,137,Lung Cancer,Cancer,1,12.0,$25-$50k,8300.0,5627.6602,11.0,white,15.0,1,0,0,metastatic,0.899999619,0.4,no dnr,5.0,82.0,14.6992188,107.0,28.0,38.69531,183.84375,3.2998047,3.29980469,1.0,128.0,7.399414,134.0,24.0,4100.0,2.0932617,no(M2 and SIP pres)
72.28699,1,male,0,13,309,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,25326.0,16010.8594,11.0,white,29.0,11,0,0,no,0.5,0.35,dnr before sadm,-1.0,101.0,11.1992188,100.0,20.0,36.29688,261.875,4.0,1.39990234,0.79992676,136.0,7.40918,94.0,13.0,2502.0,1.8388672,SIP>=30
38.66098,0,male,0,27,689,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,68693.0,43661.0312,41.5,white,43.0,2,0,0,no,0.849999905,0.85,no dnr,27.0,114.0,8.19921875,150.0,50.0,36.0,136.0,2.7998047,0.5,1.0,135.0,7.379883,248.0,20.0,2505.0,0.0,SIP>=30
49.202,1,male,0,34,37,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,30122.0,21783.8438,13.5,black,52.0,1,0,0,no,0.899999619,0.6,dnr after sadm,5.0,133.0,8.29882812,116.0,10.0,35.09375,167.71875,3.2998047,1.5,0.79992676,140.0,7.389648,114.0,19.0,2716.0,6.0,<2 mo. follow-up
55.29099,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,56771.0,35733.5,42.0,white,47.0,5,0,0,no,0.299999952,0.25,dnr after sadm,18.0,99.0,4.69921875,88.0,20.0,36.89844,180.0,4.3994141,0.5,1.39990234,131.0,7.349609,105.0,16.0,2502.0,6.0,<2 mo. follow-up
72.047,1,female,0,6,637,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4441.0,3018.7148,8.0,white,33.0,1,1,0,no,1.0,1.0,no dnr,6.0,63.0,49.296875,77.0,22.0,36.19531,596.0,1.7998047,0.5,3.69970703,137.0,7.369141,205.0,53.0,1605.0,2.0,no(M2 and SIP pres)
68.94995,1,male,0,21,46,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,32833.0,21437.5469,26.0,white,44.0,1,1,0,no,0.599999905,0.3,no dnr,21.0,128.0,13.7988281,133.0,6.0,38.0,155.0,3.2998047,0.5,1.09985352,142.0,7.319336,106.0,13.0,1492.0,4.0,<2 mo. follow-up
35.918,1,female,0,14,549,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,18968.0,12872.1094,17.0,white,62.0,1,1,0,no,0.5,0.5,no dnr,14.0,126.0,6.59960938,107.0,20.0,36.0,333.3,3.0996094,1.0,1.29980469,134.0,7.419922,193.0,19.0,400.0,5.0,SIP>=30
31.625,0,male,0,97,687,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$25-$50k,149704.0,96637.25,45.5,black,20.0,1,0,0,yes,0.899999619,0.9,no dnr,97.0,119.0,8.29882812,50.0,22.0,36.5,247.59375,3.5996094,0.59997559,1.09985352,137.0,7.439453,107.0,24.0,2502.0,6.0,adl>=4 (>=5 if sur)
66.81494,0,female,0,4,685,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,5201.0,14452.7344,8.0,white,9.0,1,0,0,no,1.0,1.0,no dnr,4.0,79.0,7.79980469,64.0,16.0,36.39844,333.3,4.5996094,0.69995117,0.89990234,135.0,7.419922,96.0,13.0,900.0,0.494751,no(M2 and SIP pres)
63.89899,1,female,0,5,17,Lung Cancer,Cancer,1,9.0,under $11k,4045.0,2675.9766,12.0,black,23.0,1,0,0,metastatic,0.299999952,0.05,dnr before sadm,-1.0,53.0,21.0976562,132.0,12.0,38.5,108.32812,1.5998535,1.0,1.29980469,134.0,7.439453,296.0,36.0,2755.0,1.8388672,<2 mo. follow-up
72.77197,1,male,0,10,226,Cirrhosis,COPD/CHF/Cirrhosis,3,9.0,under $11k,12968.0,8341.4062,10.5,black,26.0,1,0,0,no,0.799999714,0.8,no dnr,10.0,139.0,1.39990234,167.0,32.0,32.0,154.0,4.2998047,0.79992676,2.09960938,132.0,7.419922,196.0,24.0,3685.0,1.0,no(M2 and SIP pres)
59.62997,0,female,0,3,684,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,2429.0,1262.1367,22.610928270087555,black,11.0,1,1,0,no,0.699999809,0.5,no dnr,3.0,138.0,13.7988281,129.0,10.0,38.39844,66.0,3.0,12.2988281,0.79992676,135.0,7.469727,147.0,11.0,2385.0,1.1667481,SIP>=30
56.60199,1,male,0,19,401,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,42496.0,26078.9531,28.333328,white,36.0,1,0,0,no,0.799999714,0.7,no dnr,19.0,99.0,18.5,100.0,24.0,36.89844,137.5,3.0,1.0,2.29980469,142.0,7.349609,232.0,46.0,1175.0,1.0,no(M2 and SIP pres)
69.21594,1,female,0,40,381,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,76690.0,48881.5938,35.0,white,37.0,1,1,0,no,0.899999619,0.9,no dnr,40.0,115.0,9.79882812,80.0,12.0,37.89844,171.09375,2.199707,1.79980469,2.79980469,137.0,7.509766,99.0,40.0,1253.0,2.6083984,<2 mo. follow-up
79.81696,0,male,0,114,679,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,252121.0,162134.5,58.25,white,44.0,3,0,0,no,0.349999905,0.25,dnr after sadm,12.0,83.0,7.09960938,78.0,20.0,36.5,304.75,3.8999023,0.59997559,1.29980469,135.0,7.459961,395.0,13.0,2502.0,0.0,adl>=4 (>=5 if sur)
70.81195,1,female,0,5,245,Lung Cancer,Cancer,1,9.0,under $11k,3972.0,2684.6875,6.0,white,33.0,1,0,0,metastatic,0.699999809,0.2,dnr after sadm,5.0,139.0,17.6992188,131.0,35.0,39.09375,173.3125,2.5,0.39996338,1.19995117,153.0,7.419922,280.0,18.0,6520.0,0.494751,adl>=4 (>=5 if sur)
57.88098,1,male,0,11,394,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,8814.0,6131.707,7.0,black,31.0,1,0,0,no,0.5,0.3,dnr after sadm,4.0,112.0,3.0,153.0,6.0,37.89844,160.0,3.0,0.5,1.0,150.0,7.539062,273.0,10.0,4029.0,0.0,no(M2 and SIP pres)
91.64398,1,female,0,3,241,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,2938.0,1826.9522,22.610928270087555,other,25.0,1,0,0,yes,1.0,1.0,no dnr,3.0,73.0,9.09960938,80.0,22.0,36.19531,512.0,3.5,1.01,1.0,138.0,7.449219,124.0,12.0,2050.0,0.494751,no(M2 and SIP pres)
82.06696,1,male,0,10,28,CHF,COPD/CHF/Cirrhosis,2,2.0,under $11k,11305.0,6523.6172,13.5,white,38.0,1,0,0,no,0.5,0.4,dnr after sadm,4.0,103.0,5.59960938,74.0,15.0,35.69531,182.84375,2.2998047,0.5,5.89941406,135.0,7.419922,147.0,56.0,2425.0,0.0,<2 mo. follow-up
58.198,0,male,0,9,677,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,9942.0,6615.8359,10.0,white,20.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,75.0,53.3984375,69.0,20.0,36.29688,333.3,2.5,0.69995117,2.39990234,132.0,7.419922,152.0,75.0,3200.0,0.0,<2 mo. follow-up
67.71796,1,male,0,3,158,Lung Cancer,Cancer,2,10.0,$25-$50k,3124.0,2075.2617,22.610928270087555,white,7.0,1,0,0,metastatic,0.899999619,0.6,no dnr,3.0,71.0,10.1992188,138.0,51.0,39.19531,142.5,2.3999023,0.89990234,1.5,147.0,7.419922,147.0,31.0,4132.0,2.6235352,<2 mo. follow-up
51.04199,0,female,0,9,675,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,24722.0,15592.6641,33.0,hispanic,38.0,2,0,0,metastatic,0.699999809,0.5,no dnr,9.0,109.0,8.09960938,72.0,20.0,36.0,333.3,3.5996094,2.0,2.19970703,135.0,7.419922,84.0,45.0,2.47998,3.7280273,<2 mo. follow-up
54.34399,0,male,0,5,675,CHF,COPD/CHF/Cirrhosis,3,16.0,under $11k,3456.0,2491.1348,12.0,black,24.0,1,1,0,no,0.899999619,0.8,no dnr,5.0,78.0,10.6992188,120.0,20.0,36.89844,333.3,2.5,3.29980469,0.79992676,119.0,7.419922,426.0,15.0,1200.0,0.0,no(M2 and SIP pres)
70.57898,0,female,0,35,675,Coma,Coma,0,12.0,under $11k,100540.0,66278.8125,23.5,white,15.0,13,0,0,no,0.799999714,0.8,no dnr,35.0,61.0,15.3984375,126.0,42.0,36.59375,313.3125,2.0996094,0.59997559,6.5,144.0,7.359375,55.0,65.0,1860.0,0.0,no(M2 and SIP pres)
69.36597,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,64100.0,33446.375,50.333313,white,81.0,5,0,0,no,0.099999964,0.1,no dnr,19.0,77.0,8.19921875,82.0,24.0,36.59375,230.53125,3.0996094,1.39990234,1.19995117,139.0,7.379883,105.0,14.0,2260.0,1.0,<2 mo. follow-up
74.06696,1,male,0,34,36,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,under $11k,73698.0,46554.7812,37.5,white,39.0,1,1,0,yes,0.5,0.5,dnr after sadm,26.0,99.0,15.0,118.0,28.0,38.19531,314.25,4.8994141,1.5,0.39996338,141.0,7.359375,95.0,7.0,770.0,6.0,<2 mo. follow-up
74.51599,1,female,1,15,15,MOSF w/Malig,ARF/MOSF,2,13.0,under $11k,48918.0,30905.7188,41.666657,white,64.0,6,0,0,metastatic,0.099999964,0.001,dnr after sadm,6.0,64.0,7.89941406,62.0,22.0,36.69531,266.625,3.8999023,0.69995117,0.79992676,148.0,7.399414,152.0,18.0,2950.0,0.0,<2 mo. follow-up
76.87897,1,female,0,41,44,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,60870.0,39182.9688,28.75,white,13.0,5,0,0,no,0.599999905,0.6,dnr before sadm,-1.0,66.0,3.0,130.0,32.0,35.69531,334.0,1.3999023,1.0,1.5,143.0,7.489258,80.0,33.0,2026.0,7.0,<2 mo. follow-up
74.133,0,male,0,6,671,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,6695.0,4200.4609,12.0,white,26.0,1,0,0,no,0.75,0.65,no dnr,6.0,106.0,5.39941406,101.0,30.0,36.59375,333.3,2.0996094,1.09985352,0.89990234,139.0,7.419922,105.0,11.0,1475.0,1.0,SIP>=30
49.18799,0,male,0,6,670,Lung Cancer,Cancer,1,12.0,under $11k,6588.0,4471.5078,15.0,white,20.0,1,0,0,metastatic,0.899999619,0.7,no dnr,6.0,69.0,11.1992188,105.0,24.0,35.59375,185.6875,3.5996094,0.89990234,0.89990234,133.0,7.269531,422.0,13.0,3490.0,0.494751,<2 mo. follow-up
72.81598,1,female,0,11,308,Lung Cancer,Cancer,1,6.0,under $11k,12796.0,8688.625,7.0,white,13.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,2.0,130.0,15.0996094,126.0,12.0,36.39844,140.71875,4.1992188,0.19998169,1.59985352,133.0,7.209961,240.0,33.0,2502.0,0.0,adl>=4 (>=5 if sur)
89.20996,1,male,0,5,667,MOSF w/Malig,ARF/MOSF,1,20.0,under $11k,5806.0,4143.7969,6.0,white,37.0,4,0,0,yes,0.699999809,0.5,no dnr,5.0,120.0,11.7988281,124.0,10.0,37.19531,142.5,3.5,1.01,0.89990234,141.0,7.449219,140.0,30.0,1750.0,0.0,no(M2 and SIP pres)
35.90399,0,female,0,7,669,Colon Cancer,Cancer,1,10.0,$11-$25k,7600.0,5096.7812,7.5,black,23.0,1,0,0,metastatic,0.5,0.2,no dnr,7.0,105.0,11.3984375,104.0,24.0,36.19531,333.3,3.5996094,0.69995117,1.19995117,154.0,7.399414,437.0,19.0,1750.0,0.0,no(M2 and SIP pres)
46.76199,0,male,0,27,669,Coma,Coma,0,12.0,$25-$50k,78762.0,51755.75,20.5,white,19.0,13,0,0,no,0.799999714,0.8,no dnr,27.0,74.0,12.0,122.0,22.0,38.0,357.125,2.3999023,3.5,1.0,135.0,7.429688,136.0,34.0,3530.0,0.0,adl>=4 (>=5 if sur)
59.00299,0,male,0,25,668,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,37381.0,26401.8438,9.0,white,73.0,16,0,0,no,0.849999905,0.85,no dnr,25.0,110.0,4.0,58.0,8.0,36.09375,285.6875,3.8999023,1.09985352,1.0,139.0,7.419922,141.0,22.0,1645.0,4.0,SIP>=30
49.07599,0,female,0,28,668,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,76917.0,50563.75,32.0,white,32.0,22,0,0,no,0.899999619,1.0,no dnr,28.0,115.0,7.09960938,72.0,20.0,35.39844,426.625,2.0996094,0.39996338,4.09960938,142.0,7.429688,102.0,34.0,1225.0,0.0,no(M2 and SIP pres)
43.76999,0,male,0,7,667,Cirrhosis,COPD/CHF/Cirrhosis,2,10.0,under $11k,6435.0,4384.043,6.0,white,30.0,1,0,0,no,0.799999714,0.7,no dnr,7.0,115.0,7.59960938,68.0,24.0,36.19531,351.375,2.2998047,0.29998779,2.39990234,129.0,7.359375,74.0,45.0,1569.0,1.0,no(M2 and SIP pres)
49.65598,1,female,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,63202.0,39159.9062,43.333313,white,58.0,1,0,0,no,0.799999714,0.8,no dnr,18.0,97.0,7.89941406,60.0,20.0,36.29688,333.3,2.199707,0.39996338,3.29980469,136.0,7.419922,157.0,43.0,2450.0,1.0,<2 mo. follow-up
56.07397,1,female,1,9,9,MOSF w/Malig,ARF/MOSF,2,14.0,under $11k,12176.0,7825.1875,35.0,white,38.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,2.0,68.0,18.0,104.0,24.0,36.59375,333.3,3.199707,0.39996338,2.0,137.0,7.419922,116.0,83.0,4005.0,7.0,<2 mo. follow-up
77.68695,0,female,0,10,665,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,12633.0,7486.4531,17.0,black,55.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,82.0,9.0,101.0,24.0,36.39844,333.3,3.8999023,0.79992676,1.29980469,140.0,7.419922,130.0,30.0,2600.0,2.0,adl>=4 (>=5 if sur)
58.995,0,male,0,7,666,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,53096.0,32736.7812,25.5,white,48.0,6,0,0,no,0.799999714,0.75,no dnr,7.0,60.0,29.0,144.0,32.0,39.19531,411.375,2.0996094,1.89990234,0.89990234,135.0,7.509766,110.0,17.0,1583.0,0.0,SIP>=30
51.73398,0,male,0,71,663,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,175041.0,109975.25,45.5,white,34.0,4,0,0,no,0.899999619,0.9,no dnr,71.0,74.0,11.2988281,55.0,24.0,35.0,263.3125,4.0996094,1.0,1.0,142.0,7.439453,118.0,17.0,1320.0,3.5986328,<2 mo. follow-up
69.54095,0,male,0,5,661,CHF,COPD/CHF/Cirrhosis,3,6.0,under $11k,8421.0,4101.3594,20.0,black,14.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,117.0,14.7988281,109.0,8.0,40.09375,186.0,2.699707,0.59997559,8.0,134.0,7.419922,287.0,55.0,128.0,1.0,no(M2 and SIP pres)
54.25299,0,female,0,7,662,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,13297.0,14452.7344,20.5,white,18.0,1,0,0,no,0.989999771,0.99,no dnr,7.0,104.0,10.7988281,96.0,24.0,36.29688,200.0,2.8999023,1.59985352,1.19995117,130.0,7.399414,85.0,17.0,2502.0,1.0,no(M2 and SIP pres)
69.62897,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,40418.0,25170.6562,28.5,white,105.0,1,0,0,no,0.099999964,0.1,no dnr,7.0,63.0,7.39941406,109.0,16.0,38.69531,93.75,2.5,4.79980469,0.69995117,132.0,7.389648,228.0,19.0,2093.0,2.0,<2 mo. follow-up
32.06799,1,male,0,6,584,Lung Cancer,Cancer,1,12.0,under $11k,5519.0,3775.5547,13.0,white,30.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,67.0,20.296875,79.0,24.0,38.59375,476.1875,2.7998047,2.0,10.5996094,133.0,7.439453,287.0,48.0,0.0,0.0,<2 mo. follow-up
62.46399,0,female,0,11,660,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,23238.0,12652.3984,22.5,white,30.0,1,0,0,no,0.899999619,0.85,no dnr,11.0,99.0,9.59960938,80.0,20.0,36.09375,193.53125,4.7998047,1.39990234,1.39990234,143.0,7.389648,263.0,10.0,800.0,0.0,SIP>=30
21.254,0,male,0,18,660,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,27953.0,19023.1406,20.666656,white,39.0,1,0,0,no,0.799999714,0.8,no dnr,18.0,10.0,10.1992188,45.0,10.0,35.69531,440.0,2.699707,2.29980469,1.5,132.0,7.429688,141.0,26.0,5528.0,0.0,no(M2 and SIP pres)
73.31396,1,male,0,20,24,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,61832.0,37814.3125,41.333313,white,43.0,1,1,0,yes,0.199999928,0.2,dnr after sadm,14.0,81.0,4.59960938,70.0,24.0,36.69531,333.3,3.0996094,0.59997559,1.09985352,131.0,7.419922,73.0,31.0,2502.0,0.0,<2 mo. follow-up
74.66095,0,female,0,19,660,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,56813.0,35549.25,39.0,white,77.0,1,0,0,no,0.199999928,0.15,no dnr,19.0,77.0,15.8984375,78.0,22.0,35.59375,333.3,2.3999023,0.5,3.69970703,136.0,7.419922,85.0,73.0,2400.0,0.0,no(M2 and SIP pres)
69.74396,1,male,1,18,18,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,57676.0,36508.4062,38.333313,white,28.0,1,0,0,yes,0.899999619,0.8,no dnr,18.0,126.0,12.2988281,148.0,45.0,39.09375,197.5,2.2998047,4.0,0.79992676,126.0,7.389648,435.0,15.0,2270.0,0.0,<2 mo. follow-up
74.93799,1,male,1,17,17,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,63280.0,39430.2812,40.666657,black,42.0,13,0,0,metastatic,0.899999619,0.3,dnr after sadm,12.0,51.0,13.7988281,80.0,23.0,38.0,92.29688,2.5996094,1.19995117,1.29980469,128.0,7.569336,373.0,36.0,2124.0,6.0,<2 mo. follow-up
59.80298,0,female,0,15,657,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,23002.0,14344.7812,21.333328,white,33.0,1,0,0,yes,0.799999714,0.7,no dnr,15.0,105.0,9.19921875,98.0,20.0,36.79688,333.3,4.0996094,0.29998779,1.0,133.0,7.419922,108.0,8.0,1975.0,6.0,SIP>=30
71.70697,1,male,1,17,17,Lung Cancer,Cancer,2,12.0,$25-$50k,27936.0,18377.7656,23.666656,white,56.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,6.0,77.0,16.0976562,72.0,24.0,36.5,138.75,3.0996094,0.39996338,1.19995117,138.0,7.019531,114.0,34.0,1575.0,0.0,<2 mo. follow-up
82.60394,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,42766.0,26497.6875,83.0,white,81.0,1,0,0,no,0.5,0.5,dnr after sadm,6.0,65.0,15.5996094,71.0,26.0,35.89844,242.84375,3.5,1.01,1.59985352,146.0,7.429688,202.0,48.0,2502.0,0.0,<2 mo. follow-up
82.24799,0,male,0,10,656,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,under $11k,12879.0,8194.1172,13.0,black,24.0,1,0,0,no,0.899999619,0.75,no dnr,10.0,61.0,16.796875,130.0,10.0,39.0,101.65625,2.7998047,0.69995117,1.09985352,138.0,7.429688,176.0,17.0,605.0,0.0,SIP>=30
89.18799,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,6131.0,3395.0547,41.0,white,42.0,1,0,1,yes,0.199999928,0.1,dnr after sadm,3.0,78.0,9.0,72.0,28.0,36.59375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,6.4472656,<2 mo. follow-up
53.03998,1,male,1,40,40,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,169814.0,108304.625,41.25,black,78.0,11,0,0,no,0.0,0.0,dnr after sadm,31.0,52.0,3.39990234,121.0,8.0,37.5,204.0,1.7998047,0.5,0.69995117,143.0,7.40918,165.0,12.0,2700.0,1.0,<2 mo. follow-up
57.87,1,female,0,9,104,Colon Cancer,Cancer,2,12.0,under $11k,9284.0,6406.5234,19.5,white,23.0,1,1,0,metastatic,0.199999928,0.1,no dnr,9.0,60.0,12.5,106.0,28.0,35.19531,333.3,2.5996094,5.09960938,0.79992676,132.0,7.419922,53.0,21.0,1450.0,0.0,adl>=4 (>=5 if sur)
30.935,0,male,0,7,653,ARF/MOSF w/Sepsis,ARF/MOSF,4,11.0,under $11k,25068.0,16130.875,12.0,white,60.0,4,0,0,no,0.299999952,0.2,no dnr,7.0,64.0,11.5996094,131.0,60.0,38.39844,234.28125,2.2998047,1.59985352,0.79992676,147.0,7.429688,261.0,18.0,3870.0,0.0,no(M2 and SIP pres)
77.47797,1,female,0,11,171,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,20604.0,10068.4219,26.5,white,17.0,1,1,0,no,0.899999619,0.8,no dnr,11.0,99.0,9.59960938,60.0,20.0,35.69531,333.3,3.5,1.09985352,3.29980469,135.0,7.419922,233.0,68.0,1150.0,0.494751,no(M2 and SIP pres)
72.01599,1,male,1,25,25,Coma,Coma,1,10.0,under $11k,182796.0,119558.625,29.5,white,76.0,104,0,0,yes,0.199999928,0.1,no dnr,25.0,116.0,13.5996094,77.0,37.0,38.39844,263.3125,2.5,1.79980469,2.5,148.0,7.489258,318.0,32.0,1777.0,6.0,<2 mo. follow-up
48.52597,0,male,0,39,650,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,$11-$25k,93397.0,60183.6562,36.0,hispanic,44.0,1,1,0,no,0.899999619,0.9,no dnr,39.0,135.0,6.79980469,150.0,35.0,36.39844,112.23438,3.0996094,0.79992676,2.29980469,131.0,7.379883,245.0,34.0,1545.0,0.0,no(M2 and SIP pres)
22.89899,1,female,1,127,127,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,245362.0,153695.375,37.25,white,67.0,1,0,0,no,0.5,0.5,no dnr,127.0,67.0,11.5,116.0,10.0,38.09375,330.0,2.5996094,1.0,0.69995117,133.0,7.469727,217.0,12.0,3254.0,6.0,adl>=4 (>=5 if sur)
41.50598,1,female,0,6,85,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,8695.0,5518.0469,21.0,white,36.0,1,0,0,no,0.849999905,0.6,no dnr,6.0,97.0,10.0996094,76.0,24.0,36.5,261.875,4.0,1.19995117,0.79992676,136.0,7.40918,163.0,14.0,2502.0,0.0,SIP>=30
62.987,0,male,0,15,650,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,21499.0,14114.6016,15.666664,white,38.0,1,1,0,yes,0.799999714,0.8,no dnr,15.0,79.0,15.5996094,100.0,14.0,36.0,312.0,2.3999023,0.29998779,0.89990234,131.0,7.369141,122.0,19.0,2502.0,6.0,adl>=4 (>=5 if sur)
77.34198,0,male,0,7,648,CHF,COPD/CHF/Cirrhosis,7,7.0,under $11k,7592.0,5155.1758,9.0,black,32.0,1,0,1,no,0.399999857,0.2,no dnr,7.0,111.0,8.59960938,80.0,34.0,34.79688,428.5625,2.7998047,1.39990234,0.69995117,138.0,7.479492,128.0,7.0,2502.0,2.0,adl>=4 (>=5 if sur)
36.57199,1,male,0,12,251,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,26524.0,16549.5156,35.0,black,22.0,2,1,0,no,0.849999905,0.85,no dnr,12.0,89.0,8.3984375,80.0,16.0,36.19531,333.3,4.5,0.69995117,1.09985352,139.0,7.419922,138.0,19.0,2502.0,6.0,SIP>=30
63.72598,0,female,0,8,644,ARF/MOSF w/Sepsis,ARF/MOSF,2,9.0,under $11k,10473.0,6091.293,15.0,white,38.0,1,1,0,no,0.899999619,0.85,no dnr,8.0,120.0,21.0976562,120.0,8.0,38.89844,203.3125,2.2998047,0.39996338,0.69995117,146.0,7.399414,112.0,17.0,1693.0,3.0,<2 mo. follow-up
50.40698,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,14228.0,0.0,57.0,white,143.0,1,0,0,no,0.019999996,0.01,no dnr,4.0,132.0,10.8984375,72.0,10.0,38.39844,183.3125,2.699707,1.89990234,1.0,139.0,7.469727,302.0,32.0,5990.0,2.0,<2 mo. follow-up
56.64099,0,female,0,19,644,Coma,Coma,3,12.0,under $11k,27058.0,18051.0,28.333328,black,33.0,1,0,0,yes,0.599999905,0.6,no dnr,19.0,66.0,14.2988281,119.0,10.0,38.69531,112.0,2.0,2.39990234,1.39990234,148.0,7.399414,74.0,26.0,3252.0,7.0,adl>=4 (>=5 if sur)
89.00494,0,male,0,27,645,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,30567.0,20325.8438,13.0,white,13.0,1,0,0,no,0.5,0.5,dnr after sadm,11.0,54.0,0.09999084,142.0,34.0,38.89844,140.0,2.8999023,0.69995117,7.59960938,151.0,7.359375,167.0,130.0,655.0,2.0,adl>=4 (>=5 if sur)
67.98395,0,male,0,3,643,CHF,COPD/CHF/Cirrhosis,5,12.0,$11-$25k,2880.0,1813.3848,22.610928270087555,white,26.0,1,1,0,no,0.979999542,0.97,no dnr,3.0,102.0,7.5,71.0,22.0,36.0,333.3,4.0996094,0.29998779,1.0,133.0,7.419922,114.0,27.0,46.796875,6.0,adl>=4 (>=5 if sur)
61.24597,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,11.0,under $11k,6452.0,4052.2188,19.0,black,40.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,2.0,75.0,8.8984375,68.0,28.0,35.59375,333.3,4.0,1.69995117,1.79980469,136.0,7.419922,84.0,43.0,2502.0,0.0,<2 mo. follow-up
67.98895,1,male,1,10,10,Colon Cancer,Cancer,1,12.0,$11-$25k,11578.0,7914.1523,16.5,white,25.0,1,0,0,metastatic,0.599999905,0.3,dnr after sadm,7.0,93.0,4.19921875,96.0,20.0,36.29688,371.375,3.3999023,2.09960938,2.29980469,138.0,7.459961,107.0,41.0,2502.0,4.0,<2 mo. follow-up
69.21594,0,male,0,8,640,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,8595.0,6019.7344,10.5,black,32.0,1,1,0,no,0.5,0.1,no dnr,8.0,63.0,11.1992188,110.0,30.0,35.0,333.3,4.3994141,1.89990234,1.89990234,136.0,7.419922,97.0,35.0,1075.0,0.494751,no(M2 and SIP pres)
71.99695,1,male,1,12,12,COPD,COPD/CHF/Cirrhosis,3,7.0,under $11k,14243.0,8705.5938,14.0,white,43.0,1,1,0,no,0.75,0.6,no dnr,12.0,124.0,8.69921875,68.0,22.0,36.29688,333.3,3.8999023,0.5,1.5,139.0,7.419922,86.0,14.0,1950.0,3.0,<2 mo. follow-up
72.03796,0,female,0,8,639,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,12585.0,7749.5625,10.5,white,39.0,1,0,0,no,0.599999905,0.5,no dnr,8.0,91.0,9.5,96.0,22.0,36.39844,333.3,3.5,1.01,0.89990234,134.0,7.419922,88.0,9.0,2502.0,0.0,no(M2 and SIP pres)
48.75,1,male,0,67,447,Coma,Coma,0,12.0,$11-$25k,87147.0,58913.9375,22.25,black,53.0,9,0,0,no,0.099999964,0.1,dnr after sadm,2.0,116.0,10.0,124.0,28.0,38.59375,170.0,1.5,0.5,0.89990234,134.0,7.399414,118.0,7.0,3225.0,0.0,adl>=4 (>=5 if sur)
47.57599,1,male,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,111177.0,71540.375,55.0,white,48.0,39,0,0,no,0.099999964,0.1,dnr after sadm,14.0,117.0,7.39941406,84.0,16.0,35.89844,333.3,3.0,0.39996338,3.29980469,133.0,7.419922,156.0,36.0,2830.0,2.7724609,<2 mo. follow-up
52.38599,0,female,0,3,639,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,2328.0,1536.1953,22.610928270087555,white,28.0,1,1,0,no,0.899999619,0.8,no dnr,3.0,131.0,13.5996094,71.0,14.0,36.09375,359.25,3.5,1.01,0.5,134.0,7.419922,133.0,12.0,4336.0,0.0,no(M2 and SIP pres)
35.38898,0,female,0,6,637,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,9632.0,6360.7422,26.0,black,13.0,1,0,0,no,0.849999905,0.8,no dnr,6.0,55.0,10.1992188,199.0,10.0,39.39844,110.0,2.0,4.59960938,2.09960938,138.0,7.359375,116.0,42.0,1124.0,0.0,no(M2 and SIP pres)
51.086,1,male,1,66,66,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,215577.0,139854.75,49.25,white,47.0,36,0,0,no,0.849999905,0.85,dnr after sadm,66.0,71.0,9.69921875,56.0,8.0,36.89844,156.65625,3.199707,0.79992676,1.79980469,145.0,7.469727,162.0,44.0,1523.0,0.0,SIP>=30
73.37396,1,female,1,29,29,Coma,Coma,0,6.0,under $11k,81819.0,44954.6562,36.5,white,75.0,8,0,0,no,0.099999964,0.05,dnr after sadm,2.0,54.0,6.89941406,122.0,8.0,38.09375,173.3125,2.0996094,0.69995117,6.09960938,137.0,7.399414,112.0,82.0,439.0,6.0,<2 mo. follow-up
31.93199,0,female,0,25,638,MOSF w/Malig,ARF/MOSF,2,11.0,under $11k,45723.0,30022.0938,21.0,white,42.0,6,1,0,yes,0.649999619,0.6,no dnr,25.0,110.0,12.5996094,69.0,8.0,38.39844,346.0,2.8999023,0.5,0.69995117,131.0,7.469727,120.0,17.0,3158.0,1.0,no(M2 and SIP pres)
46.34399,0,male,0,16,633,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,32986.0,20115.125,29.666656,white,27.0,2,0,0,no,0.799999714,0.7,no dnr,16.0,124.0,10.3984375,104.0,24.0,36.0,257.125,3.5,0.39996338,1.19995117,133.0,7.429688,150.0,14.0,800.0,1.0,no(M2 and SIP pres)
44.64899,0,male,0,10,634,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,15277.0,9645.8906,13.0,white,28.0,1,0,0,no,0.899999619,0.8,no dnr,10.0,58.0,3.5,96.0,20.0,38.69531,333.3,3.5,1.01,1.0,139.0,7.419922,143.0,4.0,2250.0,3.0,no(M2 and SIP pres)
81.60199,1,female,0,3,114,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3870.0,14452.7344,22.610928270087555,white,23.0,1,1,0,yes,0.699999809,0.5,no dnr,3.0,108.0,8.8984375,87.0,28.0,36.79688,269.5625,3.5,1.01,1.09985352,136.0,7.339844,146.0,26.0,4750.0,2.7114258,no(M2 and SIP pres)
48.84299,0,male,0,19,633,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,44920.0,27563.8125,30.0,white,23.0,1,0,0,no,0.899999619,0.85,no dnr,19.0,75.0,8.0,65.0,24.0,36.59375,333.3,3.2998047,0.5,0.89990234,137.0,7.419922,141.0,19.0,2502.0,0.0,no(M2 and SIP pres)
66.31598,0,female,0,16,632,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,59995.78781114967,14452.7344,30.0,white,43.0,1,0,0,no,0.549999714,0.5,no dnr,14.58258953168044,61.0,113.59375,63.0,20.0,36.69531,333.3,3.5,1.01,2.0,129.0,7.419922,76.0,39.0,1650.0,0.0,no(M2 and SIP pres)
49.13599,1,female,0,14,94,Colon Cancer,Cancer,2,10.0,under $11k,16748.0,11049.1641,9.333328,white,36.0,1,0,0,metastatic,0.599999905,0.4,no dnr,14.0,131.0,8.59960938,118.0,20.0,37.0,333.3,5.0,0.69995117,0.69995117,135.0,7.419922,69.0,11.0,2350.0,5.0,adl>=4 (>=5 if sur)
39.99197,0,male,0,12,631,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,$11-$25k,25774.0,14531.3438,32.0,white,27.0,2,0,0,no,0.949999809,0.95,no dnr,12.0,126.0,11.0996094,75.0,28.0,36.59375,385.125,3.699707,0.39996338,1.0,137.0,7.439453,125.0,18.0,4485.0,4.0,no(M2 and SIP pres)
64.38898,1,female,0,26,51,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,42764.0,27070.0781,18.75,white,67.0,1,1,0,no,0.849999905,0.8,no dnr,26.0,63.0,26.0976562,122.0,24.0,35.19531,333.3,1.6999512,0.59997559,6.0,136.0,7.419922,74.0,66.0,230.0,0.0,<2 mo. follow-up
50.22299,1,female,1,7,7,MOSF w/Malig,ARF/MOSF,2,11.0,under $11k,28142.0,17324.5156,67.0,black,112.0,1,0,0,metastatic,0.299999952,0.25,no dnr,7.0,77.0,23.0976562,134.0,10.0,39.0,245.0,1.5998535,0.39996338,0.5,134.0,7.459961,117.0,6.0,3925.0,6.0,<2 mo. follow-up
74.75397,1,male,0,95,335,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,222934.0,140409.75,38.75,white,48.0,29,0,0,no,0.299999952,0.2,no dnr,95.0,92.0,5.89941406,100.0,20.0,36.89844,333.3,2.199707,10.3984375,0.89990234,133.0,7.419922,95.0,8.0,3720.0,3.972168,<2 mo. follow-up
43.66098,1,female,0,6,117,Colon Cancer,Cancer,1,12.0,under $11k,8078.0,5345.1172,14.0,hispanic,11.0,1,0,0,metastatic,0.599999905,0.5,no dnr,6.0,70.0,27.0,126.0,12.0,36.59375,133.3125,2.5996094,1.09985352,3.29980469,128.0,7.40918,347.0,66.0,1089.0,4.0,adl>=4 (>=5 if sur)
71.77295,1,male,0,78,213,Coma,Coma,1,16.0,$11-$25k,154189.0,87083.3125,39.75,white,51.0,1,0,0,no,0.5,0.4,no dnr,78.0,43.0,11.7988281,120.0,28.0,35.5,295.1875,3.2998047,0.5,0.59997559,137.0,7.489258,112.0,16.0,3275.0,0.0,adl>=4 (>=5 if sur)
67.71497,0,female,0,9,629,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,14637.0,9498.2578,16.5,white,23.0,1,0,0,yes,0.599999905,0.5,no dnr,9.0,109.0,10.8984375,122.0,26.0,35.89844,122.21875,2.5,1.19995117,1.5,133.0,7.449219,71.0,42.0,2400.0,0.0,no(M2 and SIP pres)
65.28094,0,male,0,14,628,MOSF w/Malig,ARF/MOSF,2,8.0,$11-$25k,27779.0,17367.5938,22.666656,white,38.0,1,1,0,yes,0.399999857,0.2,no dnr,14.0,127.0,12.7988281,124.0,10.0,39.69531,184.0,2.0996094,4.39941406,1.29980469,144.0,7.40918,189.0,31.0,1478.0,0.0,no(M2 and SIP pres)
89.58197,1,male,0,10,179,Lung Cancer,Cancer,2,12.0,under $11k,7092.0,4953.8047,6.0,black,14.0,1,0,1,metastatic,0.099999964,0.0,dnr after sadm,2.0,114.0,17.796875,107.0,24.0,36.29688,292.0,3.3999023,0.5,0.89990234,137.0,7.179688,165.0,13.0,1750.0,1.0,adl>=4 (>=5 if sur)
62.79498,0,male,0,9,626,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,19330.0,11695.375,23.5,white,35.0,1,0,0,no,0.699999809,0.6,no dnr,9.0,55.0,14.5,112.0,12.0,38.69531,120.0,3.5,1.01,0.69995117,134.0,7.419922,105.0,7.0,3385.0,0.0,no(M2 and SIP pres)
57.448,0,female,0,6,622,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,8879.0,5460.3359,10.0,white,16.0,1,0,0,no,0.649999619,0.5,no dnr,6.0,100.0,7.5,118.0,24.0,36.0,333.3,4.0,1.29980469,1.19995117,136.0,7.419922,100.0,14.0,2502.0,0.0,SIP>=30
51.409,0,male,0,21,622,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,52650.0,14452.7344,36.333313,white,43.0,1,0,0,no,0.799999714,0.75,no dnr,21.0,83.0,13.2988281,100.0,10.0,36.89844,158.0,4.0996094,2.09960938,0.59997559,132.0,7.389648,116.0,13.0,2690.0,0.0,SIP>=30
78.41199,1,male,0,80,274,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,150578.0,95131.25,37.0,white,60.0,8,0,0,no,0.599999905,0.6,no dnr,80.0,52.0,20.0976562,128.0,28.0,40.0,106.65625,1.7998047,3.39990234,2.69970703,134.0,7.299805,54.0,29.0,885.0,5.0,<2 mo. follow-up
60.56897,0,male,0,18,621,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,39502.0,23890.2812,27.333328,white,27.0,6,0,0,no,0.799999714,0.7,no dnr,18.0,79.0,0.69995117,71.0,24.0,36.0,333.3,3.3999023,0.89990234,0.89990234,136.0,7.419922,87.0,10.0,3250.0,6.0,SIP>=30
69.69995,1,male,0,5,592,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,6091.0,3742.6777,18.0,white,14.0,1,0,0,no,0.799999714,0.6,no dnr,5.0,66.0,16.296875,65.0,40.0,36.5,261.25,3.5996094,0.59997559,0.89990234,138.0,7.40918,129.0,30.0,1700.0,0.494751,no(M2 and SIP pres)
22.68599,0,female,0,32,621,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,under $11k,113240.0,70633.0,41.75,black,65.0,7,0,0,no,0.199999928,1.0,no dnr,32.0,121.0,18.5,129.0,38.0,39.0,172.5,3.0996094,0.89990234,1.19995117,141.0,7.379883,148.0,23.0,4995.0,0.0,<2 mo. follow-up
24.241,0,female,0,17,620,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,61561.0,39252.0312,51.333313,white,62.0,10,0,0,no,0.5,0.5,no dnr,17.0,71.0,15.2988281,141.0,14.0,36.89844,238.0,2.699707,1.29980469,1.59985352,140.0,7.519531,158.0,35.0,2860.0,0.0,no(M2 and SIP pres)
68.18896,1,female,0,9,237,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,21855.0,13324.9297,24.0,white,26.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,45.0,13.3984375,127.0,10.0,35.89844,185.0,1.7998047,8.29882812,1.19995117,145.0,7.389648,304.0,25.0,1938.0,0.0,SIP>=30
64.63495,1,male,0,13,525,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,23165.0,14729.3906,20.5,black,42.0,3,0,0,no,0.849999905,0.75,no dnr,13.0,106.0,7.09960938,100.0,32.0,35.59375,283.3125,3.5996094,1.39990234,1.29980469,143.0,7.469727,213.0,28.0,2600.0,1.0,no(M2 and SIP pres)
68.37195,1,female,0,7,551,CHF,COPD/CHF/Cirrhosis,3,3.0,under $11k,9644.0,5550.4375,20.0,black,37.0,1,0,0,no,0.799999714,0.7,no dnr,7.0,110.0,8.09960938,141.0,30.0,36.0,177.5,2.5996094,0.5,1.39990234,144.0,7.419922,203.0,40.0,2558.0,0.494751,no(M2 and SIP pres)
68.39398,0,female,0,21,618,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,20174.0,13773.9844,8.666664,white,38.0,1,0,0,no,0.899999619,0.7,no dnr,21.0,132.0,22.296875,114.0,8.0,36.59375,140.0,3.3999023,1.0,1.19995117,140.0,7.429688,180.0,20.0,3085.0,0.0,no(M2 and SIP pres)
75.81396,0,male,0,6,618,COPD,COPD/CHF/Cirrhosis,3,5.0,under $11k,10247.0,6206.1992,27.0,white,22.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,61.0,0.59997559,77.0,28.0,36.29688,333.3,2.2998047,1.09985352,1.5,128.0,7.489258,110.0,21.0,2502.0,0.0,no(M2 and SIP pres)
77.90295,0,male,0,11,617,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,47992.0,30387.8594,36.0,hispanic,49.0,9,0,0,no,0.849999905,0.75,no dnr,11.0,36.0,35.5,118.0,10.0,36.0,140.0,1.0998535,0.79992676,2.59960938,131.0,7.359375,211.0,48.0,1935.0,0.0,no(M2 and SIP pres)
79.54797,1,male,1,58,58,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,>$50k,121636.0,77842.5625,30.25,white,71.0,7,1,0,yes,0.699999809,0.7,dnr after sadm,44.0,76.0,36.3984375,64.0,24.0,36.5,230.0,3.199707,1.39990234,1.19995117,137.0,7.529297,90.0,25.0,2502.0,0.0,<2 mo. follow-up
79.67694,0,male,0,10,616,COPD,COPD/CHF/Cirrhosis,2,2.0,under $11k,9488.0,6038.7539,7.5,hispanic,33.0,1,0,0,yes,0.799999714,0.8,no dnr,10.0,105.0,11.0996094,75.0,37.0,36.69531,298.0,2.5996094,0.29998779,1.39990234,138.0,7.40918,244.0,48.0,1280.0,0.0,no(M2 and SIP pres)
70.409,1,female,0,4,277,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,8335.0,5702.4609,20.0,white,30.0,4,0,0,metastatic,0.599999905,0.35,no dnr,4.0,77.0,14.5996094,77.0,14.0,36.29688,116.0,2.199707,9.59960938,5.59960938,127.0,7.339844,80.0,88.0,48.0,1.0,no(M2 and SIP pres)
66.146,1,female,1,11,11,Coma,Coma,0,12.0,under $11k,22287.0,13867.5391,38.0,white,30.0,1,0,0,no,0.299999952,0.2,dnr after sadm,9.0,109.0,10.2988281,122.0,24.0,37.0,333.3,3.5,1.01,0.59997559,119.0,7.419922,321.0,7.0,4450.0,0.0,<2 mo. follow-up
52.71997,1,female,1,13,13,Coma,Coma,3,12.0,under $11k,25744.0,16137.1641,31.5,white,35.0,1,0,0,no,0.149999976,0.1,dnr after sadm,10.0,132.0,15.0996094,116.0,22.0,36.5,343.3125,3.5,1.29980469,8.09960938,132.0,7.449219,94.0,78.0,240.0,0.0,<2 mo. follow-up
72.20294,1,male,0,8,51,CHF,COPD/CHF/Cirrhosis,2,9.0,under $11k,14810.0,8979.4531,19.5,black,42.0,4,0,0,no,0.5,0.4,no dnr,8.0,69.0,13.0996094,63.0,24.0,37.59375,268.0,3.699707,0.89990234,1.0,139.0,7.209961,194.0,16.0,1795.0,0.0,<2 mo. follow-up
30.508,0,male,0,35,613,MOSF w/Malig,ARF/MOSF,0,12.0,$25-$50k,63693.0,42754.375,28.0,white,26.0,3,0,0,yes,0.5,0.4,no dnr,35.0,62.0,19.5976562,164.0,35.0,38.19531,126.65625,1.3999023,0.5,1.29980469,143.0,7.369141,57.0,64.0,2025.0,0.0,SIP>=30
74.24194,0,male,0,4,613,CHF,COPD/CHF/Cirrhosis,6,11.0,$11-$25k,4050.0,2718.4883,15.0,white,16.0,1,1,0,no,1.0,0.75,no dnr,4.0,115.0,15.3984375,117.0,10.0,38.59375,216.65625,2.0,0.79992676,5.89941406,141.0,7.319336,261.0,75.0,2905.0,0.0,no(M2 and SIP pres)
21.681,0,male,0,24,613,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,59995.78781114967,14452.7344,31.666656,white,26.0,2,1,0,no,0.899999619,0.75,no dnr,14.58258953168044,50.0,10.8984375,141.0,30.0,38.89844,170.0,2.3999023,0.5,0.59997559,130.0,7.479492,217.0,10.0,1469.0,6.0,adl>=4 (>=5 if sur)
59.12698,0,female,0,3,613,Cirrhosis,COPD/CHF/Cirrhosis,4,8.0,under $11k,2768.0,1807.0713,22.610928270087555,white,27.0,1,0,0,no,0.899999619,0.85,no dnr,3.0,47.0,7.29980469,133.0,26.0,36.09375,422.1875,4.0,1.09985352,0.89990234,137.0,7.479492,98.0,14.0,1200.0,3.059082,no(M2 and SIP pres)
75.15399,1,male,0,13,276,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,27731.0,17547.8125,38.5,white,29.0,1,0,0,yes,0.099999964,0.0,dnr after sadm,7.0,114.0,13.5,113.0,20.0,36.39844,452.0,2.2998047,0.39996338,1.39990234,144.0,7.299805,282.0,46.0,2420.0,0.0,no(M2 and SIP pres)
52.31998,0,male,0,16,612,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,116727.0,74622.125,34.0,white,39.0,31,0,0,no,0.199999928,0.1,no dnr,16.0,100.0,5.19921875,104.0,28.0,35.29688,333.3,4.0996094,1.0,2.0,142.0,7.419922,142.0,27.0,2502.0,0.0,no(M2 and SIP pres)
79.52594,1,male,0,30,66,ARF/MOSF w/Sepsis,ARF/MOSF,3,7.0,under $11k,54021.0,34340.0,33.25,white,34.0,1,0,1,no,0.5,0.1,dnr before sadm,-1.0,66.0,8.69921875,118.0,12.0,38.19531,377.5,2.699707,1.09985352,0.19998169,137.0,7.459961,86.0,12.0,1969.0,6.0,<2 mo. follow-up
65.78497,1,female,0,63,137,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,147956.0,80905.9375,44.75,white,39.0,1,0,0,no,0.699999809,0.7,no dnr,63.0,114.0,12.6992188,72.0,20.0,35.59375,333.3,2.7998047,1.69995117,2.0,130.0,7.419922,113.0,47.0,625.0,1.0,SIP>=30
46.77298,0,male,0,9,609,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,14136.0,9081.2031,23.0,white,20.0,1,0,0,no,0.799999714,0.5,no dnr,9.0,26.0,68.0,200.0,43.0,36.29688,93.0,1.3999023,4.5,2.5,139.0,7.189453,51.0,26.0,33.0,0.494751,no(M2 and SIP pres)
68.34796,0,male,0,14,610,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,36287.0,19190.4219,34.0,white,52.0,1,0,0,no,0.699999809,0.7,no dnr,14.0,115.0,24.0,122.0,40.0,38.59375,200.0,3.7998047,0.5,0.79992676,143.0,7.489258,181.0,14.0,3230.0,1.0,no(M2 and SIP pres)
47.78598,0,male,0,5,608,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,6856.0,4204.9961,45.0,white,31.0,1,1,0,no,0.899999619,0.9,no dnr,5.0,83.0,16.5,72.0,24.0,35.5,238.09375,2.5,0.89990234,1.19995117,148.0,7.539062,104.0,12.0,2502.0,7.0,adl>=4 (>=5 if sur)
75.18396,1,female,1,4,4,Coma,Coma,0,18.0,$25-$50k,5757.0,3093.8828,21.0,white,43.0,1,0,0,no,0.099999964,0.0,dnr after sadm,1.0,87.0,10.2988281,83.0,18.0,36.29688,152.375,4.1992188,0.69995117,1.09985352,138.0,7.369141,170.0,24.0,2502.0,2.9394531,<2 mo. follow-up
78.57397,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,14106.0,7519.918,25.5,black,30.0,1,0,0,no,0.599999905,0.6,no dnr,7.0,104.0,19.5,110.0,24.0,36.39844,295.1875,2.3999023,0.39996338,1.0,146.0,7.519531,105.0,13.0,1250.0,7.0,<2 mo. follow-up
47.75098,0,male,0,4,608,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,6113.0,3234.4648,7.0,black,44.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,84.0,4.69921875,104.0,24.0,38.29688,333.3,4.0,3.69970703,1.89990234,133.0,7.419922,83.0,34.0,2120.0,0.0,no(M2 and SIP pres)
56.94199,1,female,0,68,410,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,151280.0,87473.1875,39.25,white,53.0,2,0,0,no,0.699999809,0.55,no dnr,68.0,80.0,7.09960938,74.0,30.0,36.5,390.4375,3.8999023,0.79992676,1.59985352,138.0,7.469727,35.0,171.0,2502.0,3.0,adl>=4 (>=5 if sur)
63.30197,0,male,0,16,609,ARF/MOSF w/Sepsis,ARF/MOSF,5,6.0,under $11k,34857.0,0.0,20.333328,white,31.0,1,1,0,yes,0.099999964,0.01,no dnr,16.0,100.0,13.1992188,100.0,26.0,35.89844,129.625,4.0,0.5,1.69995117,141.0,7.379883,140.0,28.0,2200.0,0.0,no(M2 and SIP pres)
58.69098,0,female,0,5,608,Lung Cancer,Cancer,1,11.0,under $11k,4652.0,3178.8379,15.0,white,23.0,1,0,0,metastatic,0.799999714,0.6,dnr after sadm,1.0,121.0,8.19921875,72.0,40.0,36.0,262.5,3.7998047,0.5,1.19995117,146.0,7.389648,107.0,20.0,542.0,1.8388672,no(M2 and SIP pres)
71.92096,0,female,0,6,607,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,7801.0,4774.4648,8.0,white,21.0,1,1,0,yes,0.949999809,0.8,no dnr,6.0,114.0,12.7988281,126.0,52.0,38.59375,280.0,3.5,0.59997559,2.79980469,152.0,7.449219,181.0,54.0,1645.0,1.0,no(M2 and SIP pres)
75.47699,1,male,0,8,130,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,10021.0,6822.0508,16.0,white,32.0,1,0,0,metastatic,0.799999714,0.8,no dnr,8.0,114.0,25.796875,157.0,24.0,38.89844,55.0,2.5996094,1.0,0.89990234,141.0,7.359375,219.0,19.0,3484.0,1.0,no(M2 and SIP pres)
62.69098,0,female,0,45,606,Coma,Coma,0,13.0,>$50k,113273.0,74069.0625,34.0,white,21.0,11,0,0,no,0.899999619,0.9,no dnr,45.0,125.0,5.89941406,80.0,20.0,36.39844,385.6875,3.5,0.29998779,5.89941406,137.0,7.349609,109.0,70.0,2502.0,0.0,<2 mo. follow-up
56.435,0,female,0,9,605,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,17310.0,11485.0781,19.5,black,30.0,2,0,0,no,0.979999542,0.9,no dnr,9.0,116.0,21.0,118.0,14.0,38.29688,295.0,3.3999023,0.39996338,1.0,136.0,7.399414,111.0,6.0,2161.0,2.0,no(M2 and SIP pres)
59.39999,1,female,1,29,29,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,56070.0,37395.5938,16.0,white,55.0,24,0,0,no,0.099999964,0.1,dnr before sadm,-15.0,69.0,12.5,129.0,32.0,39.0,207.5,2.2998047,9.3984375,0.89990234,143.0,7.419922,115.0,18.0,3345.0,1.8388672,<2 mo. follow-up
29.084,1,female,1,4,4,Coma,Coma,1,9.0,under $11k,13539.0,8298.5625,48.0,black,45.0,2,0,0,no,0.699999809,0.5,no dnr,4.0,53.0,14.0996094,121.0,10.0,39.0,254.0,3.199707,0.69995117,3.79980469,129.0,7.489258,105.0,50.0,388.0,2.9140625,<2 mo. follow-up
39.84097,0,male,0,4,603,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,3907.0,2596.8574,7.0,white,15.0,1,0,0,no,0.799999714,0.8,no dnr,4.0,115.0,20.796875,122.0,10.0,38.69531,133.3125,2.199707,0.69995117,1.19995117,132.0,7.429688,309.0,24.0,2365.0,3.5180664,no(M2 and SIP pres)
45.008,0,female,0,17,602,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,27270.0,17162.2031,30.0,hispanic,23.0,2,0,0,no,0.799999714,0.8,no dnr,17.0,110.0,8.79882812,65.0,8.0,38.39844,108.32812,3.0,1.39990234,0.89990234,155.0,7.30957,118.0,18.0,1506.0,7.0,adl>=4 (>=5 if sur)
45.37198,1,male,0,20,113,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,47996.0,30335.0,40.0,white,42.0,5,1,0,no,0.5,0.2,no dnr,20.0,115.0,11.1992188,98.0,28.0,35.79688,214.28125,3.199707,0.5,1.19995117,141.0,7.30957,90.0,10.0,2502.0,1.0,no(M2 and SIP pres)
33.50598,1,female,1,4,4,Coma,Coma,1,12.0,>$50k,25573.0,16683.2969,25.0,white,62.0,5,0,0,no,0.199999928,0.1,dnr before sadm,-1.0,90.0,9.5,93.0,18.0,36.09375,333.3,4.0996094,1.0,1.59985352,133.0,7.419922,122.0,31.0,900.0,1.9797363,<2 mo. follow-up
59.89899,1,female,1,4,4,Coma,Coma,0,8.0,under $11k,9295.0,0.0,43.0,white,17.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,110.0,6.69921875,58.0,14.0,36.19531,172.0,3.0996094,0.59997559,0.79992676,144.0,7.259766,128.0,19.0,1355.0,2.1816406,<2 mo. follow-up
39.47699,1,male,0,4,191,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,3750.0,2512.3398,8.0,white,28.0,1,0,0,no,0.979999542,0.9,no dnr,4.0,57.0,24.3984375,97.0,12.0,38.09375,96.25,2.199707,0.69995117,1.39990234,145.0,7.389648,198.0,35.0,2305.0,1.8388672,no(M2 and SIP pres)
57.16898,1,male,0,5,237,CHF,COPD/CHF/Cirrhosis,6,11.0,under $11k,7378.0,4067.5879,14.0,white,51.0,1,1,0,no,0.949999809,0.95,no dnr,5.0,79.0,11.2988281,98.0,20.0,37.89844,333.3,2.3999023,15.1992188,0.5,133.0,7.419922,118.0,4.0,4600.0,2.0,no(M2 and SIP pres)
63.90097,1,male,0,36,47,Coma,Coma,0,12.0,$11-$25k,41951.0,28123.5781,19.75,white,34.0,1,0,0,no,0.599999905,0.3,no dnr,36.0,116.0,15.2988281,129.0,32.0,38.19531,228.5625,3.0,0.69995117,1.09985352,136.0,7.379883,119.0,9.0,816.0,7.0,<2 mo. follow-up
57.01797,1,male,0,5,106,Coma,Coma,1,14.0,$11-$25k,14711.0,8914.6719,39.0,white,33.0,2,0,0,no,0.099999964,0.02,no dnr,5.0,119.0,11.2988281,150.0,28.0,36.19531,200.0,3.5,1.01,1.79980469,136.0,7.469727,290.0,35.0,3800.0,2.5009766,adl>=4 (>=5 if sur)
61.65399,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,39699.0,20316.4531,44.5,black,44.0,4,0,0,no,0.699999809,0.6,no dnr,12.0,51.0,1.69995117,167.0,46.0,34.79688,170.0,2.5996094,20.5976562,2.69970703,157.0,7.419922,278.0,75.0,3470.0,0.0,<2 mo. follow-up
34.86697,0,female,0,5,597,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,6884.0,4639.6836,9.0,white,24.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,128.0,6.09960938,56.0,27.0,35.19531,122.5,1.5,0.39996338,0.89990234,147.0,7.349609,143.0,30.0,6755.0,1.1667481,no(M2 and SIP pres)
48.44098,1,male,0,20,365,Cirrhosis,COPD/CHF/Cirrhosis,1,7.0,under $11k,35164.0,22682.7031,22.666656,hispanic,52.0,1,0,0,no,0.199999928,0.1,no dnr,20.0,78.0,11.0,74.0,20.0,36.89844,333.3,3.5,1.01,0.89990234,136.0,7.419922,107.0,8.0,3400.0,0.0,no(M2 and SIP pres)
63.10498,1,male,1,16,16,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,28143.0,18493.375,31.0,hispanic,39.0,1,0,0,no,0.5,0.3,no dnr,16.0,123.0,11.2988281,114.0,26.0,39.19531,148.375,3.0996094,0.79992676,1.5,139.0,7.449219,160.0,33.0,1555.0,0.0,<2 mo. follow-up
43.64099,0,male,0,30,594,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,73868.0,0.0,33.0,white,29.0,1,0,0,no,0.5,0.5,no dnr,30.0,117.0,12.5996094,106.0,42.0,35.09375,233.3125,3.199707,1.0,0.89990234,150.0,7.429688,123.0,16.0,3410.0,2.215332,<2 mo. follow-up
64.64899,1,female,0,5,53,Lung Cancer,Cancer,1,12.0,under $11k,4989.0,3433.8477,15.0,white,35.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,119.0,19.1992188,111.0,10.0,36.5,80.0,3.3999023,0.29998779,1.79980469,138.0,7.419922,292.0,35.0,4150.0,0.0,<2 mo. follow-up
68.64099,1,female,0,7,124,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,7854.0,5231.3164,7.0,black,21.0,1,0,0,yes,0.699999809,0.5,dnr before sadm,-1.0,65.0,5.69921875,69.0,24.0,36.09375,220.0,3.0996094,0.79992676,0.79992676,136.0,7.469727,98.0,10.0,2502.0,5.0,no(M2 and SIP pres)
21.131,0,female,0,4,592,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,4054.0,2702.7734,7.0,black,16.0,1,0,0,no,0.899999619,0.75,no dnr,4.0,106.0,12.0996094,111.0,25.0,37.29688,180.0,3.2998047,1.29980469,0.89990234,136.0,7.5,175.0,23.0,1091.0,1.0,no(M2 and SIP pres)
58.11899,0,male,0,13,590,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,37539.0,22527.0625,49.5,black,41.0,1,1,0,no,0.949999809,0.9,no dnr,13.0,101.0,8.19921875,98.0,22.0,36.79688,307.375,4.3994141,0.69995117,0.79992676,137.0,7.229492,255.0,7.0,700.0,0.0,no(M2 and SIP pres)
54.00998,0,male,0,19,590,Coma,Coma,1,13.0,>$50k,71350.0,45354.1562,37.0,white,14.0,8,1,0,no,0.899999619,0.9,no dnr,19.0,127.0,19.0976562,71.0,12.0,36.59375,144.0,1.1999512,1.79980469,0.79992676,143.0,7.239258,201.0,19.0,3019.0,0.0,no(M2 and SIP pres)
66.48895,1,male,0,4,95,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$11-$25k,5894.0,3746.8457,22.0,white,42.0,1,0,0,no,0.599999905,0.2,no dnr,4.0,60.0,18.3984375,109.0,26.0,38.09375,116.65625,2.199707,4.89941406,2.09960938,138.0,7.389648,152.0,44.0,1675.0,3.8549805,adl>=4 (>=5 if sur)
83.17896,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,7201.0,4544.6953,22.0,white,49.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,63.0,10.3984375,116.0,24.0,38.0,180.0,1.8999023,0.19998169,0.89990234,130.0,7.439453,277.0,32.0,1150.0,3.4541016,<2 mo. follow-up
27.409,1,male,0,9,146,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,14843.0,7282.5781,17.5,white,42.0,1,0,0,no,0.849999905,0.75,no dnr,9.0,140.0,8.5,60.0,48.0,38.09375,263.3125,3.3999023,0.79992676,1.09985352,137.0,7.319336,109.0,16.0,1681.0,3.2412109,<2 mo. follow-up
69.88898,0,male,0,4,589,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,3291.0,2203.3281,6.0,black,16.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,84.0,12.1992188,72.0,26.0,36.09375,190.0,3.8999023,1.19995117,0.69995117,135.0,7.399414,209.0,12.0,2502.0,0.0,no(M2 and SIP pres)
58.79498,1,female,0,20,130,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,63773.0,41674.5312,31.0,white,70.0,7,0,0,no,0.199999928,0.1,no dnr,20.0,111.0,37.0,139.0,14.0,39.09375,90.65625,2.699707,1.19995117,1.5,146.0,7.40918,252.0,35.0,23.546875,0.0,<2 mo. follow-up
74.27795,1,female,0,31,243,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,75639.0,48561.3438,37.75,white,42.0,7,1,0,metastatic,0.5,0.2,no dnr,31.0,47.0,11.3984375,140.0,14.0,39.5,128.75,1.0998535,0.89990234,1.5,132.0,7.279297,102.0,15.0,2970.0,1.1667481,<2 mo. follow-up
86.396,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,22576.0,14125.9297,25.0,black,51.0,1,0,0,no,0.199999928,0.1,dnr after sadm,9.0,100.0,4.09960938,85.0,22.0,36.79688,333.3,3.5,0.29998779,1.0,137.0,7.419922,97.0,8.0,2502.0,0.0,<2 mo. follow-up
44.271,0,male,0,9,587,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,$11-$25k,25203.0,15283.0938,41.0,white,40.0,1,1,0,no,0.799999714,0.7,no dnr,9.0,124.0,19.5976562,112.0,38.0,36.59375,290.0,3.199707,0.19998169,0.79992676,138.0,7.469727,146.0,12.0,2206.0,2.0,adl>=4 (>=5 if sur)
38.73499,0,male,0,15,586,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,35055.0,22357.8594,22.0,white,50.0,1,0,0,no,0.799999714,0.5,no dnr,15.0,162.0,10.1992188,118.0,24.0,35.29688,137.5,3.0996094,1.0,0.89990234,144.0,7.479492,132.0,20.0,4346.0,0.0,no(M2 and SIP pres)
77.95996,1,female,1,12,12,Coma,Coma,1,10.0,under $11k,14080.0,9115.1172,22.0,white,25.0,1,0,1,no,0.099999964,0.05,dnr after sadm,2.0,125.0,8.0,133.0,24.0,36.39844,333.3,3.0,0.89990234,2.09960938,137.0,7.419922,169.0,48.0,3867.0,7.0,<2 mo. follow-up
70.98395,1,male,1,13,13,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,13517.0,9117.9766,19.5,white,66.0,2,0,0,yes,0.0,0.0,dnr after sadm,2.0,104.0,16.796875,112.0,22.0,36.59375,296.0,3.5,0.79992676,0.89990234,135.0,7.5,96.0,22.0,900.0,6.0,<2 mo. follow-up
61.478,0,female,0,23,584,Coma,Coma,1,15.0,$25-$50k,36243.0,24187.8906,21.666656,white,34.0,1,0,0,no,0.5,0.5,no dnr,23.0,82.0,11.0,125.0,24.0,36.0,257.125,3.0,0.79992676,0.89990234,135.0,7.469727,96.0,15.0,1025.0,0.0,SIP>=30
53.15799,0,male,0,15,584,Cirrhosis,COPD/CHF/Cirrhosis,3,7.0,under $11k,14057.0,9531.0156,10.666664,white,21.0,1,0,0,no,0.5,0.5,no dnr,15.0,117.0,31.8984375,65.0,28.0,38.19531,144.0,1.5998535,2.89990234,1.0,135.0,7.349609,199.0,25.0,3110.0,2.0,no(M2 and SIP pres)
85.28094,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,17283.0,11183.0078,30.5,white,23.0,1,0,0,no,0.899999619,0.75,dnr after sadm,8.0,110.0,12.5996094,75.0,8.0,35.39844,412.5,3.5,1.01,0.69995117,131.0,7.519531,169.0,10.0,3800.0,3.0,<2 mo. follow-up
66.17896,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,44025.0,24229.0469,43.5,white,63.0,7,0,0,metastatic,0.299999952,0.2,dnr after sadm,11.0,73.0,14.2988281,110.0,28.0,38.29688,274.5,1.6999512,2.0,2.09960938,147.0,7.469727,232.0,60.0,1124.0,2.9399414,<2 mo. follow-up
42.43399,1,male,1,11,11,Cirrhosis,COPD/CHF/Cirrhosis,5,13.0,under $11k,20016.0,12737.4922,21.0,white,37.0,1,0,0,no,0.899999619,0.9,no dnr,11.0,109.0,5.79980469,108.0,26.0,36.0,268.0,3.7998047,3.69970703,1.19995117,137.0,7.379883,173.0,24.0,2502.0,0.0,<2 mo. follow-up
78.73798,1,female,1,12,12,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,12840.0,8583.8594,21.0,black,35.0,1,1,0,no,0.5,0.3,dnr after sadm,7.0,65.0,1.5,76.0,20.0,35.39844,333.3,3.199707,1.29980469,2.0,141.0,7.419922,109.0,14.0,1800.0,5.1992188,<2 mo. follow-up
61.09497,1,female,0,9,248,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,11517.0,6906.7031,15.5,black,33.0,1,0,0,no,0.599999905,0.4,no dnr,9.0,131.0,20.5,126.0,12.0,39.19531,224.0,3.8999023,0.69995117,0.69995117,138.0,7.509766,197.0,17.0,2270.0,1.0,SIP>=30
47.50699,0,male,0,19,577,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,under $11k,47910.0,30549.9375,26.0,white,34.0,3,0,0,no,0.949999809,0.75,no dnr,19.0,118.0,18.6992188,129.0,40.0,39.19531,157.5,3.3999023,1.89990234,0.79992676,138.0,7.459961,234.0,17.0,3132.0,0.0,no(M2 and SIP pres)
73.60394,1,female,0,8,333,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,7122.0,4773.0312,7.0,black,10.0,1,1,0,no,0.799999714,0.8,no dnr,8.0,75.0,8.79882812,129.0,32.0,36.5,288.875,3.5,1.01,3.19970703,137.0,7.479492,111.0,40.0,2512.0,0.0,SIP>=30
82.78198,1,male,0,28,90,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,45892.0,30361.7188,24.0,black,60.0,1,0,1,no,0.5,0.5,no dnr,28.0,63.0,9.69921875,66.0,8.0,36.59375,272.5,2.7998047,1.19995117,0.5,139.0,7.439453,136.0,15.0,2677.0,6.0,adl>=4 (>=5 if sur)
54.853,0,female,0,4,577,Colon Cancer,Cancer,1,12.0,under $11k,6463.0,4173.7656,22.610928270087555,white,6.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,63.0,12.0,114.0,28.0,39.29688,333.3,2.699707,1.0,1.09985352,133.0,7.419922,102.0,10.0,4125.0,1.4726562,no(M2 and SIP pres)
62.5,0,female,0,7,576,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,19388.0,12000.6562,21.0,white,28.0,1,0,0,no,0.75,0.6,no dnr,7.0,103.0,5.09960938,60.0,21.0,35.09375,333.3,3.0996094,0.69995117,1.5,137.0,7.419922,187.0,16.0,1525.0,0.0,no(M2 and SIP pres)
84.646,0,female,0,15,576,CHF,COPD/CHF/Cirrhosis,4,4.0,under $11k,13008.0,9023.8516,13.333328,white,26.0,1,1,0,no,0.5,0.3,dnr before sadm,-1.0,119.0,6.0,77.0,20.0,36.59375,333.3,4.2998047,0.59997559,1.59985352,140.0,7.419922,122.0,17.0,3550.0,2.0,SIP>=30
50.53799,1,male,1,5,5,Coma,Coma,2,16.0,under $11k,14516.0,9036.8359,49.0,black,37.0,1,0,0,no,0.399999857,0.1,dnr after sadm,5.0,69.0,12.8984375,131.0,24.0,37.79688,336.625,3.5,1.29980469,0.19998169,132.0,7.489258,118.0,3.0,1594.0,1.0,<2 mo. follow-up
75.59796,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,12337.0,7863.7266,37.0,white,48.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,77.0,12.2988281,96.0,18.0,36.0,333.3,2.199707,6.5,0.69995117,131.0,7.419922,81.0,8.0,2502.0,0.0,<2 mo. follow-up
68.96594,0,male,0,25,573,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,29136.0,19419.5469,12.5,white,25.0,1,1,0,yes,0.949999809,0.8,no dnr,25.0,120.0,17.796875,69.0,12.0,38.5,224.0,2.5,1.5,0.89990234,142.0,7.459961,96.0,27.0,2210.0,3.0,SIP>=30
71.72095,0,male,0,12,572,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,37137.0,20216.1875,27.5,white,30.0,7,0,0,no,0.349999905,0.3,no dnr,12.0,70.0,24.796875,107.0,11.0,36.69531,252.5,2.0,6.39941406,1.39990234,132.0,7.479492,137.0,36.0,3431.0,0.0,no(M2 and SIP pres)
79.53198,1,female,0,8,178,CHF,COPD/CHF/Cirrhosis,3,5.0,under $11k,5455.0,3881.6113,5.5,white,23.0,1,1,0,no,0.649999619,0.6,no dnr,8.0,56.0,11.0996094,101.0,42.0,38.79688,177.5,2.5,1.19995117,0.69995117,140.0,7.449219,110.0,17.0,2700.0,0.0,SIP>=30
64.23798,0,female,0,10,569,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,36752.0,23325.2969,19.5,black,35.0,11,1,0,no,0.949999809,0.95,no dnr,10.0,62.0,16.5976562,114.0,24.0,38.19531,350.0,1.6999512,0.59997559,1.09985352,133.0,7.40918,102.0,24.0,1808.0,0.0,no(M2 and SIP pres)
32.76398,1,male,0,15,47,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,26332.0,17805.6875,18.333328,black,41.0,1,0,0,yes,0.299999952,0.1,dnr after sadm,3.0,117.0,4.5,51.0,24.0,38.59375,118.35938,3.199707,3.19970703,0.69995117,141.0,7.469727,146.0,19.0,2688.0,4.0,<2 mo. follow-up
48.92499,1,female,1,5,5,Coma,Coma,3,12.0,under $11k,9953.0,6292.3242,28.0,black,53.0,1,0,0,no,0.5,0.2,dnr after sadm,3.0,66.0,10.2988281,128.0,10.0,37.59375,170.0,2.0,2.19970703,1.0,138.0,7.449219,111.0,15.0,1830.0,3.4702148,<2 mo. follow-up
61.39398,0,female,0,6,566,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,7346.0,4556.8477,12.0,black,25.0,1,1,0,no,0.699999809,0.6,no dnr,6.0,65.0,4.19921875,106.0,28.0,36.0,283.3125,2.5996094,0.39996338,0.59997559,132.0,7.289062,320.0,34.0,2275.0,1.0,no(M2 and SIP pres)
48.87299,0,male,0,36,566,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,66240.0,0.0,19.0,black,44.0,1,1,1,no,0.5,0.5,no dnr,36.0,53.0,14.0996094,131.0,15.0,39.19531,308.0,3.0996094,1.09985352,1.29980469,134.0,7.439453,147.0,41.0,975.0,0.0,no(M2 and SIP pres)
62.02298,1,male,0,3,490,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,6203.0,3106.6641,22.610928270087555,white,13.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,67.0,9.5,64.0,40.0,35.29688,356.625,4.0996094,1.0,0.5,123.0,7.5,96.0,17.0,2323.0,2.2661133,no(M2 and SIP pres)
67.79199,1,female,0,5,32,COPD,COPD/CHF/Cirrhosis,4,7.0,under $11k,7180.0,4506.6172,14.0,black,28.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,76.0,6.39941406,122.0,22.0,36.19531,460.0,4.1992188,2.29980469,2.29980469,134.0,7.349609,105.0,25.0,5105.0,0.0,<2 mo. follow-up
38.35999,1,male,0,7,319,CHF,COPD/CHF/Cirrhosis,1,12.0,under $11k,5947.0,4122.4805,10.5,black,13.0,1,0,0,no,0.5,0.3,no dnr,7.0,66.0,15.2988281,146.0,40.0,36.0,177.125,3.0996094,1.09985352,0.89990234,146.0,7.30957,229.0,20.0,1900.0,0.0,no(M2 and SIP pres)
76.82397,0,female,0,6,565,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,7858.0,4810.7148,19.0,black,18.0,1,0,0,no,0.699999809,0.6,no dnr,6.0,129.0,7.69921875,136.0,10.0,38.5,130.0,2.5,0.39996338,0.79992676,143.0,7.469727,141.0,21.0,3895.0,1.0,no(M2 and SIP pres)
34.63699,1,male,0,6,384,Colon Cancer,Cancer,1,12.0,$11-$25k,7318.0,4904.5078,13.0,white,24.0,1,0,0,metastatic,0.5,0.3,no dnr,6.0,58.0,3.89990234,77.0,21.0,36.09375,120.40625,3.5,0.79992676,0.69995117,137.0,7.429688,198.0,6.0,2502.0,0.494751,<2 mo. follow-up
73.19397,1,female,0,10,157,Colon Cancer,Cancer,3,5.0,under $11k,10796.0,7406.375,19.0,black,17.0,1,1,0,metastatic,0.75,0.5,no dnr,10.0,117.0,8.19921875,71.0,24.0,36.09375,333.3,4.1992188,0.69995117,1.39990234,144.0,7.419922,95.0,26.0,1050.0,0.494751,SIP>=30
85.95197,0,male,0,4,564,CHF,COPD/CHF/Cirrhosis,1,6.0,under $11k,3808.0,2535.5977,7.0,black,22.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,70.0,4.79980469,114.0,16.0,37.79688,333.3,4.0996094,0.39996338,1.0,133.0,7.419922,178.0,12.0,2502.0,4.0,no(M2 and SIP pres)
87.90399,0,male,0,8,563,CHF,COPD/CHF/Cirrhosis,1,5.0,under $11k,7083.0,4946.9805,9.5,black,13.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,133.0,10.6992188,144.0,28.0,36.59375,157.5,2.2998047,0.5,2.39990234,164.0,7.319336,402.0,42.0,3100.0,0.0,SIP>=30
85.89697,1,male,0,11,124,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,$11-$25k,9573.0,6428.7617,14.5,white,50.0,1,0,0,no,0.599999905,0.4,dnr before sadm,-1.0,58.0,9.0,107.0,24.0,36.89844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,3475.0,7.0,adl>=4 (>=5 if sur)
46.71899,1,male,0,33,413,Colon Cancer,Cancer,1,16.0,>$50k,40332.0,28580.7031,18.25,white,2.0,1,0,0,metastatic,1.0,0.7,no dnr,33.0,72.0,0.69995117,76.0,20.0,37.5,333.3,2.5,0.69995117,1.19995117,127.0,7.419922,136.0,13.0,2000.0,0.0,no(M2 and SIP pres)
76.34497,1,male,1,25,25,Colon Cancer,Cancer,1,11.0,$11-$25k,45699.0,31086.625,20.75,white,19.0,1,0,0,metastatic,1.0,0.8,no dnr,25.0,129.0,15.5,60.0,26.0,36.09375,347.5625,3.5,1.01,0.59997559,154.0,7.479492,208.0,8.0,3715.0,0.0,<2 mo. follow-up
47.00598,1,male,0,5,155,COPD,COPD/CHF/Cirrhosis,1,16.0,under $11k,6784.0,4249.8789,31.0,hispanic,29.0,1,0,0,no,0.799999714,0.8,dnr before sadm,-1.0,65.0,10.0996094,143.0,24.0,37.59375,304.75,3.5,1.01,0.79992676,128.0,7.389648,122.0,8.0,2010.0,6.0,SIP>=30
55.80798,0,female,0,6,554,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,7740.0,4909.0391,17.0,black,34.0,1,1,0,no,1.0,0.58,no dnr,6.0,130.0,16.3984375,150.0,28.0,36.29688,235.6875,3.699707,0.39996338,0.69995117,141.0,7.459961,124.0,14.0,715.0,0.0,no(M2 and SIP pres)
63.60797,1,male,0,15,58,Lung Cancer,Cancer,2,11.0,$11-$25k,14862.0,10421.2578,12.333328,hispanic,31.0,1,0,0,metastatic,0.399999857,0.1,dnr after sadm,1.0,172.0,18.6992188,195.0,8.0,41.0,336.0,3.5996094,0.79992676,1.19995117,143.0,7.269531,120.0,14.0,3976.0,3.0,<2 mo. follow-up
65.599,1,male,0,30,31,MOSF w/Malig,ARF/MOSF,3,5.0,under $11k,104257.0,70112.8125,21.25,black,83.0,53,0,0,yes,0.599999905,0.25,dnr after sadm,1.0,101.0,3.79980469,72.0,16.0,36.69531,333.3,2.5,4.89941406,0.69995117,136.0,7.419922,107.0,8.0,2502.0,2.0,<2 mo. follow-up
53.26199,0,male,0,136,553,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,>$50k,416335.0,14452.7344,45.0,white,40.0,5,0,0,no,0.989999771,1.0,no dnr,136.0,116.0,9.8984375,104.0,11.0,37.69531,118.32812,2.7998047,0.59997559,0.5,141.0,7.369141,95.0,5.0,1963.0,1.0,adl>=4 (>=5 if sur)
22.648,0,male,0,52,554,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,159204.0,100065.688,52.25,white,52.0,2,0,0,no,0.799999714,0.8,no dnr,52.0,67.0,11.8984375,122.0,12.0,37.89844,246.65625,3.699707,1.09985352,1.89990234,132.0,7.539062,234.0,70.0,2095.0,0.0,SIP>=30
59.17297,0,male,0,5,555,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,4299.0,2597.7227,11.0,black,20.0,1,0,0,no,0.5,0.4,no dnr,5.0,123.0,22.5,176.0,44.0,39.19531,420.0,2.7998047,1.59985352,4.69921875,153.0,7.489258,185.0,68.0,1415.0,0.494751,no(M2 and SIP pres)
53.24799,0,female,0,48,550,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,150933.0,98468.1875,45.0,white,62.0,8,0,0,no,0.5,0.5,no dnr,48.0,137.0,19.3984375,70.0,9.0,39.5,177.5,3.699707,0.5,1.39990234,144.0,7.469727,156.0,18.0,4134.0,0.0,<2 mo. follow-up
51.836,0,male,0,22,548,Coma,Coma,0,12.0,>$50k,55578.0,35750.125,35.0,black,37.0,4,0,0,no,0.75,0.75,no dnr,22.0,77.0,4.59960938,104.0,16.0,37.69531,333.3,2.8999023,9.29882812,0.69995117,137.0,7.419922,93.0,8.0,2500.0,0.0,SIP>=30
74.58997,1,female,1,6,6,Coma,Coma,1,2.0,under $11k,22804.0,14215.2188,27.0,white,27.0,3,0,0,yes,1.0,1.0,dnr after sadm,6.0,119.0,13.7988281,120.0,23.0,36.19531,104.0,3.3999023,0.59997559,2.19970703,134.0,7.469727,160.0,33.0,1725.0,2.7744141,<2 mo. follow-up
63.34299,1,male,0,5,203,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,5817.0,3469.6367,9.0,black,24.0,1,0,0,no,0.899999619,0.85,no dnr,5.0,28.0,9.8984375,62.0,28.0,38.59375,324.9375,3.3999023,1.0,0.69995117,138.0,7.439453,137.0,11.0,1213.0,1.0,no(M2 and SIP pres)
55.34598,1,male,0,12,53,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,9537.0,6663.3281,12.0,white,18.0,1,1,0,no,0.899999619,0.7,no dnr,12.0,123.0,15.8984375,108.0,30.0,39.5,380.0,3.2998047,2.29980469,1.0,143.0,7.489258,147.0,28.0,1600.0,5.0,<2 mo. follow-up
38.58197,0,male,0,7,546,Cirrhosis,COPD/CHF/Cirrhosis,4,14.0,under $11k,10237.0,6853.0312,5.0,white,38.0,2,0,0,no,0.799999714,0.7,no dnr,7.0,162.0,10.2988281,113.0,12.0,38.59375,172.0,3.5,1.01,2.89990234,138.0,7.399414,151.0,49.0,4455.0,1.1667481,no(M2 and SIP pres)
64.70398,1,male,0,13,143,Cirrhosis,COPD/CHF/Cirrhosis,4,6.0,under $11k,13719.0,9278.8438,13.5,white,19.0,1,0,0,no,1.0,0.8,dnr after sadm,7.0,70.0,4.0,106.0,28.0,37.69531,333.3,2.2998047,0.59997559,0.79992676,140.0,7.419922,91.0,8.0,2500.0,2.0,SIP>=30
36.71198,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,35488.0,22316.1406,26.0,white,62.0,1,0,0,no,0.599999905,0.6,dnr after sadm,15.0,131.0,11.2988281,120.0,10.0,38.19531,140.0,2.8999023,10.5,0.79992676,136.0,7.509766,112.0,21.0,2050.0,5.0,<2 mo. follow-up
72.48499,1,female,0,16,22,Colon Cancer,Cancer,1,12.0,under $11k,11836.0,8465.2109,10.0,black,26.0,1,0,0,metastatic,0.0,0.0,dnr before sadm,-1.0,145.0,14.1992188,62.0,8.0,36.29688,390.4375,2.5,0.79992676,1.89990234,152.0,7.489258,107.0,82.0,2561.0,1.1667481,<2 mo. follow-up
56.49298,1,male,0,5,235,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,13141.0,14452.7344,22.0,white,31.0,1,1,0,no,0.75,0.75,no dnr,5.0,124.0,8.0,113.0,10.0,39.39844,130.0,2.7998047,2.89990234,1.19995117,139.0,7.40918,115.0,13.0,2421.0,0.494751,<2 mo. follow-up
49.34698,0,female,0,6,543,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,11578.0,5765.3867,22.0,white,37.0,1,0,0,no,0.949999809,0.9,no dnr,6.0,74.0,18.5,118.0,20.0,35.79688,333.3,1.8999023,0.59997559,0.69995117,122.0,7.419922,70.0,14.0,1750.0,0.0,no(M2 and SIP pres)
53.24298,0,male,0,3,543,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3076.0,2029.4961,22.610928270087555,black,18.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,111.0,3.39990234,88.0,20.0,37.09375,275.0,3.199707,2.09960938,1.29980469,133.0,7.439453,72.0,22.0,2470.0,0.494751,no(M2 and SIP pres)
68.21899,0,female,0,44,542,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,123039.0,77160.75,44.25,white,63.0,4,0,0,yes,0.25,0.25,no dnr,44.0,80.0,8.19921875,108.0,28.0,37.0,485.6875,3.699707,4.79980469,1.29980469,139.0,7.429688,88.0,14.0,2000.0,0.0,adl>=4 (>=5 if sur)
66.18195,0,female,0,17,541,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,43734.0,30188.2969,17.0,white,31.0,17,1,0,no,0.699999809,0.5,no dnr,17.0,63.0,7.19921875,75.0,12.0,38.29688,231.0,1.7998047,1.0,1.09985352,138.0,7.339844,271.0,18.0,1525.0,3.1425781,SIP>=30
72.28699,1,male,0,110,541,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,282321.0,176853.25,41.5,white,45.0,6,0,0,no,0.799999714,0.8,dnr after sadm,17.0,136.0,12.8984375,70.0,11.0,38.5,317.5,3.2998047,1.59985352,0.79992676,134.0,7.40918,167.0,14.0,2965.0,0.0,adl>=4 (>=5 if sur)
71.797,1,male,1,15,15,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,67318.0,41797.9062,52.666657,black,91.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,9.0,61.0,5.69921875,80.0,22.0,35.79688,242.84375,2.0996094,1.09985352,0.79992676,127.0,7.579102,203.0,18.0,2502.0,0.0,<2 mo. follow-up
76.75299,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,13099.0,8319.3828,31.0,black,64.0,1,0,1,no,0.5,0.4,dnr after sadm,1.0,173.0,27.0,22.0,8.0,35.89844,193.3125,3.5,1.79980469,1.09985352,140.0,7.459961,331.0,21.0,1554.0,1.0,<2 mo. follow-up
64.16394,0,male,0,13,537,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,$25-$50k,29954.0,19255.5625,42.5,white,42.0,2,0,0,yes,0.799999714,0.8,no dnr,13.0,78.0,10.0,124.0,24.0,35.79688,333.3,3.0996094,2.0,0.5,128.0,7.419922,83.0,27.0,425.0,1.0,<2 mo. follow-up
44.20297,0,female,0,19,536,Cirrhosis,COPD/CHF/Cirrhosis,5,11.0,under $11k,67791.0,45628.75,18.333328,white,60.0,27,0,0,no,0.099999964,0.05,no dnr,19.0,80.0,10.0996094,60.0,22.0,36.0,333.3,3.699707,1.79980469,1.59985352,140.0,7.419922,96.0,21.0,2502.0,7.0,no(M2 and SIP pres)
72.81897,1,male,0,9,346,CHF,COPD/CHF/Cirrhosis,5,6.0,under $11k,6878.0,4825.4375,10.0,white,10.0,1,1,0,yes,1.0,0.6,no dnr,9.0,47.0,31.796875,158.0,28.0,36.59375,354.8125,3.2998047,3.19970703,3.89990234,136.0,7.349609,165.0,62.0,2534.0,0.494751,no(M2 and SIP pres)
63.94498,0,male,0,5,535,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,4836.0,3275.541,12.0,white,24.0,1,1,0,no,0.899999619,0.6,no dnr,5.0,141.0,8.8984375,132.0,24.0,38.5,295.1875,3.0,0.69995117,1.29980469,137.0,7.529297,216.0,23.0,1965.0,0.0,SIP>=30
73.336,1,female,0,7,100,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,10886.0,6786.2812,11.0,black,39.0,1,0,0,yes,0.5,0.5,no dnr,7.0,114.0,19.0,111.0,40.0,35.79688,190.0,3.0,0.69995117,2.79980469,144.0,7.40918,204.0,50.0,910.0,0.0,adl>=4 (>=5 if sur)
61.72198,1,male,0,4,93,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,5234.0,3014.6914,16.0,white,18.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,122.0,17.796875,120.0,36.0,38.39844,134.0,2.5,0.5,0.29998779,145.0,7.379883,74.0,14.0,1979.0,0.494751,no(M2 and SIP pres)
68.07098,0,male,0,15,531,Cirrhosis,COPD/CHF/Cirrhosis,6,9.0,under $11k,47397.0,31747.0938,41.333313,white,35.0,1,0,0,no,0.299999952,0.1,no dnr,15.0,126.0,11.2988281,120.0,32.0,38.89844,167.5,2.2998047,4.59960938,0.69995117,142.0,7.519531,96.0,17.0,1045.0,2.0,adl>=4 (>=5 if sur)
64.99896,0,male,0,15,531,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,40531.0,25163.0469,28.0,white,60.0,1,0,0,no,0.899999619,0.9,no dnr,15.0,123.0,15.3984375,59.0,6.0,36.19531,293.3125,4.2998047,0.59997559,1.5,146.0,7.439453,202.0,24.0,4240.0,1.0,no(M2 and SIP pres)
57.96298,1,male,1,13,13,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,50618.0,31324.4531,52.5,white,67.0,1,0,0,no,0.199999928,0.1,dnr after sadm,13.0,69.0,13.6992188,107.0,28.0,37.5,185.6875,2.7998047,0.39996338,1.5,130.0,7.429688,119.0,26.0,7.5,2.0,<2 mo. follow-up
53.82599,0,female,0,10,530,COPD,COPD/CHF/Cirrhosis,0,10.0,$11-$25k,21187.0,12924.2812,29.5,white,39.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,125.0,23.8984375,107.0,34.0,36.0,260.0,3.0,1.0,0.69995117,134.0,7.509766,156.0,16.0,1685.0,4.0,<2 mo. follow-up
26.91299,0,male,0,15,529,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,$25-$50k,20458.0,13595.0078,12.333328,white,31.0,1,0,0,no,0.799999714,0.89,no dnr,15.0,79.0,3.5,76.0,20.0,36.5,333.3,3.0,5.29980469,1.09985352,130.0,7.419922,97.0,7.0,3050.0,5.0,adl>=4 (>=5 if sur)
57.79599,0,male,0,40,528,ARF/MOSF w/Sepsis,ARF/MOSF,5,11.0,under $11k,114737.0,75503.9375,44.25,white,92.0,3,1,0,no,0.299999952,0.1,no dnr,40.0,111.0,13.2988281,103.0,22.0,36.0,386.0,2.2998047,0.59997559,1.19995117,133.0,7.469727,71.0,18.0,2295.0,6.0,SIP>=30
65.94397,0,female,0,27,527,Coma,Coma,0,12.0,$11-$25k,86330.0,55693.9688,32.0,white,36.0,9,0,0,no,0.75,0.85,no dnr,27.0,67.0,11.8984375,157.0,36.0,38.69531,97.5,1.7998047,0.5,0.59997559,133.0,7.529297,198.0,10.0,3160.0,0.0,adl>=4 (>=5 if sur)
71.35394,1,male,0,8,350,Colon Cancer,Cancer,3,12.0,$11-$25k,5664.0,4086.1523,7.5,white,14.0,1,1,0,metastatic,0.099999964,0.0,no dnr,8.0,118.0,8.5,120.0,28.0,37.69531,306.625,2.5,14.6992188,0.69995117,145.0,7.489258,74.0,10.0,4655.0,1.0,no(M2 and SIP pres)
39.15399,0,female,0,21,526,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,65108.0,41013.4688,34.0,white,16.0,1,0,0,no,0.699999809,0.7,no dnr,21.0,49.0,5.29980469,68.0,20.0,35.0,333.3,3.199707,0.5,1.29980469,143.0,7.419922,159.0,58.0,1220.0,7.0,<2 mo. follow-up
63.211,1,male,1,12,12,Lung Cancer,Cancer,2,12.0,under $11k,13598.0,9065.5,14.5,black,37.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,10.0,115.0,8.69921875,80.0,28.0,36.39844,186.9375,4.0,1.79980469,1.19995117,139.0,7.40918,170.0,32.0,3030.0,0.0,<2 mo. follow-up
58.53,1,male,0,3,155,Lung Cancer,Cancer,1,13.0,$11-$25k,4163.0,0.0,22.610928270087555,black,31.0,1,0,0,metastatic,1.0,1.0,no dnr,3.0,115.0,14.6992188,67.0,42.0,39.39844,142.0,3.0996094,7.59960938,0.69995117,142.0,7.429688,96.0,11.0,4586.0,2.4672852,no(M2 and SIP pres)
41.97098,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,28025.0,17503.9375,47.5,white,46.0,4,0,0,no,0.369999886,0.23,no dnr,7.0,87.0,7.29980469,72.0,24.0,37.59375,333.3,3.5,1.01,0.89990234,136.0,7.419922,211.0,17.0,2502.0,0.0,<2 mo. follow-up
42.31097,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,1,16.0,under $11k,11722.0,7771.1914,20.5,white,53.0,3,0,0,metastatic,0.0,0.0,dnr after sadm,3.0,118.0,22.0,113.0,25.0,35.5,165.0,3.0996094,1.19995117,11.6992188,141.0,7.389648,145.0,111.0,4.0,2.0,<2 mo. follow-up
72.60498,1,female,0,3,29,Lung Cancer,Cancer,3,8.0,under $11k,1733.0,1235.1172,22.610928270087555,white,17.0,1,1,0,metastatic,0.099999964,0.0,dnr before sadm,-1.0,99.0,4.69921875,76.0,20.0,37.89844,333.3,4.6992188,1.0,0.89990234,141.0,7.419922,97.0,14.0,2502.0,3.3725586,<2 mo. follow-up
48.27399,1,female,1,45,45,Coma,Coma,0,10.0,$25-$50k,91330.0,60467.9062,44.0,white,49.0,1,0,0,no,0.5,0.5,dnr after sadm,31.0,60.0,12.6992188,64.0,30.0,38.5,134.0,2.699707,0.79992676,0.59997559,140.0,7.5,104.0,5.0,2444.0,0.0,<2 mo. follow-up
65.40698,0,female,0,32,518,Coma,Coma,1,12.0,under $11k,75896.0,51033.0938,29.0,white,9.0,14,0,1,no,0.649999619,0.65,no dnr,32.0,77.0,10.0,68.0,28.0,36.39844,333.3,3.5,1.0,1.19995117,136.0,7.419922,369.0,26.0,2502.0,4.0,adl>=4 (>=5 if sur)
54.31097,0,female,0,4,517,CHF,COPD/CHF/Cirrhosis,6,8.0,$11-$25k,4114.0,2559.4043,15.0,white,20.0,1,1,0,no,0.5,0.4,no dnr,4.0,144.0,13.3984375,65.0,36.0,39.19531,178.0,3.2998047,0.89990234,1.59985352,133.0,7.469727,184.0,16.0,2137.0,1.8388672,SIP>=30
61.03198,0,female,0,3,516,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,4608.0,2287.1426,22.610928270087555,white,16.0,1,0,0,yes,0.399999857,0.3,no dnr,3.0,121.0,19.5976562,144.0,48.0,38.39844,197.9375,2.7998047,0.79992676,2.79980469,142.0,7.419922,170.0,39.0,2525.0,2.2612305,no(M2 and SIP pres)
45.55499,1,male,0,9,320,Cirrhosis,COPD/CHF/Cirrhosis,2,11.0,under $11k,16900.0,10686.7422,29.0,white,47.0,1,0,0,no,0.849999905,0.75,no dnr,9.0,113.0,7.09960938,96.0,24.0,35.29688,333.3,2.8999023,0.59997559,2.29980469,137.0,7.419922,66.0,35.0,3550.0,0.494751,<2 mo. follow-up
76.41595,0,male,0,6,513,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,17222.0,9349.5156,27.0,hispanic,6.0,1,0,0,yes,0.949999809,0.9,no dnr,6.0,66.0,9.5,78.0,26.0,36.0,212.875,3.0996094,0.89990234,1.39990234,131.0,7.40918,137.0,33.0,2581.0,0.0,SIP>=30
55.73999,1,male,0,5,46,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4888.0,3340.1641,7.0,white,36.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,81.0,5.39941406,68.0,18.0,37.0,333.3,3.199707,0.39996338,4.29980469,141.0,7.419922,81.0,60.0,2502.0,0.494751,<2 mo. follow-up
49.008,0,female,0,4,509,CHF,COPD/CHF/Cirrhosis,4,16.0,under $11k,3640.0,2666.0059,11.0,black,19.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,109.0,10.8984375,111.0,40.0,37.69531,142.5,3.5,1.01,0.89990234,135.0,7.389648,131.0,6.0,883.0,1.1667481,SIP>=30
31.55399,0,female,0,22,507,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,38997.0,25602.6406,19.333328,hispanic,37.0,1,1,0,no,0.899999619,0.9,no dnr,22.0,63.0,200.0,156.0,32.0,39.09375,333.3,3.199707,0.89990234,1.19995117,140.0,7.419922,101.0,9.0,4600.0,0.0,SIP>=30
56.616,0,male,0,12,507,Cirrhosis,COPD/CHF/Cirrhosis,3,18.0,$25-$50k,19741.0,12691.1953,24.5,white,26.0,1,0,0,no,0.75,0.65,no dnr,12.0,157.0,17.796875,179.0,41.0,39.59375,215.0,3.3999023,0.69995117,1.29980469,133.0,7.519531,315.0,18.0,1264.0,1.0,<2 mo. follow-up
66.78699,0,female,0,13,507,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,26886.0,18592.5,17.5,black,52.0,10,0,0,metastatic,0.5,0.4,dnr before sadm,-4.0,105.0,11.0996094,60.0,20.0,38.29688,333.3,3.3999023,0.5,1.59985352,137.0,7.419922,463.0,29.0,2502.0,7.0,<2 mo. follow-up
74.13599,0,female,0,44,507,COPD,COPD/CHF/Cirrhosis,6,4.0,under $11k,71806.0,47299.75,23.25,black,52.0,1,1,0,no,0.949999809,0.9,no dnr,44.0,121.0,19.796875,63.0,64.0,35.5,288.0,2.3999023,1.69995117,0.79992676,141.0,7.469727,257.0,12.0,5725.0,0.0,adl>=4 (>=5 if sur)
30.39,1,male,0,6,26,Cirrhosis,COPD/CHF/Cirrhosis,1,11.0,under $11k,6106.0,4069.7422,10.0,white,35.0,1,0,0,no,1.0,0.9,no dnr,6.0,85.0,8.59960938,92.0,20.0,37.39844,333.3,2.3999023,1.59985352,0.89990234,132.0,7.419922,100.0,12.0,2502.0,0.0,<2 mo. follow-up
26.35999,0,female,0,48,506,COPD,COPD/CHF/Cirrhosis,4,11.0,under $11k,95201.0,59971.8125,25.25,black,19.0,1,0,0,no,0.849999905,0.7,no dnr,48.0,97.0,4.79980469,100.0,28.0,36.79688,91.42188,3.699707,0.59997559,0.79992676,134.0,7.369141,162.0,10.0,2100.0,4.0,SIP>=30
43.03897,1,female,0,7,227,MOSF w/Malig,ARF/MOSF,2,10.0,under $11k,48817.0,31306.2031,19.5,black,45.0,19,0,0,yes,0.549999714,0.5,no dnr,7.0,101.0,6.79980469,96.0,16.0,36.0,333.3,3.0996094,0.79992676,1.09985352,135.0,7.419922,80.0,27.0,2050.0,0.0,no(M2 and SIP pres)
79.02496,1,female,0,5,83,Lung Cancer,Cancer,2,12.0,under $11k,5753.0,3172.6074,8.0,white,19.0,1,0,0,metastatic,0.349999905,0.05,dnr after sadm,2.0,71.0,18.3984375,80.0,20.0,36.0,308.6875,3.5,1.01,1.19995117,140.0,7.439453,108.0,23.0,2502.0,5.0,SIP>=30
23.11299,0,male,0,43,503,Coma,Coma,0,12.0,under $11k,104075.0,66718.4375,35.5,black,35.0,3,0,0,no,0.049999982,0.02,no dnr,43.0,107.0,11.7988281,76.0,24.0,37.89844,333.3,3.5996094,0.5,3.09960938,135.0,7.419922,104.0,33.0,5300.0,0.0,adl>=4 (>=5 if sur)
44.42999,0,male,0,5,503,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,3720.0,2596.6738,13.0,black,9.0,1,1,0,no,0.989999771,0.9,no dnr,5.0,113.0,7.29980469,104.0,24.0,39.59375,333.3,2.8999023,0.5,0.79992676,134.0,7.419922,379.0,4.0,3700.0,0.0,no(M2 and SIP pres)
64.12,0,male,0,18,503,CHF,COPD/CHF/Cirrhosis,7,12.0,$11-$25k,40679.0,21071.2031,20.666656,white,73.0,4,1,0,no,0.049999982,0.01,dnr after sadm,14.0,125.0,3.89990234,72.0,22.0,36.29688,309.5,3.5,1.01,1.19995117,146.0,7.429688,108.0,27.0,2075.0,1.0,no(M2 and SIP pres)
54.19299,1,male,0,10,55,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,12546.0,7809.6836,13.0,white,13.0,1,0,0,no,0.949999809,0.9,no dnr,10.0,80.0,4.89941406,50.0,22.0,36.19531,333.3,3.5996094,0.89990234,1.5,152.0,7.419922,94.0,16.0,1695.0,4.0,<2 mo. follow-up
18.77599,0,male,0,12,501,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,31368.0,19824.9375,41.5,white,33.0,1,0,0,no,0.649999619,0.6,no dnr,12.0,94.0,17.0976562,100.0,32.0,37.89844,46.66406,3.3999023,1.09985352,1.69995117,142.0,7.549805,125.0,42.0,795.0,0.0,no(M2 and SIP pres)
72.97998,0,female,0,10,501,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,13111.0,7897.5391,16.5,white,25.0,1,1,0,no,0.5,0.2,dnr after sadm,3.0,81.0,8.5,58.0,20.0,36.19531,333.3,4.1992188,1.0,1.19995117,137.0,7.419922,84.0,12.0,2502.0,1.0,adl>=4 (>=5 if sur)
70.43695,1,female,1,7,7,Coma,Coma,3,12.0,under $11k,30399.0,19896.4531,25.5,black,73.0,13,1,0,no,0.099999964,0.05,dnr after sadm,1.0,109.0,6.5,74.0,20.0,36.09375,333.3,3.0996094,6.59960938,1.0,134.0,7.419922,109.0,11.0,2502.0,6.0,<2 mo. follow-up
67.86597,1,male,1,32,32,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,61337.0,39699.4375,20.25,white,37.0,2,1,0,no,0.799999714,0.8,no dnr,32.0,153.0,4.69921875,54.0,38.0,37.89844,319.0,3.199707,0.5,0.89990234,142.0,7.459961,107.0,7.0,3154.0,0.0,<2 mo. follow-up
25.54099,0,male,0,9,498,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,14621.0,9416.0859,17.0,asian,29.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,121.0,20.0,60.0,24.0,36.69531,392.0,2.8999023,0.39996338,3.89990234,137.0,7.399414,376.0,57.0,2502.0,0.494751,<2 mo. follow-up
67.61896,1,male,0,41,58,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,$25-$50k,114873.0,74604.5625,37.0,white,43.0,12,0,0,metastatic,0.399999857,0.3,no dnr,41.0,69.0,2.39990234,66.0,20.0,34.5,280.9375,3.2998047,0.79992676,0.79992676,141.0,7.55957,166.0,11.0,2502.0,0.0,<2 mo. follow-up
44.09299,0,male,0,5,496,Lung Cancer,Cancer,3,12.0,under $11k,3904.0,2738.0293,13.0,black,11.0,1,0,0,metastatic,0.75,0.6,no dnr,5.0,124.0,6.39941406,146.0,36.0,35.69531,261.875,2.2998047,2.79980469,6.89941406,143.0,7.209961,54.0,40.0,2036.0,0.494751,no(M2 and SIP pres)
33.741,0,male,0,28,494,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,88800.0,58121.7188,43.5,white,47.0,5,0,0,no,0.799999714,0.7,no dnr,28.0,119.0,14.5996094,131.0,33.0,40.09375,131.09375,3.5,1.01,1.59985352,151.0,7.479492,180.0,26.0,2735.0,0.0,no(M2 and SIP pres)
49.09,0,female,0,8,493,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,10245.0,6872.3477,9.0,white,22.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,76.0,33.1953125,124.0,10.0,38.79688,86.65625,1.8999023,4.39941406,1.0,143.0,7.459961,89.0,17.0,4050.0,0.494751,no(M2 and SIP pres)
63.88797,0,male,0,75,492,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,187289.0,113972.438,30.75,white,30.0,4,0,0,no,0.849999905,0.8,no dnr,75.0,100.0,4.79980469,72.0,16.0,36.09375,504.75,5.1992188,5.29980469,1.09985352,135.0,7.439453,155.0,13.0,4150.0,0.0,adl>=4 (>=5 if sur)
73.88599,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,81752.0,51140.0625,64.5,white,80.0,5,0,0,no,0.0,0.0,dnr after sadm,12.0,167.0,8.8984375,122.0,10.0,38.09375,200.0,1.5,8.59960938,0.79992676,137.0,7.189453,197.0,27.0,1548.0,1.0,<2 mo. follow-up
32.65198,0,male,0,18,491,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,23825.0,15030.7344,19.333328,white,29.0,1,0,0,no,0.849999905,0.8,no dnr,18.0,155.0,10.6992188,72.0,32.0,39.19531,370.0,3.199707,0.89990234,3.0,142.0,7.40918,126.0,32.0,1715.0,3.1831055,no(M2 and SIP pres)
92.65399,1,female,1,8,8,Coma,Coma,1,12.0,under $11k,33577.0,21423.25,39.0,white,30.0,10,1,0,no,0.0,0.0,dnr after sadm,6.0,53.0,5.5,78.0,10.0,39.0,124.0,3.699707,0.59997559,1.39990234,130.0,7.279297,225.0,29.0,2125.0,1.0,<2 mo. follow-up
33.46997,0,male,0,4,490,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,3483.0,2353.5195,11.0,white,6.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,124.0,12.5,116.0,24.0,38.59375,276.625,3.0,0.5,1.09985352,143.0,7.429688,135.0,20.0,1288.0,0.0,no(M2 and SIP pres)
39.62198,0,male,0,47,489,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,99971.0,62746.625,33.0,black,46.0,1,0,0,no,0.75,0.7,no dnr,47.0,99.0,7.29980469,120.0,24.0,36.59375,212.5,3.5,1.01,2.29980469,139.0,7.389648,90.0,10.0,1400.0,6.0,adl>=4 (>=5 if sur)
74.39294,1,female,0,11,16,Lung Cancer,Cancer,1,15.0,under $11k,13282.0,8855.1875,17.5,white,23.0,1,0,0,metastatic,0.599999905,0.2,dnr after sadm,1.0,73.0,7.59960938,64.0,24.0,35.59375,442.8125,2.7998047,1.89990234,1.09985352,136.0,7.509766,73.0,26.0,2375.0,2.0,<2 mo. follow-up
60.51199,0,female,0,6,488,CHF,COPD/CHF/Cirrhosis,0,8.0,$11-$25k,5472.0,3706.3887,12.0,black,14.0,1,0,0,no,0.799999714,0.6,no dnr,6.0,63.0,5.79980469,152.0,16.0,39.09375,333.3,2.5996094,3.89990234,0.79992676,127.0,7.419922,94.0,6.0,1450.0,0.494751,no(M2 and SIP pres)
68.12,1,male,1,25,25,Cirrhosis,COPD/CHF/Cirrhosis,1,18.0,under $11k,25188.0,17244.2031,7.5,white,59.0,1,0,0,no,0.899999619,0.7,dnr after sadm,17.0,108.0,6.89941406,96.0,22.0,35.39844,333.3,2.5996094,4.79980469,0.5,126.0,7.419922,94.0,1.0,2502.0,0.494751,<2 mo. follow-up
60.04398,1,male,0,6,169,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,15198.0,10064.9766,41.0,white,52.0,1,1,0,no,0.899999619,0.9,no dnr,6.0,136.0,11.7988281,133.0,36.0,36.5,125.0,2.0996094,0.39996338,3.79980469,139.0,7.329102,120.0,72.0,1237.0,0.0,no(M2 and SIP pres)
70.56799,0,male,0,9,481,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,12137.0,6805.6562,15.0,white,27.0,1,0,0,yes,0.899999619,0.8,no dnr,9.0,69.0,8.79882812,80.0,20.0,36.79688,333.3,3.5996094,1.19995117,1.29980469,143.0,7.419922,65.0,33.0,850.0,0.0,adl>=4 (>=5 if sur)
50.543,1,female,0,21,39,MOSF w/Malig,ARF/MOSF,2,3.0,$25-$50k,50746.0,34318.1875,29.666656,white,41.0,9,0,0,yes,0.75,0.6,no dnr,21.0,66.0,6.29980469,109.0,25.0,36.29688,202.21875,2.699707,1.0,1.09985352,132.0,7.389648,126.0,33.0,1115.0,7.0,<2 mo. follow-up
72.50696,1,male,0,6,119,CHF,COPD/CHF/Cirrhosis,1,0.0,under $11k,14569.0,7082.6367,20.0,white,28.0,3,0,0,no,0.799999714,0.7,no dnr,6.0,116.0,14.0996094,147.0,26.0,36.79688,328.5625,4.0,0.69995117,1.0,135.0,7.469727,109.0,16.0,1750.0,3.0854492,<2 mo. follow-up
66.672,1,male,0,22,183,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,$11-$25k,29171.0,18045.1094,19.333328,black,29.0,1,1,0,no,0.899999619,0.8,no dnr,22.0,77.0,6.29980469,77.0,20.0,36.19531,404.75,4.2998047,1.09985352,2.09960938,134.0,7.399414,100.0,16.0,2502.0,0.0,no(M2 and SIP pres)
61.13898,1,male,0,8,283,Coma,Coma,0,12.0,under $11k,7577.0,5176.9258,11.0,black,30.0,1,0,0,no,0.599999905,0.5,no dnr,8.0,60.0,18.0,74.0,10.0,36.39844,63.0,1.2998047,2.59960938,2.79980469,146.0,7.319336,97.0,56.0,992.0,7.0,adl>=4 (>=5 if sur)
69.36896,0,female,0,13,484,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,14009.0,9544.2656,17.5,white,43.0,1,0,0,no,0.5,0.4,dnr after sadm,1.0,109.0,14.6992188,125.0,22.0,36.5,353.3125,1.7998047,0.5,1.5,132.0,7.369141,107.0,12.0,3120.0,4.0,<2 mo. follow-up
72.96594,1,male,0,18,49,Colon Cancer,Cancer,1,19.0,$25-$50k,26584.0,19455.9688,23.0,white,49.0,1,0,0,metastatic,0.75,0.6,dnr after sadm,17.0,137.0,10.0,122.0,12.0,38.09375,240.0,1.8999023,1.19995117,0.89990234,149.0,7.539062,194.0,27.0,1232.0,0.0,<2 mo. follow-up
68.54797,0,male,0,95,481,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,197417.0,126041.625,55.25,white,42.0,3,0,0,no,0.699999809,0.5,no dnr,95.0,61.0,104.0,176.0,26.0,39.29688,105.0,2.199707,2.39990234,2.89990234,141.0,7.319336,376.0,70.0,1113.0,5.3330078,Coma or Intub
79.12396,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,18622.0,11870.8281,22.610928270087555,black,113.0,5,1,0,no,0.699999809,0.5,no dnr,3.0,66.0,6.69921875,50.0,30.0,35.0,404.0625,2.0996094,0.59997559,2.69970703,136.0,7.279297,81.0,108.0,337.0,2.6459961,<2 mo. follow-up
62.883,0,female,0,4,480,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3748.0,2488.6074,7.0,white,14.0,1,0,0,no,0.5,0.4,no dnr,4.0,71.0,21.6992188,109.0,26.0,38.29688,134.6875,2.0,0.79992676,1.59985352,134.0,7.429688,100.0,30.0,5752.0,0.494751,SIP>=30
78.31897,0,female,0,9,480,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,12338.0,7648.0586,20.5,white,55.0,1,0,0,no,0.5,0.25,dnr after sadm,1.0,60.0,9.5,118.0,40.0,36.19531,285.6875,2.3999023,2.19970703,1.39990234,130.0,7.379883,124.0,50.0,966.0,5.0,adl>=4 (>=5 if sur)
69.21295,1,male,0,3,118,Lung Cancer,Cancer,2,16.0,$11-$25k,3566.0,2432.3281,22.610928270087555,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,99.0,6.0,72.0,20.0,35.79688,333.3,3.199707,1.39990234,1.0,138.0,7.419922,331.0,13.0,2600.0,2.800293,no(M2 and SIP pres)
58.76797,0,male,0,5,479,Coma,Coma,1,12.0,$11-$25k,14700.0,8925.7891,29.0,black,34.0,1,1,0,no,0.399999857,0.4,no dnr,5.0,109.0,4.69921875,64.0,20.0,36.09375,333.3,3.8999023,0.69995117,1.59985352,140.0,7.419922,153.0,22.0,1700.0,0.0,adl>=4 (>=5 if sur)
38.11899,0,female,0,16,479,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,47093.0,28861.0938,30.333328,white,25.0,1,0,0,yes,0.899999619,0.9,no dnr,16.0,133.0,19.5,133.0,36.0,36.19531,223.0625,3.0996094,0.89990234,0.5,141.0,7.389648,161.0,9.0,1425.0,0.0,no(M2 and SIP pres)
66.91296,1,female,1,26,26,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,86018.0,52848.6875,32.25,white,32.0,3,0,0,no,0.899999619,0.8,no dnr,26.0,103.0,7.59960938,80.0,24.0,35.89844,220.0,3.699707,0.29998779,1.0,132.0,7.399414,139.0,16.0,1850.0,0.0,<2 mo. follow-up
36.80798,0,male,0,9,476,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,29838.0,18833.5156,35.0,white,47.0,1,0,0,no,0.5,0.4,no dnr,9.0,69.0,15.5,67.0,10.0,35.69531,502.0,1.8999023,1.79980469,0.69995117,136.0,7.419922,182.0,13.0,1915.0,0.0,no(M2 and SIP pres)
76.57996,1,male,1,7,7,Coma,Coma,2,10.0,$11-$25k,16563.0,10596.4062,32.0,white,41.0,1,1,0,no,0.299999952,0.2,dnr after sadm,3.0,69.0,11.5996094,171.0,55.0,38.79688,142.5,2.7998047,0.89990234,1.39990234,144.0,7.519531,107.0,17.0,1092.0,0.0,<2 mo. follow-up
71.24396,0,female,0,35,474,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,108652.0,71450.875,23.25,white,37.0,31,0,0,metastatic,0.0,0.0,dnr after sadm,2.0,126.0,6.39941406,134.0,32.0,38.0,106.65625,2.199707,11.1992188,0.89990234,128.0,7.549805,134.0,5.0,575.0,2.0,<2 mo. follow-up
67.25,0,male,0,3,473,CHF,COPD/CHF/Cirrhosis,4,14.0,under $11k,2763.0,1765.1641,22.610928270087555,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,69.0,24.0,126.0,22.0,36.69531,220.0,3.5,0.59997559,1.19995117,137.0,7.369141,160.0,40.0,1560.0,2.7089844,no(M2 and SIP pres)
52.698,0,female,0,9,472,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,21141.0,12759.8672,33.5,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,127.0,16.296875,107.0,24.0,38.19531,288.0,2.5996094,1.0,2.09960938,140.0,7.329102,81.0,63.0,3993.0,3.0,no(M2 and SIP pres)
52.00497,1,male,1,7,7,Coma,Coma,1,8.0,$11-$25k,14741.0,9165.6875,17.0,white,29.0,1,0,0,no,0.399999857,0.35,dnr after sadm,4.0,0.0,11.0,150.0,31.0,38.79688,297.5,1.7998047,4.19921875,3.69970703,125.0,7.379883,42.0,66.0,5930.0,0.0,<2 mo. follow-up
59.89297,0,female,0,4,468,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3672.0,2393.9316,6.0,black,17.0,1,1,0,no,0.949999809,0.95,no dnr,4.0,135.0,14.8984375,105.0,5.0,38.39844,356.625,3.5,1.01,0.69995117,131.0,7.479492,144.0,13.0,1618.0,3.2749023,<2 mo. follow-up
57.98499,1,female,0,5,415,COPD,COPD/CHF/Cirrhosis,6,12.0,$11-$25k,7687.0,4499.8242,22.0,white,32.0,1,1,0,yes,0.899999619,0.6,no dnr,5.0,120.0,3.79980469,77.0,20.0,37.0,333.3,3.2998047,1.0,1.0,134.0,7.419922,176.0,10.0,2502.0,1.0,<2 mo. follow-up
72.31494,0,female,0,8,468,CHF,COPD/CHF/Cirrhosis,3,10.0,$11-$25k,17686.0,10106.5,14.5,white,18.0,1,1,0,no,0.989999771,0.9,no dnr,8.0,64.0,4.5,111.0,8.0,38.19531,523.75,2.5996094,0.39996338,0.59997559,137.0,7.429688,83.0,10.0,4105.0,0.0,no(M2 and SIP pres)
54.32397,0,male,0,9,466,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,12159.0,7667.8555,15.5,black,41.0,1,0,0,no,0.799999714,0.75,dnr after sadm,6.0,110.0,3.5,122.0,28.0,37.89844,333.3,2.699707,0.39996338,1.5,133.0,7.419922,112.0,30.0,1275.0,4.0,SIP>=30
60.30698,1,male,1,14,14,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,63465.0,39629.4688,38.333313,white,65.0,8,0,0,yes,0.699999809,0.7,dnr after sadm,7.0,83.0,0.69995117,101.0,20.0,35.79688,333.3,3.5996094,0.59997559,1.29980469,133.0,7.419922,108.0,18.0,2502.0,2.0,<2 mo. follow-up
63.258,1,male,1,51,51,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,128478.0,79063.25,37.75,white,36.0,6,1,0,metastatic,0.5,0.4,dnr after sadm,51.0,140.0,15.0996094,150.0,25.0,38.69531,314.0,3.5,1.01,1.19995117,149.0,7.429688,163.0,31.0,3680.0,3.0,<2 mo. follow-up
65.01599,1,male,1,10,10,MOSF w/Malig,ARF/MOSF,1,10.0,under $11k,31724.0,20273.4844,40.0,white,57.0,1,0,0,yes,0.199999928,0.0,dnr after sadm,7.0,69.0,0.79992676,146.0,24.0,36.39844,333.3,2.0,1.0,0.69995117,131.0,7.419922,117.0,11.0,5050.0,1.0,<2 mo. follow-up
32.12299,0,female,0,6,463,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,6625.0,4011.2188,12.0,white,28.0,1,0,0,no,1.0,0.75,no dnr,6.0,90.0,10.6992188,76.0,20.0,35.89844,333.3,2.2998047,0.5,1.0,131.0,7.419922,127.0,17.0,2502.0,0.494751,<2 mo. follow-up
73.98999,0,female,0,5,463,Colon Cancer,Cancer,1,12.0,$11-$25k,4497.0,3107.4102,13.0,white,20.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,3.0,120.0,17.5976562,71.0,26.0,38.69531,190.0,2.699707,0.79992676,5.59960938,144.0,7.319336,99.0,65.0,1517.0,1.0,no(M2 and SIP pres)
75.98395,0,male,0,21,463,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,40937.0,27263.9688,30.0,black,58.0,4,0,0,no,0.5,0.5,no dnr,21.0,118.0,9.59960938,55.0,10.0,37.69531,363.3125,3.5,1.01,0.5,134.0,7.419922,120.0,11.0,2285.0,7.0,adl>=4 (>=5 if sur)
64.26599,0,female,0,5,461,COPD,COPD/CHF/Cirrhosis,2,6.0,under $11k,10697.0,6611.6211,15.0,white,24.0,1,1,0,no,1.0,1.0,no dnr,5.0,76.0,9.79882812,130.0,20.0,36.5,200.0,3.2998047,1.09985352,1.0,137.0,7.449219,102.0,18.0,2502.0,1.0,no(M2 and SIP pres)
67.95898,0,male,0,3,461,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,2667.0,1682.0225,22.610928270087555,white,10.0,1,0,0,no,1.0,0.9,no dnr,3.0,90.0,10.1992188,116.0,20.0,36.29688,333.3,3.5996094,0.39996338,1.09985352,136.0,7.419922,106.0,17.0,1700.0,0.0,no(M2 and SIP pres)
57.383,0,male,0,3,461,CHF,COPD/CHF/Cirrhosis,1,15.0,under $11k,9595.0,5629.1094,14.0,white,23.0,1,0,0,no,0.949999809,0.9,no dnr,3.0,131.0,5.89941406,53.0,38.0,38.59375,158.0,2.5996094,7.0,0.79992676,137.0,7.399414,176.0,28.0,1868.0,0.0,SIP>=30
65.51398,0,male,0,15,460,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,89647.0,58617.6562,26.666656,white,64.0,37,0,0,no,0.299999952,0.3,no dnr,15.0,110.0,16.3984375,71.0,22.0,36.19531,172.0,3.5,0.5,0.89990234,138.0,7.269531,97.0,13.0,2190.0,0.0,no(M2 and SIP pres)
76.72296,1,female,0,6,245,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,8117.0,5389.4609,20.0,black,26.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,99.0,8.29882812,106.0,16.0,35.5,500.0,3.4399414,5.29980469,1.39990234,130.0,7.509766,51.0,42.0,2502.0,0.0,no(M2 and SIP pres)
60.76398,1,female,0,88,89,ARF/MOSF w/Sepsis,ARF/MOSF,2,1.0,under $11k,192117.0,117801.75,42.5,white,22.0,1,0,0,no,0.699999809,0.75,dnr after sadm,14.0,101.0,10.0996094,72.0,24.0,36.59375,333.3,4.2998047,0.59997559,1.5,138.0,7.419922,107.0,17.0,1925.0,0.0,adl>=4 (>=5 if sur)
75.92297,1,male,1,47,47,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,210541.0,138336.5,49.0,white,66.0,38,0,0,no,0.099999964,0.05,dnr after sadm,45.0,128.0,16.0,78.0,32.0,36.59375,228.5625,3.0,1.0,1.29980469,114.0,7.379883,188.0,19.0,4805.0,0.0,<2 mo. follow-up
24.69299,0,male,0,24,455,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,155743.0,101314.812,28.333328,white,35.0,68,0,0,yes,0.899999619,0.9,no dnr,24.0,126.0,3.0,77.0,28.0,38.0,267.8125,2.5996094,5.0,0.89990234,136.0,7.439453,85.0,13.0,2975.0,0.0,<2 mo. follow-up
57.24799,0,female,0,5,455,Colon Cancer,Cancer,1,13.0,under $11k,6553.0,4324.3398,7.0,white,3.0,1,0,0,metastatic,1.0,0.9,no dnr,5.0,99.0,0.69995117,120.0,40.0,38.29688,333.3,2.0996094,1.19995117,0.89990234,137.0,7.419922,164.0,7.0,1600.0,0.494751,no(M2 and SIP pres)
72.19995,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,44016.0,30163.4062,27.5,white,31.0,20,0,1,yes,0.5,0.5,dnr before sadm,-9.0,117.0,4.19921875,60.0,22.0,36.29688,196.0,2.0996094,0.19998169,2.29980469,138.0,7.319336,117.0,62.0,1150.0,7.0,<2 mo. follow-up
40.06598,0,male,0,48,453,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,159555.0,98485.4375,43.0,white,62.0,1,1,0,no,0.799999714,0.8,no dnr,48.0,71.0,17.8984375,84.0,20.0,36.89844,333.3,2.3999023,20.3984375,1.0,127.0,7.419922,70.0,13.0,2502.0,7.0,SIP>=30
66.26398,1,male,0,5,114,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,13492.0,8294.0156,13.0,black,25.0,4,1,0,metastatic,0.5,0.25,no dnr,5.0,69.0,10.2988281,61.0,10.0,37.89844,190.0,3.0996094,1.39990234,1.09985352,143.0,7.389648,118.0,11.0,4375.0,0.0,no(M2 and SIP pres)
50.155,0,male,0,19,450,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,47488.0,30988.4062,24.333328,white,53.0,9,1,0,no,0.899999619,0.9,no dnr,19.0,73.0,15.2988281,122.0,36.0,35.89844,276.1875,2.5996094,1.0,0.89990234,135.0,7.579102,82.0,10.0,5220.0,2.0,SIP>=30
59.05798,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,>$50k,162877.0,101907.938,47.333313,white,48.0,11,0,0,no,0.5,0.5,dnr after sadm,21.0,93.0,3.69970703,120.0,16.0,36.0,333.3,3.0996094,0.29998779,1.29980469,136.0,7.419922,86.0,20.0,2502.0,2.3476562,<2 mo. follow-up
58.49399,1,female,0,8,57,Cirrhosis,COPD/CHF/Cirrhosis,1,8.0,$25-$50k,11768.0,7699.5938,14.0,white,31.0,1,0,0,no,0.399999857,0.25,dnr before sadm,-1.0,117.0,10.5996094,149.0,36.0,40.19531,410.0,3.5,1.01,1.09985352,139.0,7.459961,119.0,18.0,2016.0,1.0,<2 mo. follow-up
78.30499,1,male,1,70,70,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,207901.0,131304.625,57.5,black,56.0,14,0,0,metastatic,0.699999809,0.5,dnr after sadm,45.0,97.0,6.89941406,97.0,20.0,35.69531,333.3,3.699707,0.69995117,1.29980469,135.0,7.419922,140.0,18.0,2500.0,0.0,<2 mo. follow-up
80.18298,1,female,0,10,44,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,22539.0,12764.4297,28.0,white,57.0,1,0,0,no,0.599999905,0.55,no dnr,10.0,130.0,24.6992188,98.0,24.0,38.59375,348.0,3.3999023,1.0,0.79992676,137.0,7.479492,348.0,28.0,1200.0,7.0,<2 mo. follow-up
72.13995,0,male,0,3,449,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4233.0,2018.9502,22.610928270087555,white,24.0,1,0,0,no,0.799999714,0.75,no dnr,3.0,77.0,13.7988281,200.0,30.0,36.0,333.3,1.5998535,5.19921875,1.39990234,128.0,7.419922,59.0,31.0,1275.0,2.4848633,no(M2 and SIP pres)
64.05499,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,7.0,under $11k,20604.0,12852.2578,47.5,black,55.0,1,0,0,metastatic,0.399999857,0.3,no dnr,7.0,97.0,13.6992188,72.0,20.0,36.29688,252.375,3.5,1.01,1.09985352,138.0,7.369141,141.0,25.0,2150.0,6.0,<2 mo. follow-up
56.50897,1,male,0,6,169,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,10470.0,6250.8945,20.0,black,50.0,1,0,0,no,0.399999857,0.2,no dnr,6.0,112.0,19.8984375,107.0,23.0,38.69531,71.10938,2.5,0.29998779,1.5,133.0,7.489258,141.0,16.0,3316.0,6.0,SIP>=30
101.84796,0,female,0,3,447,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3497.0,1888.5098,22.610928270087555,white,24.0,1,0,0,no,0.799999714,0.5,dnr after sadm,1.0,65.0,8.0,69.0,24.0,35.5,333.3,3.699707,1.5,1.69995117,139.0,7.419922,124.0,29.0,2000.0,4.0,<2 mo. follow-up
66.22595,1,female,0,16,31,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,19176.0,12381.0938,14.0,white,39.0,1,0,0,no,0.5,0.4,dnr after sadm,2.0,118.0,24.5,114.0,30.0,36.29688,200.0,1.7998047,3.59960938,5.09960938,136.0,7.479492,344.0,38.0,0.0,5.0,<2 mo. follow-up
55.38699,1,male,1,6,6,Lung Cancer,Cancer,2,8.0,under $11k,4879.0,3245.5215,8.0,white,28.0,1,0,0,metastatic,0.049999982,0.01,dnr before sadm,-1.0,128.0,7.59960938,83.0,24.0,36.59375,312.0,3.7998047,0.5,2.79980469,134.0,7.479492,277.0,34.0,1625.0,6.0,<2 mo. follow-up
71.82495,1,male,1,3,3,Lung Cancer,Cancer,4,12.0,under $11k,2710.0,1770.377,14.0,white,20.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,2.0,129.0,24.1992188,129.0,36.0,38.59375,132.625,4.1992188,1.0,1.09985352,137.0,7.449219,116.0,8.0,2900.0,4.5302734,<2 mo. follow-up
79.15094,1,female,0,86,326,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,186222.0,14452.7344,54.75,white,55.0,1,0,0,no,0.199999928,0.15,dnr after sadm,4.0,63.0,10.5996094,109.0,6.0,37.79688,172.5,1.8999023,1.5,1.39990234,129.0,7.519531,189.0,27.0,1705.0,4.0,adl>=4 (>=5 if sur)
36.13397,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,28437.0,17370.5,58.5,black,68.0,2,0,0,no,0.5,0.5,dnr after sadm,5.0,72.0,4.5,61.0,20.0,36.09375,333.3,3.0,0.5,0.79992676,135.0,7.419922,97.0,7.0,3050.0,7.0,<2 mo. follow-up
38.021,0,female,0,3,445,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,4508.0,2343.2285,22.610928270087555,white,5.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,103.0,17.0,141.0,28.0,38.5,190.0,2.0996094,2.89990234,0.69995117,128.0,7.509766,99.0,17.0,7495.0,1.7924805,no(M2 and SIP pres)
77.72998,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,2,16.0,under $11k,52972.0,35296.4688,40.5,white,40.0,21,0,0,yes,0.799999714,0.6,no dnr,8.0,80.0,20.5,68.0,28.0,36.5,247.59375,2.7998047,1.0,0.59997559,110.0,7.419922,194.0,8.0,1850.0,0.0,<2 mo. follow-up
42.17899,1,male,1,16,16,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,65312.0,39065.2188,53.333313,black,98.0,1,0,0,no,0.5,0.5,no dnr,16.0,112.0,6.79980469,73.0,28.0,36.19531,236.0,3.0996094,0.79992676,0.69995117,135.0,7.489258,216.0,11.0,2700.0,1.0,<2 mo. follow-up
39.81897,0,female,0,6,443,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,under $11k,5006.0,3479.6816,9.0,white,11.0,1,0,0,no,0.899999619,0.9,no dnr,6.0,51.0,18.8984375,156.0,12.0,35.79688,105.0,2.0996094,1.5,1.5,134.0,7.25,245.0,16.0,508.0,0.494751,no(M2 and SIP pres)
53.86697,0,male,0,6,441,COPD,COPD/CHF/Cirrhosis,1,5.0,$11-$25k,7160.0,4400.0234,22.0,white,22.0,1,0,0,no,0.599999905,0.5,no dnr,6.0,112.0,12.8984375,128.0,36.0,36.19531,200.0,3.5,0.29998779,0.69995117,145.0,7.359375,128.0,11.0,1145.0,0.0,SIP>=30
51.17297,0,female,0,5,440,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,5386.0,3353.3106,12.0,white,22.0,1,0,0,no,0.699999809,0.6,no dnr,5.0,74.0,12.5996094,69.0,26.0,38.0,196.65625,3.5,1.01,0.89990234,136.0,7.40918,233.0,36.0,2640.0,0.0,no(M2 and SIP pres)
64.43799,1,female,1,4,4,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,13930.0,9046.1719,32.0,black,60.0,2,1,0,yes,0.099999964,0.1,dnr after sadm,1.0,107.0,9.29882812,65.0,20.0,36.29688,333.3,3.3999023,0.69995117,1.09985352,139.0,7.419922,89.0,16.0,2502.0,6.0,<2 mo. follow-up
76.84296,0,male,0,5,440,CHF,COPD/CHF/Cirrhosis,3,3.0,under $11k,11660.0,6288.6953,18.0,black,15.0,3,0,0,no,0.699999809,0.5,no dnr,5.0,108.0,15.5,126.0,13.0,39.29688,212.0,2.3999023,0.39996338,1.09985352,143.0,7.329102,101.0,27.0,1958.0,0.0,<2 mo. follow-up
35.19199,0,female,0,4,439,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,$25-$50k,5861.0,3415.1387,18.0,black,33.0,1,1,0,no,0.989999771,0.98,no dnr,4.0,65.0,11.2988281,107.0,26.0,36.69531,333.3,2.8999023,0.89990234,0.79992676,133.0,7.419922,77.0,18.0,2502.0,0.494751,no(M2 and SIP pres)
61.33298,0,female,0,4,439,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,4118.0,2522.3262,9.0,black,33.0,1,0,0,no,0.5,0.3,no dnr,4.0,109.0,4.5,72.0,16.0,36.39844,333.3,3.3999023,2.09960938,1.09985352,141.0,7.419922,99.0,15.0,2925.0,1.1667481,no(M2 and SIP pres)
73.03497,0,female,0,14,438,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,16154.0,10277.6406,10.666664,white,32.0,1,0,0,no,0.899999619,0.8,no dnr,14.0,83.0,10.1992188,76.0,18.0,36.69531,333.3,2.699707,29.0976562,2.19970703,128.0,7.419922,94.0,43.0,380.0,4.0,no(M2 and SIP pres)
48.564,0,male,0,5,440,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,10627.0,14452.7344,13.0,hispanic,8.0,1,1,0,no,0.799999714,0.7,no dnr,5.0,149.0,15.8984375,120.0,12.0,38.29688,150.0,3.0,0.59997559,14.6992188,139.0,7.419922,123.0,46.0,408.0,0.494751,<2 mo. follow-up
62.95099,1,female,1,8,8,Coma,Coma,0,11.0,under $11k,23065.0,14024.0391,35.0,white,31.0,1,0,0,no,0.049999982,0.0,dnr after sadm,1.0,73.0,16.296875,109.0,24.0,36.0,131.65625,4.5996094,1.89990234,0.79992676,139.0,7.239258,110.0,24.0,1350.0,0.0,<2 mo. follow-up
56.65399,0,male,0,4,437,COPD,COPD/CHF/Cirrhosis,4,9.0,$11-$25k,3524.0,2321.0527,9.0,white,13.0,1,1,0,no,0.899999619,0.8,no dnr,4.0,67.0,0.10998535,114.0,20.0,35.39844,333.3,2.699707,0.89990234,1.0,132.0,7.419922,193.0,10.0,5550.0,0.494751,SIP>=30
33.72998,1,male,0,6,108,Lung Cancer,Cancer,3,8.0,under $11k,6140.0,4036.418,17.0,white,14.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,73.0,9.0,120.0,32.0,36.29688,333.3,3.199707,0.39996338,1.29980469,135.0,7.419922,95.0,23.0,2025.0,3.0,SIP>=30
73.03796,0,male,0,29,436,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,$11-$25k,108958.0,67792.0,32.25,white,14.0,8,0,0,no,0.899999619,0.9,no dnr,29.0,108.0,14.5996094,79.0,30.0,36.89844,252.0,3.3999023,1.59985352,1.59985352,142.0,7.5,168.0,29.0,2515.0,1.0,no(M2 and SIP pres)
65.34998,0,male,0,7,436,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,7626.0,5014.125,7.5,white,17.0,1,1,0,yes,0.899999619,0.8,no dnr,7.0,74.0,10.5996094,98.0,24.0,34.5,333.3,3.2998047,0.79992676,1.19995117,131.0,7.419922,121.0,19.0,725.0,1.1667481,no(M2 and SIP pres)
81.27295,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,$11-$25k,15340.0,9386.2031,46.0,white,78.0,1,1,1,no,0.699999809,0.5,dnr after sadm,2.0,51.0,22.0,64.0,16.0,36.09375,295.1875,3.5,1.19995117,1.29980469,134.0,7.539062,254.0,29.0,1300.0,6.0,<2 mo. follow-up
51.11298,0,male,0,14,435,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,31211.0,19024.2031,20.0,black,44.0,1,0,0,no,0.599999905,0.6,no dnr,14.0,74.0,10.1992188,92.0,36.0,36.0,380.9375,2.7998047,5.29980469,1.69995117,132.0,7.419922,108.0,38.0,1625.0,3.0,no(M2 and SIP pres)
59.61899,0,female,0,24,434,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,57393.0,34737.5312,28.333328,white,57.0,3,1,0,no,0.899999619,0.9,no dnr,24.0,65.0,8.5,104.0,24.0,39.0,200.0,2.8999023,16.0976562,1.39990234,136.0,7.489258,127.0,22.0,2250.0,0.0,no(M2 and SIP pres)
74.02899,1,female,1,6,6,Cirrhosis,COPD/CHF/Cirrhosis,1,9.0,under $11k,26218.0,17460.0938,34.0,black,42.0,13,0,0,yes,0.75,0.7,dnr before sadm,-11.0,61.0,7.69921875,122.0,10.0,38.09375,150.0,1.1999512,1.5,1.19995117,131.0,7.379883,103.0,12.0,1120.0,2.0,<2 mo. follow-up
59.38397,1,female,0,15,91,Lung Cancer,Cancer,3,10.0,under $11k,17749.0,11602.1875,12.333328,white,25.0,1,0,0,metastatic,0.799999714,0.4,dnr before sadm,-1.0,0.0,14.5,0.0,0.0,38.89844,79.0,2.5996094,1.19995117,6.79980469,140.0,7.029297,136.0,45.0,0.0,5.0,SIP>=30
62.612,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,56654.0,36087.9375,49.5,white,84.0,7,0,0,no,0.299999952,0.3,dnr after sadm,9.0,93.0,11.7988281,94.0,24.0,36.19531,237.03125,4.0,0.29998779,0.79992676,135.0,7.439453,144.0,9.0,1275.0,6.0,<2 mo. follow-up
73.91595,0,female,0,9,433,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,6936.0,5204.4727,7.5,black,21.0,1,1,0,no,0.899999619,0.7,no dnr,9.0,152.0,8.8984375,73.0,28.0,35.69531,191.40625,3.3999023,0.89990234,1.5,138.0,7.459961,134.0,40.0,1200.0,0.0,adl>=4 (>=5 if sur)
79.88794,1,male,0,11,16,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,38565.0,23817.125,42.0,white,30.0,4,1,0,no,0.099999964,0.05,dnr after sadm,9.0,111.0,4.19921875,83.0,24.0,36.09375,333.3,2.8999023,0.5,1.09985352,135.0,7.419922,133.0,8.0,2502.0,0.0,<2 mo. follow-up
62.81998,1,male,0,7,424,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,6640.0,4745.4609,8.0,white,32.0,1,1,0,no,0.699999809,0.6,no dnr,7.0,167.0,16.796875,120.0,24.0,38.69531,275.0,3.7998047,1.19995117,1.19995117,137.0,7.529297,231.0,27.0,1518.0,0.0,no(M2 and SIP pres)
62.08099,1,female,1,44,44,Coma,Coma,1,12.0,under $11k,73327.0,45294.6875,35.5,white,36.0,1,0,0,no,0.099999964,0.1,dnr after sadm,14.0,109.0,4.89941406,107.0,10.0,38.0,112.0,2.199707,0.69995117,0.59997559,136.0,7.469727,192.0,6.0,2145.0,0.0,<2 mo. follow-up
54.45599,0,male,0,9,431,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,10217.0,6392.75,7.5,white,24.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,141.0,13.0996094,126.0,10.0,36.29688,268.5625,3.5996094,0.29998779,0.69995117,136.0,7.399414,167.0,24.0,1590.0,1.8388672,<2 mo. follow-up
79.33197,1,female,0,19,146,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,40059.0,26422.0469,17.666656,white,40.0,3,0,0,no,0.75,0.5,dnr after sadm,9.0,115.0,5.79980469,171.0,34.0,38.5,180.0,2.5996094,2.89990234,0.59997559,127.0,7.469727,103.0,16.0,6990.0,0.0,no(M2 and SIP pres)
61.45898,0,male,0,3,429,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3372.0,1992.3457,22.610928270087555,white,33.0,1,0,0,no,0.899999619,0.5,no dnr,3.0,134.0,11.5996094,105.0,8.0,38.79688,192.5,2.699707,0.59997559,2.5,143.0,7.429688,284.0,51.0,1386.0,0.494751,<2 mo. follow-up
85.80194,0,female,0,12,427,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,17244.0,11318.9609,15.5,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,67.0,12.0996094,66.0,15.0,36.39844,333.3,3.5996094,0.59997559,0.79992676,131.0,7.419922,348.0,10.0,3300.0,0.0,no(M2 and SIP pres)
69.96899,0,male,0,4,428,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,5496.0,3477.2148,13.0,white,24.0,1,0,0,no,0.599999905,0.6,no dnr,4.0,70.0,23.296875,106.0,40.0,38.09375,795.125,1.7998047,0.89990234,0.59997559,134.0,7.469727,88.0,12.0,2290.0,3.8188477,SIP>=30
49.80698,1,female,0,9,32,Lung Cancer,Cancer,1,12.0,$11-$25k,11255.0,7635.7148,23.5,black,32.0,1,0,0,metastatic,0.399999857,0.15,no dnr,9.0,83.0,14.1992188,122.0,22.0,35.89844,347.5625,4.0,1.0,1.59985352,136.0,7.469727,140.0,44.0,2502.0,1.1667481,<2 mo. follow-up
54.57898,1,female,0,7,163,Cirrhosis,COPD/CHF/Cirrhosis,5,10.0,under $11k,7291.0,4929.8164,5.5,black,28.0,1,1,0,yes,0.599999905,0.5,no dnr,7.0,108.0,15.0996094,120.0,8.0,36.89844,147.5,3.8999023,1.29980469,2.29980469,143.0,7.419922,192.0,64.0,1968.0,1.0,SIP>=30
49.94397,1,female,0,14,120,Colon Cancer,Cancer,3,12.0,under $11k,15414.0,11019.7266,11.333328,black,26.0,1,1,0,metastatic,0.799999714,0.6,no dnr,14.0,129.0,20.1992188,67.0,28.0,38.5,333.3,4.0996094,0.89990234,1.19995117,139.0,7.489258,100.0,39.0,1062.0,0.0,no(M2 and SIP pres)
78.59296,0,female,0,16,425,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,63650.0,40586.125,22.333328,white,34.0,9,0,0,no,0.849999905,0.85,no dnr,16.0,70.0,9.0,72.0,22.0,35.19531,333.3,3.8999023,0.79992676,1.0,138.0,7.419922,141.0,12.0,1600.0,1.0,no(M2 and SIP pres)
22.894,0,female,0,21,425,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,65950.0,43141.9062,40.666657,black,50.0,9,0,0,no,0.899999619,0.9,no dnr,21.0,67.0,9.8984375,68.0,24.0,36.59375,180.9375,3.699707,1.79980469,0.69995117,136.0,7.40918,240.0,18.0,1925.0,1.0,no(M2 and SIP pres)
46.06198,0,female,0,25,424,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,57769.0,0.0,15.75,white,33.0,6,0,0,yes,0.799999714,0.7,no dnr,25.0,73.0,10.2988281,73.0,24.0,36.09375,333.3,4.0,0.5,1.0,136.0,7.419922,137.0,20.0,2502.0,1.0,SIP>=30
76.70898,1,female,0,16,42,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,29230.0,18786.9844,27.0,white,43.0,1,0,1,no,0.099999964,0.1,dnr after sadm,1.0,123.0,13.5996094,124.0,20.0,36.79688,193.53125,4.3994141,0.39996338,1.5,142.0,7.429688,200.0,36.0,1675.0,7.0,<2 mo. follow-up
64.21899,1,male,1,4,4,Colon Cancer,Cancer,2,10.0,under $11k,4376.0,2553.582,8.0,black,69.0,1,0,0,metastatic,0.0,0.0,dnr before sadm,-1.0,123.0,2.0,141.0,36.0,38.59375,157.125,2.2998047,2.79980469,0.79992676,144.0,7.259766,344.0,22.0,2710.0,2.6982422,<2 mo. follow-up
46.53497,0,female,0,13,422,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17345.0,10715.5078,24.0,black,35.0,1,0,0,no,0.899999619,0.5,no dnr,13.0,120.0,13.3984375,129.0,28.0,37.59375,245.6875,2.0996094,0.69995117,0.79992676,137.0,7.439453,298.0,11.0,1594.0,5.0,no(M2 and SIP pres)
72.04095,1,male,0,11,36,Lung Cancer,Cancer,3,11.0,under $11k,8729.0,6092.3672,6.0,black,30.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,5.0,69.0,4.5,140.0,44.0,38.5,277.75,2.7998047,2.29980469,1.69995117,127.0,7.509766,194.0,32.0,2502.0,0.0,<2 mo. follow-up
61.28998,1,male,1,8,8,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,15891.0,11420.1797,4.0,black,39.0,13,1,0,metastatic,0.049999982,0.0,dnr before sadm,-12.0,77.0,11.1992188,120.0,20.0,35.69531,304.75,3.5,1.01,0.89990234,139.0,7.359375,159.0,23.0,3100.0,5.3056641,<2 mo. follow-up
72.01398,1,male,0,10,40,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,10015.0,6940.5156,11.5,white,27.0,1,1,0,no,0.5,0.4,dnr after sadm,2.0,70.0,9.19921875,64.0,28.0,37.59375,485.6875,2.5,2.29980469,0.59997559,135.0,7.419922,170.0,9.0,3075.0,3.0,<2 mo. follow-up
39.228,1,male,0,44,230,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,135498.0,87864.1875,43.0,white,32.0,17,0,0,metastatic,0.5,0.4,no dnr,44.0,122.0,15.8984375,116.0,38.0,38.69531,245.6875,2.0,0.69995117,3.5,131.0,7.509766,95.0,61.0,1175.0,0.0,no(M2 and SIP pres)
79.81097,1,male,0,6,254,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5842.0,3620.1133,15.0,white,20.0,1,0,0,no,0.599999905,0.5,no dnr,6.0,72.0,15.0996094,110.0,26.0,36.59375,191.65625,3.7998047,0.79992676,0.69995117,134.0,7.289062,298.0,16.0,3935.0,0.0,SIP>=30
68.0,1,female,1,3,3,Coma,Coma,1,12.0,under $11k,14464.0,9795.5312,22.610928270087555,white,31.0,3,1,0,no,0.699999809,0.5,dnr after sadm,3.0,102.0,7.69921875,104.0,20.0,36.0,290.4375,4.0,0.5,1.19995117,141.0,7.439453,93.0,12.0,2502.0,2.7285156,<2 mo. follow-up
82.82794,1,female,0,18,23,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,15211.0,10818.75,12.333328,white,53.0,1,0,0,yes,0.299999952,0.2,dnr after sadm,1.0,77.0,16.8984375,61.0,24.0,35.79688,266.625,3.5,1.01,1.09985352,131.0,7.509766,223.0,19.0,2502.0,2.0,<2 mo. follow-up
38.98199,1,female,0,20,274,ARF/MOSF w/Sepsis,ARF/MOSF,6,11.0,under $11k,26427.0,17700.375,19.666656,white,73.0,1,1,0,yes,0.799999714,0.75,no dnr,20.0,113.0,9.29882812,78.0,20.0,36.29688,333.3,4.0996094,0.79992676,2.09960938,137.0,7.419922,105.0,35.0,2275.0,6.0,no(M2 and SIP pres)
55.91498,1,male,1,58,58,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,131906.0,14452.7344,38.75,white,44.0,1,1,0,yes,0.699999809,0.5,dnr after sadm,46.0,107.0,17.1992188,133.0,10.0,39.19531,170.0,3.0996094,9.69921875,2.59960938,144.0,7.469727,166.0,67.0,1820.0,0.0,<2 mo. follow-up
86.72699,0,female,0,13,415,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,23290.0,15441.0625,26.5,white,26.0,1,0,0,no,0.799999714,0.6,no dnr,13.0,105.0,16.0976562,137.0,26.0,37.89844,217.125,3.3999023,0.5,1.09985352,135.0,7.399414,166.0,19.0,1100.0,1.0,adl>=4 (>=5 if sur)
57.40997,0,male,0,48,415,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,69865.0,45832.9062,28.25,white,37.0,1,0,0,no,0.199999928,0.1,no dnr,48.0,66.0,1.79980469,118.0,22.0,39.09375,333.3,2.5996094,0.79992676,1.5,138.0,7.419922,90.0,8.0,2502.0,2.8574219,no(M2 and SIP pres)
41.84,0,female,0,45,413,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,139684.0,0.0,52.75,white,24.0,3,0,0,no,0.899999619,0.9,no dnr,45.0,70.0,18.1992188,107.0,10.0,36.69531,267.5,2.2998047,0.39996338,0.59997559,134.0,7.359375,156.0,8.0,1584.0,0.0,adl>=4 (>=5 if sur)
59.439,1,female,0,12,97,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,23150.0,0.0,31.0,white,28.0,1,0,0,no,0.799999714,0.7,no dnr,12.0,66.0,8.79882812,127.0,27.0,38.59375,246.65625,2.699707,1.09985352,5.09960938,139.0,7.40918,128.0,67.0,270.0,0.494751,SIP>=30
68.0,0,female,0,41,413,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,99097.0,64199.9688,42.75,white,16.0,9,0,0,no,0.849999905,0.9,no dnr,41.0,76.0,7.89941406,129.0,30.0,36.59375,220.0,2.5996094,1.39990234,0.59997559,136.0,7.469727,118.0,9.0,4375.0,0.0,adl>=4 (>=5 if sur)
57.91898,1,male,1,78,78,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,186135.0,14452.7344,35.0,white,50.0,39,1,0,no,0.899999619,0.8,dnr after sadm,6.0,80.0,9.0,76.0,20.0,38.5,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,4100.0,5.0,<2 mo. follow-up
50.51599,0,male,0,24,413,Coma,Coma,2,12.0,under $11k,56631.0,0.0,27.666656,black,27.0,6,0,0,no,0.649999619,0.65,no dnr,24.0,74.0,1.0,57.0,24.0,38.0,333.3,2.199707,0.69995117,1.19995117,130.0,7.419922,163.0,24.0,2502.0,0.0,<2 mo. follow-up
63.92599,0,female,0,4,410,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,3902.0,0.0,8.0,black,7.0,1,0,0,no,1.0,0.98,no dnr,4.0,59.0,13.3984375,129.0,36.0,38.5,151.40625,2.0,0.79992676,0.59997559,134.0,7.439453,316.0,5.0,5730.0,2.4707031,no(M2 and SIP pres)
67.70398,0,female,0,7,407,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,15639.0,9370.6797,15.5,white,23.0,1,1,0,yes,0.899999619,0.8,no dnr,7.0,82.0,17.3984375,72.0,24.0,36.69531,228.5625,3.199707,0.29998779,1.09985352,134.0,7.279297,322.0,16.0,2250.0,4.359375,<2 mo. follow-up
54.93997,1,female,0,38,54,Coma,Coma,2,11.0,under $11k,38899.0,26061.3438,18.25,white,10.0,1,1,0,yes,0.299999952,0.1,dnr after sadm,25.0,132.0,6.09960938,73.0,27.0,38.19531,177.5,2.3999023,0.69995117,6.29980469,139.0,7.5,176.0,80.0,1390.0,3.0,<2 mo. follow-up
64.68695,1,male,0,6,250,CHF,COPD/CHF/Cirrhosis,6,7.0,$11-$25k,7166.0,4626.8594,21.0,white,54.0,1,1,0,no,0.5,0.4,no dnr,6.0,67.0,19.5,112.0,35.0,38.79688,266.625,1.7998047,1.29980469,1.19995117,145.0,7.469727,154.0,31.0,1881.0,5.0,no(M2 and SIP pres)
41.29797,1,male,1,21,21,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,>$50k,113373.0,71772.75,48.0,white,56.0,5,0,0,no,0.299999952,0.2,dnr after sadm,17.0,106.0,6.39941406,73.0,20.0,36.39844,357.125,3.5996094,11.8984375,0.59997559,152.0,7.469727,137.0,12.0,4010.0,0.0,<2 mo. follow-up
69.06195,0,male,0,3,405,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,5951.0,3269.6738,22.610928270087555,white,19.0,1,0,0,yes,0.75,0.7,no dnr,3.0,114.0,13.5996094,127.0,47.0,38.59375,263.3125,1.5998535,3.5,0.89990234,137.0,7.479492,201.0,30.0,2010.0,0.0,no(M2 and SIP pres)
69.79095,0,male,0,53,404,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,64291.0,14452.7344,13.0,white,15.0,1,0,0,no,0.799999714,0.6,no dnr,53.0,59.0,14.5,116.0,40.0,38.09375,200.0,2.7998047,0.29998779,1.0,130.0,7.459961,156.0,21.0,1564.0,5.1992188,SIP>=30
64.047,1,female,0,10,345,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,16228.0,10813.0156,9.5,white,39.0,3,0,0,no,0.799999714,0.6,no dnr,10.0,71.0,5.69921875,83.0,20.0,35.5,333.3,3.5,1.01,1.89990234,137.0,7.419922,181.0,24.0,2502.0,0.0,SIP>=30
82.47498,1,male,0,33,350,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,44225.0,29886.6406,23.0,white,60.0,1,0,1,no,0.799999714,0.6,no dnr,33.0,122.0,3.09960938,212.0,44.0,36.29688,98.32812,2.0996094,1.29980469,0.69995117,134.0,7.379883,114.0,16.0,1750.0,6.2919922,no(M2 and SIP pres)
64.745,0,male,0,5,401,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,3720.0,2660.5898,4.0,white,13.0,1,0,0,no,0.599999905,0.6,no dnr,5.0,64.0,14.5,118.0,45.0,36.09375,153.5625,4.0,0.5,0.69995117,138.0,7.299805,143.0,10.0,830.0,3.0,no(M2 and SIP pres)
49.54999,1,female,0,211,395,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,$25-$50k,500572.0,14452.7344,51.75,white,37.0,1,0,0,no,0.5,0.4,no dnr,211.0,83.0,9.79882812,72.0,20.0,35.79688,225.90625,3.0996094,0.69995117,1.89990234,132.0,7.419922,92.0,25.0,2502.0,4.0,adl>=4 (>=5 if sur)
79.27197,0,male,0,14,398,ARF/MOSF w/Sepsis,ARF/MOSF,4,0.0,under $11k,20713.0,12282.9062,11.333328,hispanic,53.0,1,1,1,no,0.5,0.5,no dnr,14.0,119.0,6.69921875,120.0,24.0,35.79688,92.0,4.0,0.39996338,0.79992676,139.0,7.40918,166.0,17.0,1025.0,6.3398438,no(M2 and SIP pres)
33.19098,0,female,0,32,398,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,102718.0,67687.6875,37.0,white,18.0,1,0,0,no,0.299999952,0.3,no dnr,32.0,75.0,9.0,118.0,12.0,35.89844,333.3,2.199707,0.39996338,0.69995117,136.0,7.419922,108.0,6.0,2200.0,1.0,SIP>=30
79.55096,1,male,0,4,240,CHF,COPD/CHF/Cirrhosis,6,0.0,under $11k,3952.0,2600.4746,12.0,black,22.0,1,0,0,no,0.599999905,0.4,no dnr,4.0,62.0,19.0976562,118.0,20.0,38.39844,315.6875,3.199707,1.29980469,1.09985352,136.0,7.469727,92.0,7.0,2502.0,1.0,no(M2 and SIP pres)
58.40097,0,female,0,18,397,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,26552.0,17132.6406,23.333328,black,32.0,2,0,0,metastatic,0.5,0.08,no dnr,18.0,131.0,5.19921875,128.0,28.0,38.5,115.98438,2.3999023,0.79992676,1.79980469,135.0,7.359375,123.0,51.0,3845.0,1.0,no(M2 and SIP pres)
70.784,1,male,0,6,135,Lung Cancer,Cancer,1,11.0,$11-$25k,17307.0,10759.3359,19.0,white,20.0,1,0,0,metastatic,0.699999809,0.2,no dnr,6.0,52.0,7.79980469,232.0,43.0,39.09375,67.0,2.5,0.39996338,0.5,144.0,7.30957,172.0,16.0,584.0,0.0,adl>=4 (>=5 if sur)
47.09698,1,male,1,45,45,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,170334.0,14452.7344,44.75,hispanic,62.0,4,0,0,no,0.949999809,1.0,no dnr,45.0,85.0,9.19921875,70.0,20.0,36.79688,333.3,3.8999023,0.39996338,1.39990234,137.0,7.419922,104.0,14.0,2502.0,6.0,<2 mo. follow-up
48.74698,0,female,0,13,396,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,30269.0,18756.7812,27.0,white,49.0,1,0,0,no,1.0,1.0,no dnr,13.0,112.0,0.52990723,135.0,24.0,39.79688,333.3,3.199707,1.19995117,1.0,128.0,7.419922,236.0,11.0,2502.0,0.0,no(M2 and SIP pres)
73.74896,1,male,1,22,22,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,61904.0,38719.8438,54.0,white,64.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,165.0,17.3984375,144.0,40.0,35.0,54.0,1.8999023,5.5,1.5,134.0,7.189453,206.0,11.0,1013.0,2.4453125,<2 mo. follow-up
61.85397,0,male,0,18,396,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,62548.0,35952.625,48.0,white,62.0,5,0,0,no,0.5,0.5,no dnr,18.0,98.0,5.5,76.0,24.0,36.29688,333.3,2.699707,3.0,0.69995117,139.0,7.419922,64.0,7.0,2100.0,0.0,adl>=4 (>=5 if sur)
70.771,1,male,0,14,19,COPD,COPD/CHF/Cirrhosis,4,11.0,$11-$25k,12505.0,8552.2188,11.0,white,40.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,77.0,7.0,68.0,24.0,36.0,186.65625,3.5,1.01,0.69995117,139.0,7.429688,167.0,16.0,3800.0,7.0,<2 mo. follow-up
40.159,0,male,0,9,396,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,15154.0,10078.6094,18.5,white,18.0,1,0,0,no,1.0,1.0,no dnr,9.0,106.0,9.59960938,67.0,24.0,36.59375,182.375,3.699707,0.5,0.59997559,131.0,7.349609,113.0,12.0,2502.0,0.0,no(M2 and SIP pres)
71.47699,1,male,1,13,13,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,68154.0,42684.25,61.0,white,43.0,3,1,1,no,0.299999952,0.3,no dnr,13.0,63.0,33.5,140.0,44.0,40.29688,333.3,2.7998047,0.29998779,1.39990234,146.0,7.419922,244.0,32.0,1450.0,0.0,<2 mo. follow-up
37.60397,0,female,0,24,392,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,53459.0,33585.25,28.666656,black,41.0,1,0,0,no,1.0,1.0,no dnr,24.0,117.0,8.0,61.0,24.0,36.59375,333.3,3.5,1.01,1.09985352,138.0,7.419922,139.0,19.0,1650.0,0.0,no(M2 and SIP pres)
64.57996,0,female,0,5,393,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,6380.0,4103.3086,7.0,hispanic,24.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,62.0,8.79882812,76.0,24.0,36.69531,263.875,2.5,0.29998779,4.89941406,135.0,7.389648,138.0,57.0,3680.0,1.1667481,SIP>=30
54.62799,0,female,0,6,391,Colon Cancer,Cancer,1,13.0,$25-$50k,7690.0,5136.7578,13.0,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,57.0,7.79980469,100.0,24.0,35.5,309.5,3.5,0.5,1.39990234,141.0,7.449219,122.0,23.0,2502.0,0.0,SIP>=30
66.61499,0,male,0,6,391,Lung Cancer,Cancer,2,13.0,under $11k,59995.78781114967,14452.7344,3.0,black,15.0,1,0,0,metastatic,0.399999857,0.3,no dnr,14.58258953168044,114.0,14.0996094,118.0,24.0,36.29688,263.75,4.2998047,0.29998779,1.39990234,137.0,7.429688,355.0,30.0,1000.0,1.0,SIP>=30
58.11099,1,female,1,13,13,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,17463.0,0.0,19.5,white,52.0,1,0,0,metastatic,0.399999857,0.2,dnr before sadm,-1.0,107.0,6.59960938,67.0,20.0,36.19531,407.5625,4.0996094,1.39990234,0.89990234,141.0,7.429688,197.0,13.0,2502.0,4.0,<2 mo. follow-up
42.51599,0,male,0,12,388,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,30221.0,19361.6875,31.0,white,31.0,1,0,0,no,0.899999619,0.5,no dnr,12.0,117.0,11.5,77.0,36.0,38.39844,200.0,2.5996094,0.59997559,1.0,150.0,7.469727,232.0,23.0,2753.0,0.0,no(M2 and SIP pres)
71.34296,0,male,0,13,386,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,17512.0,11379.1406,13.0,white,31.0,4,0,0,no,0.949999809,0.95,no dnr,13.0,98.0,13.2988281,96.0,20.0,37.19531,285.6875,4.0996094,1.0,1.09985352,136.0,7.389648,158.0,21.0,2502.0,0.494751,no(M2 and SIP pres)
53.51999,1,female,0,12,265,CHF,COPD/CHF/Cirrhosis,5,9.0,under $11k,18157.0,10024.0,33.5,white,42.0,1,0,0,no,0.75,0.5,no dnr,12.0,77.0,7.5,101.0,20.0,35.39844,333.3,3.0996094,0.39996338,0.59997559,138.0,7.419922,114.0,9.0,2502.0,1.0,adl>=4 (>=5 if sur)
39.75098,0,female,0,17,385,Cirrhosis,COPD/CHF/Cirrhosis,3,11.0,under $11k,19635.0,13662.0312,14.666664,black,33.0,1,0,0,no,0.899999619,0.7,dnr after sadm,2.0,106.0,8.79882812,67.0,10.0,38.0,263.3125,2.5996094,1.0,0.79992676,135.0,7.419922,120.0,12.0,1711.0,0.0,<2 mo. follow-up
72.35596,1,female,1,24,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,97395.0,14452.7344,55.333313,white,50.0,1,0,0,no,0.299999952,0.3,no dnr,24.0,120.0,6.29980469,80.0,20.0,36.59375,333.3,4.0996094,1.5,1.19995117,138.0,7.419922,156.0,24.0,4595.0,1.0,<2 mo. follow-up
33.58798,1,male,1,56,56,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,171848.0,14452.7344,32.0,black,68.0,14,0,0,no,0.599999905,0.5,dnr after sadm,54.0,46.0,32.09375,61.0,16.0,35.69531,248.5625,1.5998535,1.09985352,5.59960938,148.0,7.359375,172.0,89.0,0.0,7.0,<2 mo. follow-up
64.99896,1,female,0,4,174,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,3993.0,14452.7344,9.0,black,12.0,1,0,0,no,0.799999714,0.7,no dnr,4.0,122.0,9.29882812,120.0,40.0,36.09375,162.5,3.199707,0.29998779,1.29980469,140.0,7.439453,323.0,25.0,2371.0,0.0,no(M2 and SIP pres)
56.86499,0,male,0,5,384,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,6002.0,4028.7656,14.0,white,17.0,1,0,0,no,0.899999619,0.85,no dnr,5.0,134.0,5.89941406,122.0,28.0,36.5,143.3125,2.5,0.59997559,0.69995117,139.0,7.479492,154.0,12.0,320.0,4.0634766,<2 mo. follow-up
48.008,0,male,0,16,384,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,29124.0,18779.5469,23.666656,white,20.0,1,0,0,no,0.949999809,0.95,no dnr,16.0,135.0,13.7988281,135.0,40.0,36.0,350.6875,2.2998047,1.79980469,0.89990234,147.0,7.439453,108.0,17.0,1890.0,1.1667481,SIP>=30
50.78699,0,female,0,24,384,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,75232.0,14452.7344,41.0,black,51.0,1,1,0,no,0.899999619,0.9,no dnr,24.0,53.0,7.89941406,118.0,20.0,38.69531,333.3,2.699707,0.29998779,0.69995117,137.0,7.419922,128.0,7.0,2425.0,1.0,<2 mo. follow-up
52.05698,1,female,0,10,183,Lung Cancer,Cancer,1,12.0,$25-$50k,22565.0,14776.0312,17.5,black,19.0,1,0,0,metastatic,0.5,0.2,no dnr,10.0,50.0,2.79980469,113.0,14.0,35.69531,294.0,1.7998047,3.0,1.89990234,133.0,7.40918,231.0,25.0,307.0,0.0,SIP>=30
71.00897,1,male,1,23,23,MOSF w/Malig,ARF/MOSF,1,6.0,under $11k,85068.0,14452.7344,44.666657,white,40.0,9,0,0,metastatic,0.299999952,0.3,dnr after sadm,6.0,123.0,4.19921875,70.0,24.0,35.89844,333.3,2.5996094,0.69995117,1.29980469,137.0,7.419922,151.0,20.0,2502.0,0.0,<2 mo. follow-up
75.62799,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,10501.0,5917.3359,37.0,white,29.0,1,0,1,no,0.049999982,0.25,dnr after sadm,1.0,132.0,13.8984375,59.0,10.0,36.09375,149.46875,3.0996094,0.39996338,0.89990234,141.0,7.529297,215.0,17.0,1494.0,6.0,<2 mo. follow-up
71.45496,1,female,0,19,345,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,22573.0,14452.7344,18.0,white,57.0,1,0,1,no,0.5,0.1,dnr after sadm,2.0,113.0,7.09960938,80.0,20.0,36.5,333.3,4.6992188,1.19995117,2.89990234,135.0,7.419922,319.0,47.0,5200.0,7.0,<2 mo. follow-up
62.94299,0,male,0,9,381,COPD,COPD/CHF/Cirrhosis,5,11.0,under $11k,17524.0,10476.25,19.5,black,41.0,1,1,0,no,0.949999809,0.8,no dnr,9.0,116.0,14.0996094,130.0,35.0,38.19531,218.28125,4.1992188,0.79992676,0.79992676,133.0,7.479492,162.0,12.0,1980.0,0.0,no(M2 and SIP pres)
65.93597,1,male,0,10,154,Cirrhosis,COPD/CHF/Cirrhosis,4,9.0,under $11k,22260.0,14452.7344,36.0,white,42.0,1,0,0,no,0.5,0.4,no dnr,10.0,113.0,9.0,77.0,26.0,36.0,205.59375,3.5996094,0.29998779,0.79992676,137.0,7.30957,190.0,14.0,1350.0,0.0,SIP>=30
80.03796,1,male,0,7,180,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,7385.0,14452.7344,6.5,black,22.0,1,0,0,no,0.599999905,0.4,no dnr,7.0,68.0,10.2988281,110.0,24.0,35.29688,172.5,2.3999023,1.29980469,0.69995117,139.0,7.489258,204.0,23.0,2260.0,6.0,adl>=4 (>=5 if sur)
35.01999,0,male,0,4,365,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,5801.0,14452.7344,13.0,white,16.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,138.0,17.0,110.0,28.0,36.09375,226.65625,4.0,0.79992676,1.09985352,142.0,7.389648,150.0,21.0,2502.0,0.0,no(M2 and SIP pres)
71.79999,0,male,0,23,363,ARF/MOSF w/Sepsis,ARF/MOSF,2,18.0,>$50k,30752.0,14452.7344,24.0,white,35.0,2,0,1,no,0.799999714,0.7,no dnr,23.0,68.0,8.8984375,124.0,24.0,36.79688,417.375,3.2998047,0.39996338,1.19995117,134.0,7.429688,94.0,23.0,1300.0,5.0,adl>=4 (>=5 if sur)
21.37999,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,44161.0,14452.7344,75.0,white,61.0,2,0,0,no,0.149999976,0.15,dnr after sadm,8.0,108.0,21.5,84.0,24.0,36.29688,265.0,3.699707,0.79992676,2.19970703,134.0,7.429688,154.0,31.0,2502.0,0.0,<2 mo. follow-up
66.41797,1,male,0,8,358,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,6424.0,14452.7344,8.5,white,15.0,1,1,0,no,0.699999809,0.7,no dnr,8.0,121.0,48.0,126.0,20.0,34.29688,333.3,2.699707,1.01,0.79992676,145.0,7.419922,141.0,11.0,2502.0,5.0,SIP>=30
60.62698,0,female,0,14,361,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,21111.0,14452.7344,13.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,81.0,8.3984375,64.0,20.0,36.89844,333.3,1.7998047,3.69970703,0.69995117,132.0,7.419922,101.0,3.0,1800.0,3.0,<2 mo. follow-up
84.50696,1,female,1,71,71,Coma,Coma,2,12.0,under $11k,162084.0,14452.7344,41.5,black,33.0,14,0,0,no,0.599999905,0.45,dnr after sadm,45.0,103.0,19.1992188,66.0,20.0,38.59375,333.3,2.699707,1.0,1.89990234,128.0,7.419922,116.0,36.0,1550.0,4.0,adl>=4 (>=5 if sur)
53.29797,0,female,0,33,360,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,48988.0,14452.7344,19.0,white,10.0,2,0,0,no,0.899999619,0.9,dnr after sadm,13.0,53.0,9.5,107.0,40.0,36.39844,280.3125,2.5996094,0.5,0.59997559,131.0,7.469727,96.0,12.0,3035.0,0.0,adl>=4 (>=5 if sur)
37.69998,0,male,0,7,360,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,13431.0,14452.7344,12.0,white,32.0,1,0,0,no,0.799999714,0.75,no dnr,7.0,142.0,19.296875,130.0,12.0,36.5,418.625,1.7998047,1.19995117,10.0,138.0,7.359375,79.0,80.0,2136.0,0.494751,no(M2 and SIP pres)
24.57199,0,female,0,37,360,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,107908.0,14452.7344,44.75,black,28.0,1,0,0,no,0.699999809,0.7,no dnr,37.0,67.0,0.79992676,72.0,20.0,38.89844,333.3,3.5,0.5,1.0,133.0,7.419922,145.0,7.0,2550.0,0.0,SIP>=30
54.91299,1,male,0,13,340,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,24833.0,14452.7344,22.0,white,37.0,4,1,0,no,0.5,0.4,no dnr,13.0,66.0,28.1992188,107.0,20.0,34.89844,271.375,1.3999023,0.79992676,0.5,130.0,7.369141,147.0,17.0,1983.0,6.0,SIP>=30
33.96597,0,male,0,11,358,Coma,Coma,1,12.0,under $11k,34737.0,14452.7344,14.5,white,11.0,5,0,0,yes,0.899999619,0.9,no dnr,11.0,49.0,10.6992188,107.0,24.0,35.89844,333.3,1.5998535,9.19921875,1.29980469,137.0,7.419922,25.0,58.0,2502.0,4.0,no(M2 and SIP pres)
59.754,1,male,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,50528.0,14452.7344,41.5,white,46.0,9,0,0,no,0.399999857,0.25,dnr after sadm,1.0,103.0,17.1992188,136.0,32.0,39.29688,247.59375,3.0996094,0.5,0.69995117,133.0,7.5,72.0,9.0,1275.0,7.0,<2 mo. follow-up
42.883,0,male,0,31,356,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,59667.0,14452.7344,28.25,white,37.0,1,0,0,no,0.799999714,0.8,no dnr,31.0,73.0,9.5,100.0,20.0,37.69531,333.3,3.2998047,0.59997559,2.0,136.0,7.419922,125.0,43.0,2050.0,5.0,no(M2 and SIP pres)
62.44199,1,male,0,4,193,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3378.0,14452.7344,6.0,black,23.0,1,0,0,no,0.699999809,0.7,no dnr,4.0,101.0,16.0,93.0,32.0,36.79688,333.3,3.0,1.39990234,2.19970703,134.0,7.419922,168.0,48.0,1975.0,0.494751,<2 mo. follow-up
60.89499,1,male,0,3,194,Lung Cancer,Cancer,1,12.0,under $11k,2920.0,14452.7344,22.610928270087555,white,16.0,1,0,0,metastatic,1.0,0.8,no dnr,3.0,82.0,11.1992188,72.0,20.0,36.09375,521.5,2.0,4.5,0.69995117,127.0,7.519531,178.0,11.0,850.0,0.494751,no(M2 and SIP pres)
68.20294,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,5,10.0,under $11k,17767.0,14452.7344,22.610928270087555,white,115.0,1,1,0,no,0.049999982,0.05,dnr after sadm,3.0,134.0,14.6992188,148.0,8.0,36.79688,160.96875,3.5,1.01,0.59997559,126.0,7.429688,165.0,3.0,2265.0,4.1640625,<2 mo. follow-up
67.17297,0,male,0,4,355,CHF,COPD/CHF/Cirrhosis,4,3.0,under $11k,3384.0,14452.7344,7.0,black,25.0,1,1,0,no,0.699999809,0.3,no dnr,4.0,69.0,5.79980469,76.0,24.0,36.19531,308.0625,3.699707,1.39990234,1.59985352,137.0,7.439453,112.0,14.0,2502.0,3.8549805,SIP>=30
71.35895,1,male,0,15,79,ARF/MOSF w/Sepsis,ARF/MOSF,6,12.0,under $11k,33683.0,14452.7344,29.333328,white,40.0,1,0,0,no,0.899999619,0.85,no dnr,15.0,100.0,14.7988281,65.0,10.0,38.09375,254.65625,3.5,1.01,1.0,149.0,7.359375,280.0,29.0,1712.0,5.0,<2 mo. follow-up
58.17398,0,female,0,3,355,CHF,COPD/CHF/Cirrhosis,1,9.0,under $11k,2640.0,14452.7344,22.610928270087555,white,14.0,1,1,0,no,1.0,1.0,no dnr,3.0,79.0,7.89941406,80.0,22.0,36.09375,333.3,2.199707,5.29980469,2.19970703,132.0,7.419922,164.0,52.0,450.0,1.1667481,no(M2 and SIP pres)
59.70999,0,male,0,18,351,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,44170.0,14452.7344,31.0,white,69.0,1,0,0,no,0.899999619,0.9,no dnr,18.0,133.0,9.29882812,72.0,12.0,36.0,385.6875,1.6999512,15.0,6.59960938,145.0,7.289062,183.0,59.0,2490.0,0.0,adl>=4 (>=5 if sur)
65.45099,1,female,0,7,9,MOSF w/Malig,ARF/MOSF,1,15.0,$11-$25k,6485.0,14452.7344,9.5,white,30.0,1,0,0,metastatic,0.799999714,0.6,dnr after sadm,1.0,111.0,17.6992188,142.0,28.0,39.0,334.8125,2.5,0.69995117,2.59960938,146.0,7.329102,182.0,43.0,3735.0,6.0,<2 mo. follow-up
69.19098,0,female,0,33,351,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,80869.0,14452.7344,46.0,white,48.0,1,0,0,no,0.899999619,0.85,no dnr,33.0,63.0,18.796875,64.0,18.0,36.39844,333.3,4.1992188,0.89990234,1.19995117,139.0,7.419922,175.0,27.0,875.0,2.0,SIP>=30
57.88397,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,301188.0,14452.7344,54.0,black,94.0,137,1,0,no,0.5,0.4,dnr after sadm,8.0,67.0,12.5996094,104.0,10.0,36.0,191.40625,2.0,1.0,1.39990234,149.0,7.379883,338.0,22.0,8040.0,0.0,<2 mo. follow-up
72.23798,0,female,0,6,349,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,7178.0,14452.7344,13.0,white,19.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,63.0,11.5,103.0,12.0,39.89844,170.0,3.5,1.01,0.69995117,141.0,7.459961,93.0,13.0,1762.0,1.1667481,<2 mo. follow-up
59.56998,0,male,0,4,347,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,3941.0,14452.7344,13.0,white,14.0,1,1,0,no,0.699999809,0.4,no dnr,4.0,69.0,9.5,106.0,24.0,35.79688,271.875,2.3999023,0.89990234,0.79992676,148.0,7.40918,315.0,12.0,4685.0,1.0,no(M2 and SIP pres)
79.76697,0,female,0,13,346,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,13791.0,14452.7344,9.5,white,23.0,1,1,0,no,0.799999714,0.8,no dnr,13.0,126.0,14.6992188,65.0,10.0,39.09375,317.6875,2.3999023,0.69995117,0.79992676,142.0,7.379883,120.0,9.0,2653.0,0.0,no(M2 and SIP pres)
64.62994,1,male,0,3,298,COPD,COPD/CHF/Cirrhosis,7,16.0,$11-$25k,7279.0,14452.7344,31.0,white,30.0,1,1,0,no,0.799999714,0.75,no dnr,3.0,55.0,17.296875,66.0,6.0,36.59375,251.40625,2.199707,0.39996338,4.09960938,144.0,7.399414,279.0,58.0,1418.0,1.8388672,SIP>=30
39.84399,1,male,0,6,76,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,4983.0,14452.7344,14.0,white,16.0,1,0,0,no,0.899999619,0.7,no dnr,6.0,133.0,10.6992188,75.0,27.0,37.59375,333.3,3.5,1.01,0.79992676,139.0,7.419922,130.0,25.0,2300.0,3.559082,<2 mo. follow-up
62.17099,0,male,0,7,344,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,under $11k,7050.0,14452.7344,8.0,white,11.0,1,1,0,no,0.899999619,0.8,no dnr,7.0,85.0,11.0,72.0,20.0,36.79688,333.3,2.8999023,1.29980469,0.89990234,133.0,7.419922,114.0,7.0,2502.0,0.0,no(M2 and SIP pres)
78.198,1,female,1,20,20,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,18591.0,14452.7344,24.666656,white,69.0,1,1,0,yes,0.0,0.0,dnr after sadm,2.0,118.0,9.69921875,70.0,24.0,36.19531,200.0,3.2998047,1.09985352,1.19995117,137.0,7.349609,441.0,23.0,4465.0,6.0,<2 mo. follow-up
76.07898,1,male,0,3,4,Coma,Coma,0,12.0,under $11k,2946.0,2442.3652,26.0,white,43.0,1,0,0,no,0.099999964,0.001,dnr after sadm,1.0,125.0,10.8984375,130.0,44.0,39.19531,206.65625,3.5996094,0.39996338,0.89990234,143.0,7.589844,135.0,23.0,2502.0,1.9990234,<2 mo. follow-up
83.66296,0,male,0,6,2029,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,2453.0,2665.6504,6.0,white,29.0,1,0,0,no,0.989999771,0.95,dnr after sadm,1.0,76.0,9.8984375,63.0,24.0,35.79688,366.625,3.5,1.01,1.29980469,139.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.01196,1,male,0,15,372,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,13287.0,11490.5469,7.666664,white,48.0,1,1,0,no,0.899999619,0.75,dnr after sadm,1.0,109.0,10.2988281,73.0,28.0,36.39844,276.1875,3.5,1.09985352,3.69970703,139.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.65594,1,female,0,20,1439,ARF/MOSF w/Sepsis,ARF/MOSF,2,17.0,under $11k,31977.0,25987.8906,28.333328,white,33.0,10,1,0,yes,0.599999905,0.4,no dnr,20.0,113.0,8.8984375,103.0,24.0,39.19531,222.5,2.3999023,0.59997559,1.5,131.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.758,1,male,0,5,790,Lung Cancer,Cancer,1,12.0,under $11k,3078.0,2769.9531,11.0,white,36.0,1,0,0,metastatic,0.899999619,0.9,no dnr,5.0,61.0,4.29980469,130.0,28.0,38.79688,333.3,3.5,1.01,1.59985352,136.0,7.419922,135.0,23.0,2502.0,2.1616211,<2 mo. follow-up
73.88397,1,male,0,5,773,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3335.0,3146.0723,14.0,white,11.0,1,0,0,yes,0.899999619,0.8,no dnr,5.0,99.0,12.3984375,52.0,24.0,36.39844,320.0,3.7998047,1.09985352,1.19995117,142.0,7.449219,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
70.771,1,female,0,4,192,Colon Cancer,Cancer,1,12.0,under $11k,1922.0,1871.2832,10.0,white,22.0,1,0,0,metastatic,0.799999714,0.5,no dnr,4.0,111.0,5.0,73.0,18.0,36.59375,333.3,3.8999023,0.29998779,1.19995117,130.0,7.419922,135.0,23.0,2502.0,1.607666,<2 mo. follow-up
61.478,0,male,0,41,2020,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,51744.0,47658.8438,19.75,white,37.0,4,0,0,no,0.699999809,0.5,no dnr,41.0,55.0,21.6992188,66.0,12.0,36.69531,182.84375,3.199707,0.89990234,1.29980469,140.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.27295,1,male,0,7,66,Lung Cancer,Cancer,2,10.0,under $11k,4365.0,4049.3203,18.0,white,43.0,1,0,0,metastatic,0.899999619,0.1,dnr after sadm,1.0,65.0,11.1992188,63.0,26.0,34.89844,366.625,2.3999023,0.59997559,0.79992676,134.0,7.509766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
55.198,1,male,0,26,552,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,$11-$25k,57924.0,44915.9375,25.25,white,19.0,12,0,0,no,0.699999809,0.7,no dnr,26.0,110.0,18.8984375,106.0,10.0,38.0,270.0,3.699707,0.79992676,1.19995117,145.0,7.469727,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
67.10999,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,74747.0,51656.3438,53.5,white,66.0,13,1,0,no,0.0,0.0,dnr after sadm,1.0,69.0,26.6992188,108.0,22.0,39.09375,250.0,4.5996094,3.69970703,5.69921875,144.0,7.359375,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.79498,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,17599.0,14781.3359,21.5,white,32.0,11,0,0,no,0.199999928,0.2,no dnr,10.0,115.0,24.3984375,120.0,28.0,37.79688,192.5,3.2998047,1.09985352,1.39990234,145.0,7.489258,135.0,23.0,2502.0,2.2851562,<2 mo. follow-up
26.73499,0,male,0,7,2016,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,9401.0,7158.1367,19.0,white,67.0,2,0,0,yes,0.979999542,0.97,no dnr,7.0,75.0,0.29998779,64.0,32.0,36.29688,120.0,3.5,1.01,3.39990234,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.46594,1,male,0,12,60,Lung Cancer,Cancer,1,8.0,under $11k,5886.0,6097.1445,8.0,white,18.0,1,0,0,metastatic,0.5,0.1,dnr after sadm,4.0,109.0,4.19921875,100.0,24.0,35.5,333.3,3.199707,0.29998779,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.95197,1,male,0,5,399,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,2538.0,2126.2324,14.0,white,18.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,108.0,9.5,110.0,24.0,37.0,285.125,3.5,1.01,0.69995117,125.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
74.75195,1,female,0,19,336,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,10244.0,11008.7188,10.0,white,35.0,1,0,0,no,0.799999714,0.5,no dnr,19.0,69.0,10.2988281,93.0,22.0,35.69531,295.1875,3.2998047,1.09985352,1.29980469,130.0,7.469727,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
65.69196,1,male,0,25,26,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,206035.0,79364.5625,38.25,white,63.0,69,0,0,no,0.299999952,0.1,dnr after sadm,24.0,151.0,15.7988281,146.0,32.0,39.19531,282.0,2.199707,0.89990234,4.59960938,141.0,7.429688,135.0,23.0,2502.0,2.1088867,<2 mo. follow-up
69.28094,1,male,0,10,53,Colon Cancer,Cancer,1,8.0,under $11k,8684.0,7511.8164,18.0,white,21.0,1,0,0,metastatic,0.989999771,0.51,no dnr,10.0,128.0,12.5,116.0,20.0,35.39844,333.3,3.5,1.39990234,1.09985352,139.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
83.30695,1,male,0,9,167,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,3965.0,4165.9961,8.5,white,31.0,1,0,0,no,0.699999809,0.6,dnr after sadm,1.0,73.0,7.5,76.0,20.0,36.89844,371.375,2.5996094,2.59960938,1.5,139.0,7.619141,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
81.44299,0,female,0,6,2009,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,2281.0,2301.5898,14.0,white,26.0,1,1,0,no,0.799999714,0.8,no dnr,6.0,83.0,8.79882812,59.0,24.0,35.69531,447.5625,3.5,0.89990234,1.5,139.0,7.579102,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
54.93198,1,female,0,5,107,Lung Cancer,Cancer,2,8.0,under $11k,2899.0,2545.9961,7.0,white,14.0,1,0,0,metastatic,0.5,0.1,no dnr,5.0,96.0,20.5976562,83.0,24.0,35.39844,333.3,3.699707,0.29998779,0.89990234,133.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
21.92699,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,8477.0,5827.5898,41.0,white,85.0,2,0,0,no,0.699999809,0.5,dnr after sadm,3.0,33.0,1.69995117,170.0,30.0,39.0,55.0,3.0996094,1.29980469,2.09960938,142.0,7.269531,135.0,23.0,2502.0,2.4248047,<2 mo. follow-up
72.33398,0,male,0,6,2006,CHF,COPD/CHF/Cirrhosis,2,12.0,>$50k,2239.0,2402.2305,6.0,white,28.0,1,1,0,no,0.899999619,0.5,no dnr,6.0,99.0,7.89941406,60.0,20.0,35.79688,257.125,4.1992188,0.69995117,1.69995117,143.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.96198,1,male,0,5,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9456.0,7077.1641,26.0,white,63.0,2,0,0,yes,0.0,0.0,dnr after sadm,1.0,127.0,13.7988281,148.0,50.0,40.09375,100.0,3.5,1.01,1.09985352,147.0,7.269531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
43.603,1,female,0,92,1356,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,83252.0,69330.625,26.0,white,25.0,2,0,0,no,0.899999619,0.9,dnr after sadm,48.0,121.0,14.1992188,102.0,22.0,38.79688,80.0,3.5,1.01,0.79992676,137.0,7.40918,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
58.49698,1,female,0,6,134,Colon Cancer,Cancer,1,12.0,under $11k,2741.0,2667.8516,13.0,white,20.0,1,0,0,metastatic,0.5,0.05,no dnr,6.0,93.0,9.29882812,77.0,22.0,36.59375,333.3,3.5,1.01,1.5,136.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
59.01199,1,male,0,61,77,CHF,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,81821.0,63425.1875,36.0,white,45.0,1,0,0,no,0.899999619,0.9,no dnr,61.0,75.0,17.6992188,135.0,40.0,39.19531,176.0,4.0,1.29980469,1.69995117,145.0,7.459961,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
69.57697,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,53794.0,36784.875,43.0,white,54.0,1,0,0,no,0.25,0.25,dnr after sadm,18.0,101.0,27.3984375,102.0,22.0,37.19531,83.0625,2.2998047,0.5,2.69970703,134.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
34.83899,0,female,0,29,1999,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,22063.0,19388.7031,9.75,white,15.0,1,0,0,no,0.899999619,0.9,no dnr,29.0,72.0,10.8984375,58.0,24.0,38.79688,333.3,5.0,0.5,0.69995117,135.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
77.06494,1,female,0,16,1539,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,8666.0,9628.8203,12.666664,white,45.0,1,1,0,no,0.299999952,0.3,no dnr,16.0,69.0,9.29882812,114.0,24.0,35.0,380.9375,3.7998047,0.5,2.39990234,136.0,7.529297,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.862,1,male,1,18,18,Coma,Coma,2,12.0,$11-$25k,63622.0,46171.6562,48.666657,white,71.0,18,0,0,yes,0.199999928,0.1,dnr after sadm,4.0,118.0,23.8984375,140.0,46.0,39.69531,240.0,2.2998047,3.79980469,2.09960938,130.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
70.29999,0,female,0,13,1995,Cirrhosis,COPD/CHF/Cirrhosis,2,13.0,under $11k,7277.0,6996.793,8.5,white,37.0,1,0,0,no,0.099999964,0.001,no dnr,13.0,76.0,9.0,74.0,24.0,37.89844,271.375,2.2998047,4.5,0.89990234,134.0,7.519531,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
41.50299,1,male,0,6,1036,Lung Cancer,Cancer,1,14.0,$25-$50k,2684.0,2610.9629,6.0,white,6.0,1,0,0,metastatic,0.899999619,0.75,no dnr,6.0,102.0,9.0,76.0,20.0,36.79688,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
50.10797,1,male,0,4,5,COPD,COPD/CHF/Cirrhosis,0,8.0,under $11k,2082.0,1808.2393,7.0,white,26.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,116.0,9.0,130.0,40.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.25897,1,male,0,21,1699,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,16185.0,14571.4766,13.0,white,31.0,1,1,0,no,0.699999809,0.5,no dnr,21.0,99.0,6.29980469,64.0,32.0,36.29688,244.0,3.5996094,0.89990234,1.69995117,137.0,7.399414,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
75.56494,1,female,0,21,1152,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,34520.0,27436.7031,16.0,white,34.0,9,0,0,no,0.949999809,0.99,no dnr,21.0,121.0,8.59960938,52.0,8.0,38.39844,195.90625,2.2998047,0.69995117,4.19921875,135.0,7.379883,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
63.12097,1,male,0,13,39,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,17871.0,16333.0469,21.5,white,35.0,14,0,0,no,0.899999619,0.7,no dnr,13.0,150.0,11.0996094,56.0,16.0,35.59375,333.3,3.5,1.01,3.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
39.25497,1,female,0,158,700,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,>$50k,238874.0,186060.625,23.0,white,62.0,4,0,0,no,0.699999809,0.5,no dnr,158.0,50.0,11.2988281,155.0,30.0,38.69531,333.3,3.5,1.01,12.8984375,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.19397,1,male,0,12,214,CHF,COPD/CHF/Cirrhosis,3,24.0,>$50k,6472.0,6969.9648,8.0,white,26.0,1,1,0,no,0.899999619,0.5,no dnr,12.0,71.0,10.3984375,59.0,24.0,36.0,380.9375,3.7998047,1.69995117,1.5,127.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.396,1,male,0,5,917,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,2389.0,2352.4883,5.0,white,33.0,1,0,0,no,0.949999809,0.9,dnr after sadm,2.0,64.0,16.5,118.0,24.0,36.79688,216.0,3.0996094,0.39996338,1.19995117,131.0,7.429688,135.0,23.0,2502.0,6.0,<2 mo. follow-up
59.02298,1,female,0,9,496,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5395.0,5061.0938,9.5,white,18.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,79.0,6.79980469,73.0,24.0,37.69531,309.5,3.5,1.01,1.0,139.0,7.479492,135.0,23.0,2502.0,2.2543945,<2 mo. follow-up
88.82697,1,female,0,5,207,CHF,COPD/CHF/Cirrhosis,1,8.0,under $11k,1944.0,2102.9981,12.0,white,23.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,64.0,4.39941406,59.0,24.0,36.29688,333.3,3.699707,0.79992676,1.29980469,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.26297,0,male,0,16,1988,Coma,Coma,2,12.0,under $11k,22661.0,16517.4375,26.333328,white,44.0,1,0,0,no,0.199999928,0.1,no dnr,16.0,111.0,12.1992188,120.0,8.0,38.0,130.0,2.5996094,1.59985352,1.39990234,133.0,7.539062,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
81.41296,1,male,0,7,41,COPD,COPD/CHF/Cirrhosis,4,7.0,under $11k,5227.0,4446.5977,33.0,white,53.0,1,1,0,yes,0.899999619,0.9,dnr before sadm,-1.0,69.0,16.796875,118.0,32.0,37.29688,81.625,3.2998047,0.29998779,1.29980469,126.0,7.379883,135.0,23.0,2502.0,2.0,<2 mo. follow-up
68.96399,0,male,0,14,1990,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,9267.0,9465.5312,9.666664,white,29.0,1,0,0,no,0.899999619,0.75,no dnr,14.0,114.0,8.59960938,43.0,28.0,37.89844,202.84375,3.699707,0.59997559,1.19995117,140.0,7.40918,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
72.28497,0,male,0,68,1988,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,71553.0,59249.6562,24.0,white,30.0,5,0,0,no,0.599999905,0.6,no dnr,68.0,117.0,12.6992188,68.0,46.0,39.19531,288.5625,3.0996094,2.39990234,1.0,145.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.25098,0,female,0,6,1987,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,2644.0,2685.9668,12.0,white,17.0,1,0,0,no,0.75,0.5,no dnr,6.0,69.0,9.0,76.0,24.0,36.0,217.375,3.5,1.01,0.79992676,141.0,7.349609,135.0,23.0,2502.0,3.0200195,<2 mo. follow-up
63.392,1,female,0,5,105,Lung Cancer,Cancer,1,8.0,$11-$25k,2787.0,2425.0137,7.0,white,10.0,1,0,0,metastatic,0.799999714,0.2,no dnr,5.0,102.0,7.29980469,76.0,20.0,36.59375,333.3,4.0,0.39996338,0.89990234,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.20795,1,female,0,8,31,Colon Cancer,Cancer,1,12.0,under $11k,3755.0,4024.25,9.5,white,11.0,1,0,0,metastatic,0.75,0.1,no dnr,8.0,84.0,9.3984375,81.0,24.0,36.19531,333.3,3.7998047,0.29998779,1.0,137.0,7.419922,135.0,23.0,2502.0,2.074707,<2 mo. follow-up
71.64996,1,male,1,50,50,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,$25-$50k,133354.0,92709.3125,45.0,white,38.0,8,0,0,yes,0.699999809,0.5,dnr after sadm,45.0,61.0,18.8984375,116.0,8.0,36.59375,253.3125,2.8999023,1.29980469,7.19921875,141.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
77.112,1,male,0,60,465,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,110668.0,81567.25,32.5,white,48.0,9,1,0,no,0.899999619,0.8,dnr after sadm,32.0,110.0,20.5,120.0,34.0,38.79688,152.0,3.5,1.01,1.89990234,135.0,7.489258,135.0,23.0,2502.0,3.0029297,<2 mo. follow-up
64.39996,1,female,0,18,963,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,15896.0,13637.4609,16.333328,white,9.0,1,0,0,no,0.899999619,0.5,no dnr,18.0,95.0,14.0996094,104.0,20.0,36.59375,224.4375,3.2998047,0.69995117,0.59997559,132.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
29.06799,0,male,0,41,1984,Coma,Coma,1,19.0,$25-$50k,50502.0,42701.6875,24.75,white,46.0,8,0,0,no,0.299999952,0.3,no dnr,41.0,65.0,20.8984375,130.0,32.0,35.59375,350.0,2.0,0.59997559,1.0,128.0,7.5,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
84.271,1,female,1,5,5,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,2439.0,2348.707,13.0,white,36.0,1,0,0,no,0.049999982,0.000125,dnr before sadm,-1.0,69.0,9.29882812,80.0,44.0,36.39844,285.125,4.0996094,0.39996338,0.59997559,143.0,7.189453,135.0,23.0,2502.0,3.0,<2 mo. follow-up
75.51794,1,male,0,6,77,Colon Cancer,Cancer,1,8.0,$11-$25k,2927.0,2886.5352,12.0,white,20.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,112.0,9.0,73.0,16.0,37.0,333.3,3.5,1.01,1.0,136.0,7.419922,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
79.17297,1,female,0,9,56,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,10831.0,8347.8672,22.5,white,38.0,1,0,0,no,0.899999619,0.75,no dnr,9.0,73.0,11.2988281,120.0,28.0,38.0,272.5,2.7998047,0.29998779,1.0,138.0,7.089844,135.0,23.0,2502.0,1.0,<2 mo. follow-up
52.45398,0,male,0,5,1980,CHF,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,4430.0,3420.4375,11.0,white,24.0,1,0,0,no,0.75,0.75,no dnr,5.0,59.0,6.69921875,46.0,24.0,36.0,333.3,4.2998047,0.39996338,1.19995117,137.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
47.978,0,male,0,4,1980,CHF,COPD/CHF/Cirrhosis,2,16.0,$25-$50k,2944.0,2810.1133,14.0,white,18.0,1,0,0,no,0.899999619,0.7,no dnr,4.0,60.0,9.0,67.0,16.0,36.29688,333.3,3.5,1.01,1.39990234,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.09998,1,female,0,8,185,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,4045.0,3967.3262,5.5,white,27.0,1,0,0,no,0.949999809,0.85,no dnr,8.0,77.0,7.19921875,74.0,28.0,36.19531,336.0,3.3999023,0.09999084,0.79992676,137.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
64.40198,1,male,0,17,23,Lung Cancer,Cancer,2,13.0,$11-$25k,11896.0,9567.375,12.666664,white,14.0,1,0,0,metastatic,0.899999619,0.2,no dnr,17.0,76.0,9.0,74.0,20.0,36.59375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,2.8867188,<2 mo. follow-up
52.57797,1,female,0,8,17,Lung Cancer,Cancer,1,12.0,$11-$25k,3866.0,3825.4043,11.5,white,21.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,100.0,23.5,68.0,26.0,35.39844,280.9375,2.7998047,0.5,0.89990234,137.0,7.529297,135.0,23.0,2502.0,4.0,<2 mo. follow-up
64.112,1,male,0,3,895,Colon Cancer,Cancer,2,12.0,under $11k,9439.0,6126.6133,24.0,white,17.0,1,1,0,metastatic,0.949999809,0.5,no dnr,3.0,70.0,8.79882812,56.0,20.0,36.19531,333.3,3.5,1.01,1.19995117,137.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
35.25497,0,male,0,12,1978,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,9425.0,8858.6172,11.5,white,9.0,1,0,0,no,1.0,0.9,no dnr,12.0,110.0,7.09960938,71.0,20.0,36.0,300.0,3.2998047,0.69995117,1.19995117,138.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
75.08795,1,female,0,6,188,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,2721.0,2737.4766,7.0,white,18.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,97.0,4.39941406,80.0,24.0,36.59375,333.3,2.7998047,4.69921875,0.69995117,141.0,7.419922,135.0,23.0,2502.0,2.5110989,no(M2 and SIP pres)
61.16098,1,male,0,12,24,Lung Cancer,Cancer,1,12.0,$11-$25k,5474.0,5262.7461,12.0,white,20.0,1,0,0,metastatic,0.099999964,0.001,no dnr,12.0,113.0,3.39990234,96.0,24.0,35.89844,392.5625,3.5,1.01,1.59985352,137.0,7.489258,135.0,23.0,2502.0,5.0,<2 mo. follow-up
60.62399,0,male,0,6,1973,Lung Cancer,Cancer,1,12.0,$25-$50k,3184.0,3054.2676,6.0,white,19.0,1,0,0,metastatic,0.899999619,0.9,no dnr,6.0,78.0,9.0,63.0,16.0,36.29688,333.3,3.5,1.01,1.39990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
38.18997,1,female,0,5,274,Lung Cancer,Cancer,1,11.0,$11-$25k,3008.0,2698.291,7.0,white,6.0,1,0,0,metastatic,1.0,1.0,no dnr,5.0,97.0,9.0,93.0,16.0,36.59375,333.3,3.5,1.01,0.89990234,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.52298,1,male,0,5,146,Lung Cancer,Cancer,2,12.0,$25-$50k,3019.0,2819.0898,9.0,white,25.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,103.0,9.0,118.0,28.0,37.0,333.3,3.5,1.01,0.89990234,133.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
63.52597,1,female,0,19,71,Lung Cancer,Cancer,2,14.0,>$50k,9732.0,9939.6406,7.0,white,15.0,1,0,0,metastatic,0.899999619,0.6,no dnr,19.0,102.0,6.0,64.0,24.0,35.89844,333.3,3.3999023,0.39996338,0.69995117,137.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
51.62997,1,female,0,21,195,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,26097.0,21064.1406,24.333328,white,23.0,1,0,0,no,0.899999619,0.75,no dnr,21.0,62.0,14.0996094,81.0,20.0,35.79688,252.0,5.1992188,0.29998779,1.0,131.0,7.429688,135.0,23.0,2502.0,2.2124023,<2 mo. follow-up
53.24799,1,male,0,16,18,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$11-$25k,31599.0,24138.4062,20.666656,white,27.0,5,0,0,no,0.75,0.75,dnr after sadm,13.0,129.0,16.5,99.0,28.0,37.79688,145.4375,3.5,1.01,0.89990234,134.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.23798,1,male,0,12,529,Lung Cancer,Cancer,1,12.0,under $11k,5094.0,4922.6289,9.0,white,7.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,83.0,9.0,107.0,20.0,36.09375,333.3,3.5,1.01,0.79992676,137.0,7.419922,135.0,23.0,2502.0,2.8227539,<2 mo. follow-up
64.08997,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,25603.0,17680.8281,43.0,white,20.0,3,0,0,no,0.699999809,0.5,dnr after sadm,5.0,119.0,21.1992188,106.0,10.0,36.89844,260.0,2.5996094,0.39996338,1.39990234,130.0,7.459961,135.0,23.0,2502.0,3.0,<2 mo. follow-up
71.56696,0,male,0,8,1964,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,7708.0,6010.5898,26.5,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,97.0,16.1992188,104.0,16.0,37.59375,116.0,4.1992188,1.0,1.59985352,137.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.64899,1,male,0,13,75,Lung Cancer,Cancer,4,13.0,$11-$25k,7133.0,6788.6484,12.0,white,8.0,1,0,0,metastatic,0.799999714,0.2,no dnr,13.0,82.0,9.0,96.0,16.0,36.29688,333.3,3.5,1.01,1.0,135.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
33.03497,0,male,0,24,1958,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,34366.0,25804.8906,27.666656,white,46.0,1,0,0,no,0.099999964,0.001,no dnr,24.0,63.0,11.0,168.0,40.0,39.39844,250.0,2.0996094,0.09999084,0.59997559,136.0,7.479492,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
37.84799,1,male,1,60,60,MOSF w/Malig,ARF/MOSF,1,20.0,$25-$50k,153931.0,108927.438,47.75,white,60.0,9,0,0,yes,0.699999809,0.5,dnr after sadm,55.0,107.0,0.89990234,112.0,12.0,39.39844,232.5,3.2998047,4.79980469,6.5,141.0,7.40918,135.0,23.0,2502.0,4.0,<2 mo. follow-up
72.54999,0,male,0,47,1956,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,7980.0,58163.2188,38.75,white,52.0,3,0,0,no,0.199999928,0.2,no dnr,47.0,62.0,23.796875,130.0,10.0,36.69531,198.0,2.0996094,4.79980469,1.5,142.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
47.15399,1,female,0,6,130,Lung Cancer,Cancer,1,12.0,$25-$50k,1495.0,1585.3633,8.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,74.0,3.69970703,104.0,16.0,36.89844,333.3,3.5996094,0.39996338,1.09985352,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.74298,1,male,0,5,484,Cirrhosis,COPD/CHF/Cirrhosis,4,15.0,$11-$25k,4862.0,3947.4746,6.0,white,22.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,63.0,6.09960938,51.0,24.0,36.09375,361.875,3.5996094,3.19970703,0.59997559,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.69397,1,female,1,17,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,50034.0,35662.0938,34.333313,white,66.0,10,0,0,yes,0.75,0.5,no dnr,17.0,67.0,10.7988281,156.0,8.0,37.79688,116.0,3.5,1.01,2.29980469,132.0,7.589844,135.0,23.0,2502.0,2.1435547,<2 mo. follow-up
71.24695,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,11031.0,7678.4141,55.0,white,42.0,1,0,0,no,0.0,0.0,dnr after sadm,4.0,63.0,7.09960938,98.0,12.0,39.59375,150.0,2.8999023,0.89990234,7.69921875,129.0,7.419922,135.0,23.0,2502.0,2.0878906,<2 mo. follow-up
74.78998,1,female,1,213,213,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,305357.0,240289.875,45.25,white,25.0,22,1,0,yes,0.5,0.5,dnr after sadm,15.0,63.0,18.1992188,106.0,12.0,38.0,120.0,2.5996094,0.69995117,0.79992676,142.0,7.469727,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
59.32098,1,male,0,6,7,COPD,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,3759.0,3812.2266,7.0,white,43.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,1.0,111.0,5.79980469,122.0,32.0,36.69531,160.84375,4.0996094,0.29998779,1.09985352,140.0,7.449219,135.0,23.0,2502.0,6.0,<2 mo. follow-up
33.19397,1,male,0,12,1253,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,11717.0,9524.1484,20.5,white,31.0,1,0,0,no,0.899999619,0.9,no dnr,12.0,99.0,11.2988281,118.0,36.0,38.59375,98.32812,3.0,0.5,0.79992676,139.0,7.30957,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
54.31897,1,female,1,6,6,Coma,Coma,0,12.0,$11-$25k,10406.0,7773.2188,35.0,white,29.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,79.0,11.7988281,70.0,30.0,38.39844,148.0,3.5996094,2.19970703,0.69995117,137.0,7.479492,135.0,23.0,2502.0,2.0,<2 mo. follow-up
71.13794,0,female,0,10,1943,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4705.0,5213.4844,7.5,white,45.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,61.0,8.3984375,64.0,28.0,35.89844,447.5625,3.5,1.01,2.5,137.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.681,1,male,0,7,28,Lung Cancer,Cancer,1,12.0,$25-$50k,2993.0,3229.3281,10.0,white,25.0,1,0,0,metastatic,0.899999619,0.5,dnr after sadm,1.0,77.0,13.6992188,120.0,20.0,38.19531,272.0,2.5996094,0.89990234,0.69995117,133.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.27795,0,male,0,8,1941,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,4964.0,4387.3906,10.5,white,52.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,128.0,20.796875,64.0,26.0,36.69531,180.9375,4.2998047,0.69995117,2.39990234,138.0,7.379883,135.0,23.0,2502.0,3.1635742,<2 mo. follow-up
53.5,1,female,0,3,139,Lung Cancer,Cancer,2,8.0,under $11k,3024.0,2026.7148,11.0,white,11.0,1,0,0,metastatic,0.75,0.1,no dnr,3.0,98.0,15.5,74.0,20.0,36.09375,333.3,3.8999023,0.5,0.89990234,132.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
83.17596,1,male,1,14,14,COPD,COPD/CHF/Cirrhosis,2,6.0,$11-$25k,7633.0,7289.1836,4.0,white,32.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,67.0,13.5,102.0,28.0,38.0,278.25,4.3994141,0.39996338,1.29980469,137.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.65399,1,female,0,4,673,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,7349.0,5321.2695,24.0,white,25.0,1,1,0,no,0.979999542,0.95,no dnr,4.0,105.0,9.0,68.0,24.0,36.0,186.0,3.5,1.01,2.0,136.0,7.40918,135.0,23.0,2502.0,2.9790039,no(M2 and SIP pres)
65.54095,1,female,0,24,231,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,19670.0,19666.4375,9.0,white,46.0,1,1,0,no,0.299999952,0.1,no dnr,24.0,60.0,7.0,24.0,36.0,35.39844,271.375,3.5996094,0.69995117,1.39990234,131.0,7.479492,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
60.36697,1,male,0,15,499,Lung Cancer,Cancer,2,10.0,under $11k,11616.0,9475.8438,14.0,white,14.0,1,0,0,metastatic,0.799999714,0.5,no dnr,15.0,100.0,3.5,100.0,20.0,36.19531,333.3,3.199707,0.19998169,0.69995117,139.0,7.419922,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
73.86694,1,male,0,17,1474,Colon Cancer,Cancer,1,12.0,under $11k,12604.0,11720.6719,6.333332,white,17.0,1,0,0,metastatic,0.989999771,0.5,no dnr,17.0,71.0,9.29882812,64.0,16.0,36.59375,333.3,3.699707,0.29998779,0.89990234,136.0,7.419922,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
71.60596,0,female,0,36,1931,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,102027.0,87378.1875,29.25,white,34.0,42,0,0,no,0.699999809,0.5,no dnr,36.0,68.0,8.8984375,120.0,28.0,38.19531,192.5,2.699707,2.0,0.69995117,127.0,7.439453,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
70.54095,1,female,0,16,42,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,31484.0,25302.75,10.666664,white,43.0,13,1,0,no,0.099999964,0.001,dnr after sadm,1.0,62.0,9.0,5.299805,32.0,38.19531,333.3,3.5,1.01,1.69995117,133.0,7.419922,135.0,23.0,2502.0,3.5058594,<2 mo. follow-up
83.66895,1,female,1,9,9,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,5823.0,5288.7266,15.0,white,36.0,1,0,0,yes,0.699999809,0.5,no dnr,9.0,103.0,5.39941406,112.0,32.0,37.5,238.09375,3.0,0.19998169,1.0,141.0,7.40918,135.0,23.0,2502.0,2.0,<2 mo. follow-up
67.74298,1,female,1,9,9,COPD,COPD/CHF/Cirrhosis,4,15.0,$11-$25k,12086.0,8880.1875,36.5,white,33.0,1,0,0,no,0.799999714,0.7,no dnr,9.0,71.0,7.79980469,110.0,8.0,37.79688,100.0,3.7998047,0.79992676,1.29980469,133.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
57.71899,1,female,0,7,448,Lung Cancer,Cancer,1,12.0,$11-$25k,4462.0,4133.8125,10.0,white,33.0,1,0,0,metastatic,0.75,0.5,no dnr,7.0,106.0,4.29980469,76.0,76.0,36.79688,333.3,3.7998047,0.29998779,1.0,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.55597,0,female,0,9,1924,COPD,COPD/CHF/Cirrhosis,0,6.0,under $11k,4447.0,4356.1719,10.0,white,37.0,1,0,0,no,0.699999809,0.55,no dnr,9.0,75.0,13.2988281,76.0,24.0,36.29688,74.0625,3.5,1.01,1.19995117,140.0,7.299805,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
29.50899,1,female,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,33162.0,22278.0781,41.0,white,22.0,1,0,0,no,0.799999714,0.8,dnr after sadm,11.0,78.0,6.5,104.0,24.0,38.59375,100.0,2.8999023,0.69995117,0.59997559,136.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
74.32697,1,male,0,13,77,Lung Cancer,Cancer,2,8.0,>$50k,7749.0,7208.8281,7.0,white,21.0,1,0,0,metastatic,0.799999714,0.2,no dnr,13.0,97.0,7.29980469,104.0,20.0,36.39844,333.3,4.0,0.89990234,1.5,133.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
83.047,1,female,0,15,76,Colon Cancer,Cancer,2,12.0,under $11k,12151.0,10807.6719,19.666656,white,33.0,1,0,0,metastatic,0.149999976,0.1,no dnr,15.0,60.0,8.69921875,58.0,28.0,35.79688,142.84375,3.0996094,1.29980469,1.0,129.0,7.429688,135.0,23.0,2502.0,3.6347656,<2 mo. follow-up
66.57397,0,male,0,6,1921,COPD,COPD/CHF/Cirrhosis,2,9.0,under $11k,3834.0,3461.3555,13.0,white,25.0,1,0,0,no,0.799999714,0.5,no dnr,6.0,107.0,12.1992188,122.0,24.0,36.19531,232.0,4.2998047,0.5,1.0,130.0,7.30957,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.521,0,male,0,38,1922,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,79564.0,63266.0312,24.25,white,48.0,28,0,0,no,0.699999809,0.5,no dnr,38.0,100.0,9.0,114.0,40.0,39.29688,136.71875,2.2998047,0.69995117,1.5,134.0,7.399414,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
71.59497,1,male,0,15,90,Lung Cancer,Cancer,2,8.0,under $11k,6543.0,7237.9766,4.666664,white,20.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,67.0,4.5,43.0,18.0,36.19531,333.3,4.3994141,0.69995117,0.69995117,128.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.93396,1,male,1,75,75,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,121309.0,89989.5625,32.0,white,40.0,1,0,0,no,0.699999809,0.7,dnr after sadm,75.0,50.0,13.7988281,130.0,12.0,38.39844,146.125,2.0996094,0.89990234,0.89990234,140.0,7.489258,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
69.61499,1,male,0,5,7,Coma,Coma,0,8.0,$11-$25k,4395.0,4332.0352,4.0,white,24.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,111.0,12.2988281,67.0,36.0,39.0,198.5625,4.2998047,0.69995117,1.0,140.0,7.379883,135.0,23.0,2502.0,2.0942383,<2 mo. follow-up
78.91595,1,male,1,23,23,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,16501.0,12762.3359,11.333328,white,58.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,56.0,12.1992188,77.0,32.0,35.59375,323.75,3.7998047,0.29998779,3.29980469,132.0,7.529297,135.0,23.0,2502.0,5.0,<2 mo. follow-up
58.18799,1,male,0,21,187,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,23590.0,16798.2969,21.333328,white,17.0,1,1,0,yes,0.699999809,0.5,no dnr,21.0,107.0,6.39941406,76.0,24.0,35.0,147.5,3.5,1.01,0.59997559,138.0,7.339844,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
79.56696,1,male,0,8,9,Coma,Coma,2,8.0,under $11k,68703.0,52034.0,37.0,white,38.0,19,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,76.0,7.59960938,70.0,6.0,38.09375,313.3125,3.2998047,5.5,2.0,139.0,7.509766,135.0,23.0,2502.0,1.0,<2 mo. follow-up
84.75598,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,19689.0,14387.6172,32.5,white,28.0,5,0,0,no,0.5,0.5,no dnr,11.0,71.0,12.0996094,106.0,24.0,38.59375,280.0,3.5996094,0.69995117,1.79980469,132.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
77.23199,1,female,0,16,19,Lung Cancer,Cancer,1,12.0,under $11k,10536.0,9141.625,6.333332,white,50.0,1,0,0,metastatic,0.049999982,0.000125,no dnr,16.0,65.0,20.0976562,107.0,28.0,35.59375,200.0,1.5998535,1.79980469,0.89990234,136.0,7.509766,135.0,23.0,2502.0,5.0,<2 mo. follow-up
76.38098,1,male,0,23,25,Colon Cancer,Cancer,1,9.0,under $11k,20869.0,15689.7109,19.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,16.0,98.0,8.69921875,82.0,20.0,36.59375,333.3,3.5,1.01,1.29980469,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.05194,1,male,0,7,1789,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,7054.0,5307.9805,11.0,white,23.0,1,0,0,no,0.75,0.5,no dnr,7.0,72.0,7.69921875,83.0,22.0,36.59375,372.0,4.0996094,1.39990234,1.29980469,136.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.03595,1,male,0,9,536,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4391.0,3785.9277,9.0,white,17.0,1,0,0,no,0.949999809,0.8,dnr before sadm,-1.0,107.0,5.89941406,78.0,24.0,35.59375,380.9375,3.5996094,1.59985352,1.29980469,136.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
72.02197,0,male,0,26,1897,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,76882.0,51433.0312,29.0,white,55.0,12,0,0,no,0.799999714,0.6,no dnr,26.0,63.0,29.0976562,116.0,46.0,38.89844,240.8125,3.199707,0.79992676,2.29980469,133.0,7.399414,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
62.543,1,male,0,10,196,Colon Cancer,Cancer,1,12.0,$11-$25k,5456.0,4397.0312,10.0,other,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,10.0,80.0,10.5,68.0,28.0,36.19531,333.3,3.5,1.01,1.0,134.0,7.489258,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
54.31097,1,male,0,15,17,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,>$50k,62864.0,43044.2812,25.666656,white,27.0,25,0,0,no,0.049999982,0.000125,dnr after sadm,13.0,72.0,8.29882812,77.0,36.0,38.69531,122.0,3.5,1.01,0.59997559,130.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
86.32397,1,female,0,11,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,8545.0,6640.6719,20.5,white,41.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,56.0,18.296875,105.0,24.0,36.19531,333.3,2.7998047,3.79980469,1.19995117,133.0,7.419922,135.0,23.0,2502.0,3.15625,<2 mo. follow-up
61.23199,1,female,0,21,198,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,15661.0,12649.1484,13.0,white,46.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,65.0,12.0,126.0,24.0,38.09375,180.0,4.0996094,0.39996338,1.0,136.0,7.519531,135.0,23.0,2502.0,3.855299,adl>=4 (>=5 if sur)
74.22894,1,female,0,11,61,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,6582.0,5642.9492,11.0,white,41.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,101.0,8.79882812,83.0,28.0,36.29688,285.6875,4.0,0.5,1.29980469,137.0,7.549805,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
71.01996,0,female,0,10,1889,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,6888.0,5454.8125,13.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,69.0,10.3984375,80.0,24.0,36.29688,191.28125,3.5996094,0.69995117,0.79992676,138.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.50696,1,female,0,8,9,Cirrhosis,COPD/CHF/Cirrhosis,1,16.0,$11-$25k,32917.0,23600.4844,42.0,white,32.0,6,0,0,no,0.699999809,0.5,dnr after sadm,7.0,125.0,16.5976562,135.0,10.0,38.5,198.0,2.5996094,3.69970703,1.09985352,138.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
85.90594,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,183453.0,73059.375,24.0,white,68.0,95,0,0,no,0.699999809,0.5,dnr before sadm,-88.0,69.0,33.59375,74.0,27.0,36.19531,333.3,2.0996094,11.5,2.0,144.0,7.419922,135.0,23.0,2502.0,2.7734375,<2 mo. follow-up
59.754,0,male,0,5,1887,Cirrhosis,COPD/CHF/Cirrhosis,0,18.0,$25-$50k,2433.0,2052.5488,6.0,white,22.0,1,0,0,no,0.949999809,0.05,no dnr,5.0,77.0,22.0976562,118.0,24.0,38.0,376.1875,2.5,0.89990234,0.69995117,134.0,7.539062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.34595,0,female,0,9,1887,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,5860.0,4906.1016,12.0,white,38.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,66.0,16.0976562,128.0,28.0,37.0,195.8125,3.8999023,0.5,0.79992676,138.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
80.45697,1,male,0,14,1062,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,under $11k,30311.0,21456.9531,23.666656,white,60.0,7,0,0,no,0.5,0.5,no dnr,14.0,77.0,7.59960938,112.0,28.0,37.79688,228.5625,3.5,1.01,2.29980469,150.0,7.509766,135.0,23.0,2502.0,3.1665039,<2 mo. follow-up
72.83496,0,male,0,14,1885,COPD,COPD/CHF/Cirrhosis,6,12.0,under $11k,10872.0,8019.3438,15.0,white,44.0,1,1,0,no,0.75,0.6,dnr after sadm,1.0,78.0,23.0976562,126.0,44.0,37.5,247.8125,4.2998047,0.5,1.19995117,139.0,7.439453,135.0,23.0,2502.0,4.1503906,<2 mo. follow-up
81.51398,0,female,0,13,1884,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,6709.0,5749.2891,8.5,white,45.0,1,1,0,no,0.5,0.3,dnr after sadm,1.0,61.0,9.69921875,104.0,24.0,35.59375,172.0,3.5,1.01,1.29980469,138.0,7.509766,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
78.396,1,male,0,11,12,COPD,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,11293.0,8076.2969,15.5,white,43.0,1,0,0,yes,0.199999928,0.05,dnr after sadm,1.0,124.0,5.59960938,114.0,24.0,36.59375,200.0,3.7998047,0.39996338,1.19995117,133.0,7.369141,135.0,23.0,2502.0,3.4487305,<2 mo. follow-up
68.60498,1,male,0,8,226,Colon Cancer,Cancer,1,10.0,$11-$25k,6653.0,4879.6797,13.5,white,8.0,1,0,0,metastatic,0.949999809,0.8,no dnr,8.0,99.0,9.0,61.0,24.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.47299,1,male,0,3,1546,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,3448.0,2522.4512,29.0,white,23.0,1,0,0,no,0.899999619,0.9,no dnr,3.0,80.0,16.796875,67.0,20.0,36.29688,126.51562,4.6992188,0.59997559,1.29980469,138.0,7.319336,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.07397,1,female,0,40,958,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,165585.0,126004.438,30.25,white,79.0,31,0,0,no,0.699999809,0.5,dnr after sadm,2.0,63.0,29.6992188,138.0,13.0,38.29688,196.65625,3.7998047,13.7988281,5.09960938,142.0,7.379883,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
57.42099,1,male,0,7,591,Colon Cancer,Cancer,1,12.0,$25-$50k,7708.0,5461.6094,13.0,white,11.0,1,0,0,metastatic,0.949999809,0.6,no dnr,7.0,107.0,6.69921875,101.0,20.0,38.09375,333.3,3.5,1.01,1.0,135.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
54.98398,1,male,1,11,11,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,15063.0,10865.6094,17.0,white,72.0,1,1,0,no,0.099999964,0.001,dnr after sadm,11.0,139.0,15.6992188,62.0,30.0,35.39844,266.625,2.199707,21.1992188,3.59960938,140.0,7.419922,135.0,23.0,2502.0,4.34375,<2 mo. follow-up
75.422,0,male,0,5,1875,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,3121.0,2554.6328,13.0,white,24.0,1,0,0,no,0.899999619,0.5,no dnr,5.0,123.0,6.19921875,56.0,24.0,35.69531,342.8125,4.0,0.79992676,1.39990234,138.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.97998,1,female,0,22,31,Coma,Coma,2,12.0,under $11k,13639.0,11426.5,13.666664,white,44.0,1,0,1,no,0.099999964,0.001,no dnr,22.0,99.0,26.5976562,96.0,40.0,39.0,333.3,3.199707,0.59997559,2.69970703,141.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
59.45798,1,male,0,3,107,Lung Cancer,Cancer,2,12.0,$11-$25k,1553.0,1255.5518,11.0,white,17.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,1.0,107.0,6.09960938,24.0,24.0,36.09375,457.125,4.0,0.29998779,1.19995117,136.0,7.639648,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
44.25998,1,female,0,10,1143,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,$11-$25k,10970.0,7433.0586,17.0,other,15.0,1,0,0,no,0.899999619,0.7,no dnr,10.0,62.0,11.6992188,62.0,24.0,36.0,271.375,3.0996094,0.19998169,0.59997559,141.0,7.449219,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
55.55899,0,female,0,4,1872,Lung Cancer,Cancer,4,14.0,$11-$25k,2302.0,1812.6016,4.0,white,25.0,1,0,0,metastatic,0.989999771,0.99,no dnr,4.0,65.0,14.0,65.0,26.0,36.79688,309.5,4.6992188,0.69995117,0.69995117,135.0,7.429688,135.0,23.0,2502.0,2.1035156,no(M2 and SIP pres)
67.95099,1,female,0,33,82,COPD,COPD/CHF/Cirrhosis,2,4.0,under $11k,26722.0,20023.5625,11.0,white,37.0,1,0,0,no,0.199999928,0.2,dnr after sadm,1.0,81.0,22.296875,110.0,32.0,35.79688,147.5,2.1396484,0.79992676,0.69995117,134.0,7.40918,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
74.15698,1,male,0,5,1009,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,2651.0,2370.9727,2.0,white,25.0,1,0,0,no,0.5,0.5,no dnr,5.0,63.0,8.3984375,60.0,24.0,35.69531,333.3,3.699707,0.69995117,1.39990234,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.73999,0,female,0,50,1867,Coma,Coma,3,13.0,under $11k,62833.0,44241.5,25.0,white,8.0,7,1,0,yes,0.25,0.1,dnr before sadm,-6.0,81.0,12.7988281,78.0,6.0,36.39844,420.0,2.8999023,0.39996338,0.69995117,127.0,7.479492,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
69.67596,1,male,0,10,12,Lung Cancer,Cancer,3,8.0,under $11k,7891.0,6284.1953,9.5,white,11.0,1,0,0,metastatic,0.199999928,0.0,dnr after sadm,1.0,87.0,11.0996094,98.0,22.0,36.39844,333.3,3.199707,0.19998169,0.89990234,133.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
60.49597,1,female,1,10,10,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,22177.0,15144.3828,45.5,white,29.0,1,0,0,no,0.299999952,0.3,dnr after sadm,9.0,113.0,21.6992188,138.0,32.0,38.29688,540.0,2.0996094,1.89990234,0.79992676,143.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
86.185,1,female,0,10,606,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,5999.0,4802.1836,8.5,white,22.0,1,0,0,no,0.5,0.4,dnr after sadm,1.0,66.0,6.69921875,79.0,22.0,36.79688,382.5625,3.5,1.01,1.0,139.0,7.40918,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
87.25,1,female,0,3,6,Coma,Coma,1,12.0,under $11k,2891.0,2500.2188,8.0,white,17.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,93.0,7.79980469,96.0,24.0,37.5,276.1875,4.0,0.59997559,1.29980469,136.0,7.449219,135.0,23.0,2502.0,2.3583984,<2 mo. follow-up
70.93994,1,female,0,10,19,Lung Cancer,Cancer,2,12.0,under $11k,6611.0,5093.9492,6.0,white,26.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,69.0,15.0,73.0,28.0,35.0,333.3,3.3999023,0.59997559,0.59997559,128.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
66.74597,1,female,1,5,5,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,4426.0,3189.6523,14.0,white,59.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,52.0,11.3984375,110.0,30.0,36.0,157.125,3.0996094,0.79992676,0.79992676,143.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
71.745,1,female,0,4,10,Coma,Coma,0,8.0,under $11k,10217.0,7638.0469,29.0,white,12.0,2,0,0,no,0.099999964,0.001,no dnr,4.0,110.0,9.0,76.0,12.0,38.59375,135.53125,3.8999023,0.69995117,0.69995117,136.0,7.5,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.26196,0,female,0,11,1860,COPD,COPD/CHF/Cirrhosis,1,13.0,$25-$50k,14092.0,9658.3047,29.5,white,41.0,1,0,0,no,0.899999619,0.85,no dnr,11.0,129.0,11.8984375,156.0,10.0,38.59375,168.0,4.5,0.29998779,1.0,134.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.909,1,male,0,6,320,Lung Cancer,Cancer,2,12.0,under $11k,3340.0,2626.6504,17.0,white,23.0,1,0,0,metastatic,0.699999809,0.2,no dnr,6.0,63.0,6.39941406,76.0,24.0,36.39844,333.3,3.5,1.01,1.39990234,135.0,7.419922,135.0,23.0,2502.0,2.3173828,<2 mo. follow-up
60.57999,1,female,1,4,4,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,2080.0,1654.6143,10.0,white,27.0,1,0,0,no,0.099999964,0.001,dnr after sadm,1.0,77.0,13.6992188,106.0,22.0,35.5,333.3,3.2998047,2.89990234,1.09985352,131.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
70.10498,0,male,0,15,1858,MOSF w/Malig,ARF/MOSF,1,8.0,>$50k,76778.0,67495.8125,19.666656,white,18.0,63,0,0,yes,0.699999809,0.5,no dnr,15.0,73.0,8.69921875,118.0,24.0,38.59375,285.6875,3.5,1.01,1.0,143.0,7.479492,135.0,23.0,2502.0,2.0,<2 mo. follow-up
58.793,1,male,0,21,51,MOSF w/Malig,ARF/MOSF,2,11.0,$11-$25k,54473.0,38711.1562,23.333328,white,33.0,15,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,77.0,35.09375,102.0,26.0,38.89844,129.0625,2.5,1.79980469,0.59997559,136.0,7.519531,135.0,23.0,2502.0,3.4208984,<2 mo. follow-up
75.13495,1,male,0,7,13,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,8814.0,6860.8555,18.0,white,19.0,1,0,0,no,0.949999809,0.7,dnr after sadm,1.0,85.0,9.0,107.0,24.0,36.19531,204.0,3.5,1.01,1.01,140.0,7.349609,135.0,23.0,2502.0,2.0,<2 mo. follow-up
77.60394,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,under $11k,25038.0,16361.9688,43.5,white,38.0,2,0,0,no,0.699999809,0.5,dnr after sadm,2.0,63.0,10.3984375,74.0,26.0,37.89844,265.0,3.5,1.0,2.69970703,138.0,7.379883,135.0,23.0,2502.0,4.0,<2 mo. follow-up
72.75,1,female,0,8,447,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,4467.0,3677.4961,9.5,white,10.0,1,0,1,no,0.599999905,0.5,dnr after sadm,1.0,82.0,7.39941406,60.0,24.0,36.79688,240.0,3.5,1.01,0.5,137.0,7.40918,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
97.26495,1,female,0,12,1038,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,8296.0,6480.2188,13.5,white,33.0,1,0,0,no,0.799999714,0.6,no dnr,12.0,113.0,12.5,110.0,40.0,36.09375,388.0,4.3994141,0.39996338,1.0,139.0,7.349609,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
75.31299,1,male,1,12,12,Lung Cancer,Cancer,2,8.0,$11-$25k,13414.0,9397.8672,16.0,white,38.0,1,0,0,metastatic,0.509999752,0.2,dnr after sadm,1.0,76.0,5.0,122.0,28.0,36.09375,333.3,2.2998047,0.89990234,0.59997559,132.0,7.419922,135.0,23.0,2502.0,5.0,<2 mo. follow-up
60.93399,1,female,0,5,306,COPD,COPD/CHF/Cirrhosis,1,12.0,$25-$50k,4130.0,2908.0137,15.0,white,16.0,1,0,0,yes,0.949999809,0.75,dnr after sadm,2.0,102.0,6.89941406,72.0,20.0,36.59375,347.5625,4.0,0.5,0.5,125.0,7.399414,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
74.30298,0,male,0,10,1849,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,6503.0,4888.7773,13.0,white,30.0,1,0,0,no,0.989999771,0.95,no dnr,10.0,102.0,8.79882812,84.0,28.0,36.39844,264.0,3.5,1.01,1.19995117,138.0,7.379883,135.0,23.0,2502.0,2.7675781,<2 mo. follow-up
86.26398,1,female,0,8,1466,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3748.0,3288.6504,9.0,white,29.0,1,1,0,no,0.75,0.5,no dnr,8.0,110.0,7.09960938,65.0,32.0,36.39844,333.3,3.3999023,0.69995117,1.19995117,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
63.017,0,male,0,11,1848,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,51051.0,14452.7344,33.0,white,24.0,20,0,0,no,0.599999905,0.5,no dnr,11.0,127.0,8.8984375,102.0,26.0,38.19531,200.0,3.199707,1.19995117,0.69995117,133.0,7.449219,135.0,23.0,2502.0,2.6108398,no(M2 and SIP pres)
78.073,1,male,0,5,1664,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,4193.0,3009.7422,20.0,white,42.0,1,0,0,no,0.899999619,0.6,dnr after sadm,1.0,68.0,7.09960938,122.0,40.0,36.19531,234.78125,3.449707,0.5,1.0,140.0,7.369141,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.00397,1,female,0,18,217,Colon Cancer,Cancer,1,9.0,under $11k,8549.0,7534.168,7.666664,white,23.0,1,0,0,metastatic,0.5,0.1,no dnr,18.0,68.0,10.3984375,71.0,24.0,37.29688,333.3,4.0,0.59997559,1.09985352,138.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
57.51099,1,male,1,6,6,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3293.0,2865.4961,7.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,63.0,6.89941406,57.0,20.0,35.69531,333.3,3.5,1.01,1.29980469,130.0,7.419922,135.0,23.0,2502.0,2.0,<2 mo. follow-up
63.06897,0,female,0,17,1845,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,13703.0,10648.0156,7.666664,white,20.0,1,1,0,no,0.899999619,0.5,no dnr,17.0,63.0,9.0,53.0,20.0,35.59375,333.3,3.5,1.01,1.19995117,140.0,7.419922,135.0,23.0,2502.0,2.9570312,<2 mo. follow-up
71.90698,1,male,0,23,27,COPD,COPD/CHF/Cirrhosis,5,8.0,under $11k,27122.0,18723.4531,12.0,white,34.0,1,1,0,yes,0.699999809,0.5,dnr after sadm,1.0,126.0,12.0,104.0,29.0,36.39844,220.0,3.7998047,0.79992676,1.39990234,136.0,7.479492,135.0,23.0,2502.0,4.0,<2 mo. follow-up
71.79498,0,male,0,5,1840,COPD,COPD/CHF/Cirrhosis,1,13.0,$11-$25k,4419.0,3358.459,17.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,103.0,8.0,58.0,28.0,36.89844,333.3,4.7998047,0.5,1.59985352,145.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.75397,1,female,1,48,48,Colon Cancer,Cancer,1,12.0,under $11k,48359.0,37019.1875,11.75,white,25.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,37.0,64.0,7.09960938,62.0,24.0,36.39844,333.3,2.8999023,4.69921875,0.89990234,140.0,7.419922,135.0,23.0,2502.0,2.6743164,<2 mo. follow-up
66.86096,0,male,0,38,1838,Coma,Coma,2,12.0,under $11k,63139.0,41355.1562,24.5,white,40.0,1,0,0,no,0.099999964,0.001,no dnr,38.0,57.0,11.2988281,116.0,36.0,40.0,276.625,2.699707,0.79992676,0.59997559,133.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.16898,1,female,0,56,60,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,133465.0,89469.875,30.5,white,38.0,21,1,0,no,0.5,0.3,dnr after sadm,32.0,145.0,11.0,154.0,24.0,39.59375,236.65625,2.199707,0.29998779,0.59997559,152.0,7.319336,135.0,23.0,2502.0,5.0,<2 mo. follow-up
80.76398,0,male,0,6,1833,COPD,COPD/CHF/Cirrhosis,1,8.0,$11-$25k,3553.0,2823.6777,16.0,white,26.0,1,0,0,no,0.899999619,0.4,dnr after sadm,2.0,66.0,8.29882812,118.0,24.0,36.09375,270.3125,4.0,0.89990234,1.0,137.0,7.439453,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
58.14099,1,female,0,16,41,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,22293.0,17607.4688,19.666656,white,47.0,1,0,0,no,0.299999952,0.2,dnr after sadm,2.0,62.0,6.79980469,132.0,40.0,40.0,252.375,3.7998047,1.29980469,1.0,140.0,7.519531,135.0,23.0,2502.0,0.0,<2 mo. follow-up
50.74597,0,male,0,4,1832,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,2421.0,1880.4121,8.0,white,15.0,1,0,0,no,0.849999905,0.85,no dnr,4.0,77.0,8.69921875,98.0,20.0,36.79688,183.3125,3.5,1.01,1.0,142.0,7.439453,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
71.28296,1,male,0,3,139,Lung Cancer,Cancer,2,12.0,$25-$50k,4032.0,3012.9531,27.0,white,27.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,2.0,65.0,9.0,79.0,28.0,38.0,182.5,3.5,1.01,1.01,140.0,7.429688,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
64.74194,0,female,0,35,1830,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,$11-$25k,66579.0,44250.1562,35.5,white,60.0,1,1,0,no,0.699999809,0.5,no dnr,35.0,127.0,10.1992188,104.0,42.0,39.19531,84.0,2.5,3.39990234,2.09960938,137.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.05798,1,male,0,8,39,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,3829.0,3359.2793,5.5,white,33.0,1,0,0,no,0.899999619,0.9,no dnr,8.0,101.0,11.3984375,60.0,24.0,35.69531,333.3,3.5,0.5,2.09960938,133.0,7.419922,135.0,23.0,2502.0,3.918457,<2 mo. follow-up
62.37399,1,male,0,5,7,Lung Cancer,Cancer,2,12.0,under $11k,2110.0,1810.6055,5.0,white,29.0,1,0,0,metastatic,0.699999809,0.5,dnr before sadm,-1.0,73.0,15.0,114.0,10.0,35.89844,333.3,3.5996094,0.29998779,0.89990234,127.0,7.419922,135.0,23.0,2502.0,2.4160156,<2 mo. follow-up
85.15796,1,male,0,20,99,ARF/MOSF w/Sepsis,ARF/MOSF,1,5.0,$11-$25k,15484.0,12240.1953,19.0,white,49.0,1,0,0,no,0.5,0.4,no dnr,20.0,73.0,11.6992188,115.0,32.0,38.0,190.0,3.699707,0.89990234,2.29980469,136.0,7.459961,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
74.31097,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,16942.0,11618.4844,32.0,white,51.0,3,0,0,no,0.099999964,0.001,dnr after sadm,5.0,72.0,12.0996094,116.0,42.0,38.19531,192.5,3.5996094,0.69995117,2.09960938,131.0,7.40918,135.0,23.0,2502.0,2.6572266,<2 mo. follow-up
60.78299,1,female,0,14,52,Lung Cancer,Cancer,1,12.0,under $11k,9817.0,7615.7344,10.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,no dnr,14.0,96.0,11.3984375,118.0,16.0,37.0,280.9375,3.5,1.01,0.5,130.0,7.469727,135.0,23.0,2502.0,3.0,<2 mo. follow-up
63.41397,1,female,0,13,66,Lung Cancer,Cancer,2,8.0,under $11k,10723.0,7882.6562,17.0,white,45.0,1,1,0,metastatic,0.599999905,0.1,dnr after sadm,1.0,112.0,13.8984375,174.0,28.0,36.0,285.6875,3.5,1.01,1.29980469,139.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
58.22897,1,male,1,6,6,Lung Cancer,Cancer,2,12.0,under $11k,3920.0,3139.7871,14.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,75.0,8.59960938,81.0,28.0,36.39844,333.3,2.5996094,1.29980469,0.79992676,136.0,7.419922,135.0,23.0,2502.0,2.9116211,<2 mo. follow-up
61.42398,0,male,0,13,1827,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,16383.0,12483.0938,23.0,white,15.0,1,0,0,no,0.899999619,0.9,no dnr,13.0,109.0,6.0,46.0,24.0,35.89844,313.3125,3.8999023,0.29998779,0.69995117,141.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
74.52698,1,female,0,13,92,CHF,COPD/CHF/Cirrhosis,3,20.0,$11-$25k,7505.0,6412.2891,10.5,white,38.0,1,0,0,yes,0.699999809,0.5,no dnr,13.0,59.0,10.1992188,76.0,14.0,36.29688,333.3,3.5,1.01,1.5,134.0,7.589844,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
70.78699,1,male,0,6,129,Lung Cancer,Cancer,3,8.0,under $11k,3736.0,2807.2519,18.0,white,35.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,68.0,14.0996094,69.0,32.0,36.29688,333.3,3.5,1.01,1.5,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
40.17798,0,male,0,25,1825,CHF,COPD/CHF/Cirrhosis,2,18.0,under $11k,14033.0,12213.4141,9.75,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,25.0,59.0,10.0,98.0,20.0,36.69531,333.3,2.7998047,0.69995117,1.19995117,128.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
63.439,1,female,0,9,15,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,10268.0,8213.5078,6.0,white,41.0,1,1,0,yes,0.5,0.2,dnr after sadm,3.0,66.0,12.7988281,104.0,28.0,35.29688,333.3,3.5,1.01,1.89990234,124.0,7.419922,135.0,23.0,2502.0,3.6025391,<2 mo. follow-up
56.99399,0,male,0,7,1823,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,3978.0,3115.3379,12.0,white,34.0,1,0,0,no,0.899999619,0.8,dnr after sadm,2.0,59.0,17.8984375,93.0,24.0,35.69531,284.0,4.1992188,0.5,1.89990234,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
56.68399,1,male,0,9,11,Lung Cancer,Cancer,1,11.0,$25-$50k,7076.0,5450.5039,9.5,white,29.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,69.0,18.1992188,122.0,26.0,38.59375,176.65625,3.5,1.01,0.79992676,136.0,7.369141,135.0,23.0,2502.0,1.8389997,<2 mo. follow-up
63.23099,1,male,0,5,1250,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,2849.0,2504.1836,5.0,white,19.0,1,1,0,no,0.899999619,0.8,no dnr,5.0,82.0,7.5,65.0,24.0,36.19531,333.3,3.8999023,0.79992676,1.29980469,140.0,7.419922,135.0,23.0,2502.0,2.0068359,<2 mo. follow-up
51.49597,1,male,0,8,69,Cirrhosis,COPD/CHF/Cirrhosis,6,12.0,under $11k,8660.0,7003.3945,10.5,white,32.0,1,0,0,yes,0.899999619,0.4,no dnr,8.0,68.0,8.0,79.0,15.0,36.29688,333.3,2.0996094,3.0,1.09985352,132.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
75.422,1,male,0,12,755,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$25-$50k,18862.0,13873.7031,24.0,white,47.0,6,1,0,no,0.899999619,0.8,no dnr,12.0,53.0,15.5,78.0,20.0,38.19531,107.5,3.5,1.01,1.19995117,139.0,7.459961,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
63.88797,1,male,0,9,155,Lung Cancer,Cancer,2,10.0,$11-$25k,4809.0,3962.3945,7.5,white,15.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,81.0,9.0,77.0,12.0,36.89844,333.3,3.5,1.01,1.19995117,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.89996,0,male,0,14,1818,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,23842.0,16305.4531,32.333313,white,49.0,1,1,0,no,0.5,0.4,no dnr,14.0,78.0,12.5996094,106.0,26.0,38.59375,80.0,2.8999023,1.09985352,1.19995117,139.0,7.469727,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
73.19098,1,male,0,4,5,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,34609.0,26301.4688,22.0,white,30.0,14,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,103.0,16.0,82.0,36.0,39.19531,94.65625,3.5,1.01,0.59997559,137.0,7.429688,135.0,23.0,2502.0,2.1376953,<2 mo. follow-up
71.37598,1,male,0,14,285,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,16882.0,12369.4453,18.0,white,43.0,1,0,1,no,0.099999964,0.001,dnr after sadm,1.0,77.0,24.5,106.0,28.0,36.19531,288.0,2.8999023,0.79992676,4.69921875,133.0,7.359375,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
60.931,1,male,1,4,4,Lung Cancer,Cancer,2,12.0,under $11k,2094.0,1653.3262,12.0,white,41.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,56.0,18.8984375,126.0,24.0,36.39844,319.0,3.199707,1.39990234,1.29980469,143.0,7.379883,135.0,23.0,2502.0,2.9448242,<2 mo. follow-up
58.75198,1,male,0,4,109,Lung Cancer,Cancer,4,12.0,under $11k,1401.0,1250.9248,4.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,65.0,6.5,114.0,20.0,36.0,333.3,4.0996094,0.59997559,1.09985352,133.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
73.69196,1,male,0,5,30,COPD,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,8756.0,6566.4023,22.0,white,43.0,7,0,0,yes,0.899999619,0.61,no dnr,5.0,69.0,16.5976562,160.0,28.0,38.5,297.125,3.699707,0.19998169,1.0,130.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.68195,1,male,0,5,500,Lung Cancer,Cancer,2,16.0,>$50k,2699.0,2069.0703,9.0,white,23.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,65.0,6.09960938,101.0,24.0,35.79688,333.3,4.0,0.39996338,0.89990234,131.0,7.419922,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
66.57599,1,female,0,11,17,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,16643.0,14302.6328,35.0,white,16.0,1,1,0,no,0.299999952,0.3,no dnr,11.0,72.0,9.0,68.0,24.0,36.39844,306.625,4.0,1.29980469,0.89990234,135.0,7.5,135.0,23.0,2502.0,3.0,<2 mo. follow-up
57.46698,1,female,0,27,122,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,26240.0,19473.25,13.25,white,29.0,1,1,0,no,0.949999809,0.85,no dnr,27.0,74.0,8.09960938,87.0,20.0,36.69531,596.25,2.7998047,1.89990234,1.69995117,134.0,7.369141,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
57.75998,1,female,0,24,743,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,34429.0,26154.9844,25.666656,white,28.0,3,0,0,yes,0.699999809,0.6,no dnr,24.0,119.0,11.3984375,150.0,28.0,36.39844,222.4375,3.3999023,0.39996338,0.59997559,133.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
82.56299,1,female,1,4,4,Coma,Coma,0,12.0,under $11k,3348.0,2935.7285,18.0,white,14.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,123.0,13.0996094,59.0,24.0,39.0,114.0,3.5,1.01,0.89990234,141.0,7.429688,135.0,23.0,2502.0,2.7348633,<2 mo. follow-up
61.27298,1,male,0,5,503,Lung Cancer,Cancer,4,16.0,>$50k,2824.0,2126.25,9.0,white,12.0,1,0,0,metastatic,0.75,0.4,no dnr,5.0,79.0,9.29882812,83.0,20.0,36.89844,333.3,4.1992188,0.19998169,0.89990234,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.44498,1,female,0,5,78,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,3171.0,2591.4394,19.0,white,23.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,83.0,7.59960938,76.0,20.0,36.79688,333.3,2.3999023,6.0,1.09985352,136.0,7.419922,135.0,23.0,2502.0,2.1303711,<2 mo. follow-up
77.46698,1,female,0,15,261,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,10748.0,8356.8438,9.333328,white,45.0,1,1,0,no,0.949999809,0.9,dnr after sadm,1.0,67.0,11.5996094,104.0,32.0,38.09375,285.6875,4.0996094,0.89990234,1.0,139.0,7.319336,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
74.86694,0,female,0,5,1802,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,2715.0,2189.9961,8.0,white,39.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,77.0,12.8984375,71.0,32.0,36.39844,233.3125,3.5,1.01,0.89990234,139.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
78.297,1,male,0,14,1063,ARF/MOSF w/Sepsis,ARF/MOSF,1,3.0,under $11k,12855.0,9787.6484,7.333332,white,39.0,1,0,0,yes,0.699999809,0.5,no dnr,14.0,147.0,11.3984375,110.0,42.0,36.79688,240.0,3.5996094,0.39996338,1.29980469,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.14099,1,male,1,13,13,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,17808.0,14600.1484,44.5,white,75.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,9.0,41.0,4.59960938,122.0,44.0,39.69531,309.0625,3.5,0.69995117,14.0,130.0,7.05957,135.0,23.0,2502.0,4.21875,<2 mo. follow-up
81.19098,1,female,0,11,99,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6344.0,5242.9648,9.5,white,50.0,1,0,0,no,0.599999905,0.4,dnr after sadm,1.0,51.0,33.6953125,73.0,28.0,35.0,295.1875,3.5,1.01,1.29980469,135.0,7.5,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
68.69299,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,0,12.0,under $11k,11160.0,7682.8633,19.0,white,29.0,1,0,0,no,0.799999714,0.75,dnr after sadm,6.0,103.0,12.0996094,104.0,34.0,37.89844,250.0,2.5,1.0,1.69995117,149.0,7.439453,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.35596,0,female,0,32,1798,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,88405.0,58013.2188,35.5,white,39.0,12,1,0,no,0.199999928,0.1,no dnr,32.0,60.0,26.6992188,160.0,8.0,39.39844,191.09375,2.699707,0.69995117,1.19995117,148.0,7.459961,135.0,23.0,2502.0,2.0,adl>=4 (>=5 if sur)
68.68396,1,male,1,7,7,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,4790.0,3761.4238,7.5,white,52.0,1,0,0,yes,0.099999964,0.001,dnr before sadm,-1.0,72.0,13.3984375,110.0,26.0,36.5,333.3,2.199707,1.59985352,6.19921875,129.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
77.26794,1,female,0,3,710,Lung Cancer,Cancer,2,12.0,under $11k,1990.0,1382.8867,11.0,white,10.0,1,0,0,metastatic,0.599999905,0.25,no dnr,3.0,81.0,9.0,76.0,20.0,35.79688,333.3,3.5,1.01,0.69995117,140.0,7.419922,135.0,23.0,2502.0,2.3745117,<2 mo. follow-up
69.02399,1,male,0,9,15,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,5258.0,4392.2266,9.5,white,32.0,1,0,0,no,0.199999928,0.5,dnr after sadm,5.0,114.0,12.3984375,106.0,24.0,38.0,414.25,2.699707,3.19970703,1.69995117,136.0,7.529297,135.0,23.0,2502.0,7.0,<2 mo. follow-up
63.39499,1,male,0,7,810,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3169.0,2724.1191,12.0,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,69.0,7.39941406,76.0,24.0,36.0,333.3,3.5,1.01,1.5,134.0,7.419922,135.0,23.0,2502.0,1.8408203,no(M2 and SIP pres)
62.63898,1,male,0,4,735,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,18106.0,12157.1406,16.0,white,21.0,15,0,0,yes,0.599999905,0.5,no dnr,4.0,111.0,8.19921875,65.0,24.0,35.79688,328.0,3.5,1.01,1.5,139.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.75598,1,female,0,14,1143,CHF,COPD/CHF/Cirrhosis,3,10.0,$11-$25k,9652.0,8003.9648,10.666664,white,39.0,1,0,0,yes,0.699999809,0.5,no dnr,14.0,65.0,15.5996094,93.0,20.0,36.19531,206.65625,4.2998047,0.79992676,2.29980469,130.0,7.489258,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
45.021,0,female,0,26,1795,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,39258.0,30343.0781,17.5,white,36.0,1,0,0,no,0.799999714,0.6,no dnr,26.0,65.0,19.0,130.0,12.0,36.19531,226.0,2.3999023,4.0,1.0,147.0,7.439453,135.0,23.0,2502.0,4.5273972,no(M2 and SIP pres)
79.47198,1,male,0,8,228,Colon Cancer,Cancer,1,4.0,under $11k,6229.0,4599.8047,14.5,white,20.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,68.0,7.79980469,78.0,22.0,35.79688,333.3,3.5,0.39996338,0.89990234,138.0,7.419922,135.0,23.0,2502.0,3.855299,no(M2 and SIP pres)
82.91895,1,male,0,8,738,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,6971.0,14452.7344,12.0,white,38.0,1,1,0,no,0.5,0.3,no dnr,8.0,70.0,15.6992188,102.0,12.0,36.59375,114.0,3.8999023,0.69995117,1.59985352,139.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.24298,0,male,0,17,1795,MOSF w/Malig,ARF/MOSF,1,13.0,$11-$25k,22190.0,15718.0469,19.333328,white,36.0,1,0,0,yes,0.899999619,0.9,no dnr,17.0,113.0,10.7988281,46.0,24.0,35.69531,333.3,3.199707,0.39996338,2.5,132.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.72095,1,male,0,12,757,Colon Cancer,Cancer,1,12.0,under $11k,13773.0,9978.6094,18.5,white,21.0,1,0,0,metastatic,0.799999714,0.6,no dnr,12.0,71.0,6.79980469,60.0,20.0,35.59375,333.3,4.3994141,0.59997559,1.19995117,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
54.366,1,male,0,7,18,Lung Cancer,Cancer,2,12.0,under $11k,4439.0,3419.9531,4.0,white,10.0,1,0,0,metastatic,0.5,0.05,dnr after sadm,1.0,106.0,11.5996094,73.0,20.0,36.19531,333.3,4.2998047,0.39996338,0.79992676,135.0,7.419922,135.0,23.0,2502.0,2.4677734,<2 mo. follow-up
85.36896,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,5435.0,3947.9746,20.0,white,50.0,1,0,0,no,0.099999964,0.001,dnr after sadm,3.0,67.0,8.09960938,72.0,44.0,38.19531,134.28125,3.8999023,1.39990234,1.39990234,153.0,7.269531,135.0,23.0,2502.0,2.605957,<2 mo. follow-up
71.12897,1,male,0,6,396,Lung Cancer,Cancer,2,6.0,under $11k,3305.0,2610.459,13.0,white,32.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,118.0,9.0,81.0,36.0,35.69531,333.3,3.5,1.01,1.59985352,138.0,7.419922,135.0,23.0,2502.0,3.2324219,<2 mo. follow-up
43.12097,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,25591.0,16153.5859,36.5,white,43.0,3,0,0,no,0.399999857,0.5,no dnr,11.0,148.0,6.0,160.0,42.0,39.0,340.0,2.5996094,0.39996338,0.89990234,144.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
59.715,0,female,0,11,1783,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,15675.0,12458.0078,13.0,white,34.0,11,1,0,no,0.75,0.7,no dnr,11.0,101.0,13.5,96.0,20.0,36.29688,161.21875,3.8999023,0.5,2.79980469,136.0,7.399414,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
75.25299,1,male,0,4,1224,Lung Cancer,Cancer,1,5.0,under $11k,1982.0,1703.4512,15.0,white,22.0,1,0,0,metastatic,0.5,0.2,no dnr,4.0,98.0,4.59960938,79.0,24.0,35.09375,333.3,3.699707,0.69995117,1.5,135.0,7.419922,135.0,23.0,2502.0,2.1186523,no(M2 and SIP pres)
81.85895,1,male,1,8,8,Coma,Coma,2,12.0,under $11k,30573.0,22404.1562,43.0,white,29.0,7,0,0,yes,0.0,0.0,dnr after sadm,5.0,134.0,11.6992188,120.0,10.0,38.0,266.625,3.0996094,0.5,1.19995117,140.0,7.5,135.0,23.0,2502.0,3.027832,<2 mo. follow-up
58.30499,0,male,0,6,1777,Lung Cancer,Cancer,1,12.0,$25-$50k,4919.0,3350.6582,10.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,101.0,4.19921875,76.0,22.0,35.89844,333.3,4.2998047,0.69995117,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
66.99194,1,male,0,12,289,Coma,Coma,1,12.0,under $11k,7107.0,5761.1719,10.0,white,22.0,1,0,0,metastatic,0.799999714,0.05,dnr after sadm,1.0,101.0,12.0996094,71.0,24.0,35.59375,261.875,3.699707,0.69995117,0.89990234,137.0,7.479492,135.0,23.0,2502.0,2.3081055,<2 mo. follow-up
73.63397,1,male,0,19,1018,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,11955.0,9600.3672,9.0,white,43.0,1,0,1,no,0.949999809,0.95,no dnr,19.0,66.0,25.296875,104.0,28.0,38.79688,142.84375,4.0,1.0,1.09985352,130.0,7.519531,135.0,23.0,2502.0,4.6796875,<2 mo. follow-up
68.45398,1,female,1,22,22,Coma,Coma,2,12.0,under $11k,31886.0,27470.5625,24.666656,white,39.0,3,0,0,no,0.699999809,0.5,dnr after sadm,3.0,50.0,5.39941406,72.0,10.0,37.89844,330.0,2.699707,2.39990234,1.89990234,137.0,7.439453,135.0,23.0,2502.0,2.2504883,<2 mo. follow-up
79.04395,1,male,0,15,1184,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,14976.0,11266.9609,7.333332,white,30.0,3,1,0,no,0.949999809,0.9,no dnr,15.0,103.0,16.1992188,104.0,28.0,38.59375,333.3,3.5,1.01,1.29980469,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
84.89795,1,male,0,20,24,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,58625.0,39888.9688,30.0,white,41.0,20,0,0,no,0.5,0.4,dnr before sadm,-13.0,70.0,21.296875,130.0,10.0,35.79688,113.32812,3.199707,1.29980469,1.39990234,140.0,7.469727,135.0,23.0,2502.0,2.0,<2 mo. follow-up
71.685,0,male,0,62,1771,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,157606.0,118813.875,34.5,white,44.0,13,0,0,no,0.599999905,0.58,no dnr,62.0,56.0,22.5976562,122.0,10.0,38.69531,262.5,3.0,2.19970703,1.59985352,145.0,7.459961,135.0,23.0,2502.0,2.2739258,<2 mo. follow-up
64.24597,1,female,0,10,117,Lung Cancer,Cancer,3,12.0,under $11k,6996.0,5719.0234,11.5,white,29.0,1,1,0,metastatic,0.599999905,0.5,no dnr,10.0,70.0,6.39941406,130.0,28.0,38.59375,333.3,3.5996094,0.29998779,0.69995117,132.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
59.26099,1,male,0,3,107,ARF/MOSF w/Sepsis,ARF/MOSF,3,16.0,>$50k,2339.0,1853.75,19.0,white,33.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,55.0,7.79980469,76.0,20.0,36.09375,333.3,4.1992188,1.59985352,1.5,129.0,7.419922,135.0,23.0,2502.0,4.5273972,no(M2 and SIP pres)
70.43695,0,male,0,7,1769,CHF,COPD/CHF/Cirrhosis,2,4.0,under $11k,4158.0,3417.3438,10.0,white,15.0,1,0,0,no,0.899999619,0.6,no dnr,7.0,82.0,8.29882812,63.0,24.0,35.89844,385.6875,4.0996094,0.69995117,1.19995117,132.0,7.429688,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
74.85596,1,female,0,10,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,under $11k,11499.0,7894.8828,8.0,white,62.0,1,0,0,no,0.299999952,0.2,dnr after sadm,1.0,73.0,0.89990234,82.0,28.0,36.19531,347.5625,2.8999023,6.5,1.69995117,133.0,7.429688,135.0,23.0,2502.0,7.0,<2 mo. follow-up
51.23099,1,female,1,94,94,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,144148.0,137408.625,35.5,white,68.0,16,0,0,yes,0.599999905,0.6,dnr after sadm,92.0,149.0,7.29980469,112.0,40.0,38.89844,110.0,2.2998047,1.0,2.59960938,148.0,7.429688,135.0,23.0,2502.0,4.0,<2 mo. follow-up
78.57397,1,male,0,10,1524,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,6569.0,5492.7266,15.0,white,49.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,109.0,7.0,120.0,32.0,36.0,280.9375,4.0,0.29998779,2.89990234,131.0,7.359375,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
42.88599,1,female,0,6,240,Colon Cancer,Cancer,1,16.0,$25-$50k,2807.0,2326.2715,11.0,white,21.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,62.0,2.39990234,81.0,16.0,36.39844,333.3,4.6992188,0.39996338,0.89990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.19299,1,male,0,17,49,Colon Cancer,Cancer,1,12.0,under $11k,15429.0,11362.0781,13.666664,white,31.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,12.0,104.0,6.89941406,110.0,24.0,37.59375,333.3,4.6992188,0.59997559,1.29980469,131.0,7.419922,135.0,23.0,2502.0,1.8774414,<2 mo. follow-up
66.47998,0,female,0,21,1762,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,39037.0,26767.1094,19.333328,white,35.0,13,0,0,yes,0.5,0.25,no dnr,21.0,103.0,0.39996338,118.0,24.0,36.69531,333.3,2.5,1.19995117,0.79992676,131.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.08398,1,male,0,36,38,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,61341.0,39997.9062,38.75,white,25.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,29.0,70.0,18.0,112.0,9.0,36.09375,256.0,2.7998047,1.29980469,1.09985352,143.0,7.479492,135.0,23.0,2502.0,3.1894531,<2 mo. follow-up
82.05298,1,female,0,27,144,Coma,Coma,3,10.0,under $11k,31768.0,22055.1719,25.5,white,38.0,1,0,1,no,0.299999952,0.1,no dnr,27.0,74.0,12.6992188,120.0,36.0,39.69531,187.09375,3.2998047,0.79992676,1.19995117,137.0,7.439453,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
73.21295,1,male,0,12,1087,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,8677.0,7295.0273,16.0,white,56.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,61.0,10.7988281,118.0,32.0,34.5,409.5,3.5996094,2.29980469,2.19970703,136.0,7.519531,135.0,23.0,2502.0,2.921875,<2 mo. follow-up
55.17899,1,male,0,6,296,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,12149.0,10395.0312,14.0,white,34.0,1,0,0,no,0.949999809,0.95,no dnr,6.0,82.0,5.29980469,69.0,28.0,35.69531,333.3,4.5,1.39990234,1.59985352,133.0,7.419922,135.0,23.0,2502.0,2.3027344,<2 mo. follow-up
77.31696,1,male,0,9,554,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,5602.0,4353.6445,11.0,white,32.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,67.0,7.79980469,107.0,28.0,36.39844,432.0,4.3994141,0.39996338,0.89990234,145.0,7.359375,135.0,23.0,2502.0,3.6791992,<2 mo. follow-up
88.62695,1,male,0,15,202,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,14022.0,9969.0078,16.333328,white,44.0,1,0,0,no,0.299999952,0.027,dnr after sadm,2.0,62.0,6.59960938,77.0,28.0,36.19531,146.65625,3.199707,0.29998779,1.19995117,136.0,7.359375,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
65.23798,1,male,0,10,923,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,5633.0,4668.2891,7.5,white,42.0,1,1,0,no,0.75,0.7,no dnr,10.0,110.0,7.0,59.0,28.0,35.69531,428.5625,3.3999023,0.39996338,2.09960938,133.0,7.439453,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.68994,1,male,0,5,201,Lung Cancer,Cancer,2,15.0,$25-$50k,2750.0,2121.5391,9.0,white,15.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,100.0,5.09960938,74.0,20.0,36.39844,333.3,3.7998047,0.39996338,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.78198,1,male,0,12,447,Lung Cancer,Cancer,2,9.0,$11-$25k,6459.0,5058.5156,7.0,white,31.0,1,0,0,metastatic,0.989999771,0.99,no dnr,12.0,108.0,3.69970703,120.0,20.0,36.89844,333.3,4.6992188,0.39996338,1.29980469,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.27197,1,male,0,18,20,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,13300.0,10862.1719,6.333332,white,42.0,1,0,0,no,0.299999952,0.1,dnr after sadm,7.0,120.0,11.1992188,112.0,28.0,35.89844,256.0,4.5996094,0.5,1.29980469,138.0,7.299805,135.0,23.0,2502.0,2.9174805,<2 mo. follow-up
72.29797,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,12367.0,8481.9609,42.5,white,54.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,77.0,16.5,130.0,36.0,38.59375,140.0,2.8999023,0.79992676,2.29980469,137.0,7.459961,135.0,23.0,2502.0,7.0,<2 mo. follow-up
76.25696,1,male,0,9,44,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,5556.0,4400.3125,2.5,white,32.0,1,0,0,no,0.75,0.5,no dnr,9.0,100.0,4.89941406,93.0,24.0,36.19531,185.6875,4.3994141,0.39996338,1.19995117,140.0,7.389648,135.0,23.0,2502.0,4.0,<2 mo. follow-up
66.97595,1,male,0,16,709,Lung Cancer,Cancer,2,12.0,$25-$50k,10591.0,8733.6641,6.666664,white,22.0,1,0,0,metastatic,0.899999619,0.75,no dnr,16.0,100.0,9.8984375,77.0,20.0,35.79688,333.3,4.1992188,0.29998779,1.39990234,137.0,7.419922,135.0,23.0,2502.0,3.855299,no(M2 and SIP pres)
47.60797,0,male,0,8,1748,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,13782.0,5093.8789,18.5,white,35.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,80.0,7.39941406,78.0,28.0,38.09375,133.3125,4.0996094,2.19970703,0.89990234,137.0,7.30957,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
60.85699,1,female,0,10,76,COPD,COPD/CHF/Cirrhosis,0,12.0,$11-$25k,22608.0,17245.4531,17.5,white,42.0,8,0,0,no,0.899999619,0.3,no dnr,10.0,137.0,9.59960938,62.0,14.0,36.19531,166.65625,3.7998047,0.5,8.29882812,128.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.50098,1,female,0,7,830,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,4447.0,3547.3477,18.0,white,17.0,1,1,0,no,0.5,0.4,no dnr,7.0,118.0,6.19921875,79.0,20.0,36.89844,414.25,3.0,0.59997559,1.29980469,137.0,7.449219,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
84.32898,1,male,0,6,667,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,3099.0,2538.4727,8.0,white,35.0,1,1,0,no,0.849999905,0.75,dnr after sadm,1.0,108.0,11.7988281,74.0,24.0,36.09375,240.0,3.5,1.01,1.09985352,136.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
72.745,1,male,0,7,1734,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,4613.0,3877.4629,12.0,white,16.0,1,1,0,no,0.75,0.5,no dnr,7.0,86.0,9.0,60.0,24.0,36.19531,333.3,3.5996094,0.69995117,1.39990234,139.0,7.419922,135.0,23.0,2502.0,2.1606445,<2 mo. follow-up
68.45697,0,male,0,5,1744,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,4895.0,3740.168,21.0,white,31.0,1,0,0,no,0.899999619,0.7,no dnr,5.0,68.0,11.2988281,82.0,24.0,35.5,280.9375,4.5996094,0.69995117,1.19995117,136.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.00696,1,male,0,12,611,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,7402.0,5895.6055,6.5,white,35.0,1,1,0,no,0.699999809,0.5,no dnr,12.0,72.0,3.39990234,102.0,28.0,35.79688,211.09375,3.699707,0.59997559,1.29980469,137.0,7.439453,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
89.57397,1,female,0,9,11,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,11755.0,8758.7344,23.5,white,40.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,147.0,18.296875,122.0,42.0,36.09375,426.625,4.2998047,0.39996338,1.19995117,127.0,7.40918,135.0,23.0,2502.0,4.0,<2 mo. follow-up
50.50198,0,male,0,11,1744,COPD,COPD/CHF/Cirrhosis,0,6.0,$11-$25k,20682.0,13876.9766,18.5,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,113.0,7.89941406,67.0,30.0,36.19531,165.6875,3.699707,0.89990234,1.0,138.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.02399,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,57521.0,37854.5625,48.0,white,64.0,15,0,0,no,0.049999982,0.000125,dnr after sadm,1.0,70.0,20.5976562,122.0,40.0,37.79688,148.96875,2.5,11.1992188,1.89990234,141.0,7.509766,135.0,23.0,2502.0,3.2089844,<2 mo. follow-up
60.991,0,male,0,17,1736,COPD,COPD/CHF/Cirrhosis,2,11.0,under $11k,23869.0,16551.0469,27.333328,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,17.0,117.0,11.7988281,70.0,40.0,36.09375,133.3125,2.3999023,1.59985352,1.29980469,139.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.72095,0,female,0,11,1734,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,23276.0,16485.125,26.5,hispanic,50.0,1,1,0,no,0.989999771,0.99,no dnr,11.0,60.0,17.5976562,103.0,28.0,36.59375,209.5,3.2998047,1.0,1.5,137.0,7.40918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
19.21999,0,male,0,11,1734,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,16817.0,11411.9375,22.0,white,14.0,2,0,0,no,0.989999771,0.99,no dnr,11.0,81.0,8.3984375,66.0,42.0,38.79688,380.0,3.5,1.01,0.89990234,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.57098,1,male,0,16,1661,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,47395.0,35246.6875,16.0,white,31.0,16,1,0,no,0.699999809,0.5,no dnr,16.0,101.0,12.0,72.0,26.0,36.29688,144.875,3.3999023,1.69995117,1.39990234,140.0,7.479492,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.84497,1,male,1,27,27,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$25-$50k,90802.0,63460.4688,36.5,white,48.0,8,0,0,no,0.5,0.5,dnr after sadm,2.0,63.0,11.1992188,127.0,10.0,39.29688,198.0,2.8999023,3.89990234,2.69970703,135.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.70999,1,female,0,4,194,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4510.0,3111.0527,6.0,white,44.0,1,1,0,no,0.96999979,0.5,no dnr,4.0,53.0,9.0,44.0,24.0,35.79688,333.3,3.5,1.01,1.79980469,134.0,7.419922,135.0,23.0,2502.0,3.0136719,<2 mo. follow-up
77.00494,1,female,0,19,408,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,14665.0,12091.9844,16.333328,white,54.0,1,1,0,no,0.699999809,0.5,no dnr,19.0,58.0,8.69921875,124.0,44.0,35.39844,366.625,3.5,1.01,1.39990234,132.0,7.449219,135.0,23.0,2502.0,3.5424805,<2 mo. follow-up
52.92499,1,male,0,7,262,Colon Cancer,Cancer,1,12.0,$11-$25k,5568.0,4115.2227,15.0,white,13.0,1,0,0,metastatic,0.699999809,0.1,no dnr,7.0,73.0,9.19921875,62.0,20.0,36.89844,333.3,3.5,1.29980469,0.79992676,131.0,7.419922,135.0,23.0,2502.0,1.7587891,no(M2 and SIP pres)
59.96997,1,male,0,8,812,Lung Cancer,Cancer,2,12.0,$25-$50k,10149.0,7605.6875,8.0,white,31.0,1,0,0,metastatic,0.799999714,0.8,no dnr,8.0,113.0,13.0,55.0,40.0,36.39844,371.375,3.5,1.01,1.0,133.0,7.469727,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
59.18399,1,male,0,5,366,Lung Cancer,Cancer,1,12.0,under $11k,3055.0,2468.2969,11.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,105.0,7.5,69.0,16.0,36.39844,333.3,3.7998047,0.39996338,0.79992676,137.0,7.419922,135.0,23.0,2502.0,1.845459,<2 mo. follow-up
65.53894,0,female,0,17,1728,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,25633.0,17160.4375,17.666656,white,36.0,4,0,0,no,0.899999619,0.9,no dnr,17.0,68.0,7.5,64.0,28.0,39.29688,54.53906,2.199707,0.79992676,0.79992676,134.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
81.79895,0,female,0,8,1720,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,7246.0,5610.4219,6.5,white,34.0,1,0,0,no,0.899999619,0.7,no dnr,8.0,64.0,7.69921875,98.0,28.0,36.09375,295.1875,3.5,0.29998779,0.69995117,142.0,7.469727,135.0,23.0,2502.0,3.855299,adl>=4 (>=5 if sur)
58.42599,1,male,0,9,65,Lung Cancer,Cancer,2,12.0,under $11k,2853.0,2602.0938,5.0,white,11.0,1,0,0,metastatic,0.699999809,0.3,no dnr,9.0,85.0,6.29980469,83.0,20.0,36.69531,333.3,4.0,0.29998779,1.19995117,137.0,7.419922,135.0,23.0,2502.0,2.4575195,<2 mo. follow-up
75.72595,1,male,0,14,15,ARF/MOSF w/Sepsis,ARF/MOSF,3,11.0,under $11k,38125.0,28336.0469,27.666656,white,40.0,3,0,0,yes,0.299999952,0.5,dnr after sadm,14.0,67.0,5.29980469,106.0,30.0,38.0,140.0,2.7998047,4.5,1.09985352,142.0,7.429688,135.0,23.0,2502.0,2.0,<2 mo. follow-up
73.58197,1,male,0,11,59,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,27783.0,19685.6406,26.0,white,32.0,14,0,0,no,0.5,0.5,dnr after sadm,2.0,72.0,17.3984375,119.0,44.0,38.79688,170.0,3.5,1.01,0.69995117,142.0,7.429688,135.0,23.0,2502.0,5.0,<2 mo. follow-up
75.18994,1,male,0,16,803,Coma,Coma,1,11.0,under $11k,28256.0,18162.5,30.0,white,13.0,1,0,0,no,0.699999809,0.1,dnr after sadm,2.0,119.0,13.2988281,82.0,10.0,39.0,217.75,6.2998047,0.5,0.79992676,129.0,7.429688,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
59.68198,0,male,0,16,1714,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,27637.0,20644.2188,12.666664,white,30.0,8,0,0,no,0.989999771,0.99,no dnr,16.0,79.0,5.79980469,104.0,32.0,36.29688,182.5,3.5,1.01,1.19995117,133.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
27.57599,0,female,0,36,1713,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,66054.0,44900.9688,38.25,white,38.0,1,0,0,yes,0.699999809,0.5,no dnr,36.0,114.0,14.3984375,156.0,8.0,39.79688,90.0,2.5,0.79992676,0.79992676,141.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.17896,1,male,0,7,13,Coma,Coma,3,12.0,$11-$25k,8144.0,6759.1758,7.0,white,30.0,1,1,0,yes,0.099999964,0.001,dnr after sadm,1.0,160.0,9.0,55.0,10.0,38.69531,333.3,4.3994141,1.39990234,1.09985352,136.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
83.71497,1,male,0,16,24,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,14147.0,11711.2266,8.666664,white,35.0,1,0,1,no,0.099999964,0.001,no dnr,16.0,113.0,11.0,98.0,32.0,36.19531,328.5625,3.2998047,0.59997559,1.59985352,145.0,7.469727,135.0,23.0,2502.0,6.2451172,<2 mo. follow-up
56.87299,1,female,0,5,339,Lung Cancer,Cancer,1,13.0,$11-$25k,3967.0,3125.1289,6.0,white,9.0,1,0,0,metastatic,0.899999619,0.6,no dnr,5.0,120.0,9.0,70.0,16.0,37.39844,333.3,3.5,1.01,0.89990234,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
81.23798,1,male,0,8,172,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,3321.0,2890.4688,8.0,white,43.0,1,0,0,no,0.899999619,0.6,dnr after sadm,2.0,66.0,6.5,67.0,26.0,35.09375,314.25,3.5,1.01,3.19970703,138.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.11597,1,female,0,6,356,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4026.0,3175.8555,15.0,white,38.0,1,0,0,no,0.299999952,0.3,dnr after sadm,4.0,111.0,6.19921875,60.0,20.0,36.19531,432.0,4.1992188,3.0,2.19970703,142.0,7.449219,135.0,23.0,2502.0,2.0263672,<2 mo. follow-up
75.56696,1,male,0,6,445,CHF,COPD/CHF/Cirrhosis,2,15.0,$25-$50k,3858.0,3200.0078,12.0,white,35.0,1,0,0,no,0.299999952,0.3,no dnr,6.0,63.0,10.0996094,62.0,28.0,36.19531,333.3,3.5,1.01,1.79980469,129.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.70398,1,male,0,3,382,Lung Cancer,Cancer,1,9.0,$11-$25k,2892.0,1818.7529,20.0,white,13.0,1,0,0,metastatic,0.899999619,0.75,no dnr,3.0,119.0,4.39941406,70.0,20.0,36.19531,333.3,4.0996094,0.29998779,1.09985352,134.0,7.419922,135.0,23.0,2502.0,1.7631836,no(M2 and SIP pres)
47.836,1,male,0,8,35,Lung Cancer,Cancer,1,12.0,under $11k,12897.0,9535.0703,9.0,white,12.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,5.0,65.0,19.8984375,64.0,24.0,36.79688,187.75,3.5,1.01,1.01,140.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.24896,1,male,0,5,54,Lung Cancer,Cancer,2,12.0,under $11k,2348.0,2023.4707,3.0,white,28.0,1,0,0,metastatic,0.25,0.05,dnr after sadm,2.0,68.0,15.2988281,60.0,24.0,36.19531,328.5625,3.5,0.29998779,1.29980469,133.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.61896,1,male,0,11,1194,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,6593.0,5362.8945,13.5,white,25.0,1,0,0,no,0.399999857,0.3,dnr after sadm,1.0,104.0,5.19921875,114.0,24.0,36.39844,230.40625,4.3994141,0.69995117,0.69995117,127.0,7.289062,135.0,23.0,2502.0,3.0,<2 mo. follow-up
76.74194,1,male,0,8,335,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,7830.0,14452.7344,14.0,white,40.0,1,0,0,metastatic,0.75,0.5,dnr after sadm,1.0,116.0,12.5,101.0,28.0,36.19531,166.65625,3.5,1.29980469,1.0,140.0,7.439453,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
68.19397,1,female,0,9,582,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,17719.0,11150.5703,18.0,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,67.0,14.0,79.0,30.0,38.59375,297.125,3.699707,0.39996338,2.79980469,137.0,7.459961,135.0,23.0,2502.0,1.0,<2 mo. follow-up
49.74899,1,male,0,5,941,Colon Cancer,Cancer,1,14.0,$25-$50k,3279.0,2579.3574,2.0,white,9.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,112.0,18.796875,71.0,20.0,36.29688,333.3,4.1992188,0.69995117,1.0,135.0,7.419922,135.0,23.0,2502.0,1.5302734,no(M2 and SIP pres)
60.63797,1,male,0,40,41,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,49563.0,35439.3438,18.0,white,19.0,7,0,0,yes,0.699999809,0.5,no dnr,40.0,106.0,13.0,70.0,26.0,37.39844,333.3,3.5,1.01,0.89990234,157.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
75.12097,1,male,0,3,7,Coma,Coma,1,10.0,$11-$25k,132648.0,96514.8125,37.0,white,42.0,49,1,0,no,0.0,0.0,dnr after sadm,3.0,106.0,15.0996094,120.0,10.0,35.89844,185.6875,3.5,1.01,1.19995117,149.0,7.519531,135.0,23.0,2502.0,1.0,<2 mo. follow-up
60.31198,0,male,0,8,1698,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,15597.0,11050.25,17.5,white,10.0,1,1,0,yes,0.699999809,0.5,no dnr,8.0,119.0,9.0,80.0,22.0,37.89844,236.65625,3.5,1.01,1.01,140.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
46.16299,0,female,0,14,1697,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,15063.0,10876.1328,16.666656,white,18.0,1,1,0,no,0.949999809,0.95,no dnr,14.0,72.0,15.8984375,101.0,24.0,37.79688,385.6875,2.7998047,0.19998169,0.69995117,138.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
81.383,1,male,0,5,1119,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,3057.0,2497.6152,6.0,white,47.0,1,0,0,no,0.799999714,0.8,dnr after sadm,1.0,115.0,9.5,104.0,32.0,36.29688,200.0,3.699707,0.89990234,1.59985352,141.0,7.289062,135.0,23.0,2502.0,2.5249023,no(M2 and SIP pres)
64.797,1,male,0,3,15,Lung Cancer,Cancer,3,13.0,$11-$25k,17922.0,14452.7344,14.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,85.0,12.5,74.0,28.0,35.59375,216.0,2.8999023,0.39996338,1.0,135.0,7.519531,135.0,23.0,2502.0,2.7763672,<2 mo. follow-up
60.50699,0,female,0,10,1693,Cirrhosis,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,4271.0,3857.6211,3.0,white,23.0,1,0,0,no,0.5,0.2,no dnr,10.0,101.0,8.19921875,98.0,20.0,37.59375,333.3,2.5,4.69921875,1.19995117,133.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.30499,1,female,0,12,95,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,11889.0,10361.5,7.0,white,51.0,1,0,0,no,0.5,0.25,dnr after sadm,7.0,144.0,9.5,57.0,36.0,35.69531,333.3,3.3999023,0.69995117,10.6992188,138.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
58.58499,1,male,0,17,137,Lung Cancer,Cancer,1,10.0,under $11k,19331.0,14248.3594,1.666666,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,17.0,107.0,5.79980469,74.0,20.0,36.39844,333.3,4.6992188,0.39996338,0.79992676,141.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
69.63995,1,male,0,6,252,Colon Cancer,Cancer,1,12.0,under $11k,2711.0,2272.2207,9.0,white,14.0,1,0,0,metastatic,0.799999714,0.5,no dnr,6.0,84.0,2.59960938,69.0,16.0,36.59375,333.3,4.1992188,0.29998779,0.79992676,140.0,7.419922,135.0,23.0,2502.0,1.4626465,no(M2 and SIP pres)
77.74896,1,male,0,5,307,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,3096.0,2368.7988,12.0,white,30.0,1,0,0,no,1.0,0.9,dnr after sadm,1.0,107.0,6.69921875,107.0,36.0,35.69531,292.25,4.0996094,0.69995117,1.0,136.0,7.399414,135.0,23.0,2502.0,2.4277344,adl>=4 (>=5 if sur)
50.92999,1,male,0,10,30,COPD,COPD/CHF/Cirrhosis,4,14.0,under $11k,9339.0,7388.5195,16.0,white,35.0,1,1,0,no,0.799999714,0.7,no dnr,10.0,63.0,17.8984375,64.0,26.0,36.29688,174.4375,5.0,0.29998779,1.29980469,133.0,7.269531,135.0,23.0,2502.0,1.0,<2 mo. follow-up
52.797,0,male,0,8,1689,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,4438.0,3861.0684,7.0,white,25.0,1,0,0,no,0.899999619,0.9,no dnr,8.0,69.0,4.79980469,81.0,24.0,35.89844,371.375,3.7998047,1.29980469,1.5,138.0,7.449219,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
31.713,0,male,0,9,1688,ARF/MOSF w/Sepsis,ARF/MOSF,0,9.0,$11-$25k,10920.0,8458.4609,17.5,white,23.0,1,0,0,no,0.949999809,0.95,no dnr,9.0,99.0,13.6992188,112.0,34.0,38.39844,122.0,3.8999023,0.39996338,1.09985352,135.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.29199,1,female,0,12,136,COPD,COPD/CHF/Cirrhosis,4,6.0,under $11k,13456.0,11271.9844,29.0,white,43.0,1,1,0,no,0.299999952,0.1,no dnr,12.0,69.0,23.0976562,74.0,30.0,39.29688,135.375,3.7998047,0.39996338,1.59985352,136.0,7.269531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.52496,1,female,0,6,52,Lung Cancer,Cancer,1,15.0,$11-$25k,5701.0,3808.8281,3.0,white,19.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,76.0,8.69921875,83.0,16.0,35.79688,333.3,3.5,1.01,1.0,140.0,7.419922,135.0,23.0,2502.0,2.0385742,<2 mo. follow-up
86.29199,1,female,0,5,1507,Coma,Coma,1,12.0,under $11k,3476.0,2653.5254,9.0,white,34.0,1,0,0,no,0.599999905,0.5,dnr after sadm,1.0,55.0,3.89990234,66.0,16.0,36.29688,409.5,3.8999023,0.39996338,1.5,137.0,7.329102,135.0,23.0,2502.0,1.9753418,adl>=4 (>=5 if sur)
62.245,0,female,0,15,1685,Lung Cancer,Cancer,1,12.0,under $11k,15038.0,11057.7109,5.666664,white,7.0,1,0,0,metastatic,1.0,0.9,no dnr,15.0,83.0,9.5,56.0,16.0,36.29688,383.3125,4.0996094,0.39996338,0.69995117,138.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
82.461,1,male,0,9,97,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,8452.0,6526.9961,12.5,white,32.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,76.0,14.0996094,94.0,32.0,38.19531,333.3,4.0996094,0.79992676,1.5,140.0,7.419922,135.0,23.0,2502.0,1.8389997,no(M2 and SIP pres)
77.32495,0,female,0,15,1682,Coma,Coma,2,9.0,under $11k,27359.0,19229.3594,29.0,white,55.0,1,1,0,no,0.699999809,0.5,no dnr,15.0,68.0,20.1992188,38.0,8.0,36.0,98.0,3.199707,0.79992676,2.09960938,132.0,7.569336,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.35699,1,female,0,25,26,Lung Cancer,Cancer,2,12.0,under $11k,18644.0,14690.625,8.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,125.0,6.79980469,98.0,20.0,36.0,333.3,3.7998047,0.5,0.5,128.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
63.81897,1,male,0,12,989,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,11890.0,14882.8672,7.0,white,35.0,1,0,0,no,0.949999809,0.9,no dnr,12.0,114.0,3.59960938,77.0,28.0,36.39844,395.1875,2.199707,5.09960938,1.0,132.0,7.439453,135.0,23.0,2502.0,3.0957031,<2 mo. follow-up
84.40198,0,male,0,26,1680,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,$11-$25k,39436.0,28832.125,17.25,white,42.0,4,0,0,yes,0.699999809,0.5,no dnr,26.0,108.0,13.2988281,114.0,34.0,38.5,165.0,2.5,5.79980469,1.19995117,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.83899,1,male,0,19,608,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,35532.0,25060.6406,20.0,white,38.0,8,0,0,no,0.899999619,0.5,no dnr,19.0,113.0,0.59997559,78.0,28.0,38.19531,333.3,3.5,1.01,1.09985352,134.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.00397,1,male,0,16,1320,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,13530.0,10402.1641,16.0,white,42.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,115.0,6.19921875,114.0,40.0,36.39844,200.0,4.2998047,0.59997559,1.29980469,133.0,7.30957,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
80.65399,1,male,0,17,56,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,11279.0,8929.6641,5.0,white,30.0,1,0,0,no,0.949999809,0.7,no dnr,17.0,117.0,14.7988281,76.0,32.0,37.69531,212.0,3.5996094,0.29998779,1.09985352,136.0,7.419922,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
61.84799,1,male,0,10,1263,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,9035.0,7038.8789,3.0,white,20.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,117.0,12.0,52.0,20.0,36.29688,333.3,3.5,1.01,1.79980469,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.92096,1,male,0,8,1293,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,7176.0,5485.707,7.5,white,30.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,115.0,15.5996094,73.0,28.0,36.09375,316.0,3.8999023,2.19970703,1.09985352,138.0,7.489258,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
81.32495,1,male,0,12,1082,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,17767.0,12111.5,44.0,white,42.0,1,0,1,no,0.5,0.5,no dnr,12.0,153.0,14.7988281,180.0,30.0,37.0,260.0,3.5,0.59997559,1.29980469,137.0,7.439453,135.0,23.0,2502.0,4.4462891,<2 mo. follow-up
82.034,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,29147.0,19972.7969,49.0,white,32.0,3,0,0,no,0.699999809,0.5,dnr after sadm,7.0,70.0,13.2988281,104.0,34.0,36.89844,108.15625,3.0,1.89990234,0.59997559,138.0,7.40918,135.0,23.0,2502.0,1.0,<2 mo. follow-up
18.16299,1,male,1,13,13,MOSF w/Malig,ARF/MOSF,2,11.0,under $11k,28791.0,19518.8125,29.0,white,51.0,4,0,0,yes,0.799999714,0.4,dnr after sadm,4.0,99.0,0.39996338,162.0,30.0,35.59375,333.3,2.8999023,1.09985352,0.89990234,128.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.05099,1,male,0,8,1289,COPD,COPD/CHF/Cirrhosis,0,8.0,under $11k,5982.0,4658.9492,11.5,white,46.0,1,0,0,no,0.75,0.6,no dnr,8.0,75.0,5.89941406,120.0,28.0,36.0,180.9375,4.3994141,0.59997559,1.19995117,144.0,7.399414,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
71.95898,0,female,0,10,1671,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,12002.0,8890.0938,17.5,white,16.0,2,0,0,no,0.989999771,0.9,no dnr,10.0,109.0,8.5,80.0,14.0,36.79688,263.3125,3.5,1.01,0.89990234,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
73.46198,0,male,0,9,1671,CHF,COPD/CHF/Cirrhosis,4,8.0,$11-$25k,13836.0,9594.8672,9.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,121.0,11.0,77.0,24.0,36.29688,333.3,4.2998047,0.89990234,3.29980469,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.95599,1,female,0,14,812,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,12203.0,9469.4922,12.333328,white,40.0,1,0,0,yes,0.099999964,0.001,no dnr,14.0,67.0,14.0,98.0,14.0,37.09375,152.5,2.7998047,0.29998779,0.79992676,128.0,7.489258,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
69.27594,0,female,0,27,1667,Coma,Coma,0,12.0,under $11k,38022.0,26870.375,13.5,white,26.0,4,0,0,no,0.699999809,0.5,no dnr,27.0,121.0,10.5,48.0,12.0,37.59375,333.3,3.5996094,0.39996338,0.79992676,132.0,7.419922,135.0,23.0,2502.0,1.7868652,<2 mo. follow-up
60.11499,1,female,0,6,275,CHF,COPD/CHF/Cirrhosis,7,9.0,under $11k,4692.0,3511.5918,15.0,white,16.0,1,1,0,yes,0.799999714,0.5,no dnr,6.0,67.0,4.59960938,106.0,24.0,36.69531,695.625,3.5,1.01,1.19995117,141.0,7.379883,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.38397,1,male,0,11,338,Lung Cancer,Cancer,3,13.0,under $11k,5350.0,4478.0977,6.0,white,11.0,1,1,0,metastatic,0.699999809,0.9,no dnr,11.0,97.0,9.0,64.0,22.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
28.38599,0,male,0,19,1665,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,18497.0,13451.375,16.333328,white,27.0,1,0,0,no,0.989999771,0.98,no dnr,19.0,104.0,13.5996094,130.0,36.0,38.69531,291.375,3.5996094,1.69995117,1.0,129.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
49.98499,1,male,0,5,678,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,3431.0,2554.0234,21.0,white,56.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,77.0,0.0,118.0,28.0,36.79688,226.0625,3.5,0.5,1.29980469,139.0,7.339844,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
76.29797,1,female,1,42,42,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,120826.0,89628.6875,45.25,white,46.0,4,0,0,yes,0.5,0.5,dnr after sadm,25.0,115.0,7.5,108.0,24.0,36.19531,65.32812,3.0,1.19995117,3.5,128.0,7.289062,135.0,23.0,2502.0,1.0,<2 mo. follow-up
75.15399,1,female,0,16,195,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,22379.0,14452.7344,21.666656,white,20.0,1,0,0,no,0.5,0.4,dnr after sadm,8.0,113.0,8.79882812,122.0,8.0,37.89844,165.6875,2.8999023,0.29998779,0.69995117,137.0,7.429688,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
84.36395,1,female,1,5,5,Coma,Coma,2,12.0,under $11k,13091.0,9422.0234,30.0,white,32.0,9,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,65.0,17.3984375,68.0,10.0,38.09375,134.28125,3.5,1.01,0.69995117,139.0,7.329102,135.0,23.0,2502.0,1.0,<2 mo. follow-up
64.21899,1,female,0,5,470,Lung Cancer,Cancer,2,10.0,under $11k,3567.0,2746.0898,10.0,white,17.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,61.0,10.7988281,101.0,22.0,36.39844,333.3,4.0996094,0.19998169,0.59997559,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.10095,1,female,0,16,35,Lung Cancer,Cancer,3,14.0,under $11k,9337.0,8238.9609,6.0,white,28.0,1,0,0,metastatic,0.989999771,0.5,dnr after sadm,9.0,111.0,10.2988281,69.0,26.0,36.0,333.3,3.699707,1.0,1.0,134.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.14197,0,female,0,10,1657,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,14128.0,11301.0312,20.0,white,48.0,1,0,0,no,0.099999964,0.001,dnr after sadm,1.0,124.0,12.0,67.0,44.0,37.59375,132.125,4.0996094,0.5,1.0,142.0,7.359375,135.0,23.0,2502.0,3.59375,<2 mo. follow-up
70.74298,1,female,0,4,52,Colon Cancer,Cancer,1,8.0,$11-$25k,4544.0,3273.3379,6.0,white,9.0,1,0,0,metastatic,1.0,1.0,no dnr,4.0,118.0,8.5,76.0,20.0,36.89844,333.3,3.3999023,1.09985352,0.79992676,136.0,7.419922,135.0,23.0,2502.0,1.7038574,<2 mo. follow-up
76.92297,1,female,0,13,683,COPD,COPD/CHF/Cirrhosis,0,12.0,$11-$25k,20151.0,14541.9453,13.5,white,26.0,4,0,0,no,0.699999809,0.5,no dnr,13.0,102.0,9.69921875,76.0,24.0,36.09375,300.0,2.7998047,0.5,1.19995117,128.0,7.379883,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
71.461,0,male,0,10,1655,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,13818.0,9869.6172,14.5,white,25.0,1,0,0,no,0.949999809,0.9,no dnr,10.0,73.0,8.69921875,60.0,24.0,36.29688,128.5625,4.3994141,1.79980469,1.19995117,139.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
70.15997,1,male,1,3,3,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,3284.0,2367.4102,16.0,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,113.0,10.2988281,109.0,26.0,38.29688,414.8125,3.5,1.01,1.09985352,147.0,7.489258,135.0,23.0,2502.0,2.4467773,<2 mo. follow-up
83.33496,1,male,0,200,226,Coma,Coma,2,17.0,$11-$25k,344708.0,266838.25,33.0,white,43.0,12,0,0,yes,0.699999809,0.5,dnr after sadm,103.0,103.0,31.796875,118.0,38.0,39.19531,143.3125,3.5,1.01,1.39990234,144.0,7.429688,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
65.23499,1,male,0,24,26,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,14680.0,11844.125,9.0,white,41.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,82.0,16.5976562,126.0,26.0,36.09375,196.0,4.8994141,0.5,0.89990234,134.0,7.439453,135.0,23.0,2502.0,4.0,<2 mo. follow-up
68.74695,1,male,0,17,19,Coma,Coma,1,6.0,under $11k,13519.0,10571.8984,13.333328,white,35.0,1,1,0,no,0.25,0.2,dnr after sadm,1.0,131.0,12.7988281,71.0,24.0,39.0,333.3,5.0996094,0.59997559,2.0,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.67694,1,female,0,91,112,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,259766.0,208491.375,22.75,white,36.0,52,1,0,no,0.299999952,0.05,dnr after sadm,38.0,63.0,10.5,124.0,10.0,36.29688,440.0,3.5,1.01,1.59985352,126.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
72.68195,1,male,0,5,666,CHF,COPD/CHF/Cirrhosis,6,12.0,under $11k,2763.0,2216.8535,10.0,white,35.0,1,0,0,no,0.799999714,0.7,dnr after sadm,1.0,62.0,7.79980469,74.0,32.0,36.09375,357.125,3.5,0.59997559,1.79980469,131.0,7.399414,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
71.15094,1,male,0,4,425,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,2546.0,2086.7031,17.0,white,45.0,1,0,1,no,0.799999714,0.5,no dnr,4.0,107.0,7.59960938,96.0,36.0,35.79688,370.0,3.3999023,0.39996338,3.79980469,129.0,7.519531,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.98297,1,male,0,14,151,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,8698.0,7073.2539,21.0,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,98.0,10.7988281,73.0,40.0,35.79688,274.0625,4.0,1.0,1.5,136.0,7.369141,135.0,23.0,2502.0,2.5110989,<2 mo. follow-up
70.79297,1,male,0,3,386,Lung Cancer,Cancer,1,6.0,under $11k,2528.0,1650.9307,14.0,white,16.0,1,0,0,metastatic,0.5,0.1,no dnr,3.0,103.0,4.69921875,101.0,18.0,36.09375,333.3,3.7998047,0.39996338,0.89990234,137.0,7.419922,135.0,23.0,2502.0,1.9401856,<2 mo. follow-up
42.50497,1,male,0,7,20,Lung Cancer,Cancer,2,12.0,$25-$50k,5223.0,3816.0859,15.0,white,45.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,107.0,24.3984375,140.0,28.0,36.09375,214.28125,3.0,0.59997559,0.89990234,135.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
75.06897,0,male,0,3,1641,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,1650.0,1356.8184,19.0,white,33.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,107.0,9.29882812,60.0,24.0,35.69531,304.75,3.8999023,1.09985352,2.69970703,141.0,7.479492,135.0,23.0,2502.0,2.0209961,<2 mo. follow-up
66.30298,1,female,1,68,68,ARF/MOSF w/Sepsis,ARF/MOSF,4,13.0,under $11k,211130.0,158519.25,31.25,white,32.0,30,1,0,no,0.699999809,0.5,dnr after sadm,68.0,67.0,12.2988281,104.0,10.0,38.29688,310.0,3.5,1.01,2.39990234,139.0,7.399414,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
64.91394,1,male,0,6,1312,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,3954.0,3177.4356,10.0,white,40.0,1,0,0,no,0.5,0.4,dnr after sadm,2.0,119.0,13.3984375,69.0,30.0,37.89844,155.53125,4.0996094,0.29998779,1.5,139.0,7.329102,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.06598,0,female,0,25,1639,Coma,Coma,0,8.0,under $11k,23227.0,17351.5156,21.25,white,41.0,1,0,0,no,0.299999952,0.2,dnr after sadm,1.0,114.0,12.2988281,75.0,32.0,39.09375,151.40625,4.5996094,0.5,0.79992676,131.0,7.339844,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.50098,1,male,0,6,833,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,3319.0,2655.6875,4.0,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,6.0,105.0,13.0996094,69.0,20.0,36.19531,344.4375,3.699707,0.19998169,0.89990234,141.0,7.479492,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
62.35498,1,male,0,27,41,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,57132.0,47951.4062,28.75,white,40.0,2,0,0,no,0.5,0.5,dnr after sadm,20.0,52.0,6.39941406,148.0,31.0,36.39844,210.0,3.5,1.01,0.59997559,130.0,7.369141,135.0,23.0,2502.0,2.0,<2 mo. follow-up
71.07196,0,male,0,41,1631,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,54979.0,41784.8125,34.25,white,51.0,1,1,0,yes,0.25,0.0156,no dnr,41.0,57.0,15.6992188,102.0,12.0,38.09375,178.0,2.5,1.79980469,2.69970703,139.0,7.339844,135.0,23.0,2502.0,6.0,no(M2 and SIP pres)
50.51599,0,female,0,6,1633,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,5910.0,4305.207,20.0,white,31.0,1,0,0,no,0.899999619,0.9,no dnr,6.0,74.0,19.6992188,110.0,24.0,36.59375,261.875,3.2998047,0.5,1.39990234,139.0,7.429688,135.0,23.0,2502.0,4.0,adl>=4 (>=5 if sur)
79.99695,1,male,0,30,32,ARF/MOSF w/Sepsis,ARF/MOSF,1,17.0,under $11k,65864.0,41325.25,38.75,white,24.0,3,0,0,no,0.349999905,0.35,dnr after sadm,18.0,140.0,12.1992188,138.0,15.0,38.59375,224.4375,3.5,1.01,0.79992676,125.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
56.99399,1,male,1,24,24,Lung Cancer,Cancer,1,12.0,>$50k,2625.0,34046.4062,24.333328,white,20.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,7.0,51.0,5.19921875,74.0,24.0,36.69531,333.3,3.699707,0.29998779,0.89990234,136.0,7.419922,135.0,23.0,2502.0,4.0,<2 mo. follow-up
70.09399,1,male,0,8,1388,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,6099.0,5066.2188,11.5,white,26.0,1,1,0,no,0.949999809,0.9,no dnr,8.0,80.0,10.7988281,77.0,20.0,36.39844,309.5,4.3994141,0.39996338,1.59985352,139.0,7.439453,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
84.30396,1,male,0,22,29,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,29884.0,21718.8906,20.0,white,36.0,4,0,1,no,0.199999928,0.1,dnr after sadm,4.0,78.0,5.89941406,71.0,15.0,36.5,93.32812,3.5,1.01,2.0,138.0,7.379883,135.0,23.0,2502.0,1.0,<2 mo. follow-up
79.69897,1,male,0,7,71,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,9814.0,8019.625,11.0,white,34.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,110.0,21.1992188,118.0,28.0,35.59375,304.75,4.1992188,0.39996338,1.19995117,139.0,7.459961,135.0,23.0,2502.0,4.4316406,<2 mo. follow-up
51.27197,1,female,0,5,338,Colon Cancer,Cancer,1,12.0,$25-$50k,2531.0,2096.4453,6.0,white,11.0,1,0,0,metastatic,0.599999905,0.2,no dnr,5.0,75.0,9.0,89.0,22.0,36.19531,333.3,3.8999023,0.29998779,0.79992676,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.62695,1,female,0,8,1531,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5192.0,4223.6055,13.0,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,63.0,11.6992188,73.0,32.0,36.39844,200.0,4.1992188,0.5,0.69995117,134.0,7.299805,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
70.21796,1,female,0,8,18,Coma,Coma,2,8.0,under $11k,9225.0,7920.3242,13.5,white,17.0,1,0,1,no,0.049999982,0.000125,dnr after sadm,2.0,115.0,6.39941406,60.0,24.0,35.59375,333.3,3.3999023,0.29998779,0.89990234,143.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
76.22699,1,male,1,5,5,COPD,COPD/CHF/Cirrhosis,3,7.0,under $11k,7085.0,4792.3516,26.0,white,23.0,1,0,0,no,0.199999928,0.1,dnr after sadm,5.0,85.0,13.5996094,138.0,10.0,38.09375,170.0,4.2998047,0.29998779,1.19995117,139.0,7.399414,135.0,23.0,2502.0,4.0,<2 mo. follow-up
76.159,1,male,0,4,257,Lung Cancer,Cancer,2,8.0,$11-$25k,3508.0,2545.4492,11.0,white,25.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,67.0,18.5976562,66.0,24.0,36.29688,333.3,3.5,1.01,1.0,132.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
64.71698,1,male,0,5,38,CHF,COPD/CHF/Cirrhosis,2,11.0,>$50k,2744.0,2202.8066,18.0,white,33.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,67.0,10.0,57.0,24.0,36.09375,333.3,3.5996094,1.79980469,2.39990234,129.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
83.474,0,male,0,8,1622,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,4876.0,4143.4727,7.0,white,20.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,106.0,10.0,69.0,24.0,35.39844,333.3,3.5,1.01,1.29980469,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.34799,1,female,0,7,118,Colon Cancer,Cancer,1,12.0,under $11k,58947.0,62907.3125,20.0,white,18.0,1,0,0,metastatic,0.489999771,0.39,dnr after sadm,6.0,101.0,5.5,132.0,20.0,38.19531,333.3,3.5,1.01,0.59997559,128.0,7.419922,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
57.36099,1,male,1,6,6,Coma,Coma,2,12.0,under $11k,5527.0,4044.2441,23.0,white,19.0,1,0,0,yes,0.099999964,0.001,dnr after sadm,1.0,72.0,11.0996094,101.0,24.0,38.0,333.3,3.5,1.01,1.39990234,148.0,7.419922,135.0,23.0,2502.0,2.0004883,<2 mo. follow-up
78.89899,1,female,0,9,807,Colon Cancer,Cancer,1,12.0,under $11k,13276.0,8470.8203,16.5,white,18.0,1,0,0,metastatic,0.699999809,0.6,no dnr,9.0,68.0,7.29980469,67.0,16.0,36.79688,333.3,3.5996094,0.39996338,0.69995117,141.0,7.419922,135.0,23.0,2502.0,2.4057617,<2 mo. follow-up
60.76099,1,male,0,9,176,ARF/MOSF w/Sepsis,ARF/MOSF,3,20.0,under $11k,10343.0,8276.0,12.5,white,44.0,1,0,0,no,0.949999809,0.8,no dnr,9.0,122.0,12.7988281,108.0,28.0,36.29688,525.875,2.5,0.89990234,11.5,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.54099,0,male,0,23,1618,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,43636.0,37861.7188,17.333328,white,34.0,11,0,0,yes,0.699999809,0.5,no dnr,23.0,103.0,34.3984375,98.0,24.0,37.89844,219.96875,3.5,1.01,1.5,145.0,7.419922,135.0,23.0,2502.0,1.9804688,<2 mo. follow-up
67.39996,1,male,1,7,7,COPD,COPD/CHF/Cirrhosis,6,20.0,under $11k,6910.0,4843.6016,13.5,white,46.0,1,0,0,yes,0.099999964,0.001,dnr after sadm,2.0,115.0,35.296875,114.0,32.0,36.09375,69.375,3.2998047,0.69995117,0.5,128.0,7.269531,135.0,23.0,2502.0,3.0,<2 mo. follow-up
65.57397,1,female,1,8,8,Coma,Coma,4,12.0,under $11k,16053.0,11305.8203,26.5,white,28.0,8,1,1,no,0.099999964,0.001,no dnr,8.0,44.0,12.1992188,78.0,8.0,38.0,170.0,2.699707,0.29998779,0.89990234,131.0,7.449219,135.0,23.0,2502.0,4.0,<2 mo. follow-up
79.10199,1,female,0,24,37,Colon Cancer,Cancer,1,8.0,under $11k,12781.0,11217.625,12.333328,white,33.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,107.0,8.79882812,84.0,28.0,36.59375,342.8125,3.3999023,0.59997559,1.19995117,134.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
68.383,1,male,0,9,64,CHF,COPD/CHF/Cirrhosis,5,8.0,$11-$25k,5863.0,4946.7148,6.0,white,47.0,1,0,0,no,0.799999714,0.5,dnr after sadm,1.0,53.0,13.0,70.0,24.0,36.79688,214.8125,4.0,0.79992676,2.29980469,130.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.95697,0,female,0,5,1610,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,4206.0,3423.6699,15.0,white,31.0,1,0,0,no,0.899999619,0.9,no dnr,5.0,54.0,5.59960938,59.0,24.0,36.89844,333.3,3.2998047,1.0,1.29980469,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.04596,1,female,0,21,77,Colon Cancer,Cancer,1,14.0,under $11k,10583.0,9048.7578,7.333332,white,17.0,1,0,0,metastatic,1.0,0.55,dnr after sadm,15.0,129.0,4.5,93.0,16.0,37.89844,333.3,3.7998047,1.69995117,1.0,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
40.39697,1,male,1,23,23,MOSF w/Malig,ARF/MOSF,2,16.0,$25-$50k,82155.0,101362.375,38.333313,white,68.0,53,0,0,yes,0.049999982,0.000125,no dnr,23.0,64.0,0.09999084,146.0,34.0,40.09375,333.3,2.8999023,2.5,1.19995117,133.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
42.133,1,female,1,75,75,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,262140.0,178584.375,42.5,white,31.0,9,0,0,no,0.899999619,0.9,dnr after sadm,74.0,103.0,15.5,120.0,12.0,39.69531,103.32812,2.3999023,0.5,0.59997559,137.0,7.479492,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
74.95697,1,male,0,4,52,Lung Cancer,Cancer,1,15.0,$25-$50k,3143.0,2138.3906,10.0,white,20.0,1,0,0,metastatic,0.899999619,0.7,no dnr,4.0,119.0,14.5996094,87.0,20.0,36.09375,333.3,3.7998047,0.29998779,1.19995117,138.0,7.419922,135.0,23.0,2502.0,2.0615234,<2 mo. follow-up
73.04297,1,female,0,10,1164,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,8504.0,6603.0742,17.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,107.0,19.296875,65.0,28.0,36.0,216.0,3.7998047,0.59997559,1.09985352,138.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
80.78894,1,male,0,6,644,COPD,COPD/CHF/Cirrhosis,4,7.0,under $11k,3369.0,2766.6016,14.0,white,34.0,1,0,0,yes,0.5,0.1,no dnr,6.0,70.0,7.0,114.0,28.0,35.69531,460.0,3.5,0.79992676,1.19995117,138.0,7.339844,135.0,23.0,2502.0,3.1791992,<2 mo. follow-up
78.02295,0,female,0,7,1604,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,5563.0,4325.4375,9.0,white,38.0,1,1,0,yes,0.699999809,0.5,no dnr,7.0,109.0,6.19921875,76.0,28.0,36.79688,204.75,3.0,0.19998169,0.59997559,140.0,7.369141,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
74.25598,1,female,0,16,111,Colon Cancer,Cancer,1,8.0,$11-$25k,7361.0,6515.6016,7.666664,white,20.0,1,0,0,metastatic,0.799999714,0.5,dnr after sadm,16.0,104.0,7.29980469,74.0,24.0,38.0,333.3,4.0,0.5,1.09985352,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.02295,1,female,0,4,170,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,1851.0,1514.1279,11.0,white,22.0,1,0,0,no,0.899999619,0.9,no dnr,4.0,107.0,9.0,98.0,28.0,36.0,452.0,3.5,1.01,1.01,140.0,7.379883,135.0,23.0,2502.0,2.0834961,<2 mo. follow-up
68.44897,1,male,0,7,70,Colon Cancer,Cancer,1,12.0,under $11k,3947.0,3385.7012,6.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,80.0,10.0,107.0,24.0,38.59375,333.3,3.5996094,0.5,1.0,133.0,7.419922,135.0,23.0,2502.0,2.2514648,<2 mo. follow-up
64.698,0,male,0,4,1600,CHF,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,1917.0,1679.8438,14.0,white,16.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,70.0,9.0,73.0,16.0,35.39844,333.3,3.5,1.01,1.19995117,140.0,7.419922,135.0,23.0,2502.0,1.8212891,no(M2 and SIP pres)
82.99799,1,male,1,4,4,CHF,COPD/CHF/Cirrhosis,7,12.0,under $11k,2277.0,1776.459,26.0,white,39.0,1,1,1,yes,0.099999964,0.001,dnr after sadm,1.0,106.0,9.29882812,60.0,40.0,37.89844,300.0,3.199707,0.89990234,1.5,145.0,7.349609,135.0,23.0,2502.0,6.2666016,<2 mo. follow-up
54.79498,0,female,0,11,1598,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,10684.0,7769.9062,19.5,white,22.0,1,0,0,no,0.799999714,0.5,no dnr,11.0,110.0,12.0996094,76.0,32.0,36.79688,193.3125,3.5,1.01,0.89990234,140.0,7.379883,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
75.09399,1,male,0,10,60,Cirrhosis,COPD/CHF/Cirrhosis,2,8.0,under $11k,15305.0,10673.5938,33.0,white,41.0,1,0,0,yes,0.5,0.25,dnr after sadm,1.0,117.0,12.1992188,42.0,49.0,36.29688,333.3,3.0,2.69970703,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.88098,0,female,0,39,1596,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,66800.0,45979.0625,37.0,white,60.0,1,0,0,no,0.699999809,0.5,no dnr,39.0,49.0,7.59960938,138.0,39.0,39.39844,195.0,2.8999023,4.89941406,1.59985352,148.0,7.389648,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.56097,1,male,0,7,49,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3628.0,3037.8301,6.0,white,53.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,53.0,7.89941406,74.0,28.0,34.69531,545.625,4.0,2.89990234,1.89990234,139.0,7.339844,135.0,23.0,2502.0,5.0,<2 mo. follow-up
70.26398,1,female,0,9,22,Colon Cancer,Cancer,2,8.0,under $11k,12682.0,10659.3516,13.5,white,14.0,1,0,0,metastatic,0.75,0.25,no dnr,9.0,60.0,12.8984375,77.0,20.0,38.69531,333.3,3.2998047,0.19998169,0.79992676,134.0,7.419922,135.0,23.0,2502.0,6.0,<2 mo. follow-up
70.66095,1,female,0,15,1269,MOSF w/Malig,ARF/MOSF,1,16.0,under $11k,15128.0,11270.9531,16.666656,white,36.0,3,0,0,metastatic,0.699999809,0.5,no dnr,15.0,142.0,5.89941406,138.0,16.0,36.0,452.0,3.8999023,0.5,1.89990234,142.0,7.369141,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
74.97595,0,male,0,22,1590,Coma,Coma,0,14.0,>$50k,44963.0,32121.5469,31.666656,white,15.0,1,0,0,no,0.989999771,0.9,no dnr,22.0,117.0,7.19921875,66.0,24.0,36.79688,163.0,4.3994141,0.59997559,0.89990234,138.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
61.61499,1,female,0,3,5,Lung Cancer,Cancer,1,13.0,under $11k,2784.0,2036.6143,3.0,white,10.0,1,0,0,metastatic,0.949999809,0.6,no dnr,3.0,100.0,9.0,93.0,20.0,36.19531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,1.9853516,<2 mo. follow-up
66.97894,1,male,0,5,528,Lung Cancer,Cancer,2,15.0,under $11k,3928.0,3099.3711,7.0,white,19.0,1,1,0,metastatic,0.799999714,0.6,no dnr,5.0,111.0,8.0,72.0,20.0,35.19531,333.3,4.2998047,0.59997559,1.09985352,134.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
53.91599,0,female,0,17,1588,Coma,Coma,1,11.0,$11-$25k,24481.0,16262.6328,22.333328,white,12.0,3,0,0,yes,0.799999714,0.8,dnr after sadm,1.0,119.0,16.296875,42.0,10.0,38.39844,262.5,4.1992188,0.59997559,0.79992676,143.0,7.489258,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
47.07498,1,female,0,57,119,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,82385.0,56124.2812,32.0,white,24.0,1,0,0,metastatic,0.299999952,0.3,no dnr,57.0,75.0,12.6992188,127.0,8.0,38.79688,116.0,3.5996094,0.39996338,0.89990234,141.0,7.169922,135.0,23.0,2502.0,4.0966797,<2 mo. follow-up
89.54095,1,female,1,4,4,Coma,Coma,0,14.0,under $11k,4136.0,3253.3594,22.0,white,67.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,3.0,58.0,9.09960938,110.0,40.0,38.5,140.8125,4.5,0.79992676,3.0,143.0,7.169922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
91.34595,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,20829.0,13574.1875,41.0,white,57.0,3,0,1,no,0.299999952,0.3,dnr after sadm,7.0,47.0,15.5996094,160.0,9.0,39.69531,123.32812,2.5996094,1.39990234,1.69995117,133.0,7.429688,135.0,23.0,2502.0,2.0,<2 mo. follow-up
88.79895,1,male,1,5,5,Coma,Coma,1,6.0,under $11k,2583.0,2126.9863,12.0,white,40.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,61.0,8.19921875,66.0,10.0,38.79688,352.375,4.0996094,1.69995117,2.0,138.0,7.429688,135.0,23.0,2502.0,3.0,<2 mo. follow-up
78.02295,1,female,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,$11-$25k,33443.0,21901.5781,31.0,white,48.0,12,0,0,yes,0.25,0.25,no dnr,10.0,107.0,0.39996338,120.0,26.0,36.39844,268.0,3.5,1.01,0.59997559,131.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
82.31299,1,male,0,3,4,Coma,Coma,0,8.0,under $11k,6698.0,4614.625,57.0,white,51.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,42.0,15.0996094,114.0,20.0,35.89844,12.0,3.0,0.59997559,1.39990234,145.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.12097,1,male,0,5,89,Lung Cancer,Cancer,2,12.0,under $11k,4309.0,3033.959,11.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,103.0,5.5,104.0,22.0,36.29688,333.3,4.1992188,0.69995117,0.79992676,134.0,7.419922,135.0,23.0,2502.0,1.9672852,<2 mo. follow-up
75.88995,1,male,0,7,58,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,4709.0,3727.0742,11.0,white,47.0,1,1,1,no,0.799999714,0.7,dnr after sadm,1.0,69.0,11.5996094,104.0,24.0,35.5,157.125,3.8999023,0.59997559,1.59985352,135.0,7.369141,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
75.87695,1,male,0,7,977,CHF,COPD/CHF/Cirrhosis,2,13.0,$25-$50k,4041.0,3294.3086,17.0,white,35.0,1,0,0,no,0.799999714,0.7,dnr after sadm,1.0,63.0,9.8984375,73.0,28.0,35.79688,295.1875,3.8999023,0.79992676,1.09985352,140.0,7.399414,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.45996,1,female,0,12,1179,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,10293.0,7336.9844,11.5,white,20.0,1,0,0,yes,0.75,0.75,no dnr,12.0,87.0,34.3984375,132.0,24.0,38.29688,285.125,4.0996094,0.79992676,0.69995117,134.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
60.42999,1,female,0,5,1513,Lung Cancer,Cancer,1,12.0,under $11k,3457.0,2783.0488,15.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,72.0,3.5,70.0,20.0,36.19531,333.3,4.1992188,0.39996338,0.79992676,136.0,7.419922,135.0,23.0,2502.0,1.7109375,no(M2 and SIP pres)
67.16498,1,male,0,8,898,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,5430.0,4154.957,8.0,white,36.0,1,0,0,yes,0.899999619,0.9,no dnr,8.0,101.0,21.0,120.0,24.0,35.69531,209.0625,3.5,1.01,1.09985352,138.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.95798,1,male,0,5,686,Lung Cancer,Cancer,2,9.0,under $11k,2227.0,1943.7852,10.0,white,16.0,1,0,0,metastatic,1.0,1.0,no dnr,5.0,107.0,7.79980469,77.0,24.0,36.79688,333.3,3.5,1.01,1.39990234,136.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
82.57898,0,female,0,6,1572,CHF,COPD/CHF/Cirrhosis,4,16.0,under $11k,2881.0,2437.209,10.0,white,23.0,1,1,0,yes,1.0,1.0,no dnr,6.0,106.0,10.5996094,54.0,24.0,35.59375,342.8125,3.5,1.01,1.19995117,135.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.883,1,male,0,6,296,CHF,COPD/CHF/Cirrhosis,3,14.0,under $11k,15018.0,10734.4688,19.0,white,40.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,58.0,8.69921875,50.0,22.0,36.39844,333.3,4.0996094,0.59997559,2.59960938,130.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.57098,1,male,0,6,254,Lung Cancer,Cancer,2,7.0,under $11k,3154.0,2479.1641,6.0,white,23.0,1,0,0,metastatic,0.599999905,0.3,no dnr,6.0,69.0,6.0,81.0,24.0,36.59375,333.3,4.3994141,0.39996338,1.09985352,142.0,7.419922,135.0,23.0,2502.0,1.6772461,no(M2 and SIP pres)
82.06696,1,male,0,6,356,Lung Cancer,Cancer,2,8.0,under $11k,3685.0,3021.3086,8.0,white,26.0,1,0,0,metastatic,0.5,0.3,no dnr,6.0,77.0,6.09960938,77.0,22.0,35.59375,333.3,3.699707,0.39996338,1.09985352,134.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
68.17798,1,male,0,6,101,Colon Cancer,Cancer,3,12.0,$25-$50k,3745.0,2759.084,10.0,white,13.0,1,1,0,metastatic,0.799999714,0.5,no dnr,6.0,92.0,9.0,56.0,20.0,35.59375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
84.03796,0,female,0,8,1566,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,5013.0,3908.5117,14.5,white,41.0,1,0,0,no,0.5,0.25,dnr after sadm,1.0,59.0,11.8984375,69.0,26.0,36.19531,268.0,3.8999023,0.29998779,1.0,137.0,7.379883,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
66.31299,0,male,0,7,1566,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,14233.0,11140.5781,13.0,white,19.0,9,0,0,no,0.699999809,0.5,no dnr,7.0,62.0,9.0,105.0,20.0,38.0,145.0,3.5,1.01,1.19995117,135.0,7.429688,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
58.883,1,male,1,4,4,Coma,Coma,0,6.0,$11-$25k,10109.0,6643.3828,27.0,white,45.0,1,0,0,no,0.009999998,1e-06,dnr after sadm,1.0,167.0,15.5996094,182.0,8.0,39.0,164.0,4.5996094,0.39996338,0.79992676,155.0,7.569336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
81.88397,1,female,0,4,1045,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,2367.0,1813.1553,6.0,hispanic,35.0,1,0,0,no,0.699999809,0.7,no dnr,4.0,61.0,4.59960938,80.0,28.0,36.0,252.375,3.5,1.01,1.09985352,136.0,7.519531,135.0,23.0,2502.0,2.1430664,no(M2 and SIP pres)
70.034,0,male,0,32,1566,Coma,Coma,0,16.0,>$50k,36490.0,25928.2812,18.5,white,18.0,1,0,0,no,0.699999809,0.5,no dnr,32.0,133.0,18.796875,106.0,10.0,38.09375,140.0,3.5,1.01,1.0,143.0,7.529297,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
45.06497,0,female,0,12,1564,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,9426.0,7679.543,9.0,white,17.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,74.0,10.5,126.0,20.0,35.59375,333.3,4.2998047,1.29980469,1.09985352,139.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
81.85394,1,male,0,13,1083,CHF,COPD/CHF/Cirrhosis,5,8.0,$11-$25k,6725.0,5676.6602,7.5,white,32.0,1,0,0,no,0.699999809,0.6,no dnr,13.0,112.0,7.89941406,76.0,20.0,36.19531,238.09375,3.699707,0.79992676,1.79980469,133.0,7.509766,135.0,23.0,2502.0,5.0,SIP>=30
61.71399,1,female,0,41,65,Coma,Coma,0,12.0,under $11k,57452.0,48214.875,30.25,white,21.0,1,0,0,no,1.0,0.99,no dnr,41.0,123.0,19.296875,68.0,8.0,38.0,210.0,4.7998047,0.89990234,1.09985352,147.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
71.461,0,female,0,42,1562,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,43218.0,32969.0,18.75,white,59.0,1,1,0,yes,0.799999714,0.8,no dnr,42.0,68.0,28.0,134.0,28.0,35.19531,333.3,3.199707,0.5,5.89941406,132.0,7.419922,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
80.84094,0,female,0,13,1563,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,17250.0,12146.3047,19.5,white,23.0,1,0,0,no,0.75,0.5,no dnr,13.0,63.0,6.0,52.0,20.0,36.69531,333.3,3.5,1.01,1.19995117,141.0,7.419922,135.0,23.0,2502.0,3.0585938,<2 mo. follow-up
71.58099,0,male,0,3,1560,Lung Cancer,Cancer,1,9.0,$11-$25k,1985.0,1450.2559,7.0,white,20.0,1,0,0,metastatic,0.899999619,0.8,no dnr,3.0,117.0,5.5,62.0,24.0,36.09375,333.3,3.5996094,0.5,1.5,139.0,7.419922,135.0,23.0,2502.0,2.019043,no(M2 and SIP pres)
59.49298,1,male,0,5,59,Lung Cancer,Cancer,1,12.0,$25-$50k,2963.0,2366.2129,9.0,white,19.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,1.0,73.0,40.0,101.0,20.0,36.0,338.0625,3.5,0.59997559,0.79992676,130.0,7.40918,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
74.55695,0,male,0,3,1560,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,2100.0,1671.5469,18.0,white,26.0,1,0,0,no,0.799999714,0.8,no dnr,3.0,71.0,9.29882812,60.0,20.0,36.19531,376.1875,4.7998047,0.5,1.29980469,141.0,7.459961,135.0,23.0,2502.0,2.1650391,<2 mo. follow-up
70.11096,1,male,1,10,10,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,10505.0,7555.5586,26.5,white,45.0,1,0,0,no,0.899999619,0.75,dnr after sadm,9.0,105.0,36.3984375,110.0,36.0,38.29688,242.84375,4.0,0.39996338,1.39990234,136.0,7.5,135.0,23.0,2502.0,2.8256836,<2 mo. follow-up
58.71899,0,male,0,343,1558,ARF/MOSF w/Sepsis,ARF/MOSF,0,18.0,$25-$50k,556878.0,463230.0,47.75,white,66.0,13,0,0,no,0.699999809,0.5,dnr after sadm,45.0,53.0,20.6992188,124.0,34.0,39.19531,62.10156,3.5,1.01,4.39941406,153.0,7.25,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
63.16498,1,female,0,6,556,Lung Cancer,Cancer,1,12.0,$11-$25k,2532.0,2167.4883,9.0,white,21.0,1,0,0,metastatic,0.899999619,0.5,no dnr,6.0,73.0,2.0,107.0,16.0,37.89844,333.3,3.5,1.01,1.0,129.0,7.419922,135.0,23.0,2502.0,2.0966797,no(M2 and SIP pres)
79.77496,0,male,0,5,1555,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,3239.0,2465.4785,16.0,white,27.0,1,0,0,no,0.989999771,0.8,no dnr,5.0,93.0,7.39941406,71.0,22.0,36.09375,190.46875,3.5996094,0.29998779,1.19995117,137.0,7.439453,135.0,23.0,2502.0,2.4570312,<2 mo. follow-up
63.48297,1,male,0,116,618,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,101761.0,154723.125,27.5,white,47.0,10,1,0,no,0.799999714,0.9,no dnr,116.0,100.0,15.1992188,116.0,12.0,39.69531,212.5,3.3999023,7.69921875,4.19921875,150.0,7.399414,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
88.11499,1,male,0,11,1347,COPD,COPD/CHF/Cirrhosis,1,5.0,under $11k,7987.0,6105.9609,14.0,white,36.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,105.0,11.2988281,100.0,36.0,36.19531,159.15625,4.3994141,0.39996338,1.69995117,142.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
84.62695,1,female,0,13,582,CHF,COPD/CHF/Cirrhosis,4,13.0,under $11k,7392.0,6289.4883,11.5,white,31.0,1,1,0,no,0.699999809,0.5,no dnr,13.0,71.0,11.3984375,70.0,24.0,36.79688,333.3,3.8999023,0.19998169,1.79980469,134.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
88.17499,1,male,0,8,385,CHF,COPD/CHF/Cirrhosis,3,6.0,under $11k,5614.0,4470.8594,13.5,white,45.0,1,1,0,no,0.75,0.7,no dnr,8.0,76.0,7.59960938,64.0,28.0,35.79688,237.5,4.2998047,0.39996338,1.79980469,137.0,7.449219,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
74.125,1,male,0,5,1237,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,37841.0,27540.0938,19.0,white,17.0,24,0,0,no,0.899999619,0.9,no dnr,5.0,77.0,8.8984375,60.0,24.0,36.29688,404.0,2.5996094,0.5,0.89990234,139.0,7.279297,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
60.20798,1,female,0,5,147,Lung Cancer,Cancer,3,12.0,under $11k,2978.0,1929.8897,11.0,white,19.0,1,0,0,metastatic,0.299999952,0.1,no dnr,5.0,102.0,1.39990234,114.0,20.0,36.89844,354.25,4.1992188,0.5,0.59997559,137.0,7.489258,135.0,23.0,2502.0,2.1625977,<2 mo. follow-up
78.49396,1,male,0,5,19,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,2454.0,1688.2568,11.0,white,23.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,71.0,12.7988281,66.0,24.0,36.19531,333.3,3.5,1.01,1.59985352,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
74.146,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,19965.0,15764.0625,27.0,white,45.0,1,0,0,yes,0.149999976,0.1,dnr after sadm,2.0,106.0,24.8984375,114.0,10.0,35.29688,147.5,3.0996094,0.59997559,3.39990234,132.0,7.449219,135.0,23.0,2502.0,5.0,<2 mo. follow-up
69.40198,1,male,0,56,116,COPD,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,75868.0,49369.375,22.5,white,56.0,1,0,0,no,0.799999714,0.7,no dnr,56.0,73.0,9.09960938,60.0,10.0,35.5,153.84375,3.5,4.09960938,2.59960938,143.0,7.279297,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
78.78998,0,male,0,39,1552,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,87229.0,58370.875,36.0,white,52.0,5,0,0,no,0.5,0.4,no dnr,39.0,68.0,21.0,40.0,12.0,38.19531,163.0625,3.199707,2.0,3.89990234,135.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
76.71198,1,male,0,16,669,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,30223.0,22569.3125,17.333328,white,65.0,8,0,0,no,0.899999619,0.9,no dnr,16.0,59.0,16.796875,72.0,32.0,35.89844,126.51562,3.5,1.01,11.5996094,145.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
75.849,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,133616.0,93028.6875,53.666657,white,60.0,13,0,0,no,0.699999809,0.5,dnr after sadm,18.0,56.0,21.8984375,112.0,24.0,39.19531,189.0,3.5,1.01,5.69921875,138.0,7.389648,135.0,23.0,2502.0,2.2705078,<2 mo. follow-up
70.35199,1,female,0,19,1360,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,30342.0,19691.1719,23.0,white,35.0,1,1,0,no,0.899999619,0.9,no dnr,19.0,79.0,9.79882812,69.0,26.0,35.89844,333.3,4.1992188,0.19998169,1.19995117,134.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
50.23999,1,female,0,28,38,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,138255.0,92819.25,38.25,white,30.0,62,0,0,no,0.699999809,0.5,dnr after sadm,27.0,119.0,2.0,108.0,34.0,39.39844,187.5,3.5,1.01,1.09985352,143.0,7.489258,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.38898,1,male,0,17,27,MOSF w/Malig,ARF/MOSF,4,8.0,under $11k,51502.0,36644.375,17.0,white,45.0,15,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,107.0,15.0,36.0,30.0,38.09375,214.28125,3.5,1.01,1.0,133.0,7.489258,135.0,23.0,2502.0,3.0,<2 mo. follow-up
68.92297,0,male,0,4,1549,CHF,COPD/CHF/Cirrhosis,3,13.0,under $11k,2206.0,1526.5645,3.0,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,111.0,6.39941406,42.0,29.0,36.59375,271.375,3.8999023,1.19995117,1.5,137.0,7.459961,135.0,23.0,2502.0,2.0327148,no(M2 and SIP pres)
71.50995,0,male,0,11,1547,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,20986.0,13111.0078,22.5,white,28.0,1,0,0,no,0.699999809,0.5,no dnr,11.0,68.0,7.5,65.0,20.0,36.19531,493.3125,3.7998047,0.5,1.59985352,136.0,7.549805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.22198,1,female,0,25,724,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,44402.0,28899.2344,35.5,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,25.0,64.0,11.0996094,75.0,10.0,38.0,186.65625,3.199707,0.5,1.0,134.0,7.509766,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.36499,1,female,0,33,715,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,83102.0,63425.4688,18.0,white,27.0,19,0,0,no,0.5,0.4,no dnr,33.0,70.0,23.0,72.0,28.0,36.29688,360.0,3.5,1.01,1.69995117,141.0,7.449219,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
49.80399,1,male,0,3,84,Lung Cancer,Cancer,2,17.0,$25-$50k,2533.0,1633.0664,13.0,white,13.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,103.0,6.39941406,79.0,20.0,36.39844,333.3,3.5996094,0.29998779,1.0,135.0,7.419922,135.0,23.0,2502.0,2.0419922,adl>=4 (>=5 if sur)
53.39398,1,female,0,5,325,Lung Cancer,Cancer,1,12.0,under $11k,3540.0,2517.4844,9.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,93.0,5.89941406,98.0,20.0,36.39844,333.3,4.3994141,0.29998779,0.69995117,133.0,7.419922,135.0,23.0,2502.0,1.732666,no(M2 and SIP pres)
65.79297,1,male,0,3,161,Lung Cancer,Cancer,1,12.0,under $11k,3527.0,1990.7373,13.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,93.0,15.5,76.0,20.0,36.59375,333.3,3.8999023,0.69995117,1.19995117,136.0,7.419922,135.0,23.0,2502.0,1.8259277,<2 mo. follow-up
90.79297,1,female,1,6,6,Coma,Coma,2,12.0,under $11k,5507.0,3241.8184,30.0,white,48.0,1,1,0,yes,0.049999982,0.000125,dnr after sadm,1.0,55.0,7.59960938,45.0,32.0,37.89844,319.0,3.5,1.01,1.29980469,139.0,7.419922,135.0,23.0,2502.0,3.2290039,<2 mo. follow-up
78.25098,1,male,0,11,109,Lung Cancer,Cancer,1,16.0,$11-$25k,11474.0,7410.6758,7.5,white,22.0,1,0,0,metastatic,0.5,0.1,no dnr,11.0,118.0,16.796875,85.0,20.0,35.89844,333.3,4.0996094,0.59997559,1.39990234,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
53.46997,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,49510.0,32146.2031,33.0,white,82.0,23,0,0,no,0.0,0.0,dnr after sadm,2.0,64.0,22.1992188,158.0,37.0,37.79688,101.25,2.699707,8.3984375,1.5,132.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
52.80798,1,male,0,20,27,Coma,Coma,5,12.0,under $11k,50898.0,34947.625,36.666657,white,35.0,10,0,0,no,0.099999964,0.001,dnr after sadm,13.0,66.0,14.8984375,166.0,10.0,39.59375,151.40625,3.199707,1.59985352,1.09985352,135.0,7.609375,135.0,23.0,2502.0,3.8149414,<2 mo. follow-up
69.22095,1,male,0,11,1160,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,20614.0,13453.0234,23.0,white,30.0,5,0,0,yes,0.949999809,0.8,no dnr,11.0,77.0,9.0,72.0,40.0,36.19531,160.0,3.0996094,1.19995117,0.69995117,134.0,7.439453,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
71.88794,0,male,0,9,1531,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5793.0,3965.2519,6.5,white,35.0,1,0,0,no,0.75,0.5,no dnr,9.0,63.0,7.69921875,46.0,32.0,36.0,342.8125,3.5,1.01,1.69995117,139.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.35199,1,male,0,7,388,CHF,COPD/CHF/Cirrhosis,6,15.0,$25-$50k,3522.0,2367.6758,18.0,white,23.0,1,1,0,yes,0.699999809,0.5,no dnr,7.0,113.0,7.89941406,76.0,24.0,36.09375,356.0,3.199707,0.59997559,1.29980469,140.0,7.469727,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
60.56897,0,female,0,80,1531,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,123165.0,83129.6875,10.75,white,60.0,15,0,0,no,0.699999809,0.5,no dnr,80.0,63.0,26.0976562,122.0,28.0,38.29688,150.0,3.5,1.01,6.0,143.0,7.379883,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
71.45795,0,female,0,13,1530,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,7726.0,5278.8398,11.5,white,26.0,1,0,0,yes,0.75,0.65,no dnr,13.0,68.0,9.19921875,102.0,24.0,35.5,452.375,3.699707,1.19995117,1.39990234,134.0,7.549805,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
78.20398,1,female,0,36,412,Coma,Coma,2,12.0,under $11k,91560.0,62189.1875,25.75,white,41.0,8,1,0,no,0.699999809,0.7,no dnr,36.0,117.0,14.1992188,70.0,55.0,39.09375,255.0,3.5,1.01,1.5,141.0,7.459961,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
63.32098,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,2,12.0,$25-$50k,32987.0,21631.4844,44.0,white,59.0,15,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,77.0,0.19998169,132.0,28.0,36.39844,104.07812,3.5,1.01,1.5,136.0,7.289062,135.0,23.0,2502.0,2.1523438,<2 mo. follow-up
68.11798,1,male,0,18,20,CHF,COPD/CHF/Cirrhosis,7,8.0,under $11k,18851.0,12522.1797,15.666664,white,67.0,4,1,0,no,0.699999809,0.5,dnr after sadm,3.0,56.0,9.0,68.0,32.0,34.79688,112.5,3.8999023,0.89990234,1.59985352,128.0,7.529297,135.0,23.0,2502.0,5.0,<2 mo. follow-up
64.99695,1,male,0,12,86,Cirrhosis,COPD/CHF/Cirrhosis,3,13.0,under $11k,9728.0,6943.918,14.5,white,35.0,1,0,0,no,0.799999714,0.6,no dnr,12.0,106.0,18.6992188,80.0,32.0,36.59375,308.6875,2.5996094,0.69995117,1.5,142.0,7.449219,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
71.99695,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,62426.0,43641.0,53.0,white,55.0,40,0,0,metastatic,0.699999809,0.5,no dnr,7.0,50.0,10.6992188,132.0,34.0,37.89844,108.15625,3.3999023,0.59997559,1.19995117,137.0,7.179688,135.0,23.0,2502.0,2.5317383,<2 mo. follow-up
42.77298,0,male,0,8,1528,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,8097.0,4892.0781,10.5,white,24.0,1,0,0,no,1.0,1.0,no dnr,8.0,81.0,14.8984375,76.0,36.0,38.09375,135.0,4.0,0.5,0.89990234,134.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.53894,1,male,0,4,824,Colon Cancer,Cancer,2,12.0,$25-$50k,5133.0,3023.4414,7.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,111.0,11.6992188,53.0,20.0,36.69531,333.3,4.1992188,0.59997559,1.5,142.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
67.32397,1,female,0,15,19,Cirrhosis,COPD/CHF/Cirrhosis,3,8.0,under $11k,30640.0,20329.25,10.666664,white,39.0,14,1,0,no,0.099999964,0.001,dnr after sadm,14.0,63.0,13.0,76.0,22.0,36.69531,333.3,3.5,1.01,4.39941406,121.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
53.00998,1,male,0,8,249,Lung Cancer,Cancer,2,10.0,under $11k,9445.0,5743.1953,8.5,white,35.0,1,0,0,metastatic,0.899999619,0.7,no dnr,8.0,67.0,0.19998169,66.0,24.0,38.69531,333.3,3.3999023,1.19995117,1.19995117,129.0,7.419922,135.0,23.0,2502.0,3.1367188,no(M2 and SIP pres)
72.51996,1,male,0,13,1040,COPD,COPD/CHF/Cirrhosis,5,8.0,under $11k,12209.0,8282.5,17.0,white,57.0,1,1,0,no,0.699999809,0.5,no dnr,13.0,61.0,9.09960938,75.0,36.0,36.5,186.9375,4.0996094,0.39996338,2.19970703,148.0,7.369141,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
61.19598,1,male,0,150,1021,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,304423.0,202078.875,35.25,white,64.0,12,0,0,no,0.949999809,0.9,no dnr,150.0,42.0,13.8984375,144.0,28.0,38.69531,92.0,2.8999023,1.39990234,1.5,133.0,7.699219,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
67.64697,0,male,0,42,1519,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,87706.0,55599.4062,29.5,white,49.0,2,0,0,no,0.899999619,0.9,no dnr,42.0,48.0,8.19921875,122.0,30.0,38.79688,114.28125,3.5,1.01,1.09985352,135.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
69.69495,0,male,0,9,1520,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,7717.0,5093.1133,13.0,white,16.0,1,0,0,no,0.899999619,0.5,dnr after sadm,1.0,103.0,6.29980469,70.0,24.0,37.0,266.625,4.0996094,0.89990234,1.0,144.0,7.369141,135.0,23.0,2502.0,0.0,<2 mo. follow-up
83.95599,1,male,0,13,122,CHF,COPD/CHF/Cirrhosis,5,7.0,$11-$25k,8863.0,5815.418,14.5,white,48.0,1,0,0,no,0.5,0.4,no dnr,13.0,108.0,10.2988281,140.0,40.0,36.69531,304.0,3.5,1.01,1.59985352,137.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
74.33496,1,male,0,17,185,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,$11-$25k,25606.0,16679.2188,20.666656,white,65.0,3,0,0,no,0.699999809,0.5,no dnr,17.0,60.0,12.3984375,70.0,32.0,36.19531,163.3125,2.8999023,4.29980469,4.0,141.0,7.539062,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
59.32898,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,2,11.0,$25-$50k,25116.0,16730.25,41.0,white,71.0,8,0,0,yes,0.049999982,0.000125,dnr after sadm,6.0,77.0,0.09999084,150.0,30.0,39.19531,210.1875,2.3999023,1.39990234,2.39990234,142.0,7.479492,135.0,23.0,2502.0,0.0,<2 mo. follow-up
67.86896,0,female,0,18,1517,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,24268.0,17109.0,27.0,white,56.0,1,0,0,no,0.5,0.45,no dnr,18.0,103.0,6.19921875,132.0,76.0,36.19531,333.3,3.3999023,0.79992676,2.59960938,141.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
84.95599,1,female,0,26,235,Colon Cancer,Cancer,1,12.0,under $11k,28041.0,17552.5156,16.5,white,28.0,1,0,0,metastatic,0.5,0.125,no dnr,26.0,66.0,25.6992188,63.0,22.0,36.5,333.3,3.5,1.09985352,1.0,137.0,7.419922,135.0,23.0,2502.0,2.9375,<2 mo. follow-up
77.95496,1,male,0,12,851,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19490.0,12830.0469,14.0,white,39.0,1,0,0,no,0.5,0.5,dnr after sadm,1.0,114.0,9.8984375,78.0,20.0,36.39844,260.0,4.3994141,0.59997559,3.19970703,146.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
54.086,1,female,1,36,36,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,90082.0,59675.3438,32.75,white,34.0,4,0,0,no,0.699999809,0.5,dnr after sadm,17.0,62.0,4.59960938,110.0,12.0,39.79688,93.75,2.7998047,0.79992676,0.69995117,151.0,7.40918,135.0,23.0,2502.0,2.5556641,<2 mo. follow-up
76.55597,1,male,1,15,15,Colon Cancer,Cancer,3,8.0,$11-$25k,9715.0,6996.0273,7.333332,white,22.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,137.0,9.3984375,81.0,20.0,35.89844,347.5625,3.199707,1.0,0.89990234,134.0,7.469727,135.0,23.0,2502.0,1.0,<2 mo. follow-up
37.63397,0,male,0,7,1510,CHF,COPD/CHF/Cirrhosis,3,12.0,>$50k,5411.0,3474.9941,19.0,white,21.0,1,0,0,no,0.5,0.7,no dnr,7.0,71.0,9.0,150.0,24.0,36.19531,333.3,3.5,1.01,1.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
79.57599,1,female,0,6,48,Lung Cancer,Cancer,1,7.0,under $11k,3169.0,2122.8106,12.0,white,19.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,1.0,69.0,8.69921875,106.0,24.0,36.5,333.3,3.199707,0.29998779,0.79992676,136.0,7.419922,135.0,23.0,2502.0,2.4267578,<2 mo. follow-up
84.51495,1,male,0,7,14,Coma,Coma,7,8.0,under $11k,7884.0,14452.7344,10.5,white,39.0,1,1,0,yes,0.099999964,0.001,dnr after sadm,1.0,116.0,17.1992188,114.0,34.0,38.79688,192.5,4.0,0.39996338,1.89990234,135.0,7.399414,135.0,23.0,2502.0,6.0,<2 mo. follow-up
86.58698,1,female,0,8,235,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,5752.0,3898.1152,10.5,white,31.0,1,0,0,no,0.5,0.1,no dnr,8.0,79.0,6.79980469,64.0,20.0,35.79688,295.1875,3.5,1.01,0.89990234,134.0,7.459961,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
89.06494,1,female,0,4,319,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,1830.0,1201.4512,14.0,white,28.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,77.0,12.5996094,63.0,28.0,35.89844,468.0,3.5,1.01,1.0,140.0,7.299805,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
59.18997,1,male,1,5,5,MOSF w/Malig,ARF/MOSF,2,6.0,$25-$50k,33846.0,21978.1562,33.0,white,45.0,18,1,0,yes,0.699999809,0.5,no dnr,5.0,72.0,12.5,113.0,32.0,38.69531,195.90625,2.3999023,0.19998169,1.79980469,149.0,7.339844,135.0,23.0,2502.0,5.0,<2 mo. follow-up
60.87598,0,male,0,8,1504,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,6616.0,4464.9961,7.5,white,35.0,1,0,0,no,1.0,1.0,no dnr,8.0,119.0,7.19921875,125.0,22.0,36.39844,300.0,4.2998047,0.5,1.89990234,139.0,7.40918,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
71.81396,1,male,1,7,7,Lung Cancer,Cancer,2,13.0,$25-$50k,3552.0,2271.9121,12.0,white,34.0,1,0,0,metastatic,0.699999809,0.5,no dnr,7.0,111.0,7.79980469,130.0,36.0,36.29688,333.3,3.699707,0.79992676,1.09985352,130.0,7.419922,135.0,23.0,2502.0,2.4077148,<2 mo. follow-up
67.37897,1,male,1,24,24,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,34907.0,23411.4688,20.0,white,27.0,6,0,0,no,0.799999714,0.8,no dnr,24.0,60.0,9.0,106.0,26.0,37.69531,155.0,3.5,1.01,1.29980469,140.0,7.349609,135.0,23.0,2502.0,4.0,<2 mo. follow-up
61.50897,1,male,0,9,998,CHF,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,7431.0,5242.8906,10.0,white,24.0,1,0,0,no,0.699999809,0.5,dnr after sadm,5.0,61.0,10.2988281,79.0,20.0,36.09375,333.3,4.5,0.79992676,1.29980469,135.0,7.419922,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
68.78595,1,male,0,4,185,Lung Cancer,Cancer,4,8.0,under $11k,4051.0,2365.6758,11.0,white,41.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,113.0,7.5,98.0,28.0,35.29688,333.3,4.0996094,0.59997559,2.09960938,134.0,7.419922,135.0,23.0,2502.0,2.737793,no(M2 and SIP pres)
49.89499,0,female,0,7,1495,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,7770.0,5283.8047,32.0,white,34.0,1,1,0,no,1.0,1.0,no dnr,7.0,120.0,21.8984375,133.0,22.0,38.0,333.3,2.7998047,0.59997559,1.79980469,147.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
69.40198,1,female,0,12,1133,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,25649.0,17458.9375,18.5,white,40.0,8,1,0,no,0.75,0.6,no dnr,12.0,71.0,24.0,96.0,24.0,37.69531,118.35938,3.5,1.01,4.39941406,137.0,7.379883,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
73.17499,1,male,1,22,22,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,42914.0,28734.4531,40.333313,white,54.0,5,0,0,yes,0.899999619,0.9,dnr after sadm,13.0,57.0,9.79882812,160.0,14.0,38.29688,203.3125,2.5996094,6.09960938,1.0,133.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
85.41296,1,male,0,8,1012,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,13014.0,8535.0312,16.0,white,54.0,5,0,0,yes,0.699999809,0.5,dnr after sadm,3.0,69.0,15.5,112.0,28.0,36.69531,125.70312,3.5,1.01,1.69995117,143.0,7.55957,135.0,23.0,2502.0,3.9628906,<2 mo. follow-up
66.71899,1,female,0,5,372,Lung Cancer,Cancer,2,12.0,under $11k,3790.0,2324.3262,8.0,white,18.0,1,0,0,metastatic,0.899999619,0.7,no dnr,5.0,106.0,6.19921875,114.0,24.0,37.5,333.3,3.8999023,0.29998779,0.89990234,138.0,7.419922,135.0,23.0,2502.0,2.0195312,<2 mo. follow-up
69.44299,1,female,0,11,405,COPD,COPD/CHF/Cirrhosis,5,12.0,under $11k,8271.0,5386.6602,14.5,other,32.0,1,0,0,metastatic,0.899999619,0.8,no dnr,11.0,104.0,10.0,83.0,40.0,37.59375,280.9375,3.3999023,0.09999084,0.79992676,133.0,7.359375,135.0,23.0,2502.0,4.6015625,<2 mo. follow-up
70.64795,1,female,0,14,15,Coma,Coma,0,12.0,$25-$50k,12994.0,8343.4141,20.333328,white,44.0,1,0,0,no,0.199999928,0.1,dnr after sadm,1.0,121.0,28.5,138.0,40.0,38.19531,220.40625,4.5,0.69995117,1.29980469,138.0,7.539062,135.0,23.0,2502.0,0.0,<2 mo. follow-up
64.35596,0,male,0,7,1489,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9355.0,5870.8125,12.0,white,21.0,1,0,0,no,0.989999771,0.9,no dnr,7.0,103.0,9.8984375,58.0,24.0,36.59375,325.875,4.0996094,0.59997559,1.5,133.0,7.429688,135.0,23.0,2502.0,2.3896484,<2 mo. follow-up
56.54498,1,male,0,3,664,Lung Cancer,Cancer,1,12.0,under $11k,2563.0,1645.4492,13.0,white,15.0,1,0,0,metastatic,0.799999714,0.5,no dnr,3.0,104.0,9.0,79.0,20.0,36.0,333.3,3.5,0.39996338,1.0,125.0,7.419922,135.0,23.0,2502.0,2.1313477,<2 mo. follow-up
68.68994,0,male,0,5,1484,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,9280.0,5733.3477,19.0,white,32.0,1,0,0,no,0.799999714,0.8,no dnr,5.0,77.0,16.3984375,79.0,25.0,36.19531,242.84375,4.0,0.59997559,1.69995117,137.0,7.419922,135.0,23.0,2502.0,1.8334961,<2 mo. follow-up
57.30899,1,male,0,19,20,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,59005.0,38558.0625,32.666657,white,41.0,3,0,0,yes,0.049999982,0.000125,dnr after sadm,15.0,52.0,9.69921875,76.0,32.0,39.09375,196.65625,2.5996094,0.39996338,1.19995117,138.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
73.78796,1,female,0,114,540,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,116672.0,82243.5625,19.0,white,43.0,6,0,1,no,0.699999809,0.5,dnr after sadm,39.0,44.0,16.3984375,102.0,28.0,38.89844,150.0,3.5,1.01,1.5,137.0,7.459961,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
54.28299,0,female,0,12,1483,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,15432.0,10693.2188,30.0,white,17.0,1,1,0,no,0.699999809,0.5,no dnr,12.0,68.0,8.59960938,65.0,22.0,38.29688,333.3,3.2998047,1.0,1.19995117,139.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.849,0,female,0,9,1480,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,5383.0,3525.8086,7.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,67.0,18.5,70.0,24.0,37.69531,239.125,4.5996094,0.29998779,1.5,137.0,7.369141,135.0,23.0,2502.0,2.6914062,no(M2 and SIP pres)
71.81897,1,female,0,6,879,Lung Cancer,Cancer,3,16.0,under $11k,4949.0,3180.9316,7.0,white,24.0,1,0,0,metastatic,0.899999619,0.9,no dnr,6.0,78.0,9.29882812,85.0,20.0,36.39844,333.3,3.7998047,0.39996338,1.19995117,134.0,7.419922,135.0,23.0,2502.0,2.1992188,<2 mo. follow-up
76.46497,1,female,0,13,17,Cirrhosis,COPD/CHF/Cirrhosis,3,16.0,under $11k,16170.0,11200.375,11.5,white,31.0,1,1,0,no,1.0,1.0,dnr after sadm,10.0,85.0,7.09960938,92.0,20.0,36.39844,338.0625,2.7998047,2.79980469,1.69995117,132.0,7.489258,135.0,23.0,2502.0,1.1668997,<2 mo. follow-up
53.72998,1,male,0,26,28,Coma,Coma,4,11.0,>$50k,47203.0,31308.5312,28.25,white,38.0,1,0,0,no,0.199999928,0.2,dnr after sadm,15.0,57.0,34.59375,108.0,12.0,39.19531,180.0,4.5,0.5,1.29980469,133.0,7.40918,135.0,23.0,2502.0,0.0,<2 mo. follow-up
59.44998,1,female,0,7,439,Colon Cancer,Cancer,1,12.0,>$50k,7654.0,4569.625,9.0,white,12.0,1,0,0,metastatic,0.599999905,0.4,no dnr,7.0,75.0,9.0,65.0,20.0,36.69531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
92.53894,1,male,0,9,234,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5446.0,3765.416,4.0,hispanic,37.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,78.0,7.39941406,70.0,20.0,36.39844,252.375,3.5,1.01,2.39990234,140.0,7.439453,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
59.556,1,male,0,5,389,Lung Cancer,Cancer,1,8.0,under $11k,4463.0,2632.8672,11.0,white,22.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,77.0,5.09960938,74.0,24.0,36.29688,333.3,3.5,0.29998779,1.39990234,137.0,7.419922,135.0,23.0,2502.0,1.9589844,no(M2 and SIP pres)
42.965,1,male,1,28,28,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,125903.0,78030.25,42.0,white,55.0,8,0,0,no,0.5,0.5,no dnr,28.0,43.0,19.5,138.0,36.0,38.79688,235.0,3.5,1.01,3.0,144.0,7.529297,135.0,23.0,2502.0,1.0,<2 mo. follow-up
63.25,0,female,0,22,1469,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,30327.0,21310.875,24.333328,white,74.0,2,1,0,no,0.699999809,0.5,no dnr,22.0,43.0,23.5,146.0,40.0,38.39844,203.3125,3.5,1.01,2.19970703,134.0,7.25,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.04797,1,male,0,8,10,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,21947.0,14963.3359,24.5,other,34.0,7,0,0,yes,0.699999809,0.5,dnr after sadm,5.0,68.0,4.69921875,66.0,12.0,36.29688,250.0,3.5,0.69995117,7.09960938,140.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
80.08997,1,female,0,7,1373,COPD,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,3531.0,2403.7617,7.0,white,33.0,1,0,0,no,0.949999809,0.95,dnr after sadm,1.0,71.0,10.7988281,87.0,16.0,36.0,223.78125,4.8994141,0.79992676,0.79992676,139.0,7.419922,135.0,23.0,2502.0,2.409668,no(M2 and SIP pres)
61.60999,1,male,1,6,6,Coma,Coma,1,14.0,$11-$25k,3837.0,2556.6562,19.0,white,27.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,111.0,14.1992188,101.0,28.0,38.59375,422.5,4.5996094,0.5,1.39990234,142.0,7.30957,135.0,23.0,2502.0,2.3256836,<2 mo. follow-up
72.59998,1,male,0,11,739,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,7230.0,4681.4297,7.5,white,31.0,1,0,0,no,0.75,0.5,dnr before sadm,-1.0,67.0,14.0,104.0,32.0,36.09375,232.0,3.7998047,0.69995117,1.19995117,141.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
90.26697,1,female,0,16,20,Coma,Coma,4,8.0,under $11k,8338.0,5678.207,5.666664,white,43.0,1,1,1,no,0.699999809,0.5,no dnr,16.0,113.0,27.3984375,107.0,24.0,38.59375,333.3,3.5996094,0.69995117,2.0,134.0,7.419922,135.0,23.0,2502.0,5.3515625,<2 mo. follow-up
63.18698,1,male,0,7,345,Lung Cancer,Cancer,2,8.0,under $11k,3640.0,2633.0938,9.0,white,9.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,2.0,83.0,9.0,101.0,24.0,36.5,333.3,4.1992188,0.39996338,1.0,140.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
50.71298,1,male,1,5,5,Coma,Coma,0,10.0,under $11k,14165.0,9191.4375,29.0,white,7.0,1,0,0,no,0.699999809,0.5,no dnr,5.0,117.0,18.796875,72.0,24.0,38.59375,163.25,3.5,1.01,0.89990234,138.0,7.519531,135.0,23.0,2502.0,1.4685059,<2 mo. follow-up
63.33499,1,male,0,12,1138,CHF,COPD/CHF/Cirrhosis,3,16.0,under $11k,10998.0,7141.5117,14.5,white,36.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,59.0,10.5,39.0,20.0,36.39844,333.3,3.5,1.01,1.5,138.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.34796,1,male,0,6,198,Lung Cancer,Cancer,2,10.0,under $11k,4317.0,2808.6426,11.0,white,22.0,1,0,0,metastatic,0.5,0.2,no dnr,6.0,103.0,5.79980469,122.0,20.0,36.79688,333.3,3.3999023,0.09999084,0.79992676,138.0,7.419922,135.0,23.0,2502.0,2.4418945,no(M2 and SIP pres)
78.24799,0,female,0,13,1456,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,8286.0,5489.4648,5.0,white,27.0,1,0,0,no,1.0,1.0,no dnr,13.0,107.0,6.09960938,71.0,28.0,36.29688,271.375,3.3999023,0.29998779,0.59997559,128.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.185,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,20.0,>$50k,104716.0,71111.0,38.0,white,77.0,42,0,0,no,0.199999928,0.008,dnr after sadm,1.0,53.0,35.09375,70.0,28.0,34.39844,137.5,3.2998047,5.0,6.29980469,136.0,7.349609,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.42798,0,female,0,26,1455,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,63652.0,43971.6875,19.5,white,35.0,11,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,81.0,22.5,128.0,26.0,38.29688,351.375,3.5,1.01,2.69970703,137.0,7.449219,135.0,23.0,2502.0,2.5898438,<2 mo. follow-up
42.38998,0,male,0,37,1455,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,$11-$25k,56976.0,37833.6562,24.25,white,72.0,1,1,0,no,0.199999928,0.2,no dnr,37.0,54.0,11.5,160.0,50.0,40.0,188.5625,2.0996094,0.59997559,0.89990234,150.0,7.389648,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
53.34698,1,male,0,5,160,Lung Cancer,Cancer,3,12.0,$25-$50k,3856.0,2521.207,8.0,white,18.0,1,0,0,metastatic,0.5,0.2,no dnr,5.0,109.0,12.5996094,122.0,20.0,36.19531,333.3,3.5,0.29998779,0.69995117,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
58.90997,1,female,0,9,55,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,7424.0,4781.4648,9.0,white,32.0,1,1,0,no,0.949999809,0.95,no dnr,9.0,75.0,11.0996094,66.0,24.0,36.29688,204.75,3.7998047,0.5,0.89990234,143.0,7.439453,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
85.94696,1,male,0,11,127,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,7914.0,5262.6758,8.5,white,30.0,1,1,1,no,1.0,1.0,no dnr,11.0,60.0,8.19921875,79.0,24.0,35.89844,333.3,3.5,0.5,1.19995117,131.0,7.419922,135.0,23.0,2502.0,4.84375,Coma or Intub
22.55699,1,male,0,5,6,MOSF w/Malig,ARF/MOSF,3,13.0,under $11k,17616.0,12264.8516,41.0,white,57.0,1,0,0,yes,0.009999998,1e-06,dnr after sadm,5.0,114.0,2.5,146.0,36.0,39.59375,304.75,2.7998047,0.79992676,2.19970703,125.0,7.479492,135.0,23.0,2502.0,5.0,<2 mo. follow-up
57.10098,1,female,0,4,1000,Lung Cancer,Cancer,1,11.0,$11-$25k,2784.0,1590.1895,13.0,white,13.0,1,0,0,metastatic,0.949999809,0.75,no dnr,4.0,104.0,10.5996094,69.0,24.0,38.09375,333.3,3.5,0.19998169,1.09985352,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
83.19495,1,female,0,3,89,Lung Cancer,Cancer,2,12.0,under $11k,1538.0,1025.7471,15.0,white,27.0,1,1,0,metastatic,0.599999905,0.4,dnr after sadm,1.0,74.0,12.2988281,77.0,24.0,36.69531,333.3,2.699707,0.59997559,0.89990234,134.0,7.419922,135.0,23.0,2502.0,2.9667969,adl>=4 (>=5 if sur)
70.82495,1,female,0,8,1135,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,5587.0,3600.9805,9.5,white,38.0,1,0,0,no,0.949999809,0.85,dnr after sadm,1.0,77.0,17.3984375,71.0,28.0,36.19531,236.0,3.5,1.01,1.5,134.0,7.379883,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
69.15295,0,male,0,8,1440,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,10159.0,6785.2852,10.5,white,29.0,4,0,0,no,0.799999714,0.6,no dnr,8.0,102.0,11.0,66.0,24.0,35.69531,224.0,3.8999023,0.89990234,1.19995117,131.0,7.239258,135.0,23.0,2502.0,3.2470703,<2 mo. follow-up
73.08398,1,male,0,12,76,ARF/MOSF w/Sepsis,ARF/MOSF,4,8.0,under $11k,14307.0,10014.0859,19.0,white,26.0,1,0,0,yes,0.949999809,0.9,no dnr,12.0,75.0,11.2988281,70.0,24.0,36.39844,268.0,3.8999023,1.09985352,1.39990234,137.0,7.389648,135.0,23.0,2502.0,0.0,<2 mo. follow-up
65.396,1,male,0,12,147,CHF,COPD/CHF/Cirrhosis,7,11.0,under $11k,7884.0,5273.1055,6.0,white,46.0,1,1,0,no,0.799999714,0.6,no dnr,12.0,79.0,9.59960938,73.0,28.0,36.39844,333.3,4.5996094,0.79992676,3.0,139.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
75.93695,1,male,1,17,17,CHF,COPD/CHF/Cirrhosis,5,6.0,$11-$25k,24965.0,16674.9531,20.333328,white,35.0,1,1,0,no,0.199999928,0.1,dnr after sadm,3.0,70.0,12.7988281,110.0,40.0,37.59375,210.0,2.8999023,0.79992676,1.39990234,136.0,7.449219,135.0,23.0,2502.0,7.0,<2 mo. follow-up
54.34399,1,male,0,3,207,Lung Cancer,Cancer,2,11.0,>$50k,1509.0,1049.8047,5.0,white,16.0,1,0,0,metastatic,0.599999905,0.4,no dnr,3.0,81.0,9.0,96.0,28.0,35.79688,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
73.34698,0,female,0,11,1439,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,18090.0,11908.6641,20.5,white,22.0,6,0,0,no,0.75,0.6,no dnr,11.0,120.0,23.3984375,60.0,24.0,36.69531,145.0,3.8999023,0.39996338,1.0,141.0,7.429688,135.0,23.0,2502.0,5.0,no(M2 and SIP pres)
77.43195,1,male,0,12,432,Lung Cancer,Cancer,1,12.0,under $11k,13719.0,14452.7344,6.5,white,17.0,1,0,0,metastatic,0.989999771,0.95,no dnr,12.0,113.0,12.5996094,76.0,20.0,36.39844,333.3,4.0996094,0.59997559,1.19995117,141.0,7.419922,135.0,23.0,2502.0,2.5205078,<2 mo. follow-up
76.73096,1,female,1,36,36,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,$11-$25k,83635.0,61648.1562,24.75,white,58.0,12,0,0,no,0.099999964,0.001,no dnr,36.0,53.0,16.3984375,134.0,12.0,35.59375,152.0,2.3999023,1.79980469,2.59960938,146.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.45398,1,male,1,35,35,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,154093.0,101554.438,43.5,white,51.0,19,0,0,yes,0.099999964,0.001,dnr after sadm,7.0,73.0,0.19998169,110.0,30.0,39.5,253.3125,3.5,1.01,1.39990234,139.0,7.5,135.0,23.0,2502.0,1.9077148,<2 mo. follow-up
50.133,1,male,0,15,22,Cirrhosis,COPD/CHF/Cirrhosis,1,14.0,under $11k,28895.0,20353.9219,28.666656,white,40.0,1,0,0,no,0.699999809,0.6,no dnr,15.0,67.0,11.6992188,134.0,10.0,39.59375,233.3125,2.5,1.09985352,0.89990234,138.0,7.419922,135.0,23.0,2502.0,2.6918945,<2 mo. follow-up
85.96295,1,female,0,6,1328,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,6391.0,4357.6367,20.0,white,36.0,1,0,0,no,0.899999619,0.5,no dnr,6.0,79.0,23.796875,116.0,32.0,38.69531,186.65625,4.0996094,0.19998169,0.69995117,131.0,7.489258,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
69.47797,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,25801.0,16894.9688,40.5,white,54.0,4,0,0,metastatic,0.099999964,0.001,no dnr,7.0,105.0,16.296875,120.0,34.0,38.19531,86.25,3.5,1.01,2.69970703,124.0,7.509766,135.0,23.0,2502.0,2.0,<2 mo. follow-up
70.836,1,male,0,4,122,Lung Cancer,Cancer,1,7.0,under $11k,3294.0,1952.7148,7.0,white,20.0,1,0,0,metastatic,0.899999619,0.5,no dnr,4.0,119.0,5.5,98.0,24.0,36.5,333.3,4.0996094,0.39996338,1.09985352,136.0,7.419922,135.0,23.0,2502.0,1.7722168,no(M2 and SIP pres)
70.86395,1,male,0,6,982,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,5788.0,4110.832,20.0,white,32.0,1,0,0,no,0.5,0.25,dnr after sadm,1.0,53.0,10.0996094,56.0,12.0,38.39844,333.3,2.699707,1.79980469,1.0,133.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
80.58295,1,male,1,14,14,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,22019.0,14455.2656,29.0,white,32.0,1,0,0,no,0.5,0.1,dnr after sadm,4.0,70.0,8.59960938,77.0,30.0,38.29688,137.5,3.0996094,0.5,0.69995117,138.0,7.399414,135.0,23.0,2502.0,3.4072266,<2 mo. follow-up
53.81198,1,male,0,8,173,Lung Cancer,Cancer,2,12.0,$11-$25k,4288.0,3318.6133,2.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,8.0,113.0,9.09960938,56.0,20.0,36.19531,333.3,3.699707,0.29998779,1.0,133.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
77.58197,0,female,0,6,1421,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,8004.0,5128.5703,10.0,white,32.0,2,0,0,no,0.899999619,0.75,no dnr,6.0,115.0,9.0,74.0,22.0,36.29688,184.0,3.5,1.01,1.01,140.0,7.289062,135.0,23.0,2502.0,2.940918,<2 mo. follow-up
54.689,0,female,0,7,1422,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,6362.0,4323.1992,17.0,white,34.0,1,0,0,no,0.989999771,0.99,no dnr,7.0,65.0,3.19970703,72.0,24.0,36.19531,333.3,2.7998047,0.29998779,4.19921875,135.0,7.419922,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
66.00397,1,male,0,6,104,Lung Cancer,Cancer,2,8.0,under $11k,5387.0,3580.7188,13.0,white,22.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,79.0,7.29980469,130.0,24.0,38.5,333.3,3.7998047,0.39996338,1.09985352,123.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
88.04395,1,male,0,5,100,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,2461.0,1665.71,6.0,white,34.0,1,1,1,no,0.25,0.25,no dnr,5.0,102.0,9.0,83.0,24.0,36.0,333.3,3.5,0.29998779,2.69970703,132.0,7.419922,135.0,23.0,2502.0,4.0,no(M2 and SIP pres)
66.32397,1,male,0,19,902,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,30250.0,20162.25,17.333328,white,39.0,5,1,0,yes,0.799999714,0.6,no dnr,19.0,67.0,8.29882812,65.0,10.0,38.59375,85.70312,1.7998047,0.29998779,1.09985352,134.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.63699,1,male,0,6,423,CHF,COPD/CHF/Cirrhosis,1,11.0,under $11k,4544.0,2984.0488,9.0,white,30.0,1,1,0,no,0.949999809,0.8,no dnr,6.0,75.0,8.5,60.0,20.0,36.59375,107.5,3.8999023,0.69995117,1.19995117,136.0,7.389648,135.0,23.0,2502.0,0.4947999,no(M2 and SIP pres)
74.92096,1,male,0,5,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,28116.0,18203.4219,44.0,white,71.0,8,1,0,yes,0.0,0.0,dnr after sadm,2.0,67.0,0.39996338,104.0,32.0,39.5,265.6875,3.199707,2.0,2.89990234,141.0,7.439453,135.0,23.0,2502.0,5.0,<2 mo. follow-up
60.62097,1,female,0,14,36,COPD,COPD/CHF/Cirrhosis,2,9.0,>$50k,42474.0,27756.9531,23.0,white,43.0,1,0,0,no,0.049999982,0.000125,dnr after sadm,2.0,56.0,19.8984375,160.0,32.0,36.69531,220.0,3.699707,0.39996338,0.69995117,139.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.86099,0,male,0,5,1417,CHF,COPD/CHF/Cirrhosis,4,13.0,$25-$50k,3150.0,2122.1133,6.0,white,24.0,1,1,0,no,0.799999714,0.5,no dnr,5.0,65.0,7.79980469,79.0,24.0,36.09375,261.875,4.6992188,0.79992676,0.89990234,133.0,7.469727,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
68.99695,1,male,0,6,1124,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,3835.0,2503.3379,3.0,white,19.0,1,0,0,no,0.599999905,0.4,no dnr,6.0,80.0,6.59960938,101.0,28.0,36.59375,307.375,4.7998047,0.29998779,0.5,138.0,7.379883,135.0,23.0,2502.0,2.2167969,no(M2 and SIP pres)
64.85394,0,male,0,9,1410,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,6961.0,4712.75,13.5,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,132.0,6.0,148.0,28.0,36.09375,248.125,4.3994141,0.5,1.0,143.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
66.76495,0,female,0,6,1411,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,7166.0,4621.0664,22.0,white,31.0,1,0,0,yes,0.5,0.25,dnr after sadm,3.0,107.0,11.8984375,126.0,24.0,36.5,300.0,3.5996094,0.39996338,0.89990234,137.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
44.48199,0,female,0,13,1410,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,15664.0,10359.6328,18.5,white,49.0,1,0,0,no,0.699999809,0.5,no dnr,13.0,110.0,19.1992188,142.0,28.0,38.69531,173.46875,2.5996094,0.39996338,2.69970703,138.0,7.469727,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
54.40097,1,female,0,7,260,COPD,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,7488.0,5050.7344,13.0,white,25.0,1,0,0,no,0.649999619,0.6,no dnr,7.0,63.0,16.6992188,107.0,24.0,36.39844,204.0,4.1992188,0.19998169,0.79992676,140.0,7.479492,135.0,23.0,2502.0,1.1668997,no(M2 and SIP pres)
65.02899,0,male,0,19,1409,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,56325.0,35421.8438,27.666656,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,19.0,113.0,9.09960938,146.0,30.0,38.29688,202.03125,4.1992188,0.59997559,1.29980469,134.0,7.469727,135.0,23.0,2502.0,2.9389648,<2 mo. follow-up
81.48096,1,female,1,3,3,Coma,Coma,0,16.0,under $11k,32997.0,21490.9688,14.0,white,32.0,27,0,0,no,0.699999809,0.5,dnr after sadm,3.0,117.0,9.0,134.0,32.0,38.5,377.75,3.0996094,0.69995117,1.09985352,131.0,7.489258,135.0,23.0,2502.0,2.612793,<2 mo. follow-up
71.737,0,male,0,5,1406,Lung Cancer,Cancer,2,12.0,$11-$25k,3561.0,2334.3106,7.0,white,14.0,1,0,0,metastatic,0.989999771,0.99,no dnr,5.0,110.0,7.29980469,89.0,20.0,35.69531,333.3,4.3994141,0.19998169,1.0,137.0,7.419922,135.0,23.0,2502.0,1.7917481,no(M2 and SIP pres)
80.02197,1,female,0,3,350,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,1665.0,1115.0947,18.0,white,33.0,1,1,1,no,0.849999905,0.7,dnr after sadm,1.0,73.0,4.19921875,104.0,20.0,35.89844,314.25,4.0996094,0.59997559,1.69995117,135.0,7.399414,135.0,23.0,2502.0,4.0419922,no(M2 and SIP pres)
93.41498,1,female,0,10,1325,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,6652.0,4363.7539,7.5,white,17.0,1,0,0,no,0.5,0.25,dnr before sadm,-1.0,85.0,17.8984375,64.0,24.0,36.29688,333.3,3.3999023,0.59997559,0.89990234,136.0,7.419922,135.0,23.0,2502.0,5.0,adl>=4 (>=5 if sur)
57.952,1,male,0,7,211,Lung Cancer,Cancer,1,7.0,$25-$50k,3660.0,2429.7559,9.0,white,16.0,1,0,0,metastatic,0.799999714,0.3,no dnr,7.0,63.0,8.59960938,62.0,24.0,36.09375,333.3,4.0996094,0.5,1.19995117,133.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
81.11395,1,male,0,50,818,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$11-$25k,91897.0,61603.1875,40.0,white,58.0,9,0,0,yes,0.699999809,0.5,no dnr,50.0,51.0,9.0,68.0,28.0,35.89844,242.84375,3.5,1.01,4.79980469,135.0,7.279297,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
73.70294,0,male,0,10,1401,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,6145.0,3975.1602,6.0,white,27.0,1,0,0,no,1.0,1.0,no dnr,10.0,75.0,14.7988281,69.0,28.0,35.5,240.0,3.5,1.01,0.89990234,138.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.07898,1,female,0,4,278,Colon Cancer,Cancer,1,14.0,under $11k,2834.0,1935.4111,9.0,white,14.0,1,0,0,metastatic,0.799999714,0.3,no dnr,4.0,76.0,9.0,93.0,16.0,36.29688,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
58.905,1,female,0,5,93,Lung Cancer,Cancer,2,15.0,$25-$50k,3402.0,2032.0908,9.0,white,12.0,1,0,0,metastatic,0.5,0.15,no dnr,5.0,121.0,17.796875,96.0,20.0,37.39844,333.3,4.2998047,0.59997559,1.0,139.0,7.419922,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
52.90097,1,female,0,6,1379,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,4159.0,2839.4883,14.0,white,16.0,1,0,0,no,0.899999619,0.6,no dnr,6.0,109.0,9.29882812,118.0,20.0,36.39844,333.3,3.7998047,0.29998779,1.19995117,136.0,7.419922,135.0,23.0,2502.0,3.2626953,<2 mo. follow-up
71.05499,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,2,14.0,under $11k,21861.0,14073.1797,28.0,white,39.0,1,0,0,yes,0.5,0.3,dnr after sadm,3.0,55.0,14.7988281,116.0,31.0,38.29688,296.625,2.7998047,0.39996338,1.29980469,134.0,7.419922,135.0,23.0,2502.0,2.0761719,<2 mo. follow-up
76.28998,1,male,1,4,4,Lung Cancer,Cancer,2,12.0,$11-$25k,4655.0,2850.7129,21.0,white,58.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,69.0,0.89990234,126.0,36.0,35.69531,333.3,3.5,1.01,0.89990234,132.0,7.419922,135.0,23.0,2502.0,2.7319336,<2 mo. follow-up
64.93097,0,female,0,43,1393,ARF/MOSF w/Sepsis,ARF/MOSF,3,10.0,under $11k,85693.0,57021.0,35.75,white,39.0,1,0,0,no,0.5,0.2,no dnr,43.0,74.0,24.296875,125.0,42.0,38.09375,148.0,3.5,1.01,0.79992676,141.0,7.479492,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
73.74896,1,female,1,9,9,Coma,Coma,1,12.0,under $11k,21303.0,14874.0625,29.5,white,44.0,4,0,0,no,0.599999905,0.6,dnr after sadm,9.0,129.0,14.2988281,114.0,40.0,36.5,166.0,3.5,1.01,1.5,139.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
35.11298,1,female,0,11,106,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,12351.0,8735.1953,14.5,white,33.0,1,0,0,metastatic,0.899999619,0.8,no dnr,11.0,45.0,1.69995117,76.0,26.0,37.89844,333.3,3.699707,0.5,1.19995117,138.0,7.419922,135.0,23.0,2502.0,3.855299,no(M2 and SIP pres)
88.52295,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,11769.0,7572.7656,39.0,white,41.0,1,0,0,yes,0.099999964,0.001,no dnr,6.0,106.0,29.796875,70.0,41.0,38.0,110.20312,2.8999023,1.19995117,1.39990234,132.0,7.429688,135.0,23.0,2502.0,0.0,<2 mo. follow-up
62.92999,0,male,0,14,1391,Coma,Coma,1,12.0,under $11k,32123.0,21794.6094,43.666657,white,28.0,2,1,0,no,0.699999809,0.5,no dnr,14.0,96.0,10.1992188,102.0,40.0,39.19531,164.4375,3.5996094,0.79992676,1.29980469,142.0,7.419922,135.0,23.0,2502.0,1.6655273,no(M2 and SIP pres)
58.55197,1,male,0,5,74,Colon Cancer,Cancer,1,12.0,under $11k,3079.0,1990.9004,11.0,white,38.0,1,0,0,metastatic,0.25,0.05,no dnr,5.0,115.0,5.79980469,124.0,20.0,36.59375,333.3,3.2998047,16.796875,1.09985352,135.0,7.419922,135.0,23.0,2502.0,1.8415527,adl>=4 (>=5 if sur)
64.24396,0,male,0,6,1390,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,4388.0,2943.1934,9.0,white,33.0,1,0,0,no,0.979999542,0.98,no dnr,6.0,72.0,7.09960938,48.0,20.0,35.69531,323.75,3.5,1.01,1.69995117,136.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
57.36099,0,female,0,11,1390,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,16935.0,14452.7344,13.0,white,38.0,1,0,0,no,0.599999905,0.6,dnr after sadm,10.0,66.0,11.0996094,114.0,36.0,39.59375,192.5625,2.699707,1.5,1.0,135.0,7.40918,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
50.18997,1,male,0,6,100,Lung Cancer,Cancer,4,12.0,>$50k,3883.0,2523.0332,9.0,white,18.0,1,1,0,metastatic,0.199999928,0.05,dnr after sadm,1.0,77.0,10.3984375,70.0,20.0,35.69531,333.3,3.2998047,0.19998169,0.59997559,132.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
62.37399,0,female,0,6,1388,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,5885.0,3970.6641,16.0,white,23.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,83.0,8.5,101.0,20.0,36.79688,180.9375,4.2998047,0.5,0.69995117,127.0,7.449219,135.0,23.0,2502.0,2.4643555,<2 mo. follow-up
79.07697,1,male,0,6,828,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,4192.0,2770.7383,7.0,white,53.0,1,0,0,no,0.799999714,0.5,no dnr,6.0,121.0,5.69921875,215.0,28.0,36.19531,219.03125,3.5,1.01,1.19995117,143.0,7.349609,135.0,23.0,2502.0,2.8769531,no(M2 and SIP pres)
70.48596,0,female,0,23,1385,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$11-$25k,28320.0,18725.5,18.666656,white,41.0,2,0,0,no,0.699999809,0.7,no dnr,23.0,65.0,18.5976562,146.0,38.0,39.39844,104.07812,2.699707,1.5,0.5,130.0,7.359375,135.0,23.0,2502.0,2.1953125,adl>=4 (>=5 if sur)
71.91498,1,male,0,9,650,Cirrhosis,COPD/CHF/Cirrhosis,2,17.0,$25-$50k,5357.0,3685.5586,9.0,white,16.0,1,0,0,no,0.899999619,0.95,no dnr,9.0,95.0,6.89941406,64.0,24.0,36.69531,333.3,3.0,1.59985352,1.19995117,145.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.35596,1,male,0,24,841,ARF/MOSF w/Sepsis,ARF/MOSF,2,7.0,under $11k,56732.0,37232.125,30.666656,white,69.0,6,0,0,no,0.079999983,0.000512,dnr after sadm,10.0,113.0,26.6992188,64.0,28.0,38.19531,132.0,2.199707,10.7988281,3.0,141.0,7.429688,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
64.06598,0,male,0,16,1377,Lung Cancer,Cancer,2,8.0,$11-$25k,21757.0,13109.3281,21.666656,white,25.0,1,0,0,metastatic,0.799999714,0.7,no dnr,16.0,64.0,8.0,76.0,10.0,38.09375,276.1875,4.0,0.29998779,0.69995117,133.0,7.40918,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
70.37097,1,female,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,98681.0,67149.75,43.0,white,51.0,8,0,0,no,0.5,0.5,dnr after sadm,42.0,65.0,22.3984375,72.0,40.0,37.69531,100.0,1.6999512,0.29998779,0.69995117,131.0,7.449219,135.0,23.0,2502.0,0.0,<2 mo. follow-up
75.52594,1,male,1,9,9,Coma,Coma,1,10.0,>$50k,79205.0,53814.1875,36.5,white,41.0,18,0,0,no,0.5,0.5,dnr after sadm,8.0,75.0,32.796875,68.0,12.0,39.19531,204.0,2.2998047,1.19995117,1.89990234,141.0,7.509766,135.0,23.0,2502.0,0.0,<2 mo. follow-up
61.51398,1,male,0,7,107,Lung Cancer,Cancer,2,12.0,under $11k,8858.0,5507.6953,13.0,white,19.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,75.0,9.0,77.0,22.0,37.79688,333.3,3.5,1.01,1.39990234,139.0,7.419922,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
51.87698,1,male,0,15,1228,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,12740.0,8003.8203,13.666664,white,33.0,1,0,0,no,0.899999619,0.5,no dnr,15.0,79.0,10.5996094,98.0,24.0,35.59375,361.875,4.0,1.39990234,1.69995117,135.0,7.459961,135.0,23.0,2502.0,0.0,<2 mo. follow-up
40.93597,0,female,0,10,1371,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,9355.0,6916.2422,9.0,white,53.0,1,1,0,no,1.0,0.9,no dnr,10.0,109.0,12.8984375,108.0,22.0,37.69531,93.875,3.5,0.19998169,7.29980469,129.0,7.349609,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
52.93597,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,>$50k,37033.0,24434.8125,45.5,white,88.0,1,1,0,no,0.699999809,0.5,dnr after sadm,8.0,39.0,16.8984375,154.0,28.0,39.29688,102.84375,2.5,4.19921875,3.39990234,144.0,7.379883,135.0,23.0,2502.0,1.0,<2 mo. follow-up
77.23999,1,male,0,17,168,ARF/MOSF w/Sepsis,ARF/MOSF,6,6.0,$11-$25k,19734.0,14627.5234,15.333328,white,50.0,2,1,0,no,0.049999982,0.000125,no dnr,17.0,63.0,13.5,124.0,28.0,37.59375,333.3,4.0,0.5,2.79980469,147.0,7.419922,135.0,23.0,2502.0,4.3447266,no(M2 and SIP pres)
74.04498,1,male,0,26,33,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,75250.0,48129.75,21.75,white,24.0,23,0,0,yes,0.199999928,0.008,dnr after sadm,25.0,105.0,5.19921875,104.0,36.0,36.59375,352.5,3.5,1.01,1.39990234,141.0,7.769531,135.0,23.0,2502.0,5.0,<2 mo. follow-up
78.33496,1,male,0,14,267,COPD,COPD/CHF/Cirrhosis,3,5.0,$11-$25k,20412.0,13551.75,21.0,white,47.0,1,0,0,no,0.0,0.0,dnr after sadm,1.0,120.0,13.8984375,59.0,33.0,37.79688,180.0,3.7998047,0.89990234,2.19970703,134.0,7.299805,135.0,23.0,2502.0,1.0,adl>=4 (>=5 if sur)
48.63797,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,$25-$50k,11142.0,7791.1289,63.0,white,70.0,1,1,0,no,0.699999809,0.5,dnr after sadm,3.0,42.0,15.6992188,68.0,35.0,34.19531,110.20312,2.0,1.89990234,2.59960938,154.0,7.539062,135.0,23.0,2502.0,4.2148438,<2 mo. follow-up
74.52197,1,male,0,7,794,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,4039.0,2678.4492,7.0,white,18.0,1,0,0,no,0.899999619,0.9,dnr after sadm,1.0,79.0,8.29882812,73.0,24.0,35.89844,186.65625,4.0996094,0.39996338,0.69995117,140.0,7.389648,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
29.97899,0,male,0,73,1362,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,123456.0,92438.0,16.5,white,23.0,20,0,0,yes,0.75,0.7,no dnr,73.0,77.0,14.5,126.0,30.0,37.79688,240.0,2.5996094,0.39996338,0.89990234,141.0,7.389648,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
52.02197,0,female,0,10,1361,Colon Cancer,Cancer,1,12.0,under $11k,15758.0,10225.4141,22.5,white,21.0,1,0,0,metastatic,1.0,0.1,no dnr,10.0,113.0,10.0,70.0,10.0,35.79688,282.0,3.5,1.01,0.79992676,135.0,7.479492,135.0,23.0,2502.0,2.3129883,<2 mo. follow-up
71.00598,1,female,0,6,28,CHF,COPD/CHF/Cirrhosis,2,17.0,under $11k,3023.0,2051.9375,6.0,white,52.0,1,0,0,no,0.899999619,0.6,no dnr,6.0,29.0,5.79980469,59.0,24.0,37.0,333.3,3.0996094,0.59997559,5.0,132.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
63.918,1,male,0,40,65,Coma,Coma,4,12.0,under $11k,60050.0,77295.875,36.5,white,27.0,1,1,0,no,0.949999809,0.8,dnr after sadm,3.0,61.0,17.5976562,78.0,6.0,37.89844,94.28125,2.7998047,1.69995117,1.19995117,139.0,7.579102,135.0,23.0,2502.0,2.715332,<2 mo. follow-up
79.31799,1,male,0,4,14,Cirrhosis,COPD/CHF/Cirrhosis,5,6.0,under $11k,10346.0,6697.7539,21.0,white,75.0,1,0,1,no,0.699999809,0.5,dnr after sadm,1.0,57.0,5.29980469,112.0,36.0,39.59375,485.6875,1.6999512,2.69970703,2.09960938,148.0,7.469727,135.0,23.0,2502.0,6.0,<2 mo. follow-up
75.58698,1,female,0,5,809,CHF,COPD/CHF/Cirrhosis,4,14.0,$11-$25k,2641.0,1807.6631,11.0,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,75.0,8.8984375,70.0,20.0,35.69531,333.3,3.699707,1.89990234,1.5,136.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
65.875,0,male,0,5,1350,Lung Cancer,Cancer,2,11.0,under $11k,5483.0,3792.6484,10.0,white,28.0,1,0,0,metastatic,0.75,0.5,no dnr,5.0,71.0,22.8984375,67.0,26.0,35.09375,333.3,3.7998047,0.5,0.89990234,124.0,7.419922,135.0,23.0,2502.0,2.4208984,no(M2 and SIP pres)
60.53897,1,female,1,3,3,Coma,Coma,1,12.0,under $11k,42868.0,27519.3594,59.0,white,66.0,6,0,0,no,0.699999809,0.5,no dnr,3.0,43.0,17.6992188,140.0,12.0,38.69531,132.71875,3.5,1.01,5.29980469,130.0,7.319336,135.0,23.0,2502.0,1.0,<2 mo. follow-up
72.34998,0,male,0,42,1349,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,112532.0,79493.25,29.75,white,41.0,13,0,0,no,0.699999809,0.5,no dnr,42.0,69.0,10.1992188,78.0,40.0,39.89844,240.0,3.5,1.01,1.69995117,146.0,7.469727,135.0,23.0,2502.0,0.0,<2 mo. follow-up
78.80396,1,male,0,9,258,Cirrhosis,COPD/CHF/Cirrhosis,2,14.0,$11-$25k,4893.0,3245.4336,10.5,white,24.0,1,0,0,no,0.949999809,0.8,dnr after sadm,1.0,97.0,4.5,74.0,16.0,35.19531,333.3,3.5996094,0.69995117,1.79980469,133.0,7.419922,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
87.70398,1,male,0,14,380,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,9576.0,6121.2734,13.0,white,42.0,1,0,0,yes,0.599999905,0.5,dnr after sadm,1.0,103.0,6.39941406,96.0,28.0,38.0,204.75,3.7998047,1.09985352,1.5,139.0,7.379883,135.0,23.0,2502.0,4.5566406,<2 mo. follow-up
54.52197,1,male,0,20,137,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,81712.0,49968.125,21.333328,white,24.0,38,0,0,yes,0.5,0.2,no dnr,20.0,75.0,4.89941406,126.0,28.0,36.29688,346.9375,3.5,1.01,1.09985352,140.0,7.439453,135.0,23.0,2502.0,5.0,<2 mo. follow-up
75.30194,1,male,0,8,632,Colon Cancer,Cancer,2,8.0,$11-$25k,11949.0,7253.4805,17.0,white,24.0,1,0,0,metastatic,0.899999619,0.7,no dnr,8.0,73.0,5.39941406,96.0,24.0,38.09375,333.3,3.5,1.01,1.29980469,132.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
65.17499,0,male,0,28,1347,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,31065.0,19741.4375,17.0,white,39.0,1,0,0,no,0.899999619,0.8,dnr after sadm,1.0,79.0,7.89941406,103.0,36.0,37.89844,185.6875,2.3999023,0.59997559,1.0,138.0,7.469727,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
22.88799,1,male,0,40,604,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,54848.0,37453.5625,27.0,white,62.0,10,0,0,no,0.799999714,0.8,no dnr,40.0,63.0,21.796875,140.0,50.0,36.09375,182.84375,2.0,3.5,0.39996338,137.0,7.449219,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
61.30899,1,male,0,31,730,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,$11-$25k,135370.0,82462.5,21.5,white,36.0,28,0,0,yes,0.699999809,0.5,no dnr,31.0,116.0,0.09999084,112.0,24.0,36.19531,353.0,3.5,1.01,1.19995117,135.0,7.5,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
62.073,1,male,0,11,68,Lung Cancer,Cancer,1,12.0,under $11k,6530.0,4838.1602,2.0,white,20.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,115.0,14.6992188,73.0,24.0,36.29688,357.125,4.5996094,0.39996338,1.19995117,134.0,7.459961,135.0,23.0,2502.0,2.1611328,no(M2 and SIP pres)
63.22198,1,male,0,5,632,Lung Cancer,Cancer,1,12.0,under $11k,6315.0,14452.7344,7.0,white,17.0,1,0,0,metastatic,0.899999619,0.8,no dnr,5.0,75.0,6.69921875,83.0,18.0,36.39844,333.3,3.5,1.01,1.09985352,136.0,7.419922,135.0,23.0,2502.0,1.9411621,<2 mo. follow-up
81.21594,1,male,1,6,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,18554.0,13085.6641,32.0,white,42.0,4,0,0,yes,0.699999809,0.5,dnr after sadm,4.0,59.0,77.390625,58.0,30.0,36.79688,155.09375,3.5,1.01,1.5,138.0,7.339844,135.0,23.0,2502.0,0.0,<2 mo. follow-up
68.43799,0,male,0,9,1335,Colon Cancer,Cancer,2,12.0,$11-$25k,12932.0,7977.168,19.0,white,23.0,1,1,0,metastatic,0.979999542,0.8,no dnr,9.0,113.0,12.5996094,76.0,16.0,36.19531,333.3,3.5,1.01,1.59985352,137.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
59.53198,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,1,14.0,$25-$50k,9529.0,6561.9961,29.0,white,77.0,2,0,0,metastatic,0.099999964,0.001,dnr after sadm,5.0,61.0,9.69921875,120.0,28.0,36.39844,207.5,1.6999512,15.5,4.09960938,135.0,7.439453,135.0,23.0,2502.0,0.0,<2 mo. follow-up
76.70599,1,male,0,17,18,COPD,COPD/CHF/Cirrhosis,3,11.0,under $11k,46129.0,29804.6719,38.333313,white,44.0,2,0,0,no,0.699999809,0.5,dnr after sadm,15.0,70.0,15.8984375,116.0,40.0,38.29688,215.0,1.7998047,0.29998779,1.0,140.0,7.389648,135.0,23.0,2502.0,6.0,<2 mo. follow-up
73.26996,0,female,0,46,1335,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,65771.0,44039.9375,27.0,white,41.0,1,0,0,no,0.5,0.5,dnr after sadm,30.0,55.0,7.29980469,71.0,8.0,37.59375,187.5,2.7998047,0.89990234,2.5,142.0,7.669922,135.0,23.0,2502.0,3.0683594,<2 mo. follow-up
53.66199,1,male,0,5,90,Lung Cancer,Cancer,1,11.0,under $11k,5210.0,3389.5176,12.0,white,8.0,1,0,0,metastatic,0.199999928,0.1,dnr after sadm,1.0,104.0,3.39990234,69.0,24.0,37.0,344.4375,2.5996094,0.39996338,0.69995117,142.0,7.40918,135.0,23.0,2502.0,2.5151367,no(M2 and SIP pres)
81.62598,1,male,0,7,180,COPD,COPD/CHF/Cirrhosis,5,7.0,under $11k,4685.0,3020.8144,18.0,white,36.0,1,0,1,yes,0.5,0.5,no dnr,7.0,74.0,4.89941406,81.0,24.0,36.09375,233.3125,3.5,1.01,0.89990234,145.0,7.379883,135.0,23.0,2502.0,2.0,no(M2 and SIP pres)
43.63898,1,male,0,35,39,Coma,Coma,0,12.0,$25-$50k,22306.0,27158.3594,22.75,white,23.0,1,0,0,no,0.699999809,0.5,dnr after sadm,11.0,114.0,25.796875,74.0,34.0,36.09375,445.0,2.699707,0.89990234,0.69995117,129.0,7.5,135.0,23.0,2502.0,1.0,<2 mo. follow-up
69.47797,0,female,0,15,1329,CHF,COPD/CHF/Cirrhosis,2,14.0,$25-$50k,11658.0,7918.2812,12.0,white,20.0,1,0,0,no,0.799999714,0.8,no dnr,15.0,65.0,9.0,63.0,20.0,36.0,333.3,3.5,1.01,1.19995117,135.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.96594,1,male,0,51,85,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,158804.0,111121.562,30.0,white,32.0,30,0,0,yes,0.699999809,0.5,dnr after sadm,16.0,79.0,11.6992188,80.0,40.0,38.69531,223.3125,3.5,1.01,1.39990234,146.0,7.439453,135.0,23.0,2502.0,6.0,adl>=4 (>=5 if sur)
61.64798,0,female,0,8,1328,CHF,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,5194.0,3546.2168,6.0,white,53.0,1,0,0,no,0.899999619,0.9,no dnr,8.0,109.0,4.19921875,110.0,24.0,36.09375,285.6875,3.3999023,0.79992676,3.29980469,129.0,7.509766,135.0,23.0,2502.0,2.6704102,<2 mo. follow-up
73.68695,0,male,0,4,1323,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,4337.0,2941.3672,15.0,white,12.0,1,0,0,no,0.799999714,0.75,no dnr,4.0,99.0,19.0,107.0,20.0,36.29688,210.0,4.0996094,0.5,1.19995117,140.0,7.429688,135.0,23.0,2502.0,2.081543,no(M2 and SIP pres)
70.51599,1,female,0,4,5,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,9541.0,6665.918,33.0,white,50.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,99.0,62.1953125,64.0,32.0,35.79688,100.0,3.5,10.6992188,0.89990234,137.0,7.449219,135.0,23.0,2502.0,2.2207031,<2 mo. follow-up
81.77399,1,male,0,25,163,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,82252.0,58002.0938,24.75,white,51.0,34,0,0,no,0.699999809,0.5,no dnr,25.0,58.0,21.3984375,120.0,14.0,38.09375,257.125,2.5996094,0.59997559,2.39990234,132.0,7.369141,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
64.05695,1,male,0,8,17,Lung Cancer,Cancer,1,10.0,under $11k,8466.0,14452.7344,17.5,white,25.0,1,0,0,metastatic,0.489999771,0.19,dnr after sadm,2.0,73.0,9.8984375,110.0,24.0,35.69531,376.0,2.199707,0.5,0.89990234,136.0,7.509766,135.0,23.0,2502.0,6.0,<2 mo. follow-up
85.22095,1,female,0,3,290,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,1936.0,1283.6807,21.0,white,16.0,1,0,0,yes,0.899999619,0.8,dnr after sadm,1.0,77.0,7.79980469,73.0,20.0,35.79688,320.0,3.7998047,0.59997559,0.69995117,135.0,7.429688,135.0,23.0,2502.0,3.1811523,<2 mo. follow-up
68.75299,0,female,0,17,1320,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,12189.0,7941.2812,13.0,white,21.0,1,1,0,no,0.799999714,0.5,no dnr,17.0,82.0,9.0,81.0,26.0,36.09375,196.28125,3.3999023,0.79992676,1.0,136.0,7.339844,135.0,23.0,2502.0,1.0,no(M2 and SIP pres)
72.70599,0,male,0,21,1319,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,$11-$25k,81726.0,53869.1562,21.0,white,42.0,24,0,0,no,0.699999809,0.5,no dnr,21.0,80.0,11.0996094,112.0,27.0,36.89844,93.32812,3.5,1.01,1.39990234,138.0,7.509766,135.0,23.0,2502.0,0.0,adl>=4 (>=5 if sur)
67.146,1,female,1,57,57,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,184437.0,121788.375,35.5,white,27.0,33,0,0,no,0.699999809,0.7,dnr after sadm,53.0,132.0,8.19921875,150.0,8.0,39.0,315.0,3.5,1.01,0.59997559,135.0,7.469727,135.0,23.0,2502.0,2.1689453,<2 mo. follow-up
67.30695,1,female,0,37,39,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,94682.0,66285.875,28.75,white,52.0,11,1,1,no,0.699999809,0.5,dnr after sadm,5.0,118.0,22.796875,120.0,26.0,36.59375,128.5625,2.7998047,0.5,1.59985352,141.0,7.25,135.0,23.0,2502.0,3.8125,<2 mo. follow-up
79.90997,1,male,0,34,225,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,28112.0,19613.2969,17.5,white,26.0,1,0,1,no,0.699999809,0.7,dnr after sadm,2.0,68.0,20.6992188,78.0,22.0,36.69531,333.3,3.5,1.01,1.0,133.0,7.419922,135.0,23.0,2502.0,3.0,adl>=4 (>=5 if sur)
60.58899,0,female,0,47,1316,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,109058.0,75702.5,31.0,white,68.0,24,1,0,no,0.899999619,0.9,no dnr,47.0,51.0,22.0,135.0,35.0,36.79688,192.0,2.5996094,1.09985352,4.89941406,135.0,7.429688,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.80194,1,male,0,13,137,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,10474.0,7049.2891,11.0,white,44.0,1,1,0,no,0.899999619,0.8,dnr after sadm,4.0,112.0,9.0,70.0,36.0,36.0,132.0,3.5,1.01,1.29980469,137.0,7.299805,135.0,23.0,2502.0,3.9086914,no(M2 and SIP pres)
59.168,1,male,0,4,245,Lung Cancer,Cancer,1,19.0,$25-$50k,3412.0,2211.0644,12.0,white,16.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,102.0,3.5,101.0,20.0,36.59375,333.3,4.0,0.5,1.19995117,139.0,7.419922,135.0,23.0,2502.0,1.8078613,no(M2 and SIP pres)
69.09796,0,male,0,22,1312,Coma,Coma,0,8.0,under $11k,23301.0,34290.9688,20.0,white,38.0,1,0,0,no,0.75,0.5,dnr after sadm,1.0,107.0,8.8984375,78.0,36.0,37.69531,305.0,2.8999023,0.5,2.39990234,141.0,7.40918,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
32.27399,1,female,0,37,124,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,80302.0,49708.4688,26.75,white,38.0,25,0,0,no,0.5,0.4,dnr after sadm,5.0,107.0,5.89941406,126.0,40.0,38.89844,152.5,2.3999023,0.79992676,0.59997559,138.0,7.469727,135.0,23.0,2502.0,2.4047852,<2 mo. follow-up
78.21198,1,male,0,7,38,CHF,COPD/CHF/Cirrhosis,4,9.0,under $11k,3987.0,2706.4766,6.0,white,17.0,1,0,0,no,0.899999619,0.75,no dnr,7.0,82.0,11.0996094,104.0,24.0,36.59375,333.3,3.199707,1.19995117,1.19995117,136.0,7.419922,135.0,23.0,2502.0,0.4947999,<2 mo. follow-up
59.87698,1,male,0,6,78,Lung Cancer,Cancer,3,12.0,$11-$25k,4064.0,2535.625,7.0,white,31.0,1,0,0,metastatic,0.389999866,0.19,no dnr,6.0,65.0,0.89990234,63.0,20.0,36.39844,333.3,2.699707,0.5,0.59997559,135.0,7.419922,135.0,23.0,2502.0,2.7900391,adl>=4 (>=5 if sur)
75.93195,1,male,0,21,1059,CHF,COPD/CHF/Cirrhosis,2,6.0,under $11k,29476.0,19041.3281,18.666656,white,42.0,1,0,0,no,0.899999619,0.7,no dnr,21.0,63.0,5.09960938,70.0,29.0,36.39844,333.3,3.5,1.01,2.0,131.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
68.05695,1,male,0,18,1097,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,25959.0,18683.5469,27.333328,white,45.0,1,1,0,yes,0.699999809,0.5,no dnr,18.0,57.0,100.0,105.0,12.0,38.39844,131.65625,3.0996094,1.69995117,1.39990234,146.0,7.489258,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
69.711,1,male,0,5,1212,Lung Cancer,Cancer,2,8.0,under $11k,5852.0,3574.4023,7.0,white,25.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,108.0,5.79980469,107.0,18.0,35.89844,333.3,3.5,1.01,1.29980469,125.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
76.76898,1,female,1,12,12,Colon Cancer,Cancer,1,12.0,under $11k,7139.0,4815.7656,15.5,white,24.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,75.0,14.2988281,110.0,22.0,35.59375,333.3,3.199707,0.5,0.89990234,136.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
84.159,1,female,0,14,18,Coma,Coma,1,14.0,under $11k,17962.0,12456.6641,14.0,white,41.0,4,0,0,no,0.25,0.1,no dnr,14.0,123.0,17.8984375,150.0,36.0,38.19531,333.3,3.5,1.01,0.69995117,136.0,7.419922,135.0,23.0,2502.0,0.0,<2 mo. follow-up
66.30798,0,male,0,3,1302,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,2328.0,1629.7373,24.0,white,25.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,121.0,6.09960938,68.0,24.0,35.29688,342.8125,3.3999023,0.79992676,1.79980469,140.0,7.379883,135.0,23.0,2502.0,2.3129883,no(M2 and SIP pres)
62.58197,0,female,0,9,1305,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,8455.0,6367.9336,11.5,white,21.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,91.0,12.3984375,104.0,24.0,38.59375,140.0,3.0996094,1.09985352,0.89990234,139.0,7.379883,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
66.13794,0,female,0,46,1301,Coma,Coma,1,12.0,under $11k,132609.0,94985.75,23.5,white,30.0,27,0,0,no,0.699999809,0.5,no dnr,46.0,100.0,9.0,124.0,32.0,38.0,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,7.0,adl>=4 (>=5 if sur)
63.90097,1,male,1,4,4,Coma,Coma,1,12.0,under $11k,4364.0,3167.4707,25.0,white,43.0,1,0,0,no,0.5,0.3,dnr after sadm,3.0,123.0,10.5996094,152.0,42.0,38.19531,155.0,3.0996094,1.0,1.09985352,142.0,7.439453,135.0,23.0,2502.0,2.5844727,<2 mo. follow-up
62.98199,1,male,0,3,479,Lung Cancer,Cancer,1,14.0,$11-$25k,3867.0,2166.8477,7.0,white,18.0,1,0,0,metastatic,0.949999809,0.5,no dnr,3.0,117.0,2.79980469,104.0,20.0,36.09375,333.3,3.5,0.29998779,1.19995117,139.0,7.419922,135.0,23.0,2502.0,3.0,no(M2 and SIP pres)
68.11798,0,female,0,38,1089,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,52306.0,38925.5625,21.5,white,48.0,1,1,0,no,0.5,0.5,no dnr,38.0,103.0,8.5,108.0,10.0,38.5,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,3140.0,5.0,adl>=4 (>=5 if sur)
50.47198,1,male,0,7,647,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,5953.0,3888.6113,7.5,white,9.0,1,0,0,no,0.849999905,0.65,no dnr,7.0,66.0,9.5,106.0,26.0,36.0,393.75,3.7998047,1.5,1.89990234,134.0,7.519531,155.0,32.0,350.0,2.0,no(M2 and SIP pres)
42.72699,0,female,0,13,1088,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,62248.0,40416.125,28.5,white,55.0,25,0,0,no,0.5,0.4,no dnr,13.0,68.0,10.8984375,67.0,11.0,38.5,204.0,2.0996094,1.0,5.5,137.0,7.469727,120.0,55.0,100.0,0.0,no(M2 and SIP pres)
65.11694,1,female,0,7,172,COPD,COPD/CHF/Cirrhosis,2,7.0,under $11k,6253.0,4228.2773,4.0,white,17.0,1,0,0,yes,0.599999905,0.3,dnr after sadm,5.0,77.0,8.19921875,97.0,22.0,36.79688,333.3,4.0996094,1.0,0.89990234,142.0,7.419922,120.0,13.0,400.0,1.1667481,no(M2 and SIP pres)
87.461,1,female,0,21,26,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,17285.0,11621.2344,8.333328,white,17.0,1,0,0,no,0.799999714,0.5,dnr after sadm,1.0,93.0,2.19970703,60.0,20.0,36.19531,333.3,3.199707,2.09960938,0.59997559,138.0,7.419922,103.0,13.0,2502.0,3.0,<2 mo. follow-up
63.41998,1,male,0,12,72,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,9577.0,6214.8398,8.0,white,51.0,1,0,0,no,0.699999809,0.4,no dnr,12.0,123.0,7.79980469,79.0,32.0,35.09375,492.0,3.699707,1.09985352,1.79980469,135.0,7.439453,131.0,35.0,1265.0,3.7543945,<2 mo. follow-up
69.24597,1,female,1,10,10,MOSF w/Malig,ARF/MOSF,2,16.0,$25-$50k,17546.0,11843.5469,18.0,white,20.0,5,0,0,metastatic,0.5,0.4,dnr after sadm,9.0,126.0,27.5,109.0,26.0,35.89844,432.0,2.2998047,1.19995117,7.59960938,131.0,7.339844,153.0,154.0,2276.0,5.0,<2 mo. follow-up
63.83798,1,female,0,9,281,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,5725.0,3879.4102,8.0,white,18.0,1,1,0,no,0.75,0.75,no dnr,9.0,71.0,5.89941406,76.0,16.0,36.69531,333.3,3.8999023,0.89990234,1.29980469,134.0,7.419922,86.0,16.0,2502.0,1.0,no(M2 and SIP pres)
79.39795,0,male,0,10,1082,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,8833.0,6296.0547,10.5,white,28.0,1,0,0,no,0.989999771,0.8,dnr before sadm,-1.0,109.0,5.5,132.0,8.0,39.5,399.625,1.6999512,1.59985352,0.79992676,148.0,7.359375,152.0,21.0,1225.0,0.0,no(M2 and SIP pres)
75.56995,1,female,1,39,39,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,$25-$50k,77306.0,48291.8438,23.75,white,32.0,3,0,0,no,0.899999619,0.8,dnr after sadm,39.0,68.0,39.59375,68.0,24.0,36.09375,333.3,2.5,5.29980469,2.39990234,129.0,7.419922,272.0,62.0,1230.0,1.0,<2 mo. follow-up
34.65298,0,male,0,12,1081,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,29222.0,20343.5312,15.0,white,48.0,8,0,0,no,0.699999809,0.5,no dnr,12.0,115.0,4.5,60.0,12.0,36.59375,173.53125,2.0,1.19995117,0.69995117,142.0,7.549805,151.0,15.0,3153.0,0.0,no(M2 and SIP pres)
74.57898,1,male,0,8,567,Lung Cancer,Cancer,1,12.0,under $11k,4308.0,2934.709,6.5,white,14.0,1,0,0,metastatic,0.75,0.5,dnr before sadm,-1.0,111.0,6.79980469,64.0,22.0,36.09375,333.3,3.199707,0.79992676,1.89990234,139.0,7.419922,93.0,32.0,1425.0,2.6640625,<2 mo. follow-up
72.97498,0,female,0,9,1079,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,8002.0,5365.7031,12.5,white,37.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,68.0,6.29980469,113.0,28.0,37.19531,244.4375,3.5,1.01,1.0,137.0,7.359375,108.0,6.0,1384.0,0.0,no(M2 and SIP pres)
77.823,1,male,0,8,776,COPD,COPD/CHF/Cirrhosis,1,11.0,under $11k,8005.0,5048.3125,11.5,white,32.0,1,0,0,no,0.899999619,0.75,no dnr,8.0,107.0,12.2988281,96.0,32.0,35.69531,333.3,3.3999023,0.79992676,1.0,126.0,7.419922,132.0,10.0,5350.0,0.0,no(M2 and SIP pres)
77.5,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,16565.0,10627.6406,48.0,white,67.0,4,0,0,yes,0.089999974,0.09,dnr before sadm,-3.0,149.0,6.29980469,114.0,26.0,36.69531,190.0,2.0996094,1.69995117,4.5,141.0,7.469727,211.0,92.0,438.0,1.0,<2 mo. follow-up
64.18597,1,female,1,12,12,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,168012.0,105001.0,42.5,white,50.0,95,0,0,no,0.049999982,0.03,dnr after sadm,4.0,131.0,16.5976562,118.0,25.0,37.69531,206.0,3.3999023,0.59997559,2.79980469,136.0,7.399414,180.0,33.0,1327.0,6.0,<2 mo. follow-up
82.55396,1,female,1,4,4,Cirrhosis,COPD/CHF/Cirrhosis,1,8.0,under $11k,8436.0,6312.2773,38.0,white,100.0,1,0,0,no,0.199999928,0.02,dnr after sadm,4.0,67.0,14.6992188,126.0,34.0,35.69531,183.3125,1.7998047,0.79992676,2.89990234,138.0,7.369141,174.0,75.0,4340.0,3.8344727,<2 mo. follow-up
30.987,0,female,0,10,1075,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,10124.0,6855.1562,17.0,white,37.0,1,0,0,no,0.849999905,0.5,no dnr,10.0,132.0,20.8984375,147.0,38.0,38.59375,84.0,2.5,2.29980469,0.79992676,138.0,7.519531,238.0,19.0,3565.0,0.0,no(M2 and SIP pres)
74.508,0,male,0,4,1075,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,2104.0,1398.7158,5.0,white,37.0,1,0,0,yes,0.299999952,0.2,dnr after sadm,1.0,97.0,15.3984375,116.0,32.0,37.09375,146.03125,2.5,1.0,0.89990234,122.0,7.239258,107.0,17.0,1250.0,0.0,no(M2 and SIP pres)
66.245,1,male,0,7,146,Colon Cancer,Cancer,1,10.0,$11-$25k,7801.0,4927.7969,5.5,white,23.0,1,0,0,metastatic,1.0,1.0,dnr after sadm,1.0,121.0,10.0996094,80.0,28.0,36.09375,52.59375,3.3999023,0.69995117,0.89990234,144.0,7.30957,134.0,4.0,3630.0,0.0,no(M2 and SIP pres)
66.80597,0,female,0,6,1071,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,4827.0,3117.4648,10.0,white,21.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,116.0,16.1992188,139.0,10.0,35.89844,195.46875,2.0,2.0,1.19995117,143.0,7.449219,296.0,47.0,3455.0,1.9628906,no(M2 and SIP pres)
61.43997,1,female,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,43480.0,29285.5938,24.5,white,55.0,5,0,0,no,0.799999714,0.5,no dnr,8.0,63.0,21.6992188,126.0,22.0,39.19531,166.0,1.3999023,2.5,1.0,149.0,7.419922,108.0,15.0,2063.0,0.494751,<2 mo. follow-up
37.54999,0,male,0,29,1070,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,40796.0,29316.4375,9.75,white,41.0,11,1,0,no,0.799999714,0.5,no dnr,29.0,70.0,7.39941406,140.0,20.0,36.79688,333.3,4.2998047,1.09985352,1.0,136.0,7.419922,107.0,7.0,2502.0,5.0,adl>=4 (>=5 if sur)
52.88998,1,male,0,10,12,Coma,Coma,2,8.0,$11-$25k,20327.0,13971.5,35.0,white,39.0,1,1,0,no,0.099999964,0.0,dnr after sadm,4.0,75.0,4.0,74.0,20.0,37.79688,333.3,4.0,0.39996338,0.89990234,140.0,7.419922,98.0,8.0,2502.0,1.0,<2 mo. follow-up
41.862,1,female,0,18,60,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,63260.0,44163.5312,22.333328,white,45.0,5,0,0,no,0.5,0.3,no dnr,18.0,143.0,8.0,100.0,20.0,36.69531,333.3,4.1992188,0.69995117,1.39990234,138.0,7.419922,101.0,18.0,2502.0,2.5761719,<2 mo. follow-up
73.68097,1,male,0,11,355,CHF,COPD/CHF/Cirrhosis,5,15.0,$11-$25k,9157.0,6739.75,9.0,white,38.0,1,1,1,no,0.699999809,0.5,no dnr,11.0,103.0,0.18997192,85.0,24.0,35.0,326.1875,2.199707,0.39996338,0.5,129.0,7.519531,200.0,7.0,1200.0,6.0,SIP>=30
88.58899,1,male,0,5,666,CHF,COPD/CHF/Cirrhosis,1,3.0,under $11k,2930.0,2039.8115,6.0,white,30.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,74.0,14.7988281,52.0,30.0,37.59375,105.0,3.3999023,2.89990234,0.79992676,131.0,7.449219,144.0,16.0,1823.0,3.3774414,no(M2 and SIP pres)
62.56,1,male,1,5,5,Coma,Coma,1,16.0,$25-$50k,7629.0,14452.7344,21.0,white,24.0,1,0,0,no,0.099999964,0.0,dnr after sadm,2.0,111.0,7.0,118.0,24.0,35.89844,212.5,3.699707,0.29998779,1.59985352,137.0,7.289062,122.0,48.0,2650.0,2.3105469,<2 mo. follow-up
67.82495,1,female,0,17,950,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,20390.0,14021.3594,24.666656,white,63.0,1,1,0,no,0.849999905,0.7,no dnr,17.0,71.0,10.2988281,122.0,32.0,35.79688,409.5,3.7998047,1.69995117,0.79992676,115.0,7.509766,217.0,19.0,5620.0,0.0,no(M2 and SIP pres)
81.82599,1,female,1,6,6,MOSF w/Malig,ARF/MOSF,5,12.0,under $11k,9599.0,6960.7734,34.0,white,48.0,1,0,1,yes,0.0,0.0,dnr after sadm,3.0,110.0,10.2988281,80.0,22.0,36.59375,333.3,1.1999512,1.89990234,1.5,134.0,7.419922,94.0,25.0,2502.0,4.6826172,<2 mo. follow-up
61.20697,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,12832.0,35940.7188,30.0,hispanic,53.0,5,0,0,no,0.5,0.5,dnr after sadm,7.0,79.0,5.89941406,114.0,10.0,38.0,103.42188,2.199707,0.5,2.59960938,143.0,7.449219,126.0,26.0,1062.0,2.6088867,<2 mo. follow-up
82.11395,1,female,0,16,719,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,20328.0,13797.9531,20.0,hispanic,13.0,1,0,0,no,0.5,0.5,dnr after sadm,7.0,110.0,39.0,142.0,40.0,35.89844,75.0,1.1999512,0.89990234,1.09985352,142.0,7.509766,101.0,16.0,4175.0,0.0,no(M2 and SIP pres)
70.00696,1,male,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,31634.0,22024.7656,23.0,white,20.0,9,0,0,no,0.699999809,0.5,no dnr,6.0,101.0,5.39941406,104.0,20.0,36.69531,253.4375,2.699707,0.69995117,1.29980469,141.0,7.439453,97.0,16.0,2502.0,0.0,<2 mo. follow-up
71.198,1,female,0,10,18,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,29653.0,19878.0469,26.0,white,47.0,3,1,0,yes,0.949999809,0.65,dnr after sadm,5.0,97.0,10.0,66.0,20.0,36.19531,170.9375,3.699707,0.39996338,1.09985352,140.0,7.349609,118.0,10.0,4250.0,1.0,<2 mo. follow-up
66.02899,1,male,0,5,93,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,3923.0,2519.0059,8.0,white,10.0,1,0,0,yes,0.799999714,0.6,dnr after sadm,1.0,133.0,4.79980469,73.0,24.0,35.79688,240.0,3.5996094,0.89990234,0.79992676,132.0,7.40918,208.0,9.0,4354.0,5.0,SIP>=30
66.086,1,female,0,12,305,MOSF w/Malig,ARF/MOSF,4,12.0,under $11k,11931.0,7972.5547,14.0,white,41.0,1,0,0,yes,0.599999905,0.5,dnr after sadm,2.0,141.0,10.0996094,138.0,47.0,38.69531,73.0,3.199707,0.69995117,0.89990234,135.0,7.369141,226.0,17.0,2462.0,3.1611328,<2 mo. follow-up
47.76498,1,female,0,3,85,Lung Cancer,Cancer,2,12.0,$25-$50k,2900.0,1750.4297,22.610928270087555,white,11.0,1,0,0,metastatic,0.799999714,0.5,no dnr,3.0,123.0,11.1992188,96.0,20.0,36.0,303.3125,3.8999023,0.69995117,1.29980469,133.0,7.489258,130.0,11.0,2502.0,2.1274414,no(M2 and SIP pres)
67.05298,1,male,0,19,57,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,66940.0,41353.8438,26.0,white,52.0,34,0,0,yes,0.5,0.25,no dnr,19.0,129.0,14.2988281,128.0,24.0,36.39844,430.6875,2.2998047,1.19995117,0.79992676,129.0,7.519531,96.0,24.0,1310.0,0.0,<2 mo. follow-up
56.41299,1,female,0,16,417,Colon Cancer,Cancer,2,12.0,$25-$50k,16094.0,10771.8047,15.666664,white,9.0,1,0,0,metastatic,0.899999619,0.7,no dnr,16.0,68.0,14.6992188,60.0,32.0,36.29688,501.625,3.5996094,1.19995117,0.59997559,132.0,7.449219,125.0,20.0,1766.0,0.0,no(M2 and SIP pres)
56.67398,1,female,0,3,56,Lung Cancer,Cancer,1,14.0,under $11k,9091.0,6717.8398,22.610928270087555,white,17.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,60.0,20.296875,106.0,24.0,36.39844,191.40625,2.0996094,0.59997559,5.5,147.0,7.349609,143.0,113.0,1015.0,2.3798828,<2 mo. follow-up
64.84094,0,male,0,13,1054,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,25119.0,16538.7188,29.5,white,42.0,3,1,0,no,0.849999905,0.5,no dnr,13.0,118.0,9.5,76.0,10.0,36.39844,178.5625,3.699707,0.59997559,2.29980469,142.0,7.219727,173.0,61.0,4335.0,0.0,no(M2 and SIP pres)
62.20099,1,male,0,9,28,Lung Cancer,Cancer,3,8.0,$25-$50k,6164.0,4395.6094,4.0,white,27.0,1,1,0,metastatic,0.25,0.05,dnr after sadm,6.0,101.0,14.0996094,63.0,38.0,36.5,171.40625,3.199707,0.89990234,1.09985352,130.0,7.469727,156.0,37.0,3945.0,4.0,<2 mo. follow-up
76.04095,1,male,1,3,3,Coma,Coma,1,8.0,$11-$25k,8063.0,5650.8984,19.0,white,38.0,4,0,0,no,0.699999809,0.5,dnr after sadm,2.0,75.0,4.0,80.0,22.0,36.29688,376.625,3.5,1.01,1.19995117,139.0,7.549805,24.0,18.0,2502.0,2.7197266,<2 mo. follow-up
75.79999,0,female,0,7,1052,CHF,COPD/CHF/Cirrhosis,6,7.0,under $11k,4941.0,3309.6856,6.5,white,13.0,1,1,0,no,0.849999905,0.75,no dnr,7.0,74.0,23.5,81.0,24.0,36.09375,174.28125,3.5996094,0.29998779,0.79992676,140.0,7.419922,125.0,9.0,1710.0,0.0,no(M2 and SIP pres)
63.93997,0,female,0,56,1052,Coma,Coma,1,14.0,$11-$25k,90996.0,63028.9375,33.25,white,24.0,6,0,0,yes,0.799999714,0.7,no dnr,56.0,66.0,12.0,118.0,22.0,38.5,145.09375,2.5996094,0.5,2.59960938,149.0,7.40918,149.0,53.0,2745.0,0.0,adl>=4 (>=5 if sur)
70.70197,1,male,0,5,67,Lung Cancer,Cancer,1,12.0,under $11k,2796.0,1861.1143,10.0,white,15.0,1,0,0,metastatic,0.799999714,0.4,no dnr,5.0,58.0,24.5,153.0,18.0,39.0,47.19531,1.7998047,1.09985352,0.69995117,145.0,7.349609,241.0,15.0,5812.0,2.2177734,<2 mo. follow-up
74.43896,1,male,1,11,11,ARF/MOSF w/Sepsis,ARF/MOSF,2,16.0,under $11k,45006.0,29696.6562,36.0,white,16.0,5,0,0,no,0.5,0.5,dnr after sadm,11.0,91.0,7.89941406,72.0,20.0,37.59375,333.3,2.699707,1.79980469,0.69995117,132.0,7.419922,118.0,6.0,525.0,0.0,<2 mo. follow-up
76.59698,1,female,0,5,19,Lung Cancer,Cancer,1,12.0,under $11k,2698.0,1880.1592,6.0,white,19.0,1,0,0,metastatic,0.399999857,0.05,dnr after sadm,3.0,122.0,5.39941406,120.0,28.0,36.59375,206.4375,3.5996094,0.19998169,0.79992676,139.0,7.289062,129.0,10.0,1905.0,2.2382812,<2 mo. follow-up
72.44598,0,male,0,6,1049,CHF,COPD/CHF/Cirrhosis,6,3.0,under $11k,4549.0,3150.8008,12.0,white,12.0,1,1,0,no,0.949999809,0.9,no dnr,6.0,115.0,10.3984375,75.0,10.0,36.0,203.125,1.8999023,2.0,0.69995117,127.0,7.459961,152.0,11.0,1970.0,0.0,no(M2 and SIP pres)
79.409,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,5,8.0,under $11k,27343.0,18724.5156,11.666664,white,38.0,1,1,0,no,0.699999809,0.5,no dnr,23.0,109.0,13.5,54.0,24.0,38.39844,382.8125,2.5,0.39996338,0.79992676,139.0,7.5,116.0,11.0,2835.0,2.0,<2 mo. follow-up
75.46899,0,female,0,6,1048,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,6738.0,4597.5352,22.0,white,48.0,1,0,0,no,0.949999809,0.8,no dnr,6.0,103.0,11.5,113.0,22.0,37.19531,168.5625,2.3999023,0.89990234,0.79992676,138.0,7.299805,183.0,28.0,2502.0,1.8955078,<2 mo. follow-up
70.00098,1,female,1,5,5,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,16813.0,11912.1953,29.0,white,70.0,3,0,0,yes,0.299999952,0.2,dnr after sadm,4.0,111.0,12.2988281,131.0,28.0,36.69531,275.0,2.5,1.59985352,0.89990234,138.0,7.55957,109.0,11.0,1340.0,3.0,<2 mo. follow-up
64.862,0,female,0,5,1046,Lung Cancer,Cancer,1,12.0,under $11k,3304.0,2222.3672,6.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,111.0,6.59960938,75.0,16.0,35.79688,333.3,3.5,1.01,2.29980469,139.0,7.419922,301.0,40.0,1420.0,1.9821777,<2 mo. follow-up
66.06396,0,male,0,8,1045,Colon Cancer,Cancer,3,8.0,under $11k,4612.0,3072.0527,8.5,white,5.0,1,1,0,metastatic,0.699999809,0.4,no dnr,8.0,101.0,13.6992188,61.0,24.0,36.29688,473.75,3.5,1.01,0.89990234,130.0,7.449219,125.0,19.0,2240.0,1.0,no(M2 and SIP pres)
80.70599,0,male,0,7,1044,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,15582.0,10023.0312,9.5,white,28.0,3,0,0,yes,0.979999542,0.9,no dnr,7.0,63.0,24.796875,56.0,36.0,35.5,333.3,2.699707,1.09985352,2.0,132.0,7.419922,181.0,90.0,6176.0,0.494751,<2 mo. follow-up
20.15599,0,male,0,26,1044,Coma,Coma,0,14.0,under $11k,66661.0,43215.5625,21.0,white,54.0,1,0,0,no,0.75,0.9,no dnr,26.0,122.0,6.89941406,62.0,12.0,37.59375,244.0,2.8999023,1.09985352,1.59985352,145.0,7.519531,135.0,31.0,3052.0,0.0,no(M2 and SIP pres)
65.68896,1,male,0,6,44,Lung Cancer,Cancer,2,14.0,$11-$25k,3969.0,2548.1445,4.0,white,12.0,1,1,0,metastatic,0.299999952,0.1,no dnr,6.0,81.0,4.89941406,55.0,24.0,36.29688,333.3,3.2998047,0.89990234,2.0,137.0,7.419922,88.0,31.0,1500.0,0.0,<2 mo. follow-up
79.09094,1,male,0,9,926,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,6378.0,4197.3984,6.5,white,26.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,115.0,9.3984375,91.0,20.0,36.5,333.3,3.699707,0.39996338,1.5,133.0,7.419922,142.0,10.0,6275.0,3.0078125,<2 mo. follow-up
75.87695,1,female,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,86926.0,56362.8438,26.0,white,52.0,30,0,0,no,0.099999964,0.6,no dnr,20.0,33.0,13.6992188,161.0,10.0,37.5,90.54688,1.5,1.39990234,2.89990234,138.0,7.369141,233.0,62.0,75.0,1.0,<2 mo. follow-up
77.29498,1,male,1,36,36,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,89062.0,58730.5312,30.0,white,39.0,24,0,0,no,0.799999714,0.8,dnr after sadm,36.0,82.0,6.19921875,96.0,24.0,36.79688,140.90625,3.8999023,1.59985352,1.09985352,142.0,7.419922,153.0,13.0,750.0,1.0,<2 mo. follow-up
66.75397,1,male,0,16,31,CHF,COPD/CHF/Cirrhosis,4,15.0,$25-$50k,14292.0,10103.7656,16.0,white,35.0,1,0,0,no,0.699999809,0.5,no dnr,16.0,115.0,8.8984375,126.0,40.0,38.89844,377.5,2.5,0.69995117,1.79980469,144.0,7.469727,191.0,52.0,2915.0,6.0,<2 mo. follow-up
75.79498,1,male,0,10,15,ARF/MOSF w/Sepsis,ARF/MOSF,6,8.0,under $11k,34789.0,23674.0156,31.5,white,50.0,7,1,0,yes,0.299999952,0.2,dnr after sadm,9.0,103.0,11.2988281,68.0,20.0,37.0,295.1875,3.5996094,0.69995117,0.89990234,139.0,7.459961,181.0,14.0,2502.0,1.0,<2 mo. follow-up
70.76495,1,male,0,14,19,Coma,Coma,5,12.0,$11-$25k,11963.0,8354.4531,11.0,white,34.0,1,1,1,no,0.299999952,0.3,dnr before sadm,-1.0,121.0,27.3984375,120.0,50.0,38.89844,235.6875,2.0,2.69970703,1.09985352,143.0,7.549805,115.0,16.0,2742.0,4.0,<2 mo. follow-up
78.67798,0,male,0,11,1038,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,17143.0,11050.6875,8.0,white,25.0,1,0,0,no,0.949999809,0.6,no dnr,11.0,58.0,17.0976562,53.0,24.0,36.39844,333.3,3.5,1.01,0.29998779,125.0,7.419922,88.0,8.0,1480.0,0.0,no(M2 and SIP pres)
68.97998,1,male,0,12,96,Lung Cancer,Cancer,1,11.0,$11-$25k,6820.0,4525.5234,3.5,white,2.0,1,0,0,metastatic,1.0,1.0,no dnr,12.0,51.0,18.5976562,112.0,16.0,38.0,84.53125,2.0,1.09985352,1.09985352,143.0,7.459961,123.0,18.0,1915.0,1.920166,no(M2 and SIP pres)
40.86798,0,female,0,4,1036,CHF,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,3969.0,2673.0996,10.0,white,21.0,1,0,0,no,0.949999809,0.9,no dnr,4.0,50.0,18.6992188,109.0,8.0,35.5,256.3125,1.6999512,9.0,4.79980469,141.0,7.399414,221.0,57.0,0.0,1.5061035,no(M2 and SIP pres)
77.28998,1,male,0,9,959,COPD,COPD/CHF/Cirrhosis,2,11.0,$11-$25k,6355.0,4204.3125,6.5,white,12.0,1,0,0,no,0.899999619,0.5,no dnr,9.0,99.0,13.1992188,100.0,24.0,35.79688,165.21875,3.2998047,1.69995117,0.69995117,140.0,7.399414,128.0,10.0,2502.0,0.0,no(M2 and SIP pres)
58.34399,1,male,0,28,120,Lung Cancer,Cancer,2,12.0,under $11k,48555.0,31352.5781,25.5,white,31.0,1,0,0,metastatic,0.399999857,0.1,no dnr,28.0,105.0,11.7988281,78.0,16.0,36.0,302.8125,4.1992188,0.69995117,1.39990234,126.0,7.399414,79.0,15.0,2800.0,2.9013672,<2 mo. follow-up
69.50299,0,male,0,9,1034,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,19367.0,12622.4766,14.5,white,40.0,2,0,0,no,0.989999771,0.99,no dnr,9.0,107.0,11.5996094,70.0,24.0,36.19531,284.25,3.699707,1.0,1.39990234,145.0,7.40918,75.0,48.0,2350.0,0.0,no(M2 and SIP pres)
77.13098,0,male,0,28,1034,Coma,Coma,1,13.0,$25-$50k,37480.0,25343.3125,22.75,white,21.0,2,0,0,yes,0.5,0.5,no dnr,28.0,127.0,7.89941406,79.0,24.0,35.09375,266.625,3.5996094,0.89990234,2.29980469,138.0,7.369141,207.0,27.0,3055.0,0.0,adl>=4 (>=5 if sur)
80.66498,0,female,0,9,1033,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,7578.0,5084.1562,12.0,white,15.0,1,0,0,no,0.899999619,0.5,dnr before sadm,-1.0,112.0,3.0,104.0,16.0,36.29688,333.3,2.8999023,4.89941406,0.59997559,137.0,7.419922,90.0,9.0,2502.0,0.0,no(M2 and SIP pres)
64.03595,1,male,0,9,22,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,6096.0,4047.0644,7.5,white,22.0,1,0,0,no,0.699999809,0.6,dnr after sadm,1.0,102.0,8.3984375,78.0,24.0,37.89844,333.3,3.0,1.59985352,1.0,133.0,7.419922,101.0,9.0,3650.0,0.0,<2 mo. follow-up
80.62396,1,female,1,3,3,MOSF w/Malig,ARF/MOSF,3,9.0,$11-$25k,5328.0,3825.4981,29.0,white,60.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,56.0,16.1992188,96.0,13.0,36.09375,333.3,2.3999023,0.79992676,6.5,139.0,7.419922,162.0,60.0,304.0,4.1298828,<2 mo. follow-up
64.159,0,male,0,84,1030,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,196926.0,140458.25,23.25,white,83.0,17,1,0,no,0.699999809,0.7,no dnr,84.0,63.0,21.5976562,104.0,10.0,37.89844,292.0,2.5,0.19998169,4.5,133.0,7.399414,236.0,34.0,195.0,2.6699219,Coma or Intub
71.20599,1,male,1,19,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,19.0,>$50k,81716.0,57042.6875,45.666657,white,69.0,1,0,0,metastatic,0.25,0.25,dnr after sadm,18.0,101.0,7.79980469,107.0,22.0,35.5,333.3,3.699707,0.69995117,1.29980469,135.0,7.419922,123.0,16.0,3400.0,0.0,<2 mo. follow-up
76.01398,1,male,0,11,89,CHF,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,8210.0,5734.2891,10.0,white,31.0,1,0,0,no,0.899999619,0.9,no dnr,11.0,63.0,0.79992676,124.0,32.0,40.29688,333.3,3.5,1.01,1.0,140.0,7.419922,152.0,23.0,2725.0,0.0,no(M2 and SIP pres)
76.86499,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,34265.0,22998.5156,35.5,white,46.0,7,0,0,yes,0.75,0.75,dnr before sadm,-6.0,70.0,5.29980469,71.0,20.0,36.79688,257.125,4.1992188,0.29998779,0.89990234,140.0,7.519531,105.0,7.0,3400.0,5.0,<2 mo. follow-up
76.05695,1,female,0,7,468,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,7822.0,5231.5078,8.5,white,18.0,1,0,0,yes,0.699999809,0.5,no dnr,7.0,77.0,9.79882812,64.0,24.0,35.29688,333.3,4.2998047,0.79992676,1.19995117,137.0,7.419922,123.0,23.0,2502.0,6.0,<2 mo. follow-up
58.65598,0,male,0,10,1025,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,6493.0,4331.8125,7.0,white,23.0,1,0,0,no,0.799999714,0.7,no dnr,10.0,108.0,32.6953125,122.0,28.0,36.19531,209.5,3.0,0.59997559,0.79992676,140.0,7.40918,210.0,25.0,2000.0,0.0,no(M2 and SIP pres)
42.66098,1,male,0,4,7,Colon Cancer,Cancer,1,10.0,>$50k,4419.0,2632.5547,12.0,white,14.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,63.0,4.09960938,101.0,22.0,36.09375,296.25,3.5,1.01,0.79992676,148.0,7.419922,139.0,11.0,570.0,1.7751465,<2 mo. follow-up
49.37698,0,male,0,13,1022,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,24837.0,17625.0469,23.5,white,32.0,5,0,0,no,0.979999542,0.98,no dnr,13.0,105.0,10.6992188,81.0,24.0,36.19531,333.3,3.5,1.01,1.59985352,136.0,7.419922,218.0,19.0,2375.0,1.0,no(M2 and SIP pres)
58.81198,0,male,0,7,1024,CHF,COPD/CHF/Cirrhosis,3,20.0,under $11k,11502.0,7187.3828,8.0,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,83.0,14.2988281,70.0,28.0,36.59375,122.4375,3.5,1.01,1.19995117,134.0,7.279297,220.0,21.0,2750.0,1.0,no(M2 and SIP pres)
44.79099,1,male,0,5,423,Lung Cancer,Cancer,1,12.0,$25-$50k,6825.0,3957.3223,10.0,white,8.0,1,0,0,metastatic,0.949999809,0.9,no dnr,5.0,67.0,16.0976562,56.0,24.0,36.39844,207.5,3.5,1.01,2.09960938,140.0,7.329102,110.0,61.0,1600.0,1.9291992,no(M2 and SIP pres)
57.80197,1,female,0,11,932,Cirrhosis,COPD/CHF/Cirrhosis,1,12.0,under $11k,8502.0,5531.3594,20.5,white,36.0,1,0,0,no,0.75,0.75,no dnr,11.0,105.0,33.0,140.0,30.0,36.79688,220.0,3.2998047,0.59997559,1.09985352,152.0,7.519531,169.0,38.0,1300.0,2.6430664,<2 mo. follow-up
95.34796,1,male,0,4,574,CHF,COPD/CHF/Cirrhosis,3,10.0,$25-$50k,2889.0,2034.4414,5.0,white,23.0,1,1,0,no,0.989999771,0.98,no dnr,4.0,96.0,6.69921875,62.0,16.0,37.19531,333.3,3.5996094,0.19998169,1.39990234,139.0,7.419922,92.0,19.0,875.0,3.2104492,no(M2 and SIP pres)
78.40399,1,female,0,11,34,Coma,Coma,1,12.0,under $11k,18964.0,12842.6953,10.5,white,23.0,1,0,0,no,0.299999952,0.1,dnr after sadm,4.0,110.0,9.79882812,215.0,24.0,35.89844,261.875,3.3999023,0.39996338,0.69995117,138.0,7.40918,219.0,11.0,1050.0,0.0,<2 mo. follow-up
66.85596,0,female,0,17,1019,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,30742.0,21348.7344,14.0,hispanic,30.0,7,0,0,yes,0.799999714,0.75,no dnr,17.0,109.0,1.09985352,81.0,24.0,36.19531,292.5625,4.0,0.79992676,1.09985352,141.0,7.379883,209.0,24.0,700.0,2.1176758,no(M2 and SIP pres)
68.862,1,male,0,39,200,MOSF w/Malig,ARF/MOSF,3,12.0,$25-$50k,64543.0,42614.5,35.5,white,81.0,1,0,0,metastatic,0.299999952,0.3,dnr after sadm,27.0,59.0,23.3984375,120.0,28.0,35.59375,67.76562,2.0,1.09985352,1.19995117,148.0,7.25,237.0,37.0,2900.0,1.0,no(M2 and SIP pres)
76.24097,0,female,0,7,1017,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,5039.0,3335.2715,3.5,white,33.0,1,0,0,yes,0.899999619,0.9,no dnr,7.0,54.0,14.5,72.0,16.0,38.19531,237.5,2.0,1.59985352,3.39990234,132.0,7.329102,151.0,86.0,1150.0,0.0,no(M2 and SIP pres)
53.55197,1,female,0,8,36,Coma,Coma,1,12.0,$11-$25k,21253.0,16260.5625,17.5,white,11.0,1,0,0,yes,0.5,0.1,no dnr,8.0,38.0,10.3984375,49.0,24.0,35.79688,156.25,3.0996094,8.29882812,3.0,135.0,7.269531,74.0,95.0,30.0,2.0,<2 mo. follow-up
58.62299,1,female,0,15,164,COPD,COPD/CHF/Cirrhosis,0,13.0,$11-$25k,14096.0,9527.4844,10.666664,white,35.0,1,0,0,no,1.0,0.9,no dnr,15.0,72.0,16.296875,124.0,16.0,38.29688,316.0,2.199707,6.69921875,0.89990234,130.0,7.479492,171.0,2.0,4660.0,0.0,adl>=4 (>=5 if sur)
91.96698,1,male,0,10,31,CHF,COPD/CHF/Cirrhosis,4,4.0,under $11k,6512.0,4440.8672,5.0,white,32.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,61.0,52.3984375,101.0,28.0,36.39844,266.625,4.0,0.79992676,1.59985352,129.0,7.449219,124.0,26.0,3380.0,2.0,<2 mo. follow-up
70.20398,1,male,0,4,9,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,1742.0,1199.4209,5.0,white,27.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,125.0,9.0,114.0,20.0,36.5,242.84375,3.5996094,0.5,1.5,129.0,7.40918,135.0,15.0,2725.0,1.9011231,<2 mo. follow-up
73.47595,1,male,0,8,277,Colon Cancer,Cancer,2,12.0,under $11k,4644.0,3087.9258,7.0,white,12.0,1,0,0,metastatic,0.799999714,0.6,no dnr,8.0,115.0,8.09960938,81.0,24.0,36.29688,208.6875,3.7998047,0.19998169,0.59997559,135.0,7.329102,190.0,6.0,4050.0,1.9111328,<2 mo. follow-up
67.146,0,male,0,9,1011,CHF,COPD/CHF/Cirrhosis,6,11.0,under $11k,6888.0,4779.3477,11.0,white,47.0,1,1,0,no,0.799999714,0.5,no dnr,9.0,41.0,7.19921875,97.0,20.0,37.79688,333.3,3.5,1.01,10.1992188,130.0,7.419922,135.0,54.0,0.0,3.0,no(M2 and SIP pres)
35.978,1,female,1,32,32,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,123597.0,76373.9375,40.25,white,44.0,1,0,0,yes,0.849999905,0.25,dnr after sadm,28.0,114.0,14.2988281,107.0,24.0,37.79688,333.3,2.699707,0.29998779,6.59960938,125.0,7.419922,169.0,31.0,0.0,0.0,<2 mo. follow-up
78.65796,1,male,0,21,264,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,51280.0,33954.9688,20.333328,white,40.0,3,1,0,yes,0.699999809,0.5,no dnr,21.0,63.0,19.1992188,59.0,7.0,38.69531,150.0,2.0,0.5,2.29980469,141.0,7.40918,113.0,33.0,1670.0,2.4047852,<2 mo. follow-up
73.97894,1,female,0,20,562,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,13754.0,9171.4688,7.333332,white,10.0,1,1,0,no,0.799999714,0.6,dnr after sadm,1.0,63.0,5.39941406,58.0,10.0,39.29688,152.0,2.8999023,11.2988281,0.79992676,135.0,7.459961,168.0,10.0,750.0,6.0,adl>=4 (>=5 if sur)
21.60199,0,female,0,64,1010,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,$11-$25k,184711.0,117790.562,46.5,white,40.0,15,0,0,no,0.799999714,0.7,no dnr,64.0,115.0,14.1992188,70.0,14.0,36.29688,242.84375,3.699707,0.5,3.59960938,139.0,7.279297,247.0,80.0,1900.0,0.0,no(M2 and SIP pres)
83.02795,1,female,0,25,36,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,76505.0,49727.5938,24.25,white,66.0,13,1,0,no,0.199999928,0.1,dnr after sadm,24.0,102.0,7.29980469,60.0,24.0,35.69531,285.6875,3.3999023,0.79992676,1.59985352,134.0,7.579102,88.0,39.0,2502.0,5.0,<2 mo. follow-up
62.35199,1,female,0,12,94,Lung Cancer,Cancer,1,8.0,under $11k,9029.0,7019.7617,7.5,white,25.0,1,0,0,metastatic,0.299999952,0.1,no dnr,12.0,70.0,14.7988281,68.0,14.0,39.0,162.5,3.2998047,0.29998779,1.19995117,140.0,7.549805,126.0,26.0,2250.0,0.0,no(M2 and SIP pres)
88.20496,0,male,0,9,1007,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,5190.0,3528.1582,7.5,white,32.0,1,0,0,no,0.75,0.5,dnr after sadm,1.0,54.0,21.0976562,54.0,36.0,38.79688,122.84375,3.3999023,0.5,1.59985352,137.0,7.379883,145.0,45.0,1975.0,0.0,no(M2 and SIP pres)
43.80298,1,male,1,162,162,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,357329.0,247808.5,43.25,hispanic,64.0,1,0,0,no,0.75,0.7,dnr after sadm,144.0,113.0,52.8984375,68.0,28.0,38.29688,140.0,3.0,0.39996338,1.0,136.0,7.359375,192.0,49.0,410.0,0.0,adl>=4 (>=5 if sur)
79.73999,0,female,0,29,1005,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,32877.0,21715.0469,11.75,white,58.0,2,0,0,no,0.75,0.6,no dnr,29.0,50.0,10.5,138.0,10.0,38.19531,124.28125,2.199707,0.5,1.09985352,142.0,7.399414,126.0,28.0,1925.0,0.0,no(M2 and SIP pres)
43.50198,0,male,0,28,1002,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,115064.0,74479.25,20.5,hispanic,38.0,69,0,0,yes,0.5,0.125,no dnr,28.0,113.0,7.69921875,110.0,10.0,38.19531,268.5625,4.0,0.79992676,0.59997559,140.0,7.399414,147.0,9.0,2000.0,0.0,<2 mo. follow-up
77.47296,0,male,0,6,1001,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,4194.0,2887.7383,11.0,white,25.0,1,0,0,no,0.799999714,0.7,no dnr,6.0,107.0,18.8984375,64.0,44.0,38.89844,333.3,3.5,1.01,0.89990234,141.0,7.419922,145.0,14.0,2700.0,0.0,no(M2 and SIP pres)
77.36896,1,male,0,5,825,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,3151.0,2127.6445,11.0,white,45.0,1,0,0,no,0.799999714,0.7,no dnr,5.0,59.0,7.5,72.0,28.0,36.19531,266.625,3.5,1.01,1.69995117,148.0,7.469727,165.0,32.0,2490.0,2.0,adl>=4 (>=5 if sur)
43.362,0,male,0,9,999,ARF/MOSF w/Sepsis,ARF/MOSF,1,16.0,$25-$50k,12516.0,8738.4375,18.5,white,26.0,3,0,0,no,0.799999714,0.8,no dnr,9.0,99.0,11.0,69.0,24.0,36.29688,183.3125,4.5,0.39996338,0.69995117,136.0,7.359375,157.0,15.0,3200.0,0.0,no(M2 and SIP pres)
54.63699,0,male,0,4,998,CHF,COPD/CHF/Cirrhosis,5,9.0,under $11k,9328.0,5555.5078,16.0,white,28.0,1,1,0,no,0.5,0.2,no dnr,4.0,102.0,59.59375,130.0,36.0,38.29688,264.0,3.2998047,0.39996338,0.69995117,133.0,7.439453,166.0,10.0,1105.0,0.494751,no(M2 and SIP pres)
79.33698,1,female,0,7,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,31978.0,20569.3281,25.0,white,73.0,8,0,0,no,0.25,0.1,dnr after sadm,2.0,69.0,9.0,79.0,16.0,35.89844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,7.0,<2 mo. follow-up
76.88196,1,male,0,13,224,Lung Cancer,Cancer,1,12.0,$11-$25k,8986.0,6350.6172,3.5,hispanic,13.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,114.0,30.6992188,112.0,26.0,36.19531,344.0,1.6999512,1.0,2.19970703,138.0,7.319336,110.0,61.0,3500.0,0.0,no(M2 and SIP pres)
71.22198,1,male,0,5,506,Lung Cancer,Cancer,1,14.0,$11-$25k,5354.0,3412.1113,5.0,white,12.0,1,0,0,metastatic,1.0,1.0,no dnr,5.0,117.0,7.19921875,73.0,20.0,36.59375,333.3,2.699707,0.29998779,0.69995117,143.0,7.419922,97.0,5.0,3410.0,2.0625,no(M2 and SIP pres)
66.823,1,female,0,35,36,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,135347.0,89832.8125,40.75,white,60.0,14,0,0,yes,0.199999928,0.2,dnr after sadm,12.0,84.0,13.6992188,101.0,8.0,36.29688,295.1875,3.5,0.29998779,0.89990234,137.0,7.449219,150.0,6.0,2502.0,1.0,<2 mo. follow-up
70.84698,0,female,0,21,992,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,53893.0,35381.0312,18.333328,hispanic,23.0,6,1,0,no,0.699999809,0.5,no dnr,21.0,55.0,14.2988281,250.0,24.0,35.79688,200.0,3.5,1.01,0.89990234,131.0,7.389648,213.0,11.0,2875.0,0.0,<2 mo. follow-up
71.99695,1,male,0,10,53,Lung Cancer,Cancer,3,8.0,$11-$25k,8201.0,5417.3125,13.0,white,31.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,68.0,5.09960938,122.0,22.0,36.69531,290.4375,3.5,0.29998779,0.59997559,126.0,7.439453,200.0,8.0,2850.0,0.0,<2 mo. follow-up
52.98599,1,female,0,8,179,Colon Cancer,Cancer,1,12.0,under $11k,7862.0,4907.9609,13.0,white,15.0,1,0,0,metastatic,1.0,0.7,no dnr,8.0,120.0,10.1992188,20.0,8.0,40.5,333.3,3.5,1.01,1.0,134.0,7.419922,235.0,14.0,1500.0,0.494751,<2 mo. follow-up
81.60394,1,male,0,6,305,COPD,COPD/CHF/Cirrhosis,3,6.0,under $11k,4271.0,2869.4863,18.0,white,34.0,1,0,0,no,0.799999714,0.7,dnr after sadm,1.0,114.0,9.69921875,71.0,24.0,36.39844,333.3,3.5,1.01,1.09985352,134.0,7.419922,189.0,18.0,3675.0,3.2646484,<2 mo. follow-up
69.495,0,male,0,17,987,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,49628.0,33131.5,22.0,white,49.0,9,0,0,no,0.699999809,0.65,no dnr,17.0,49.0,7.0,102.0,8.0,38.0,283.3125,3.5,1.01,0.69995117,137.0,7.40918,252.0,18.0,3360.0,0.0,no(M2 and SIP pres)
79.10199,1,female,0,9,94,Colon Cancer,Cancer,2,12.0,under $11k,6205.0,4033.4512,11.0,white,12.0,1,1,0,metastatic,0.5,0.2,dnr before sadm,-1.0,69.0,8.8984375,104.0,24.0,36.29688,333.3,3.0996094,0.29998779,1.39990234,134.0,7.419922,104.0,15.0,2502.0,2.5585938,<2 mo. follow-up
69.81,1,female,0,5,149,COPD,COPD/CHF/Cirrhosis,6,13.0,under $11k,2747.0,1855.1836,6.0,white,33.0,1,0,0,metastatic,0.799999714,0.2,dnr after sadm,1.0,115.0,10.0996094,72.0,24.0,38.09375,115.375,3.199707,0.5,1.0,135.0,7.429688,131.0,15.0,2745.0,1.8388672,no(M2 and SIP pres)
49.66699,0,female,0,15,986,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,19633.0,13279.7969,15.666664,white,39.0,2,0,0,no,0.849999905,0.8,no dnr,15.0,61.0,8.29882812,51.0,24.0,39.19531,333.3,3.2998047,0.29998779,0.69995117,139.0,7.419922,99.0,20.0,2502.0,0.0,no(M2 and SIP pres)
36.90298,1,female,0,41,303,MOSF w/Malig,ARF/MOSF,1,14.0,$11-$25k,142705.0,89958.5625,41.0,white,81.0,14,0,0,metastatic,0.299999952,0.2,no dnr,41.0,107.0,10.5,112.0,24.0,36.39844,428.5625,3.5,1.01,1.19995117,138.0,7.509766,115.0,12.0,2885.0,0.0,no(M2 and SIP pres)
20.67899,0,female,0,16,985,ARF/MOSF w/Sepsis,ARF/MOSF,1,18.0,$25-$50k,32881.0,23235.1719,24.0,hispanic,50.0,3,0,0,no,0.149999976,0.15,no dnr,16.0,67.0,9.59960938,63.0,24.0,38.89844,102.03125,3.2998047,0.39996338,1.79980469,134.0,7.509766,204.0,45.0,3750.0,0.0,no(M2 and SIP pres)
67.35095,1,male,0,15,105,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,32054.0,21528.0625,19.333328,white,42.0,5,0,0,no,0.799999714,0.7,no dnr,15.0,56.0,20.5976562,74.0,28.0,36.39844,423.75,2.7998047,2.79980469,1.89990234,134.0,7.469727,128.0,30.0,2502.0,0.0,no(M2 and SIP pres)
56.91199,0,female,0,6,983,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,4438.0,3007.2383,8.0,white,14.0,1,1,0,no,0.899999619,0.85,no dnr,6.0,66.0,0.39996338,136.0,26.0,35.59375,174.28125,2.5,0.59997559,2.29980469,144.0,7.359375,235.0,47.0,2355.0,1.8388672,no(M2 and SIP pres)
89.88397,1,male,0,5,439,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,2318.0,1608.4033,8.0,white,40.0,1,0,0,no,0.949999809,0.6,dnr after sadm,1.0,61.0,9.0,96.0,20.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2800.0,1.0,no(M2 and SIP pres)
65.99298,0,female,0,30,982,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,118602.0,78316.0,20.75,white,42.0,29,1,0,no,0.699999809,0.6,no dnr,30.0,98.0,4.19921875,76.0,20.0,37.0,333.3,2.5996094,1.59985352,1.19995117,136.0,7.419922,124.0,10.0,2502.0,2.9072266,<2 mo. follow-up
71.98395,1,male,0,45,309,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,96019.0,63468.125,21.75,white,26.0,7,1,0,yes,0.899999619,0.9,no dnr,45.0,115.0,10.5,74.0,22.0,38.09375,112.5,3.5,1.01,1.69995117,137.0,7.429688,115.0,17.0,2095.0,0.0,no(M2 and SIP pres)
80.53894,0,female,0,7,976,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,5578.0,3624.8731,7.0,white,32.0,1,0,1,no,0.899999619,0.7,dnr after sadm,1.0,129.0,15.0996094,136.0,28.0,39.39844,106.0,2.5996094,0.69995117,5.19921875,144.0,7.359375,118.0,60.0,1540.0,2.0,no(M2 and SIP pres)
67.74799,1,male,0,13,22,Lung Cancer,Cancer,1,20.0,under $11k,8261.0,5839.0312,4.5,hispanic,24.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,71.0,11.1992188,101.0,20.0,36.19531,333.3,3.2998047,0.39996338,0.79992676,139.0,7.419922,154.0,12.0,3000.0,3.5273438,<2 mo. follow-up
34.491,1,female,0,7,10,Lung Cancer,Cancer,1,12.0,$25-$50k,9067.0,6019.6328,6.5,hispanic,38.0,1,0,0,metastatic,0.049999982,0.0,dnr after sadm,7.0,103.0,9.09960938,63.0,36.0,36.0,216.0,4.0,0.89990234,1.19995117,136.0,7.369141,136.0,21.0,2502.0,3.0,<2 mo. follow-up
76.36694,1,male,0,11,47,Lung Cancer,Cancer,1,8.0,$11-$25k,13244.0,9110.2578,10.5,white,19.0,1,0,0,metastatic,0.5,0.25,no dnr,11.0,109.0,10.3984375,126.0,36.0,38.29688,192.0,3.5,1.01,0.69995117,139.0,7.55957,256.0,25.0,5450.0,1.0,<2 mo. follow-up
74.43097,0,male,0,12,973,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,9343.0,6462.2656,5.5,white,27.0,1,0,0,no,0.5,0.5,dnr before sadm,-1.0,56.0,17.6992188,136.0,30.0,38.69531,420.375,2.199707,1.59985352,1.19995117,135.0,7.40918,183.0,19.0,2125.0,0.0,no(M2 and SIP pres)
86.63397,1,male,0,4,335,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,2045.0,1430.6904,6.0,white,25.0,1,0,0,no,0.899999619,0.8,dnr before sadm,-1.0,71.0,11.0,200.0,22.0,36.19531,333.3,3.8999023,0.39996338,1.39990234,136.0,7.419922,119.0,24.0,3180.0,0.0,no(M2 and SIP pres)
55.22498,1,male,0,3,161,Lung Cancer,Cancer,1,8.0,under $11k,1169.0,768.2168,22.610928270087555,white,11.0,1,0,0,metastatic,0.899999619,0.4,no dnr,3.0,100.0,6.09960938,70.0,40.0,37.59375,192.0,3.5,1.01,2.19970703,138.0,7.319336,252.0,52.0,1805.0,1.8388672,no(M2 and SIP pres)
66.56494,0,male,0,14,971,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,14408.0,9784.1094,11.0,white,25.0,1,1,0,no,0.799999714,0.7,dnr after sadm,8.0,66.0,13.0,60.0,28.0,35.59375,333.3,3.8999023,0.79992676,2.19970703,142.0,7.419922,129.0,31.0,2250.0,0.0,<2 mo. follow-up
55.82498,0,female,0,5,970,Lung Cancer,Cancer,1,14.0,>$50k,8226.0,5446.2383,6.0,white,6.0,1,0,0,metastatic,0.979999542,0.95,no dnr,5.0,68.0,7.29980469,59.0,24.0,35.79688,336.0,4.1992188,1.79980469,1.69995117,139.0,7.449219,165.0,31.0,1150.0,2.0825195,<2 mo. follow-up
83.64099,1,male,0,56,628,COPD,COPD/CHF/Cirrhosis,3,9.0,under $11k,56792.0,35551.625,11.5,white,11.0,1,0,0,yes,0.5,0.5,dnr before sadm,0.0,96.0,9.0,69.0,20.0,36.89844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2950.0,0.0,SIP>=30
77.28998,1,male,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,72115.0,47257.7188,41.666657,white,67.0,1,0,0,no,0.25,0.25,dnr after sadm,1.0,61.0,7.39941406,70.0,20.0,36.29688,309.5,4.2998047,0.29998779,1.19995117,138.0,7.419922,124.0,14.0,1450.0,0.0,<2 mo. follow-up
85.68695,1,female,0,7,276,CHF,COPD/CHF/Cirrhosis,6,15.0,under $11k,6017.0,4248.1484,10.5,white,22.0,1,0,1,no,0.199999928,0.5,no dnr,7.0,101.0,7.89941406,72.0,24.0,36.09375,252.375,3.5,1.01,1.19995117,138.0,7.319336,133.0,17.0,2502.0,4.0,adl>=4 (>=5 if sur)
82.97095,1,male,1,21,21,COPD,COPD/CHF/Cirrhosis,2,16.0,under $11k,36986.0,25526.625,22.333328,white,36.0,3,0,0,no,0.799999714,0.65,dnr after sadm,21.0,53.0,5.69921875,120.0,10.0,38.0,130.0,4.0,0.5,0.89990234,131.0,7.439453,148.0,11.0,2320.0,3.1513672,<2 mo. follow-up
43.38898,0,female,0,14,968,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,30170.0,21486.7188,19.333328,white,50.0,1,1,0,no,0.899999619,0.9,no dnr,14.0,110.0,12.0,72.0,28.0,35.69531,108.15625,3.5,1.01,2.59960938,134.0,7.339844,144.0,33.0,1630.0,0.0,no(M2 and SIP pres)
70.76495,1,male,0,7,33,Coma,Coma,2,8.0,under $11k,8484.0,5791.332,2.0,white,19.0,1,1,0,metastatic,0.199999928,0.1,dnr after sadm,1.0,71.0,9.0,65.0,25.0,38.09375,333.3,3.0996094,0.59997559,1.29980469,141.0,7.419922,157.0,14.0,800.0,6.0,<2 mo. follow-up
27.63899,0,male,0,39,964,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,83491.0,62021.4062,36.0,white,62.0,4,1,0,yes,0.5,0.45,no dnr,39.0,123.0,10.6992188,60.0,24.0,36.39844,244.0,3.699707,0.69995117,1.39990234,136.0,7.389648,110.0,18.0,2200.0,0.0,no(M2 and SIP pres)
75.21399,0,female,0,26,963,MOSF w/Malig,ARF/MOSF,2,18.0,under $11k,28177.0,19605.7812,12.25,white,20.0,1,0,0,metastatic,0.299999952,0.25,dnr after sadm,8.0,71.0,9.29882812,98.0,24.0,36.79688,218.5,3.5,1.01,0.89990234,141.0,7.359375,117.0,20.0,2502.0,0.0,no(M2 and SIP pres)
64.159,1,female,0,29,46,Cirrhosis,COPD/CHF/Cirrhosis,5,7.0,under $11k,65508.0,45789.5,15.25,white,83.0,23,1,0,no,0.5,0.2,dnr after sadm,2.0,39.0,46.09375,54.0,28.0,40.09375,200.0,3.2998047,1.29980469,1.0,130.0,7.369141,143.0,53.0,2502.0,5.0,<2 mo. follow-up
29.32199,0,male,0,14,962,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,61935.0,40505.625,16.333328,white,62.0,6,0,0,no,0.899999619,0.85,no dnr,14.0,59.0,19.1992188,155.0,30.0,38.79688,217.5,2.0996094,3.0,1.69995117,144.0,7.519531,352.0,67.0,670.0,0.0,no(M2 and SIP pres)
78.49097,1,female,0,16,45,Colon Cancer,Cancer,1,8.0,$11-$25k,17797.0,11066.9062,10.333328,white,19.0,1,0,0,metastatic,0.699999809,0.7,dnr after sadm,2.0,135.0,13.5996094,130.0,24.0,36.39844,267.5,2.8999023,19.296875,3.29980469,136.0,7.439453,104.0,39.0,8.0,1.0,<2 mo. follow-up
77.80695,1,female,0,11,270,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,7835.0,5073.3906,10.0,white,29.0,1,0,1,no,0.75,0.5,dnr after sadm,1.0,61.0,10.6992188,65.0,22.0,35.19531,333.3,4.0,0.89990234,1.89990234,134.0,7.419922,119.0,40.0,2050.0,2.0,no(M2 and SIP pres)
64.14197,1,male,0,29,32,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,29101.0,24080.6406,10.5,white,57.0,1,0,0,no,0.599999905,0.2,dnr after sadm,1.0,129.0,11.5996094,160.0,26.0,35.59375,180.0,3.5,1.01,1.09985352,136.0,7.359375,125.0,16.0,1165.0,1.0,<2 mo. follow-up
71.83795,1,male,0,13,575,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,18689.0,13812.0234,21.5,white,48.0,1,1,0,no,0.799999714,0.5,dnr after sadm,7.0,66.0,4.19921875,62.0,16.0,36.09375,368.0,2.8999023,0.89990234,1.19995117,140.0,7.40918,106.0,12.0,570.0,1.0,<2 mo. follow-up
72.91998,0,male,0,4,953,CHF,COPD/CHF/Cirrhosis,3,10.0,under $11k,2772.0,1852.792,9.0,white,32.0,1,0,0,yes,0.899999619,0.5,dnr after sadm,1.0,128.0,8.59960938,66.0,32.0,36.5,257.125,3.8999023,0.5,0.89990234,137.0,7.369141,122.0,16.0,1725.0,1.0,no(M2 and SIP pres)
72.58295,0,male,0,10,951,Coma,Coma,1,8.0,under $11k,26865.0,17952.7344,20.5,white,32.0,6,0,0,no,0.75,0.7,no dnr,10.0,97.0,13.3984375,114.0,20.0,36.0,333.3,4.0,0.79992676,0.89990234,133.0,7.419922,163.0,17.0,2502.0,0.0,no(M2 and SIP pres)
64.89294,1,male,0,18,24,Colon Cancer,Cancer,3,12.0,under $11k,18815.0,12221.5391,9.666664,white,36.0,1,0,0,metastatic,0.25,0.1,dnr after sadm,3.0,66.0,13.7988281,122.0,36.0,36.39844,232.5,3.5,1.01,0.5,129.0,7.469727,115.0,14.0,1950.0,0.0,<2 mo. follow-up
75.33698,1,female,0,3,269,Lung Cancer,Cancer,1,12.0,under $11k,3367.0,1993.8936,22.610928270087555,white,7.0,1,0,0,metastatic,1.0,1.0,no dnr,3.0,63.0,7.59960938,120.0,16.0,38.29688,333.3,3.5996094,0.69995117,1.09985352,140.0,7.419922,105.0,11.0,1335.0,1.0,<2 mo. follow-up
80.698,1,female,0,7,8,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,>$50k,15560.0,10941.5469,12.5,white,52.0,4,0,0,no,0.049999982,0.0,dnr after sadm,2.0,79.0,9.0,77.0,24.0,36.29688,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2550.0,2.0,<2 mo. follow-up
78.62299,1,female,0,7,294,CHF,COPD/CHF/Cirrhosis,5,5.0,under $11k,5117.0,3498.4219,4.0,white,39.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,65.0,5.79980469,100.0,28.0,36.5,276.1875,2.5,3.59960938,0.79992676,135.0,7.5,84.0,9.0,1050.0,5.0,adl>=4 (>=5 if sur)
72.48999,1,male,0,19,247,ARF/MOSF w/Sepsis,ARF/MOSF,2,14.0,under $11k,37936.0,25669.4531,30.333328,white,42.0,2,0,0,no,0.5,0.5,dnr after sadm,1.0,78.0,10.6992188,62.0,20.0,35.69531,319.0,3.5,1.01,1.09985352,136.0,7.509766,131.0,18.0,1200.0,1.0,no(M2 and SIP pres)
72.51495,1,female,0,5,167,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,3035.0,2042.083,9.0,white,23.0,1,0,0,metastatic,1.0,0.9,no dnr,5.0,103.0,2.89990234,67.0,36.0,36.39844,309.5,4.2998047,0.69995117,1.0,138.0,7.469727,140.0,11.0,2502.0,1.1667481,adl>=4 (>=5 if sur)
74.54297,1,male,0,6,334,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,4039.0,2884.7246,13.0,white,40.0,1,0,0,no,0.799999714,0.6,dnr after sadm,1.0,58.0,10.5,70.0,12.0,38.5,160.0,2.0996094,0.69995117,0.59997559,134.0,7.469727,106.0,9.0,2990.0,1.0,no(M2 and SIP pres)
84.68695,1,male,0,11,142,COPD,COPD/CHF/Cirrhosis,2,10.0,$11-$25k,9362.0,6366.5742,9.5,white,37.0,1,0,0,no,0.899999619,0.65,dnr after sadm,1.0,61.0,0.69995117,136.0,30.0,38.59375,153.3125,3.3999023,0.29998779,3.19970703,133.0,7.329102,137.0,52.0,5225.0,0.494751,no(M2 and SIP pres)
73.25397,1,female,0,8,664,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,7249.0,5278.793,8.0,white,26.0,1,1,0,no,0.799999714,0.6,no dnr,8.0,71.0,9.0,98.0,24.0,36.09375,180.9375,4.5,0.29998779,1.39990234,143.0,7.369141,179.0,28.0,2502.0,0.0,no(M2 and SIP pres)
70.01196,1,female,0,11,237,Coma,Coma,2,12.0,under $11k,17659.0,11679.6562,16.0,white,25.0,5,0,0,metastatic,0.25,0.2,no dnr,11.0,109.0,5.5,67.0,22.0,36.39844,333.3,3.3999023,0.29998779,0.59997559,133.0,7.419922,119.0,13.0,3000.0,2.5756836,<2 mo. follow-up
51.11298,1,male,0,4,11,ARF/MOSF w/Sepsis,ARF/MOSF,4,10.0,under $11k,15226.0,10579.2344,43.0,white,45.0,1,0,0,no,0.0,0.0,dnr after sadm,3.0,122.0,8.3984375,116.0,40.0,36.39844,240.0,3.699707,0.59997559,0.69995117,131.0,7.30957,154.0,7.0,1905.0,1.8388672,<2 mo. follow-up
74.39294,1,male,0,6,38,Colon Cancer,Cancer,1,12.0,under $11k,4666.0,3002.5547,10.0,white,28.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,73.0,7.39941406,52.0,24.0,35.69531,333.3,3.3999023,0.29998779,2.59960938,135.0,7.419922,122.0,81.0,2275.0,0.0,<2 mo. follow-up
80.55896,1,male,0,7,86,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,4963.0,3264.0234,5.0,white,24.0,1,0,0,no,0.899999619,0.75,no dnr,7.0,73.0,6.59960938,65.0,16.0,35.69531,309.5,4.0996094,0.39996338,1.5,136.0,7.359375,97.0,24.0,2075.0,5.0,adl>=4 (>=5 if sur)
51.25,1,female,0,29,310,MOSF w/Malig,ARF/MOSF,1,11.0,$11-$25k,114515.0,73225.1875,40.75,white,102.0,10,0,0,yes,0.599999905,0.55,no dnr,29.0,63.0,6.79980469,73.0,18.0,37.0,333.3,4.3994141,0.69995117,1.19995117,137.0,7.419922,95.0,3.0,3000.0,0.0,no(M2 and SIP pres)
79.90997,0,male,0,30,937,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,65546.0,46235.5938,23.75,white,51.0,5,1,0,no,0.799999714,0.7,dnr after sadm,15.0,59.0,12.0,70.0,24.0,35.39844,409.5,3.5,1.01,2.0,132.0,7.539062,102.0,45.0,1725.0,0.0,adl>=4 (>=5 if sur)
86.80896,1,male,0,74,891,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,197774.0,131938.75,33.5,white,42.0,23,0,0,yes,0.049999982,0.01,dnr after sadm,3.0,63.0,4.59960938,112.0,52.0,38.59375,133.3125,2.5996094,0.19998169,0.69995117,134.0,7.519531,139.0,4.0,6500.0,0.0,Coma or Intub
70.09698,0,female,0,149,936,Coma,Coma,4,8.0,$11-$25k,254992.0,191685.625,27.5,white,61.0,22,1,0,yes,0.299999952,0.3,no dnr,149.0,97.0,78.796875,112.0,30.0,35.89844,146.125,3.5,1.01,1.5,142.0,7.319336,326.0,39.0,1440.0,6.0,adl>=4 (>=5 if sur)
75.67999,1,male,0,8,9,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,41646.0,28043.875,37.5,white,41.0,5,0,0,no,0.5,0.5,dnr after sadm,8.0,104.0,7.09960938,107.0,24.0,36.09375,333.3,4.1992188,0.69995117,1.29980469,136.0,7.419922,235.0,14.0,2502.0,0.0,<2 mo. follow-up
68.14197,1,male,0,25,34,Lung Cancer,Cancer,1,12.0,under $11k,29137.0,19464.4375,3.75,white,32.0,1,0,0,metastatic,1.0,1.0,dnr after sadm,14.0,117.0,46.6953125,156.0,11.0,39.79688,205.6875,3.5,1.01,0.69995117,148.0,7.439453,173.0,26.0,4000.0,3.0,<2 mo. follow-up
66.935,1,male,0,8,106,Cirrhosis,COPD/CHF/Cirrhosis,5,9.0,$11-$25k,4510.0,3092.8125,7.0,white,26.0,1,0,0,yes,0.75,0.5,dnr after sadm,1.0,53.0,19.0,110.0,25.0,36.59375,160.0,2.0,3.39990234,2.59960938,132.0,7.339844,195.0,54.0,3200.0,1.0,<2 mo. follow-up
70.02594,0,male,0,11,930,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,25514.0,16332.7109,21.5,white,30.0,8,1,0,no,0.699999809,0.5,no dnr,11.0,67.0,7.5,122.0,24.0,35.69531,333.3,3.8999023,0.5,1.0,136.0,7.419922,124.0,13.0,1800.0,0.0,no(M2 and SIP pres)
62.35699,0,female,0,4,929,COPD,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,4064.0,2609.4922,18.0,white,26.0,1,0,0,yes,0.799999714,0.7,no dnr,4.0,67.0,9.0,101.0,40.0,35.59375,333.3,3.5,1.01,1.29980469,134.0,7.419922,90.0,27.0,2502.0,2.0,<2 mo. follow-up
83.948,1,male,0,4,454,Coma,Coma,3,8.0,under $11k,4574.0,3325.3496,16.0,white,23.0,1,0,1,no,0.899999619,0.9,dnr before sadm,-1.0,63.0,14.8984375,144.0,28.0,39.29688,77.64062,2.0,9.3984375,0.79992676,133.0,7.349609,143.0,10.0,2375.0,4.0,<2 mo. follow-up
69.10895,1,male,0,4,69,Colon Cancer,Cancer,5,12.0,$11-$25k,5263.0,3212.4961,11.0,white,20.0,1,1,0,metastatic,0.699999809,0.4,no dnr,4.0,143.0,9.0,118.0,28.0,36.69531,117.5,3.5,1.01,1.69995117,124.0,7.319336,157.0,34.0,430.0,1.1667481,no(M2 and SIP pres)
56.41599,0,male,0,46,929,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,90783.0,60371.0625,44.75,white,75.0,1,0,0,no,0.199999928,0.2,no dnr,46.0,59.0,9.79882812,102.0,24.0,36.19531,78.75,2.199707,0.19998169,0.89990234,133.0,7.419922,116.0,12.0,2750.0,2.2651367,no(M2 and SIP pres)
87.15698,0,male,0,22,927,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,66731.0,44561.1875,32.666657,white,41.0,9,0,0,no,0.799999714,0.8,no dnr,22.0,73.0,7.39941406,64.0,20.0,36.39844,333.3,3.5,1.39990234,1.69995117,139.0,7.419922,200.0,39.0,2300.0,0.0,no(M2 and SIP pres)
76.02496,1,male,0,9,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,10.0,under $11k,98962.0,66981.1875,35.0,white,25.0,22,1,0,no,0.599999905,0.5,dnr after sadm,2.0,148.0,9.29882812,104.0,28.0,35.59375,240.0,4.6992188,0.59997559,1.69995117,147.0,7.369141,106.0,29.0,1025.0,0.0,<2 mo. follow-up
72.48199,1,female,1,42,42,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,72553.0,49537.2188,20.25,white,35.0,1,0,0,no,0.799999714,0.6,no dnr,42.0,77.0,8.59960938,67.0,28.0,35.89844,333.3,3.5,1.01,1.0,139.0,7.419922,115.0,18.0,1470.0,6.0,<2 mo. follow-up
70.92096,1,female,0,7,491,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,5492.0,4187.9258,8.5,white,45.0,1,0,0,yes,0.699999809,0.5,no dnr,7.0,67.0,12.6992188,107.0,28.0,36.39844,333.3,3.5,1.01,1.19995117,129.0,7.419922,242.0,22.0,3550.0,1.8825684,<2 mo. follow-up
71.26099,1,male,1,3,3,MOSF w/Malig,ARF/MOSF,1,3.0,$11-$25k,70697.0,48408.125,46.0,white,87.0,16,0,0,yes,0.5,0.5,no dnr,3.0,59.0,25.6992188,70.0,40.0,36.39844,200.0,3.5,1.01,2.09960938,130.0,7.399414,138.0,37.0,385.0,2.4321289,<2 mo. follow-up
43.31799,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,21711.0,14850.7891,44.5,white,50.0,1,1,0,no,0.049999982,0.04,no dnr,8.0,94.0,11.7988281,76.0,20.0,35.69531,400.0,3.699707,0.5,1.09985352,138.0,7.399414,144.0,32.0,1500.0,2.3359375,<2 mo. follow-up
85.82898,1,male,1,5,5,Coma,Coma,1,6.0,under $11k,3794.0,2479.2109,26.0,white,23.0,1,0,1,no,0.009999998,0.0,dnr after sadm,3.0,111.0,17.0,81.0,20.0,36.29688,333.3,3.5,1.01,1.09985352,133.0,7.419922,155.0,9.0,5450.0,4.8251953,<2 mo. follow-up
72.86798,1,female,0,15,147,Lung Cancer,Cancer,1,13.0,$11-$25k,10252.0,6784.1055,3.0,white,10.0,1,0,0,metastatic,0.899999619,0.75,dnr after sadm,12.0,50.0,12.8984375,104.0,8.0,39.29688,273.3125,2.5,12.2988281,2.29980469,146.0,7.539062,123.0,51.0,1850.0,5.0,no(M2 and SIP pres)
79.53998,1,male,0,10,43,Colon Cancer,Cancer,1,8.0,under $11k,6102.0,4132.4961,9.0,white,28.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,68.0,7.29980469,81.0,28.0,38.59375,277.5,2.5,0.79992676,1.0,138.0,7.419922,168.0,18.0,1138.0,1.0,<2 mo. follow-up
59.88498,1,female,0,8,83,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,6514.0,4453.6914,5.5,white,36.0,1,1,0,no,0.899999619,0.85,no dnr,8.0,66.0,18.5976562,122.0,24.0,35.39844,233.3125,3.5,1.01,1.19995117,135.0,7.489258,244.0,25.0,2800.0,0.494751,<2 mo. follow-up
52.42398,1,male,0,10,63,CHF,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,8569.0,5841.957,12.0,white,45.0,1,1,0,no,0.75,0.5,no dnr,10.0,65.0,16.1992188,70.0,24.0,39.0,244.0,3.5996094,0.69995117,0.89990234,135.0,7.429688,159.0,12.0,2775.0,2.0,no(M2 and SIP pres)
68.35297,0,female,0,7,915,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,4881.0,3302.4414,5.0,white,30.0,1,0,0,no,0.799999714,0.6,dnr after sadm,1.0,139.0,12.7988281,59.0,24.0,36.29688,260.0,3.5,0.39996338,1.69995117,141.0,7.269531,175.0,49.0,3350.0,0.0,no(M2 and SIP pres)
75.26398,0,male,0,10,914,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,13348.0,8931.6172,12.0,white,31.0,2,0,0,no,0.799999714,0.8,no dnr,10.0,111.0,14.0,108.0,26.0,35.69531,130.59375,3.2998047,6.5,2.19970703,149.0,7.479492,128.0,45.0,2310.0,2.2651367,<2 mo. follow-up
81.77399,1,male,0,9,11,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,68292.0,44787.375,35.5,white,69.0,10,0,0,no,0.599999905,0.6,dnr after sadm,6.0,96.0,9.69921875,65.0,20.0,36.59375,333.3,3.7998047,0.79992676,1.0,134.0,7.419922,311.0,19.0,2502.0,2.8564453,<2 mo. follow-up
47.23297,1,male,0,117,504,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,176303.0,111901.188,24.25,white,24.0,8,0,0,no,0.599999905,0.5,dnr after sadm,86.0,103.0,5.69921875,67.0,22.0,36.39844,213.03125,2.8999023,3.69970703,0.79992676,141.0,7.389648,118.0,13.0,850.0,1.0,<2 mo. follow-up
53.99899,0,female,0,32,909,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,65056.0,44875.375,31.0,white,53.0,1,0,0,no,0.5,0.5,no dnr,32.0,43.0,19.5976562,68.0,28.0,39.29688,376.0,3.5,1.01,1.89990234,144.0,7.439453,176.0,43.0,2625.0,0.0,no(M2 and SIP pres)
73.98199,0,male,0,6,909,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,4949.0,3425.7734,16.0,white,23.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,52.0,0.19998169,142.0,26.0,39.09375,64.0,3.5,1.01,1.19995117,142.0,7.359375,341.0,36.0,3500.0,0.0,no(M2 and SIP pres)
73.41498,1,male,0,12,181,Lung Cancer,Cancer,4,12.0,under $11k,8663.0,5505.293,9.5,white,8.0,1,1,0,metastatic,1.0,0.95,no dnr,12.0,122.0,7.79980469,39.0,24.0,34.39844,333.3,3.5,1.01,2.69970703,138.0,7.419922,160.0,76.0,1515.0,0.0,no(M2 and SIP pres)
76.63794,1,male,1,10,10,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,66572.0,43853.0312,54.5,white,53.0,10,0,0,no,0.699999809,0.65,no dnr,10.0,65.0,8.0,100.0,42.0,37.0,152.5,3.5,1.01,1.79980469,140.0,7.419922,90.0,47.0,2150.0,1.0,<2 mo. follow-up
60.008,1,male,0,9,392,CHF,COPD/CHF/Cirrhosis,8,14.0,under $11k,5204.0,3598.4394,7.5,white,35.0,1,1,0,yes,0.799999714,0.6,no dnr,9.0,120.0,9.0,115.0,20.0,36.09375,333.3,3.5,1.01,0.69995117,138.0,7.419922,197.0,9.0,2850.0,0.0,SIP>=30
68.88397,1,male,0,8,214,Lung Cancer,Cancer,1,8.0,$11-$25k,11507.0,7948.1367,4.0,white,12.0,1,0,0,metastatic,0.899999619,0.5,no dnr,8.0,56.0,6.69921875,61.0,28.0,36.19531,333.3,3.8999023,0.39996338,2.0,136.0,7.419922,98.0,36.0,2502.0,1.0,adl>=4 (>=5 if sur)
75.97296,0,female,0,3,904,MOSF w/Malig,ARF/MOSF,1,12.0,$25-$50k,25406.0,16600.0938,22.610928270087555,white,31.0,6,0,0,metastatic,0.0,0.0,dnr after sadm,1.0,61.0,8.3984375,98.0,34.0,36.79688,130.59375,3.5,1.01,4.79980469,133.0,7.459961,106.0,95.0,3050.0,2.9101562,adl>=4 (>=5 if sur)
77.05096,1,male,0,5,159,Lung Cancer,Cancer,3,16.0,under $11k,7321.0,4370.6797,11.0,white,8.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,73.0,12.5996094,120.0,10.0,38.29688,211.09375,2.2998047,1.19995117,1.19995117,136.0,7.529297,145.0,12.0,4225.0,0.0,adl>=4 (>=5 if sur)
75.70197,1,male,0,12,109,COPD,COPD/CHF/Cirrhosis,3,15.0,$11-$25k,8417.0,5477.293,10.0,white,26.0,1,0,0,no,0.5,0.4,dnr after sadm,5.0,69.0,5.5,71.0,28.0,36.19531,288.875,3.5,0.39996338,1.29980469,136.0,7.349609,175.0,42.0,1100.0,2.0,adl>=4 (>=5 if sur)
59.409,0,male,0,31,897,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,89880.0,61031.75,36.0,white,36.0,4,0,0,no,0.599999905,0.6,no dnr,31.0,72.0,8.5,122.0,32.0,36.19531,333.3,3.5,1.01,0.89990234,138.0,7.419922,159.0,10.0,2502.0,0.0,<2 mo. follow-up
90.38495,1,male,0,11,19,CHF,COPD/CHF/Cirrhosis,5,8.0,under $11k,11069.0,7677.5391,29.5,white,76.0,1,0,0,metastatic,0.099999964,0.05,dnr after sadm,4.0,69.0,14.6992188,146.0,26.0,38.09375,333.3,2.5996094,0.39996338,0.89990234,134.0,7.419922,125.0,13.0,950.0,4.5429688,<2 mo. follow-up
77.29498,0,male,0,9,893,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,6750.0,4606.7539,17.5,white,31.0,1,0,0,no,0.5,0.5,no dnr,9.0,114.0,10.5,73.0,28.0,35.79688,333.3,3.2998047,0.29998779,1.39990234,142.0,7.459961,181.0,18.0,2502.0,0.0,no(M2 and SIP pres)
83.91498,1,male,0,10,382,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,6141.0,4087.0391,9.0,white,38.0,1,0,1,no,0.699999809,0.5,no dnr,10.0,77.0,28.5976562,53.0,22.0,35.69531,333.3,3.5,1.19995117,1.39990234,132.0,7.419922,150.0,20.0,2525.0,5.9384766,<2 mo. follow-up
81.81195,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,14.0,under $11k,66049.0,43404.0,55.0,white,54.0,16,0,0,no,0.699999809,0.5,no dnr,8.0,110.0,4.89941406,79.0,24.0,36.09375,333.3,3.5,1.01,1.59985352,141.0,7.419922,94.0,25.0,575.0,0.0,<2 mo. follow-up
73.75494,1,male,0,6,14,Colon Cancer,Cancer,2,6.0,under $11k,3420.0,2306.7441,8.0,white,14.0,1,0,0,metastatic,0.199999928,0.01,dnr after sadm,1.0,70.0,3.0,76.0,20.0,36.69531,333.3,3.5,0.39996338,1.09985352,140.0,7.419922,135.0,23.0,2502.0,1.0,<2 mo. follow-up
66.85596,1,female,0,3,530,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,1968.0,1304.7432,22.610928270087555,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,3.0,73.0,9.59960938,116.0,28.0,36.09375,177.125,2.5996094,0.5,1.29980469,131.0,7.359375,144.0,9.0,2625.0,2.1381836,<2 mo. follow-up
76.68994,0,male,0,8,891,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4607.0,3228.2344,5.5,white,34.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,107.0,16.5976562,53.0,16.0,36.79688,333.3,3.5,1.01,0.79992676,138.0,7.419922,117.0,8.0,3025.0,3.2080078,<2 mo. follow-up
67.07996,0,male,0,14,890,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,13903.0,7774.2031,6.666664,white,32.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,113.0,8.09960938,107.0,24.0,36.29688,232.0,4.3994141,0.79992676,1.39990234,140.0,7.369141,154.0,15.0,2502.0,0.0,no(M2 and SIP pres)
45.125,1,male,0,11,12,MOSF w/Malig,ARF/MOSF,2,9.0,under $11k,52438.0,34762.4688,33.5,other,34.0,27,0,0,yes,0.5,0.4,dnr after sadm,2.0,124.0,12.1992188,162.0,35.0,38.0,217.125,3.199707,3.79980469,4.19921875,134.0,7.279297,163.0,55.0,3675.0,0.0,<2 mo. follow-up
67.48499,0,female,0,4,885,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,2125.0,1470.4014,7.0,white,10.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,104.0,12.3984375,98.0,26.0,36.19531,483.3125,3.5,1.01,1.5,133.0,7.319336,112.0,19.0,2555.0,0.494751,<2 mo. follow-up
75.85797,0,female,0,21,883,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,72352.0,46216.5625,30.333328,white,28.0,7,0,0,no,0.5,0.5,no dnr,21.0,68.0,17.0,52.0,10.0,35.89844,172.0,3.5,1.01,1.39990234,135.0,7.359375,103.0,50.0,1075.0,0.0,no(M2 and SIP pres)
28.88199,1,male,0,19,290,ARF/MOSF w/Sepsis,ARF/MOSF,2,11.0,under $11k,49937.0,34050.25,30.333328,white,51.0,6,1,0,no,0.5,0.5,no dnr,19.0,59.0,12.6992188,115.0,26.0,39.29688,180.0,2.3999023,0.29998779,0.69995117,145.0,7.479492,181.0,4.0,1348.0,2.2426758,<2 mo. follow-up
70.18799,1,female,0,4,28,Lung Cancer,Cancer,2,13.0,under $11k,3494.0,2189.0508,9.0,white,18.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,1.0,125.0,4.39941406,56.0,24.0,36.29688,333.3,3.5,1.01,0.89990234,141.0,7.419922,167.0,15.0,750.0,2.0996094,<2 mo. follow-up
57.21799,1,male,0,22,344,Coma,Coma,0,8.0,$11-$25k,31051.0,21368.125,21.0,white,29.0,1,0,0,no,0.099999964,0.05,no dnr,22.0,123.0,5.5,134.0,26.0,39.09375,170.0,2.199707,0.59997559,4.29980469,139.0,7.319336,149.0,23.0,1299.0,0.0,adl>=4 (>=5 if sur)
45.13599,0,male,0,8,878,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,8785.0,5756.7539,8.5,white,47.0,1,0,0,no,0.699999809,0.5,no dnr,8.0,117.0,15.2988281,110.0,32.0,37.69531,333.3,4.2998047,1.0,0.89990234,138.0,7.419922,179.0,8.0,2920.0,2.2753906,<2 mo. follow-up
76.82098,1,female,0,10,268,COPD,COPD/CHF/Cirrhosis,6,16.0,under $11k,6023.0,4087.3184,5.5,white,47.0,1,0,0,no,0.849999905,0.75,no dnr,10.0,55.0,13.7988281,120.0,6.0,35.39844,333.3,2.3999023,2.59960938,3.09960938,140.0,7.419922,353.0,132.0,400.0,0.0,no(M2 and SIP pres)
84.64294,1,female,0,6,15,Coma,Coma,3,18.0,under $11k,7579.0,5323.4609,12.0,white,9.0,1,1,0,no,0.5,0.5,dnr before sadm,-1.0,59.0,7.39941406,140.0,40.0,39.09375,197.125,2.2998047,1.19995117,1.09985352,140.0,7.459961,124.0,26.0,2275.0,3.0,<2 mo. follow-up
42.25299,1,female,1,8,8,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,36798.0,23911.3906,33.0,white,43.0,15,0,0,yes,0.199999928,0.1,dnr after sadm,8.0,80.0,18.6992188,69.0,16.0,37.89844,333.3,3.0996094,0.39996338,2.29980469,135.0,7.419922,85.0,38.0,2502.0,2.0083008,<2 mo. follow-up
58.48898,0,male,0,29,876,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,66086.0,43458.0938,17.25,white,51.0,9,0,0,no,0.699999809,0.7,no dnr,29.0,123.0,19.3984375,110.0,28.0,36.19531,261.875,4.3994141,0.69995117,0.89990234,137.0,7.40918,208.0,17.0,2950.0,0.0,no(M2 and SIP pres)
75.66095,1,male,0,6,82,Lung Cancer,Cancer,2,10.0,under $11k,6004.0,3841.6426,10.0,white,20.0,1,0,0,metastatic,1.0,1.0,dnr after sadm,1.0,57.0,15.6992188,70.0,22.0,37.0,333.3,2.0996094,0.59997559,6.5,132.0,7.419922,120.0,39.0,0.0,1.0,<2 mo. follow-up
85.74396,1,male,1,10,10,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,7922.0,5375.1914,13.5,white,22.0,1,0,1,no,0.75,0.6,dnr after sadm,1.0,69.0,19.0976562,68.0,8.0,36.39844,213.3125,3.199707,0.5,8.79882812,138.0,7.389648,103.0,55.0,0.0,1.0,<2 mo. follow-up
71.86896,1,male,0,11,87,COPD,COPD/CHF/Cirrhosis,3,14.0,$11-$25k,87179.0,59329.0938,17.5,white,24.0,35,0,0,no,0.5,0.4,dnr after sadm,10.0,77.0,1.89990234,110.0,20.0,36.09375,246.65625,3.5,1.01,1.39990234,136.0,7.389648,98.0,60.0,2130.0,4.0,no(M2 and SIP pres)
75.07996,1,male,0,6,60,Lung Cancer,Cancer,1,6.0,$11-$25k,3316.0,2170.2188,8.0,white,9.0,1,0,0,metastatic,1.0,1.0,no dnr,6.0,65.0,11.1992188,62.0,32.0,35.79688,155.53125,3.5,1.01,1.09985352,137.0,7.439453,164.0,22.0,1105.0,1.0,<2 mo. follow-up
74.81696,1,female,0,4,292,Lung Cancer,Cancer,2,12.0,$11-$25k,2259.0,1534.4443,8.0,white,29.0,1,0,0,metastatic,1.0,1.0,no dnr,4.0,107.0,7.19921875,130.0,24.0,36.09375,95.23438,3.7998047,1.5,1.0,133.0,7.40918,112.0,15.0,1765.0,1.0,no(M2 and SIP pres)
65.75494,1,male,0,15,112,Colon Cancer,Cancer,3,11.0,$11-$25k,10259.0,6809.7266,12.666664,white,29.0,1,1,0,metastatic,0.099999964,0.01,dnr after sadm,2.0,99.0,8.69921875,96.0,20.0,36.59375,333.3,3.7998047,0.19998169,0.69995117,127.0,7.419922,96.0,10.0,2502.0,3.0,adl>=4 (>=5 if sur)
68.36096,1,female,0,7,81,Lung Cancer,Cancer,2,12.0,$11-$25k,7018.0,4296.5391,4.0,white,19.0,1,0,0,metastatic,0.699999809,0.3,dnr after sadm,6.0,108.0,14.7988281,130.0,44.0,35.39844,333.3,3.5,1.01,1.09985352,155.0,7.419922,229.0,68.0,1450.0,1.9816894,<2 mo. follow-up
66.94299,1,male,0,6,15,Coma,Coma,1,12.0,under $11k,18074.0,12242.7344,33.0,white,36.0,1,1,0,no,0.0,0.0,dnr after sadm,6.0,74.0,5.39941406,66.0,32.0,36.29688,390.4375,3.5,1.01,1.59985352,139.0,7.459961,1.599854,27.0,1100.0,2.5024414,<2 mo. follow-up
76.81,0,male,0,9,868,CHF,COPD/CHF/Cirrhosis,5,14.0,$11-$25k,8619.0,6012.4805,13.0,white,46.0,1,1,0,no,0.799999714,0.6,no dnr,9.0,75.0,14.5,142.0,24.0,37.89844,132.0,3.0,0.5,0.79992676,138.0,7.289062,155.0,20.0,1620.0,2.0,no(M2 and SIP pres)
66.35498,0,male,0,63,866,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,116735.0,73369.3125,38.5,white,30.0,1,0,0,no,0.899999619,0.9,no dnr,63.0,61.0,5.59960938,107.0,16.0,35.69531,366.625,3.2998047,0.59997559,1.19995117,134.0,7.439453,255.0,17.0,5300.0,5.0,adl>=4 (>=5 if sur)
79.16199,1,male,0,11,343,CHF,COPD/CHF/Cirrhosis,5,14.0,under $11k,8505.0,5740.9141,16.0,hispanic,18.0,1,0,0,yes,0.599999905,0.5,dnr after sadm,1.0,59.0,6.19921875,74.0,44.0,35.69531,333.3,3.5,0.79992676,1.29980469,141.0,7.419922,105.0,25.0,2502.0,3.0,no(M2 and SIP pres)
56.92499,0,female,0,31,865,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,65550.0,43867.9062,23.5,white,22.0,1,0,0,no,0.699999809,0.5,no dnr,31.0,75.0,16.3984375,49.0,24.0,36.39844,202.03125,3.5,1.19995117,1.69995117,140.0,7.209961,280.0,39.0,600.0,0.0,no(M2 and SIP pres)
59.77298,0,male,0,7,864,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,18898.0,13060.3906,4.5,white,20.0,9,0,0,no,0.989999771,0.95,no dnr,7.0,76.0,11.0996094,65.0,24.0,36.09375,295.1875,3.5,0.79992676,1.89990234,140.0,7.429688,125.0,49.0,2502.0,0.0,no(M2 and SIP pres)
81.20496,1,female,1,5,5,Coma,Coma,0,12.0,$11-$25k,6553.0,5017.4922,23.0,white,18.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,54.0,7.09960938,70.0,20.0,37.79688,333.3,2.5,0.29998779,0.79992676,136.0,7.419922,132.0,3.0,1325.0,2.5078125,<2 mo. follow-up
40.55298,1,male,1,4,4,Coma,Coma,0,0.0,under $11k,5672.0,3994.7324,17.0,white,41.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,68.0,10.3984375,64.0,40.0,36.09375,268.0,2.5,3.89990234,0.79992676,137.0,7.40918,168.0,25.0,4550.0,2.3710938,<2 mo. follow-up
37.94098,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,15509.0,11319.9766,28.0,white,77.0,5,1,0,no,0.699999809,0.6,no dnr,4.0,81.0,11.6992188,77.0,20.0,36.39844,333.3,2.5996094,18.0,1.0,140.0,7.419922,119.0,10.0,775.0,2.0,<2 mo. follow-up
73.03796,0,male,0,7,860,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,8538.0,5824.7461,10.0,white,29.0,1,1,0,no,0.75,0.6,no dnr,7.0,76.0,7.0,61.0,24.0,36.39844,333.3,2.5996094,0.5,1.09985352,133.0,7.419922,98.0,43.0,2100.0,0.494751,<2 mo. follow-up
52.40799,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,15597.0,9914.5703,43.0,white,87.0,1,0,0,no,0.009999998,0.0,no dnr,3.0,41.0,0.09999084,196.0,36.0,38.19531,351.0,3.0,0.69995117,2.19970703,145.0,7.519531,256.0,91.0,1375.0,3.3017578,<2 mo. follow-up
47.04398,1,male,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,22789.0,17392.75,28.0,white,106.0,13,1,0,no,0.299999952,0.2,no dnr,3.0,133.0,15.7988281,122.0,40.0,36.69531,157.5,2.5996094,1.59985352,1.69995117,146.0,7.429688,173.0,55.0,2502.0,3.734375,<2 mo. follow-up
69.77399,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,4,12.0,$11-$25k,23180.0,15646.0391,20.0,white,58.0,4,0,0,metastatic,0.0,0.0,dnr after sadm,6.0,73.0,22.3984375,104.0,40.0,39.0,142.5,3.5,1.01,1.29980469,145.0,7.419922,151.0,53.0,1900.0,0.0,<2 mo. follow-up
71.64099,1,male,0,54,269,MOSF w/Malig,ARF/MOSF,3,14.0,$25-$50k,75094.0,50020.4688,21.5,white,51.0,11,0,0,yes,0.699999809,0.5,no dnr,54.0,56.0,36.5,70.0,40.0,36.59375,254.28125,2.3999023,1.19995117,1.19995117,138.0,7.419922,217.0,76.0,760.0,0.0,no(M2 and SIP pres)
75.78894,1,male,0,5,217,Lung Cancer,Cancer,3,8.0,$11-$25k,2268.0,1554.6572,14.0,white,13.0,1,0,0,metastatic,0.599999905,0.4,dnr after sadm,2.0,109.0,9.5,80.0,30.0,38.79688,101.42188,3.5,1.01,1.69995117,152.0,7.479492,136.0,51.0,3515.0,0.0,no(M2 and SIP pres)
83.54596,0,male,0,5,853,COPD,COPD/CHF/Cirrhosis,2,7.0,under $11k,3826.0,2541.1699,13.0,white,34.0,1,0,0,no,0.5,0.45,dnr after sadm,3.0,69.0,21.8984375,122.0,24.0,36.79688,333.3,3.2998047,1.0,1.0,138.0,7.419922,177.0,20.0,1245.0,2.0,no(M2 and SIP pres)
65.29999,1,male,0,5,452,Colon Cancer,Cancer,1,10.0,$11-$25k,2361.0,1575.5684,10.0,white,17.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,79.0,61.1953125,87.0,24.0,37.0,333.3,2.699707,4.19921875,1.59985352,135.0,7.419922,185.0,14.0,2502.0,0.494751,no(M2 and SIP pres)
67.625,1,male,0,3,70,Colon Cancer,Cancer,1,8.0,under $11k,3589.0,2204.9473,22.610928270087555,white,7.0,1,0,0,metastatic,0.399999857,0.05,no dnr,3.0,76.0,10.5996094,60.0,32.0,35.59375,142.84375,3.5,1.01,1.0,141.0,7.399414,247.0,21.0,4750.0,1.6945801,<2 mo. follow-up
70.76794,1,male,0,8,9,Lung Cancer,Cancer,1,11.0,under $11k,9416.0,5896.3711,15.5,white,11.0,1,0,0,metastatic,0.099999964,0.0,dnr after sadm,3.0,106.0,17.0976562,101.0,24.0,36.79688,147.59375,3.2998047,0.29998779,0.89990234,143.0,7.349609,146.0,19.0,2502.0,1.0,<2 mo. follow-up
21.99899,1,male,0,46,247,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,109718.0,77263.5,40.75,white,37.0,3,0,0,no,0.699999809,0.5,no dnr,46.0,113.0,13.7988281,105.0,32.0,38.39844,290.0,3.5,0.59997559,1.0,138.0,7.40918,98.0,20.0,960.0,6.0,adl>=4 (>=5 if sur)
83.82495,1,female,1,31,31,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,93539.0,63046.8438,41.25,white,84.0,15,0,0,no,0.799999714,0.8,no dnr,31.0,113.0,7.19921875,77.0,12.0,36.0,333.3,4.0,2.09960938,1.0,132.0,7.419922,196.0,4.0,3995.0,2.4829102,<2 mo. follow-up
56.75598,1,male,0,5,483,Lung Cancer,Cancer,1,12.0,under $11k,4327.0,2830.0215,10.0,white,13.0,1,0,0,metastatic,0.949999809,0.8,no dnr,5.0,59.0,9.8984375,130.0,10.0,39.09375,93.32812,2.199707,1.09985352,4.89941406,138.0,7.179688,122.0,70.0,1220.0,1.8344727,<2 mo. follow-up
83.15094,1,male,0,7,304,CHF,COPD/CHF/Cirrhosis,6,8.0,under $11k,5243.0,3663.084,6.0,white,55.0,1,1,0,yes,0.799999714,0.5,no dnr,7.0,78.0,13.6992188,100.0,26.0,36.39844,207.5,2.3999023,0.79992676,2.09960938,137.0,7.40918,141.0,50.0,3675.0,2.0,SIP>=30
76.19995,1,male,0,15,16,MOSF w/Malig,ARF/MOSF,4,12.0,$11-$25k,90858.0,56111.8438,18.666656,white,66.0,40,1,0,yes,0.5,0.5,dnr before sadm,-39.0,74.0,9.0,110.0,10.0,38.79688,171.40625,3.5,1.01,0.89990234,141.0,7.469727,161.0,28.0,2375.0,1.0,<2 mo. follow-up
66.97894,1,female,0,9,220,COPD,COPD/CHF/Cirrhosis,6,13.0,$11-$25k,11621.0,7526.9648,16.0,white,34.0,1,1,0,yes,0.899999619,0.8,dnr after sadm,1.0,106.0,8.59960938,110.0,24.0,36.39844,261.875,3.5,0.5,2.79980469,137.0,7.379883,119.0,60.0,2502.0,0.0,no(M2 and SIP pres)
68.04395,1,male,0,20,411,Coma,Coma,3,8.0,$11-$25k,32601.0,21729.9375,32.666657,white,42.0,1,0,0,no,0.699999809,0.5,no dnr,20.0,123.0,4.89941406,76.0,20.0,36.19531,333.3,3.0996094,0.89990234,10.0,139.0,7.419922,98.0,62.0,170.0,0.0,no(M2 and SIP pres)
92.33398,0,male,0,8,838,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3869.0,2705.2637,2.5,white,32.0,1,0,0,no,0.799999714,0.7,no dnr,8.0,135.0,0.69995117,112.0,8.0,39.39844,103.32812,3.5,1.01,5.09960938,134.0,7.299805,90.0,83.0,133.0,1.0,no(M2 and SIP pres)
77.61298,0,male,0,5,836,COPD,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,3524.0,2386.709,8.0,white,9.0,1,1,0,no,0.699999809,0.5,no dnr,5.0,71.0,17.1992188,162.0,30.0,39.39844,145.0,1.7998047,0.29998779,0.59997559,126.0,7.399414,182.0,12.0,2175.0,1.0,<2 mo. follow-up
86.73499,1,male,0,11,126,MOSF w/Malig,ARF/MOSF,4,9.0,under $11k,11041.0,7323.082,16.0,white,27.0,1,0,0,metastatic,0.649999619,0.1,dnr before sadm,-1.0,112.0,11.3984375,76.0,20.0,36.19531,392.0,3.5,0.59997559,1.69995117,135.0,7.469727,318.0,26.0,2000.0,5.0,no(M2 and SIP pres)
50.20697,1,male,0,4,95,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,5789.0,3933.3066,18.0,white,14.0,1,0,0,no,0.799999714,0.6,no dnr,4.0,93.0,4.79980469,73.0,16.0,37.09375,333.3,3.7998047,0.59997559,1.0,137.0,7.419922,116.0,7.0,1300.0,0.0,no(M2 and SIP pres)
50.69098,1,male,0,4,345,Lung Cancer,Cancer,1,16.0,>$50k,7055.0,4063.3086,11.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,4.0,73.0,7.5,63.0,20.0,35.0,476.1875,3.5,1.01,1.19995117,132.0,7.549805,130.0,32.0,975.0,0.0,no(M2 and SIP pres)
40.09299,1,male,0,22,265,CHF,COPD/CHF/Cirrhosis,3,18.0,$25-$50k,96734.0,68584.5,7.0,white,43.0,1,0,0,no,0.899999619,0.7,no dnr,22.0,110.0,29.5,86.0,28.0,36.19531,240.0,3.5,0.29998779,1.09985352,131.0,7.419922,346.0,29.0,3325.0,0.0,no(M2 and SIP pres)
60.35599,0,female,0,10,827,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,7059.0,4664.6719,9.5,white,24.0,1,1,0,no,1.0,1.0,no dnr,10.0,60.0,17.0,155.0,24.0,35.19531,414.25,3.2998047,1.0,1.79980469,137.0,7.479492,75.0,24.0,2502.0,0.0,<2 mo. follow-up
59.60797,0,male,0,7,827,COPD,COPD/CHF/Cirrhosis,5,11.0,$11-$25k,6488.0,4236.8203,8.5,white,22.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,81.0,7.69921875,83.0,26.0,37.09375,247.59375,3.5,1.01,2.0,138.0,7.479492,101.0,24.0,2450.0,0.0,no(M2 and SIP pres)
85.06494,1,female,0,13,74,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,9352.0,6178.2148,11.0,white,30.0,1,0,0,no,0.949999809,0.8,dnr after sadm,1.0,74.0,5.89941406,77.0,20.0,36.59375,204.75,3.5,1.0,1.0,134.0,7.469727,118.0,10.0,3425.0,6.0,adl>=4 (>=5 if sur)
68.84296,1,male,0,12,126,Lung Cancer,Cancer,3,12.0,$11-$25k,9346.0,6076.0195,5.0,white,15.0,1,0,0,metastatic,1.0,0.55,dnr after sadm,1.0,60.0,26.0976562,108.0,10.0,38.39844,125.0,2.2998047,15.1992188,2.19970703,135.0,7.359375,208.0,40.0,3690.0,2.0,adl>=4 (>=5 if sur)
68.45197,0,female,0,4,825,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,4204.0,2914.7578,9.0,white,22.0,1,0,0,no,0.899999619,0.8,no dnr,4.0,58.0,9.0,66.0,8.0,38.79688,184.4375,3.5,1.01,1.01,140.0,7.469727,135.0,23.0,1842.0,0.0,no(M2 and SIP pres)
24.18599,0,female,0,9,822,Coma,Coma,2,12.0,under $11k,10604.0,7159.0547,15.5,white,25.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,65.0,19.6992188,118.0,60.0,38.59375,73.75,2.5,1.89990234,1.0,143.0,7.459961,159.0,29.0,2265.0,0.0,no(M2 and SIP pres)
69.84796,1,male,0,20,24,Coma,Coma,2,10.0,$11-$25k,58550.0,42939.125,35.666657,white,47.0,4,0,0,no,0.5,0.4,dnr after sadm,10.0,67.0,9.0,49.0,20.0,35.69531,333.3,3.5,1.01,1.29980469,140.0,7.419922,105.0,29.0,2705.0,2.0,<2 mo. follow-up
58.185,0,female,0,21,820,Coma,Coma,0,12.0,>$50k,28158.0,20724.0938,21.0,white,21.0,1,0,0,no,0.799999714,0.7,no dnr,21.0,77.0,9.0,96.0,22.0,37.59375,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
70.35999,1,female,0,6,51,Colon Cancer,Cancer,1,12.0,under $11k,4961.0,3193.9883,16.0,white,53.0,1,0,0,metastatic,0.299999952,0.1,dnr after sadm,1.0,65.0,22.0,98.0,12.0,39.79688,165.0,10.8984375,8.79882812,1.5,133.0,7.439453,164.0,55.0,2325.0,0.494751,<2 mo. follow-up
57.547,1,male,0,5,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,18402.0,12561.375,28.0,white,26.0,4,0,0,no,0.099999964,0.1,dnr after sadm,3.0,121.0,7.39941406,83.0,20.0,35.79688,328.5625,3.199707,0.29998779,5.69921875,137.0,7.439453,195.0,57.0,3425.0,0.0,<2 mo. follow-up
62.22897,0,male,0,11,820,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,11740.0,8060.9922,14.0,white,12.0,1,1,0,no,0.699999809,0.5,no dnr,11.0,101.0,18.3984375,66.0,24.0,35.59375,333.3,3.5,1.01,1.19995117,137.0,7.419922,191.0,16.0,4900.0,0.0,adl>=4 (>=5 if sur)
79.65198,0,female,0,8,817,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,20446.0,13634.6875,20.5,white,46.0,5,1,0,no,0.699999809,0.5,no dnr,8.0,111.0,9.0,74.0,12.0,35.69531,293.3125,3.5,1.01,2.0,137.0,7.65918,114.0,46.0,2502.0,0.0,no(M2 and SIP pres)
76.79395,1,male,0,9,473,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,6728.0,4467.4805,8.0,white,29.0,1,0,0,no,0.949999809,0.9,dnr after sadm,2.0,82.0,3.79980469,77.0,20.0,36.29688,333.3,4.1992188,0.69995117,1.09985352,138.0,7.419922,138.0,18.0,5150.0,3.3759766,<2 mo. follow-up
85.88898,1,female,0,7,15,Coma,Coma,0,16.0,$11-$25k,34805.0,24401.1719,22.5,white,28.0,12,0,0,no,0.019999996,0.0,dnr after sadm,3.0,66.0,8.29882812,56.0,28.0,36.0,221.71875,4.2998047,1.09985352,0.89990234,137.0,7.329102,168.0,15.0,1700.0,0.0,<2 mo. follow-up
35.15399,0,male,0,22,811,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,100043.0,66069.8125,32.666657,white,37.0,12,0,0,no,0.799999714,0.75,no dnr,22.0,126.0,14.1992188,132.0,10.0,39.29688,154.0,2.199707,1.89990234,1.0,135.0,7.389648,235.0,17.0,2785.0,0.0,adl>=4 (>=5 if sur)
46.57599,0,female,0,37,811,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,100646.0,68337.125,35.0,white,60.0,1,0,0,no,0.899999619,0.9,no dnr,37.0,43.0,10.5996094,0.0,0.0,38.39844,133.3125,3.5,1.39990234,2.5,132.0,7.379883,345.0,38.0,1300.0,2.0078125,<2 mo. follow-up
68.38898,0,female,0,15,808,COPD,COPD/CHF/Cirrhosis,5,11.0,under $11k,26261.0,17221.2969,11.666664,white,17.0,1,0,0,yes,1.0,1.0,no dnr,15.0,78.0,7.0,83.0,20.0,35.89844,323.75,3.8999023,0.89990234,1.89990234,143.0,7.519531,95.0,39.0,1975.0,0.0,no(M2 and SIP pres)
78.29999,1,male,1,154,154,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,245741.0,169825.875,24.25,white,39.0,1,0,0,no,0.799999714,0.6,dnr after sadm,133.0,70.0,5.89941406,54.0,22.0,35.89844,295.1875,3.5,1.01,2.09960938,143.0,7.419922,98.0,48.0,1700.0,1.0,Coma or Intub
73.89697,1,female,1,42,42,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,84535.0,57884.5625,28.75,white,35.0,1,0,0,no,0.5,0.5,dnr after sadm,40.0,53.0,9.0,105.0,10.0,38.79688,87.04688,2.8999023,1.39990234,2.79980469,132.0,7.5,169.0,68.0,1898.0,1.0,<2 mo. follow-up
38.90799,0,female,0,22,808,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$11-$25k,46452.0,32660.1562,22.0,white,47.0,1,1,0,yes,0.75,0.75,no dnr,22.0,81.0,10.0996094,74.0,22.0,35.79688,333.3,3.5996094,2.89990234,1.09985352,125.0,7.419922,111.0,9.0,2502.0,1.0,<2 mo. follow-up
78.18994,1,male,0,3,126,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,2297.0,1613.8281,22.610928270087555,white,22.0,1,0,0,no,0.5,0.2,no dnr,3.0,122.0,8.19921875,87.0,24.0,35.89844,133.3125,4.5996094,0.59997559,0.69995117,142.0,7.339844,113.0,11.0,2502.0,2.0756836,<2 mo. follow-up
32.13397,0,male,0,11,803,ARF/MOSF w/Sepsis,ARF/MOSF,1,9.0,under $11k,9885.0,6642.668,13.0,white,21.0,1,1,0,no,0.989999771,0.99,no dnr,11.0,119.0,11.5996094,67.0,16.0,36.09375,333.3,2.2998047,0.39996338,1.79980469,137.0,7.419922,240.0,26.0,1425.0,1.0,<2 mo. follow-up
38.25098,0,male,0,33,804,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,47539.0,31000.7188,8.25,white,43.0,1,0,0,no,0.949999809,0.95,no dnr,33.0,111.0,8.69921875,122.0,24.0,37.89844,252.375,3.5,0.39996338,1.5,134.0,7.429688,124.0,20.0,2000.0,2.7905273,no(M2 and SIP pres)
56.46298,1,male,0,3,142,Lung Cancer,Cancer,1,12.0,under $11k,3338.0,2026.9092,22.610928270087555,white,5.0,1,0,0,metastatic,0.899999619,0.6,no dnr,3.0,63.0,3.29980469,130.0,9.0,39.29688,155.0,2.699707,2.29980469,0.79992676,133.0,7.419922,94.0,9.0,5025.0,1.9328613,<2 mo. follow-up
63.24197,0,female,0,8,801,COPD,COPD/CHF/Cirrhosis,7,12.0,under $11k,6430.0,4216.7852,9.5,white,42.0,1,1,0,no,1.0,1.0,no dnr,8.0,72.0,9.0,53.0,22.0,36.19531,333.3,3.5,1.01,1.0,137.0,7.419922,90.0,17.0,2250.0,1.0,no(M2 and SIP pres)
43.21698,1,female,0,11,492,Lung Cancer,Cancer,1,13.0,>$50k,18964.0,12439.8594,12.0,white,18.0,1,0,0,metastatic,0.599999905,0.1,no dnr,11.0,75.0,16.6992188,120.0,12.0,36.19531,210.0,2.5,1.79980469,0.79992676,138.0,7.449219,179.0,39.0,1200.0,0.0,no(M2 and SIP pres)
59.74298,1,male,0,3,163,Lung Cancer,Cancer,2,14.0,$25-$50k,4125.0,2489.4258,22.610928270087555,white,2.0,1,0,0,metastatic,0.799999714,0.5,no dnr,3.0,69.0,21.0976562,130.0,44.0,39.09375,108.875,2.5996094,1.01,0.69995117,142.0,7.459961,249.0,14.0,1575.0,0.494751,no(M2 and SIP pres)
69.46698,0,female,0,5,796,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,4184.0,2792.2969,15.0,white,13.0,1,1,0,no,0.899999619,0.8,no dnr,5.0,72.0,9.5,79.0,22.0,36.59375,333.3,3.5,1.01,0.89990234,140.0,7.419922,113.0,25.0,2502.0,0.0,<2 mo. follow-up
83.25494,1,female,0,4,337,CHF,COPD/CHF/Cirrhosis,0,16.0,$11-$25k,2127.0,1396.165,11.0,white,56.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,72.0,9.0,104.0,40.0,38.09375,222.84375,3.0,0.59997559,0.79992676,134.0,7.469727,154.0,17.0,1200.0,0.494751,no(M2 and SIP pres)
74.41199,1,male,0,9,667,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,5954.0,4052.7539,5.5,white,35.0,1,1,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,80.0,4.79980469,81.0,24.0,36.5,480.9375,2.0996094,8.19921875,1.69995117,133.0,7.40918,127.0,28.0,1600.0,1.0,no(M2 and SIP pres)
69.68396,1,male,1,4,4,COPD,COPD/CHF/Cirrhosis,4,12.0,$25-$50k,33100.0,21796.5625,63.0,white,62.0,1,1,0,no,0.5,0.5,no dnr,4.0,105.0,9.0,101.0,48.0,36.09375,181.46875,3.5,1.01,1.01,140.0,7.359375,135.0,23.0,48.0,3.7246094,<2 mo. follow-up
58.85797,1,female,0,109,130,Coma,Coma,1,10.0,under $11k,116164.0,109721.812,29.5,white,23.0,12,1,0,no,0.75,0.75,no dnr,109.0,81.0,9.09960938,63.0,24.0,35.89844,333.3,3.5,0.5,1.0,128.0,7.419922,257.0,10.0,2450.0,0.0,<2 mo. follow-up
84.27698,1,male,1,5,5,COPD,COPD/CHF/Cirrhosis,3,13.0,under $11k,5460.0,3369.4941,18.0,white,35.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,60.0,3.69970703,150.0,42.0,38.79688,108.0,2.5996094,0.59997559,0.69995117,137.0,7.25,160.0,7.0,3950.0,3.4150391,<2 mo. follow-up
40.29797,1,female,0,7,251,Colon Cancer,Cancer,5,14.0,$11-$25k,5921.0,3866.3652,8.5,white,19.0,1,0,0,metastatic,0.599999905,0.1,no dnr,7.0,107.0,13.3984375,110.0,40.0,38.69531,307.25,2.0996094,1.0,1.39990234,145.0,7.349609,262.0,46.0,2875.0,2.4750977,<2 mo. follow-up
86.89899,1,male,0,7,23,CHF,COPD/CHF/Cirrhosis,7,8.0,under $11k,5325.0,3531.0039,5.5,white,22.0,1,1,0,yes,0.979999542,0.95,dnr after sadm,1.0,78.0,5.89941406,93.0,16.0,36.29688,333.3,3.5,1.01,1.09985352,134.0,7.419922,101.0,23.0,3425.0,0.0,<2 mo. follow-up
65.49799,1,female,0,12,174,Colon Cancer,Cancer,1,12.0,$25-$50k,16509.0,10621.1328,17.0,white,11.0,1,0,0,metastatic,0.899999619,0.5,no dnr,12.0,69.0,9.19921875,69.0,24.0,35.59375,193.3125,3.5,0.59997559,1.09985352,151.0,7.25,97.0,19.0,2502.0,1.0,no(M2 and SIP pres)
74.08899,1,female,0,13,657,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,13953.0,8987.8828,13.5,white,31.0,1,1,0,no,0.899999619,0.8,dnr after sadm,2.0,61.0,11.0996094,87.0,24.0,35.79688,195.90625,3.5,1.29980469,1.5,138.0,7.359375,153.0,29.0,2502.0,1.0,SIP>=30
70.97894,1,male,0,5,375,Lung Cancer,Cancer,2,12.0,under $11k,5531.0,3486.9531,11.0,white,21.0,1,0,0,metastatic,0.599999905,0.3,no dnr,5.0,83.0,4.09960938,70.0,20.0,36.19531,333.3,3.2998047,0.39996338,1.0,132.0,7.419922,102.0,17.0,2675.0,2.3779297,<2 mo. follow-up
73.40997,0,male,0,12,783,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,12190.0,7729.9258,9.0,white,44.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,141.0,3.69970703,89.0,24.0,36.59375,342.8125,3.5,0.19998169,0.69995117,135.0,7.469727,95.0,23.0,1175.0,4.0,no(M2 and SIP pres)
65.35498,1,male,0,14,244,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,25070.0,17162.6562,16.333328,white,34.0,1,1,0,no,0.949999809,0.8,no dnr,14.0,111.0,9.09960938,96.0,24.0,36.59375,333.3,2.3999023,0.5,2.5,137.0,7.419922,101.0,37.0,2025.0,0.0,SIP>=30
81.18298,0,female,0,6,779,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,3984.0,2696.1523,9.0,white,19.0,1,0,0,no,0.75,0.5,dnr before sadm,-1.0,62.0,4.69921875,79.0,20.0,36.39844,333.3,3.7998047,0.39996338,0.89990234,134.0,7.419922,160.0,5.0,1375.0,3.0,no(M2 and SIP pres)
74.61694,1,male,0,20,90,Lung Cancer,Cancer,1,12.0,$11-$25k,12082.0,8386.3984,7.0,white,21.0,1,0,0,metastatic,0.799999714,0.4,no dnr,20.0,64.0,21.6992188,136.0,10.0,39.09375,182.0,3.5,0.69995117,1.59985352,165.0,7.489258,535.0,16.0,8150.0,1.0,no(M2 and SIP pres)
78.85797,1,female,0,5,10,Coma,Coma,2,12.0,under $11k,11071.0,7437.3203,33.0,white,21.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,64.0,11.0,102.0,36.0,36.59375,204.75,3.5,0.89990234,2.0,140.0,7.40918,91.0,32.0,2595.0,2.4863281,<2 mo. follow-up
54.38998,1,male,0,12,45,Lung Cancer,Cancer,2,12.0,under $11k,7294.0,4587.8359,3.5,white,20.0,1,0,0,metastatic,1.0,0.95,no dnr,12.0,70.0,16.296875,67.0,34.0,37.5,148.0,3.5,0.39996338,0.69995117,137.0,7.30957,157.0,19.0,1475.0,0.0,<2 mo. follow-up
89.47797,1,female,0,9,319,CHF,COPD/CHF/Cirrhosis,6,13.0,under $11k,5923.0,3958.7891,12.5,white,31.0,1,0,0,no,0.75,0.25,dnr after sadm,1.0,69.0,7.5,104.0,24.0,35.89844,320.0,3.5,1.39990234,1.09985352,138.0,7.5,99.0,19.0,2502.0,7.0,adl>=4 (>=5 if sur)
76.74695,1,male,0,10,211,CHF,COPD/CHF/Cirrhosis,6,8.0,under $11k,6191.0,4101.8906,4.5,white,14.0,1,0,0,yes,0.699999809,0.5,no dnr,10.0,77.0,11.0996094,77.0,24.0,36.09375,223.78125,4.0,0.5,1.0,140.0,7.429688,120.0,8.0,3740.0,2.0,SIP>=30
46.702,0,male,0,6,773,Coma,Coma,1,12.0,$25-$50k,11002.0,7584.875,11.0,white,16.0,3,0,0,no,0.949999809,0.95,no dnr,6.0,71.0,6.0,71.0,24.0,36.39844,253.84375,3.5,1.01,0.79992676,141.0,7.40918,120.0,10.0,1075.0,0.0,no(M2 and SIP pres)
90.53497,0,male,0,14,774,COPD,COPD/CHF/Cirrhosis,3,5.0,under $11k,9899.0,6333.6719,7.333332,white,32.0,1,0,0,no,0.799999714,0.5,dnr before sadm,0.0,121.0,16.8984375,112.0,8.0,38.89844,255.0,3.8999023,0.79992676,1.09985352,140.0,7.429688,226.0,12.0,2905.0,1.0,no(M2 and SIP pres)
80.745,1,male,0,4,5,ARF/MOSF w/Sepsis,ARF/MOSF,2,6.0,under $11k,8599.0,5789.1133,31.0,white,40.0,1,0,0,no,0.25,0.1,dnr after sadm,1.0,43.0,21.6992188,104.0,36.0,35.59375,168.3125,2.699707,0.39996338,0.5,143.0,7.399414,149.0,18.0,805.0,5.0,<2 mo. follow-up
48.47897,0,male,0,53,772,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,99065.0,66641.9375,39.25,white,40.0,1,0,0,no,0.75,0.75,no dnr,53.0,107.0,41.8984375,112.0,30.0,35.79688,91.65625,2.5996094,0.79992676,6.59960938,129.0,7.439453,202.0,40.0,0.0,0.0,adl>=4 (>=5 if sur)
57.21597,0,male,0,11,770,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,9600.0,6362.043,16.5,other,32.0,1,1,0,no,0.5,0.4,dnr after sadm,3.0,57.0,8.29882812,60.0,26.0,36.09375,304.75,3.5,1.01,1.09985352,135.0,7.399414,212.0,16.0,2485.0,7.0,adl>=4 (>=5 if sur)
70.90796,1,male,0,4,19,Lung Cancer,Cancer,2,12.0,under $11k,3590.0,2661.1875,4.0,white,21.0,1,0,0,metastatic,0.5,0.2,dnr after sadm,1.0,55.0,16.6992188,142.0,22.0,39.69531,201.65625,1.6999512,2.29980469,3.0,137.0,7.199219,388.0,31.0,2502.0,2.0996094,<2 mo. follow-up
78.245,1,male,0,35,50,Coma,Coma,3,8.0,under $11k,43459.0,28174.9375,15.0,white,29.0,1,0,0,yes,0.699999809,0.6,dnr after sadm,9.0,36.0,42.296875,128.0,54.0,38.39844,252.375,2.2998047,1.09985352,8.59960938,129.0,7.399414,215.0,120.0,0.0,1.0,<2 mo. follow-up
88.375,0,female,0,11,763,ARF/MOSF w/Sepsis,ARF/MOSF,0,5.0,under $11k,10371.0,7066.0859,17.0,white,44.0,1,0,0,no,0.799999714,0.75,dnr after sadm,1.0,63.0,9.0,114.0,38.0,38.29688,174.28125,1.8999023,1.29980469,1.39990234,142.0,7.509766,143.0,49.0,1925.0,1.0,no(M2 and SIP pres)
50.62598,1,female,0,5,422,Colon Cancer,Cancer,2,16.0,>$50k,3827.0,2371.9648,7.0,white,9.0,1,0,0,metastatic,0.899999619,0.5,no dnr,5.0,141.0,26.6992188,132.0,24.0,36.59375,106.65625,3.5,1.01,0.89990234,133.0,7.40918,178.0,20.0,4100.0,0.0,no(M2 and SIP pres)
66.08099,1,male,0,5,509,Lung Cancer,Cancer,3,12.0,>$50k,5742.0,3662.0156,14.0,white,15.0,1,0,0,metastatic,0.799999714,0.6,no dnr,5.0,79.0,4.79980469,65.0,18.0,35.79688,333.3,4.0,0.39996338,1.0,138.0,7.419922,95.0,16.0,2502.0,2.4194336,no(M2 and SIP pres)
65.11395,1,male,0,7,77,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,7216.0,4896.9844,12.0,white,57.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,101.0,10.6992188,60.0,24.0,35.39844,208.0,3.5,1.29980469,1.5,135.0,7.419922,176.0,43.0,1725.0,1.0,<2 mo. follow-up
72.534,1,male,0,13,146,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,26337.0,17738.7656,34.5,white,19.0,3,0,0,no,0.799999714,0.8,no dnr,13.0,72.0,7.09960938,61.0,20.0,36.19531,333.3,3.2998047,0.29998779,1.19995117,142.0,7.419922,76.0,18.0,1775.0,1.0,no(M2 and SIP pres)
76.26294,0,female,0,30,755,ARF/MOSF w/Sepsis,ARF/MOSF,0,10.0,under $11k,101645.0,65776.875,27.5,white,24.0,32,0,0,no,0.75,0.5,no dnr,30.0,83.0,6.29980469,89.0,18.0,36.79688,333.3,3.5,1.01,0.79992676,134.0,7.419922,98.0,12.0,2502.0,1.9389648,<2 mo. follow-up
79.37299,1,male,0,11,290,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,7302.0,4651.1211,10.0,white,31.0,1,0,0,no,0.799999714,0.7,no dnr,11.0,117.0,15.5996094,79.0,20.0,36.0,333.3,3.5996094,0.29998779,1.09985352,134.0,7.419922,141.0,11.0,2502.0,0.0,no(M2 and SIP pres)
78.42596,0,female,0,11,750,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19552.0,13048.4062,20.0,white,38.0,5,0,0,no,0.25,0.1,dnr after sadm,2.0,64.0,3.0,40.0,12.0,31.69922,333.3,3.0,1.89990234,1.39990234,142.0,7.419922,98.0,12.0,2390.0,1.0,no(M2 and SIP pres)
69.56598,1,male,0,19,276,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,21123.0,15517.9609,12.666664,white,57.0,1,0,0,no,0.5,0.3,no dnr,19.0,73.0,31.796875,122.0,44.0,36.69531,145.0,1.7998047,3.0,2.69970703,128.0,7.449219,95.0,73.0,1098.0,0.0,no(M2 and SIP pres)
71.20099,1,male,1,16,16,Coma,Coma,2,12.0,under $11k,23547.0,16675.1406,29.0,white,66.0,1,0,0,no,0.699999809,0.5,dnr after sadm,3.0,105.0,8.0,98.0,16.0,36.19531,333.3,4.0996094,0.19998169,1.29980469,133.0,7.419922,104.0,17.0,3225.0,0.0,<2 mo. follow-up
50.93799,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,47782.0,31594.3594,49.0,white,63.0,2,0,0,no,0.799999714,0.7,no dnr,7.0,60.0,10.5996094,131.0,28.0,36.59375,276.875,3.5,0.69995117,2.0,133.0,7.479492,83.0,49.0,1200.0,2.0288086,<2 mo. follow-up
54.95398,1,male,1,36,36,MOSF w/Malig,ARF/MOSF,3,12.0,under $11k,188415.0,120854.812,34.75,white,75.0,26,0,0,yes,0.799999714,0.6,dnr after sadm,35.0,61.0,3.39990234,67.0,28.0,34.79688,333.3,2.3999023,11.5,1.09985352,139.0,7.419922,206.0,66.0,1750.0,0.0,<2 mo. follow-up
92.68195,0,male,0,5,748,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,3435.0,2327.6621,11.0,white,31.0,1,0,0,no,0.899999619,0.6,no dnr,5.0,68.0,16.0976562,107.0,24.0,36.39844,165.0,4.0996094,0.19998169,1.19995117,132.0,7.339844,446.0,42.0,3150.0,0.0,no(M2 and SIP pres)
52.38599,1,male,0,4,120,Lung Cancer,Cancer,2,12.0,$25-$50k,3526.0,2257.0606,10.0,white,19.0,1,0,0,metastatic,0.899999619,0.75,no dnr,4.0,69.0,12.1992188,64.0,35.0,35.69531,133.84375,2.699707,0.79992676,0.89990234,138.0,7.449219,168.0,24.0,1375.0,0.0,no(M2 and SIP pres)
62.004,1,male,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,11.0,under $11k,68056.0,47110.8438,40.0,white,67.0,12,0,0,no,0.099999964,0.1,no dnr,5.0,134.0,10.1992188,107.0,20.0,36.19531,357.125,3.5,1.01,1.59985352,131.0,7.389648,133.0,25.0,1775.0,0.0,<2 mo. follow-up
59.67697,1,male,0,12,96,Lung Cancer,Cancer,2,11.0,$11-$25k,16618.0,10802.1797,9.5,white,30.0,1,0,0,metastatic,0.949999809,0.5,dnr after sadm,10.0,80.0,20.0976562,81.0,24.0,36.0,278.25,4.2998047,0.5,0.79992676,133.0,7.379883,136.0,11.0,2502.0,0.0,SIP>=30
45.38498,0,male,0,59,743,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,129834.0,14452.7344,35.75,white,34.0,3,0,1,no,0.799999714,0.8,no dnr,59.0,63.0,5.19921875,69.0,24.0,35.79688,185.0,3.5,1.01,1.09985352,145.0,7.359375,87.0,25.0,1425.0,4.0810547,no(M2 and SIP pres)
68.81598,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,12606.0,8449.125,24.0,white,68.0,1,0,0,yes,0.699999809,0.5,no dnr,4.0,109.0,8.19921875,50.0,24.0,36.29688,333.3,3.5,1.01,1.19995117,136.0,7.419922,97.0,23.0,4050.0,2.4926758,<2 mo. follow-up
78.85596,0,male,0,7,744,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,3988.0,2595.7773,2.5,white,39.0,1,0,0,no,0.699999809,0.5,no dnr,7.0,72.0,8.3984375,74.0,20.0,36.59375,333.3,3.7998047,0.39996338,1.0,140.0,7.419922,76.0,9.0,8600.0,2.6123047,<2 mo. follow-up
41.83197,0,female,0,13,742,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,28393.0,18363.4062,28.0,white,44.0,3,0,0,no,0.5,0.5,no dnr,13.0,57.0,10.3984375,167.0,24.0,35.89844,333.3,3.5,1.01,1.0,137.0,7.419922,91.0,21.0,2502.0,0.0,no(M2 and SIP pres)
70.97095,1,male,0,11,76,Lung Cancer,Cancer,3,12.0,$25-$50k,9176.0,6019.9141,8.0,white,31.0,1,0,0,metastatic,0.699999809,0.5,no dnr,11.0,74.0,13.1992188,79.0,26.0,36.19531,183.3125,3.199707,0.39996338,0.59997559,141.0,7.439453,207.0,4.0,2700.0,0.0,<2 mo. follow-up
56.09,1,male,0,8,169,Cirrhosis,COPD/CHF/Cirrhosis,5,12.0,$25-$50k,11949.0,8494.4922,19.5,white,44.0,1,1,0,yes,0.299999952,0.2,no dnr,8.0,90.0,13.5996094,69.0,28.0,36.19531,276.0,3.5,0.59997559,0.79992676,141.0,7.369141,242.0,20.0,3300.0,0.0,no(M2 and SIP pres)
77.03796,0,female,0,5,723,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,3384.0,2219.3242,8.0,white,11.0,1,0,0,no,0.699999809,0.6,dnr after sadm,1.0,71.0,6.79980469,101.0,28.0,35.79688,446.625,3.7998047,0.29998779,1.09985352,136.0,7.319336,117.0,26.0,875.0,3.0,no(M2 and SIP pres)
71.28796,1,male,0,7,26,Lung Cancer,Cancer,2,12.0,under $11k,4495.0,2965.0957,6.0,white,27.0,1,0,0,metastatic,0.25,0.1,dnr after sadm,1.0,101.0,9.8984375,66.0,20.0,35.79688,347.5625,2.699707,0.19998169,0.59997559,128.0,7.459961,120.0,14.0,3400.0,2.0,<2 mo. follow-up
56.33899,1,male,1,5,5,Coma,Coma,1,8.0,under $11k,16220.0,11137.3359,47.0,white,36.0,4,1,0,no,0.5,0.5,dnr after sadm,5.0,100.0,31.3984375,104.0,24.0,36.19531,319.0,3.5,1.01,0.89990234,137.0,7.429688,168.0,21.0,3800.0,2.0561523,<2 mo. follow-up
31.22198,1,male,0,80,173,CHF,COPD/CHF/Cirrhosis,4,16.0,>$50k,100714.0,64004.9688,15.25,white,23.0,1,1,0,yes,0.5,0.25,no dnr,80.0,61.0,10.7988281,58.0,15.0,36.79688,91.82812,3.5,1.0,0.89990234,139.0,7.419922,163.0,11.0,2685.0,0.0,no(M2 and SIP pres)
75.22198,1,female,0,22,518,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,16569.0,10865.5234,12.666664,white,34.0,1,1,0,no,0.699999809,0.5,no dnr,22.0,61.0,7.29980469,100.0,24.0,39.39844,136.0,2.0,0.79992676,10.0996094,135.0,7.459961,188.0,72.0,2502.0,2.8203125,<2 mo. follow-up
18.18999,0,female,0,21,718,Coma,Coma,0,11.0,under $11k,49598.0,32209.9375,26.0,white,39.0,10,0,0,no,0.489999771,0.49,no dnr,21.0,117.0,16.6992188,76.0,32.0,36.0,188.0,3.5,0.29998779,0.79992676,139.0,7.429688,183.0,16.0,1625.0,0.0,no(M2 and SIP pres)
91.28796,1,female,1,5,5,CHF,COPD/CHF/Cirrhosis,3,10.0,$11-$25k,3350.0,2227.3711,14.0,white,39.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,108.0,0.69995117,156.0,22.0,36.69531,333.3,2.0996094,1.29980469,0.69995117,132.0,7.419922,122.0,8.0,2750.0,3.1645508,<2 mo. follow-up
33.09497,0,male,0,5,717,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,9241.0,6637.9531,16.0,white,18.0,3,0,0,no,0.949999809,0.95,no dnr,5.0,113.0,10.1992188,59.0,28.0,38.79688,200.0,3.5,1.01,1.59985352,137.0,7.479492,121.0,17.0,2440.0,2.6635742,<2 mo. follow-up
30.69099,0,female,0,10,717,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,22970.0,14684.5781,22.0,white,12.0,3,0,0,no,0.949999809,0.95,no dnr,10.0,76.0,18.3984375,72.0,26.0,36.39844,262.5,3.3999023,0.5,0.69995117,136.0,7.389648,102.0,9.0,2700.0,0.0,<2 mo. follow-up
82.60596,1,female,1,5,5,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,50759.0,33172.375,47.0,white,58.0,30,0,0,no,0.199999928,0.2,dnr after sadm,5.0,105.0,9.09960938,140.0,40.0,38.29688,194.28125,3.5,1.01,1.39990234,140.0,7.339844,249.0,24.0,2175.0,2.0,<2 mo. follow-up
69.90796,1,male,0,11,121,Lung Cancer,Cancer,1,12.0,under $11k,14305.0,9534.0078,8.0,white,12.0,1,0,0,metastatic,0.5,0.3,dnr after sadm,4.0,65.0,8.29882812,85.0,28.0,36.19531,320.0,3.5,1.01,1.39990234,128.0,7.419922,140.0,58.0,2502.0,0.0,no(M2 and SIP pres)
69.58795,0,female,0,32,712,CHF,COPD/CHF/Cirrhosis,4,12.0,under $11k,29039.0,19057.5938,10.5,white,19.0,1,1,0,no,0.699999809,0.5,no dnr,32.0,77.0,11.1992188,80.0,29.0,39.0,202.5,2.0996094,0.39996338,0.69995117,129.0,7.469727,99.0,11.0,2440.0,0.0,SIP>=30
68.19397,1,male,1,20,20,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,64704.0,42494.7812,38.0,white,55.0,1,0,0,no,0.299999952,0.25,no dnr,20.0,76.0,24.796875,72.0,28.0,39.09375,413.3125,2.199707,0.39996338,1.19995117,139.0,7.469727,209.0,36.0,2250.0,6.0,<2 mo. follow-up
64.93396,1,male,0,4,7,Coma,Coma,1,10.0,under $11k,7978.0,14452.7344,46.0,white,48.0,1,0,0,yes,0.25,0.2,no dnr,4.0,50.0,18.8984375,118.0,30.0,40.0,90.0,3.0,1.09985352,1.5,136.0,7.389648,137.0,34.0,910.0,0.0,<2 mo. follow-up
81.88599,0,male,0,7,710,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5530.0,3641.418,4.5,white,13.0,1,0,0,no,0.599999905,0.8,no dnr,7.0,115.0,7.89941406,93.0,20.0,36.89844,333.3,3.5996094,0.29998779,1.29980469,136.0,7.419922,201.0,14.0,2502.0,3.4697266,<2 mo. follow-up
64.24396,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,22241.0,15178.0938,41.0,white,58.0,4,0,0,no,0.5,0.3,dnr after sadm,3.0,105.0,9.0,71.0,24.0,35.79688,280.9375,3.5,1.01,0.69995117,137.0,7.379883,96.0,9.0,975.0,0.0,<2 mo. follow-up
51.01199,0,female,0,6,706,CHF,COPD/CHF/Cirrhosis,3,12.0,$25-$50k,5990.0,4180.5078,16.0,white,34.0,1,1,0,no,0.949999809,0.9,no dnr,6.0,60.0,10.5,148.0,32.0,36.39844,155.0,2.5996094,0.39996338,0.69995117,141.0,7.389648,130.0,13.0,1200.0,3.0,SIP>=30
78.32196,1,male,1,33,33,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,110595.0,73481.75,46.5,white,37.0,7,0,0,no,0.599999905,0.5,dnr after sadm,32.0,108.0,16.6992188,126.0,46.0,39.39844,182.5,3.5,0.79992676,1.39990234,143.0,7.389648,204.0,21.0,2100.0,2.0,<2 mo. follow-up
63.04999,1,female,0,18,124,Colon Cancer,Cancer,1,13.0,under $11k,21542.0,13636.2188,15.0,white,15.0,1,0,0,metastatic,0.949999809,0.9,no dnr,18.0,52.0,22.296875,76.0,6.0,36.19531,420.0,2.0996094,0.69995117,2.79980469,147.0,7.369141,221.0,81.0,2725.0,0.0,no(M2 and SIP pres)
66.95099,1,female,0,36,154,ARF/MOSF w/Sepsis,ARF/MOSF,2,15.0,$25-$50k,125149.0,84051.8125,35.0,white,38.0,21,1,0,no,0.75,0.6,dnr after sadm,2.0,101.0,12.0,66.0,20.0,36.39844,352.375,3.5,1.5,1.69995117,138.0,7.479492,110.0,31.0,2502.0,7.0,adl>=4 (>=5 if sur)
73.04895,0,female,0,9,699,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,7873.0,5457.4727,12.0,white,13.0,1,1,0,no,0.899999619,0.8,no dnr,9.0,103.0,9.69921875,74.0,22.0,36.79688,247.59375,2.699707,0.29998779,0.79992676,143.0,7.279297,158.0,8.0,2502.0,1.0,no(M2 and SIP pres)
83.77295,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$25-$50k,93380.0,63700.25,47.0,white,103.0,19,1,0,no,0.0,0.0,no dnr,3.0,109.0,8.29882812,114.0,12.0,37.79688,333.3,1.7998047,4.69921875,0.59997559,139.0,7.419922,132.0,7.0,965.0,2.8720703,<2 mo. follow-up
22.146,0,male,0,11,698,ARF/MOSF w/Sepsis,ARF/MOSF,1,15.0,under $11k,29891.0,19014.0,23.0,white,17.0,16,0,0,yes,0.699999809,0.7,no dnr,11.0,83.0,10.8984375,76.0,18.0,36.79688,333.3,3.5,0.39996338,1.09985352,140.0,7.419922,96.0,9.0,2502.0,0.0,no(M2 and SIP pres)
68.06,1,female,0,3,432,Lung Cancer,Cancer,2,12.0,$11-$25k,4051.0,2550.0,22.610928270087555,white,19.0,1,0,0,metastatic,0.599999905,0.4,no dnr,3.0,51.0,12.3984375,45.0,24.0,36.69531,217.375,3.5996094,0.39996338,1.29980469,130.0,7.399414,211.0,23.0,1700.0,0.0,no(M2 and SIP pres)
69.91895,0,male,0,6,697,CHF,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,4386.0,2976.1621,14.0,white,15.0,1,0,0,no,1.0,0.9,no dnr,6.0,72.0,3.89990234,42.0,20.0,35.79688,333.3,4.0,0.39996338,0.79992676,138.0,7.419922,144.0,12.0,3250.0,0.494751,no(M2 and SIP pres)
78.21497,1,female,0,10,679,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,6278.0,4128.7109,8.5,white,31.0,1,0,0,no,0.799999714,0.6,dnr after sadm,1.0,84.0,9.0,67.0,20.0,36.19531,333.3,3.5,1.01,1.09985352,136.0,7.419922,110.0,13.0,2502.0,3.0,SIP>=30
56.64899,1,male,1,9,9,MOSF w/Malig,ARF/MOSF,1,13.0,$25-$50k,64165.0,39395.8125,32.5,white,44.0,18,0,0,yes,0.799999714,0.7,no dnr,9.0,96.0,9.5,107.0,24.0,36.09375,280.9375,3.699707,1.39990234,1.29980469,142.0,7.479492,117.0,18.0,3225.0,0.0,<2 mo. follow-up
74.85297,0,male,0,26,694,Coma,Coma,2,8.0,$25-$50k,26893.0,18100.0,16.75,white,39.0,1,0,0,no,0.039999992,0.04,no dnr,26.0,59.0,5.89941406,76.0,30.0,35.79688,333.3,4.0996094,2.0,2.69970703,138.0,7.419922,98.0,58.0,1125.0,0.0,<2 mo. follow-up
70.86096,1,female,0,9,370,CHF,COPD/CHF/Cirrhosis,3,11.0,under $11k,8175.0,5472.7891,8.5,white,35.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,127.0,6.09960938,65.0,24.0,35.69531,419.0,3.5,0.19998169,2.89990234,140.0,7.429688,120.0,63.0,2050.0,2.0,no(M2 and SIP pres)
84.85394,0,male,0,14,691,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,22306.0,14743.6094,16.333328,white,37.0,1,0,0,no,0.799999714,0.8,no dnr,14.0,46.0,19.296875,105.0,10.0,39.39844,133.84375,3.199707,0.5,2.29980469,133.0,7.339844,301.0,24.0,353.0,0.0,<2 mo. follow-up
86.14899,1,male,1,10,10,Coma,Coma,1,10.0,under $11k,15476.0,9943.0547,27.5,white,39.0,1,0,0,no,0.299999952,0.3,dnr after sadm,9.0,64.0,6.79980469,114.0,24.0,36.19531,400.0,3.199707,0.89990234,1.09985352,138.0,7.509766,158.0,21.0,2150.0,1.0,<2 mo. follow-up
91.33197,0,male,0,12,686,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,22799.0,15125.9453,18.5,white,52.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,107.0,18.5,70.0,10.0,35.89844,207.5,4.1992188,0.59997559,0.69995117,138.0,7.489258,254.0,23.0,1790.0,0.0,SIP>=30
58.80099,0,female,0,69,686,COPD,COPD/CHF/Cirrhosis,7,11.0,under $11k,140005.0,99652.9375,40.0,white,52.0,5,1,0,no,0.299999952,0.3,no dnr,69.0,72.0,11.1992188,74.0,28.0,36.39844,106.65625,3.5,0.69995117,1.09985352,135.0,7.30957,178.0,36.0,2502.0,6.0,SIP>=30
68.45398,1,male,0,65,168,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,94981.0,58759.7812,25.75,white,50.0,3,0,0,metastatic,0.699999809,0.5,no dnr,65.0,76.0,20.3984375,135.0,16.0,36.69531,333.3,3.5,1.01,1.0,138.0,7.419922,90.0,10.0,2600.0,0.0,SIP>=30
73.396,1,female,0,8,377,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,6134.0,4247.75,4.5,white,26.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,101.0,10.3984375,96.0,24.0,36.29688,333.3,3.5996094,0.69995117,1.69995117,135.0,7.419922,260.0,17.0,1900.0,0.0,no(M2 and SIP pres)
41.88898,1,female,0,5,504,Lung Cancer,Cancer,1,13.0,under $11k,7325.0,5001.2109,4.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,70.0,8.5,62.0,20.0,37.69531,333.3,3.5,1.01,0.89990234,138.0,7.419922,84.0,11.0,2502.0,1.0,no(M2 and SIP pres)
79.33698,1,female,0,21,109,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,24248.0,16439.4375,16.0,white,43.0,1,1,0,no,0.049999982,0.02,no dnr,21.0,64.0,12.7988281,77.0,28.0,36.5,174.28125,3.2998047,0.29998779,1.29980469,138.0,7.429688,264.0,30.0,2110.0,0.0,no(M2 and SIP pres)
49.96597,1,male,0,11,261,ARF/MOSF w/Sepsis,ARF/MOSF,0,0.0,under $11k,14104.0,9735.3125,23.5,white,32.0,1,0,0,no,1.0,0.8,no dnr,11.0,106.0,3.69970703,79.0,28.0,38.09375,247.59375,4.1992188,0.5,1.0,134.0,7.419922,92.0,4.0,4425.0,7.0,adl>=4 (>=5 if sur)
78.22296,1,male,1,25,25,Coma,Coma,2,12.0,under $11k,59397.0,39876.875,31.25,white,54.0,9,0,1,no,0.699999809,0.5,dnr after sadm,20.0,118.0,13.7988281,69.0,40.0,37.89844,82.84375,3.5,0.69995117,0.79992676,140.0,7.379883,262.0,37.0,2502.0,4.9912109,<2 mo. follow-up
64.18896,0,female,0,9,676,Lung Cancer,Cancer,4,12.0,$11-$25k,10001.0,6335.3242,14.0,white,12.0,1,0,0,metastatic,0.949999809,0.95,no dnr,9.0,105.0,31.5,70.0,22.0,36.29688,261.1875,3.5,0.89990234,2.89990234,136.0,7.459961,184.0,69.0,1860.0,0.0,no(M2 and SIP pres)
73.73297,0,female,0,12,675,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,13660.0,9851.0547,28.0,white,69.0,1,1,0,no,0.599999905,0.5,no dnr,12.0,112.0,9.0,69.0,24.0,35.79688,333.3,3.5,1.01,1.59985352,138.0,7.419922,75.0,38.0,2600.0,2.0,SIP>=30
58.47198,1,female,0,13,80,Lung Cancer,Cancer,1,9.0,under $11k,16624.0,10855.6016,9.5,white,6.0,1,0,0,metastatic,0.799999714,0.5,no dnr,13.0,83.0,20.5976562,67.0,20.0,35.39844,333.3,4.1992188,0.39996338,1.5,140.0,7.419922,126.0,27.0,1400.0,3.0,adl>=4 (>=5 if sur)
65.659,1,female,0,5,224,Lung Cancer,Cancer,3,8.0,under $11k,3161.0,2090.9981,5.0,white,18.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,1.0,115.0,17.296875,115.0,10.0,38.5,320.0,3.5,1.01,0.79992676,134.0,7.509766,155.0,12.0,1500.0,5.0,<2 mo. follow-up
57.65598,1,male,0,19,120,Lung Cancer,Cancer,2,10.0,under $11k,26969.0,18235.4688,3.333332,white,14.0,1,0,0,metastatic,1.0,0.51,no dnr,19.0,72.0,5.69921875,101.0,30.0,38.59375,333.3,3.7998047,0.59997559,0.89990234,131.0,7.419922,179.0,12.0,2502.0,0.0,SIP>=30
65.90796,1,male,0,5,406,CHF,COPD/CHF/Cirrhosis,3,14.0,$25-$50k,2496.0,1644.8779,10.0,white,40.0,1,1,0,no,0.799999714,0.5,no dnr,5.0,61.0,6.09960938,51.0,32.0,35.59375,485.6875,3.5,1.01,1.29980469,132.0,7.449219,96.0,64.0,2200.0,0.0,no(M2 and SIP pres)
52.87097,1,male,0,19,38,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,36129.0,25131.2344,21.333328,white,35.0,6,0,0,yes,0.25,0.05,no dnr,19.0,99.0,10.1992188,81.0,22.0,36.09375,247.59375,3.5,0.19998169,1.29980469,134.0,7.429688,83.0,23.0,2502.0,0.0,<2 mo. follow-up
72.77496,1,male,0,7,548,CHF,COPD/CHF/Cirrhosis,5,9.0,under $11k,5221.0,3341.7441,5.5,white,30.0,1,1,0,no,0.899999619,0.85,no dnr,7.0,73.0,10.2988281,60.0,24.0,35.59375,244.0,3.3999023,0.89990234,1.09985352,134.0,7.519531,130.0,15.0,2450.0,0.0,no(M2 and SIP pres)
57.44299,0,female,0,6,668,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,7868.0,5170.9336,20.0,white,35.0,1,0,0,no,0.989999771,0.99,no dnr,6.0,103.0,6.29980469,65.0,32.0,35.89844,276.1875,3.0996094,0.29998779,1.29980469,141.0,7.40918,101.0,32.0,1925.0,1.0,no(M2 and SIP pres)
59.20599,1,male,1,7,7,Coma,Coma,0,12.0,$25-$50k,17033.0,12977.8281,18.0,white,40.0,1,0,0,no,0.299999952,0.25,dnr after sadm,6.0,70.0,11.8984375,130.0,40.0,38.0,86.65625,3.8999023,0.69995117,1.0,143.0,7.40918,181.0,27.0,3225.0,0.0,<2 mo. follow-up
58.94897,0,male,0,5,667,COPD,COPD/CHF/Cirrhosis,4,13.0,$11-$25k,3548.0,2230.9492,10.0,white,22.0,1,0,0,yes,0.949999809,0.9,no dnr,5.0,49.0,18.0976562,60.0,24.0,38.39844,190.0,1.2998047,0.69995117,0.59997559,132.0,7.349609,184.0,5.0,825.0,1.1667481,no(M2 and SIP pres)
45.53299,0,male,0,10,664,Cirrhosis,COPD/CHF/Cirrhosis,1,13.0,under $11k,9094.0,6265.3672,14.0,white,35.0,1,0,0,no,0.5,0.5,no dnr,10.0,101.0,12.5996094,81.0,24.0,36.69531,333.3,3.5,0.39996338,2.39990234,134.0,7.419922,210.0,44.0,2250.0,0.0,no(M2 and SIP pres)
67.85199,1,male,0,5,59,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,4016.0,2785.1367,21.0,white,23.0,1,0,0,yes,0.699999809,0.6,dnr after sadm,4.0,65.0,8.0,48.0,20.0,35.59375,333.3,4.0996094,1.19995117,1.0,134.0,7.419922,104.0,8.0,2502.0,0.0,<2 mo. follow-up
68.98596,1,male,0,5,279,Colon Cancer,Cancer,1,13.0,$11-$25k,2823.0,1840.5918,8.0,white,13.0,1,0,0,metastatic,0.799999714,0.5,no dnr,5.0,110.0,3.69970703,76.0,24.0,38.19531,333.3,3.5,1.01,1.69995117,131.0,7.419922,245.0,25.0,1785.0,0.0,no(M2 and SIP pres)
41.64499,0,male,0,20,661,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$11-$25k,28886.0,19517.5781,28.333328,white,48.0,1,0,0,no,0.799999714,0.8,no dnr,20.0,65.0,14.5,119.0,24.0,36.19531,209.5,3.3999023,0.59997559,0.89990234,138.0,7.429688,115.0,20.0,600.0,0.0,no(M2 and SIP pres)
71.41095,1,female,0,13,77,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,10856.0,7223.6719,9.0,white,47.0,1,0,0,no,0.699999809,0.5,dnr after sadm,2.0,62.0,9.0,81.0,20.0,37.0,333.3,3.5,1.01,0.69995117,141.0,7.419922,129.0,8.0,2075.0,3.0,adl>=4 (>=5 if sur)
54.12997,1,female,0,13,527,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,under $11k,29479.0,20409.8906,27.0,white,67.0,2,1,0,no,0.849999905,0.75,no dnr,13.0,108.0,8.09960938,79.0,20.0,35.39844,333.3,3.3999023,0.69995117,1.0,134.0,7.419922,111.0,19.0,3175.0,5.0,SIP>=30
64.99097,0,male,0,5,657,Colon Cancer,Cancer,1,12.0,>$50k,3960.0,2424.6211,6.0,white,7.0,1,0,0,metastatic,0.899999619,0.8,no dnr,5.0,59.0,10.0996094,135.0,40.0,35.69531,333.3,3.7998047,0.79992676,1.5,124.0,7.419922,171.0,40.0,3775.0,1.1667481,no(M2 and SIP pres)
46.56497,0,male,0,5,657,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,8909.0,6108.7539,11.0,white,15.0,1,0,0,no,0.989999771,0.95,no dnr,5.0,118.0,9.69921875,60.0,10.0,37.79688,144.0,2.5,0.39996338,1.0,134.0,7.5,126.0,11.0,2650.0,2.7460938,<2 mo. follow-up
78.54297,1,male,0,6,275,Colon Cancer,Cancer,2,12.0,under $11k,4668.0,2988.3613,13.0,white,12.0,1,0,0,metastatic,0.899999619,0.75,dnr before sadm,-1.0,107.0,12.0996094,117.0,10.0,37.89844,217.5,3.5,1.01,0.89990234,149.0,7.40918,164.0,51.0,2580.0,1.1667481,<2 mo. follow-up
77.55798,0,male,0,9,655,CHF,COPD/CHF/Cirrhosis,4,7.0,$11-$25k,7842.0,5684.3164,9.5,white,37.0,1,1,0,no,0.699999809,0.5,no dnr,9.0,79.0,8.29882812,52.0,24.0,38.79688,390.4375,3.5,0.89990234,4.29980469,140.0,7.389648,110.0,67.0,1950.0,0.0,no(M2 and SIP pres)
72.06598,0,male,0,16,655,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,30235.0,19548.6094,19.666656,white,26.0,4,0,0,yes,1.0,1.0,no dnr,16.0,108.0,20.8984375,160.0,32.0,38.39844,287.75,3.2998047,0.79992676,0.79992676,131.0,7.479492,110.0,15.0,3950.0,0.0,SIP>=30
69.37994,1,male,0,8,9,Lung Cancer,Cancer,1,8.0,under $11k,9324.0,5800.918,13.0,white,30.0,1,0,0,metastatic,1.0,0.6,dnr after sadm,1.0,72.0,9.0,70.0,28.0,35.59375,333.3,3.7998047,0.69995117,8.69921875,134.0,7.419922,99.0,56.0,0.0,0.0,<2 mo. follow-up
68.20294,1,male,0,15,17,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,46267.0,45581.8438,49.0,white,41.0,8,0,0,no,0.5,0.5,dnr after sadm,14.0,64.0,21.5,36.0,32.0,37.89844,318.0,2.7998047,0.89990234,2.69970703,132.0,7.279297,268.0,49.0,1125.0,0.0,<2 mo. follow-up
52.22699,1,male,1,20,20,Cirrhosis,COPD/CHF/Cirrhosis,5,8.0,under $11k,26657.0,18330.8281,15.666664,white,22.0,1,1,0,no,0.699999809,0.5,dnr after sadm,20.0,56.0,9.19921875,160.0,40.0,38.29688,218.5,3.5,1.01,1.39990234,132.0,7.469727,149.0,13.0,1300.0,5.0,<2 mo. follow-up
57.59097,1,male,0,27,207,COPD,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,39876.0,27313.75,28.75,white,27.0,1,1,0,no,0.5,0.5,no dnr,27.0,63.0,0.39996338,130.0,40.0,39.59375,182.84375,2.8999023,3.0,1.39990234,140.0,7.439453,395.0,31.0,5450.0,0.0,SIP>=30
63.98898,1,male,1,5,5,Lung Cancer,Cancer,3,12.0,under $11k,5764.0,3601.0,29.0,white,21.0,1,0,0,metastatic,0.199999928,0.2,dnr after sadm,1.0,68.0,4.59960938,39.0,22.0,35.89844,466.625,3.5,0.89990234,1.19995117,142.0,7.529297,132.0,26.0,1850.0,4.3330078,<2 mo. follow-up
83.31299,0,male,0,9,648,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,11919.0,8023.8086,24.5,white,40.0,1,0,0,no,0.899999619,0.8,no dnr,9.0,76.0,7.0,70.0,24.0,36.59375,333.3,4.5996094,0.39996338,1.0,137.0,7.419922,114.0,5.0,1975.0,0.0,no(M2 and SIP pres)
76.83197,0,male,0,7,647,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,3917.0,2545.1894,5.0,white,24.0,1,0,1,no,0.75,0.75,dnr after sadm,5.0,117.0,24.5,58.0,10.0,38.89844,154.53125,2.5996094,24.0,5.89941406,141.0,7.40918,118.0,81.0,30.0,6.0,no(M2 and SIP pres)
67.79999,1,male,0,8,12,Coma,Coma,1,14.0,under $11k,28580.0,18889.2812,32.5,white,38.0,3,0,0,no,0.199999928,0.05,dnr after sadm,5.0,75.0,26.796875,118.0,20.0,35.29688,309.5,3.5,0.5,0.69995117,137.0,7.449219,150.0,14.0,1500.0,6.0,<2 mo. follow-up
58.59799,1,female,0,8,19,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,20012.0,15636.9688,15.5,white,53.0,8,0,0,no,0.25,0.1,dnr after sadm,8.0,66.0,3.5,79.0,26.0,38.69531,128.875,2.199707,1.29980469,0.59997559,156.0,7.459961,119.0,9.0,6200.0,2.7685547,<2 mo. follow-up
78.10498,0,female,0,5,644,CHF,COPD/CHF/Cirrhosis,3,5.0,under $11k,3989.0,2674.8652,14.0,white,26.0,1,0,1,no,0.699999809,0.5,no dnr,5.0,67.0,15.5,114.0,28.0,36.89844,112.5,4.0996094,0.69995117,3.0,132.0,7.489258,123.0,40.0,830.0,5.21875,no(M2 and SIP pres)
66.71899,1,female,0,20,370,MOSF w/Malig,ARF/MOSF,2,12.0,$11-$25k,40797.0,14452.7344,12.666664,white,35.0,1,1,0,metastatic,0.699999809,0.5,no dnr,20.0,76.0,7.39941406,74.0,24.0,35.89844,222.71875,4.0,1.79980469,1.0,142.0,7.319336,92.0,28.0,1220.0,0.0,no(M2 and SIP pres)
73.5,1,male,0,16,120,Colon Cancer,Cancer,1,12.0,$11-$25k,14996.0,9510.5469,11.333328,white,13.0,1,0,0,metastatic,0.799999714,0.75,dnr after sadm,1.0,63.0,13.5,132.0,28.0,39.29688,123.625,1.8999023,1.09985352,0.69995117,139.0,7.419922,127.0,3.0,5375.0,1.0,no(M2 and SIP pres)
71.77295,1,male,0,7,18,COPD,COPD/CHF/Cirrhosis,3,10.0,under $11k,6705.0,4389.4414,6.0,white,36.0,1,0,0,no,0.849999905,0.8,no dnr,7.0,59.0,7.5,79.0,16.0,36.19531,333.3,3.8999023,0.19998169,1.5,139.0,7.419922,134.0,23.0,2502.0,2.0,<2 mo. follow-up
82.93799,1,female,1,4,4,COPD,COPD/CHF/Cirrhosis,5,8.0,under $11k,6338.0,4364.4844,22.0,white,63.0,2,1,1,no,0.5,0.0,dnr before sadm,-1.0,67.0,15.1992188,128.0,30.0,34.39844,260.0,2.699707,0.29998779,0.89990234,135.0,7.479492,240.0,23.0,1350.0,5.9931641,<2 mo. follow-up
81.63995,1,male,0,38,345,ARF/MOSF w/Sepsis,ARF/MOSF,0,7.0,under $11k,55955.0,35859.2188,19.25,white,64.0,6,0,0,no,0.5,0.125,dnr after sadm,8.0,137.0,13.5996094,60.0,24.0,35.69531,369.5625,3.5,1.01,0.89990234,130.0,7.319336,194.0,25.0,1975.0,5.0,SIP>=30
69.60999,1,female,0,32,34,Coma,Coma,3,12.0,$11-$25k,150249.0,106119.312,28.5,white,48.0,40,1,0,no,0.5,0.5,dnr after sadm,26.0,117.0,11.0996094,68.0,28.0,35.59375,160.0,2.2998047,3.79980469,0.89990234,144.0,7.329102,256.0,25.0,5550.0,0.0,<2 mo. follow-up
79.995,1,female,0,11,197,COPD,COPD/CHF/Cirrhosis,7,9.0,$25-$50k,8495.0,5334.9688,9.5,white,38.0,1,0,1,no,0.5,0.4,dnr after sadm,1.0,102.0,3.89990234,63.0,24.0,35.79688,333.3,3.5,1.01,0.89990234,139.0,7.419922,100.0,9.0,2502.0,6.0,adl>=4 (>=5 if sur)
76.63196,0,male,0,18,639,COPD,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,10375.0,6827.0039,7.333332,white,34.0,1,0,0,yes,0.899999619,0.9,no dnr,18.0,52.0,9.19921875,118.0,24.0,35.79688,333.3,3.5,0.29998779,0.89990234,137.0,7.419922,153.0,16.0,2502.0,2.0,no(M2 and SIP pres)
72.61298,1,male,0,7,17,Lung Cancer,Cancer,2,8.0,$11-$25k,10843.0,6651.1914,5.0,white,16.0,1,0,0,metastatic,0.5,0.15,dnr after sadm,3.0,117.0,23.796875,60.0,14.0,38.69531,213.3125,3.2998047,0.79992676,4.39941406,145.0,7.369141,299.0,67.0,1081.0,0.0,<2 mo. follow-up
70.56494,0,male,0,4,635,COPD,COPD/CHF/Cirrhosis,1,13.0,$25-$50k,2365.0,1585.7607,5.0,white,20.0,1,0,0,no,0.899999619,0.9,no dnr,4.0,73.0,5.39941406,63.0,24.0,35.89844,333.3,3.0996094,1.5,1.39990234,128.0,7.419922,218.0,30.0,4275.0,0.0,no(M2 and SIP pres)
74.70996,1,male,1,43,43,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,200862.0,143377.125,37.75,white,46.0,21,0,0,no,0.699999809,0.5,dnr after sadm,35.0,51.0,9.79882812,81.0,20.0,36.5,400.0,4.0,0.5,1.19995117,134.0,7.459961,181.0,35.0,1475.0,0.0,<2 mo. follow-up
69.47296,1,female,0,7,20,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5038.0,3265.9492,2.0,white,39.0,1,0,0,no,0.899999619,0.8,dnr after sadm,1.0,43.0,8.8984375,130.0,29.0,40.19531,300.0,2.5996094,0.29998779,0.59997559,135.0,7.399414,138.0,6.0,1550.0,1.1667481,<2 mo. follow-up
65.487,1,male,0,7,28,CHF,COPD/CHF/Cirrhosis,2,7.0,under $11k,5066.0,3334.2227,5.0,white,24.0,1,0,0,no,0.799999714,0.512,dnr after sadm,3.0,58.0,9.69921875,77.0,32.0,35.5,333.3,3.5,1.01,1.39990234,136.0,7.419922,108.0,41.0,2502.0,0.0,<2 mo. follow-up
67.84399,1,female,1,12,12,Coma,Coma,0,16.0,>$50k,34959.0,24302.5469,29.0,white,33.0,7,0,0,no,0.23999989,0.24,dnr after sadm,5.0,75.0,17.0,105.0,25.0,38.09375,285.6875,3.5,1.01,0.69995117,138.0,7.429688,112.0,6.0,3975.0,0.0,<2 mo. follow-up
76.26794,0,male,0,9,634,COPD,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,8633.0,5600.3711,14.5,white,33.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,102.0,3.89990234,110.0,10.0,36.79688,374.25,2.7998047,0.19998169,0.5,139.0,7.40918,121.0,6.0,2125.0,1.0,no(M2 and SIP pres)
50.86099,0,male,0,7,634,CHF,COPD/CHF/Cirrhosis,5,14.0,under $11k,3603.0,2394.8223,4.5,white,21.0,1,1,0,no,0.699999809,0.5,dnr after sadm,1.0,56.0,8.5,106.0,10.0,38.89844,135.0,2.2998047,0.69995117,5.0,127.0,7.399414,96.0,55.0,472.0,0.0,SIP>=30
62.92398,1,female,1,3,3,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,58428.0,38707.1562,47.0,white,82.0,21,0,0,no,0.0,0.0,dnr after sadm,1.0,99.0,6.89941406,126.0,18.0,36.29688,333.3,3.8999023,0.79992676,0.89990234,140.0,7.419922,116.0,14.0,2502.0,1.0,<2 mo. follow-up
75.22198,0,male,0,15,633,ARF/MOSF w/Sepsis,ARF/MOSF,1,7.0,under $11k,46467.0,31250.3906,27.333328,white,39.0,9,0,0,no,0.199999928,0.1,no dnr,15.0,121.0,8.29882812,70.0,16.0,36.09375,309.5,4.1992188,0.39996338,1.39990234,140.0,7.449219,194.0,22.0,3400.0,0.0,no(M2 and SIP pres)
90.36798,0,female,0,4,631,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,2206.0,1536.5508,11.0,white,36.0,1,0,0,no,0.799999714,0.8,no dnr,4.0,75.0,8.09960938,145.0,24.0,37.79688,230.0,3.5,1.01,1.19995117,128.0,7.519531,166.0,20.0,1570.0,1.1667481,no(M2 and SIP pres)
79.27698,0,male,0,7,631,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,6405.0,4273.7734,7.5,white,39.0,1,1,0,no,0.699999809,0.5,no dnr,7.0,70.0,12.5,110.0,32.0,38.69531,125.45312,2.0996094,5.5,1.19995117,133.0,7.5,124.0,33.0,2525.0,0.0,no(M2 and SIP pres)
89.12,1,male,0,5,248,CHF,COPD/CHF/Cirrhosis,6,4.0,under $11k,3031.0,2076.1348,15.0,white,20.0,1,1,1,no,0.799999714,0.7,no dnr,5.0,57.0,16.5976562,134.0,12.0,37.5,285.0,3.0996094,0.5,1.69995117,137.0,7.449219,126.0,34.0,775.0,5.0,adl>=4 (>=5 if sur)
74.42798,1,female,0,10,102,Colon Cancer,Cancer,2,5.0,under $11k,7917.0,5127.7461,13.0,white,25.0,1,0,1,metastatic,0.049999982,0.0,no dnr,10.0,98.0,10.2988281,77.0,24.0,35.69531,304.0,3.5,0.79992676,0.89990234,137.0,7.349609,334.0,17.0,2502.0,0.0,<2 mo. follow-up
63.97498,1,male,0,5,145,Lung Cancer,Cancer,2,12.0,under $11k,5272.0,3413.043,10.0,white,11.0,1,0,0,metastatic,0.699999809,0.1,dnr after sadm,1.0,59.0,6.59960938,113.0,11.0,36.39844,100.0,2.5,9.5,1.39990234,140.0,7.569336,108.0,31.0,3470.0,2.0,adl>=4 (>=5 if sur)
73.28998,0,female,0,17,628,ARF/MOSF w/Sepsis,ARF/MOSF,3,8.0,under $11k,44287.0,29971.6406,29.333328,white,50.0,7,1,0,no,0.199999928,0.1,dnr after sadm,2.0,68.0,8.29882812,120.0,20.0,36.39844,333.3,4.2998047,0.39996338,1.5,138.0,7.419922,233.0,42.0,2025.0,0.0,adl>=4 (>=5 if sur)
21.63199,0,female,0,53,628,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,148162.0,101257.312,47.0,white,38.0,1,0,0,no,0.75,0.75,no dnr,53.0,66.0,17.1992188,104.0,32.0,38.39844,165.0,3.5,1.01,1.5,133.0,7.479492,163.0,22.0,2502.0,0.0,no(M2 and SIP pres)
72.435,0,male,0,25,627,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$11-$25k,74657.0,49330.9062,16.75,white,42.0,16,0,0,yes,0.899999619,0.9,no dnr,25.0,96.0,5.69921875,69.0,16.0,36.09375,323.75,4.0996094,0.39996338,1.19995117,136.0,7.459961,115.0,6.0,1450.0,0.0,no(M2 and SIP pres)
70.75195,1,male,0,5,240,COPD,COPD/CHF/Cirrhosis,5,8.0,under $11k,3427.0,2172.2734,9.0,white,44.0,1,1,0,yes,0.899999619,0.8,no dnr,5.0,67.0,9.5,80.0,24.0,39.09375,257.5,2.0996094,0.29998779,1.69995117,137.0,7.40918,82.0,40.0,775.0,0.0,<2 mo. follow-up
83.71497,0,female,0,15,627,MOSF w/Malig,ARF/MOSF,2,8.0,under $11k,35843.0,24067.2188,28.0,white,43.0,7,0,0,metastatic,0.799999714,0.7,no dnr,15.0,62.0,18.8984375,134.0,28.0,38.69531,136.0,1.6999512,0.19998169,0.89990234,140.0,7.459961,206.0,16.0,1325.0,0.0,no(M2 and SIP pres)
78.75696,1,male,0,9,536,MOSF w/Malig,ARF/MOSF,0,8.0,under $11k,27466.0,18589.9375,27.5,white,40.0,7,0,0,yes,0.899999619,0.8,no dnr,9.0,70.0,12.7988281,78.0,24.0,35.79688,362.9375,3.5,0.29998779,1.09985352,138.0,7.429688,278.0,18.0,2502.0,0.0,no(M2 and SIP pres)
71.37897,1,male,0,6,26,CHF,COPD/CHF/Cirrhosis,3,9.0,under $11k,3740.0,2478.7617,9.0,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,39.0,32.59375,130.0,10.0,36.0,152.0,3.199707,8.19921875,5.19921875,127.0,7.369141,212.0,105.0,75.0,0.0,<2 mo. follow-up
78.77594,1,female,0,6,557,Cirrhosis,COPD/CHF/Cirrhosis,6,8.0,under $11k,4257.0,2828.1602,11.0,white,18.0,1,1,0,yes,0.5,0.25,dnr after sadm,1.0,74.0,4.89941406,77.0,24.0,36.39844,260.0,2.199707,0.09999084,0.89990234,137.0,7.319336,141.0,17.0,3210.0,1.0,no(M2 and SIP pres)
48.68698,0,female,0,109,623,Cirrhosis,COPD/CHF/Cirrhosis,1,13.0,under $11k,130793.0,86623.625,34.25,white,59.0,1,0,0,no,0.699999809,0.5,dnr after sadm,27.0,129.0,12.3984375,85.0,22.0,36.5,333.3,3.8999023,0.59997559,1.0,135.0,7.419922,148.0,27.0,2502.0,0.0,SIP>=30
74.17096,0,male,0,14,625,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,10170.0,6691.2109,8.0,white,46.0,1,0,0,no,0.399999857,0.4,no dnr,14.0,78.0,8.29882812,53.0,16.0,35.89844,333.3,3.5,1.01,1.39990234,138.0,7.419922,124.0,18.0,3100.0,0.0,no(M2 and SIP pres)
56.92798,1,female,1,10,10,Lung Cancer,Cancer,1,12.0,under $11k,7075.0,4833.2344,11.0,white,11.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,4.0,117.0,9.29882812,126.0,24.0,36.39844,224.0,3.5,0.59997559,1.09985352,135.0,7.449219,115.0,23.0,1055.0,7.0,<2 mo. follow-up
69.54095,1,male,0,9,20,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,6304.0,4241.2578,6.0,white,28.0,1,0,0,no,0.799999714,0.6,no dnr,9.0,82.0,0.09999084,148.0,22.0,36.09375,333.3,3.5,1.01,1.39990234,145.0,7.419922,155.0,39.0,2502.0,3.0,<2 mo. follow-up
74.93994,0,male,0,9,621,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,$11-$25k,48671.0,31515.9844,24.5,white,35.0,9,0,0,no,0.699999809,0.5,no dnr,9.0,79.0,12.0996094,40.0,15.0,35.59375,355.0,3.5996094,0.79992676,1.19995117,137.0,7.399414,146.0,25.0,1000.0,0.0,no(M2 and SIP pres)
70.13794,1,female,0,3,194,Lung Cancer,Cancer,1,10.0,under $11k,4685.0,2963.8652,22.610928270087555,white,12.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,65.0,12.0,79.0,24.0,36.09375,292.0,3.5,0.5,1.39990234,134.0,7.389648,354.0,43.0,1465.0,1.722168,no(M2 and SIP pres)
72.90295,0,male,0,10,620,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,23344.0,16110.2969,41.5,white,43.0,1,0,0,no,0.699999809,0.5,dnr after sadm,8.0,61.0,10.6992188,140.0,24.0,38.09375,87.14062,3.5,0.29998779,1.09985352,129.0,7.369141,136.0,12.0,3200.0,1.0,SIP>=30
53.95798,0,female,0,28,619,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,30829.0,17709.4688,11.5,white,44.0,1,0,0,no,0.5,0.4,dnr after sadm,2.0,57.0,11.7988281,88.0,30.0,39.0,182.5,3.0996094,2.39990234,1.19995117,137.0,7.509766,152.0,15.0,1424.0,6.0,no(M2 and SIP pres)
91.90997,1,male,0,10,175,COPD,COPD/CHF/Cirrhosis,5,16.0,under $11k,13204.0,8966.2344,16.0,white,56.0,1,0,0,no,0.5,0.4,dnr after sadm,1.0,70.0,0.89990234,73.0,28.0,35.69531,333.3,2.699707,1.29980469,1.79980469,135.0,7.419922,239.0,42.0,5980.0,0.494751,no(M2 and SIP pres)
56.31998,0,male,0,6,618,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,4302.0,2707.6777,13.0,white,32.0,1,0,0,metastatic,0.849999905,0.8,no dnr,6.0,127.0,12.7988281,143.0,24.0,36.19531,110.0,3.699707,2.0,1.39990234,135.0,7.189453,113.0,34.0,900.0,2.581543,no(M2 and SIP pres)
87.56696,0,female,0,14,617,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,9171.0,6001.6445,7.333332,white,24.0,1,1,0,no,0.699999809,0.5,dnr after sadm,2.0,121.0,16.5976562,58.0,32.0,37.89844,127.5,3.2998047,0.59997559,2.79980469,133.0,7.379883,254.0,111.0,765.0,2.0,no(M2 and SIP pres)
54.13797,1,male,1,6,6,Coma,Coma,0,12.0,$25-$50k,13290.0,9129.0234,40.0,white,29.0,1,0,0,no,0.099999964,0.05,dnr after sadm,4.0,99.0,0.19998169,115.0,30.0,39.19531,333.3,3.0,1.01,1.79980469,146.0,7.419922,139.0,41.0,2800.0,0.0,<2 mo. follow-up
60.08499,1,male,0,6,80,Lung Cancer,Cancer,2,12.0,>$50k,6801.0,4314.7969,12.0,white,21.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,101.0,7.19921875,70.0,22.0,37.29688,520.0,3.5,1.01,2.19970703,140.0,7.349609,185.0,60.0,2150.0,0.0,no(M2 and SIP pres)
81.95496,1,male,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,22645.0,15302.2266,42.5,white,48.0,3,0,0,no,0.25,0.25,dnr after sadm,5.0,73.0,13.7988281,61.0,20.0,36.79688,333.3,3.5,1.01,1.0,138.0,7.419922,162.0,15.0,2850.0,2.0,<2 mo. follow-up
70.94598,1,male,0,25,26,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,68567.0,47417.0,25.75,white,68.0,9,0,0,no,0.699999809,0.5,dnr after sadm,24.0,49.0,13.5,134.0,10.0,37.89844,215.0,3.3999023,0.29998779,1.5,137.0,7.449219,238.0,30.0,1650.0,0.0,<2 mo. follow-up
80.07098,1,male,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,>$50k,54121.0,36237.0625,63.0,white,63.0,13,0,0,no,0.699999809,0.5,no dnr,4.0,120.0,7.29980469,14.0,10.0,38.89844,129.0,3.699707,0.69995117,0.5,137.0,7.40918,137.0,15.0,3525.0,0.0,<2 mo. follow-up
61.03799,0,male,0,10,606,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,11265.0,7681.9844,20.5,white,26.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,49.0,6.5,158.0,10.0,36.79688,136.0,2.199707,0.59997559,1.59985352,131.0,7.429688,78.0,12.0,2875.0,0.0,no(M2 and SIP pres)
82.71899,0,female,0,21,603,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,33923.0,21274.0625,25.0,white,36.0,1,0,1,no,0.799999714,0.8,no dnr,21.0,83.0,11.1992188,101.0,28.0,39.09375,333.3,3.5,1.01,0.89990234,138.0,7.419922,130.0,6.0,3175.0,6.0,adl>=4 (>=5 if sur)
50.00699,1,male,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,>$50k,28269.0,18869.2031,27.0,white,34.0,1,0,0,no,0.489999771,0.49,no dnr,14.0,65.0,19.0,70.0,15.0,36.09375,108.15625,3.699707,0.69995117,5.39941406,126.0,7.479492,267.0,96.0,190.0,1.0,<2 mo. follow-up
69.59296,1,male,0,5,103,Colon Cancer,Cancer,1,8.0,under $11k,2545.0,1613.3086,13.0,white,16.0,1,0,0,metastatic,0.199999928,0.05,dnr after sadm,3.0,111.0,9.0,62.0,16.0,36.39844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.494751,no(M2 and SIP pres)
74.05096,1,female,1,49,49,ARF/MOSF w/Sepsis,ARF/MOSF,1,6.0,under $11k,100702.0,66196.125,40.0,white,31.0,4,0,0,yes,0.699999809,0.7,dnr after sadm,47.0,104.0,8.19921875,79.0,24.0,35.5,333.3,3.8999023,0.39996338,0.79992676,136.0,7.419922,116.0,31.0,2300.0,6.0,<2 mo. follow-up
64.58899,1,female,0,6,91,Lung Cancer,Cancer,1,12.0,under $11k,7143.0,4358.4766,10.0,white,10.0,1,0,0,metastatic,1.0,0.51,no dnr,6.0,108.0,5.79980469,114.0,16.0,36.19531,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,1.9821777,<2 mo. follow-up
81.41797,0,male,0,14,598,CHF,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,11063.0,7162.5781,4.333332,white,23.0,1,0,0,no,0.799999714,0.75,no dnr,14.0,71.0,9.0,57.0,20.0,35.89844,304.75,3.699707,1.19995117,1.69995117,135.0,7.519531,120.0,44.0,2502.0,0.0,<2 mo. follow-up
88.28699,1,female,1,9,9,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,20082.0,13371.9375,44.0,white,49.0,1,0,0,no,0.099999964,0.1,dnr after sadm,1.0,61.0,3.69970703,65.0,20.0,36.09375,333.3,4.0996094,2.0,1.09985352,132.0,7.419922,176.0,35.0,850.0,0.0,<2 mo. follow-up
65.495,1,male,0,8,48,CHF,COPD/CHF/Cirrhosis,6,15.0,under $11k,5817.0,3923.6973,5.5,white,31.0,1,1,1,no,0.699999809,0.5,no dnr,8.0,64.0,11.2988281,72.0,14.0,36.09375,157.5,3.5,1.01,1.0,141.0,7.419922,354.0,24.0,725.0,2.0,<2 mo. follow-up
69.65399,1,female,1,11,11,Coma,Coma,1,12.0,under $11k,41832.0,29165.875,27.5,white,57.0,10,1,0,no,0.699999809,0.5,no dnr,11.0,77.0,10.0,57.0,28.0,35.79688,333.3,4.2998047,1.39990234,1.29980469,136.0,7.419922,271.0,21.0,1695.0,2.309082,<2 mo. follow-up
75.96698,0,female,0,12,593,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,17883.0,12190.1406,17.0,white,21.0,1,1,1,no,0.699999809,0.5,no dnr,12.0,57.0,11.5996094,101.0,28.0,36.39844,130.0,2.8999023,0.29998779,0.79992676,137.0,7.399414,178.0,19.0,1100.0,2.0,no(M2 and SIP pres)
69.58795,1,female,0,6,64,Lung Cancer,Cancer,3,9.0,$11-$25k,4334.0,2818.1992,10.0,white,14.0,1,1,0,metastatic,0.5,0.3,no dnr,6.0,59.0,18.0976562,96.0,16.0,38.69531,127.5,3.5,0.19998169,1.79980469,139.0,7.5,222.0,36.0,2631.0,2.5786133,<2 mo. follow-up
60.51999,1,male,0,7,8,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,$25-$50k,15369.0,10618.8906,20.0,white,89.0,1,1,0,no,0.799999714,0.8,dnr after sadm,4.0,104.0,16.5,79.0,28.0,35.89844,333.3,4.6992188,1.19995117,1.0,134.0,7.419922,104.0,17.0,2502.0,0.0,<2 mo. follow-up
63.52597,1,male,0,61,173,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,195557.0,77800.1875,34.75,white,39.0,5,0,0,yes,0.299999952,0.3,dnr after sadm,15.0,67.0,12.5,100.0,20.0,36.09375,333.3,2.199707,6.69921875,1.09985352,131.0,7.419922,105.0,18.0,1900.0,0.0,no(M2 and SIP pres)
87.98596,0,male,0,10,590,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,6883.0,4599.7266,8.0,white,27.0,1,0,0,yes,0.799999714,0.6,no dnr,10.0,109.0,15.0996094,104.0,34.0,36.79688,309.5,3.8999023,0.59997559,1.09985352,132.0,7.489258,123.0,13.0,2502.0,1.0,no(M2 and SIP pres)
84.29297,1,male,0,17,156,CHF,COPD/CHF/Cirrhosis,5,8.0,$25-$50k,18165.0,11636.9922,12.333328,white,57.0,1,1,0,no,0.599999905,0.4,no dnr,17.0,80.0,9.79882812,68.0,24.0,38.69531,364.0,3.5,1.29980469,1.09985352,137.0,7.489258,184.0,26.0,1775.0,1.0,no(M2 and SIP pres)
63.24399,0,male,0,12,587,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,16650.0,10887.9375,25.0,white,43.0,1,0,0,no,0.75,0.65,no dnr,12.0,70.0,6.09960938,73.0,22.0,36.29688,333.3,3.8999023,0.79992676,1.09985352,132.0,7.419922,111.0,14.0,2502.0,0.0,no(M2 and SIP pres)
67.06097,1,male,0,8,93,Lung Cancer,Cancer,2,8.0,$11-$25k,5283.0,3447.1289,8.5,white,25.0,1,0,0,metastatic,0.949999809,0.6,no dnr,8.0,57.0,25.0,120.0,26.0,39.09375,237.125,2.199707,0.79992676,1.19995117,138.0,7.399414,135.0,19.0,1815.0,1.0,no(M2 and SIP pres)
79.27997,1,female,0,13,132,COPD,COPD/CHF/Cirrhosis,3,16.0,under $11k,12408.0,8012.3398,12.0,white,19.0,1,0,0,metastatic,0.599999905,0.4,no dnr,13.0,59.0,6.09960938,70.0,28.0,36.19531,176.1875,4.0996094,0.79992676,1.0,139.0,7.40918,113.0,14.0,800.0,3.0,no(M2 and SIP pres)
79.29596,1,male,0,13,123,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,10628.0,7019.793,7.0,white,51.0,1,0,0,no,0.5,0.25,no dnr,13.0,53.0,15.8984375,150.0,20.0,37.5,245.0,2.5996094,0.39996338,8.59960938,140.0,7.219727,178.0,61.0,0.0,1.0,no(M2 and SIP pres)
61.465,1,male,0,43,376,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,$11-$25k,137058.0,91445.5,42.25,white,54.0,18,1,0,no,0.5,0.5,no dnr,43.0,82.0,9.0,62.0,16.0,35.89844,333.3,3.5,1.01,1.19995117,140.0,7.419922,139.0,18.0,4500.0,0.0,adl>=4 (>=5 if sur)
50.54898,1,female,1,4,4,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,$25-$50k,19326.0,12621.3359,39.0,white,90.0,3,0,0,no,0.049999982,0.02,dnr after sadm,3.0,104.0,7.29980469,101.0,24.0,37.79688,266.625,3.699707,0.69995117,1.0,135.0,7.479492,102.0,6.0,2400.0,2.1044922,<2 mo. follow-up
41.04898,1,male,0,18,111,ARF/MOSF w/Sepsis,ARF/MOSF,5,12.0,under $11k,21882.0,15987.7266,16.333328,white,65.0,1,1,0,no,0.899999619,0.85,no dnr,18.0,80.0,6.69921875,48.0,16.0,35.59375,333.3,3.5,0.5,1.09985352,138.0,7.419922,125.0,13.0,2125.0,5.0,SIP>=30
53.41299,1,male,0,18,176,Lung Cancer,Cancer,1,14.0,under $11k,18409.0,12327.4141,8.0,white,20.0,1,0,0,metastatic,0.599999905,0.4,dnr after sadm,1.0,119.0,14.5,100.0,20.0,36.5,128.5625,2.5,0.19998169,3.5,133.0,7.459961,320.0,54.0,4570.0,2.0,adl>=4 (>=5 if sur)
78.43896,1,female,0,18,300,Lung Cancer,Cancer,4,10.0,under $11k,7898.0,5355.1562,5.0,white,11.0,1,0,0,metastatic,0.899999619,0.4,dnr before sadm,-1.0,114.0,14.0996094,81.0,28.0,36.19531,237.03125,3.5,1.01,1.19995117,146.0,7.449219,166.0,23.0,2900.0,0.494751,no(M2 and SIP pres)
87.23895,0,female,0,5,577,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,3197.0,2192.7578,8.0,white,31.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,112.0,5.29980469,93.0,24.0,36.39844,333.3,4.0,0.39996338,0.89990234,134.0,7.419922,254.0,9.0,2502.0,2.4526367,<2 mo. follow-up
64.34998,1,female,0,14,20,Cirrhosis,COPD/CHF/Cirrhosis,4,12.0,under $11k,20747.0,13424.3281,12.0,white,60.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,1.0,74.0,13.1992188,98.0,24.0,35.59375,290.4375,3.699707,0.5,1.0,130.0,7.479492,126.0,17.0,1125.0,2.0,<2 mo. follow-up
53.73297,1,female,1,3,3,Coma,Coma,0,12.0,$11-$25k,22779.0,16649.6875,42.0,white,48.0,12,0,0,no,0.699999809,0.5,dnr after sadm,3.0,74.0,21.3984375,60.0,8.0,38.69531,188.0,2.3999023,1.0,1.79980469,151.0,7.419922,243.0,63.0,3300.0,0.0,<2 mo. follow-up
71.11597,1,male,1,17,17,Cirrhosis,COPD/CHF/Cirrhosis,3,10.0,under $11k,17697.0,12093.5391,17.333328,white,57.0,1,0,0,no,0.599999905,0.5,dnr after sadm,17.0,110.0,11.0996094,108.0,32.0,37.79688,333.3,2.199707,1.5,0.89990234,141.0,7.419922,136.0,13.0,2250.0,1.0,<2 mo. follow-up
66.29395,0,female,0,22,572,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,58552.0,40298.8438,37.666657,white,37.0,14,0,0,yes,0.96999979,0.95,no dnr,22.0,56.0,9.0,110.0,10.0,36.39844,202.5,3.5,0.59997559,1.0,137.0,7.429688,237.0,14.0,1770.0,0.0,no(M2 and SIP pres)
54.91599,0,male,0,7,571,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,4256.0,2674.3203,7.0,white,25.0,1,0,0,no,1.0,0.9,no dnr,7.0,77.0,9.59960938,128.0,32.0,38.19531,333.3,2.5,0.39996338,0.89990234,137.0,7.419922,104.0,7.0,2502.0,0.0,<2 mo. follow-up
66.612,1,female,0,189,370,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,428707.0,14452.7344,39.75,white,47.0,17,0,0,no,0.5,0.5,no dnr,189.0,107.0,5.5,106.0,32.0,38.39844,197.5,0.5,3.39990234,1.0,139.0,7.389648,118.0,20.0,2502.0,0.0,adl>=4 (>=5 if sur)
71.59796,1,female,0,7,8,Coma,Coma,1,17.0,$11-$25k,8412.0,5682.4062,5.5,white,42.0,1,1,0,no,0.5,0.5,dnr after sadm,4.0,98.0,8.5,44.0,28.0,36.39844,333.3,4.1992188,0.79992676,1.69995117,142.0,7.419922,104.0,21.0,3050.0,1.0,<2 mo. follow-up
71.90399,1,male,0,6,47,Colon Cancer,Cancer,1,13.0,under $11k,10473.0,6775.8359,12.0,white,26.0,1,0,0,metastatic,0.5,0.2,no dnr,6.0,65.0,11.5,116.0,26.0,38.29688,124.4375,2.8999023,0.69995117,0.59997559,133.0,7.529297,119.0,19.0,990.0,3.0,<2 mo. follow-up
71.72595,1,female,0,21,80,Coma,Coma,4,13.0,$11-$25k,43394.0,14452.7344,21.666656,white,42.0,1,1,0,no,0.599999905,0.3,dnr after sadm,2.0,142.0,13.0996094,64.0,28.0,35.69531,305.0,2.2998047,0.29998779,8.8984375,134.0,7.519531,308.0,67.0,2502.0,1.0,adl>=4 (>=5 if sur)
71.409,1,female,0,5,7,Lung Cancer,Cancer,2,13.0,under $11k,19918.0,13905.8516,38.0,white,40.0,1,0,0,metastatic,0.099999964,0.05,dnr after sadm,3.0,73.0,14.2988281,150.0,22.0,35.69531,436.0,3.3999023,0.79992676,1.0,138.0,7.459961,94.0,12.0,2502.0,5.0,<2 mo. follow-up
54.78998,1,male,0,6,28,ARF/MOSF w/Sepsis,ARF/MOSF,2,10.0,under $11k,7798.0,5192.0,19.0,white,27.0,1,1,0,no,0.899999619,0.9,no dnr,6.0,117.0,0.29998779,79.0,16.0,38.19531,578.25,3.5996094,1.19995117,1.29980469,133.0,7.449219,88.0,30.0,2100.0,4.0,<2 mo. follow-up
48.07898,1,female,1,5,5,Coma,Coma,1,12.0,under $11k,8935.0,6365.5859,35.0,white,30.0,1,0,0,yes,0.5,0.5,dnr after sadm,4.0,102.0,6.79980469,67.0,24.0,36.19531,333.3,4.3994141,0.59997559,1.5,140.0,7.419922,150.0,14.0,2502.0,7.0,<2 mo. follow-up
76.71997,0,male,0,6,562,COPD,COPD/CHF/Cirrhosis,2,16.0,under $11k,5013.0,3363.3359,16.0,white,39.0,1,0,0,no,0.949999809,0.9,no dnr,6.0,80.0,10.5996094,114.0,32.0,35.69531,240.0,3.5996094,0.5,1.09985352,140.0,7.369141,124.0,25.0,875.0,1.0,no(M2 and SIP pres)
69.771,0,male,0,5,559,Lung Cancer,Cancer,1,12.0,>$50k,4444.0,2842.6035,14.0,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,57.0,16.8984375,165.0,40.0,38.19531,280.75,3.5,1.01,1.29980469,138.0,7.369141,274.0,32.0,1250.0,0.0,no(M2 and SIP pres)
68.64099,0,female,0,7,559,CHF,COPD/CHF/Cirrhosis,3,13.0,$11-$25k,6748.0,4771.9883,8.5,white,26.0,1,1,0,no,0.899999619,0.8,no dnr,7.0,64.0,9.5,180.0,25.0,39.09375,185.0,1.5998535,1.09985352,0.89990234,136.0,7.449219,74.0,24.0,1500.0,1.0,no(M2 and SIP pres)
66.39294,1,male,0,3,81,Lung Cancer,Cancer,1,15.0,$25-$50k,3660.0,2215.7246,22.610928270087555,white,14.0,1,0,0,metastatic,1.0,0.9,no dnr,3.0,71.0,7.39941406,114.0,29.0,38.89844,354.25,3.5,1.01,3.39990234,137.0,7.399414,239.0,76.0,675.0,0.494751,<2 mo. follow-up
75.409,0,female,0,4,558,COPD,COPD/CHF/Cirrhosis,1,12.0,under $11k,2968.0,1964.3272,6.0,white,15.0,1,0,0,no,0.799999714,0.75,no dnr,4.0,73.0,39.09375,128.0,24.0,35.69531,276.0,3.5,0.79992676,0.69995117,138.0,7.379883,227.0,18.0,1900.0,2.8183594,<2 mo. follow-up
68.797,0,female,0,8,558,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,5659.0,3657.3691,6.0,white,31.0,1,0,0,no,0.799999714,0.75,no dnr,8.0,69.0,9.0,83.0,20.0,36.09375,190.46875,3.5,1.01,1.69995117,140.0,7.349609,83.0,26.0,2502.0,0.0,no(M2 and SIP pres)
63.28299,1,female,0,10,256,COPD,COPD/CHF/Cirrhosis,4,10.0,under $11k,11033.0,7063.0547,17.0,white,16.0,1,1,0,no,0.5,0.5,no dnr,10.0,108.0,23.0976562,104.0,24.0,35.5,333.3,3.199707,0.5,0.89990234,132.0,7.419922,113.0,9.0,5050.0,4.0,no(M2 and SIP pres)
71.047,1,male,0,15,69,Colon Cancer,Cancer,1,12.0,under $11k,12943.0,7935.8086,14.333328,white,26.0,1,0,0,metastatic,0.199999928,0.5,dnr after sadm,2.0,71.0,9.19921875,60.0,28.0,35.79688,268.0,3.5,0.5,1.09985352,140.0,7.319336,118.0,10.0,2502.0,1.0,adl>=4 (>=5 if sur)
68.84595,0,female,0,48,554,Coma,Coma,0,14.0,under $11k,95299.0,64149.3125,25.0,white,13.0,22,0,0,no,0.099999964,0.5,dnr after sadm,2.0,105.0,24.3984375,130.0,10.0,39.39844,132.0,3.5,1.01,4.69921875,137.0,7.449219,139.0,123.0,955.0,1.8666992,<2 mo. follow-up
72.64294,0,male,0,7,555,COPD,COPD/CHF/Cirrhosis,1,12.0,$11-$25k,6267.0,4345.1367,4.0,white,33.0,1,0,0,yes,0.849999905,0.5,no dnr,7.0,76.0,10.1992188,101.0,28.0,36.19531,170.34375,3.5,0.39996338,1.0,139.0,7.369141,173.0,28.0,2500.0,0.0,no(M2 and SIP pres)
76.56396,1,male,0,52,122,MOSF w/Malig,ARF/MOSF,2,8.0,$11-$25k,149618.0,99931.6875,41.75,white,56.0,6,0,0,yes,0.699999809,0.5,no dnr,52.0,103.0,10.8984375,57.0,24.0,36.29688,333.3,3.5,0.5,1.5,138.0,7.419922,114.0,24.0,1615.0,0.0,no(M2 and SIP pres)
56.76898,0,female,0,18,553,ARF/MOSF w/Sepsis,ARF/MOSF,0,15.0,>$50k,38863.0,26176.9688,23.333328,white,16.0,1,0,0,no,0.899999619,0.9,no dnr,18.0,100.0,15.0,120.0,26.0,36.09375,253.3125,3.5,1.01,0.69995117,131.0,7.459961,144.0,11.0,1950.0,0.0,no(M2 and SIP pres)
71.26898,0,male,0,5,553,Colon Cancer,Cancer,1,10.0,under $11k,3105.0,2058.2598,8.0,white,5.0,1,0,0,metastatic,0.75,0.5,dnr after sadm,1.0,79.0,9.3984375,81.0,36.0,36.19531,196.65625,3.5,0.89990234,1.29980469,122.0,7.329102,163.0,19.0,1300.0,0.0,<2 mo. follow-up
78.89099,0,male,0,8,550,CHF,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,4300.0,2863.4453,6.5,white,26.0,1,0,0,no,0.699999809,0.5,dnr before sadm,-1.0,75.0,9.69921875,104.0,24.0,35.69531,385.6875,2.5996094,0.5,1.39990234,125.0,7.469727,124.0,32.0,3475.0,0.0,no(M2 and SIP pres)
35.52899,0,male,0,10,550,CHF,COPD/CHF/Cirrhosis,2,12.0,under $11k,9998.0,6636.9492,13.0,white,30.0,1,0,0,no,0.699999809,0.5,no dnr,10.0,33.0,9.0,76.0,20.0,38.59375,102.34375,3.5,1.01,4.19921875,144.0,7.199219,235.0,70.0,330.0,2.5805664,no(M2 and SIP pres)
74.74298,0,male,0,14,548,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,24344.0,16322.3438,14.0,white,32.0,9,1,0,yes,0.699999809,0.5,no dnr,14.0,65.0,12.0,109.0,40.0,38.19531,177.5,2.5,1.19995117,1.39990234,134.0,7.489258,147.0,43.0,3400.0,3.4067383,<2 mo. follow-up
75.96399,0,male,0,13,546,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,44512.0,30112.0156,29.5,white,24.0,9,0,0,no,0.699999809,0.5,no dnr,13.0,110.0,11.5996094,73.0,28.0,36.0,271.375,3.5,1.09985352,1.5,142.0,7.529297,107.0,31.0,825.0,0.0,no(M2 and SIP pres)
81.81,1,male,1,109,109,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,318295.0,214994.25,45.5,white,43.0,15,0,0,yes,0.649999619,0.6,no dnr,109.0,105.0,15.1992188,60.0,40.0,38.19531,286.625,2.8999023,5.39941406,4.5,137.0,7.449219,119.0,88.0,60.0,0.0,adl>=4 (>=5 if sur)
78.74597,1,male,1,4,4,Coma,Coma,0,17.0,$25-$50k,5388.0,3861.7012,26.0,white,24.0,1,0,0,no,0.0,0.0,dnr after sadm,2.0,64.0,6.09960938,81.0,28.0,35.79688,285.6875,3.5,0.39996338,1.69995117,136.0,7.479492,85.0,22.0,1475.0,2.4335938,<2 mo. follow-up
55.29599,0,male,0,12,544,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,19255.0,12978.9453,27.5,white,28.0,1,0,0,no,0.799999714,0.75,no dnr,12.0,118.0,8.29882812,79.0,24.0,36.29688,347.5625,3.5,0.79992676,2.09960938,138.0,7.429688,85.0,29.0,2800.0,0.0,no(M2 and SIP pres)
68.56696,1,male,0,18,459,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,21864.0,14747.625,20.666656,white,37.0,1,0,0,no,0.5,0.5,no dnr,18.0,105.0,6.39941406,70.0,24.0,36.19531,333.3,3.7998047,0.39996338,1.5,138.0,7.419922,125.0,25.0,1050.0,3.0,no(M2 and SIP pres)
71.70697,1,female,0,6,129,Lung Cancer,Cancer,1,13.0,under $11k,8243.0,5390.5586,11.0,white,21.0,1,0,0,metastatic,0.5,0.4,no dnr,6.0,109.0,7.59960938,107.0,24.0,36.19531,333.3,3.5,1.01,1.0,138.0,7.419922,132.0,6.0,4150.0,0.494751,adl>=4 (>=5 if sur)
67.67694,1,female,0,5,6,Lung Cancer,Cancer,3,12.0,under $11k,4048.0,2656.3848,9.0,white,21.0,1,0,0,metastatic,0.0,0.0,dnr after sadm,5.0,50.0,13.7988281,65.0,30.0,36.29688,122.4375,2.8999023,0.29998779,1.59985352,130.0,7.439453,249.0,34.0,1375.0,3.296875,<2 mo. follow-up
69.06799,0,male,0,21,537,ARF/MOSF w/Sepsis,ARF/MOSF,3,9.0,$11-$25k,57387.0,38371.0312,19.666656,white,51.0,6,1,0,no,0.699999809,0.5,no dnr,21.0,64.0,9.69921875,150.0,12.0,39.29688,164.4375,1.3999023,1.19995117,0.59997559,134.0,7.429688,140.0,6.0,3390.0,2.0,no(M2 and SIP pres)
84.18298,0,male,0,7,538,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,5122.0,3361.4199,6.0,white,21.0,1,0,0,yes,0.699999809,0.5,no dnr,7.0,62.0,19.5976562,117.0,24.0,38.69531,190.90625,3.5,1.01,2.59960938,130.0,7.379883,178.0,74.0,3725.0,0.0,<2 mo. follow-up
62.245,0,female,0,9,536,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,10163.0,7103.2852,16.0,white,32.0,1,1,0,metastatic,0.899999619,0.8,no dnr,9.0,53.0,15.2988281,60.0,28.0,35.69531,333.3,3.0,0.5,1.69995117,134.0,7.419922,202.0,24.0,2502.0,0.0,SIP>=30
48.71698,0,female,0,8,534,CHF,COPD/CHF/Cirrhosis,5,11.0,under $11k,5478.0,3701.6191,10.0,white,9.0,1,1,0,no,0.949999809,0.95,no dnr,8.0,134.0,16.5976562,113.0,12.0,38.59375,187.5,3.199707,0.19998169,0.89990234,132.0,7.5,209.0,25.0,2100.0,2.0,no(M2 and SIP pres)
81.28998,0,female,0,7,532,COPD,COPD/CHF/Cirrhosis,3,15.0,under $11k,4894.0,3127.5078,4.5,white,34.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,72.0,5.19921875,74.0,16.0,36.59375,230.40625,3.5,0.39996338,0.59997559,143.0,7.389648,100.0,13.0,1800.0,5.0,adl>=4 (>=5 if sur)
70.52698,0,male,0,5,533,ARF/MOSF w/Sepsis,ARF/MOSF,3,5.0,under $11k,5894.0,4113.6797,18.0,white,45.0,1,1,0,yes,0.699999809,0.5,no dnr,5.0,73.0,19.296875,50.0,13.0,38.19531,177.125,3.5,1.01,1.59985352,131.0,7.459961,117.0,28.0,1690.0,0.0,no(M2 and SIP pres)
81.91394,0,male,0,5,531,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,5965.0,4162.9961,12.0,white,20.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,65.0,8.69921875,68.0,10.0,35.59375,240.21875,2.8999023,1.19995117,1.0,141.0,7.489258,153.0,22.0,1725.0,1.0,no(M2 and SIP pres)
62.46997,1,male,0,11,265,Colon Cancer,Cancer,4,14.0,under $11k,8591.0,5707.1836,15.0,white,14.0,1,1,0,metastatic,0.699999809,0.5,no dnr,11.0,65.0,6.29980469,85.0,28.0,36.0,248.0,3.5,1.01,1.09985352,138.0,7.399414,105.0,17.0,2900.0,1.0,no(M2 and SIP pres)
67.47198,0,male,0,4,530,Lung Cancer,Cancer,1,8.0,under $11k,2660.0,1693.166,11.0,white,12.0,1,0,0,metastatic,1.0,0.99,no dnr,4.0,66.0,5.29980469,83.0,16.0,36.19531,333.3,2.199707,0.89990234,0.59997559,137.0,7.419922,109.0,11.0,2502.0,0.494751,no(M2 and SIP pres)
58.448,1,female,1,16,16,Lung Cancer,Cancer,1,12.0,under $11k,13341.0,8917.6797,10.0,white,8.0,1,0,0,metastatic,0.699999809,0.6,dnr after sadm,13.0,71.0,24.296875,119.0,32.0,36.79688,171.40625,2.3999023,6.59960938,1.19995117,136.0,7.349609,313.0,40.0,1805.0,4.0,<2 mo. follow-up
68.76398,1,female,0,6,38,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,3837.0,2528.0312,4.0,white,55.0,1,0,0,no,0.299999952,0.2,dnr before sadm,-1.0,136.0,7.89941406,126.0,36.0,36.19531,233.3125,3.5,0.5,1.29980469,140.0,7.379883,174.0,21.0,1300.0,7.0,<2 mo. follow-up
67.05499,1,male,0,5,100,Lung Cancer,Cancer,2,18.0,$25-$50k,4679.0,2942.6231,9.0,white,23.0,1,0,0,metastatic,0.799999714,0.7,no dnr,5.0,117.0,8.69921875,59.0,16.0,35.0,333.3,3.5996094,0.29998779,0.5,138.0,7.419922,108.0,9.0,2502.0,1.8310547,adl>=4 (>=5 if sur)
71.31598,0,male,0,21,527,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,98932.0,67951.6875,26.0,white,57.0,10,0,0,no,0.599999905,0.6,no dnr,21.0,95.0,9.0,83.0,24.0,35.59375,333.3,2.0,4.59960938,1.29980469,128.0,7.419922,98.0,23.0,2365.0,0.0,no(M2 and SIP pres)
65.336,1,male,1,4,4,MOSF w/Malig,ARF/MOSF,2,10.0,under $11k,61342.0,40270.5625,19.0,white,94.0,25,1,0,yes,0.099999964,0.0,dnr after sadm,2.0,115.0,19.5,68.0,28.0,38.19531,155.0,3.5,1.01,1.69995117,131.0,7.30957,191.0,45.0,1725.0,2.5527344,<2 mo. follow-up
58.77899,1,male,1,4,4,Coma,Coma,0,12.0,under $11k,5555.0,3875.2422,36.0,white,41.0,1,0,0,no,0.0,0.0,dnr after sadm,2.0,88.0,8.8984375,93.0,20.0,36.79688,333.3,4.0996094,0.29998779,0.89990234,137.0,7.419922,164.0,20.0,2150.0,2.2841797,<2 mo. follow-up
80.05499,1,male,0,4,50,CHF,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,2719.0,1778.9102,6.0,white,57.0,1,0,0,yes,0.949999809,0.8,dnr before sadm,0.0,127.0,8.09960938,102.0,38.0,37.79688,138.75,3.0996094,2.39990234,1.69995117,147.0,7.479492,164.0,32.0,3325.0,1.0,<2 mo. follow-up
33.16599,1,male,0,7,35,Lung Cancer,Cancer,1,12.0,$25-$50k,11651.0,7486.0234,7.0,white,15.0,1,0,0,metastatic,1.0,0.5,no dnr,7.0,101.0,6.89941406,112.0,24.0,36.0,280.9375,3.5,10.5,0.69995117,141.0,7.519531,221.0,10.0,1320.0,5.0,<2 mo. follow-up
62.86398,1,female,0,14,258,COPD,COPD/CHF/Cirrhosis,2,14.0,under $11k,18628.0,12560.0,17.0,white,21.0,1,0,0,no,0.699999809,0.5,no dnr,14.0,68.0,8.69921875,120.0,22.0,38.09375,93.875,3.5,0.39996338,4.29980469,134.0,7.15918,115.0,60.0,2250.0,0.0,no(M2 and SIP pres)
68.16199,1,male,0,3,317,CHF,COPD/CHF/Cirrhosis,4,8.0,under $11k,2142.0,1490.7353,22.610928270087555,white,32.0,1,1,0,no,0.599999905,0.6,dnr after sadm,1.0,67.0,11.7988281,74.0,24.0,35.89844,233.3125,5.5,0.69995117,0.89990234,135.0,7.379883,111.0,10.0,2300.0,2.2172852,no(M2 and SIP pres)
64.17798,1,male,0,6,23,CHF,COPD/CHF/Cirrhosis,2,10.0,under $11k,9287.0,6525.3086,19.0,white,14.0,4,0,0,no,0.399999857,0.25,dnr after sadm,2.0,109.0,9.8984375,83.0,38.0,37.89844,212.0,3.5,1.19995117,1.39990234,137.0,7.519531,69.0,19.0,5950.0,1.9035644,<2 mo. follow-up
81.14697,0,male,0,9,522,CHF,COPD/CHF/Cirrhosis,2,8.0,under $11k,7115.0,4636.8008,7.5,white,20.0,1,0,0,no,0.799999714,0.6,no dnr,9.0,78.0,13.5,118.0,28.0,38.69531,128.0,3.7998047,0.39996338,1.09985352,138.0,7.439453,199.0,10.0,1500.0,0.0,no(M2 and SIP pres)
86.60095,1,female,1,9,9,Coma,Coma,1,12.0,under $11k,7479.0,4767.1875,18.0,white,51.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,135.0,18.3984375,110.0,22.0,39.19531,251.40625,3.0996094,0.59997559,0.89990234,123.0,7.509766,126.0,30.0,2015.0,0.0,<2 mo. follow-up
75.19196,1,female,0,25,477,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,92096.0,61565.2812,26.0,white,40.0,16,1,0,no,0.799999714,0.6,no dnr,25.0,108.0,9.79882812,110.0,24.0,38.89844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,850.0,2.8457031,<2 mo. follow-up
75.10699,1,female,0,7,35,COPD,COPD/CHF/Cirrhosis,4,16.0,$25-$50k,78995.0,14452.7344,20.0,white,48.0,6,1,0,no,0.699999809,0.6,dnr after sadm,5.0,71.0,30.0,136.0,24.0,38.89844,103.32812,2.2998047,0.39996338,1.0,148.0,7.399414,172.0,27.0,1300.0,0.0,<2 mo. follow-up
62.44498,1,male,0,3,5,Coma,Coma,1,8.0,under $11k,42538.0,26397.3906,22.610928270087555,white,38.0,21,0,0,no,0.0,0.0,no dnr,3.0,67.0,11.5996094,57.0,56.0,38.39844,167.125,3.0,3.59960938,2.0,132.0,7.30957,184.0,50.0,1760.0,0.0,<2 mo. follow-up
63.90997,1,male,0,9,150,Colon Cancer,Cancer,1,12.0,under $11k,6562.0,4100.4648,18.0,white,19.0,1,0,0,metastatic,0.699999809,0.4,no dnr,9.0,63.0,31.5,122.0,26.0,36.39844,89.32812,3.5,1.01,1.5,130.0,7.339844,151.0,57.0,623.0,5.0,SIP>=30
68.92499,0,male,0,4,512,COPD,COPD/CHF/Cirrhosis,4,11.0,under $11k,2300.0,1623.6016,8.0,white,18.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,72.0,13.2988281,68.0,10.0,36.59375,145.0,3.5,1.01,0.89990234,142.0,7.40918,130.0,30.0,1725.0,1.0,no(M2 and SIP pres)
72.19397,0,female,0,5,513,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,2975.0,1970.3672,5.0,white,24.0,1,0,0,no,0.949999809,0.85,no dnr,5.0,64.0,9.3984375,108.0,10.0,37.79688,187.5,3.5,0.29998779,2.0,141.0,7.389648,94.0,43.0,1100.0,0.0,no(M2 and SIP pres)
59.46899,1,female,0,71,87,ARF/MOSF w/Sepsis,ARF/MOSF,1,11.0,under $11k,189010.0,126933.812,41.0,white,52.0,1,0,0,yes,0.699999809,0.5,no dnr,71.0,109.0,20.8984375,112.0,30.0,36.0,145.4375,2.7998047,1.29980469,1.09985352,127.0,7.439453,243.0,15.0,4985.0,1.0,SIP>=30
65.15497,1,female,0,4,84,Lung Cancer,Cancer,2,8.0,$25-$50k,7074.0,4313.1484,7.0,white,6.0,1,0,0,metastatic,1.0,0.75,dnr after sadm,1.0,69.0,11.0996094,69.0,20.0,35.79688,333.3,3.5996094,1.79980469,0.79992676,132.0,7.419922,153.0,16.0,2502.0,2.4003906,adl>=4 (>=5 if sur)
64.06799,1,female,0,5,166,Lung Cancer,Cancer,1,16.0,$25-$50k,4993.0,3091.2793,11.0,white,23.0,1,0,0,metastatic,0.899999619,0.8,no dnr,5.0,114.0,13.0996094,110.0,14.0,35.79688,153.3125,3.5,1.01,0.59997559,138.0,7.439453,147.0,23.0,1485.0,2.0605469,<2 mo. follow-up
66.05597,1,female,0,16,162,Lung Cancer,Cancer,2,12.0,under $11k,13890.0,8675.6484,8.0,white,18.0,1,0,0,metastatic,0.799999714,0.4,no dnr,16.0,105.0,7.59960938,69.0,22.0,36.09375,333.3,3.5,0.89990234,0.89990234,144.0,7.419922,107.0,9.0,5525.0,3.0,no(M2 and SIP pres)
88.112,1,female,0,13,112,CHF,COPD/CHF/Cirrhosis,4,11.0,under $11k,9488.0,6267.2305,12.5,white,27.0,1,0,0,yes,0.75,0.75,dnr after sadm,1.0,64.0,5.79980469,70.0,20.0,35.59375,333.3,4.2998047,1.59985352,1.39990234,136.0,7.419922,118.0,29.0,1390.0,1.0,adl>=4 (>=5 if sur)
22.459,0,female,0,10,498,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,15931.0,10389.1562,18.0,white,31.0,1,1,0,no,0.5,0.5,no dnr,10.0,121.0,20.1992188,115.0,28.0,38.89844,144.0,1.7998047,1.0,0.59997559,132.0,7.419922,157.0,28.0,2595.0,6.0,no(M2 and SIP pres)
66.25098,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,8.0,under $11k,29086.0,19636.125,24.5,white,54.0,4,0,0,yes,0.299999952,0.2,dnr after sadm,1.0,99.0,8.8984375,71.0,24.0,36.09375,233.3125,3.5,0.29998779,2.79980469,137.0,7.40918,174.0,46.0,1325.0,5.0,<2 mo. follow-up
74.46698,0,male,0,7,493,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,5049.0,3338.9648,6.0,white,18.0,1,0,0,no,0.5,0.4,dnr before sadm,-1.0,51.0,9.0,106.0,40.0,39.09375,92.5,3.0,0.69995117,1.29980469,132.0,7.479492,240.0,25.0,1150.0,0.0,no(M2 and SIP pres)
73.47595,0,male,0,12,491,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,16876.0,11452.4375,33.5,white,49.0,1,0,0,no,0.699999809,0.5,no dnr,12.0,115.0,12.0,76.0,29.0,36.29688,223.3125,3.5,1.01,0.89990234,135.0,7.349609,177.0,17.0,2025.0,0.0,no(M2 and SIP pres)
66.24194,0,female,0,15,491,ARF/MOSF w/Sepsis,ARF/MOSF,4,16.0,$25-$50k,14301.0,9458.6797,11.0,white,28.0,1,0,0,no,0.899999619,0.7,no dnr,15.0,109.0,7.69921875,110.0,20.0,36.19531,333.3,3.0996094,0.29998779,1.09985352,139.0,7.419922,74.0,11.0,3250.0,0.0,no(M2 and SIP pres)
71.49097,0,female,0,17,490,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,11254.0,7470.0898,4.0,white,33.0,1,1,1,yes,0.699999809,0.5,dnr after sadm,1.0,146.0,29.8984375,152.0,44.0,38.79688,250.0,3.0,4.39941406,1.79980469,150.0,7.289062,368.0,56.0,1400.0,0.0,no(M2 and SIP pres)
69.61298,0,female,0,5,489,Cirrhosis,COPD/CHF/Cirrhosis,3,12.0,under $11k,4322.0,2903.8184,9.0,white,35.0,1,0,0,no,0.799999714,0.5,no dnr,5.0,57.0,10.2988281,120.0,32.0,38.59375,250.0,2.2998047,1.0,0.69995117,136.0,7.349609,95.0,10.0,2600.0,0.0,no(M2 and SIP pres)
78.61694,0,male,0,16,489,CHF,COPD/CHF/Cirrhosis,6,8.0,$25-$50k,15164.0,9715.0,12.0,white,45.0,1,1,0,no,0.899999619,0.7,no dnr,16.0,76.0,8.69921875,60.0,22.0,35.5,220.0,3.5,0.69995117,0.89990234,144.0,7.289062,176.0,26.0,950.0,6.0,adl>=4 (>=5 if sur)
76.22498,0,male,0,16,487,ARF/MOSF w/Sepsis,ARF/MOSF,1,13.0,under $11k,37726.0,25119.125,20.333328,white,44.0,9,0,0,no,0.799999714,0.6,dnr before sadm,-8.0,71.0,10.8984375,158.0,32.0,35.79688,244.4375,2.7998047,0.5,2.19970703,141.0,7.40918,144.0,49.0,2550.0,1.0,no(M2 and SIP pres)
66.55396,1,male,0,12,290,Colon Cancer,Cancer,2,8.0,under $11k,8866.0,5766.2461,12.5,white,22.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,2.0,67.0,0.5,102.0,24.0,37.79688,330.0,2.0996094,0.59997559,1.09985352,142.0,7.419922,122.0,18.0,2550.0,2.9042969,adl>=4 (>=5 if sur)
65.56097,0,male,0,11,484,COPD,COPD/CHF/Cirrhosis,3,8.0,$11-$25k,29387.0,19287.9688,22.5,white,39.0,3,1,0,no,0.699999809,0.5,no dnr,11.0,111.0,6.19921875,107.0,24.0,38.79688,333.3,4.5,0.69995117,1.5,136.0,7.419922,110.0,25.0,2150.0,0.0,no(M2 and SIP pres)
83.39496,0,female,0,49,485,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,under $11k,112915.0,75452.5,25.25,white,45.0,10,0,0,no,1.0,0.9,no dnr,49.0,79.0,8.19921875,67.0,24.0,37.89844,316.0,2.8999023,0.19998169,0.69995117,138.0,7.419922,124.0,18.0,1000.0,0.0,adl>=4 (>=5 if sur)
67.35699,0,male,0,6,485,Lung Cancer,Cancer,1,12.0,$25-$50k,5986.0,3713.4238,10.0,white,10.0,1,0,0,metastatic,0.699999809,0.5,no dnr,6.0,51.0,10.0,181.0,24.0,36.19531,356.0,3.5,0.59997559,1.19995117,133.0,7.469727,168.0,27.0,930.0,0.494751,no(M2 and SIP pres)
48.19998,0,male,0,5,482,COPD,COPD/CHF/Cirrhosis,2,12.0,$25-$50k,5518.0,3836.4785,18.0,white,28.0,1,0,0,no,0.75,0.7,dnr after sadm,2.0,63.0,10.0,127.0,8.0,40.89844,155.0,2.5,1.5,3.69970703,144.0,7.469727,108.0,72.0,1510.0,3.5776367,no(M2 and SIP pres)
59.95599,1,male,0,23,132,MOSF w/Malig,ARF/MOSF,2,20.0,under $11k,48649.0,14452.7344,33.666657,white,61.0,10,0,0,yes,0.799999714,0.7,no dnr,23.0,41.0,14.7988281,140.0,20.0,35.19531,88.75,2.3999023,10.2988281,1.09985352,131.0,7.30957,94.0,23.0,350.0,0.0,no(M2 and SIP pres)
81.66699,0,male,0,33,482,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,96173.0,61584.6562,23.5,white,50.0,20,0,0,no,0.599999905,0.5,no dnr,33.0,67.0,20.1992188,74.0,28.0,35.39844,440.0,3.0,6.09960938,4.89941406,135.0,7.449219,154.0,50.0,175.0,0.0,adl>=4 (>=5 if sur)
78.05096,1,female,0,32,65,Coma,Coma,0,16.0,under $11k,36552.0,24587.2344,16.5,white,27.0,2,0,0,no,0.649999619,0.6,dnr before sadm,-1.0,100.0,17.0,70.0,16.0,35.59375,333.3,4.0,0.5,1.0,127.0,7.419922,276.0,21.0,2502.0,0.0,<2 mo. follow-up
72.87299,1,male,0,3,66,Lung Cancer,Cancer,1,8.0,under $11k,4081.0,2483.1133,22.610928270087555,white,12.0,1,0,0,metastatic,0.799999714,0.3,no dnr,3.0,79.0,11.6992188,74.0,16.0,36.29688,333.3,3.5,0.19998169,0.89990234,140.0,7.419922,135.0,23.0,3300.0,0.494751,adl>=4 (>=5 if sur)
76.07697,1,male,0,13,18,Lung Cancer,Cancer,2,12.0,$11-$25k,12127.0,7949.0078,17.0,white,18.0,1,0,0,metastatic,0.699999809,0.5,dnr after sadm,1.0,58.0,10.7988281,69.0,20.0,36.39844,238.09375,3.5,0.39996338,1.5,140.0,7.439453,108.0,32.0,2502.0,0.0,<2 mo. follow-up
70.09198,1,female,0,13,77,ARF/MOSF w/Sepsis,ARF/MOSF,5,9.0,under $11k,14271.0,9694.8438,20.5,white,49.0,1,1,0,no,0.699999809,0.6,dnr before sadm,-1.0,65.0,58.296875,70.0,24.0,36.19531,333.3,3.2998047,2.19970703,2.19970703,128.0,7.419922,103.0,57.0,370.0,3.0,SIP>=30
87.45795,1,male,0,12,187,COPD,COPD/CHF/Cirrhosis,3,5.0,under $11k,7245.0,4796.3047,4.5,white,23.0,1,0,0,yes,0.949999809,0.9,dnr after sadm,1.0,47.0,9.0,150.0,10.0,38.69531,438.0625,3.5,1.01,0.69995117,134.0,7.519531,158.0,19.0,1175.0,0.0,no(M2 and SIP pres)
72.21594,1,female,0,5,144,Colon Cancer,Cancer,1,19.0,under $11k,14195.0,9840.3594,13.0,white,8.0,1,0,0,metastatic,0.699999809,0.5,no dnr,5.0,58.0,5.69921875,123.0,32.0,39.29688,333.3,2.0,16.796875,1.19995117,134.0,7.419922,98.0,3.0,2502.0,1.7155762,adl>=4 (>=5 if sur)
71.69098,0,male,0,16,474,CHF,COPD/CHF/Cirrhosis,3,12.0,under $11k,21106.0,13825.9844,16.666656,white,32.0,1,1,0,no,0.699999809,0.5,no dnr,16.0,101.0,19.6992188,78.0,24.0,37.39844,180.0,2.0996094,0.5,5.0,130.0,7.319336,98.0,61.0,1570.0,0.0,no(M2 and SIP pres)
64.31195,1,female,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,29670.0,19539.4844,34.5,white,33.0,1,0,0,no,0.5,0.5,dnr after sadm,6.0,115.0,7.19921875,130.0,28.0,35.69531,276.0,3.5,1.01,0.79992676,143.0,7.429688,103.0,11.0,2200.0,0.0,<2 mo. follow-up
82.21497,1,male,1,26,26,COPD,COPD/CHF/Cirrhosis,3,12.0,under $11k,54639.0,38227.9688,33.0,white,57.0,1,0,0,no,0.549999714,0.55,dnr after sadm,18.0,73.0,16.1992188,120.0,14.0,38.19531,198.15625,1.3999023,1.79980469,0.89990234,132.0,7.40918,183.0,36.0,1610.0,3.5541992,<2 mo. follow-up
75.60297,0,female,0,16,472,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,17139.0,10977.4531,13.333328,white,18.0,1,0,0,no,0.799999714,0.7,no dnr,16.0,117.0,8.09960938,122.0,36.0,38.59375,338.0625,3.3999023,0.59997559,0.69995117,128.0,7.489258,274.0,17.0,1200.0,2.0,no(M2 and SIP pres)
81.72198,1,male,0,4,437,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,3043.0,2024.9912,16.0,white,19.0,1,0,0,yes,0.989999771,0.9,dnr after sadm,2.0,113.0,8.69921875,98.0,42.0,38.09375,124.0,3.0,0.89990234,0.89990234,141.0,7.459961,286.0,33.0,1910.0,2.8847656,no(M2 and SIP pres)
57.396,1,female,0,19,69,Colon Cancer,Cancer,2,10.0,under $11k,13334.0,8906.5859,6.666664,other,17.0,1,1,0,metastatic,0.599999905,0.2,dnr after sadm,1.0,78.0,18.1992188,140.0,22.0,37.79688,333.3,3.3999023,0.79992676,1.0,128.0,7.419922,133.0,14.0,2900.0,4.0,SIP>=30
60.64099,0,male,0,4,468,COPD,COPD/CHF/Cirrhosis,1,10.0,under $11k,2783.0,1856.5303,6.0,white,16.0,1,0,0,no,0.849999905,0.8,no dnr,4.0,125.0,13.2988281,100.0,24.0,38.79688,333.3,2.0,0.19998169,2.59960938,149.0,7.419922,162.0,54.0,1350.0,0.494751,no(M2 and SIP pres)
73.00195,0,female,0,19,469,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,$11-$25k,24180.0,15589.9375,16.333328,white,36.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,14.0,70.0,8.19921875,172.0,24.0,36.09375,153.03125,2.699707,1.0,1.0,144.0,7.399414,113.0,46.0,4225.0,1.0,adl>=4 (>=5 if sur)
40.19699,0,female,0,29,466,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,63906.0,42971.0625,26.0,white,44.0,5,0,0,no,0.699999809,0.5,no dnr,29.0,119.0,16.5976562,118.0,32.0,36.19531,308.0,3.2998047,0.39996338,0.69995117,138.0,7.459961,310.0,18.0,2025.0,1.8581543,no(M2 and SIP pres)
75.19196,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,31223.0,20360.9844,52.0,white,37.0,1,1,0,no,0.099999964,0.1,dnr after sadm,7.0,57.0,11.1992188,66.0,14.0,38.59375,262.5,2.699707,0.5,0.79992676,139.0,7.459961,84.0,18.0,580.0,2.0,<2 mo. follow-up
42.61499,0,male,0,18,461,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,48707.0,32075.2656,25.666656,white,29.0,1,0,0,no,0.599999905,0.6,no dnr,18.0,117.0,6.59960938,67.0,24.0,36.39844,308.6875,4.0996094,1.0,1.89990234,138.0,7.469727,216.0,31.0,1550.0,0.0,SIP>=30
64.29297,1,female,0,11,84,COPD,COPD/CHF/Cirrhosis,4,12.0,under $11k,16955.0,11483.3438,23.5,white,37.0,1,0,0,yes,0.75,0.75,no dnr,11.0,106.0,6.5,93.0,16.0,36.09375,333.3,4.3994141,0.39996338,1.19995117,139.0,7.419922,108.0,16.0,2475.0,4.5273438,<2 mo. follow-up
63.866,1,male,0,4,21,Lung Cancer,Cancer,2,12.0,$25-$50k,2016.0,1293.1191,5.0,white,21.0,1,1,0,metastatic,0.199999928,0.5,no dnr,4.0,72.0,9.0,106.0,10.0,35.69531,333.3,3.5,1.01,1.39990234,136.0,7.419922,152.0,27.0,2370.0,5.0,<2 mo. follow-up
40.241,1,female,1,6,6,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,59750.0,43047.4375,51.0,white,66.0,29,1,0,no,0.699999809,0.5,dnr after sadm,6.0,84.0,8.3984375,76.0,20.0,36.39844,333.3,3.5,1.01,1.19995117,134.0,7.419922,159.0,20.0,2502.0,2.2714844,<2 mo. follow-up
70.80896,0,male,0,24,460,COPD,COPD/CHF/Cirrhosis,3,21.0,$11-$25k,28045.0,14452.7344,19.666656,white,27.0,1,0,0,no,0.799999714,0.6,no dnr,24.0,120.0,8.19921875,83.0,24.0,35.79688,247.59375,3.5,0.69995117,0.79992676,138.0,7.40918,84.0,13.0,2502.0,0.0,no(M2 and SIP pres)
74.52197,1,female,0,3,309,CHF,COPD/CHF/Cirrhosis,5,8.0,$11-$25k,2172.0,1436.1357,4.0,white,40.0,1,1,0,yes,0.699999809,0.6,no dnr,3.0,67.0,23.3984375,98.0,24.0,35.79688,195.21875,2.699707,0.29998779,0.59997559,131.0,7.419922,141.0,14.0,2502.0,2.8486328,no(M2 and SIP pres)
65.71399,0,male,0,5,454,COPD,COPD/CHF/Cirrhosis,1,11.0,$25-$50k,3842.0,2439.6562,10.0,white,20.0,1,0,0,no,0.799999714,0.8,no dnr,5.0,81.0,13.3984375,73.0,24.0,36.09375,204.0,3.5,1.01,1.19995117,142.0,7.349609,191.0,33.0,3175.0,0.0,no(M2 and SIP pres)
88.46497,0,female,0,8,453,MOSF w/Malig,ARF/MOSF,0,8.0,under $11k,19050.0,12381.9688,10.0,white,21.0,6,0,0,yes,0.699999809,0.5,no dnr,8.0,63.0,7.69921875,64.0,16.0,36.29688,333.3,3.3999023,0.39996338,1.29980469,134.0,7.419922,101.0,24.0,950.0,6.0,no(M2 and SIP pres)
68.41095,1,male,0,22,46,Coma,Coma,1,14.0,$25-$50k,50312.0,33776.4688,17.666656,white,22.0,20,0,0,no,0.5,0.3,dnr after sadm,2.0,63.0,6.09960938,106.0,10.0,39.0,420.0,2.8999023,1.29980469,0.59997559,131.0,7.439453,141.0,12.0,2500.0,0.0,<2 mo. follow-up
75.16998,0,female,0,13,451,COPD,COPD/CHF/Cirrhosis,3,8.0,under $11k,13763.0,9029.9922,15.0,white,57.0,1,0,0,no,0.75,0.75,no dnr,13.0,119.0,13.1992188,104.0,28.0,35.59375,264.0,3.5996094,0.79992676,1.09985352,131.0,7.269531,316.0,21.0,2502.0,0.0,no(M2 and SIP pres)
66.96198,1,female,1,59,59,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,191281.0,14452.7344,42.75,white,65.0,39,0,0,no,0.199999928,0.0,dnr after sadm,29.0,52.0,10.7988281,72.0,34.0,38.59375,153.3125,1.5998535,4.5,1.0,140.0,7.479492,131.0,24.0,4105.0,0.0,<2 mo. follow-up
78.10498,0,male,0,95,447,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,177145.0,120634.875,28.25,white,50.0,13,0,0,no,0.699999809,0.5,no dnr,95.0,72.0,14.1992188,68.0,8.0,37.89844,190.0,4.3994141,0.29998779,1.09985352,137.0,7.389648,181.0,15.0,2915.0,0.0,adl>=4 (>=5 if sur)
74.90198,0,male,0,8,446,COPD,COPD/CHF/Cirrhosis,1,8.0,under $11k,5133.0,3393.2227,7.0,white,21.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,98.0,11.5,69.0,22.0,36.19531,333.3,3.5,1.09985352,1.09985352,139.0,7.419922,116.0,13.0,2502.0,0.0,no(M2 and SIP pres)
67.40295,1,female,0,4,159,COPD,COPD/CHF/Cirrhosis,4,8.0,under $11k,2456.0,1675.9453,2.0,white,15.0,1,0,0,no,0.799999714,0.4,dnr after sadm,3.0,67.0,7.59960938,57.0,20.0,35.69531,333.3,4.6992188,1.39990234,1.79980469,139.0,7.419922,88.0,35.0,2000.0,1.8388672,no(M2 and SIP pres)
71.54297,0,male,0,7,445,CHF,COPD/CHF/Cirrhosis,3,12.0,$11-$25k,5544.0,3609.9824,3.5,white,36.0,1,0,0,no,0.699999809,0.6,no dnr,7.0,76.0,10.0,121.0,24.0,36.19531,540.0,3.5,1.01,1.39990234,133.0,7.509766,110.0,24.0,1250.0,0.0,no(M2 and SIP pres)
48.89798,1,female,1,7,7,Coma,Coma,3,12.0,under $11k,22480.0,16014.5625,10.5,white,49.0,6,0,0,no,0.349999905,0.35,no dnr,7.0,76.0,9.79882812,60.0,14.0,36.39844,333.3,3.5,1.01,4.39941406,132.0,7.419922,143.0,86.0,3550.0,3.0512695,<2 mo. follow-up
58.26099,0,female,0,46,442,Coma,Coma,4,9.0,under $11k,47880.0,30861.125,17.0,white,27.0,1,1,0,yes,0.5,0.4,dnr after sadm,1.0,65.0,8.8984375,63.0,27.0,38.09375,320.0,2.699707,1.5,1.39990234,146.0,7.399414,177.0,30.0,3750.0,0.0,adl>=4 (>=5 if sur)
64.25494,0,male,0,4,442,COPD,COPD/CHF/Cirrhosis,4,9.0,under $11k,2845.0,1856.4043,8.0,white,15.0,1,0,0,yes,0.899999619,0.9,no dnr,4.0,64.0,13.5996094,100.0,28.0,36.19531,105.0,3.0,4.89941406,0.79992676,131.0,7.479492,155.0,19.0,1400.0,2.4755859,<2 mo. follow-up
53.38797,1,male,0,20,184,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,44781.0,81412.1875,24.333328,white,55.0,24,0,0,yes,0.599999905,0.5,no dnr,20.0,108.0,15.0,80.0,10.0,39.5,401.0,4.0996094,0.89990234,1.79980469,140.0,7.479492,161.0,15.0,2250.0,0.0,no(M2 and SIP pres)
54.48898,0,male,0,19,440,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,55248.0,37118.6562,24.666656,white,35.0,7,0,0,no,0.799999714,0.8,no dnr,19.0,108.0,11.0,58.0,10.0,36.29688,156.0,3.7998047,0.79992676,1.19995117,143.0,7.5,182.0,32.0,825.0,0.0,no(M2 and SIP pres)
59.96698,1,male,1,15,15,ARF/MOSF w/Sepsis,ARF/MOSF,5,5.0,$11-$25k,27965.0,20384.6875,34.333313,white,85.0,1,1,0,no,0.25,0.5,no dnr,15.0,107.0,5.89941406,72.0,7.0,36.09375,158.0,3.199707,0.59997559,1.09985352,141.0,7.489258,133.0,33.0,700.0,6.0,<2 mo. follow-up
58.64999,1,male,0,17,394,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,19976.0,13563.8828,17.333328,white,45.0,1,0,0,no,0.5,0.4,no dnr,17.0,117.0,1.0,76.0,20.0,36.59375,333.3,4.1992188,0.89990234,0.89990234,139.0,7.419922,169.0,21.0,2150.0,2.9140625,<2 mo. follow-up
57.50897,0,female,0,5,436,COPD,COPD/CHF/Cirrhosis,2,10.0,under $11k,3509.0,2254.9258,5.0,white,10.0,1,0,0,no,0.899999619,0.8,no dnr,5.0,77.0,19.796875,104.0,20.0,36.09375,333.3,2.7998047,1.09985352,1.19995117,120.0,7.419922,155.0,28.0,2502.0,1.1667481,no(M2 and SIP pres)
41.66998,0,male,0,47,436,COPD,COPD/CHF/Cirrhosis,7,12.0,under $11k,91054.0,14452.7344,31.75,white,97.0,6,1,0,no,0.299999952,0.3,no dnr,47.0,55.0,29.0976562,50.0,14.0,36.69531,163.25,3.7998047,2.39990234,2.89990234,132.0,7.429688,202.0,68.0,2350.0,3.8598633,adl>=4 (>=5 if sur)
75.737,0,female,0,6,436,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,4229.0,2747.5625,8.0,white,23.0,1,0,0,no,0.699999809,0.5,dnr after sadm,1.0,79.0,8.09960938,60.0,20.0,35.69531,333.3,4.5,1.09985352,1.29980469,136.0,7.419922,104.0,28.0,2900.0,2.2514648,no(M2 and SIP pres)
73.98999,0,male,0,6,436,CHF,COPD/CHF/Cirrhosis,4,12.0,$11-$25k,4473.0,2867.5469,9.0,white,24.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,68.0,10.7988281,78.0,28.0,36.0,456.625,3.5,0.59997559,1.19995117,128.0,7.459961,124.0,23.0,1380.0,1.0,no(M2 and SIP pres)
60.68997,0,male,0,9,436,CHF,COPD/CHF/Cirrhosis,3,9.0,$11-$25k,10136.0,6580.168,7.0,white,15.0,1,0,0,yes,0.949999809,0.8,no dnr,9.0,99.0,6.29980469,74.0,20.0,36.09375,309.5,3.5,1.01,1.09985352,143.0,7.449219,154.0,16.0,3750.0,2.6113281,no(M2 and SIP pres)
61.81799,1,female,0,17,77,ARF/MOSF w/Sepsis,ARF/MOSF,2,13.0,$25-$50k,52105.0,74461.5625,39.333313,white,40.0,3,0,0,yes,0.25,0.25,dnr after sadm,1.0,113.0,17.5976562,114.0,28.0,36.09375,260.0,3.199707,0.29998779,0.69995117,136.0,7.399414,210.0,12.0,625.0,1.0,SIP>=30
77.27594,1,male,0,7,109,CHF,COPD/CHF/Cirrhosis,6,10.0,>$50k,5305.0,3511.0664,4.0,white,40.0,1,0,0,yes,0.699999809,0.5,no dnr,7.0,79.0,13.5,68.0,24.0,35.59375,276.1875,3.3999023,0.5,1.69995117,137.0,7.319336,255.0,45.0,1250.0,1.0,no(M2 and SIP pres)
81.36896,1,female,1,27,27,MOSF w/Malig,ARF/MOSF,1,12.0,$11-$25k,49066.0,34163.25,22.25,white,48.0,1,0,0,yes,0.799999714,0.6,dnr after sadm,26.0,105.0,1.69995117,128.0,35.0,38.19531,80.0,3.5,0.5,1.09985352,127.0,7.519531,175.0,22.0,3850.0,1.0,<2 mo. follow-up
68.39398,1,female,0,15,28,Lung Cancer,Cancer,3,12.0,under $11k,15760.0,10211.2812,7.666664,white,20.0,1,0,0,metastatic,0.399999857,0.3,no dnr,15.0,115.0,9.79882812,74.0,20.0,36.09375,333.3,3.7998047,1.79980469,1.29980469,137.0,7.419922,111.0,27.0,1900.0,2.0,<2 mo. follow-up
70.67499,0,female,0,7,430,COPD,COPD/CHF/Cirrhosis,3,14.0,under $11k,6195.0,3941.9727,6.0,white,33.0,1,1,0,no,0.5,0.3,dnr before sadm,-1.0,71.0,13.0996094,54.0,20.0,36.89844,333.3,4.6992188,0.5,1.19995117,134.0,7.419922,194.0,16.0,2875.0,3.1831055,no(M2 and SIP pres)
68.10394,0,female,0,20,430,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$11-$25k,61528.0,41360.8438,21.666656,white,36.0,6,0,0,no,0.5,0.4,no dnr,20.0,87.0,1.79980469,64.0,22.0,36.29688,333.3,4.0,0.79992676,1.09985352,134.0,7.419922,118.0,9.0,3100.0,0.0,<2 mo. follow-up
63.59799,1,female,0,5,7,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,38249.0,23373.0781,23.0,white,50.0,28,0,0,no,0.099999964,0.0,dnr after sadm,1.0,80.0,12.0996094,74.0,22.0,36.39844,333.3,3.5,1.01,0.79992676,135.0,7.419922,205.0,12.0,2225.0,2.0,<2 mo. follow-up
80.12897,1,male,0,10,55,Cirrhosis,COPD/CHF/Cirrhosis,1,8.0,under $11k,6034.0,4013.293,7.0,white,28.0,1,0,0,no,0.5,0.3,dnr after sadm,9.0,63.0,6.5,122.0,40.0,36.0,128.5625,3.5,1.09985352,1.09985352,142.0,7.379883,126.0,45.0,2502.0,5.0,<2 mo. follow-up
72.76898,1,male,1,6,6,Coma,Coma,3,11.0,under $11k,14014.0,9511.0781,35.0,white,66.0,1,0,0,yes,0.699999809,0.5,no dnr,6.0,64.0,1.69995117,69.0,24.0,36.5,366.625,4.1992188,0.89990234,1.19995117,134.0,7.439453,127.0,11.0,1925.0,2.409668,<2 mo. follow-up
58.26099,0,male,0,17,423,ARF/MOSF w/Sepsis,ARF/MOSF,0,13.0,$25-$50k,58584.0,39209.1562,33.333313,white,58.0,4,0,0,no,0.799999714,0.512,no dnr,17.0,69.0,16.796875,117.0,26.0,36.89844,400.0,3.5,1.01,5.09960938,134.0,7.459961,135.0,80.0,220.0,0.0,no(M2 and SIP pres)
76.53894,1,male,0,5,129,Lung Cancer,Cancer,1,8.0,under $11k,4560.0,2875.1504,9.0,white,11.0,1,0,0,metastatic,0.699999809,0.3,no dnr,5.0,44.0,0.29998779,170.0,24.0,38.29688,183.65625,3.0,0.89990234,5.0,137.0,7.369141,237.0,96.0,5.0,1.9309082,no(M2 and SIP pres)
91.30695,0,female,0,3,421,CHF,COPD/CHF/Cirrhosis,6,9.0,under $11k,1573.0,1085.8164,22.610928270087555,white,20.0,1,0,1,yes,0.5,0.3,dnr after sadm,1.0,110.0,10.5996094,62.0,24.0,36.0,283.3125,3.0,0.89990234,0.89990234,138.0,7.449219,110.0,11.0,2600.0,5.4931641,<2 mo. follow-up
46.836,0,male,0,70,423,ARF/MOSF w/Sepsis,ARF/MOSF,0,14.0,under $11k,59768.0,64931.875,20.0,white,13.0,1,0,0,no,0.099999964,0.1,no dnr,70.0,158.0,27.296875,118.0,29.0,36.39844,220.0,3.5,1.01,1.0,142.0,7.589844,171.0,16.0,1800.0,0.0,adl>=4 (>=5 if sur)
77.69995,0,male,0,9,421,ARF/MOSF w/Sepsis,ARF/MOSF,0,16.0,under $11k,9447.0,6500.4805,9.5,white,20.0,1,0,0,no,0.899999619,0.9,no dnr,9.0,77.0,6.19921875,140.0,28.0,35.29688,338.0625,3.8999023,0.5,3.59960938,137.0,7.339844,88.0,49.0,800.0,0.0,no(M2 and SIP pres)
61.09497,1,male,0,13,52,Colon Cancer,Cancer,2,12.0,under $11k,15908.0,10149.2031,18.5,white,13.0,1,0,0,metastatic,0.5,0.25,dnr after sadm,1.0,104.0,9.0,118.0,18.0,36.09375,333.3,3.5,1.01,0.79992676,133.0,7.419922,128.0,18.0,3350.0,0.0,<2 mo. follow-up
30.683,1,male,1,10,10,Coma,Coma,1,12.0,under $11k,20055.0,14092.5156,33.0,other,38.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,101.0,17.3984375,77.0,12.0,36.39844,177.125,3.5,1.01,0.79992676,139.0,7.369141,132.0,15.0,1975.0,3.1933594,<2 mo. follow-up
72.24896,0,male,0,6,420,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,13811.0,10387.7812,29.0,white,28.0,1,0,0,no,0.75,0.75,no dnr,6.0,78.0,7.29980469,59.0,24.0,36.29688,323.75,3.5,0.59997559,2.0,137.0,7.389648,203.0,51.0,2502.0,1.7448731,<2 mo. follow-up
59.59998,0,male,0,23,417,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,35184.0,23657.5312,28.666656,white,48.0,1,0,0,no,0.599999905,0.55,no dnr,23.0,63.0,9.0,112.0,24.0,36.09375,333.3,3.5,1.01,1.29980469,136.0,7.419922,104.0,16.0,2225.0,0.0,adl>=4 (>=5 if sur)
45.35498,0,female,0,44,418,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,83628.0,14452.7344,15.5,white,52.0,2,0,0,yes,0.799999714,0.7,no dnr,44.0,81.0,8.69921875,53.0,24.0,35.09375,333.3,3.2998047,0.5,1.69995117,131.0,7.419922,108.0,33.0,3100.0,0.0,SIP>=30
76.25995,1,female,1,23,23,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,62544.0,44539.9062,41.333313,white,55.0,1,1,0,no,0.489999771,0.49,dnr after sadm,13.0,120.0,17.0,76.0,32.0,36.59375,183.3125,3.5,1.01,2.0,141.0,7.40918,202.0,40.0,1920.0,0.0,<2 mo. follow-up
74.05896,1,female,0,17,79,Lung Cancer,Cancer,1,11.0,$11-$25k,13262.0,8684.1641,12.0,white,14.0,1,0,0,metastatic,0.5,0.2,no dnr,17.0,56.0,17.796875,76.0,10.0,36.0,111.65625,2.199707,0.59997559,1.39990234,151.0,7.429688,76.0,39.0,2625.0,7.0,adl>=4 (>=5 if sur)
56.60498,0,male,0,10,412,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,18098.0,12675.5469,24.5,white,38.0,1,0,0,no,0.899999619,0.9,no dnr,10.0,48.0,12.2988281,137.0,9.0,38.19531,97.76562,3.5,1.01,0.59997559,140.0,7.429688,256.0,10.0,1100.0,1.0,no(M2 and SIP pres)
65.51697,1,female,0,15,80,CHF,COPD/CHF/Cirrhosis,5,10.0,under $11k,16334.0,11352.4531,10.333328,white,29.0,1,1,0,no,0.75,0.6,no dnr,15.0,74.0,12.2988281,134.0,36.0,39.5,234.28125,3.5,1.01,0.69995117,140.0,7.509766,224.0,21.0,2285.0,3.3754883,adl>=4 (>=5 if sur)
69.67297,0,male,0,11,411,CHF,COPD/CHF/Cirrhosis,3,17.0,>$50k,15937.0,10393.5,23.0,white,34.0,1,1,0,no,0.799999714,0.8,dnr after sadm,2.0,66.0,12.5996094,79.0,20.0,36.39844,333.3,3.699707,0.39996338,1.19995117,135.0,7.419922,124.0,21.0,2800.0,2.0,no(M2 and SIP pres)
36.73398,0,male,0,12,409,MOSF w/Malig,ARF/MOSF,2,13.0,$25-$50k,24756.0,16661.5625,25.5,white,48.0,3,0,0,yes,0.399999857,0.3,no dnr,12.0,71.0,9.59960938,60.0,20.0,36.19531,247.59375,3.5,1.01,1.01,140.0,7.399414,135.0,23.0,1650.0,0.0,no(M2 and SIP pres)
65.96594,0,female,0,9,408,COPD,COPD/CHF/Cirrhosis,0,12.0,under $11k,8106.0,5174.0039,7.5,white,24.0,1,0,0,no,0.699999809,0.5,no dnr,9.0,75.0,11.2988281,74.0,20.0,35.5,460.0,3.5,1.01,1.19995117,143.0,7.389648,154.0,21.0,1050.0,2.0,no(M2 and SIP pres)
77.58197,1,female,0,5,6,MOSF w/Malig,ARF/MOSF,1,12.0,under $11k,22607.0,15861.0156,32.0,white,26.0,4,0,0,metastatic,0.699999809,0.5,no dnr,5.0,47.0,23.8984375,102.0,24.0,38.19531,215.6875,2.0996094,2.0,0.79992676,130.0,7.399414,230.0,17.0,1162.0,2.3554688,<2 mo. follow-up
44.44397,1,male,1,8,8,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,$11-$25k,26887.0,18224.4375,34.5,white,40.0,3,0,0,no,0.299999952,0.3,no dnr,8.0,119.0,12.1992188,79.0,16.0,36.29688,333.3,2.8999023,0.5,0.59997559,139.0,7.419922,142.0,12.0,3650.0,0.0,<2 mo. follow-up
65.96594,1,male,0,5,320,Cirrhosis,COPD/CHF/Cirrhosis,2,12.0,under $11k,3082.0,2044.9668,11.0,white,43.0,1,1,0,no,0.799999714,0.4,no dnr,5.0,48.0,5.09960938,79.0,16.0,36.29688,333.3,3.8999023,0.5,1.39990234,136.0,7.419922,205.0,14.0,3750.0,2.0,no(M2 and SIP pres)
36.81,1,female,1,25,25,MOSF w/Malig,ARF/MOSF,1,14.0,under $11k,127198.0,82520.25,36.0,white,78.0,13,0,0,metastatic,0.75,0.7,no dnr,25.0,79.0,8.29882812,104.0,24.0,36.19531,319.0,3.5,0.5,0.69995117,131.0,7.399414,110.0,5.0,4800.0,0.0,<2 mo. follow-up
79.61694,1,male,0,14,35,Lung Cancer,Cancer,1,12.0,under $11k,8930.0,5929.5664,9.333328,white,6.0,1,0,0,metastatic,0.399999857,0.1,no dnr,14.0,64.0,8.0,112.0,24.0,38.69531,314.25,4.2998047,0.59997559,1.19995117,139.0,7.519531,123.0,16.0,1775.0,0.0,<2 mo. follow-up
69.36597,0,male,0,6,405,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,$25-$50k,6555.0,4531.9766,16.0,white,38.0,1,0,0,no,0.949999809,0.9,no dnr,6.0,120.0,10.8984375,110.0,32.0,35.5,163.25,2.5,0.29998779,1.09985352,149.0,7.449219,149.0,30.0,4375.0,0.0,no(M2 and SIP pres)
50.41199,0,male,0,15,403,ARF/MOSF w/Sepsis,ARF/MOSF,0,12.0,under $11k,51775.0,35385.375,29.333328,white,33.0,5,0,0,no,0.899999619,0.9,no dnr,15.0,133.0,24.796875,120.0,10.0,39.0,126.14062,2.7998047,1.39990234,3.19970703,150.0,7.329102,81.0,64.0,840.0,0.0,SIP>=30
75.13995,0,male,0,37,403,ARF/MOSF w/Sepsis,ARF/MOSF,0,8.0,under $11k,59514.0,38261.4688,22.75,white,41.0,2,0,0,no,0.699999809,0.5,no dnr,37.0,81.0,13.3984375,64.0,16.0,36.29688,195.90625,3.5,0.69995117,1.09985352,138.0,6.829102,320.0,20.0,1925.0,2.6010742,<2 mo. follow-up
53.21298,1,male,1,7,7,ARF/MOSF w/Sepsis,ARF/MOSF,2,12.0,under $11k,18549.0,12547.3359,45.0,white,35.0,1,1,0,no,0.25,0.2,dnr after sadm,1.0,59.0,19.1992188,130.0,12.0,36.39844,131.09375,3.0,0.79992676,2.19970703,135.0,7.359375,123.0,60.0,3105.0,0.0,<2 mo. follow-up
77.33295,1,female,0,3,20,Lung Cancer,Cancer,2,12.0,$11-$25k,1212.0,805.0625,3.0,white,14.0,1,0,0,metastatic,0.399999857,0.2,dnr after sadm,1.0,67.0,7.79980469,74.0,28.0,38.39844,154.28125,3.5,0.89990234,1.09985352,143.0,7.419922,165.0,18.0,1025.0,0.0,<2 mo. follow-up
48.405,1,female,1,11,11,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,76273.0,49159.5,45.0,white,91.0,7,0,0,metastatic,0.5,0.48,dnr after sadm,9.0,65.0,10.6992188,74.0,24.0,36.19531,192.0,3.5,1.01,1.0,144.0,7.399414,104.0,22.0,2600.0,0.0,<2 mo. follow-up
49.11697,0,male,0,6,394,COPD,COPD/CHF/Cirrhosis,2,8.0,under $11k,5799.0,3943.543,12.0,white,27.0,1,0,0,no,0.699999809,0.5,no dnr,6.0,109.0,3.5,71.0,24.0,36.19531,336.0,2.3999023,8.19921875,0.89990234,137.0,7.259766,139.0,11.0,2502.0,2.9858398,<2 mo. follow-up
70.36798,0,male,0,4,394,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,4504.0,3093.8516,11.0,white,18.0,1,0,0,no,0.699999809,0.5,no dnr,4.0,67.0,6.89941406,66.0,28.0,36.29688,238.09375,4.5,1.5,2.0,143.0,7.449219,143.0,53.0,1175.0,2.3125,no(M2 and SIP pres)
66.146,1,male,1,12,12,MOSF w/Malig,ARF/MOSF,2,12.0,under $11k,53671.0,37465.8438,33.5,white,50.0,40,0,0,yes,0.699999809,0.5,dnr after sadm,6.0,59.0,8.79882812,128.0,40.0,36.29688,333.3,2.5,1.89990234,1.39990234,134.0,7.419922,108.0,24.0,2700.0,2.3876953,<2 mo. follow-up
63.43298,1,male,0,3,143,Lung Cancer,Cancer,2,10.0,under $11k,1822.0,1216.1992,22.610928270087555,white,9.0,1,0,0,metastatic,0.699999809,0.5,no dnr,3.0,71.0,16.5976562,48.0,16.0,36.19531,333.3,2.5,0.29998779,0.79992676,131.0,7.419922,77.0,15.0,1500.0,2.046875,<2 mo. follow-up
59.53198,1,female,0,13,22,Coma,Coma,0,13.0,>$50k,22471.0,18157.375,26.0,white,14.0,1,0,0,no,0.699999809,0.5,dnr after sadm,7.0,59.0,14.7988281,94.0,10.0,38.09375,282.5,3.5,1.01,1.69995117,133.0,7.5,405.0,31.0,2750.0,0.0,<2 mo. follow-up
62.84998,0,male,0,93,391,ARF/MOSF w/Sepsis,ARF/MOSF,3,12.0,under $11k,188562.0,128103.5,35.75,white,8.0,1,1,0,no,0.699999809,0.5,dnr after sadm,55.0,65.0,19.296875,140.0,22.0,36.59375,195.0,3.5,1.01,2.0,132.0,7.449219,137.0,58.0,2570.0,2.0,adl>=4 (>=5 if sur)
76.72797,1,male,0,4,242,Lung Cancer,Cancer,1,12.0,under $11k,10134.0,6054.043,10.0,white,15.0,1,0,0,metastatic,0.989999771,0.75,no dnr,4.0,91.0,3.29980469,67.0,16.0,36.09375,333.3,3.5996094,0.5,0.89990234,136.0,7.419922,97.0,9.0,1475.0,1.7753906,no(M2 and SIP pres)
53.32498,1,male,0,5,308,Lung Cancer,Cancer,2,12.0,$25-$50k,5467.0,3386.6055,11.0,white,18.0,1,1,0,metastatic,0.599999905,0.3,no dnr,5.0,71.0,8.0,135.0,20.0,36.39844,230.40625,3.5,1.29980469,1.09985352,137.0,7.30957,118.0,19.0,1510.0,1.9765625,no(M2 and SIP pres)
51.47998,0,male,0,40,386,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,33830.0,22221.5781,10.25,white,70.0,1,1,0,no,0.899999619,0.85,no dnr,40.0,60.0,0.19998169,160.0,34.0,38.39844,333.3,2.7998047,0.89990234,1.0,141.0,7.419922,169.0,26.0,2502.0,2.0,<2 mo. follow-up
54.05298,1,male,0,9,272,Lung Cancer,Cancer,1,12.0,$25-$50k,7228.0,4629.1406,9.5,white,18.0,1,0,0,metastatic,0.5,0.2,no dnr,9.0,125.0,12.6992188,78.0,25.0,38.29688,256.0,1.8999023,2.0,1.29980469,144.0,7.479492,121.0,47.0,3100.0,0.0,no(M2 and SIP pres)
75.40594,1,male,1,10,10,Coma,Coma,2,12.0,under $11k,32243.0,21154.6875,39.0,white,50.0,1,1,0,yes,0.099999964,0.02,dnr after sadm,6.0,109.0,15.3984375,110.0,30.0,36.19531,222.5,3.699707,0.79992676,0.89990234,140.0,7.239258,147.0,18.0,1515.0,0.0,<2 mo. follow-up
85.66498,1,female,1,4,4,Coma,Coma,1,8.0,under $11k,3906.0,2507.3887,19.0,white,28.0,1,1,0,no,0.099999964,0.0,dnr after sadm,1.0,102.0,24.296875,70.0,20.0,35.89844,333.3,3.5,1.01,1.19995117,137.0,7.419922,158.0,11.0,2502.0,1.0,<2 mo. follow-up
65.06195,1,female,0,16,376,ARF/MOSF w/Sepsis,ARF/MOSF,3,14.0,under $11k,19709.0,13702.2266,19.333328,white,44.0,1,1,0,no,0.699999809,0.5,no dnr,16.0,109.0,7.39941406,63.0,16.0,35.39844,333.3,2.8999023,1.0,1.29980469,139.0,7.419922,130.0,27.0,2502.0,0.0,no(M2 and SIP pres)
18.41499,0,male,0,9,380,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,>$50k,22047.0,13396.9062,23.0,white,17.0,4,0,0,yes,0.979999542,0.96,no dnr,9.0,65.0,38.3984375,104.0,30.0,36.0,152.5,3.5,1.0,1.29980469,132.0,7.419922,243.0,25.0,1225.0,0.0,<2 mo. follow-up
70.48297,0,male,0,4,364,COPD,COPD/CHF/Cirrhosis,2,12.0,$11-$25k,2787.0,1799.1553,7.0,white,26.0,1,0,0,yes,0.899999619,0.9,no dnr,4.0,93.0,15.5,69.0,32.0,36.0,280.9375,3.5,0.39996338,1.19995117,139.0,7.399414,144.0,32.0,950.0,2.3222656,no(M2 and SIP pres)
75.50696,0,male,0,23,364,COPD,COPD/CHF/Cirrhosis,1,13.0,$11-$25k,45129.0,30240.5156,34.0,white,29.0,1,0,0,no,0.5,0.35,dnr after sadm,16.0,102.0,9.0,71.0,24.0,35.89844,333.3,3.5,1.01,1.01,140.0,7.419922,135.0,23.0,2502.0,0.0,no(M2 and SIP pres)
51.452,1,female,0,3,337,Lung Cancer,Cancer,1,12.0,$11-$25k,8023.0,4859.3516,11.0,white,12.0,1,0,0,metastatic,0.989999771,0.99,no dnr,3.0,118.0,9.59960938,60.0,16.0,36.19531,333.3,3.5996094,0.39996338,2.59960938,135.0,7.419922,154.0,59.0,1450.0,1.9226074,no(M2 and SIP pres)
74.62,0,male,0,9,361,CHF,COPD/CHF/Cirrhosis,5,12.0,under $11k,6963.0,4772.4609,10.0,white,25.0,1,1,0,yes,0.699999809,0.5,no dnr,9.0,66.0,8.3984375,132.0,23.0,38.59375,215.0,2.0996094,1.89990234,0.79992676,143.0,7.399414,280.0,38.0,2650.0,0.0,<2 mo. follow-up
64.51196,0,male,0,14,361,COPD,COPD/CHF/Cirrhosis,2,8.0,$11-$25k,23105.0,16030.1719,18.0,white,60.0,2,0,0,no,0.299999952,0.15,no dnr,14.0,49.0,19.5,116.0,34.0,36.0,208.5625,2.5996094,0.39996338,2.69970703,136.0,7.289062,175.0,50.0,1205.0,0.0,no(M2 and SIP pres)
79.17596,0,male,0,27,359,COPD,COPD/CHF/Cirrhosis,2,4.0,under $11k,20070.0,13088.1406,7.0,white,28.0,1,0,0,no,0.899999619,0.5,dnr after sadm,20.0,80.0,15.7988281,107.0,32.0,35.69531,328.0,3.0,0.29998779,0.69995117,135.0,7.449219,149.0,11.0,1150.0,0.0,no(M2 and SIP pres)
75.948,0,male,0,13,359,ARF/MOSF w/Sepsis,ARF/MOSF,2,8.0,under $11k,25038.0,17292.6562,14.5,white,43.0,4,0,0,no,0.699999809,0.5,no dnr,13.0,71.0,4.59960938,67.0,24.0,36.29688,252.375,3.5,0.39996338,1.29980469,141.0,7.379883,113.0,32.0,2502.0,2.0,no(M2 and SIP pres)
69.64795,1,female,1,14,14,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,$25-$50k,44632.0,29434.5938,29.333328,white,49.0,1,0,0,no,0.699999809,0.85,dnr after sadm,13.0,178.0,8.19921875,76.0,20.0,36.19531,333.3,2.8999023,0.29998779,0.69995117,132.0,7.419922,144.0,8.0,3320.0,3.0,<2 mo. follow-up
18.04199,0,female,0,12,358,MOSF w/Malig,ARF/MOSF,0,12.0,under $11k,32141.0,14452.7344,18.0,white,57.0,4,0,0,yes,0.699999809,0.5,no dnr,12.0,77.0,11.5996094,60.0,24.0,35.69531,240.0,3.5,1.01,0.89990234,140.0,7.419922,159.0,18.0,2502.0,2.1474609,<2 mo. follow-up
80.60199,1,female,0,6,295,CHF,COPD/CHF/Cirrhosis,3,8.0,under $11k,4047.0,2704.1426,12.0,white,33.0,1,1,0,no,0.699999809,0.5,no dnr,6.0,69.0,23.5,104.0,20.0,36.19531,184.0,3.5,0.69995117,0.69995117,132.0,7.489258,170.0,7.0,1175.0,1.8388672,no(M2 and SIP pres)
66.05597,0,male,0,17,356,Coma,Coma,1,12.0,$11-$25k,19160.0,12187.2031,10.333328,white,19.0,1,0,0,yes,0.199999928,0.1,dnr after sadm,1.0,56.0,65.59375,134.0,10.0,38.69531,349.0625,3.5,1.01,0.79992676,142.0,7.449219,127.0,19.0,1570.0,0.0,no(M2 and SIP pres)
64.48499,0,female,0,3,356,Lung Cancer,Cancer,2,11.0,$11-$25k,6830.0,4100.5508,22.610928270087555,white,14.0,1,1,0,metastatic,0.989999771,0.99,no dnr,3.0,64.0,6.19921875,116.0,8.0,39.39844,175.0,3.0,1.01,1.69995117,129.0,7.359375,278.0,59.0,3828.0,1.9428711,no(M2 and SIP pres)
70.42297,1,male,0,15,17,ARF/MOSF w/Sepsis,ARF/MOSF,4,12.0,under $11k,80504.0,56370.8125,40.666657,white,60.0,11,1,0,yes,0.5,0.5,dnr after sadm,13.0,129.0,24.5976562,57.0,10.0,37.5,217.0,3.5,1.01,1.19995117,136.0,7.419922,179.0,22.0,2010.0,2.7148438,<2 mo. follow-up
68.61597,0,female,0,4,353,COPD,COPD/CHF/Cirrhosis,2,12.0,under $11k,2758.0,1847.376,3.0,white,19.0,1,0,0,yes,0.699999809,0.5,dnr after sadm,1.0,71.0,12.5996094,110.0,10.0,36.19531,135.0,4.0996094,0.59997559,0.79992676,128.0,7.489258,142.0,17.0,950.0,0.494751,no(M2 and SIP pres)
66.073,0,male,0,23,350,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,under $11k,52870.0,34329.3125,20.333328,white,22.0,13,0,0,no,0.799999714,0.512,no dnr,23.0,109.0,7.39941406,104.0,22.0,35.69531,280.0,3.699707,0.39996338,1.09985352,131.0,7.459961,188.0,21.0,2502.0,0.0,<2 mo. follow-up
55.15399,0,female,0,29,347,Coma,Coma,1,11.0,under $11k,35377.0,23558.5,18.0,white,31.0,1,0,0,no,0.5,0.5,no dnr,29.0,43.0,9.0,0.0,8.0,38.59375,218.5,3.5,1.01,5.89941406,135.0,7.289062,190.0,49.0,0.0,0.0,<2 mo. follow-up
70.38196,0,male,0,8,346,ARF/MOSF w/Sepsis,ARF/MOSF,1,12.0,under $11k,46564.0,31409.0156,23.0,white,39.0,18,0,0,no,0.899999619,0.8,no dnr,8.0,111.0,8.3984375,83.0,24.0,36.69531,180.0,3.5,0.39996338,2.69970703,139.0,7.379883,189.0,60.0,3900.0,2.5253906,<2 mo. follow-up
47.01999,1,male,1,7,7,MOSF w/Malig,ARF/MOSF,1,13.0,under $11k,58439.0,14452.7344,35.5,white,51.0,22,0,0,yes,0.089999974,0.09,dnr after sadm,5.0,99.0,7.59960938,110.0,24.0,36.39844,428.5625,1.1999512,0.39996338,3.5,135.0,7.469727,246.0,55.0,2502.0,0.0,<2 mo. follow-up
81.53894,1,female,0,12,198,ARF/MOSF w/Sepsis,ARF/MOSF,1,8.0,$11-$25k,15604.0,10605.7578,13.5,white,7.0,1,1,0,no,0.699999809,0.5,no dnr,12.0,75.0,8.59960938,69.0,24.0,36.19531,230.40625,4.5,0.59997559,1.19995117,137.0,7.289062,187.0,15.0,2502.0,0.494751,no(M2 and SIP pres)
